FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Eisenbarth, E
   Meyle, J
   Nachtigall, W
   Breme, J
AF Eisenbarth, E
   Meyle, J
   Nachtigall, W
   Breme, J
TI Influence of the surface structure of titanium materials on the adhesion
   of fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; surface microstructures; titanium
ID CELL BEHAVIOR; TOPOGRAPHICAL CONTROL; GROOVED SUBSTRATA; CONTACT
   GUIDANCE; FOCAL ADHESIONS; INVITRO; PROTEIN
AB Of utmost importance for the successful use of an implant is a good adhesion of the surrounding tissue to the biomaterial, in addition to the surface composition of the implant, the surface topography also influences the properties of the adherent cells. The aim of this investigation was thus to study the influence of the surface structure of the substrate on the formation of focal contacts and on the orientation of cultivated gingival fibroblasts by means of fluorescence microscopy. A further goal was to determine the effect of the material composition on the cell shape, on the assumption that in each case a lengthening of the cells can be expected to provide a more favourable adhesion behaviour than a spherical cell shape. In order to describe the shape of the cell, a shape factor was defined which was calculated from the area cove red by the cells and from their circumference. To determine the influence of the surface structure, substrate platelets of cp-titanium, TiAl6V4 and TiTa30 were ground. Onto these specimens hu man gingival fibroblasts of the 5th to 7th passages were cultivated. After a culture time of two days the cells were fixed and stained. The number of orientated cells was determined as a function of the surface roughness of the substrate. The number of orientated cells was shown to increase - independent of the material - with increasing roughness of the ground substrate. On a polished surface the number of orientated cells was 11% (average peak-to-valley height 0.04 mu m); at a peak-to-valley height of 1.36 mu m the number of orientated cells increased to 72%. It could be observed that the orientated cells had a higher density of focal contacts where they were in contact with the edges of the grinding grooves. In order to determine the effect of the surface composition, gingival fibroblasts were cultured for 14 d on polished substrate specimens of cp-titanium, TiAl6V4 and TiTa30 and examined for differences in shape. The cells grown on cp-titanium and on TiTa30 had shape factors of 1.76 and 1.58 respectively, whereas those grown on TiAl6V4 had a shape factor of 0.93. The unfavourable spherical shape of the fibroblasts (resulting in a poor adhesion) grown on TiAl6V4 after a culture period of 14 d may be the result of a locally increased vanadium concentration in the substrate, with an accompanying increase in the release of toxic vanadium ions. (C) 1996 Elsevier Science Limited
C1 UNIV SAARLAND,LEHRSTUHL MET WERKSTOFFE,D-66041 SAARBRUCKEN,GERMANY.
   ZENTRUM ZAHN MUND & KIEFERHEILKUNDE,D-35392 GIESSEN,GERMANY.
   UNIV SAARLAND,FACHBEREICH ZOOL,D-66041 SAARBRUCKEN,GERMANY.
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X
   BREME J, 1989, VERBUNDWERKSTOFFE ST, P123
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CASTRO R, 1966, REV MET, V12, P1025
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Duerig T.W., 1980, P 4 INT C TI AIME, P1299
   DUNN GA, 1978, EXP CELL RES, V111, P475, DOI 10.1016/0014-4827(78)90196-9
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   JANSEN JA, 1990, J MATER SCI-MATER M, V1, P192, DOI 10.1007/BF00701076
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   NUCKOLLS GH, 1992, J CELL SCI, V102, P753
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059
   VANRECUM AF, 1990, CLIN IMPLANT MAT, P297
NR 23
TC 133
Z9 141
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1996
VL 17
IS 14
BP 1399
EP 1403
DI 10.1016/0142-9612(96)87281-4
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UW737
UT WOS:A1996UW73700007
PM 8830966
DA 2018-10-19
ER

PT J
AU Mutter, D
   Aprahamian, M
   Damge, C
   Sonzini, P
   Marescaux, J
AF Mutter, D
   Aprahamian, M
   Damge, C
   Sonzini, P
   Marescaux, J
TI Biomaterial supports for colonic wall defect healing - An experimental
   study in the rat
SO BIOMATERIALS
LA English
DT Article
DE collagen; artificial matrix; colon; surgery
ID COLLAGEN; BIOSYNTHESIS; TISSUE
AB New artificial biomaterials were tested for support of gastro-intestinal tract wound healing in the rat. Double layered collagenic matrices were prepared with purified collagens extracted from human placental tissues. Two types of patches were tested, the first constituted from a collagen type I+III layer covered by collagen IV in a liquid phase (patch I+III/IV) and the second from a collagen IV layer covered by liquid collagen IV (patch IV/IV). The matrices were applied with fibrin sealant to the edges of a 1 cm diameter colonic wall defect in the rat. Healing evolution was determined by macroscopic, microscopic and immunostaining studies. The reconstitution of the three colonic wall layers was achieved within 45 days without retraction or inflammatory reaction, while the biomaterial was resorbed. Human collagen I and III antibodies failed to stain extracellular matrix. This failure may be a consequence of outdated antibodies or more likely epitope alteration during extraction and preparation of the collagens. A human collagen type IV antibody staining of the scar zone showed the basement membranes of newly developed vessels within 10 days, and newly formed colonic mucosa within 20 days. The collagen reconstituted matrix was able to assist healing of normal digestive tract defects as shown by the labelling of the new synthesized extracellular matrix by collagen type IV antibody. These findings support the use of collagen biomaterial in gastro-intestinal anastomosis. This new surgical approach allowing healing of colonic wall defects could reduce occurrence of anastomotic leakage in human. (C) 1996 Elsevier Science Limited
C1 HOP CIVIL,CHIRURG CLIN A,F-67091 STRASBOURG,FRANCE.
RP Mutter, D (reprint author), HOP CIVIL,IRCAD,F-67091 STRASBOURG,FRANCE.
CR APRAHAMIAN M, 1992, BIOMATERIALS, V13, P697, DOI 10.1016/0142-9612(92)90130-G
   BELL E, 1983, J INVEST DERMATOL, V81, P25
   CRONIN K, 1968, SURG GYNECOL OBSTET, V128, P747
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DUPONT D, 1989, CORNEA, V8, P251
   GOTTRUP F, 1981, AM J SURG, V141, P222, DOI 10.1016/0002-9610(81)90162-8
   GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8
   LEVEBVRE F, 1989, J BIOMED MATER RES, V107, P450
   MARESCAUX JF, 1991, BRIT J SURG, V78, P440, DOI 10.1002/bjs.1800780417
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P77, DOI 10.1056/NEJM197907123010204
   SHOSHAN S, 1974, ISRAEL J MED SCI, V10, P537
   TARDY M, 1836, Patent No. 931546
   TARDY M, 1986, Patent No. 86401794
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
   VANDERHAM AC, 1993, J SURG RES, V55, P256, DOI 10.1006/jsre.1993.1137
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
NR 16
TC 8
Z9 8
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1996
VL 17
IS 14
BP 1411
EP 1415
DI 10.1016/0142-9612(96)87283-8
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UW737
UT WOS:A1996UW73700009
PM 8830968
DA 2018-10-19
ER

PT J
AU Lemons, JE
AF Lemons, JE
TI Ceramics: Past, present, and future
SO BONE
LA English
DT Article; Proceedings Paper
CT Portland Bone Symposium
CY AUG 02-05, 1995
CL PORTLAND, OR
DE biomaterials; biocompatibility; bioceramics; composites; surgical
   implants; synthetics
ID TRICALCIUM PHOSPHATE; HYDROXYLAPATITE
AB The selection and application of synthetic materials for surgical implants has been directly dependent upon the biocompatibility profiles of specific prosthetic devices. The early rationale for ceramic biomaterials was based upon the chemical and biochemical inertness (minimal bioreactivity) of elemental compounds constituted into structural forms (materials). Subsequently, mildly reactive (bioactive), and partially and fully degradable ceramics were identified for clinical uses.
   Structural forms have included bulk solids or particulates with and without porosities for tissue ingrowth, and more recently, coatings onto other types of biomaterial substrates. The physical shapes selected were application dependent, with advantages and disadvantages determined by: (1) the basic material and design properties of the device construct; and (2) the patient-based functional considerations. Most of the ceramics (bioceramics) selected in the 1960s and 1970s have continued over the long-term, and the science and technology for thick and thin coatings have evolved significantly over the past decade.
   Applications of ceramic biomaterials range from bulk (100%) ceramic structures as joint and bone replacements to fully or partially biodegradable substrates for the controlled delivery of pharmaceutical drugs, growth factors, and morphogenetically inductive substances. Because of the relatively unique properties of bioceramics, expanded uses as structural composites with other biomaterials and macromolecular biologically-derived substances are anticipated in the future.
RP Lemons, JE (reprint author), UNIV ALABAMA,509 MED EDUC BLDG,1813 6TH AVE S,BIRMINGHAM,AL 35294, USA.
CR Bajpai P.K., 1980, US. Patent, Patent No. 4218255
   BOBYN JD, 1982, CLIN ORTHOP RELAT R, V166, P301
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DENISSEN H, 1985, HYDROXYAPATITE IMPLA
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, V5, P1
   DRISKELL TD, 1973, J DENT RES, V52, P123
   Driskell TD, 1972, BIOCERAMICS ENG MED, P345
   DUSCHERYNE P, 1988, BIOCERAMICS MAT CHAR
   ESCALAS F, 1976, J BIOMED MATER RES, V10, P43
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, V225, P147
   GRAVES GA, 1971, J BIOMED MATER RES S, V2, P91
   GRISS P, 1971, J BIOMED MATER RES, V5, P39
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HIRSCHHORN J S, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P49
   HOLLINGER JO, 1989, J BIOMED MATER RES, V23, P17, DOI 10.1002/jbm.820230103
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   HOROWITZ F, 1994, ASTM STP, V1196
   HULBERT SF, 1973, J BIOMED MATER RES S, V4, P1
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JARCHO M, 1977, J BIOENG, V1, P79
   Kawahara H, 1979, J Oral Implantol, V8, P411
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOENEMAN J, 1990, J APPL BIOMATER, V1, P79, DOI 10.1002/jab.770010110
   Lemons J. E., 1983, BIOMATERIALS RECONST, P662
   LEMONS JE, 1978, DAMD1775C5044 US ARM, P1
   LEMONS JE, 1974, J DENT RES, V55
   LEMONS JE, 1988, CLIN ORTHOPAEDICS, V235, P220
   LUDWIGSON DC, 1964, J MET, V16, P1
   LYNG S, 1973, ACTA ORTHOP SCAND, V44, P694, DOI 10.3109/17453677308989109
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   NTESGER DS, 1985, MED DEVICE DIAGN IND, V117, P55
   OONISHI H, 1989, BIOCERAMICS
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P401, DOI 10.1002/jbm.820060507
   RATNER BD, IN PRESS BIOMATERIAL
   SMITH L, 1963, ARCH SURG-CHICAGO, V87, P653
   VINCENZINI P, 1983, CERAMICS SURG
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WHEELER KR, 1973, BIOMAT MED EV ARTIF, V1, P337
   WILLIAMS DF, 1991, CONCISE ENCY MED DEN
   WILLIAMS DF, 1973, IMPLANTS SURG
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1
   Yamamuro T., 1990, HDB BIOACTIVE CERAMI
   1995, T ORTHOPAEDIC RES SO, V20, P1
   1995, SOC BIOMAWTERIALS, V18, P1
NR 48
TC 32
Z9 32
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 8756-3282
J9 BONE
JI Bone
PD JUL
PY 1996
VL 19
IS 1
SU S
BP S121
EP S128
DI 10.1016/S8756-3282(96)00128-7
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA UW664
UT WOS:A1996UW66400010
PM 8831003
DA 2018-10-19
ER

PT J
AU Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
AF Mitura, E
   Niedzielska, A
   Niedzielski, P
   Klimek, L
   Rylski, A
   Mitura, S
   Moll, J
   Pietrzykowski, W
TI The properties of carbon layers deposited onto titanium substrates
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th European Conference on Diamond, Diamond-like and Related Materials
   (Diamond Films 95)
CY SEP 10-15, 1995
CL BARCELONA, SPAIN
DE amorphous carbon; adhesion; biomaterial; biomedical applications;
   interface
ID RF DENSE-PLASMA; COATINGS; FILMS
AB Thin, hard, amorphous carbon layers, deposited using a dense r.f. methane plasma onto titanium substrate, were investigated. This includes an examination of the interface between the carbon layer and the substrate and the optimization of the process and its application.
   The substrates coated with carbon layers were analysed by Auger electron spectroscopy (AES) and scanning electron microscopy (SEM). Results of AES studies show that the surface layer, several thousand angstroms thick, consists of carbon. The carbon film passes smoothly into a thick layer (about 1 mu m) consisting of titanium carbide. The composition varies across the transitional layer between carbon and carbide regions. This coating structure ensures a high mechanical strength and very good adhesion to Ti substrates. These coatings also protect metal implants against corrosion, and protect man from a serious illness, metallosis.
   Preliminary,investigations in vivo and in vitro confirm the biocompatibility of the C/TiC/Ti system and its biointegration. In addition, investigations of the mechanical, anticorrosive and structural properties of the coatings, deposited using a dense methane plasma excited in an r.f. electric field, show that this can be a very good material to apply in cardiovascular surgery.
   The r.f. decomposition of methane seems to be a very convenient method for the production of superhard carbon coatings on Ti substrates for medical applications.
C1 TECH UNIV LODZ,INST MAT SCI & ENGN,PL-90924 LODZ,POLAND.
   MED ACAD LODZ,PAEDIAT CARDIAC SURG DEPT,PL-93338 LODZ,POLAND.
RP Mitura, E (reprint author), TECH UNIV LODZ,FAC PROC & ENVIRONM ENGN,WOLCZANSKA 175,PL-90924 LODZ,POLAND.
RI Mitura, Stanislaw/L-6013-2014; Klimek, Leszek/K-5958-2015
OI Mitura, Stanislaw/0000-0001-9280-3748; Klimek,
   Leszek/0000-0003-3617-8225; Niedzielski, Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   CHUAN CC, 1974, CHARACTERIZATION SOL, P534
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   GRIL A, 1994, DIAM RELAT MATER, V2, P597
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 1995, ADV SCI TECHNOLOGY, V6, P273
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   WEI R, 1994, DIAM RELAT MATER, V2, P898
NR 12
TC 19
Z9 20
U1 1
U2 14
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD JUL
PY 1996
VL 5
IS 9
BP 998
EP 1001
DI 10.1016/0925-9635(95)00469-6
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA VA325
UT WOS:A1996VA32500022
DA 2018-10-19
ER

PT J
AU Escudero, ML
   Lopez, MF
   Ruiz, J
   GarciaAlonso, MC
   Canahua, H
AF Escudero, ML
   Lopez, MF
   Ruiz, J
   GarciaAlonso, MC
   Canahua, H
TI Comparative study of the corrosion behavior of MA-956 and conventional
   metallic biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
AB In this work the corrosion behavior of a new biomaterial, the MA-956 superalloy, immersed in Hank's solution is evaluated. A comparison with conventional metallic alloys used as articular implants is established. To determine the corrosion behavior we employed electrochemical methods: evaluation of corrosion potential E(corr), electrochemical impedance spectroscopy (EIS), and anodic polarization curves. The corrosion resistance of the MA-956 superalloy preoxidized at 1100 degrees C during 100 h is at least two orders of magnitude higher than for the other alloys. This satisfactory behavior is stationary with time. Also the probability of the appearance of the pitting corrosion process is very low. When cracking is generated in the alpha-alumina layer the repassivation process is assured because of the high Cr content in the superalloy. This study is the first step in proposing this new alloy as a biomaterial. The low toxicity of these metallic alloys in the physiological environment suggests that in vivo their biocompatibility could be satisfactory. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV NACL JORGE BASADRE GROHMANN,TACNA,PERU.
RP Escudero, ML (reprint author), CSIC,CTR NACL INVEST MET,AVDA GREGORIO AMO 8,E-28040 MADRID,SPAIN.
RI Lopez, Maria/C-4571-2011; Escudero, Maria Lorenza/L-7113-2014;
   Garcia-Alonso, Maria Cristina/K-3779-2014
OI Lopez, Maria/0000-0001-7894-566X; Escudero, Maria
   Lorenza/0000-0002-2181-448X; Garcia-Alonso, Maria
   Cristina/0000-0003-0275-4626
CR ALVAREZ MG, 1984, CORROS SCI, V24, P27, DOI 10.1016/0010-938X(84)90133-1
   CHAO J, IN PRESS EFFECTS ALU
   ESCUDERO ML, 1988, WERKST KORROS, V39, P364
   ESCUDERO ML, 1995, BIOMATERIALS, V16, P735, DOI 10.1016/0142-9612(95)99703-O
   ESCUDERO ML, 1994, BIOMATERIALS, V15, P1175, DOI 10.1016/0142-9612(94)90239-9
   FRAKER AC, 1977, J MET, P22
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P491, DOI 10.1007/BF00058989
   GESSINGER GH, 1984, POWDER METALLURGY SU, P214
   GROSS KA, 1994, J MATER SCI-MATER M, V5, P219, DOI 10.1007/BF00121092
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   KOHN DH, 1992, MAT SCI TECHNOLOGY, P38
   LOPEZ V, 1993, MAT SCI ENG A-STRUCT, V172, P189, DOI 10.1016/0921-5093(93)90440-P
   LYTH C, 1970, AUSTRALASIAN CORROSI, P25
   MORONI A, 1994, J MATER SCI-MATER M, V5, P411, DOI 10.1007/BF00058975
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
NR 16
TC 28
Z9 28
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1996
VL 31
IS 3
BP 313
EP 317
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UU786
UT WOS:A1996UU78600004
PM 8806056
DA 2018-10-19
ER

PT J
AU Gong, J
   Larsson, R
   Ekdahl, KN
   Mollnes, TE
   Nilsson, U
   Nilsson, B
AF Gong, J
   Larsson, R
   Ekdahl, KN
   Mollnes, TE
   Nilsson, U
   Nilsson, B
TI Tubing loops as a model for cardiopulmonary bypass circuits: Both the
   biomaterial and the blood-gas phase interfaces induce complement
   activation in an in vitro model
SO JOURNAL OF CLINICAL IMMUNOLOGY
LA English
DT Article
DE complement activation; C3a; terminal sC5b-9; cardiopulmonary bypass;
   heparin
ID ALTERNATIVE PATHWAY; PUTATIVE THIOESTER; BINDING-SITE; HEPARIN; C-3;
   C3B; INHIBITION; GENERATION; CONVERTASE; SURFACE
AB We describe here a model for the study of blood/surface and blood/air interaction as encountered in cardiopulmonary bypass (CPB) circuits. Polyethylene tubing was filled with serum or blood and closed end to end into loops whereby the volume of the remaining air bubble was inversely varied with respect to that of the fluid. The loops were rotated vertically in a water bath at 37 degrees C. The profiles of C3a, iC3, and TCC generation were similar to those observed at surgery, involving CPB. Soluble heparin and heparan sulfate inhibited both C3a and TCC formation, but surface-conjugated heparin had only a minor effect. Binding of C3 and/or C3 fragments to the heparin surface was much reduced compared to the amine matrix to which heparin was linked, but compared with the polyethylene surface the effect was less pronounced. These data suggest that, in addition to the biomaterial surface, the blood-gas interface seems to play an important role in the activation of complement and that this activation is inhibitable by high concentrations of soluble glucose aminoglycans.
C1 UNIV UPPSALA HOSP, DEPT CLIN IMMUNOL & TRANSFUS MED, S-75185 UPPSALA, SWEDEN.
   UNIV TROMSO, TROMSO, NORWAY.
   NORDLAND CENT HOSP, DEPT IMMUNOL & TRANSFUS MED, BODO, NORWAY.
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR ANDERSSON LO, 1976, THROMB RES, V9, P575, DOI 10.1016/0049-3848(76)90105-5
   BHAKDI S, 1988, J IMMUNOL, V141, P3117
   CHEUNG AK, 1992, J AM SOC NEPHROL, V2, P1328
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   EKRE HPT, 1986, INT J IMMUNOPHARMACO, V8, P277, DOI 10.1016/0192-0561(86)90109-8
   GADD KJ, 1981, BIOCHEM J, V195, P471, DOI 10.1042/bj1950471
   GILLINOV AM, 1993, ANN THORAC SURG, V55, P619, DOI 10.1016/0003-4975(93)90264-I
   GREELEY WJ, 1991, ANN THORAC SURG, V52, P417, DOI 10.1016/0003-4975(91)90900-B
   HIRSH J, 1992, ADV EXP MED BIOL, V313, P283
   Johnson R J, 1990, Prog Clin Biol Res, V337, P507
   KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202
   KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017
   KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A
   Kirklin JK, 1989, CARDIOPULMONARY BYPA, P131
   LAW SK, 1979, J IMMUNOL, V123, P1388
   MAILLET F, 1983, MOL IMMUNOL, V20, P1401, DOI 10.1016/0161-5890(83)90172-4
   MELLBYE OJ, 1988, EUR SURG RES, V20, P101, DOI 10.1159/000128748
   MOLLNES T, 1985, SCAND J IMMUNOL, V22, P703
   MOLLNES TE, 1991, ANN THORAC SURG, V52, P92, DOI 10.1016/0003-4975(91)91426-V
   NILSSON B, 1988, J IMMUNOL METHODS, V107, P281, DOI 10.1016/0022-1759(88)90229-3
   NILSSON L, 1990, ARTIF ORGANS, V14, P46
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   OEVEREN W, 1985, J THORAC CARDIOVASC, V89, P888
   PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102
   PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   PEKNA M, 1994, ANN THORAC SURG, V58, P421, DOI 10.1016/0003-4975(94)92219-5
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   VIDEM V, 1989, J THORAC CARDIOV SUR, V97, P764
   VIDEM V, 1992, J THORAC CARDIOV SUR, V103, P806
   WESTABY S, 1987, INTENS CARE MED, V13, P89
NR 32
TC 54
Z9 54
U1 0
U2 4
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0271-9142
J9 J CLIN IMMUNOL
JI J. Clin. Immunol.
PD JUL
PY 1996
VL 16
IS 4
BP 222
EP 229
DI 10.1007/BF01541228
PG 8
WC Immunology
SC Immunology
GA VA015
UT WOS:A1996VA01500006
PM 8840224
DA 2018-10-19
ER

PT J
AU Piattelli, A
   Scarano, A
   Piattelli, M
   Matarasso, S
AF Piattelli, A
   Scarano, A
   Piattelli, M
   Matarasso, S
TI Cellular colonization and bone formation into expanded
   polytetrafluoroethylene membranes: A light microscopical and
   histochemical time course study in the rabbit
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone regeneration; guided tissue regeneration; membranes, artificial;
   membranes, barrier; polytetrafluoroethylene; cellular colonization;
   osteoblasts
ID REGENERATION
AB WE REPORT ON A TIME COURSE STUDY of cellular colonization of expanded polytetrafluoroethylene (ePTFE) membranes in rabbits. Bone defects (8 mm) were prepared with low speed burs in rabbit tibial metaphyses and covered with ePTFE membranes. The membranes were retrieved after 3, 6, 9, and 12 weeks. At 3 weeks, all membranes were filled by cells and osteoid tissue: no mineralized tissue was found. Osteoblasts positive for alkaline phosphatase (ALP) were observed on the outer surface and inside the material interstices of the membrane. At 6 weeks, it was possible to observe an increase of the quantity of the osteoid material inside the membranes. At 9 weeks, bone tissue was present and it usually originated from the most external part of the membrane, and spread to the central part of the membrane. Only the central portion of this bone appeared to be completely mineralized. A sharp decrease in the number of ALP-positive osteoblasts was observed. At 12 weeks, the quantity of bone present appeared to be substantially increased. Only a small percentage of the bone inside the membrane appeared to be completely mineralized. No cells positive to acid phosphatase were observed. These histological results confirm the high biocompatibility of ePTFE membranes and the bone formation inside the ePTFE interconnected nodes could, probably, help in achieving a good biomaterial-tissue integration with predictable results in bone regeneration.
C1 UNIV CHIETI,SCH DENT,CHIETI,ITALY.
   SCH DENT,NAPLES,ITALY.
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
CR ABOE M, 1993, CLIN ORAL IMPLANT RE, V4, P172
   BUSER D, 1994, GUIDED BONE REGENERA, P189
   Dahlin C, 1994, GUIDED BONE REGENERA, P31
   HAMMERLE CHF, 1995, J ORAL MAXIL SURG, V53, P167, DOI 10.1016/0278-2391(95)90396-8
   Hardwick R, 1994, GUIDED BONE REGENERA, P101
   PIATTELLI A, 1995, BIOMATERIALS, V16, P1333, DOI 10.1016/0142-9612(95)91049-5
   SANDBERG E, 1993, J ORAL MAXIL SURG, V51, P1106, DOI 10.1016/S0278-2391(10)80450-1
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   SCHENK RK, 1994, GUIDED BONE REGENERA, P49
   SIMION M, 1994, INT J PERIODONT REST, V14, P199
NR 10
TC 2
Z9 2
U1 0
U2 1
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 1996
VL 67
IS 7
BP 720
EP 725
DI 10.1902/jop.1996.67.7.720
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA UZ358
UT WOS:A1996UZ35800011
PM 8832484
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Bujan, J
   Contreras, LA
   CarreraSanMartin, A
   Jurado, F
AF Bellon, JM
   Bujan, J
   Contreras, LA
   CarreraSanMartin, A
   Jurado, F
TI Comparison of a new type of polytetrafluoroethylene patch (Mycro Mesh)
   and polypropylene prosthesis (Marlex) for repair of abdominal wall
   defects
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article
ID EXPANDED POLYTETRAFLUOROETHYLENE; GROWTH-FACTOR; MACROPHAGE; RAT
AB BACKGROUND: Two types of prosthetic material used for repairing hernial defects of the abdominal wall were compared: Mycro Mesh and Marlex. Mycro Mesh (MM) is a new polytetrafluoroethylene product of layered, microporous structure. Macroscopically, it presents regularly distributed, 2-mm orifices that perforate the biomaterial. Marlex (PL) is a well-known polypropylene mesh product with a macroporous structure.
   STUDY DESIGN: In 24 white New Zealand rabbits, a full-thickness (except skin) 5x7-cm defect was created in the anterior wall of the abdomen. Defects were repaired with either MM (n=12) or PL (n=12) implants and studied at 14, 30, 60, and 90 days after implantation. Samples of the interfaces between prosthesis and subcutaneous tissue, visceral peritoneum, and receptor tissue, respectively, were studied. Samples were processed for optical microscopy and scanning electron microscopy (SEM). An immunohistochemical study was made using RAM-11, a monoclonal antibody specific for rabbit macrophages. The tensile strength of the repairs was made using an Instron tensiometer on 2-cm wide transversal strips that included the prosthesis and its anchor zones to the receptor tissue.
   RESULTS: The formation of adhesions between the prosthesis and intestine was important with the PL implants but not with the MM implants. Optical microscopy and SEM showed formation of an organized connective tissue surrounding the MM implants. At 90 days, compact bridges of connective tissue linked the tissue on the subcutaneous and peritoneal sides of the prosthesis. The PL implants became integrated into a disorganized, highly vascularized connective tissue. The intensity of the macrophage response was similar in both prostheses and decreased between days 14 and 90 (Student-Newman-Keuls test p=0.01). The tensile strength of the PL implants was greater than that of the MM implants. At 90 days, the tensile strength of the PL implants was mean equals 33.11 N and of the MM implants, mean equals 22.65 N (Mann-Whitney test p<0.001).
   CONCLUSIONS: The tissue integration of the PL and MM implants differed; fewer visceral adhesions formed on MM than on FL; the macrophage reaction was not determinant of the success or failure of either biomaterial; and the tensile strength of the prosthesis-receptor tissue interface was much greater in the PL implants than in the MM implants.
RP Bellon, JM (reprint author), UNIV ALCALA DE HENARES,FAC MED,DEPT MORPHOL SCI & SURG,CRTA MADRID BARCELONA,KM 33600,E-28871 ALCALA DE HENARES,SPAIN.
OI bujan, Julia/0000-0003-2419-2476; BELLON, JUAN M./0000-0002-6071-5011
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   BELLON JM, 1994, BRIT J SURG, V81, P69
   BJURSTEN LM, 1991, 9 EUR C BIOM CHEST U, P39
   BROWDER W, 1988, SURGERY, V104, P224
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   JENKINS SD, 1983, SURGERY, V94, P392
   LAW NW, 1991, SURGERY, V109, P652
   Law NW, 1988, CLIN MATER, V3, P95
   LAW NW, 1990, ACTA CHIR SCAND, V156, P159
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   MOLLOY RG, 1991, BRIT J SURG, V78, P242, DOI 10.1002/bjs.1800780237
   MURPHY JL, 1989, CAN J SURG, V32, P244
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
   SIMMERMACHER RKJ, 1991, BIOMATERIALS, V12, P22, DOI 10.1016/0142-9612(91)90126-U
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
NR 20
TC 87
Z9 96
U1 0
U2 4
PU AMER COLL SURGEONS
PI CHICAGO
PA 54 EAST ERIE ST, CHICAGO, IL 60611
SN 1072-7515
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD JUL
PY 1996
VL 183
IS 1
BP 11
EP 18
PG 8
WC Surgery
SC Surgery
GA UV697
UT WOS:A1996UV69700002
PM 8673302
DA 2018-10-19
ER

PT J
AU Czygan, G
   Hartung, C
AF Czygan, G
   Hartung, C
TI Mechanical testing of isolated senile human eye lens nuclei
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE eye lens nucleus; cataract; phacoemulsification; measuring system;
   mechanical behaviour; viscoelastic; penetration; deep; relaxation;
   hysteresis
ID LIGHT SCATTER; AGE
AB Phacoemulsification is a cataract surgery technique during which the eye lens nucleus is carefully dissected by an oscillating hollow needle simultaneously serving as a suction line for lens fragments. As the success of this procedure depends greatly on the mechanical properties of the nucleus, the basic mechanical properties of extracted senile human eye lens nuclei were studied. For this purpose a novel measuring system had to be developed enabling the study of the biomaterial's responses to any chosen excitation function. Either force- or displacement-controlled testing signals can be selected serving as a one-dimensional input. The resultant quantity can be recorded in the time or frequency domain. An almost linear viscoelastic behaviour of lens nuclei is observed. Typical phenomena such as hysteresis, creep, relaxation, and a frequency-dependent compliance are evaluated The ultimate strength of the specimen is studied by penetration tests. Finally the possible correlation between mechanical and optical parameters of lens nuclei is discussed. If correlated, a surgeon could use this information when deciding whether an extracapsular extraction or a phacoemulsification should be the preferred approach. Copyright (C) 1996 Elsevier Science Ltd for IPEMB.
C1 HANNOVER MED SCH, INST BIOMED ENGN & HOSP ENGN, D-30623 HANNOVER, GERMANY.
CR BETTELHEIM FA, 1985, OCULAR LENS STRUCTUR, P265
   BLOEMENDAL H, 1985, BIOCH AUGES, P82
   CZYGAN G, 1995, FORTSCHR BER VDI REI, V125
   DAVSON H, 1980, PHYSL EYE
   DORRINGTON KL, 1980, S SOC EXP BIOL, V13, P289
   EJIRI M, 1969, VISION RES, V9, P233, DOI 10.1016/0042-6989(69)90003-0
   FISHER RF, 1971, J PHYSIOL-LONDON, V212, P147, DOI 10.1113/jphysiol.1971.sp009315
   Flugge W, 1975, VISCOELASTICITY
   Fukuda M., 1963, JPN J OPHTHALMOL, V7, P47
   FUNG YC, 1981, BIOMECHANICS MECHANI, P196
   HARTUNG C, 1975, FORTSCHR BER VDI REI, V2
   ITOI MOTOKAZU, 1965, EXP EYE RES, V4, P168, DOI 10.1016/S0014-4835(65)80028-8
   Kelman C D, 1969, Int Ophthalmol Clin, V9, P739, DOI 10.1097/00004397-196900930-00012
   KELMAN CD, 1967, AM J OPHTHALMOL, V64, P23, DOI 10.1016/0002-9394(67)93340-5
   KIKKAWA Y, 1963, EXP EYE RES, V2, P210, DOI 10.1016/S0014-4835(63)80015-9
   KUWABARA T, 1975, EXP EYE RES, V20, P427, DOI 10.1016/0014-4835(75)90085-8
   PAU H, 1991, GRAEF ARCH CLIN EXP, V229, P294, DOI 10.1007/BF00167888
   RAFFERTY NS, 1985, OCULAR LENS STRUCTUR, P1
   SIIK S, 1992, ACTA OPHTHALMOL, V70, P383
   SPECTOR A, 1974, INVEST OPHTH VISUAL, V13, P795
   TROKEL S, 1962, INVEST OPHTH VISUAL, V1, P493
   VIDIIK A, 1978, VERH ANAT GES, V72, P78
NR 22
TC 20
Z9 23
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
EI 1873-4030
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD JUL
PY 1996
VL 18
IS 5
BP 345
EP 349
DI 10.1016/1350-4533(95)00076-3
PG 5
WC Engineering, Biomedical
SC Engineering
GA UU591
UT WOS:A1996UU59100001
PM 8818131
DA 2018-10-19
ER

PT J
AU Boxus, T
   DeldimeRubbens, M
   Mougenot, P
   Schneider, YJ
   MarchandBrynaert, J
AF Boxus, T
   DeldimeRubbens, M
   Mougenot, P
   Schneider, YJ
   MarchandBrynaert, J
TI Chemical assays of end-groups displayed on the surface of poly(ethylene
   terephthalate) (PET) films and membranes by radiolabeling
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE poly(ethylene terephthalate) film; membrane; surface chemistry;
   reactivity assay; radiolabeling; end-group characterization; SEM
   analysis; biomaterial
ID FACILE REDUCTION; CARBOXYLIC-ACIDS; POLY(ETHYLENE-TEREPHTHALATE);
   IMMOBILIZATION; POLYMERS; ALCOHOLS
AB Poly(ethylene terephthalate) BET) films and track-etched microporous membranes naturally display, on their surfaces, reactive chain-ends, i.e. carboxyl and hydroxyl functions. These were assayed by suitable activation (reaction with carbodiimide and tosyl chloride, respectively), followed by coupling with H-3-lysine and liquid scintillation counting of the sample-associated radioactivity. Values ranging between 5 and 30 pmol/cm(2) (open surface) of labeled end-groups were obtained, depending on the physico-chemical nature of the samples. Basic hydrolysis enriched the PET films with both types of endings (15-25 pmol/cm(2)). Reduction of films with the NaBH4-catechol complex in tetrahydrofuran enriched their surfaces with hydroxyl groups. However, this procedure was not readily applicable to the surface modification of membranes; we observed an erosion effect that was confirmed by scanning electron microscope analyses. In contrast with the reduction process, the oxidation with KMnO4 in 1.2 N H2SO4 could be easily applied to the modification of either films or membranes; their surfaces were significantly enriched with carboxyl groups (15-50 pmol/cm(2)). This surface modification strategy has been used for the covalent coupling of adhesive proteins on PET membranes developed as supports for cell cultivation.
C1 UNIV CATHOLIQUE LOUVAIN,LAB CHIM ORGAN SYNTH,B-1348 LOUVAIN,BELGIUM.
   UNIV CATHOLIQUE LOUVAIN,BIOCHIM CELLULAIRE LAB,B-1348 LOUVAIN,BELGIUM.
CR Barrett A. G. M, 1991, COMPREHENSIVE ORGANI, V8, P235
   Beamson G., 1992, HIGH RESOLUTION XPS
   BEE TG, 1993, POLYM SURFACES INTER, V2, pCH1
   BONZON N, 1995, BIOMATERIALS, V16, P747, DOI 10.1016/0142-9612(95)99636-Z
   BUI LN, 1993, ANALYST, V118, P463
   CRAIG WS, 1995, BIOPOLYMERS, V37, P157, DOI 10.1002/bip.360370209
   DELDIME M, 1995, APPL SURF SCI, V90, P1, DOI 10.1016/0169-4332(95)00077-1
   GARBASSI F, 1994, POLYM SURFACES PHYSI
   HALLEUX C, 1994, J CELL PHYSIOL, V158, P17, DOI 10.1002/jcp.1041580104
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   JAUMOTTETHELEN S, 1996, IN PRESS J BIOMED MA
   KABALKA GW, 1977, J ORG CHEM, V42, P512, DOI 10.1021/jo00423a025
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LEGRAS R, 1986, Patent No. 8705850
   MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319
   Mark H.F., 1985, ENCY POLYM SCI ENG
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MUGENOT P, 1996, J COLLOID INTERF SCI, V177, P162
   NARASIMHAN S, 1995, J ORG CHEM, V60, P5314, DOI 10.1021/jo00121a060
   OLIVEIRA EA, 1989, APPL BIOCHEM BIOTECH, V22, P109, DOI 10.1007/BF02922700
   PESEK JJ, 1994, CHEM MODIFIED SURFAC
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   RATNER BD, 1990, CONCISE ENCY MED DEN, P337
   SERGENT-ENGELEN T, 1990, Biotechnology Techniques, V4, P89, DOI 10.1007/BF00163279
   SERGENTENGELEN T, 1993, BIOCHEM PHARMACOL, V46, P1393, DOI 10.1016/0006-2952(93)90104-5
   SHARMA R, 1995, SYNLETT, P839
   Silver FH., 1994, BIOMATERIALS MED DEV
   SUSEELA Y, 1992, TETRAHEDRON, V48, P371, DOI 10.1016/S0040-4020(01)88148-5
   Szycher M., 1991, HIGH PERFORMANCE BIO
   WARD WJ, 1990, ENCY POLYM SCI ENG S, P674
   Williams D., 1990, CONCISE ENCY MED DEN
   XU GF, 1992, CHEM MATER, V4, P1240, DOI 10.1021/cm00024a024
NR 34
TC 24
Z9 24
U1 0
U2 7
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD JUL
PY 1996
VL 7
IS 7
BP 589
EP 598
DI 10.1002/(SICI)1099-1581(199607)7:7<589::AID-PAT551>3.3.CO;2-2
PG 10
WC Polymer Science
SC Polymer Science
GA VB599
UT WOS:A1996VB59900004
DA 2018-10-19
ER

PT J
AU Pandey, R
   Quinn, JMW
   Sabokbar, A
   Athanasou, NA
AF Pandey, R
   Quinn, JMW
   Sabokbar, A
   Athanasou, NA
TI Bisphosphonate inhibition of bone resorption induced by particulate
   biomaterial-associated macrophages
SO ACTA ORTHOPAEDICA SCANDINAVICA
LA English
DT Article
ID HIP-REPLACEMENT; OSTEOCLASTS; CELLS; INVITRO; DIFFERENTIATION;
   PROLIFERATION; OSTEOLYSIS; ORIGIN
AB Aseptic loosening of total joint replacements is associated with bone resorption. A heavy infiltrate of foreign body macrophages in response to biomaterial wear particles is commonly found in the fibrous membrane surrounding loose components. It has recently been shown that foreign body macrophages can differentiate into osteoclastic cells. To determine whether pharmacological inhibitors of bone resorption have a role to play in controlling the osteolysis of aseptic loosening, we analyzed the effect of a bisphosphonate, disodium ethane-1, 1-diphosphonate (EHDP) on this process. Murine monocytes and foreign body macrophages (derived from granulomas formed by subcutaneous implantation of particles of prosthetic biomaterials) were co-cultured with UMR106 osteoblast-like cells in the presence of 1,25 dihydroxyvitamin D-3 for 14 days on glass coverslips and bone slices. EHDP significantly inhibited bone resorption in these co-cultures. There was little or no expression of the osteoclast-associated enzyme, tartrate-resistant acid phosphatase (TRAP) in EHDP-treated co-cultures. Addition of EHDP to monocyte-UMR106 co-cultures after the appearance of TRAP-positive cells did not abolish bone resorption, indicating that EHDP, in addition to its known inhibitory effect on osteoclast function, suppresses differentiation of osteoclast precursors. EHDP inhibition of the osteolysis induced by particulate biomaterial-associated macrophages shows that pharmacological inhibition of bone resorption might be used to control the osteolysis of aseptic loosening.
C1 NUFFIELD ORTHOPAED CTR,DEPT PATHOL,OXFORD OX3 7LD,ENGLAND.
   UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND.
   UNIV OXFORD,NUFFIELD ORTHOPAED CTR,NUFFIELD DEPT ORTHOPAED SURG,OXFORD OX3 7LD,ENGLAND.
FU Wellcome Trust
CR AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   ATHANASOU NA, 1989, BRIT J CANCER, V59, P491, DOI 10.1038/bjc.1989.102
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   BOONEKAMP PM, 1986, BONE MINER, V1, P27
   BULLOUGH PG, 1988, ORTHOP CLIN N AM, V19, P611
   CARANO A, 1990, J CLIN INVEST, V85, P456, DOI 10.1172/JCI114459
   CECCHINI MG, 1990, J BONE MINER RES, V5, P1019
   CECCHINI MG, 1987, J BONE MINER RES, V2, P135
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   CHAMBERS TJ, 1980, J PATHOL, V132, P255, DOI 10.1002/path.1711320307
   FLANAGAN AM, 1991, CALCIFIED TISSUE INT, V49, P407, DOI 10.1007/BF02555852
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   HUGHES DE, 1991, DRUG EXP CLIN RES, V17, P109
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   LOWIK CWGM, 1988, J BONE MINER RES, V3, P185
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   QUINN JMW, 1994, ENDOCRINOLOGY, V134, P2416, DOI 10.1210/en.134.6.2416
   REITSMA PH, 1982, J CLIN INVEST, V70, P927, DOI 10.1172/JCI110704
   REVELL PA, 1982, CURRENT TRENDS PATHO, P73
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P980
   Schlesinger Paul H., 1992, P397
   SPECTOR WG, 1966, J PATHOL BACTERIOL, V92, P163, DOI 10.1002/path.1700920117
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600
   TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179
   UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260
NR 33
TC 26
Z9 29
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0001-6470
J9 ACTA ORTHOP SCAND
JI Acta Orthop. Scand.
PD JUN
PY 1996
VL 67
IS 3
BP 221
EP 228
DI 10.3109/17453679608994677
PG 8
WC Orthopedics
SC Orthopedics
GA UW553
UT WOS:A1996UW55300002
PM 8686457
OA Bronze
DA 2018-10-19
ER

PT J
AU Pandey, R
   Quinn, J
   Joyner, C
   Murray, DW
   Triffitt, JT
   Athanasou, NA
AF Pandey, R
   Quinn, J
   Joyner, C
   Murray, DW
   Triffitt, JT
   Athanasou, NA
TI Arthroplasty implant biomaterial particle associated macrophages
   differentiate into lacunar bone resorbing cells
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Article
ID RAT OSTEOBLASTIC CELLS; MARROW CULTURES; RESORPTION; REPLACEMENT;
   OSTEOCLASTS; BIOLOGY; ORIGIN
AB Objective-To study the pathogenesis of aseptic loosening: in particular, to determine whether macrophages responding to particles of biomaterials commonly used in arthroplasty surgery for arthritis are capable of differentiating into osteoclastic bone resorbing cells, and the cellular and hormonal conditions required for this to occur.
   Methods-Biomaterial particles (polymethylmethacrylate, high density polyethylene, titanium, chromium-cobalt, stainless steel) were implanted subcutaneously into mice. Macrophages were isolated from the foreign body granulomas that resulted, cultured on bone slices and coverslips, and assessed for both cytochemical and functional evidence of osteoclast differentiation.
   Results-Tartrate resistant acid phosphatase (TRAP) negative macrophages isolated from granulomas containing particles of all types of biomaterial composition were capable of differentiating into TRAP positive cells capable of extensive lacunar bone resorption (assessed by scanning electron microscopy). The presence of both UMR106 rat osteoblast-like cells and 1,25-dihydroxy vitamin D-3 was necessary for this to occur.
   Conclusion-All implant materials produce wear particles that are the focus of a heavy foreign body macrophage response in the fibrous membrane between a loose implant component and the host bone undergoing resorption. These findings underline the importance of biomaterial wear particle generation and the macrophage response to different types of biomaterial wear particles in the pathogenesis of aseptic loosening.
C1 UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND.
   UNIV OXFORD,JOHN RADCLIFFE HOSP,MRC,BONE RES LAB,OXFORD OX3 9DU,ENGLAND.
   UNIV OXFORD,NUFFIELD ORTHOPAED CTR,NUFFIELD DEPT ORTHOPAED SURG,OXFORD OX3 7LD,ENGLAND.
RI Murray, David/D-7117-2011
FU Wellcome Trust
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   Andersson Goran, 1992, P55
   ATHANASOU NA, 1989, BRIT J CANCER, V59, P491, DOI 10.1038/bjc.1989.102
   ATHANASOU NA, 1992, BRIT J CANCER, V65, P523, DOI 10.1038/bjc.1992.108
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   BULLOUGH PG, 1988, ORTHOP CLIN N AM, V19, P611
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HATTERSLEY G, 1989, ENDOCRINOLOGY, V125, P1606, DOI 10.1210/endo-125-3-1606
   HAYNES DR, 1993, J BONE JOINT SURG AM, V75A, P825, DOI 10.2106/00004623-199306000-00004
   JASTY M, 1992, CLIN ORTHOP RELAT R, V285, P116
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, V218, P123
   JONES LC, 1987, CLIN ORTHOP RELAT R, V225, P192
   Kaplow L. S., 1981, MANUAL MACROPHAGE ME, P199
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   MALCOLM AJ, 1988, J BONE JOINT SURG BR, V70, P153
   MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P835, DOI 10.2106/00004623-199306000-00005
   MCSHEEHY PMJ, 1987, J CLIN INVEST, V80, P425, DOI 10.1172/JCI113089
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213
   PAZZAGLIA UE, 1988, ARCH ORTHOP TRAUM SU, V107, P20
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   QUINN JM, 1996, IN PRESS J PATHOL
   QUINN JMW, 1994, ENDOCRINOLOGY, V134, P2416, DOI 10.1210/en.134.6.2416
   REVELL PA, 1982, CURRENT TRENDS PATHO, P73
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P980
   SPECTOR WG, 1966, J PATHOL BACTERIOL, V92, P163, DOI 10.1002/path.1700920117
   SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373
   TEITELBAUM SL, 1979, CALCIFIED TISSUE INT, V27, P255, DOI 10.1007/BF02441194
   UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260
   van Furth R, 1989, Curr Top Pathol, V79, P125
NR 39
TC 59
Z9 62
U1 0
U2 0
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR
SN 0003-4967
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD JUN
PY 1996
VL 55
IS 6
BP 388
EP 395
DI 10.1136/ard.55.6.388
PG 8
WC Rheumatology
SC Rheumatology
GA UP474
UT WOS:A1996UP47400011
PM 8694579
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU SanGalli, F
   Deminiere, C
   Guerin, J
   Rabaud, M
AF SanGalli, F
   Deminiere, C
   Guerin, J
   Rabaud, M
TI Use of a biodegradable elastin-fibrin material, Neuroplast(R), as a
   dural substitute
SO BIOMATERIALS
LA English
DT Article
DE Neuroplast(R); dura mater substitution
ID BIOMATERIAL; VICRYL; MESH
AB Since the new Neuroplast(R) biomaterial is now commonly used in several domains of restorative and curative surgery, its preliminary evaluation as a dura mater substitute in the rabbit was performed and is described herein. Whereas the importance of prosthesis thickness was implicated and solved (0.2 rather than 1.0 mm), both macroscopic examination and histological studies revealed for the neo-tissue an effective patency, a good continuity and especially no or almost no adherence at all. As Neuroplast(R) is now available for use everywhere in humans, this material is being developed in several fields of neurosurgery. (C) 1996 Elsevier Science Limited
C1 UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
   HOP PELLEGRIN,SERV NEUROCHIRURG A,F-33076 BORDEAUX,FRANCE.
   HOP PELLEGRIN,SERV ANATOMOPATHOL,F-33076 BORDEAUX,FRANCE.
   CHU BORDEAUX,F-33076 BORDEAUX,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   BONZON N, 1995, BIOMATERIALS, V16, P881, DOI 10.1016/0142-9612(95)94151-A
   COLLET D, 1991, BIOMATERIALS, V12, P763, DOI 10.1016/0142-9612(91)90027-8
   COLLINS RLL, 1991, J BIOMED MATER RES, V25, P267, DOI 10.1002/jbm.820250212
   COURCIERSOUSTRE E, 1995, 2 M CER CELLS TISS F
   FRADIN D, 1993, J THORAC CARDIOV SUR, V105, P364
   LEE JF, 1967, J NEUROSURG, V27, P558, DOI 10.3171/jns.1967.27.6.0558
   MAURER PK, 1985, J NEUROSURG, V63, P448, DOI 10.3171/jns.1985.63.3.0448
   MEDDINGS N, 1992, ACTA NEUROCHIR, V117, P53, DOI 10.1007/BF01400636
   NAROTAM PK, 1995, J NEUROSURG, V82, P406, DOI 10.3171/jns.1995.82.3.0406
   Rabaud M, 1992, J Biomater Appl, V7, P20, DOI 10.1177/088532829200700102
   RIQUET M, 1990, BIOMATERIALS, V11, P518, DOI 10.1016/0142-9612(90)90069-3
   SANGALLI F, 1992, NEUROSURGERY, V30, P396, DOI 10.1227/00006123-199203000-00014
NR 14
TC 21
Z9 21
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1996
VL 17
IS 11
BP 1081
EP 1085
DI 10.1016/0142-9612(96)85908-4
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UM081
UT WOS:A1996UM08100004
PM 8718967
DA 2018-10-19
ER

PT J
AU Chang, YS
   Oka, M
   Kobayashi, M
   Gu, HO
   Li, ZL
   Nakamura, T
   Ikada, Y
AF Chang, YS
   Oka, M
   Kobayashi, M
   Gu, HO
   Li, ZL
   Nakamura, T
   Ikada, Y
TI Significance of interstitial bone ingrowth under load-bearing
   conditions: A comparison between solid and porous implant materials
SO BIOMATERIALS
LA English
DT Article
DE interstitial bone ingrowth; bone remodelling; load-bearing condition;
   solid structure; porous structure
ID ORTHOPEDIC IMPLANTS; TITANIUM IMPLANTS
AB Interstitial bone ingrowth is extremely important for optimum fixation of implanted materials under load-bearing conditions. In this study, three types of biomaterial test piece were manufactured in solid and open-pore structures, and implanted into dog femoral condyles. Bone formation and remodelling were observed histologically and roentgenologically for 24 weeks thereafter. The study demonstrated that, 24 weeks after implantation, thick fibrous tissue surrounded by corticalized bone formed around both solid smooth-surfaced alumina and titanium implants. On the other hand, however, with an implant made of an artificial osteochondral composite material, thickening of ingrown trabeculae could be observed as early as 4 weeks. Bone ingrowth into the titanium fibre mesh was abundant and increased with time after implantation. This interstitial bone ingrowth resulted in the complete integration of this implant and the viable host bone. Our findings suggest that interstitial bone ingrowth has great significance, even though new bone formation and remodelling follows Wolff's law after the completion of the bonding between the bone and implanted material under load-bearing conditions. The artificial osteochondral composite material could lead to complete integration of the implant and viable bone, suggesting that it is a promising material for joint replacements. Moreover, the tibial joint surface which bore against the polyvinyl alcohol hydrogel surface of this implant remained intact, which suggests that this composite is a very promising biomaterial for use in joint prostheses. (C) 1996 Elsevier Science Limited
C1 KYOTO UNIV, BIOMED ENGN RES CTR, SAKYO KU, KYOTO 606, JAPAN.
   KYOTO UNIV, FAC MED, DEPT ORTHOPED SURG, KYOTO 606, JAPAN.
CR ALPERT B, 1992, CLIN ORTHOP RELAT R, V284, P164
   BALLINTYN NJ, 1979, BIOMATER ARTIF CELL, V7, P23, DOI 10.3109/10731197909119369
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COOK SD, 1988, CLIN ORTHOP RELAT R, V234, P90
   COOLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   DUCHEYNE P, 1978, J BONE JOINT SURG AM, V60, P384, DOI 10.2106/00004623-197860030-00021
   DUCHEYNE P, 1977, J BIOMED MATER RES, V11, P811, DOI 10.1002/jbm.820110603
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   Ducheyne P, 1974, Acta Orthop Belg, V40, P799
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Gross U, 1988, Ann N Y Acad Sci, V523, P211, DOI 10.1111/j.1749-6632.1988.tb38514.x
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   GROSS U, 1988, BIOCERAMICS MAT CHAR, P211
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, V266, P244
   INOUE K, 1992, BIOCERAMICS, V5, P125
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JASTY M, 1988, NONCEMENTED TOTAL HI, P175
   LEONG JCY, 1994, CLIN ORTHOP RELAT R, P52
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   OHGUSHI H, 1992, BIOCERAMICS, V5, P119
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   OKA M, 1994, CLIN BIOMECHANICS RE, P124
   OKA M, 1992, BIOMECHANICS ORTHOPE, P282
   Roberts W E, 1988, J Dent Educ, V52, P804
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   SPIVAK JM, 1990, BIOMATERIALS, V11, P79
   STUCHIN SA, 1991, CLIN ORTHOP RELAT R, P42
   WILLIAMS DF, 1974, J BIOMED MATER RES, V8, P1, DOI 10.1002/jbm.820080303
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
NR 32
TC 52
Z9 52
U1 2
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1996
VL 17
IS 11
BP 1141
EP 1148
DI 10.1016/0142-9612(96)85917-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UM081
UT WOS:A1996UM08100013
PM 8718976
DA 2018-10-19
ER

PT J
AU Groth, T
   Altankov, G
AF Groth, T
   Altankov, G
TI Studies on cell-biomaterial interaction role of tyrosine phosphorylation
   during fibroblast spreading on surfaces varying in wettability
SO BIOMATERIALS
LA English
DT Article
DE wettability; fibroblasts; tissue compatibility; fibronectin; integrins;
   tyrosine phosphorylation; signalling
ID HUMAN-ENDOTHELIAL CELLS; FIBRONECTIN ADSORPTION; EXTRACELLULAR-MATRIX;
   SIGNAL TRANSDUCTION; PROTEIN ADSORPTION; ADHESION; INTEGRINS; RECEPTORS;
   SUBSTRATA; BINDING
AB In a previous study we observed that protein tyrosine phosphorylation was significantly diminished in the focal adhesions of human fibroblasts attached on a hydrophobic surface in comparison with hydrophilic glass. This result raises the possibility that the tyrosine phosphorylation pathway may be involved in the regulation of cell-biomaterial interaction. To learn more about the interaction of anchorage-dependent cells with biomaterials, four different materials with wettability ranging from hydrophilic (water contact angle 25 degrees) to hydrophobic (water contact angle 111 degrees) were investigated, i.e. clean glass (glass), aminopropylsilane (APS), octadecylsilane (ODS) and silicone (SI). Immunofluorescence microscopy revealed increased stress formation and fibronectin (FN) receptor-rich focal adhesions for fibroblasts attached on more hydrophilic surfaces (glass and APS) in comparison to the relatively hydrophobic materials (ODS and SI). Phosphorylation of tyrosine residues, also studied by immunofluorescence microscopy, was considerably higher on glass and APS, lower for ODS, negligible for SI, and was found to colocalize with FN receptor-rich focal adhesions. Preadsorption of FN tended to restore cell adhesion and spreading on the hydrophobic ODS and SI. Quantitative data on cell proliferation and tyrosine phosphorylation showed moderate wettable material maximum values for APS, followed by glass, ODS and SI, demonstrating a non-linearity of these parameters with the wettability of materials. Interestingly, the preadsorption of FN increased both parameters, particularly for the hydrophobic materials ODS and SI. Phosphorylation of tyrosine on FN-coated substrata was corroborated by the accessibility of binding sites estimated by ELISA using polyclonal and monoclonal FN antibodies. Our results suggest that measurement of the phosphotyrosine activity of cells may be a sensitive parameter for the ability of biomaterials to support the attachment and proliferation of cells. (C) 1996 Elsevier Science Limited.
C1 BULGARIAN ACAD SCI, INST BIOPHYS, BU-1113 SOFIA, BULGARIA.
RP Groth, T (reprint author), GKSS FORSCHUNGSZENTRUM GEESTHACHT GMBH, INST CHEM, DEPT MEMBRANE RES TELTOW, KANSTR 55, D-14513 TELTOW, GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   ALTANKOV G, IN PRESS J BIOMED MA
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148
   CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   GEIGER B, 1989, CELL MUSCLE MOTILITY, V5, P195
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   GROTH T, 1992, ATLA-ALTERN LAB ANIM, V20, P390
   GUAN JL, 1991, CELL REGUL, V2, P951
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PITT WG, 1987, ACS SYM SER, V343, P324
   RODRIGUEZ J, 1960, VIROLOGY, V12, P316, DOI 10.1016/0042-6822(60)90205-1
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192
   SHATTIL SJ, 1993, THROMB HAEMOSTASIS, V70, P224
   SLACK SM, 1991, J BIOMAT SCI-POLYM E, V3, P49
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
NR 43
TC 106
Z9 106
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1996
VL 17
IS 12
BP 1227
EP 1234
DI 10.1016/0142-9612(96)84943-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UR418
UT WOS:A1996UR41800008
PM 8799507
DA 2018-10-19
ER

PT J
AU Kitano, T
   Yutani, Y
   Shimazu, A
   Yano, I
   Ohashi, H
   Yamano, Y
AF Kitano, T
   Yutani, Y
   Shimazu, A
   Yano, I
   Ohashi, H
   Yamano, Y
TI The role of physicochemical properties of biomaterials and bacterial
   cell adhesion in vitro
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE biomaterials centered infection; physicochemical property of
   biomaterial; surface free energy; cell adhesion molecule; S-aureus
ID STAPHYLOCOCCUS-AUREUS; FIBRONECTIN-BINDING
AB This study was undertaken to investigate the physicochemical aspects of the interaction between the surface of biomaterials and bacterial cell membranes in vitro, aimed at studying the mechanisms of bacterial adhesion to biomaterials. Correlations were made between the number of adherent bacterial cells (S, aureus) and each of the calculated components of surface free energy (ie., dispersion, polarity and hydrogen bond) of biomaterials. The effect of antibodies to cell-adhesion molecules on bacterial adhesion was also studied using monoclonal antibodies to vitronectin receptor fibronectin receptor and CD44. This study indicates the polarity component of surface free energy plays a dominant role in the process of bacterial adhesion at least in vitro. The number of cells adherent to materials decreased to 44-73% of the control value in the presence of antibodies tested showing that cell adhesion molecules affect adherence to biomaterials. Moreover, the results suggested that bacterial adhesion was prevented by specific blockade of cell adhesion molecule receptors.
C1 OSAKA CITY UNIV,SCH MED,DEPT BACTERIOL,ABENO KU,OSAKA 545,JAPAN.
RP Kitano, T (reprint author), OSAKA CITY UNIV,SCH MED,DEPT ORTHOPAED SURG,ABENO KU,1-5-7 ASAHIMACHI,OSAKA 545,JAPAN.
CR BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503
   FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1991, INFECT ORTHOPAEDIC P, P30
   GRISTINA AG, 1994, CLIN ORTHOPAEDICS, V298, P106
   KITANO T, 1993, SURFACE MODIFICATION TECHNOLOGIES VI, P581
   Kitazaki Y., 1972, J ADHES SOC JPN, V8, P131
   OGA M, 1993, ACTA ORTHOP SCAND, V64, P273, DOI 10.3109/17453679308993623
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PROCTOR RA, 1982, J BIOL CHEM, V257, P4788
   SPEZIALE P, 1986, J BACTERIOL, V167, P77, DOI 10.1128/jb.167.1.77-81.1986
   Wadstrom T, 1989, J Invest Surg, V2, P353, DOI 10.3109/08941938909018261
NR 16
TC 10
Z9 11
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUN
PY 1996
VL 19
IS 6
BP 353
EP 358
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA UV307
UT WOS:A1996UV30700009
PM 8814499
DA 2018-10-19
ER

PT J
AU Chou, LS
   Firth, JD
   Nathanson, D
   Uitto, VJ
   Brunette, DM
AF Chou, LS
   Firth, JD
   Nathanson, D
   Uitto, VJ
   Brunette, DM
TI Effects of titanium on transcriptional and post-transcriptional
   regulation of fibronectin in human fibroblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID EXTRACELLULAR-MATRIX; GENE-EXPRESSION; ADSORPTION; SURFACES;
   BIOMATERIAL; IMPLANTS; INVITRO
AB The effects of commercially pure titanium (Ti) on the regulation of fibronectin gene expression and synthesis were investigated in early-passage human gingival fibroblasts. The fibroblasts were cultured on 50 nm Ti-coated silicon wafers treated with radio-frequency glow discharge prior to use and on Falcon tissue culture plastic (TCP) dishes as a control. Northern hybridization analysis revealed that fibroblasts cultured on Ti reduced the fibronectin mRNA level by 58% at 16 h, but increased it by 2.6-fold at 90 h, although the cell numbers and house-keeping gene GAPD mRNA levels on these two surfaces were essentially the same. The amount of total RNA was slightly less on the Ti surface. While the total [S-35]methionine incorporation was essentially unaltered, the amount of [S-35]methionine-labeled fibronectin was significantly increased in cells cultured on a Ti surface in early cultures but decreased in the late cultures. The apparent discrepancy between the increased fibronectin mRNA levels and decreased translation could be explained by a 30% reduction in fibronectin mRNA half life in cells cultured on Ti. The distribution of fibronectin between the medium and the cell layer also was altered on Ti surfaces, with a similar to 100-fold increase of fibronectin assembled in extracellular matrix at 16 h, but a 36% reduction at 90 h. In contrast, the amount of fibronectin recovered in the medium was essentially unchanged. The total amount of protein assembled into the extracellular matrix by cells on Ti increased 2.1-fold at 16 h but decreased by 19% in 90-h cultures. These significant changes in fibronectin gene activity and gene product distribution by cells cultured on Ti surfaces demonstrate that the surface chemistry of biomaterials can selectively regulate the cellular behavior at the molecular level and, conversely, that molecular biological techniques provide sensitive indicators of the molecular biocompatibility of implant materials. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV BRITISH COLUMBIA, FAC DENT, DEPT ORAL BIOL, VANCOUVER, BC V6T 1Z3, CANADA.
RP Chou, LS (reprint author), BOSTON UNIV, GOLDMAN SCH GRAD DENT, DEPT BIOMAT, BOSTON, MA 02218 USA.
CR ABIKO Y, 1993, CELL MATER, V3, P161
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   BAIER R E, 1988, Journal of Oral Implantology, V13, P594
   BERNARD MP, 1985, BIOCHEMISTRY-US, V24, P2698, DOI 10.1021/bi00332a016
   BRASH JL, 1987, ANN NY ACAD SCI, V516, P206, DOI 10.1111/j.1749-6632.1987.tb33043.x
   BRUNETTE DM, 1976, ARCH ORAL BIOL, V21, P393, DOI 10.1016/0003-9969(76)90001-7
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P1148, DOI 10.1016/S0955-0674(89)80065-1
   DONLEY TG, 1991, J PERIODONTOL, V62, P153, DOI 10.1902/jop.1991.62.2.153
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   FRENKEL L, 1986, DNA-J MOLEC CELL BIO, V5, P539, DOI 10.1089/dna.1.1986.5.539
   GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   HAAS R, 1982, J CELL PHYSIOL, V113, P289, DOI 10.1002/jcp.1041130217
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEALY KE, 1989, 15 ANN M SOC BIOM LA
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   KIRCOS LT, 1989, ORAL SURG ORAL MED O, V68, P787, DOI 10.1016/0030-4220(89)90174-6
   McDonald JA, 1989, CURR OPIN CELL BIOL, V1, P995, DOI 10.1016/0955-0674(89)90071-9
   OVERALL CM, 1991, J BIOL CHEM, V266, P14064
   SINGER II, 1989, BIOL EXTRACELLULAR M, P139
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   SMART KM, 1992, J ORAL IMPL, V18, P130
   SPORN SA, 1990, J IMMUNOL, V144, P4434
   TOTH RW, 1985, J PROSTHET DENT, V54, P564, DOI 10.1016/0022-3913(85)90435-4
   TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485
   ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648
   YAMADA KM, 1984, CELL CULTURE METHODS, V1, P216
   YISRAELI JK, 1990, DEVELOPMENT, V108, P289
NR 35
TC 24
Z9 26
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1996
VL 31
IS 2
BP 209
EP 217
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UG003
UT WOS:A1996UG00300007
PM 8731209
DA 2018-10-19
ER

PT J
AU Yang, JM
   Hsiue, GH
AF Yang, JM
   Hsiue, GH
TI Radiation-induced graft copolymer SBS-g-VP for biomaterial usage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID MEMBRANE
AB The grafting of 4-vinyl pyridine (VP) to styrene-butadienestyrene triblock copolymer (SBS) by radiation-induced graft copolymerization was studied. The cohesive properties such as cohesive energy (E(coh)), molar volume (V), solubility parameter (delta), molar molecular weight (W-M), specific volume (V-g), and density (1/V-g) of SBS-g-VP graft copolymer were calculated according to the group contribution of Fedors. The morphology of SBS-g-VP was studied by optical polarizing microscopy. We also measured the glass transition temperature and the mechanical properties of SBS-g-VP graft copolymer. Contact angle and blood-clotting time experiments were also performed to evaluate the biocompatibility of SBS-g-VP. A second domain was found in the SBS-g-VP graft copolymer, which resulted in different properties between SBS-g-VP and SBS. The blood compatibility of SBS-g-VP as measured by the Lee-White clotting test was better than that of SBS and polystyrene. (C) 1996 John Wiley & Sons, Inc.
C1 NATL TSING HUA UNIV,DEPT CHEM ENGN,HSINCHU 300,TAIWAN.
RP Yang, JM (reprint author), CHANG GUNG COLL MED & TECHNOL,DEPT CHEM ENGN,TAYUAN 333,TAIWAN.
CR Holden G., 1969, J POLYM SCI        C, VC26, P37
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   KUSANO T, 1970, B CHEM RES I NONAQUE, V20, P199
   RATNER BD, 1976, ACS S SERIES, V31
   TRELOAR LRG, 1958, PHYSICS RUBBER ELAST
   VANKREVELEN DW, 1976, PROPERTIES POLYM, pCH7
   YANG JM, 1990, ANGEW MAKROMOL CHEM, V179, P99, DOI 10.1002/apmc.1990.051790108
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   YANG JM, 1995, DIE ANGEW MAKROMOL C, V231, P1
NR 10
TC 35
Z9 35
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1996
VL 31
IS 2
BP 281
EP 286
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UG003
UT WOS:A1996UG00300016
PM 8731218
DA 2018-10-19
ER

PT J
AU GardeaTorresdey, JL
   Tiemann, KJ
   Gonzalez, JH
   Henning, JA
   Townsend, MS
AF GardeaTorresdey, JL
   Tiemann, KJ
   Gonzalez, JH
   Henning, JA
   Townsend, MS
TI Ability of silica-immobilized Medicago sativa (alfalfa) to remove copper
   ions from solution
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE biofiltration; phytoremediation; Medicago sativa; alfalfa; copper;
   removal; recovery
ID CADMIUM; BINDING; WATER; POLY(GAMMA-GLUTAMYLCYSTEINYL)GLYCINE;
   ADSORPTION; BIOMASS; METALS; ROOTS; ZINC
AB Preliminary screening laboratory batch experiments to determine the binding ability of seven different populations of Medicago sativa (alfalfa) showed good copper binding characteristics of the biomasses studied. All seven populations examined had similar trends for binding copper as a function of pH. The copper binding by the different alfalfa populations occurred within 5 min. All the alfalfa biomasses showed high copper binding, but the capacities varied according to the alfalfa sample studied. The pH dependence of the copper ion binding to the alfalfa biomasses suggested that it might be possible to recycle the system much like an ion-exchange resin. However, the alfalfa cells cannot be packed into a column because the cells clump together and restrict the flow. We immobilized the cells of Malone alfalfa shoots in a silica matrix. Column experiments for copper binding by the silica immobilized alfalfa demonstrated that the alfalfa tissues were capable of removing considerable amounts of copper ions under flow conditions. After every copper binding cycle most of the copper was desorbed with a few bed volumes of 0.1 M HCl. Our work indicates that the Malone-silica preparations are highly durable. We subjected the biomaterial to as many as 10 cycles of binding and elution without observing any significant decrease in copper binding capacity.
C1 NEW MEXICO STATE UNIV,DEPT AGRON & HORT,LAS CRUCES,NM 88003.
RP GardeaTorresdey, JL (reprint author), UNIV TEXAS,DEPT CHEM,EL PASO,TX 79968, USA.
CR ANGLE JS, 1991, WATER AIR SOIL POLL, V57-8, P597, DOI 10.1007/BF00282923
   ATLAS RM, 1995, CHEM ENG NEWS, V3, P32
   BALIGAR VC, 1993, J PLANT NUTR, V16, P219, DOI 10.1080/01904169309364525
   BENDER J, 1994, APPL ENVIRON MICROB, V60, P2311
   CAJUSTE LJ, 1991, WATER AIR SOIL POLL, V57-8, P763, DOI 10.1007/BF00282940
   Carrillo G R., 1992, J ENV SCI HLTH, V27, P1771
   CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121
   DELHAIZE E, 1989, PLANT PHYSIOL, V89, P700, DOI 10.1104/pp.89.2.700
   DEROME L, 1991, J IND MICROBIOL, V7, P97
   GardeaTorresdey JL, 1996, SOLVENT EXTR ION EXC, V14, P119, DOI 10.1080/07366299608918330
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   HUELYANG DK, 1993, APPL SPECTROSC, V47, P44
   HUNT S, 1986, IMMOBILIZATION IONS
   JACKSON PJ, 1987, P NATL ACAD SCI USA, V84, P6619, DOI 10.1073/pnas.84.19.6619
   JAIN SK, 1990, WATER RES, V24, P177, DOI 10.1016/0043-1354(90)90100-K
   JOOST RE, 1986, CROP SCI, V26, P1250, DOI 10.2135/cropsci1986.0011183X002600060037x
   LUEKIM H, 1986, PLANT PHYSIOL, V81, P896, DOI 10.1104/pp.81.3.896
   LUJAN JR, 1994, SOLVENT EXTR ION EXC, V12, P803, DOI 10.1080/07366299408918239
   MICERA G, 1988, J INORG BIOCHEM, V34, P157, DOI 10.1016/0162-0134(88)85026-8
   RAMELOW GJ, 1993, INT J ENVIRON AN CH, V53, P219, DOI 10.1080/03067319308045991
   RAO CRN, 1993, J ENVIRON ENG-ASCE, V119, P369, DOI 10.1061/(ASCE)0733-9372(1993)119:2(369)
   RECHCIGL JE, 1988, COMMUN SOIL SCI PLAN, V19, P989, DOI 10.1080/00103628809367989
   ROMHELD V, 1983, PLANT PHYSIOL, V71, P949, DOI 10.1104/pp.71.4.949
   RUNNELLS DD, 1992, ENVIRON SCI TECHNOL, V26, P2316, DOI 10.1021/es00036a001
   SALE PWG, 1993, GENETIC ASPECTS PLAN, P45
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   Segel I. H., 1976, BIOCH CALCULATIONS
   TAN H, 1994, ENVIRON SCI TECHNOL, V26, P2402
   *USDA, 1977, TECH B USDA, V1571
   VIRARAGHAVAN T, 1993, J ENVIRON SCI HEAL A, V28, P1261, DOI 10.1080/10934529309375941
   ZHANG WX, 1994, ENVIRON SCI TECHNOL, V28, P1577, DOI 10.1021/es00058a007
NR 31
TC 53
Z9 54
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JUN
PY 1996
VL 48
IS 1-3
BP 181
EP 190
DI 10.1016/0304-3894(95)00155-7
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA UG820
UT WOS:A1996UG82000012
DA 2018-10-19
ER

PT J
AU An, YH
   Friedman, RJ
AF An, YH
   Friedman, RJ
TI Prevention of sepsis in total joint arthroplasty
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Review
DE prosthetic infection; implant; bacteria; arthroplasty
ID TOTAL HIP-REPLACEMENT; HUMAN POLYMORPHONUCLEAR LEUKOCYTES;
   COAGULASE-NEGATIVE STAPHYLOCOCCI; LOW-FRICTION ARTHROPLASTY;
   FOREIGN-BODY INFECTION; BACTERIAL-COLONIZATION; ANTIBIOTIC-PROPHYLAXIS;
   EXCHANGE ARTHROPLASTY; DENTAL TREATMENT; ULTRACLEAN AIR
AB Because of the adoption of effective prophylactic measures such as improved operating room techniques and systemic antibiotics, the prosthetic infection rate for artificial joint procedures has been reduced to 1-2%. However, because of the devastating results and large number of prosthetic procedures, prosthetic infection remains a major challenge. Common pathogens and mechanisms of infection, methods of preventing bacterial adherence to biomaterial surfaces, and clinical preventive strategies for prosthetic infections are discussed.
RP An, YH (reprint author), MED UNIV S CAROLINA,DEPT ORTHOPAED SURG,171 ASHLEY AVE,CHARLESTON,SC 29425, USA.
CR ACKART WB, 1975, J BIOMED MATER RES, V9, P55, DOI 10.1002/jbm.820090106
   An Yuehuei H., 1996, P19
   ANDREWS HJ, 1981, J BONE JOINT SURG BR, V63, P53
   ARIZONO T, 1992, ACTA ORTHOP SCAND, V63, P661
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BARTZOKAS CA, 1994, BRIT MED J, V309, P506, DOI 10.1136/bmj.309.6953.506
   Bengston S, 1989, CLIN ORTHOP RELAT R, V245, P173
   BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   BENSON MKD, 1975, ACTA ORTHOP SCAND, V46, P968, DOI 10.3109/17453677508989286
   BLENKINSOPP SA, 1991, TRENDS BIOTECHNOL, V9, P138, DOI 10.1016/0167-7799(91)90045-J
   BOWERS WH, 1973, J BONE JOINT SURG AM, VA 55, P795, DOI 10.2106/00004623-197355040-00014
   BRADY LP, 1985, J BONE JOINT SURG AM, V57, P80
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   CANNER GC, 1984, J BONE JOINT SURG AM, V66A, P1393, DOI 10.2106/00004623-198466090-00012
   CARLSSON AS, 1977, ACTA ORTHOP SCAND, V48, P405, DOI 10.3109/17453677708992017
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   CHANG TMS, 1970, T AM SOC ART INT ORG, V16, P141
   Charnley J, 1972, Clin Orthop Relat Res, V87, P167, DOI 10.1097/00003086-197209000-00020
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   CHEATLE MD, 1991, ORTHOP CLIN N AM, V22, P539
   CHERNEY DL, 1983, J BONE JOINT SURG AM, V65, P1256, DOI 10.2106/00004623-198365090-00006
   CHU CC, 1984, AM J SURG, V147, P197, DOI 10.1016/0002-9610(84)90088-6
   COSTERTON JW, 1985, BACTERIAL ADHESION M, P1
   COVENTRY MB, 1975, ORTHOP CLIN N AM, V6, P991
   DICARLO E F, 1992, Clinical Materials, V9, P235, DOI 10.1016/0267-6605(92)90104-2
   DICKINSON GM, 1993, INT J ARTIF ORGANS, V16, P749
   DOBBINS JJ, 1988, J INFECT DIS, V158, P203, DOI 10.1093/infdis/158.1.203
   Dougherty S H, 1989, Infect Dis Clin North Am, V3, P199
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DUNCAN CP, 1991, J BONE JOINT SURG S2, V73, P115
   DURAN LW, 1993, T SOC BIOMATER, V16, P35
   EFTEKHAR NS, 1976, ARCH SURG-CHICAGO, V111, P150
   ELSON RA, 1993, ORTHOP CLIN N AM, V24, P761
   ESKINAZI D, 1988, ORAL SURG ORAL MED O, V66, P430, DOI 10.1016/0030-4220(88)90261-7
   FARBER BF, 1992, J INFECT DIS, V166, P861, DOI 10.1093/infdis/166.4.861
   Fitzgerald R H Jr, 1989, Infect Dis Clin North Am, V3, P329
   FITZGERALD RH, 1977, J BONE JOINT SURG AM, V59, P847, DOI 10.2106/00004623-197759070-00001
   FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4
   FITZGERALD RH, 1973, J BONE JOINT SURG AM, VA 55, P1242, DOI 10.2106/00004623-197355060-00011
   FLETCHER M, 1976, J GEN MICROBIOL, V94, P400, DOI 10.1099/00221287-94-2-400
   FRIEDMAN RJ, 1993, T ORTHOP RES SOC, V18, P456
   GARVIN KL, 1994, CLIN ORTHOPAEDICS, V298, P97
   Gillespie W J, 1990, Infect Dis Clin North Am, V4, P465
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GORDON AS, 1981, CAN J MICROBIOL, V27, P698, DOI 10.1139/m81-108
   GOWER D J, 1985, Pediatric Neuroscience, V12, P127, DOI 10.1159/000120247
   GRAY ED, 1984, LANCET, V1, P365
   GREENFELD JI, 1995, CRIT CARE MED, V23, P894, DOI 10.1097/00003246-199505000-00018
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1983, J BONE JOINT SURG AM, V65, P128, DOI 10.2106/00004623-198365010-00021
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   GRISTINA AG, 1984, BIOMATERIALS T, V7, P175
   GRISTINA AG, 1990, INFECT DIS CLIN N AM, V4, P392
   GROGAN TJ, 1986, J BONE JOINT SURG AM, V68A, P226, DOI 10.2106/00004623-198668020-00008
   HANSSEN AD, 1994, CLIN ORTHOP RELAT R, V309, P44
   HENRICKS PAJ, 1983, INFECT IMMUN, V41, P294
   HILL C, 1981, LANCET, V1, P795
   HIRSCHMANN JV, 1980, REV INFECT DIS, V2, P1
   HUGHES SPF, 1988, J HOSP INFECT, V11, P41, DOI 10.1016/0195-6701(88)90021-7
   INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0
   JACOBSON JJ, 1987, ORAL SURG ORAL MED O, V63, P122, DOI 10.1016/0030-4220(87)90352-5
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   JERRY GJ, 1988, CLIN ORTHOP RELAT R, V236, P135
   JOSEFSSON G, 1993, CLIN ORTHOP RELAT R, V292, P210
   JOSEFSSON G, 1990, CLIN ORTHOPAEDICS, V253, P173
   JOSEFSSON G, 1981, CLIN ORTHOP RELAT R, V159, P194
   KAMME C, 1981, CLIN ORTHOP RELAT R, V154, P201
   KIESWETTER K, 1993, T SOC BIOMATER, V16, P220
   KIM YY, 1988, J BONE JOINT SURG BR, V70, P756
   KLOCK JC, 1976, BLOOD, V48, P149
   KUUSELA P, 1985, INFECT IMMUN, V50, P77
   LEARMONTH ID, 1993, ORTHOP CLIN N AM, V24, P735
   LEUNG JWC, 1992, GASTROINTEST ENDOSC, V38, P338, DOI 10.1016/S0016-5107(92)70428-3
   LIDWELL OM, 1988, J HOSP INFECT, V11, P18, DOI 10.1016/0195-6701(88)90020-5
   LIDWELL OM, 1987, ACTA ORTHOP SCAND, V58, P4, DOI 10.3109/17453678709146334
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   LIEBERMAN JR, 1994, CLIN ORTHOP RELAT R, P205
   LOWRY FD, 1983, ANN INTERN MED, V99, P834
   MADERAZO EG, 1988, CLIN ORTHOP RELAT R, V229, P131
   MASON JC, 1992, BRIT MED J, V305, P300, DOI 10.1136/bmj.305.6848.300
   MCDOWELL S, 1994, T SOC BIOMATER, V17, P201
   MENON TJ, 1983, J BONE JOINT SURG BR, V65, P580
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MERRITT K, 1991, T SOC BIOMATER, V14, P106
   Merritt K, 1992, T SOC BIOMATER, V15, P63
   MURRAY WR, 1984, CLIN ORTHOP RELAT R, V190, P89
   Naylor P T, 1990, Clin Orthop Relat Res, P126
   NAYLOR PT, 1989, T ORTHOP RES SOC, V14, P561
   NELSON JP, 1980, CLIN ORTHOPAEDICS, V147, P167
   NORDEN CW, 1991, REV INFECT DIS, V13, pS842
   NORMAN DC, 1994, CLIN GERIATR MED, V10, P703, DOI 10.1016/S0749-0690(18)30324-0
   OLSSON J, 1991, CARIES RES, V25, P51, DOI 10.1159/000261342
   OLSSON J, 1992, CARIES RES, V26, P28
   PARISI JT, 1988, BIOMATERIALS, V9, P285
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PASCUAL A, 1993, J HOSP INFECT, V24, P211, DOI 10.1016/0195-6701(93)90050-A
   PATTERSON FP, 1972, J BONE JOINT SURG AM, VA 54, P257, DOI 10.2106/00004623-197254020-00003
   PETTY W, 1988, J BONE JOINT SURG AM, V70A, P536, DOI 10.2106/00004623-198870040-00009
   POLLARD JP, 1979, BRIT MED J, V1, P707, DOI 10.1136/bmj.1.6165.707
   PRATTTERPSTRA IH, 1987, J GEN MICROBIOL, V133, P3199
   RAE T, 1983, BIOMATERIALS, V4, P175, DOI 10.1016/0142-9612(83)90006-6
   ROGERS JM, 1993, T SOC BIOMATER, V16, P256
   SANDERSON PJ, 1988, J HOSP INFECT, V11, P57, DOI 10.1016/0195-6701(88)90023-0
   SANZEN L, 1988, CLIN ORTHOPAEDICS, V229, P165
   SCOTT IR, 1993, J BONE JOINT SURG BR, V75, P28
   SHETH NK, 1985, LANCET, V2, P1266
   SIMPSON WA, 1987, REV INFECT DIS, V9, pS351
   SIVERHUS DJ, 1991, T SOC BIOMATER, V14, P13
   SPEIER JL, 1982, J COLLOID INTERF SCI, V89, P68, DOI 10.1016/0021-9797(82)90121-7
   STUART GW, 1995, T ORTHOP RES SOC, V20, P262
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TAYLOR T, 1995, CLIN RADIOL, V50, P149, DOI 10.1016/S0009-9260(05)83044-2
   TEBBS SE, 1994, EUR J CLIN MICROBIOL, V13, P111, DOI 10.1007/BF01982182
   THYNE GM, 1991, J BONE JOINT SURG BR, V73, P191
   TODD RC, 1972, BMJ-BRIT MED J, V2, P752, DOI 10.1136/bmj.2.5816.752
   TOLLEFSON DF, 1987, ARCH SURG-CHICAGO, V122, P38
   TUNKEL AR, 1993, AM J MED, V94, P100, DOI 10.1016/0002-9343(93)90127-B
   UENG WN, 1995, INT ORTHOP, V19, P55
   VAUDAUX PE, 1985, INFECT IMMUN, V50, P472
   VERGERES P, 1992, J INFECT DIS, V165, P281, DOI 10.1093/infdis/165.2.281
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P775, DOI 10.1002/jbm.820270610
   WENT P, 1995, J BONE JOINT SURG BR, V77B, P307
   WHYTE W, 1988, J HOSP INFECT, V11, P2, DOI 10.1016/0195-6701(88)90019-9
   WILSON PD, 1972, J BONE JOINT SURG AM, VA 54, P207, DOI 10.2106/00004623-197254020-00001
   WYMENGA AB, 1991, CLIN PHARMACOL THER, V50, P215, DOI 10.1038/clpt.1991.127
   Yandrich T J, 1995, Orthop Nurs, V14, P15
   YAO JDC, 1993, J CLIN MICROBIOL, V31, P3323
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 134
TC 68
Z9 70
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD JUN
PY 1996
VL 33
IS 2
BP 93
EP 108
DI 10.1016/S0195-6701(96)90094-8
PG 16
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA UT201
UT WOS:A1996UT20100002
PM 8808743
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Bujan, J
   Contreras, L
   Hernando, A
AF Bellon, JM
   Bujan, J
   Contreras, L
   Hernando, A
TI Interface formed between visceral peritoneum and experimental
   polypropylene or polytetrafluoroethylene abdominal wall implants
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID REPAIR; DEFECTS; MESH; MACROPHAGE; MARLEX; RATS
AB The objective of this work was to study the healing process at the interface between biomaterial and visceral peritoneum. Implants of polytetrafluoroethylene (ePTFE) and polypropylene prostheses were introduced into the abdominal wall of New Zea la nd rabbits. The behaviour of the biomaterials was analysed using light and scanning electron microscopy and immunohistochemistry in which a specific anti-rabbit macrophage monoclonal antibody (RAM 11) was employed. According to macroscopic observation,there was significantly fewer adhesions prosthesis-viscera to ePTFE than to polypropylene implants. After ePTFE implantation, restoration of the peritoneum took place in an orderly fashion. When polypropylene was used, the peritoneum formed was a disorderly tissue in which small areas of haemorrhage and necrosis could be seen to coincide with the appearance of adhesions. The number of labelled macrophages peaked 14 days after ePTFE or polypropylene implantation, after wh ich it decreased gradually. It is concluded that, given the low rate of adhesion provoked by PTFE, this material is ideal for im-plants contiguous to the peritoneal cavity viscera. The macrophage response does not determine the use of one material or the other. The structure of the newly formed peritoneum and development of adhesions depends on the porosity of the biomaterial.
RP Bellon, JM (reprint author), UNIV ALCALA DE HENARES, FAC MED, DEPT MORPHOL SCI & SURG, SURG RES LAB, MADRID, SPAIN.
RI Hernando, Antonio/E-2105-2015
OI Hernando, Antonio/0000-0001-7856-3768; bujan, Julia/0000-0003-2419-2476;
   BELLON, JUAN M./0000-0002-6071-5011
CR BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   BLEICHRODT RP, 1993, SURG GYNECOL OBSTET, V176, P18
   BROWDER W, 1988, SURGERY, V104, P224
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   JENKINS SD, 1983, SURGERY, V94, P392
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   LAMB JP, 1983, SURGERY, V93, P643
   Law NW, 1988, CLIN MATER, V3, P95
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   MILLIGAN DW, 1974, BRIT J SURG, V61, P274, DOI 10.1002/bjs.1800610406
   MURPHY JL, 1989, CAN J SURG, V32, P244
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   MYHREJENSEN O, 1969, ARCH PATHOL, V88, P623
   PANS A, 1992, EUR SURG RES, V24, P54, DOI 10.1159/000129188
   PORTER J M, 1969, Surgical Forum (Chicago), V20, P80
   SCHNEIDER R, 1979, AM SURGEON, V45, P337
   STONE HH, 1981, ANN SURG, V193, P612, DOI 10.1097/00000658-198105000-00011
NR 19
TC 17
Z9 17
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 1996
VL 7
IS 6
BP 331
EP 336
DI 10.1007/BF00154544
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UT352
UT WOS:A1996UT35200004
DA 2018-10-19
ER

PT J
AU Hauptmann, S
   Klosterhalfen, B
   Mittermayer, C
   Ruhlmann, KU
   Kaufmann, R
   Hocker, H
AF Hauptmann, S
   Klosterhalfen, B
   Mittermayer, C
   Ruhlmann, KU
   Kaufmann, R
   Hocker, H
TI Evidence for macrophage-mediated defluorization of a Teflon vascular
   graft
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYTETRAFLUOROETHYLENE ARTERIAL PROSTHESES; HUMANS
AB Polytetrafluoroethylene (PTFE) is a common biomaterial used for vascular grafts because it is regarded as a nondegradable material with good healing characteristics and a low complication rate, even as a long-term implant. XPS-investigation of a ruptured arterial PTFE-prosthesis with formation of a false aneurysm revealed loss of fluorine at the area of rupture, whereas fluorine was found in the morphologically intact areas in normal concentrations. Because macrophages, found in large number at the ruptured a nd degraded area, are capable of producing hydroperoxide radicals, it is assumed that the present case is an example of macrophage-mediated defluorization with subsequent rupture of the PTFE-prosthesis.
C1 CLIN ANGIOL,DOMHOFKLIN,D-52062 AACHEN,GERMANY.
   UNIV TECHNOL,D-52062 AACHEN,GERMANY.
RP Hauptmann, S (reprint author), UNIV TECHNOL,INST PATHOL,PAUWELSSTR 30,D-52057 AACHEN,GERMANY.
CR ANDERSON CB, 1980, DIALYSIS TRANSPLANT, V47, P145
   CAMILLERI JP, 1985, ARCH PATHOL LAB MED, V109, P833
   CAMPBELL CD, 1976, SURGERY, V79, P485
   Chakfe N, 1991, J Biomater Appl, V5, P227, DOI 10.1177/088532829100500306
   Formichi M J, 1988, Ann Vasc Surg, V2, P14, DOI 10.1016/S0890-5096(06)60773-5
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   GUIDOIN R, 1993, BIOMATERIALS, V14, P694, DOI 10.1016/0142-9612(93)90068-D
   KAEBNICK HW, 1987, SURGERY, V102, P756
   MATSUMOTO H, 1973, SURGERY, V74, P519
   NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815
   SOYER T, 1972, SURGERY, V72, P864
NR 11
TC 7
Z9 7
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 1996
VL 7
IS 6
BP 345
EP 348
DI 10.1007/BF00154546
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UT352
UT WOS:A1996UT35200006
DA 2018-10-19
ER

PT J
AU Heberle, J
   Zscherp, C
AF Heberle, J
   Zscherp, C
TI ATR/FT-IR difference spectroscopy of biological matter with microsecond
   time resolution
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE time-resolved infrared spectroscopy; step-scan; attenuated total
   reflection; photosynthesis; bacteriorhodopsin; proton transfer
ID TRANSFORM INFRARED-SPECTROSCOPY; HYDROGEN-BONDED CHAINS; INDUCED PROTON
   RELEASE; PURPLE MEMBRANE; BACTERIORHODOPSIN PHOTOCYCLE;
   HALOBACTERIUM-HALOBIUM; CONFORMATIONAL-CHANGES; RETINAL CHROMOPHORE;
   FTIR-SPECTROSCOPY; SCHIFF-BASE
AB Attenuated total reflection (ATR) spectroscopy allows precise control of external parameters vital for proper functioning of biological matter. For the first time in biospectroscopy, ATR difference spectroscopy has been combined with the step-scan technique. The current setup integrates a broad frequency range (800-25,000 cm (1)) with high temporal resolution (5 mu s). Vibrations are detected that arise from single amino acids (<10-3 absorbance units) of the chromoprotein bacteriorhodopsin. Time-resolved ATR/FT-IR difference spectra are compared with conventional transmission spectra. The high mirror stability enables time-resolved FT-vis spectroscopy of the same sample with the same instrument. Potential applications even to non-light-absorbing biomaterial are discussed.
RP Heberle, J (reprint author), FORSCHUNGSZENTRUM JULICH, INST BIOL INFORMAT VERARBEITUNG, IBI STRUCT BIOL 2, D-52425 JULICH, GERMANY.
RI Heberle, Joachim/D-8605-2016
OI Heberle, Joachim/0000-0001-6321-2615
CR ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543
   BAGLEY K, 1982, P NATL ACAD SCI-BIOL, V79, P4972, DOI 10.1073/pnas.79.16.4972
   BRAIMAN M, 1982, P NATL ACAD SCI-BIOL, V79, P403, DOI 10.1073/pnas.79.2.403
   BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002
   CAO Y, 1991, BIOCHEMISTRY-US, V30, P10972, DOI 10.1021/bi00109a023
   CHEN WG, 1991, PHOTOCHEM PHOTOBIOL, V54, P905, DOI 10.1111/j.1751-1097.1991.tb02110.x
   EARNEST TN, 1986, BIOCHEMISTRY-US, V25, P7793, DOI 10.1021/bi00372a002
   ECKERT M, 1988, J PHYS CHEM-US, V92, P7016, DOI 10.1021/j100335a035
   ELSAYED MA, 1992, ACCOUNTS CHEM RES, V25, P279, DOI 10.1021/ar00019a002
   FAHMY K, 1992, PHOTOCHEM PHOTOBIOL, V56, P1073, DOI 10.1111/j.1751-1097.1992.tb09731.x
   FISCHER WB, 1994, BIOCHEMISTRY-US, V33, P12757, DOI 10.1021/bi00209a005
   Fringeli U. P., 1992, INTERNAL REFLECTION, P255
   GERWERT K, 1992, BIOCHIM BIOPHYS ACTA, V1101, P147, DOI 10.1016/0005-2728(92)90199-C
   GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943
   GRIFFITHS RP, 1986, FOURIER TRANSFORM IN
   GRZESIEK S, 1986, FEBS LETT, V208, P337, DOI 10.1016/0014-5793(86)81045-6
   HARTLAND GV, 1992, REV SCI INSTRUM, V63, P3261, DOI 10.1063/1.1143815
   HEBERLE J, 1990, FEBS LETT, V277, P277, DOI 10.1016/0014-5793(90)80864-F
   HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996
   HEBERLE J, 1994, NATURE, V370, P379, DOI 10.1038/370379a0
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   HESSLING B, 1993, BIOPHYS J, V65, P1929, DOI 10.1016/S0006-3495(93)81264-5
   HOFRICHTER J, 1985, BIOCHEMISTRY-US, V24, P2667, DOI 10.1021/bi00332a012
   KANDORI H, 1995, J AM CHEM SOC, V117, P2118, DOI 10.1021/ja00112a036
   KREBS MP, 1993, J BACTERIOL, V175, P1555
   LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0
   LECOUTRE J, 1995, P NATL ACAD SCI USA, V92, P11
   LIDE DR, 1993, CRC HDB CHEM PHYSICS
   LOZIER RH, 1976, BIOCHIM BIOPHYS ACTA, V440, P545, DOI 10.1016/0005-2728(76)90041-4
   LUDLAM CFC, 1995, BIOCHEMISTRY-US, V32, P2
   MAEDA A, 1992, BIOCHEMISTRY-US, V31, P462, DOI 10.1021/bi00117a023
   MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q
   MARRERO H, 1987, FEBS LETT, V223, P289, DOI 10.1016/0014-5793(87)80306-X
   MARRERO H, 1987, BIOPHYS J, V52, P629, DOI 10.1016/S0006-3495(87)83254-X
   MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423
   MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239
   MULLER KH, 1991, EUR BIOPHYS J, V19, P241
   NAGLE JF, 1980, J CHEM PHYS, V72, P3959, DOI 10.1063/1.439674
   NOLKER K, 1992, SPRINGER P PHYSICS, V68, P57
   OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0
   OLEJNIK J, 1992, J MOL STRUCT, V271, P157, DOI 10.1016/0022-2860(92)80123-Y
   OSAWA M, 1994, LANGMUIR, V10, P640, DOI 10.1021/la00015a009
   PALMER RA, 1993, APPL SPECTROSC, V47, P1297, DOI 10.1366/0003702934067568
   PAPADOPOULOS G, 1990, J MOL BIOL, V214, P15, DOI 10.1016/0022-2836(90)90140-H
   RIESLE J, UNPUB BIOCHEMISTRY
   ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674
   SASAKI J, 1994, BIOCHEMISTRY-US, V33, P3178, DOI 10.1021/bi00177a006
   SIEBERT F, 1983, EUR J BIOCHEM, V130, P565, DOI 10.1111/j.1432-1033.1983.tb07187.x
   SIEBERT F, 1995, METHOD ENZYMOL, V246, P501
   SKULACHEV VP, 1981, CHEMIOSMOTIC PROTON, P3
   SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263
   SONAR S, 1994, NAT STRUCT BIOL, V1, P512, DOI 10.1038/nsb0894-512
   SOUVIGNIER G, 1992, BIOPHYS J, V63, P1393, DOI 10.1016/S0006-3495(92)81722-8
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   SZARAZ S, 1994, BIOPHYS J, V67, P1706, DOI 10.1016/S0006-3495(94)80644-7
   THIEDEMANN G, 1992, STRUCTURES FUNCTIONS, V221, P221
   UHMANN W, 1991, APPL SPECTROSC, V45, P390, DOI 10.1366/0003702914337128
   VARO G, 1991, BIOPHYS J, V59, P313, DOI 10.1016/S0006-3495(91)82225-1
   WILLIAMS RJP, 1994, BBA-BIOENERGETICS, V1187, P125, DOI 10.1016/0005-2728(94)90097-3
NR 60
TC 50
Z9 50
U1 0
U2 14
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA 201B BROADWAY ST, FREDERICK, MD 21701 USA
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD MAY
PY 1996
VL 50
IS 5
BP 588
EP 596
DI 10.1366/0003702963905907
PG 9
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA UM065
UT WOS:A1996UM06500011
DA 2018-10-19
ER

PT J
AU Campoccia, D
   Hunt, JA
   Doherty, PJ
   Zhong, SP
   ORegan, M
   Benedetti, L
   Williams, DF
AF Campoccia, D
   Hunt, JA
   Doherty, PJ
   Zhong, SP
   ORegan, M
   Benedetti, L
   Williams, DF
TI Quantitative assessment of the tissue response to films of hyaluronan
   derivatives
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; hyaluronan; tissue response; resorbable biomaterial
ID DERMAL SHEEP COLLAGEN; BIOMATERIALS
AB The aim of this study was to evaluate the in vivo response following implantation into a rat model of three innovative hyaluronan derivatives for clinical use: HYAFF 7, HYAFF 11 and HYAFF 11p75 (respectively, the 100% ethyl ester, 100% and 75% benzyl esters). The tissue reaction evoked by films of these new biomaterials implanted into the dorsolumbar musculature of rats was assessed quantitatively using a well established technique based upon an image analysis system. The number of inflammatory cells present and the patterns of cell distribution around the implant up to a distance of 642 mu m were examined at different time periods after implantation. Since a well-delineated tissue-material interface was needed for this type of investigation, it was not possible to apply image analysis to sections once dissolution of the implanted materials had begun. Films of both the total esters, HYAFF 7 and HYAFF 11, were found to undergo a slow dissolution process and, after a month, films of these materials were still present at the site of implantation. Differences in response to the two materials were observed only during the first two weeks, particularly with respect to neutrophil distribution and total cellularity. HYAFF 7 was found to be more reactive, with higher numbers of neutrophils near the surface of the implant than HYAFF 11. Thereafter, the differences between the two materials were minimal and owing mainly to a faster dissolution of HYAFF 7 films. After 3 and 5 months, considerable degradation of films of both total esters had occurred. Significant quantities of material appeared inside numerous macrophages with an ED1-positive phenotype. Only a very thin layer of fibrous connective tissue, indicative of low reactivity, was found to surround the site of implantation, separating the dissolved material and the phagocytic cells from healthy muscular tissue. ED2-positive macrophages were primarily confined within the lining connective tissue. The partial benzyl ester, HYAFF 11p75, showed a different behaviour. In fact, evidence of film dissolution was already present a week after the implantation. After two weeks, the implanted films were completely dissolved and numerous ED1-positive macrophages phagocytosing the material were observed at the site of implantation. Therefore, in agreement with previous in vitro studies, which showed a greater susceptibility to degradation of hyaluronan derivatives with lower percentage of esterification, HYAFF 11p75 underwent resorption faster than the corresponding total ester.
C1 UNIV LIVERPOOL,DEPT CLIN ENGN,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
   FIDIA ADV BIOPOLYMERS SRL,I-35031 ABANO TERME,PADUA,ITALY.
RI Campoccia, Davide/K-5348-2018; Hunt, John/G-6366-2012
OI Campoccia, Davide/0000-0002-3336-0219; Hunt, John/0000-0002-5168-4778
CR ANDREASSI L, 1991, WOUNDS, V3, P116
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   CAMPOCCIA D, 1993, BIOMATERIALS, V14, P1135, DOI 10.1016/0142-9612(93)90156-V
   CAMPOCCIA D, 1996, THESIS U LIVERPOOL U
   DAVIDSON J M, 1991, Clinical Materials, V8, P171, DOI 10.1016/0267-6605(91)90027-D
   HUNT JA, 1993, BIOMATERIALS, V14, P378, DOI 10.1016/0142-9612(93)90058-A
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   LAM KH, 1992, BIOCOMPATIBILITY DEG, P67
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   PAPINI D, 1991, P 18 INT S CONTR REL, P611
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   St Pierre B. A., 1994, J APPL PHYSIOL, V77, P290
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
NR 16
TC 55
Z9 56
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1996
VL 17
IS 10
BP 963
EP 975
DI 10.1016/0142-9612(96)84670-9
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UL396
UT WOS:A1996UL39600003
PM 8736730
DA 2018-10-19
ER

PT J
AU Matsui, R
   Osaki, K
   Konishi, J
   Ikegami, K
   Koide, M
AF Matsui, R
   Osaki, K
   Konishi, J
   Ikegami, K
   Koide, M
TI Evaluation of an artificial dermis full-thickness skin defect model in
   the rat
SO BIOMATERIALS
LA English
DT Article
DE collagen; dehydrothermal cross-linking; artificial dermis
ID CROSS-LINKING; COLLAGEN; GLUTARALDEHYDE; STABILIZATION; BIOMATERIAL;
   FIBRILLAR; MATRICES
AB An artificial dermis product was applied to full-thickness skin defects in rats and cell infiltration into the collagen matrix was investigated. Host fibroblasts and capillaries infiltrated as far as the upper end of the collagen matrix by day 14 after application. Determination of glycosaminoglycan levels in the matrix showed that hyaluronic acid was generated in a similar amount to that seen in the intact skin by day 14. An autologous thin split-thickness skin graft was placed onto the artificial dermis simultaneously or several days after its application to the defect. The take rate was 100% when a split-thickness skin graft was performed on day 14 after application of the artificial dermis. At 6 weeks after the skin defect was created, the wound area was 80% of the original area and the dermis at the grafted site was as thick as that of normal skin. These results suggested that the artificial dermis provides a good matrix for thin split-thickness skin graft and is useful for the reconstruction of full-thickness skin defects. This method is considered to be an alternative to the conventional procedure using thick skin grafts or skin flaps.
RP Matsui, R (reprint author), TERUMO CO LTD, CTR RES & DEV, 1500 INOKUCHI, NAKAI, KANAGAWA 25901, JAPAN.
CR BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   BURKE JF, 1983, J TRAUMA, V23, P543, DOI 10.1097/00005373-198307000-00001
   COOKE A, 1983, BR J EXP PATHOL, V64, P351
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   FU MX, 1992, DIABETES, V41, P42, DOI 10.2337/diab.41.2.S42
   GADE JN, 1991, J BIOMED MATER RES, V25, P799, DOI 10.1002/jbm.820250702
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HATA R, 1973, PROTEIN NUCLEOTIDE E, V18, P843
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   HEY KB, 1990, BIOTECHNOL APPL BIOC, V12, P85
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   MATSUDA K, 1993, BIOMATERIALS, V14, P1030, DOI 10.1016/0142-9612(93)90197-A
   MATSUDA S, 1990, BR J PLAST SURG, V43, P47
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   MOWRY RW, 1963, ANN NY ACAD SCI, V106, P402
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NORTON L, 1981, J TRAUMA, V21, P463
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   PETITE H, 1994, J BIOMED MATER RES, V28, P159, DOI 10.1002/jbm.820280204
   POSTLETHWAITE AE, 1988, INFLAMMATION BASIC P, P577
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   SUZUKI S, 1990, BIOMATERIALS, V11, P356, DOI 10.1016/0142-9612(90)90114-6
   TAKEDA U, 1983, Journal of Dermatology (Tokyo), V10, P475
   VANGULIK TM, 1989, NETH J SURG, V41, P65
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WANG MC, 1994, BIOMATERIALS, V15, P507
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   YANNAS AV, 1967, NATURE, V215, P509
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 30
TC 36
Z9 36
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1996
VL 17
IS 10
BP 989
EP 994
DI 10.1016/0142-9612(96)84673-4
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UL396
UT WOS:A1996UL39600006
PM 8736733
DA 2018-10-19
ER

PT J
AU Tunney, MM
   Bonner, MC
   Keane, PF
   Gorman, SP
AF Tunney, MM
   Bonner, MC
   Keane, PF
   Gorman, SP
TI Development of a model for assessment of biomaterial encrustation in the
   upper urinary tract
SO BIOMATERIALS
LA English
DT Article
DE ureteral stents; encrustation; polyurethanes; artificial urine
ID CATHETERS; HYDROGEL
AB A need exists for ureteral stent materials capable of preventing or reducing encrustation. The aim of this study, therefore, was to develop an in vitro model producing biomaterial encrustation similar to that on stents in vivo. Three models were designed and evaluated. Polyurethane stent sections were immersed in human urine (37 degrees C, 5% CO2): (1) with and (2) without crushed human kidney stone and (3) in an artificial urine (37 degrees C, 5% CO2). Encrustation of similar composition, as determined by infrared spectroscopy, X-ray diffraction and energy dispersive X-ray analysis, formed on stent materials in vivo, in artificial urine and in human urine with crushed kidney stone. Magnesium ammonium phosphate (struvite) and calcium phosphate (hydroxyapatite) predominated in all encrustations. The reproducibility and ease of use of the artificial urine model provided optimum encrustation assessment of materials presently used in ureteral stents and evaluation of novel biomaterials.
C1 QUEENS UNIV BELFAST,SCH PHARM,BELFAST,ANTRIM,NORTH IRELAND.
   BELFAST CITY HOSP,DEPT UROL,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND.
CR Bonner M. C., 1994, Journal of Pharmacy and Pharmacology, V46, P1081
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   COX AJ, 1989, UROL RES, V17, P349, DOI 10.1007/BF00510523
   COX AJ, 1987, ENG MED, V126, P37
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   GLEESON MJ, 1989, T AM SOC ART INT ORG, V35, P495
   GORDON NSI, 1989, BRIT J UROL, V64, P195, DOI 10.1111/j.1464-410X.1989.tb05987.x
   GORMAN SP, 1993, PHARMACOTHERAPY, V13, P281
   GORMAN SP, 1991, P 10 PHARM TECH C, V2, P649
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   MILLER JM, 1974, INVEST UROL, V11, P402
   ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6
NR 14
TC 31
Z9 31
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1996
VL 17
IS 10
BP 1025
EP 1029
DI 10.1016/0142-9612(96)84679-5
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UL396
UT WOS:A1996UL39600012
PM 8736739
DA 2018-10-19
ER

PT J
AU Pande, MV
   Spalton, DJ
   Marshall, J
AF Pande, MV
   Spalton, DJ
   Marshall, J
TI In vivo human lens epithelial cell proliferation on the anterior surface
   of PMMA intraocular lenses
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID POSTERIOR CAPSULAR OPACIFICATION; ENDOCAPSULAR CATARACT-SURGERY;
   FIBRONECTIN; REMOVAL; PATHOGENESIS; ADHESION; CULTURE; LAMININ; RABBITS;
   DESIGN
AB Aims-To study in vivo human lens epithelial cell proliferation on the anterior surface of PMMA implants and its interaction with postoperative blood-aqueous barrier breakdown in eyes undergoing cataract surgery.
   Methods-A prospective study was carried out on three consecutive patient cohorts undergoing cataract surgery with intraocular lens implantation using three different surgical techniques which produce different anatomical relations between the implant and lens capsule. Specular microscopy of the anterior implant surface was used to document the natural history, topography, and density of lens epithelial cells and the laser flare and cell meter were used to measure postoperative blood-aqueous barrier breakdown.
   Results-Ah groups showed lens epithelial cell proliferation onto the anterior surface of PMMA implants. This was initiated by and restricted to the region of anterior capsule-implant contact and decreased with the onset of anterior capsular opacification. Significant correlation was found in all groups between lens epithelial cell proliferation and postoperative blood-aqueous barrier breakdown.
   Conclusions-Human lens epithelial cell behaviour on PMMA surfaces in vivo differs from that seen in culture studies. Humoral factors in the aqueous, biomaterial properties of the implant, and its anatomical relations with the anterior and posterior lens capsule influence lens epithelial cell behaviour in vivo.
C1 ST THOMAS HOSP,DEPT OPHTHALMOL,CATARACT & REFRACT SURG RES UNIT,LONDON,ENGLAND.
CR APPLE DJ, 1984, SURV OPHTHALMOL, V29, P1, DOI 10.1016/0039-6257(84)90113-9
   ARITA T, 1993, INVEST OPHTH VIS SCI, V34, P355
   AYAKI M, 1990, Nippon Ganka Gakkai Zasshi, V94, P559
   BORN CP, 1990, J CATARACT REFR SURG, V16, P188, DOI 10.1016/S0886-3350(13)80728-6
   BOYD W, 1992, J CATARACT REFR SURG, V18, P180, DOI 10.1016/S0886-3350(13)80928-5
   COBO LM, 1984, OPHTHALMOLOGY, V91, P857
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   Davis P, 1989, EUR J IMPLANT REFRAC, V1, P237
   Davis PL, 1991, EUR J IMPLANT REFRAC, V3, P127
   FAGERHOLM P, 1992, ACTA OPHTHALMOL, V205, P58
   FREZZOTTI R, 1990, J CATARACT REFR SURG, V16, P353, DOI 10.1016/S0886-3350(13)80708-0
   HANSEN TE, 1988, J CATARACT REFR SURG, V14, P383, DOI 10.1016/S0886-3350(88)80143-3
   HARA T, 1988, J CATARACT REFR SURG, V14, P533, DOI 10.1016/S0886-3350(88)80012-9
   HARA T, 1992, OPHTHALMIC SURG LAS, V23, P94
   Hettlich H J, 1990, Fortschr Ophthalmol, V87, P147
   HUMPHRY RC, 1991, EYE, V5, P66, DOI 10.1038/eye.1991.13
   ICHIJIMA H, 1992, J CATARACT REFR SURG, V18, P395, DOI 10.1016/S0886-3350(13)80079-X
   KANAGAWA R, 1990, GRAEF ARCH CLIN EXP, V228, P398, DOI 10.1007/BF00927249
   KAPPELHOF JP, 1986, AM J OPHTHALMOL, V102, P750, DOI 10.1016/0002-9394(86)90403-4
   LOVICU FJ, 1993, INVEST OPHTH VIS SCI, V34, P3355
   LUNDGREN B, 1992, ACTA OPHTHALMOL    S, V205, P25
   MARTIN RG, 1992, J CATARACT REFR SURG, V18, P333, DOI 10.1016/S0886-3350(13)80067-3
   MCDONNELL PJ, 1983, OPHTHALMOLOGY, V90, P1548
   NISHI K, 1991, Nippon Ganka Gakkai Zasshi, V95, P581
   NISHI O, 1987, OPHTHALMIC SURG LAS, V18, P577
   NISHI O, 1993, J CATARACT REFR SURG, V19, P56, DOI 10.1016/S0886-3350(13)80282-9
   NISHI O, 1991, J CATARACT REFR SURG, V17, P218, DOI 10.1016/S0886-3350(13)80253-2
   OHARA K, 1985, AM J OPHTHALMOL, V99, P304, DOI 10.1016/0002-9394(85)90360-5
   OHARA K, 1992, ACTA OPHTHALMOL, V205, P29
   OLIVERO DK, 1993, INVEST OPHTH VIS SCI, V34, P2825
   PANDE M, IN PRESS J CATARACT
   PARMIGIANI CM, 1991, CURR EYE RES, V10, P501, DOI 10.3109/02713689109001758
   SAIKA S, 1984, JPN J OPHTHALMOL, V36, P184
   SAKAMOTO T, 1990, Nippon Ganka Gakkai Zasshi, V94, P1074
   SIEVERS H, 1984, AM J OPHTHALMOL, V97, P743, DOI 10.1016/0002-9394(84)90507-5
   STERLING S, 1986, J CATARACT REFR SURG, V12, P655, DOI 10.1016/S0886-3350(86)80080-3
   TETZ MR, 1988, J CATARACT REFR SURG, V14, P614, DOI 10.1016/S0886-3350(88)80028-2
   WENZEL M, 1988, GRAEF ARCH CLIN EXP, V226, P449, DOI 10.1007/BF02170007
   WILHELMUS KR, 1980, OPHTHALMIC SURG LAS, V11, P264
NR 39
TC 28
Z9 30
U1 0
U2 0
PU BRITISH MED JOURNAL PUBL GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR
SN 0007-1161
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD MAY
PY 1996
VL 80
IS 5
BP 469
EP 474
DI 10.1136/bjo.80.5.469
PG 6
WC Ophthalmology
SC Ophthalmology
GA UM864
UT WOS:A1996UM86400020
PM 8695571
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Grippo, JO
AF Grippo, JO
TI Bioengineering seeds of contemplation: A private practitioner's
   perspective
SO DENTAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 1995 Academy-of-Dental-Materials Annual Meeting
CY 1995
CL LA JOLLA, CA
SP Acad Dental Mat
ID CERVICAL LESIONS; STRESS
AB In a precise semantic sense, the most significant biomaterial in dentistry is the human tooth. How it reacts, changes and is affected during the dynamics of occlusal loading should be reexamined in light of modern technology. Much is known about the embryology, histology, biochemistry, anatomy, and the microbiology affecting teeth; however, there are areas of biomechanics, biochemistry, and bioelectricity which also affect dental hard tissues that remain largely unexplored. Technological advances enable us to use more sophisticated instrumentation to measure and quantify changes that occur during the dynamics of occlusal activity. Armed with this information, dentistry can better understand how teeth interact with restorative materials in order to increase the longevity of both.
CR ANDERSON D J, 1956, J Dent Res, V35, P664, DOI 10.1177/00220345560350050201
   ANDERSON DJ, 1953, J DENT RES, V32, P785, DOI 10.1177/00220345530320060601
   Bayne S. C., 1992, BIOMATERIALS SCI
   BIBBY BG, 1968, ANN NY ACAD SCI, V153, P197, DOI 10.1111/j.1749-6632.1968.tb11735.x
   BRAEM M, 1992, J PROSTHET DENT, V67, P718, DOI 10.1016/0022-3913(92)90178-D
   Caputo AA, 1987, BIOMECHANICS CLIN DE, P19
   Grippo J O, 1991, J Esthet Dent, V3, P14, DOI 10.1111/j.1708-8240.1991.tb00799.x
   Grippo J O, 1991, J Esthet Dent, V3, P71, DOI 10.1111/j.1708-8240.1991.tb00813.x
   GRIPPO JO, 1995, J AM DENT ASSOC, V126, P619, DOI 10.14219/jada.archive.1995.0241
   Grosskopf G, 1967, THESIS FRANKFURT
   HAINES KJ, 1963, J DENT RES, V42, P885
   HARRIS C, 1871, PRINCIPLES PRACTICE, P248
   HEYMANN HO, 1991, J AM DENT ASSOC, V122, P41, DOI 10.1016/S0002-8177(91)25015-1
   Kohler E., 1965, DTSCH ZAHNARZTL Z, V20, P721
   KORBER KH, 1962, DTSCH ZAHNARZTL Z, V20, P691
   Lebau G I, 1968, Bull Union Cty Dent Soc, V47, P11
   LEE WC, 1984, J PROSTHET DENT, V52, P374, DOI 10.1016/0022-3913(84)90448-7
   LEHMAN ML, 1966, J DENT RES, V45, P1706, DOI 10.1177/00220345660450062301
   LEVITCH LC, 1994, J DENT, V22, P195, DOI 10.1016/0300-5712(94)90107-4
   Lukas D, 1973, Dtsch Zahnarztl Z, V28, P280
   MCCOY G, 1983, ORAL IMPLANTOL, V11, P248
   Miller WD, 1907, DENT COSMOS, V2, P109
   Miller WD., 1907, DENT COSMOS, V49, P1
   MILLER WD, 1907, DENT COSMOS, V49, P225
   NEUMANN H. H., 1957, JOUR DENTAL RES, V36, P286, DOI 10.1177/00220345570360022001
   NEUMANN HH, 1965, ANN NY ACAD SCI, V131, P893, DOI 10.1111/j.1749-6632.1965.tb34854.x
   NEUMANN HH, 1950, J DENT RES, V29, P101
   NEUMANN HH, 1957, J AM DENT ASSOC, V54, P598
   Spranger H, 1995, Quintessence Int, V26, P149
   Spranger H, 1969, Stoma (Heidelb), V22, P145
   SPRANGER H, 1973, KARIESPROPHYAXE KARI, P328
   Weiss M B, 1990, J Mass Dent Soc, V39, P23
   ZGISMONDY U, 1894, OSTERR UNGAR VIHRSCH, V1, P439
NR 33
TC 7
Z9 7
U1 0
U2 0
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAY
PY 1996
VL 12
IS 3
BP 198
EP 202
DI 10.1016/S0109-5641(96)80022-4
PG 5
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA VM158
UT WOS:A1996VM15800010
PM 9002864
DA 2018-10-19
ER

PT J
AU Yung, LYL
   Lim, F
   Khan, MMH
   Kunapuli, SP
   Rick, L
   Colman, RW
   Cooper, SL
AF Yung, LYL
   Lim, F
   Khan, MMH
   Kunapuli, SP
   Rick, L
   Colman, RW
   Cooper, SL
TI Neutrophil adhesion on surfaces preadsorbed with high molecular weight
   kininogen under well-defined flow conditions
SO IMMUNOPHARMACOLOGY
LA English
DT Article; Proceedings Paper
CT 14th International Symposium on Bradykinin and Related Kinins (KININ 95)
CY SEP 10-15, 1995
CL DENVER, CO
DE neutrophil adhesion; high molecular weight kininogen; radial flow system
ID CELL-ADHESION; HEMODIALYSIS; LEUKOCYTES
AB The adhesion of neutrophils and other leukocytes to biomaterial surfaces is an important phenomenon in the host response to biomaterials because the number of adherent leukocytes is often related to the inflammatory response after implantation. After adhering to biomaterial surfaces, other leukocyte reactions, such as phagocytosis, respiratory burst, and protease release, may occur and result in the deterioration of the implanted biomaterial and injury to peripheral tissue. This study of neutrophil adhesion quantitatively characterizes neutrophil adhesion under well-defined laminar flow conditions using a radial flow chamber. In this theologically well-defined system, the fluid shear rate on the surface varies continuously with radial position. This allows the study of shear-dependent behavior of neutrophil adhesion. Exploiting the variable shear rate in the radial flow chamber, the kinetics of neutrophil adhesion was obtained using automated video microscopy and image analysis to recursively acquire cell counts from multiple fields in different radial positions, and to quantify the surface density of neutrophil as a function of time. Neutrophil adhesion was studied on glass preadsorbed with fibrinogen and high-molecular-weight kininogen (HK). At a shear rate of 20 s(-1), the number of adherent cells on the preadsorbed fibrinogen surface was similar to that on ban glass, and the number of adherent cells on the HK surface was less than 10% of that on the bare glass. We conclude that surfaces preadsorbed with HK are anti-adhesive to neutrophils.
C1 TEMPLE UNIV,SCH MED,SOL SHERRY THROMBOSIS RES CTR,PHILADELPHIA,PA 19140.
RP Yung, LYL (reprint author), UNIV DELAWARE,DEPT CHEM ENGN,NEWARK,DE 19716, USA.
RI Yung, Lanry/B-6515-2009
OI Yung, Lanry/0000-0001-7579-6347
FU NHLBI NIH HHS [HL-45486, HL-47179]
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   BOHLER J, 1983, CONT HEPHROL, V36, P1
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   CURTIS ASG, 1973, PROGR BIOPHYS MOL BI, V27, P317
   DICKINSON RB, IN PRESS AM I CHEM E
   FORRESTER JV, 1984, J CELL SCI, V70, P93
   HALLGREN R, 1982, NEPHRON, V32, P329, DOI 10.1159/000182874
   LONG J, 1983, BIOMATER ARTIF CELL, V11, P63, DOI 10.3109/10731198309118795
   MARCHANT RE, 1984, J ADHESION, V20, P211
   MOLLER PS, 1963, AERONATUTICAL Q  MAY, V163
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   RYHANEN P, 1979, J THORAC CARDIOV SUR, V77, P259
   van Oss C. J., 1975, PHAGOCYTIC ENGULFMEN
   ZIMMERMAN GA, 1982, AM REV RESPIR DIS, V126, P1097
NR 17
TC 20
Z9 20
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0162-3109
J9 IMMUNOPHARMACOLOGY
JI Immunopharmacology
PD MAY
PY 1996
VL 32
IS 1-3
BP 19
EP 23
DI 10.1016/0162-3109(96)00003-3
PG 5
WC Immunology; Pharmacology & Pharmacy
SC Immunology; Pharmacology & Pharmacy
GA UR643
UT WOS:A1996UR64300006
PM 8796260
DA 2018-10-19
ER

PT J
AU Bento, AC
   Almond, DP
   Brown, SR
   Turner, IG
AF Bento, AC
   Almond, DP
   Brown, SR
   Turner, IG
TI Thermal and optical characterization of the calcium phosphate
   biomaterial hydroxyapatite
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID IMPLANTS
AB Thermal wave interferometry (TWI) has been used to measure the thermophysical properties of hydroxyapatite (HA) coatings, prepared by the plasma-spraying process on titanium alloy substrates. The properties measured were thermal diffusivity, thermal conductivity, thermal effusivity, and volumetric heat capacity and the optical absorption coefficient. The thermal conductivity obtained was found to be of similar magnitude to that of human tooth enamel. The results presented confirm the usefulness of TWI as a nondestructive technique for the characterization of plasma-sprayed HA coatings. (C) 1996 American Institute of Physics.
C1 UNIV BATH,SCH MAT SCI,BATH BA2 7AY,AVON,ENGLAND.
RP Bento, AC (reprint author), UNIV ESTADUAL MARINGA,DEPT FIS,AV COLOMBO 5790,BR-87020900 MARINGA,PARANA,BRAZIL.
RI Bento, A/B-5831-2013
OI Bento, A/0000-0001-6051-0940
CR BENNETT CA, 1982, APPL OPTICS, V21, P49, DOI 10.1364/AO.21.000049
   BENTO AC, 1995, J MATER SCI-MATER M, V6, P335, DOI 10.1007/BF00120301
   BENTO AC, 1995, MEAS SCI TECHNOL, V6, P1
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   CIELO P, 1986, J MAT ENG SYST, V9, P71
   DEGROOT K, 1993, CERAM INT, V19, P363, DOI 10.1016/0272-8842(93)90050-2
   GEESINK RGT, 1989, ORTHOPEDICS, V12, P1239
   LUCAS LC, 1993, COLLOID SURFACE A, V77, P141, DOI 10.1016/0927-7757(93)80110-Z
   NAGAI M, 1991, J MATER SCI, V26, P2949, DOI 10.1007/BF01124826
   PATEL PM, 1991, EUR J NDT, V1, P64
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   SIPERKO LM, 1993, J MATER SCI LETT, V12, P1068, DOI 10.1007/BF00420523
   SOWA MG, 1994, CALCIFIED TISSUE INT, V54, P481, DOI 10.1007/BF00334328
   TOULOUKIAN YS, 1973, THERMOPHYSICAL PROPE, V1
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   ZIEGLER G, 1981, J MATER SCI, V16, P495, DOI 10.1007/BF00738642
NR 16
TC 32
Z9 32
U1 1
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD MAY 1
PY 1996
VL 79
IS 9
BP 6848
EP 6852
DI 10.1063/1.362650
PG 5
WC Physics, Applied
SC Physics
GA UJ084
UT WOS:A1996UJ08400020
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Bujan, J
   Contreras, LA
   Hernando, A
   Jurado, F
AF Bellon, JM
   Bujan, J
   Contreras, LA
   Hernando, A
   Jurado, F
TI Similarity in behavior of polytetrafluoroethylene (ePTFE) prostheses
   implanted into different interfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ABDOMINAL-WALL DEFECTS; EXPANDED POLYTETRAFLUOROETHYLENE; REPAIR;
   GRAFTS; RECONSTRUCTION; PTFE
AB The biomaterial ePTFE is widely used in the clinical environment for vascular replacement or bypass, as well as in the repair of tissue defects, especially those involving the abdominal wall. The objective of this study was to evaluate the healing response to ePTFE prostheses implanted into a circulatory interface and a tissue interface, each in a different animal species. For vascular implants, the Sprague-Dawley rat (n = 60) was used, while the New Zealand white rabbit (n = 20) was used in the tissue replacement model. In the former, a vascular microprosthesis measuring 5 mm in length and 1 mm in internal diameter, having a porosity of 30 mu m, was implanted into the common iliac artery. In the rabbit, a 7 x 5-cm fragment of ePTFE (Soft-Tissue Patch) was implanted into a defect in anterior abdominal wall that involved all the tissue layers. In this case, the prosthesis was left touching the intestinal loops. The implants were studied between 14 and 90 days of postimplantation by means of light micros copy, scanning electron microscopy, and immunohistochemistry. The latter involved the use of anti-rat (MAC-341) and anti-rabbit (RAM-11) macrophage-specific monoclonal antibodies. The behavior of the ePTFE in the different interfaces (vascular and abdominal wall) was similar with respect to the following aspects: the prosthesis presented a process of encapsulation which was more intense on the outer surface; colonization of the implant was limited to the outermost two thirds, with minimal invasion of the middle portion; colonization was absent on the edges of the prosthesis; collagenization of the interstice of the mesh occurred late; the foreign body reaction taking place on the outer surface was similar in both interfaces, with formation of a barrier consisting of macrophages and giant cells that did not penetrate the prosthesis; and, finally, in neither of the two models was vascular colonization of the PTFE prosthesis observed; rather, the angiogenic process was limited to the periprosthetic zones. The integration of the implant made of ePTFE is similar despite the differences in interfaces and the use of different animal species. The macrophage response does not determine the success or failure of the implant. (C) 1996 John Wiley & Sons, Inc.
RP Bellon, JM (reprint author), UNIV ALCALA DE HENARES,FAC MED,DEPT MORPHOL SCI & SURG,CRTA MADRID BARCELONA,KM 33600,E-28871 ALCALA DE HENARES,SPAIN.
RI Hernando, Antonio/E-2105-2015
OI Hernando, Antonio/0000-0001-7856-3768; bujan, Julia/0000-0003-2419-2476;
   BELLON, JUAN M./0000-0002-6071-5011
CR BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   BELLON JM, 1994, EUR J VASCULAR SURG, V8, P694, DOI 10.1016/S0950-821X(05)80649-8
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   BRANSON DF, 1985, PLAST RECONSTR SURG, V76, P754, DOI 10.1097/00006534-198511000-00017
   BREARLY W, 1987, CURR SURG, V44, P407
   BROWN GL, 1985, ANN SURG, V201, P705, DOI 10.1097/00000658-198506000-00006
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   DEYSINE M, 1992, AM J SURG, V163, P422, DOI 10.1016/0002-9610(92)90045-S
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GOMDHI RH, 1994, J VASC SURG, V19, P198
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Law NW, 1988, CLIN MATER, V3, P95
   MURPHY JL, 1989, CAN J SURG, V32, P244
   OBRIEN CJ, 1985, PLAST RECONSTR SURG, V76, P748, DOI 10.1097/00006534-198511000-00015
   PAIROLERO PC, 1986, MAYO CLIN PROC, V61, P557, DOI 10.1016/S0025-6196(12)62004-7
   PANS A, 1992, EUR SURG RES, V24, P54, DOI 10.1159/000129188
   PICCIOCCHI A, 1993, INT SURG, V78, P221
   ROBINSON PH, 1985, J RECONSTR MICROSURG, V5, P331
   SANCHEZ LA, 1991, J VASC SURG, V14, P729, DOI 10.1067/mva.1991.33159
   SISE MJ, 1992, J VASC SURG, V16, P601, DOI 10.1016/0741-5214(92)90167-7
   Sottiurai V S, 1988, Eur J Vasc Surg, V2, P245, DOI 10.1016/S0950-821X(88)80034-3
   VANDERLEI B, 1988, PLAST RECONSTR SURG, V81, P735, DOI 10.1097/00006534-198805000-00015
   VANDERLEI B, 1989, BRIT J SURG, V76, P803, DOI 10.1002/bjs.1800760813
NR 24
TC 41
Z9 41
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1996
VL 31
IS 1
BP 1
EP 9
DI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UG002
UT WOS:A1996UG00200001
PM 8731143
DA 2018-10-19
ER

PT J
AU Hunt, JA
   Flanagan, BF
   McLaughlin, PJ
   Strickland, I
   Williams, DF
AF Hunt, JA
   Flanagan, BF
   McLaughlin, PJ
   Strickland, I
   Williams, DF
TI Effect of biomaterial surface charge on the inflammatory response:
   Evaluation of cellular infiltration and TNF alpha production
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TUMOR NECROSIS FACTOR; TISSUE-RESPONSE
AB A rat model was used to investigate the effect of net surface charge on polymer biocompatibility and its potential to modify and stimulate the inflammatory response. Poly(ether)urethane was taken as the base material and the net charge altered by introducing sulphonate ionic groups to the polymer backbone. Three differently charged poly(ether)urethanes were made with 10, 20, and 30% sulphonate substitution, giving a range of negative charge, with unmodified poly(ether)urethane used as a control. The polymers were implanted intramuscularly into rats for 2 days, and for 1, 2, and 12 weeks. After explantation, the cellular infiltration in the tissue surrounding the implants was evaluated using immunohistochemistry to stain for specific cell types: macrophages, neutrophils, lymphocytes, and the cytokine TNF alpha. In situ hybridization was used to detect expression of mRNA encoding TNF alpha. Stained sections were analyzed and the cellular response quantified using image analysis. Initially macrophages and neutrophils were observed around all the materials, but neutrophils were absent in all samples at 12 weeks. The 2-day time point had significantly more macrophages than the later time points. By 2 weeks the 20%-charged polymer elicited significantly less neutrophil infiltration than the other three polymers. In all samples where macrophages were observed, cells staining positive for TNF alpha protein and message also were observed. No T or B lymphocytes were observed in the infiltrates around the materials at any time point. The results indicate that surface charge can influence the early phase acute inflammatory response to an implanted material. (C) 1996 John Wiley and Sons, Inc.
C1 UNIV LIVERPOOL,DEPT IMMUNOL,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
RP Hunt, JA (reprint author), UNIV LIVERPOOL,DEPT CLIN ENGN,POB 147,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
RI Hunt, John/G-6366-2012
OI Hunt, John/0000-0002-5168-4778
CR DINARELLO CA, 1988, INFLAMMATION BASIC P, P195
   FERRANTE A, 1988, INT ARCH ALLER A IMM, V86, P82, DOI 10.1159/000234610
   FREVERT CW, 1995, J IMMUNOL, V154, P335
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P160, DOI 10.1007/BF00713443
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P192, DOI 10.1007/BF00713449
   HUNT JA, 1994, J MATER SCI-MATER M, V5, P381, DOI 10.1007/BF00058968
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   HUNT JA, 1993, BIOMATERIALS, V14, P376
   JOHNSON RA, 1989, ENDOCRINOLOGY, V124, P1424, DOI 10.1210/endo-124-3-1424
   MCLAUGHLIN PJ, 1992, BIOCH INFLAMMATION, P211
   MOONEY DP, 1990, ANN SURG, V211, P124, DOI 10.1097/00000658-199002000-00002
   PANAGAKOS FS, 1994, INFLAMMATION, V18, P243, DOI 10.1007/BF01534267
   SAMBROOK S, 1989, MOL CLONING LAB MANU
   STRIETER RM, 1988, BIOCHEM BIOPH RES CO, V156, P1340, DOI 10.1016/S0006-291X(88)80779-4
   Vilcek J, 1987, J Cell Physiol Suppl, VSuppl 5, P57
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   WILLIAMS DF, 1990, INTERDISCIPL SCI REV, V15, P20
   WILLIAMS DF, 1987, DEFINITIONS BIOMATER, V4, P21
NR 19
TC 74
Z9 74
U1 0
U2 11
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1996
VL 31
IS 1
BP 139
EP 144
DI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UG002
UT WOS:A1996UG00200016
PM 8731158
DA 2018-10-19
ER

PT J
AU Greisler, HP
AF Greisler, HP
TI Growth factor release from vascular grafts
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Recent Advances in Drug Delivery Systems
CY FEB 27-MAR 02, 1995
CL SALT LAKE CITY, UT
SP Baxter Healthcare Corp, Becton Dickinson & Co, Ciba Geigy Corp, Hoffmann La Roche Inc, MacroMed Inc, Marion Merrell Dow Inc, Pacific Corp, JAGO Pharma AG, Sam Yang Co Ltd, TheraTech Inc, Shiseido Res Ctr, 3M Pharm, Drug Delivery Syst, Jpjohn Co, Yamanouchi Pharm Co Ltd
DE drug delivery; vascular graft; fibrin glue; fibrin glue factor; heparin;
   endothelial cell
ID EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS; MACROPHAGE BIOMATERIAL
   INTERACTIONS; ENDOTHELIAL-CELL-GROWTH; DACRON; PROLIFERATION;
   IMPLANTATION; MECHANISMS
AB The impregnation of vascular grafts with therapeutic agents contained with a controlled delivery vehicle and in a biologically active configuration can theoretically be of clinical value for purposes of either intra-arterial or intravenous drug delivery for systems applications or for local drug delivery for modifying the response of blood and/or the surrounding tissue to the implanted graft. Our laboratory has been interested primarily in local drug delivery by impregnating vascular grafts with factors designed to induce a spontaneous endothelialization and/or to inhibit smooth muscle cell proliferation. Fibroblast growth factor type I (FGF-I) and heparin (10 mg:250 U) placed into suspensions of fibrinogen polymerized by addition of thrombin promoted endothelial cell proliferation while suppressing smooth muscle cell proliferation in vitro. The kinetics of I-125-FGF-I release from grafts implanted into rabbit aortas was quantitated and irrespective of heparin concentration, grafts retained approximately 10% of the applied radiolabel at 1 week. Impregnated 60 mu m internodal distance ePTFE grafts implanted into two canine models resulted in a transinterstitial ingrowth of capillary-rich mesenchymal tissue from the surrounding bed yielding near complete surface endothelialization by 1 month throughout 30 cm long bypass grafts. For purposes of systemic delivery, modifications of the fibrin glue preparation can significantly impact on the kinetics of growth factor release into circulation. It is likely that other therapeutic agents can be added to fibrin glue suspensions to achieve their systemic intravascular delivery.
RP Greisler, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
CR BJORNSSON TD, 1991, P NATL ACAD SCI USA, V88, P8651, DOI 10.1073/pnas.88.19.8651
   BURGESS WH, 1985, J BIOL CHEM, V260, P1389
   CALLOW AD, 1982, SURG CLIN N AM, V62, P501
   Clagett GP, 1987, HEMOSTASIS THROMBOSI, P1348
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   CRAWFORD ES, 1981, SURGERY, V90, P1055
   DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453
   GALLOWAY AC, 1984, SURGERY, V96, P435
   GEISLER HP, 1987, ARCH SURG-CHICAGO, V122, P715
   GOSSELIN C, 1995, IN PRESS J SURG RES
   GRAY JL, 1994, J SURG RES, V57, P596, DOI 10.1006/jsre.1994.1189
   Greisler H P, 1991, ASAIO Trans, V37, pM472
   Greisler H P, 1986, ASAIO Trans, V32, P346
   Greisler H. P., 1991, NEW BIOL SYNTHETIC V
   GREISLER HP, 1991, SURGERY, V110, P645
   GREISLER HP, 1992, SURGERY, V112, P244
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1993, J BIOMED MATER RES, V27, P955, DOI 10.1002/jbm.820270715
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1993, J BIOMAT SCI-POLYM E, V4, P415, DOI 10.1163/156856293X00672
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1991, J VASC SURG, V13, P748, DOI 10.1016/0741-5214(91)90374-4
   GREISLER HP, 1991, J VASC SURG, V14, P10
   GREISLER HP, UNPUB
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V177, P1425
   GREISLER HP, 1987, J VASC SURG, V2, P393
   HERRING M, 1994, J VASC SURG, V20, P650, DOI 10.1016/0741-5214(94)90291-7
   KANG SS, 1995, SURGERY, V118, P280, DOI 10.1016/S0039-6060(05)80335-6
   KOHLER TR, 1992, SURGERY, V112, P901
   LAM TM, 1992, ANGIOGENESIS KEY PRI, P346
   LINDNER V, 1991, CIRC RES, V68, P106, DOI 10.1161/01.RES.68.1.106
   LINDNER V, 1990, J CLIN INVEST, V85, P2004, DOI 10.1172/JCI114665
   ORTENWALL P, 1989, J VASC SURG, V10, P374
   ORTENWALL P, 1990, J VASC SURG, V11, P403
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   PETSIKAS D, 1991, Surgical Forum (Chicago), V42, P326
   THOMPSON R, 1986, FED AM SOC EXP BIOL, V1, P404
   THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659
   ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4
NR 39
TC 13
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY
PY 1996
VL 39
IS 2-3
BP 267
EP 280
DI 10.1016/0168-3659(95)00159-X
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA UT432
UT WOS:A1996UT43200017
DA 2018-10-19
ER

PT J
AU Higashi, T
   Okamoto, H
AF Higashi, T
   Okamoto, H
TI Influence of particle size of hydroxyapatite as a capping agent on cell
   proliferation of cultured fibroblasts
SO JOURNAL OF ENDODONTICS
LA English
DT Article
ID PERIODONTAL OSSEOUS DEFECTS; HYDROXYLAPATITE; TISSUE
AB The influence of particle size of biomaterials on cell reaction and cell proliferation was studied by means of coculturing fibroblasts with calcium phosphate ceramics, Both dense and porous hydroxyapatite ceramics obtained under different sintering conditions were selected, and two particle sizes of 300 and 40 mu m were used to examine cell reaction, The four materials were each cocultured with dental pulp-derived fibroblasts for 7 days, Cell reaction was observed by phase-contrast microscopy and scanning electron microscopy, Cell proliferation was measured by counting the number of trypsinized cells in 7-day-old culture, On the seventh day, the dense 300-mu m particles of hydroxyapatite were completely covered by cultured cells that had proliferated on the dish surface, On the other hand, the porous and dense 40-mu m particles were captured or gathered by the cultured cells, which seemed not to proliferate, The porous 300-mu m particles were accompanied by numerous small broken pieces on the dish surface, and the cells proliferated only around the large particles, From these results, the dense 300-mu m particles of hydroxyapatite can be considered the most appropriate biomaterial.
RP Higashi, T (reprint author), HIROSHIMA UNIV,SCH DENT,DEPT ENDODONTOL & PERIODONTOL,MINAMI KU,1-2-3 KASUMI,HIROSHIMA 734,JAPAN.
CR BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOONE ME, 1979, ORAL SURG ORAL MED O, V47, P369, DOI 10.1016/0030-4220(79)90262-7
   BUEHLER GA, 1977, J CELL BIOL, V72, P595
   Heller A L, 1975, J Endod, V1, P95, DOI 10.1016/S0099-2399(75)80025-2
   HENTRICH R L, 1971, Journal of Biomedical Materials Research, V5, P25, DOI 10.1002/jbm.820050104
   JEAN A, 1988, J ENDODONT, V14, P83, DOI 10.1016/S0099-2399(88)80006-2
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   PISSIOTIS E, 1990, J ENDODONT, V16, P468, DOI 10.1016/S0099-2399(07)80175-0
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   SHAPOFF CA, 1980, J PERIODONTOL, V51, P625, DOI 10.1902/jop.1980.51.11.625
   ZANDER DJ, 1984, J PERIODONTOL, V55, P406
NR 13
TC 20
Z9 22
U1 0
U2 2
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD MAY
PY 1996
VL 22
IS 5
BP 236
EP 239
DI 10.1016/S0099-2399(06)80139-1
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA UH159
UT WOS:A1996UH15900002
PM 8632134
DA 2018-10-19
ER

PT J
AU Grunkemeier, JM
   Horbett, TA
AF Grunkemeier, JM
   Horbett, TA
TI Fibrinogen adsorption to receptor-like biomaterials made by
   pre-adsorbing peptides to polystyrene substrates
SO JOURNAL OF MOLECULAR RECOGNITION
LA English
DT Article
DE biomaterial; fibrinogen; hemocompatibility; peptide; adsorption;
   GPIIb/IIIa
ID PLATELET INTEGRIN; GAMMA-CHAIN; ANTIBODY-BINDING; ADHESION; IIIA;
   RECOGNITION; AGGREGATION; SURFACES; PROTEINS; LIGANDS
AB Two peptides from the ligand-binding site of the platelet receptor GPIIb/IIIa, residues 296-306 of GPIIb, designated B12 by D'Souza et al. (1991), and 300-311 of GPIIb, designated G13 by Taylor et al., (1992), as well as two control peptides, designated C14 and C20, were adsorbed to treated polystyrene substrates. Fibrinogen adsorption to the peptide-coated substrates was characterized.
   The specificity of I-125 labeled fibrinogen binding to the peptide-coated substrates was investigated by measuring the amount of fibrinogen adsorbed to each substrate and the inhibition of fibrinogen binding by RGDS peptide, bovine serum albumin, a divalent ion chelator (ethylene diamine tetra-acetic acid disodium salt), unlabeled fibrinogen and the B12 peptide. The results show. that non-specific binding of fibrinogen to the B12-coated substrate is predominant under most conditions.
   Binding of monoclonal antibodies to fibrinogen adsorbed to the peptide coated substrates was characterized. The failure of several antibodies to bind fibrinogen adsorbed to the B12 substrate suggested that adsorption of fibrinogen to the B12-coated substrate alters its conformation relative to fibrinogen adsorbed to the bare substrate.
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
FU NHLBI NIH HHS [HL19419]
CR Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BRASH JL, 1981, INTERACTIONS BLOOD N, P37
   CHARO IF, 1991, J BIOL CHEM, V266, P1415
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   CIERNIEWSKI CS, 1994, BIOCHEMISTRY-US, V33, P12238, DOI 10.1021/bi00206a029
   COLLINS WE, 1987, SCANNING MICROSCOPY, V1, P1669
   DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HORBATSCH M, 1986, Z PHYS D ATOM MOL CL, V2, P183, DOI 10.1007/BF01429072
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   HORBETT TA, 1976, J BIOENG, V1, P61
   KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PLOW EF, 1992, J LAB CLIN MED, V120, P198
   Rao Gundu H. R., 1993, Indian Journal of Physiology and Pharmacology, V37, P263
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SHIBA E, 1991, AM PHYSL SOC, V260, P965
   TAYLOR DB, 1992, J BIOL CHEM, V267, P11729
   TSOMIDES TJ, 1993, ANAL BIOCHEM, V210, P129, DOI 10.1006/abio.1993.1162
   UGAROVA TP, 1993, J BIOL CHEM, V268, P21080
   VANOSS CJ, 1995, COLLOID SURFACE B, V4, P185, DOI DOI 10.1016/0927-7765(94)01170-A
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 29
TC 14
Z9 14
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0952-3499
J9 J MOL RECOGNIT
JI J. Mol. Recognit.
PD MAY-JUN
PY 1996
VL 9
IS 3
BP 247
EP 257
DI 10.1002/(SICI)1099-1352(199605)9:3<247::AID-JMR336>3.0.CO;2-H
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA VU430
UT WOS:A1996VU43000006
PM 8938598
DA 2018-10-19
ER

PT J
AU Friedman, RJ
   An, YHH
   Ming, J
   Draughn, RA
   Bauer, TW
AF Friedman, RJ
   An, YHH
   Ming, J
   Draughn, RA
   Bauer, TW
TI Influence of biomaterial surface texture on bone ingrowth in the rabbit
   femur
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID TITANIUM IMPLANTS; FATIGUE-STRENGTH; COATED IMPLANTS; DENTAL IMPLANTS;
   POROUS METAL; ALLOY; CERAMICS
AB The purpose of this study was to examine both the histologic and the mechanical characteristics a of bone apposition to an experimental surface, are-deposited titanium, in a rabbit model and to compare them with those of four previously studied surfaces: one layer of cobalt-chromium beads, three layers of cobalt-chromium beads, plasma-sprayed cobalt-chromium, and uncoated titanium alloy. Bilateral cylindrical implants were press-fit into the lateral femoral condyles of 70 adult New Zealand White rabbits, which were allowed unrestricted activity and then killed at 6 or 12 weeks. The distal femora were harvested, radiographed, and prepared for either mechanical or histologic evaluation. All of the implants with coated surfaces had significantly greater shear strength than the implants of grit-blasted titanium alloy after both 6 and 12 weeks. After 6 weeks, maximum bone apposition occurred in the beaded surfaces. After 12 weeks, the shear strengths and bone apposition of implants of are-deposited titanium and of one and three layers of cobalt-chromium beads were significantly greater than those of implants of plasma-sprayed cobalt-chromium and grit-blasted titanium alloy. The histologic studies correlated with the mechanical results. After 12 weeks, the bone apposition and mechanical stability of are-deposited titanium were similar to those of a single layer of beads. There appeared to be no advantage to multiple layers of beads, and the plasma-sprayed cobalt-chromium and grit-blasted titanium surfaces showed lower shear strength and bone apposition than the other groups.
C1 MED UNIV S CAROLINA,DEPT MAT SCI,CHARLESTON,SC 29425.
   CLEVELAND CLIN,DEPT PATHOL,CLEVELAND,OH 44106.
RP Friedman, RJ (reprint author), MED UNIV S CAROLINA,DEPT ORTHOPAED SURG,171 ASHLEY AVE,CHARLESTON,SC 29425, USA.
OI Bauer, Thomas/0000-0003-0976-2119
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   BARBOS MP, 1988, J BONE JOINT SURG BR, V70, P85
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Bobyn JD, 1980, CLIN ORTHOPAEDICS, V150, P263
   BUCHERT PK, 1986, J BONE JOINT SURG AM, V68A, P606, DOI 10.2106/00004623-198668040-00020
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CALLAGHAN JJ, 1993, J BONE JOINT SURG AM, V75A, P299, DOI 10.2106/00004623-199302000-00020
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1985, CLIN ORTHOP RELAT R, V193, P271
   COOK SD, 1988, CLIN ORTHOP RELAT R, V234, P90
   DALLANT P, 1987, ASTM SPECIAL TECHNIC, V953, P286
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   FRIEDMAN RJ, 1993, T SOC BIOMATER, V16, P109
   FRIEDMAN RJ, 1992, ORTHOP T, V16, P514
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Huiskes R, 1990, Clin Orthop Relat Res, P27
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JASTY M, 1992, CLIN ORTHOP RELAT R, V280, P300
   JORGENSON TJ, 1983, CLIN ORTHOP RELAT R, V176, P124
   JUDET R, 1978, CLIN ORTHOP RELAT R, V137, P76
   KANG JD, 1991, J BONE JOINT SURG AM, V73A, P93, DOI 10.2106/00004623-199173010-00012
   KELLER JC, 1987, J BIOMED MATER RES, V21, P305, DOI 10.1002/jbm.820210304
   KELLER JC, 1987, T SOC BIOMATER, V10, P50
   KELLER JC, 1987, T ORTHOP RES SOC, V12, P437
   KELMAN DC, 1991, T SOC BIOMATER, V14, P290
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KUMMER FJ, 1992, J APPL BIOMATER, V3, P39, DOI 10.1002/jab.770030107
   LORD G, 1983, CLIN ORTHOP RELAT R, V176, P67
   LUCKEY HA, 1992, J BIOMED MATER RES, V26, P557, DOI 10.1002/jbm.820260502
   LUECK R A, 1969, Surgical Forum (Chicago), V20, P456
   MAGEE FP, 1990, T SOC BIOMATER, V13, P168
   PILLIAR RM, 1991, J BIOMED MATER RES, V25, P467, DOI 10.1002/jbm.820250405
   PILLIAR RM, 1975, BIOMED ENG, V10, P126
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, V156, P249
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   SAHA S, 1987, ASTM SPECIAL TECHNIC, V953, P276
   SHIMIZU T, 1988, J ORTHOPAED RES, V6, P248, DOI 10.1002/jor.1100060212
   SMITH L, 1963, ARCH SURG-CHICAGO, V87, P653
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   SUMNER DR, 1990, SURGERY MUSCULOSKELE, P151
   TAKEUCHI MJ, 1991, T SOC BIOMATER, V14, P291
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
   WEINSTEIN AM, 1976, J BIOMED MATER RES, V10, P231, DOI 10.1002/jbm.820100205
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   YOUNG FA, 1979, J PROSTHET DENT, V41, P561, DOI 10.1016/0022-3913(79)90094-5
   YOUNG FA, 1979, J BIOMED MATER RES, V13, P843, DOI 10.1002/jbm.820130604
   YUE S, 1984, J BIOMED MATER RES, V18, P1043, DOI 10.1002/jbm.820180908
NR 55
TC 41
Z9 41
U1 1
U2 4
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD MAY
PY 1996
VL 14
IS 3
BP 455
EP 464
DI 10.1002/jor.1100140316
PG 10
WC Orthopedics
SC Orthopedics
GA UT655
UT WOS:A1996UT65500015
PM 8676259
DA 2018-10-19
ER

PT J
AU Ito, Y
   Zheng, J
   Imanishi, Y
   Yonezawa, K
   Kasuga, M
AF Ito, Y
   Zheng, J
   Imanishi, Y
   Yonezawa, K
   Kasuga, M
TI Protein-free cell culture on an artificial substrate with covalently
   immobilized insulin
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE growth factor; cell growth; biomaterial
ID POLY(METHYL METHACRYLATE) MEMBRANE; RECEPTOR TYROSINE KINASE;
   GROWTH-FACTOR; FIBROBLAST CELLS; ADHESION; MATRIX
AB Insulin was immobilized on a surface-hydrolyzed poly(methyl methacrylate) film, Chinese hamster ovary cells overexpressing human insulin receptors were cultured on the film in the absence of serum or soluble proteins, Small amounts of immobilized insulin (1-10% of the required amount of free insulin) were sufficient to stimulate cell proliferation. In addition, the maximal mitogenic effect of immobilized insulin was greater than that of free insulin. Immobilized insulin activated the insulin receptor and downstream signaling proteins, and this activation persisted for longer periods than that obtained with free insulin, probably explaining the greater mitogenic effect of the Immobilized insulin, Finally the immobilized-insulin film was usable repeatedly without marked loss of activity.
C1 KOBE UNIV,SCH MED,DEPT INTERNAL MED 2,KOBE,HYOGO 650,JAPAN.
RP Ito, Y (reprint author), KYOTO UNIV,FAC ENGN,DEPT CHEM MAT,KYOTO 60601,JAPAN.
RI Ito, Yoshihiro/F-4370-2012
CR BUTCHER RW, 1973, SCIENCE, V182, P396, DOI 10.1126/science.182.4110.396-a
   CUATRECA.P, 1973, SCIENCE, V182, P397
   CUATRECASAS P, 1969, P NATL ACAD SCI USA, V63, P450, DOI 10.1073/pnas.63.2.450
   ENDEMANN G, 1990, J BIOL CHEM, V265, P396
   GARWIN JL, 1974, ARCH BIOCHEM BIOPHYS, V164, P52, DOI 10.1016/0003-9861(74)90007-1
   HOFMANN C, 1989, J BIOL CHEM, V264, P8606
   HORWITZ JI, 1993, MOL IMMUNOL, V30, P1041, DOI 10.1016/0161-5890(93)90129-Y
   HUBBELL JA, 1994, BIOTECH BIOENG, V43
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ITO Y, 1992, BIOMATERIALS, V13, P789, DOI 10.1016/0142-9612(92)90019-K
   ITO Y, 1992, BIOTECHNOL BIOENG, V40, P1271, DOI 10.1002/bit.260401017
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   ITO Y, 1995, BIOTECH PROG, V11, P677
   KOLB HJ, 1975, P NATL ACAD SCI USA, V72, P248, DOI 10.1073/pnas.72.1.248
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU SQ, 1993, J BIOMED MATER RES, V27, P909, DOI 10.1002/jbm.820270710
   LIU SQ, 1992, J BIOCHEM BIOPH METH, V25, P139
   LIU SQ, 1992, BIOMATERIALS, V13, P50, DOI 10.1016/0142-9612(92)90095-6
   OKA T, 1974, P NATL ACAD SCI USA, V71, P1630, DOI 10.1073/pnas.71.5.1630
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   REDDY CC, 1994, BIOTECHNOL PROGR, V10, P377, DOI 10.1021/bp00028a006
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   VENTER JC, 1982, PHARMACOL REV, V34, P153
   VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156
   WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263
   YONEZAWA K, 1992, J BIOL CHEM, V267, P440
   ZHENG J, 1994, BIOMATERIALS, V15, P963, DOI 10.1016/0142-9612(94)90076-0
NR 28
TC 113
Z9 117
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 16
PY 1996
VL 93
IS 8
BP 3598
EP 3601
DI 10.1073/pnas.93.8.3598
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA UF740
UT WOS:A1996UF74000083
PM 8622981
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Neo, M
   Voigt, CF
   Herbst, H
   Gross, UM
AF Neo, M
   Voigt, CF
   Herbst, H
   Gross, UM
TI Analysis of osteoblast activity at biomaterial-bone interfaces by in
   situ hybridization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INSITU HYBRIDIZATION; OSTEOGENIC DIFFERENTIATION; BIOACTIVE GLASS;
   MESSENGER-RNAS; LOCALIZATION; EXPRESSION; COLLAGEN; CELLS; INVITRO;
   GROWTH
AB To investigate the effects of bioactive materials on bone formation in vivo, a new experimental model using in situ hybridization has been developed. A hole was drilled bilaterally in the distal epiphysis of rabbit femurs with subsequent implantations of beta-tricalcium phosphate (beta-TCP) cylinders in a press-fit manner. Specimens were collected at 3, 7, 14, and 28 days after operation. Femurs with empty drilling holes, and normal distal femurs without operation were used as controls. All specimens were decalcified and hybridized with a procollagen alpha 1(I) complementary RNA probe labeled with digoxygenin. In normal-bone sections, procollagen alpha 1(I) RNA was clearly demonstrated in periosteal osteoblasts, in osteoblasts in the mineralizing zone adjacent to growth plates, and in osteoblasts lining remodeling canals. As for beta-TCP, labeled osteoblasts around the material were not found at day 3, whereas they were most intensively observed at day 7 and a little less at day 14, in accordance with new-bone formation around the material. Weaker signals were also detected in fibroblasts at day 7. At day 28, osteoblasts lining the surface of newly formed bone were mainly negative, whereas those adjacent to the resorption sites of the beta-TCP showed positive signals, demonstrating an active remodeling at the material surface. The temporal expression of procollagen alpha 1(I) RNA in the beta-TCP specimens was fundamentally the same as that in the empty-hole specimens, suggesting no remarkable acceleration or suppression of bone-forming activity of osteoblasts by beta-TCP, which is consistent with osteoconductive bone formation. This in situ hybridization method was suggested to be a powerful tool in analyzing the biological effects of bioactive materials. (C) 1996 John Wiley & Sons, Inc.
C1 FREE UNIV BERLIN,HOSP BENJAMIN FRANKLIN,INST PATHOL,D-12200 BERLIN,GERMANY.
   FREE UNIV BERLIN,HOSP BENJAMIN FRANKLIN,DEPT TRAUMATOL & RECONSTRUC SURG,D-12200 BERLIN,GERMANY.
CR GENOVESE C, 1984, BIOCHEMISTRY-US, V23, P6210, DOI 10.1021/bi00320a049
   HENCH LL, 1991, BONE-BIOMATERIAL INTERFACE, P33
   HENCH LL, 1994, BIOCERAMICS, V7, P3
   HERBST H, 1992, BLOOD, V80, P484
   HIROTA S, 1994, CELL TISSUE RES, V277, P27, DOI 10.1007/BF00303077
   IKEDA T, 1992, J HISTOCHEM CYTOCHEM, V40, P1079, DOI 10.1177/40.8.1619274
   KAHARI VM, 1987, MED SCI RES-BIOCHEM, V15, P417
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1989, BIOCERAMICS, V1, P157
   MILANI S, 1990, AM J PATHOL, V137, P59
   MULLERMAI CM, 1992, CELL MATER, V2, P309
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   NAKASE T, 1994, J BONE MINER RES, V9, P651
   NAKASE T, 1994, BONE MINER, V26, P109, DOI 10.1016/S0169-6009(08)80056-6
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NOMURA S, 1988, J CELL BIOL, V106, P441, DOI 10.1083/jcb.106.2.441
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   OHGUSHI H, 1992, BONE BONDING BIOMATE, P47
   OHGUSHI H, 1994, BIOCERAMICS, V7, P331
   ONO K, 1990, BIOMATERIALS, V11, P265
   POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315
   SANDBERG M, 1988, DEV BIOL, V130, P324, DOI 10.1016/0012-1606(88)90438-1
   SANDBERG M, 1987, J CELL BIOL, V104, P1077, DOI 10.1083/jcb.104.4.1077
   SANDBERG MM, 1993, CLIN ORTHOP RELAT R, V289, P292
   STRAUSS PG, 1990, J CELL BIOL, V110, P1369, DOI 10.1083/jcb.110.4.1369
   SWALLA BJ, 1988, DEV BIOL, V125, P51, DOI 10.1016/0012-1606(88)90057-7
   TAKANOYAMAMOTO T, 1994, J HISTOCHEM CYTOCHEM, V42, P885, DOI 10.1177/42.7.8014472
   VOIGT CF, 1995, J MATER SCI-MATER M, V6, P279, DOI 10.1007/BF00120271
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
NR 31
TC 24
Z9 25
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1996
VL 30
IS 4
BP 485
EP 492
DI 10.1002/(SICI)1097-4636(199604)30:4<485::AID-JBM6>3.0.CO;2-L
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UD183
UT WOS:A1996UD18300008
PM 8847356
DA 2018-10-19
ER

PT J
AU Hsieh, KH
   Liao, DC
   Chen, CY
   Chiu, WY
AF Hsieh, KH
   Liao, DC
   Chen, CY
   Chiu, WY
TI Interpenetrating polymer networks of polyurethane and
   maleimide-terminated polyurethane for biomedical applications
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE polyurethane; bismaleimide; biomaterial; blood compatibility; surface
   property; mechanical property; degree of compatibility
AB Interpenetrating polymer networks (IPNs) of polyurethane (PU) and maleimide-terminated polyurethane (UBMI) were prepared by using a simultaneous polymerization technique. The effects of the UBMI molecular weight and amounts of the UBMI in the IPNs on the mechanical properties, dynamic mechanical properties, degree of compatibility, water absorption, surface properties and dynamic thrombosis were investigated. Bulk structure and surface properties were analyzed in order to correlate their blood compatibility. The IPNs exhibited a higher ultimate tensile strength especially when the UBMI with short soft chains was introduced. The heterogeneous characteristics were found for the IPNs when longer soft segment chains were incorporated in the PU component polymer. The presence of hydrophilic/hydrophobic alternative microdomains on the IPN surface was proposed to be the reason for good blood compatibility. The degree of compatibility, compositions of each domain and content of each domain in the matrix were calculated and correlated with the blood compatibility.
C1 NATL TAIWAN UNIV,DEPT CHEM ENGN,TAIPEI 106,TAIWAN.
OI CHIU, WEN-YEN/0000-0001-5110-0392
CR AKUTSU T, 1985, ARTIFICIAL HEART, V2
   AKUTSU T, 1985, ARTIFICIAL HEART, V1
   ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   Hepburn C, 1982, POLYURETHANE ELASTOM
   HSIEH KH, 1995, J APPL POLYM SCI, V57, P319, DOI 10.1002/app.1995.070570308
   HSIEH KH, 1994, BIOMED ENG APPL BASI, V6, P517
   JIA D, 1989, ADV INTERPENETRATING, V1, P303
   KIM SC, 1975, MACROMOLECULES, V17, P263
   Krause S., 1978, POLYM BLENDS, V1, P16
   LIAO DC, 1994, J POLYM SCI POL CHEM, V32, P1665, DOI 10.1002/pola.1994.080320908
   LIAO DC, 1995, J POLYM SCI POL CHEM, V33, P481, DOI 10.1002/pola.1995.080330315
   LIAO DC, 1994, J POLYM RES, V1, P69
   LIPATOV YS, 1989, ADV INTERPENETRATING, V1, P261
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   SCHAUWECKER HH, 1989, ARTIF ORGANS, V13, P216, DOI 10.1111/j.1525-1594.1989.tb02866.x
   Sperling L.H., 1981, INTERPENETRATING POL
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
NR 19
TC 14
Z9 15
U1 1
U2 2
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD APR
PY 1996
VL 7
IS 4
BP 265
EP 272
PG 8
WC Polymer Science
SC Polymer Science
GA UT984
UT WOS:A1996UT98400008
DA 2018-10-19
ER

PT J
AU Rizvi, S
AF Rizvi, S
TI New applications of supercritical fluids in food and biomaterial
   processing
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CORNELL UNIV,INST FOOD SCI,ITHACA,NY 14850.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 24
PY 1996
VL 211
BP 159
EP IEC
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA UA482
UT WOS:A1996UA48202957
DA 2018-10-19
ER

PT J
AU Larsson, C
   Thomsen, P
   Aronsson, BO
   Rodahl, M
   Lausmaa, J
   Kasemo, B
   Ericson, LE
AF Larsson, C
   Thomsen, P
   Aronsson, BO
   Rodahl, M
   Lausmaa, J
   Kasemo, B
   Ericson, LE
TI Bone response to surface-modified titanium implants: Studies on the
   early tissue response to machined and electropolished implants with
   different oxide thicknesses
SO BIOMATERIALS
LA English
DT Article
DE titanium; surface analysis; electropolishing; anodic oxidation;
   morphometry; bone; oxide; surface topography
ID RABBIT CORTICAL BONE; PREPARATIVE PROCEDURES; STAINLESS-STEEL;
   MICROSCOPY; INTERFACE; BIOMATERIAL; TI-6AL-4V; INVIVO; FILMS
AB The bone formation around titanium implants with varied surface properties is investigated. Machined and electropolished samples with and without thick, anodically formed surface oxides were prepared, surface characterized and inserted in the cortical bone of rabbits (1, 3 and 6 weeks). Scanning electron microscopy, scanning Auger electron spectroscopy and atomic force microscopy revealed marked differences in oxide thickness, surface topography and roughness, but no significant differences in surface chemical composition, between the different groups of implants. Light microscopic morphology and morphometry showed that all implants were in contact with bone and had a large proportion of bone within the threads at 6 weeks. The smooth, electropolished implants, irrespective of anodic oxidation, were surrounded by less bone than the machined implants after 1 week. After 6 weeks the bone volume as well as the bone-implant contact were lower for the merely electropolished implants than for the other three groups. Our study shows that a high degree of bone contact and bone formation are achieved with titanium implants which are modified with respect to oxide thickness and surface topography. However, the result with the smooth (electropolished) implants indicates that a reduction of surface roughness, in the initial phase, decreases the rate of bone formation in rabbit cortical bone.
C1 CHALMERS UNIV TECHNOL,DEPT APPL PHYS,S-41390 GOTHENBURG,SWEDEN.
RP Larsson, C (reprint author), GOTHENBURG UNIV,DEPT ANAT & CELL BIOL,MEDICINAREGATAN 3-5,S-41390 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BAIER RE, 1992, TISSUE INTEGRATION IN ORAL, ORTHOPEDIC, AND MAXILLOFACIAL RECONSTRUCTION, P240
   BARO AM, 1986, BIOMATERIALS, V7, P463, DOI 10.1016/0142-9612(86)90036-0
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1202
   DAVIS GD, 1983, APPL SURF SCI, V15, P321, DOI 10.1016/0378-5963(83)90026-0
   Davis L. E., 1978, HDB AUGER ELECT SPEC
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   GARDELLA JA, 1988, SURFACE CHARACTERIZA, P145
   GRIFFITH JE, 1992, J VAC SCI TECHNOL A, V10, P674, DOI 10.1116/1.577708
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   JOBIN M, 1991, J VAC SCI TECHNOL B, V9, P1263, DOI 10.1116/1.585217
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1985, Swed Dent J Suppl, V28, P19
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Klauber C, 1990, Int J Oral Maxillofac Implants, V5, P264
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   LANDOLT D, 1987, ELECTROCHIM ACTA, V32, P1, DOI 10.1016/0013-4686(87)87001-9
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   LAUSMAA J, 1990, SURF INTERFACE ANAL, V15, P328, DOI 10.1002/sia.740150506
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1986, BIOMEDICAL MAT, P351
   LAUSMAA J, 1983, THESIS U GOTHENBURG
   Lausmaa J., 1991, THESIS U GOTHENBURG
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   MCTEGART WJ, 1959, ELECT CHEM POLISHING
   OLIN H, 1992, ULTRAMICROSCOPY, V44, P567
   Quirynen M, 1994, Int J Oral Maxillofac Implants, V9, P71
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RICCI JL, 1991, BONE-BIOMATERIAL INTERFACE, P334
   ROSS SD, 1975, ORGANIC CHEM, V32
   SARID D, 1991, J VAC SCI TECHNOL B, V9, P431, DOI 10.1116/1.585585
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   SENNERBY L, 1993, J MATER SCI-MATER M, V4, P240, DOI 10.1007/BF00122275
   SENNERBY L, 1993, J MATER SCI-MATER M, V4, P494, DOI 10.1007/BF00120129
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   Swart K M, 1992, J Oral Implantol, V18, P130
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wennerberg A, 1993, Int J Oral Maxillofac Implants, V8, P622
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
NR 53
TC 242
Z9 251
U1 0
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1996
VL 17
IS 6
BP 605
EP 616
DI 10.1016/0142-9612(96)88711-4
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UA342
UT WOS:A1996UA34200007
PM 8652779
DA 2018-10-19
ER

PT J
AU KohlerOckmore, J
   Feneley, RCL
AF KohlerOckmore, J
   Feneley, RCL
TI Long-term catheterization of the bladder: Prevalence and morbidity
SO BRITISH JOURNAL OF UROLOGY
LA English
DT Article
DE long-term catheterization; prevalence; morbidity; blockage
ID INDWELLING URINARY CATHETERS; ENCRUSTATION; MANAGEMENT
AB Objective To estimate the prevalence and morbidity of long-term catheterization (LTC) of the urinary bladder.
   Patients and methods A postal survey was conducted over two successive years from February 1989 to determine the incidence of LTC in three Bristol Health Districts with a total population of 827 595. During the first gear the number of patients requiring emergency treatment for complications of LTC was also monitored over a 6-month period. In the second year, 54 patients were selected from the first survey and each was visited by one investigator every 2 weeks for 12 weeks to obtain information on catheter management, the incidence and type of complications, the attitudes of the patients or carers about the catheter and to assess the pH and microbiology of the patient's urine.
   Results The initial surveys identified 457 and 467 patients with. long-term catheters during the 2 years, respectively; there were similar numbers of men and women in both years. The survey of catheter complications recorded 506 emergency referrals during the 6 months and the detailed study of 54 patients showed that 48% experienced catheter blockage, 37% reported urine by-passing the catheter and 30% noted haematuria. Patients found the catheter uncomfortable and depended on nursing support, Catheter blockage was associated with bladder stones, a high urinary pH and the presence of Proteus spp in the urine.
   Conclusion The prevalence and high morbidity of LTC cause a considerable demand on the available District and Hospital nursing services: most patients with long-term catheters are elderly, disabled or debilitated and more nurses need to be trained in the technique of catheterization and the management of the catheterized patient. Further research is required to reduce the morbidity of LTC by investigating measures to reduce catheter blockage and encrustation at the urine/biomaterial interface.
C1 SOUTHMEAD GEN HOSP,BRISTOL UROL INST,BRISTOL BS10 5NB,AVON,ENGLAND.
CR BROCKLEHURST JC, 1978, BRIT J UROL, V50, P102, DOI 10.1111/j.1464-410X.1978.tb03035.x
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1987, BRIT J UROL, V59, P159, DOI 10.1111/j.1464-410X.1987.tb04810.x
   COX AJ, 1987, NURS TIMES, V83, P48
   GETLIFFE K, 1990, NURS STAND, V21, P33
   GETLIFFE KA, 1991, BRIT J UROL, V67, P337, DOI 10.1111/j.1464-410X.1991.tb15157.x
   HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x
   KENNEDY AP, 1982, J ADV NURS, V7, P411, DOI 10.1111/j.1365-2648.1982.tb00257.x
   Kunin C M, 1987, Am J Med, V82, P405, DOI 10.1016/0002-9343(87)90438-4
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   Mulhall A, 1991, Nurs Stand, V5, P26
   MUNCIE HL, 1990, J UROLOGY, V143, P507, DOI 10.1016/S0022-5347(17)40003-6
   NORBERG B, 1983, GERONTOLOGY, V29, P332
   Roe B, 1989, Nurs Times, V85, P43
   ROE BH, 1989, J ADV NURS, V14, P494, DOI 10.1111/j.1365-2648.1989.tb01581.x
   RUWALDT MM, 1983, UROLOGY, V21, P127, DOI 10.1016/0090-4295(83)90005-5
   Sassoon E, 1991, Health Trends, V23, P109
   Stamm WE, 1991, AM J MED, V91, p65S
NR 19
TC 114
Z9 118
U1 3
U2 8
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0007-1331
J9 BRIT J UROL
JI Br. J. Urol.
PD MAR
PY 1996
VL 77
IS 3
BP 347
EP 351
DI 10.1046/j.1464-410X.1996.09074.x
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA TZ248
UT WOS:A1996TZ24800004
PM 8814836
DA 2018-10-19
ER

PT J
AU Szpunar, J
   Schmitt, VO
   Lobinski, R
   Monod, JL
AF Szpunar, J
   Schmitt, VO
   Lobinski, R
   Monod, JL
TI Rapid speciation of butyltin compounds in sediments and biomaterials by
   capillary gas chromatography - Microwave-induced plasma atomic emission
   spectrometry after microwave-assisted leaching digestion
SO JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY
LA English
DT Article
DE speciation; organotin; microwave-assisted sample preparation; capillary
   gas chromatography; microwave-induced plasma atomic emission
   spectrometry; environmental analysis
ID EXTRACTION; ORGANOTIN; MATRICES
AB A rapid procedure for the simultaneous determination of mono-, di- and tributyltin in sediments and biological materials is described, The target compounds in sediments were subject to quantitative microwave-assisted leaching with acetic acid, Biomaterials were dissolved in a tetramethylammonium hydroxide solution under the action of a low-power microwave field in such a way that the organotin moiety remained intact, The leaching of the analytes from a sediment as well as the dissolution of a biomaterial in a focused microwave field took only 1-5 min, which is much faster than previously reported methods. It was also demonstrated that the leaching efficiency of monobutyltin from certified reference sediments was superior to that of most literature procedures, The butyltins were derivatized with sodium tetraethylborate (NaBEt(4),) in the aqueous phase, and simultaneously extracted into isooctane (5 min), The analysis was carried out by capillary gas chromatography (GC) with microwave-induced plasma atomic emission detection, The sample throughput was limited by the duration of the GC run (10 min), The detection limit was 2 ng g(-1) for 0.2 g of sample (dry) without preconcentration; it could be improved by a factor 10 if preconcentration was applied, The developed method was applied to a variety of real samples and was validated by analysing three certified reference materials: PACS-1, CRM 462 and NIES 11.
C1 UNIV AIX MARSEILLE,FAC PHARM,LAB HYDROL & MOLYSMOL AQUAT,F-13385 MARSEILLE,FRANCE.
RP Szpunar, J (reprint author), UNIV BORDEAUX 1,CNRS URA 318,PHOTOPHYS & PHOTOCHIM MOLEC LAB,351 CRS LIBERAT,F-33405 TALENCE,FRANCE.
CR ARIZA GJL, 1995, APPL ORGANOMET CHEM, V9, P51
   ASTRUC A, 1994, ANALUSIS, V22, P257
   BAYONA JM, 1994, TRAC-TREND ANAL CHEM, V13, P327, DOI 10.1016/0165-9936(94)87005-5
   CAI Y, 1994, ANAL CHEM, V66, P1161, DOI 10.1021/ac00079a034
   CAI Y, 1995, J CHROMATOGR SCI, V33, P89, DOI 10.1093/chromsci/33.3.89
   CEULEMANS M, 1994, APPL ORGANOMET CHEM, V8, P451, DOI 10.1002/aoc.590080505
   CEULEMANS M, IN PRESS ANAL CHIM A
   CHAU YK, 1995, ANAL CHIM ACTA, V304, P85, DOI 10.1016/0003-2670(94)00556-2
   DAUCHY X, 1994, ENVIRON TECHNOL, V15, P569, DOI 10.1080/09593339409385462
   DIRKX W, 1993, ANAL SCI, V9, P273, DOI 10.2116/analsci.9.273
   DIRKX WMR, 1994, ANAL CHIM ACTA, V286, P309, DOI 10.1016/0003-2670(94)85077-1
   DIRKX WMR, 1994, QUALITY ASSURANCE EN
   DONARD O, 1993, TECHNIQUES ENV ANAL, P549
   DONARD OFX, 1995, ANAL CHEM, V67, P4250, DOI 10.1021/ac00119a008
   FORSYTH DS, 1995, FRESEN J ANAL CHEM, V351, P403, DOI 10.1007/BF00322909
   HUGGETT RJ, 1992, ENVIRON SCI TECHNOL, V26, P232, DOI 10.1021/es00026a001
   INOUE Y, 1995, J ANAL ATOM SPECTROM, V10, P363, DOI 10.1039/ja9951000363
   Kingston H. M., 1988, INTRO MICROWAVE SAMP
   KUBALLA J, 1995, ANALYST, V120, P667, DOI 10.1039/an9952000667
   KUSS HM, 1992, FRESEN J ANAL CHEM, V343, P788, DOI 10.1007/BF00633568
   LALERE B, 1995, ANALYST, V120, P2665, DOI 10.1039/an9952002665
   LIU Y, 1994, ANAL CHEM, V66, P3788, DOI 10.1021/ac00093a040
   LIU Y, 1993, J HIGH RES CHROMATOG, V16, P106
   LOBINSKI R, 1992, ANAL CHEM, V64, P159, DOI 10.1021/ac00026a013
   LOBINSKI R, 1995, SPECTROCHEMICAL TREE
   LOPEZAVILA V, 1994, ANAL CHEM, V66, P1097, DOI 10.1021/ac00079a027
   MACLAREN JW, 1990, FRESEN Z ANAL CHEM, V337, P721
   Maguire R.J., 1987, Applied Organometallic Chemistry, V1, P475, DOI 10.1002/aoc.590010602
   MARTIN FM, 1995, FRESEN J ANAL CHEM, V351, P230, DOI 10.1007/BF00321643
   MATUSIEWICZ H, 1989, PROG ANAL SPECTROSC, V4, P14
   ONUSKA FI, 1993, CHROMATOGRAPHIA, V36, P191, DOI 10.1007/BF02263861
   PANNIER F, 1994, APPL ORGANOMET CHEM, V8, P595, DOI 10.1002/aoc.590080708
   PANNIER F, 1993, APPL ORGANOMET CHEM, V7, P231
   PARE JRJ, 1994, TRAC-TREND ANAL CHEM, V13, P176
   PRANGE A, 1995, J ANAL ATOM SPECTROM, V10, P105, DOI 10.1039/ja9951000105
   QUEVAUVILLER P, 1992, MIKROCHIM ACTA, V109, P169, DOI 10.1007/BF01243233
   QUEVAUVILLER P, 1994, APPL ORGANOMET CHEM, V8, P629, DOI 10.1002/aoc.590080713
   RAPSOMANIKIS S, 1994, ANALYST, V119, P1429, DOI 10.1039/an9941901429
   SARRADIN PM, 1995, ANALYST, V120, P79, DOI 10.1039/an9952000079
   SCOTT BF, 1991, APPL ORGANOMET CHEM, V5, P151, DOI 10.1002/aoc.590050303
   SIU KWM, 1989, J CHROMATOGR, V475, P373, DOI 10.1016/S0021-9673(01)89691-6
   STAB JA, 1994, APPL ORGANOMET CHEM, V8, P577, DOI 10.1002/aoc.590080706
   TOLOSA I, 1991, FRESEN J ANAL CHEM, V339, P646, DOI 10.1007/BF00325552
   TSANGARIS JM, 1992, APPL ORGANOMET CHEM, V6, P3, DOI 10.1002/aoc.590060103
   WITTE C, 1994, APPL ORGANOMET CHEM, V8, P621, DOI 10.1002/aoc.590080712
   ZHANG SH, 1991, APPL ORGANOMET CHEM, V5, P431, DOI 10.1002/aoc.590050510
   ZLOTORZYNSKI A, 1995, CRIT REV ANAL CHEM, V25, P43, DOI 10.1080/10408349508050557
NR 47
TC 124
Z9 130
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0267-9477
J9 J ANAL ATOM SPECTROM
JI J. Anal. At. Spectrom.
PD MAR
PY 1996
VL 11
IS 3
BP 193
EP 199
DI 10.1039/ja9961100193
PG 7
WC Chemistry, Analytical; Spectroscopy
SC Chemistry; Spectroscopy
GA UB098
UT WOS:A1996UB09800004
DA 2018-10-19
ER

PT J
AU Fricain, JC
   Rouais, F
   Dupuy, B
AF Fricain, JC
   Rouais, F
   Dupuy, B
TI A two-step embedding process for better preservation of soft tissue
   surrounding coral implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BONE-MARROW; UNDECALCIFIED BONE; SECTIONS; METHACRYLATE; ENZYME
AB Infiltration of paraffin or embedding polymers proceeds more quickly in soft than in mineralized tissue specimens (bone or biomaterial). The proposed method takes advantage of this difference to protect soft tissue from the action of decalcifying agents. After embedding a bone-soft-tissue sample in a hydrophobic polymer, it is cleared of the resin on one of its sides to permit access of the decalcifying solution to the mineral component. A second infiltration with another polymerizable solution that cures in the empty pores created by the dissolution makes it possible to obtain a homogeneous hard block, make thin slices, and perform enzyme histochemistry and immunostaining on well-preserved soft tissue with most of its antigenic and enzymatic properties intact. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
CR BIANCO P, 1984, BASIC APPL HISTOCHEM, V28, P265
   BUIJS R, 1983, STAIN TECHNOL, V58, P135, DOI 10.3109/10520298309066774
   BURGIO VL, 1991, HISTOPATHOLOGY, V18, P37, DOI 10.1111/j.1365-2559.1991.tb00812.x
   CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   HAHN M, 1991, VIRCHOWS ARCH A, V418, P1, DOI 10.1007/BF01600238
   HERMANNS W, 1986, J HISTOCHEM CYTOCHEM, V34, P827, DOI 10.1177/34.6.3517152
   LIU C, 1987, HISTOCHEMISTRY, V86, P559, DOI 10.1007/BF00489547
   ROHER MD, 1992, ORAL SURG ORAL MED O, V74, P73
   SCHAEFFER HE, 1984, PATHOLOGIE, V1, P440
   SPIJKER HJD, 1978, MICROSC ACTA, V81, P17
   STERCHI DL, 1989, STAIN TECHNOL, V64, P201, DOI 10.3109/10520298909107000
   VAANANEN HK, 1984, METHODS CALCIFIED TI, P309
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   WOLF E, 1992, VIRCHOWS ARCH A, V420, P17, DOI 10.1007/BF01605979
NR 15
TC 9
Z9 9
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SPR
PY 1996
VL 33
IS 1
BP 23
EP 27
DI 10.1002/(SICI)1097-4636(199621)33:1<23::AID-JBM4>3.0.CO;2-O
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UD185
UT WOS:A1996UD18500004
PM 8734070
DA 2018-10-19
ER

PT J
AU Ramelow, US
   Guidry, CN
   Fisk, SD
AF Ramelow, US
   Guidry, CN
   Fisk, SD
TI A kinetic study of metal ion binding by biomass immobilized in polymers
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE polymer; kinetics; biomass; Langmuir adsorption
AB A kinetic study of metal binding by various types of nonliving, immobilized biomass was carried out. Biomaterial studied included lichens, water hyacinth root, and some marine algae. All of these organisms have previously been shown to be strong sorbers of metal ions. Biomass was immobilized in polymeric matrix such as polysulfone, polyphenylene sulfide, and styrene-divinylbenzene copolymers.
   The ability of nonliving biomass to sorb metal ions when immobilized in a polymeric matrix was evaluated. First-order rate constants indicate that copper and lead ion uptake on polysulfone-biomass systems are ten times larger than on the polysulfone only. The activation energy of copper ion sorption at pH 5.5 is lower than the activation energy at pH 4.7, an indication that copper is activated more easily and sorbs greater at pH 5.5. The activation energies of each metal-biomass interaction were calculated by using the Langmuir adsorption model; it was found that the activation energy is three times higher for copper sorption on the polysulfone matrix only without incorporation of algal biomass as compared to the sorption on polymer-biomass matrix. This shows that the sorption process is less efficient without algae.
   Kinetic plots for both copper and lead sorption demonstrate that single sorption sites are responsible for binding. The equilibrium constants for the sorptions at different temperatures were evaluated as well as the rate constants for metal binding processes. As temperature increases, the equilibrium constant decreases for all sorptions. The most suitable conditions for polymer-biomass matrix for the maximum sorption of each metal ion were evaluated. This study indicates that algal biomass can be immobilized in a polymer matrix and packed into columns for a very efficient use as an ion exchanger.
RP Ramelow, US (reprint author), MCNEESE STATE UNIV,DEPT CHEM,POB 90455,LAKE CHARLES,LA 70609, USA.
CR Brierley J. A., 1987, US Patent, Patent No. 4690894
   Collins E. A., 1973, EXPT POLYM SCI, P353
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   DARNALL DW, 1986, TECHNICAL COMPLETION
   Ferguson CR, 1989, BIOTECHNOLOGY MINERA, P193
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   JEFFERS TH, 1989, INT S BIOHYDR JACKS
   MAHAN CA, 1989, ANAL CHEM, V61, P624, DOI 10.1021/ac00181a026
   NIEBOER E, 1976, CAN J BOT, V54, P724, DOI 10.1139/b76-078
   PUCKETT KJ, 1973, NEW PHYTOL, P329
   RAMELOW GJ, 1993, INT J ENVIRON AN CH, V53, P219, DOI 10.1080/03067319308045991
   SAUNDERS MS, 1989, AICHE J, V35, P53, DOI 10.1002/aic.690350106
   SUWANAYUEN S, 1980, AICHE J, V26, P68, DOI 10.1002/aic.690260112
   TONDEUR D, 1967, IND ENG CHEM FUND, V6, P351, DOI 10.1021/i160023a005
   TONG C, 1994, INT J ENVIRON AN CH, V56, P175, DOI 10.1080/03067319408034099
   TRUJILLO EM, 1991, ENVIRON SCI TECHNOL, V25, P1559, DOI 10.1021/es00021a005
   TSEZOS M, 1985, CAN METALL QUART, V24, P141
   YU JW, 1980, IND ENG CHEM RES, V29, P220
NR 19
TC 14
Z9 15
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAR
PY 1996
VL 46
IS 1
BP 37
EP 55
DI 10.1016/0304-3894(95)00104-2
PG 19
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA UA117
UT WOS:A1996UA11700004
DA 2018-10-19
ER

PT J
AU Burg, KJL
   Jenkins, L
   Powers, DL
   Shalaby, SW
AF Burg, KJL
   Jenkins, L
   Powers, DL
   Shalaby, SW
TI Special considerations in embedding a lactide absorbable polymer
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE epoxy; methacrylate; paraffin; polyester; polylactide; styrene
AB Absorbable biomaterial implants are advantageous in that they require no retrieval surgery and they absorb as the affected tissue heals. The nature of the in vivo or in vitro absorption process may be determined by processing, embedding, and sectioning an explanted specimen and surrounding tissue or by directly embedding and sectioning an in vitro specimen. It is important to utilize an embedding medium that will not chemically interact with the polymer, in order to accurately determine the tissue/material absorption interaction.
   Poly-1-lactide absorbable polymeric films were embedded in 5 different resins to observe the chemical interaction between the resin and the absorbable material and to examine the relative ease of sectioning: methylmethacrylate, hydroxyethyl methacrylate, paraffin, epoxy, and polyester based resins. Paraffin, epoxy, and polyester resins best preserved the surface of the films. The study further suggests that paraffin may be too soft for monitoring materials used in long term absorption studies and that polyester is suitable only if polymerization is initiated before the material is embedded. Hydroxyethyl methacrylate was the most susceptible to environmental conditions. In all cases, the direction of sectioning had a substantial impact on the section quality.
C1 POLYMED INC,ANDERSON,SC.
RP Burg, KJL (reprint author), CLEMSON UNIV,DEPT BIOENGN,RHODES ENGN RES CTR 301,CLEMSON,SC 29634, USA.
CR BARON R, 1983, BONE HISTOMORPHOMETR, P19
   BROWNING A, 1986, J BIOMED MATER RES, V20, P613, DOI 10.1002/jbm.820200507
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31
   PREECE A, 1972, MANUAL HISTOLOGIC TE, P60
   RODRIGUEZ F, 1989, PRINCIPLES POLYM SYS, P483
   SANDERSON C, 1994, J HISTOTECHNOL, V17, P343, DOI 10.1179/his.1994.17.4.343
   SANDERSON C, 1992, NATL SOC HIST TEL MA
   SCHENK RK, 1984, METHODS CALCIFIED TI, P10
   SCHMITT EE, 1966, Patent No. 3297033
NR 10
TC 9
Z9 9
U1 0
U2 1
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD MAR
PY 1996
VL 19
IS 1
BP 39
EP 43
PG 5
WC Cell Biology
SC Cell Biology
GA UA131
UT WOS:A1996UA13100006
DA 2018-10-19
ER

PT J
AU Vajaradul, Y
AF Vajaradul, Y
TI Bone banking in Thailand - A 10-year experience (1984-1994)
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID ALLOGRAFT TRANSPLANTATION; TUMORS
AB The tissue bank of the Bangkok Biomaterial Center was initiated in Thailand in 1984, and the first 10 years of progress are summarized. Three hundred ninety-seven cadavers and sixteen living donors provided a total of 13,676 bone and soft tissue allografts. They were used by 134 surgeons in 44 hospitals. A total of 1178 patients were surgically treated (581 males and 486 females). There were 240 cases of deep-frozen bone allografts, 600 cases of freeze-dried bone allografts, and 338 cases of soft tissue allografts. The results for 1035 cases (95.3%) were normal, whereas the results for 51 cases (4.33%) showed complications.
RP Vajaradul, Y (reprint author), MAHIDOL UNIV,SIRIRAJ HOSP,DEPT ORTHOPAED SURG,BANGKOK BIOMED CTR,BANGKOK 10700,THAILAND.
CR ACKERMAN G, 1988, J BONE JOINT SURG AM, V70A, P75, DOI 10.2106/00004623-198870010-00012
   AURORI BF, 1986, CLIN ORTHOPAEDICS, V1, P153
   BROWN MD, 1976, CLIN ORTHOP RELAT R, V119, P231
   CARR CR, 1955, J BONE JOINT SURG AM, V37, P549, DOI 10.2106/00004623-195537030-00010
   CONWAY B, 1990, T ORTHOP RES SOC, V15, P225
   CZITRON AA, 1988, AAOS INSTR COURS LEC, V38, P13
   DICK HM, 1985, CLIN ORTHOP RELAT R, V197, P88
   DODD CAF, 1988, J BONE JOINT SURG BR, V70, P431
   GEBHARDT MC, 1990, J BONE JOINT SURG AM, V72A, P334, DOI 10.2106/00004623-199072030-00004
   GEBHARDT MC, 1987, J BONE JOINT SURG AM, V69A, P1177, DOI 10.2106/00004623-198769080-00011
   GROSS AE, 1985, CLIN ORTHOP RELAT R, V197, P115
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, V188, P239
   JACKSON DW, 1990, AM J SPORT MED, V18, P1, DOI 10.1177/036354659001800101
   KNAPP DR, 1988, CLIN ORTHOP RELAT R, V229, P99
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   MALININ TI, 1985, CLIN ORTHOP RELAT R, V197, P15
   MANKIN HJ, 1976, NEW ENGL J MED, V294, P1247, DOI 10.1056/NEJM197606032942301
   MANKIN HJ, 1982, CANCER-AM CANCER SOC, V50, P613, DOI 10.1002/1097-0142(19820815)50:4<613::AID-CNCR2820500402>3.0.CO;2-L
   MANKIN HJ, 1983, CLIN ORTHOP RELAT R, V174, P69
   MCANDREW MP, 1989, J ORTHOP TRAUMA, P250
   MCCARTHY RE, 1986, J BONE JOINT SURG AM, V68A, P370, DOI 10.2106/00004623-198668030-00009
   MCGANN W, 1986, J BONE JOINT SURG AM, V68A, P4, DOI 10.2106/00004623-198668010-00002
   MNAYMNEH W, 1985, CLIN ORTHOP RELAT R, V197, P76
   NASCA RJ, 1987, SPINE, V12, P222, DOI 10.1097/00007632-198704000-00005
   OTTOLENGHI CARLOS E., 1966, J BONE JOINT SURG BRIT, V48, P646
   PARRISH FF, 1973, J BONE JOINT SURG AM, VA 55, P1
   PARRISH FF, 1966, J BONE JOINT SURG, V188, P239
   PELKER R R, 1984, Journal of Orthopaedic Research, V1, P405
   REYNOLDS FC, 1951, J BONE JOINT SURG AM, V33-A, P873, DOI 10.2106/00004623-195133040-00006
   SIM FH, 1987, CLIN ORTHOP RELAT R, V221, P188
   SPENCE KF, 1976, J BONE JOINT SURG AM, V58, P636, DOI 10.2106/00004623-197658050-00010
   SPIRE B, 1985, LANCET, V1, P188
   TOMFORD WW, 1984, J BONE JOINT SURG AM, V66A, P253, DOI 10.2106/00004623-198466020-00012
   TOMFORD WW, 1990, J BONE JOINT SURG AM, V72A, P1137, DOI 10.2106/00004623-199072080-00003
   VAJARADUL Y, 1992, THAI J ORAL MAXILLOF, V11, P10
   WITHROW SJ, 1990, T ORTHOP RES SOC, V15, P225
   1994, STANDARDS AM RED CRO
NR 37
TC 4
Z9 5
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD FEB
PY 1996
IS 323
BP 173
EP 180
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA TW783
UT WOS:A1996TW78300023
PM 8625575
DA 2018-10-19
ER

PT J
AU Mougenot, P
   Koch, M
   Dupont, I
   Schneider, YJ
   MarchandBrynaert, J
AF Mougenot, P
   Koch, M
   Dupont, I
   Schneider, YJ
   MarchandBrynaert, J
TI Surface functionalization of polyethylene terephthalate film and
   membranes by controlled wet chemistry .2. Reactivity assays of hydroxyl
   chain ends
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE polyethylene terephthalate, PET; membrane; wet chemistry; surface
   derivatization; chain-end characterization; radiolabeling; liquid
   scintillation counting; XPS analysis; covalent coupling of amino acids;
   spacer-arm coupling; biomaterial
ID RAY PHOTOELECTRON-SPECTROSCOPY; CHEMICAL DERIVATIZATION; PROTEINS; XPS
AB Surface functionalization of polyethylene terephthalate film and track-etched microporous membranes was performed using organic synthesis at the solid-liquid interface. The hydroxyl chain ends, naturally occurring in the membranes or created by basic hydrolysis in the film, were activated by reaction with p-toluenesulfonyl chloride and then coupled to [4,5-H-3]lysine used as a model of water-soluble bioactive molecules. The ratios of derivatization were determined by liquid scintillation counting of the radioactivity associated with the samples. The hydroxyl chain ends were further reacted with 4,4'-methylene di(phenyl isocyanate); the resulting surfaces equipped with sensitive isocyanate spacers were assayed as before using [4,5-H-3] lysine. The ranges of derivatization were from 5 to 60 pmol of fixed amino acid per open surface unit (cm(2)). Some samples were also analyzed by X-ray photoelectron spectroscopy. (C) 1996 Academic Press, Inc.
C1 UNIV CATHOLIQUE LOUVAIN,LAB CHIM ORGAN SYNTHESE,B-1348 LOUVAIN,BELGIUM.
   UNIV CATHOLIQUE LOUVAIN,BIOCHIM CELLULAIRE LAB,B-1348 LOUVAIN,BELGIUM.
CR AMEEN AP, 1993, POLYMER, V34, P1795, DOI 10.1016/0032-3861(93)90418-A
   AVNY Y, 1986, J APPL POLYM SCI, V32, P4009, DOI 10.1002/app.1986.070320318
   Beamson G., 1992, HIGH RESOLUTION XPS
   BONAFINI JA, 1985, POLYM PREPR-ACS, V26, P178
   BUI LN, 1993, ANALYST, V118, P463
   CHILKOTI A, 1990, J VAC SCI TECHNOL A, V8, P2274, DOI 10.1116/1.576750
   CHILKOTI A, 1991, SURF INTERFACE ANAL, V17, P567, DOI 10.1002/sia.740170805
   COLLIER WG, 1987, ANAL CHEM, V59, P396, DOI 10.1021/ac00130a004
   DANG TA, 1990, SURF INTERFACE ANAL, V15, P113, DOI 10.1002/sia.740150209
   DANG TA, 1992, SURF INTERFACE ANAL, V18, P141, DOI 10.1002/sia.740180214
   DELDIME M, 1995, APPL SURF SCI, V90, P1, DOI 10.1016/0169-4332(95)00077-1
   DEVOS R, 1986, POLYM BULL, V15, P547, DOI 10.1007/BF00281766
   DICKIE RA, 1982, ANAL CHEM, V54, P2045, DOI 10.1021/ac00249a031
   EVERHART DS, 1981, ANAL CHEM, V53, P665, DOI 10.1021/ac00227a022
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   HALLEUX C, 1994, J CELL PHYSIOL, V158, P17, DOI 10.1002/jcp.1041580104
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   LEGRAS R, 1986, Patent No. 8705850
   LOCCUFIER J, 1991, POLYM BULL, V27, P201, DOI 10.1007/BF00296031
   March J., 1992, ADV ORG CHEM
   MARCHANDBRYNAER.J, 1994, 5TH EUR POL FED S PO
   MARCHANDBRYNAERT J, 1995, J COLLOID INTERF SCI, V173, P236, DOI 10.1006/jcis.1995.1319
   MARCHANT RE, 1990, POLYM MATER SCI ENG, V62, P264
   MCCARTHY TJ, 1990, CHIMIA, V44, P316
   NILSSON K, 1980, EUR J BIOCHEM, V112, P397, DOI 10.1111/j.1432-1033.1980.tb07218.x
   NILSSON K, 1981, ACTA CHEM SCAND B, V35, P19, DOI 10.3891/acta.chem.scand.35b-0019
   PATAI S, 1977, CHEM CYANATES THEIR, P425
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   TAMADA Y, 1993, POLYMER, V34, P2207
   WENG LT, 1993, SURF INTERFACE ANAL, V20, P179, DOI 10.1002/sia.740200302
   WILLIAMS DAR, 1983, J CELL PLAST, P121
   XU GF, 1992, CHEM MATER, V4, P1240, DOI 10.1021/cm00024a024
   ZEGGANE S, 1988, APPL SURF SCI, V31, P151, DOI 10.1016/0169-4332(88)90028-1
NR 33
TC 34
Z9 34
U1 2
U2 10
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JAN 15
PY 1996
VL 177
IS 1
BP 162
EP 170
DI 10.1006/jcis.1996.0017
PG 9
WC Chemistry, Physical
SC Chemistry
GA TN491
UT WOS:A1996TN49100017
DA 2018-10-19
ER

PT B
AU Kveton, JF
   Friedman, CD
AF Kveton, JF
   Friedman, CD
BE Sterkers, JM
   Charachon, R
   Sterkers, O
   ODonoghue, G
   Fenton, J
TI Hydroxyapatite cement reconstruction of craniectomy defects after
   translabyrinthine removal of acoustic neuroma
SO ACOUSTIC NEUROMA AND SKULL BASE SURGERY
LA English
DT Proceedings Paper
CT 2nd International Conference on Acoustic Neuroma Surgery / 2nd
   European-Skull-Base-Society Congress
CY APR 22-26, 1995
CL PARIS, FRANCE
SP European Skull Base Soc
AB Hydroxyapatite cement (HAC) is a new biomaterial under clinical investigation in the United States for reconstruction of cranial defects. This new biological bone cement was used to reconstruct craniectomy defects produced by the translabyrinthine approach in five patients immediately after acoustic tumor removal, and in one patient with a postoperative cerebrospinal fluid leak after routine adipose obliteration of the mastoid and middle ear. These six patients have been followed up for two years under protocol to determine implant stability as well as metabolic abnormalities related to use of the cement. Cranial bone integrity was restored and cranial bone contour has been maintained in all six patients. There were no postoperative complications, including cerebrospinal fluid leak, in the five immediate reconstructions. HAC reconstruction successfully controlled the cerebrospinal fluid rhinorrhea in the additional case. There were no metabolic complications related to the use of the HAC. This paper describes the method of successful application of this osseointegrative and osseoconductive biomaterial in the reconstruction of cranial defects produced by the translabyrinthine approach.
RP Kveton, JF (reprint author), YALE UNIV,SCH MED,DEPT SURG,OTOLARYNGOL SECT,POB 208041,333 CEDAR ST,NEW HAVEN,CT 06510, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KUGLER PUBLICATIONS BV
PI AMSTELVEEN
PA PO BOX 516, 1180 AM AMSTELVEEN, NETHERLANDS
BN 90-6299-128-9
PY 1996
BP 201
EP 203
PG 3
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA BJ79M
UT WOS:A1996BJ79M00035
DA 2018-10-19
ER

PT B
AU Akashi, M
   Furuzono, T
   Matsumoto, T
   Kishida, A
   Maruyama, I
AF Akashi, M
   Furuzono, T
   Matsumoto, T
   Kishida, A
   Maruyama, I
BE Ogata, N
   Kim, SW
   Feijen, J
   Okano, T
TI Novel biomaterial: Aramid-silicone resin
SO ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY
   SYSTEMS
LA English
DT Proceedings Paper
CT 5th Iketani Conference on Biomedical Polymers
CY APR 18-22, 1995
CL KAGOSHIMA UNIV, KAGOSHIMA, JAPAN
SP Iketani Sci & Technol Fdn
HO KAGOSHIMA UNIV
DE poly(dimethylsiloxane); multiblock copolymer; blood compatibility;
   surface analysis; oxygen permeability
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT CHEM ENGN & APPL CHEM,KAGOSHIMA 890,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO 113, JAPAN
BN 4-431-70163-X
PY 1996
BP 183
EP 187
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials; Pharmacology &
   Pharmacy
SC Engineering; Materials Science; Pharmacology & Pharmacy
GA BF14A
UT WOS:A1996BF14A00034
DA 2018-10-19
ER

PT S
AU Jones, DW
AF Jones, DW
BE Mostaghaci, H
TI Ceramic biomaterials
SO ADVANCED CERAMIC MATERIALS: APPLICATIONS OF ADVANCED MATERIALS IN A
   HIGH-TECH SOCIETY I
SE Key Engineering Materials
LA English
DT Review
DE biocompatible; bioactive; composite; dental ceramic; glass ceramic;
   implant; ionic release; orthopedic; osteogenesis; sol-gel; wet chemistry
ID SOL-GEL PROCESS; INDENTATION FRACTURE-TOUGHNESS; MONODISPERSE TIO2
   POWDERS; BIOACTIVE GLASS-CERAMICS; DENTAL ROOT IMPLANTS; DOPED ZRO2
   POWDERS; RAT TIBIAL BONE; CALCIUM-PHOSPHATE; HIGH-STRENGTH; TRICALCIUM
   PHOSPHATE
AB This chapter aims to present representative examples of the use of ceramic materials as biomaterials. Ceramic biomaterials play a very important and significant role in the health care of our modern society. Applications for ceramics range from customized prosthesis fashioned into replacement or support parts for bones, teeth, or they may also contain drugs which are released into the body in a controlled manner. Ceramic materials are an excellent choice as biomaterials since an artificial biomaterial must be biocompatible such that the material exists within a physiological environment, without adversely affecting the body. Also the environment or the body should not significantly affect the material.
RP Jones, DW (reprint author), DALHOUSIE UNIV, FAC DENT & MED, DIV BIOMAT, 5981 UNIV AVE, HALIFAX, NS B3H 3J5, CANADA.
CR Adair P J, 1984, Int J Periodontics Restorative Dent, V4, P32
   ADAMS R, 1977, J MATER SCI, V12, P643, DOI 10.1007/BF00548153
   AE Y, 1990, MAT MED, V1, P233
   AMIR D, 1989, BIOMATERIALS, V10, P585, DOI 10.1016/0142-9612(89)90111-7
   ANDERSSON OH, 1988, GLASTECH BER-GLASS, V61, P300
   ANUSAVIC KJ, 1985, PERSPECTIVES DENT RE, P175
   ANUSAVICE KJ, 1980, J DENT RES, V59, P608, DOI 10.1177/00220345800590030901
   ANUSAVICE KJ, 1985, J DENT RES, V64, P1094, DOI 10.1177/00220345850640081501
   ANUSAVICE KJ, 1985, DENT CLIN N AM, V29, P789
   ANUSAVICE KJ, 1992, DENT MATER, V8, P149, DOI 10.1016/0109-5641(92)90072-K
   ANUSAVICE KJ, 1994, DENT MATER, V10, P230, DOI 10.1016/0109-5641(94)90066-3
   Asada K, 1987, Nihon Seikeigeka Gakkai Zasshi, V61, P155
   AYRAL A, 1988, ADV CERAM MATER, V3, P575
   AYRAL A, 1988, MATER RES SOC S P, V121, P239
   BAJPAI PK, 1988, J BIOMED MATER RES, V22, P1245, DOI 10.1002/jbm.820221212
   BARGHI N, 1975, J PROSTHET DENT, V34, P314, DOI 10.1016/0022-3913(75)90109-2
   BARRINGER EA, 1985, LANGMUIR, V1, P414, DOI 10.1021/la00064a005
   BARRINGER EA, 1982, J AM CERAM SOC, V65, pC199
   BARRINGER EA, 1984, ULTRASTRUCTURE PROCE, P315
   BARTH E, 1986, BIOMATERIALS, V7, P273, DOI 10.1016/0142-9612(86)90049-9
   Benghuzzi H A, 1989, Biomed Sci Instrum, V25, P169
   Benghuzzi H A, 1989, Biomed Sci Instrum, V25, P179
   Benghuzzi H A, 1988, J Invest Surg, V1, P163, DOI 10.3109/08941938809141102
   BESSING C, 1990, ACTA ODONTOL SCAND, V48, P351, DOI 10.3109/00016359009033628
   BIBBY DM, 1985, NATURE, V317, P157, DOI 10.1038/317157a0
   BLAYNEY AW, 1986, J LARYNGOL OTOL, V100, P1359, DOI 10.1017/S0022215100101148
   BLENDELL JE, 1984, AM CERAM SOC BULL, V63, P797
   Blendell JE, 1979, THESIS MIT
   BLUMENTHAL NM, 1988, J PERIODONTOL, V59, P18, DOI 10.1902/jop.1988.59.1.18
   BOND WD, 1988, ULTRASTRUCTURE PROCE
   BONFIELD W, 1987, ADV BIOMATER, V7, P13
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   BOYAJIAN GK, 1988, WV DENT J, P6
   BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   BROMER H, 1973, Patent No. 2326100
   BRUCE GJ, 1995, COMPENDIUM, V17, P180
   BURR DB, 1993, J BIOMED MATER RES, V27, P645, DOI 10.1002/jbm.820270512
   Campbell S D, 1989, Int J Prosthodont, V2, P459
   CAMPBELL SD, 1989, J PROSTHET DENT, V62, P476, DOI 10.1016/0022-3913(89)90184-4
   CASTALDINI A, 1987, BIOMATERIALS CLIN AP, V7, P517
   CASTELLANI D, 1994, J PROSTHET DENT, V72, P360, DOI 10.1016/0022-3913(94)90554-1
   Cavel W T, 1988, Quintessence Int, V19, P257
   Chae J C, 1988, Ann N Y Acad Sci, V523, P81, DOI 10.1111/j.1749-6632.1988.tb38502.x
   Cho SB, 1996, J AM CERAM SOC, V79, P88, DOI 10.1111/j.1151-2916.1996.tb07884.x
   CHO SB, 1994, CERAM T SCI TECHNOLO, V54
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   CHRISTEL P, 1984, 2 WORLD C BIOM BIRM, P178
   CHRISTENSEN GJ, 1988, J AM DENT ASSOC, V117, pE12, DOI 10.14219/jada.archive.1988.0036
   CHRISTENSEN GJ, 1986, J PROSTHET DENT, V56, P1, DOI 10.1016/0022-3913(86)90271-4
   CONGSHEN Z, 1984, J NONCRYST SOLIDS, V63, P105
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1986, SPINE, V11, P305, DOI 10.1097/00007632-198605000-00002
   *CORN DEV NEW CERM, 1957, AM CER SOC B, V36, P279
   Coyne B M, 1988, J Ir Dent Assoc, V34, P98
   CRIMALDI AJ, 1994, J DENT RES, V73, P135
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAVID SB, 1994, COMPENDIUM, V25, P802
   DAVID SB, 1994, COMPENDIUM, V25, P806
   DAVIS SB, 1994, COMPENDIUM, V25, P804
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DELONG R, 1989, DENT MATER, V5, P266, DOI 10.1016/0109-5641(89)90073-0
   DENRY IL, 1993, J DENT RES, V72, P572, DOI 10.1177/00220345930720030301
   DICKINSON AJG, 1989, J PROSTHET DENT, V61, P297, DOI 10.1016/0022-3913(89)90132-7
   Dietschi D, 1990, Quintessence Int, V21, P823
   Donovan T, 1988, CDA J, V16, P10
   DORSCH P, 1982, CERAMIC FORUM INT BE, V59, P1
   DRUMMOND JL, 1991, DENT MATER, V7, P133, DOI 10.1016/0109-5641(91)90060-C
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   Ellinger R F, 1986, Int J Periodontics Restorative Dent, V6, P22
   EXNER HV, 1987, TYDSKR TANDHEELKD VE, V42, P299
   FAIRHURST CW, 1981, J DENT RES, V60, P815, DOI 10.1177/00220345810600040801
   FAIRHURST CW, 1980, J BIOMED MATER RES, V14, P435, DOI 10.1002/jbm.820140410
   FAIRHURST CW, 1993, DENT MATER, V9, P269, DOI 10.1016/0109-5641(93)90073-Y
   Fan P L, 1987, Int Dent J, V37, P197
   FANELLI AJ, 1986, J AM CERAM SOC, V69, pC174
   FEGLEY B, 1985, AM CERAM SOC BULL, V64, P1115
   FEGLEY B, 1984, J AM CERAM SOC, V67, pC113
   FEGLEY B, 1984, BETTER CERAMICS CHEM, V32, P187
   FILIAGGI MJ, 1993, J BIOMED MATER RES, V27, P191, DOI 10.1002/jbm.820270208
   Flatley TJ, 1983, CLIN ORTHOP RELAT R, V179, P246
   FRIEDMAN MJ, 1991, J AM DENT ASSOC, V122, P29, DOI 10.14219/jada.archive.1991.0180
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   Giordano R, 1995, Int J Prosthodont, V8, P311
   GIORDANO RA, 1995, J PROSTHET DENT, V73, P411, DOI 10.1016/S0022-3913(05)80067-8
   Gleiter H., 1992, Nanostructured Materials, V1, P1, DOI 10.1016/0965-9773(92)90045-Y
   Gross U, 1988, Ann N Y Acad Sci, V523, P211, DOI 10.1111/j.1749-6632.1988.tb38514.x
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   GUAN WY, 1990, INT ORTHOP, V14, P387
   HARRIS MT, 1988, J NON-CRYST SOLIDS, V103, P49, DOI 10.1016/0022-3093(88)90415-2
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1983, BIOMATERIALS INTERFA
   HENCH LL, 1986, BIOL BIOMECHANICAL P, P99
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HERMANSSON L, 1976, P 8 INT S REACT SOL, P541
   HILLIG WB, 1965, HIGH STRENGTH MATERI, P682
   HOJJATIE B, 1990, J BIOMECH, V23, P1157, DOI 10.1016/0021-9290(90)90008-Q
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Hollenbach D E, 1988, Biomed Sci Instrum, V24, P109
   HOSHIKAWA T, 1972, YOGYO KYOKAISHI, V80, P42
   HOSHIKAWA T, 1978, REPORT OSAKA PUBLIC, P89
   Ikemoto T., 1985, Yogyo-Kyokai-Shi, V93, P585
   Ikemoto T., 1985, Yogyo-Kyokai-Shi, V93, P261
   Ikenaga M., 1991, BIOCERAMICS, V4, P255
   INOUE M, 1989, J AM CERAM SOC, V72, P352, DOI 10.1111/j.1151-2916.1989.tb06134.x
   INOUE M, 1988, INORG CHEM, V27, P215, DOI 10.1021/ic00275a001
   INOUE M, 1991, J AM CERAM SOC, V74, P1452, DOI 10.1111/j.1151-2916.1991.tb04129.x
   INOUE M, 1989, CLAY CLAY MINER, V37, P71, DOI 10.1346/CCMN.1989.0370109
   INOUE M, 1990, J AM CERAM SOC, V73, P1100, DOI 10.1111/j.1151-2916.1990.tb05164.x
   JACOBI R, 1991, J PROSTHET DENT, V66, P303, DOI 10.1016/0022-3913(91)90254-T
   JAGGER DC, 1995, J ORAL REHABIL, V22, P349, DOI 10.1111/j.1365-2842.1995.tb00784.x
   JOHNSON DW, 1985, AM CERAM SOC BULL, V64, P1597
   JOHNSON DW, 1978, CERAMIC PROCESSING F, P125
   Jones D W, 1988, Ann N Y Acad Sci, V523, P19, DOI 10.1111/j.1749-6632.1988.tb38498.x
   JONES D W, 1992, Journal of Dental Research, V71, P312
   Jones D W, 1988, J Can Dent Assoc, V54, P163
   JONES DM, 1996, IN PRESS AM CERAM J
   JONES DW, 1988, CAN CERAM QUART, V57, P39
   JONES DW, 1987, BRIT CERAM TRANS J, V86, P40
   JONES DW, 1988, MAT SCI ENG A-STRUCT, V105, P207, DOI 10.1016/0025-5416(88)90498-3
   JONES DW, 1991, J MATER SCI, V26, P6501, DOI 10.1007/BF00551904
   JONES DW, 1990, J DENT RES, V69, P211
   JONES DW, 1985, DENT CLIN N AM, V29, P621
   JONES DW, 1985, BRIT CERAM TRANS J, V84, P40
   JONES DW, 1994, J DENT RES, V73, P196
   JONES DW, 1986, J CAN CERAM SOC, V55, P42
   JONES DW, 1966, 5 WORLD BIOM C TOR M, P754
   JONES DW, 1988, 4 INT CER S, P29
   JONES DW, 1996, CAN CER SOC 84 ANN C
   JONES DW, 1996, J DENT RES, P35
   JONES DW, 1982, BIOCOMPATIBILITY DEN, P79
   JONES DW, 1977, DENTAL PORCELAIN STA, P342
   JONES DW, 1992, 4 WORLD BIOM C BERL
   JONES DW, 1983, 1 INT S DENT CERM NE, P853
   JONES DW, 1996, IN PRESS J APPL BIOM
   JONES DW, 1996, 5 WORLD BIOM C TOR C, P140
   JONES E, 1992, J FAM THER, V14, P429
   KARINO K, 1982, Patent No. 5331716
   KARINO S, 1977, J JPN SOC APPARATUS, V34, P52
   KARINO S, 1976, J JAPN SOC APPARATUS, V33, P379
   KARINO S, 1982, THESIS GIFU U JAPAN
   KASUGA T, 1992, J AM CERAM SOC, V75, P1103, DOI 10.1111/j.1151-2916.1992.tb05545.x
   Katz S., 1989, US Patent, Patent No. [4,798,536, 4798536]
   Kawaguchi M, 1989, Dent Mater J, V8, P40
   KAWAI K, 1995, J AM DENT ASSOC, V126, P1414, DOI 10.14219/jada.archive.1995.0053
   KAY JF, 1986, STRUCTURE PROPERTIES, P13
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   Kimura H, 1990, J Osaka Univ Dent Sch, V30, P43
   KNAHR K, 1987, ARCH ORTHOP TRAUM SU, V106, P297, DOI 10.1007/BF00454337
   KOBAYASHI S, 1987, NEUROSURGERY, V21, P751, DOI 10.1227/00006123-198711000-00032
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   KOKUBO T, 1991, CENTENNIAL MEMORIAL, V99, P9655
   KON K, 1994, DENT MATER J, V13, P138
   KONONEN M, 1994, J BIOMED MATER RES, V28, P1027, DOI 10.1002/jbm.820280907
   KVAM K, 1991, SCAND J DENT RES, V99, P527
   KVAM K, 1992, BIOMATERIALS, V13, P101, DOI 10.1016/0142-9612(92)90003-7
   KWON HJ, 1986, J ORAL MAXIL SURG, V44, P503, DOI 10.1016/S0278-2391(86)80089-1
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   LACEFIELD WR, 1986, BIOMATERIALS, V7, P104, DOI 10.1016/0142-9612(86)90064-5
   LAUFER D, 1988, J CRANIO MAXILL SURG, V16, P40, DOI 10.1016/S1010-5182(88)80013-1
   LI R, 1990, 16 ANN M SOC BIOM CH, P40
   LI R, 1991, J DENT RES, V70, P456
   LI Z, 1989, J AM CERAM SOC, V72, P904, DOI 10.1111/j.1151-2916.1989.tb06242.x
   Ling G S, 1987, J Tongji Med Univ, V7, P161
   Littleton JT, 1935, J AM CERAM SOC, V18, P239, DOI 10.1111/j.1151-2916.1935.tb19389.x
   MACCULLOCH WT, 1968, BR DENT J, V125, P361
   MACKERT JR, 1986, J AM CERAM SOC, V69, pC69
   MACKERT JR, 1986, DENT MATER, V2, P32, DOI 10.1016/S0109-5641(86)80067-7
   MACKERT JR, 1995, J DENT RES, V74, P1259, DOI 10.1177/00220345950740060401
   MACKERT JR, 1991, J DENT RES, V70, P137, DOI 10.1177/00220345910700020801
   MAHALICK JA, 1971, J AM DENT ASSOC, V82, P154, DOI 10.14219/jada.archive.1971.0018
   MARTIN S, 1989, NEUROCHIRURGIE, V35, P209
   MATHAI JK, 1989, AUST DENT J, V34, P421, DOI 10.1111/j.1834-7819.1989.tb00700.x
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   MATSUYAMA I, 1984, CERAMIC B, V63, P408
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P111, DOI 10.1002/jbm.820270114
   MAZDIYASNI KS, 1984, BETTER CERAMICS CHEM, P175
   McLean J W, 1965, Br Dent J, V119, P251
   MCLEAN JW, 1988, BRIT DENT J, V164, P187, DOI 10.1038/sj.bdj.4806398
   MCLEAN JW, 1980, BRIT DENT J, V149, P368, DOI 10.1038/sj.bdj.4804525
   MCLEAN JW, 1983, P 1 INT S CER
   McMillan PW, 1979, GLASS CERAMICS
   MEHROTRA RC, 1988, J NON-CRYST SOLIDS, V100, P1, DOI 10.1016/0022-3093(88)90003-8
   MERWIN GE, 1986, ARCH OTOLARYNGOL, V112, P280
   MERWIN GE, 1986, ANN OTO RHINOL LARYN, V1, P1
   Mesaros A J Jr, 1994, Am J Dent, V7, P137
   MESSER PF, 1991, J DENT, V19, P51, DOI 10.1016/0300-5712(91)90040-6
   MILLEDING P, 1995, J ORAL REHABIL, V22, P571, DOI 10.1111/j.1365-2842.1995.tb01051.x
   Miller E H, 1986, Instr Course Lect, V35, P188
   Minami M, 1988, J Arthroplasty, V3, P157, DOI 10.1016/S0883-5403(88)80081-0
   MONASKY GE, 1971, J PROSTHET DENT, V25, P299, DOI 10.1016/0022-3913(71)90191-0
   MONTANARO L, 1989, AM CERAM SOC BULL, V68, P1017
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   MORETA R, 1986, J AM CERAM SOC, V60, pC75
   MORISHITZ M, 1987, ADV BIOMATER, V7, P275
   MULLERMAI C, 1990, J BIOMED MATER RES, V24, P1571, DOI 10.1002/jbm.820241203
   Muzina D J, 1989, Biomed Sci Instrum, V25, P191
   Myers M L, 1994, Int J Prosthodont, V7, P549
   NAGAMINE T, 1987, J ORAL MAXIL SURG, V45, P173, DOI 10.1016/0278-2391(87)90409-5
   NERY EB, 1990, J PERIODONTOL, V61, P737, DOI 10.1902/jop.1990.61.12.737
   NIPARKO JK, 1988, LARYNGOSCOPE, V8, P1
   Nishiyama M, 1983, J Nihon Univ Sch Dent, V25, P262
   NOGAMI M, 1982, J NON-CRYST SOLIDS, V48, P359, DOI 10.1016/0022-3093(82)90171-5
   NOGAMI M, 1985, J NON-CRYST SOLIDS, V69, P415, DOI 10.1016/0022-3093(85)90043-2
   NOGAMI M, 1986, J AM CERAM SOC, V69, P99, DOI 10.1111/j.1151-2916.1986.tb04709.x
   NORDBO H, 1994, J DENT, V22, P342, DOI 10.1016/0300-5712(94)90085-X
   O'Leary J F, 1988, J Arthroplasty, V3, P87, DOI 10.1016/S0883-5403(88)80057-3
   OBRIEN WJ, 1985, DENT CLIN N AM, V29, P719
   OBRIEN WJ, 1984, J DENT RES, V63, P216
   OBRIEN WJ, 1994, J DENT RES, V73, P135
   OBRIEN WJ, 1993, DENT MATER, V9, P242, DOI 10.1016/0109-5641(93)90068-2
   OGIHARA T, 1991, J AM CERAM SOC, V74, P2263, DOI 10.1111/j.1151-2916.1991.tb08294.x
   OGIHARA T, 1989, J AM CERAM SOC, V72, P421, DOI 10.1111/j.1151-2916.1989.tb06146.x
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OKAMURA H, 1989, J MATER SCI, V24, P1867, DOI 10.1007/BF01105717
   OKAMURA H, 1986, J AM CERAM SOC, V69, pC22
   ONO K, 1990, BIOMATERIALS, V11, P265
   PALVA T, 1987, CLIN OTOLARYNGOL, V12, P33, DOI 10.1111/j.1365-2273.1987.tb00160.x
   PANG SE, 1995, INT J PROSTHODONT, V24, P33
   PARSELL DE, 1994, DENT MATER, V10, P167, DOI 10.1016/0109-5641(94)90027-2
   PAZZAGLIA UE, 1989, J BIOMED MATER RES, V23, P1289, DOI 10.1002/jbm.820231106
   PENDRY NR, 1971, BRIT CERAM TRANS J, V70, P124
   Phoenix R D, 1995, Int J Prosthodont, V8, P187
   PIDDOCK V, 1990, J DENT, V18, P227, DOI 10.1016/0300-5712(90)90019-B
   PILLIAR RM, 1976, J BIOMED MATER RES, V10, P893, DOI 10.1002/jbm.820100608
   PIZZOFERRATO A, 1988, J BIOMED MATER RES, V22, P1181, DOI 10.1002/jbm.820221209
   Preston F.W., 1933, Journal of the Society of Glass Technology, V17, P5
   Probster L, 1992, Quintessence Int, V23, P25
   Reck R, 1988, Ann N Y Acad Sci, V523, P100, DOI 10.1111/j.1749-6632.1988.tb38504.x
   RINGLE RD, 1983, J DENT RES, V62, P933, DOI 10.1177/00220345830620081801
   Rinke S, 1995, Int J Prosthodont, V8, P303
   RIZKALA AS, 1995, IN PRESS BRIT CERAMT
   RIZKALLA AS, 1992, BRIT CERAM TRANS J, V91, P12
   RIZKALLA AS, 1994, J DENT RES, V73, P197
   RIZKALLA AS, 1992, BRIT CERAM TRANS J, V91, P41
   RIZKALLA AS, 1987, J CAN CERAM SOC, V56, P54
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P81
   RIZKALLA AS, 1991, BRIT CERAM TRANS J, V90, P1
   RIZKALLA AS, 1991, J DENT RES, V70, P455
   RIZKALLA AS, 1996, 5 WORLD BIOM C TOR M, P446
   RIZKALLA AS, 1996, IN PRESS J BIOMED MA
   RIZKALLA AS, 1991, P 12 ANN C CAN IOM H, P14
   RIZKALLA AS, 1989, 15 ANN M SOC BIOM LA
   RIZKALLA AS, 1995, BRIT CERAM T
   RIZKALLA AS, 1989, J DENT RES, V68, P323
   ROSENSTIEL SF, 1989, J PROSTHET DENT, V62, P529, DOI 10.1016/0022-3913(89)90073-5
   ROSENSTIEL SF, 1993, DENT MATER, V9, P274, DOI 10.1016/0109-5641(93)90074-Z
   ROUF MA, 1978, BRIT CERAM TRANS J, V77, P36
   SATOMI K, 1988, J ORAL REHABIL, V15, P339, DOI 10.1111/j.1365-2842.1988.tb00166.x
   SCHEPERS E, 1988, J ORAL REHABIL, V15, P473, DOI 10.1111/j.1365-2842.1988.tb00183.x
   SCHEPERS E, 1989, J BIOMED MATER RES, V23, P735, DOI 10.1002/jbm.820230706
   Schmid M, 1992, Schweiz Monatsschr Zahnmed, V102, P1046
   Scotti R, 1995, Int J Prosthodont, V8, P320
   SEGHI RR, 1991, J DENT RES, V70, P221, DOI 10.1177/00220345910700031301
   SEGHI RR, 1990, DENT MATER, V6, P181, DOI 10.1016/0109-5641(90)90026-B
   SHAKLEE CA, 1994, J AM CERAM SOC, V77, P2977, DOI 10.1111/j.1151-2916.1994.tb04534.x
   SHERRILL CA, 1974, J DENT RES, V53, P683, DOI 10.1177/00220345740530032801
   SHYU JJ, 1990, J AM CERAM SOC, V73, P1062, DOI 10.1111/j.1151-2916.1990.tb05157.x
   SIEGEL RW, 1991, ANNU REV MATER SCI, V21, P559
   Siervo S, 1994, Int J Prosthodont, V7, P434
   SMITH DC, 1982, BIOCOMPATIBILITY DEN, V4
   SMYTH AB, 1996, 5 WORLD BIOM C TOR C, P388
   Snow K R, 1989, Biomed Sci Instrum, V25, P203
   SOLTEZ U, 1988, BIOCERAMICS MAT CHAR, V523, P137
   Southan D E, 1970, Aust Dent J, V15, P507
   Southan D E, 1974, Aust Dent J, V19, P7
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   TAIRA M, 1990, J ORAL REHABIL, V17, P551, DOI 10.1111/j.1365-2842.1990.tb01426.x
   THOMPSON JY, 1994, J DENT RES, V73, P1824, DOI 10.1177/00220345940730120601
   TYSZBLAT M, 1993, Patent No. 7846
   TYSZBLAT M, 1989, Patent No. 4772436
   UCHIYAMA K, 1987, J MATER SCI, V22, P4343, DOI 10.1007/BF01132027
   VANHERLE G, 1985, INT S POST COMP RES
   VANMEERBEEK B, 1992, J DENT, V20, P18, DOI 10.1016/0300-5712(92)90004-V
   WANG SA, 1989, J ORAL REHABIL, V16, P229
   WARD MT, 1995, OPER DENT, V20, P106
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   Weinstein M, 1962, US Patent, Patent No. [3,052,983, 3052983]
   WEINSTEIN M, 1962, Patent No. 3052982
   WHITE SN, 1993, DENT MATER, V9, P260, DOI 10.1016/0109-5641(93)90071-W
   WHITE SN, 1994, DENT MATER, V10, P52, DOI 10.1016/0109-5641(94)90022-1
   WHITEHEAD SA, 1995, J ORAL REHABIL, V22, P421, DOI 10.1111/j.1365-2842.1995.tb00795.x
   WIEDERHORN SM, 1968, INT J FRACT MECH, V4, P171
   WIEDERHORN SM, 1972, J AM CERAM SOC, V55, P81, DOI 10.1111/j.1151-2916.1972.tb11215.x
   WIEDERHORN SM, 1975, J NON-CRYST SOLIDS, V19, P169, DOI 10.1016/0022-3093(75)90083-6
   Williams D.F., 1981, BIOCOMPATIBILITY CLI, V1
   Williams D. F., 1992, MAT SCI TECHNOLOGY C, V14
   WILLIAMS DF, 1992, MAT SCI TECHNOLOGY C, V14, P259
   WILSON J, 1988, J BIOMED MAT RES
   WILSON J, 1991, BIOCERAMICS, V4, P99
   Wohlwend A, 1989, Int J Prosthodont, V2, P13
   YAMAGUCHI O, 1989, J AM CERAM SOC, V72, P1065, DOI 10.1111/j.1151-2916.1989.tb06273.x
   YAMASHIMA T, 1988, ACTA NEUROCHIR, V90, P157, DOI 10.1007/BF01560572
   YING L, 1989, Patent No. 1259149
   YOLDAS BE, 1973, J APPL CHEM BIOTECHN, V23, P803, DOI 10.1002/jctb.5020231103
   YOLDAS BE, 1979, J MATER SCI, V14, P1843, DOI 10.1007/BF00551023
   YOLDAS BE, 1977, J MATER SCI, V12, P1203, DOI 10.1007/BF02426858
   YOLDAS BE, 1974, CERAM B, V54, P289
   YOLDAS BE, 1975, CERAMIC B, V54, P288
   ZHU CS, 1984, J NON-CRYST SOLIDS, V63, P105
   ZOLLNER C, 1986, AM J OTOL, V7, P289
   1991, J AM DENT ASSOC, V122, P22
   1993, Patent No. 558835
NR 315
TC 5
Z9 5
U1 0
U2 16
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-745-5
J9 KEY ENG MATER
PY 1996
VL 122-1
BP 345
EP 383
DI 10.4028/www.scientific.net/KEM.122-124.345
PG 39
WC Materials Science, Multidisciplinary
SC Materials Science
GA BH23G
UT WOS:A1996BH23G00018
DA 2018-10-19
ER

PT J
AU Elbert, DL
   Hubbell, JA
AF Elbert, DL
   Hubbell, JA
TI Surface treatments of polymers for biocompatibility
SO ANNUAL REVIEW OF MATERIALS SCIENCE
LA English
DT Review
DE biomaterial; peptide; saccharide; hydrogel; poly(ethylene glycol)
ID SELF-ASSEMBLED MONOLAYERS; MONOCLONAL-ANTIBODY BINDING; BLOOD-CONTACTING
   PROPERTIES; NEURONAL CELL ATTACHMENT; PROTEIN ADSORPTION; POLY(ETHYLENE
   GLYCOL); EXTRACELLULAR-MATRIX; POLYETHYLENE OXIDE; POLYURETHANE
   SURFACES; PHOSPHOLIPID POLYMERS
AB Biological recognition mediates cell and tissue interactions with biomaterials, be the materials employed in a biotechnical environment in vitro or a biomedical environment in vivo. These interactions are typically mediated by proteins that have adsorbed to the biomaterial surface. The principles of protein adsorption and biological recognition are described. Polymer surface modifications to reduce protein adsorption upon biomaterial surfaces are summarized, as are modifications to enhance the irreversible adsorption of proteins. Using these approaches, it may be possible to reduce the extent to which the biomaterial surface and the protein-biomaterial surface are recognized by cells and tissues. Polymer surface modifications to incorporate oligopeptide-, saccharide-, and oligosaccharide-based receptor-binding sequences are described to enable direct binding of cells with the polymer surface. With use of these approaches, it is possible to endow an entirely synthetic material with the biological recognition characteristics of biological macromolecules.
RP Elbert, DL (reprint author), CALTECH,DIV CHEM & CHEM ENGN,PASADENA,CA 91125, USA.
RI Elbert, Donald/B-2040-2008; Hubbell, Jeffrey/A-9266-2008
OI Elbert, Donald/0000-0001-6480-9536; Hubbell, Jeffrey/0000-0003-0276-5456
CR ADACHI N, 1994, J BIOMAT SCI-POLYM E, V6, P463
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI MM, 1994, J APPL POLYM SCI, V52, P539, DOI 10.1002/app.1994.070520409
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BERGSTROM K, 1994, J BIOMAT SCI-POLYM E, V6, P123
   BROWN EJ, 1992, INFECT AGENT DIS, V1, P63
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURNS NL, 1995, LANGMUIR, V11, P2768, DOI 10.1021/la00007a070
   BYUN Y, 1994, J BIOMAT SCI-POLYM E, V6, P1
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   CHO CS, 1993, J BIOMED MATER RES, V27, P199, DOI 10.1002/jbm.820270209
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   CINNI E, 1993, BIOMATERIALS, V14, P588
   CLAPPER DL, 1994, J CELL BIOCHEM     S, V18, P283
   DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797
   DESAI NP, 1994, ABSTR PAP AM CHEM S, V207, P8
   DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105
   DRUMHELLER PD, 1994, J POLYM SCI POL CHEM, V32, P2715, DOI 10.1002/pola.1994.080321412
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   DRUMMOND RK, 1991, BIOMATERIALS, V12, P356, DOI 10.1016/0142-9612(91)90002-R
   ESMON CT, 1995, FASEB J, V9, P946
   FENG L, 1995, J BIOMAT SCI-POLYM E, V7, P439, DOI 10.1163/156856295X00445
   FERGUSON GS, 1993, MACROMOLECULES, V26, P5870, DOI 10.1021/ma00074a007
   FREIJLARSSON C, 1993, J APPL POLYM SCI, V50, P345, DOI 10.1002/app.1993.070500215
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1994, ACS SYM SER, V540, P228
   GEFFEN I, 1992, INT REV CYTOL, V137B, P181
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRASEL TG, 1990, J BIOMED MATER RES, V24, P605, DOI 10.1002/jbm.820240507
   GU YJ, 1994, CELL TRANSPLANT, V3, pS19
   GUIRE PE, 1993, Patent No. 5263992
   GUTSCHE AT, 1994, BIOTECHNOL BIOENG, V43, P801, DOI 10.1002/bit.260430815
   HAN DK, 1993, J BIOMAT SCI-POLYM E, V4, P401
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HATANAKA K, 1993, MACROMOLECULES, V26, P1483, DOI 10.1021/ma00059a001
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   HUBBELL JA, 1993, CARDIOVASC PATHOL, V2, pS121
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, Patent No. 5462990
   HUMPHRIES MJ, 1990, J CELL SCI, V97, P585
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INTVELD PJA, 1994, J POLYM SCI POL CHEM, V32, P1063, DOI 10.1002/pola.1994.080320608
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P1347, DOI 10.1002/jbm.820281113
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIM YJ, 1994, J APPL POLYM SCI, V54, P1863, DOI 10.1002/app.1994.070541209
   KISHIDA A, 1994, BIOMATERIALS, V15, P1170, DOI 10.1016/0142-9612(94)90238-0
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEES WJ, 1994, J MED CHEM, V37, P3419, DOI 10.1021/jm00046a027
   LELLAH MD, 1986, POLYURETHANES MED
   LI S, 1995, ABSTR PAP AM CHEM S, V209, P305
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   LOFAS S, 1995, PURE APPL CHEM, V67, P829, DOI 10.1351/pac199567050829
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MATTHEWS KH, 1994, MAT SCI ENG C-BIOMIM, V2, P51, DOI 10.1016/0928-4931(94)90029-9
   MECHAM RP, 1991, ANNU REV CELL BIOL, V7, P71, DOI 10.1146/annurev.cb.07.110191.000443
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   OSHEA GM, 1986, DIABETES, V35, P943, DOI 10.2337/diabetes.35.8.943
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PLOW EF, 1995, FASEB J, V9, P939
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMPP P, 1991, POLYM PREPR-ACS, V32, P687
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUOSLAHTI E, 1986, Patent No. 4578079
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   SCHAKENRAAD JM, 1992, CELL MATER, V2, P193
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHOICHET MS, 1994, BIOTECHNOL BIOENG, V43, P563, DOI 10.1002/bit.260430705
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   SILVER JH, 1994, BIOMATERIALS, V15, P695, DOI 10.1016/0142-9612(94)90168-6
   SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171
   SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   TERLINGEN JGA, 1992, J BIOMAT SCI-POLYM E, V4, P31
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   TSENG YC, 1995, BIOMATERIALS, V16, P963, DOI 10.1016/0142-9612(95)94902-W
   UCHIDA E, 1994, LANGMUIR, V10, P481, DOI 10.1021/la00014a023
   UCHIDA M, 1991, MACROMOLECULES, V24, P3238, DOI 10.1021/ma00011a031
   VANALSTINE JM, 1993, COLLOID SURFACE A, V77, P149, DOI 10.1016/0927-7757(93)80111-Q
   VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390
   WOJCIECHOWSKI P, 1991, Journal of Biomaterials Science Polymer Edition, V2, P203
   WOODHOUSE KA, 1994, J COLLOID INTERF SCI, V164, P40, DOI 10.1006/jcis.1994.1141
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   YANG Z, 1995, J AM CHEM SOC, V117, P4843, DOI 10.1021/ja00122a014
   YOON SC, 1990, MACROMOLECULES, V23, P4351, DOI 10.1021/ma00222a004
   YU XH, 1990, J APPL POLYM SCI, V41, P1777, DOI 10.1002/app.1990.070410734
NR 125
TC 388
Z9 391
U1 4
U2 152
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0084-6600
J9 ANNU REV MATER SCI
JI Annu. Rev. Mater. Sci.
PY 1996
VL 26
BP 365
EP 394
DI 10.1146/annurev.ms.26.080196.002053
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA VB465
UT WOS:A1996VB46500015
DA 2018-10-19
ER

PT J
AU Sevastianov, VI
AF Sevastianov, VI
TI Biomaterial development in Russia and the independent states
SO ASAIO JOURNAL
LA English
DT Article
ID USSR
RP Sevastianov, VI (reprint author), CTR BLOOD COMPATIBLE BIOMAT,RES INST TRANSPLANTOL & ARTIFICIAL ORGANS,1 SHUKINSKAYA,MOSCOW 123436,RUSSIA.
RI Sevastianov, Victor/B-6674-2017
OI Sevastianov, Victor/0000-0003-1995-3373
CR ADAMYAN AA, 1988, KHIRURGIA, V3, P148
   ADAMYAN AA, 1994, BIOMATER LIVING SYST, V2, P91
   BRUSOVA LA, 1993, BIOMATER LIVING SYST, V1, P215
   CHABRONA L, 1992, 1 INT C ADV MAT HANG, P320
   CHABROVA L, 1991, 2 INT S REFR SURG IO, P98
   DOBROVA NB, 1994, J ADV MAT, V1, P69
   GALATANKO NA, 1988, P UKRAINIAN ACAD SCI, V2, P64
   HORAK D, 1990, Clinical Materials, V6, P287, DOI 10.1016/0267-6605(90)90049-2
   KARELSKAYA E, 1992, T 4 WORLD BIOM C BER, P671
   KASJANOV V, 1987, MODERN PROBLEMS BIOM, V4, P5
   KUDAIBERGENOVA I, 1993, BIOMATERIAL LIVING S, V1, P153
   Nemets E A, 1993, ASAIO J, V39, pM319
   NEMETS EA, 1994, BIOMATER LIVING SYST, V2, P63
   NIKOLAEV V, 1992, CLIN MAT, V9, P125
   NIKOLAEV VG, 1990, BIOMATER ARTIF CELL, V18, P555, DOI 10.3109/10731199009119633
   NOVIKOVA S, 1989, EXPT HEART VASCULAR, P33
   PKHAKADZE GA, 1993, BIOMATERIAL LIVING S, V1, P31
   PKHAKADZE GA, 1990, BIODEGRADATION POLYM
   SERGEEV V, 1990, BIOMAT ARTIF CELLS A, V17, P353
   SEVASTIANOV V, 1992, ARTIF ORGANS, P19
   SEVASTIANOV VI, 1991, J BIOMED MATER RES, V25, P255, DOI 10.1002/jbm.820250211
   SKUDA N, 1989, B EXP BIOL MED, V3, P379
   SNEZHKOVA EA, 1992, BIOMAT ARTIF CELL IM, V20, P1201, DOI 10.3109/10731199209117347
   VALUYNIN T, 1991, P C MR INT 90, P501
NR 24
TC 1
Z9 1
U1 1
U2 6
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JAN-FEB
PY 1996
VL 42
IS 1
BP 4
EP 7
DI 10.1097/00002480-199601000-00002
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA UM355
UT WOS:A1996UM35500003
PM 8808448
DA 2018-10-19
ER

PT J
AU Dai, KR
   Chu, YY
AF Dai, KR
   Chu, YY
TI Studies and applications of NiTi shape memory alloys in the medical
   field in China
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE shape memory alloy; biomedical study; surgical implant; NiTi alloy;
   biomaterial
AB The biomedical study of NiTi shape memory alloys has been undertaken in China since 1978. A series of stimulating corrosion tests, histological observations, toxicity tests, carcinogenicity tests, trace nickel elements analysis and a number of clinical trials have been conducted. The results showed that the NiTi shape memory alloy is a good biomaterial with good biocompatibility and no obvious local tissue reaction, carcinogenesis or erosion of implants were found experimentally or clinically. In 1981, on the basis of fundamental studies, a shape memory staple was used for the first time inside the human body. Subsequently, various shape memory devices were designed and applied clinically for internal fixation of fractures, spine surgery, endoprostheses, gynaecological and craniofacial surgery. Since 1990, a series of internal stents have been developed for the management of biliary, tracheal and esophageal strictures and urethrostenosis as well as vascular obturator for tumour management. Several thousand cases have been treated and had a 1-10 year follow-up and good clinical results with a rather low complication rate were obtained.
C1 SHANGHAI MED UNIV 2,PEOPLES HOSP 9,SHANGHAI 200011,PEOPLES R CHINA.
   NONFERROUS MET SOC CHINA,BEIJING,PEOPLES R CHINA.
CR BAO YY, 1983, CHINESE J STOMATOLOG, V18, P15
   CHU YY, 1984, P MRS INT M ADV MAT, V9, P569
   Dai Kei-Rong, 1994, CHINESE J SURG, V32, P629
   DAI KR, 1993, INJURY, V24, P651, DOI 10.1016/0020-1383(93)90313-U
   Dai KR, 1983, CHINESE J SURG, V21, P343
   DAI KR, 1990, P INT C MED APPL SHA, P87
   DAI KR, 1983, CHINESE J SURG, V21, P540
   DONG JY, 1995, CHINESE J SURG, V31, P263
   DONG ZZ, 1993, CHINESE J SURG, V31, P264
   GAO N, 1994, P INT S SHAP MEM MAT, P677
   GU WQ, 1993, CHINESE J SURG, V31, P260
   LIU Y, 1993, CHINESE J SURG, V31, P267
   LU SB, 1986, CHINESE J SURG, V24, P129
   PAN KF, 1986, P INT S SHAP MEM ALL, P427
   QIU CY, 1993, CHINESE J SURG, V31, P275
   QIU CY, 1991, CHINESE J SURG, V29, P369
   *SHANGH 9 PEOPL HO, 1982, J SHANGHAI 2 MED COL, V2, P31
   SUN HX, 1992, CHINESE J ORTHOP, V12, P261
   TANG JB, 1994, P INT S SHAP MEM MAT, P674
   WANG DZ, 1986, CHINESE J NEUROSURG, V4, P180
   WANG JF, 1992, BEIJING J BIOMEDICAL, V11, P84
   WANG XX, 1994, P INT S SHAP MEM MAT, P621
   WU XT, 1995, CHINESE J TRAUMATOLO, V11, P89
   XU XT, 1995, J BONE JOINT INJURY, V10, P164
   XUE M, 1982, NATL MED J CHINA, V62, P758
   XUE M, 1986, P INT S SHAP MEM ALL, P411
   XUE M, 1981, STOMATOLOGY, V1, P40
   XUE M, 1983, CHINESE J BIOMED ENG, V2, P28
   XUE M, 1990, J SHANGHAI 2 MED U, V4, P61
   XUE P, 1986, P INT S SHAP MEM ALL, P444
   YANG PJ, 1983, CHINESE J ORTHOP, V3, P137
   YANG PT, 1991, CHINESE J TRAUMATOLO, V7, P69
   Zhang CC, 1993, CHINESE J SURG, V31, P269
   ZHANG CC, 1992, CHINESE J SURG, V30, P111
   ZHANG CC, 1993, CHINESE J SURG, V31, P275
   ZHANG CC, 1990, P INT C MED APPL SHA, P144
   Zhang Chuncai, 1989, CHINESE J SURG, V27, P692
   ZHANG SM, 1995, J WUHAN UNIV TECHNOL, V10, P36
   Zhao D. L., 1984, CHINESE J SURG, V22, P410
   ZU XS, 1995, J APPL BIOMECH, V10, P45
NR 40
TC 49
Z9 56
U1 3
U2 9
PU IOS PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 1996
VL 6
IS 4
BP 233
EP 240
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VY578
UT WOS:A1996VY57800002
PM 8980832
DA 2018-10-19
ER

PT J
AU Villermaux, F
   Tabrizian, M
   Yahia, L
   Czeremuszkin, G
   Piron, DL
AF Villermaux, F
   Tabrizian, M
   Yahia, L
   Czeremuszkin, G
   Piron, DL
TI Corrosion resistance improvement of NiTi osteosynthesis staples by
   plasma polymerized tetrafluoroethylene coating
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE NiTi shape memory alloy; osteosynthesis staple; plasma polymerized
   tetrafluoroethylene coating; pitting resistance; biomaterial
ID SHAPE-MEMORY ALLOY; BEHAVIOR; IMPLANT; BIOCOMPATIBILITY; FILMS
AB NiTi Shape Memory Alloys (SMA) are potential biomaterial candidates for medical devices such as osteosynthesis staples. However, Ni dissolution induced by uniform or localized corrosion could lead to toxicity. In this work, plasma polymerized tetrafluoroethylene (PPFTE) coating is used to improve the corrosion resistance of NiTi plates and corresponding NiTi staples. The scratch test indicates a good surface adhesion of the film but that it lacks cohesiveness. Potentiodynamic tests in physiological Hank's solution show that PPTFE coating improved the pitting corrosion resistance. The passivation range is increased from 35% to 96% compared to the untreated sample and the pit diameter is decreased from 100 mu m to 10 mu m. The uniformity of the deposited him is a very important parameter. When the Aim is damaged, the corrosion seems to increase in comparison to the untreated samples. Otherwise, if the staple is carefully manipulated, the coating follows the large deformations induced by the memory effect of the alloy without cracking, and then, protects efficiently the staple from pitting.
C1 ECOLE POLYTECH,INST BIOMED ENGN,BIOMECH BIOMAT RES GRP,MONTREAL,PQ H3C 3A7,CANADA.
   ECOLE POLYTECH,COUCHES MINCES GRP,DEPT ENGN PHYS,MONTREAL,PQ H3C 3A7,CANADA.
   ECOLE POLYTECH,DEPT MET,MONTREAL,PQ H3C 3A7,CANADA.
CR ABIKIDO Y, 1994, 1 INT C SHAP MEM SUP
   ASSAD M, 1994, ANN CHIR, V48, P731
   BARBOSA MA, 1991, BIOMATERIALS DEGRADA, P227
   BUTLER MA, 1992, J APPL PHYS, V72, P4041, DOI 10.1063/1.352259
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CHO DL, 1991, J APPL POLYM SCI, V42, P233
   DESJARDINS D, 1992, CORROSION CONTRAINTE, P1
   DUTTA RS, 1993, BRIT CORROS J, V28, P217
   ENDO K, 1994, 1 INT C SHAP MEM SUP
   GRANT DM, 1995, ACTA METALL MATER, V43, P1045, DOI 10.1016/0956-7151(94)00310-E
   GREEN SM, 1993, J MATER SCI LETT, V12, P618, DOI 10.1007/BF00465570
   IKEGAWA M, 1988, P 7 S PLASM PROC, P378
   KIMURA H, 1987, DENT MAT APPARATUS, V6, P73
   LOMBARDI S, 1994, 1 INT C SHAP MEM SUP
   MANKOWSKI G, 1992, CORROSION CONTRAINTE, P645
   MARTINU L, 1989, APPL PHYS LETT, V54, P2645, DOI 10.1063/1.101566
   NAKAYAMA Y, 1989, BIOMATERIALS, V10, P420, DOI 10.1016/0142-9612(89)90134-8
   PIRON DL, 1991, ELECTROCHEMISTRY COR, P183
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   ROSS RC, 1994, J NONCRYSTALLINE SOL, V66, P81
   SANDERS JO, 1993, SPINE, V18, P1640, DOI 10.1097/00007632-199309000-00012
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   SHABALOVSKAYA S, 1994, 1 INT C SHAP MEM SUP
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   TANG RG, 1994, 1 INT C SHAP MEM SUP
   XU Y, 1993, J ELECTROCHEM SOC, V140, P3448, DOI 10.1149/1.2221108
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 27
TC 40
Z9 46
U1 0
U2 2
PU IOS PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 1996
VL 6
IS 4
BP 241
EP 254
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA VY578
UT WOS:A1996VY57800003
PM 8980833
DA 2018-10-19
ER

PT J
AU Ripamonti, U
AF Ripamonti, U
TI Osteoinduction in porous hydroxyapatite implanted in heterotopic sites
   of different animal models
SO BIOMATERIALS
LA English
DT Article
DE bone morphogenetic proteins; hydroxyapatite; osteoinduction; primates;
   animal models
ID BONE MORPHOGENETIC PROTEIN; OSTEOGENIC PROTEIN; BETA FAMILY; BOVINE
   BONE; INDUCTION; BABOONS; GEOMETRY; CERAMICS; HYDROXYLAPATITE;
   PURIFICATION
AB Previous studies have demonstrated the induction of bone in coral-derived porous hydroxyapatite when implanted intramuscularly in baboons. This hydroxyapatite-induced bone differentiation model was used to study the effect of different animal species on heterotopic bone formation. Porous hydroxyapatite, obtained after hydrothermal conversion of the calcium carbonate exoskeleton of coral (genus Goniopora), was implanted in the rectus abdominis of adult rabbits, dogs and baboons (Papio ursinus). Specimens were harvested on day 90 after implantation and subjected to histological and histomorphometrical analysis. Minimal amounts of bone formed in hydroxyapatite specimens harvested from rabbits and dogs. Substantial bone differentiation did occur, however, in hydroxyapatite specimens harvested from the rectus abdominis of the baboons. In primates, the porous hydroxyapatite, as used in this study, may act as a solid matrix for adsorption, storage and controlled release of circulating or locally produced bone morphogenetic proteins, which locally initiate bone formation. The results of this study on heterotopic bone formation in porous hydroxyapatite underscore the importance of primate models in biomaterial research, which should be exploited for the formulation of porous substrata with intrinsic osteoinductive activity.
RP Ripamonti, U (reprint author), UNIV WITWATERSRAND,MRC,BONE RES LAB,SCH MED,7 YORK RD,JOHANNESBURG 2193,SOUTH AFRICA.
CR BOUABBOUD NN, 1994, BIOMATERIALS, V15, P201, DOI 10.1016/0142-9612(94)90068-X
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   CHIROFF RT, 1975, J BIOMED MATER RES S, V6, P29
   DOLL BA, 1990, J PERIODONTOL, V61, P745, DOI 10.1902/jop.1990.61.12.745
   ELDEEB M, 1989, J ORAL MAXIL SURG, V47, P50
   GLASS DA, 1989, J PERIODONTOL, V60, P121, DOI 10.1902/jop.1989.60.3.121
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   MELTON DA, 1982, S AFR J ZOOL, V17, P85
   MILLER TA, 1991, PLAST RECONSTR SURG, V87, P87, DOI 10.1097/00006534-199101000-00014
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x
   Parfitt AM, 1983, BONE HISTOMORPHOMETR, P53
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   Reddi A H, 1974, Adv Biol Med Phys, V15, P1
   Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850
   REDDI AH, 1973, P SOC EXP BIOL MED, V143, P634
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   RIPAMONTI U, 1989, J ORAL MAXIL SURG, V47, P963, DOI 10.1016/0278-2391(89)90381-9
   RIPAMONTI U, 1993, BIOCHEM BIOPH RES CO, V193, P509, DOI 10.1006/bbrc.1993.1653
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V89, P731, DOI 10.1097/00006534-199204000-00025
   RIPAMONTI U, 1993, MATRIX, V13, P491, DOI 10.1016/S0934-8832(11)80115-0
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   RIPAMONTI U, 1992, MATRIX, V12, P369, DOI 10.1016/S0934-8832(11)80033-8
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   SCHNITZLER CM, 1993, CALCIFIED TISSUE INT, V52, P447, DOI 10.1007/BF00571335
   TAKOAKA K, 1988, CLIN ORTHOPAEDICS, V234, P250
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   Wells J. W., 1956, TREATISE INVERTEBR F, P328
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   YOSHIKAWA T, 1992, CALCIFIED TISSUE INT, V50, P184, DOI 10.1007/BF00298798
NR 45
TC 325
Z9 337
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1996
VL 17
IS 1
BP 31
EP 35
DI 10.1016/0142-9612(96)80752-6
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TY457
UT WOS:A1996TY45700005
PM 8962945
DA 2018-10-19
ER

PT J
AU Shakesheff, KM
   Davies, MC
   Roberts, CJ
   Tendler, SJB
   Williams, PM
AF Shakesheff, KM
   Davies, MC
   Roberts, CJ
   Tendler, SJB
   Williams, PM
TI The role of scanning probe microscopy in drug delivery research
SO CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
LA English
DT Review
DE atomic force microscopy; scanning tunneling microscopy; drug targeting;
   biodegradable polymers; microparticles
ID ATOMIC-FORCE MICROSCOPY; SURFACE-PLASMON RESONANCE;
   TUNNELING-MICROSCOPY; POLY(ETHYLENE OXIDE); ELECTRON-MICROSCOPY;
   MICROTITER WELLS; POLYMER BLEND; KUPFFER CELLS; REAL-SPACE; THIN-FILMS
AB The success of a drug delivery system is often dependent on the surface properties of the device. These surface properties will determine the complex dynamic interfacial events that occur when the system is introduced into the aqueous environment of a patient. Development of the scanning probe microscopes has provided a number of very powerful new surface analytical techniques that are making a significant contribution to the characterization of drug delivery systems and the interfacial processes that occur when such systems are exposed to aqueous living environments. In this review, we describe the design and attributes of these instruments and discuss the impact of the techniques on a wide range of drug delivery research. The scanning probe microscopes are providing new insights into important problems concerning drug delivery, including the molecular structure of polymeric biomaterial surfaces, the conformation of target biomolecules, the influence of morphology on biodegradation, the adsorption of proteins to synthetic surfaces, and the structure and interactions of colloidal particles. As the whole field of scanning probe microscopy continues to advance, drug delivery research is set to benefit; in the final section of the review, the future potential derived from the ability to characterize new surface properties under aqueous conditions is discussed.
C1 UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,LAB BIOPHYS & SURFACE ANAL,NOTTINGHAM NG7 2RD,ENGLAND.
RI Roberts, Clive/C-6970-2009; Williams, Philip/C-6947-2009
OI Roberts, Clive/0000-0001-9443-3445; Williams,
   Philip/0000-0002-1822-2133; Shakesheff, Kevin/0000-0003-3236-2439;
   Davies, Martyn/0000-0001-7695-0596
CR AKAMINE S, 1990, APPL PHYS LETT, V57, P316, DOI 10.1063/1.103677
   AKARI SO, 1994, APPL PHYS LETT, V65, P1918
   ANDRADE JD, 1985, SURFACE INTERFACIAL
   ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   ANNIS BK, 1992, MAKROMOL CHEM, V193, P2589
   BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189
   BINNIG G, 1986, PHYS REV LETT, V56, P55
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BRINDLEY A, 1995, J COLLOID INTERF SCI, V171, P150, DOI 10.1006/jcis.1995.1161
   BURNHAM NA, 1993, SCANNING TUNNELING M
   CHEN X, 1995, J PHYS CHEM-US, V11, P2547
   CHI QJ, 1994, J CHEM SOC FARADAY T, V90, P2057, DOI 10.1039/ft9949002057
   COLLIN B, 1992, MACROMOLECULES, V25, P1621, DOI 10.1021/ma00031a042
   CULLEN DC, 1994, J COLLOID INTERF SCI, V166, P102, DOI 10.1006/jcis.1994.1276
   DAVIES J, 1994, LANGMUIR, V10, P2654, DOI 10.1021/la00020a026
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   DOMB AJ, 1993, J POLYM SCI POL CHEM, V31, P1973, DOI 10.1002/pola.1993.080310805
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   EDSTROM RD, 1990, BIOPHYS J, V58, P1437, DOI 10.1016/S0006-3495(90)82489-9
   EMCH R, 1992, ULTRAMICROSCOPY, V42, P1155, DOI 10.1016/0304-3991(92)90417-I
   ERIE DA, 1994, SCIENCE, V266, P1562, DOI 10.1126/science.7985026
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   GARBASSI F, 1994, POLYM SURFACES PHYSI
   GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68
   GOPFERICH A, 1993, J POLYM SCI POL CHEM, V31, P2445, DOI 10.1002/pola.1993.080311004
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GROSSMAN SA, 1992, J NEUROSURG, V76, P640, DOI 10.3171/jns.1992.76.4.0640
   HAMERS RJ, 1986, PHYS REV LETT, V56, P1972, DOI 10.1103/PhysRevLett.56.1972
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   HARPER GR, 1995, BIOMATERIALS, V16, P427, DOI 10.1016/0142-9612(95)98815-V
   Hemsley DA, 1989, APPL POLYM LIGHT MIC
   HOH JH, 1993, BIOPHYS J, V65, P149, DOI 10.1016/S0006-3495(93)81074-9
   ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975
   JEFFREY AM, 1993, NUCLEIC ACIDS RES, V21, P5896, DOI 10.1093/nar/21.25.5896
   JONES RAL, 1989, PHYS REV LETT, V62, P280, DOI 10.1103/PhysRevLett.62.280
   KELLER D, 1991, SURF SCI, V253, P353, DOI 10.1016/0039-6028(91)90606-S
   KELLER DJ, 1992, SURF SCI, V268, P333, DOI 10.1016/0039-6028(92)90973-A
   LAL R, 1994, AM J PHYSIOL, V266, P51
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LEA AS, 1994, COLLOID SURFACE A, V93, P349, DOI 10.1016/0927-7757(94)02878-8
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   LEUNG OM, 1992, SCIENCE, V255, P64, DOI 10.1126/science.255.5040.64
   LI Y, 1991, REV SCI INSTRUM, V62, P2630, DOI 10.1063/1.1142243
   LI YQ, 1993, LANGMUIR, V9, P637, DOI 10.1021/la00027a003
   LINDSAY SM, 1993, J VAC SCI TECHNOL A, V11, P808, DOI 10.1116/1.578309
   LINDSAY SM, 1993, SCANNING TUNNELING M
   MANASSEN Y, 1994, ADV MATER, V6, P401, DOI 10.1002/adma.19940060514
   MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807
   MATHIOWITZ E, 1993, MACROMOLECULES, V26, P6756, DOI 10.1021/ma00077a010
   MEYER G, 1988, APPL PHYS LETT, V53, P2400, DOI 10.1063/1.100425
   MISSIRLIS YF, 1989, MODERN ASPECTS PROTE
   MOGHIMI SM, 1994, CRIT REV THER DRUG, V11, P31
   MOGHIMI SM, 1993, BIOCHIM BIOPHYS ACTA, V1179, P157, DOI 10.1016/0167-4889(93)90137-E
   MOTOMATSU M, 1994, JPN J APPL PHYS 1, V33, P3775, DOI 10.1143/JJAP.33.3775
   NICK L, 1994, COLLOID POLYM SCI, V272, P367, DOI 10.1007/BF00655511
   OVERNEY RM, 1994, J APPL PHYS, V75, P1401, DOI 10.1063/1.357025
   OVERNEY RM, 1992, NATURE, V359, P133, DOI 10.1038/359133a0
   PATHAK YV, 1993, CELL MATER, V3, P51
   PATIL R, 1994, POLYMER, V35, P1909, DOI 10.1016/0032-3861(94)90980-6
   PEKAREK KJ, 1994, NATURE, V367, P258, DOI 10.1038/367258a0
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   POOL R, 1990, SCIENCE, V247, P634, DOI 10.1126/science.247.4943.634
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   REES WA, 1993, SCIENCE, V260, P1646, DOI 10.1126/science.8503010
   ROBERTS CJ, 1995, LANGMUIR, V11, P1822, DOI 10.1021/la00005a063
   ROBERTS CJ, 1994, TRENDS BIOTECHNOL, V12, P127, DOI 10.1016/0167-7799(94)90090-6
   SHAKESHEFF KM, 1994, SURF SCI, V304, pL393, DOI 10.1016/0039-6028(94)90739-0
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P2547, DOI 10.1021/la00007a038
   SHAKESHEFF KM, 1995, LANGMUIR, V11, P3921, DOI 10.1021/la00010a049
   SHAKESHEFF KM, 1995, MACROMOLECULES, V28, P1108, DOI 10.1021/ma00108a044
   SHAKESHEFF KM, 1994, LANGMUIR, V10, P4417, DOI 10.1021/la00024a005
   SHAKESHEFF KM, 1994, NANOBIOLOGY, V3, P41
   SHEIKO SS, 1993, POLYM BULL, V31, P693, DOI 10.1007/BF00300129
   SNETIVY D, 1992, POLYMER, V33, P432, DOI 10.1016/0032-3861(92)91006-N
   SNETIVY D, 1994, J MATER CHEM, V4, P55, DOI 10.1039/jm9940400055
   SOMMER F, 1995, LANGMUIR, V11, P440, DOI 10.1021/la00002a013
   STOCKER W, 1993, MACROMOLECULES, V26, P5915, DOI 10.1021/ma00074a013
   STOCKER W, 1994, MACROMOLECULES, V27, P6948, DOI 10.1021/ma00101a036
   SYKES KE, 1995, J MATER SCI, V30, P623, DOI 10.1007/BF00356320
   VALLOTTON PH, 1994, J BIOMAT SCI-POLYM E, V6, P609
   WILLIAMS DF, 1992, MAT SCI TECHNOLOGY, V14
   WILLIAMS PM, 1994, J VAC SCI TECHNOL B, V12, P1456, DOI 10.1116/1.587315
   WOODWARD AE, 1989, ATLAS POLYM MORPHOLO, pCH9
   YANG J, 1994, FEBS LETT, V338, P89, DOI 10.1016/0014-5793(94)80122-3
NR 86
TC 12
Z9 12
U1 0
U2 8
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 0743-4863
J9 CRIT REV THER DRUG
JI Crit. Rev. Ther. Drug Carr. Syst.
PY 1996
VL 13
IS 3-4
BP 225
EP 256
DI 10.1615/CritRevTherDrugCarrierSyst.v13.i3-4.20
PG 32
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA WB285
UT WOS:A1996WB28500002
PM 9016382
DA 2018-10-19
ER

PT B
AU Inoue, T
   Miyakoshi, S
   Shimono, M
AF Inoue, T
   Miyakoshi, S
   Shimono, M
BE Shimono, M
   Maeda, T
   Suda, H
   Takahashi, K
TI Dentin pulp adhesive resin interface. Biological view from basic science
   to clinic
SO DENTIN/PULP COMPLEX
LA English
DT Proceedings Paper
CT International Conference on Dentin/Pulp Complex 1995 / International
   Meeting on Clinical Topics of Dentin/Pulp Complex
CY JUL 01-04, 1995
CL CHIBA, JAPAN
SP Int Assoc Dent Res Pulp Biol Grp, Japanese Assoc Dent Sci, Japanese Assoc Oral Biol, Japanese Assoc Dent Res
AB The effect of 4-META/MMA-TBB adhesive resin(4-META) to pulp tissue was evaluated in vivo and in vitro. First, a cell proliferation test and a cell toxicity test were carried out in, vitro. 4-META causes weak cytotoxic damage and suppresses the cell proliferation but does not kill the cells. Second, direct pulp capping with 4-META was performed in vivo. Only a little inflammatory cell infiltration and macrophages were found in some case and dentin bridge was found in half of the cases. Third, 4-META was applied directly on the pulp tissue, and allowed to polymerize. Then, the soft tissue hybrid layer(STHL) which is produced by both resin and pulp was analysed by SEM, TEM, XPS and gas chromatography. SEM data showed fixation of capillaries, cells, and collagen fibers, giving the surface a rough and porous interface. TEM data showed collagen fibers, degenerated cells and capillaries in the STHL. XPS analysis showed presence of nitrogen and sulfur on the surface of the STHL, indicated this layer contained pulp tissue components. Gas chromatograph analysis showed when the STHL was placed in 37 degrees C distilled water, some carboxylic acid derivatives were eluted. These data suggested that 4-MET is a feasible component of the carboxylic acid derivatives. Finally, dental pulp cells were cultured on the STHL and bone-like nodules could be seen on the STHL. These results might be a good evidence for STHL could be a proper substrata for dentinogenesis in situ. From these results, 4-META is a biomaterial that has a high affinity for pulp tissue.
RP Inoue, T (reprint author), TOKYO DENT COLL,DEPT PATHOL,CHIBA,JAPAN.
NR 0
TC 8
Z9 8
U1 0
U2 0
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 N KIMBERLY DR, CAROL STREAM, IL 60188-1881
BN 4-87417-522-8
PY 1996
BP 217
EP 220
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BG73N
UT WOS:A1996BG73N00035
DA 2018-10-19
ER

PT B
AU Liu, XD
   Strumillo, C
   Zbicinski, I
AF Liu, XD
   Strumillo, C
   Zbicinski, I
BE Strumillo, C
   Pakowski, Z
TI Protection of thermo- and xero-labile materials during thermal drying
SO DRYING '96, VOL B
LA English
DT Proceedings Paper
CT 10th International Drying Symposium (IDS 96)
CY JUL 30-AUG 02, 1996
CL KRAKOW, POLAND
SP Polish Acad Sci, State Comm Sci Res, Poland, SiTPChem, Poland, European Federat Chem Engineers, Drying Working Party EFChEng, Canadian Soc Chem Engn, Amer Inst Chem Engineers, Inst Chem Engineers, London, Japan Soc Chem Engineers, AFSIA, France
DE biomaterial; heat processing; quality protection
C1 TIANJIN INST LIGHT IND,DEPT MECH ENGN,TIANJIN,PEOPLES R CHINA.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU DRUKARNIA PAPAJ
PI LODZ
PA UL STARORUDZKA 52, 93-424 LODZ, POLAND
BN 83-86903-07-4
PY 1996
BP 1237
EP 1244
PG 8
WC Engineering, Chemical; Engineering, Mechanical; Food Science &
   Technology
SC Engineering; Food Science & Technology
GA BG33X
UT WOS:A1996BG33X00065
DA 2018-10-19
ER

PT J
AU Nastaj, JF
AF Nastaj, JF
TI Some aspects of freeze drying of dairy biomaterials
SO DRYING TECHNOLOGY
LA English
DT Article
DE vacuum freeze drying; process/biomaterial parameters; biomaterials
   quality estimations; dairy biomaterials viability; contact-radiant
   heating; mathematical model
ID AQUEOUS-SOLUTIONS; VACUUM; MODEL; HEAT; SOLIDIFICATION; SUBLIMATION;
   SIMULATION; TRANSPORT; PRODUCTS; LIQUID
AB Different theoretical and experimental aspects of freeze drying of dairy biomaterials are reported. The following dairy biomaterials were chosen for investigations: three kefir bacterial cultures and one bacterial concentrate of a dairy vaccine. Experiments were performed both at one-region conductive or radiative heating and at combined two-region conductive-radiative heating. Emphasis was put on quality interactions between physical and biological properties of the material to be dried and freeze drying process parameters. Qualitative estimations of the following properties of biomaterials: a) colour, b) suppleness to caking and c) suppleness to scraping from the hot surface in dependence with the process parameters were performed using four-step subjective scales. On the basis of this estimations a synthetic quality criterion SQC was defined whose numerical value reflects general product quality. The results of mathematical modelling, numerical solution of the model and comparison with experimental data indicated that the process was heat transfer controlled and that the main factors resulting in good product quality and high SQC are low temperature of the conductive heated surface and vacuum chamber pressure affecting sublimation temperature. The influence of the sample freezing parameters on the elimination of the foaming or puffing and on the product quality was observed and examined. Furthermore, preliminary measurements of the dairy biomaterials viability after freeze drying were presented.
RP Nastaj, JF (reprint author), TECH UNIV SZCZECIN,DEPT CHEM ENGN,AL PIASTOW 42,PL-70065 SZCZECIN,POLAND.
RI Nastaj, Jozef/I-8971-2016
CR ADAMIEC J, 1990, CONSERVATION BIOACTI, P1
   Bruin S, 1980, ADV DRYING, V1, P155
   Burbianka M, 1983, MIKROBIOLOGIA ZYWNOS
   CHEN PS, 1989, INT J HEAT MASS TRAN, V32, P297, DOI 10.1016/0017-9310(89)90177-4
   CHEN XD, 1994, DRY TECHNOL, V12, P1105, DOI 10.1080/07373939408960991
   DONGHUA Y, 1986, P 5 INT DRYING S IDS, V1, P149
   DYER DF, 1971, ASME, V93, P427
   FEY YC, 1988, DRY TECHNOL, V6, P69, DOI 10.1080/07373938808916361
   Flink J, 1975, FREEZE DRYING ADV FO, P143
   FLINK JM, 1974, J FOOD SCI, V39, P1244, DOI 10.1111/j.1365-2621.1974.tb07364.x
   FLINK JM, 1982, P 3 INT DRYING S IDS, V2, P497
   FOX EC, 1972, AICHE J, V18, P792, DOI 10.1002/aic.690180422
   GAWEL J, 1990, ANAL TECHNICZNA W PR
   GENSKOW LR, 1988, P 6 INT DRYING S IDS, V2, P39
   GERALD CF, 1989, APPLIED NUMERICAL AN
   Goldblith SA, 1975, FREEZE DRYING ADV FO
   GREENFIELD PF, 1974, CHEM ENG SCI, V29, P115
   HARDIN LL, 1973, ASME, V95, P516
   HARPER JC, 1964, IND ENG CHEM FUND, V3, P318, DOI 10.1021/i160012a007
   HARPER JC, 1962, AICHE J, V8, P298, DOI 10.1002/aic.690080308
   HAYES LJ, 1984, CRYO-LETT, V5, P97
   JOCHEM M, 1993, WARME STOFFUBERTRAG, V28, P195, DOI 10.1007/BF01541190
   KAREL M, 1983, ADV DRYING, V2, P103
   KAREL M, 1990, P 7 INT DRYING S IDS
   KAREL M, 1992, DRYING 92 A, P3
   KAREL M, 1990, ENG FOOD, V1, P22
   KAWALA Z, 1994, PRZEMYSL SPOZYWCZY, V5, P134
   KING CJ, 1984, P 4 INT DRYING S IDS, V1, P69
   KOCHS M, 1991, INT J HEAT MASS TRAN, V34, P2395, DOI 10.1016/0017-9310(91)90064-L
   KORBER C, 1988, Q REV BIOPHYS, V21, P229
   KRASUK JH, 1974, CHEM ENG SCI, V29, P181, DOI 10.1016/0009-2509(74)85043-8
   Lebedev D. P., 1979, TEORETICHESKIE OSNOV, V13, P825
   LEBEDEV DP, 1972, INZH FIZ ZH, V23, P1059
   LEBEDEV DP, 1973, INZH FIZ ZH, V24, P424
   Liapis A. I., 1987, HDB IND DRYING, P295
   LIAPIS AI, 1979, CHEM ENG SCI, V34, P975, DOI 10.1016/0009-2509(79)85009-5
   LIN S, 1982, INT J HEAT MASS TRAN, V25, P625, DOI 10.1016/0017-9310(82)90167-3
   LIN S, 1982, DRYING 82, P201
   Lin S., 1981, ASME, V103, P165
   LITCHFIELD RJ, 1981, CHEM ENG SCI, V36, P1233, DOI 10.1016/0009-2509(81)85072-5
   LITCHFIELD RJ, 1982, CHEM ENG SCI, V37, P45, DOI 10.1016/0009-2509(82)80066-3
   LOMBRANA JI, 1993, DRY TECHNOL, V11, P471
   LOMBRANA JI, 1987, CHEM ENG J BIOCH ENG, V35, pB23, DOI 10.1016/0300-9467(87)85033-5
   LUIKOV AV, 1973, INT J HEAT MASS TRAN, V16, P1087, DOI 10.1016/0017-9310(73)90121-X
   MA YH, 1975, AICHE J, V21, P344, DOI 10.1002/aic.690210216
   MA YH, 1975, AICHE J, V21, P335, DOI 10.1002/aic.690210215
   MA YH, 1982, DRYING 82, P196
   Mac Kenzie AP, 1975, FREEZE DRYING ADV FO, P277
   MELLOR JD, 1978, FUNDAMENTALS FREEZE
   MILLMAN MJ, 1984, J FOOD TECHNOL, V19, P725
   NASTAJ J, 1991, DRYING 91, P405
   NASTAJ J, 1992, DRYING 92, P374
   NASTAJ J, 1989, 0411318 SZCZEC TU 4
   NASTAJ J, 1988, P 6 INT DRYING S IDS, V2, P25
   NASTAJ JF, 1994, DRY TECHNOL, V12, P1145, DOI 10.1080/07373939408960993
   OKAZAKI M, 1982, P 3 INT DRYING S IDS, V1, P457
   PIJANOWSKI E, 1984, ZARYS CHEM TECHNOLOG, V1
   PIKAL MJ, 1984, J PHARM SCI, V73, P1234
   PISECKY J, 1985, F214 NIR AT
   RAWSON N, 1983, LEBENSM WISS TECHNOL, V16, P313
   SAGARA Y, 1994, DRY TECHNOL, V12, P1081, DOI 10.1080/07373939408960990
   SAGARA Y, 1982, P 3 INT DRYING S IDS, V2, P487
   SCHADLER N, 1987, INT J HEAT MASS TRAN, V30, P2031, DOI 10.1016/0017-9310(87)90084-6
   SHINAGAWA H, 1979, J CHEM ENG JPN, V12, P406, DOI 10.1252/jcej.12.406
   STOTLAND DM, 1980, TEORETICHESKIE OSNOV, V14, P48
   STRUMILLO C, 1989, CHEM ENG PROCESS, V26, P139, DOI 10.1016/0255-2701(89)90006-8
   STRUMILLO C, 1991, DRYING 91, P36
   STRUMILLO C, 1988, 6 INT DRYING S IDS 8, V2, P17
   TRIEBES TA, 1966, IND ENG CHEM PROC DD, V5, P430, DOI 10.1021/i260020a015
   TUTOVA EG, 1982, P 3 INT DRYING S IDS, V2, P239
   TUTOVA EG, 1981, FIZ ZH, V40, P296
   UPADHYAYA RL, 1984, P 4 INT DRYING S IDS, V1, P316
   WENU F, 1990, P 7 INT DRYING S IDS
   WIJLHUIZEN AE, 1979, CHEM ENG SCI, V34, P651, DOI 10.1016/0009-2509(79)85110-6
   WOLFF E, 1989, CHEM ENG PROCESS, V25, P153, DOI 10.1016/0255-2701(89)80005-4
   WOLFF E, 1990, CRYOBIOLOGY, V27, P569, DOI 10.1016/0011-2240(90)90044-5
   WOLFF E, 1990, ENG FOOD, V2, P741
   WOLLHOVER K, 1985, INT J HEAT MASS TRAN, V28, P897, DOI 10.1016/0017-9310(85)90270-4
NR 78
TC 5
Z9 5
U1 0
U2 6
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 1996
VL 14
IS 9
BP 1967
EP 2002
DI 10.1080/07373939608917192
PG 36
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA VG946
UT WOS:A1996VG94600004
DA 2018-10-19
ER

PT J
AU Alves, O
   Strommen, I
AF Alves, O
   Strommen, I
TI The application of heat pump in drying of biomaterials
SO DRYING TECHNOLOGY
LA English
DT Article
DE bacteria; enthalpy; enzymes; fish; fluidized bed; fruits; quality;
   rehydration; Rhodococcus; sorption; survival
AB The UN estimates that 6.4 billion people will be living on Earth by the year 2000. As a consequence, dried biomaterials demand will rise and equipments will have to be built or redesigned to accommodate changes. The design and innovations on industrial dryers require fundamental knowledge conceived in laboratory units. The new heat pump dryer operates at a wide relative humidity and the air temperature is adjustable from -20 to 100 degrees C. Above and below freezing point drying modes are done in the same plant which allows the control of biomaterial properties. The technique consists of two stages, unbound weakly held water removal by freeze drying, and tightly bound moisture desorption by medium temperature drying. The fluidized and shelf heat pump dryers have the required features to dry heat sensitive biomaterials. The dryers were built and extensive research on biomaterials has been conducted at The Norwegian Institute of Technology. Many experiments were done on effect of heat pump drying conditions on enzyme and biological active bacteria solutions, fruits, cod fish, fish feed and shrimps. At optimum heat drying conditions, the bacteria Rhodococcus reached 100% viability and dried biomolecules attained full biological activity. The heat pump dryer allowed adjustment of the biomaterial properties and quality according to its phase, shape and size. Dried samples showed improvements on survival rate, rehydration, colour, hardness and mono-multimolecular sorption isotherms over poorly dried products. Beneficial results were achieved for nearly all tests. This indicates that the heat pump dryer application has high potential in processing heat sensitive biomaterials.
RP Alves, O (reprint author), NORWEGIAN INST TECHNOL,FAC MECH ENGN,DEPT REFRIGERAT & AIR CONDITIONING,N-7034 TRONDHEIM,NORWAY.
CR ALVESFILHO O, 1995, HEAT PUMP FLUIDIZED
   FARKAS BE, 1990, ENG FOOD, V2, P751
   Heldman D. R., 1992, HDB FOOD ENG
   PILDITCH J, 1989, WINNING WAYS
   SJOHOLM I, 1995, J FOOD ENG, V25, P123, DOI 10.1016/0260-8774(94)00001-P
   SONG X, 1990, THESIS NORWEGIAN I T
   STROMMEN I, 1994, DRY TECHNOL, V12, P889, DOI 10.1080/07373939408960000
   STROMMEN I, 1995, IN PRESS THERMAL DRY
   STROMMEN I, 1994, IDS 94
   STROMMEN I, 1986, JONT ISR NORW S TEL
NR 10
TC 29
Z9 29
U1 0
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 1996
VL 14
IS 9
BP 2061
EP 2090
PG 30
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA VG946
UT WOS:A1996VG94600008
DA 2018-10-19
ER

PT B
AU Hattler, BG
AF Hattler, BG
BE Lin, YK
   Su, TC
TI Changes in the host to biomaterial surface-blood contact, activation of
   host components
SO ENGINEERING MECHANICS: PROCEEDINGS OF THE 11TH CONFERENCE, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 11th Engineering Mechanics Conference
CY MAY 19-22, 1996
CL FT LAUDERDALE, FL
SP Amer Soc Civil Engineers, Engn Mech Div, Appl Stochast Res, Florida Atlantic Univ Ctr
C1 UNIV PITTSBURGH,PITTSBURGH,PA 15213.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CIVIL ENGINEERS
PI NEW YORK
PA UNITED ENGINEERING CENTER, 345 E 47TH ST, NEW YORK, NY 10017-2398
BN 0-7844-0172-1
PY 1996
BP 36
EP 38
PG 3
WC Engineering, Civil; Mechanics
SC Engineering; Mechanics
GA BG42L
UT WOS:A1996BG42L00006
DA 2018-10-19
ER

PT J
AU Drake, LR
   Lin, S
   Rayson, GD
   Jackson, PJ
AF Drake, LR
   Lin, S
   Rayson, GD
   Jackson, PJ
TI Chemical modification and metal binding studies of Datura innoxia
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID EU(III) LUMINESCENCE; ALGAE CELLS; SITES; PRECONCENTRATION; SPECTROMETRY
AB The esterification of carboxylate functionalities present in the cell walls of Datura innoxia results in a decrease in metal uptake by as much as 40%, depending on the metal studied. These findings suggest that carboxylate groups are important in metal ion adsorption to this biomaterial. Base hydrolysis of the native plant material resulted in a slight increase in metal ion uptake for Cu2+ and Sr2+ and a decrease in uptake for Cd2+. These results are attributed to the hydrolysis of esters native to the plant material, which increases the carboxylate content but also results in conformational changes in the macromolecules that comprise the cell fragments. Both the esterified product and the hydrolyzed material were examined via infrared spectroscopy. A peak occuring at 1735 cm(-1) (attributed to the carbonyl stretch) confirmed the esterification process. The infrared spectra of the hydrolyzed samples indicate further ionization of carboxylate groups or hydrolysis of esters native to D. innoxia.
C1 NEW MEXICO STATE UNIV,DEPT CHEM & BIOCHEM,DEPT 3C,LAS CRUCES,NM 88003.
   LOS ALAMOS NATL LAB,DIV LIFE SCI,GEG & STRUCT BIOL GRP,LOS ALAMOS,NM 87545.
CR CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P496, DOI 10.1021/es00027a007
   CRIST RH, 1994, ENVIRON SCI TECHNOL, V28, P1859, DOI 10.1021/es00060a016
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P1523, DOI 10.1021/es00032a004
   DARNALL D W, 1986, P1
   DARNALL DW, 1991, BIOL PROCESSES
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY J, 1988, J ELECTROANAL CHEM, V252, P197, DOI 10.1016/0022-0728(88)85082-4
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   JACKSON PJ, 1993, IN VITRO CELL DEV-PL, V29P, P220
   JACKSON PJ, 1984, PLANT PHYSIOL, V75, P914, DOI 10.1104/pp.75.4.914
   JAKOBSEN RJ, 1990, APPL SPECTROSC, V44, P1478, DOI 10.1366/0003702904417724
   KAIDEN K, 1987, APPL SPECTROSC, V41, P180, DOI 10.1366/000370287774986714
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   LUJAN JR, 1994, SOLVENT EXTR ION EXC, V12, P803, DOI 10.1080/07366299408918239
   MAHAN CA, 1992, SPECTROCHIM ACTA B, V47, P1483, DOI 10.1016/0584-8547(92)80138-7
   MAHAN CA, 1992, ANAL CHEM, V64, P1933, DOI 10.1021/ac00041a031
   MONCRIEF RM, 1995, SEPAR SCI TECHNOL, V30, P2421, DOI 10.1080/01496399508013120
   NAKAJIMA A, 1990, BIOMASS, V21, P55, DOI 10.1016/0144-4565(90)90047-N
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   SKOOG DA, 1985, PRINCIPLES INSTRUMEN, P344
   STARK PC, 1994, THESIS NEW MEXICO ST, P23
NR 29
TC 82
Z9 86
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JAN
PY 1996
VL 30
IS 1
BP 110
EP 114
DI 10.1021/es950131d
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA TN497
UT WOS:A1996TN49700038
DA 2018-10-19
ER

PT J
AU Godin, C
   Caprani, A
AF Godin, C
   Caprani, A
TI Interactions of erythrocytes with an artificial wall: Influence of the
   electrical surface charge
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE surface charge; charge density; red cell; artificial wall; electrical
   impedance
ID ROTATING-DISK ELECTRODE; RED BLOOD-CELLS; IMPEDANCE MEASUREMENTS;
   PROTEIN ADSORPTION; ALBUMIN; FLOW; NEURAMINIDASE; CARBON
AB Electrical charge on any biological surface plays a crucial role in its interaction with other molecules or surfaces. Here, we study, under flow conditions, the interactions of erythrocyte. with an artificial surface: a platinum microelectrode whose charge density ranges from -15 to +27 mu C/cm(2). This artificial surface could be similar in surface charge to an endothelium or a biomaterial. In this model, interactions are measured as a transient relative increase of the electrolyte resistance obtained by impedance measurement of a microelectrode. A maximal interaction of erythrocytes viith the charged surface is calculated in the 0 to +10 mu C/cm(2) charge density range. At negative surface charge, a less efficient contact was obtained because of electrostatic repulsion forces. High positive surface charge (charge density >10 mu C/cm(2)) does not improve the contact but induces a progressive decrease in the contact efficiency, which could be explained by a re arrangement of macromolecules on the erythrocyte surface or an effect of positive groups on the cell membrane. This work suggests that a greater surface area of contact is obtained in the 0 to +10 mu C/cm(2) charge density range and that this is provided by more molecular bridges.
RP Godin, C (reprint author), UNIV PARIS 07,LAB BIORHEOL & HYDRODYNAM PHYSICOCHIM,CNRS,URA 343,2 PL JUSSIEU,F-75251 PARIS,FRANCE.
CR Bard A. J., 1980, ELECTROCHEMICAL METH
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543
   BORN GVR, 1989, J PHYSIOL-LONDON, V419, P169, DOI 10.1113/jphysiol.1989.sp017867
   CAPRANI A, 1991, BIOELECTROCH BIOENER, V25, P241, DOI 10.1016/0302-4598(91)87006-3
   CAPRANI A, 1983, BIOELECTROCH BIOENER, V10, P213, DOI 10.1016/0302-4598(83)85080-6
   CHIEN S, 1975, RED BLOOD CELL, P1031
   DANON D, 1976, ANN NY ACAD SCI, V275, P47, DOI 10.1111/j.1749-6632.1976.tb43337.x
   ENGELHARDT H, 1988, BIOPHYS J, V54, P495, DOI 10.1016/S0006-3495(88)82982-5
   EYLAR EH, 1962, J BIOL CHEM, V237, P1992
   GABRIELLI C, 1984, 00483 ZOL INSTR
   GINGELL D, 1976, BIOPHYS J, V16, P1131, DOI 10.1016/S0006-3495(76)85763-3
   GODIN C, 1995, BIORHEOLOGY, V32, P571, DOI 10.1016/0006-355X(95)00033-6
   LACOUR F, 1993, COLLOID SURFACE B, V1, P251
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   PECH MA, 1993, BIOELECTROCH BIOENER, V29, P277, DOI 10.1016/0302-4598(93)85003-C
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   SEAMAN GVF, 1963, ARCH BIOCHEM BIOPHYS, V100, P493, DOI 10.1016/0003-9861(63)90117-6
   SIMCHON S, 1988, AM J PHYSIOL, V254, pH1167
   TAMISIER L, 1989, ELECTROCHIM ACTA, V34, P1339, DOI 10.1016/0013-4686(89)85031-5
   VARGAS FF, 1989, MEMBRANE BIOCHEM, V8, P221, DOI 10.3109/09687688909026816
   Velick S, 1940, J GEN PHYSIOL, V23, P753, DOI 10.1085/jgp.23.6.753
   WALTER H, 1986, BIOCHIM BIOPHYS ACTA, V860, P650, DOI 10.1016/0005-2736(86)90565-1
NR 24
TC 14
Z9 14
U1 0
U2 5
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0175-7571
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PY 1996
VL 25
IS 1
BP 25
EP 30
DI 10.1007/s002490050012
PG 6
WC Biophysics
SC Biophysics
GA WC401
UT WOS:A1996WC40100004
PM 8900052
DA 2018-10-19
ER

PT J
AU Mutter, D
   Aprahamian, M
   Evrard, S
   Damge, C
   Marescaux, J
AF Mutter, D
   Aprahamian, M
   Evrard, S
   Damge, C
   Marescaux, J
TI Biomaterials for primary closure of a choledochotomy in dogs
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE artificial matrix; collagen; common bile duct; primary closure, common
   bile duct
ID COMMON BILE-DUCT; FIBRIN GLUE; SURGERY
AB Since primary closure of the common bile duct is often not undertaken because of the risks of biliary leakage and peritonitis, we have evaluated feasibility and reliability of closure using biomaterials. In three groups of dogs, an unsutured choledochotomy was closed with circular glued patches: a scleroprotein patch in 4 dogs and an oxidized, compressed human collagen patch reinforced (n = 6) or not (n = 6) with three stitches. The scleroprotein patch (n = 4) was resorbed too soon, and in 2 dogs the unstitched collagen patches became unglued; biliary leakage was the result in both instances. The bile duct healed successfully within 1 month in the other 10 animals fitted with collagen patches, despite one common bile duct stricture. Safe primary closure of a choledochotomy may be envisioned in humans if the duct suture is protected by this new collagen biomaterial.
RP Mutter, D (reprint author), UNIV HOP STRASBOURG,DEPT SURG A,BP 426,F-67091 STRASBOURG,FRANCE.
CR ANDERSSON R, 1990, BRIT J SURG, V77, P36, DOI 10.1002/bjs.1800770113
   APRAHAMIAN M, 1992, BIOMATERIALS, V13, P697, DOI 10.1016/0142-9612(92)90130-G
   BORDLEY J, 1979, ANN SURG, V189, P442
   CAHILL CJ, 1988, BRIT J SURG, V75, P1169, DOI 10.1002/bjs.1800751208
   COUTO J, 1987, SURGERY, V101, P354
   DEVIRGILIO C, 1990, ARCH SURG-CHICAGO, V125, P1378
   HERTZER NR, 1973, SURG GYNECOL OBSTET, V137, P413
   KEIGHLEY MRB, 1976, BRIT J SURG, V63, P754, DOI 10.1002/bjs.1800631007
   KRAM HB, 1990, J TRAUMA, V30, P97, DOI 10.1097/00005373-199001000-00016
   KRAM HB, 1985, ARCH SURG-CHICAGO, V120, P1250
   LAWSON JH, 1990, BLOOD, V76, P2249
   LYGIDAKIS NJ, 1983, AM J SURG, V146, P254, DOI 10.1016/0002-9610(83)90385-9
   MARESCAUX JF, 1991, BRIT J SURG, V78, P440, DOI 10.1002/bjs.1800780417
   RABAUD M, 1987, BIOMATERIALS, V8, P217, DOI 10.1016/0142-9612(87)90067-6
   TARDY M, 1986, Patent No. 86401794
   TARDY M, 1990, Patent No. 4931546
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
   WACLAWICZEK HW, 1990, LYON CHIR, V86, P412
   ZEHNDER JL, 1990, BLOOD, V76, P2011
NR 19
TC 4
Z9 5
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PD JAN-FEB
PY 1996
VL 28
IS 1
BP 32
EP 38
DI 10.1159/000129437
PG 7
WC Surgery
SC Surgery
GA TJ858
UT WOS:A1996TJ85800005
PM 8682142
DA 2018-10-19
ER

PT J
AU Richards, RG
AF Richards, RG
TI The effect of surface roughness on fibroblast adhesion in vitro
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE scanning electron microscopy; back-scattered electron imaging; cells;
   adhesion; infection; image analysis
ID SCANNING ELECTRON-MICROSCOPY; CELLS; UNDERSURFACE
AB Adhesion of tissue cells to biomaterial implants is a major factor of their biocompatibility. Quantitative or qualitative adhesion measurements would therefore be useful in the screening of new implant materials. Results from a quantitative method of measuring the total cell adhesion area of cultured cells is presented. It is postulated that the more compatible the surface, the greater the amount of cell adhesion. Fibroblastic cells were cultured on discs of plastic (Thermanox), commercially pure titanium (LSO 5832/2) or steel (ISO 5832/1), as used in AO fixation plates. The cells were fixed, stained, embedded in resin and their discs removed. Backscattered electron (BSE) imaging in a scanning electron microscope displayed the stained cells within the unstained resin. Imaging at high beam energy allowed visualization of the entire cell. Low beam energy displayed the regions of cell contact with the substrate, i.e. the focal adhesion sites. Images were analyzed with an image analysis and measurement system which allowed the percentage of the cell area involved with adhesion to be calculated. Results show that the material roughness, with the materials and cells tested, does not affect the total amount of cell adhesion. Implant surface design to encourage cell adhesion and discourage bacterial adhesion is discussed.
RP Richards, RG (reprint author), ASIF,RES INST,AO,CLAVADELERSTR,CH-7270 DAVOS,SWITZERLAND.
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480
CR BOXMA H, 1995, THESIS U AMSTERDAM
   ELVIN P, 1982, EUR J CANCER CLIN ON, V18, P669, DOI 10.1016/0277-5379(82)90213-9
   ELVIN P, 1983, BIOL CELL, V48, P1
   EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   PORTER K, 1973, J CELL BIOL, V57, P815, DOI 10.1083/jcb.57.3.815
   REID G, 1989, COLLOID SURFACE, V42, P299
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   RICHARDS RG, 1995, J MATER SCI-MATER M, V6, P120, DOI 10.1007/BF00120419
   RICHARDS RG, 1995, CELL BIOL INT REP, V12, P1015
   WEISS L, 1963, EXP CELL RES, V30, P331, DOI 10.1016/0014-4827(63)90304-5
   WEISS LEONARD, 1961, EXPTL CELL RES SUPPL, V8, P141, DOI 10.1016/0014-4827(61)90345-7
NR 13
TC 29
Z9 30
U1 0
U2 9
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PY 1996
VL 27
SU 3
BP 38
EP 43
PG 6
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA VX194
UT WOS:A1996VX19400011
DA 2018-10-19
ER

PT J
AU Mack, D
   Fischer, W
   Krokotsch, A
   Leopold, K
   Hartmann, R
   Egge, H
   Laufs, R
AF Mack, D
   Fischer, W
   Krokotsch, A
   Leopold, K
   Hartmann, R
   Egge, H
   Laufs, R
TI The intercellular adhesin involved in biofilm accumulation of
   Staphylococcus epidermidis is a linear beta-1,6-linked
   glucosaminoglycan: Purification and structural analysis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN;
   SCANNING ELECTRON-MICROSCOPY; SLIME PRODUCTION; LIPOTEICHOIC ACID;
   INTRAVENOUS CATHETERS; TEICHOIC-ACID; ADHERENCE; INFECTIONS; INVITRO
AB The primary attachment to polymer surfaces followed by accumulation in multilayered cell clusters leads to biofilm production of Staphylococcus epidermidis, which is thought to contribute to virulence in biomaterial-related infections. We purified a specific polysaccharide antigen of biofilm-producing S. epidermidis 1457 and RP62A, which was recently shown to have a function in the accumulative phase of biofilm production by mediating intercellular adhesion (D. Mack, M. Nedelmann, A. Krokotsch, A. Schwarzkopf, J. Heesemann, and R. Laufs, Infect. Immun. 62:3244-3253, 1994). Following Sephadex G-200 gel filtration, this antigen was separated by Q-Sepharose chromatography into a major polysaccharide, polysaccharide I (>80%), which did not bind to Q-Sepharose, and a minor polysaccharide, polysaccharide II (<20%), which was moderately anionic. As shown by chemical analyses and nuclear magnetic resonance spectroscopy, polysaccharide I is a linear homoglycan of at least 130 beta-1,6-linked 2-deoxy-2-amino-D-glucopyranosyl residues. On average, 80 to 85% of them are N acetylated; the rest are non-N-acetylating and positively charged. Chain cleavage by deamination with HNO2 revealed a more or less random distribution of the non-N-acetylated glucosaminyl residues, with some prevalence of glucosaminyl-rich sequences. Cation-exchange chromatography separated molecular species whose content of non-N-acetylated glucosaminyl residues varied between 2 and 26%. Polysaccharide II is structurally related to polysaccharide I but has a lower content of non-N-acetylated D-glucosaminyl residues and contains phosphate and ester-linked succinate, rendering it anionic. Enzyme-linked immunosorbent assay inhibition with various monosaccharides revealed the beta-anomeric form and the acetylated amino group of the D-glucosaminyl residues as important for reactivity with the specific antiserum. The unbranched polysaccharide structure favors long-range contacts and interactions between polysaccharide strands and the cell wall and/or lectin-like proteins, leading to intercellular adhesion and biofilm accumulation. The structure of the polysaccharide is, so far, considered to be unique and, according to its function, is referred to as S. epidermidis polysaccharide intercellular adhesin (PIA).
C1 UNIV ERLANGEN NURNBERG,FAK MED,INST BIOCHEM,D-91054 ERLANGEN,GERMANY.
   UNIV BONN,INST PHYSIOL CHEM,D-53115 BONN,GERMANY.
RP Mack, D (reprint author), UNIV HAMBURG,KRANKENHAUS EPPENDORF,INST MED MIKROBIOL & IMMUNOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.
RI Chiang, Vincent, Ming-Hsien/D-4312-2016; Hartmann, Rudolf/H-9345-2017
OI Chiang, Vincent, Ming-Hsien/0000-0002-2029-7863; Hartmann,
   Rudolf/0000-0001-7807-6273
CR Ames BN., 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338
   ARVANITI A, 1994, ARCH BIOCHEM BIOPHYS, V308, P432, DOI 10.1006/abbi.1994.1061
   BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x
   BEUTLER HO, 1985, METHOD ENZYMAT AN, V7, P25
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHALLACOMBE SJ, 1988, ELISA OTHER SOLID PH, P319
   CHAPLIN MF, 1986, CARBOHYDRATE ANAL, P1
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   CHUGH TD, 1990, INFECT IMMUN, V58, P315
   CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   CURTISS R, 1986, CURR TOP MICROBIOL I, V118, P253
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442
   DIAZMITOMA F, 1987, J INFECT DIS, V156, P555
   DIXON JS, 1954, ANAL CHEM, V26, P1092, DOI 10.1021/ac60090a046
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   DUCKWORTH M, 1970, CHEM IND-LONDON, P747
   DUNNE WM, 1987, PEDIATR INFECT DIS J, V6, P1031
   EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428
   ESPERSEN F, 1990, APMIS, V98, P471, DOI 10.1111/j.1699-0463.1990.tb01059.x
   FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X
   HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HUSSAIN M, 1992, J MED MICROBIOL, V37, P368, DOI 10.1099/00222615-37-6-368
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   Jansson P. E., 1976, CHEM COMMUN U STOCKH, V8, P1
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   LAINE RA, 1975, J LIPID RES, V16, P102
   LAMPRECHT W, 1984, METHOD ENZYMAT AN, V6, P570
   LaneSmith R, 1979, ANAL BIOCHEM, V98, P478
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V258, P256, DOI 10.1016/S0176-6724(84)80043-7
   MACK D, 1994, INFECT IMMUN, V62, P3244
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, 1994, ZBL BAKT S, V26, P411
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   MARTIN GE, 1991, J NAT PROD, V54, P1, DOI 10.1021/np50073a001
   Mollering H., 1985, METHOD ENZYMAT AN, V7, P39
   MULLER E, 1993, INFECT IMMUN, V61, P551
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PATRICK CC, 1995, PEDIATR RES, V37, P70, DOI 10.1203/00006450-199501000-00014
   PETERS G, 1981, ZBL BAKT MIK HYG B, V173, P293
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Peters GF, 1987, ZENTRALBLATT BAKTE S, V16, P15
   PFALLER M A, 1988, Clinical Microbiology Reviews, V1, P281
   RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   RUSSELL PB, 1987, J CLIN MICROBIOL, V25, P1083
   SCHMITT DD, 1986, ARCH SURG-CHICAGO, V121, P89
   STAAT RH, 1980, INFECT IMMUN, V27, P675
   TERHO TT, 1971, ANAL BIOCHEM, V41, P471, DOI 10.1016/0003-2697(71)90167-9
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VONWULFFEN H, 1988, EUR J CLIN MICROBIOL, V7, P559
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Williams J. M., 1975, ADV CARBOHYD CHEM BI, V31, P9, DOI DOI 10.1016/S0065-2318(08)60294-2
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 70
TC 525
Z9 544
U1 2
U2 36
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD JAN
PY 1996
VL 178
IS 1
BP 175
EP 183
DI 10.1128/jb.178.1.175-183.1996
PG 9
WC Microbiology
SC Microbiology
GA TM789
UT WOS:A1996TM78900024
PM 8550413
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Veenstra, GJC
   Cremers, FFM
   vanDijk, H
   Fleer, A
AF Veenstra, GJC
   Cremers, FFM
   vanDijk, H
   Fleer, A
TI Ultrastructural organization and regulation of a biomaterial adhesin of
   Staphylococcus epidermidis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; INTENSIVE-CARE UNIT; ADHERENCE;
   SEPTICEMIA; PROTEINS; TISSUE
AB Coagulase-negative staphylococci have emerged as important pathogens in infections associated with intravascular devices. Microbial adherence to biomaterial surfaces is a crucial step in the pathogenesis of these infections. Staphylococcal surface proteins (herein referred to as SSP-1 and SSP-2) are involved in the attachment of Staphylococcus epidermidis 354 to polystyrene. In the present study we show that the adhesin protrudes from the cell surface as a fimbria-like polymer. Furthermore, in vitro proteolytic cleavage of SSP-1 produces an SSP-2-like protein which coincides with a loss of adhesive function. SSP-1 expression is down-regulated in a phenotypical variant of S. epidermidis 354 whereas SSP-2 expression is not. These results could suggest that proteolytic cleavage is a key to the regulation of the adhesive state of S. epidermidis in vivo.
C1 HET WILHELMINA CHILDRENS HOSP,3501 CA UTRECHT,NETHERLANDS.
   UNIV UTRECHT,EIJKMAN WINKLER INST CLIN & MED MICROBIOL,FAC MED,UTRECHT,NETHERLANDS.
   UNIV UTRECHT,DEPT MOLEC CELL BIOL,FAC BIOL,3584 CH UTRECHT,NETHERLANDS.
RI Veenstra, Gert Jan C./D-4963-2012
OI Veenstra, Gert Jan C./0000-0002-7787-4940
CR Archer GL, 1990, PRINCIPLES PRACTICE, P1511
   BATTISTI O, 1981, ARCH DIS CHILD, V56, P775, DOI 10.1136/adc.56.10.775
   BEACHEY E, 1982, CURRENT CONCEPTS BAC
   BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8
   CHRISTENSEN GD, 1982, ANN INTERN MED, V96, P1, DOI 10.7326/0003-4819-96-1-1
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   KLEMM P, 1985, REV INFECT DIS, V7, P321
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEUNISSEN J, 1984, CELL BIOL INT REP, V8, P187, DOI 10.1016/0309-1651(84)90026-2
   LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834
   MUNSON DP, 1982, J PEDIATR-US, V101, P602, DOI 10.1016/S0022-3476(82)80718-X
   OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455
   PARISI JT, 1985, MICROBIOL REV, V49, P126
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Stryer L., 1988, BIOCHEMISTRY
   TIMMERMAN CP, 1991, J MED MICROBIOL, V35, P65, DOI 10.1099/00222615-35-2-65
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOKOYASU KT, 1980, HISTOCHEM J, V12, P381
   WONNACOTT TH, 1985, INTRO STATISTICS
NR 21
TC 99
Z9 105
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD JAN
PY 1996
VL 178
IS 2
BP 537
EP 541
DI 10.1128/jb.178.2.537-541.1996
PG 5
WC Microbiology
SC Microbiology
GA TP522
UT WOS:A1996TP52200029
PM 8550477
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Mitchell, CA
   Davies, MJ
   Grounds, MD
   McGeachie, JK
   Crawford, GJ
   Hong, Y
   Chirila, TV
AF Mitchell, CA
   Davies, MJ
   Grounds, MD
   McGeachie, JK
   Crawford, GJ
   Hong, Y
   Chirila, TV
TI Enhancement of neovascularization in regenerating skeletal muscle by the
   sustained release of erucamide from a polymer matrix
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE neovascularization; skeletal muscle; erucamide; Elvax copolymer;
   sustained release; regeneration
ID GROWTH-FACTOR; ANGIOGENIC FACTOR; BOVINE OMENTUM; MICE; REPLICATION;
   FIBROBLAST; INITIATION; DURATION; INJURY
AB The angiogenic agent erucamide (cis-13-docosenamide), incorporated into a polymeric biomaterial (Elvax(R) 40P, a copolymer of ethylene and vinyl acetate), was used to determine whether angiogenesis can be increased in the regenerating skeletal muscle, and whether the enhanced revascularization improves the new muscle formation. The angiogenic nature of this lipid was confirmed in a rat cornea-micropocket assay, prior to insertion of small strips of the polymer containing either 3 mu g, 30 mu g, 300 mu g erucamide or only polymer as a control into the mid-region of crush-injured tibialis anterior (TA) muscles of forty-five adult male BALB/c mice. All TA muscles were sampled ten days after injury and analyzed morphometrically. Statistical analyses of the mean blood vessel area density in lesions from twelve perfused TA muscles (three from each of the erucamide-treated or control group), revealed a dose-dependent angiogenic effect of erucamide: a dosage of 3 mu g increased mean blood vessel area density to 5.1% compared to 2.0% in controls, due to numerous large caliber, thin-walled vessels, whereas the mean vessel area density in both the 30-mu g (3.5%) and 300-mu g (1.5%) doses were similar to controls. However, at all three doses tested, erucamide did not significantly alter the degree of new muscle formation, connective tissue deposition, or removal of necrotic debris.
C1 UNIV WESTERN AUSTRALIA,DEPT PATHOL,NEDLANDS,WA 6009,AUSTRALIA.
   UNIV WESTERN AUSTRALIA,DEPT ANAT & HUMAN BIOL,NEDLANDS,WA 6009,AUSTRALIA.
   LIONS EYE INST,NEDLANDS,WA 6009,AUSTRALIA.
CR ALLBROOK D, 1981, MUSCLE NERVE, V4, P234, DOI 10.1002/mus.880040311
   CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187
   CARTIER R, 1990, J THORAC CARDIOV SUR, V99, P264
   FOLKMAN J, 1986, CANCER RES, V46, P467
   FOURNIER GA, 1981, INVEST OPHTH VIS SCI, V80, P351
   GOLDSMITH HS, 1978, STROKE, V9, P224, DOI 10.1161/01.STR.9.3.224
   GOLDSMITH HS, 1984, JAMA-J AM MED ASSOC, V252, P2034, DOI 10.1001/jama.252.15.2034
   GOLDSMITH HS, 1986, SURG GYNECOL OBSTET, V162, P579
   GOLDSMITH HS, 1980, SURGERY, V88, P732
   GOSPODAROWICZ D, 1979, EXP EYE RES, V28, P501, DOI 10.1016/0014-4835(79)90038-1
   HANSENSMITH FM, 1980, AM J ANAT, V158, P65, DOI 10.1002/aja.1001580107
   IMAIZUMI T, 1990, EXP CELL RES, V187, P292, DOI 10.1016/0014-4827(90)90094-Q
   JAMES NT, 1981, J MORPHOL, V168, P43, DOI 10.1002/jmor.1051680106
   KNIGHTON DR, 1982, ANN SURG, V196, P379, DOI 10.1097/00000658-198210000-00001
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   MARKLEY JM, 1978, PLAST RECONSTR SURG, V62, P415, DOI 10.1097/00006534-197809000-00013
   MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972
   MITCHELL CA, 1992, CELL TISSUE RES, V269, P159, DOI 10.1007/BF00384736
   MONTGOMERY RR, 1989, J LEUKOCYTE BIOL, V45, P29
   Morison R, 1906, Br Med J, V1, P76
   NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097
   OHTAKI T, 1989, BIOCHEM BIOPH RES CO, V161, P169, DOI 10.1016/0006-291X(89)91576-3
   Phillips G D, 1992, Growth Factors, V6, P77, DOI 10.3109/08977199209008873
   ROBERTS P, 1989, ANAT REC, V224, P1, DOI 10.1002/ar.1092240102
   ROBERTS P, 1990, J ANAT, V169, P197
   TURRENTINE MW, 1990, ANN THORAC SURG, V49, P574, DOI 10.1016/0003-4975(90)90303-N
   VINEBERG AM, 1964, SURGERY, V57, P836
   WAKAMATSU K, 1990, BIOCHEM BIOPH RES CO, V168, P423, DOI 10.1016/0006-291X(90)92338-Z
   WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1, P110
   WILKIE DPD, 1911, BRIT MED J, V2, P1103
NR 30
TC 23
Z9 23
U1 1
U2 4
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 1996
VL 10
IS 3
BP 230
EP 249
DI 10.1177/088532829601000304
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TX005
UT WOS:A1996TX00500004
PM 8667175
DA 2018-10-19
ER

PT J
AU Mandrusov, E
   Vroman, L
   Leonard, EF
AF Mandrusov, E
   Vroman, L
   Leonard, EF
TI Detection of specific plasma proteins on surfaces by immunospecific
   adhesion of dyed polystyrene beads
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE blood plasma; albumin; fibrinogen; IgG; HMK; adsorption; immunospecific
   beads; glass; biomaterial; shear rare
ID COMPETITIVE ADSORPTION; POLYMERIC BIOMATERIALS; FIBRINOGEN ADSORPTION;
   HYDROPHOBIC SURFACES; SOLID-SURFACES; BLOOD-PLASMA; GLASS; ALBUMIN;
   BINDING; QUANTITATION
AB This paper describes and evaluates a method for quantifying the amounts of specific plasma proteins adsorbed to biomaterial surfaces. In particular, it demonstrates that macroscopic images ('stains'), that assess the spatial distribution of albumin, IgG, fibrinogen, and HMK (high molecular weight kininogen), can be obtained over areas of at least 12 cm(2) using immunospecific adhesion of dyed polystyrene beads. Stain intensities, measured with a scanner and an image analysis system, were found to quantify the amount of specific protein in the solution used to coat the surfaces. Results obtained with the proposed method produced single protein isotherms for albumin, immunoglobulin G (IgG) and fibrinogen that followed Langmuir-like adsorption behavior and were similar to previously published isotherms. The HMK isotherm also exhibited Langmuir-like adsorption behavior. The proposed method also detected the presence of an expected maximum in the adsorption of fibrinogen onto glass as a function of plasma dilution. Adsorption of fibrinogen out of 6.4% plasma onto glass from a separated flow produced results indicating the quantity as well as the location of fibrinogen at the boundary of the separated region. This result confirmed the utility of the proposed method for detecting spatial distributions of specific proteins adsorbed from plasma in practical devices.
C1 COLUMBIA UNIV,DEPT CHEM ENGN MAT SCI & MIN ENGN,ARTIFICIAL ORGANS RES LAB,NEW YORK,NY 10027.
FU NHLBI NIH HHS [HL-44535]
CR BEISSINGER RL, 1982, J COLLOID INTERF SCI, V85, P521, DOI 10.1016/0021-9797(82)90018-2
   BEISSINGER RL, 1981, T AM SOC ART INT ORG, V27, P225
   BOSCO MC, 1981, J COLLOID INTERF SCI, V82, P217
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BROOKS DE, 1994, PROTEIN ADSORPTION L
   CORNELIUS RM, 1992, J COLLOID INTERF SCI, V150, P121, DOI 10.1016/0021-9797(92)90273-O
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0
   DENKOV ND, 1992, LANGMUIR, V8, P3183, DOI 10.1021/la00048a054
   ELWING H, 1991, J BIOMAT SCI-POLYM E, V3, P7
   ELWING H, 1986, EUR J BIOCHEM, V156, P359, DOI 10.1111/j.1432-1033.1986.tb09591.x
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FAGRAEUS A, 1965, IMMUNOLOGY, V9, P161
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   HLADY V, 1986, J COLLOID INTERF SCI, V111, P555, DOI 10.1016/0021-9797(86)90059-7
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   LEDUC C, 1994, J BIOMAT SCI-POLYM E, V6, P599
   LEDUC C, 1995, J BIOMAT SCI-POLYM E, V7, P531
   LEONARD EF, 1991, J BIOMAT SCI-POLYM E, V3, P95, DOI 10.1163/156856292X00105
   LUTANIE E, 1992, J DISPER SCI TECHNOL, V13, P379, DOI 10.1080/01932699208943323
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P490, DOI 10.1006/jcis.1994.1322
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SLACK SM, 1991, J BIOMAT SCI-POLYM E, V3, P49
   STANFORD MF, 1987, ANN NY ACAD SCI, V516, P389
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   VROMAN L, 1986, J IMMUNOL METHODS, V93, P213, DOI 10.1016/0022-1759(86)90191-2
   WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   WOJCIECHOWSKI PW, 1993, COLLOID SURFACE B, V1, P107, DOI 10.1016/0927-7765(93)80041-V
   WOJCIECHOWSKI PW, 1990, J COLLOID INTERF SCI, V140, P239, DOI 10.1016/0021-9797(90)90339-P
   YAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
NR 38
TC 5
Z9 5
U1 0
U2 0
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 8
IS 1
BP 1
EP 18
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA VR802
UT WOS:A1996VR80200001
PM 8933287
DA 2018-10-19
ER

PT J
AU Altankov, G
   Groth, T
AF Altankov, G
   Groth, T
TI Fibronectin matrix formation by human fibroblasts on surfaces varying in
   wettability
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterials; wettability; fibroblasts; fibronectin; extracellular
   matrix
ID SUBSTRATUM-BOUND FIBRONECTIN; CELL-ADHESION; EXTRACELLULAR-MATRIX;
   TYROSINE PHOSPHORYLATION; HYDROPHOBIC SURFACES; ADSORBED FIBRONECTIN;
   SIGNAL TRANSDUCTION; PROTEIN ADSORPTION; ANTIBODY-BINDING;
   BIOCOMPATIBILITY
AB The spatial organization of extracellular fibronectin on biomaterial surfaces might be important for interaction with tissue cells. In previous investigations we have demonstrated that hydrophilic materials bind preadsorbed fibronectin that can easily be reorganized by fibroblasts in a specific matrix-like structure, while on less wettable materials (possessing water contact angles above 60 deg) the cells were unable to do this. As the cells continuously produce their fibronectin matrix, we tried in this study to answer the question of how the surface wettability of biomaterials influences the endogenous fibronectin matrix formation and its subsequent organization on the substrate. We cultured fibroblasts for 72 h on five different wettable surfaces: glass, aminopropyltriethoxysilane, pellethane, polyvinylchloride, and silicone, with water-contact angles gradually ranging from 25 to 105 deg. We demonstrated that the decreasing wettability of the materials significantly reduced endogenous fibronectin deposition on the substratum. Moreover, fibrillar organization of fibronectin appeared only on relatively hydrophilic glass and APS substrate, while on more hydrophobic materials like PVC and SI, cells secreted some fibronectin but were not able to organize it into a fibronectin matrix. These results were correlated with an altered cell morphology and spreading on these materials. In addition, an ELISA method has been implemented to quantify fibronectin matrix formation as a possible measure of the biocompatibility of materials, where a clear relation has been found between fibroblast growth and fibronectin matrix formation.
C1 GKSS FORSCHUNGSZENTRUM GEESTHACHT GMBH,INST CHEM,DEPT MEMBRANE RES,D-14513 TELTOW,GERMANY.
RP Altankov, G (reprint author), BULGARIAN ACAD SCI,INST BIOPHYS,STR ACAD G BONCHEV,BL 21,SOFIA 1113,BULGARIA.
OI Groth, Thomas/0000-0001-6647-9657
CR AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V
   ALBELDA SM, 1990, FASEB J, V4, P2868
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1978, INT REV CYTOL, V53, P65
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GROTH T, 1995, J BIOMAT SCI-POLYM E, V7, P297
   HENKIN RI, 1993, OTOLARYNGOLOGY, V2, P1
   Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IKADA Y, 1994, ACS SYM SER, V540, P35
   IMAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cellbio.4.1.183
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573
   Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
   WINTERTON LC, 1986, J COLLOID INTERF SCI, V111, P314, DOI 10.1016/0021-9797(86)90038-X
   WOLF H, 1988, ADV BIOMEDICAL MEASU, P133
   WU C, 1996, CELL, V83, P715
   YAMASHIRO DJ, 1984, CELL, V37, P789, DOI 10.1016/0092-8674(84)90414-8
NR 34
TC 39
Z9 44
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 8
IS 4
BP 299
EP 310
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA WF919
UT WOS:A1996WF91900005
PM 9041043
DA 2018-10-19
ER

PT J
AU Bell, CL
   Peppas, NA
AF Bell, CL
   Peppas, NA
TI Swelling/syneresis phenomena in gel-forming interpolymer complexes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE interpolymer complexation; poly(ethylene glycol); poly(methacrylic
   acid); graft copolymers; swelling; deswelling; syneresis
ID INTERPENETRATING POLYMER NETWORKS; LABELED POLY(ETHYLENE GLYCOL);
   POLY(ACRYLIC ACID); POLY(METHACRYLIC ACID); POLYOXYETHYLENE;
   EQUILIBRIUM; DIFFUSION
AB Grafted poly(methacrylic acid-g-ethylene glycol) (P(MAA-g-EG)) copolymers were synthesized and their pH sensitivity investigated as a function of copolymer composition and PEG graft molecular weight. Interpolymer complexation occurred by hydrogen bonding between carboxylic groups on poly(methacrylic acid) (PMAA) and ether groups on poly(ethylene glycol) (PEG). This complexation was sensitive to the surrounding environment as complexes formed at pH levels low enough to insure substantial protonation of PMAA acid groups. At high pH, the acid groups became neutralized and did not form complexes. P(MAA-g-EG) membranes showed pH-sensitivity due to complex formation and dissociation. Uncomplexed equilibrium swelling ratios were much higher than those of the complexed states and varied according to copolymer composition and PEG graft length. Mesh sizes in the two states were determined. Swelling under oscillatory pH conditions and constant ionic strength revealed the dynamic sensitivity of P(MAA-g-EG) membranes. Under changing pH conditions, network syneresis (complexation) occurred more rapidly than network expansion (decomplexation) because of the rates of diffusion of specific ions causing the responses. No distinct water fronts were observed. Instead, water transport was continuous through the gel. These gels show great promise for a number of biomedical applications where fast biomaterial response is necessary.
C1 PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907.
FU NIGMS NIH HHS [GM 43337]
CR ADACHI H, 1982, POLYM J, V14, P985, DOI 10.1295/polymj.14.985
   ANTIPINA AD, 1972, VYSOKOMOL SOEDIN A, V14, P941
   BADIGER MV, 1993, BIOMATERIALS, V14, P1059, DOI 10.1016/0142-9612(93)90206-H
   BAILEY FE, 1964, J POLYM SCI PART A, V2, P845, DOI 10.1002/pol.1964.100020221
   BARANOVSKY V, 1991, EUR POLYM J, V27, P643, DOI 10.1016/0014-3057(91)90149-I
   BARTON AFM, 1990, CRC HDB POLYM SOLVEN
   BEKTUROV EA, 1981, ADV POLYM SCI, V41, P99
   BOKIAS G, 1994, MACROMOLECULES, V27, P427, DOI 10.1021/ma00080a016
   Brandrup J., 1989, POLYM HDB
   Crank J, 1975, MATH DIFFUSION
   Cussler E. L., 1984, DIFFUSION MASS TRANS
   DRUMMOND RK, 1989, MACROMOLECULES, V22, P3816, DOI 10.1021/ma00199a059
   HEMKER DJ, 1987, MACROMOLECULES, V23, P4411
   KLIER J, 1990, MACROMOLECULES, V23, P4944, DOI 10.1021/ma00225a011
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   NISHI S, 1989, POLYM J, V21, P393, DOI 10.1295/polymj.21.393
   Odian G., 1970, PRINCIPLES POLYM
   OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605
   OSADA Y, 1979, J POLYM SCI POL CHEM, V17, P3485, DOI 10.1002/pol.1979.170171107
   OSADA Y, 1976, J POLYM SCI POL LETT, V14, P129, DOI 10.1002/pol.1976.130140302
   OYAMA HT, 1987, MACROMOLECULES, V20, P474, DOI 10.1021/ma00169a002
   OYAMA HT, 1987, MACROMOLECULES, V20, P1839, DOI 10.1021/ma00174a024
   PAPISOV IM, 1974, VYSOKOMOL SOEDIN A+, V16, P1133
   PEPPAS NA, 1983, J MEMBRANE SCI, V15, P275, DOI 10.1016/S0376-7388(00)82304-2
   PEPPAS NA, 1986, HYDROGELS MED PHARM, V1, P28
   Perry RH, 1984, PERRYS CHEM ENG HDB
   TYN MT, 1990, BIOTECHNOL BIOENG, V35, P327, DOI 10.1002/bit.260350402
NR 27
TC 28
Z9 29
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 8
BP 671
EP 683
DI 10.1163/156856296X00444
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA TW718
UT WOS:A1996TW71800003
PM 8639476
DA 2018-10-19
ER

PT J
AU VanDelden, CJ
   Engbers, GHM
   Feijen, J
AF VanDelden, CJ
   Engbers, GHM
   Feijen, J
TI The effect of protein adsorption on the anticoagulant activity of
   surface immobilized heparin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE heparin; immobilization; anticoagulant activity; proteins; adsorption
ID HISTIDINE-RICH GLYCOPROTEIN; PLATELET FACTOR-4; ANTITHROMBIN-III;
   PLASMA-PROTEINS; HIGH-AFFINITY; BINDING; NEUTRALIZATION;
   OLIGOSACCHARIDES; BIOMATERIAL; THROMBIN
AB The anticoagulant activity of albumin-heparin conjugates covalently immobilized on carboxylated polystyrene beads was determined before and after exposure to different plasma/PBS dilutions using a thrombin inhibition assay, a FXa inhibition assay, and a modified aPTT assay. Exposure of albumin-heparin modified surfaces (alb-hep surfaces) to plasma dilutions resulted in surfaces with a lower anticoagulant activity than surfaces which were not exposed to plasma dilutions. The reduction of the activity increased up to +/-80% when the surfaces were exposed to solutions containing more than 70% plasma. Alb-hep surfaces incubated in plasma which was preexposed to heparin-Sepharose retained 30% of their initial activity. These observations were attributed to non-specific adsorption of plasma proteins onto the surface and to interaction of heparin binding proteins with the immobilized heparin. Both processes result in a decreased accessibility of the immobilized heparin and thus in a reduced anticoagulant activity displayed by the heparinized surface. Identification of adsorbed proteins with SDS gel electrophoresis and immunoblotting revealed that many different proteins were present at the heparinized surface. Only small differences were observed between the gel electrophoresis pattern of adsorbed proteins obtained from heparinized surfaces and from a surface containing immobilized albumin.
C1 UNIV TWENTE,INST BIOMED TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VanDelden, CJ (reprint author), UNIV TWENTE,DEPT CHEM ENGN,BIOMAT SECT,POB 217,7500 AE ENSCHEDE,NETHERLANDS.
CR CHANDLER WL, 1988, J BIOMED MATER RES, V22, P497, DOI 10.1002/jbm.820220606
   DENTON J, 1983, BIOCHEM J, V209, P455, DOI 10.1042/bj2090455
   EBERT CD, 1982, THROMB RES, V26, P43, DOI 10.1016/0049-3848(82)90149-9
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   ENGBERS GHM, 1990, ADV BIOMAT, V9, P487
   ENGBERS GHM, 1990, THESIS U TWENTE ENSC, pCH3
   ERIKSSON JC, 1979, J COLLOID INTERF SCI, V72, P142, DOI 10.1016/0021-9797(79)90191-7
   GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HEIMBURGER N, 1972, H-S Z PHYSIOL CHEM, V353, P1133, DOI 10.1515/bchm2.1972.353.2.1133
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   LANE DA, 1984, BIOCHEM J, V218, P725, DOI 10.1042/bj2180725
   LANE DA, 1986, J BIOL CHEM, V261, P3980
   LANE DA, 1989, HEPARIN CHEM BIOL PR, P363
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LIJNEN HR, 1983, J BIOL CHEM, V258, P3803
   LINDON JN, 1985, J LAB CLIN MED, V105, P219
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   OLSON ST, 1981, J BIOL CHEM, V256, P11073
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PETERSON CB, 1987, J BIOL CHEM, V262, P7567
   PREISSNER KT, 1987, J BIOL CHEM, V262, P1224
   SCHMITT E, 1983, BIOMATERIALS, V4, P309, DOI 10.1016/0142-9612(83)90034-0
   SMITH BAH, 1988, J BIOMED MATER RES, V22, P673, DOI 10.1002/jbm.820220802
   THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2
   VANDELDEN CJ, IN PRESS J BIOMED MA
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   WINTERTON LC, 1986, J COLLOID INTERF SCI, V111, P314, DOI 10.1016/0021-9797(86)90038-X
   YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625
   ZAMMIT A, 1993, THROMB HAEMOSTASIS, V70, P951
NR 31
TC 11
Z9 11
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 8
BP 727
EP 740
DI 10.1163/156856296X00499
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA TW718
UT WOS:A1996TW71800008
PM 8639481
DA 2018-10-19
ER

PT J
AU Irigaray, JL
   Braye, F
   Oudadesse, H
   Jallot, E
   Weber, G
   Amiribadi, A
   Tixier, H
AF Irigaray, JL
   Braye, F
   Oudadesse, H
   Jallot, E
   Weber, G
   Amiribadi, A
   Tixier, H
TI Diffusion of mineral elements evaluated by PIXE at the bone-coral
   interface
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biomaterial; particles induced X-ray emission (PIXE); osseous
   substitution; kinetics of biomaterial resorption; interface
AB Substituting the tissue of human organs with biomaterials is problematic. However, its importance and relevance justify all the efforts made. An interdisciplinary approach is required. We report on our study of a product for bone substitution. Coral is a natural product, the interest of which we have already demonstrated in our previous work. Following sterilization, natural coral was implanted in sheep femurs. We regularly extracted the implants from the femurs to study the kinetics of elemental mineral transformation of the bone substitutes. For the first time ever, and thanks to the PIXE method (particles induced X-ray emission), we were able to measure the concentration of mineral elements at different time intervals after implantation over a whole cross-section. We found a discontinuity of the mineral elements (Ca, P, Sr, Zn, Fe) at the interface between the implant and the receiver. This shows that the osseous attack is not global but, on the contrary, centripetal. Moreover, the fit of the concentration time course indicates that the kinetics of ossification are different for each atomic element and characterize a distinct biological phenomenon. Our analyses confirm the biocompatibility and the ossification of the implanted coral.
C1 UNIV CLERMONT FERRAND,F-63177 CLERMONT FERRAND,FRANCE.
   IPNE,B-4000 LIEGE,BELGIUM.
   ATOM ENERGY ORG IRAN,TEHRAN,IRAN.
   HOP HOTEL DIEU,SERV CHIRURG INFANTILE,F-63000 CLERMONT FERRAND,FRANCE.
RP Irigaray, JL (reprint author), CNRS,IN2P3,LAB PHYS CORPUSULAIRE CLERMONT FERRAND,F-63177 CLERMONT FERRAND,FRANCE.
CR ALOUPOGIANNIS P, 1989, NUCL INSTRUM METH B, V42, P358
   BOULANGER P, 1971, BIOCH MED SANG HUMEU, P32
   BRAITTER P, 1977, J RADIOANAL CHEM, V37, P393
   BRAYE F, 1994, THESIS U BLAISEPASCA
   BRUN R, 1987, HDB USER GUIDE, P38
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V174, P93, DOI 10.1007/BF02040337
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   1991, GUIDE PRELEVEMENT SE
   CORAIL BIOCORAIL, V3
NR 9
TC 8
Z9 8
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 8
BP 741
EP 749
DI 10.1163/156856296X00507
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA TW718
UT WOS:A1996TW71800009
PM 8639482
DA 2018-10-19
ER

PT J
AU Nagel, JA
   Dickinson, RB
   Cooper, SL
AF Nagel, JA
   Dickinson, RB
   Cooper, SL
TI Bacterial adhesion to polyurethane surfaces in the presence of
   pre-adsorbed high molecular weight kininogen
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE bacterial adhesion; polyurethanes; high molecular weight kininogen and
   protein adsorption
ID FIBRINOGEN; FIBRONECTIN; ADSORPTION; ADHERENCE; PLASMA
AB The factors which affect the adherence of a bacteria cell to the surface of a biomaterial include the surface chemistry of the cell and material, as well as the composition of the adsorbed protein layer when the biomaterial is exposed to circulating blood. In an effort to better understand the mechanisms by which bacteria adhere to such surfaces, and specifically to determine the effects of high molecular weight kininogen on bacterial adhesion, experiments were performed in which the attachment of Staphylococcus aureus was directly observed on glass and on a series of functionalized polyurethanes. These surfaces had been pre-adsorbed with various concentrations of high molecular weight kininogen and fibrinogen. Attachment was observed using a radial flow chamber, in which shear stress varied inversely with radial distance. Protein adsorption studies were also performed using I-125 labeled fibrinogen to investigate the relationship between surface chemistry, protein adsorption, and bacterial attachment. Bacterial attachment was significantly decreased when the glass surface was pre-adsorbed with high molecular weight kininogen-either alone, or following adsorption of fibrinogen. High molecular weight kininogen thus exhibited and-adhesive effects. On polyurethane surfaces pre-adsorbed with fibrinogen, kininogen, and albumin, the highest bacterial attachment was found on the base polyurethane, while significant decreases were seen on the hydrophilic polyurethanes. In addition, it was found that the surface with the least bacterial attachment and fibrinogen deposition was the polyurethane with pendant phosphonate groups.
C1 UNIV DELAWARE,DEPT CHEM ENGN,NEWARK,DE 19716.
   UNIV FLORIDA,DEPT CHEM ENGN,GAINESVILLE,FL 32611.
RI Dickinson, Richard/A-4435-2012
OI Dickinson, Richard/0000-0002-7415-2889
CR ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BRASH JL, 1988, BLOOD, V71, P932
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   COLMAN RW, 1994, PURE APPL CHEM, V66, P27, DOI 10.1351/pac199466010027
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Lelah M. D., 1986, POLYURETHANES MED
   MOLLER PS, 1963, AERO             MAY, V163
   Neu T R, 1990, J Biomater Appl, V5, P107, DOI 10.1177/088532829000500203
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   POOT A, 1990, J BIOMED MATER RES, V24, P1021, DOI 10.1002/jbm.820240805
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   VERHEYEN CCPM, 1993, BIOMATERIALS, V14, P383, DOI 10.1016/0142-9612(93)90059-B
   VROMAN L, 1980, BLOOD, V55, P156
   YOUNG BR, 1988, J COLLOID INTERF SCI, V124, P28, DOI 10.1016/0021-9797(88)90321-9
   ZIATS NP, 1994, T SOC BIOMAT, V17, P74
NR 20
TC 40
Z9 41
U1 0
U2 7
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 9
BP 769
EP 780
DI 10.1163/156856296X00110
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA UQ070
UT WOS:A1996UQ07000003
PM 8773881
DA 2018-10-19
ER

PT J
AU Furuzono, T
   Kishida, A
   Yanagi, M
   Matsumoto, T
   Kanda, T
   Nakamura, T
   Aiko, T
   Maruyama, I
   Akashi, M
AF Furuzono, T
   Kishida, A
   Yanagi, M
   Matsumoto, T
   Kanda, T
   Nakamura, T
   Aiko, T
   Maruyama, I
   Akashi, M
TI Novel functional polymers: Poly(dimethylsiloxane)polyamide multiblock
   copolymer .5. The interaction between biomolecules and the surface of
   aramid-silicone resins
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE poly(dimethylsiloxane); aramid; multiblock copolymer; protein
   adsorption; cell adhesion; implant
ID BICINCHONINIC ACID; BREAST IMPLANTS; BIOMATERIAL; ADSORPTION; ASSAY;
   WATER
AB Multiblock copolymers consisting of aromatic polyamide(aramid) and poly(dimethylsiloxane) (PDMS) aramid-silicone resins (PASs) were synthesized by low temperature solution polycondensation, and PAS films were prepared by casting from an N,N'-dimethylacetamide solution. In this study, we investigated bovine serum albumin (BSA) adsorption, L929 cell adhesion, and tissue reaction on the surface of PAS in order to clarify the interaction between PAS and biomolecules. It was found that the amount of adsorbed biomolecules on PAS was extremely low in contrast with those on aramid and nylon films, and it was comparable to SILASTIC(R) 500-1 film. This suppression of adsorption of biomolecules onto PAS seemed to be due to the low surface free energy of the outermost surface of PAS, where PDMS block was condensed.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT CHEM ENGN & APPL CHEM,KAGOSHIMA 890,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT SURG 1,KAGOSHIMA 890,JAPAN.
   NOF CORP LTD,TSUKUBA RES LAB,TSUKUBA,IBARAKI 30026,JAPAN.
   KAGOSHIMA INST PREVENT MED,IJUIN 89925,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT CLIN LAB MED,KAGOSHIMA 890,JAPAN.
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FRISCH EE, 1984, ACS SYM SER, V256, P63
   Furuzono T., 1993, Japanese Journal of Artificial Organs, V22, P370
   FURUZONO T, 1993, J BIOMAT SCI-POLYM E, V5, P89
   Furuzono T, 1996, J APPL POLYM SCI, V59, P1059, DOI 10.1002/(SICI)1097-4628(19960214)59:7<1059::AID-APP2>3.0.CO;2-D
   GIFFORD GH, 1976, J BIOMED MATER RES, V10, P857, DOI 10.1002/jbm.820100605
   HARTMAN LC, 1988, J BIOMED MATER RES, V22, P475, DOI 10.1002/jbm.820220604
   IKADA Y, 1989, JPN J ARTIF ORGANS, V15, P12
   Ikada Y, 1986, POLYM MED, V2, P101
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   KAJIYAMA M, 1989, MACROMOLECULES, V22, P4143, DOI 10.1021/ma00201a001
   KESZLER B, 1992, POLYM BULL, V29, P681, DOI 10.1007/BF01041155
   KISHIDA A, 1994, ANGEW MAKROMOL CHEM, V220, P89, DOI 10.1002/apmc.1994.052200108
   KISHIDA A, IN PRESS BIOMATERIAL
   KOSSOVSKY N, 1995, J BIOMAT SCI-POLYM E, V7, P101
   LANSDOWN ABG, 1994, ASAIO J, V40, P202
   Lynch W, 1978, HDB SILICONE RUBBER
   MANCINO D, 1984, INT ARCH ALLER A IMM, V73, P10, DOI 10.1159/000233429
   Matsumoto T, 1996, J APPL POLYM SCI, V59, P1067, DOI 10.1002/(SICI)1097-4628(19960214)59:7<1067::AID-APP3>3.0.CO;2-C
   MCGRATH MH, 1984, PLAST RECONSTR SURG, V74, P550, DOI 10.1097/00006534-198410000-00019
   MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OHSHIGE T, 1995, POLYM PREPRINTS, V44, P768
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   PARK D, 1995, MACROMOLECULES, V28, P2596
   ROWE VK, 1948, J IND HYG TOXICOL, V30, P332
   ROWE VK, 1953, ARCH IND HYG OCC MED, V1, P539
   RUDOLPH R, 1978, PLAST RECONSTR SURG, V62, P185, DOI 10.1097/00006534-197808000-00006
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Van S.J., 1991, J BIOMAT SCI-POLYM E, V2, P91
   WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1
NR 33
TC 11
Z9 12
U1 2
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 10
BP 871
EP 880
DI 10.1163/156856296X00048
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA UZ917
UT WOS:A1996UZ91700004
PM 8836833
DA 2018-10-19
ER

PT J
AU VanDelden, CJ
   Engbers, GHM
   Feijen, J
AF VanDelden, CJ
   Engbers, GHM
   Feijen, J
TI The interactions between antithrombin III, thrombin and surface
   immobilized heparin
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE immobilization; heparin; antithrombin III; thrombin
ID ANTI-THROMBIN; INACTIVATION; BIOMATERIAL
AB The interactions between antithrombin III (ATIII), thrombin, and surface immobilized heparin were investigated. Carboxylated polystyrene modified with covalently immobilized albumin-heparin conjugate contain sites which can bind ATIII from buffer and plasma solutions. Approximately 65% of the ATIII molecules present at the heparinized surface either adsorbed from a buffer or plasma solution, exchanged with ATIII in buffer solution. The exchange between surface bound ATIII and ATIII in solution was repeated several times on the same heparinized surface. The number of binding sires that could bind and release ATIII was much higher when the heparinized surface was exposed to an ATIII containing buffer solution than to a plasma solution. The reduction in binding sites available for ATIII using plasma solutions as compared to buffer solutions could be explained by the competition of other plasma proteins with ATIII for the heparinized surface. It was observed that heparin binding proteins were able to compete with ATIII for binding to the immobilized heparin. Furthermore adsorption of proteins on the heparinized surface significantly reduced the availability of binding sites for ATIII.
   Exposure of thrombin to the heparinized surface resulted in thrombin activity at the surface. The thrombin activity on the heparinized surfaces was lower on surfaces with a higher ATIII concentration. The activity of surface bound thrombin was not affected by the presence of other plasma proteins. Enzymatically active thrombin molecules present at the heparinized surface were completely inactivated when the surface was exposed to a solution containing ATIII. The inactivation rate of surface bound thrombin by ATIII was higher than the rate of the uncatalyzed inactivation of thrombin in solution. Part of the Thrombin-Antithrombin III (TAT) complexes (10-20%) that were formed upon inactivation of thrombin remained bound to the heparinized surface.
   In general it was concluded that only the surface immobilized heparin molecules that can bind ATIII in a reversible way determine the anticoagulant properties of the surface. The mechanism of inactivation of a protease on a heparinized surface depends either on the catalytic effect of heparin on the inactivation rate of proteases by ATIII or on an increased uncatalytic inactivation due to increased concentrations of ATIII near the surface as compared to the concentration of ATIII in the bulk phase.
C1 UNIV TWENTE,INST BIOMED TECHNOL,NL-7500 AE ENSCHEDE,NETHERLANDS.
RP VanDelden, CJ (reprint author), UNIV TWENTE,DEPT CHEM ENGN,BIOMAT SECT,POB 217,NL-7500 AE ENSCHEDE,NETHERLANDS.
CR AMANDER C, 1986, Journal of Biomedical Materials Research, V20, P235
   CHANDLER WL, 1988, J BIOMED MATER RES, V22, P497, DOI 10.1002/jbm.820220606
   COLMAN RW, 1989, ANN NY ACAD SCI, V556, P95
   ELQUE G, 1993, ART ORGANS, V17, P721
   ENGBERS GHM, 1990, THESIS U TWENTE ENSC, pCH3
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HATTON MWC, 1983, THROMB HAEMOSTASIS, V50, P873
   LARSSON R, 1986, THROMB RES, V19, P43
   LINDON JN, 1985, J LAB CLIN MED, V105, P219
   PASCHE B, 1986, THROMB RES, V44, P739, DOI 10.1016/0049-3848(86)90020-4
   PASCHE B, 1991, ARTIF ORGANS, V15, P481
   ROLLASON G, 1989, J BIOMATER SCI POL E, V1
   ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
   SANCHEZ J, 1995, J BIOMED MATER RES, V19, P655
   TILTON RD, 1990, J COLLOID INTERF SCI, V137, P192, DOI 10.1016/0021-9797(90)90056-T
   VANDELDEN CJ, IN PRESS J BIOMED MA
   VANDELDEN CJ, IN PRESS J BIOMATER
   WONG RF, 1983, BIOCHEMISTRY-US, V22, P3994, DOI 10.1021/bi00286a001
NR 18
TC 5
Z9 5
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1996
VL 7
IS 11
BP 989
EP 1004
DI 10.1163/156856296X00390
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA VB892
UT WOS:A1996VB89200006
PM 8858487
DA 2018-10-19
ER

PT J
AU Kaplan, SS
   Basford, RE
   Jeong, MH
   Simmons, RL
AF Kaplan, SS
   Basford, RE
   Jeong, MH
   Simmons, RL
TI Biomaterial-neutrophil interactions: Dysregulation of oxidative
   functions of fresh neutrophils induced by prior neutrophil-biomaterial
   interaction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FOREIGN-BODY INFECTION; NITRIC-OXIDE; POLYMORPHONUCLEAR LEUKOCYTES;
   SUPEROXIDE PRODUCTION; BIOLOGICAL SURFACES; MICROBIAL ADHESION; TISSUE
   INTEGRATION; RELAXING FACTOR; L-ARGININE; INTERLEUKIN-8
AB Biomaterial-associated infection results in increased morbidity and mortality, and may occur because of nonproductive premature activation of neutrophils resulting in impaired phagocyte function at the biomaterial surface in the event of bacterial challenge. To further explore the effects of this premature activation, we evaluated the supernatants of biomaterial associated neutrophils to determine whether soluble mediators were released, and the likely role of these mediators. We show that these supernatants contain a chemoattractant and thereby induce chemotaxis by fresh neutrophils. No evidence of enhanced oxidative free radical production by either unstimulated neutrophils or a primed response to other mediators occurs when neutrophils were incubated with these supernatants. We also examined the effect of adding fresh neutrophils to a biomaterial surface containing a previous inoculum of neutrophils, and observed that the fresh cells did not become stimulated to release reactive oxygen intermediates (ROI) and also exhibited impaired killing of staphylococci. These studies suggest that not only does the biomaterial surface activate the initial wave of neutrophils but that subsequent waves of neutrophils exhibit an impaired host-defense function. These results are consistent with the known impairment of host defense in the presence of biomaterials, and provide evidence for a long-term down-regulation of neutrophil function at biomaterial surfaces. (C) 1996 John Wiley & Sons, Inc.
C1 UNIV PITTSBURGH, SCH MED, DEPT MOLEC GENET & BIOCHEM, PITTSBURGH, PA 15261 USA.
   UNIV PITTSBURGH, SCH MED, DEPT SURG, PITTSBURGH, PA USA.
RP Kaplan, SS (reprint author), UNIV PITTSBURGH, MED CTR,SCH MED,DEPT PATHOL,200 LOTHROP ST, ROOM 5930 CHP MT, PITTSBURGH, PA 15213 USA.
FU NIGMS NIH HHS [GM41734-06]
CR BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265
   BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z
   BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   CICCO NA, 1990, BLOOD, V75, P2049
   DAHINDEN CA, 1983, J CLIN INVEST, V72, P113, DOI 10.1172/JCI110948
   DEFORGE LE, 1993, J BIOL CHEM, V268, P25568
   DEJU JY, 1990, BLOOD, V76, P1405
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   FEHR J, 1985, J CLIN INVEST, V76, P535, DOI 10.1172/JCI112003
   FURLONG B, 1987, BRIT J PHARMACOL, V90, P687, DOI 10.1111/j.1476-5381.1987.tb11221.x
   GENIS I, 1990, BLOOD, V76, P1233
   GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092
   GRAZIANO MP, 1987, TRENDS PHARMACOL SCI, V8, P478, DOI 10.1016/0165-6147(87)90042-3
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   HARVATH L, 1991, EXP SUPPL, V59, P35
   JOHNSTON RB, 1976, J CLIN INVEST, V57, P836, DOI 10.1172/JCI108359
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAPLAN SS, 1977, J RETICULOENDOTH SOC, V22, P499
   KAPLAN SS, 1987, ANN ALLERGY, V59, P213
   KAPLAN SS, 1990, ASAIO T, V36, P12
   KASAMA T, 1994, J IMMUNOL, V152, P3559
   KOENDERMAN L, 1990, FEBS LETT, V270, P49, DOI 10.1016/0014-5793(90)81232-D
   KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651
   KUHNS DB, 1986, BLOOD, V68, P535
   LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D
   LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541
   LEY K, 1993, J IMMUNOL, V151, P6347
   LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M
   MCCALL TB, 1989, BIOCHEM J, V261, P293, DOI 10.1042/bj2610293
   MCPHAIL LC, 1993, EUR J HAEMATOL, V51, P294
   MOILANEN E, 1993, BRIT J PHARMACOL, V109, P852, DOI 10.1111/j.1476-5381.1993.tb13653.x
   NATHAN CF, 1989, BLOOD, V73, P301
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   NEWMAN M, 1989, AGENTS ACTIONS, V26, P183
   OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153
   RIMELE TJ, 1988, J PHARMACOL EXP THER, V245, P102
   SALVEMINI D, 1989, P NATL ACAD SCI USA, V86, P6328, DOI 10.1073/pnas.86.16.6328
   SCHMIDT HHHW, 1989, FEBS LETT, V244, P357, DOI 10.1016/0014-5793(89)80562-9
   SKLAR LA, 1985, J BIOL CHEM, V260, P1461
   SNYDERMAN R, 1986, J LEUKOCYTE BIOL, V40, P785
   SNYDERMAN R, 1988, INFLAMMATION BASIC P, P303
   STRIETER RM, 1992, AM J PATHOL, V141, P397
   SUGERMAN B, 1989, INF DIS CLIN N AM, V3, P187
   VONANDRIAN UH, 1993, BLOOD, V82, P182
   WADE BH, 1983, AM J MED, V74, P686, DOI 10.1016/0002-9343(83)91028-8
   WANG P, 1994, BLOOD, V83, P2678
   WIEDERMANN CJ, 1993, CLIN INVESTIGATOR, V71, P985
   WRIGHT CD, 1989, BIOCHEM BIOPH RES CO, V160, P813, DOI 10.1016/0006-291X(89)92506-0
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIPSER RD, 1986, AM J MED, V80, P78, DOI 10.1016/0002-9343(86)90934-4
NR 55
TC 19
Z9 19
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1996
VL 30
IS 1
BP 67
EP 75
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA UD180
UT WOS:A1996UD18000009
PM 8788107
DA 2018-10-19
ER

PT J
AU Galliani, S
   Cremieux, A
   VanDerAuwera, P
   Viot, M
AF Galliani, S
   Cremieux, A
   VanDerAuwera, P
   Viot, M
TI Influence of strain, biomaterial, proteins, and oncostatic chemotherapy
   on Staphylococcus epidermidis adhesion to intravascular catheters in
   vitro
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; VENOUS CATHETERS; INNER SURFACE;
   ADHERENCE; PATHOGENESIS; FIBRONECTIN; HYDROPHOBICITY; FIBRINOGEN;
   INFECTION; BACTERIA
AB Initial adhesion of four phenotypically different strains of Staphylococcus epidermidis to 16 silicone, polyurethane, or hydrophilic polyurethane catheters was assessed in vitro by a bacterial radiolabeling method. The effect of catheter exposure to plasma proteins, to an anticancer polychemotherapy (5-fluorouracil, doxorubicin, cyclophosphamide), or to both of them was determined. Bacterial adhesion on native catheters was dependent on the hydrophobicity of both bacteria and catheters. The four strains tested adhered preferentially to silicone catheters (p < 0.05); adhesion was moderate to polyurethane surfaces, whereas the least adhesion was obtained for hydrophilic polyurethane catheters. Adsorption of plasma proteins on the surface produced a marked decrease in adhesion on silicone (-66.2%; p < 0.001) and polyurethane (-32.8%; p < 0.01) catheters and a marked increase in adhesion on hydrophilic surfaces (+91.7%; p < 0.05). Chemotherapeutic treatment of the catheter produced a slight but not significant decrease in adhesion on silicone (-17.4%) and polyurethane (-19.8%) catheters and a marked increase in adhesion on hydrophilic polyurethanes (+148.2%; p < 0.001). The in vitro simulation of catheter use suggested that oncostatic drugs and plasma proteins play an important role in S. epidermidis adhesion to intravascular catheters. Overall, bacterial adhesion is lowest on hydrophilic polyurethane catheters before and after simulation of catheter use.
C1 CTR ANTOINE LACASSAGNE,MICROBIOL LAB,F-06054 NICE,FRANCE.
   FREE UNIV BRUSSELS,CLIN MALAD INFECT,BRUSSELS,BELGIUM.
   FREE UNIV BRUSSELS,MED SERV,MICROBIOL LAB,BRUSSELS,BELGIUM.
   FREE UNIV BRUSSELS,CTR TUMEURS,INST JULES BORDET,LAB INVEST CLIN HJ TAGNON,BRUSSELS,BELGIUM.
   FAC PHARM MARSEILLE,MICRAAM,F-13385 MARSEILLE,FRANCE.
CR [Anonymous], 1988, J CLIN ONCOL, V6, P679
   COOPER GL, 1988, J CLIN MICROBIOL, V26, P8
   COULLIOUD D, 1993, SUPPORT CARE CANCER, V1, P34, DOI 10.1007/BF00326637
   DAVIES J, 1980, ANTIBIOTICS LABORATO, P474
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   GALLIANI S, 1994, J LAB CLIN MED, V123, P1085
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LINARES J, 1985, J CLIN MICROBIOL, V21, P357
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   MARTIN MA, 1989, AM J INFECT CONTROL, V17, P130, DOI 10.1016/0196-6553(89)90199-5
   MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9
   MERMEL LA, 1991, AM J MED, V91, pS197, DOI 10.1016/0002-9343(91)90369-9
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PAUL JH, 1985, APPL ENVIRON MICROB, V50, P431
   PFALLER M, 1988, EUR J CLIN MICROBIOL, V7, P30, DOI 10.1007/BF01962167
   Raad Issam, 1993, Journal of Infectious Diseases, V168, P400
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   RUSSELL PB, 1987, J CLIN MICROBIOL, V25, P1083
   SITGESSERRA A, 1985, SURGERY, V97, P355
   STEINHAUSER H, 1989, BIOMATERIALS, V10, P213, DOI 10.1016/0142-9612(89)90028-8
   TABONE E, 1991, BIOMATERIALS, V12, P741, DOI 10.1016/0142-9612(91)90023-4
   TENNEY JH, 1986, ARCH INTERN MED, V146, P1949, DOI 10.1001/archinte.146.10.1949
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VIOT M, 1990, INT CONSENSUS CUPPOR, P256
   VIOT M, 1993, REV EUROPENNE TECHNO, V15, P12
   VIOT M, 1992, 3RD INT S SUPP CAR C, P85
   WIDMER AF, 1993, PREVENTION CONTROL N, P556
NR 31
TC 15
Z9 16
U1 0
U2 2
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD JAN
PY 1996
VL 127
IS 1
BP 71
EP 80
DI 10.1016/S0022-2143(96)90168-7
PG 10
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA TR917
UT WOS:A1996TR91700011
PM 8592099
DA 2018-10-19
ER

PT J
AU Chen, ZP
   Kaplan, DL
   Yang, K
   Kumar, J
   Marx, KA
   Tripathy, SK
AF Chen, ZP
   Kaplan, DL
   Yang, K
   Kumar, J
   Marx, KA
   Tripathy, SK
TI Phycobiliproteins encapsulated in sol-gel glass
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE sol-gel glass; phycobiliproteins; biomaterial; biosensor
ID BACTERIORHODOPSIN; PHYCOBILISOMES; FILMS
AB Light transducing phycobiliproteins are encapsulated in optically transparent sol-gel matrices. Absorption and fluorescence spectroscopies are used to characterize the effect of the sol-gel encapsulation on the conformation and aggregation states of the three major phycobiliproteins present in phycobilisomes: phycoerythrin, phycocyanin, and allophycocyanin. It is found that the effects of sol-gel entrapment on the spectroscopic properties are significantly different for the three phycobiliproteins. The results indicate that phycoerythrin undergoes only minor change in its native structure when entrapped in sol-gel. However, significant changes in conformation and aggregation state occur when phycocyanin and allophycocyanin are entrapped in sol-gel matrices. A thin film of sol-gel encapsulated phycoerythrin is also coated on an optical fiber surface and strong fluorescence from the evanescent wave excitation is detected. The potential applications of sol-gel encapsulated phycobiliproteins in biosensors are discussed.
C1 USA, NATICK RES DEV & ENGN CTR, DIV BIOTECHNOL, NATICK, MA 01760 USA.
   UNIV LOWELL, DEPT PHYS, CTR ADV MAT, LOWELL, MA 01854 USA.
   UNIV LOWELL, DEPT PHYS, CTR INTELLIGENT BIOMAT, LOWELL, MA 01854 USA.
   UNIV LOWELL, DEPT CHEM, CTR ADV MAT, LOWELL, MA 01854 USA.
   UNIV LOWELL, DEPT CHEM, CTR INTELLIGENT BIOMAT, LOWELL, MA 01854 USA.
CR AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343
   BRAUCHLE C, 1991, ADV MATER, V3, P420, DOI 10.1002/adma.19910030903
   BRAUN S, 1990, MAT LETT, V10
   Brinker C. J., 1990, SOL GEL SCI
   CHEN Z, 1990, P INT JOINT C NEUR N, V2, P803
   CHEN ZP, 1991, APPL OPTICS, V30, P5188, DOI 10.1364/AO.30.005188
   CHEN ZP, 1993, TRENDS BIOTECHNOL, V11, P292, DOI 10.1016/0167-7799(93)90017-4
   CHEN ZP, 1995, CHEM MATER, V7, P1779, DOI 10.1021/cm00058a005
   CHEN ZP, 1994, MATER RES SOC SYMP P, V330, P263
   EDMISTON PL, 1994, J COLLOID INTERF SCI, V163, P395, DOI 10.1006/jcis.1994.1119
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   GANTT E, 1981, ANNU REV PLANT PHYS, V32, P327, DOI 10.1146/annurev.pp.32.060181.001551
   Gao HH, 1995, OPT ENG, V34, P3465, DOI 10.1117/12.215379
   GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47
   GLAZER AN, 1984, TRENDS BIOCHEM SCI, V9, P423, DOI 10.1016/0968-0004(84)90146-4
   GLAZER AN, 1973, J BIOL CHEM, V252, P5487
   GLAZER NA, 1984, BIOCHIM BIOPHYS ACTA, V768, P28
   GOLDEN JP, 1992, SPIE P, V1796, P2
   KRONICK MN, 1983, CLIN CHEM, V29, P1582
   Mac Craith BD, 1994, J SOL-GEL SCI TECHN, V2, P661, DOI 10.1007/BF00486328
   MACCOLL R, 1981, ISR J CHEM, V21, P296
   MARX KA, 1994, MOL BIOMOLECULAR ELE, P395
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   SAMUELSON LA, 1994, J INTEL MAT SYST STR, V5, P305, DOI 10.1177/1045389X9400500302
   SAMUELSON LA, 1992, BIOMIMETICS, V1, P51
   SHARIARI MR, 1994, SOL GEL OPTICS PROCE, P279
   TAKEI H, 1991, APPL OPTICS, V30, P500, DOI 10.1364/AO.30.000500
   WEETALL HH, 1993, BIOCHIM BIOPHYS ACTA, V1142, P211, DOI 10.1016/0005-2728(93)90105-O
   WOLFBEIS OS, 1991, FIBER OPTIC CHEM SEN
   WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022
NR 31
TC 20
Z9 20
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PY 1996
VL 7
IS 1-2
BP 99
EP 108
DI 10.1007/BF00401889
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA VK535
UT WOS:A1996VK53500014
DA 2018-10-19
ER

PT J
AU Klee, D
   Severich, B
   Hocker, H
AF Klee, D
   Severich, B
   Hocker, H
TI Correlation between chemical and physical surface properties and blood
   compatibility of PPE/EVA-blends
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 5th Dresden Polymer Discussion on Polymers and Medicine
CY APR 24-27, 1995
CL KONIGSTEIN, GERMANY
SP Deut Forschungsgemeinsch, Sachs Staatsminist Wissensch & Kunst, Inst Fresenius Grp, Inst Polymerforsch Dresden, Verein Forder
AB The chemical and physical surface properties of a biomaterial are of high importance for the blood compatibility of an implant. Blends of poly(propylene-co-ethylene) with various amounts of poly(ethylene-co-vinyl acetate) (PPE/EVA-blends) were examined because of the varying surface hydrophilicity. Surface characterizations were performed by means of X-ray Photoelectron Spectroscopy (XPS), Infrared Spectroscopy in Attenuated Totalreflexion Mode (IR-ATR) in relation to dynamic contact angle and zeta potential measurements. The examination of the blood compatibility of the polymer surfaces was carried out in vitro in a modified BOWRY blood chamber with native whole human blood. A balanced ratio of polar and dispersive surface free energy and a zeta potential of -4 mV are the conditions for a good blood compatibility of the investigated PPE/EVA-blends.
RP Klee, D (reprint author), RHEIN WESTFAL TH AACHEN, DEPT MACROMOLEC & TEXT CHEM, VELTMANPL 8, D-52062 AACHEN, GERMANY.
CR BANTJES A, 1978, BRIT POLYM J, V10, P147
   BASKIN A, 1986, ARTIFICIAL HEART, V1, P23
   JACOBASCH HJ, 1975, PAPIER, V29, P555
   Klinkmann H., 1987, UREMIA THERAPY, P125
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   LYKLEMA J, 1985, INTERFACIAL ELECTROC, V1, P293
   MEYER JG, 1986, BLUTGERINNUNG FIBRIN
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   YUI N, 1986, BLOOD COMPATIBLE MAT, P39
NR 11
TC 4
Z9 4
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 1996
VL 103
BP 19
EP 29
PG 11
WC Polymer Science
SC Polymer Science
GA TV571
UT WOS:A1996TV57100004
DA 2018-10-19
ER

PT J
AU Hocker, H
   Klee, D
AF Hocker, H
   Klee, D
TI Polymers for medical uses
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 9th Rolduc Polymer Meeting on Smart Polymer Materials and Products
CY MAY 08-11, 1995
CL ROLDUC ABBEY, NETHERLANDS
AB An increasing demand for biomaterials corresponds to the deficiency in the knowledge on biocompatibility. To increase this knowledge the modification of polymer surfaces, their characterization, and the investigation of the response of the biosystem is considered to be a suitable approach. Surface modification may be performed in the wet-chemical way (heterogeneous reaction) or by means of treatment with a suitable plasma (glow discharge).
   Surface sensitive methods such as X-ray photoelectron spectroscopy, infrared spectroscopy in the attenuated total reflexion mode as well as surface energy measurements are useful for surface characterization.
   To determine the bioresponse to the polymer surface, enzyme-linked immunosorbent assays, cell growth and full blood tests may be used.
   In the present paper several systems are described with respect to their surface modification, characterization, and bioresponse. It is shown that the protein adsorption is triggered by the surface, that SO2 plasma treatment enhances cell growth and that there seems to be a biocompatibility window for a surface characterized by a zeta-potential between -4 and -8 mV and a ratio of dispersive to polar contributions of surface energy around 12.
   It is stressed, however, that the final solution for a biomaterial is a material which, in the course of degradation, constantly presents a new biocompatible surface.
C1 RHEIN WESTFAL TH AACHEN,DEUTSCH WOLLFORSCHUNGSINST,D-52062 AACHEN,GERMANY.
RP Hocker, H (reprint author), RHEIN WESTFAL TH AACHEN,LEHRSTUHL TEXT CHEM & MAKROMOLEK CHEM,VELTMANPL 8,D-52062 AACHEN,GERMANY.
CR HOCKER H, 1995, MACROMOL SYMP, V100, P15, DOI 10.1002/masy.19951000104
   KLEE D, 1994, J MATER SCI-MATER M, V5, P592, DOI 10.1007/BF00120336
   KLEE D, 1995, SPEKTRUM WISSENSCHAF, V6, P90
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SEVERICH B, 1994, THESIS RWTH
   THELEN H, THESIS RWTH AACHEN
   THELEN H, IN PRESS FRESENIUS J
   WIRSCHING J, THESIS RWTH AACHEN
NR 8
TC 5
Z9 5
U1 0
U2 3
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD JAN
PY 1996
VL 102
BP 421
EP 427
DI 10.1002/masy.19961020149
PG 7
WC Polymer Science
SC Polymer Science
GA TT969
UT WOS:A1996TT96900048
DA 2018-10-19
ER

PT J
AU Saito, N
   Sugawara, T
   Matsuda, T
AF Saito, N
   Sugawara, T
   Matsuda, T
TI Synthesis and hydrophilicity of multifunctionally hydroxylated
   poly(acrylamides)
SO MACROMOLECULES
LA English
DT Article
ID BIOMATERIAL; SURFACES; KINETICS; WATER
AB This paper reports synthesis and hydrophilicity of hydroxylated poly(acrylamides), in which one, three, and six hydroxyl groups were attached to the terminal of their side chains, respectively: poly(a-hydroxyethyl acrylamide), poly(N-[tris(hydroxymethyl)methyl] acrylamide), and poly(N,N-di(N-[tris(hydroxymethyl)methyl]-2-acetamido) acrylamide). The initial hypothesis of molecular design of a very hydrophilic polymer was that hydrophilicity increases with an increase in the number of hydroxyl groups per repeating unit due to the enhanced shielding effect on hydrophobic main chains. Contrary to expectations, the relative hydrophilicity of these polymers, determined from the surface tension of these aqueous solutions, tended to decrease with an increase in the number of hydroxyl groups per repeating unit. As the number of hydroxyl groups per repeating unit increased, the chain mobility of the methylene groups adjacent to the terminal hydroxyl groups (determined from the spin-lattice relaxation time (T-1) measurement) was restricted, the fraction of bound water (determined from the DSC measurement) was decreased, and the proton-deuterium exchange rate of hydroxyl groups in D2O-DMSO-d(6) (DMSO-d(6) = dimethyl sulfoxide-d(6)) mixed solution (determined from H-1 NMR spectroscopic measurement) was decreased. These results indicate that the degree of intramolecular hydrogen bonding of the hydroxyl groups is enhanced with an increase in the number of hydroxyl groups per repeating unit, which eventually reduces the hydrogen bonding with water, resulting in a reduction of the hydrophilicity.
C1 NATL CARDIOVASC CTR,RES INST,DEPT BIOENGN,SUITA,OSAKA 565,JAPAN.
   TERUMO CO LTD,CTR RES & DEV,KANAGAWA 25901,JAPAN.
CR ABRAGAM A, 1961, PRINCIPLES NUCLEAR M
   ALLERHAN.A, 1972, J CHEM PHYS, V56, P3718, DOI 10.1063/1.1677754
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   ANDRADE JD, 1985, PRINCIPLES PROTEIN A, V2, pCH1
   ANDRADE JD, 1986, ADV POLYM SCI, V1, P79
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   CONWAY BE, 1972, MACROMOL CHEM OXFORD, V7, P113
   FLORY PJ, 1953, PRINCIPLES POLYM CHE, pCH16
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GUNDERSON LO, 1966, Patent No. 3285886
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, pR9, DOI 10.1002/jbm.820200903
   HORBETT TA, 1987, ACS S SERIES, V343, pCH1
   IKADA Y, 1980, ACS SYM SER, V127, P287
   INOUE Y, 1973, J POLYM SCI POL PHYS, V11, P2237, DOI 10.1002/pol.1973.180111113
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   LEE HB, 1975, J COLLOID INTERF SCI, V51, P225, DOI 10.1016/0021-9797(75)90107-1
   MATSUDA T, UNPUB MACROMOLECULES
   MOLYNEUX P, 1983, WATER SOLUBLE SYNTHE, pCH1
   NAKAMURA K, 1983, POLYM J, V15, P361, DOI 10.1295/polymj.15.361
   RICHARZ R, 1979, J MOL BIOL, V130, P19, DOI 10.1016/0022-2836(79)90549-7
   SCHAKENRAAD JM, 1989, BIOMATERIALS, V10, P43, DOI 10.1016/0142-9612(89)90008-2
   1993, ALDRICH CATALOG, P1264
NR 23
TC 36
Z9 36
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 1
PY 1996
VL 29
IS 1
BP 313
EP 319
DI 10.1021/ma950419n
PG 7
WC Polymer Science
SC Polymer Science
GA TN905
UT WOS:A1996TN90500045
DA 2018-10-19
ER

PT J
AU Rozalska, B
   Ljungh, A
   PaziakDomanska, B
   Rudnicka, W
AF Rozalska, B
   Ljungh, A
   PaziakDomanska, B
   Rudnicka, W
TI Effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on
   biomaterial-associated staphylococcal infection in mice
SO MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE biomaterial-associated infection; GM-CSF; staphylococci; phagocytes
ID NEUTROPHILS; TERM
AB Staphylococcal infections are a major complication in the usage of biomaterials. Different modifications of polymers have been made to reduce the incidence of such infections. We studied the effects of modifying heparinized polyethylene (H-PE) with mouse recombinant granulocyte-macrophage stimulating factor (rGM-CSF), The elimination of staphylococci (Staphylococcus aureus, S. epidermidis) from the peritoneum of mice implanted with rGM-CSF-coated H-PE was slightly more effective than the elimination of the bacteria from the peritoneum of animals implanted with uncoated H-PE. Most interestingly, the number of staphylococci present in the biofilms covering rGM-CSF-coated implants were significantly lower than the number of bacteria detected on the surface of H-PE not coated with rGM-CSF. In vitro, rGM-CSF restored the anti-bacterial potency of the phagocytes, which had been reduced by surface contact with H-PE, The results suggest that modification of biomaterials with rGM-CSF could be one way of preventing staphylococcal infections; especially in neutropenic disorders, which constitute the highest risk factor for foreign body-associated infections.
C1 UNIV LODZ,INST MICROBIOL & IMMUNOL,DEPT INFECT BIOL,PL-90237 LODZ,POLAND.
   LUND UNIV,DEPT MED MICROBIOL,S-22362 LUND,SWEDEN.
CR ARAI K, 1990, ANN REV BIOCH, V59, P786
   BONILLA MA, 1994, BRIT J HAEMATOL, V88, P723, DOI 10.1111/j.1365-2141.1994.tb05110.x
   HAMILTON JA, 1993, IMMUNOL TODAY, V14, P18, DOI 10.1016/0167-5699(93)90319-G
   HO JL, 1990, J INFECT DIS, V162, P224
   JASWON MS, 1994, PEDIATR RES, V36, P623, DOI 10.1203/00006450-199411000-00016
   KAPLAN SS, 1990, ASAIO T, V36, pM1172
   KARP JE, 1994, CURR OPIN INFECT DIS, V7, P430, DOI 10.1097/00001432-199408000-00003
   KAYASHIMA S, 1993, IMMUNOLOGY, V80, P471
   KOHAMA T, 1994, MICROBIOL IMMUNOL, V9, P741
   LORENZ W, 1994, SURGERY, V116, P925
   MATSUMOTO M, 1990, MICROBIOL IMMUNOL, V9, P765
   NISHIJIMA I, 1995, MOL BIOL CELL, V6, P497
   NOVALES JS, 1993, BLOOD, V81, P923
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PIGUET D, 1994, ACTA ONCOL, V33, P639, DOI 10.3109/02841869409121775
   ROBERTS PJ, 1990, J LEUKOCYTE BIOL, V48, P247
   ROILIDES E, 1991, J INFECT DIS, V163, P579, DOI 10.1093/infdis/163.3.579
   Rozalska B, 1996, IMMUNOL LETT, V49, P99, DOI 10.1016/0165-2478(95)02489-1
   ROZALSKA B, 1995, MICROBIOL IMMUNOL, V39, P443
   ROZALSKA B, 1995, FEMS IMMUNOL MED MIC, V11, P307, DOI 10.1111/j.1574-695X.1995.tb00161.x
   Rozalska Barbara, 1995, Acta Microbiologica Polonica, V44, P243
   SHIMONO N, 1994, CLIN DIAGN LAB IMMUN, V1, P556
   SHINOMIYA N, 1991, INFECT IMMUN, V59, P4740
   SMITH PD, 1990, J IMMUNOL, V144, P3829
   SMITH PD, 1990, J INFECT DIS, V161, P999, DOI 10.1093/infdis/161.5.999
   WADSTROM T, 1990, PATHOGENESIS WOUND B
   WHITEOWEN C, 1993, CLIN EXP IMMUNOL, V92, P477
   YASUDA H, 1990, INFECT IMMUN, V58, P2502
NR 28
TC 5
Z9 5
U1 0
U2 2
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 4-16 YAYOI 2-CHOME, BUNKYO-KU, TOKYO 113, JAPAN
SN 0385-5600
J9 MICROBIOL IMMUNOL
JI Microbiol. Immunol.
PY 1996
VL 40
IS 12
BP 931
EP 939
DI 10.1111/j.1348-0421.1996.tb01162.x
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA VZ248
UT WOS:A1996VZ24800007
PM 9013491
OA Bronze
DA 2018-10-19
ER

PT S
AU Storandt, R
   Farber, I
   Pulz, O
   Hahlweg, R
AF Storandt, R
   Farber, I
   Pulz, O
   Hahlweg, R
BE Staudemann, J
   Schonborn, A
   Etnier, C
TI Procedure and pilot plant for the disposal of inorganic loads from
   circulating water in aquacultures by microalgal cultivation
SO RECYCLING THE RESOURCE: PROCEEDINGS OF THE SECOND INTERNATIONAL
   CONFERENCE ON ECOLOGICAL ENGINEERING FOR WASTEWATER TREATMENT
SE ENVIRONMENTAL RESEARCH FORUM
LA English
DT Proceedings Paper
CT 2nd International Conference on Ecological Engineering for Wastewater
   Treatment
CY SEP 18-22, 1995
CL SCH ENGN WADENSWIL, ZURICH, SWITZERLAND
SP Int Ecol Engn Soc, Swiss Fed Inst Technol, Zurich, DIANE Oeko-Bau, Ctr Appl Ecol Schattweid, Steinhuserberg, Switzerland, Stensund Ecol Ctr, Trosa, Sweden
HO SCH ENGN WADENSWIL
DE aquacultures; closed circulating plants; elimination of nitrates and
   phosphates; assimilation ability of microalgae; microalgal biomass;
   valuable biomaterial for aquacultures; algae
C1 IGV Inst Getreideverarbeitung GMBH, D-14558 Bergholz Rehbrucke, Germany.
RP Storandt, R (reprint author), IGV Inst Getreideverarbeitung GMBH, Arthur Scheunert Allee 40-41, D-14558 Bergholz Rehbrucke, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1421-0274
BN 0-87849-741-2
J9 ENVIRONM RES FORUM
PY 1996
VL 5-6
BP 431
EP 433
PG 3
WC Ecology; Engineering, Environmental; Environmental Sciences; Water
   Resources
SC Environmental Sciences & Ecology; Engineering; Water Resources
GA BL20Q
UT WOS:000074669800072
DA 2018-10-19
ER

PT J
AU Chan, CM
   Ko, TM
   Hiraoka, H
AF Chan, CM
   Ko, TM
   Hiraoka, H
TI Polymer surface modification by plasmas and photons
SO SURFACE SCIENCE REPORTS
LA English
DT Review
ID GLOW-DISCHARGE POLYMERIZATION; AMMONIA GASEOUS PLASMA; EXCIMER LASER
   ABLATION; LOW-TEMPERATURE-PLASMA; ION MASS-SPECTROMETRY; OXYGEN PLASMA;
   PLATELET-ADHESION; POLY(METHYL METHACRYLATE); ENZYME-IMMOBILIZATION;
   INTRAOCULAR LENSES
AB Polymers have been applied successfully in fields such as adhesion, biomaterials, protective coatings, friction and wear, composites, microelectronic devices, and thin-film technology. In general, special surface properties with regard to chemical composition, hydrophilicity, roughness, crystallinity, conductivity, lubricity, and cross-linking density are required for the success of these applications. Polymers very often do not possess the surface properties needed for these applications. However, they have excellent bulk physical and chemical properties, are inexpensive, and are easy to process. For these reasons, surface modification techniques which can transform these inexpensive materials into highly valuable finished products have become an important part of the plastics and many other industries. In recent years, many advances have been made in developing surface treatments to alter the chemical and physical properties of polymer surfaces without affecting bulk properties. Common surface modification techniques include treatments by flame, corona, plasmas, photons, electron beams, ion beams, X-rays, and gamma-rays.
   Plasma treatment is probably the most versatile surface treatment technique. Different types of gases such as argon, oxygen, nitrogen, fluorine, carbon dioxide, and water can produce the unique surface properties required by various applications. For example, oxygen-plasma treatment can increase the surface energy of polymers, whereas fluorine-plasma treatment can decrease the surface energy and improve the chemical inertness. Cross-linking at a polymer surface can be introduced by an inert-gas plasma. Modification by plasma treatment is usually confined to the top several hundred angstroms and does not affect the bulk properties. The main disadvantage of this technique is that it requires a vacuum system, which increases the cost of operation.
   Thin polymer films with unique chemical and physical properties are produced by plasma polymerization. This technology is still in its infancy, and the plasma chemical process is not fully understood. The films are prepared by vapor phase deposition and can be formed on practically any substrate with good adhesion between the film and the substrate. These films, which are usually highly cross-linked and pinhole-free, have very good barrier properties. Such films find great potential in biomaterial applications and in the microelectronics industry.
   Very high-power microwave-driven mercury lamps are available, and they are used in UV-hardening of photoresist patterns for image stabilization at high temperatures. Other applications of UV irradiation include surface photo-oxidation, increase of hydrophilicity, and photocuring of paintings.
   Pulsed UV-lasers are used in surface modification in many areas. Pulsed UV-laser irradiation can produce submicron periodic linear and dot patterns on polymer surfaces without photomask. These interference patterns can be used to increase surface roughness of inert polymers for improved adhesion. These images can also be transferred to silicon surfaces by reactive ion etching. Pulsed laser beams can be applied to inert polymer surfaces for increased hydrophilicity and wettability. Polymer surfaces treated by pulsed UV-laser irradiation can be positively or negatively charged to enhance chemical reactivity and processability. Pulsed UV-laser exposures with high fluence give rise to photoablation with a clean wall profile. There are many other practical applications of laser photoablation, including via-hole fabrication, and diamond-film deposition. The present review discusses all these current applications, especially in the biomedical and microelectronics areas.
C1 HONG KONG UNIV SCI & TECHNOL, DEPT CHEM, KOWLOON, HONG KONG.
RP Chan, CM (reprint author), HONG KONG UNIV SCI & TECHNOL, DEPT CHEM ENGN, KOWLOON, HONG KONG.
CR ALLING E, 1985, P SOC PHOTO-OPT INST, V539, P194
   ASFARDJANI K, 1991, J APPL POLYM SCI, V43, P271, DOI 10.1002/app.1991.070430206
   BACHMANN F, 1990, EUR MAT RES SOC 1990
   BAIK KH, 1994, J PHOTOPOLYM SCI TEC, V7, P517
   BIEG KW, 1980, SOL ENERG MATER, V3, P301, DOI 10.1016/0165-1633(80)90068-4
   BIRCH AD, 1983, MICROELECTRON MANUF, V6, P20
   BLAIS PD, 1983, P SOC PHOTO-OPT INS, V333, P20
   BOLLE M, 1993, J APPL PHYS, V73, P3516, DOI 10.1063/1.352957
   BRADLEY A, 1975, ANAL CHEM, V47, P1838, DOI 10.1021/ac60361a044
   BRENNAN WJ, 1991, POLYMER, V32, P1527, DOI 10.1016/0032-3861(91)90436-M
   BRINEN JS, 1991, SURF INTERFACE ANAL, V17, P63, DOI 10.1002/sia.740170202
   Chan C. M, 1994, POLYM SURFACE MODIFI
   CHAPPELL PJC, 1991, SURF INTERFACE ANAL, V17, P143, DOI 10.1002/sia.740170305
   CHEN KS, 1982, J APPL POLYM SCI, V27, P4655, DOI 10.1002/app.1982.070271212
   CHO DL, 1990, J APPL POLYM SCI, V41, P1373, DOI 10.1002/app.1990.070410702
   CHO DL, 1988, J APPL POLYM SCI APP, V42, P139
   CHUANG TJ, 1988, APPL PHYS A-MATER, V45, P277, DOI 10.1007/BF00617932
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P957, DOI 10.1002/pol.1979.170170404
   CLARK DT, 1975, J POLYM SCI POL CHEM, V13, P857, DOI 10.1002/pol.1975.170130408
   CLARK DT, 1979, J POLYM SCI POL CHEM, V17, P1317, DOI 10.1002/pol.1979.170170507
   CLARK DT, 1987, J POLYM SCI POL CHEM, V25, P2643, DOI 10.1002/pola.1987.080251002
   CLARK DT, 1980, J POLYM SCI POL CHEM, V18, P27, DOI 10.1002/pol.1980.170180103
   CLARK DT, 1977, J POLYM SCI POL CHEM, V15, P2321, DOI 10.1002/pol.1977.170151004
   CLARK DT, 1978, J POLYM SCI POL CHEM, V16, P911, DOI 10.1002/pol.1978.170160506
   Clark DT, 1978, POLYM SURFACES, P185
   COBURN JW, 1979, IBM J RES DEV, V23, P33, DOI 10.1147/rd.231.0033
   COLLINS GCS, 1973, EUR POLYM J, V9, P1173, DOI 10.1016/0014-3057(73)90120-1
   CORN S, 1991, J ADHES SCI TECHNOL, V5, P239, DOI 10.1163/156856191X00170
   d'Agostino R., 1990, PLASMA DEPOSITION TR, P95
   d'Agostino R, 1982, PLASMA CHEM PLASMA P, V2, P213
   DAGOSTINO R, 1983, J APPL PHYS, V54, P1284, DOI 10.1063/1.332193
   DAUTARTAS MF, 1987, J ELECTROANAL CHEM, V219, P71, DOI 10.1016/0022-0728(87)85032-5
   DEMURA M, 1992, BIOMATERIALS, V13, P276, DOI 10.1016/0142-9612(92)90050-X
   DONOHOE KG, 1979, J APPL POLYM SCI, V23, P2591, DOI 10.1002/app.1979.070230905
   EGITTO FD, 1990, PURE APPL CHEM, V62, P1699, DOI 10.1351/pac199062091699
   EPAILLARD F, 1989, J APPL POLYM SCI, V38, P887, DOI 10.1002/app.1989.070380510
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Evans J.R.G., 1987, J ADHES SCI TECHNOL, V1, P291
   FAKES DW, 1988, SURF INTERFACE ANAL, V13, P233, DOI 10.1002/sia.740130411
   FOERCH R, 1991, J ADHES SCI TECHNOL, V5, P549, DOI 10.1163/156856191X00747
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   FOERCH R, 1990, J POLYM SCI POL CHEM, V28, P803, DOI 10.1002/pola.1990.080280409
   FUKUMURA H, 1991, APPL PHYS A-MATER, V53, P255, DOI 10.1007/BF00324261
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GERENSER LJ, 1993, J ADHES SCI TECHNOL, V7, P10
   GEUSKENS G, 1978, EUR POLYM J, V14, P291, DOI 10.1016/0014-3057(78)90051-4
   GIROUX TA, 1991, J APPL POLYM SCI, V43, P145, DOI 10.1002/app.1991.070430112
   GOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   GRANT JL, 1988, J VAC SCI TECHNOL A, V6, P2213, DOI 10.1116/1.575013
   GRIFFING BF, 1983, P SOC PHOTO-OPT INS, V394, P33
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P2457, DOI 10.1002/app.1987.070340710
   HASIRCI N, 1987, J APPL POLYM SCI, V34, P1135, DOI 10.1002/app.1987.070340322
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   HIRAOKA H, 1989, J VAC SCI TECHNOL B, V7, P1760, DOI 10.1116/1.584453
   HIRAOKA H, 1981, J ELECTROCHEM SOC, V128, P2645, DOI 10.1149/1.2127321
   HIRAOKA H, 1981, J VAC SCI TECHNOL, V19, P1132, DOI 10.1116/1.571183
   HIRAOKA H, 1994, APPL PHYS LETT, V64, P563, DOI 10.1063/1.111104
   Hiraoka H., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P174
   Hiraoka H., 1987, Microelectronic Engineering, V6, P407, DOI 10.1016/0167-9317(87)90066-9
   HIRAOKA H, 1994, JPN J APPL PHYS 1, V33, P7135, DOI 10.1143/JJAP.33.7135
   HIRAOKA H, 1991, MATER RES SOC SYMP P, V227, P329, DOI 10.1557/PROC-227-329
   Hiraoka H, 1989, PHOTOCHEMISTRY SOLID, P448
   HIRAOKA H, 1994, MAT MANUF PROCESSES, V9, P467
   HIRAOKA H, UNPUB MICROGRAPH TAK
   HIRAOKA H, 1989, PHOTOCHEMISTRY SOLID
   HIRAOKA H, 1984, P 10 INT C EL ION BE, P171
   HIRAOKA H, 1987, 172 M EL SOC OCT 19
   HIRAOKA H, 1993, JPN J APPL PHYS, V32, P6182
   HIROTSU T, 1980, J ADHESION, V11, P57, DOI 10.1080/00218468008078904
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   HO CP, 1990, J APPL POLYM SCI, V39, P1541, DOI 10.1002/app.1990.070390712
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HSIEH YL, 1989, J APPL POLYM SCI, V38, P1719, DOI 10.1002/app.1989.070380911
   HULT A, 1985, MACROMOLECULES, V18, P1804, DOI 10.1021/ma00152a003
   INAGAKI N, 1983, J APPL POLYM SCI, V28, P3629, DOI 10.1002/app.1983.070281204
   INAGAKI N, 1990, J ADHES SCI TECHNOL, V4, P99, DOI 10.1163/156856190X00126
   INAGAKI N, 1989, J ADHES SCI TECHNOL, V3, P637, DOI 10.1163/156856189X00461
   INAGAKI N, 1986, J POLYM SCI POL LETT, V24, P447, DOI 10.1002/pol.1986.140240903
   INAGAKI N, 1985, J APPL POLYM SCI, V30, P3385, DOI 10.1002/app.1985.070300821
   INAGAKI N, 1987, J POLYM SCI POL CHEM, V25, P1803, DOI 10.1002/pola.1987.080250709
   INAGAKI N, 1984, POLYM BULL, V12, P437
   Inagaki N., 1982, INT J ADHES ADHES, V2, P169
   INOUE H, 1990, J APPL POLYM SCI, V41, P1815, DOI 10.1002/app.1990.070410737
   INYAMA Y, 1988, J APPL POLYM SCI APP, V42, P97
   ISHIKAWA Y, 1985, MAKROMOL CHEM-RAPID, V6, P495
   ITO H, 1982, SPE REG TECH C ELL N
   KATNANI AD, 1989, J ADHES SCI TECHNOL, V3, P441, DOI 10.1163/156856189X00326
   KAWAKAMI M, 1988, BIOTECHNOL BIOENG, V32, P369, DOI 10.1002/bit.260320316
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   KNICKMEYER WW, 1974, J APPL POLYM SCI, V18, P301, DOI 10.1002/app.1974.070180126
   KNOP A, 1979, CHEM APPLICATION PHE
   KO TM, 1993, BIOMATERIALS, V14, P657
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   KO TM, 1993, J COLLOID INTERF SCI, V156, P207, DOI 10.1006/jcis.1993.1101
   KO TM, 1994, FRONTIERS OF POLYMERS AND ADVANCED MATERIALS, P439
   KO TM, 1991, THESIS U WISCONSIN M
   KUMAGAI H, 1993, J APPL PHYS, V73, P1971, DOI 10.1063/1.353161
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAOHAROJANAPHAND P, 1990, J APPL POLYM SCI, V40, P369, DOI 10.1002/app.1990.070400306
   LATSCH S, 1994, MATER RES SOC S P, V312, P239
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LIEPINS R, 1981, J VAC SCI TECHNOL, V18, P1218, DOI 10.1116/1.570897
   LOH IH, 1987, POLYM ENG SCI, V27, P861, DOI 10.1002/pen.760271115
   LUB J, 1989, J POLYM SCI POL CHEM, V27, P4035, DOI 10.1002/pola.1989.080271213
   LUB J, 1989, POLYMER, V30, P40, DOI 10.1016/0032-3861(89)90380-7
   LUB J, 1989, POLYMER, V30, P35
   MA WHL, 1980, Patent No. 4187331
   MACDONALD SA, 1985, P SPE REGIONAL TECHN, P177
   MARCHANT RE, 1988, J APPL POLYM SCI APP, V42, P125
   MATIENZO LJ, 1988, J VAC SCI TECHNOL A, V6, P950, DOI 10.1116/1.575037
   MATZAKIS M, 1980, MICR ENG P AMST, P439
   McColgin W. C., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V920, P260
   MOMOSE Y, 1988, J APPL POLYM SCI APP, V42, P49
   MORITA S, 1979, J POLYM SCI POL CHEM, V17, P2775, DOI 10.1002/pol.1979.170170914
   MORITA S, 1985, PURE APPL CHEM, V57, P1277, DOI 10.1351/pac198557091277
   MORITZ H, 1978, Patent No. 4104070
   MORRA M, 1989, J COLLOID INTERF SCI, V132, P504, DOI 10.1016/0021-9797(89)90264-6
   MORRA M, 1990, SURF INTERFACE ANAL, V16, P412, DOI 10.1002/sia.740160186
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   MOSHONOV A, 1980, J APPL POLYM SCI, V25, P771, DOI 10.1002/app.1980.070250506
   MUNRO HS, 1988, J COATING TECHNOL, V60, P41
   MUNRO HS, 1987, POLYM COMMUN, V28, P339
   MURATSUGU M, 1991, J COLLOID INTERF SCI, V147, P378, DOI 10.1016/0021-9797(91)90170-D
   MUTLU M, 1991, J MATER CHEM, V1, P447, DOI 10.1039/jm9910100447
   NAKAJIMA K, 1979, J APPL POLYM SCI, V23, P2627, DOI 10.1002/app.1979.070230908
   NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219
   NIEHUIS E, 1989, SURF INTERFACE ANAL, V14, P135, DOI 10.1002/sia.740140307
   NIINO H, 1989, APPL PHYS LETT, V55, P510, DOI 10.1063/1.101863
   NIINO H, 1993, APPL PHYS LETT, V63, P3527, DOI 10.1063/1.110091
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V60, P2697, DOI 10.1063/1.106877
   OCCHIELLO E, 1988, POLYMER, V29, P2277, DOI 10.1016/0032-3861(88)90122-X
   OCCHIELLO E, 1989, J PHYS D APPL PHYS, V22, P983, DOI 10.1088/0022-3727/22/7/018
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P2045, DOI 10.1002/app.1991.070420732
   OHKUBO J, 1990, J APPL POLYM SCI, V41, P349, DOI 10.1002/app.1990.070410127
   OKOSHI M, 1992, J MATER RES, V7, P1912, DOI 10.1557/JMR.1992.1912
   OSADA Y, 1987, THIN SOLID FILMS, V151, P71, DOI 10.1016/0040-6090(87)90010-1
   PETRAT FM, 1994, SURF INTERFACE ANAL, V21, P274, DOI 10.1002/sia.740210503
   PITTS J, 1964, PHOTOCHEMISTRY, P686
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RENEKER DH, 1976, J MACROMOL SCI CHEM, VA 10, P599, DOI 10.1080/00222337608061202
   Roland B., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V771, P69
   Sanchez Urrutia M., 1988, J APPL POLYM SCI APP, V42, P305
   SCHONHORN H, 1967, J APPL POLYM SCI, V11, P1461, DOI 10.1002/app.1967.070110809
   SHAW JM, 1989, J VAC SCI TECHNOL B, V7, P1709, DOI 10.1116/1.584444
   SHEN M, 1979, ACS S SER, V108
   SHEN MS, 1992, J ADHES SCI TECHNOL, V6, P995
   SIMIONESCU BC, 1981, POLYM BULL, V4, P415, DOI 10.1007/BF00254973
   SIPEHIA R, 1988, J BIOMED MATER RES, V22, P417, DOI 10.1002/jbm.820220505
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   SOWELL RR, 1972, J ADHESION, V4, P15, DOI 10.1080/00218467208072207
   SPIERTZ E, 1984, MICROCIRCUIT WENG, V68, P1
   SRINIVASAN R, 1994, N-HOLLAND D, P137
   STERRETT TL, 1992, J MATER SCI-MATER M, V3, P402, DOI 10.1007/BF00701235
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P1295, DOI 10.1002/pola.1987.080250508
   STROBEL M, 1987, J POLYM SCI POL CHEM, V25, P3343, DOI 10.1002/pola.1987.080251213
   STROBEL M, 1985, J POLYM SCI POL CHEM, V23, P1125, DOI 10.1002/pol.1985.170230417
   STROM DR, 1986, SEMICOND INT     MAY
   SUHR H, 1988, PLASMA CHEM PLASMA P, V8, P9, DOI 10.1007/BF01016927
   TANIGAWA S, 1991, J ADHES SCI TECHNOL, V5, P543, DOI 10.1163/156856191X00738
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P1179, DOI 10.1002/app.1972.070160512
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2317, DOI 10.1002/app.1972.070160912
   THOMPSON LF, 1972, J APPL POLYM SCI, V16, P2291, DOI 10.1002/app.1972.070160911
   TRAN CNB, 1989, J COLLOID INTERF SCI, V132, P373, DOI 10.1016/0021-9797(89)90252-X
   URY MG, 1983, OPTICAL MICROLITHOGR, V344, P241
   *USH EL, 1994, UER20172
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VARGO TG, 1989, J POLYM SCI POL CHEM, V27, P1267, DOI 10.1002/pola.1989.080270413
   VARGO TG, 1988, POLYM PREP-ACS, V2, P303
   VOLLENBROEK FA, 1983, POLYM ENG SCI, V23, P925, DOI 10.1002/pen.760231702
   WANG D, 1991, J APPL POLYM SCI, V42, P233, DOI 10.1002/app.1991.070420128
   WERTHEIMER MR, 1981, J APPL POLYM SCI, V26, P2087, DOI 10.1002/app.1981.070260630
   YADUSA H, 1977, J APPL POLYM, V21, P3167
   YAGI T, 1982, J APPL POLYM SCI, V27, P4019, DOI 10.1002/app.1982.070271032
   YAMAGISHI FG, 1981, THIN SOLID FILMS, V84, P427, DOI 10.1016/0040-6090(81)90183-8
   YAMAGISHI FG, 1991, THIN SOLID FILMS, V202, P39, DOI 10.1016/0040-6090(91)90539-A
   YAO YG, 1993, J ADHES SCI TECHNOL, V7, P63
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P991, DOI 10.1002/pol.1977.170150420
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P415, DOI 10.1002/pol.1978.170160212
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3179, DOI 10.1002/app.1977.070211128
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P313, DOI 10.1002/pol.1978.170160201
   YASUDA H, 1973, J APPL POLYM SCI, V17, P137, DOI 10.1002/app.1973.070170111
   YASUDA H, 1977, J APPL POLYM SCI, V21, P3139, DOI 10.1002/app.1977.070211124
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P2587, DOI 10.1002/pol.1978.170161013
   Yasuda H., 1985, PLASMA POLYM
   YASUDA HK, 1990, PURE APPL CHEM, V63, P1689
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P1781, DOI 10.1002/polb.1988.090260817
   YASUDA T, 1988, J POLYM SCI POL PHYS, V26, P2061, DOI 10.1002/polb.1988.090261004
   YEH YS, 1986, J POLYM SCI POL CHEM, V24, P3233, DOI 10.1002/pola.1986.080241208
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOUNG JF, 1983, PHYS REV B, V27, P1155, DOI 10.1103/PhysRevB.27.1155
NR 196
TC 317
Z9 317
U1 16
U2 200
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-5729
J9 SURF SCI REP
JI Surf. Sci. Rep.
PY 1996
VL 24
IS 1-2
BP 3
EP 54
PG 52
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA UU393
UT WOS:A1996UU39300001
DA 2018-10-19
ER

PT J
AU VojinovicMiloradov, M
   Buzarov, D
   Adamov, J
   Simic, S
   Popovic, E
AF VojinovicMiloradov, M
   Buzarov, D
   Adamov, J
   Simic, S
   Popovic, E
TI Determination of polychlorinated biphenyls and polyaromatic hydrocarbons
   in frog liver
SO WATER SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 18th Biennial Conference of the
   International-Association-on-Water-Quality
CY JUN 23-28, 1996
CL SINGAPORE, SINGAPORE
SP Int Assoc Water Qual
DE benzo(a)pyrene; frog liver; GC/MS; PAH; PCBs; water pollution
AB The aim of this work was to determine the content of the residues of the most commonly detected organohalogens and polychlorinated biphenyls in biomaterial. It is also the introduction of frogs as a new fine indicator of pollution in aquatic and terrestrial systems, due to their abundance all over Europe and their habitats in still and running waters. The residues of or organohalogens and polyaromatic hydrocarbons in frog liver samples were taken from four sites - the river Danube and canal DTD in Vojvodina (northern part of Serbia), from the river Dubasnica near the town of Bor and in the Zlot canyon, Serbia, Yugoslavia. They were determined using gas chromatography with mass detector (GC/MS) and they indicate the high level of contamination of the chosen aquatic and terrestrial ecosystems by HCH, PCB, PAH and herbicides. Copyright (C) 1996 IAWQ.
C1 UNIV NOVI SAD,INST BIOL,YU-21000 NOVI SAD,YUGOSLAVIA.
RP VojinovicMiloradov, M (reprint author), UNIV NOVI SAD,INST CHEM,TRG DOSITEJA OBRADOVICA 3,YU-21000 NOVI SAD,YUGOSLAVIA.
CR VOJINOVIC M, 1993, SZEGEDI OKOLOGIAI NA, P24
   VOJINOVICMILORA.M, 1992, WAT SCI TECH, P2361
   VOJINOVICMILORA.M, 1994, 30 ARB IAD ZUOZ SCHW, P220
NR 3
TC 11
Z9 11
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0273-1223
J9 WATER SCI TECHNOL
JI Water Sci. Technol.
PY 1996
VL 34
IS 7-8
BP 153
EP 156
DI 10.1016/S0273-1223(96)00738-X
PG 4
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA VZ159
UT WOS:A1996VZ15900023
DA 2018-10-19
ER

PT J
AU Colgin, MA
   Lewis, RV
AF Colgin, MA
   Lewis, RV
TI Spider silk: A biomaterial for the future
SO CHEMISTRY & INDUSTRY
LA English
DT Article
ID MAJOR AMPULLATE SILK; NEPHILA-CLAVIPES; DRAGLINE SILK; FIBROIN; ARANEAE
RP Colgin, MA (reprint author), UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071, USA.
CR ANDERSON JP, 1994, ACS SYM SER, V544, P137
   CANDELAS GC, 1983, COMP BIOCHEM PHYS B, V74, P637, DOI 10.1016/0305-0491(83)90242-0
   CANTOR EJ, 1994, ACS SYM SER, V544, P98
   Cappello J, 1994, ACS SYM SER, V544, P311
   CASE ST, 1994, ACS SYM SER, V544, P91
   DENNY M, 1976, J EXP BIOL, V65, P483
   DONG ZY, 1991, ARCH BIOCHEM BIOPHYS, V284, P53, DOI 10.1016/0003-9861(91)90262-H
   FISCHER E, 1907, PHYSIOL CHEM PHYS M, V53, P440
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   HINMAN M, 1992, BIOPOLYMERS, P227
   HINMAN M, UNPUB
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   JACKSON C, 1995, MACROMOLECULES, V28, P5975, DOI 10.1021/ma00121a042
   Kovoor J., 1987, P160
   LEWIS RJ, UNPUB
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   LEWIS RV, IN PRESS J MOL RECOG
   LI SFY, 1994, BIOPHYS J, V66, P1209, DOI 10.1016/S0006-3495(94)80903-8
   LUCAS FRED, 1964, DISCOVERY, V25, P20
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   MELLO CM, 1994, ACS SYM SER, V544, P67
   MULLER WS, 1994, ACS SYM SER, V544, P342
   PLAZAOLA A, 1991, TISSUE CELL, V23, P277, DOI 10.1016/0040-8166(91)90082-5
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   RIPPON WB, 1971, BIOPOLYMERS, V10, P1207, DOI 10.1002/bip.360100710
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   STAUFFER SL, 1994, J ARACHNOL, V22, P5
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   THEIL BL, 1994, BIOPOLYMERS, V34, P1089
   VADLAMUDI S, 1995, THESIS U WYOMING
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   WARWICKER DB, 1960, ACS SYM SER, V52, P554
   WORK RW, 1985, J EXP BIOL, V118, P379
   WORK RW, 1984, T AM MICROSC SOC, V103, P113, DOI 10.2307/3226233
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 35
TC 3
Z9 3
U1 0
U2 1
PU SOC CHEMICAL INDUSTRY
PI LONDON
PA 14 BELGRAVE SQUARE, LONDON, ENGLAND SW1X 8PS
SN 0009-3068
J9 CHEM IND-LONDON
JI Chem. Ind.
PD DEC 18
PY 1995
IS 24
BP 1009
EP 1012
PG 4
WC Chemistry, Applied
SC Chemistry
GA TM097
UT WOS:A1995TM09700007
DA 2018-10-19
ER

PT J
AU Canham, LT
AF Canham, LT
TI Bioactive silicon structure fabrication through nanoetching techniques
SO ADVANCED MATERIALS
LA English
DT Article
ID POROUS SILICON; RATS
AB Communication: A microporous film of silicon is shown to induce hydroxyapatite growth both on itself and on neighboring areas of bulk silicon (e.g. see figure). This indicates that silicon could be developed as an active biomaterial, which has encouraging implications for the use of VLSI technology in, for example, invasive sensing and biosensing and other electronic prosthetic devices.
RP Canham, LT (reprint author), DEF RES AGCY, ST ANDREWS RD, MALVERN WR14 3PS, WORCS, ENGLAND.
CR BEALE MIJ, 1986, J CRYST GROWTH, V75, P408, DOI 10.1016/0022-0248(86)90082-5
   BELLIA JP, 1994, LANCET, V343, P235, DOI 10.1016/S0140-6736(94)91019-7
   BERCOWY GM, 1994, J ANAL TOXICOL, V18, P46, DOI 10.1093/jat/18.1.46
   BOWMAN L, 1986, IEEE T BIO-MED ENG, V33, P248, DOI 10.1109/TBME.1986.325807
   CANHAM LT, 1991, J APPL PHYS, V70, P422, DOI 10.1063/1.350293
   CANHAM LT, 1992, MATER RES SOC SYMP P, V256, P63
   CANHAM LT, 1992, J APPL PHYS, V72, P1558, DOI 10.1063/1.351725
   CANHAM LT, 1994, ADV MATER, V6, P865, DOI 10.1002/adma.19940061115
   CANHAM LT, UNPUB
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   GAMBLE JL, 1964, CHHEM ANATOMY PHYSL
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   KANDA Y, 1981, ELECTRON LETT, V17, P558, DOI 10.1049/el:19810391
   KAWANABE K, 1992, J BIOMED MATER RES, V26, P209, DOI 10.1002/jbm.820260207
   LAMBRECHT M, 1992, BIOSENSORS MICROELEC, P171
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   MADOU M, 1993, APPL BIOCHEM BIOTECH, V41, P109, DOI 10.1007/BF02918537
   PENNINGTON JAT, 1991, FOOD ADDIT CONTAM, V8, P97, DOI 10.1080/02652039109373959
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   SMITH RL, 1988, IEEE T ELECTRON DEV, V35, P787, DOI 10.1109/16.2532
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   Williams DF, 1987, DEFINITIONS BIOMATER, V4
   WISE KD, 1989, VLSI MED, pCH10
NR 26
TC 449
Z9 449
U1 1
U2 53
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD DEC
PY 1995
VL 7
IS 12
BP 1033
EP +
DI 10.1002/adma.19950071215
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA TL756
UT WOS:A1995TL75600014
DA 2018-10-19
ER

PT J
AU Rafii, S
   Oz, MC
   Seldomridge, JA
   Ferris, B
   Asch, AS
   Nachman, RL
   Shapiro, F
   Rose, EA
   Levin, HR
AF Rafii, S
   Oz, MC
   Seldomridge, JA
   Ferris, B
   Asch, AS
   Nachman, RL
   Shapiro, F
   Rose, EA
   Levin, HR
TI Characterization of hematopoietic cells arising on the textured surface
   of left ventricular assist devices
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT 31st Annual Meeting of the Society-of-Thoracic-Surgeons
CY JAN 30-FEB 02, 1995
CL PALM SPRINGS, CA
SP Soc Thorac Surgeons
AB Background. Textured biomaterial surfaces in implantable left ventricular assist devices induce development of a nonthrombotic neointimal surface and allow elimination of anticoagulation therapy in device recipients. Characterization of the hematopoietic cells formed within the neointimal surfaces of these devices will contribute to our understanding of this unique neointima.
   Methods. The blood-contacting surface of seven ThermoCardiosystems left ventricular assist devices was removed, washed with phosphate-buffered saline solution, and digested with 0.1% collagenase for 15 to 20 minutes. The hematopoietic cells released from the explants were isolated and analyzed by now cytometry and immunohistochemical staining.
   Results. More than 80% +/- 6% of hematopoietic cells isolated in this fashion are of myelomonocytic origin and express CD14, CD15, and CD33 surface molecules. Four percent of cells express the CD34 surface marker, which suggests that the neointima is colonized by pluripotent hematopoietic stem cells. Continuous culture of these hematopoietic cells in the presence of the cytokines interleukin-3, c-kit ligand, granulocyte colony-stimulating factor, and granulocyte/macrophage colony-stimulating factor resulted in tenfold expansion by day 7 and 25-fold expansion by day 14.
   Conclusions. Pluripotent hematopoietic cells with a high proliferative capacity colonize textured surfaces of left ventricular assist devices and may contribute to the development of a biologically nonthrombogenic neointima.
C1 CORNELL UNIV,MED CTR,DEPT HEMATOL ONCOL,NEW YORK,NY 10021.
   COLUMBIA UNIV,COLL PHYS & SURG,DIV CARDIOTHORAC SURG,NEW YORK,NY.
   COLUMBIA UNIV,COLL PHYS & SURG,DIV CIRCULATORY PHYSIOL,NEW YORK,NY.
CR DASSE KA, 1987, T AM SOC ART INT ORG, V33, P418
   DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303
   FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080, DOI 10.1016/0003-4975(92)90393-I
   GORDON MY, 1987, NATURE, V326, P403, DOI 10.1038/326403a0
   GRAHAM TR, 1990, EUR J CARDIO-THORAC, V4, P182, DOI 10.1016/1010-7940(90)90002-H
   LETAH MD, 1986, POLYURETHANES MED
   MCCARTHY PM, 1991, J THORAC CARDIOV SUR, V102, P578
   MENCONI MJ, 1992, J CARDIAC SURG, V7, P177, DOI 10.1111/j.1540-8191.1992.tb00794.x
   MENCONI MJ, 1989, CARDIOVASC SCI TECHN, V1, P294
   PIERCE WS, 1981, SURGERY, V90, P137
   RAFII S, 1994, BLOOD, V84, P10
   ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0
   ROSE EA, 1994, CIRCULATION, V90, P87
   SALIH V, AM J CARDIOVASC PATH, V4, P317
   SUTHERLAND DR, 1994, EXP HEMATOL, V22, P1003
   Szycher M, 1987, J Biomater Appl, V2, P290, DOI 10.1177/088532828700200206
   SZYCHER M, 1980, T AM SOC ART INT ORG, V25, P493
   TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218
   THOMA SJ, 1994, BLOOD, V83, P2103
   ULRICH H, 1984, EMERGING BIOMEDICAL, P165
NR 20
TC 78
Z9 82
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD DEC
PY 1995
VL 60
IS 6
BP 1627
EP 1632
DI 10.1016/0003-4975(95)00807-1
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA TV392
UT WOS:A1995TV39200019
PM 8787455
DA 2018-10-19
ER

PT J
AU Richards, RG
   apGwynn, I
   Bundy, KJ
   Rahn, BA
AF Richards, RG
   apGwynn, I
   Bundy, KJ
   Rahn, BA
TI Microjet impingement followed by scanning electron microscopy as a
   qualitative technique to compare cellular adhesion to various
   biomaterials
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE scanning electron microscopy; 3T3 cells; L929 cells; tissue culture;
   adhesion; jet impingement
ID JET IMPINGEMENT; CELLS; FORCES; STRESS; GLASS
AB Adhesion of cells to biomaterial surfaces is one of the major factors which mediates their biocompatibility. Quantitative or qualitative cell adhesion measurements would be useful for screening new implant materials. Microjet impingement has been evaluated by scanning electron microscopy, to determine to what extent it measures cell adhesion. The shear forces of the impingement, on the materials tested here, are seen to be greater than the cohesive strength of the cells in the impinged area, causing their rupture. The cell bodies are removed during impingement, leaving the sites of adhesion and other cellular material behind. Thus the method is shown not to provide quantification of cell adhesion forces for the metals and culture plastic tested. It is suggested that with highly adherent biomaterials, the distribution and patterns of these adhesion sites could be used for qualitative comparisons for screening of implant surfaces.
C1 UNIV WALES,INST BIOL SCI,ABERYSTWYTH SY23 3DA,DYFED,WALES.
   TULANE UNIV,DEPT BIOMED ENGN,NEW ORLEANS,LA 70118.
RP Richards, RG (reprint author), AO ASIF RES INST,CLAVADELERSTR,CH-7270 DAVOS,SWITZERLAND.
RI Richards, Robert/I-8235-2015
OI Richards, Robert/0000-0002-7778-2480
CR BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   BERKEN A, 1966, J EXP MED, V123, P119, DOI 10.1084/jem.123.1.119
   BONGRAND P, 1983, J IMMUNOL METHODS, V58, P209, DOI 10.1016/0022-1759(83)90276-4
   BOWERS VM, 1989, J BIOMED MATER RES, V23, P1453, DOI 10.1002/jbm.820231208
   BOYDE A, 1981, SCANNING, V4, P69, DOI 10.1002/sca.4950040203
   BUNDY KJ, 1994, J MATER SCI-MATER M, V5, P500, DOI 10.1007/BF00058991
   BUNDY KJ, 1993, 39TH T M ORTH RES SO, P513
   Coman DR, 1944, CANCER RES, V4, P625
   COZENSROBERTS C, 1990, BIOPHYS J, V46, P423
   CROSS SJ, 1987, CYTOBIOS, V50, P41
   DESHPANDE F, 1982, J FLUID MECH, V114, P214
   DESHPANDE MD, 1983, J ENG MECH-ASCE, V109, P479, DOI 10.1061/(ASCE)0733-9399(1983)109:2(479)
   EASTY GC, 1960, EXP CELL RES, V19, P539, DOI 10.1016/0014-4827(60)90062-8
   ELVIN P, 1982, EUR J CANCER CLIN ON, V18, P669, DOI 10.1016/0277-5379(82)90213-9
   ELVIN P, 1983, BIOL CELL, V48, P1
   EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2
   FLETCHER RD, 1978, J DENT RES, V58, P1750
   HALLAB N, 1995, 14TH SO BIOM ENG C L
   MCLAY DR, 1981, P NATL ACAD SCI USA, V78, P4975
   ONO M, 1993, BIOL CELL, V77, P219, DOI 10.1016/S0248-4900(05)80191-1
   PORTER K, 1973, J CELL BIOL, V57, P815, DOI 10.1083/jcb.57.3.815
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
   WEISS L, 1963, EXP CELL RES, V30, P331, DOI 10.1016/0014-4827(63)90304-5
   WEISS LEONARD, 1961, EXPTL CELL RES SUPPL, V8, P141, DOI 10.1016/0014-4827(61)90345-7
   WOJCIAK B, 1995, J MATER SCI-MATER M, V6, P266, DOI 10.1007/BF00120269
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
NR 28
TC 20
Z9 20
U1 0
U2 3
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 1065-6995
J9 CELL BIOL INT
JI Cell Biol. Int.
PD DEC
PY 1995
VL 19
IS 12
BP 1015
EP 1024
DI 10.1006/cbir.1995.1044
PG 10
WC Cell Biology
SC Cell Biology
GA TU685
UT WOS:A1995TU68500009
PM 9721627
DA 2018-10-19
ER

PT J
AU Lasic, DD
   Needham, D
AF Lasic, DD
   Needham, D
TI The ''Stealth'' liposome: A prototypical biomaterial
SO CHEMICAL REVIEWS
LA English
DT Review
ID STERICALLY STABILIZED LIPOSOMES; LONG-CIRCULATING LIPOSOMES;
   AQUEOUS-ELECTROLYTE SOLUTIONS; LARGE UNILAMELLAR LIPOSOMES; LIPID
   BILAYER-MEMBRANES; GRAFTED POLYMER BRUSH; POLYETHYLENE OXIDE; PROLONGED
   CIRCULATION; POLY(ETHYLENE OXIDE); REPULSIVE INTERACTIONS
C1 LIPOSOME TECHNOL INC,MENLO PK,CA 94025.
   DUKE UNIV,DEPT MECH ENGN & MAT SCI,DURHAM,NC 27706.
OI nedham, david/0000-0002-0082-9148
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   AGRAWAL A K, 1992, Biophysical Journal, V61, pA493
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7
   ALLEN TM, 1992, CANCER RES, V52, P2431
   ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5
   ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9
   Andrade J. D., 1987, ASAIO J, V33, P75
   Antonsen K.P, 1992, POLYETHYLENE GLYCOL, P15
   ARNOLD K, 1987, MOL MECHANISMS MEMBR, P225
   AUVRAY L, UNPUB
   AZUREE V, 1992, CHIMICAOGGI, V10, P15
   BAEKMARK T, IN PRESS LANGMUIR
   Bailey FE, 1976, POLYETHYLENE OXIDE
   BAKKERWOUDENBERG IAJM, 1993, J INFECT DIS, V168, P164, DOI 10.1093/infdis/168.1.164
   Bangham A. D., 1983, LIPOSOME LETT
   BANGHAM AD, 1964, J MOL BIOL, V8, P660, DOI 10.1016/S0022-2836(64)80115-7
   BARENHOLZ Y, 1993, CHEM PHYS LIPIDS, V64, P1, DOI 10.1016/0009-3084(93)90052-5
   BLUME G, 1993, BIOCHIM BIOPHYS ACTA, V1149, P180, DOI 10.1016/0005-2736(93)90039-3
   BLUME G, 1993, BIOCHIM BIOPHYS ACTA, V1146, P157, DOI 10.1016/0005-2736(93)90351-Y
   BLUME G, 1990, BIOCHIM BIOPHYS ACTA, V1029, P91, DOI 10.1016/0005-2736(90)90440-Y
   BOGGNER J, 1995, STEALTH LIPOSOMES, P267
   BONTE F, 1986, CHEM PHYS LIPIDS, V40, P359, DOI 10.1016/0009-3084(86)90079-4
   BURNER H, 1994, J COLLOID INTERF SCI, V168, P183, DOI 10.1006/jcis.1994.1407
   CALDWELL KD, COMMUNICATION
   CHONN A, 1992, J BIOL CHEM, V267, P18759
   Cullis P.R., 1992, J LIPOSOME RES, V2, P397
   DAN N, 1992, MACROMOLECULES, V25, P2890, DOI 10.1021/ma00037a016
   de Gennes P. G., 1985, SCALING CONCEPTS POL
   de Gennes P. G., 1988, PHYSICAL BASIS CELL, P39
   DEGENNES PG, 1981, MACROMOLECULES, V14, P1637, DOI 10.1021/ma50007a007
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   DEGENNES PG, 1982, MACROMOLECULES, V15, P492, DOI 10.1021/ma00230a055
   DEGENNES PG, 1991, CR ACAD SCI II, V313, P1117
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DEVANAND K, 1990, NATURE, V343, P739, DOI 10.1038/343739a0
   Dewhirst M. W., 1995, STEALTH LIPOSOMES, P127
   DISALVO EA, 1994, BIOPHYS J, V66, P1943
   DOLAN A, 1973, P ROY SOC LOND A MAT, V337, P509
   DOLAN A, 1974, P ROY SOC LOND A MAT, V343, P427
   DVORAK HF, 1988, AM J PATHOL, V133, P95
   EDWARDS SF, 1965, P PHYS SOC LOND, V85, P613, DOI 10.1088/0370-1328/85/4/301
   EDWARDS SF, 1966, P PHYS SOC LOND, V88, P265, DOI 10.1088/0370-1328/88/2/301
   EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094
   EVANS E, 1988, MACROMOLECULES, V21, P1822, DOI 10.1021/ma00184a049
   EVANS E, 1984, BIOPHYS J, V45, P715, DOI 10.1016/S0006-3495(84)84213-7
   EVANS E, 1986, FARADAY DISCUSS, V81, P267, DOI 10.1039/dc9868100267
   EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003
   EVANS E, 1984, BIOPHYS J, V46, P423, DOI 10.1016/S0006-3495(84)84039-4
   EVANS E, 1988, PHYSICAL BASIS CELL, P91
   EVANS E, 1988, MOL MECHANISMS MEMBR, P83
   EVANS EA, 1986, P NATL ACAD SCI USA, V83, P7132, DOI 10.1073/pnas.83.19.7132
   EVANS EA, 1980, BIOPHYS J, V30, P265, DOI 10.1016/S0006-3495(80)85093-4
   EVANS EA, 1980, MECHANICS THERMODYNA
   FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K
   FIDLER IJ, 1989, LIPOSOMES THERAPY IN
   GABIZON A, 1988, P NATL ACAD SCI USA, V85, P6949, DOI 10.1073/pnas.85.18.6949
   GABIZON A, 1993, J LIPOSOME RES, V3, P517
   GABIZON AA, 1992, CANCER RES, V52, P891
   Gombotz W. R., 1992, POLYETHYLENE GLYCOL, P247
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GREGORIADIS G, 1989, NEWS PHYSIOL SCI, V4, P146
   Gregoriadis G, 1988, LIPOSOMES DRUG CARRI
   GREGORIADIS G, 1980, LIPOSOMES BIOL SYSTE
   Harris M.J, 1992, POLYETHYLENE GLYCOL
   HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693
   HELFRICH W, 1978, Z NATURFORSCH A, V33, P303
   HRISTOVA K, 1995, MACROMOLECULES, V28, P991, DOI 10.1021/ma00108a029
   HRISTOVA K, 1995, LIQ CRYST, V18, P423, DOI 10.1080/02678299508036641
   HRISTOVA K, 1994, J COLLOID INTERF SCI, V168, P302, DOI 10.1006/jcis.1994.1424
   HRISTOVA K, 1993, THESIS DUKE U
   HUANG L, 1992, J LIPOSOME RES, V2, P186
   HUANG SK, 1992, CANCER RES, V52, P6774
   ILLUM L, 1987, LIFE SCI, V40, P367, DOI 10.1016/0024-3205(87)90138-X
   IPSEN JH, 1990, BIOPHYS J, V57, P405, DOI 10.1016/S0006-3495(90)82557-1
   IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4
   ISRAELACHVILI JN, 1974, Q REV BIOPHYS, V6, P341
   ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975
   ISRAELACHVILI JN, 1992, J PHYS CHEM-US, V96, P520, DOI 10.1021/j100181a007
   ISRAELACHVILL JN, 1985, SURFACE INTERPARTICL
   JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   KENWORTHY AK, 1995, BIOPHYS J, V68, P1903, DOI 10.1016/S0006-3495(95)80368-1
   KENWORTHY AK, 1995, BIOPHYS J, V68, P1921, DOI 10.1016/S0006-3495(95)80369-3
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   Klibanov A., 1992, J LIPOSOME RES, V2, P321
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   KNIGHT CG, 1981, LIPOSOMES PHYSICAL S
   KRONBERG B, 1990, J PHARM SCI, V79, P667, DOI 10.1002/jps.2600790803
   KRZYWICKI T, 1969, MOL CRYST LIQ CRYST, V8, P285
   KUHL TL, 1994, BIOPHYS J, V66, P1479, DOI 10.1016/S0006-3495(94)80938-5
   KUHL TL, 1995, STEALTH LIPOSOMES, P73
   KWOK R, 1981, BIOPHYS J, V35, P367
   Lasic D. D., 1995, STEALTH LIPOSOMES
   LASIC DD, 1992, FEBS LETT, V312, P255, DOI 10.1016/0014-5793(92)80947-F
   LASIC DD, 1992, NATURE, V355, P279, DOI 10.1038/355279a0
   LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422
   LASIC DD, 1991, BIOCHIM BIOPHYS ACTA, V1070, P187, DOI 10.1016/0005-2736(91)90162-2
   LASIC DD, 1994, ANGEW CHEM INT EDIT, V33, P1685, DOI 10.1002/anie.199416851
   LASIC DD, 1991, PERIOD BIOL, V93, P287
   LASIC DD, 1990, J COLLOID INTERF SCI, V140, P302, DOI 10.1016/0021-9797(90)90348-R
   LASIC DD, UNPUB
   LASIC DD, 1993, LIPOSOMES PHYSICS AP
   LASIC DD, 1995, IN PRESS CHIM OGGI C
   LATTA H, 1975, J ULTRA MOL STRUCT R, V51, P354, DOI 10.1016/S0022-5320(75)80100-6
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE KD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P85
   LENEVEU DM, 1977, BIOPHYS J, V18, P209, DOI 10.1016/S0006-3495(77)85608-7
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LUZZATI V, 1960, ACTA CRYSTALLOGR, V13, P660, DOI 10.1107/S0365110X60001564
   MARRA J, 1985, BIOCHEMISTRY-US, V24, P4608, DOI 10.1021/bi00338a020
   MARRA J, 1986, BIOPHYS J, V50, P815, DOI 10.1016/S0006-3495(86)83522-6
   MAYHEW EG, 1992, INT J CANCER, V51, P302, DOI 10.1002/ijc.2910510221
   MCINTOSH TJ, 1989, BIOCHEMISTRY-US, V28, P7904, DOI 10.1021/bi00445a053
   MCINTOSH TJ, 1989, BIOCHEMISTRY-US, V28, P17, DOI 10.1021/bi00427a004
   MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P7325, DOI 10.1021/bi00397a020
   MCINTOSH TJ, 1986, BIOCHEMISTRY-US, V25, P4058, DOI 10.1021/bi00362a011
   MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2020, DOI 10.1021/bi00122a018
   MCINTOSH TJ, 1990, BIOPHYS J, V57, P1187, DOI 10.1016/S0006-3495(90)82638-2
   MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042
   MCINTOSH TJ, 1989, BIOPHYS J, V55, P897, DOI 10.1016/S0006-3495(89)82888-7
   MCINTOSH TJ, 1995, STEALTH LIPOSOMES, P63
   MCINTOSH TJ, 1991, FEBS LETT, V284, P263
   MILNER ST, 1988, EUROPHYS LETT, V5, P413, DOI 10.1209/0295-5075/5/5/006
   MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   MILNER ST, 1989, MACROMOLECULES, V22, P853, DOI 10.1021/ma00192a057
   MOGHIMI SM, 1989, BIOCHIM BIOPHYS ACTA, V984, P384
   MORI A, 1991, FEBS LETT, V284, P263, DOI 10.1016/0014-5793(91)80699-4
   NAGAOKA S, 1987, ASAIO, V10, P76
   NEEDHAM D, 1995, ANN BIOMED ENG, V23, P287, DOI 10.1007/BF02584429
   NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041
   NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P4668, DOI 10.1021/bi00413a013
   NEEDHAM D, 1992, BIOCHIM BIOPHYS ACTA, V1108, P40, DOI 10.1016/0005-2736(92)90112-Y
   NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9
   Needham D., 1992, J LIPOSOME RES, V2, P411
   New R. R. C, 1990, LIPOSOMES PRACTICAL
   NOPPL D, IN PRESS BIOPHYS J
   Northfelt DW, 1995, STEALTH LIPOSOMES, P257
   OKAMURA Y, 1993, P JPN ACAD SCI B, V69, P45
   Ostro M. J., 1983, LIPOSOMES
   PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460
   Papahadjopoulos D., 1978, ANN NY ACAD SCI, V308, P1, DOI [10.1111/j.1749-6632.1978.tb22009.x, DOI 10.1111/J.1749-6632.1978.TB22009.X]
   PARR JP, 1994, BIOCHIM BIOPHYS ACTA, V1195, P21
   PARSEGIAN VA, 1973, J THEOR BIOL, V38, P101, DOI 10.1016/0022-5193(73)90227-0
   PARSEGIAN VA, 1979, P NATL ACAD SCI USA, V76, P2750, DOI 10.1073/pnas.76.6.2750
   PINCUS P, 1995, COMMUNICATION
   PINCUS PA, 1988, LECTURES THERMODYNAM, P1
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RAND RP, 1981, ANNU REV BIOPHYS BIO, V10, P277, DOI 10.1146/annurev.bb.10.060181.001425
   ROERDINK F, 1981, BIOCHIM BIOPHYS ACTA, V677, P79, DOI 10.1016/0304-4165(81)90148-3
   RUTKOWSKI CA, 1991, BIOCHEMISTRY-US, V30, P657
   SACKMANN E, 1995, HDB MEMBRANES
   SAFINYA CR, UNPUB
   SCHERPHOF G, 1978, BIOCHIM BIOPHYS ACTA, V542, P296, DOI 10.1016/0304-4165(78)90025-9
   Scherphof G.L., 1991, HDB EXPT PHARM, V100, P285
   SCOTTO AW, 1995, BIOPHYS J, V68, P215
   SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8
   SENIOR JH, 1987, CRC CR REV THER DRUG, V3, P123
   SILVIUS JR, 1993, BIOCHEMISTRY-US, V32, P3153, DOI 10.1021/bi00063a030
   SIMON SA, 1989, P NATL ACAD SCI USA, V86, P9263, DOI 10.1073/pnas.86.23.9263
   SIMON SA, 1992, BIOPHYS J
   STILBS P, UNPUB
   SUROLIA A, 1975, NATURE, V257, P802, DOI 10.1038/257802a0
   SZEBENI J, 1994, BIOCHEM BIOPH RES CO, V30, P255
   SZEBENI J, UNPUB
   TABOR D, 1969, PROC R SOC LON SER-A, V312, P435, DOI 10.1098/rspa.1969.0169
   TAKAHASHI Y, 1973, MACROMOLECULES, V6, P672, DOI 10.1021/ma60035a005
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P181, DOI 10.1016/0005-2736(94)90025-6
   TORCHILIN VP, 1980, FEBS LETT, V111, P184, DOI 10.1016/0014-5793(80)80789-7
   VAAGE J, 1992, INT J CANCER, V51, P942, DOI 10.1002/ijc.2910510618
   VERWEY EJW, 1948, THEORY STABILITY LYO
   VIRDEN JW, 1992, J COLLOID INTERF SCI, V153, P411, DOI 10.1016/0021-9797(92)90332-G
   WATANABE H, 1993, MACROMOLECULES, V26, P6455, DOI 10.1021/ma00076a023
   WILLIAMS BD, 1986, BRIT MED J, V293, P1114
   WILLIAMS SS, 1993, CANCER RES, V53, P3964
   WINTERHALTER M, UNPUB
   WINTERHALTER M, 1993, BIOPHYS J, V65, pA173
   WINTERHALTER M, 1995, BIOPHYS J, V67, pA302
   WINTERHALTER M, 1995, IN PRESS TRENDS COLL
   Woodle M.C., 1990, P INT S CONTROL REL, V17, P77
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   WOODLE MC, 1992, BIOPHYS J, V61, P902, DOI 10.1016/S0006-3495(92)81897-0
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1105, P193, DOI 10.1016/0005-2736(92)90194-Q
   WOODLE MC, 1992, PHARMACEUT RES, V9, P260, DOI 10.1023/A:1018953810705
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   Working P. K., 1994, Journal of Liposome Research, V4, P667, DOI 10.3109/08982109409037065
   WU NZ, 1993, CANCER RES, V53, P3765
   YANG R, 1990, J PHYS CHEM-US, V94, P6123, DOI 10.1021/j100378a088
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
   ZALIPSKY S, 1994, FEBS LETT, V353, P71, DOI 10.1016/0014-5793(94)01013-7
   ZALIPSKY S, 1993, BIOCONJUGATE CHEM, V4, P296, DOI 10.1021/bc00022a008
   ZALIPSKY S, 1995, STEALTH LIPOSOMES, P93
   Zheng S, 1993, J LIPOSOME RES, V3, P575
NR 196
TC 313
Z9 315
U1 5
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0009-2665
J9 CHEM REV
JI Chem. Rev.
PD DEC
PY 1995
VL 95
IS 8
BP 2601
EP 2628
DI 10.1021/cr00040a001
PG 28
WC Chemistry, Multidisciplinary
SC Chemistry
GA TL945
UT WOS:A1995TL94500001
DA 2018-10-19
ER

PT J
AU Redondo, LM
   Cantera, JMG
   Hernandez, AV
   Puerta, CV
AF Redondo, LM
   Cantera, JMG
   Hernandez, AV
   Puerta, CV
TI Effect of particulate porous hydroxyapatite on osteoinduction of
   demineralized bone autografts in experimental reconstruction of the rat
   mandible
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE demineralized bone; hydroxyapatite; osteoconduction; osteoinduction
ID HYDROXYLAPATITE
AB In an experimental model in the rat, a nonhealing bone defect was created in the left ascending mandibular ramus to test the effect of particulate porous hydroxyapatite (HA) on osteoinduction of demineralized bone autografts. The bone fragment removed was demineralized in HCl and used as an autograft for mandibular reconstruction. Granules of HA were added to the lingual and vestibular surfaces of the graft. The effect of this material was evaluated by determining the number of mesenchymal cells induced in the biomaterial and the central and peripheral zones of the bone graft, at 2- and 6-week intervals. The results show that the sites containing HA showed inhibition of osteoinduction by the bone matrix. In all groups, a proliferative gradient from the peripheral zone toward the center of the bone was observed. Similarly, the HA experienced a greater cellular increase in the regions in contact with the demineralized bone matrix.
C1 HOSP DEL RIO HORTEGA,REG DEPT MAXILLOFACIAL SURG,VALLADOLID,SPAIN.
   FAC MED,EXPTL SURG LAB,VALLADOLID,SPAIN.
OI REDONDO, LUIS MIGUEL/0000-0002-3568-986X
CR ALPER G, 1989, AM J MED SCI, V298, P371, DOI 10.1097/00000441-198912000-00003
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   BOYNE PJ, 1976, AM J SURG, V132, P49, DOI 10.1016/0002-9610(76)90289-0
   BOYNE PJ, 1970, CLIN ORTHOPAEDICS, V73, P199
   GLASS DA, 1989, J PERIODONTOL, V60, P121, DOI 10.1902/jop.1989.60.3.121
   HOLMES R, 1984, CLIN ORTHOPAEDICS, V188, P252
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   REDDI AH, 1971, P SOC EXP BIOL MED, V137, P127
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1968, CLIN ORTHOPAEDICS, V59, P59
NR 11
TC 11
Z9 13
U1 0
U2 1
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD DEC
PY 1995
VL 24
IS 6
BP 445
EP 448
DI 10.1016/S0901-5027(05)80475-8
PG 4
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA TR213
UT WOS:A1995TR21300012
PM 8636642
DA 2018-10-19
ER

PT J
AU PHANEUF, MD
   QUIST, WC
   BIDE, MJ
   LOGERFO, FW
AF PHANEUF, MD
   QUIST, WC
   BIDE, MJ
   LOGERFO, FW
TI MODIFICATION OF POLYETHYLENE TEREPHTHALATE (DACRON) VIA DENIER REDUCTION
   - EFFECTS ON MATERIAL TENSILE-STRENGTH, WEIGHT, AND PROTEIN-BINDING
   CAPABILITIES
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID ARTERIAL PROSTHESES; CELL-ADHESION; ALBUMIN; GRAFTS; ACTIVATION;
   SURFACES; INVIVO
AB Thrombosis remains a significant and potentially catastrophic complication of polyethylene terephthalate (Dacron) prosthetic vascular graft implantation. Numerous attempts have been made to create a novel surface that reduces the adverse effects of blood interaction with the material. The purpose of this study was to create reactive groups on Dacron without significantly altering the chemical and physical properties of the biomaterial. These groups would then serve as ''anchor sites'' for covalent attachment of the blood protein albumin to the surface, thus creating a more biocompatible surface. Denier reduction, an established textile chemistry procedure that creates carboxyl groups on the fiber surface via hydrolysis of the material, was performed at 100 degrees C using sodium hydroxide concentrations of 0.5, 1.0, 2.5, and 5.0% (treated materials referred to as 0.5% hydrolyzed etc.). Tensile strength determination of hydrolyzed materials revealed no statistically significant difference in material strength between control, 0.5, and 1.0% hydrolyzed materials; the 2.5 and 5.0% hydrolyzed materials had significant strength loss as compared to the controls. Significant fiber weight loss occurred in the 1.0, 2.5, and 5.0% hydrolyzed Dacron segments. The 0.5% hydrolyzed material did not have any significant weight loss. Covalent linkage of I-125-albumin to these modified materials using the crosslinker 1-ethyl-3-(3-dimethyl aminopropyl)-carbodiimide hydrochloride (EDC) resulted in the 0.5% hydrolyzed material having the greatest protein binding (330 ng/mg Dacron, 2.4-fold greater than control). Incubation of the 0.5% hydrolyzed material with EDC and various concentrations of I-125-albumin resulted in the 14.80 mu M solution permitting the greatest binding per milligram Dacron (330 ng/mg Dacron). Scanning electron microscopy, performed blindly, revealed no change in the 0.5% hydrolyzed Dacron as compared to untreated Dacron. The 5.0% hydrolyzed Dacron, however, had noticeable structural damage on the outer periphery of the fiber surface. Observation of the untreated Dacron with nonspecifically bound albumin showed scattered areas of albumin adherent to the fiber surface whereas covalent linkage of albumin to the 0.5% hydrolyzed Dacron via EDC crosslinking showed numerous albumin moieties on each fiber. This study demonstrates that a clinically accepted biomaterial (Dacron) can be chemically modified, without significantly altering the physical and chemical characteristics of the biomaterial, in order to covalently bind albumin to the fiber surface. Thus, these results serve as foundation for creating potential novel biomaterials without significantly altering the properties of the original biomaterial. (C) 1995 John Wiley & Sons, Inc.
C1 UNIV RHODE ISL, DEPT TEXT, KINGSTON, RI USA.
RP PHANEUF, MD (reprint author), HARVARD UNIV, DEACONESS HOSP, SCH MED, 21-27 BURLINGTON AVE, ROOM 512, BOSTON, MA 02215 USA.
FU NHLBI NIH HHS [R01-HL21796-15]
CR ADAMS GA, 1981, ASAIO J, V4, P90
   BASCOM J, 1961, SURGERY, V50, P947
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   Colman RW, 1987, HEMOSTASIS THROMBOSI
   COMEROTA A, 1995, VASCULAR SURG, P571
   COOLEY DA, 1981, CARDIOVASC DIS, V8, P48
   DRURY J, 1987, ANN VASC SURG, P542
   EBERHART R, 1982, BIOMATERIALS INTERFA
   Freischlag J A, 1990, Ann Vasc Surg, V4, P449, DOI 10.1016/S0890-5096(07)60069-7
   Greisler H. P., 1991, NEW BIOL SYNTHETIC V
   GUIDOIN R, 1989, BIOMATERIALS, V10, P156, DOI 10.1016/0142-9612(89)90018-5
   ITO RK, 1991, J VASC SURG, V13, P822
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   KISSA E, 1984, HDB FIBER SCI TECHNO, P265
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MERHI Y, 1989, BIOMATERIALS, V10, P56, DOI 10.1016/0142-9612(89)90010-0
   OZAKI CK, 1993, J VASC SURG, V18, P486, DOI 10.1016/0741-5214(93)90267-P
   QUINONESBALDRICH WJ, 1986, J VASC SURG, V3, P895, DOI 10.1067/mva.1986.avs0030895
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   RUMISEK JD, 1986, J VASC SURG, V4, P136, DOI 10.1067/mva.1986.avs0040136
   RUMISEK JD, 1989, SURGERY, V105, P654
   RUTHERFORD RB, 1984, J VASC SURG, V1, P765, DOI 10.1067/mva.1984.avs0010765
   SAUVAGE L, 1978, GRAFT MATERIALS VASC
   SCALES J, 1953, P ROY SOC MED, V46, P654
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SLIMANE S B, 1988, European Surgical Research, V20, P18
   SLIMANE S B, 1988, European Surgical Research, V20, P66
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
NR 31
TC 32
Z9 32
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD WIN
PY 1995
VL 6
IS 4
BP 289
EP 299
DI 10.1002/jab.770060410
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TF552
UT WOS:A1995TF55200009
PM 8589514
DA 2018-10-19
ER

PT J
AU LAROCHE, G
   MAROIS, Y
   GUIDOIN, R
   KING, MW
   MARTIN, L
   HOW, T
   DOUVILLE, Y
AF LAROCHE, G
   MAROIS, Y
   GUIDOIN, R
   KING, MW
   MARTIN, L
   HOW, T
   DOUVILLE, Y
TI POLYVINYLIDENE FLUORIDE (PVDF) AS A BIOMATERIAL - FROM POLYMERIC
   RAW-MATERIAL TO MONOFILAMENT VASCULAR SUTURE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID 3 CRYSTALLINE FORMS; POLY(VINYLIDENE FLUORIDE); ELECTRIC-FIELD; PHASE;
   PYROELECTRICITY
AB This study identified the effects of various manufacturing processes on the crystalline microstructure, mechanical properties, and biocompatibility of a polyvinylidene fluoride (PVDF) suture. To achieve this, changes in the crystalline microstructure and the tensile behavior of PVDF monofilaments were monitored in vitro after different thermal processing, coloration, and sterilization treatments. in addition, the in vivo biocompatibility of the manufactured and sterilized PVDF suture was assessed by using it to anastomose a preclotted polyester vascular prosthesis as a thoracoabdominal bypass in a series of dogs. The tissue response was followed by histologic and scanning electron microscopy over implantation periods ranging from 4 h to 6 months. Differential scanning calorimetry and infrared spectroscopy (FTIR-ATR) showed that thermal processing and the addition of a coloring agent had a direct effect on modifying the crystalline microstructure and hence changing the mechanical properties. For example, thermal processing converted some of the alpha phase into the beta and gamma polymorphs, whereas coloration led only to a major increase in the beta-to-alpha ratio. The tensile properties were found to be optimized when the relative proportion of the beta and gamma phases combined compared to the alpha form gave rise to an FTIR A(509)/A(532) absorption ratio between 4.0 and 4.5. Sterilization was found to cause some modifications to the crystalline microstructure near the surface of the monofilaments, but it did not change their mechanical properties. Pathologic examination of the anastomotic regions after different periods of implantation revealed a minimal cellular response, with no mineralization, intimal hyperplasia, or excessive fibrous tissue reaction. This good biocompatibility, together with other desirable characteristics such as ease of manipulation and satisfactory mechanical strength, makes PVDF an attractive alternative monofilament suture material for cardiovascular surgery. (C) 1995 John Wiley & Sons, Inc.
C1 UNIV LAVAL,DEPT CHIRURG,EXPTL SURG LAB,QUEBEC CITY,PQ G1K 7P4,CANADA.
   HOP ST FRANXOIS ASSIE,INST BIOMAT QUEBEC,QUEBEC CITY,PQ,CANADA.
   HOP ST SACREMENT,DEPT CHIRURG,QUEBEC CITY,PQ,CANADA.
   UNIV LIVERPOOL,DEPT CLIN ENGN,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
CR ALAJMO F, 1985, ANN THORAC SURG, V39, P400, DOI 10.1016/S0003-4975(10)62647-1
   BACHMANN MA, 1979, J APPL PHYS, V17, P595
   BENEDETTI E, 1989, POLYM BULL, V22, P645, DOI 10.1007/BF00718947
   BERGMAN JG, 1971, APPL PHYS LETT, V18, P203, DOI 10.1063/1.1653624
   BRANDT B, 1982, AM SURGEON, V48, P255
   BUCHTEMANN A, 1991, POLYMER, V32, P215, DOI 10.1016/0032-3861(91)90004-3
   CHAKFE N, 1993, POLYM POLYM COMPOS, V1, P229
   CORNEL G, 1982, ANN THORAC SURG, V33, P641, DOI 10.1016/S0003-4975(10)60830-2
   DAVIES GR, 1979, POLYMER, V20, P772, DOI 10.1016/0032-3861(79)90253-2
   DAVIS GT, 1978, J APPL PHYS, V49, P4998, DOI 10.1063/1.324446
   DOLL WW, 1970, J MACROMOL SCI PHYS, VB  4, P309, DOI 10.1080/00222347008212505
   GRANZ B, 1989, IEEE T ELECTR INSUL, V24, P499, DOI 10.1109/14.30896
   HASEGAWA R, 1972, POLYM J, V3, P591, DOI 10.1295/polymj.3.591
   HASEGAWA R, 1972, POLYM J, V3, P600, DOI 10.1295/polymj.3.600
   HSU SL, 1985, MACROMOLECULES, V18, P2583, DOI 10.1021/ma00154a038
   KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975
   LANDO JB, 1966, J POLYM SCI A1, V4, P941, DOI 10.1002/pol.1966.150040420
   Lovinger A. J., 1982, DEV CRYSTALLINE POLY, V1, P195
   MATSUSHIGE K, 1980, J POLYM SCI POL PHYS, V18, P1665, DOI 10.1002/pol.1980.180180718
   MERHI Y, 1988, CLIN INVEST MED, V11, P403
   NAEGELE D, 1978, MACROMOLECULES, V11, P1297, DOI 10.1021/ma60066a051
   NAKAMURA K, 1971, J POLYM SCI A2, V9, P161, DOI 10.1002/pol.1971.160090111
   OSAKI S, 1975, J POLYM SCI POL PHYS, V13, P1071, DOI 10.1002/pol.1975.180130602
   PAGE M, 1992, USE CHLOROFLUOROHYDR
   STARR DS, 1979, ARCH SURG-CHICAGO, V114, P412
   Urban E, 1994, ASAIO J, V40, P145
   WEINHOLD S, 1980, MACROMOLECULES, V13, P1178, DOI 10.1021/ma60077a029
   XIAO DQ, 1989, IEEE T ELECTR INSUL, V24, P503, DOI 10.1109/14.30897
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
NR 29
TC 108
Z9 113
U1 0
U2 35
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1995
VL 29
IS 12
BP 1525
EP 1536
DI 10.1002/jbm.820291209
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TG459
UT WOS:A1995TG45900009
PM 8600143
DA 2018-10-19
ER

PT J
AU Sawtell, RM
   Downes, S
   Kayser, MV
AF Sawtell, RM
   Downes, S
   Kayser, MV
TI An in vitro investigation of the PEMA/THFMA system using chondrocyte
   culture
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID ARTICULAR CHONDROCYTES; OSTEOCHONDRAL DEFECTS; RABBIT KNEE; CELL-SHAPE;
   CARTILAGE; COLLAGEN; REPAIR; IMPLANTS; MATRIX; EXPRESSION
AB Adult articular cartilage has a limited capacity for self-repair and a biomaterial to aid the process would be ideal. The polymer system, poly(ethyl methacrylate)/tetrahydrofurfuryl methacrylate (PEMA/THFMA) has shown potential in a rabbit model for such a role. The ability of the polymer system to support chondrocytes in vitro was investigated by light microscopy, transmission electron microscopy and biochemical assays. The PEMA/THFMA system maintained chondrocytes in agarose in a viable state with more glycosaminoglycan (GAG) produced per unit DNA after 14 days in culture compared to the tissue culture plastic control. Chondrocytes remained rounded on the polymer system surface as opposed to well spread on the Thermanox. The PEMA/THFMA system has been shown to be biocompatible for bovine chondrocytes maintaining them in a differentiated state with enhanced GAG production.
C1 RNOHT,INST ORTHOPAED,STANMORE HA7 4LP,MIDDX,ENGLAND.
RP Sawtell, RM (reprint author), QUEENS MED CTR,DEPT HUMAN MORPHOL,NOTTINGHAM NG7 2UH,ENGLAND.
CR ARCHER CW, 1990, J CELL SCI, V97, P361
   ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0
   AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Breck L W, 1967, Clin Orthop Relat Res, V54, P133
   Cobey M C, 1967, Clin Orthop Relat Res, V54, P139
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   FINE EG, 1994, 20TH P ANN M SOC BIO, P279
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   ITAY S, 1987, CLIN ORTHOP RELAT R, V220, P284
   KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4
   KLOMPMAKER J, 1992, BIOMATERIALS, V13, P625, DOI 10.1016/0142-9612(92)90031-I
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MESSNER K, 1994, BIOMATERIALS, V15, P657, DOI 10.1016/0142-9612(94)90163-5
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   NIXON AJ, 1993, AM J VET RES, V54, P349
   NOGUCHI T, 1994, CLIN ORTHOP RELA MAY, P251
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   PATEL MP, 1991, BIOMATERIALS, V12, P649, DOI 10.1016/0142-9612(91)90111-M
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P402, DOI 10.1007/BF00058973
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P793, DOI 10.1007/BF00213137
   RICH D, 1994, 40TH P ANN M ORTH RE, P241
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Robinson Dror, 1993, Bulletin Hospital for Joint Diseases, V53, P75
   ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007
   SAWTELL RM, IN PRESS CELLS MATER
   Speer DP, 1979, CLIN ORTHOP RELAT R, V144, P326
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   TOOLAN BC, 1994, 20TH P ANN M SOC BIO, P313
   ULREICH J B, 1985, Journal of Cell Biology, V101, p96A
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WATT FM, 1988, DIFFERENTIATION, V38, P140, DOI 10.1111/j.1432-0436.1988.tb00208.x
NR 41
TC 12
Z9 12
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 676
EP 679
DI 10.1007/BF00134299
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600002
DA 2018-10-19
ER

PT J
AU Pinilla, M
   Berrocal, JRG
   RamirezCamacho, R
   Bujan, J
   Herrero, EJ
AF Pinilla, M
   Berrocal, JRG
   RamirezCamacho, R
   Bujan, J
   Herrero, EJ
TI Biomaterials in the reconstruction of the human middle ear
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID SURGERY; OSSICULOPLASTY
AB The use of biomaterials for reconstruction of the ossicular chain in middle ear involves a different approach from that associated with other regions of the organism. The features of the implantation site and the composition of the prosthesis are responsible for functional failures that result from deterioration or extrusion of the implant. Since the fifties, different types of materials, both biological and synthetic, have been employed in the attempt to achieve the ideal middle ear prosthesis. We present a reprospective study of 166 patients who underwent ossicular chain reconstruction involving autografts and homografts of cartilage or auditory ossicle (n = 104) or synthetic prostheses (n = 62). We compare prostheses of different compositions on the basis of the cases of extrusion and the histological deterioration encountered with each. In our experience, polymers are associated with frequent extrusion a nd deterioration of the biomaterial, while the results a re better with biological implants and those made of hydroxyapatite.
C1 UNIV ALCALA DE HENARES,DEPT MORFOL CELULAR,MADRID,SPAIN.
   UNIV AUTONOMA MADRID,CLIN PUERTA HIERRO,SERV CIRUGIA EXPTL,MADRID,SPAIN.
   UNIV AUTONOMA MADRID,CLIN PUERTA HIERRO,SERV OTORRINOLARINGOL,MADRID,SPAIN.
CR BABIGHIAN G, 1985, AM J OTOL, V6, P285
   BLAYNEY AW, 1986, J LARYNGOL OTOL, V100, P1359, DOI 10.1017/S0022215100101148
   BRACKMANN DE, 1979, LARYNGOSCOPE, V89, P108
   GLASSCOCK ME, 1988, ARCH OTOLARYNGOL, V114, P1252
   GROTE JJ, 1981, ORL J OTO-RHINO-LARY, V43, P248, DOI 10.1159/000275544
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   MERCHANT SN, 1994, OTOLARYNG CLIN N AM, V27, P813
   RAMIREZCAMACHO RA, 1981, ARCH OTOLARYNGOL, V107, P608
   RECK R, 1985, AM J OTOL, V6, P280
   SHEA J, 1976, LARYNGOSCOPE, V86, P239, DOI 10.1288/00005537-197602000-00015
   SHEA JJ, 1974, LARYNGOSCOPE, V84, P1835, DOI 10.1288/00005537-197410000-00014
   SHEA JJ, 1978, ARCH OTOLARYNGOL, V104, P191
   SHEA JJ, 1977, ORL DIGEST, V39, P9
   SHEA MC, 1976, 5TH P SHAMB INT WORK, P348
   SHEEHY JL, 1978, CLIN OTOLARYNGOL, V3, P451, DOI 10.1111/j.1365-2273.1978.tb00728.x
   SILVERSTEIN H, 1986, LARYNGOSCOPE, V96, P159
   SMYTH GDL, 1982, OTOLARYNG HEAD NECK, V90, P343
   WULLSTEIN H, 1956, Laryngoscope, V66, P1076
   WULLSTEIN H, 1953, 5TH P INT C OT, V104, P104
   ZOLLNER F, 1955, J Laryngol Otol, V69, P637, DOI 10.1017/S0022215100051240
NR 20
TC 3
Z9 3
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 745
EP 748
DI 10.1007/BF00134311
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600014
DA 2018-10-19
ER

PT J
AU Reissis, N
   Kayser, M
   Bentley, G
   Downes, S
AF Reissis, N
   Kayser, M
   Bentley, G
   Downes, S
TI A hydrophylic polymer system enhanced articular cartilage regeneration
   in vivo
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID HETEROCYCLIC METHACRYLATES; CLINICAL-APPLICATIONS; TEMPORARY CROWN;
   INVITRO
AB This study describes a new method for the repair of large articular cartilage defects in the knee joint a nd com pa res the effect of two polymer systems on the quality of the repair tissue. The two systems are a newly developed hydrophylic system, based on poly-ethylmethacrylate (PEMA) polymer and tetra-hydro-furfuryl-methacrylate (THFMA) monomer and the conventional bone cement polymer system, based on poly-methyl-methacrylate (PMMA) polymer and methyl-methacrylate (MMA) monomer. Thirty adult Sandy-lop rabbits were used. Both knees were operated on in each animal, the one defect received either PEMA/THFMA or conventional bone cement and the contralateral defect received no biomaterial (control group). Femora were retrieved at six weeks and the repair tissue was studied by histology, histochemistry and immuno-histochemistry. PEMA/THFMA enhanced the quality of the repair significantly (p < 0.0001). By six weeks hyaline-like articular cartilage was the predominant tissue covering the defects and it was fully integrated with the surrounding normal articular cartilage. Immune-localization showed cartilage components, including collagen type II, distributed evenly throughout its matrix. PMMA/MMA on the other hand did not improve significantly the repair tissue, which was predominately fibro-cartilaginous, poorly bonded to the adjacent normal articular cartilage. The method of implantation is simple and easily reproducible and the new polymer has been well-accepted by the rabbits.
C1 IRC BIOMED MAT,STANMORE HA7 4LP,MIDDX,ENGLAND.
   SCH MED,DEPT HUMAN MORPHOL,NOTTINGHAM NG7 2UH,ENGLAND.
RP Reissis, N (reprint author), INST ORTHOPAED,STANMORE HA7 4LP,MIDDX,ENGLAND.
CR ASH P, 1975, J ENDOCRINOL, V66, P71, DOI 10.1677/joe.0.0660071
   Batchelor G.Y., 1991, ANIMAL TECHNOL, V42, P109
   BRADEN M, 1976, BRIT DENT J, V141, P269, DOI 10.1038/sj.bdj.4803835
   CARLSON CS, 1986, CALCIFIED TISSUE INT, V38, P44, DOI 10.1007/BF02556594
   CHEUNG HS, 1980, ARTHRITIS RHEUM, V23, P211, DOI 10.1002/art.1780230212
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   HEMMEN B, 1991, T ORTHOP RES SOC, V16, P278
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   MINNS RJ, 1989, BIOMATERIALS, V10, P273, DOI 10.1016/0142-9612(89)90105-1
   OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   PATEL MP, 1991, BIOMATERIALS, V12, P649, DOI 10.1016/0142-9612(91)90111-M
   PEARSON GJ, 1986, INT ENDOD J, V19, P121, DOI 10.1111/j.1365-2591.1986.tb00464.x
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P402, DOI 10.1007/BF00058973
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P793, DOI 10.1007/BF00213137
   SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831
NR 18
TC 10
Z9 10
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 768
EP 772
DI 10.1007/BF00134315
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600018
DA 2018-10-19
ER

PT J
AU Zaat, SAJ
   Dankert, J
   VanderWerff, J
   Brokke, P
   Feijen, J
AF Zaat, SAJ
   Dankert, J
   VanderWerff, J
   Brokke, P
   Feijen, J
TI Presence of a biomaterial implant facilitates induction of experimental
   infective endocarditis due to streptococci and staphylococci
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID PROSTHETIC VALVE ENDOCARDITIS; FOREIGN-BODY INFECTION; ESCHERICHIA-COLI;
   GROWTH; COLONIZATION; PATHOGENESIS; EPIDERMIDIS; SURGERY; RATS
AB Infective endocarditis (IE) usually is studied using animals with catheters inserted into the heart, which causes formation of platelet-fibrin thrombi (vegetations, VGs). We used two rabbit models to study the respective roles of the catheter and the VGs in the development of IE. The influence of the catheter was studied by either removing the catheter before bacterial challenge, or leaving the catheter in place. In all cases, removal of the catheter caused a strong decrease in the frequency of IE. The presence of the catheter stimulated population increase of streptococci within 4 h after challenge. As most catheters were sterile 4 h after challenge, they did not serve as a reservoir of bacteria. To study the requirement of a preformed VG catheters were inserted either 24 h or 30 min before bacterial challenge. In the former model VGs were present, in the latter VGs were not yet formed when bacteria were injected. The frequencies of IE due to 2 S. sanguis and 2 S. epidermidis strains in the 24 h model or 30 min model were similar, indicating that a preformed VG is not necessary for development of IE. Five coagulase-negative stains were shown to vary in their capacity to cause IE in the 30 min model. Variation was not caused by differences in early adhesion br colonization of the aortic valve, but reflects differences in persistence after initial colonization. Like in the 24 h model, persistence of the bacteria was greatly enhanced by the continuous presence of the catheter. Possible mechanisms of the infection-potentiating effect of the catheters are discussed.
C1 UNIV GRONINGEN HOSP,DEPT HOSP EPIDEMIOL,9700 RB GRONINGEN,NETHERLANDS.
   UNIV TWENTE,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP Zaat, SAJ (reprint author), UNIV AMSTERDAM,ACAD MED CTR,DEPT MED MICROBIOL,1105 AZ AMSTERDAM,NETHERLANDS.
CR BOYCE JM, 1990, J INFECT DIS, V161, P493, DOI 10.1093/infdis/161.3.493
   BROKKE P, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P419
   DANKERT J, 1995, INFECT IMMUN, V63, P663
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DENIS M, 1992, CELL IMMUNOL, V141, P182, DOI 10.1016/0008-8749(92)90137-E
   DENIS M, 1991, INFECT IMMUN, V59, P1853
   DURACK DT, 1972, BRIT J EXP PATHOL, V53, P44
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   HERAIEF E, 1982, INFECT IMMUN, V37, P127
   HESS J, 1983, J ANTIMICROB CHEMOTH, V11, P555, DOI 10.1093/jac/11.6.555
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P129
   KLUGE RM, 1974, JAMA-J AM MED ASSOC, V230, P1415, DOI 10.1001/jama.230.10.1415
   MAYER KH, 1982, PROG CARDIOVASC DIS, V25, P43, DOI 10.1016/0033-0620(82)90003-2
   NOBLE WC, 1965, BRIT J EXP PATHOL, V46, P254
   PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820
   VANDENBROEK PJ, 1985, BRIT MED J, V291, P949, DOI 10.1136/bmj.291.6500.949
   YERSIN B, 1988, INFECT IMMUN, V56, P1273
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 21
TC 1
Z9 1
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 773
EP 778
DI 10.1007/BF00134316
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600019
DA 2018-10-19
ER

PT J
AU Leitao, E
   Barbosa, MA
   DeGroot, K
AF Leitao, E
   Barbosa, MA
   DeGroot, K
TI In vitro calcification of orthopaedic implant materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 12th European Conference on Biomaterials
CY SEP 10-13, 1995
CL OPORTO, PORTUGAL
ID TITANIUM; INVITRO
AB The formation of an apatite-like layer is achieved by immersing Ti6Al4V and TiAl2.5Fe substrata in Hank's Balanced Salt Solution (HBSS). The layer was characterized by several techniques, namely X-ray microanalysis, X-ray diffraction and X-ray photoelectron spectroscopy. The results suggest that the layer produced by immersion in HBSS is in the form of an amorphous apatite. The pH and the concentrations of calcium and phosphate were monitored as a function of time. in vitro tests with rat bone marrow were performed in order to mimic the bone/biomaterial interface. They were performed on both immersed and non-immersed samples. The in vitro bone marrow results suggest that the apatite-like layer formed may improve the bone bonding characteristics of the studied titanium alloys.
C1 LEIDEN UNIV, BIOMAT RES GRP, 3723 MB BILTHOVEN, NETHERLANDS.
RP Leitao, E (reprint author), UNIV PORTO, FAC ENGN, INST BIOMED ENGN, PRACA CORONEL PACHECO 1, P-4050 OPORTO, PORTUGAL.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482
CR ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   COURTENEYHARRIS RG, 1995, BIOMATERIALS, V16, P489, DOI 10.1016/0142-9612(95)98823-W
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P214
   DEBRUIJN JD, 1993, THESIS LEIDEN U NETH
   DUCHEYNE P, 1992, BONE BONDING BIOMATE, P213
   GOMI K, 1993, J BIOMED MATER RES, V27, P429, DOI 10.1002/jbm.820270403
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HARMAND MF, 1994, CLIN MATER, V15, P281, DOI 10.1016/0267-6605(94)90059-0
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   LEITAO E, UNPUB
   LI P, 1993, THESIS LEIDEN U NETH
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   ONG JL, 1995, J BIOMED MATER RES, V29, P165, DOI 10.1002/jbm.820290205
   Sousa S. R., 1993, Clinical Materials, V14, P287, DOI 10.1016/0267-6605(93)90015-Y
NR 16
TC 26
Z9 26
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1995
VL 6
IS 12
BP 849
EP 852
DI 10.1007/BF00134330
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TM616
UT WOS:A1995TM61600033
DA 2018-10-19
ER

PT J
AU Kohnen, W
   Jansen, B
AF Kohnen, W
   Jansen, B
TI Polymer materials for the prevention of catheter-related infections
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 1st National Workshop on Catheter Infections
CY NOV 24-25, 1994
CL COLOGNE, GERMANY
ID STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL-COLONIZATION; ESCHERICHIA-COLI;
   INVITRO EFFICACY; URINARY CATHETER; COATED CATHETERS; ADHERENCE;
   SURFACE; ADHESION; POLYSTYRENE
AB Catheter-related infections are major problems in medicine because of severe consequences for the patient, prolongation of hospitalization, and increasing therapy costs. Beside progress in hygienic measures, development of catheters with antiinfective properties seems to be a promising approach to the prevention of such infections. Two approaches for infection-resistant catheter materials have been developed: materials with antiadhesive properties and materials with antimicrobial properties. Antiadhesive polymers shall prevent the adhesion of microorganisms to the medical device. However, up to now there has been no material which would lead to a complete inhibition of adherence (''zero adherence''). Materials with antimicrobial properties contain antimicrobial substances which are incorporated into the biomaterial or bound to the polymer surface. These devices seem to be effective in the prevention of ''early onset infections''. In this paper, an overview of the development and efficiency of antiadhesive or antimicrobial polymers is given.
RP Kohnen, W (reprint author), UNIV COLOGNE,INST MED MIKROBIOL & HYG,GOLDENFELSSTR 19-21,D-50935 COLOGNE,GERMANY.
CR ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778
   BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
   BRAUSE BD, 1986, CLIN RHEUM DIS, V12, P523
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Carballo J, 1992, J Biomater Appl, V7, P130, DOI 10.1177/088532829200700203
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   CHOO MH, 1981, AM J CARDIOL, V48, P559, DOI 10.1016/0002-9149(81)90088-6
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dunkirk S G, 1991, J Biomater Appl, V6, P131, DOI 10.1177/088532829100600203
   EHRENKRANZ NJ, 1991, REV INFECT DIS, V13, P803
   FERRERAS JM, 1989, CELL MOL BIOL, V35, P89
   FITZGERALD RH, 1977, J BONE JOINT SURG AM, V59, P847, DOI 10.2106/00004623-197759070-00001
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P937, DOI 10.1002/jbm.820250803
   GRECO RS, 1984, J SURG RES, V36, P237, DOI 10.1016/0022-4804(84)90093-3
   HAMPL J, 1995, ACTA NEUROCHIR, V133, P147, DOI 10.1007/BF01420065
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HATTORI R, 1989, J GEN APPL MICROBIOL, V31, P147
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   Jansen B, 1988, J Biomater Appl, V2, P520
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   JANSEN B, 1990, ZBL BAKT-INT J MED M, V272, P401, DOI 10.1016/S0934-8840(11)80040-X
   JANSEN B, 1993, CURR OPIN INFECT DIS, V6, P526, DOI 10.1097/00001432-199308000-00007
   JANSEN B, 1992, J ANTIMICROB CHEMOTH, V30, P135, DOI 10.1093/jac/30.2.135
   JANSEN B, 1992, J HOSP INFECT, V22, P93, DOI 10.1016/0195-6701(92)90093-2
   Jansen B, 1987, POLYM MATERIAL SCI E, V57, P43
   JOHNSON JR, 1990, J INFECT DIS, V162, P1145, DOI 10.1093/infdis/162.5.1145
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KINGSTON D, 1986, J HYG CAMB, P185
   KLUGE RM, 1974, JAMA-J AM MED ASSOC, V230, P1415, DOI 10.1001/jama.230.10.1415
   KOHNEN W, 1992, BIOTECHNOL BIOACT PO, P317
   KOHNEN W, POLYM MATERIALS ENCY
   Kristinsson K G, 1991, J Biomater Appl, V5, P173, DOI 10.1177/088532829100500303
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   LIEDBERG H, 1990, International Urology and Nephrology, V22, P487, DOI 10.1007/BF02549783
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V256, P479, DOI 10.1016/S0174-3031(84)80024-4
   MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3
   MAKI DG, 1994, INFECT CONT HOSP EP, V15, P227
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   MCLEAN RJC, 1993, CAN J MICROBIOL, V39, P895, DOI 10.1139/m93-134
   MORO ML, 1994, INFECT CONT HOSP EP, V15, P253
   NOSHER JL, 1990, CARDIOVASC INTER RAD, V13, P102, DOI 10.1007/BF02577362
   REID G, 1989, COLLOID SURFACE, V42, P299
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98
   SIOSHANSI P, 1994, ARTIF ORGANS, V18, P266, DOI 10.1111/j.1525-1594.1994.tb02193.x
   SOLOVSKIJ MV, 1983, BIOMATERIALS, V4, P44, DOI 10.1016/0142-9612(83)90069-8
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TEBBS SE, 1994, EUR J CLIN MICROBIOL, V13, P111, DOI 10.1007/BF01982182
   TEBBS SE, 1994, BRIT J ANAESTH, V72, P587, DOI 10.1093/bja/72.5.587
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WILCOX MH, 1994, J ANTIMICROB CHEMOTH, V33, P431, DOI 10.1093/jac/33.3.431
   YU JL, 1994, J MED MICROBIOL, V41, P133, DOI 10.1099/00222615-41-2-133
NR 58
TC 23
Z9 23
U1 0
U2 7
PU GUSTAV FISCHER VERLAG
PI STUTTGART
PA WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD DEC
PY 1995
VL 283
IS 2
BP 175
EP 186
PG 12
WC Microbiology; Virology
SC Microbiology; Virology
GA TQ660
UT WOS:A1995TQ66000007
PM 8825109
DA 2018-10-19
ER

PT J
AU BUCHER, PJM
   BUCHI, ER
   DAICKER, BC
AF BUCHER, PJM
   BUCHI, ER
   DAICKER, BC
TI DYSTROPHIC CALCIFICATION OF AN IMPLANTED HYDROXYETHYLMETHACRYLATE
   INTRAOCULAR-LENS
SO ARCHIVES OF OPHTHALMOLOGY
LA English
DT Article
ID OCULAR COMPATIBILITY; HYDROGEL; DEPOSITS; VISCOAT
AB Hydroxyethylmethacrylate is a biomaterial still under clinical trial for use in foldable intraocular lenses. We observed a patient in whom a geographic opacification developed within an implanted hydroxyethylmethacrylate lens, together with granular deposits on the posterior lens capsule and in the scar of a paracentesis. The intraocular lens and posterior lens capsule were removed because of impaired visual acuity. Light and scanning electron microscopy disclosed nodular calcifications within the intraocular lens and granular, partially crystalline, calcifications on the posterior lens capsule. Energy-dispersive x-ray analysis and x-ray diffraction showed the deposits in the intraocular lens to consist of calcium hydroxyapatite. We presume this mineralization to be dystrophic, with calcium derived from lens remnants and phosphorus possibly derived from a thymoxamine solution used briefly during the cararact operation. Our observation suggests caution in the use of phosphated solutions together with hydroxyethylmethacrylate intraocular lenses and may warrant reconsideration of the suitability of hydroxyethylmethacrylate intraocular lenses, should additional similar cases be reported.
C1 UNIV BASEL,HOSP EYE,BASEL,SWITZERLAND.
   CANTONAL HOSP,FRAUENFELD,SWITZERLAND.
CR AMON M, 1991, J CATARACT REFR SURG, V17, P774, DOI 10.1016/S0886-3350(13)80410-5
   BARRETT G, 1984, AM J OPHTHALMOL, V98, P157, DOI 10.1016/0002-9394(87)90350-3
   BARRETT GD, 1986, J CATARACT REFR SURG, V12, P623, DOI 10.1016/S0886-3350(86)80076-1
   BITO LZ, 1970, EXP EYE RES, V10, P102, DOI 10.1016/S0014-4835(70)80016-1
   BLUMENTHAL M, 1982, CORNEA, V1, P129
   BOWERS RWJ, 1987, BIOMATERIALS, V8, P83, DOI 10.1016/0142-9612(87)90094-9
   BOWERS RWJ, 1987, BIOMATERIALS, V8, P172, DOI 10.1016/0142-9612(87)90059-7
   BROCKHURST RJ, 1993, AM J OPHTHALMOL, V115, P524, DOI 10.1016/S0002-9394(14)74457-5
   BRUDER PS, 1987, ARCH OPHTHALMOL-CHIC, V105, P1243
   COFFMAN MR, 1986, AM J OPHTHALMOL, V102, P279, DOI 10.1016/0002-9394(86)90162-5
   DUKEELDER S, 1969, SYSTEM OPHTHALMOLOGY, V11, P134
   DUNCAN G, 1984, EYE B, V1, P159
   EHRICH W, 1977, KLIN MONATSBL AUGENH, V171, P443
   Fellenbaum P S, 1994, J Glaucoma, V3, P81
   GREHN F, 1986, GRAEF ARCH CLIN EXP, V224, P174, DOI 10.1007/BF02141493
   Keener GT, 1990, CATARACT SURG ALTERN, P163
   KUCK JFR, 1970, BIOCH EYE, P185
   LEVY JH, 1990, J CATARACT REFR SURG, V16, P563, DOI 10.1016/S0886-3350(13)80770-5
   MENAPACE R, 1992, J CATARACT REFR SURG, V18, P252, DOI 10.1016/S0886-3350(13)80902-9
   NEVYAS AS, 1987, ARCH OPHTHALMOL-CHIC, V105, P958
   OBENBERGER J, 1970, Ophthalmic Research, V1, P175
   OCONNOR GR, 1972, ST AM OPHTHALMOL SOC, V120, P58
   PERCIVAL SPB, 1994, EUR J IMPLANT REFRAC, V6, P10
   SPENCER WH, 1985, OPHTHALMIC PATHOLOGY, V1, P453
   ULLMAN S, 1986, J CATARACT REFR SURG, V12, P489, DOI 10.1016/S0886-3350(86)80121-3
   WEHRLI CP, 1993, THESIS U BASEL BASEL
   YALON M, 1991, OCULAR SURG NEWS, V2, P1
   ZIMMERMAN LE, 1958, ARCH OPHTHALMOL-CHIC, V60, P372, DOI 10.1001/archopht.1958.00940080388005
NR 28
TC 55
Z9 58
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0003-9950
J9 ARCH OPHTHALMOL-CHIC
JI Arch. Ophthalmol.
PD NOV
PY 1995
VL 113
IS 11
BP 1431
EP 1435
DI 10.1001/archopht.1995.01100110091031
PG 5
WC Ophthalmology
SC Ophthalmology
GA TD680
UT WOS:A1995TD68000027
PM 7487606
DA 2018-10-19
ER

PT J
AU Heaton, RJ
   Haris, PI
   Russell, JC
   Chapman, D
AF Heaton, RJ
   Haris, PI
   Russell, JC
   Chapman, D
TI Application of SPR & FTIR spectroscopy to the study of
   protein-biomaterial interactions
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 655th Meeting of the Biochemical-Society
CY JUL 18-21, 1995
CL MANCHESTER, ENGLAND
SP Biochem Soc
C1 BIOCOMPATIBLES LTD,UXBRIDGE UB8 3PQ,MIDDX,ENGLAND.
RP Heaton, RJ (reprint author), ROYAL FREE HOSP,SCH MED,IRC BIOMED MAT,ROWLAND HILL ST,LONDON NW3 2PF,ENGLAND.
CR BROWNE JE, 1995, T SOC BIOMATERIALS, V18, P55
   HARIS PI, 1992, TRENDS BIOCHEM SCI, V17, P328, DOI 10.1016/0968-0004(92)90305-S
   MALMQVIST M, 1993, CURR OPIN IMMUNOL, V5, P282, DOI 10.1016/0952-7915(93)90019-O
   OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739
   637309
NR 5
TC 6
Z9 6
U1 0
U2 1
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD NOV
PY 1995
VL 23
IS 4
BP S502
EP S502
DI 10.1042/bst023502s
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA TH865
UT WOS:A1995TH86500079
PM 8654687
DA 2018-10-19
ER

PT J
AU CENNI, E
   GRANCHI, D
   ARCIOLA, CR
   CIAPETTI, G
   SAVARINO, L
   STEA, S
   CAVEDAGNA, D
   DILEO, A
   PIZZOFERRATO, A
AF CENNI, E
   GRANCHI, D
   ARCIOLA, CR
   CIAPETTI, G
   SAVARINO, L
   STEA, S
   CAVEDAGNA, D
   DILEO, A
   PIZZOFERRATO, A
TI ADHESIVE PROTEIN EXPRESSION ON ENDOTHELIAL-CELLS AFTER CONTACT IN-VITRO
   WITH POLYETHYLENE TEREPHTHALATE COATED WITH PYROLYTIC CARBON
SO BIOMATERIALS
LA English
DT Article
DE ENDOTHELIUM; ADHESINS; PYROLYTIC CARBON; FLOW CYTOMETRY
ID ADSORPTION; PROSTHESES; CULTURE; GRAFTS
AB This research aims at evaluating the expression of some adhesive proteins on endothelial cell surface after contact with polyethylene terephthalate coated with pyrolytic carbon (PET + PC). Twenty-two different cultures of human umbilical vein endothelial cells (HUVECs) were put in contact with PET + PC. Both HUVECs grown without the biomaterial and HUVECs incubated with endotoxin were used as control. After 24 h, platelet endothelial cell adhesion molecule-1 (PECAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were evaluated on the cells by monoclonal antibodies and flow cytometry. In agreement with the literature, after 24 h the culture incubated with endotoxin determined a significant increase in the percentage of positive cells for ELAM-1, a significant increase in fluorescence intensity for ICAM-1, and a significant increase in the percentage of positive cells and fluorescence intensity for VCAM-1. After 24 h of culture with PET + PC, no significant variations in the antigens examined were observed. This demonstrates that such material does not activate in vitro the proteins involved in the adhesion between leucocytes and endothelium or in the adhesion between endothelial cells themselves.
C1 POLICLIN S ORSOLA,IST FISIOPATOL RIPROD,I-40136 BOLOGNA,ITALY.
RP CENNI, E (reprint author), IST ORTOPED RIZZOLI,BIOCOMPATIBIL RES IMPLANT MAT LAB,I-40136 BOLOGNA,ITALY.
RI Granchi, Donatella/J-3647-2016
OI Granchi, Donatella/0000-0001-7225-0023; Ciapetti,
   Gabriela/0000-0001-6740-0357; savarino, lucia/0000-0002-3177-3546
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   BARBUCCI R, 1985, BIOMATERIALS, V6, P102, DOI 10.1016/0142-9612(85)90071-7
   BARD RJ, 1968, CARBON, V6, P603, DOI 10.1016/0008-6223(68)90004-3
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V91, P80, DOI 10.1097/00006534-199301000-00011
   BOKROS JC, 1977, CARBON, V15, P355
   BOKROS JC, 1965, CARBON, V3, P17
   CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x
   CENNI E, IN PRESSPLATELET COA
   CENNI E, IN PRESS EXPRESSION
   COOK SD, 1986, J BIOMED MATER RES, V20, P1347, DOI 10.1002/jbm.820200909
   FERRERO E, 1993, IMMUNOLOGY 94, P201
   Haubold A, 1983, ASAIO J, V29, P88
   HAUBOLD AD, 1979, BIOCOMPATIBILITY CLI, V2, P3
   HERRING M, 1978, SURGERY, V84, P498
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KLASSON DH, 1977, INT SURG, V62, P179
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LEAKE DL, 1989, BIOMATERIALS, V10, P441, DOI 10.1016/0142-9612(89)90083-5
   OPPENHEIMERMARKS N, 1991, J IMMUNOL, V147, P2913
   OSBORN L, 1990, CELL, V62, P48
   PACCAGNELLA A, 1986, CERAMICS CLIN APPLIC, P23
   PIZZOFERRATO A, 1979, BIOMATER ARTIF CELL, V7, P321, DOI 10.3109/10731197909117588
   PIZZOFERRATO A, 1984, BIOMATERIALS BIOMECH, P337
   SOTTIURAI VS, 1983, SURGERY, V93, P809
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   WILKINSON LS, 1993, LAB INVEST, V68, P82
NR 28
TC 42
Z9 42
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1995
VL 16
IS 16
BP 1223
EP 1227
DI 10.1016/0142-9612(95)98128-2
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RZ308
UT WOS:A1995RZ30800004
PM 8589191
DA 2018-10-19
ER

PT J
AU BENMAKROHA, Y
   ZHANG, S
   ROLFE, P
AF BENMAKROHA, Y
   ZHANG, S
   ROLFE, P
TI HEMOCOMPATIBILITY OF INVASIVE SENSORS
SO MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
LA English
DT Review
DE BIOSENSOR; HEMOCOMPATIBILITY; INVASIVE SENSORS; PROTEIN ADSORPTION
ID GLUCOSE ENZYME ELECTRODE; CANINE ENDOTHELIAL-CELLS; HUMAN-PLASMA
   ALBUMIN; BLOOD COMPATIBILITY; PHOSPHOLIPID POLYMERS; BIOMATERIAL
   SURFACES; VASCULAR PROSTHESES; PH; HEPARIN; MEMBRANES
AB In recent years the importance and utilisation of invasive chemical sensors have increased, especially in respect to their function and behaviour in a biological environment. This review aims to highlight the development of various sensors and reflect on the problems which can occur when the sensors come into contact with blood. Thus their haemocompatibility is a key area of importance. A clear understanding of their interaction with plasma proteins at the point of interface is fundamental as this determines their ultimate capability to function safely and effectively. There is also an overview of various techniques that have been developed, together with a broad summary of inherent problems which may arise when aiming to improve the haemocompatability of invasive sensors for in vivo applications.
RP BENMAKROHA, Y (reprint author), KEELE UNIV, N STAFFORDSHIRE HOSP TRUST, DEPT BIOMED ENGN & MED PHYS, THORNBURROW DR, STOKE ON TRENT ST4 7QB, STAFFS, ENGLAND.
CR ABAOLOM DR, 1985, J COLLOID INTERF SCI, V104, P51
   ABSOLOM DR, 1986, COLLOID SURFACE, V21, P447, DOI 10.1016/0166-6622(86)80108-1
   ADAMS GA, 1981, J AM SOC ARTIF INTER, V3, P90
   ADAMSON AW, 1976, PHYSICAL CHEM SURFAC
   ADDONIZIO VP, 1982, BIOMATERIALS, V3, P9, DOI 10.1016/0142-9612(82)90054-0
   AMMANN D, 1981, ANAL CHEM, V53, P2267, DOI 10.1021/ac00237a031
   ANTHONY EGC, 1984, ANAL CHEM, V56, P667
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   BAIER RE, 1978, ARTIF ORGANS, V2, P422
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAKER KS, 1985, AM J SURG, V150, P197, DOI 10.1016/0002-9610(85)90118-7
   BAND DM, 1966, J PHYSIOL-LONDON, V184, pP58
   BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BINDSLEV L, 1986, T AM SOC ART INT ORG, V32, P530
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   BRASH JL, 1971, CHEM BIOSURFACES, P77
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BROWN EG, 1972, PED RES SOC, V54, P123
   BRUCK D, 1980, PROPERTIES BIOMATERI
   CHA GS, 1989, TALANTA, V36, P271, DOI 10.1016/0039-9140(89)80106-7
   CHANG TM, 1978, ARTIFICIAL KIDNEY AR
   CHAPMAN D, 1993, BIOCHEM SOC T, V21, P258, DOI 10.1042/bst0210258
   CHEN CY, 1992, APPL BIOCHEM BIOTECH, V36, P211, DOI 10.1007/BF02921780
   CHOAY J, 1989, ANN NY ACAD SCI, V556, P61
   CLARK LC, 1953, J APPL PHYSIOL, V6, P189
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   CURLING JM, 1977, VOX SANG, V33, P97, DOI 10.1111/j.1423-0410.1977.tb02240.x
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   DESAI MA, 1993, SCAND J CLIN LAB INV, V53, P53, DOI 10.3109/00365519309090679
   DEUTSCH DG, 1972, J MED, V3, P224
   DIPAK B, 1987, MEMBRANE BIOCHEM, P1
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   DURRANI AA, 1987, POLYM SURFACES INTER, P189
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   ENSON Y, 1962, J APPL PHYS, V17, P552
   ESKIN SG, 1985, ASAIO J, V8, P109
   ESNOUF MP, 1977, BRIT MED BULL, V33, P213, DOI 10.1093/oxfordjournals.bmb.a071438
   Fasol R, 1985, Trans Am Soc Artif Intern Organs, V31, P276
   FOGT EJ, 1978, CLIN CHEM, V24, P1366
   GEHRICH J, 1986, IEEE T BME, V33, P23
   GIMBRONE MA, 1982, ANN NY ACAD SCI, V401, P171, DOI 10.1111/j.1749-6632.1982.tb25716.x
   GOLDSMITH HL, 1972, PROGR HAEMOSTASIS TH, V1
   GOTT VL, 1961, SURGERY, V50, P382
   GOTT VL, 1971, FED PROC, V30, P1679
   GRAHAM LM, 1982, SURGERY, V91, P550
   GRAHAM LM, 1985, ASAIO J, V8, P65
   GRIFFEN JH, 1976, P NAT ACAD SCI, V74, P2554
   GRODE GA, 1969, T AM SOC ART INT ORG, V15, P1
   GUIBAULT GG, 1973, ANAL CHIM ACTA, V64, P439
   GUNASINGHAM H, 1990, ANAL CHIM ACTA, V234, P321, DOI 10.1016/S0003-2670(00)83573-4
   GURLAND HJ, 1994, NEPHROL DIAL TRANSPL, V9, P4
   Hall E. A. H., 1990, BIOSENSORS
   HANNING I, 1986, ANAL LETT, V19, P461
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, SURGERY, V96, P745
   HESS F, 1992, BIOMATERIALS, V13, P657, DOI 10.1016/0142-9612(92)90124-7
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   JORDAN DM, 1987, ANAL CHEM, V59, P437, DOI 10.1021/ac00130a013
   JOZEFOWICZ M, 1984, PURE APPL CHEM, V56, P1335, DOI 10.1351/pac198456101335
   KEEDY FH, 1986, THESIS U NEWCASTLE U
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KNOPP JA, 1972, BIOCHIM BIOPHYS ACTA, V279, P393, DOI 10.1016/0304-4165(72)90158-4
   KUSSEROV BK, 1971, T AM SOC ART INT ORG, V19, P8
   KUSSEROW BK, 1972, CIRCULATION S, V2, P54
   LAMBRECHT LK, 1983, T AM SOC ART INT ORG, V29, P194
   LANDERGREN HR, 1971, T AM SOC ART INT ORG, V17, P10
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   LARSSON R, 1987, ANN NY ACAD SCI, V516, P102, DOI 10.1111/j.1749-6632.1987.tb33034.x
   LEBLANC OH, 1976, J APPL PHYSIOL, V40, P644
   LEE RG, 1974, J BIOMED MATER RES, V8, P393, DOI 10.1002/jbm.820080607
   LEMUEL B, 1982, DIABETES CARE, V5, P222
   LLANOS GR, 1992, BIOMATERIALS, V13, P421, DOI 10.1016/0142-9612(92)90161-G
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   MALMSTADT HV, 1965, ANAL CHEM, V37, P34, DOI 10.1021/ac60220a006
   MANSFIELD PB, 1975, T AM SOC ART INT ORG, V21, P264
   MANSOURI S, 1984, BIO-TECHNOL, V2, P885, DOI 10.1038/nbt1084-885
   MARTIN MJ, 1985, 1JTH P ICMBE 7TH ICM
   MCDONNELL MB, 1989, SELECT ELECTR REV, V11, P17
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MESSING RA, 1975, J NON-CRYST SOLIDS, V19, P277, DOI 10.1016/0022-3093(75)90093-9
   MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0
   MOSQUERA DA, 1991, BRIT J SURG, V78, P656, DOI 10.1002/bjs.1800780608
   MULLEN WH, 1986, ANAL CHIM ACTA, V183, P59, DOI 10.1016/0003-2670(86)80074-5
   MURPHY AP, 1991, J MED ENG TECHNOL, V15, P116, DOI 10.3109/03091909109016209
   MURPHY P, 1967, T AM SOC ART INT ORG, V13, P131
   NAGAOKA S, 1990, BIOMATERIALS, V11, P414, DOI 10.1016/0142-9612(90)90097-A
   NILSSON E, 1982, SCAND J CLIN LAB INV, V42, P331
   NILSSON E, 1981, CONTINUOUS INTRAARTE, P127
   NORDE W, 1978, J COLLOID INTERF SCI, V66, P295, DOI 10.1016/0021-9797(78)90307-7
   OCHOA JL, 1978, BIOCHIMIE, V60, P1, DOI 10.1016/S0300-9084(78)80193-X
   ODOWD M, 1988, J BIOMED ENG, V10, P165, DOI 10.1016/0141-5425(88)90094-5
   OHSHIRO T, 1980, T AM SOC ART INT ORG, V4, P58
   OLSSON P, 1984, ANN NY ACAD SCI, V416, P262
   OPITZ N, 1983, SENSOR ACTUATOR, V9, P473
   OWEN EW, 1990, J THORAC CARDIOV SUR, V100, P31
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PETERSON JI, 1982, DIABETES CARE, V5, P272, DOI 10.2337/diacare.5.3.272
   PETERSON JI, 1980, ANAL CHEM, V52, P864, DOI 10.1021/ac50056a022
   PETERSON JI, 1984, ANAL CHEM, V56, P62, DOI 10.1021/ac00265a017
   PISKIN E, 1992, Clinical Materials, V11, P3, DOI 10.1016/0267-6605(92)90023-M
   PLATE NA, 1982, THROMB RES, V27, P131, DOI 10.1016/0049-3848(82)90192-X
   RITHALIA SVS, 1981, INTENS CARE MED, V7, P305, DOI 10.1007/BF01709727
   ROLFE P, 1988, J BIOMED ENG, V10, P138, DOI 10.1016/0141-5425(88)90089-1
   ROLFE P, 1975, BIOMED ENG, V10, P399
   ROLFE P, 1990, MED BIOL ENG COMPUT, V28, pB34, DOI 10.1007/BF02442679
   ROLFE P, 1993, IN VIVOCHEM SENSORS, P67
   ROLFE P, 1991, CURR ANAESTH CRIT CA, V2, P122
   ROLFE P, 1988, NEONATAL BLOOD GAS P
   ROOTH G, 1961, ACTA MED SCAND, V170, P617
   Salzman E W, 1969, J Biomed Mater Res, V3, P69
   SANTIAGO JV, 1979, DIABETES, V28, P71
   SAWYER PN, 1972, B NEW YORK ACAD MED, V48, P235
   SCHAFFAR BBP, 1989, P SPIE INT SOC OPT E, V990, P122
   SCHMITT JM, 1984, J BIOMED MATER RES, V18, P797, DOI 10.1002/jbm.820180710
   SCHULTZ JS, 1982, DIABETES CARE, V5, P245, DOI 10.2337/diacare.5.3.245
   SEGESSER LK, 1992, 38TH ASAIO ANN M ASA, V25, P12
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SEVERINGHAUS JW, 1958, J APPL PHYSIOL, V13, P515
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P38, DOI 10.1016/0021-9797(84)90271-6
   SHARMA CP, 1981, BIOMATERIALS, V2, P57, DOI 10.1016/0142-9612(81)90091-0
   SHARP WV, 1966, T AM SOC ART INT ORG, V12, P179
   SHICHIRI M, 1982, LANCET, V2, P1129
   SHICHIRI M, 1984, DIABETES NUTR METAB, V2, P309
   SIBBALD A, 1984, CLIN CHEM, V30, P135
   SMITH BAH, 1993, J BIOMED MATER RES, V27, P89, DOI 10.1002/jbm.820270112
   SMITH RL, 1972, J APPL PHYSIOL, V32, P261
   STAMM O, 1976, AM J OBSTET GYNECOL, V124, P193, DOI 10.1016/S0002-9378(16)33297-5
   SUGAWARA KF, 1974, ANAL CHEM, V46, P489, DOI 10.1021/ac60340a016
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   TANG LX, 1990, ANAL CHIM ACTA, V232, P357, DOI 10.1016/S0003-2670(00)81254-4
   TSUCHIDA T, 1981, ENZYME MICROB TECH, V3, P326, DOI 10.1016/0141-0229(81)90008-9
   Turner A. P. F., 1987, BIOSENSORS FUNDAMENT
   TURNER JS, 1994, J BIOMAT SCI-POLYM E, V5, P353, DOI 10.1163/156856294X00077
   UPDIKE SJ, 1982, DIABETES CARE, V5, P207, DOI 10.2337/diacare.5.3.207
   VADGAMA P, 1989, BIOMED BIOCHIM ACTA, V48, P935
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1988, BIOMATERIALS, V9, P121, DOI 10.1016/0142-9612(88)90083-X
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   WIGGINS RC, 1977, P NATL ACAD SCI USA, V74, P4636, DOI 10.1073/pnas.74.10.4636
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   WILLIAMS DF, 1990, CONCISE ENCY MED DEN, P51
   WILSON RS, 1985, TECHNIQUES BIOCOMPAT
   WISE DL, 1989, APPLIED BIOSENSORS
   WOLDRING S, 1966, SCIENCE, V153, P885, DOI 10.1126/science.153.3738.885
   WOLFBEIS OS, 1986, SENSOR ACTUATOR, V9, P85, DOI 10.1016/0250-6874(86)80009-9
   WOLFBEIS OS, 1989, NOV P WORKSH BIOM EN
   YON RJ, 1978, INT J BIOCHEM, V9, P373, DOI 10.1016/0020-711X(78)90048-4
   ZHANG S, 1995, MED BIOL ENG COMPUT, V33, P152, DOI 10.1007/BF02523033
NR 154
TC 27
Z9 27
U1 1
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0140-0118
EI 1741-0444
J9 MED BIOL ENG COMPUT
JI Med. Biol. Eng. Comput.
PD NOV
PY 1995
VL 33
IS 6
BP 811
EP 821
DI 10.1007/BF02523013
PG 11
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology; Medical Informatics
SC Computer Science; Engineering; Mathematical & Computational Biology;
   Medical Informatics
GA TJ627
UT WOS:A1995TJ62700009
PM 8558954
DA 2018-10-19
ER

PT J
AU CHEN, ZP
   SAMUELSON, LA
   AKKARA, J
   KAPLAN, DL
   GAO, H
   KUMAR, J
   MARX, KA
   TRIPATHY, SK
AF CHEN, ZP
   SAMUELSON, LA
   AKKARA, J
   KAPLAN, DL
   GAO, H
   KUMAR, J
   MARX, KA
   TRIPATHY, SK
TI SOL-GEL ENCAPSULATED LIGHT-TRANSDUCING PROTEIN PHYCOERYTHRIN - A NEW
   BIOMATERIAL
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID FLUORESCENCE MICROSCOPY; BACTERIORHODOPSIN; STORAGE; PHYCOBILISOMES;
   GLASSES; FILMS
AB An optically transparent biomaterial is produced by encapsulating a light-transducing protein, phycoerythrin, in a sol-gel matrix. Absorption and fluorescence measurements indicate that the protein not only retains its native optical properties in the sol-gel matrix but also shows an enhanced stability toward photodegradation. Two-photon induced fluorescence is observed from phycoerythrin in both solution and sol-gel matrices. The potential application of this biomaterial in biosensors, three-dimensional biomolecular imaging, and three-dimensional optical storage is discussed.
C1 UNIV MASSACHUSETTS,CTR ADV MAT,DEPT PHYS,LOWELL,MA 01854.
   UNIV MASSACHUSETTS,CTR ADV MAT,DEPT CHEM,LOWELL,MA 01854.
   UNIV MASSACHUSETTS,CTR INTELLIGENT BIOMAT,DEPT PHYS,LOWELL,MA 01854.
   UNIV MASSACHUSETTS,CTR INTELLIGENT BIOMAT,DEPT CHEM,LOWELL,MA 01854.
RP CHEN, ZP (reprint author), USA,NATICK RES DEV & ENGN CTR,DIV BIOTECHNOL,NATICK,MA 01760, USA.
CR AVNIR D, 1984, J PHYS CHEM-US, V88, P5956, DOI 10.1021/j150668a042
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343
   BRAUCHLE C, 1991, ADV MATER, V3, P420, DOI 10.1002/adma.19910030903
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   CHEN Z, 1990, P INT JOINT C NEUR N, V2, P803
   CHEN Z, 1994, BIOMOLECULAR MAT DES, P263
   CHEN ZP, 1991, APPL OPTICS, V30, P5188, DOI 10.1364/AO.30.005188
   CHEN ZP, 1993, TRENDS BIOTECHNOL, V11, P292, DOI 10.1016/0167-7799(93)90017-4
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   EDMISTON PL, 1994, J COLLOID INTERF SCI, V163, P395, DOI 10.1006/jcis.1994.1119
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   GANTT E, 1981, ANNU REV PLANT PHYS, V32, P327, DOI 10.1146/annurev.pp.32.060181.001551
   GARRISON MD, 1992, J COLLOID INTERF SCI, V148, P415, DOI 10.1016/0021-9797(92)90180-T
   GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47
   GLAZER AN, 1984, TRENDS BIOCHEM SCI, V9, P423, DOI 10.1016/0968-0004(84)90146-4
   GROSSMAN AR, 1993, MICROBIOL REV, V57, P725
   HAMPP N, 1992, MOL ELECT SCI TECHNO, P181
   HOLZWARTH AR, 1989, Q REV BIOPHYS, V22, P239, DOI 10.1017/S0033583500002985
   KRONICK MN, 1983, CLIN CHEM, V29, P1582
   Mac Craith BD, 1994, J SOL-GEL SCI TECHN, V2, P661, DOI 10.1007/BF00486328
   MARX KA, 1994, MOL BIOMOLECULAR ELE, P395
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843
   SAMUELSON LA, 1994, J INTEL MAT SYST STR, V5, P305, DOI 10.1177/1045389X9400500302
   SAMUELSON LA, 1992, BIOMIMETICS, V1, P51
   SHEPPARD CJR, 1990, OPTIK, V86, P104
   STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780
   TAKEI H, 1991, APPL OPTICS, V30, P500, DOI 10.1364/AO.30.000500
   WEETALL HH, 1993, BIOCHIM BIOPHYS ACTA, V1142, P211, DOI 10.1016/0005-2728(93)90105-O
   WU SG, 1993, CHEM MATER, V5, P115, DOI 10.1021/cm00025a022
NR 31
TC 40
Z9 40
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA PO BOX 57136, WASHINGTON, DC 20037-0136
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD OCT
PY 1995
VL 7
IS 10
BP 1779
EP 1783
DI 10.1021/cm00058a005
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA TB561
UT WOS:A1995TB56100006
DA 2018-10-19
ER

PT J
AU COUVRAT, P
   DENIS, M
   LANGER, M
   MITURA, S
   NIEDZIELSKI, P
   MARCINIAK, J
AF COUVRAT, P
   DENIS, M
   LANGER, M
   MITURA, S
   NIEDZIELSKI, P
   MARCINIAK, J
TI THE CORROSION TESTS OF AMORPHOUS-CARBON COATINGS DEPOSITED BY RF
   DENSE-PLASMA ONTO STEEL WITH DIFFERENT CHROMIUM CONTENTS
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE DIAMOND-LIKE COATINGS; INTERFACE; RF PCVD; BIOMATERIAL
ID FILMS
AB In the paper the results of experimental studies concerning characterization of amorphous carbon layers obtained by a new method of r.f. dense plasma CVD onto steel with different chromium contents are presented. Thin, amorphous carbon layers, deposited onto these substrates, are the subject of structural and physical investigations. This refers also to the system of carbon layer-steel substrate correlated with a microstructure of the layer, and to the determination of specifications resulting from the model for optimization of the synthesis and applicability of a new system as medical implants. Amorphous carbon coatings produced by the dense r.f CH4 plasma method from steel AISI-316L used in medicine were investigated to determine their suitability as biomaterials.
C1 TECH UNIV LODZ,INST MAT SCI & ENGN,PL-90924 LODZ,POLAND.
   SILESIAN TECH UNIV,INST MET SCI,PL-44100 GLIWICE,POLAND.
RP COUVRAT, P (reprint author), ECOLE CATHOLIQUE ARTS & METIERS,40 MONTEE ST BARTHELEMY,F-69321 LYON 05,FRANCE.
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748; Niedzielski,
   Piotr/0000-0002-6966-9154
CR ANGUS J, 1986, PLASMA DEPOSITED THI
   COOPER CV, 1994, DIAM RELAT MATER, V3, P534, DOI 10.1016/0925-9635(94)90219-4
   GRIL A, 1994, DIAM RELAT MATER, V2, P597
   LANGER M, 1994, ESSAI MODELISATION P
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MARCINIAK J, 1993, WERKST KORROS, V44, P379
   MARCINIAK J, 1992, BIOMATERIALY W CHIRU
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1994, 8TH P CIMTEC WORLD C
   MITURA S, 1995, 1994 P DIAM FILMS 94, V4, P302
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   WEI R, 1994, DIAM RELAT MATER, V2, P898
   WILLIAMS DF, 1973, IMPLANTS SURGERY
   ZOLYNSKI K, 1995, JUN INT C C BN DIAM
NR 15
TC 11
Z9 11
U1 0
U2 7
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD OCT
PY 1995
VL 4
IS 11
BP 1251
EP 1254
DI 10.1016/0925-9635(95)00307-X
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA TJ750
UT WOS:A1995TJ75000002
DA 2018-10-19
ER

PT J
AU KLEIN, CL
   OTTO, M
   KOHLER, H
   KIRKPATRICK, CJ
AF KLEIN, CL
   OTTO, M
   KOHLER, H
   KIRKPATRICK, CJ
TI METHODOLOGICAL APPROACHES TO BIOCOMPATIBILITY AND HEMOCOMPATIBILITY
   TESTING OF BIOMATERIALS
SO INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
LA English
DT Article; Proceedings Paper
CT 27th Congress of the
   Deutschen-Gesellschaft-fur-Transfusionsmedizin-und-Immunhamatologie on
   Transfusion Medicine 1994-1995
CY OCT 19-22, 1994
CL SAARBRUCKEN, GERMANY
SP Deut Gesell Transfusionsmed & Immunhamatol
DE PROSTHETIC DEVICES; METAL CORROSION; POLYMERIC MATERIALS; FLOW SYSTEM;
   ISO STANDARDS
AB Methods of in vitro cytotoxicity testing of materials in medical and dental applications, as well as the selection of tests for interactions with blood have been standardized by ISO. On the basis of these ISO standards we established a panel of relevant in vitro methods for biomaterial evaluation. These methods are based on cell culture models using both cell lines (e.g. HeLa, L929,THP-1) as well as primary isolated human cells (e.g. juvenile and adult micro- and macrovascular endothelial cells, mesothelial cells, fibroblasts, smooth muscle cells). Biomaterials are placed in direct or indirect contact with the cell species. Cells and materials as well as functional mediator release have been investigated using a wide panel of methods Thus, morphological and ultrastructural changes are detected tvith the help of light, immunofluorescence, laser scanning and electron microscopy, while mediator responses are studied using biochemical analysis, molecular biological methods and flow cytometry. The combination of relevant in vitro systems and the use of highly sensitive analytical as well as molecular biological methods are in our view an important prerequisite for reliable biomaterial evaluation and guarantee for the high performance of these methods and model systems.
RP KLEIN, CL (reprint author), UNIV MAINZ,INST PATHOL,LANGENBECKSTR 1,D-55101 MAINZ,GERMANY.
CR KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P798, DOI 10.1007/BF00213138
   KLEIN CL, 1994, PATHOBIOLOGY, V62, P199, DOI 10.1159/000163911
   WILLIAMS DF, PROGR BIOMEDICAL ENG, V4, P54
NR 5
TC 3
Z9 3
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1019-8466
J9 INFUSIONSTHERAPIE
JI Infusionsther. Transfusionsmed.
PD OCT
PY 1995
VL 22
SU 1
BP 155
EP 158
PG 4
WC Hematology; Immunology
SC Hematology; Immunology
GA TH914
UT WOS:A1995TH91400058
DA 2018-10-19
ER

PT J
AU GIRIDHAR, G
   MYRVIK, QN
   GRISTINA, AG
AF GIRIDHAR, G
   MYRVIK, QN
   GRISTINA, AG
TI BIOMATERIAL-INDUCED DYSFUNCTION IN THE CAPACITY OF RABBIT ALVEOLAR
   MACROPHAGES TO KILL STAPHYLOCOCCUS-EPIDERMIDIS RP12
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID NYLON WOOL; INFECTION; PATHOGENESIS; RESPONSES; ADHESION; INVITRO
AB The effect of poly(methyl methacrylate) (PMMA), titanium alloy, and silicone discs on the capacity of rabbit alveolar macrophages (AM) to kill RP12 strain of Staphylococcus epidermidis (RP12) was studied in vitro. When freshly harvested AM were preincubated with PMMA discs for 3 h and subsequently assayed for RP12 killing, there was no change in the RP12 killing capacity of AM. However, when AM were incubated with PMMA discs for 6 or 18 h at 37 degrees C in 5% CO2, the RP12 killing capacity of AM was reduced to 15% and 4%, respectively. Preincubation of AM with titanium alloy for 6 h reduced RP12 killing capacity of AM to 30%, and to 21% in 18-h incubation. Silicone discs did not affect the RP12 killing by AM at 6 h of preincubation, but reduced RP12 killing (35%) by AM when preincubated for 18 h. Preincubation of AM with PMMA discs for 3 or 6 h did not affect the level of PMA-elicited oxidative burst of AM as measured by a luminol-enhanced chemiluminescent assay. Superoxide dismutase, which eliminated the oxidative burst of AM by 90%, did not affect the RP12 killing by AM. (C) 1995 John Wiley & Sons, Inc.
C1 MED SCI RES INST,HERNDON,VA 22070.
FU NHLBI NIH HHS [HL 31624]; NIAMS NIH HHS [AR 26957]
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205
   CHAMBERS TJ, 1981, FUNDAMENTAL ASPECTS, P145
   CHIDA K, 1987, INFECT IMMUN, V55, P1476
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   GIRIDHAR G, IN PRESS J BIOMED MA
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   Gristina Anthony G., 1994, P131
   KAPLAN DS, 1994, 20TH T ANN M SOC BIO, V17, P142
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   KLOCK JC, 1977, J CLIN INVEST, V60, P1183, DOI 10.1172/JCI108871
   KLOCK JC, 1976, BLOOD, V48, P149
   MYRVIK QN, 1961, J IMMUNOL, V86, P128
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 18
TC 9
Z9 9
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1995
VL 29
IS 10
BP 1179
EP 1183
DI 10.1002/jbm.820291004
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RW721
UT WOS:A1995RW72100003
PM 8557719
DA 2018-10-19
ER

PT J
AU MIRZADEH, H
   KATBAB, AA
   BURFORD, RP
AF MIRZADEH, H
   KATBAB, AA
   BURFORD, RP
TI CO2-LASER GRAFT-COPOLYMERIZATION OF HEMA AND NVP ONTO ETHYLENE-PROPYLENE
   RUBBER (EPR) AS BIOMATERIAL-(III)
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 9th International Meeting on Radiation Processing
CY SEP 11-16, 1994
CL ISTANBUL, TURKEY
DE CO2-PULSED LASER; GRAFTING; HEMA; NVP; EPR; BIOMATERIAL; MACROPHAGE
AB For the purpose of improved surface hydrophilicity and biocompatibility of Ethylene-Propylene rubber 2-Hydroxyethyle methacrylate (HEMA) and N-Vinylpyrrolidone (NVP) have been grafted onto the surface of this polymer using CO2 pulsed laser at different fluence (output power J/cm(2)) as excitation source. Alveolar macrophages (AMs) cultured on the surface of unmodified films showed more cell attachment with greater degree of spreading and flattening while AMs adhered onto the modified EPR appeared rounded with minimal cytoplasmic spreading and ruffling. Percentage of AMs attached to the surface of modified EPR versus graft level has also been studied.
C1 AMIRKABIR UNIV,DEPT POLYMER ENGN,TEHRAN,IRAN.
   POLYMER RES CTR,TEHRAN,IRAN.
   UNIV NEW S WALES,DEPT POLYMER SCI,KENSINGTON,NSW 2033,AUSTRALIA.
CR BRAND GK, 1975, COMPREHENSIVE TREATI, V1
   CHAMBERS TJ, 1981, FUNDAMENTAL ASPECTS, P145
   DECKER C, 1990, RAD CURING POLYM MAT, P439
   FISHER JP, 1979, J POLYM SCI POLYM S, V66, P443
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   LOUGNOT DJ, 1993, MAKROM CHEM RAPID CO, V4, P11
   MIRZADEH H, 1994, ANGEW MAKROMOL CHEM, V218, P23, DOI 10.1002/apmc.1994.052180103
   MIRZADEH H, 1993, RADIAT PHYS CHEM, V41, P507, DOI 10.1016/0969-806X(93)90013-K
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   RATNER BD, 1976, J POLYM SCI POLYM S, V66, P363
NR 10
TC 21
Z9 21
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1995
VL 46
IS 4-6
BP 859
EP 862
DI 10.1016/0969-806X(95)00278-6
PN 1
PG 4
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TD685
UT WOS:A1995TD68500096
DA 2018-10-19
ER

PT J
AU DUNG, NA
   HUYEN, ND
   HANG, ND
   CANH, TT
AF DUNG, NA
   HUYEN, ND
   HANG, ND
   CANH, TT
TI IMMOBILIZATION OF UREASE ON GRAFTED STARCH BY RADIATION METHOD
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
AB The acrylamide was grafted by radiation onto starch which is a kind polymeric biomaterial. The urease was immobilized on the grafted starch. Some experiments to observe the quantitative relationships between the percent graft and the activity of immobilized enzyme were determined. The enzyme activity was maintained by more than seven batch enzyme reactions.
C1 NUCL RES INST, DA LAT, VIETNAM.
RP DUNG, NA (reprint author), HO CHI MINH UNIV, FAC BIOL, HO CHI MINH CITY, VIETNAM.
CR ALLAN S, 1980, RADIAT PHYS CHEM, V27, P265
   DOANE WM, 1977, ACS SYM SER, V53, P74
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KUMAKURA M, 1983, J APPL POLYM SCI, V28, P2167, DOI 10.1002/app.1983.070280704
   SAYED EA, 1986, RADIAT PHYS CHEM, V27, P323
NR 6
TC 7
Z9 9
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1995
VL 46
IS 4-6
BP 1037
EP 1042
DI 10.1016/0969-806X(95)00316-P
PN 2
PG 6
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA TD120
UT WOS:A1995TD12000023
DA 2018-10-19
ER

PT J
AU LEGEAIS, JM
   WERNER, L
   BRIAT, B
   THEVENIN, D
   RENARD, G
   POULIQUEN, Y
AF LEGEAIS, JM
   WERNER, L
   BRIAT, B
   THEVENIN, D
   RENARD, G
   POULIQUEN, Y
TI A NEW BIOMATERIAL FOR INTRAOCULAR-LENS, EXPERIMENTAL IN-VIVO STUDY
SO VISION RESEARCH
LA English
DT Meeting Abstract
C1 HOP HOTEL DIEU,DEPT OPHTHALMOL,INSERM,U86,PARIS,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0042-6989
J9 VISION RES
JI Vision Res.
PD OCT
PY 1995
VL 35
SU S
BP 3143
EP 3143
PG 1
WC Neurosciences; Ophthalmology; Psychology
SC Neurosciences & Neurology; Ophthalmology; Psychology
GA RZ562
UT WOS:A1995RZ56200259
OA Bronze
DA 2018-10-19
ER

PT J
AU ESPADASTORRE, C
   MEYERHOFF, ME
AF ESPADASTORRE, C
   MEYERHOFF, ME
TI THROMBOGENIC PROPERTIES OF UNTREATED AND POLY(ETHYLENE OXIDE)-MODIFIED
   POLYMERIC MATRICES USEFUL FOR PREPARING INTRAARTERIAL ION-SELECTIVE
   ELECTRODES
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID WHOLE-BLOOD; BIOMATERIAL SURFACES; PLATELET-ADHESION; CRITICAL CARE;
   IN-VIVO; SENSORS; POTASSIUM; COMPATIBILITY; POLYURETHANES; COPOLYMERS
AB In vitro platelet adhesion studies are used to compare the thrombogenic properties of various polymer matrices useful for preparing implantable ion-selective membrane electrodes. Conventional plasticized poly(vinyl chloride) and alternate polyurethane materials (Tecoflex, Pellethane) doped with proton- (tridodecylamine) and potassium-selective (valinomycin) ionophores are shown to be potentially thrombogenic. Incorporation of high molecular weight block copolymers of poly(ethylene oxide) and poly(propylene oxide) (e.g., Pluronic F108 and Tetronic 1508) within ion-selective membranes reduces platelet adhesion. A more marked decrease in platelet adhesion is, however, observed when the Tecoflex-based membranes are coated with a thin photo-cross-linked layer of poly(ethylene oxide). Such surface-modified membranes are shown to retain potentiometric ion response properties (i.e., selectivity, response times, response slopes, etc.) essentially equivalent to untreated membranes.
C1 UNIV MICHIGAN,DEPT CHEM,ANN ARBOR,MI 48109.
FU NIGMS NIH HHS [GM 28882-14]
CR ADAMS MD, 1990, TALANTA, V37, P875, DOI 10.1016/0039-9140(90)80246-C
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   AMMANN D, 1985, ION MEASUREMENTS PHY, P102
   ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   BAILEY PL, 1980, ANAL IONSELECTIVE EL
   BAKKER E, 1994, ANAL CHIM ACTA, V295, P253, DOI 10.1016/0003-2670(94)80230-0
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   CHA GS, 1991, ANAL CHEM, V63, P1666, DOI 10.1021/ac00017a003
   CHEN CY, 1993, ELECTROANAL, V5, P269, DOI 10.1002/elan.1140050402
   COLLISON ME, 1989, ANAL CHEM, V61, P2365, DOI 10.1021/ac00196a010
   COSOFRET VV, 1994, ANALYST, V119, P2283, DOI 10.1039/an9941902283
   DORAZIO P, 1992, ELECTROLYTES BLOOD G, P21
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   ESPADASTORRE C, 1995, INTERFACE, V4, P41
   FIEDLER U, 1973, ANAL CHIM ACTA, V67, P179, DOI 10.1016/S0003-2670(01)80244-0
   FOGHANDERSEN N, 1978, CLIN CHEM, V24, P1545
   FOGT EJ, 1980, CLIN CHEM, V26, P1425
   GAJEWSKI J, 1971, AM J VET RES, V32, P405
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   KOBER M, 1992, J POLYM SCI POL CHEM, V30, P1061, DOI 10.1002/pola.1992.080300611
   KOST GJ, 1993, CRIT REV CL LAB SCI, V30, P153, DOI 10.3109/10408369309084667
   Lelah M. D., 1986, POLYURETHANES MED
   LIM M, 1982, ANESTHESIOLOGY, V57, P272, DOI 10.1097/00000542-198210000-00004
   LINDNER E, 1994, J BIOMED MATER RES, V28, P591, DOI 10.1002/jbm.820280509
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   MATHEW J, 1993, BIOMATERIALS, V14, P57, DOI 10.1016/0142-9612(93)90076-E
   MCINTIRE LV, 1985, NIH852185 US DEP HLT
   MEIER PC, 1982, ANAL CHIM ACTA, V136, P363, DOI 10.1016/S0003-2670(01)95397-8
   MEYERHOFF ME, 1990, CLIN CHEM, V36, P1567
   Morra M., 1993, Clinical Materials, V14, P255, DOI 10.1016/0267-6605(93)90010-5
   MURPHY SM, 1992, BIOMATERIALS, V14, P979
   OESCH U, 1986, CLIN CHEM, V32, P1448
   OSSWALD HF, 1979, CLIN CHEM, V25, P39
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PICKUP JC, 1991, BIOSENS BIOELECTRON, V6, P639, DOI 10.1016/0956-5663(91)87016-5
   PLANCK H, 1984, POLYURETHANES BIOMED
   SIMON W, 1984, ANN NY ACAD SCI, V428, P279, DOI 10.1111/j.1749-6632.1984.tb12303.x
   TELTINGDIAZ M, 1994, ANAL CHEM, V66, P576, DOI 10.1021/ac00076a025
NR 42
TC 73
Z9 73
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA PO BOX 57136, WASHINGTON, DC 20037-0136
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 15
PY 1995
VL 67
IS 18
BP 3108
EP 3114
DI 10.1021/ac00114a003
PG 7
WC Chemistry, Analytical
SC Chemistry
GA RU331
UT WOS:A1995RU33100003
PM 8686883
DA 2018-10-19
ER

PT J
AU DICKINSON, RB
   COOPER, SL
AF DICKINSON, RB
   COOPER, SL
TI ANALYSIS OF SHEAR-DEPENDENT BACTERIAL ADHESION KINETICS TO BIOMATERIAL
   SURFACES
SO AICHE JOURNAL
LA English
DT Article
ID PLATE FLOW CHAMBER; MEDIATED CELL ATTACHMENT; COLLOIDAL PARTICLES;
   STAPHYLOCOCCUS-AUREUS; DETACHMENT KINETICS; SOLID-SURFACES; FIBRINOGEN;
   INFECTION; MODEL; FIBRONECTIN
AB A methodology and analysis is presented to quantitatively characterize bacterial attachment and detachment kinetics on biomaterial surfaces in a laminar flow field as a function of shear stress. The spatial distribution of adherent bacteria on the surface of a radial-flow chamber is monitored via automated videomicroscopy with motorized three-axis stage and focus control, allowing rapid automated measurement of the attached cell density as a function of time and radial position. Intrinsic rate constants for attachment and detachment are defined and estimated by fitting mathematical models to the resulting data. The model for cell attachment accounts for the global transport of cell in the chamber to estimate the cells concentration near the collector surface. The model for cell detachment accounts for heterogeneity in the adhesion energy of the attached cell population. These models yield first-order attachment and detachment rate constants that intrinsically reflect the probabilities of bacteria attachment and detachment as a function of applied shear stress, depending on only the local interactions between the cell and the surface. The validity of each model was tested by statistical analyses of the goodness-of-fit to data that resulted from a study comparing adhesion of Staphylococcus aureus to three different polymeric surfaces of varying surface properties and adhesive prolein coatings.
C1 UNIV DELAWARE,COLL ENGN,NEWARK,DE 19716.
RP DICKINSON, RB (reprint author), UNIV FLORIDA,DEPT CHEM ENGN,GAINESVILLE,FL 32611, USA.
RI Dickinson, Richard/A-4435-2012
OI Dickinson, Richard/0000-0002-7415-2889
CR ADAMCZYK Z, 1983, ADV COLLOID INTERFAC, V19, P183, DOI 10.1016/0001-8686(83)80001-3
   Bates D. M., 1988, NONLINEAR REGRESSION
   BOWEN BD, 1976, J COLLOID INTERF SCI, V54, P374
   BRENNER H, 1961, CHEM ENG SCI, V16, P242, DOI 10.1016/0009-2509(61)80035-3
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   BROMBERG JP, 1984, PHYSICAL CHEM
   BUSSCHER HJ, 1992, J DENT RES, V71, P491, DOI 10.1177/00220345920710031301
   CHARI K, 1985, J COLLOID INTERF SCI, V107, P278, DOI 10.1016/0021-9797(85)90175-4
   COWAN M, 1993, MICROBIOS, V73, P135
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P841, DOI 10.1016/S0006-3495(90)82430-9
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   CROUCH CF, 1985, J CHEM TECHNOL BIOT, V35, P273, DOI 10.1002/jctb.280350408
   Cussler E. L., 1984, DIFFUSION MASS TRANS
   DABROS T, 1982, J COLLOID INTERF SCI, V89, P232, DOI 10.1016/0021-9797(82)90137-0
   DAHNEKE B, 1975, J COLLOID INTERF SCI, V50, P89, DOI 10.1016/0021-9797(75)90257-X
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   DICKINSON RB, 1995, UNPUB J BIOMAT SCI P
   DICKINSON RB, 1994, AICHE M SAN FRANCISC
   Dormand JR, 1980, J COMPUT APPL MATH, V6, P19, DOI [DOI 10.1016/0771-050X(80)90013-3, 10.1016/0771-050X(80)90013-3]
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DOWLER HW, 1980, MICROBIAL ADHESION S, P143
   GODDARD RJ, 1994, J POLYM SCI POL PHYS, V32, P1557, DOI 10.1002/polb.1994.090320827
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GRASEL TG, 1987, THESIS U WISCONSIN M
   Gristina A. G., 1987, ZENTRALBL BAKTERIO S, V16, P143
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   HERGENROTHER RW, 1991, THESIS U WISCONSIN M
   HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HUBBE MA, 1984, COLLOID SURFACE, V12, P151, DOI 10.1016/0166-6622(84)80096-7
   JEN CJ, 1991, AM J PHYSIOL, V261, pH1457
   LAWRENCE MB, 1990, BLOOD, V75, P227
   MCDEVITT D, 1992, INFECT IMMUN, V60, P1514
   MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x
   MEINDERS JM, 1993, COLLOID SURFACE A, V80, P279, DOI 10.1016/0927-7757(93)80209-W
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   MEINDERS JM, 1992, J COLLOID INTERF SCI, V152, P265, DOI 10.1016/0021-9797(92)90026-I
   MOLLER PS, 1963, AERONAUT QUART, V14, P163, DOI 10.1017/S0001925900002742
   OHTOMO T, 1988, ZBL BAKT-INT J MED M, V268, P325
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   REPORT N, 1989, NUMERICAL SIMULATION
   RUCKENSTEIN E, 1975, J THEOR BIOL, V51, P429, DOI 10.1016/0022-5193(75)90072-7
   SATERBAK A, 1993, BIOPHYS J, V65, P243, DOI 10.1016/S0006-3495(93)81077-4
   Seber GAF, 1989, NONLINEAR REGRESSION
   SHARMA MM, 1992, J COLLOID INTERF SCI, V149, P121, DOI 10.1016/0021-9797(92)90398-6
   SJOLLEMA J, 1989, J MICROBIOL METH, V9, P73, DOI 10.1016/0167-7012(89)90057-2
   Sjollema J., 1988, Biofouling, V1, P101
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   VAUDAUX PE, 1985, INFECT IMMUN, V50, P472
   Wadstrom T, 1989, J Invest Surg, V2, P353, DOI 10.3109/08941938909018261
   WILKINSON PC, 1984, J CELL BIOL, V99, P1761, DOI 10.1083/jcb.99.5.1761
NR 56
TC 50
Z9 50
U1 5
U2 18
PU AMER INST CHEMICAL ENGINEERS
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017
SN 0001-1541
J9 AICHE J
JI AICHE J.
PD SEP
PY 1995
VL 41
IS 9
BP 2160
EP 2174
DI 10.1002/aic.690410915
PG 15
WC Engineering, Chemical
SC Engineering
GA RT799
UT WOS:A1995RT79900014
DA 2018-10-19
ER

PT J
AU BOON, ME
   RUIJGROK, JM
   VARDAXIS, MJ
AF BOON, ME
   RUIJGROK, JM
   VARDAXIS, MJ
TI COLLAGEN IMPLANTS REMAIN SUPPLE NOT ALLOWING FIBROBLAST INGROWTH
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN IMPLANTS; CROSS-LINKING; FIBROBLAST INGROWTH
ID BOVINE PERICARDIUM; GLUTARALDEHYDE; BIOPROSTHESES; CALCIFICATION; VALVE;
   CELLS; RAT
AB Dense, reconstituted collagen membranes, using an optimized cross-linking protocol, were implanted subcutaneously into rats. After implantation, only a mild inflammatory response in the surrounding tissues was observed. The morphology of the fibroblasts around the membranes was seen to go through characteristic stages of proliferation and synthesis. In the 7 week follow-up it was found that these membranes did not allow any fibroblast ingrowth into their substance and remained completely intact and supple without signs of calcification, whereas the non-cross-linked controls proved to be completely degraded. The cross-linked reconstituted collagen may thus be considered for use in situations where neither incorporation nor dissolution of the biomaterial is desired.
C1 LEIDEN UNIV,DEPT BIOMAT,LEIDEN,NETHERLANDS.
   ROYAL MELBOURNE INST TECHNOL,DEPT MED LAB SCI,BUNDOORA,VIC 3083,AUSTRALIA.
RP BOON, ME (reprint author), LEIDEN CYTOL & PATHOL LAB,POB 16084,2301 GB LEIDEN,NETHERLANDS.
CR BOON ME, 1992, PATHOL RES PRACT, V188, P832
   CHVAPIL M, 1987, J BIOMED MATER RES, V21, P1383, DOI 10.1002/jbm.820211204
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GRIMM M, 1991, J THORAC CARDIOV SUR, V102, P195
   KAPLAN S, 1985, J SURG RES, V38, P45, DOI 10.1016/0022-4804(85)90009-5
   Kok L. P., 1992, MICROWAVE COOKBOOK M
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   OKAMURA K, 1980, SURGERY, V87, P170
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   RAMSHAW JAM, 1990, CURRENT PERSPECTIVES, V2, P151
   RUIJGROK JM, 1994, J MATER SCI-MATER M, V5, P80, DOI 10.1007/BF00121695
   RUIJGROK JM, 1993, EUR J MORPHOL, V31, P290
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   STRATES BS, 1957, J PHYS CHEM-US, V61, P279, DOI 10.1021/j150549a005
   URRY DW, PERSPECT BIOL MED, V18, P68
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VARDAXIS NJ, 1994, J BIOMED MATER RES, V28, P1013, DOI 10.1002/jbm.820280906
   VONDERHEIDE RH, 1990, IMMUNOLOGY, V69, P542
NR 19
TC 15
Z9 16
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 1995
VL 16
IS 14
BP 1089
EP 1093
DI 10.1016/0142-9612(95)98905-T
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RQ870
UT WOS:A1995RQ87000006
PM 8519930
DA 2018-10-19
ER

PT J
AU Bean, TA
   Zhuang, WC
   Tong, PY
   Eick, JD
   Chappelow, CC
   Yourtee, DM
AF Bean, TA
   Zhuang, WC
   Tong, PY
   Eick, JD
   Chappelow, CC
   Yourtee, DM
TI Comparison of tetrazolium colorimetric and Cr-51 release assays for
   cytotoxicity determination of dental biomaterials
SO DENTAL MATERIALS
LA English
DT Article
ID SURVIVAL; GROWTH
AB Objectives. The purpose of this study was to compare a methylthiazole tetrazolium (MTT) dye colorimeiric method with the standard Cr-51 assay as methods of assessing cytotoxicity of denial materials.
   Methods. Two MTT-based colorimetric formals, test tube and 96-well microplate methods, were compared to the Cr-51 release assay. A series of eight dental materials were evaluated. Cytotoxicity profiles were determined for each test material. A TC50 value (Toxic Concentration required to kill 50% of the cells) was determined for each biomaterial, and these results were used to make statistical comparisons between the methods.
   Results. The three methods were statistically correlated (p < 0.005) by comparison of the eight samples tested. That is, the same rank in toxicity was given by the two tetrazolium sample formats and the Cr-51 method.
   Significance. The MTT assay was found to have several advantages in comparison to the current standard Cr-51 release assay. Optimized in the 96 well format, complete dose response curves and greater sample comparisons can be made rapidly, making the MTT method more economical in time and cost. Furthermore, the MTT method is based on intracellular biochemical changes, measuring cell viability rather than cell morbidity, and has lower detectable limits than the Cr-51 release method. There is also less detector chemical binding interference than encountered in the Cr-51 release method.
C1 UNIV MISSOURI,DIV PHARMACOL,TOXICORE LAB,KANSAS CITY,MO 64108.
   UNIV MISSOURI,SCH DENT,KANSAS CITY,MO 64108.
   MIDWEST RES INST,KANSAS CITY,KS.
FU NIDCR NIH HHS [DE09696]
CR BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
   CARMICHAEL J, 1987, CANCER RES, V47, P943
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   HEO DS, 1990, CANCER RES, V50, P3681
   JOST LM, 1992, J IMMUNOL METHODS, V147, P153, DOI 10.1016/S0022-1759(12)80003-2
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Recommended Standard Practices For Biological Evaluation Of Dental Materials, 1980, INT DENT J, V30, P140
   RUBEN RL, 1987, CANCER TREAT REP, V71, P1141
   SMITH MD, 1992, INT J ARTIF ORGANS, V15, P191
   SPANGBERG L, 1973, ORAL SURG ORAL MED O, V35, P389, DOI 10.1016/0030-4220(73)90077-7
   WATAHA JC, 1992, DENT MATER, V8, P65, DOI 10.1016/0109-5641(92)90056-I
   1982, ANSI ADA41 AM NAT ST
NR 15
TC 28
Z9 28
U1 0
U2 1
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD SEP-NOV
PY 1995
VL 11
IS 5-6
BP 327
EP 331
DI 10.1016/0109-5641(95)80029-8
PG 5
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA TL487
UT WOS:A1995TL48700006
PM 8595830
DA 2018-10-19
ER

PT J
AU CHESMEL, KD
   BLACK, J
AF CHESMEL, KD
   BLACK, J
TI CELLULAR-RESPONSES TO CHEMICAL AND MORPHOLOGIC ASPECTS OF BIOMATERIAL
   SURFACES .1. A NOVEL IN-VITRO MODEL SYSTEM
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROTEIN ADSORPTION; CONTACT GUIDANCE; ORIENTATION; INVITRO; CELLS;
   FIBROBLASTS; TOPOGRAPHY; POLYMERS; INVIVO; SMOOTH
AB The clinical success of any implant is directly dependent upon the cellular behavior in the immediate vicinity of the interface established between the host tissue and the biomaterial(s) used to fabricate the device, All biomaterials have morphologic, chemical, and electrical surface characteristics that influence the cellular response to the implant. Quantitative measurement of specific aspects of this local host response to different but well-characterized biomaterial surfaces provides a crucial link in the understanding of the overall phenomenon of implant biocompatibility. A system has been devised for in vitro examination of responses of cells to controlled but independent changes in both the chemistry and morphology of polystyrene (PS) tissue culture surfaces. Micromachined silicon wafers wore used as templates to solvent-cast PS replicas [using 0, 1, or 2 wt % styrene (S) monomer additions] with either none, 0.5- or 5.0-mu m-deep surface grooves arranged in a radial array. When all possible morphologies were combined with all possible polymers, nine model biomaterial surfaces (MBSs) were produced. The chemical characteristics of the MBSs were determined using electron spectroscopy for chemical analysis, secondary ion mas's spectroscopy, and contact angle techniques and were found to be distinct. The types and amount of proteins that adsorb onto these surfaces from serum containing media were examined and found to consist of multiple molecular layers of relatively uniform composition. Self-contained tissue culture vessels formed from the MBSs were capable of supporting the growth of confluent cultures of rat calvarial cells. The model biomaterial system described here can be used to examine how simultaneous stimuli resulting from the chemical and morphological characteristics of a test material may influence biologic responses. Such multifactorial biocompatibility research is needed to properly document material-host interactions. (C) 1995 John Wiley and Sons, Inc.
C1 THOMAS JEFFERSON UNIV,DEPT ORTHOPAED SURG,PHILADELPHIA,PA 19107.
   CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634.
FU NIAMS NIH HHS [AR07132]
CR ADAMSON AW, 1967, PHYSICAL CHEM SURFAC
   Andrade J D, 1973, Med Instrum, V7, P110
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BORDENAVE I, 1994, J BIOMED MATER RES, V27, P1367
   Boundy R. H., 1952, STYRENE ITS POLYM CO
   BRAND JS, 1984, CELL SEPARATION METH, V3, P265
   BUCK RC, 1982, IN VITRO, V18, P783
   CASTNER D, 1990, ANAL STATIC SIMS DAT
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   CHESMEL KD, 1992, 4 WORLD BIOM C BERL, P139
   CHESMEL KD, 1990, 16TH ANN SOC BIOM CH, P204
   CLARK P, 1991, J CELL SCI, V99, P73
   DUNN GA, 1986, J CELL SCI, V83, P313
   GRNNEL F, 1972, BIOCH MED, V7, P87
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   HOMSY CA, 1970, J MACROMOL SCI CHEM, VA  4, P615, DOI 10.1080/00222337008074366
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   KAPUR R, 1993, BIOMATERIALS, V14, P854, DOI 10.1016/0142-9612(93)90007-O
   KUPP T, 1980, BIOMATERIALS 1980, P787
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1994, J BIOMED MATER RES, V27, P1553
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NYILAS E, 1977, J BIOMED MATER RES S, V8, P51
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   SCHAKENRAAD JM, 1988, 3RD T WORLD BIOM C K, P451
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V10, P1317
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, P113
NR 32
TC 61
Z9 61
U1 1
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1995
VL 29
IS 9
BP 1089
EP 1099
DI 10.1002/jbm.820290909
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RR477
UT WOS:A1995RR47700008
PM 8567707
DA 2018-10-19
ER

PT J
AU CHESMEL, KD
   CLARK, CC
   BRIGHTON, CT
   BLACK, J
AF CHESMEL, KD
   CLARK, CC
   BRIGHTON, CT
   BLACK, J
TI CELLULAR-RESPONSES TO CHEMICAL AND MORPHOLOGIC ASPECTS OF BIOMATERIAL
   SURFACES .2. THE BIOSYNTHETIC AND MIGRATORY RESPONSE OF BONE
   CELL-POPULATIONS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID EXTRACELLULAR-MATRIX; ORIENTATION; OSTEOBLASTS; SUBSTRATA; ATTACHMENT;
   INVITRO; GROWTH; DIFFERENTIATION; PROTEINS; GUIDANCE
AB The biosynthetic and migratory response of bone cells to changes in both surface composition and morphology of polystyrene (PS) substrates was examined. A system was devised wherein micromachined silicon wafers were used as templates to solvent-cast PS replicas [using 0, 1, or 2 wt % styrene (S) monomer additions] with either 0.5- or 5.0-mu m-deep surface grooves. Smooth replicas (0% S) served as the control surfaces. The chemical and morphologic characteristics of the nine unique model biomaterial surfaces (MBSs) produced using this system were documented and were found to be distinct. For the biosynthetic studies, bone cells isolated from neonatal rat calvaria were plated onto the MBSs and labeled at postconfluence with [C-14]proline for 24 h. Total DNA per surface, total newly synthesized collagenous (CP), and noncollagenous protein (NCP) (cell associated and secreted) were determined. Cell-associated CP was found to increase significantly for the bone cells cultured on the substrates with 0.5-mu m grooves and 2% S (P <.05). Cell-associated NCP was found to be elevated for all 2% S substrates and for the 0.5-mu m grooves substrates with 1% S. For the migration studies, bone cells were plated first onto 5-mm nitrocellulose disks that were attached to standard Petri dishes using a plasma clot. At confluence, the disks were removed aseptically and placed on the replicas. The cellular area occupied as a result of the outward migration of the bone cells was measured after 4 days of culture using an image analysis system. An average velocity for the leading edge of bone cell populations on each of the nine MBSs was calculated: Cells on surfaces with either 1% S or 5.0-mu m grooves displayed significantly higher velocities than did the control cultures. A significant interaction effect between chemistry and morphology was observed. The biosynthetic and migratory responses of in vitro cultures of bone cells were not predictable from the observations of the cellular responses to the individual features, but appeared to depend on cellular responses to more than one substrate factor. (C) 1995 John Wiley and Sons, Inc.
C1 THOMAS JEFFERSON UNIV, DEPT ORTHOPAED SURG RES, PHILADELPHIA, PA 19107 USA.
   UNIV PENN, DEPT ORTHOPAED SURG, PHILADELPHIA, PA 19104 USA.
FU NIAMS NIH HHS [AR07132]
CR BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x
   BOYDE A, 1976, CELL TISSUE RES, V166, P65, DOI 10.1007/BF00215125
   BRAND JS, 1984, CELL SEPARATION METH, V3, P265
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BUCK RC, 1982, IN VITRO CELL DEV B, V18, P783, DOI 10.1007/BF02796502
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK CC, 1985, COLLAGEN REL RES, V5, P205
   CLARK P, 1991, J CELL SCI, V99, P73
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DIEGELMANN RF, 1972, DEV BIOL, V28, P443, DOI 10.1016/0012-1606(72)90028-0
   DUNN GA, 1991, BIOESSAYS, V13, P541, DOI 10.1002/bies.950131008
   FISHER LW, 1987, J BIOL CHEM, V262, P9702
   Freshney RI, 1983, CULTURE ANIMAL CELLS
   HARRIS A, 1973, EXP CELL RES, V77, P285, DOI 10.1016/0014-4827(73)90579-X
   HOCH HC, 1987, SCIENCE, V235, P1659, DOI 10.1126/science.235.4796.1659
   HOMSY CA, 1970, J MACROMOL SCI CHEM, VA  4, P615, DOI 10.1080/00222337008074366
   JONES SJ, 1977, J CELL SCI, V25, P247
   JONES SJ, 1977, CELL TISSUE RES, V184, P179
   KUPP T, 1980, BIOMATERIALS 1980, P787
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lackie J.M., 1986, CELL MOVEMENT CELL B
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   PITARU S, 1984, J PERIODONTAL RES, V19, P408, DOI 10.1111/j.1600-0765.1984.tb01014.x
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   RICCI JL, 1990, J APPL BIOMATER, V1, P103, DOI 10.1002/jab.770010202
   RICCI JL, 1994, 20THH ANN SOC BIOM B, P401
   SCHAKENRAAD JM, 1988, 3RD T WORLD BIOM C K, P451
   SOMERMAN MJ, 1987, J BONE MINER RES, V2, P259
   STEIN GS, 1990, FASEB J, V4, P3111
NR 32
TC 87
Z9 91
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1995
VL 29
IS 9
BP 1101
EP 1110
DI 10.1002/jbm.820290910
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RR477
UT WOS:A1995RR47700009
PM 8567708
DA 2018-10-19
ER

PT J
AU VANLOON, JJWA
   BIERKENS, J
   MAES, J
   SCHOETERS, GER
   OOMS, D
   DOULABI, BZ
   VELDHUIJZEN, JP
AF VANLOON, JJWA
   BIERKENS, J
   MAES, J
   SCHOETERS, GER
   OOMS, D
   DOULABI, BZ
   VELDHUIJZEN, JP
TI POLYSULFONE INHIBITS FINAL DIFFERENTIATION STEPS OF OSTEOGENESIS
   IN-VITRO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYSULFONE; BIOMATERIAL; COMPOSITES; INDUCTION; INVITRO; CELLS
AB Biocompatibility is an important factor in the development of orthopedic implants as well as in the development of new tissue culture devices. Polysulphone has been used for orthopedic implants because of its mechanical properties, ease of sterilization, molding capacity, and biocompatibility. Therefore, polysulphone has been chosen as the prime material for the construction of tissue culture devices to be used for the cultivation of osteogenic cells (preosteoblast-like MN7 cells and primary bone marrow fragments), as well as complete fetal long bone explants under space flight conditions. Whereas polysulphone did not interfere with the proliferation in early stages of bone-forming cells, we show that leachable factors within the polysulphone polymer prevented the final steps of matrix formation as measured by collagen synthesis and matrix mineralization. These data argue against polysulphone as a material for orthopedic implants. (C) 1995 John Wiley and Sons, Inc.
C1 VLAAMSE INSTELLING TECHNOL ONDERZOEK, DIV ENVIRONM, MOL, BELGIUM.
RP VANLOON, JJWA (reprint author), VRIJE UNIV AMSTERDAM, ACTA, DEPT ORAL CELL BIOL, VD BOECHORST STR 7, 1081 BT AMSTERDAM, NETHERLANDS.
RI van Loon, Jack/A-4250-2013
CR ANDERSEN DE, 1988, 5TH INT WORKSH IN VI, P2
   ANGLE CR, 1993, BIOMETALS, V6, P179
   BURRI C, 1989, UNFALLCHIRURG, V89, P528
   CLAES L, 1989, BIOMED TECH, V34, P315, DOI 10.1515/bmte.1989.34.12.315
   DEGROOT RP, 1990, J CELL SCI, V97, P33
   Foerster W, 1984, Dtsch Z Mund Kiefer Gesichtschir, V8, P437
   IIO K, 1994, J BIOMED MATER RES, V28, P459, DOI 10.1002/jbm.820280408
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   Leach CS, 1977, NASA SP, P204
   MANDENIUS CF, 1991, BIOMATERIALS, V12, P369, DOI 10.1016/0142-9612(91)90004-T
   MATHIEU E, 1992, CALCIFIED TISSUE INT, V50, P362, DOI 10.1007/BF00301635
   MIWA M, 1991, BONE MINER, V14, P15, DOI 10.1016/0169-6009(91)90099-L
   MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643
   PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   SCHOETERS GER, 1988, CELL TISSUE KINET, V21, P363, DOI 10.1111/j.1365-2184.1988.tb00794.x
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   STEIN GS, 1990, FASEB J, V4, P3111
   UBBELS GA, 1988, ESA SP, V1091, P147
   VANDERVEGT AK, 1991, POLYM CHAIN RESIN
   VANLOON JJWA, 1990, ESA SP PUBL, V307, P393
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   VOSE GP, 1974, AM J ROENTGENOL, V121, P1
   WATAHA JC, 1994, J BIOMED MATER RES, V28, P427, DOI 10.1002/jbm.820280404
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
NR 25
TC 4
Z9 4
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1995
VL 29
IS 9
BP 1155
EP 1163
DI 10.1002/jbm.820290916
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RR477
UT WOS:A1995RR47700015
PM 8567714
DA 2018-10-19
ER

PT J
AU KHARDORI, N
   YASSIEN, M
AF KHARDORI, N
   YASSIEN, M
TI BIOFILMS IN DEVICE-RELATED INFECTIONS
SO JOURNAL OF INDUSTRIAL MICROBIOLOGY
LA English
DT Article
DE BIOFILMS; GLYCOCALYX; BIOMATERIALS; PROSTHETIC DEVICES
ID STAPHYLOCOCCUS-AUREUS BACTEREMIA; CENTRAL VENOUS CATHETERS; TOTAL
   PARENTERAL-NUTRITION; POLYMORPHONUCLEAR LEUKOCYTES; SEMIQUANTITATIVE
   CULTURE; PSEUDOMONAS-AERUGINOSA; INTRAVENOUS CATHETERS;
   HOSPITALIZED-PATIENTS; MICROBIAL ADHESION; TISSUE INTEGRATION
AB The use of various medical devices including indwelling vascular catheters, cardiac pacemakers, prosthetic heart valves, chronic ambulatory peritoneal dialysis catheters and prosthetic joints has greatly facilitated the management of serious medical and surgical illness, However, the successful development of synthetic materials and introduction of these artificial devices into various body systems has been accompanied by the ability of microorganisms to adhere to these devices in the environment of biofilms that protect them from the activity of antimicrobial agents and from host defense mechanisms. A number of host, biomaterial and microbial factors are unique to the initiation, persistence and treatment failures of device-related infections, Intravascular catheters are the most common devices used in clinical practice and interactions associated with these devices are the leading cause of nosocomial bacteremias, The infections associated with these devices include insertion site infection, septic thrombophlebitis, septicemia, endocarditis and metastatic abscesses, Other important device-related infections include infections of vascular prostheses, intracardiac prostheses, total artificial hearts, indwelling urinary catheters, orthopedic prostheses, endotracheal tubes and extended wear lenses. The diagnosis and management of biofilm-associated infections remain difficult but critical issues, Appropriate antimicrobial therapy is often not effective in eradicating these infections and the removal of the device becomes necessary, Several improved diagnostic and therapeutic modalities have been reported in recent experimental studies, The clinical usefulness of these strategies remains to be determined.
C1 SO ILLINOIS UNIV,SCH MED,DEPT IMMUNOL MICROBIOL,SPRINGFIELD,IL 62794.
RP KHARDORI, N (reprint author), SO ILLINOIS UNIV,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,POB J19230,SPRINGFIELD,IL 62794, USA.
CR ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BANDYK DF, 1991, J VASC SURG, V13, P575
   BANERJEE C, 1988, ARCH INTERN MED, V148, P1769, DOI 10.1001/archinte.148.8.1769
   BENEZRA D, 1988, AM J MED, V85, P495
   BJORNSON HS, 1982, SURGERY, V92, P720
   BLENKINSOPP SA, 1992, APPL ENVIRON MICROB, V58, P3770
   BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873
   BUSSCHER HJ, 1991, CELL MATER, V1, P49
   BUSSCHER HJ, 1991, J BIOMAT SCI POLYMER, V3, P85094
   CHAUDHARI P, 1986, SCI AM, V255, P136, DOI 10.1038/scientificamerican1086-136
   CLERI DJ, 1980, J INFECT DIS
   COLLIGNON PJ, 1986, J CLIN MICROBIOL, V24, P532
   COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503
   COSTERTON JW, 1989, ASM NEWS, V650
   DICKINSON GM, 1993, INT J ARTIF ORGANS, V16, P749
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P597, DOI 10.1128/AAC.33.5.597
   Dudman W.F., 1977, SURFACE CARBOHYDRATE, P357
   DUGDALE DC, 1990, AM J MED, V89, P137, DOI 10.1016/0002-9343(90)90290-T
   ELTING LS, 1990, INFECT CONT HOSP EP, V11, P134
   ELTING LS, 1990, MEDICINE, V69, P296, DOI 10.1097/00005792-199009000-00003
   ENGEL T, 1986, SCIENCE, V234, P327, DOI 10.1126/science.234.4774.327
   EPPES SC, 1989, PEDIATR INFECT DIS J, V8, P99
   FLETCHER M, 1980, BACTERIAL ADHERENCE, P345
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   GIL RT, 1989, ARCH INTERN MED, V149, P1139, DOI 10.1001/archinte.149.5.1139
   GORMER R, 1982, SCI AM, V247, P98
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   Gristina AG, 1984, INFECT SURG, V3, P655
   HAMPTON AA, 1988, SURG CLIN N AM, V68, P57
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HIEMENZ J, 1986, PEDIATR INFECT DIS J, V5, P6, DOI 10.1097/00006454-198601000-00002
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   JONES HC, 1969, J BACTERIOL, V99, P316
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KHARDORI N, 1969, 92 ANN M AM SOC MICR, pB241
   LASKOWSKI LF, 1977, NEW ENGL J MED, V297, P101, DOI 10.1056/NEJM197707142970209
   LIBMAN H, 1984, ARCH INTERN MED, V144, P541, DOI 10.1001/archinte.144.3.541
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   Maki DG, 1989, INFECT ASS INDWELLIN, P161
   MARRIE TJ, 1983, APPL ENVIRON MICROB, V45, P1018
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MARRIE TJ, 1983, AM J OBSTET GYNECOL, V146, P384, DOI 10.1016/0002-9378(83)90818-9
   MARRIE TJ, 1979, J INFECT DIS, V19, P357
   MARTINO P, 1990, REV INFECT DIS, V12, P250
   MICHEL L, 1979, AM J SURG, V137, P745, DOI 10.1016/0002-9610(79)90085-0
   MIRAMONOFF RO, 1982, ARCH INTERN MED, V142, P1311
   MOYER MA, 1983, ARCH INTERN MED, V143, P66, DOI 10.1001/archinte.143.1.66
   MYLOTTE JM, 1987, AM J INFECT CONTROL, V15, P1, DOI 10.1016/0196-6553(87)90069-1
   NICKEL JC, 1985, CAN J SURG, V28, P50
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P752, DOI 10.2106/00004623-197860060-00004
   PETTY W, 1978, J BONE JOINT SURG AM, V60, P492, DOI 10.2106/00004623-197860040-00011
   PLATT R, 1982, NEW ENGL J MED, V307, P637, DOI 10.1056/NEJM198209093071101
   POWELL C, 1988, J PARENTER ENTERAL N, V12, P464
   PRAGER RL, 1984, SOUTHERN MED J, V77, P458, DOI 10.1097/00007611-198404000-00012
   PULVERER G, 1987, ZENTRALBL BAKTERIO A, V16
   RAAD I, 1992, INFECT CONT HOSP EP, V13, P215
   RAAD II, 1992, CLIN INFECT DIS, V14, P75, DOI 10.1093/clinids/14.1.75
   RAAD II, 1991, DIAGN MICROBIOL INFE, V15, P13
   SALEH RA, 1987, PEDIATR INFECT DIS J, V6, P851, DOI 10.1097/00006454-198709000-00013
   SHERERTZ RJ, 1990, J CLIN MICROBIOL, V28, P76
   SHETH NK, 1983, J CLIN MICROBIOL, V18, P1061
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   SNYDMAN DR, 1982, AM J MED, V73, P695, DOI 10.1016/0002-9343(82)90412-0
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   STAMM WE, 1975, ANN INTERN MED, V82, P386, DOI 10.7326/0003-4819-82-3-386
   STERN GA, 1985, ARCH OPHTHALMOL-CHIC, V103, P1221, DOI 10.1001/archopht.1985.01050080133033
   STRINDEN WD, 1985, ANN SURG, V202, P653, DOI 10.1097/00000658-198511000-00019
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   WANG EEL, 1984, PEDIATR INFECT DIS J, V3, P110, DOI 10.1097/00006454-198403000-00005
   WARREN JW, 1982, J INFECT DIS, V146, P719, DOI 10.1093/infdis/146.6.719
   WARREN JW, 1981, J UROLOGY, V124, P1
   WATNAKUNAKORN C, 1977, AM J MED, V63, P253
   YASUDA H, 1994, ANTIMICROB AGENTS CH, V38, P138, DOI 10.1128/AAC.38.1.138
NR 79
TC 96
Z9 96
U1 1
U2 18
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE, HANTS, ENGLAND RG21 2XS
SN 0169-4146
J9 J IND MICROBIOL
JI J. Indust. Microbiol.
PD SEP
PY 1995
VL 15
IS 3
BP 141
EP 147
DI 10.1007/BF01569817
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA TA263
UT WOS:A1995TA26300003
PM 8519469
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI TOPICAL CONFERENCE ON BIOMATERIAL INTERFACES - 24-28 OCTOBER 1994 -
   COLORADO-CONVENTION-CENTER - DENVER, COLORADO - PREFACE
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0734-2101
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A-Vac. Surf. Films
PD SEP-OCT
PY 1995
VL 13
IS 5
BP 2605
EP 2605
PG 1
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA RV828
UT WOS:A1995RV82800047
DA 2018-10-19
ER

PT J
AU FITZGERALD, ER
   FITZGERALD, JW
AF FITZGERALD, ER
   FITZGERALD, JW
TI BLUBBER AND COMPLIANT COATINGS FOR DRAG REDUCTION IN WATER .1.
   VISCOELASTIC PROPERTIES OF BLUBBER AND COMPLIANT COATING MATERIALS
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC MATERIALS SENSORS AND
   SYSTEMS
LA English
DT Article; Proceedings Paper
CT International Conference on Intelligent Materials (ICIM2)
CY 1994
CL WILLIAMSBURG, VA
DE DRAG REDUCTION; HYDRODYNAMICS; COMPLIANT COATINGS; VISCOELASTIC
   PROPERTIES; BLUBBER
ID FLOWS
AB The dolphin and some related marine mammals are noted for small hydrodynamic drag, and a delay in the onset of boundary layer turbulence with increasing Reynolds number. In 1957 Kramer suggested that a compliant biomaterial coating on the dolphin is responsible for the decreased drag, and drag reduction was reported during 1960-62 by Kramer for towed underwater bodies covered with coatings to simulate the dolphin skin. However, attempts to reproduce and verify Kramer's results have been unsuccessful; results reported are contradictory. Characterizations of the viscoelastic compliant materials used are inadequate, and a quantitative knowledge of the viscoelastic properties of the biomaterial coating of marine mammals for comparison with proposed synthetic drag reduction coatings is needed. The data reported here include values of complex shear compliance (J* = J' - iJ''), shear modulus (G* = G' + iG''), with the mechanical loss tangent (J''/J' = G'' /G'), and shear sound velocity and attenuation in the frequency range of 2 to 1000 Hz for samples of pilot whale blubber and for several compliant coating materials. A brief description of an automated measurement system for the dynamic mechanical properties mentioned above, requiring 3 to 5 seconds at any frequency between 2 and 10,000 Hz, is also included.
C1 JOHNS HOPKINS UNIV,BALTIMORE,MD 21218.
   KILDARE CORP,NEW LONDON,CT 06320.
CR FITZGERALD, 1992, Patent No. 5081872
   FITZGERALD E R, 1977, Medical Physics (Woodbury), V4, P49, DOI 10.1118/1.594383
   FITZGERALD ER, 1987, POLYM BULL, V18, P167
   FITZGERALD ER, 1975, BIORHEOLOGY, V12, P397
   FITZGERALD ER, 1957, J ACOUST SOC AM, V29, P61, DOI 10.1121/1.1908684
   FITZGERALD ER, 1957, J CHEM PHYS, V27, P1180, DOI 10.1063/1.1743952
   FITZGERALD ER, 1989, APR P PMSE ACS NAT M, V60, P573
   FITZGERALD ER, 1970, MED BIOL ENG, V9, P459
   Gad-el-Hak M., 1987, J FLUID STRUCT, V1, P55
   GADELHAK M, 1984, J FLUID MECH, V140, P257, DOI 10.1017/S0022112084000598
   GADELHAK M, 1986, APPL MECH REV, V39, P511
   HANSEN RJ, 1974, J SOUND VIB, V34, P297, DOI 10.1016/S0022-460X(74)80314-7
   Kramer M. O., 1960, J AM SOC NAVAL ENG, V72, P25
   Kramer M O, 1962, J AM SOC NAVAL ENG, V74, P341
   KRAMER MO, 1957, J AERONAUT SCI, V24, P459
   Kramer MO, 1961, J AM SOC NAVAL ENG, V73, P103
   NYBORG WL, 1975, INTERMEDIATE BIOPHYS, P456
   STAVERMAN AJ, 1956, PHYSIK HOCHPOLYMEREN, V5, P91
NR 18
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0928-4931
J9 MAT SCI ENG C-BIOMIM
JI Mater. Sci. Eng. C-Biomimetic Mater. Sens. Syst.
PD SEP
PY 1995
VL 2
IS 4
BP 209
EP 214
DI 10.1016/0928-4931(95)00079-8
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA TG131
UT WOS:A1995TG13100005
DA 2018-10-19
ER

PT J
AU GREENE, C
   MCDEVITT, D
   FRANCOIS, P
   VAUDAUX, PE
   LEW, DP
   FOSTER, TJ
AF GREENE, C
   MCDEVITT, D
   FRANCOIS, P
   VAUDAUX, PE
   LEW, DP
   FOSTER, TJ
TI ADHESION PROPERTIES OF MUTANTS OF STAPHYLOCOCCUS-AUREUS DEFECTIVE IN
   FIBRONECTIN-BINDING PROTEINS AND STUDIES ON THE EXPRESSION OF FNB GENES
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID FOREIGN-BODY INFECTION; NUCLEOTIDE-SEQUENCE; INTRAVASCULAR CATHETERS;
   ADHERENCE; ADSORPTION; FIBRINOGEN; CLEAVAGE; SITES
AB Staphylococcus aureus 8325-4 has the potential to express two distinct cell wall-associated fibronectin-binding proteins called FnBPA and FnBPB. In order to test if both proteins are expressed in S. aureus and if both are required for promoting bacterial adhesion to fibronectin-coated surfaces, insertion mutations were isolated in each gene. A DNA fragment encoding tetracycline resistance was inserted into fnbA and a fragment encoding erythromycin resistance was inserted into fnbB. A double fnbA fnbB mutant was also constructed. The fnbA and fnbB single mutants showed no significant reduction in their adhesion to polymethylmethacrylate coverslips that had been coated in vitro with fibronectin. However, the double mutant was completely defective in adhesion. Monospecific antibodies directed against the non-conserved N-terminal regions of both proteins confirmed the lack of expression of FnBPs in the mutant strains. Wild-type fnbA and fnbB genes cloned seperately on a multicopy plasmid were each able to restore fully the adhesion-defective phenotype of the 8325-4 fnbA fnbB mutant. This demonstrates that both fnb genes are expressed in S. aureus and that both contribute to the ability of strain 8325-4 to adhere to fibronectin-coated surfaces, The double mutant was also defective in adhesion to coverslips that had been removed from tissue cages implanted subcutaneously in guinea-pigs, which suggests that fibronectin is important in promoting attachment of S. aureus to biomaterial in vivo.
C1 TRINITY COLL DUBLIN,MOYNE INST PREVENT MED,DEPT MICROBIOL,DUBLIN 2,IRELAND.
   HOP CANTONAL GENEVA,DIV INFECT DIS,CH-1211 GENEVA 4,SWITZERLAND.
RI Greene, Catherine/D-3513-2012
OI Greene, Catherine/0000-0003-2549-2569
FU Wellcome Trust
CR ASHESHOV EH, 1966, J GEN MICROBIOL, V42, P403, DOI 10.1099/00221287-42-3-403
   Ausubel F., 1987, CURRENT PROTOCOLS MO
   BOZZINI S, 1992, EUR J BIOCHEM, V207, P327, DOI 10.1111/j.1432-1033.1992.tb17054.x
   COTTONARO CN, 1981, ASAIO T, V27, P391
   DELMI M, 1994, J ORTHOPAED RES, V12, P432, DOI 10.1002/jor.1100120316
   GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z
   HAMILL RJ, 1987, REV INFECT DIS, V9, pS360
   HHORINOUCHI S, 1982, J BACTERIOL, V149, P804
   HILL PJ, 1993, BIOTECHNOL APPL BIOC, V17, P3
   JONES CL, 1986, J BACTERIOL, V166, P29, DOI 10.1128/jb.166.1.29-33.1986
   JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   KREISWIRTH BN, 1983, NATURE, V305, P680
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   KUYPERS JM, 1989, INFECT IMMUN, V57, P2306
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINDBERG M, 1972, J BACTERIOL, V109, P844
   MAKI DG, 1982, CURRENT CLIN TOPICS, V3, P309
   MILLER JH, 1972, EXPT MOL GENETICS
   NOVICK RP, 1963, VIROLOGY, V33, P155
   OWEN P, 1985, ENTEROBACTERIAL SURF, P237
   PROCTOR RA, 1987, REV INFECT DIS, V9, pS317
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Sambrook J., 1989, MOL CLONING LABORATO
   SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583
   SIGNAS C, 1989, P NATL ACAD SCI USA, V86, P699, DOI 10.1073/pnas.86.2.699
   SOTTILE J, 1991, J BIOL CHEM, V266, P12840
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SPYCHER MO, 1986, BLOOD, V76, P12
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   WILSON CR, 1981, PLASMID, V5, P245, DOI 10.1016/0147-619X(81)90002-0
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   Youngman P., 1987, PLASMIDS PRACTICAL A, P79
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 37
TC 204
Z9 210
U1 1
U2 14
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD SEP
PY 1995
VL 17
IS 6
BP 1143
EP 1152
DI 10.1111/j.1365-2958.1995.mmi_17061143.x
PG 10
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA TB451
UT WOS:A1995TB45100012
PM 8594333
DA 2018-10-19
ER

PT J
AU NATHAN, A
   NUGENT, MA
   EDELMAN, ER
AF NATHAN, A
   NUGENT, MA
   EDELMAN, ER
TI TISSUE ENGINEERED PERIVASCULAR ENDOTHELIAL-CELL IMPLANTS REGULATE
   VASCULAR INJURY
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ATHEROSCLEROSIS; POLYMER-BASED CONTROLLED DELIVERY; RESTENOSIS; TISSUE
   ENGINEERING; VASCULAR REPAIR
ID FIBROBLAST GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; RECOMBINANT
   GENE-EXPRESSION; INTIMAL HYPERPLASIA; BALLOON CATHETER; ARTERIAL INJURY;
   NITRIC-OXIDE; PROLIFERATION; HEPARIN; ADHESION
AB Molecular biomaterial engineering permits in vivo transplantation of cells and tissues, offering the promise of restoration of physiologic control rather than pharmacologic dosing with isolated compounds, We engrafted endothelial cells on Gelfoam biopolymeric matrices with retention of viability, normal growth kinetics, immunoreactivity, and biochemical activity, The production of heparan sulfate proteoglycan and inhibition of basic fibroblast growth factor binding and activity by engrafted cells were indistinguishable from endothelial cells grown in culture, Perivascular implantation of Gelfoam-endothelial cell scaffolds around balloon-denuded rat carotid arteries reduced intimal hyperplasia 88.1%, far better than the isolated administration of heparin, the most effective endothelial mimic compound, In concert with a reduction in intimal area, cell proliferation was reduced by > 90%. To our knowledge, there have been no previous reports of extravascular cell implants controlling vasculoproliferative disease. Tissue engineered cells offer the potential for potent methods of vascular growth regulation and insight into the complex autocrine-paracrine control mechanisms within the blood vessel wall.
C1 HARVARD UNIV,MIT,DIV HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139.
   BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,BOSTON,MA 02115.
   HARVARD UNIV,SCH MED,BOSTON,MA 02115.
FU NIA NIH HHS [AG00294]; NIGMS NIH HHS [GM/HL 49039]
CR AUTIO I, 1989, ARTERY, V16, P72
   BJORNSSON TD, 1991, P NATL ACAD SCI USA, V88, P8651, DOI 10.1073/pnas.88.19.8651
   BUSSE R, 1985, BASIC RES CARDIOL, V80, P475, DOI 10.1007/BF01907912
   CASSCELLS W, 1992, CIRCULATION, V86, P723, DOI 10.1161/01.CIR.86.3.723
   CASTELLOT JJ, 1985, J CELL PHYSIOL, V124, P21, DOI 10.1002/jcp.1041240105
   CASTELLOT JJ, 1981, J CELL BIOL, V90, P372, DOI 10.1083/jcb.90.2.372
   CENTRA M, 1992, FASEB J, V6, P3117
   CLOWES AW, 1983, LAB INVEST, V49, P327
   CLOWES AW, 1985, LAB INVEST, V52, P611
   CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0
   CONTE MS, 1994, CIRCULATION, V23, P2161
   COOKE JP, 1992, CURR OPIN CARDIOL, V7, P799, DOI 10.1097/00001573-199210000-00013
   CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440
   DAVIES MG, 1993, ANN SURG, V218, P593, DOI 10.1097/00000658-199321850-00003
   DICHEK DA, 1989, CIRCULATION, V80, P1347, DOI 10.1161/01.CIR.80.5.1347
   DOHERTY DE, 1987, J IMMUNOL, V138, P1762
   EDELMAN ER, 1994, CIRCULATION, V89, P770, DOI 10.1161/01.CIR.89.2.770
   EDELMAN ER, 1990, P NATL ACAD SCI USA, V87, P3773, DOI 10.1073/pnas.87.10.3773
   EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   EDELMAN ER, 1993, J CLIN INVEST, V91, P2308, DOI 10.1172/JCI116460
   ESKO J, 1992, HEPARIN RELATED POLY, P97
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FISHMAN JA, 1975, LAB INVEST, V32, P339
   FLUGELMAN MY, 1992, CIRCULATION, V85, P1110, DOI 10.1161/01.CIR.85.3.1110
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   GEE AP, 1984, AM J HEMATOL, V17, P29, DOI 10.1002/ajh.2830170105
   HOOVER RL, 1980, J CELL SCI, V45, P73
   JARRELL BE, 1991, J VASC SURG, V13, P733
   KARNOVSKY MJ, 1994, AIRWAYS AND VASCULAR REMODELLING IN ASTHMA AND CARDIOVASCULAR DISEASE, P45
   LEY K, 1991, AM J PHYSIOL, V260, pH1667
   MCNAMARA DB, 1993, BIOCHEM BIOPH RES CO, V193, P291, DOI 10.1006/bbrc.1993.1622
   MESSINA LM, 1992, P NATL ACAD SCI USA, V89, P12018, DOI 10.1073/pnas.89.24.12018
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   NABEL EG, 1989, SCIENCE, V244, P1342, DOI 10.1126/science.2499928
   NATHAN A, 1994, POLYM MATER SCI ENG, V70, P320
   NUGENT MA, 1993, CIRC RES, V73, P1051, DOI 10.1161/01.RES.73.6.1051
   RAPRAEGER A, 1989, ANAL BIOCHEM, V179, P361, DOI 10.1016/0003-2697(89)90145-0
   RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002
   SCHWARTZ SM, 1975, AM J PATHOL, V81, P15
   SHEPPARD BL, 1971, PROC R SOC SER B-BIO, V176, P427, DOI 10.1098/rspb.1971.0006
   SIMONS M, 1992, NATURE, V359, P69
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
   ZWIEBEL JA, 1989, SCIENCE, V243, P220, DOI 10.1126/science.2911735
NR 44
TC 68
Z9 68
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 29
PY 1995
VL 92
IS 18
BP 8130
EP 8134
DI 10.1073/pnas.92.18.8130
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA RR844
UT WOS:A1995RR84400009
PM 7667257
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU SCHUTT, W
   THOMANECK, U
   GRUMMER, G
   KRAEFT, SK
   REINHOLZ, F
   WALDSCHLAGER, U
AF SCHUTT, W
   THOMANECK, U
   GRUMMER, G
   KRAEFT, SK
   REINHOLZ, F
   WALDSCHLAGER, U
TI NEW METHODS FOR THE INVESTIGATION OF BLOOD-BIOMATERIAL INTERACTION
SO ARTIFICIAL ORGANS
LA English
DT Article
DE CELL ELECTROPHORESIS; IMAGE PROCESSING; LASER SCANNING MICROSCOPY;
   STAINING; LYMPHOID CELLS; CYTOKINE; CHEMOTAXIS; DIALYSIS; MEMBRANES
ID MEMBRANES; CELLS
AB Quantitative microscopy with integrated image processing is a useful tool for investigation of the interaction of blood components with biomaterials. We have developed new automated measuring devices suitable for simultaneously characterizing biological cells (size, shape, localization, migration, electrophoresis), synthetic particles (electrophoretic fingerprinting), and dialysis membranes (morphology, electric charge). These techniques are useful for the investigation of cell adherence on biomaterials, localization of cells in membrane filters (Chemotaxis), characterization of the protein adsorption on model systems, detection of cytokines (produced after lymphocyte-biomaterial contact), and estimation of morphological properties and charge distribution in dialysis membranes.
C1 PROMONTA LUNDBECK,HAMBURG,GERMANY.
   HASOTEC,ROSTOCK,GERMANY.
   HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115.
   UNIV AUCKLAND,DEPT ENGN SCI,AUCKLAND,NEW ZEALAND.
   INST UMWELTTECHNOL,BERLIN,GERMANY.
RP SCHUTT, W (reprint author), CORNELL UNIV,COLL MED,DEPT PHYSIOL & BIOPHYS,1300 YORK AVE,NEW YORK,NY 10021, USA.
CR [Anonymous], COMMUNICATION
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   FIELD EJ, 1970, LANCET, V2, P1337
   GRUMMER G, 1992, CEBIT 92
   GRUMMER G, 1994, SCANNING 94
   KJELLSTRAND P, 1991, INT J ARTIF ORGANS, V14, P698
   KNIPPEL E, 1987, Z KLIN MED, V42, P1621
   KNIPPEL E, APPLICATIONS PARTICL, V2, P227
   KNIPPEL E, 1988, THESIS U ROSTOCK
   KRAEFT SK, 1993, EUR J CELL BIOL, V62, P415
   MARLOW BJ, 1988, LANGMUIR, V4, P776, DOI 10.1021/la00081a050
   MORI T, 1988, EUR J CANCER CLIN ON, V2, P1463
   MROSS KB, CANCER DIAGNOSIS OTH, V1, P871
   POHL A, 1978, JENA RUNDSCH, V6, P270
   REINHOLZ F, 1986, OPTIK STUTTGART, V483, P415
   REINHOLZ F, 1992, SPIE, V1660, P211
   SABOLOVIC D, ELECTROPHORETIC MOBI, V1, P333
   SCHUTT W, 1985, CELL ELECTROPHORESIS
   SCHUTT W, 1985, VERFAHREN UNTERSUCHU
   SCHUTT W, 1981, LABORPRAXIS MED, V3, P16
   SCHUTT W, 1991, PHYSICAL CHARACTERIZ
   SCHUTT W, PRINCIPLES CELL ELEC, V2, P215
   SCHUTT W, 1986, ELECTROPHORESIS 83
   Sherbet G., 1978, BIOPHYSICAL CHARACTE
   SHIMIZU M, 1992, ANTI-CANCER DRUG, V3, P427, DOI 10.1097/00001813-199208000-00018
   THOMANECK U, 1991, INT J ARTIF ORGANS, V14, P686
   THOMANECK U, CURRENT APPLICATION, V2, P265
   THOMANECK U, 1991, AUG ISAO C MONTR
   THOMANECK U, UNPUB
   THOMANECK U, 1991, 18 ESAO C WIEN
   THOMANECK U, 1986, IMMUNE METABOLIC ASP, P163
   WALDMANNMEYER H, 1989, 2ND P EUR C FUNCT PO
NR 32
TC 2
Z9 2
U1 0
U2 2
PU BLACKWELL SCIENCE PUBL INC CAMBRIDGE
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 1995
VL 19
IS 8
BP 847
EP 851
DI 10.1111/j.1525-1594.1995.tb02439.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA RV388
UT WOS:A1995RV38800012
PM 8573007
DA 2018-10-19
ER

PT J
AU COURTNEY, JM
   LAMBA, NMK
   GAYLOR, JDS
   RYAN, CJ
   LOWE, GDO
AF COURTNEY, JM
   LAMBA, NMK
   GAYLOR, JDS
   RYAN, CJ
   LOWE, GDO
TI BLOOD-CONTACTING BIOMATERIALS - BIOENGINEERING VIEWPOINTS
SO ARTIFICIAL ORGANS
LA English
DT Article
DE BLOOD CONTACTING BIOMATERIALS
ID BIOCOMPATIBILITY; CELLULOSE; SURFACES
AB The investigation of blood-contacting biomaterials is an important challenge and is relevant for an improvement in the clinical application of biomaterials. With the purpose of improved clinical treatment, bioengineering viewpoints of blood-contacting biomaterials cover the material options and selection, the utilization of materials, the development of materials with better properties and processing characteristics, and the design of relevant evaluation procedures. The bioengineering objective remains that of achieving an enhanced understanding of the relationship between a biomaterial and the biological response.
C1 HAMMERSMITH HOSP,DEPT SURG,LONDON W12 0HS,ENGLAND.
   ROYAL INFIRM,DEPT MED,GLASGOW G31 2ER,LANARK,SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,106 ROTTENROW,GLASGOW G4 0NW,LANARK,SCOTLAND.
CR BOSCH T, 1987, ARTIF ORGANS, V11, P144, DOI 10.1111/j.1525-1594.1987.tb02647.x
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   COURTNEY JM, 1993, ARTIF ORGANS, V17, P260
   COURTNEY JM, 1993, MANAGEMENT BLEEDING, P236
   COURTNEY JM, 1989, PROGR BIOENGINEERING, P21
   COURTNEY JM, 1991, INFLUENCE NEW TECHNO, P154
   COURTNEY JM, 1991, INFLUENCE NEW TECHNO, P163
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FORBES CD, 1994, HAEMOSTASIS THROMBOS, P1301
   Gaylor John D. S., 1994, Perfusion, V9, P173, DOI 10.1177/026765919400900304
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   KIM SW, 1976, J PHARM SCI, V651, P670
   KLINEFELTER H F, 1984, P1
   KLINKMANN H, 1994, NEPHROL DIAL TRANSPL, V9, P1
   Klinkmann H, 1989, Contrib Nephrol, V70, P213
   Klinkmann H., 1987, UREMIA THERAPY, P125
   KLINKMANN H, 1989, PROGR BIOENGINEERING, P7
   LAMBA NMK, 1994, INT J ARTIF ORGANS, V17, P433
   LIGHTFOOT N, 1974, TRANSPORT PHENOMENA
   MAHIOUT A, 1987, ARTIF ORGANS, V11, P149, DOI 10.1111/j.1525-1594.1987.tb02648.x
   MAHIOUT A, 1994, BIOMATERIALS, V15, P969, DOI 10.1016/0142-9612(94)90077-9
   MAINI R, 1984, BIOMATERIALS ARTIFIC, P186
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   RADCLIFFE DF, 1981, MED BIOL ENG COMPUT, V19, P627, DOI 10.1007/BF02442778
   RYAN CJ, 1979, BRIT J EXP PATHOL, V60, P400
   RYAN CJ, 1988, ARTIF ORGANS, V10, P135
   RYAN CJ, 1986, BIOMATERIALS ARTIF C, V18, P477
   Yin HQ, 1994, INT J ARTIF ORGANS, V17, P433
   YU J, 1991, BIOMATERIALS, V12, P119, DOI 10.1016/0142-9612(91)90188-G
NR 31
TC 10
Z9 10
U1 0
U2 3
PU BLACKWELL SCIENCE PUBL INC CAMBRIDGE
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 1995
VL 19
IS 8
BP 852
EP 856
DI 10.1111/j.1525-1594.1995.tb02440.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA RV388
UT WOS:A1995RV38800013
PM 8573008
DA 2018-10-19
ER

PT J
AU VIDAL, BD
AF VIDAL, BD
TI FROM COLLAGEN TYPE-I SOLUTION TO FIBERS WITH A HELICAL PATTERN - A
   SELF-ASSEMBLY PHENOMENON
SO COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA
   VIE-LIFE SCIENCES
LA English
DT Article
DE COLLAGEN; SELF-ASSEMBLY; SUPRAMOLECULAR ORGANIZATION
AB To determine whether collagen solubilized from tendons can characteristics of the tendon suprnorganization was the aim of the present study. Extracted and purified collagen in acetic acid solutions subjected to precipitation and extensive dialysis was found to produce gels with theological properties that allowed them to form threads and rubber-like rods. Molecular order and the ordered aggregational state of the fibers were detected by optical anisotropy at the polarization microscope. Self-assembly and self-organization resulted in a supraorganized structure in which the fibers are ordered parallel to the long axis of the thread or the rod, and in an intertwined helical organization. The highly birefringent fiber and their geometrically ordered self-organization resembled the original tendons. Some questions related to morphogenesis, recognition and adhesion events, biomechanical properties of collagen-containing structures and development of biomaterial for medical use may be answered by this model. In terms of perspectives it would be important to consider collagen fibers as models Sor producing organic-inorganic interface depositions to achieve optical properties.
RP VIDAL, BD (reprint author), UNICAMP,IB,DEPT CELL BIOL,BR-13083970 CAMPINAS,BRAZIL.
RI Vidal, Benedicto/I-3227-2012
OI Vidal, Benedicto/0000-0003-1629-5619
CR ARRUDA EF, 1995, 7TH EUR C BIOT NIC
   COSTABLE EC, 1993, NATURE, V362, P412
   COX R. W., 1967, J ROY MICROSC SOC, V87, P123
   GHOSH S, 1988, CONNECT TISSUE RES, V17, P33, DOI 10.3109/03008208808992792
   GIRAUDGUILLE MM, 1989, BIOL CELL, V67, P97, DOI 10.1111/j.1768-322X.1989.tb03014.x
   GLANVILLE RW, 1982, IMMUNOCHEMISTRY EXTR, V1, P46
   LACROIX PG, 1994, SCIENCE, V263, P658, DOI 10.1126/science.263.5147.658
   MARDER SR, 1994, SCIENCE, V263, P1706, DOI 10.1126/science.263.5154.1706
   MELLO MLS, 1972, ANN HISTOCHIM, V17, P333
   NICOUD JF, 1994, SCIENCE, V263, P636, DOI 10.1126/science.263.5147.636
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P24
   SCHNUR JM, 1994, SCIENCE, V264, P945, DOI 10.1126/science.264.5161.945
   STUPP SI, 1993, SCIENCE, V259, P59, DOI 10.1126/science.259.5091.59
   TABONY J, 1994, SCIENCE, V264, P245, DOI 10.1126/science.8146654
   THOMAS EL, 1993, SCIENCE, V259, P43, DOI 10.1126/science.259.5091.43
   TRELSTAD RL, 1985, CELL BIOL EXTRACELLU, P179
   VALLI M, 1986, CONNECT TISSUE RES, V15, P235, DOI 10.3109/03008208609001982
   VEIS A, 1979, BIOCHIM BIOPHYS ACTA, V576, P88, DOI 10.1016/0005-2795(79)90487-2
   Vidal B., 1994, REV FAC CIEN MED UNI, V4, P11
   VIDAL BC, 1975, ANN HISTOCHIM, V20, P15
   VIDAL BC, 1970, ANN HISTOCHIM, V15, P229
   VIDAL BD, 1982, HISTOCHEM J, V14, P857, DOI 10.1007/BF01005229
   VIDAL BDC, 1995, CR ACAD SCI III-VIE, V318, P173
   WALDECK DH, 1993, SCIENCE, V261, P576, DOI 10.1126/science.261.5121.576
   WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WOOD GC, 1964, INT REV CONNECT TISS, V2, P1
NR 27
TC 15
Z9 15
U1 1
U2 5
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 0764-4469
J9 CR ACAD SCI III-VIE
JI Comptes Rendus Acad. Sci. Ser. III-Sci. Vie-Life Sci.
PD AUG
PY 1995
VL 318
IS 8
BP 831
EP 836
PG 6
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA RU038
UT WOS:A1995RU03800002
DA 2018-10-19
ER

PT J
AU LAM, KH
   SCHAKENRAAD, JM
   GROEN, H
   ESSELBRUGGE, H
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF LAM, KH
   SCHAKENRAAD, JM
   GROEN, H
   ESSELBRUGGE, H
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI THE INFLUENCE OF SURFACE-MORPHOLOGY AND WETTABILITY ON THE INFLAMMATORY
   RESPONSE AGAINST POLY(L-LACTIC ACID) - A SEMIQUANTITATIVE STUDY WITH
   MONOCLONAL-ANTIBODIES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID CONTROLLED RELEASE; INTERFERON-GAMMA; TISSUE-RESPONSE; RAT MACROPHAGES;
   INVITRO; CELLS; BIOMATERIALS; GENERATION; ANTIGEN; INTERLEUKIN-1
AB In this study, the influence of surface morphology and wettability of both degradable and nondegradable polymer films on the inflammatory response after subcutaneous implantation in the rat was investigated. Degradable nonporous, porous, and ''combi'' (porous with a nonporous layer on one side) poly(L-lactic acid) (PLLA) films and nondegradable polytetrafluoroethylene (PTFE) and (porous) expanded PTFE (e-PTFE) were used. Contact angles measurements indicate that PLLA is more hydrophillic than PTFE. Assessment of the inflammatory response was performed after various periods of implantation (up till 180 days), with both conventional light microscopy and immunohistochemistry using monoclonal antibodies (mAbs). The inflammatory response observed initially can largely be considered as part of the wound healing reaction, and up till day 40 the inflammatory response against PLLA was minimally more intense than against PTFE (porous as well as nonporous). From day 40 on, the PLLA films provoke more intense inflammatory response as compared to the PTFE films. Both porous PLLA and the porous side of the ''combi'' PLLA film provoke a more intense inflammatory response than nonporous PLLA and the nonporous side of the ''combi'' PLLA film, respectively. In general, PTFE and e-PTFE films provoke an inflammatory response which is minimally more intense than the one provoked by the sham operation. Almost no ingrowth of tissue was observed in the porous e-PTFE films. In contrast, there was abundant tissue ingrowth in and an inflammatory response against porous PLLA. It can be concluded that biodegradable PLLA films provoke a more intense inflammatory response than nondegradable PTFE films. Also, porosity enhances the inflammatory response. However, porosity enhances the inflammatory response only when the wettability of a biomaterial permits cellular ingrowth. (C) 1995 John Wiley and Sons, Inc.
C1 UNIV GRONINGEN,CTR BIOMED TECHNOL,9712 KZ GRONINGEN,NETHERLANDS.
   UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT SECT,9713 EZ GRONINGEN,NETHERLANDS.
   UNIV TWENTE,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1975, ADV CHEM, V145, P1
   BARBE E, 1990, IMMUNOBIOLOGY, V182, P88, DOI 10.1016/S0171-2985(11)80586-3
   BLAAUW EH, 1987, ACTA MORPHOL NEER SC, V25, P167
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   BUSSCHER HJ, 1983, J COLLOID INTERF SCI, V95, P23, DOI 10.1016/0021-9797(83)90067-X
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   CHERFAS J, 1989, SCIENCE, V247, P630
   Cotran RS, 1994, PATHOLOGIC BASIS DIS, P51
   DALLMAN MJ, 1984, EUR J IMMUNOL, V14, P260, DOI 10.1002/eji.1830140311
   DAMOISEAUX JGMC, 1991, J LEUKOCYTE BIOL, V49, P434
   DEENEN GJ, 1987, J IMMUNOL, V139, P702
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   HERTWECK SP, 1988, BIOMATERIALS, V9, P457, DOI 10.1016/0142-9612(88)90013-0
   Ingber D.E., 1989, CELL SHAPE DETERMINA, P3
   KISILEVSKY R, 1994, PATHOLOGY, P1163
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   MARCHANT R, 1988, J BIOMED MATER RES, V18, P1169
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MENTZER SJ, 1986, J IMMUNOL, V137, P108
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   NAKAMURA T, 1994, J BIOMED MATER RES, V28, P17, DOI 10.1002/jbm.820280104
   PICKEN MM, 1990, LAB INVEST, V63, P586
   RATNER BD, 1989, COMPREHENSIVE POLYM, P201
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROZEMA FR, 1992, ADV BIOMAT, V10, P349
   SCHAKENRAAD JM, 1989, J BIOMED MATER RES, V23, P1271, DOI 10.1002/jbm.820231105
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   SEKI T, 1990, J PHARM SCI, V79, P985, DOI 10.1002/jps.2600791108
   SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   STET RJM, 1985, TRANSPLANT P, V17, P1829
   SUNDERLAND CA, 1979, EUR J IMMUNOL, V9, P155, DOI 10.1002/eji.1830090212
   VANGOOR H, 1991, LAB INVEST, V64, P754
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WACHEM PB, 1991, BIOMATERIALS, V12, P215
   WEITZMAN SA, 1990, BLOOD, V76, P655
   WHITE RA, 1981, BIOMATERIALS, V2, P171, DOI 10.1016/0142-9612(81)90046-6
   WODA BA, 1984, J IMMUNOL, V132, P2183
   ZIATS N, 1988, BIOMATERIALS, V6, P396
NR 47
TC 30
Z9 32
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1995
VL 29
IS 8
BP 929
EP 942
DI 10.1002/jbm.820290804
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RL619
UT WOS:A1995RL61900003
PM 7593036
DA 2018-10-19
ER

PT J
AU PULEO, DA
AF PULEO, DA
TI ACTIVITY OF ENZYME IMMOBILIZED ON SILANIZED CO-CR-MO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMATERIALS; SOLUBILITY; COATINGS; ADHESION; PEPTIDES; ALLOY
AB The surface of an orthopedic biomaterial was modified by the covalent immobilization of biomolecules. Derivatization of Co-Cr-Mo samples with organic and aqueous solutions of gamma-aminopropyltriethoxysilane (APS) resulted in a concentration-dependent number of reactive NH2 groups on the surface available for coupling to protein. The enzyme trypsin was used as a model biomolecule to investigate the effect of immobilization on proteolytic activity. Trypsin was coupled to the silanized samples by formation of Schiffs base linkages via glutaraldehyde. The nature of the interaction between trypsin and biomaterial was then probed by treatment with concentrated guanidine hydrochloride (GuHC1) and urea. Residual activity (following treatment with chaotropic agents) of trypsin immobilized on silanized Co-Cr-Mo was dependent both on the nature of the silane solution and on the type of chaotropic agent. Organic silanization with APS required a minimum density of approximately 49 NH2 per nm(2) of nominal surface area (> 0.021 M APS) for residual activity of immobilized trypsin. For aqueous silanization, approximately 5.4 NH2/nm(2) (0.51 M APS) resulted in maximal residual trypsin activity. Treatment with GuHCI removed more trypsin activity from Co-Cr-Mo samples silanized with organic solutions of APS than did treatment with urea. On the contrary, with aqueous silanization the samples possessed greater residual activity following treatment with GuHCI than following urea. Compared to simple adsorption with protein onto Co-Cr-Mo, both methods of silanization with APS resulted in superior residual immobilized enzyme activity. (C) 1995 John Wiley and Sons, Inc.
RP PULEO, DA (reprint author), UNIV KENTUCKY,CTR BIOMED ENGN,205 WENNER GREN LAB,LEXINGTON,KY 40506, USA.
CR Baier R. E., 1970, ADHESION BIOL SYSTEM, P15
   BAIER RE, 1983, PHYSICOCHEMICAL ASPE, V2, P895
   BERNSTEIN H, 1988, METHOD ENZYMOL, V137, P515
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   FIELDS R, 1971, BIOCHEM J, V124, P581, DOI 10.1042/bj1240581
   HALLING PJ, 1979, BIOTECHNOL BIOENG, V21, P393, DOI 10.1002/bit.260210304
   HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106
   HERMODSON MA, 1973, BIOCHEMISTRY-US, V12, P3146, DOI 10.1021/bi00741a002
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MATHEWS CK, 1990, BIOCHEMISTRY
   Messing R. A., 1975, IMMOBILIZED ENZYMES
   NOZAKI Y, 1970, J BIOL CHEM, V245, P1648
   NOZAKI Y, 1963, J BIOL CHEM, V238, P4074
   OKUYAMA T, 1960, J BIOCHEM-TOKYO, V47, P454, DOI 10.1093/oxfordjournals.jbchem.a127083
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   RAJAGOPALAN S, 1985, J CLIN INVEST, V75, P413, DOI 10.1172/JCI111715
   RICK W, 1963, METHOD ENZYMAT AN, P807
   SCOUTEN WH, 1987, METHOD ENZYMOL, V135, P30
   SPECTOR M, 1982, BIOCOMPATIBILITY ORT, P89
   STROUD RM, 1974, SCI AM, V231, P74, DOI 10.1038/scientificamerican0774-74
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   THOMPSON NG, 1980, ION IMPLANTATION MET
   TORCHILIN VP, 1988, METHOD ENZYMOL, V137, P552
   Weetall H H, 1976, Methods Enzymol, V44, P134
   WETLAUFER DB, 1964, J AM CHEM SOC, V86, P508
   WILCHEK M, 1984, METHOD ENZYMOL, V104, P3
   WILLIAMS JM, 1985, MATER SCI ENG, V69, P237, DOI 10.1016/0025-5416(85)90398-2
NR 30
TC 40
Z9 40
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1995
VL 29
IS 8
BP 951
EP 957
DI 10.1002/jbm.820290806
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RL619
UT WOS:A1995RL61900005
PM 7593038
DA 2018-10-19
ER

PT J
AU BADYLAK, SF
   TULLIUS, R
   KOKINI, K
   SHELBOURNE, KD
   KLOOTWYK, T
   VOYTIK, SL
   KRAINE, MR
   SIMMONS, C
AF BADYLAK, SF
   TULLIUS, R
   KOKINI, K
   SHELBOURNE, KD
   KLOOTWYK, T
   VOYTIK, SL
   KRAINE, MR
   SIMMONS, C
TI THE USE OF XENOGENEIC SMALL-INTESTINAL SUBMUCOSA AS A BIOMATERIAL FOR
   ACHILLES-TENDON REPAIR IN A DOG-MODEL
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID VASCULAR GRAFT; RUPTURES; INVIVO
AB A study was conducted to evaluate the tissue response to a xenogeneic biomaterial when this material was used to repair an experimentally induced Achilles tendon defect in the dog. Twenty dogs had a 1.5 cm segmental defect of the Achilles tendon created surgically which was then repaired with acellular connective tissue derived from porcine small intestinal submucosa (SIS). The animals were sacrificed at 1, 2, 4, 8, 12, 16, 24, and 48 weeks and the neotendons examined for uniaxial longitudinal tensile strength, morphologic appearance, hydroxyproline (collagen) content, and disappearance of the originally implanted SIS material over time. The contralateral normal Achilles tendons served as controls as did four additional dogs that had a 1.5 cm segmental Achilles tendon defect created surgically without subsequent surgical repair with SIS. Results showed the SIS remodeled neotendons to be stronger than the musculotendinous origin or the boney insertion (>1000 N) by 12 weeks after surgery and to consist of organized collagen-rich connective tissue similar to the contralateral normal tendons. The four dogs in which no SIS was implanted showed inferior strength at the comparable time points of 4, 8, 12, and 16 weeks. Immunohistochemical studies suggest that the SIS biomaterial becomes degraded within the first eight weeks and serves as a temporary scaffold around which the body deposits appropriate and organized connective tissue. SIS is a promising biomaterial worthy of further investigation for orthopedic soft tissue applications. (C) 1995 John Wiley & Sons, Inc.
C1 PURDUE UNIV,DEPT VET PHYSIOL & PHARMACOL,W LAFAYETTE,IN 47907.
   PURDUE UNIV,DEPT MECH ENGN,W LAFAYETTE,IN 47907.
   METHODIST SPORTS MED CTR INDIANAPOLIS,INDIANAPOLIS,IN 46206.
RP BADYLAK, SF (reprint author), PURDUE UNIV,HILLENBRAND BIOMED ENGN CTR,POTTER ENGN BLDG,W LAFAYETTE,IN 47907, USA.
OI Badylak, Stephen/0000-0003-3555-0689
CR BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, IN PRESS J VASC SURG
   BANKS WJ, 1993, APPLIED VET HISTOLOG, P339
   BESKIN JL, 1987, AM J SPORT MED, V15, P1, DOI 10.1177/036354658701500101
   Block S.S., 1991, DISINFECTION STERILI, P172
   BRADBURY P, 1990, THEORY PRACTICE HIST, P137
   CETTI R, 1993, AM J SPORT MED, V21, P791, DOI 10.1177/036354659302100606
   CHRISTENSEN I, 1953, ACTA CHIR SCAND, V106, P50
   GILLESPIE HS, 1969, J TRAUM, V9, P247, DOI 10.1097/00005373-196903000-00007
   GILLIES H, 1970, J BONE JOINT SURG AM, VA 52, P337, DOI 10.2106/00004623-197052020-00015
   HERBERT ST, 1993, ANN BIOMED ENG
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   HOWARD CB, 1984, J BONE JOINT SURG BR, V66, P206
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   INGLIS AE, 1981, CLIN ORTHOP RELAT R, V156, P160
   JACKSON D. S., 1967, METHODS BIOCHEM ANAL, V15, P25, DOI 10.1002/9780470110331.ch2
   KELLAM JF, 1985, CLIN ORTHOP RELAT R, V201, P80
   LANDVATER SJ, 1992, CLIN SPORT MED, V11, P741
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   Lindholm Arner O, 1959, ACTA CHIR SCAND, V239, P7
   NISTOR L, 1981, J BONE JOINT SURG AM, V63, P394, DOI 10.2106/00004623-198163030-00012
   Percy E C, 1978, Am J Sports Med, V6, P132, DOI 10.1177/036354657800600307
   Puddu G, 1976, Am J Sports Med, V4, P145, DOI 10.1177/036354657600400404
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SCHNEIDER P, 1992, MED DEVICE TECHN DEC, P43
   Shields C L Jr, 1978, Am J Sports Med, V6, P369, DOI 10.1177/036354657800600610
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   YANNAS IV, 1988, COLLAGEN BIOTECHNOLO, V3, pCH30
NR 31
TC 302
Z9 316
U1 0
U2 26
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1995
VL 29
IS 8
BP 977
EP 985
DI 10.1002/jbm.820290809
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RL619
UT WOS:A1995RL61900008
PM 7593041
DA 2018-10-19
ER

PT J
AU KIAEI, D
   HOFFMAN, AS
   HORBETT, TA
AF KIAEI, D
   HOFFMAN, AS
   HORBETT, TA
TI RADIOFREQUENCY GAS-DISCHARGE (RFGD) FLUORINATION OF POLYMERS - PROTEIN
   AND CELL-INTERACTIONS AT RFGD-FLUORINATED INTERFACES
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID PLATELET-ADHESION; FIBRINOGEN; ADSORPTION; BINDING
AB Proteins naturally adsorb at foreign surfaces. Adsorbed proteins on biomaterial surfaces are important to the biocompatibility of medical implants and devices, as well as to uses in biosensors, diagnostics, separations and industrial bioprocesses. There is ample evidence that the composition, organization, and conformations of the proteins adsorbed at a foreign interface are sensitive to the composition, topography, and molecular mobility of the substrate surface. The protein layer can also change in all the above aspects with time. Thus, it is a dynamic, ''living'' coating whose character is a direct reflection of the character of the substrate surface. Therefore, it is not surprising that many researchers have modified biomaterial surface compositions in order to influence protein absorption and subsequent conformational changes. The gas discharge process is one of the more useful methods for modification of biomaterial surfaces. Surfaces may be ablated (or etched) in a process which removes material and creates a cleaner, but chemically-modified surface. Gas discharge may also be used to deposit a polymer-like coating of a new composition on the surface, such as silicone and fluorocarbon coatings on hydrocarbon polymer surfaces. Certain of these fluorocarbon discharge-deposited polymers have been shown to enhance retention of adsorbed proteins, presumably by increased hydrophobic interactions with the modified substrate. Furthermore, platelet adhesion on such surfaces may be increasingly reduced as the adsorbed protein is increasingly bound to the fluorinated surface. These unusual results and their biologic implications are discussed in this paper.
C1 UNIV WASHINGTON, DEPT CHEM ENGN, SEATTLE, WA 98195 USA.
RP KIAEI, D (reprint author), UNIV WASHINGTON, DEPT BIOENGN, SEATTLE, WA 98195 USA.
CR BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   Brash JL, 1987, ACS S SERIES, V343
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   DEWANJEE MK, 1981, J NUCL MED, V22, P981
   DILKS A, 1981, ELECTRON SPECTROSCOP, V4, P289
   HELMKAMP RW, 1960, CANCER RES, V20, P1495
   HOFFMAN AS, 1991, Patent No. 5055316
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HORBETT TA, 1986, J BIOMED MATER RES, V20, P739, DOI 10.1002/jbm.820200608
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KIAEI D, 1992, J BIOMAT SCI-POLYM E, V4, P35
   KIAEI D, 1988, J APPL POLYM SCI APP, V42, P269
   KIAEI D, 1995, UNPUB PLATELET RECOG
   LINDON JN, 1986, BLOOD, V68, P355
   MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1021/j100842a055
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   WEATHERSBY PK, 1977, THROMB RES, V10, P245, DOI 10.1016/0049-3848(77)90006-8
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 21
TC 8
Z9 9
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD AUG
PY 1995
VL 46
IS 2
BP 191
EP 197
DI 10.1016/0969-806X(95)00012-M
PG 7
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA RK077
UT WOS:A1995RK07700008
DA 2018-10-19
ER

PT J
AU KATZ, DA
   HAIMOVICH, B
   GRECO, RS
AF KATZ, DA
   HAIMOVICH, B
   GRECO, RS
TI FC-GAMMA-RII, FC-GAMMA-RIII, AND CD18 RECEPTORS MEDIATE IN PART
   NEUTROPHIL ACTIVATION ON A PLASMA COATED EXPANDED
   POLYTETRAFLUOROETHYLENE SURFACE
SO SURGERY
LA English
DT Article; Proceedings Paper
CT 56th Annual Meeting of the Society-of-University-Surgeons
CY FEB 09-11, 1995
CL DENVER, CO
SP Soc Univ Surgeons
ID RESPIRATORY BURST; INTEGRINS
AB Background. A biomaterial-induced polymorhonuclear neutrophil (PMN) defect may predispose the implanted vascular graft to infection. PMNs bind, activate, and undergo morphologic changes when exposed to uncoated or plasma coated expanded polytetrafluoroethylene (ePTFE) surfaces. The purpose of this study was to investigate whether the CD18 integrin receptor or the immunoglobulin receptors FcyRII and FcyRIII mediate either PMN binding or activation on epTFE.
   Methods. PMN binding and activation were determined after incubation of these cells on human immunoglobulin (IgG) or fibrinogen coated surfaces and uncoated or plasma coated ePTFE. PMN activation was measured by using the ferricytochrome reduction assay. Binding was determined with chromium 51-labeled PMNs. To block the FryRII, FcyRIII, and CD18 receptors, PMNs were preincubated with the monoclonal antibodies (mAbs) IV.3 3G8, and IB4, respectively. Irrelevant isotype matched mAbs were used as control.
   Results. Monoclonal antibody IB4 inhibited binding of activated PMNs to fibrinogen coated surfaces. Binding to IgG was affected by either mAb IB4 or IV.3 but the greatest degree of inhibition was achieved when mAbs IB4 and IV.3 were used in combination. IgG-induced activation was partially inhibited by mAb IV.3 but was fully inhibited by a combination of mAbs IB4 and IV.3 The mAbs did not affect PMN binding to uncoated or plasma coated ePTFE nor was PMN activation on the uncoated ePTFE surface inhibited. PMN activation on the plasma coated ePTFE surface was, however, partially inhibited by the combination of mAb IB4 with either mAb IV.3 or 3G8.
   Conclusions. A synergistic interaction between the PMN FcyRII receptor and the CD18 integrin receptor accounts for surface bound IgG-induced cell activation. Both receptors also play a role in mediating PMN activation on the plasma-coated ePTFE surface.
RP KATZ, DA (reprint author), UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,433 MEB,NEW BRUNSWICK,NJ 08903, USA.
CR ANDERSON CL, 1990, J EXP MED, V171, P1333, DOI 10.1084/jem.171.4.1333
   BERTON G, 1992, J CELL BIOL, V116, P1007, DOI 10.1083/jcb.116.4.1007
   CHEUNG AK, 1993, KIDNEY INT, V43, P649, DOI 10.1038/ki.1993.94
   GRAHAM IL, 1993, J CELL BIOL, V120, P1509, DOI 10.1083/jcb.120.6.1509
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kaplan S S, 1990, ASAIO Trans, V36, pM172
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KATZ DA, 1994, SURGERY, V116, P446
   KATZ DA, 1994, PROBL GEN SURG   APR, P209
   NAZIRUDDIN B, 1992, J IMMUNOL, V149, P3702
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 15
TC 9
Z9 9
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0039-6060
J9 SURGERY
JI Surgery
PD AUG
PY 1995
VL 118
IS 2
BP 154
EP 161
DI 10.1016/S0039-6060(05)80318-6
PG 8
WC Surgery
SC Surgery
GA RM965
UT WOS:A1995RM96500005
PM 7638728
DA 2018-10-19
ER

PT J
AU KVETON, JF
   FRIEDMAN, CD
   COSTANTINO, PD
AF KVETON, JF
   FRIEDMAN, CD
   COSTANTINO, PD
TI INDICATIONS FOR HYDROXYAPATITE CEMENT RECONSTRUCTION IN LATERAL SKULL
   BASE SURGERY
SO AMERICAN JOURNAL OF OTOLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Otological-Society
CY MAY 07-08, 1994
CL PALM BEACH, FL
SP Amer Otol Soc
AB Preliminary data on the use of hydroxyapatite cement to restore cranial bone integrity has shown excellent results. Cranial base reconstruction has been accomplished for translabyrinthine, middle cranial fossa, and suboccipital craniectomy defects, as well as extensive temporal bone fractures. Fifteen patients have been followed for up to 2 years with no evidence of complication from use of the hydroxyapatite cement. Exposure to cerebrospinal fluid does not appear to alter its stability, and pre-existing infection appears to be the only contraindication to its use. Stability of the cement has been confirmed by serial radiographic analyses. This paper reviews the chemical structure and bioactivity of hydroxyapatite cement and employs case studies to illustrate the applications of this new biomaterial in lateral skull base surgery.
C1 USAF,WILFORD HALL MED CTR,DEPT OTOLARYNGOL,LACKLAND AFB,TX.
RP KVETON, JF (reprint author), YALE UNIV,SCH MED,OTOLARYNGOL SECT,333 CEDAR ST,POB 208041,NEW HAVEN,CT 06520, USA.
CR COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
NR 2
TC 70
Z9 72
U1 0
U2 1
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0192-9763
J9 AM J OTOL
JI Am. J. Otol.
PD JUL
PY 1995
VL 16
IS 4
BP 465
EP 469
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA RG142
UT WOS:A1995RG14200010
PM 8588646
DA 2018-10-19
ER

PT J
AU KISHIDA, A
   AKATSUKA, Y
   YANAGI, M
   AIKOU, T
   MARUYAMA, I
   AKASHI, M
AF KISHIDA, A
   AKATSUKA, Y
   YANAGI, M
   AIKOU, T
   MARUYAMA, I
   AKASHI, M
TI In vivo and ex vivo evaluation of the antithrombogenicity of human
   thrombomodulin immobilized biomaterials
SO ASAIO JOURNAL
LA English
DT Proceedings Paper
CT 41st Annual Conference of ASAIO
CY MAY 04-06, 1995
CL CHICAGO, IL
SP Amer Soc Artificial Internal Organs
AB Human thrombomodulin (hTM) is a newly described endothelial cell associated protein that functions as a potent natural anticoagulant by converting thrombin from a procoagulant protease to an anticoagulant. Focusing on the establishment of the practical evaluation of hTM immobilized materials, the activity of immobilized hTM was evaluated by in vivo and ex vivo blood contacting tests. As the basis for immobilization, regenerated cellulose films and hollow fibers were used. For the in vivo test, hTM immobilized cellulose hollow fibers were implanted into dog blood vessels. Using hTM immobilized cellulose hollow fibers, a small scale dialyzer was assembled and its antithrombogenic activity was studied using human blood. As a result, it was revealed that the immobilized hTM still has co-enzymatic activity for activation of Protein C and anticoagulant activity. The coagulation time of the human blood passed through the hTM immobilized small dialyzer was effectively prolonged. It is expected that hTM immobilized cellulose should be a useful antithrombogenic biomaterial.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,KAGOSHIMA 890,JAPAN.
RP KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,1-21-40 KORIMOTO,KAGOSHIMA 890,JAPAN.
NR 0
TC 14
Z9 14
U1 0
U2 2
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD JUL-SEP
PY 1995
VL 41
IS 3
BP M369
EP M374
DI 10.1097/00002480-199507000-00033
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA TC541
UT WOS:A1995TC54100034
PM 8573827
OA Bronze
DA 2018-10-19
ER

PT J
AU Shafir, EV
   Vasin, SL
   Rozanova, IB
   Sevastianov, VI
AF Shafir, EV
   Vasin, SL
   Rozanova, IB
   Sevastianov, VI
TI On the mechanism of the anticalcifying effect of sodium dodecyl sulphate
SO BIOMATERIAL-LIVING SYSTEM INTERACTIONS
LA English
DT Article
DE glutaraldehyde; sodium dodecyl sulphate; bovine pericardium;
   calcification
ID CALCIFICATION; PORCINE; SHEEP
AB The adsorption-desorption characteristics of bovine pericardium specimens treated with glutaraldehyde (GA), GA and sodium dodecyl sulphate (SDS) were studied in model solutions. Different kinetics of desorption from a solution containing protein and fatty acid have been demonstrated for these specimens. Based on kinetic parameters, it was suggested that the anticalcifying effect of SDS is associated with changes in the pore size of the biomaterial.
C1 MOSCOW TRANSPLANTOL & ARTIFICIAL ORGAN RES INST,RES CTR BLOOD COMPATIBLE MAT,MOSCOW 123436,RUSSIA.
RI Sevastianov, Victor/B-6674-2017
CR ARBUSTINI E, 1983, AM J CARDIOL, V52, P632, DOI 10.1016/0002-9149(83)90041-3
   ARBUSTINI E, 1984, AM J CARDIOL, V53, P1388, DOI 10.1016/0002-9149(84)90099-7
   CARPENTIER A, 1984, CIRCULATION, V70, P1
   CHEN WL, 1994, J BIOMED MATER RES, V28, P1485, DOI 10.1002/jbm.820281214
   Frolov YuG, 1988, COLLOID CHEM SURFACE
   GIRARDOT MN, 1995, J BIOMED MATER RES, V29, P793, DOI 10.1002/jbm.820290703
   HIRSCH D, 1993, J BIOMED MATER RES, V27, P1477, DOI 10.1002/jbm.820271203
   Jones M, 1989, J Card Surg, V4, P69, DOI 10.1111/j.1540-8191.1989.tb00258.x
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   LENTZ DJ, 1982, Patent No. 4323358
   MISCHENKO BP, 1993, THESIS MOSCOW
   ROSANOVA IB, MECHANISMS INITIAL S
   SEVASTIANOV VI, 1992, 4 WORLD BIOM C BERL, P472
   THUBRIKAR MJ, 1983, T AM SOC ART INT ORG, V29, P245
   ZAITSEV VV, 1988, THESIS MOSCOW
NR 15
TC 0
Z9 0
U1 0
U2 4
PU BIOMIR
PI MOSCOW
PA C/O VICTOR I SEVASTIANOV SHUKINSKAYA 1, 123182 MOSCOW, RUSSIA
SN 0869-4842
J9 BIOMATER LIVING SYST
JI Biomat.-Living Syst. Interact.
PD JUL-DEC
PY 1995
VL 3
IS 3-4
BP 133
EP 138
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA UL810
UT WOS:A1995UL81000007
DA 2018-10-19
ER

PT J
AU Okuyama, M
   Yahia, LH
   Piron, DL
   Lombardi, S
AF Okuyama, M
   Yahia, LH
   Piron, DL
   Lombardi, S
TI Biocompatibility of nickel-titanium shape memory alloy: An in-vitro
   electrochemical study
SO BIOMATERIAL-LIVING SYSTEM INTERACTIONS
LA English
DT Article
DE Ni-Ti shape memory alloy; biocompatibility; Ni dissolution; corrosion
   resistance; polarization; electrochemical technique
ID ANODIC POLARIZATION; BEHAVIOR
AB Quantitative corrosion of nikel-titanium (Ni-Ti) alloy was evaluated in Hank's physiological solution by using electrochemical polarization techniques combined with chemical analysis. Particular attention was paid to the Ni selective dissolution. Fitting potential of Ni-Ti alloy was observed at around 0.5 V vs saturated calomel electrode (SCE) at 25 degrees C but this potential depended on metallurgical condition. In the passive region from -0.4 V to 0.4 V, a small amount of Ni ions was detected, however, crevice corrosion seems to take place at 0 V. Therefore, Ni-Ti alloy was found to be applicable as a biomaterial in the potential range below 0 V.
C1 OYAMA NATL COLL TECHNOL,OYAMA 323,JAPAN.
   ECOLE POLYTECH,BIOMECH & BIOMAT RES CTR,MONTREAL,PQ H3C 3A7,CANADA.
   ECOLE POLYTECH,DEPT MAT & MET ENGN,MONTREAL,PQ H3C 3A7,CANADA.
CR ASSAD M, 1994, ANN CHIR, V48, P731
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CIGADA A, 1990, CLIN IMPLANT MATERIA, V9, P51
   COVINGTON JS, 1985, J PROSTHET DENT, V54, P127, DOI 10.1016/S0022-3913(85)80087-1
   DAI KR, 1993, INJURY, V24, P651, DOI 10.1016/0020-1383(93)90313-U
   HAASTERS J, 1990, ENG ASPECTS SHAPE ME, P427
   HAGEMEISTER N, 1994, IN PRESS J PHYSIQUE
   KIMURA H, 1987, DENT MAT APPARATUS, V6, P73
   LOMBARDI S, 1994, IN PRESS P INT C SHA
   LU S, 1990, ENG ASPECTS SHAPE ME, P443
   LU SB, 1993, CHINESE J SURG, V31, P259
   MATSUMOTO K, 1993, J JPN ORTHOP ASSOC, V67, P267
   NAKAYAMA Y, 1989, BIOMATERIALS, V10, P420, DOI 10.1016/0142-9612(89)90134-8
   OKUYAMA M, 1984, CORROS SCI, V4, P1
   OONISHI H, 1988, P 2 WORLD C BIOM WAS, P183
   OSHIDA Y, 1992, Bio-Medical Materials and Engineering, V2, P51
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   PESSALL N, 1971, ELECTROCHIM ACTA, V16, P1987, DOI 10.1016/0013-4686(71)85152-6
   POURBAIX M, 1974, NACE CEBELCOR, P213
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   RONDELLI G, 1990, CORROS SCI, V30, P805, DOI 10.1016/0010-938X(90)90004-O
   SARKAR NK, 1979, J DENT RES, V53, P98
   SATO N, 1971, J JAPAN I METALS, V35, P1007
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   VICENTINI B, 1986, SHAPE MEMORY ALLOY 8, P447
   YAHIA LH, 1994, SHAPE MEMORY MATERIALS '94, P616
   YAHIA LH, 1994, BIOMATER LIVING SYST, V2, P79
   YOUYI CHU, 1986, SMA 86 SHAPE MEMORY
NR 28
TC 9
Z9 9
U1 0
U2 0
PU BIOMIR
PI MOSCOW
PA C/O VICTOR I SEVASTIANOV SHUKINSKAYA 1, 123182 MOSCOW, RUSSIA
SN 0869-4842
J9 BIOMATER LIVING SYST
JI Biomat.-Living Syst. Interact.
PD JUL-DEC
PY 1995
VL 3
IS 3-4
BP 145
EP 160
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA UL810
UT WOS:A1995UL81000009
DA 2018-10-19
ER

PT J
AU BONZON, N
   LEFEBVRE, F
   FERRE, N
   DACULSI, G
   RABAUD, M
AF BONZON, N
   LEFEBVRE, F
   FERRE, N
   DACULSI, G
   RABAUD, M
TI NEW BIOACTIVATION MODE FOR VASCULAR PROSTHESES MADE OF DACRON(R)
   POLYESTER
SO BIOMATERIALS
LA English
DT Article
DE DACRON(R); VASCULAR PROSTHESES; ARTIFICIAL SUBENDOTHELIUM; BIOACTIVATION
ID ENDOTHELIAL-CELLS; INVITRO; BIOMATERIAL; PROTEINS
AB The performance of vascular prostheses, especially those of small calibre, still presents several problems. The use of polyesters such as the well-known poly(ethylene terephthalate) (Dacron(R)) and, more recently, poly(tetrafluoroethylene) and polyurethanes provides a marked improvement. We have developed a process to increase the efficiency of such prostheses, using the ability of the Dacron(R) polyester to be covalently modified by proteins under mild chemical conditions. The biomaterial is obtained from the particular interaction of elastin-solubilized peptides with type I + III collagens under very precise conditions. We have obtained an irreversible covalent bonding on Dacron(R). These biological conditions and the addition of connective proteins and glycosaminoglycans conferred on the resulting material a composition and a three-dimensional structure equivalent to the subendothelium, providing bioactive properties suitable for the development of a vascular prosthesis.
C1 FAC CHIRURG DENTAIRE NANTES,CNRS,INSERM,RECH MAT INTERETS BIOL LAB,F-44042 NANTES,FRANCE.
RP BONZON, N (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE L SAIGNAT,F-33076 BORDEAUX,FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR BONZON N, 1993, INNOV TECH BIOL MED, V14, P39
   BORDENAVE L, 1992, BIOMATERIALS, V13, P439, DOI 10.1016/0142-9612(92)90164-J
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   HIRT SW, 1993, J VASC SURG, V17, P538
   JACOB MP, 1989, FRONTIERS MATRIX BIO, V10, P92
   KIRKPATRICK CJ, 1990, PATHOBIOLOGY, V58, P221
   Kirpatovskii V I, 1992, Biull Eksp Biol Med, V114, P434
   KOBAYASHI H, 1992, J NEUROSURG, V77, P397, DOI 10.3171/jns.1992.77.3.0397
   MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112
   NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770
   OLIVEIRA EA, 1989, APPL BIOCHEM BIOTECH, V22, P109, DOI 10.1007/BF02922700
   RABAUD M, 1991, BIOMATERIALS, V12, P313, DOI 10.1016/0142-9612(91)90040-H
   UNDERWOOD PA, 1993, EXP CELL RES, V205, P311, DOI 10.1006/excr.1993.1091
NR 13
TC 23
Z9 24
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1995
VL 16
IS 10
BP 747
EP 751
DI 10.1016/0142-9612(95)99636-Z
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RE498
UT WOS:A1995RE49800001
PM 7492704
DA 2018-10-19
ER

PT J
AU LIN, FH
   LIN, CC
   LU, CM
   LIU, HC
   SUN, JS
   WANG, CY
AF LIN, FH
   LIN, CC
   LU, CM
   LIU, HC
   SUN, JS
   WANG, CY
TI MECHANICAL-PROPERTIES AND HISTOLOGICAL-EVALUATION OF SINTERED
   BETA-CA2P2O7 WITH NA4P2O7-CENTER-DOT-10H2O ADDITION
SO BIOMATERIALS
LA English
DT Article
DE BONE SUBSTITUTE; CERAMICS; BIODEGRADATION; MECHANICAL PROPERTIES;
   HISTOLOGICAL EVALUATION
ID BONE TISSUE; BIOCERAMICS; BEHAVIOR; INVIVO
AB The ultimate goal of implantation of biomaterials in the skeleton is to reach full integration of the nonliving implant with the living bone. The biomaterial can be used much as a bone graft, resorbing or dissolving as bone growth occurs, and the end result is a new remoulded bone. Calcium pyrophosphate, Ca2P2O7, is one of the intermediate products of bone mineralization. beta-Dicalcium pyrophosphate (beta-DCP) doped with certain amounts of Na4P2O7 . 10H(2)O was prepared as the developed material. Na(4)P(2)O7 . 10H(2)O was used as a liquid-phase additive to improve the sintering process and promote physiological bioresorbability. Compressive strength and four-point bending strength were measured by the Bionix test system 858. The mechanical strength of the sintered beta-DCP increased with the addition of Na(4)P(2)O7 . 10H(2)O up to 5 wt%, but thereafter decreased. The microstructure and crystal structure were analysed by the techniques of SEM, EPMA, TEM and XRD. The relationship between the mechanical strength of the sintered bioceramics and the Na4P2O7 . 10H(2)O dopant was examined in terms of the presence of NaCa(PO3)(3), grain growth and abnormal grain coalescence while the dopant increased. Preliminary in vivo evaluation was studied by rabbit femur condyle implantation. There was no inflammation or any toxic sign during the experimental period. The histological section of intraosseous implantation revealed that the new bone deposited directly on the surface of the material in the fourth week after operation. The implant gradually decreased in volume and was replaced by the surrounding regenerated bone in the rabbit condyle in vivo environment. The results led us to conclude that the developed material has great potential as a biodegradable bone substitute.
C1 NATL TAIWAN UNIV,COLL MED,CTR BIOMED ENGN,TAIPEI,TAIWAN.
   NATL TAIWAN UNIV,COLL MED,DEPT ORTHOPAED,TAIPEI,TAIWAN.
OI SUN, JUI-SHENG/0000-0001-5142-8777
CR Aebi M., 1987, BONE TRANSPLANTATION
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BURT HM, 1989, J RHEUMATOL, V16, P809
   Davidge R., 1979, CAMBRIDGE SOLID STAT
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V156, P259
   KITSUGI T, 1993, BIOMATERIALS, V4, P216
   KLAWITTER JJ, 1972, J BIOMED MATER RES S, P161
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   LENEL FV, 1984, T AIME, V175, P878
   LIN FH, 1993, J BIOMED ENG, V15, P481, DOI 10.1016/0141-5425(93)90063-5
   LIN FH, 1991, J BIOMED ENG APPL BA, V2, P98
   LIN FH, 1989, CERAM INT, V5, P53
   Meyers M.A., 1984, MECHANICAL METALLURG
   NORDBERG GF, 1976, EFFECTS DOSE RELATIO, P48
   Rolfe S T, 1977, FRACTURE FATIGUE CON
   SHACKELFORD JF, 1990, INTRO MATERIALS SCI
   Sheehan DC, 1980, THEORY PRACTICE HIST
   STUPP SI, 1993, J BIOMED MATER RES, V27, P301, DOI 10.1002/jbm.820270304
   TOMAS KA, 1987, J MATER RES, V21, P1395
   WENG J, 1993, 1ST P FAR E S BIOM M, P153
   YOON DN, 1979, ACTA METALL MATER, V27, P693, DOI 10.1016/0001-6160(79)90020-8
NR 25
TC 47
Z9 48
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1995
VL 16
IS 10
BP 793
EP 802
DI 10.1016/0142-9612(95)99642-Y
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RE498
UT WOS:A1995RE49800007
PM 7492710
DA 2018-10-19
ER

PT J
AU BONZON, N
   CARRAT, X
   DEMINIERE, C
   DACULSI, G
   LEFEBVRE, F
   RABAUD, M
AF BONZON, N
   CARRAT, X
   DEMINIERE, C
   DACULSI, G
   LEFEBVRE, F
   RABAUD, M
TI NEW ARTIFICIAL CONNECTIVE MATRIX MADE OF FIBRIN MONOMERS, ELASTIN
   PEPTIDES AND TYPE I+III COLLAGENS - STRUCTURAL STUDY, BIOCOMPATIBILITY
   AND USE AS TYMPANIC MEMBRANES IN RABBIT
SO BIOMATERIALS
LA English
DT Article
DE ARTIFICIAL CONNECTIVE MATRIX; TYMPANIC MEMBRANES; FIBRIN MONOMERS;
   ELASTIN-SOLUBILIZED PEPTIDES
ID SOLUBILIZED PEPTIDES
AB Experiments leading to the conception and development of a new artificial connective matrix based on collagen-elastin-fibrin associations are presented. Preliminary evaluation of this biomaterial as an artificial tympanic membrane is described. Morphological evaluation was performed by histopathological and scanning electron microscopic studies. Biocompatibility was documented by subcutaneous implantation and experimental grafting in rabbits was performed with histopathological studies of the tympanic grafted membranes. The positive results obtained in this experimental study enable future studies in humans to be prepared.
C1 HOP PELLEGRIN,SERV ANAT PATHOL,F-33076 BORDEAUX,FRANCE.
   FAC CHIRURG DENT,RECH TISSUS CALCIFIES & BIOMAT LAB,F-44042 NANTES 01,FRANCE.
RP BONZON, N (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR ABBENHAUS JI, 1967, SURG FORUM, V18, P490
   APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BONZON N, 1993, INNOV TECH BIOL MED, V14, P39
   BORDENAVE L, 1992, BIOMATERIALS, V13, P439, DOI 10.1016/0142-9612(92)90164-J
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   PATTERSON ME, 1967, ARCHIV OTOLARYNGOL, V86, P486
   RABAUD M, 1991, BIOMATERIALS, V12, P313, DOI 10.1016/0142-9612(91)90040-H
   Rabaud M, 1992, J Biomater Appl, V7, P20, DOI 10.1177/088532829200700102
   RABAUD M, 1987, BIOMATERIALS, V8, P217, DOI 10.1016/0142-9612(87)90067-6
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   SALEN B, 1965, J Laryngol Otol, V79, P159, DOI 10.1017/S0022215100063507
   STYPULKOWSKI P, 1991, RES MISSING LINKS OT, V101, P717
   YAMASHITA T, 1985, ACTA OTO-LARYNGOL, V100, P66, DOI 10.3109/00016488509108589
NR 14
TC 30
Z9 32
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1995
VL 16
IS 11
BP 881
EP 885
DI 10.1016/0142-9612(95)94151-A
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RK886
UT WOS:A1995RK88600010
PM 8527605
DA 2018-10-19
ER

PT J
AU ROZALSKA, B
   LJUNGH, A
AF ROZALSKA, B
   LJUNGH, A
TI BIOMATERIAL-ASSOCIATED STAPHYLOCOCCAL PERITONEAL INFECTIONS IN A
   NEUTROPAENIC MOUSE MODEL
SO FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
LA English
DT Article
DE PERITONEAL INFECTION; HEPARINIZED POLYETHYLENE FIBRONECTIN NEUTROPHIL
   PHAGOCYTOSIS; NEUTROPAENIC MOUSE MODEL; STAPHYLOCOCCUS
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTION; ADHERENCE;
   FIBRONECTIN; EPIDERMIDIS; CATHETERS; DIALYSIS; SURFACES; BINDING;
   VITRONECTIN
AB Adhesion of staphylococcal cells to polyethylene with end point-attached heparin was quantified by bioluminescence. Staphylococcus epidermidis 3380 and the slime-producing S. epidermidis RP12 adhered to the highest extent, and S. lugdunensis 2342 to the least extent. Preincubation of the polymer with dialysis fluid reduced adhesion of S. epidermidis 3380 and RP12 but enhanced that of S. aureus, and preadsorption of the surface with fibronectin decreased subsequent adhesion of S. epidermidis and S. haemolyticus strains. When staphylococci were grown in the presence of a biomaterial their ability to activate peritoneal cells was decreased. The bactericidal activity was impaired, whereas ingestion of opsonized coagulase-negative staphylococci (CNS) strains was unaffected. With S. epidermidis RP12 the presence of biomaterial did not influence either phagocytosis or bactericidal effect of peritoneal cells. After intra-peritoneal challenge with staphylococcal strains, the organ uptake of S. aureus Cowan 1 was increased in normal mice whereas immunosuppressed mice died. CNS strains increased mainly in the peritoneal cavity of immunosuppressed mice. The uptake of bacteria in liver and kidneys was increased with S. epidermidis 3380, S. lugdunensis 2343 and S. schleiferi 667-88. Generally, CNS strains persisted in the peritoneal cavity of both normal and immunosuppressed mice. These data indicate that host defense mechanisms, mainly polymorphonuclear neutrophils, fail to eliminate CNS infections in the peritoneum, and that initial adhesion to an implanted biomaterial may be of lesser importance in the peritoneal cavity than in e.g. catheter-associated infections. There are strain-specific virulence factors of bacteria, and slime producing strains evade the host defense mechanisms more efficiently than non-slime producing strains.
C1 LUND UNIV,DEPT MED MICROBIOL,S-22362 LUND,SWEDEN.
   UNIV LODZ,INST MICROBIOL,DEPT INFECT BIOL,PL-90131 LODZ,POLAND.
CR BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CLARKE DE, 1990, CHEST, V97, P966, DOI 10.1378/chest.97.4.966
   DESOLE P, 1993, J BIOLUM CHEMILUM, V8, P153, DOI 10.1002/bio.1170080305
   ELLIOTT TSJ, 1988, J MED MICROBIOL, V27, P161, DOI 10.1099/00222615-27-3-161
   FINLAYJONES JJ, 1991, J MED MICROBIOL, V34, P73, DOI 10.1099/00222615-34-2-73
   FREEMAN DJ, 1991, REV MED MICROBIOL, V2, P98
   GALLIMORE B, 1991, J INFECT DIS, V164, P1220, DOI 10.1093/infdis/164.6.1220
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRISTINA AG, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P193
   HAAGEN IA, 1990, J INFECT DIS, V161, P266, DOI 10.1093/infdis/161.2.266
   HOFFMAN J, 1983, CARBOHYD RES, V117, P328, DOI 10.1016/0008-6215(83)88103-8
   KAPLAN SS, 1990, ASAIO T, V36, pMI172
   LAMBE DW, 1990, CAN J MICROBIOL, V36, P455, DOI 10.1139/m90-080
   LEBRUN L, 1992, APMIS, V100, P531, DOI 10.1111/j.1699-0463.1992.tb00907.x
   LJUNGH A, 1995, METHODS ENZYMOLOGY M, P501
   LOPEZLOPEZ G, 1991, J MED MICROBIOL, V34, P349, DOI 10.1099/00222615-34-6-349
   LUDLAM HA, 1989, J MED MICROBIOL, V30, P167, DOI 10.1099/00222615-30-3-167
   MACKENZIE RK, 1991, J INFECT DIS, V163, P837, DOI 10.1093/infdis/163.4.837
   MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9
   NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x
   NOBLE MA, 1990, J INFECT DIS, V162, P909, DOI 10.1093/infdis/162.4.909
   PATRICK CC, 1992, INFECT IMMUN, V60, P1363
   PAULSSON M, 1993, J MED MICROBIOL, V38, P96, DOI 10.1099/00222615-38-2-96
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PAULSSON M, 1992, J CLIN MICROBIOL, V30, P2006
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   QUIE PG, 1987, J INFECT DIS, V156, P543, DOI 10.1093/infdis/156.4.543
   SCHUTZE GE, 1991, INFECT IMMUN, V59, P2573
   SPANGBERG M, 1980, J CATARACT REFR SURG, V16, P170
   SPENCER RC, 1988, J MED MICROBIOL, V27, P1, DOI 10.1099/00222615-27-1-1
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VERBRUGH H A, 1986, Journal of Medical Microbiology, V22, P291
   VONGRAEVENITZ A, 1992, CLIN MICROBIOL REV, V5, P36
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   WADSTROM T, 1990, PATHOGENESIS WOUND B
   WARD KH, 1992, J MED MICROBIOL, V36, P406, DOI 10.1099/00222615-36-6-406
   YU JL, IN PRESS J SURG RES
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 40
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-8244
J9 FEMS IMMUNOL MED MIC
JI FEMS Immunol. Med. Microbiol.
PD JUL
PY 1995
VL 11
IS 4
BP 307
EP 319
DI 10.1111/j.1574-695X.1995.tb00161.x
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA RT108
UT WOS:A1995RT10800008
PM 8541809
OA Bronze
DA 2018-10-19
ER

PT J
AU NISHI, C
   NAKAJIMA, N
   IKADA, Y
AF NISHI, C
   NAKAJIMA, N
   IKADA, Y
TI IN-VITRO EVALUATION OF CYTOTOXICITY OF DIEPOXY COMPOUNDS USED FOR
   BIOMATERIAL MODIFICATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYEPOXY COMPOUND; RABBIT CORNEA; TOXICITY TEST; POLYMERS; FIXATION;
   INVITRO; GRAFTS; ARTERY; BYPASS
AB The toxicity of various diepoxy compounds used for biomaterials crosslinking was investigated with a cell culture method and compared with an in vivo method. The neutral red uptake by cells was used to count the number of cells still alive after contact with the diepoxy compounds, because this method was more sensitive in cell counting than the other four methods studied in this work. The amount of neutral red taken up by cells depended strongly on the activity of cells in comparison with other methods; only small amounts of neutral red were taken up when cells were in a low activity state even if they were still alive. The in vitro toxicity of diepoxy compounds evaluated by the neutral red method revealed a good correlation with that found by the in vivo Draize test. The in vitro cytotoxicity to a cell line of L929 was closely related to that of primary culture cells of the normal rabbit cornea epidermal cell. The toxicity of diepoxy compounds was lower as their chain was longer, probably because of the lower chemical reactivity. All the diepoxy compounds investigated in this study exhibited lower cytotoxicity than formaldehyde, glutaraldehyde, and a water-soluble carbodiimide. (C) 1995 John Wiley and Sons, Inc.
C1 KYOTO UNIV,BIOMED ENGN RES CTR,SAKYO KU,KYOTO 606,JAPAN.
CR BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   CARPENTIER A, 1976, J THORAC CARDIOVASC, V55, P467
   Chan-Myers H B, 1992, ASAIO J, V38, P116, DOI 10.1097/00002480-199204000-00010
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   Hata C., 1992, International Journal of Artificial Organs, V15, P562
   HOCHLEY K, 1986, FOOD CHEM TOXICOL, V24, P473
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   KEMP PB, 1983, ALTERN LAB ANIM, V11, P15
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   Lohre J M, 1993, ASAIO J, V39, P106, DOI 10.1097/00002480-199304000-00007
   MATSUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   NOJIRI C, 1987, J THORAC CARDIOV SUR, V93, P867
   ROBENSBERG D, 1978, VASCULAR GRAFTS, P261
   SUMA H, 1990, TEX HEART I J, V17, P103
   Sung H. W., 1992, International Journal of Artificial Organs, V15, P562
   TOMIHATA K, 1994, ACS SYM SER, V540, P275
   Torishima H, 1990, AATEX, V1, P20
   TSENG YC, 1990, J BIOMED MATER RES, V24, P1355, DOI 10.1002/jbm.820241007
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   WANG E, 1993, INT J ARTIF ORGANS, V16, P530
   WATANABE M, 1989, TOXICOL IN VITRO, V3, P329, DOI 10.1016/0887-2333(89)90041-6
NR 26
TC 151
Z9 159
U1 1
U2 30
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1995
VL 29
IS 7
BP 829
EP 834
DI 10.1002/jbm.820290707
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RG001
UT WOS:A1995RG00100006
PM 7593021
DA 2018-10-19
ER

PT J
AU SCHNEIDER, T
   HARIG, H
AF SCHNEIDER, T
   HARIG, H
TI MECHANICAL-BEHAVIOR OF AL2O3 CERAMICS UNDER CYCLIC TENSION-COMPRESSION
   LOADIAG
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE ALUMINA; BIOMATERIAL; CYCLIC TENSION COMPRESSION LOADING, NOTCH FACTOR;
   THERMOELASTIC EFFECT; THERMOMETRY
AB During cyclic deformation, temperature measurements were carried out with thermocouples. On the basis of the thermoelastic effect, a thermometric method is described which allows the determination of the elastic part of the total deformation. Thus effective stress changes can be determined. The system is quite sensitive and makes it possible to characterize the behavior of a small volume unit during cyclic deformation. The temperature change Delta T is directly related to the stress change Delta sigma according to Thomson's formula.
   Notched Al2O3 specimens were tested under direct tension-compression loading. Cyclic tests with a stepwise load increase were carried out using a tensile tester and a servohydraulic test system. The test frequency was 0.5 and 5 Hz and the stress ratio was R=-1. Load differences and corresponding changes of temperature were measured. By means of the temperature measurements, the notch factor can be determined. It can be shown that the calculated stress concentration in the notched area is much higher than the measured value. This indicates that the stress reduction in Al2O3 is higher than in non-brittle materials. The predominant mechanism causing reduction of the stress concentration is microcracking.
   Fractographic studies with the scanning electron microscope show damage of Al2O3 under cyclic loading conditions.
C1 UNIV BREMEN,FASERINST BREMEN EV,D-28067 BREMEN,GERMANY.
CR Angerer S., 1986, OEIAZ Oesterreichische Ingenieur- und Architekten-Zeitschrift, V131, P410
   BELGEN MH, 1967, ISA T, V6, P49
   COX LJ, 1982, VDI BER, V439, P165
   DAWIHL W, 1977, Z WERKSTOFFTECH, V8, P328
   DENGEL D, 1975, HTM, V30, P112
   HARIG H, 1990, ANWENDUNG THERMOMETR
   HARIG H, 1988, BER BD TAGUNG WERKST, P489
   HARIG H, 1975, BEDEUTUNG THERMOMETR
   HARIG H, 1986, HTM, V41, P286
   John Gough, 1805, MEM LIT PHIL SOC MAN, V1, P288
   JOULE JP, 1857, P ROY SOC, V8, P355
   MACHERAUCH E, 1989, MATERIALWISS WERKST, V20, P53, DOI 10.1002/mawe.19890200217
   MIDDELDORF K, 1987, THESIS U ESSEN
   Mountain DS, 1978, P SOC PHOTO-OPT INST, V164, P189
   MULLER K, 1989, THESIS U ESSEN
   NEUBERT H, 1989, THESIS U ESSEN
   QUANG MB, 1983, THESIS U ESSEN
   SCHNEIDER T, UNPUB THERMOMETRISCH
   THOMSON W, 1882, MATH PHYS PAPERS, V1, P174
   TJERNLUND AK, 1988, SCI CERAM, V14, P799
   VONMALLINCKRODT D, 1987, MAR FRANZ TAG TECHN, P240
   WEBER D, 1989, ELEKTRONIK J AUSGABE, V2, P52
   WEBER W, 1830, ANN PHYS CHEM, V20, P177
NR 23
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 23
PY 1995
VL 4
IS 5
BP 251
EP 258
DI 10.1016/0927-7765(94)01178-8
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA RF345
UT WOS:A1995RF34500001
DA 2018-10-19
ER

PT J
AU SOBOH, F
   KHOURY, AE
   ZAMBONI, AC
   DAVIDSON, D
   MITTELMAN, MW
AF SOBOH, F
   KHOURY, AE
   ZAMBONI, AC
   DAVIDSON, D
   MITTELMAN, MW
TI EFFECTS OF CIPROFLOXACIN AND PROTAMINE SULFATE COMBINATIONS AGAINST
   CATHETER-ASSOCIATED PSEUDOMONAS-AERUGINOSA BIOFILMS
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID RESISTANCE; INFECTION; BACTERIA; TOBRAMYCIN; AGENTS; CELLS
AB Infection is a common complication associated with the use of transcutaneous and implanted medical devices. These infections are generally difficult to treat and frequently require removal of the biomaterial before the infection can be completely eradicated, The presence of a bacterial biofilm recalcitrant to treatment often mediates these infections, We studied the influence of a polycationic protein, protamine sulfate, on the efficacy of the fluoroquinolone ciprofloxacin against a clinical isolate of Pseudomonas aeruginosa. A P. aeruginosa biofilm was developed on 1-cm sections of red rubber catheter material and then treated with various combinations of protamine sulfate and ciprofloxacin, The present work demonstrated that ciprofloxacin in combination with protamine was more effective against biofilms than was ciprofloxacin alone, Protamine sulfate at 50 mu g/ml combined with antibiotic at 0.5 mu g/ml reduced the number of viable cells by an average of 98.97%, while protamine sulfate at 50 mu g/ml alone resulted in an average 107.8% increase and antibiotic alone resulted in an average 58.6% reduction after 24 h, Furthermore, protamine sulfate, in combination with ciprofloxacin, inhibited P. aeruginosa in a dose-dependent fashion. It was further observed that treatment with the combination of protamine sulfate and ciprofloxacin had a more drastic effect on planktonic organisms as compared with the P. aeruginosa biofilms; the MBC was reduced to <0.05 mu g/ml in the presence of 25 mu g of protamine sulfate per ml. These findings were substantiated by ultrastructure studies of treated cells using scanning and transmission electron microscopy, The synergism between ciprofloxacin and protamine sulfate significantly enhanced the efficacy of ciprofloxacin against planktonic and biofilm P. aeruginosa.
C1 TORONTO HOSP,CTR INFECT & BIOMAT RES,TORONTO,ON M5G 2C4,CANADA.
   UNIV TORONTO,DEPT SURG,TORONTO,ON,CANADA.
   UNIV TORONTO,DEPT MICROBIOL,TORONTO,ON,CANADA.
   HOSP SICK CHILDREN,TORONTO,ON M5G 1X8,CANADA.
CR ANTOHI S, 1979, MOL GEN GENET, V170, P345, DOI 10.1007/BF00267068
   ANWAR H, 1985, FEMS MICROBIOL LETT, V29, P225, DOI 10.1111/j.1574-6968.1985.tb00867.x
   ANWAR H, 1992, CAN J MICROBIOL, V38, P618, DOI 10.1139/m92-102
   ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P59
   COSTERTON JW, 1984, MATER PERFORMANCE, V23, P13
   COSTERTON JW, 1993, INT J ARTIF ORGANS, V16, P765
   FARBER BF, 1988, J INFECT DIS, V161, P37
   Freedman S.O., 1976, CLIN IMMUNOLOGY, P65
   FURUSAWA T, 1986, J ANTIMICROB CHEMOTH, V17, P755, DOI 10.1093/jac/17.6.755
   GIWERCMAN B, 1991, ANTIMICROB AGENTS CH, V35, P1008, DOI 10.1128/AAC.35.5.1008
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HOOPER DC, 1991, NEW ENGL J MED, V324, P384
   HOYLE BD, 1992, ANTIMICROB AGENTS CH, V36, P2054, DOI 10.1128/AAC.36.9.2054
   Miller BF, 1942, SCIENCE, V96, P428, DOI 10.1126/science.96.2497.428
   MURRAY BE, 1989, INFECT DIS CLIN N AM, V3, P434
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   PARSONS CL, 1981, J INFECT DIS, V144, P180, DOI 10.1093/infdis/144.2.180
   SELAN L, 1993, ANTIMICROB AGENTS CH, V37, P2618, DOI 10.1128/AAC.37.12.2618
   SHAND GH, 1985, INFECT IMMUN, V48, P35
   SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125
   TEICHMAN JMH, 1994, J UROLOGY, V152, P213, DOI 10.1016/S0022-5347(17)32864-1
   VAS SI, 1985, PERITONEAL DIALYSIS, P403
   1995, COMPENDIUM PHARM SPE, P261
NR 25
TC 46
Z9 48
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 1995
VL 39
IS 6
BP 1281
EP 1286
DI 10.1128/AAC.39.6.1281
PG 6
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA RB370
UT WOS:A1995RB37000011
PM 7574516
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU ARCIOLA, CR
   CENNI, E
   CARAMAZZA, R
   PIZZOFERRATO, A
AF ARCIOLA, CR
   CENNI, E
   CARAMAZZA, R
   PIZZOFERRATO, A
TI 7 SURGICAL SILICONES RETAIN STAPHYLOCOCCUS-AUREUS DIFFERENTLY IN-VITRO
SO BIOMATERIALS
LA English
DT Article
DE SILICONES; BIOMATERIAL-ASSOCIATED INFECTION; STAPHYLOCOCCI
ID BACTERIAL ADHESION; INFECTION; ADHERENCE; INVITRO; SURFACES
AB In an in vitro study, we have quantitatively evaluated the capability of seven different types of silicone to retain a Staphylococcus aureus strain, isolated from a surgical wound. All the silicone specimens were taken from prostheses already used in plastic or ophthalmological surgery. Two polymers were used as controls: polystyrene, because of its known capability to favour in vitro bacterial recovery, and nylon, for its bacterial repellence. The results show that all silicones are suitable substrata for Staphylococcus aureus. However, there are some differences among silicone types. The amounts of bacteria retained from silicone oils are greater than or equal to those obtained from the positive control material.
C1 UNIV BOLOGNA,INST OPHTHALMOL,BOLOGNA,ITALY.
RP ARCIOLA, CR (reprint author), IST ORTOPEDICI RIZZOLI,BIOCOMPATIBIL RES IMPLANT MAT LAB,VIA BARBIANO 1-10,I-40136 BOLOGNA,ITALY.
CR ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V3, P195
   ARCIOLA CR, 1988, IMPLANT MAT BIOFUNCT, P349
   ARMSTRONG RW, 1989, ANN PLAS SURG, V23, P284, DOI 10.1097/00000637-198910000-00003
   BARTH E, 1989, BIOMATERIALS, V7, P325
   BREWER AR, 1990, ANN PLAS SURG, V24, P134, DOI 10.1097/00000637-199002000-00005
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   CHRISTENSEN GD, 1985, CLIN MICROBIOL, V10, P996
   CHU CC, 1984, AM J SURG, V147, P197, DOI 10.1016/0002-9610(84)90088-6
   Costerton J, 1984, REV INFECT DIS S3, V6, P608
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   ESPERSEN F, 1990, APMIS, V98, P471, DOI 10.1111/j.1699-0463.1990.tb01059.x
   Freedman A M, 1989, Infect Dis Clin North Am, V3, P275
   HADDEN OB, 1986, AUST NZ J OPHTHALMOL, V14, P69, DOI 10.1111/j.1442-9071.1986.tb00011.x
   HOLLAND SP, 1991, OPHTHALMOLOGY, V98, P933
   OGA M, 1988, BIOMATERIALS, V10, P325
   ROSDY M, 1991, BIOMATERIALS, V12, P511, DOI 10.1016/0142-9612(91)90151-Y
   SANGER JR, 1989, ANN PLAS SURG, V22, P337, DOI 10.1097/00000637-198904000-00009
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   THORNTON JW, 1988, ANN PLAS SURG, V20, P39, DOI 10.1097/00000637-198801000-00008
   WILFINGSEDER P, 1974, CHIR PLAST, V2, P15
   WILFLINGSEDER P, 1976, 6TH T INT C PLAST RE, P535
   WILLIAMS DF, 1987, J MATER SCI, V22, P3441
NR 25
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1995
VL 16
IS 9
BP 681
EP 684
DI 10.1016/0142-9612(95)99694-H
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RF940
UT WOS:A1995RF94000003
PM 7578770
DA 2018-10-19
ER

PT J
AU BOUAZIZ, A
   VACHER, M
   CAPRANI, A
AF BOUAZIZ, A
   VACHER, M
   CAPRANI, A
TI EFFECT OF CONSTANT AND MODULATED ELECTRICAL CHARGES APPLIED TO THE
   CULTURE MATERIAL ON PGI2 AND TXA2 SECRETION BY ENDOTHELIAL-CELLS
SO BIOMATERIALS
LA English
DT Article
DE ENDOTHELIAL CELLS; ELECTRIC CHARGE; EXTRACELLULAR MATRIX; PGI2; TXA2;
   PIEZOELECTRICITY
ID PROSTACYCLIN PRODUCTION; COLLAGEN PRODUCTION; LOW-FREQUENCY;
   SHEAR-STRESS; FLOW; PROSTAGLANDINS; POLYSTYRENE; POTASSIUM; CURRENTS;
   BEADS
AB Electrical stimulation of an endothelial cell culture applied through the culture support biomaterial induced strong secretion of prostaglandin 12 (PG12) and, to a lesser extent, thromboxane A2 (TXA2), which varied with time, the sign of the stationary electrical charge and the amplitude and frequency of a superimposed sine wave. In stationary conditions, the response is more rapid at positive electrical charges (+ some tens of mu C cm(-2)) than at negative ones (- some tens of mu C cm(-2)). In sine wave conditions, the ratio [PG12]/[TXA2] is strongly increased and is maximum for an amplitude of 50 mV and a frequency of 1 Hz. These results suggest that the extracellular matrix is not only involved in cellular anchoring but also participates actively in secretion of thrombomodulatory substances, an effect apparently related to the piezoelectric properties of its components.
C1 UNIV PARIS 07,BIORHEOL & HYDRODYNAM PHYS CHIM LAB,CNRS,URA 343,F-75251 PARIS 05,FRANCE.
CR ABDELHALIM MS, PROSTAGLANDINS, V17, P405
   AUBERT N, 1987, J BIOMED MATER RES, V21, P585, DOI 10.1002/jbm.820210505
   BUNTING S, 1983, BRIT MED BULL, V39, P271, DOI 10.1093/oxfordjournals.bmb.a071832
   COLOWICK SP, 1983, METHOD ENZYMOL, V82, P33
   DEMERS LM, 1981, PROSTAG LEUKOTR ESS, V6, P413, DOI 10.1016/0161-4630(81)90073-2
   DVEKSLER G, 1989, PROSTAG LEUKOTR ESS, V36, P65, DOI 10.1016/0952-3278(89)90019-7
   EKLUND B, 1981, CLIN PHYSIOL, V1, P123, DOI 10.1111/j.1475-097X.1981.tb00880.x
   FARNDALE RW, 1985, BIOELECTROCH BIOENER, V14, P83, DOI 10.1016/0302-4598(85)85010-8
   Ficat JJ, 1984, FERROELECTRICS, V60, P313, DOI 10.1080/00150198408017532
   FITZGERALD GA, 1979, LIFE SCI, V25, P655
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   GRABOWSKI EF, 1985, J LAB CLIN MED, V105, P36
   HENSBY CN, 1988, PROSTAGLANDINS, V18, P731
   INGERMANWOJENSK.C, 1981, J CLIN INVEST, V67, P1292
   JACOBSON BS, 1977, BIOCHIM BIOPHYS ACTA, V471, P331, DOI 10.1016/0005-2736(77)90260-7
   JACOBSON BS, 1982, TISSUE CELL, V14, P69, DOI 10.1016/0040-8166(82)90008-8
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KLEINSOYER C, 1989, BIOMATERIALS, V10, P85, DOI 10.1016/0142-9612(89)90036-7
   KORENSTEIN R, BIOCHIM BIOPHYS ACTA, V803, P302
   LANSMAN JB, 1988, NATURE, V331, P481, DOI 10.1038/331481a0
   LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K
   MAEKAWA M, 1988, J CHROMATOGR-BIOMED, V429, P373, DOI 10.1016/S0378-4347(00)83879-7
   Martin-Mondiere C F, 1989, ASAIO Trans, V35, P288, DOI 10.1097/00002480-198907000-00036
   MITCHELL MD, 1978, PROSTAG LEUKOTR ESS, V1, P13, DOI 10.1016/0161-4630(78)90072-1
   MORRIS HS, 1967, NATURE, V21, P267
   MURRAY JC, 1985, BIOCHIM BIOPHYS ACTA, V838, P98, DOI 10.1016/0304-4165(85)90255-7
   NELSON MT, 1990, AM J PHYSIOL, V259, pC3
   OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0
   PIPER P, 1971, ANN NY ACAD SCI, V180, P363, DOI 10.1111/j.1749-6632.1971.tb53205.x
   RAMADAN FM, 1990, ANN THORAC SURG, V49, P916, DOI 10.1016/0003-4975(90)90865-4
   SALZMAN PM, 1980, J PHARMACOL EXP THER, V215, P240
   TAKEDA K, 1987, PFLUG ARCH EUR J PHY, V410, P385, DOI 10.1007/BF00586515
   TAKEDA K, 1990, BLOOD VESSELS, V27, P169
   TAMISIER L, 1987, ELECTROCHIM ACTA, V32, P1365, DOI 10.1016/0013-4686(87)85068-5
   TAMISIER L, 1988, BIOELECTROCH BIOENER, V19, P207, DOI 10.1016/0302-4598(88)80002-3
   VARGAS FF, 1994, MICROVASC RES, V47, P153, DOI 10.1006/mvre.1994.1012
   WHITTLE BJR, 1983, BRIT MED BULL, V39, P232, DOI 10.1093/oxfordjournals.bmb.a071825
NR 38
TC 10
Z9 11
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1995
VL 16
IS 9
BP 727
EP 734
DI 10.1016/0142-9612(95)99702-N
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RF940
UT WOS:A1995RF94000011
PM 7578778
DA 2018-10-19
ER

PT J
AU RANIERI, JP
   BELLAMKONDA, R
   BEKOS, EJ
   VARGO, TG
   GARDELLA, JA
   AEBISCHER, P
AF RANIERI, JP
   BELLAMKONDA, R
   BEKOS, EJ
   VARGO, TG
   GARDELLA, JA
   AEBISCHER, P
TI NEURONAL CELL ATTACHMENT TO FLUORINATED ETHYLENE-PROPYLENE FILMS WITH
   COVALENTLY IMMOBILIZED LAMININ OLIGOPEPTIDES YIGSR AND IKVAV .2.
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID SYNTHETIC PEPTIDE; A-CHAIN; BASEMENT-MEMBRANE; NEURITE OUTGROWTH;
   PROTEINS; ADHESION; RECEPTOR; SEQUENCE; BINDING; REGENERATION
AB Material surfaces that can mediate cellular interactions by the coupling of specific cell membrane receptors may allow for the design of a biomaterial that call control cell attachment, differentiation, and tissue organization. Cell adhesion proteins have been shown to contain minimum oligopeptide sequences that are recognized by cell surface receptors and can be covalently immobilized on material surfaces. In this study, cell attachment to fluorinated ethylene propylene (FEP) films functionalized with the laminin-derived oligopeptides, YIGSR and a 19-mer IKVAV-containing sequence, was assessed using NG108-15 neuroblastoma and PC12 cells. A radiofrequency glow discharge (RFGD) process that replaces the FEP surface fluorine atoms with reactive hydroxyl functionalities was used to activate the film surfaces. The oligopeptides were then covalently coupled to the surface by their C-terminus using a standard nucleophilic substitution reaction. The covalent attachment of the oligopeptides to the FEP surface was verified using electron spectroscopy for chemical analysis (ESCA). Receptor-mediated NG108-15 cell attachment on the YIGSR-modified films was determined using competitive binding assays. Average cell attachment on the oligopeptide immobilized films in medium containing soluble CDPGYIGSR was reduced by approximately a factor of 2, compared to cell attachment in serum-free medium alone. No significant decrease in cell attachment was noted in medium containing the mock oligopeptide sequence CDPGYIGSK. FEP films immobilized with the 19-mer IKVAV sequence demonstrated a higher percentage of receptor mediated cell attachment on the film surfaces. A sixfold decrease in PC12 cell attachment occurred on the oligopeptide immobilized films in a competitive binding assay medium containing the soluble IKVAV oligopeptide compared to cell attachment in serum-free medium alone. These results demonstrate that laminin oligopeptides can be covalently immobilized on an FEP material surface and analytically verified, and can mediate the receptor specific coupling of neuronal cells onto its surface. (C) 1995 John Wiley & Sons, Inc.
C1 UNIV LAUSANNE,SCH MED,CHU VAUDOIS,DIV RECH CHIRURG,CH-1011 LAUSANNE,SWITZERLAND.
   SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
RI Aebischer, Patrick/E-1387-2013
CR ANDRADE JD, 1990, CROAT CHEM ACTA, V63, P527
   ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0
   IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059
   JUCKER M, 1991, BRAIN RES, V555, P305, DOI 10.1016/0006-8993(91)90356-Z
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   KLEINMAN HK, 1988, P NATL ACAD SCI USA, V85, P1282, DOI 10.1073/pnas.85.4.1282
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cb.03.110187.000421
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X
   SEPHEL GC, 1989, DEV NEUROSCI-BASEL, V11, P313, DOI 10.1159/000111909
   TAMADA Y, 1986, POLYM MED, V2, P101
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V28, P767
   VARGO TJ, 1991, J POLYM CI, V29, P1267
NR 23
TC 107
Z9 108
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1995
VL 29
IS 6
BP 779
EP 785
DI 10.1002/jbm.820290614
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RA473
UT WOS:A1995RA47300013
PM 7593015
DA 2018-10-19
ER

PT J
AU STRACHAN, CJL
AF STRACHAN, CJL
TI THE PREVENTION OF ORTHOPEDIC IMPLANT AND VASCULAR GRAFT INFECTIONS
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article; Proceedings Paper
CT 3rd International Conference of the Hospital-Infection-Society
CY SEP 04-08, 1994
CL LONDON, ENGLAND
SP Hosp Infect Soc
DE ORTHOPEDIC PROSTHESES; VASCULAR IMPLANTS; WOUND INFECTION; ANTIBIOTIC
   PROPHYLAXIS
ID TOTAL HIP; ANTIBIOTIC-PROPHYLAXIS; JOINT REPLACEMENT; SURGERY; KNEE;
   ARTHROPLASTY; CEFUROXIME; PROSTHESIS; RIFAMPIN; SEPSIS
AB The infection rate for any surgical prosthesis insertion should be less than 1% in the first postoperative year. If infection occurs the patients will lose their new found mobility, lose their independence, be hospitalized with sepsis, both local and systemic, and perhaps die. Preoperative and intraoperative measures to prevent infection are well established in orthopaedic surgery but less scientifically applied in peripheral vascular surgery. In both specialties the problem of late infection has promoted research on the protection of the peri-prosthetic environment against both bacteria and biofilm. In orthopaedics, the incorporation of various antibiotics into bone cement is well accepted in revision surgery, but still debated for the primary operation. On-going research on bioresorbable ceramics and the incorporation of antibiotics more effective against coagulase-negative staphylococci should eventually counter late infections. As HIV-positive patients increasingly present with sepsis around implanted prostheses this need will increase. In vascular surgery as the risk factors for biomaterial infection are better understood, new generations of protein-sealed grafts are permitting ionically compatible antibiotic coatings. Large well-designed clinical trials have begun and are needed to confirm the forecast of improved long-term clinical outcomes.
RP STRACHAN, CJL (reprint author), ROYAL SUSSEX CTY HOSP,DEPT SURG,BRIGHTON BN2 5BE,E SUSSEX,ENGLAND.
CR ASHTON TR, 1990, P SOC BIOMATER, V13, P235
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   Bandyk DF, 1990, SEMIN VASC SURG, V3, P77
   BARTZOKAS CA, 1994, BRIT MED J, V309, P506, DOI 10.1136/bmj.309.6953.506
   BELL SM, 1990, AUST NZ J SURG, V60, P177
   BERRY DJ, 1991, J BONE JOINT SURG AM, V74, P1460
   BUCHHOLZ HW, 1970, CHIRURGIE, V41, P411
   CALHOUN JH, 1989, AM J SURG, V157, P443, DOI 10.1016/0002-9610(89)90597-7
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   CHEVRON A, 1991, J VASC SURG, V14, P521
   CHUTER TAM, 1993, J VASC SURG, V18, P185, DOI 10.1016/0741-5214(93)90598-G
   DUNCAN CP, 1991, J BONE JOINT SURG S2, V73, P115
   FISH DN, 1992, AM J HOSP PHARM, V49, P2469
   FITZGERALD RH, 1992, ORTHOP CLIN N AM, V23, P259
   GELABERT HA, 1992, MED INTELLIGENCE UNI, P88
   GOGGINS J, 1992, INFECTION CONTROL SE, P1
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   HOPE PG, 1989, J BONE JOINT SURG BR, V71, P815
   JELLIS JE, 1994, SURGERY, V12, P175
   JOHNSON DP, 1986, J BONE JOINT SURG BR, V68, P289
   Jorgensen L G, 1991, Eur J Vasc Surg, V5, P87, DOI 10.1016/S0950-821X(05)80933-8
   KAISER AB, 1983, J INFECT DIS, V147, P1103, DOI 10.1093/infdis/147.6.1103
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   MALCHAU H, 1993, ACTA ORTHOP SCAND, V64, P497, DOI 10.3109/17453679308993679
   MANNION PT, 1989, J HOSP INFECT, V14, P313, DOI 10.1016/0195-6701(89)90071-6
   MASRI BA, 1994, J BONE JOINT SURG S1, V76, P1
   MCQUEEN M, 1987, INT ORTHOP, V11, P241, DOI 10.1007/BF00271455
   MOORE WS, 1981, ARCH SURG-CHICAGO, V116, P1403
   MOORE WS, 1986, RECENT ADV VASCULAR, P216
   NEWINGTON DP, 1991, BRIT J SURG, V78, P617, DOI 10.1002/bjs.1800780530
   OBRIEN T, 1992, BRIT J SURG, V79, P1262, DOI 10.1002/bjs.1800791205
   PELLICI PM, 1991, PRINCIPLES MANAGEMEN, P1
   Periti P, 1989, Eur Surg Res, V21 Suppl 1, P25, DOI 10.1159/000129056
   PERSSON U, 1988, BRIT MED J, V250, P99
   PINN S, 1994, MED PRACTICE HOSPITA, V20, P418
   POWELL TW, 1983, SURGERY, V94, P765
   RUBIN JR, 1985, J VASC SURG, V2, P92, DOI 10.1067/mva.1985.avs0020092
   SCHMITT DD, 1990, SEMIN VASC SURG, V3, P77
   Segreti J, 1989, Infect Dis Clin North Am, V3, P357
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   STRACHAN CJL, 1993, J ANTIMICROB CHEMOTH, V31, P65, DOI 10.1093/jac/31.suppl_B.65
   SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008
   TANZER M, 1994, J BONE JOINT SUR B S, V76, P27
   TORSELLO G, 1993, J VASC SURG, V17, P768, DOI 10.1016/0741-5214(93)90124-5
   WILSON PD, 1972, J BONE JOINT SURG, V54, P20
   WYMENGA AB, 1991, CLIN PHARMACOL THER, V50, P215, DOI 10.1038/clpt.1991.127
   1986, REHOSPITALISATION GE, V324, P24
NR 47
TC 31
Z9 33
U1 0
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD JUN
PY 1995
VL 30
SU S
BP 54
EP 63
DI 10.1016/0195-6701(95)90006-3
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA RH518
UT WOS:A1995RH51800007
PM 7560996
DA 2018-10-19
ER

PT J
AU HEMMERLE, J
   LEIZE, M
   VOEGEL, JC
AF HEMMERLE, J
   LEIZE, M
   VOEGEL, JC
TI LONG-TERM BEHAVIOR OF A HYDROXYAPATITE COLLAGEN-GLYCOSAMINOGLYCAN
   BIOMATERIAL USED FOR ORAL-SURGERY - A CASE-REPORT
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; SYNTHETIC HYDROXYAPATITE; BONE;
   BIOCOMPATIBILITY; DISSOLUTION; RESORPTION; INVITRO
AB A composite biomaterial consisting of hydroxyapatite with a collagen-glycosaminoglycan coating was studied for evaluation of the osteogenesis after long-term implantation in a human freshly extracted alveolar socket. The ultrastructural investigations were realized using scanning and transmission electron microscopy on cryofractured and embedded biopsy specimens. Crystallographic data were obtained by X-ray diffraction and high resolution transmission electron microscopy, The biomaterial (Biostite(R)) was shown to consist of irregularly shaped mineral particles of high dispersity, each made up of numerous single hydroxyapatite crystals. In addition, this crystalline phase appeared to be incorporated in a fibrous network. 42 months after implantation only some intercrystalline spaces of the hydroxyapatite aggregates were invested by newly formed bone-like apatite crystals. Moreover, this investigation showed clearly well-mineralized bone interfacing with some implanted aggregates, whereas other hydroxyapatite particles were still surrounded by soft tissue. No evidence of resorption of implanted material was found and the synthetic hydroxyapatite crystals appeared to remain unaltered by long-term implantation.
RP HEMMERLE, J (reprint author), FAC CHIRURG DENT, CTR RECH ODONTOL, INSERM, U424, 1 PL HOP, F-67000 STRASBOURG, FRANCE.
CR BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1989, REV CHIR ORTHOP, V75, P65
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DAVIES JE, 1993, CELL MATER, V3, P245
   DEBRUIJN JD, 1994, J BIOMED MATER RES, V28, P105, DOI 10.1002/jbm.820280114
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   Frank R M, 1991, J Parodontol, V10, P255
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   FRANK RM, 1991, J APPL BIOMATER, V2, P243, DOI 10.1002/jab.770020405
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   HEIMKE G, 1983, BIOCERAMICS CALCIUM, P79
   HORISAKA Y, 1994, J BIOMED MATER RES, V28, P97, DOI 10.1002/jbm.820280113
   IYODA K, 1993, CLIN ORTHOP RELAT R, P287
   MARGGRAF E, 1985, DEUT ZAHNAERZTL Z, V40, P28
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   OGISO M, 1992, J LONG-TERM EFF MED, V2, P137
   SAITO M, 1994, BIOMATERIALS, V15, P156, DOI 10.1016/0142-9612(94)90266-6
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   TANAKA H, 1989, COLLOID SURFACE, V37, P357, DOI 10.1016/0166-6622(89)80131-3
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   TENHUISEN KS, 1994, J DENT RES, V73, P598, DOI 10.1177/00220345940730030501
   TRIGLIA JM, 1993, ARCH OTOLARYNGOL, V119, P87
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P11
NR 26
TC 19
Z9 19
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 1995
VL 6
IS 6
BP 360
EP 366
DI 10.1007/BF00120305
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RG811
UT WOS:A1995RG81100008
DA 2018-10-19
ER

PT J
AU HARDWICK, R
   HAYES, BK
   FLYNN, C
AF HARDWICK, R
   HAYES, BK
   FLYNN, C
TI DEVICES FOR DENTOALVEOLAR REGENERATION - AN UP-TO-DATE LITERATURE-REVIEW
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE ALVEOLAR RIDGE AUGMENTATION; BIOCOMPATIBLE MATERIALS; BONE REGENERATION;
   GUIDED TISSUE REGENERATION; MEMBRANES, BARRIER; MEMBRANES, ARTIFICIAL;
   PERIODONTAL DISEASES THERAPY
ID GUIDED TISSUE REGENERATION; PERIODONTAL REPAIR; COLLAGEN MEMBRANE;
   BIODEGRADABLE MEMBRANES; ATTACHMENT FORMATION; BONE REGENERATION; BEAGLE
   DOGS; DEFECTS; BARRIER; OSTEOPROMOTION
AB REGENERATION OF PERIODONTAL AND ALVEOLAR RIDGE DEFECTS utilizing barrier membranes has become well established in clinical dentoalveolar reconstruction. Application of this technique has evolved from the concept of separating tissues during healing to that of providing a healing environment capable of regeneration of functional structures. The biomaterial characteristics and design of membranes employed in this technique play an important role in establishing and maintaining this environment. Barrier membranes must incorporate specific features that address the biological, mechanical, and clinical use requirements involved in regenerative treatment. Although nondegradable materials require a second surgical procedure for removal, these materials simplify certain aspects of development, production, and clinical regenerative treatment for some applications. Degradable materials introduce specific considerations and limitations regarding material selection, design, and clinical application. The progressive breakdown of degradable membranes results in dynamic changes in the mechanical and biocompatibility profiles of these materials. With present technology, these factors may limit use of degradable materials to specific applications. Membrane materials, therefore, should be selected based on a thorough understanding of the benefits and limitations inherent to the material(s) in relation to the functional requirements of specific clinical applications.
RP HARDWICK, R (reprint author), WL GORE & ASSOC INC,REGENERAT TECHNOL,DIV MED,1500 N 4TH ST,FLAGSTAFF,AZ 86003, USA.
CR ANDEREGG CR, 1991, J PERIODONTOL, V62, P264, DOI 10.1902/jop.1991.62.4.264
   AUKHIL I, 1983, J PERIODONTAL RES, V18, P643, DOI 10.1111/j.1600-0765.1983.tb00401.x
   Becker W, 1988, Int J Periodontics Restorative Dent, V8, P8
   BLOMSTEDT B, 1977, ACTA CHIR SCAND, V143, P71
   BLUMENTHAL N, 1990, J PERIODONTOL, V61, P319, DOI 10.1902/jop.1990.61.6.319
   Bostman O., 1992, CLIN ORTHOPAEDICS, V278, P193
   BOYCE B, 1982, BIOL SYNTHETIC VASCU, P553
   BOYNE PJ, 1969, J AM DENT ASSOC, V78, P767, DOI 10.1016/S0002-8177(69)84023-7
   BOYNE PJ, 1964, J DENT RES, V43, P827
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   BUSER D, 1992, SCHWEIZ MONATSSCHR Z, V102, P1491
   CAFFESSE RG, 1988, J PERIODONTOL, V59, P589, DOI 10.1902/jop.1988.59.9.589
   CAFFESSE RG, 1994, J PERIODONTOL, V65, P583, DOI 10.1902/jop.1994.65.6.583
   CATON J, 1992, INT J PERIODONT REST, V12, P267
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DAHLIN C, 1993, THESIS U GOTEBORG SW, P7
   GOTTLOW J, 1993, J PERIODONTOL, V64, P1157, DOI 10.1902/jop.1993.64.11s.1157
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Hardwick R, 1994, GUIDED BONE REGENERA, P101
   HURLEY LA, 1959, J BONE JOINT SURG AM, V41, P1243, DOI 10.2106/00004623-195941070-00007
   IGLHAUT J, 1988, J PERIODONTAL RES, V23, P107, DOI 10.1111/j.1600-0765.1988.tb01342.x
   Jovanovic S A, 1995, Int J Oral Maxillofac Implants, V10, P23
   KRONENTHAL RL, 1975, BIODEGRADABLE POLYM, P119
   LEKOVIC V, 1990, J PERIODONTOL, V61, P575, DOI 10.1902/jop.1990.61.9.575
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   MAGNUSSON I, 1988, J PERIODONTOL, V59, P1, DOI 10.1902/jop.1988.59.1.1
   McClain P K, 1993, Int J Periodontics Restorative Dent, V13, P9
   MELCHER AH, 1962, J BONE JOINT SURG BR, V44, P424
   MUNDELL RD, 1993, J ORAL MAXIL SURG, V51, P1004, DOI 10.1016/S0278-2391(10)80045-X
   MURRAY G, 1957, AM J SURG, V93, P385, DOI 10.1016/0002-9610(57)90827-9
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P257, DOI 10.1111/j.1600-051X.1982.tb02065.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   PAUL BF, 1992, INT J PERIODONT REST, V12, P122
   PONTORIERO R, 1988, J CLIN PERIODONTOL, V15, P247, DOI 10.1111/j.1600-051X.1988.tb01578.x
   QUTEISH D, 1992, J CLIN PERIODONTOL, V19, P476, DOI 10.1111/j.1600-051X.1992.tb01160.x
   SANDBERG E, 1993, J ORAL MAXIL SURG, V51, P1106, DOI 10.1016/S0278-2391(10)80450-1
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   SCHALLHORN R, 1988, INT J PERIODONT REST, V8, P9
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   SIMION M, 1994, INT J PERIODONT REST, V14, P497
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   TINTI C, 1994, J PERIODONTOL, V65, P1088, DOI 10.1902/jop.1994.65.11.1088
   TINTI C, J PERIODONTOL, V64, P1184
   van Steenberghe D, 1990, J HEAD NECK PATHOL, V9, P1
   VANSWOL RL, 1993, J PERIODONTOL, V64, P622, DOI 10.1902/jop.1993.64.7.622
   VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7
   VUDDHAKANOK S, 1993, J PERIODONTOL, V64, P202, DOI 10.1902/jop.1993.64.3.202
   WARRER K, 1992, J CLIN PERIODONTOL, V19, P633, DOI 10.1111/j.1600-051X.1992.tb01711.x
   WARRER K, 1990, THESIS ROYAL DENTAL, P34
   WARRER K, 1992, CLIN ORAL IMPLAN RES, V2, P166
   WIKESJO UME, 1992, J PERIODONTOL, V63, P158, DOI 10.1902/jop.1992.63.3.158
   WIKESJO UME, 1991, J CLIN PERIODONTOL, V18, P49, DOI 10.1111/j.1600-051X.1991.tb01119.x
   WILLIAMS DF, 1993, CLIN MATER, V10, P9
   WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514
   ZELLIN G, 1995, IN PRESS BIOMATERIAL
NR 58
TC 53
Z9 61
U1 1
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUN
PY 1995
VL 66
IS 6
BP 495
EP 505
DI 10.1902/jop.1995.66.6.495
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA RH251
UT WOS:A1995RH25100011
PM 7562339
DA 2018-10-19
ER

PT J
AU LI, HC
   KHOR, E
AF LI, HC
   KHOR, E
TI A COLLAGEN-POLYPYRROLE HYBRID - INFLUENCE OF 3-BUTANESULFONATE
   SUBSTITUTION
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
ID BIOMATERIAL
AB Hybrid biomaterials derived from a water-soluble derivative of polypyrrole, poly[sodium 4-(3-pyrrolyl)butanesulfonate], and soluble collagen have been synthesized by chemical polymerization of the 4-(3-pyrrolyl)butanesulfonate monomer in a collagen solution. Interaction between the two polymers was evident in the formation of a precipitated black polymer-collagen gel obtained for a monomer concentration of 0,01 mol/L. The collagen content in the gel was determined to be around 38 wt-%. When the monomer concentration was increased five-fold, the product was a dispersed precipitate that was polymer rich with a corresponding decrease in collagen (11 wt-%) content. Fourier transform infrared spectroscopy and thermal analysis of the hybrids provide signs of interaction between the sulfonic acid group on the substituted pyrrole and side groups of amino acids in collagen. The electrical conductivities of these hybrid biomaterials were found to be in the 10(-2) S cm(-1) range.
RP LI, HC (reprint author), NATL UNIV SINGAPORE,DEPT CHEM,KENT RIDGE,SINGAPORE 0511,SINGAPORE.
CR BLYTHE AR, 1979, ELECTRICAL PROPERTIE, P132
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   GOTT VL, 1961, SURGERY, V50, P382
   Havinga E. E., 1989, CHEM MATER, V1, P650
   HEPEL M, 1992, POLYM PREP AM CHEM S, V33, P106
   KAKUSHIMA M, 1983, J ORG CHEM, V48, P3214, DOI 10.1021/jo00167a014
   LI HC, 1994, POLYM INT, V35, P53, DOI 10.1002/pi.1994.210350105
   MACHIDA S, 1989, SYNTHETIC MET, V31, P311, DOI 10.1016/0379-6779(89)90798-4
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   SCHNEIDER B, 1989, Patent No. 11648
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   VALENTINI RF, 1992, BIOMATERIALS, V13, P193
NR 14
TC 19
Z9 20
U1 0
U2 2
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JUN
PY 1995
VL 196
IS 6
BP 1801
EP 1812
DI 10.1002/macp.1995.021960601
PG 12
WC Polymer Science
SC Polymer Science
GA RC089
UT WOS:A1995RC08900001
DA 2018-10-19
ER

PT J
AU PAZIRANDEH, M
   DESCHAMPS, J
   BARAL, S
   OWLETT, R
   AGGERWAL, A
   CAMPBELL, JR
AF PAZIRANDEH, M
   DESCHAMPS, J
   BARAL, S
   OWLETT, R
   AGGERWAL, A
   CAMPBELL, JR
TI RHAPIDOSOMES FROM AQUASPIRILLUM-ITERSONII - DISRUPTION AND SUBSEQUENT
   RENATURATION AND CHARACTERIZATION OF THE COMPONENT PROTEINS
SO MICROBIOLOGY-UK
LA English
DT Article
DE AQUASPIRILLUM ITERSONII; RHAPIDOSOMES; PROTEIN SELF-ASSEMBLY;
   BIOMATERIALS
ID LAYER
AB Rhapidosomes, tubular proteinaceous microstructures found in a variety of bacteria and algae, are resistant to disruption by many denaturing agents. They have potential application as a biomaterial and may also serve as a model for the study of self-assembly. Several reagents were tested for their ability to disrupt rhapidosomes isolated from Aquaspirillum itersonii into their component proteins. Only treatments with 0.1 M hydrochloric acid and 6 M guanidinium hydrochloride were found to disrupt rhapidosomes. A protocol was developed to renature the disrupted component proteins using rapid dilution and subsequent dialysis of the residual guanidinium hydrochloride. The renatured proteins were shown to have secondary structure as determined by circular dichroism. Furthermore, upon renaturation the two component proteins interacted with each other to form a complex of molecular mass > 2500 kDa. This complex, which may be a precursor in the pathway to rhapidosome formation, is currently being used to study the self-assembly process of these unique structures in vitro.
C1 USN,RES LAB,STRUCT MATTER LAB,WASHINGTON,DC 20375.
   GEOCENTERS INC,FT WASHINGTON,MD 20744.
RP PAZIRANDEH, M (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,WASHINGTON,DC 20375, USA.
OI Deschamps, Jeffrey/0000-0001-5845-0010
CR AVILA J, 1990, FASEB J, V4, P3284
   CHANG HYY, 1974, J GEN MICROBIOL, V81, P121, DOI 10.1099/00221287-81-1-121
   CORRELL DL, 1964, CAN J MICROBIOL, V10, P63, DOI 10.1139/m64-010
   DELK AS, 1972, J MOL BIOL, V64, P287, DOI 10.1016/0022-2836(72)90336-1
   EVERS MCJM, 1980, CAN J MICROBIOL, V26, P1312, DOI 10.1139/m80-218
   JAENICKE R, 1985, BIOL CHEM H-S, V366, P663, DOI 10.1515/bchm3.1985.366.2.663
   JAENICKE R, 1990, PROTEIN STRUCTURE PR, P191
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   PAZIRANDEH M, 1993, J GEN MICROBIOL, V139, P859, DOI 10.1099/00221287-139-4-859
   Pazirandeh M, 1992, BIOMIMETICS, V1, P39
   SLEYTR UB, 1992, AIP C P, V262
   TAKUMI K, 1991, J GEN APPL MICROBIOL, V37, P455, DOI 10.2323/jgam.37.455
   WELLMAN SE, 1989, J BIOL CHEM, V264, P10878
NR 13
TC 0
Z9 0
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS
SN 1350-0872
J9 MICROBIOL-UK
JI Microbiol.-UK
PD JUN
PY 1995
VL 141
BP 1419
EP 1423
DI 10.1099/13500872-141-6-1419
PN 6
PG 5
WC Microbiology
SC Microbiology
GA RE704
UT WOS:A1995RE70400018
OA Bronze
DA 2018-10-19
ER

PT J
AU GEMMELL, CH
   BLACK, JP
   SEFTON, MV
   YEO, EL
AF GEMMELL, CH
   BLACK, JP
   SEFTON, MV
   YEO, EL
TI BIOMATERIAL INDUCED PLATELET, LEUKOCYTE AND COMPLEMENT ACTIVATION
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 UNIV TORONTO,DEPT MED & CHEM ENGN,TORONTO,ON M5S 1A1,CANADA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN
PY 1995
VL 73
IS 6
BP 1347
EP 1347
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA RP385
UT WOS:A1995RP38501712
DA 2018-10-19
ER

PT J
AU KIELSTEIN, R
   SASS, HM
AF KIELSTEIN, R
   SASS, HM
TI FROM WOODEN LIMBS TO BIOMATERIAL ORGANS - THE ETHICS OF ORGAN
   REPLACEMENT AND ARTIFICIAL ORGANS
SO ARTIFICIAL ORGANS
LA English
DT Article
DE ETHICS; MORAL ASSESSMENT; TECHNOLOGY ASSESSMENT
AB This paper discussed issues of ethical assessment and moral concern associated with organ replacement and physical enhancement: research, allocation, organ donation, artificial organs, xenografts, biomaterials, and neuromaterials. While emphasizing the medical and moral benefits over associated risks, it calls for a better integration of moral assessment into technology assessment and for the establishment of a cross-cultural and interdisciplinary International Ethics Committee for Organ Replacement Therapy.
C1 GEORGETOWN UNIV,KENNEDY INST ETH,WASHINGTON,DC 20057.
RP KIELSTEIN, R (reprint author), OTTO VONGUERICKE UNIV,INNERE MED KLIN,DEPT NEPHROL,D-39120 MAGDEBURG,GERMANY.
CR ATSUMI K, 1992, ETHICAL PROBLEMS DIA, P183
   BAILEY LL, 1990, HASTINGS CENT REP, V20, P24, DOI 10.2307/3562970
   CARTWRIGHT W, 1991, ORGAN REPLACEMENT TH, P519
   ENGELHARDT HT, 1992, ETHICAL PROBLEMS DIA, P3
   KIELSTEIN R, 1994, ETHIK MED, V6, P167
   KIELSTEIN R, 1992, ETHIK KLINISCHEN FOR
   KIELSTEIN R, 1992, KLINISCH ETHISCHE PR
   KLINKMANN H, 1994, NEPHROL DIAL TRANSPL, V9, P184
   KLINKMANN H, 1993, J LAB CLIN MED, V121, P203
   KLINKMANN H, 1987, Z KLIN MED, V42, P125
   KLINKMANN H, 1990, SOC SCI AUFBRUCH ZUK
   KOLFF W, 1984, ASAIO T, V29, P6
   Kuhn T. S., 1962, STRUCTURE SCI REVOLU
   KUPSCH A, 1991, ORGAN REPLACEMENT TH, P467
   LINKE DB, 1993, ETHICA, V1, P53
   RETTIG RA, 1991, SOUTH CALIF LAW REV, V65, P503
   SASS HM, 1992, J MED PHILOS, V17, P445, DOI 10.1093/jmp/17.4.445
   SASS HM, 1989, ETHISCHEN BEWERTUNG
   SASS HM, 1989, DRUG RES DRUG DEV 21, P239
   SHAPIRO MH, 1991, SOUTHERN CALIF LAW R, V65, P11
   1985, ARTIFICIAL HEART ASS
NR 21
TC 8
Z9 9
U1 0
U2 2
PU BLACKWELL SCIENCE PUBL INC CAMBRIDGE
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 1995
VL 19
IS 5
BP 475
EP 480
DI 10.1111/j.1525-1594.1995.tb02362.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA QX830
UT WOS:A1995QX83000018
PM 7625930
DA 2018-10-19
ER

PT J
AU MIRZADEH, H
   KATBAB, AA
   KHORASANI, MT
   BURFORD, RP
   GORGIN, E
   GOLESTANI, A
AF MIRZADEH, H
   KATBAB, AA
   KHORASANI, MT
   BURFORD, RP
   GORGIN, E
   GOLESTANI, A
TI CELL ATTACHMENT TO LASER-INDUCED AAM-GRAFTED AND HEMA-GRAFTED
   ETHYLENE-PROPYLENE RUBBER AS BIOMATERIAL - IN-VIVO STUDY
SO BIOMATERIALS
LA English
DT Article
DE CELL ATTACHMENT; MACROPHAGES; ACRYLAMIDE; 2-HYDROXYETHYL METHACRYLATE;
   LASER GRAFTING
ID HYDROPHILIC-HYDROPHOBIC COPOLYMERS; POLYMER SURFACES; BIOCOMPATIBILITY;
   ACRYLAMIDE; ADHESION; KINETICS; INVITRO; GROWTH; EPR
AB With the purpose of improved tissue compatibility, ethylene-propylene rubber (EPR)-based vulcanizates have been surface grafted with acrylamide (AAm) and 2-hydroxyethyl methacrylate (HEMA) using CO2-pulsed laser as excitation source. Grafted surfaces were characterized by performing scanning electron microscopy combined with energy dispersive X-ray analysis and attenuated total reflectance infrared spectroscopy to study the surface morphology and grafting. Surface hydrophilicity (measured by water drop contact angle) increased for the grafted samples. Fractal type of morphology is formed by the grafted poly(AAm) and poly(HEMA) chains on the surface of EPR, which provides both hydrophilic and hydrophobic sites. In vivo tissue compatibility was assessed by implanting test samples in the deep intramuscular and peritoneal layers of rabbits. After 8 weeks of implantation, comparative results indicate that the adhesion of macrophages to EPR samples modified with AAm and HEMA, with no respiratory burst and cellular damage, is significantly lower than their adhesion on unmodified surfaces which show an activated state of the attached macrophages. Also, no acute or chronic inflammatory reaction was observed at the site of implantation and a thinner fibrous tissue capsule formed around the modified samples, whereas foreign body giant cells adhered to unmodified EPR.
C1 AMIRKABIR UNIV, DEPT POLYMER ENGN, TEHRAN, IRAN.
   UNIV NEW S WALES, DEPT POLYMER SCI, SYDNEY, NSW 2052, AUSTRALIA.
   UNIV TEHRAN, FAC VET MED, TEHRAN, IRAN.
   UNIV TEHRAN, INST BIOCHEM & BIOPHYS, TEHRAN, IRAN.
RP MIRZADEH, H (reprint author), POLYMER RES CTR IRAN, POB 14185-515, TEHRAN, IRAN.
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Barth E, 1988, J Invest Surg, V1, P291, DOI 10.3109/08941938809141095
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   Buscaroli S, 1990, G Chir, V11, P144
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   CURTIS ASG, 1973, PROGR BIOPHYS MOL BI, V27, P317
   FISHER JP, 1979, J POLYM SCI PS, V6, P443
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P409
   GRISTINA AG, 1989, CURRENT PERSPECTIVES, P71
   HOFFMAN AS, 1972, POLYM PREPR, V13, P740
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   JANSEN B, 1981, RADIAT PHYS CHEM, V18, P1195, DOI 10.1016/0146-5724(81)90310-1
   JANSEN JA, 1989, BIOMATERIALS, V10, P604, DOI 10.1016/0142-9612(89)90114-2
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   KIREMITCI M, 1991, Clinical Materials, V8, P9, DOI 10.1016/0267-6605(91)90004-Y
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MATHEW J, 1992, POLYM J, V24, P31, DOI 10.1295/polymj.24.31
   MIRZADEH H, 1993, RADIAT PHYS CHEM, V42, P53, DOI 10.1016/0969-806X(93)90201-5
   MIRZADEH H, 1993, RADIAT PHYS CHEM, V41, P507, DOI 10.1016/0969-806X(93)90013-K
   MIRZADEH H, 1994, ANGEW MAKROMOL CHEM, V18, P23
   NOJIRI C, 1987, T AM SOC ART INT ORG, V33, P596
   Park JB, 1992, BIOMATERIALS INTRO, V1-6, P223
   PASCAL P, 1990, MACROMOLECULES, V23, P5161, DOI 10.1021/ma00226a024
   PELUSO G, 1991, Clinical Materials, V8, P99, DOI 10.1016/0267-6605(91)90016-9
   PISKIN E, 1992, Clinical Materials, V11, P3, DOI 10.1016/0267-6605(92)90023-M
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   VANKAMPEN CL, 1979, J BIOMED MATER RES, V13, P517, DOI 10.1002/jbm.820130402
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 36
TC 47
Z9 47
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1995
VL 16
IS 8
BP 641
EP 648
DI 10.1016/0142-9612(95)93862-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA RA257
UT WOS:A1995RA25700008
PM 7548615
DA 2018-10-19
ER

PT J
AU OZAKI, CK
   CONTRERAS, M
   PHANEUF, M
   SHEPPECK, RA
   RUTTER, CM
   QUIST, WC
   LOGERFO, FW
AF OZAKI, CK
   CONTRERAS, M
   PHANEUF, M
   SHEPPECK, RA
   RUTTER, CM
   QUIST, WC
   LOGERFO, FW
TI PLATELET ACTIVATION BY HEALING EPTFE GRAFTS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID DEPOSITION; PATENCY; BLOOD
AB The purpose of this study was to examine the effect of the in vivo maturing ePTFE graft surface on platelet activation. Ten canines were randomized to receive either a carotid to infrarenal aorta ePTFE graft or sham operation. Animals were sampled at specific time points up to 3 months postoperatively. Whole blood platelet aggregometry (arachidonic acid, ADP, and collagen agonists) and ATP secretion (in response to arachidonic acid, ADP, collagen, and thrombin) were measured. Additionally, complete hematologic analysis and histology were performed. With time, graft animals showed significantly more decrease in platelet aggregation in response to ADP compared to sham animals (P = .023). The total amount of ATP per platelet was not different, as demonstrated by equivalent ATP release per platelet in response to thrombin. Over the first week, grafted dogs developed a decrease in systemic platelet count of 50% (P < .001) that persisted over the 3-month follow-up period. With time, overall regression model slopes of graft and sham platelet count data were not statistically different (P = .29). Histologically, the grafts demonstrated limited cellular ingrowth at both anastomoses, with fibrin matrix along the remainder of the blood-biomaterial interface. These data suggest that, similar to Dacron, exposure to an ePTFE surface results in significant changes in platelet biology, and these platelet-ePTFE interactions persist even after the graft has formed a mature pseudointima. The pseudointima appears to be the primary determinant of the blood-biomaterial interaction. (C) 1995 John Wiley and Sons, Inc.
C1 HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115.
RP OZAKI, CK (reprint author), HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,21-27 BURLINGTON AVE,ROOM 512,BOSTON,MA 02215, USA.
RI Ozaki, C Keith/A-4937-2013
FU NHLBI NIH HHS [HL08730-01, HL21796-12]
CR ALLEN BT, 1986, ANN SURG, V203, P318, DOI 10.1097/00000658-198603000-00019
   BROPHY CM, 1991, J BIOMED MATER RES, V25, P1031, DOI 10.1002/jbm.820250809
   CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8
   CLAGETT GP, 1981, J LAB CLIN MED, V97, P345
   Colman RW, 1987, HEMOSTASIS THROMBOSI, P594
   CROWDER MJ, 1991, ANAL REPEATED MEASUR
   FREEMAN MB, 1988, J VASC SURG, V7, P554
   GOLDMAN M, 1983, BRIT J SURG, V70, P635, DOI 10.1002/bjs.1800701019
   GREISLER HP, 1990, J CARDIOVASC SURG, V31, P712
   ITO RK, 1991, J VASC SURG, V13, P822
   KAPLAN S, 1986, J VASC SURG, V3, P311, DOI 10.1067/mva.1986.avs0030311
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   MADRI JA, 1992, CELL INTERACTIONS AT, P166
   PATTERSON RB, 1989, J VASC SURG, V10, P650, DOI 10.1067/mva.1989.15992
   RUTTER CM, IN PRESS STATISTICS
   SALZMAN EW, 1991, J VASC SURG, V13, P829
NR 16
TC 1
Z9 1
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1995
VL 29
IS 5
BP 647
EP 653
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QV982
UT WOS:A1995QV98200011
PM 7622550
DA 2018-10-19
ER

PT J
AU SAPATNEKAR, S
   KIESWETTER, KM
   MERRITT, K
   ANDERSON, JM
   CAHALAN, L
   VERHOEVEN, M
   HENDRIKS, M
   FOUACHE, B
   CAHALAN, P
AF SAPATNEKAR, S
   KIESWETTER, KM
   MERRITT, K
   ANDERSON, JM
   CAHALAN, L
   VERHOEVEN, M
   HENDRIKS, M
   FOUACHE, B
   CAHALAN, P
TI BLOOD BIOMATERIAL INTERACTIONS IN A FLOW SYSTEM IN THE PRESENCE OF
   BACTERIA - EFFECT OF PROTEIN ADSORPTION (VOL 29, PG 247, 1995)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Correction, Addition
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   MEDTRON BAKKEN RES CTR BV,6201 MP MAASTRICHT,NETHERLANDS.
CR SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
NR 1
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1995
VL 29
IS 5
BP 679
EP 679
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QV982
UT WOS:A1995QV98200016
DA 2018-10-19
ER

PT J
AU YU, JL
   ANDERSSON, R
   WANG, LQ
   LJUNGH, A
   BENGMARK, S
AF YU, JL
   ANDERSSON, R
   WANG, LQ
   LJUNGH, A
   BENGMARK, S
TI EXPERIMENTAL FOREIGN-BODY INFECTION IN THE BILIARY-TRACT IN RATS
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE BILIARY DRAIN; BILIARY TRACT; COMPLEMENT-MEDIATED; ESCHERICHIA COLI;
   FOREIGN-BODY INFECTIONS; OPSONIC ACTIVITY; RAT
ID OBSTRUCTIVE-JAUNDICE; POLYMORPHONUCLEAR LEUKOCYTES; RETICULOENDOTHELIAL
   FUNCTION; COMPLEMENT ACTIVATION; ENDOPROSTHESES; FIBRONECTIN; BACTERIA;
   DEFENSE; BILE; REVERSIBILITY
AB Background: Biomaterials used for biliary drainage may potentially result in biomaterial-associated infections. Methods: Foreign-body infection in the biliary tract was investigated in rats. Rubber drain pieces were implanted in the biliary tract in rats for 1-4 weeks, followed by challenges with 10(2) to 10(4) colony-forming units (cfu) Escherichia coli injected into the common bile duct. The rate of infection was calculated, the bacterial growth in the biliary tract was observed over 72 h after challenges, and the opsonic activity in bile and in sera was assessed. Results: In the group with drain material, inocula as small as 10(2) cfu produced persisting infection in the common bile duct in 90% of animals, whereas the same number of E. coli infected only 30% of rats in the control and sham implantation groups (p < 0.01, chi-square test). Complement-mediated opsonic activity in bile of animals with implanted drain pieces gradually decreased with time, whereas opsonic activity in sera from the same animals remained unchanged. Conclusions: Implants in the biliary tract impair local host defense, resulting in an increased susceptibility to microbial infection.
C1 UNIV LUND HOSP,DEPT SURG,S-22185 LUND,SWEDEN.
   UNIV LUND HOSP,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR DING JW, 1992, EUR J SURG, V158, P157
   DOWIDAR N, 1992, SCAND J GASTROENTERO, V27, P77, DOI 10.3109/00365529209011171
   DOWIDAR N, 1991, SCAND J GASTROENTERO, V26, P1137, DOI 10.3109/00365529108998605
   DOWSETT JF, 1988, AM J GASTROENTEROL, V83, P1328
   EVANS DG, 1977, INFECT IMMUN, V18, P330
   FINLAYJONES JJ, 1991, J INFECT DIS, V164, P1173, DOI 10.1093/infdis/164.6.1173
   HART PH, 1987, BRIT J EXP PATHOL, V68, P89
   HARVATH L, 1978, J CLIN INVEST, V61, P1145, DOI 10.1172/JCI109029
   HOLMAN JM, 1982, J SURG RES, V32, P208, DOI 10.1016/0022-4804(82)90092-0
   HOROWITZ MA, 1980, J CLIN INVEST, V65, P82
   KATZ S, 1984, ANN SURG, V199, P14, DOI 10.1097/00000658-198401000-00003
   LEUNG JWC, 1988, GASTROINTEST ENDOSC, V34, P19, DOI 10.1016/S0016-5107(88)71223-7
   LEW PD, 1979, J CLIN INVEST, V63, P326, DOI 10.1172/JCI109306
   LIN YS, 1992, BIOMATERIALS, V13, P497
   MONTDARGENT B, 1992, BIOMATERIALS, V13, P571, DOI 10.1016/0142-9612(92)90024-I
   MORRISON L, 1984, J CLIN LAB IMMUNOL, V13, P71
   OCONNOR MJ, 1984, SURG FORUM, V35, P122
   OHSHIO G, 1988, DIGEST DIS SCI, V33, P570, DOI 10.1007/BF01798359
   OPPERMANN M, 1992, IMMUNOPHARMACOLOGY, V24, P119, DOI 10.1016/0162-3109(92)90018-8
   PAIN JA, 1987, BRIT J SURG, V74, P1091, DOI 10.1002/bjs.1800741207
   ROLAPLESZCZYNSKI M, 1975, J PEDIATR-US, V86, P690, DOI 10.1016/S0022-3476(75)80352-0
   ROUGHNEEN PT, 1987, ANN SURG, V206, P578
   ROUGHNEEN PT, 1986, J SURG RES, V41, P113, DOI 10.1016/0022-4804(86)90016-8
   SMIT JM, 1989, GASTROINTEST ENDOSC, V35, P485, DOI 10.1016/S0016-5107(89)72895-9
   SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546
   STOSSEL TP, 1970, J BIOL CHEM, V245, P6228
   SUNG JY, 1992, DIGEST DIS SCI, V37, P689, DOI 10.1007/BF01296423
   SUTER S, 1981, J INFECT DIS, V144, P499, DOI 10.1093/infdis/144.6.499
   THOMPSON RLE, 1990, BRIT J SURG, V77, P1229, DOI 10.1002/bjs.1800771112
   VANOTTERLOO JCAD, 1992, J VASC SURG, V16, P774
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   WILTON PB, 1987, J SURG RES, V42, P434, DOI 10.1016/0022-4804(87)90179-X
   YU JL, 1993, EUR J SURG, V159, P163
   ZWAHLEN A, 1982, J INFECT DIS, V145, P635, DOI 10.1093/infdis/145.2.635
   1974, SCAND J CLIN LAB INV, V33, P291
NR 36
TC 4
Z9 4
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0036-5521
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD MAY
PY 1995
VL 30
IS 5
BP 478
EP 483
DI 10.3109/00365529509093311
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA QY851
UT WOS:A1995QY85100014
PM 7638576
DA 2018-10-19
ER

PT J
AU TANG, LP
   EATON, JW
AF TANG, LP
   EATON, JW
TI INFLAMMATORY RESPONSES TO BIOMATERIALS
SO AMERICAN JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Review
DE BIOMATERIALS; FIBRINOGEN; INFLAMMATION
ID TOTAL HIP-REPLACEMENT; SYNOVIAL-LIKE MEMBRANE; BONE-CEMENT INTERFACE;
   GEL BREAST IMPLANTS; 10-YEAR FOLLOW-UP; COMPLEMENT ACTIVATION;
   SILICONE-GEL; INVIVO BIOCOMPATIBILITY; POLYMERIC BIOMATERIALS; PROTEIN
   ADSORPTION
AB Implanted biomedical devices are of increasing importance in modern medical care. However, surprisingly little is known of the factors that determine biocompatibility of the materials used in these devices. These materials, although generally inert and non-toxic, can mediate a variety of adverse reactions, including inflammation, fibrosis, coagulation, and infection. This brief review focuses on the inflammatory responses (including fibrosis) that commonly occur around implanted biomaterials. Host proteins that spontaneously associate with implant surfaces are important determinants of the acute inflammatory response. In this regard, adsorbed fibrinogen appears particularly pro-inflammatory. Chronic inflammatory processes, in many cases in response to fragments of implanted biomaterials, may cause implant failure. In the case of silicone-filled mammary prostheses, the extravasation of silicone gel has been held responsible for a number of complications, including silicone granuloma, synovitis, connective-tissue disease, and lymphadenopathy. In some instances, material-mediated inflammatory responses may even cause degradation of the material itself (via oxidative products released by implant-associated inflammatory cells). Overall, there is insufficient knowledge of the determinants and mechanisms of host: implant responses. A clear understanding of tissue:biomaterial interactions will be required both to explain the pathogenesis of many implant-mediated complications and to aid in the development of more biocompatible materials for implantable devices.
C1 ALBANY MED COLL,DEPT PATHOL & LAB MED,DIV EXPTL PATHOL,ALBANY,NY 12208.
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158
   ASPLUND O, 1984, PLAST RECONSTR SURG, V73, P270, DOI 10.1097/00006534-198402000-00022
   ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAKER JL, 1982, PLAST RECONSTR SURG, V69, P56, DOI 10.1097/00006534-198269010-00008
   BARKER DE, 1978, PLAST RECONSTR SURG, V61, P836, DOI 10.1097/00006534-197861060-00002
   BENJAMIN E, 1982, DIAGN HISTOPATHOL, V5, P133
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   BLOEBAUM RD, 1993, J ARTHROPLASTY, V8, P195
   BLOEBAUM RD, 1994, CLIN ORTHOPAEDICS, V298, P19
   BOMMER J, 1981, LANCET, V1, P1314
   BOMMER J, 1981, NEW ENGL J MED, V305, P1077, DOI 10.1056/NEJM198110293051809
   BRODY GS, 1977, PLAST RECONSTR SURG, V60, P615, DOI 10.1097/00006534-197710000-00020
   CAPOZZI A, 1981, PLAST RECONSTR SURG, V68, P512, DOI 10.1097/00006534-198110000-00006
   CAPOZZI A, 1978, PLAST RECONSTR SURG, V62, P302, DOI 10.1097/00006534-197808000-00038
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   CHINN JA, 1992, J BIOMED MATER RES, V16, P757
   CHRISTIE AJ, 1977, JAMA-J AM MED ASSOC, V237, P1463, DOI 10.1001/jama.237.14.1463
   CHUANG HYK, 1980, THROMB RES, V19, P1, DOI 10.1016/0049-3848(80)90398-9
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DAYER JM, 1979, J CLIN INVEST, V64, P1386, DOI 10.1172/JCI109596
   DIGBY JM, 1982, HAND, V14, P326, DOI 10.1016/S0072-968X(82)80069-7
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   DOOR LD, 1990, CLIN ORTHOPAEDICS, V261, P82
   EDMOND JA, 1980, PLAST RECONSTR SURG, V66, P478
   EHRLICH HP, 1983, J CELL PHYSIOL, V116, P345, DOI 10.1002/jcp.1041160312
   EISENBERG HV, 1977, PLAST RECONSTR SURG, V59, P849, DOI 10.1097/00006534-197706000-00024
   ENDO LP, 1987, SEMIN ARTHRITIS RHEU, V17, P112, DOI 10.1016/0049-0172(87)90033-3
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   GABRIELSE, 1994, NEW ENGL J MED, V330, P1697
   GOLDRING S R, 1985, Arthritis and Rheumatism, V28, pS36
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOLDRING SR, 1988, NONCEMENTED TOTAL HI, P35
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   HANDEL N, 1991, PLAST RECONSTR SURG, V88, P475, DOI 10.1097/00006534-199109000-00015
   HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   HOLTROP ME, 1982, CALCIFIED TISSUE INT, V34, P488, DOI 10.1007/BF02411290
   HOWIE DW, 1992, T ORTHOP RES SOC, V17, P344
   HUANG TT, 1978, PLAST RECONSTR SURG, V61, P277, DOI 10.1097/00006534-197802000-00026
   ITO N, 1969, CANCER RES, V29, P1137
   JASTY M, 1990, J BONE JOINT SURG BR, V72, P63
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JASTY M, 1992, CLIN ORTHOP RELAT R, V285, P116
   JENNINGS DA, 1991, ANN PLAS SURG, V27, P553, DOI 10.1097/00000637-199112000-00007
   KAUFMAN RL, 1985, J RHEUMATOL, V12, P1066
   KOSSOVSKY N, 1994, ARCH PATHOL LAB MED, V118, P686
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LEONG ASY, 1982, NEW ENGL J MED, V306, P135, DOI 10.1056/NEJM198201213060303
   LEONG ASY, 1981, LANCET, V1, P889
   LEONG ASY, 1981, LANCET, V2, P210
   LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   Mason J, 1981, Arch Dermatol, V117, P366
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCDONALD MD, 1995, J BIOMED MATER RES, V29, P1, DOI 10.1002/jbm.820290102
   MELMED EP, 1988, PLAST RECONSTR SURG, V82, P285, DOI 10.1097/00006534-198808000-00013
   MONTANDOND, 1979, PLAST RECONSTR SURG, V63, P719
   MULROY RD, 1990, J BONE JOINT SURG BR, V72, P757
   MUNDY GR, 1977, SCIENCE, V196, P1109
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARFREY PS, 1981, LANCET, V1, P1101
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   ROSTOKER W, 1978, J BIOMED MATER RES, V12, P317, DOI 10.1002/jbm.820120306
   Rudolph R, 1980, Ann Plast Surg, V4, P14
   SCHMALZRIED TP, 1991, CLIN ORTHOP RELAT R, V274, P60
   SEDEL L, 1992, ARCH ORTHOP TRAUM SU, V111, P255, DOI 10.1007/BF00571519
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SHEPARD AD, 1984, J VASC SURG, V1, P829, DOI 10.1067/mva.1984.avs0010829
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   STAUFFER RN, 1982, J BONE JOINT SURG AM, V64, P983, DOI 10.2106/00004623-198264070-00003
   STEINBACH BG, 1993, RADIOGRAPHICS, V13, P95, DOI 10.1148/radiographics.13.1.8426939
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG L, 1995, IN PRESS 21ST ANN M
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TRAVIS WD, 1985, HUM PATHOL, V16, P19, DOI 10.1016/S0046-8177(85)80209-4
   VARGA J, 1989, ANN INTERN MED, V111, P377, DOI 10.7326/0003-4819-111-5-377
   VISTNES LM, 1977, PLAST RECONSTR SURG, V59, P31, DOI 10.1097/00006534-197701000-00005
   WICKHAM MG, 1978, SCIENCE, V199, P437, DOI 10.1126/science.619466
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WINDING O, 1988, SCAND J PLAST RECONS, V22, P127, DOI 10.3109/02844318809072383
   WOLF CF, 1981, INT J ARTIF ORGANS, V5, P277
   WORSING RA, 1982, J BONE JOINT SURG AM, V64, P581, DOI 10.2106/00004623-198264040-00014
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 100
TC 289
Z9 295
U1 1
U2 83
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106
SN 0002-9173
J9 AM J CLIN PATHOL
JI Am. J. Clin. Pathol.
PD APR
PY 1995
VL 103
IS 4
BP 466
EP 471
PG 6
WC Pathology
SC Pathology
GA QQ628
UT WOS:A1995QQ62800018
PM 7726145
DA 2018-10-19
ER

PT J
AU DEFIFE, KM
   YUN, JK
   AZEEZ, A
   STACK, S
   ISHIHARA, K
   NAKABAYASHI, N
   COLTON, E
   ANDERSON, JM
AF DEFIFE, KM
   YUN, JK
   AZEEZ, A
   STACK, S
   ISHIHARA, K
   NAKABAYASHI, N
   COLTON, E
   ANDERSON, JM
TI ADHESION AND CYTOKINE PRODUCTION BY MONOCYTES ON
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE-CO-ALKYL
   METHACRYLATE)-COATED POLYMERS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROTEIN ADSORPTION; MACROPHAGE; BLOOD
AB Human monocytes isolated from peripheral venous blood were assayed for their ability to adhere to various polymers. The culture supernatants were also assayed for the cytokines, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). The polymers evaluated for adherence and cytokine production included Pellethane(R), polyethylene and poly[n-butyl methacrylate (BMA)] coated with poly[2-methacryloyloxyethyl phosphorylcholine (MPC)-co-alkyl methacrylate] copolymers. In some experiments the test polymers were adsorbed with fibrinogen or IgG prior to the addition of monocytes. MPC copolymer-coated materials inhibited monocyte and macrophage adhesion after 1 and 8 days of culture relative to corresponding uncoated polymers and tissue culture polystyrene (TCPS). The degree of inhibition by coated Pellethane compared to uncoated Pellethane was the greatest, while inhibition of adhesion by coated poly(BMA) was the least compared to uncoated poly(BMA). However, adhesion was significantly decreased on both coated and uncoated poly(BMA) by day 8. While n-1 beta, IL-6, and TNF-alpha release was variably influenced by polymer coating, release was consistently inhibited relative to TCPS on day 1. However, cytokine production was not inhibited compared to corresponding uncoated polymers on day 1. With or without protein preadsorption, IL-1 beta release was not detectable in the supernatants of any polymer on day 8, IL-6 production was diminished on day 8, and TNF-alpha production was sustained on day 8. Overall, MPC copolymer-coated and uncoated poly(BMA) were the least stimulating, while TCPS was the most stimulating. These studies suggest that MPC copolymers may improve the cell adhesion-resistant properties of a biomaterial while variably influencing the activation of cells which may contact the coated surface. (C) 1995 John Wiley & Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,CTR APPL POLYMER RES,CLEVELAND,OH 44106.
   TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,TOKYO 101,JAPAN.
FU NHLBI NIH HHS [HL 48771, HL 33849]
CR ALLISON AC, 1983, CLIN ASPECTS IMMUNOL, V1, P101
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, ASAIO, V11, P101
   BENTLEY C, 1981, LYMPHOKINES, V4, P197
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   CAMPBELL AM, 1989, BRIT J PHARMACOL, V98, P637, DOI 10.1111/j.1476-5381.1989.tb12638.x
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   DINARELLO CA, 1988, FASEB J, V2, P108
   HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621
   HELLE M, 1992, MONONUCLEAR PHAGOCYTES, P333
   HIRANO T, 1989, HUMAN MONOCYTES, P217
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P225, DOI 10.1002/jbm.820280213
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1993, POLYM J, V22, P355
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   MCGRATH MH, 1990, CLIN PLAST SURG, V17, P421
   MELLMAN I, 1992, MONONUCLEAR PHAGOCYTES, P169
   Pancre V, 1990, Eur Cytokine Netw, V1, P15
   SISSON SD, 1989, HUMAN MONOCYTES, P183
   TRACY PB, 1993, METHOD ENZYMOL, V222, P281
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   VANDERMEER JWM, 1992, MONONUCLEAR PHAGOCYTES, P323
   VANLEENEN D, 1992, MONONUCLEAR PHAGOCYTES, P346
   VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4
   WITSELL AL, 1992, P NATL ACAD SCI USA, V89, P4754, DOI 10.1073/pnas.89.10.4754
   WONG GHW, 1989, HUMAN MONOCYTES, P195
NR 30
TC 69
Z9 71
U1 0
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD APR
PY 1995
VL 29
IS 4
BP 431
EP 439
DI 10.1002/jbm.820290403
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QP943
UT WOS:A1995QP94300002
PM 7622528
DA 2018-10-19
ER

PT J
AU NAIMARK, WA
   PEREIRA, CA
   TSANG, K
   LEE, JM
AF NAIMARK, WA
   PEREIRA, CA
   TSANG, K
   LEE, JM
TI HMDC CROSS-LINKING OF BOVINE PERICARDIAL TISSUE - A POTENTIAL ROLE OF
   THE SOLVENT ENVIRONMENT IN THE DESIGN OF BIOPROSTHETIC MATERIALS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TENSILE VISCOELASTIC PROPERTIES; DERMAL SHEEP COLLAGENS; CROSS-LINKS;
   CALCIFICATION; CYTOTOXICITY; DEGRADATION; XENOGRAFT; FIXATION; INVITRO
AB The need for alternative crosslinking techniques in the processing of bioprosthetic materials is widely recognized. While glutaraldehyde remains the most commonly used crosslinking agent in biomaterial applications there is increasing concern as to its biocompatibility-principally due to its association with enhanced calcification, cytotoxicity, and undesirable changes in the mechanical properties of bioprosthetic materials. Hexamethylene diisocyanate (HMDC), like glutaraldehyde, is a bifunctional molecule which covalently bonds with amino groups of lysine residues to form covalent crosslinks. Evidence within the literature indicates HMDC-treated materials are less cytotoxic than glutaraldehyde-treated materials; however, there is limited characterization of the material properties of HMDC-treated tissue. This study uses a multi-disciplined approach to characterize the mechanical, thermal, and biochemical properties of HMDC-treated bovine pericardial tissue. Further, to facilitate stabilization of the HMDC reagent, non-aqueous solvent environments were investigated. HMDC treatment produced changes in mechanical properties, denaturation temperature, and enzymatic resistance consistent with crosslinking similar to that seen in glutaraldehyde treated tissue. The significantly lower extensibility and stiffness observed under low stresses may be attributed to the effect of the 2-propanol solvent environment during crosslinking. While the overall acceptability of HMDC as a crosslinking agent for biomaterial applications remains unclear, it appears to be an interesting alternative to glutaraldehyde with many similar features.
RP NAIMARK, WA (reprint author), UNIV TORONTO,CTR BIOMAT,170 COLL ST,TORONTO,ON M5S 1A1,CANADA.
CR BERODE M, 1991, TOXICOL LETT, V56, P173, DOI 10.1016/0378-4274(91)90104-E
   BRAUER GM, 1989, J BIOMED MATER RES, V23, P753, DOI 10.1002/jbm.820230707
   BRENDEL K, 1986, ASTM SPECIAL PUBLICA, V898, P219
   BURGER K, 1981, ADV SOLUTION CHEM, P139
   CHEUNG DT, 1990, CONNECT TISSUE RES, V25, P27, DOI 10.3109/03008209009009810
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   DAMINK LO, 1993, THESIS U TWENTE, P55
   GATTI AM, 1991, INT J ARTIF ORGANS, V14, P647
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GUSTAVSON KH, 1956, CHEMISTRY REACTIVITY, P230
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   KRASOVSKAYA SM, 1991, BIOMATERIALS, V12, P817, DOI 10.1016/0142-9612(91)90067-K
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1984, J BIOMED MATER RES, V18, P79, DOI 10.1002/jbm.820180109
   LEE JM, IN PRESS MED ENG PHY
   MARK HF, 1981, KIRKOTHEMER ENCY CHE, V13, P789
   MARTINEK K, 1986, EUR J BIOCHEM, V155, P453, DOI 10.1111/j.1432-1033.1986.tb09512.x
   MOHANHARADAKRIS.K, 1965, LEATHER SCI, V12, P12
   NAIMARK WA, 1992, AM J PHYSIOL, V263, pH1095
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   TROWBRIDGE EA, 1986, BIOMATERIALS, V7, P49, DOI 10.1016/0142-9612(86)90089-X
   TROWBRIDGE EA, 1986, J BIOMECH, V19, P1023, DOI 10.1016/0021-9290(86)90119-3
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   VANWACHEM PB, 1991, CELLS MATERIALS, V1, P1
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, pM340
   ZIOUPOS P, 1993, J MATER SCI-MATER M, V4, P531, DOI 10.1007/BF00125589
NR 31
TC 45
Z9 46
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 1995
VL 6
IS 4
BP 235
EP 241
DI 10.1007/BF00146862
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QW049
UT WOS:A1995QW04900010
DA 2018-10-19
ER

PT J
AU CONSTANTZ, BR
   ISON, IC
   FULMER, MT
   POSER, RD
   SMITH, ST
   VANWAGONER, M
   ROSS, J
   GOLDSTEIN, SA
   JUPITER, JB
   ROSENTHAL, DI
AF CONSTANTZ, BR
   ISON, IC
   FULMER, MT
   POSER, RD
   SMITH, ST
   VANWAGONER, M
   ROSS, J
   GOLDSTEIN, SA
   JUPITER, JB
   ROSENTHAL, DI
TI SKELETAL REPAIR BY IN-SITU FORMATION OF THE MINERAL PHASE OF BONE
SO SCIENCE
LA English
DT Article
AB A process has been developed for the in situ formation of the mineral phase of bone. inorganic calcium and phosphate sources are combined to form a paste that is surgically implanted by injection. Under physiological conditions, the material hardens in minutes concurrent with the formation of dahllite. After 12 hours, dahllite formation was nearly complete, and an ultimate compressive strength of 55 megapascals was achieved. The composition and crystal morphology of the dahllite formed are similar to those of bone. Animal studies provide evidence that the material is remodeled in vivo. A novel approach to skeletal repair is being tested in human trials for various applications; in one of the trials the new biomaterial is being percutaneously placed into acute fractures. After hardening, it serves as internal fixation to maintain proper alignment while healing occurs.
C1 STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305.
   UNIV MICHIGAN,ORTHORPAED SURG SECT,ANN ARBOR,MI 48109.
   MASSACHUSETTS GEN HOSP,BOSTON,MA 02114.
RP CONSTANTZ, BR (reprint author), NORIAN CORP,CUPERTINO,CA 95014, USA.
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   CONSTANTZ BR, 1992, MATER RES SOC SYMP P, V252, P79
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P99
   DIAS JJ, 1987, INJURY, V18, P304, DOI 10.1016/0020-1383(87)90047-7
   Fees E., 1992, CLIN ASSESSMENT RECO, P41
   FRANKENBURG EP, 1994, 40TH T ANN M ORTH RE, V19, P157
   GLIMCHER MJ, 1981, J CRYST GROWTH, V53, P100, DOI 10.1016/0022-0248(81)90058-0
   JUPITER JB, 1991, J BONE JOINT SURG AM, V73A, P461, DOI 10.2106/00004623-199173030-00019
   LOWENSTAM HA, 1989, BIOMINERALISATION, P144
   MCCONNELL D, 1952, J DENT RES, V31, P53, DOI 10.1177/00220345520310012301
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   Pool C, 1973, J Bone Joint Surg Br, V55, P540
   Posner A. S., 1984, Phosphate Minerals, P330
   POST JE, 1989, REV MINERAL, V20, P277
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   ROHL L, 1991, J BIOMECH, V24, P1143, DOI 10.1016/0021-9290(91)90006-9
   SCHLESINGER PH, 1991, AM J PHYS, V260, pC1315
   SCHMALHOLZ A, 1990, CLIN ORTHOP RELAT R, V254, P236
   VAES G, 1988, CLIN ORTHOP RELAT R, V231, P239
   Wolff J., 1892, GESETZ TRANSFORMATIO
NR 20
TC 558
Z9 590
U1 5
U2 73
PU AMER ASSOC ADVAN SCIENCE
PI WASHINGTON
PA 1333 H ST NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD MAR 24
PY 1995
VL 267
IS 5205
BP 1796
EP 1799
DI 10.1126/science.7892603
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QN702
UT WOS:A1995QN70200031
PM 7892603
DA 2018-10-19
ER

PT J
AU SAWTELL, RM
   KAYSER, MV
   DOWNES, S
AF SAWTELL, RM
   KAYSER, MV
   DOWNES, S
TI A MORPHOLOGICAL ASSESSMENT OF BOVINE CHONDROCYTES CULTURED ON POLY(ETHYL
   METHACRYLATE)/TETRAHYDROFURFURYL METHACRYLATE
SO CELLS AND MATERIALS
LA English
DT Article
DE CARTILAGE REPAIR; CHONDROCYTES; IN VITRO; TISSUE CULTURE; BIOMATERIAL;
   SCANNING ELECTRON MICROSCOPY; POLY(ETHYL METHACRYLATE);
   TETRAHYDROFURFURYL METHACRYLATE; HYDROXYETHYL METHACRYLATE
ID ARTICULAR-CARTILAGE DEFECTS; HETEROCYCLIC METHACRYLATES; OSTEOCHONDRAL
   DEFECTS; CLINICAL-APPLICATIONS; RABBIT KNEE; PERICHONDRIAL GRAFT;
   PERIOSTEAL GRAFTS; REPAIR; SURFACES; IMPLANTS
AB A heterocyclic methacrylate polymer system, PEMA/THFMA, has shown potential as a biomaterial for cartilage repair in a rabbit model and has properties making it suitable for use clinically. The ability of the polymer system, PEMA/THFMA, and a related system, PEMA/HEMA, to support chondrocytes in vitro was assessed by scanning electron microscopy. Chondrocytes adhered to the surface of the PEMA/THFMA by day one, having a rounded morphology and clustered appearance opposed to the Thermanox (R) control, where the cells had spread out and become fibroblastic in appearance. The chondrocytes divided rapidly on the PEMA/THFMA system by day three and had completely covered the surface by day seven. In contrast, chondrocytes did not adhere well to the more hydrophilic PEMA/HEMA system. A few cells were seen on the surface by day one and by days three and seven, there was no evidence of cell growth or spreading across the surface.
   In conclusion, the PEMA/THFMA system can support chondrocytes in vitro, whereas the PEMA/HEMA system does not.
C1 UCL,INST ORTHOPAED,STANMORE HA7 4LP,MIDDX,ENGLAND.
RP SAWTELL, RM (reprint author), QUEENS MED CTR,SCH MED,DEPT HUMAN MORPHOL,NOTTINGHAM NG7 2UH,ENGLAND.
CR ARCHER CW, 1990, J CELL SCI, V97, P361
   ASTON JE, 1986, J BONE JOINT SURG BR, V68, P29
   BAGNALL RD, 1977, J BIOMED MATER RES, V11, P939, DOI 10.1002/jbm.820110612
   Breck L W, 1967, Clin Orthop Relat Res, V54, P133
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   Cobey M C, 1967, Clin Orthop Relat Res, V54, P139
   CORKHILL PH, 1993, J BIOMAT SCI-POLYM E, V4, P615, DOI 10.1163/156856293X00834
   COUTTS RD, 1992, CLIN ORTHOP RELAT R, V275, P263
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Di Silvio L., 1994, Clinical Materials, V16, P91, DOI 10.1016/0267-6605(94)90102-3
   DOWNES S, 1994, J MATER SCI-MATER M, V5, P88, DOI 10.1007/BF00121696
   DOWNES S, 1994, SURFACE PROPERTIES B, P11
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HOMMINGA GN, 1989, ACTA ORTHOP SCAND, V60, P326, DOI 10.3109/17453678909149287
   HOMMINGA GN, 1991, ACTA ORTHOP SCAND, V62, P415, DOI 10.3109/17453679108996635
   ITAY S, 1987, CLIN ORTHOP RELAT R, V220, P284
   JAFFE FF, 1974, J BONE JOINT SURG AM, VA 56, P1031, DOI 10.2106/00004623-197456050-00014
   KLOMPMAKER J, 1992, BIOMATERIALS, V13, P625, DOI 10.1016/0142-9612(92)90031-I
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MESSNER K, 1993, BIOMATERIALS, V14, P513, DOI 10.1016/0142-9612(93)90240-3
   MESSNER K, 1994, BIOMATERIALS, V15, P657, DOI 10.1016/0142-9612(94)90163-5
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   NIXON AJ, 1993, AM J VET RES, V54, P349
   NOGUCHI T, 1994, CLIN ORTHOP RELA MAY, P251
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   PALETTA GA, 1992, AM J SPORT MED, V20, P725, DOI 10.1177/036354659202000614
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   PATEL MP, 1991, BIOMATERIALS, V12, P645, DOI 10.1016/0142-9612(91)90110-V
   PATEL MP, 1991, BIOMATERIALS, V12, P649, DOI 10.1016/0142-9612(91)90111-M
   PATEL MP, 1989, BIOMATERIALS, V10, P277, DOI 10.1016/0142-9612(89)90106-3
   PEARSON GJ, 1986, INT ENDOD J, V19, P121, DOI 10.1111/j.1365-2591.1986.tb00464.x
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P402, DOI 10.1007/BF00058973
   REISSIS N, 1994, J MATER SCI-MATER M, V5, P793, DOI 10.1007/BF00213137
   RICH D, 1994, 40TH T ANN M ORTH RE, V19, P241
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Robinson Dror, 1993, Bulletin Hospital for Joint Diseases, V53, P75
   ROSEN JJ, 1980, POLYM SCI TECHNOL B, V12, P667
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P175, DOI 10.3109/17453678208992197
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Speer DP, 1979, CLIN ORTHOP RELAT R, V144, P326
   THOMPSON RC, 1981, J BONE JOINT SURG AM, V63, P327, DOI 10.2106/00004623-198163020-00021
   ULREICH J B, 1985, Journal of Cell Biology, V101, p96A
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACHON AM, 1991, AM J VET RES, V52, P317
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WATT FM, 1988, DIFFERENTIATION, V38, P140, DOI 10.1111/j.1432-0436.1988.tb00208.x
NR 55
TC 11
Z9 11
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PD MAR
PY 1995
VL 5
IS 1
BP 63
EP 71
PG 9
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA RN485
UT WOS:A1995RN48500006
DA 2018-10-19
ER

PT J
AU ROWLAND, SA
   SHALABY, SW
   LATOUR, RA
   VONRECUM, AF
AF ROWLAND, SA
   SHALABY, SW
   LATOUR, RA
   VONRECUM, AF
TI EFFECTIVENESS OF CLEANING SURGICAL IMPLANTS - QUANTITATIVE-ANALYSIS OF
   CONTAMINANT REMOVAL
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
AB Surgical implants need to be free from contaminants before implantation. The effectiveness of a presently used Clemson bioengineering cleaning (CBC) protocol was evaluated for cleaning three different biomaterials (titanium, aluminum oxide, and polyethylene terephthalate, PET) contaminated with three different contaminants (calcium chloride, zinc chloride, and hexadecane). Radiolabeled tracer analysis (RTA), with the use of liquid scintillation, was used as the surface analytical technique to quantitatively determine the percent contaminant removed from the biomaterial surface. On average, the ultrasonic cleaning step removed 99.96% of all three contaminants from both titanium and aluminum oxide. The CBC protocol did not sufficiently clean PET fabric contaminated with hexadecane leaving 11.76% of the contaminant after the ultrasonic step. With the use of isopropyl alcohol in series with 1% Liquinox, the ultrasonic step cleaned the fabric soiled with hexadecane within 30 min, removing 99.85% of the hexadecane initially on the surface. RTA proved to be an excellent method of quantifying surface contamination on implant materials, and for assessing the effectiveness of cleaning protocols in question. (C) 1995 John Wiley and Sons, Inc.
C1 CLEMSON UNIV,COLL ENGN,DEPT BIOENGN,CLEMSON,SC 29634.
CR BLACK J, 1984, BIOL PERFORMANCE MAT
   CHOLVIN NR, 1986, HDB BIOMATERIALS EVA, P295
   FIGLIOLA RS, 1991, THEORY DESIGN MECHAN
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KRIEGER GL, 1962, ASTM SPEC TECH PUB, V342
   MOSTAFA ABM, 1976, CLEANING SURGICAL IN
   OTT L, 1988, INTRO STATISTICAL ME
   1984, ASTM F8684 AM SOC TE
NR 8
TC 34
Z9 34
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SPR
PY 1995
VL 6
IS 1
BP 1
EP 7
DI 10.1002/jab.770060102
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QH698
UT WOS:A1995QH69800001
PM 7703533
DA 2018-10-19
ER

PT J
AU MARUYAMA, M
   TERAYAMA, K
   ITO, M
   TAKEI, T
   KITAGAWA, E
AF MARUYAMA, M
   TERAYAMA, K
   ITO, M
   TAKEI, T
   KITAGAWA, E
TI HYDROXYAPATITE CLAY FOR GAP FILLING AND ADEQUATE BONE INGROWTH
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COATED IMPLANTS; TITANIUM; HYDROXYLAPATITE; POLYSULFONE; PROSTHESES;
   INTERFACE; COMPOSITE; FIXATION; COATINGS; ALGINATE
AB In uncemented total hip arthroplasty, a complete filling of the gap between femoral prosthesis and the host bone is difficult and defects would remain, because the anatomy of the reamed intramedullary canal cannot fit the prosthesis. Therefore, it seems practical to fill the gap with a clay containing hydroxyapatite (HA), which has an osteoconductive character. The clay (HA clay) is made by mixing HA granules (size 0.1 mm or more) having a homogeneous pore distribution and a porosity of 35-48 vol%, and a viscous substance such as a saline solution of sodium alginate (SSSA). In the first experiment, the ratio of HA granules and sodium alginate in SSSA is set for the same handling properties of HA clay and polymethylmethacrylate bone cement (standard viscosity) before hardening. As a result, the ratio is set for 55 wt% of HA in the clay and 12.5 wt% of sodium alginate in SSSA (i.e., KA:sodium alginate:saline solution = 9.8:1:7). In the second study, the gap between the femoral stem and bone model is completely filled with HA clay. However, the gap is not filled only with HA granules or HA granules mixed with saline solution. In the third animal experiment, using an unloaded model, histology shows that HA clay has an osteoconductive property bridging the gap between the implant and the cortical bone without any adverse reaction. HA day is considered a useful biomaterial to fill the gap with adequate bone ingrowth. (C) 1995 John Wiley & Sons, Inc.
C1 MATSUMOTO DENT COLL,INST DENT SCI,SHIOJIRI 39907,JAPAN.
   NAGANO REHABIL CTR,DEPT ORTHOPAED SURG,NAGANO 381,JAPAN.
   NATL TOSHIN HOSP,DEPT ORTHOPAED SURG,UEDA,NAGANO 386,JAPAN.
RP MARUYAMA, M (reprint author), SHINSHU UNIV,SCH MED,DEPT ORTHOPAED SURG,3-1-1 ASAHI,MATSUMOTO,NAGANO 390,JAPAN.
CR ANDERSON DMW, 1991, FOOD ADDIT CONTAM, V8, P237, DOI 10.1080/02652039109373974
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BOBYN JD, 1987, CLIN ORTHOP RELAT R, V224, P303
   Cameron H U, 1986, Clin Orthop Relat Res, P81
   CAMERON HU, 1973, J BIOMED MATER RES, V7, P301, DOI 10.1002/jbm.820070404
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Collier J P, 1993, J Arthroplasty, V8, P389, DOI 10.1016/S0883-5403(06)80037-9
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   Cook S D, 1988, J Arthroplasty, V3, P249
   COOK SD, 1988, CLIN ORTHOP RELAT R, V234, P90
   DANTONIO JA, 1992, J BONE JOINT SURG AM, V74A, P995, DOI 10.2106/00004623-199274070-00006
   DANTONIO JA, 1992, CLIN ORTHOP RELAT R, V285, P102
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1980, J BIOMED MATER RES, V14, P225, DOI 10.1002/jbm.820140305
   ENGH GA, 1988, ORTHOPEDICS, V11, P725
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, V225, P147
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, V232, P255
   GREIS PE, 1992, CLIN ORTHOP RELAT R, V274, P47
   HARDY DCR, 1991, J BONE JOINT SURG BR, V73, P732
   HUEPER WC, 1959, ARCH PATHOL, V67, P589
   HUMPHREY.ER, 1968, NATURE, V219, P1172, DOI 10.1038/2191172a0
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KAKUDA C, 1985, JPN PHARMACOL THER, V13, P367
   KENNEDY AC, 1977, CLIN RHEUM DIS, V3, P403
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   LING RSM, 1986, CLIN ORTHOP RELAT R, V210, P80
   MAISTRELLI GL, 1992, J BONE JOINT SURG BR, V74, P452
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   NILSON HW, 1951, P SOC EXP BIOL MED, V76, P630
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   POSER RD, 1992, 4TH WORLD BIOM C BER, P500
   SALVATI EA, 1993, CLIN ORTHOP RELAT R, V293, P160
   Shen W J, 1992, J Arthroplasty, V7, P43, DOI 10.1016/0883-5403(92)90031-K
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P270
   SOBALLE K, 1991, CLIN ORTHOPAEDICS, V272, P300
   SOBALLE K, 1992, CLIN ORTHOP RELAT R, V274, P282
   Thomas K A, 1989, J Arthroplasty, V4, P43, DOI 10.1016/S0883-5403(89)80053-1
   THOMAS KA, 1988, ORTHOPEDICS, V11, P441
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   THOMAS KA, 1983, J BIOMED MATER RES, V19, P875
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   ZIMMERMAN MC, 1990, J APPL BIOMATER, V1, P295, DOI 10.1002/jab.770010405
NR 46
TC 18
Z9 18
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1995
VL 29
IS 3
BP 329
EP 336
DI 10.1002/jbm.820290308
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QJ437
UT WOS:A1995QJ43700007
PM 7615585
DA 2018-10-19
ER

PT J
AU LEUNG, T
   HOBKIRK, JA
   THOROGOOD, P
AF LEUNG, T
   HOBKIRK, JA
   THOROGOOD, P
TI A NEW ORGAN-CULTURE MODEL FOR STUDYING BONE-BIOMATERIAL INTERACTIONS
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 UCL EASTMAN DENT INST, DEPT PROSTHET, LONDON, ENGLAND.
   UNIV LONDON, INST CHILD HLTH, DEV BIOL UNIT, LONDON, ENGLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 1995
VL 74
IS 3
BP 836
EP 836
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA QX162
UT WOS:A1995QX16200706
DA 2018-10-19
ER

PT J
AU WATTS, DC
   BERTENSHAW, BW
   JUGDEV, JS
AF WATTS, DC
   BERTENSHAW, BW
   JUGDEV, JS
TI PH AND TIME-DEPENDENCE OF SURFACE DEGRADATION IN A COMPOMER BIOMATERIAL
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV MANCHESTER,HOSP DENT,MANCHESTER M13 9PL,LANCS,ENGLAND.
NR 0
TC 9
Z9 10
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 1995
VL 74
IS 3
BP 912
EP 912
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA QX162
UT WOS:A1995QX16201307
DA 2018-10-19
ER

PT J
AU ROBINSON, KA
   CANDAL, FJ
   SCOTT, NA
   ADES, EW
AF ROBINSON, KA
   CANDAL, FJ
   SCOTT, NA
   ADES, EW
TI SEEDING OF VASCULAR GRAFTS WITH AN IMMORTALIZED HUMAN DERMAL
   MICROVASCULAR ENDOTHELIAL-CELL LINE
SO ANGIOLOGY
LA English
DT Article; Proceedings Paper
CT 40th Annual Meeting of the American-College-of-Angiology
CY OCT, 1993
CL ORLANDO, FL
SP AMER COLL ANGIOL
ID GROWTH
AB Small-caliber vascular grafts (< 6 mm) for arterial bypass frequently fail owing either to acute thrombosis or long-term fibrosis.  One strategy to enhance patency is the coverage (''seeding'') of luminal polymeric graft surfaces with endothelial cells (EC), which may in themselves be thromboresistant and antiproliferative, or which could be transfected with genes whose products are thrombolytic or growth-inhibitory.  Advances in understanding of EC-biomaterial interaction have led to improvements in cell coverage and retention, but the sources of EC for such procedures have been limited to large vessels (autologous veins) and microvascular endothelium isolated from autologous adipose tissue.  Before the practice of graft seeding can gain widespread clinical acceptance, the practical constraints of EC harvest, EC culture, and quick access to the seeded prosthesis for the surgical procedure must be overcome.  Ideally, an EC line with a high proliferative capacity could be preestablished on the grafts, which could then be cryopreserved and made available as needed.  The authors have seeded Dacron graft material with an immortalized human dermal microvascular EC line, HMEC-1.  These cells were initially transfected with simian virus 40A large T antigen and have been passaged more than 100 times without signs of senescence.  They also express von Willebrand factor, take up acetylated low density lipoproteins, and rapidly form tubes when cultured on matrigel.  Confluent coverage of Dacron graft segments, either untreated or coated with gelatin, was achieved in two weeks.  The cells formed a monolayer over topographically elevated regions or appeared to be > one layer thick in other areas.  Cells were also shown to remain viable after freezing.  These results suggest a potential practical method for enhancement of small-caliber vascular graft biocompatibility in humans.
C1 EMORY UNIV,SCH MED,DEPT MED,ANDREAS GRUENTZIG CARDIOVASC CTR,DIV CARDIOL,ATLANTA,GA 30322.
   NATL CTR INFECT DIS,CTR DIS CONTROL,BIOL PROD BRANCH,ATLANTA,GA.
FU NCRR NIH HHS [RR-00165]
CR ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   GORDON JL, 1990, APPLIED CARDIOVASCUL, V2, P78
   HERRING M, 1978, SURGERY, V84, P498
   JARRELL B, 1984, J VASC SURG, V1, P757, DOI 10.1067/mva.1984.avs0010757
   KIRKPATRICK CJ, 1991, CELL MATER, V1, P93
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
NR 6
TC 15
Z9 15
U1 0
U2 0
PU WESTMINSTER PUBL INC
PI GLEN HEAD
PA 708 GLEN COVE AVE, GLEN HEAD, NY 11545
SN 0003-3197
J9 ANGIOLOGY
JI Angiology
PD FEB
PY 1995
VL 46
IS 2
BP 107
EP 113
DI 10.1177/000331979504600203
PG 7
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA QG051
UT WOS:A1995QG05100003
PM 7702194
DA 2018-10-19
ER

PT J
AU REMY, M
   BORDENAVE, L
   BAREILLE, R
   LAUROUA, C
   LEFEBVRE, F
   GUERIN, V
   BAQUEY, C
AF REMY, M
   BORDENAVE, L
   BAREILLE, R
   LAUROUA, C
   LEFEBVRE, F
   GUERIN, V
   BAQUEY, C
TI BEWARE OF COMMERCIAL HUMAN THROMBINS USED TO STIMULATE CULTURED
   ENDOTHELIAL-CELLS
SO BIOMATERIALS
LA English
DT Article
DE CULTURED ENDOTHELIAL CELLS; VON WILLEBRAND FACTOR RELEASE; THROMBIN
   STIMULATION
AB In the field of in vitro biocompatibility testing, the investigation of cell response at the interface with a biomaterial is of great importance; there is a need for standard conditions and thus of well-defined and reliable sources of materials for an objective evaluation of cellular function. Thrombin is often used in vitro as a stimulating agent to check the specific functions of cultured endothelial cells. In the present work, and in order to select a thrombin of commercial origin, two criteria were borne in mind: purity towards the presence of the von Willebrand factor (VWF) and effectiveness towards VWF release by human umbilical venous endothelial cells (HUVEC) that have been submitted to four human commercial thrombins. We detected the presence of vWF in some thrombin solutions that have not yet been in contact with HUVEC. The different thrombins contained vWF antigen ranging from less than 0.1 mUnit per NIH unit of thrombin (from Diagnostica Stage and Sigma Chemical Co.) to 10-20 mUnit per NIH unit of Fibrindex (R) thrombin (from Ortho Diagnostic Systems). Thus, if vWF is present in commercial thrombins, it contributes to and overestimates the VWF appearance in the media resulting from cell stimulation. Consequently, we fixed on thrombin from Diagnostica Stage for further studies involving HUVEC on biomaterials.
C1 UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
   HOP ENFANTS,HEMATOL LAB,F-33076 BORDEAUX,FRANCE.
CR BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   BORDENAVE L, 1992, BIOMATERIALS, V13, P439, DOI 10.1016/0142-9612(92)90164-J
   BORDENAVE L, 1992, J BIOMAT SCI-POLYM E, V3, P509, DOI 10.1163/156856292X00475
   GARCIA JGN, 1992, J LAB CLIN MED, V120, P513
   HERRING M, 1978, SURGERY, V84, P498
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   SIGOTLUIZARD MF, 1993, TEST PROCEDURES BLOO, P569
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
NR 10
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1995
VL 16
IS 3
BP 193
EP 199
DI 10.1016/0142-9612(95)92117-O
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QG850
UT WOS:A1995QG85000007
PM 7748995
DA 2018-10-19
ER

PT J
AU GENTLE, CR
   TANSLEY, GD
AF GENTLE, CR
   TANSLEY, GD
TI DEVELOPMENT OF A CERAMIC CONDUIT VALVE PROSTHESIS FOR CORRECTIVE
   CARDIOVASCULAR-SURGERY
SO BIOMATERIALS
LA English
DT Article
DE HEART VALVES; CONDUITS; CERAMICS; PROSTHESES
AB This paper reports some of the ways in which biomaterial considerations have influenced the design, development and construction methods for a prototype conduit valve prosthesis in which the valve body is made from alumina. This material is used principally for its ability to grow acid support a thin (<0.1 mm) tissue covering on the surfaces in contact with the blood. This non-vascular covering does not interfere with the operation of the valve, but is thick enough to camouflage the underlying surface from any further interaction with the blood. This is important for any conduit valve because of the large internal surface area, but would be especially beneficial for children if it could obviate the need for chronic anticoagulation.
C1 UNIV ADELAIDE,DEPT ENGN MECH,ADELAIDE,SA,AUSTRALIA.
RP GENTLE, CR (reprint author), NOTTINGHAM TRENT UNIV,DEPT ENGN MECH,NOTTINGHAM NG1 4BU,ENGLAND.
CR Black M M, 1983, Life Support Syst, V1 Suppl 1, P301
   DUFF WR, 1972, J THORAC CARDIOV SUR, V63, P131
   GENTLE C R, 1983, Life Support Systems, V1, P263
   GENTLE CR, 1981, J BIOMED ENG, V3, P3, DOI 10.1016/0141-5425(81)90098-4
   GENTLE CR, 1981, P EUROPEAN SOC ARTIF, V8, P352
   GENTLE CR, 1980, MECHANICAL PROPERTIE, pCH48
   GEROULANOS S, 1978, P ESAO, V5, P13
   HEIMKE G, 1980, MECHANICAL PROPERTIE, pCH15
   JUDEN H, 1983, BIOMATERIALS, V4, P139, DOI 10.1016/0142-9612(83)90057-1
   LEEFE SE, 1993, THESIS NOTTINGHAM TR
   LEFRAK EA, 1979, CARDIAC VALVE PROSTH
   MACGREGOR DC, 1976, T AM SOC ART INT ORG, V22, P646
   MCGOON DC, 1976, J THORAC CARDIOV SUR, V72, P7
   MITAMURA Y, 1985, 5TH P WORLD C ISAO C
   Schwartz M. M, 1990, CERAMIC JOINING
   TANSLEY GD, 1988, MED BIOL ENG COMPUT, V26, P175, DOI 10.1007/BF02442261
   TANSLEY GD, 1988, THESIS NOTTINGHAM TR
NR 17
TC 11
Z9 12
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1995
VL 16
IS 3
BP 245
EP 249
DI 10.1016/0142-9612(95)92124-O
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QG850
UT WOS:A1995QG85000014
PM 7749002
DA 2018-10-19
ER

PT J
AU MULLER, ME
AF MULLER, ME
TI THE BENEFITS OF METAL-ON-METAL TOTAL HIP REPLACEMENTS
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT 22nd Open Scientific Meeting of the Hip-Society
CY 1994
CL NEW ORLEANS, LA
SP HIP SOC
ID PROSTHESES
AB The Muller's cast prosthesis with a concentric metal-on-metal articulation and 3 sliding bearings was used in Switzerland from 1965 to 1967. During the next 10 to 15 years, a number of hips in which the metal-to-metal systems were implanted were revised, Rather than osteoporosis and cranial migration occurring, the acetabular roofs were often sclerotic and the components showed no or only minor migration, At surgery, the capsule was almost normal and without signs of inflammation, Histologically, the capsule did not show the usual masses of giant cells associated with polyethylene particles, In the mid-1980s, different designs of metal-on-metal articulations were tested, From 1987 to 1990, this author developed, together with the biomaterial division of Sulzer Medical Technology, a pure titanium shell with a polyethylene-backed 28-mm forged cobalt-chromium liner insert. This combination has been successful, with no revisions required to date. In summary, with the present metal-on-metal articulations it is now possible to stop using the polyethylene. The successful long-term results of the cast cobalt-chromium metal-on-metal articulations of 1966 hold much promise for the future of the new-forged, more-precise, metallic socket.
RP MULLER, ME (reprint author), MAURICE E MULLER FDN CONTINUING EDUC & RES ORTHOP, MURTENSTR 35, POB 8354, CH-3001 BERN, SWITZERLAND.
CR AMSTUTZ HC, 1970, CLIN ORTHOP RELAT R, P123
   BERRY DJ, 1992, J BONE JOINT SURG BR, V74, P711
   Betts F, 1992, Clin Orthop Relat Res, P75
   BRIEN WW, 1992, CLIN ORTHOP RELAT R, P66
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1966, 10 P SOC INT CHIR OR, P311
   HARRIS WH, 1992, CLIN ORTHOP RELAT R, P6
   JANTSCH S, 1991, ARCH ORTHOP TRAUM SU, V110, P230, DOI 10.1007/BF00572878
   McKee G K, 1970, Clin Orthop Relat Res, V72, P85
   MCKEE GK, 1966, 10 P SOC INT CHIR OR, P320
   Morris J B, 1970, Clin Orthop Relat Res, V72, P33
   Muller M E, 1985, Acta Orthop Belg, V51, P436
   Muller M E, 1981, Hip, P46
   MULLER ME, 1970, CLIN ORTHOP RELAT R, P46
   MULLER ME, 1992, CLIN ORTHOP RELAT R, V274, P12
   MULLER ME, 1966, 10 P SOC INT CHIR OR, P329
   Postel M, 1970, Clin Orthop Relat Res, V72, P138
   SALVATI EA, 1992, CLIN ORTHOP RELAT R, V276, P2
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SEMLITSCH M, 1989, ORTHOPADE, V18, P377
   Weber B G, 1993, Nihon Seikeigeka Gakkai Zasshi, V67, P391
   WEBER BG, 1992, Z ORTHOP GRENZGEB, V130, P306, DOI 10.1055/s-2008-1039623
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILSON JN, 1970, CLIN ORTHOP RELAT R, P145
NR 24
TC 60
Z9 60
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD FEB
PY 1995
IS 311
BP 54
EP 59
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA QF554
UT WOS:A1995QF55400006
PM 7634591
DA 2018-10-19
ER

PT J
AU SAPATNEKAR, S
   KIESWETTER, KM
   MERRITT, K
   ANDERSON, JM
   CAHALAN, L
   VERHOEVEN, M
   HENDRIKS, M
   FOUACHE, B
   CAHALAN, P
AF SAPATNEKAR, S
   KIESWETTER, KM
   MERRITT, K
   ANDERSON, JM
   CAHALAN, L
   VERHOEVEN, M
   HENDRIKS, M
   FOUACHE, B
   CAHALAN, P
TI BLOOD BIOMATERIAL INTERACTIONS IN A FLOW SYSTEM IN THE PRESENCE OF
   BACTERIA - EFFECT OF PROTEIN ADSORPTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; MOLECULAR-WEIGHT KININOGEN; FACTOR
   FACTOR-XII; THROMBUS FORMATION; HUMAN-PLASMA; EPIDERMIDIS; ADHERENCE;
   SURFACES; ADHESION; FIBRINOGEN
AB An in vitro continuous flow system with whole human blood was used to study blood-biomaterial interactions on a base polyurethane and three modified surfaces in the presence and absence of circulating Staphylococcus epidermidis. We hypothesized that the composition of the protein layer adsorbed on the surface of the biomaterial would influence the response of blood components and bacteria. We examined the test surfaces for adsorption of nine plasma proteins and adsorption profiles differed on the four surfaces. The positively charged surface, UC, adsorbed significantly higher amounts of fibronectin (P < .01), von Willebrand factor (P < .01), and fibrinogen (P < .05) than the other materials. As a consequence of increased adsorption of these adhesive proteins, the adhesion of platelets and bacteria was greater on UC than on any other surface. On the base polyurethane, BC, and the negatively charged surface, UA, protein adsorption was low, and these materials were largely free of adherent blood cells and bacteria. The heparinized surface, UH, adsorbed higher quantities (P < .01) of Hageman factor and high molecular weight kininogen relative to the other surfaces. Platelet adhesion, and surface coagulation were prominent on UC, and may have contributed to increased bacterial adhesion on this surface. In the presence of circulating bacteria, adsorption was generally lower than in the absence of bacteria. The pattern of protein adsorption was largely unaffected by the strain of circulating bacteria, but platelet responses (adhesion and activation) were greater in the presence of slime-producing S. epidermidis as compared to the non-slime-producing strain, suggesting that slime may have a direct activating effect on platelets. (C) 1995 John Wiley and Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   MEDTRON BAKKEN RES CTR BV,6201 MP MAASTRICHT,NETHERLANDS.
FU NHLBI NIH HHS [HL-47300]
CR ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BITHELL TC, 1993, WINTROBES CLIN HEMAT, P540
   Bithell TC, 1993, WINTROBES CLIN HEMAT, P566
   BRASH JL, 1988, BLOOD, V71, P932
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   CHUGH TD, 1990, INFECT IMMUN, V58, P315
   FEUERSTEIN IA, 1993, BIOMATERIALS, V14, P137, DOI 10.1016/0142-9612(93)90228-T
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HERRMANN M, 1991, INFECT IMMUN, V59, P279
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   KALMAN PG, 1993, J VASC SURG, V17, P531, DOI 10.1016/0741-5214(93)90154-E
   MOHAMMAD SF, 1988, T AM SOC ART INT ORG, V34, P573
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   MULVIHILL JN, 1990, J BIOMED MATER RES, V24, P155, DOI 10.1002/jbm.820240203
   NATION JL, 1985, STAIN TECHNOL, V58, P347
   RATNOFF OD, 1972, J LAB CLIN MED, V80, P704
   STILLMAN RM, 1977, ARCH SURG-CHICAGO, V112, P1497
   TURITTO VT, 1980, SCIENCE, V207, P541, DOI 10.1126/science.7352265
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   USUI Y, 1991, MICROBIOL IMMUNOL, V35, P15, DOI 10.1111/j.1348-0421.1991.tb01529.x
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   VROMAN L, 1980, BLOOD, V55, P156
   WANG I, 1993, J BIOMED MATER RES, V27, P1119, DOI 10.1002/jbm.820270902
   ZDANOWSKI Z, 1993, APMIS, V101, P926, DOI 10.1111/j.1699-0463.1993.tb00203.x
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 28
TC 21
Z9 21
U1 2
U2 10
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1995
VL 29
IS 2
BP 247
EP 256
DI 10.1002/jbm.820290216
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QE576
UT WOS:A1995QE57600015
PM 7738073
DA 2018-10-19
ER

PT J
AU KVETON, JF
   FRIEDMAN, CD
   PIEPMEIER, JM
   COSTANTINO, PD
AF KVETON, JF
   FRIEDMAN, CD
   PIEPMEIER, JM
   COSTANTINO, PD
TI RECONSTRUCTION OF SUBOCCIPITAL CRANIECTOMY DEFECTS WITH HYDROXYAPATITE
   CEMENT - A PRELIMINARY-REPORT
SO LARYNGOSCOPE
LA English
DT Article
ID ACOUSTIC NEUROMA
AB Hydroxyapatite cement, a new biomaterial presently under clinical investigation, has been demonstrated to have potentially wide application in cranial reconstruction. We describe our experience with this biologic bone cement in the reconstruction of suboccipital craniectomy defects in seven patients after vestibular schwannoma removal. With up to 2-year follow-up, cranial bone integrity has been reestablished in five patients. Dissolution of cement has occurred in dependent areas and appears to be technique related. Cranial bone contour appears dependent on the amount of cement used. The frequency of debilitating postoperative headache was reduced in these patients when compared to patients who had no reconstruction of the craniectomy defect. Reconstruction of the bony defect after suboccipital craniectomy with hydroxypatite cement is not only useful to restore cranial contour, but also appears to reduce some of the functional deficits attributed to this surgical approach.
C1 WILFORD HALL USAF MED CTR,DEPT OTOLARYNGOL,LACKLAND AFB,TX 78236.
   YALE UNIV,SCH MED,DEPT SURG,NEUROSURG SECT,NEW HAVEN,CT 06510.
RP KVETON, JF (reprint author), YALE UNIV,SCH MED,DEPT SURG,OTOLARYNGOL SECT,333 CEDAR ST,NEW HAVEN,CT 06520, USA.
CR COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   HARNER SG, 1993, AM J OTOL, V14, P552
   KAMERER DB, 1993, HYDROXYAPATITE CEMEN, V15, P47
   SCHLESSEL DA, 1992, 1ST P INT C AC NEUR, P899
   WIEGAND DA, 1989, LARYNGOSCOPE, V99, P179
   IDE910073 FOOD DRUG
NR 7
TC 61
Z9 61
U1 0
U2 0
PU LARYNGOSCOPE CO
PI ST LOUIS
PA 10 S BROADWAY 14TH FLOOR, ST LOUIS, MO 63102-1741
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD FEB
PY 1995
VL 105
IS 2
BP 156
EP 159
DI 10.1288/00005537-199502000-00008
PG 4
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA QR142
UT WOS:A1995QR14200008
PM 8544595
OA Bronze
DA 2018-10-19
ER

PT J
AU HONG, FT
AF HONG, FT
TI FUNDAMENTALS OF PHOTOELECTRIC EFFECTS IN MOLECULAR ELECTRONIC THIN-FILM
   DEVICES - APPLICATIONS TO BACTERIORHODOPSIN-BASED DEVICES
SO BIOSYSTEMS
LA English
DT Article; Proceedings Paper
CT 1993 Meeting of the
   International-Society-for-Molecular-Electronics-and-Biocomputing
CY SEP 21-23, 1993
CL GAITHERSBURG, MD
SP INT SOC MOLEC ELECTR & BIOCOMP
DE PHOTOELECTRIC EFFECTS; BACTERIORHODOPSIN; MOLECULAR DEVICES; ADVANCED
   MATERIALS; REVERSE ENGINEERING; OPTOELECTRONIC; BIOMIMETIC SCIENCE;
   BIOMEMBRANES
ID MODEL; MEMBRANES
AB This tutorial lecture focuses on the fundamental mechanistic aspects of light-induced charge movements in pigment-containing membranes. The topic is relevant to molecular electronics because many prototypes optoelectronic devices are configured as pigment-containing thin films. We use reconstituted bacteriorhodopsin membranes as an example to illustrate the underlying principle of measurements and data interpretation. Bacteriorhodopsin, a light-driven proton pump, is the only protein component in the purple membrane of Halobacterium halobium. It resembles the visual pigment rhodopsin chemically but performs the function of photosynthesis. Bacteriorhodopsin thus offers an unprecedented opportunity for us to compare the visual photoreceptor and the photosynthetic apparatus from a mechanistic point of view. Bacteriorhodopsin, well known for its exceptional chemical and mechanical stability, is also a popular advanced biomaterial for molecular device construction. The tutorial approaches the subject from two angles. First, the fundamental photoelectric properties are exploited for device construction. Second, basic design principles for photosensors and photon energy converters can be elucidated via 'reverse engineering'. The concept of molecular intelligence and the principle of biomimetic science are discussed.
RP HONG, FT (reprint author), WAYNE STATE UNIV,DEPT PHYSIOL,DETROIT,MI 48201, USA.
CR BIRGE RR, 1992, COMPUTER, V25, P56, DOI 10.1109/2.166417
   BROWN KT, 1964, NATURE, V201, P626, DOI 10.1038/201626a0
   DRAIN CM, 1989, P NATL ACAD SCI USA, V86, P6959, DOI 10.1073/pnas.86.18.6959
   FULLER BE, 1994, IN PRESS BIOELECTROC
   HAMPP N, 1990, BIOPHYS J, V58, P83, DOI 10.1016/S0006-3495(90)82355-9
   HARONIAN D, 1991, APPL OPTICS, V30, P597, DOI 10.1364/AO.30.000597
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Hong F. T., 1992, INTELL MATER, V2, P15
   HONG FH, 1994, BIOELECTROCH BIOENER, V33, P151, DOI 10.1016/0302-4598(94)85006-2
   HONG FH, 1994, IN PRESS BIOELECTROC
   HONG FT, 1974, P NATL ACAD SCI USA, V71, P1564, DOI 10.1073/pnas.71.4.1564
   HONG FT, 1994, IEEE ENG MED BIOL, V13, P75, DOI 10.1109/51.265777
   HONG FT, 1978, BIOELECTROCH BIOENER, V5, P425, DOI 10.1016/0302-4598(87)85039-0
   HONG FT, 1986, BIOSYSTEMS, V19, P223, DOI 10.1016/0303-2647(86)90041-9
   HONG FT, 1989, J MOL ELECTRON, V5, P163
   HONG FT, 1994, ADV CHEM SER, V240, P527
   HONG FT, 1994, ADV CHEM SER, V235, P531
   HONG FT, 1992, MOL ELECT SCI TECHN, P204
   HONG FT, 1980, ACS ADV CHEM SERIES, V2188, P211
   HONG FT, 1991, MOL ELECT MAT METHOD, P291
   HONG FT, 1992, NANOBIOLOGY, V1, P39
   HONG FT, 1994, IN PRESS PROG SURF S
   LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6
   MICHAILE S, 1994, BIOELECTROCH BIOENER, V33, P135, DOI 10.1016/0302-4598(94)85004-6
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   OKAJIMA TL, 1986, BIOPHYS J, V50, P901, DOI 10.1016/S0006-3495(86)83531-7
   OKAJIMA TL, 1994, BIOELECTROCH BIOENER, V33, P143, DOI 10.1016/0302-4598(94)85005-4
   TAKAYASU T, 1993, 12TH P INT C ALC DRU, P514
   TRISSL HW, 1990, PHOTOCHEM PHOTOBIOL, V51, P793
   VSEVOLODOV NN, 1989, MOLECULAR ELECTRONICS : BIOSENSORS AND BIOCOMPUTERS, P381
NR 30
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0303-2647
J9 BIOSYSTEMS
JI Biosystems
PY 1995
VL 35
IS 2-3
BP 117
EP 121
DI 10.1016/0303-2647(94)01497-U
PG 5
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA RB643
UT WOS:A1995RB64300005
PM 7488699
DA 2018-10-19
ER

PT J
AU ZHOU, BL
AF ZHOU, BL
TI BIOMIMETIC DESIGN OF WORST BONDING INTERFACE FOR CERAMIC-MATRIX
   COMPOSITES
SO COMPOSITES ENGINEERING
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Composites Engineering (ICCE/1)
CY AUG 28-31, 1994
CL NEW ORLEANS, LA
SP Int Community Composites Engn
ID FRACTURE-TOUGHNESS; PULL-OUT
AB Ideal bonding or optimum bonding between reinforcement and matrix is always focused on in the study of composites but many of the biomaterial interfaces consist of imperfect bonding or worst bonding with excellent load transfer capability. Some biomimetic examples dealing with the design of worst bonding interface for composites, such as the model of fibers with fractal-tree structure, the optimum design of composites simulating bamboo structure and the dumb-bell model of reinforcement simulating animal bone, all able to transfer load remarkably are overviewed in this paper.
C1 ACAD SINICA,INT CTR MAT PHYS,SHENYANG 110015,PEOPLES R CHINA.
RP ZHOU, BL (reprint author), ACAD SINICA,INST MET RES,SHENYANG 110015,PEOPLES R CHINA.
CR CAO HJ, 1978, BOTANY, P98
   EVANS AG, 1991, INTRO WORKSHOP COMP
   FU SY, 1993, SCRIPTA METALL MATER, V29, P1541, DOI 10.1016/0956-716X(93)90274-V
   FUNG YC, 1983, BIOMECHANICS, P246
   Fut S. Y., 1992, SMART MATER STRUCT, V1, P180
   Gerard JT, 1978, LIFE SCI, P313
   GUO J, 1992, MATER ENG, V3, P149
   IKEGAMI K, 1985, J JPN SOC COMP MAT, V11, P108
   JIA X, 1994, FAL P 94 S CHIN MAT
   KROMT K, 1991, INTRO WORKSHOP COMP
   LI SH, 1991, ADVANCED STRUCTURAL MATERIALS, P87
   LI VC, 1990, COMPOSITES, V21, P132, DOI 10.1016/0010-4361(90)90005-H
   Mandelbrot BB, 1983, FRACTAL GEOMETRY NAT
   ONO K, 1988, J JPN SOC COMP MAT, V14, P14
   SAKAKIBARA A, 1987, J JAPAN SOC COMP MAT, V13, P252
   SATO S, 1988, J JAPAN SOC COMP MAT, V14, P91
   TATEISHI T, 1988, J JPN SOC COMP MAT, V14, P49
   TAYA M, 1989, METAL MATRIX COMPOSI, P63
   Tian Xiaobin, 1994, Acta Metallurgica Sinica, V30, pB180
   WESTING AH, 1968, BOT REV, V34, P51, DOI 10.1007/BF02858621
   XIE HP, 1989, INT J FRACTURE, V41, P267
   ZENG QY, 1992, 1ST P PAC RIM INT C, P943
   Zhao Xiaopeng, 1994, Acta Metallurgica Sinica, V30, pB187
   ZHOU BL, 1994, JOM, V2, P57
   ZHOU BL, 1991, P C MRS INT 90 FRONT, P137
NR 25
TC 5
Z9 9
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0961-9526
J9 COMPOS ENG
JI Compos. Eng.
PY 1995
VL 5
IS 10-11
BP 1261
EP 1273
DI 10.1016/0961-9526(95)00061-Q
PG 13
WC Engineering, Multidisciplinary; Materials Science, Composites
SC Engineering; Materials Science
GA TA797
UT WOS:A1995TA79700006
DA 2018-10-19
ER

PT J
AU Kohn, DH
AF Kohn, DH
TI Acoustic emission and nondestructive evaluation of biomaterials and
   tissues
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Review
DE acoustic emission; biomaterials; bone; implants; fatigue; damage; damage
   accumulation; wave
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; ULTRASONIC WAVE-PROPAGATION; VIBRATION
   TESTING INSITU; X-RAY ABSORPTIOMETRY; HUMAN CORTICAL BONE; SINGLE
   PHOTON-ABSORPTIOMETRY; FATIGUE DAMAGE ACCUMULATION; TI-6AL-4V IMPLANT
   ALLOY; EMBEDDED OPTICAL FIBER; POROUS COATED IMPLANTS
AB Acoustic emission (AE) is an acoustic wave generated by the release of energy from localized sources in a material subjected to an externally applied stimulus. This technique may be used nondestructively to analyze tissues, materials, and biomaterial/tissue interfaces. Applications of AE include use as an early warning tool for detecting tissue and material defects and incipient failure, monitoring damage progression, predicting failure, characterizing failure mechanisms, and serving as a tool to aid in understanding material properties and structure-function relations. All these applications may be performed in real time.
   This review discusses general principles of AE monitoring and the use of the technique in 3 areas of importance to biomedical engineering: (1) analysis of biomaterials, (2) analysis of tissues, and (3) analysis of tissue/biomaterial interfaces. Focus in these areas is on detection sensitivity, methods of signal analysis in both the time and frequency domains, the relationship between acoustic signals and microstructural phenomena, and the uses of the technique in establishing a relationship between signals and failure mechanisms.
C1 UNIV MICHIGAN, BIOENGN PROGRAM, ANN ARBOR, MI 48109 USA.
RP Kohn, DH (reprint author), UNIV MICHIGAN, SCH DENT, DEPT BIOL & MAT SCI, ANN ARBOR, MI 48109 USA.
RI CHEN, Jiangang/A-1549-2011
FU NIAMS NIH HHS [5-P60-AR20557]; NCRR NIH HHS [2-SO7-RR05321]
CR ABDELSALAM S, 1990, INT J FRACTURE, V45, P311, DOI 10.1007/BF00036274
   ABENDSCHEIN W, 1970, CLIN ORTHOP RELAT R, P294
   ABENDSCHEIN WF, 1972, J TRAUM, V12, P297, DOI 10.1097/00005373-197204000-00005
   ALREJA V, 1985, P 5 INT C TIT DTSCH, P933
   AN HS, 1994, SPINE, V19, P2358, DOI 10.1097/00007632-199410150-00019
   ANAST G T, 1958, Am J Phys Med, V37, P157
   ASHMAN RB, 1990, J BIOMECH, V23, P941, DOI 10.1016/0021-9290(90)90359-B
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   AWERBUCH J, 1988, ASTM STP, V964, P121
   BACHMANN V, 1976, J TEST EVAL, V4, P257
   BAKUCKAS JG, 1987, ISTFA ADV MAT S ASM, P33
   BARAN DT, 1988, CALCIFIED TISSUE INT, V43, P138, DOI 10.1007/BF02571310
   BARTLETT ML, 1987, C P FAT, P87
   BASSIM NM, 1981, ACOUSTIC EMISSION, P139
   BAXTER WJ, 1990, J TEST EVAL, V18, P430
   BAXTER WJ, 1977, RES TECHNIQUES NONDE, V3, P395
   Beattie AG., 1983, J ACOUSTIC EMISSION, V2, P95
   BEHIRI JC, 1980, J MATER SCI, V15, P1841, DOI 10.1007/BF00550605
   BENTZEN SM, 1987, J BIOMECH, V20, P743, DOI 10.1016/0021-9290(87)90053-4
   Bereiter-Hahn J., 1989, Acoustical Imaging. Vol.17, P27
   BERNDT CC, 1985, J ENG GAS TURB POWER, V107, P142, DOI 10.1115/1.3239674
   BERNDT CC, 1984, ULTRASTRUCTURE PROCE, P524
   BILGRAM R, 1985, P 5 INT C TIT DTSCH, P955
   BONFIELD W, 1982, J BIOMED ENG, V4, P23, DOI 10.1016/0141-5425(82)90022-X
   BONFIELD W, 1976, J BIOMECH, V9, P131, DOI 10.1016/0021-9290(76)90151-2
   BONSE U, 1991, J MATER SCI, V26, P4076
   BOWLES CO, 1992, J MATER SCI, V27, P5756
   BRASSOW F, 1982, EUR J RADIOL, V2, P99
   BRIGGS GAD, 1985, INTRO SCANNING ACOUS
   BRIGHTON CT, 1979, ELECTRICAL PROPERTIE
   Broek D., 1984, ELEMENTARY ENG FRACT
   Buck O., 1989, MRS Bulletin, V14, P44
   BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0
   CALER WE, 1989, J BIOMECH, V22, P625, DOI 10.1016/0021-9290(89)90013-4
   Callaghan J J, 1992, J Arthroplasty, V7, P495, DOI 10.1016/S0883-5403(05)80223-2
   CANN CE, 1985, BONE, V6, P1, DOI 10.1016/8756-3282(85)90399-0
   CARTER DR, 1976, J BIOMECH, V9, P27, DOI 10.1016/0021-9290(76)90136-6
   CARTER DR, 1981, J BIOMECH, V14, P461, DOI 10.1016/0021-9290(81)90096-8
   CARTER DR, 1981, ACTA ORTHOP SCAND, V52, P481, DOI 10.3109/17453678108992136
   CARTER DR, 1976, J BIOMECH, V9, P211, DOI 10.1016/0021-9290(76)90006-3
   CARTER DR, 1977, J BIOMECH, V10, P325, DOI 10.1016/0021-9290(77)90005-7
   CAZENEUVE C, 1990, J MATER SCI, V25, P1902, DOI 10.1007/BF01045740
   CHANCY G, 1985, P 5 INT C TIT DTSCH, P1891
   CHEN IIH, 1987, J BIOMECH, V20, P523, DOI 10.1016/0021-9290(87)90252-1
   CHEN PS, 1984, EXP MECH, V24, P342
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CHRISTENSEN AB, 1986, J BIOMECH, V19, P53, DOI 10.1016/0021-9290(86)90108-9
   CODY DD, 1991, SPINE, V16, P146
   COGNARD J, 1990, J ADHESION, V32, P45, DOI 10.1080/00218469008030179
   COLLIER RJ, 1982, J BIOMECH, V15, P545, DOI 10.1016/0021-9290(82)90067-7
   CORNELISSEN M, 1987, J BIOMECH, V20, P333, DOI 10.1016/0021-9290(87)90041-8
   CORNELISSEN P, 1986, J BIOMECH, V19, P551, DOI 10.1016/0021-9290(86)90128-4
   CRAIG RG, 1993, RESTORATIVE DENTAL M
   CULNANE AH, 1991, J MATER SCI LETT, V10, P333, DOI 10.1007/BF00719700
   CURREY JD, 1984, MECHANICAL ADAPTATIO
   CURTIS GJ, 1975, NON-DESTRUCT TEST, V8, P249, DOI 10.1016/0029-1021(75)90045-6
   DAI YZ, 1991, INT J FATIGUE, V13, P227, DOI 10.1016/0142-1123(91)90246-U
   DANIEL BL, 1994, INVEST RADIOL, V29, P933, DOI 10.1097/00004424-199410000-00012
   DAVIES JP, 1993, T SOC BIOMAT, V19, P244
   DELAVEAUX R, 1991, MATER EVAL, V49, P1042
   DOHERTY WP, 1974, J BIOMECH, V7, P559, DOI 10.1016/0021-9290(74)90090-6
   DOWLING NE, 1985, ASTM STAND NEWS, V13, P44
   DROUILLAR TF, 1983, 1 INT S AC EM REINF, P1
   DROUILLARD TF, 1988, MATER EVAL, V46, P174
   DROUILLARD TF, 1990, J ACOUSTIC EMISSION, V9, P45
   DROUILLARD TF, 1986, J ACOUSTIC EMISSION, V5, P120
   DUNEGAN HL, 1971, MATER RES STANDARD, V11, P21
   DURAY SJ, 1995, J DENT RES, V74, P184
   ELIAS JJ, 1993, 1993 BIOENG C LA BED, V24, P327
   ESSES SI, 1989, J BONE MINER RES, V4, P715
   EYRES KS, 1993, J BONE JOINT SURG BR, V75, P358
   FAH D, 1988, J BIOMECH, V21, P975, DOI 10.1016/0021-9290(88)90136-4
   FARAH JW, 1973, J BIOMECH, V6, P511, DOI 10.1016/0021-9290(73)90009-2
   FEINSTEIN L, 1975, P 10 S NDE, P143
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   FIG LM, 1990, ARCH OTOLARYNGOL, V116, P191
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   FIROOZNIA H, 1986, RADIOLOGY, V159, P737, DOI 10.1148/radiology.159.3.3704152
   FIROOZNIA H, 1984, CT-J COMPUT TOMOGR, V8, P99
   FISCHER RA, 1986, J BIOMECH, V19, P119, DOI 10.1016/0021-9290(86)90142-9
   FLORIANI LP, 1967, SURG FORUM, V18, P48
   FRANK EH, 1991, T ORTHOP RES SOC, V16, P74
   FRIESEL M, 1984, METALL TRANS A, V15, P1849, DOI 10.1007/BF02664898
   FRIESEL MA, 1984, MATER SCI ENG, V68, P107, DOI 10.1016/0025-5416(84)90248-9
   Frost H.M., 1960, H FORD HOSP B, V8, P25
   FROST HM, 1966, BONE DYNAMICS OSTEOP
   FUHRMANN J, 1993, J APPL POLYM SCI, V48, P2123, DOI 10.1002/app.1993.070481207
   FUJII Y, 1994, BONE MINER, V25, P93, DOI 10.1016/S0169-6009(08)80251-6
   GALLAGHER C, 1985, J COMPUT ASSIST TOMO, V9, P634, DOI 10.1097/00004728-198505000-00075
   GAO XJ, 1988, PROGR ACOUSTIC EMISS, V4, P201
   GAO XJ, 1986, PROGR ACOUSTIC EMISS, V3, P263
   GARDNER TN, 1992, J BIOMECH, V25, P1265, DOI 10.1016/0021-9290(92)90282-6
   GEORGE TF, 1992, J APPL BIOMATER, V3, P29, DOI 10.1002/jab.770030106
   GERLANC M, 1975, CLIN ORTHOP RELAT R, V111, P175
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GREENFIELD GB, 1991, RADIOGRAPHICS, V11, P611, DOI 10.1148/radiographics.11.4.1887116
   GREENFIELD MA, 1992, MED PHYS, V19, P1349, DOI 10.1118/1.596769
   HAMSTAD MA, 1986, EXP MECH, V26, P7, DOI 10.1007/BF02319949
   HANAGUD S, 1977, P IEEE ULTR S, P242
   HANAGUD S, 1974, P IEEE ULTR S, P77
   HARP JH, 1994, CLIN ORTHOP RELAT R, V301, P42
   HARRIS DO, 1974, EXP MECH, V14, P71, DOI 10.1007/BF02323130
   HARRIS DO, 1971, ASTM STP, V505, P238
   Hartbower C. E., 1973, Engineering Fracture Mechanics, V5, P765, DOI 10.1016/0013-7944(73)90050-7
   HASEGAWA K, 1993, BONE, V14, P737, DOI 10.1016/8756-3282(93)90205-O
   HAWORTH WL, 1979, FATIGUE ENG MATER, V1, P351, DOI 10.1111/j.1460-2695.1979.tb00392.x
   HAYES WC, 1991, RADIOL CLIN N AM, V29, P1
   HEANEY RP, 1989, JAMA-J AM MED ASSOC, V261, P2986, DOI 10.1001/jama.261.20.2986
   HEIPLE CR, 1981, ACOUSTIC EMISSION, P14
   HEROUX P, 1994, ANN BIOMED ENG, V22, P328, DOI 10.1007/BF02368239
   HIGHT TK, 1980, J BIOMECH, V13, P139, DOI 10.1016/0021-9290(80)90188-8
   HONEYCOMBE RWK, 1988, PLASTIC DEFORMATION
   HORN CA, 1965, J COLL RADIOL AUSTRA, V9, P165
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HVID I, 1989, J BIOMECH, V22, P837, DOI 10.1016/0021-9290(89)90067-5
   Irwin GR, 1957, J APPL MECH, V24, P361, DOI DOI 10.1111/J.1460-2695.2012.01707.X
   JACKSON P, 1990, J MATER SCI LETT, V9, P1165, DOI 10.1007/BF00721878
   JANES GC, 1993, J BONE JOINT SURG BR, V75, P914
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JEE WSS, 1990, ANAT REC, V227, P418, DOI 10.1002/ar.1092270405
   JENG JS, 1989, J ACOUSTIC EMISSION, V8, pS268
   JONSSON U, 1984, ACTA ORTHOP SCAND, V55, P441, DOI 10.3109/17453678408992391
   JURIST JM, 1970, PHYS MED BIOL, V15, P417, DOI 10.1088/0031-9155/15/3/002
   JURIST JM, 1973, J BIOMECH, V6, P331, DOI 10.1016/0021-9290(73)90093-6
   KANEKO T, 1986, J BIOMED MATER RES, V20, P169, DOI 10.1002/jbm.820200206
   KANEKO T, 1991, BIOMATERIALS, V12, P555, DOI 10.1016/0142-9612(91)90050-K
   KANNATEYASIBU E, 1987, J MECH SYS SIG P, V1, P333
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KATZ Y, 1970, INT J FRACT MECH, V6, P219
   KAUFMAN JJ, 1993, J BONE MINER RES, V8, P517
   KENNEDY JR, 1982, SCRIPTA METALL MATER, V16, P525, DOI 10.1016/0036-9748(82)90263-0
   KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111
   KHALIL TB, 1981, J SOUND VIB, V75, P417, DOI 10.1016/0022-460X(81)90387-4
   KIM HC, 1994, J MAT RES, V9
   KIM KH, 1994, J DENT RES, V73, P499, DOI 10.1177/00220345940730020301
   KIM KH, 1991, ENG FRACT MECH, V40, P811, DOI 10.1016/0013-7944(91)90238-V
   KISHI T, 1980, TITANIUM 80 SCI TECH, P1709
   KISHI T, 1985, TITANIUM SCI TECHNOL, P2039
   KISHI T, 1984, PROGR ACOUSTIC EMISS, V2, P547
   KLINE RA, 1990, J ENG MATER-T ASME, V112, P218, DOI 10.1115/1.2903310
   KNETS LV, 1975, MEKH POLIM, V4, P685
   KNODO S, 1985, DENT MATER J, V4, P81
   KOENEMAN J, 1990, J APPL BIOMATER, V1, P79, DOI 10.1002/jab.770010110
   KOHLES SS, 1994, J BIOMECH, V27, P137, DOI 10.1016/0021-9290(94)90202-X
   KOHN DH, 1992, J BIOMED MATER RES, V26, P19, DOI 10.1002/jbm.820260104
   KOHN DH, 1990, J BIOMED MATER RES, V24, P1483, DOI 10.1002/jbm.820241106
   KOHN DH, 1992, J MATER SCI, V27, P3133, DOI 10.1007/BF01116003
   KOHN DH, 1994, MED PROG TECHNOL, V20, P169
   KOHN DH, 1992, J MATER SCI, V27, P1633, DOI 10.1007/BF00542927
   KOHN DH, 1992, 1992 ADV BIOENGINEER, V27, P297
   KOHN DH, 1995, HDB ADV MAT TESTING, P593
   KOHN DH, 1989, TITANIUM SCI TECHNOL, P789
   KONDO S, 1992, J DENT RES, V71, P558
   KONONEN M, 1991, DENT MATER, V7, P211, DOI 10.1016/0109-5641(91)90046-2
   KRASNOW AZ, 1987, J NUCL MED, V28, P1268
   KRAUYA UE, 1978, MEKH POLIM, V7, P109
   KROGER H, 1995, ACTA ORTHOP SCAND, V66, P47, DOI 10.3109/17453679508994639
   KUPPERMAN DS, 1990, J ENG MATER-T ASME, V112, P198, DOI 10.1115/1.2903307
   Kushibiki J., 1987, IEEE 1987 Ultrasonics Symposium Proceedings (Cat. No.87CH2492-7), P837
   KWON OY, 1990, J ACOUSTIC EMISSION, V9, P123
   KWON SJ, 1985, P IEEE ULTR S, P864
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   LANG SB, 1970, IEEE T BIO-MED ENG, VBM17, P101, DOI 10.1109/TBME.1970.4502706
   LANG SM, 1988, J BONE JOINT SURG AM, V70A, P1531, DOI 10.2106/00004623-198870100-00013
   LANKFORD J, 1991, J MATER SCI, V26, P1131
   LAWRENCE JM, 1991, T ORTHOP RES SOC, V16, P518
   LAYTON MW, 1988, ARTHRITIS RHEUM, V31, P1400, DOI 10.1002/art.1780311109
   LEAITY GP, 1984, FAT FRACT ENG MAT ST, V12, P271
   LEE SY, 1995, J DENT RES, V74, P184
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   LEWIS JL, 1975, J BIOMECH, V8, P17, DOI 10.1016/0021-9290(75)90039-1
   LEWIS JL, 1975, J BONE JOINT SURG AM, V57, P576
   LI SX, 1984, MATER EVAL, V42, P1020
   LI XJ, 1990, ANAT REC, V227, P12, DOI 10.1002/ar.1092270103
   LICHT T, 1979, 2 TECH REV
   LIEBETRAU R, 1993, J OTOLARYNGOL, V22, P249
   LINGARD S, 1993, WEAR, V162, P597, DOI 10.1016/0043-1648(93)90548-Z
   LINGARD S, 1984, WEAR, V96, P75, DOI 10.1016/0043-1648(84)90105-4
   LOTZ JC, 1990, J COMPUT ASSIST TOMO, V14, P107, DOI 10.1097/00004728-199001000-00020
   LOWET G, 1993, J BIOMECH, V26, P689, DOI 10.1016/0021-9290(93)90032-A
   MA BT, 1990, POLYM COMPOSITE, V11, P211, DOI 10.1002/pc.750110403
   MAISL M, 1990, J ENG MATER-T ASME, V112, P223, DOI 10.1115/1.2903311
   MARGOLIN H, 1980, TITANIUM 80 SCI TECH, P169
   MARKEL MD, 1992, AM J VET RES, V53, P2105
   MARKEL MD, 1990, ACTA ORTHOP SCAND, V61, P487, DOI 10.3109/17453679008993569
   MARTIN B, 1992, J ORTHOP RES, V10, P818, DOI 10.1002/jor.1100100611
   MARTIN RB, 1982, J BIOMECH, V15, P137
   Martin RB, 1989, STRUCTURE FUNCTION A
   MASLOUHI A, 1989, J ACOUSTIC EMISSION, V8, pS292
   MATTHEWS JR, 1981, ACOUSTIC EMISSION
   MAZESS RB, 1989, ANN BIOMED ENG, V17, P177, DOI 10.1007/BF02368026
   MCBROOM RJ, 1985, J BONE JOINT SURG AM, V67A, P1206, DOI 10.2106/00004623-198567080-00010
   MCCABE F, 1991, J BONE MINER RES, V6, P53
   MCCARTHY RN, 1990, J BIOMECH, V23, P1139, DOI 10.1016/0021-9290(90)90006-O
   MCGUIRE SM, 1993, J MATER RES, V8, P2216, DOI 10.1557/JMR.1993.2216
   MCKELVIE ML, 1991, PHYS MED BIOL, V36, P1331, DOI 10.1088/0031-9155/36/10/003
   MEDRANO RE, 1993, REV SCI INSTRUM, V64, P250, DOI 10.1063/1.1144446
   MELANITIS N, 1990, J MATER SCI, V25, P5081, DOI 10.1007/BF00580133
   MELTON LJ, 1993, J BONE MINER RES, V8, P1227
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Mielke W., 1990, Journal of Acoustic Emission, V9, P103
   MOORTHY V, 1991, FAT FRACT STEEL CONC
   MORRIS RA, 1975, P 10 S NDE, P90
   MOSEKILDE L, 1989, BONE, V10, P465, DOI 10.1016/8756-3282(89)90080-X
   MURPHY KA, 1992, APPL OPTICS, V31, P431, DOI 10.1364/AO.31.000431
   MURRAY IPC, 1989, SKELETAL RADIOL, V18, P493, DOI 10.1007/BF00351747
   MYERS ER, 1991, CALCIFIED TISSUE INT, V49, P292, DOI 10.1007/BF02556221
   *NASA, 1992, NASA TECH BRIEFS
   *NASA, 1993, NASA TECH BRIEFS, V17, P22
   *NASA, 1992, YASA TECH BRIEFS, V16, P62
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V34, P289, DOI 10.1016/0266-3538(89)90001-8
   NETRAVALI AN, 1989, COMPOS SCI TECHNOL, V35, P13, DOI 10.1016/0266-3538(89)90068-7
   NETZ P, 1979, ACTA ORTHOP SCAND S, V176
   NICHOLLS PJ, 1981, MED BIOL ENG COMPUT, V19, P416, DOI 10.1007/BF02441305
   OBRIEN WJ, 1977, DENTAL MATERIALS REV, P123
   OCCHIELLO E, 1989, COMPOS SCI TECHNOL, V36, P133, DOI 10.1016/0266-3538(89)90084-5
   OHIRA T, 1980, 5TH P INT AE S, P137
   OHTA A, 1977, INT J FRACTURE, V13, P289
   OHTA A, 1977, ENG FRACT MECH, V9, P307
   OKAWAI H, 1989, ACOUST IMAGING, P192
   ONO K, 1979, FUNDAMENTALS ACOUSTI, P167
   ORTOFT G, 1993, BONE, V14, P667, DOI 10.1016/8756-3282(93)90090-W
   OVERGAARD K, 1992, CALCIFIED TISSUE INT, V50, P30, DOI 10.1007/BF00297294
   PAPAZLAN JM, 1992, J ENG MAT TECH, V114, P399
   PECK SD, 1989, J DENT RES, V68, P107, DOI 10.1177/00220345890680020201
   PELKER RR, 1985, J BIOMECH, V18, P745, DOI 10.1016/0021-9290(85)90049-1
   PELKER RR, 1983, J BIOMECH, V16, P481, DOI 10.1016/0021-9290(83)90062-3
   PETERS A, 1982, MED BIOL ENG COMPUT, V20, pN8
   POLEKSIC L, 1993, SKELETAL RADIOL, V22, P577
   POLIAKOFF SJ, 1989, T ORTHOP RES SOC, V14, P483
   POLLOCK AA, 1981, INT ADV NONDESTRUCTI, V7, P215
   PULS MP, 1991, METALL TRANS A, V22, P2327, DOI 10.1007/BF02664999
   PUSKAR A, 1993, ULTRASONICS, V31, P61, DOI 10.1016/0041-624X(93)90034-W
   QUINTEN A, 1989, MAT SCI ENG A-STRUCT, V122, P15, DOI 10.1016/0921-5093(89)90764-8
   RAGHAVENDRO MN, 1989, J ACOUSTIC EMISSION, V8, pS284
   RAJAN DS, 1989, J ACSOUSTIC EMISSION, V8, pS297
   RAYMAKERS JA, 1986, SKELETAL RADIOL, V15, P191, DOI 10.1007/BF00354059
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   RUBIN CT, 1987, J BIOMECH, V20, P723, DOI 10.1016/0021-9290(87)90038-8
   SACHSE W, 1991, ASTM STP, V1077
   SAFAI S, 1979, AM CERAM SOC BULL, V58, P624
   SAFAI S, 1980, 9 INT THERM SPRAY C, P129
   SAHA S, 1977, IEEE T BIO-MED ENG, V24, P508, DOI 10.1109/TBME.1977.326161
   SAHA S, 1977, J BIOMECH, V10, P393, DOI 10.1016/0021-9290(77)90015-X
   SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F
   SCHAFFLER MB, 1989, BONE, V10, P207, DOI 10.1016/8756-3282(89)90055-0
   SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2
   SCHMIDT J, 1994, MED BIOL ENG COMPUT, V32, P258, DOI 10.1007/BF02512520
   SCHUBIGER O, 1986, NEURORADIOLOGY, V28, P93, DOI 10.1007/BF00327878
   SCHUSTER J, 1990, J COMPOS TECH RES, V12, P52
   SEITZ P, 1987, J BONE JOINT SURG BR, V69, P407
   SHANKAR NR, 1982, CERAM ENG SCI P, V3, P772
   SHANKAR NR, 1983, 10 INT THERM SPRAYIN, P41
   SHIMAISHIN OA, 1976, MAT EVOL, V34, P137
   Sklarczyk C., 1992, Journal of the European Ceramic Society, V9, P427, DOI 10.1016/0955-2219(92)90103-K
   SMITH MD, 1992, CLIN ORTHOPAEDICS, V283, P244
   SMITH PA, 1990, COMPOS SCI TECHNOL, V38, P85, DOI 10.1016/0266-3538(90)90073-E
   SNYDER SM, 1991, J ORTHOPAED RES, V9, P422, DOI 10.1002/jor.1100090315
   SONSTEGARD DA, 1976, J BIOMECH, V9, P689, DOI 10.1016/0021-9290(76)90170-6
   SPIEGL PV, 1975, J BIOMECH, V8, P213, DOI 10.1016/0021-9290(75)90027-5
   SRIKANTH V, 1994, J MATER SCI, V29, P3363, DOI 10.1007/BF00356686
   STEELE CR, 1988, J BIOMECH ENG-T ASME, V110, P87, DOI 10.1115/1.3108423
   STEPHENS RR, 1988, REV SCI INSTRUM, V59, P1412, DOI 10.1063/1.1139679
   STEWART A, 1994, CALCIFIED TISSUE INT, V54, P466, DOI 10.1007/BF00334324
   SUGIYAMA H, 1989, CLIN ORTHOP RELAT R, V249, P122
   SULIMAN AA, 1993, J DENT RES, V72, P1532, DOI 10.1177/00220345930720111201
   SUNDARESAN MJ, 1994, J COMPOS TECH RES, V16, P127
   TANAKA H, 1975, SCRIPTA METALL MATER, V9, P777, DOI 10.1016/0036-9748(75)90239-2
   TATENTO H, 1989, ACOUST IMAGING, P125
   TAVAKOLI MB, 1991, PHYS MED BIOL, V36, P1529, DOI 10.1088/0031-9155/36/11/012
   THOMAS RA, 1977, P IEEE ULTR S, P237
   THOMPSN DO, 1986, REV PROGR NONDESTRUC
   THOMPSON RB, 1975, P 10 S NDE, P98
   THOMPSON RB, 1990, J TEST EVAL, V18, P421
   THOMSEN JJ, 1990, J BIOMECH, V23, P215, DOI 10.1016/0021-9290(90)90013-S
   Tiitto K., 1989, Nondestructive Testing Communications, V5, P27, DOI 10.1080/02780898908952952
   TSURUTA H, 1980, P 5 INT AE S JAP SOC, P175
   TURNER CH, 1991, CALCIFIED TISSUE INT, V49, P116, DOI 10.1007/BF02565132
   ULREN L, 1990, J ADHESION, V31, P117, DOI 10.1080/00218469008048220
   VANBERKUM FNR, 1989, J BONE MINER RES, V4, P679
   VANBUSKIRK WC, 1986, J MATER SCI, V21, P2759, DOI 10.1007/BF00551484
   VANBUSKIRK WC, 1981, J BIOMECH ENG-T ASME, V103, P67, DOI 10.1115/1.3138262
   VANDERPERRE G, 1983, J BIOMECH ENG-T ASME, V105, P244, DOI 10.1115/1.3138412
   VANDERSCHUEREN D, 1993, CALCIFIED TISSUE INT, V53, P342, DOI 10.1007/BF01351841
   VANROERMUND PM, 1987, SKELETAL RADIOL, V16, P52, DOI 10.1007/BF00349929
   VARY A, 1991, MATER EVAL, V49, P581
   VARY A, 1991, AM SOC TEST MATER, V1077, P95, DOI 10.1520/STP19087S
   VERPOEST I, 1981, FATIGUE ENG MATER ST, V3, P203
   VIANO D, 1976, J BIOMECH, V9, P703, DOI 10.1016/0021-9290(76)90172-X
   VIKSTROM M, 1989, COMPOS STRUCT, V13, P49, DOI 10.1016/0263-8223(89)90072-X
   Wadley H. N. G., 1980, International Metals Reviews, V25, P41
   WAGNER L, 1989, TITANIUM SCI TECHNOL
   WAITE SR, 1990, COMPOSITES, V21, P148, DOI 10.1016/0010-4361(90)90007-J
   WAITE SR, 1990, COMPOSITES, V21, P225, DOI 10.1016/0010-4361(90)90237-Q
   WAKAYAMA S, 1985, P 2 INT C AC EM, pS278
   WALKER D, 1991, IEEE ENG MED BIOL C, V13, P2107
   WALTER A, 1984, BIOMATERIALS BIOMECH, P55
   WALTER A, 1986, MATER RES SOC S P, V55, P181
   WEHRLI FW, 1993, CALCIFIED TISSUE INT, V53, pS162, DOI 10.1007/BF01673429
   WEI RP, 1981, ASTM STP, V738, P103
   WELLS JG, 1985, BIOMATERIALS, V6, P218, DOI 10.1016/0142-9612(85)90016-X
   WEVERS M, 1991, AM SOC TEST MATER, V1077, P416, DOI 10.1520/STP19111S
   WHITE SP, 1989, PROSTHETIC HIP JOINT
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, V258, P108
   WIOLAND M, 1993, J NUCL MED, V34, P1410
   WISHART JM, 1993, BRIT J RADIOL, V66, P435, DOI 10.1259/0007-1285-66-785-435
   WOLFARTH D, 1990, J APPL BIOMATER, V1, P3, DOI 10.1002/jab.770010103
   WOLTERS J, 1986, 2 INT S AC EM REINF, P29
   WONG ATC, 1976, J BIOMECH, V9, P813, DOI 10.1016/0021-9290(76)90189-5
   WONG FY, 1983, J BIOMECH, V16, P849, DOI 10.1016/0021-9290(83)90009-X
   WOOH SC, 1990, J ENG MATER-T ASME, V112, P175, DOI 10.1115/1.2903304
   WRIGHT TM, 1983, J BIOMECH ENG-T ASME, V105, P20, DOI 10.1115/1.3138379
   WRIGHT TM, 1976, J BIOMED MATER RES, V10, P637, DOI 10.1002/jbm.820100420
   WRIGHT TM, 1981, J BIOMECH, V14, P405, DOI 10.1016/0021-9290(81)90058-0
   WRIGHT TM, 1977, J BIOMECH, V10, P419, DOI 10.1016/0021-9290(77)90019-7
   WRIGHT TM, 1978, MATER EVAL, P37
   WRIGHT TM, 1981, 1981 BIOM S ASME NEW, P237
   WRIGHT TM, 1988, NONDESTRUCTIVE TESTI, V5, P447
   YAMAGUCHI K, 1991, AM SOC TEST MATER, V1077, P123, DOI 10.1520/STP19089S
   YAMAKI T, 1986, SURG NEUROL, V26, P551, DOI 10.1016/0090-3019(86)90338-1
   YAMAMOTO S, 1992, J MATER RES, V7, P2240, DOI 10.1557/JMR.1992.2240
   YEE BGW, 1973, TITANIUM SCI TECHNOL, P707
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   YOON HS, 1976, J BIOMECH, V9, P407, DOI 10.1016/0021-9290(76)90118-4
   YOON HS, 1980, P IEEE ULTR S, P1067
   YUYAMA S, 1982, PROGR ACOUSTIC EMISS, P126
   ZHU ZM, 1982, PROGR ACOUSTIC EMISS, P366
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
   ZIMMERMAN MC, 1994, J BIOMED MATER RES, V28, P931, DOI 10.1002/jbm.820280812
   ZIMMERMAN RA, 1987, NEURORADIOLOGY, V29, P246, DOI 10.1007/BF00451761
   ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420
   ZIOUPOS P, 1994, MED ENG PHYS, V16, P203, DOI 10.1016/1350-4533(94)90039-6
   ZUMING Z, 1984, PROGR ACOUSTIC EMISS, V2, P218
   1983, 1 INT S AC EM REINF
   1976, 2 INT S AC EM REINF
NR 340
TC 9
Z9 9
U1 1
U2 14
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0278-940X
EI 1943-619X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 1995
VL 23
IS 3-4
BP 221
EP 306
DI 10.1615/CritRevBiomedEng.v23.i3-4.20
PG 86
WC Engineering, Biomedical
SC Engineering
GA VA999
UT WOS:A1995VA99900002
PM 8853951
DA 2018-10-19
ER

PT J
AU PURI, P
   PALANIMUTHU, M
   DASS, L
AF PURI, P
   PALANIMUTHU, M
   DASS, L
TI ENDOSCOPIC TREATMENT OF PRIMARY VESICOURETERAL REFLUX IN INFANTS BY
   SUBURETERIC INJECTION OF POLYTETRAFLUOROETHYLENE - A 9-YEAR FOLLOW-UP
SO EUROPEAN UROLOGY
LA English
DT Article
DE VESICOURETERAL REFLUX; INFANTS; ENDOSCOPIC TREATMENT;
   POLYTETRAFLUOROETHYLENE
ID INTRAVESICAL INJECTION; TEFLON; MIGRATION; URETERS; BRAIN
AB Fifty-two infants (75 ureters) with primary high-grade vesicoureteric reflux (WR) treated endoscopically by subureteric injection of Polytef paste (STING) were followed up for 1-9 years. There were 30 boys and 22 girls and their ages ranged from 2 to 12 months. Forty-five percent of ureters had grade III VUR, 40% had grade IV and 15% had grade V VUR. Reflux ceased in 49 (65%) ureters after a single injection. Twenty-four percent of ureters in this series required more than one injection of Polytef paste to correct VUR. STING failed to correct VUR in 3 (4%) ureters. Eighty percent of the 49 ureters corrected after a single injection of Polytef required < 0.2 ml of paste per ureter to correct reflux. Ninety-three percent of ureters continue to show absence of VUR 1-9 years after endoscopic correction. Three of the 5 recurrences were only of grade I or grade II severity and required no treatment. No untoward effects were seen in these children with the use of Teflon as an injectable biomaterial. This day care procedure is simple, safe and effective in correcting high grades of reflux in infants.
C1 NATL CHILDRENS HOSP,DUBLIN,IRELAND.
CR AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637
   AARONSON IA, 1990, JUL ANN INT C BRIT A
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MIYAKITA H, 1993, EUR UROL, V24, P111
   MIYAKITA H, 1994, J UROLOGY, V152, P636, DOI 10.1016/S0022-5347(17)32670-8
   NINAN GK, 1993, JUN ANN M BRIT ASS U
   ODONNELL B, 1986, BRIT J UROL, V58, P601, DOI 10.1111/j.1464-410X.1986.tb05894.x
   ODONNELL B, 1986, BRIT MED J, V293, P1404, DOI 10.1136/bmj.293.6559.1404
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   PURI P, 1984, BRIT MED J, V289, P5, DOI 10.1136/bmj.289.6436.5
   PURI P, 1987, J PEDIATR SURG, V22, P1087, DOI 10.1016/S0022-3468(87)80714-5
   PURI P, 1990, LANCET, V335, P1320, DOI 10.1016/0140-6736(90)91197-I
   PURI P, 1986, BRIT J UROL, V58, P504, DOI 10.1111/j.1464-410X.1986.tb05455.x
   PURI P, 1991, PEDIATR SURG INT, V6, P269
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   1981, PAEDIATRICS, V67, P392
NR 16
TC 9
Z9 9
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0302-2838
J9 EUR UROL
JI Eur. Urol.
PY 1995
VL 27
IS 1
BP 67
EP 70
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA QH713
UT WOS:A1995QH71300015
PM 7744146
DA 2018-10-19
ER

PT J
AU PURI, P
   NINAN, GK
   SURANA, R
AF PURI, P
   NINAN, GK
   SURANA, R
TI SUBURETERIC TEFLON INJECTION (STING) - RESULTS OF A EUROPEAN SURVEY
SO EUROPEAN UROLOGY
LA English
DT Article
DE SUBURETERIC TEFLON INJECTION; POLYTETRAFLUOROETHYLENE; VESICOURETERAL
   REFLUX; ENDOSCOPIC CORRECTION
ID PRIMARY VESICOURETERAL REFLUX; URINARY-INCONTINENCE; POLYTEF PASTE;
   POLYTETRAFLUOROETHYLENE INJECTION; INTRAVESICAL INJECTION; ENDOSCOPIC
   CORRECTION; BREAST IMPLANTS; MIGRATION; CHILDREN; COLLAGEN
AB Subureteric Teflon injection (STING) has been successfully used by several investigators for treating vesicoureteric reflux (VUR) in children. This multicentre European survey reviews the results of STING in 6,216 ureters. Twenty-two paediatric surgeons/urologists from 18 centres in Europe answered an enquiry regarding their experience with STING in the treatment of VUR. 6,216 refluxing ureters were injected with Polytef paste in 4,166 children during 1984-1990. There were 975 boys and 3,191 girls. Their ages ranged from 2 months to 14 years (mean 5.1 years). The reflux was grade I in 4.4% of ureters, grade II in 36.1%, grade III in 40.2%, and grades IV and V in 19.3% of ureters. All patients were followed up for periods ranging from 3 months to 81/2 years and 90% were followed up for more than 2 years. 76.3% of all ureters stopped refluxing after a single injection of Teflon paste, cure rate increased to 84.9% after a second injection. A further 10.2% of refluxing ureters showed significant improvement in the grade of reflux after a single injection and needed no further treatment. 1.3% of ureters were cured after a third or fourth injection. Failure to correct or improve VUR was seen in 224 ureters (3.6%), necessitating reimplantation. Twenty ureters (0.32%) developed vesicoureteric junction obstruction following STING and these were reimplanted without difficulty. Results of this multicentre survey confirm that STING is an effective day care procedure for treatment of all grades of VUR. 95% of all ureters were cured or showed significant improvement after two injections of Teflon paste. No clinically untoward effects were reported in 4,166 children from use of Teflon as an injectable biomaterial.
C1 ROYAL ABERDEEN CHILDRENS HOSP, ABERDEEN, SCOTLAND.
RP PURI, P (reprint author), OUR LADYS HOSP SICK CHILDREN, CHILDRENS RES CTR, DUBLIN 12, IRELAND.
CR AARONSON IA, 1994, 5TH ANN M EUR SOC PA
   ARNOLD GE, 1962, ARCHIV OTOLARYNGOL, V76, P358
   Buckley J. F., 1993, Journal of Urology, V149, p259A
   CLAES H, 1989, J UROLOGY, V142, P821
   COHEN IK, 1984, PLAST RECONSTR SURG, V73, P857, DOI 10.1097/00006534-198405000-00034
   DAVIES N, 1991, BRIT J UROL, V67, P536, DOI 10.1111/j.1464-410X.1991.tb15202.x
   HENLY D R, 1992, Journal of Urology, V147, p376A
   KAMMERER WH, 1982, ARTHRITIS RHEUM, V25, P1024, DOI 10.1002/art.1780250820
   KAPLAN WE, 1987, J UROLOGY, V138, P953, DOI 10.1016/S0022-5347(17)43469-0
   LACOMBE A, 1990, EUR UROL, V17, P318
   LEONARD MP, 1991, J UROLOGY, V145, P115, DOI 10.1016/S0022-5347(17)38264-2
   LEVITT SB, 1981, PEDIATRICS, V67, P392
   LISPSKY H, 1993, BR J UROL, V72, P965
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MCLORIE GA, 1990, J UROLOGY, V144, P537, DOI 10.1016/S0022-5347(17)39516-2
   MITTLEMAN RE, 1983, ARCH PATHOL LAB MED, V107, P611
   MIYAKITA H, 1994, J UROLOGY, V152, P636, DOI 10.1016/S0022-5347(17)32670-8
   ODONNELL B, 1986, BRIT J UROL, V58, P601, DOI 10.1111/j.1464-410X.1986.tb05894.x
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8
   POLITANO VA, 1992, BRIT J UROL, V69, P26, DOI 10.1111/j.1464-410X.1992.tb15452.x
   PURI P, 1984, BRIT MED J, V289, P5, DOI 10.1136/bmj.289.6436.5
   PURI P, 1990, LANCET, V335, P1320, DOI 10.1016/0140-6736(90)91197-I
   PURI P, 1988, ROB SMITHS OPERATIVE, P522
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P949, DOI 10.1097/00006534-199205000-00029
   SCHULMAN CC, 1990, EUR UROL, V17, P314
   SHONS AR, 1992, ANN PLAS SURG, V28, P491, DOI 10.1097/00000637-199205000-00017
   SILVER RM, 1993, ARCH DERMATOL, V129, P63, DOI 10.1001/archderm.129.1.63
   TAMMINENMOBIUS T, 1992, J UROLOGY, V148, P1662, DOI 10.1016/S0022-5347(17)36997-5
   TAYLOR CM, 1987, BMJ-BRIT MED J, V295, P237
   1991, PEDIATRICS, V88, P410
NR 32
TC 30
Z9 33
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0302-2838
EI 1873-7560
J9 EUR UROL
JI Eur. Urol.
PY 1995
VL 27
IS 1
BP 71
EP 75
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA QH713
UT WOS:A1995QH71300016
PM 7744147
DA 2018-10-19
ER

PT J
AU DRAKE, LR
   BAKER, TR
   STARK, PC
   RAYSON, GD
AF DRAKE, LR
   BAKER, TR
   STARK, PC
   RAYSON, GD
TI A LASER-BASED SPECTROFLUOROMETER FOR THE EFFICIENT PROBING OF METAL-ION
   BINDING-SITES ON SOLID BIOMATERIALS
SO INSTRUMENTATION SCIENCE & TECHNOLOGY
LA English
DT Article
ID EU(III) LUMINESCENCE; ALGAE; BIOMASS
AB A laser based spectrofluorometer with f/# matched optics has been developed for the investigation of metal ion binding sites on nonviable biomaterials.  Solid biomaterial samples have been encapsulated in a KBr glass matrix for these investigations.  This sample preparation technique has allowed for the investigation of metal ion binding sites by both luminescence and infrared spectroscopy.  The utility of the system and the method of sample preparation has been demonstrated with Eu(III) bound to cultured cell fragments from Datura innoxia.
RP DRAKE, LR (reprint author), NEW MEXICO STATE UNIV,DEPT CHEM & BIOCHEM,LAS CRUCES,NM 88003, USA.
CR CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P496, DOI 10.1021/es00027a007
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P1523, DOI 10.1021/es00032a004
   DARNALL D W, 1986, P1
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GARNHAM GW, 1992, ENVIRON SCI TECHNOL, V26, P1764, DOI 10.1021/es00033a008
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   HAAS Y, 1971, J PHYS CHEM-US, V75, P3668, DOI 10.1021/j100693a005
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   JACKSON PJ, 1993, IN VITRO CELL DEV-PL, V29P, P220
   JACKSON PJ, 1984, PLANT PHYSIOL, V75, P914, DOI 10.1104/pp.75.4.914
   KE HY, 1992, APPL SPECTROSC, V47, P44
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1993, ENVIRON SCI TECHNOL, V27, P2466, DOI 10.1021/es00048a024
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KUBIAK WW, 1989, ANAL CHEM, V61, P468, DOI 10.1021/ac00180a018
   MAHAN CA, 1992, ANAL CHEM, V64, P1933, DOI 10.1021/ac00041a031
   MAHAN CA, 1992, SPEC CHIM ACTA B, V48, P1483
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   WRIGHT PJ, 1991, ENVIRON SCI TECHNOL, V25, P287, DOI 10.1021/es00014a011
NR 25
TC 4
Z9 4
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 1073-9149
J9 INSTRUM SCI TECHNOL
JI Instrum. Sci. Technol.
PY 1995
VL 23
IS 1
BP 57
EP 69
DI 10.1080/10739149508011697
PG 13
WC Chemistry, Analytical; Instruments & Instrumentation
SC Chemistry; Instruments & Instrumentation
GA QG897
UT WOS:A1995QG89700004
DA 2018-10-19
ER

PT J
AU BRENNAN, AB
   ARNOLD, JJ
   ZAMORA, MP
AF BRENNAN, AB
   ARNOLD, JJ
   ZAMORA, MP
TI SURFACE MODIFICATION OF ULTRA-HIGH-MOLECULAR-WEIGHT POLYETHYLENE FIBERS
   BY GAMMA-RADIATION-INDUCED GRAFTING
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Fundamentals of Adhesion and Interfaces, at the ACS 1993
   Meeting
CY AUG, 1993
CL CHICAGO, IL
SP ACS
DE POLYETHYLENE FIBERS; SURFACE TREATMENT; COMPOSITES; FIBER MATRIX
   ADHESION; GAMMA RADIATION
ID ALLYLAMINE PLASMA DEPOSITION; 2-HYDROXYETHYL METHACRYLATE; BIOMATERIAL
   APPLICATIONS; MECHANICAL-PROPERTIES; AMMONIA PLASMA; UHSPE FIBERS;
   COMPOSITES; ADHESION; POLYMERS; MORPHOLOGY
AB A technique for grafting acrylic polymers on the surface of ultra-high molecular weight polyethylene (UHMWPE) fibers utilizing Co-60 gamma radiation at low dose rates and low total dose has been developed. Unlike some of the more prevalent surface modification schemes, this technique achieves surface grafting with complete retention of the exceptional UHMWPE fiber mechanical properties. In particular, poly(butyl acrylate) and poly(cyclohexyl methacrylate) were successfully grafted onto UHMWPE fibers with no loss in tensile properties. The surface and tensile properties of the fibers were evaluated using Fourier transform infrared/photoacoustic spectroscopy (FTIR/PAS), X-ray photoelectron spectroscopy (XPS), and tensile tests. The reinforcement efficiency of untreated, polymer-grafted, and plasma-treated UHMWPE fibers in polystyrene and a poly(styrene-co-butyl acrylate-co-cyclohexyl methacrylate) statistical terpolymer was characterized using mechanical tensile tests. The thermoplastic matrix composites were prepared with 4 wt% discontinuous (10 mm), randomly distributed UHMWPE fibers. An approximate 30% increase in composite strength and modulus was observed for poly(cyclohexyl methacrylate)-grafted fibers in the terpolymer and polystyrene matrices. A comparable improvement was realized with the plasma-treated fibers. On the other hand, poly(butyl acrylate) grafts induced void formation, i.e. energy dissipation through plastic deformation and volume expansion at the fiber/matrix interface in terpolymer composites. The latter resulted in a 75% increase in the elongation to failure. The effect of polymer grafts on fiber/matrix adhesion is discussed in terms of the graft and matrix chain interactions and solubility, graft chain mobility, and fracture surface characteristics as determined by scanning electron microscopy (SEM).
RP BRENNAN, AB (reprint author), UNIV FLORIDA, DEPT MAT SCI & ENGN, 317 MAE BLDG, GAINESVILLE, FL 32611 USA.
RI Brennan, Anthony/C-8552-2009
OI Brennan, Anthony/0000-0002-0431-8425
CR ARNOLD JJ, 1993, UNPUB
   Barton A. F. M., 1990, CRC HDB POLYM LIQUID
   BRIGGS D, 1995, PRACTICAL SURFACE AN, V1, P444
   BROWN JR, 1992, J MATER SCI, V27, P3167, DOI 10.1007/BF01116006
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   COHN D, 1987, J APPL POLYM SCI, V33, P1, DOI 10.1002/app.1987.070330101
   FENG ZG, 1992, ANGEW MAKROMOL CHEM, V195, P17, DOI 10.1002/apmc.1992.051950102
   FRANK CW, 1979, MACROMOLECULES, V12, P163, DOI 10.1021/ma60067a038
   FRIEDRICH K, 1985, COMPOS SCI TECHNOL, V22, P43, DOI 10.1016/0266-3538(85)90090-9
   GOLDBERG EP, 1985, UNPUB
   HOLMES S, 1990, COMPOS SCI TECHNOL, V38, P1, DOI 10.1016/0266-3538(90)90068-G
   KAJI K, 1993, J APPL POLYM SCI, V47, P1427, DOI 10.1002/app.1993.070470814
   KAJI K, 1981, RADIAT PHYS CHEM, V18, P503, DOI 10.1016/0146-5724(81)90170-9
   KAPLAN SL, 1988, 33RD P INT SAMPE S A, P551
   KLEIN PG, 1987, J POLYM SCI POL PHYS, V25, P1359, DOI 10.1002/polb.1987.090250701
   KLEIN PG, 1991, POLYMER, V32, P1732, DOI 10.1016/0032-3861(91)90355-M
   LI ZF, 1992, J APPL POLYM SCI, V44, P319, DOI 10.1002/app.1992.070440216
   LI ZF, 1992, J APPL POLYM SCI, V44, P333, DOI 10.1002/app.1992.070440217
   LI ZF, 1992, J MATER SCI, V27, P4625, DOI 10.1007/BF01165997
   LOVELL PA, 1989, ADV CHEM SER, V222, P61
   MALLICK PK, 1988, FIBER REINFORCED COM, P73
   NARDIN M, 1987, MATER SCI TECH SER, V3, P814, DOI 10.1179/mst.1987.3.10.814
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SINGH A, 1992, RAD PROCESSING POLYM, V3
   SPERLING LH, 1992, INTRO PHYSICAL POLYM, P65
   TABOUDOUCHT A, 1992, POLYM COMPOSITE, V13, P81, DOI 10.1002/pc.750130203
   TISSINGTON B, 1991, J MATER SCI, V26, P82, DOI 10.1007/BF00576036
   ULCAY Y, 1990, PP AM SOC MECH EN 32, V131, P23
NR 28
TC 9
Z9 9
U1 1
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1995
VL 9
IS 8
BP 1031
EP 1048
DI 10.1163/156856195X00888
PG 18
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA RN521
UT WOS:A1995RN52100003
DA 2018-10-19
ER

PT J
AU GROTH, T
   ALTANKOV, G
AF GROTH, T
   ALTANKOV, G
TI FIBROBLAST SPREADING AND PROLIFERATION ON HYDROPHILIC AND HYDROPHOBIC
   SURFACES IS RELATED TO TYROSINE PHOSPHORYLATION IN FOCAL CONTACTS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE WETTABILITY; FIBROBLASTS; ADHESION; PROLIFERATION; BETA(1) INTEGRIN;
   SIGNALING; TYROSINE PHOSPHORYLATION
ID FIBRONECTIN ADSORPTION; CELL-ADHESION; PROTEIN; INTEGRINS; BINDING;
   KINASES
AB Fibroblasts adhesion, spreading, and proliferation was investigated in this study using glass and octadecyl glass (ODS) as models for hydrophobic substrata in the absence or presence of preadsorbed fibronectin (FN). To learn more about the underlying mechanism of the biocompatibility of materials, the organization of the beta(1) integrin and the phosphorylation of tyrosine residues in focal contacts was investigated by immunofluorescence microscopy. The diminished adhesion and spreading of fibroblasts on hydrophobic ODS in comparison to clean glass was indicated by a diffuse presence of actin and by the absence of focal contacts and phosphotyrosine activity. In contrast, on hydrophilic glass, initial stress fibres and focal adhesions appeared accompanied by a moderate phosphotyrosine activity. The preadsorption of FN improved the interaction of fibroblast with both surfaces as indicated by the formation of prominent actin stress fibres and the clusterization of beta(1), integrins in the focal contacts which was co-localized with an increased phosphotyrosine activity. The proliferation of fibroblasts measured after 72 h was inhibited on ODS in comparison to glass. Preadsorption of FN, however, increased the cell proliferation index on both surfaces, whch was higher than on pure glass. The improved cell adhesion, spreading, and proliferation of fibroblasts run in parallel with an increased total tyrosine phosphorylation activity measured by an enzyme immune assay (EIA). It was concluded that the signalling via integrins might be a decisive event during the cell-biomaterial interaction.
C1 HUMBOLDT UNIV BERLIN, SCH MED CHARITE, BIOMAT RES UNIT, D-10098 BERLIN, GERMANY.
   BULGARIAN ACAD SCI, INST BIOPHYS, BU-1113 SOFIA, BULGARIA.
OI Groth, Thomas/0000-0001-6647-9657
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   CHEN WT, 1985, J CELL BIOL, V100, P1103, DOI 10.1083/jcb.100.4.1103
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   GROTH T, 1992, ATLA-ALTERN LAB ANIM, V20, P390
   GUAN JL, 1991, CELL REGUL, V2, P951
   HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.bi.54.070185.004341
   HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1990, SPRINGER SERIES MOL
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423
   MACHER PA, 1985, P NATL ACAD SCI USA, V82, P6576
   MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cellbio.4.1.183
   MULLERBERGHAUS G, 1990, HAMOSTASIOLOGIE, V10, P77
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PITT WG, 1993, J BIOMAT SCI-POLYM E, V4, P337, DOI 10.1163/156856293X00023
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
NR 31
TC 32
Z9 32
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 7
IS 3
BP 297
EP 305
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA RE867
UT WOS:A1995RE86700010
PM 7577832
DA 2018-10-19
ER

PT J
AU FENG, L
   ANDRADE, JD
AF FENG, L
   ANDRADE, JD
TI PROTEIN ADSORPTION ON LOW-TEMPERATURE ISOTROPIC CARBON .5. HOW IS IT
   RELATED TO ITS BLOOD COMPATIBILITY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE BLOOD COMPATIBILITY; BIOMATERIAL; LOW TEMPERATURE ISOTROPIC CARBON;
   SURFACE STRUCTURE; PROTEIN ADSORPTION
ID PLASMA-PROTEINS; SURFACE-ENERGY; ALBUMIN; INTERFACES; POLYMERS;
   AGAROSES; BINDING; CHARGE
AB Based on our research on blood protein interactions with low temperature isotropic carbon (LTIC) and data from the literature, we propose that the carbon surface has strong interactions with adsorbed proteins. In this paper we focus on how a relatively blood-compatible material interacts with plasma proteins. We present our results on the structure and properties of the LTIC surface utilizing SEM, STM, XPS, and contact angle measurements. We briefly review protein adsorption on LTIC using DSC, impedance, radioisotopes, and two-dimensional gel electrophoresis. LTIC is characterized by a microporous, oxidized, hydrophobic, and domain mosaic structure. Surface polishing smoothens the roughness and removes the porosity, while largely destroying the ordered atomic texture, making the surface more random and more amorphous. The LTIC surface denatures all adsorbed proteins studied. The rate of protein adsorption is high and the surface concentration is large. The LTIC surface adsorbs all proteins without preference. The surface also tenaciously retains proteins such that they cannot be displaced by buffer or exchanged by proteins in solution. We conclude that LTIC accomplishes its blood compatibility through a passivating film of strongly adsorbed bland proteins, which do not interact with platelets nor participate in blood coagulation. We also suggest mechanisms for the production of such a film by the LTIC surface.
C1 UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112.
   UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112.
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1975, ARTIFICIAL LIVER SUP, P84
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158
   Andrade JD, 1986, ADV POLYM SCI, V79, P3
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   ANDRADE JD, 1987, ASAIO T, V34, P75
   Arru P, 1987, HIGH TECH CERAMICS, P117
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIER RE, 1970, T AM SOC ART INT ORG, V16, P50
   BAQUEY C, 1987, BIOMATERIALS, V10, P435
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   BEJUI J, 1988, CRIT REV BIOCOMPAT, V4, P79
   BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   BLAIER RE, 1969, J BIOMED MATER RES, V3, P191
   BOEHM HP, 1989, STRUCTURE REACTIVITY, P144
   Bokros J. C., 1972, CHEMISTRY PHYSICS CA, V9, P103
   BOKROS JC, 1977, CARBON, V15, P355
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BRASH JL, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P39
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BRUCK SD, 1977, POLYMER, V16, P25
   CAPRANI A, 1991, BIOELECTROCH BIOENER, V26, P241
   Cazenave J.-P., 1986, BLOOD SURFACE INTERA
   CHIGNIER E, 1987, BIOMATERIALS, V8, P18, DOI 10.1016/0142-9612(87)90022-6
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   CHIU TH, 1978, T AM SOC ART INT ORG, V24, P389
   CHUANG HYK, 1987, BLOOD COMPATIBILITY, V1, P88
   CHUI TH, 1977, 13TH BIENN C CARB IR, P9
   CLAES L, 1987, J BIOMED MATER RES-A, V21, P319
   DAUSKARDT RH, 1992, 4TH WORLD BIOM C, P478
   DELLSPERGER KC, 1991, BLOOD COMPATIBLE MAT, P153
   DEMIROGLOU A, 1990, J CHROMATOGR, V521, P1, DOI 10.1016/0021-9673(90)85060-9
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   EVANS AC, 1991, SURF COAT TECH, V47, P662, DOI 10.1016/0257-8972(91)90338-W
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   FENG L, 1993, J BIOMED MATER RES, V27, P177, DOI 10.1002/jbm.820270206
   FENG L, 1994, BIOMATERIALS, V15, P323
   FENG L, 1995, IN PRESS J BIOMED MA
   FENG L, 1993, THESIS U UTAH
   FENG L, 1995, IN PRESS COLLOIDS SU
   FORBES CD, 1989, BLOOD FLOW ARTIFICIA, P89
   GIMBRONE MA, 1987, ANN NY ACAD SCI, V516, P5
   Gott V L, 1973, Med Instrum, V7, P121
   HAUBOLD AD, 1986, ENCY MATERIALS SCI E, V1, P514
   HAUBOLD AD, 1981, BIOCOMPATIBILITY CLI, V2, P3
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   IORDANSKI AL, 1983, J MACROMOL SCI R M C, VC23, P33, DOI 10.1080/07366578308079438
   ISREALACHVILI JN, 1985, INTERMOLECULAR SURFA, P102
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JENNISSEN HP, 1992, J CHROMATOGR, V597, P93, DOI 10.1016/0021-9673(92)80099-G
   KAAE JL, 1985, CARBON, V23, P665, DOI 10.1016/0008-6223(85)90226-X
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P471
   KIM SW, 1977, J BIOMED MATER RES, V11, P23, DOI 10.1002/jbm.820110104
   KING RN, 1981, ACS SYM SER, V162, P382
   KOZIN F, 1982, J COLLOID INTERF SCI, V88, P326, DOI 10.1016/0021-9797(82)90262-4
   KULIK EA, 1991, ARTIF ORGANS, V15, P386
   LEE RG, 1974, J BIOMED MATER RES, V8, P393, DOI 10.1002/jbm.820080607
   LEONARD EF, 1987, ANN NY ACAD SCI, P516
   LU DR, 1986, J COLLOID INTERF SCI, V144, P271
   LUNDSTROM I, 1990, J COLLOID INTERF SCI, V136, P68, DOI 10.1016/0021-9797(90)90079-4
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196
   Mohammad S F, 1989, ASAIO Trans, V35, P384, DOI 10.1097/00002480-198907000-00069
   MORRISSEY BW, 1977, ANN NY ACAD SCI, V283, P50, DOI 10.1111/j.1749-6632.1977.tb41752.x
   NOJIRI C, 1992, 4TH WORLD BIOM C BER, P449
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   NORDE W, 1990, J BIOMAT SCI-POLYM E, V2, P183
   NYILAS E, 1978, ARTIF ORGANS S, V2, P56
   OLCOTT EL, 1974, J BIOMED MAT RES S, V5, P209
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PORATH J, 1978, J CHROMATOGR, V155, P47, DOI 10.1016/S0021-9673(00)83937-0
   PORATH J, 1978, J CHROMATOGR, V159, P13, DOI 10.1016/S0021-9673(00)98542-X
   RAMASAMY N, 1980, TOPICS BIOELECTROCHE, V3, P243
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RICCITELLI SD, 1984, T AM SOC ART INT ORG, V30, P420
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SALZMAN EW, 1977, ANN NY ACAD SCI, V283, P114, DOI 10.1111/j.1749-6632.1977.tb41760.x
   SATO H, 1987, ACS SYM SER, V343, P77
   SCHOEN FJ, 1983, BIOCOMPATIBLE POLYM, P239
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P615
   SHASBY DM, 1988, ENDOTHELIAL CELLS, V1, P39
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   SILVERBERG M, 1981, INFLAMMATION RES, V2, P165
   SING KSW, 1976, CHARACTERIZATION POW, P25
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   SLACK S M, 1991, Journal of Biomaterials Science Polymer Edition, V2, P227
   SMITH KL, 1984, J VAC SCI TECHNOL A, V2, P744, DOI 10.1116/1.572562
   SPAET TH, 1987, ANN NY ACAD SCI, V516, P1
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   TINGEY KG, 1988, POLYM SURFACE DYNAMI, P153
   TSAI CC, 1988, T AM SOC ART INT ORG, V34, P559
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   VROMAN L, 1977, ANN NY ACAD SCI, P283
   WILLIAMS DF, 1987, BLOOD COMPATIBILITY, V2, P107
   WILLIAMS DF, 1987, BLOOD COMPATIBILITY, V1
   WILLIAMS DF, 1987, BLOOD COMPATIBILITY, V1, P5
NR 103
TC 28
Z9 31
U1 0
U2 12
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 7
IS 5
BP 439
EP 452
DI 10.1163/156856295X00445
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA RX559
UT WOS:A1995RX55900006
PM 8562521
DA 2018-10-19
ER

PT J
AU Rao, KP
AF Rao, KP
TI Recent developments of collagen-based materials for medical applications
   and drug delivery systems
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
ID MORPHOLOGICAL EVALUATION; GELATIN MICROSPHERES; CONTROLLED-RELEASE;
   SHIELDS; HYDROGELS; TISSUE; 5-FLUOROURACIL; REPLACEMENT; COPOLYMERS;
   TOBRAMYCIN
AB In this review, an attempt was made to summarize some of the recent developments in the application of collagen as a biomaterial and in drug delivery systems. The main applications covered include: collagen for burn/wound cover dressings; osteogenic and bone filling materials; antithrombogenic surfaces; and immobilization of therapeutic enzymes. Recently, collagen used as a carrier for drug delivery has attracted many researchers throughout the world. The use of collagen for various drug delivery systems has also been reviewed in this article. Collagen-based drug delivery systems include: injectable microspheres based on gelatin (degraded form of collagen); implantable collagen-synthetic polymer hydrogels; interpenetrating networks of collagen; and synthetic polymers collagen membranes for ophthalmic delivery. Recent efforts to use collagen-liposomal composites for controlled drug delivery, as well as collagen as controlling membranes for transdermal delivery, were also reviewed. In this review, the main emphasis was on the work done in our laboratory.
RP Rao, KP (reprint author), CENT LEATHER RES INST, DIV BIOMAT, MADRAS 600020, TAMIL NADU, INDIA.
CR ALAMELU S, 1994, CARBOHYD POLYM, V24, P215, DOI 10.1016/0144-8617(94)90133-3
   ALAMELU S, 1994, SEP P SAT S COLL STR
   ARSHADY R, 1993, BIOMATERIALS, V14, P5, DOI 10.1016/0142-9612(93)90015-T
   BLOOMFIELD SE, 1978, ARCH OPHTHALMOL-CHIC, V96, P885
   Bovey FA, 1979, MACROMOLECULES INTRO, P445
   CHEN YF, 1990, AM J OPHTHALMOL, V109, P132, DOI 10.1016/S0002-9394(14)75976-8
   DARDIK H, 1983, VASCULAR GRAFTING, P153
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   DEHUSTRO F, 1986, J BIOMED MATER RES, V20, P109
   EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L
   GILL F, 1989, J BIOMED MATER RES-A, V23, P363, DOI 10.1002/jbm.820231410
   HOBDEN JA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1605, DOI 10.1001/archopht.1988.01060140773053
   HOSOKAWA K, 1991, ACTA MED KINKI U, V16, P23
   HRUSHEESKY WJM, 1991, ANN NY ACAD SCI, V618, P428
   HWANG DG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1375, DOI 10.1001/archopht.1989.01070020445052
   IKE O, 1992, BIOMATERIALS, V13, P230, DOI 10.1016/0142-9612(92)90189-U
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   JEYANTHI R, 1987, INT J PHARM, V35, P177, DOI 10.1016/0378-5173(87)90087-1
   JEYANTHI R, 1991, J PHARM PHARMACOL, V43, P60, DOI 10.1111/j.2042-7158.1991.tb05453.x
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   JEYANTHI R, 1990, J CONTROL RELEASE, V13, P91, DOI 10.1016/0168-3659(90)90078-8
   JEYANTHI R, 1989, INT J PHARM, V55, P31, DOI 10.1016/0378-5173(89)90273-1
   JEYANTHI R, 1990, J BIOACT COMPAT POL, V5, P194
   KATO YP, 1988, 25TH P AN ROCK MOUNT, V24, P87
   KRONENTHAL RL, POLYM SCI TECH SERIE, V8, P27
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   MARCHAND R, 1987, Society for Neuroscience Abstracts, V13, P161
   MERIKLE MC, 1993, BIOMATERIALS, V14, P177
   NARAYANI R, IN PRESS INT J PHARM
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN BIOCH, V1, P3
   PAJEAN M, 1991, INT J PHARM, V77, P31, DOI 10.1016/0378-5173(91)90298-3
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   PARSONS JR, 1985, ORTHOPEDICS, V8, P907
   PHINNEY R B, 1988, Investigative Ophthalmology and Visual Science, V29, P173
   RAGHUNATH K, 1984, BIOTECHNOL BIOENG, V26, P104, DOI 10.1002/bit.260260119
   RAGHUNATH K, 1983, J BIOMED MATER RES, V17, P613, DOI 10.1002/jbm.820170406
   RAO KP, 1992, J MEMBRANE SCI, V71, P161, DOI 10.1016/0376-7388(92)85015-B
   RAO KP, 1991, INDIAN J CHEM B, V30, P107
   RAO KP, 1989, P INT S CONTROLLED R, V16, P406
   RAO KP, 1988, COLLAGEN BIOTECHNOLO, P63
   RAO TV, 1986, INDIAN J SURG, V48, P217
   REIDY JJ, 1990, CORNEA, V9, P196
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   SASTRY TP, 1990, J BIOACT COMPAT POL, V5, P430, DOI 10.1177/088391159000500405
   SASTRY TP, 1991, HIGH PERFORMANCE BIO, P171
   SAWUSCH MR, 1988, AM J OPHTHALMOL, V106, P279, DOI 10.1016/0002-9394(88)90361-3
   SENATORE F, 1988, CRIT REV BIOCOMPAT, V4, P281
   SENATORE FF, 1986, PROGR ARTIFICIAL ORG, P1024
   SHANTHA KL, 1993, J BIOACT COMPAT POL, V8, P142, DOI 10.1177/088391159300800204
   Silver F H, 1991, J Long Term Eff Med Implants, V1, P135
   SILVER FH, 1989, BIOCOMPATIBILITY, P27
   SILVER FH, 1991, APPLICATIONS BIOMATE
   SLATTER DH, 1982, AUST VET J, V59, P4, DOI 10.1111/j.1751-0813.1982.tb02700.x
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   THACHARODI D, 1993, INT J PHARM, V96, P33, DOI 10.1016/0378-5173(93)90209-X
   THACHARODI D, IN PRESS INT J PHARM
   THACHARODI D, IN PRESS J BIOMATER
   UNTERMAN SR, 1988, J CATARACT REFR SURG, V14, P500, DOI 10.1016/S0886-3350(88)80006-3
   VASANTHA R, 1988, INT J PHARM, V47, P95
   VERRIJK R, 1991, CANCER CHEMOTH PHARM, V29, P117, DOI 10.1007/BF00687320
   WASSERMAN AJ, 1989, SCANNING MICROSCOPY, V3, P1183
   WEISSMAN BA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1706, DOI 10.1001/archopht.1988.01060140878032
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WOERLY S, 1991, BIOMATERIALS, V12, P197, DOI 10.1016/0142-9612(91)90200-T
   WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8
   1985, Patent No. 60106459
NR 67
TC 134
Z9 137
U1 1
U2 52
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 7
IS 7
BP 623
EP 645
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA TL479
UT WOS:A1995TL47900007
PM 8924427
DA 2018-10-19
ER

PT J
AU HARMAND, MF
AF HARMAND, MF
TI IN-VITRO STUDY OF BIODEGRADATION OF A CO-CR ALLOY USING A HUMAN
   CELL-CULTURE MODEL
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOMATERIAL; BIODEGRADATION; HUMAN CELL CULTURE; CO-CR ALLOY
AB The evaluation of a potential biomaterial is based on two approaches: firstly, the study of the local and systemic effects of the biomaterial implanted in the host; and secondly the study of the behaviour of the biomaterial itself with increasing time. The progress achieved in human cell culturing allows in vitro evaluation of a new biomaterial using the human cell(s) system(s) characteristic of the tissue which it will be exposed to in vivo. This kind of approach permits the assessment of the biodegradation of a biomaterial whatever it is: metal; alloy; ceramic; glass; polymer; with or without specialized coating.... The experimental approach is as follows: discs representative of the biomaterial (surface state, cleaning, sterilization process) are manufactured in order to cover the bottom of the culture wells. Thereafter, they are either brought in the presence of complete culture medium alone, or in the presence of a subconfluent cell layer. A kinetic analysis is performed using various incubation periods at 37 degrees C. Released biodegradation products are identified and quantified, in both the medium and cell compartment, and on the other hand cytotoxicity is assessed. A Co-Cr alloy was studied over a 9-day period according to the experimental schedule, and showed a higher corrosion rate in the presence of osteoblasts in the range of 25-30%. Moreover, an intracellular uptake of both Cr and Co was detected, which will have physiological importance.
RP HARMAND, MF (reprint author), TECHNOPOLE MONTESQUIEU,LEMI,F-33650 MARTILLAC,FRANCE.
CR FRAZIER ME, 1979, TRACE METALS HLTH DI
   HARMAND M-F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P67, DOI 10.1163/156856291X00070
   HARMAND MF, 1986, BIOL BIOMECHANICAL P
   HARMAND MF, 1984, CALCIFIED TISSUE INT, V36, P29
   HEGYELI AF, 1973, J BIOMED MATER RES, V7, P205, DOI 10.1002/jbm.820070209
   1991, 2ND CONS C DEF BIOM
   1944, ISO109931 INT STAND
NR 7
TC 25
Z9 37
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1995
VL 6
IS 9
BP 809
EP 814
DI 10.1163/156856295X00193
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA QH009
UT WOS:A1995QH00900004
PM 7772567
DA 2018-10-19
ER

PT J
AU RAIMONDI, ML
   SASSARA, C
   BELLOBONO, IR
   MATTURRI, L
AF RAIMONDI, ML
   SASSARA, C
   BELLOBONO, IR
   MATTURRI, L
TI KINETIC-STUDY OF RELEASE OF SILICON-COMPOUNDS FROM POLYSILOXANE TISSUE
   EXPANDERS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BREAST
AB The release behavior of typical commercial tissue expanders has been examined by carrying out two kinds of experiments: 1) Determination of chemical nature and its modification after in vivo use by X-ray photoelectron spectroscopy for chemical analysis. This study has been parallelled by scanning electron microscopy with associated energy dispersive X-ray analysis of surface, as well as by silicon compounds analysis of tissues around implants. 2) Kinetic examination of silicon compounds released by the biomaterial in physiologic solution at 36 +/- 0.3 degrees C. Results of these investigations have shown independently that the starting material was not a filler-free, pure polymer, but a composite, reinforced elastomer, with the reinforcing agent most seemingly represented by silicon dioxide. Release of latter, with a relatively fast kinetics, is compatible with data of the simulating laboratory runs in the physiologic solution. All these facts seem to rule out any hypothesis of a prevailing siloxane oligomer migration. The correlation of kinetic and physicochemical tests with the in vivo behavior is discussed. (C) 1995 John Wiley and Sons, Inc.
C1 UNIV MILAN,DEPT PHYS CHEM & ELECTROCHEM,I-20133 MILAN,ITALY.
   UNIV MILAN,FAC MED,INST PATHOL,I-20122 MILAN,ITALY.
CR CHAWLA AS, 1984, J BIOMED MATER RES, V18, P537, DOI 10.1002/jbm.820180507
   ISQUITH A, 1988, FOOD CHEM TOXICOL, V26, P255, DOI 10.1016/0278-6915(88)90127-5
   ISQUITH A, 1988, FOOD CHEM TOXICOL, V26, P263, DOI 10.1016/0278-6915(88)90128-7
   JENNINGS DA, 1991, ANN PLAS SURG, V27, P553, DOI 10.1097/00000637-199112000-00007
   MATTURRI L, 1992, PLAST RECONSTR SURG, V90, P636, DOI 10.1097/00006534-199210000-00013
   MATTURRI L, 1991, INT SURG, V76, P115
   NIGHTINGALE SL, 1992, JAMA-J AM MED ASSOC, V267, P787
   RUDOLPH R, 1978, PLAST RECONSTR SURG, V62, P185, DOI 10.1097/00006534-197808000-00006
   WICKHAM MG, 1978, SCIENCE, V199, P437, DOI 10.1126/science.619466
NR 9
TC 6
Z9 6
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1995
VL 29
IS 1
BP 59
EP 63
DI 10.1002/jbm.820290109
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY538
UT WOS:A1995PY53800008
PM 7713959
DA 2018-10-19
ER

PT J
AU CAMPBELL, P
   MA, S
   YEOM, B
   MCKELLOP, H
   SCHMALZRIED, TP
   AMSTUTZ, HC
AF CAMPBELL, P
   MA, S
   YEOM, B
   MCKELLOP, H
   SCHMALZRIED, TP
   AMSTUTZ, HC
TI ISOLATION OF PREDOMINANTLY SUBMICRON-SIZED UHMWPE WEAR PARTICLES FROM
   PERIPROSTHETIC TISSUES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID POLYETHYLENE
AB A method of tissue digestion using sodium hydroxide was applied to the isolation and recovery of ultra-high-molecular-weight polyethylene (UHMWPE) particles from tissues around failed total hip replacements. Density gradient ultracentrifugation of the digested tissues was performed to separate the UHMWPE from cell debris and other particulates. Fourier transform infrared spectroscopy and differential scanning calorimetry (DSC) verified that the recovered particles were UHMWPE. When viewed by scanning electron microscopy, individual particles were clearly observed and were either rounded or elongated. The majority were submicron in size. The application of this method to the study of particles from periprosthetic tissues may elucidate aspects of biomaterial particle size and shape that are important to the biologic response to, and clinical outcome of, total joint replacement. (C) 1995 John Wiley and Sons, Inc.
C1 GOTHENBURG UNIV,DEPT HANDICAP RES,BIOMAT GRP,GOTHENBURG,SWEDEN.
   UNIV SO CALIF,DEPT CHEM ENGN,LOS ANGELES,CA 90007.
   LOS ANGELES ORTHOPAED HOSP,J VERNON LUCK ORTHOPAED RES CTR,LOS ANGELES,CA 90007.
   UNIV CALIF LOS ANGELES,HARBOR MED CTR,TORRANCE,CA.
RP CAMPBELL, P (reprint author), LOS ANGELES ORTHOPAED HOSP,INST JOINT REPLACEMENT,IMPLANT RETRIEVAL LAB,2400 S FLOWER ST,LOS ANGELES,CA 90007, USA.
CR AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971
   CAMPBELL P, 1994, J BIOMED MATER RES, V28, P523, DOI 10.1002/jbm.820280415
   CAMPBELL P, 1993, J BONE JOINT SURG BR, V75, P161
   CAMPBELL P, 1993, 19TH ANN M SOC BIOM
   CHIBA J, 1993, 39TH ANN M ORTH RES
   EMMANUAL J, 1990, 16TH ANN M SOC BIOM
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, V244, P182
   HAQ S, 1993, 19TH ANN M SOC BIOM
   HOWIE DW, 1989, J BONE JT SURG A, V70, P257
   LEE JM, 1992, J BONE JOINT SURG BR, V74, P380
   MALONEY WJ, 1992, SEP IMPL RETR S SOC
   MCKELLOP H, IN PRESS CLIN ORTHOP
   PAINTER PC, 1982, THEORY VIBRATIONAL S, P252
   SANTAVIRTA S, 1990, J BONE JOINT SURG AM, V72A, P252, DOI 10.2106/00004623-199072020-00014
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SCHMALZRIED TP, 1993, J APPL BIOMATER, V4, P119, DOI 10.1002/jab.770040202
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
NR 18
TC 273
Z9 275
U1 1
U2 33
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1995
VL 29
IS 1
BP 127
EP 131
DI 10.1002/jbm.820290118
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY538
UT WOS:A1995PY53800017
PM 7713952
DA 2018-10-19
ER

PT J
AU DAHIYAT, BI
   RICHARDS, M
   LEONG, KW
AF DAHIYAT, BI
   RICHARDS, M
   LEONG, KW
TI CONTROLLED-RELEASE FROM POLY(PHOSPHOESTER) MATRICES
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE POLY(PHOSPHOESTER) MATRIX; BIODEGRADABLE POLYMER
ID DRUG DELIVERY SYSTEMS; HYDROLYSIS-SENSITIVE POLY<(ORGANO)PHOSPHAZENES>;
   BIODEGRADABLE POLYMERS; POLYPHOSPHONATES; COPOLYMERS; HYDROGELS
AB A class of biodegradable polymers, poly(phosphoesters), was studied for its potential as a matrix for controlled drug delivery. The degradability of the phosphorus ester linkage and the versatility of phosphorus-containing polymers make poly(phosphoesters) attractive candidates for development as a degradable biomaterial. The release of various drugs in vitro from a series of bisphenol-A based poly(phosphoesters) was examined. Sustained release for up to several months was achieved for cortisone acetate and model drug p-nitroaniline. The mechanism of release was found to be a combination of diffusion, swelling and degradation. The structure of the sidechain influenced the release behavior in all instances.
C1 JOHNS HOPKINS UNIV,DEPT BIOMED ENGN,BALTIMORE,MD 21218.
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR ALI SL, 1983, ANAL PROFILES DRUG S, V12, P73
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   BROSSE JC, 1989, MAKROMOL CHEM, V190, P2339
   CARMEN PC, 1954, P ROYAL SOC A
   COOVER HW, 1960, IND ENG CHEM, V52, P409, DOI 10.1021/ie50605a030
   Crank J.In., 1975, MATH DIFFUSION, P49
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   DAHIYAT BI, 1993, J BIOMAT SCI-POLYM E, V4, P529, DOI 10.1163/156856293X00186
   FUKUZAKI H, 1991, J BIOMED MATER RES, V25, P315, DOI 10.1002/jbm.820250304
   Groningsson K, 1985, ANAL PROFILES DRUG S, V14, P207
   HELLER J, 1990, BIOMATERIALS, V11, P345, DOI 10.1016/0142-9612(90)90112-4
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   KOST J, 1990, BIOMATERIALS, V11, P695, DOI 10.1016/0142-9612(90)90029-P
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PULAPURA S, 1990, BIOMATERIALS, V11, P666, DOI 10.1016/0142-9612(90)90025-L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   RANUCCI E, J BIOMATER SCI POLYM, P303
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   RICHARDS M, 1991, J POLYM SCI POL CHEM, V29, P1157, DOI 10.1002/pola.1991.080290809
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Sander M., 1967, J MACROMOL SCI REV C, VC1, P91
   TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402
   YASIN M, 1992, BIOMATERIALS, V13, P9, DOI 10.1016/0142-9612(92)90087-5
   YONG C, 1990, COMMUNICATION    JUL
   YOSHIDA M, 1990, J BIOMED MATER RES, V24, P1173, DOI 10.1002/jbm.820240904
NR 29
TC 35
Z9 38
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN
PY 1995
VL 33
IS 1
BP 13
EP 21
DI 10.1016/0168-3659(94)00039-W
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA QJ343
UT WOS:A1995QJ34300002
DA 2018-10-19
ER

PT J
AU CARR, AB
   PAPAZOGLOU, E
   LARSEN, PE
AF CARR, AB
   PAPAZOGLOU, E
   LARSEN, PE
TI RELATIONSHIP OF PTVS, BIOMATERIAL, JAW AND TORQUE IN ADULT BABOONS
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 OHIO STATE UNIV,COLL DENT,COLUMBUS,OH 43210.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PY 1995
VL 74
SI SI
BP 22
EP 22
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA QA008
UT WOS:A1995QA00800085
DA 2018-10-19
ER

PT J
AU CUI, PC
   OHSAKI, K
   II, K
   TENSHIN, S
   KAWATA, T
AF CUI, PC
   OHSAKI, K
   II, K
   TENSHIN, S
   KAWATA, T
TI SUBCUTANEOUS TISSUE REACTION TO SYNTHETIC AUDITORY OSSICLE (APACERAM(R))
   IN RATS
SO JOURNAL OF LARYNGOLOGY AND OTOLOGY
LA English
DT Article
DE HYDROXYAPATITES; HISTOLOGY; CELL COUNT; BIOCOMPATIBLE MATERIALS; RATS
ID GIANT-CELL FORMATION; MIDDLE-EAR; HYDROXYLAPATITE; MACROPHAGE; INVITRO;
   RECONSTRUCTION; BIOMATERIAL
AB A study was carried out in order to obtain further information about the soft tissue response to thin Apaceram(R) discs of dense hydroxyapatite (HA) implanted in rats for various periods of time between one day and 10 months. The Apaceram(R) discs were implanted subcutaneously into the interscapular region of 33 rats. A sham operation was performed on eight rats used as controls. Decalcified histological sections stained with haematoxylin and eosin and Mallory's azan were examined and the different cell types found around the implants were counted. It was found that an acute inflammatory reaction occurred after one day and disappeared at about two weeks after implantation. In the test groups, macrophages and lymphocytes disappeared about one week later, and no inflammatory reaction was observed from one to three months. However, a tissue reaction occurred at six months with the appearance of macrophages and lymphocytes, and decreased gradually at 10 months. Meanwhile, a few foreign body giant cells at the Apaceram(R)-tissue interface and a thick layer of fibrous connective tissue around the Apaceram(R) disc were observed at 10 months. No osteogenesis was observed in any specimen. The results obtained so far suggest that Apaceram(R) is still a useful material for reconstructive surgery, despite the possible appearance of a slight macrophage reaction at six months.
C1 UNIV TOKUSHIMA,SCH MED,DEPT PATHOL 1,TOKUSHIMA 770,JAPAN.
   UNIV TOKUSHIMA,SCH DENT,DEPT ORTHODONT,TOKUSHIMA 770,JAPAN.
   UNIV TOKUSHIMA,SCH MED,DIV CLIN OTOL,TOKUSHIMA 770,JAPAN.
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BOEDTS D, 1983, ARCH OTO-RHINO-LARYN, V237, P197, DOI 10.1007/BF00453724
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   ELDEEB M, 1990, J ORAL MAXIL SURG, V48, P476, DOI 10.1016/0278-2391(90)90234-S
   GOLDENBERG RA, 1992, OTOLARYNG HEAD NECK, V106, P261, DOI 10.1177/019459989210600312
   GROTE JJ, 1986, ANN OTO RHINOL LARYN, V95, P1
   GROTE JJ, 1990, ANN OTO RHINOL LARYN, V99, P12
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HENKE C, 1993, AM J PATHOL, V143, P1189
   JAHN AF, 1992, LARYNGOSCOPE, V102, P289
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   LEIBOVICH SJ, 1976, AM J PATHOL, V84, P501
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Rubin R.P., 1985, CALCIUM BIOL SYSTEMS, P5
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
NR 16
TC 7
Z9 7
U1 0
U2 1
PU HEADLEY BROTHERS LTD
PI ASHFORD
PA INVICTA PRESS, ASHFORD, KENT, ENGLAND TN24 8HH
SN 0022-2151
J9 J LARYNGOL OTOL
JI J. Laryngol. Otol.
PD JAN
PY 1995
VL 109
IS 1
BP 14
EP 18
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA QG715
UT WOS:A1995QG71500003
PM 7876730
DA 2018-10-19
ER

PT J
AU Hallab, NJ
   Bundy, KJ
   OConnor, K
   Clark, R
   Moses, RL
AF Hallab, NJ
   Bundy, KJ
   OConnor, K
   Clark, R
   Moses, RL
TI Cell adhesion to biomaterials: Correlations between surface charge,
   surface roughness, adsorbed protein, and cell morphology
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Article
DE biomaterials; cellular adhesion; protein adsorption; jet impingement;
   surface charge; cellular morphology
ID JET IMPINGEMENT; SERUM-PROTEINS; FREE-ENERGY; FIBRINOGEN; STRESS
AB Adhesion of cells to a biomaterial surface can be a major factor mediating its biocompatibility. In this investigation, jet impingement techniques were used to quantify strength of cellular adhesion to various material surfaces. The metals tested: HS25 (a cobalt-based alloy similar to F75), 316L stainless steel, Ti-6A1-4V, and commercially pure tantalum, exhibited nearly a fivefold increase in adhesion strength above that characteristic of the polymeric materials tested (PTFE, silicone rubber, and HDPE). The present study examines physical and biological factors that might influence fibroblast adhesion to the biomaterial surface. The relation between surface charge and cellular adhesion was investigated in a controlled manner by measuring adhesion strength over a range of charge densities. The cells showed charge and electrical potential-dependent adhesion maxima, suggesting that surface alloying for optimum adherence may be possible. In a preliminary series of experiments adsorbed serum protein layers on a series of materials of differing adherence were investigated using gel electrophoresis to assess protein composition. Analysis of adsorbed proteins revealed little difference in relative abundance or total adsorption quantity. SEM micrographs of cells on Ti-6A1-4V and silicone rubber (high and low adhesion materials, respectively) demonstrated differences in cell morphology and cell density.
C1 TULANE UNIV,DEPT BIOMED ENGN,NEW ORLEANS,LA 70118.
   TULANE UNIV,DEPT CHEM ENGN,NEW ORLEANS,LA 70118.
   LOUISIANA STATE UNIV,MED CTR,DEPT ANAT,NEW ORLEANS,LA 70119.
RI O'Connor, Kim/H-3145-2012
CR BAGNALL RD, 1980, J BIOMED MATER RES, V18, P1
   BOCKRIS JOM, 1970, MODERN ELECTROCHEMIS, P754
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BRYNDA E, 1984, J BIOMED MATER RES, V18, P685, DOI 10.1002/jbm.820180609
   BUNDY K, 1991, T 17 ANNN M SOC BIOM, P229
   BUNDY K, 1993, T 39 ANN ORS M, P513
   BUNDY K, 1994, T 40 ANN ORS M, V19, P93
   BUNDY KJ, 1994, J MATER SCI-MATER M, V5, P500, DOI 10.1007/BF00058991
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   COLEMAN DL, 1982, J BIOMED MATER RES, V16, P381, DOI 10.1002/jbm.820160407
   DESHPANDE MD, 1983, J ENG MECH-ASCE, V109, P479, DOI 10.1061/(ASCE)0733-9399(1983)109:2(479)
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   KAPUR R, 1993, BIOMATERIALS, V14, P854, DOI 10.1016/0142-9612(93)90007-O
   Merril CR, 1986, GEL ELECTROPHORESIS, P323
   PERREN SM, 1989, COMMUNICATION   0902
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   RICHARDS RG, 1993, 10 EUR C BIOM DAV SE
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHMALZ G, 1985, J BIOMED MATER RES, V19, P653, DOI 10.1002/jbm.820190605
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
   VANDIJK LJ, 1988, BIOFOULING, V1, P19
   VETTER KJ, 1976, ELECTROCHEMICAL KINE, P76
NR 22
TC 103
Z9 104
U1 1
U2 53
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1995
VL 5
IS 3
BP 209
EP 231
PG 23
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA UD084
UT WOS:A1995UD08400004
PM 10172729
DA 2018-10-19
ER

PT J
AU TRACANA, RB
   PEREIRA, ML
   ABREU, AM
   SOUSA, JP
   CARVALHO, GS
AF TRACANA, RB
   PEREIRA, ML
   ABREU, AM
   SOUSA, JP
   CARVALHO, GS
TI STAINLESS-STEEL CORROSION PRODUCTS CAUSE ALTERATIONS ON MOUSE SPLEEN
   CELLULAR-POPULATIONS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID METAL-SALTS; INVITRO
AB Stainless steel is a metallic biomaterial commonly used in orthopaedic surgery. In this study we looked at the effects of stainless steel corrosion products on spleen, in order to evaluate their potential immunotoxicological effects. For this purpose stainless steel, type AISI 316L, was electrochemically dissolved in a physiological salt solution. The final solution, containing 490 mu g/ml Fe, 224 mu g/ml Cr and 150 mu g/ml Ni, was injected subcutaneously in mice. After several periods of time (4, 10 and 14 days) spleens were removed and analysed for: (a) their contents in Fe, Cr and Ni, (b) histological alterations, (c) enumeration of cellular populations. Results showed that stainless steel corrosion products accumulated in spleen, caused histological alterations, and induced changes in cellular populations. When compared to chromium and nickel, iron was the metal ion preferentially accumulated in spleen. The increase of the multinucleated giant cell population was accompanied by depletion of lymphocyte populations. This study indicates that stainless steel corrosion products can spread systemically and accumulate in spleen inducing histological and cellular alterations which may give rise to immunotoxicological consequences.
C1 UNIV AVEIRO,DEPT BIOL,P-3800 AVEIRO,PORTUGAL.
RP TRACANA, RB (reprint author), NATL INST BIOMED ENGN,PRACA CORONEL PACHECO 1,P-4000 OPORTO,PORTUGAL.
RI Carvalho, Graca S./M-5669-2015
OI Carvalho, Graca S./0000-0002-0034-1329; Sousa, Joao/0000-0002-8269-9390;
   Pereira, Maria de Lourdes/0000-0001-6703-7869; Cameira Tracana Pereira,
   Rosa Branca/0000-0002-0694-8033
CR ABERNETHY NJ, 1992, LYMPHOLOGY, V25, P1
   BARBOSA MA, 1993, MONITORING ORTHOPEDI, P222
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BROWN SA, 1993, J BIOMED MATER RES, V27, P1007, DOI 10.1002/jbm.820270806
   BROWN SA, 1988, J BIOMED MATER RES, V22, P321, DOI 10.1002/jbm.820220406
   EXON JH, 1990, IMMUNOTOXICITY METAL, P30
   HILDEBRAND HF, 1988, BIOCOMPATIBILITY CO, P133
   KODAT V, 1990, IMMUNOTOXICITY OF METALS AND IMMUNOTOXICOLOGY, P293
   MERRITT K, 1989, J BIOMED MATER RES, V23, P845, DOI 10.1002/jbm.820230804
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   MICHEL R, 1988, BIOCOMPATIBILITY CO, P59
   NICKLIN S, 1990, IMMUNOTOXICITY OF METALS AND IMMUNOTOXICOLOGY, P43
   Pohler O, 1983, BIOMATERIALS RECONST, P158
   Sherman A. R., 1993, Nutrition and immunology., P285
   SINGH S, 1988, BIOCOMPATIBILITY CO, P101
   STULBERG BN, 1992, AM SOC TEST MATER, V1144, P75, DOI 10.1520/STP14854S
   THORSTENSEN K, 1990, BIOCHEM J, V271, P1
   VANKRIEKEN JHJ, 1992, HISTOLOGY PATHOLOGIS, P253
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 19
TC 23
Z9 23
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 1995
VL 6
IS 1
BP 56
EP 61
DI 10.1007/BF00121249
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA QE794
UT WOS:A1995QE79400013
DA 2018-10-19
ER

PT J
AU JENNISSEN, HP
AF JENNISSEN, HP
TI CYANOGEN-BROMIDE AND TRESYL CHLORIDE CHEMISTRY REVISITED - THE SPECIAL
   REACTIVITY OF AGAROSE AS A CHROMATOGRAPHIC AND BIOMATERIAL SUPPORT FOR
   IMMOBILIZING NOVEL CHEMICAL GROUPS
SO JOURNAL OF MOLECULAR RECOGNITION
LA English
DT Proceedings Paper
CT 10th International Symposium on Biorecognition and Affinity Technology
   (10th BRAT)
CY OCT 17-23, 1993
CL GWATT THUN, SWITZERLAND
DE CYANOGEN BROMIDE; 2,2,2-TRIFLUOROETHANESULFONYL CHLORIDE; THIOPHILIC
   INTERACTIONS; BASE-ATOM RECOGNITION; CALMODULIN; FIBRINOGEN;
   PHOSPHORYLASE
ID AFFINITY-CHROMATOGRAPHY; PROTEIN-BINDING; HYDROPHOBIC CHROMATOGRAPHY;
   GLYCOGEN-PHOSPHORYLASE; THIOPHILIC ADSORPTION; GENERAL ASPECTS;
   PURIFICATION; POLYSACCHARIDES; FRACTIONATION; PERFORMANCE
AB The cyanogen bromide and tresyl chloride (2,2,2-trifluoroethanesulfonyl chloride) methods belong to the best-known activation procedures for solid supports in biochemistry. In both cases the originally proposed reaction mechanisms were revised many years later. In this paper important aspects of these two major activation reactions in connection with the singular polysaccharide support, agarose, will be treated with emphasis on the novel reaction mechanism recently proposed for tresyl chloride. In addition, the special role played by sulfur in the new uncharged alkyl-S-S-gels is examined in connection with the phenomenon of base-atom recognition.
C1 UNIV ESSEN GESAMTHSCH, INST PHYS CHEM, D-45122 ESSEN, GERMANY.
CR AKAGI M, 1963, CHEM PHARM BULL, V11, P559
   AOMATSU Y, 1992, TRANSPLANT P, V24, P2922
   ARAKI G, 1956, B CHEM SOC JPN, V29, P543
   ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6
   AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0
   AXEN R, 1971, EUR J BIOCHEM, V18, P351
   BETHELL GS, 1979, J BIOL CHEM, V254, P2572
   Blomback B, 1956, ARK KEMI, V10, P415
   BUXTON WM, 1954, J CHEM SOC LONDON 1, P366
   Cadic-Amadeuf C M, 1992, ASAIO J, V38, pM386, DOI 10.1097/00002480-199207000-00061
   CROSSLAND RK, 1971, J AM CHEM SOC, V93, P4217, DOI 10.1021/ja00746a021
   CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636
   DEMIROGLOU A, 1990, J CHROMATOGR, V521, P1, DOI 10.1016/0021-9673(90)85060-9
   Demiroglou A., 1993, Biological Chemistry Hoppe-Seyler, V374, P763
   DEMIROGLOU A, 1994, ANGEW CHEM INT EDIT, V33, P120, DOI 10.1002/anie.199401201
   DEMIROGLOU A, 1984, 8TH INT C BIOPH BRIS, P49
   DUCKWORT.M, 1971, CARBOHYD RES, V16, P189, DOI 10.1016/S0008-6215(00)86113-3
   EREL Z, 1972, BIOCHEM BIOPH RES CO, V49, P383, DOI 10.1016/0006-291X(72)90422-6
   ERNSTCABRERA K, 1986, ANAL BIOCHEM, V159, P267, DOI 10.1016/0003-2697(86)90342-8
   FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65
   GRIBNAU TCJ, 1977, THESIS CATHOLIC U NI, P87
   HALPERIN G, 1981, J CHROMATOGR, V215, P211, DOI 10.1016/S0021-9673(00)81400-4
   HASCHKE RH, 1972, ANAL BIOCHEM, V47, P451, DOI 10.1016/0003-2697(72)90138-8
   HICKSON TGL, 1968, BIOCHIM BIOPHYS ACTA, V165, P45
   HJERTEN S, 1973, J CHROMATOGR, V87, P325, DOI 10.1016/S0021-9673(01)91733-9
   HJERTEN STELLAN, 1964, BIOCHIM ET BIOPHYS ACTA, V79, P393, DOI 10.1016/0926-6577(64)90020-8
   HOFSTEE BHJ, 1973, BIOCHEM BIOPH RES CO, V50, P751, DOI 10.1016/0006-291X(73)91308-9
   HUDLICKY M, 1971, ORGANIC FLUORINE CHE, P110
   HUTCHENS TW, 1986, ANAL BIOCHEM, V159, P217, DOI 10.1016/0003-2697(86)90331-3
   IZUMI K, 1972, J BIOCHEM-TOKYO, V72, P135, DOI 10.1093/oxfordjournals.jbchem.a129878
   IZUMI K, 1971, CARBOHYD RES, V17, P227, DOI 10.1016/S0008-6215(00)81563-3
   JACOBSSON K, 1955, Scand J Clin Lab Invest, V7 Suppl. 14, P3
   Jennissen H. P., 1993, Journal of Molecular Recognition, V6, P117, DOI 10.1002/jmr.300060304
   JENNISSEN HP, 1992, J CHROMATOGR, V597, P93, DOI 10.1016/0021-9673(92)80099-G
   JENNISSEN HP, 1976, BIOCHEMISTRY-US, V15, P5683, DOI 10.1021/bi00671a001
   JENNISSEN HP, 1979, INT J BIOL MACROMOL, V1, P171, DOI 10.1016/0141-8130(79)90045-X
   JENNISSEN HP, 1975, BIOCHEMISTRY-US, V14, P754, DOI 10.1021/bi00675a017
   JONES RG, 1947, J AM CHEM SOC, V69, P2346, DOI 10.1021/ja01202a028
   JOUSTRA M, 1976, PROTIDES BIOL FLUIDS, V23, P525
   KOHN J, 1981, ANAL BIOCHEM, V115, P375, DOI 10.1016/0003-2697(81)90020-8
   LAKI K, 1951, ARCH BIOCHEM BIOPHYS, V32, P317, DOI 10.1016/0003-9861(51)90277-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAHN I, 1975, HAEMOSTASIS, V4, P40
   MOHR P, 1986, PRACTICAL THEORETICA, P42
   NADKARNI S, 1965, J CHEM SOC, P3496
   NETSCHER T, 1987, TETRAHEDRON LETT, V28, P2115, DOI 10.1016/S0040-4039(00)96057-X
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   PORATH J, 1985, FEBS LETT, V185, P306, DOI 10.1016/0014-5793(85)80928-5
   PORATH J, 1973, NATURE, V245, P465, DOI 10.1038/245465a0
   PORATH J, 1988, MAKROMOL CHEM-M SYMP, V17, P359, DOI 10.1002/masy.19880170127
   PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0
   PORATH J, 1975, CHROMATOGRAPHY SYNTH, V1, P9
   PORATH J, 1975, PROTEINS, P95
   RATNER BD, 1993, CARDIOVASC PATHOL, V2, pS87, DOI 10.1016/1054-8807(93)90049-8
   Rees D A, 1969, Adv Carbohydr Chem Biochem, V24, P267
   REES DA, 1972, BIOCHEM J, V126, P257, DOI 10.1042/bj1260257
   RICHARDSON AC, 1969, CARBOHYD RES, V10, P395, DOI 10.1016/S0008-6215(00)80900-3
   RONG D, 1990, TETRAHEDRON LETT, V31, P4275, DOI 10.1016/S0040-4039(00)97599-3
   STEERS E, 1971, J BIOL CHEM, V246, P196
   SUGIHARA JM, 1953, ADV CARBOHYD CHEM, V8, P1, DOI 10.1016/S0096-5332(08)60097-1
   SUGIHARA JM, 1964, J ORG CHEM, V29, P550, DOI 10.1021/jo01026a007
   TANAKA K, 1978, TETRAHEDRON LETT, P3103
   TIPSON RS, 1953, ADV CARBOHYD CHEM, V8, P107
   UENO A, 1982, TETRAHEDRON LETT, V23, P3451, DOI 10.1016/S0040-4039(00)87639-X
   VANSOMMEREN APG, 1993, J CHROMATOGR, V639, P23, DOI 10.1016/0021-9673(93)83084-6
   YON RJ, 1972, BIOCHEM J, V126, P765, DOI 10.1042/bj1260765
   1979, AFFINITY CHROMATOGR, P12
NR 67
TC 14
Z9 15
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3499
EI 1099-1352
J9 J MOL RECOGNIT
JI J. Mol. Recognit.
PD JAN-APR
PY 1995
VL 8
IS 1-2
BP 116
EP 124
DI 10.1002/jmr.300080121
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA QR672
UT WOS:A1995QR67200020
PM 7598945
DA 2018-10-19
ER

PT J
AU HANTSON, P
   MAHIEU, P
   GERSDORFF, M
   SINDIC, C
   LAUWERYS, R
AF HANTSON, P
   MAHIEU, P
   GERSDORFF, M
   SINDIC, C
   LAUWERYS, R
TI FATAL ENCEPHALOPATHY AFTER OTONEUROSURGERY PROCEDURE WITH AN
   ALUMINUM-CONTAINING BIOMATERIAL
SO JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
LA English
DT Article; Proceedings Paper
CT 5th World Congress of the
   World-Federation-of-Association-of-Clinical-Toxicology-Centers-and-Poiso
   n-Control-Centers
CY NOV 08-11, 1994
CL TAIPEI, TAIWAN
SP World Federat Assoc Clin Toxicol Ctr & Poison Control Ctr
DE ENCEPHALOPATHY; SEIZURES; ALUMINUM; HUMAN
ID ALZHEIMERS-DISEASE
AB Refractory status epilepticus was observed in two patients who underwent vestibular neurectomy. We investigated the relationship with the use of an aluminum containing bone cement during the procedure. Two patients developed focal and thereafter generalized seizures in the late postoperative period of vestibular neurectomy (respectively after 42 and 35 days). A cement (1 g aluminum-calcium fluorosilicate) was used during the procedure to bridge bone defects. Both patients presented cerebrospinal fluid fistula. Investigations excluded common etiologies, in particular infections, and a toxic oligin was suspected. Aluminum concentration was determined repeatedly in serum urine, cerebrospinal fluid and retroauricular fistula. The highest aluminum values were respectively in case 1 and 2, 112 and 63 mu g/L for the cerebrospinal fluid, 495 and 1440 mu g/L for the fistula, 4.4 and 4.4 mu g/L in Serum. Desferrioxamine was used as chelating agent and aluminum elimination was analyzed in the urine. Status epilepticus became refractory to intensive care therapy. The patients never recovered normal consciousness. Case 1 died 143 days after the procedure and case 2 at 80 days from brain failure. Brain post-mortem examination was obtained in Case 2. Brian aluminum concentration was 2.5 mu g/g (wet weight) (0.85 mu g/g in a control non exposed cadaver). The cement (0.2 g) was incubated in vitro (16 h-37 degrees C) with the cerebrospinal fluid of a control patient (cerebrospinal fluid aluminum 8 mu g/L): aluminum concentration reached 2750 mu g/L. A close contact between an aluminum containing cement and the cerebrospinal fluid may have resulted in encephalopathy and fatal status epilepticus in these two patients.
RP HANTSON, P (reprint author), UNIV CATHOLIQUE LOUVAIN,CLIN UNIV ST LUC,DEPT INTENS CARE,AVE HIPPOCRATE 10,B-1200 BRUSSELS,BELGIUM.
CR ALFREY AC, 1993, THER DRUG MONIT, V15, P593, DOI 10.1097/00007691-199312000-00025
   ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   BAKIR AA, 1986, T AM SOC ART INT ORG, V32, P171
   CRAPPERMCLACHLA.DR, 1991, LANCET, V337, P1304
   Kopeloff LM, 1942, AM J PSYCHIAT, V98, P881, DOI 10.1176/ajp.98.6.881
   Lukiw WJ, 1995, HDB NEUROTOXICOLOGY, P105
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   RENARD JL, 1994, LANCET, V344, P63, DOI 10.1016/S0140-6736(94)91089-8
   RIFAT SL, 1994, LANCET, V343, P3, DOI 10.1016/S0140-6736(94)90868-0
   SHORE D, 1983, J NERV MENT DIS, V171, P553, DOI 10.1097/00005053-198309000-00005
NR 10
TC 17
Z9 18
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0731-3810
J9 J TOXICOL-CLIN TOXIC
JI J. Toxicol.-Clin. Toxicol.
PY 1995
VL 33
IS 6
BP 645
EP 648
DI 10.3109/15563659509010622
PG 4
WC Toxicology
SC Toxicology
GA TJ428
UT WOS:A1995TJ42800012
PM 8523486
DA 2018-10-19
ER

PT B
AU LAJOIE, EN
   BAROFSKY, AD
   GREGORY, KW
   PRAHL, SA
AF LAJOIE, EN
   BAROFSKY, AD
   GREGORY, KW
   PRAHL, SA
BE Anderson, RR
   Katzir, A
TI Welding artificial biomaterial with a pulsed diode laser and indocyanine
   green dye
SO LASERS IN SURGERY: ADVANCED CHARACTERIZATION, THERAPEUTICS, AND SYSTEMS
   V, PROCEEDINGS OF
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Lasers in Surgery: Advanced Characterization,
   Therapeutics, and Systems V
CY FEB 04-06, 1995
CL SAN JOSE, CA
SP SOC PHOTO OPT INSTRUMENTAT ENGINEERS
C1 OREGON GRAD INST,PORTLAND,OR 97291.
NR 0
TC 10
Z9 10
U1 0
U2 1
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
BN 0-8194-1742-4
J9 P SOC PHOTO-OPT INS
PY 1995
VL 2395
BP 508
EP 516
DI 10.1117/12.209139
PG 9
WC Optics; Surgery
SC Optics; Surgery
GA BD11K
UT WOS:A1995BD11K00073
DA 2018-10-19
ER

PT J
AU ROZALSKA, B
   LJUNGH, A
   BUROW, A
   RUDNICKA, W
AF ROZALSKA, B
   LJUNGH, A
   BUROW, A
   RUDNICKA, W
TI BIOMATERIAL-ASSOCIATED INFECTION WITH CANDIDA-ALBICANS IN MICE
SO MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE CANDIDA; PHAGOCYTES; NEUTROPENIA; ADHESION
ID PERITONEAL-MACROPHAGES; ADHERENCE; FIBRONECTIN; BINDING; EXPRESSION;
   DIALYSIS; CELLS; MODEL; CAPD
AB Candida yeasts are frequently isolated from patients with continuous ambulatory peritoneal dialysis peritonitis or other biomaterial-associated infections. The mouse model of candidal peritonitis was used to study the interaction of Candida cells with end-point attached heparinized polyethylene (H-PE) and with polymorphonuclear leukocytes (PMNs) or macrophages (M phi). Two Candida strains differing in cell surface hydrophobicity and in expression of fibronectin (Fn) binding were used for the study. Cells of both Candida strains adhered at higher numbers to H-PE surfaces preadsorbed with Fn or with human dialysis fluid (HDF) than to non-modified H-PE, supporting a role of Fn in mediating adhesion. C. albicans 4016 cells expressing low hydrophobicity and low binding of soluble Fn demonstrated stronger adhesion to PMNs than the more hydrophobic C, albicans 3248 yeasts, which express high binding of soluble Fn. However, C. albicans 4016 cells were more resistant to phagocytic kilting and were hardly eradicated in intraperitoneally infected mice. The animals depleted in PMNs by treatment with CY were neither able to eradicate C. albicans 3248 (rapidly eliminated by normal mice) nor C. albicans 4016 yeasts (with a tendency to persist in the tissues of normal mice).
C1 UNIV LODZ,INST MICROBIOL & IMMUNOL,DEPT INFECT BIOL,PL-90237 LODZ,POLAND.
   LUND UNIV,DEPT MED MICROBIOL,S-22362 LUND,SWEDEN.
CR BETJES MGH, 1993, KIDNEY INT, V43, P641, DOI 10.1038/ki.1993.93
   CALDERONE R, 1993, J MICROBIOL METH, V18, P197, DOI 10.1016/0167-7012(93)90036-H
   DEFIJTER CWH, 1993, CLIN NEPHROL, V39, P75
   DENNING DW, 1991, J ANTIMICROB CHEMOTH, V28, P1
   DESOLE P, 1993, J BIOLUM CHEMILUM, V8, P153, DOI 10.1002/bio.1170080305
   ELLIOTT TSJ, 1988, J MED MICROBIOL, V27, P161, DOI 10.1099/00222615-27-3-161
   FUKAYAMA M, 1992, INFECT IMMUN, V60, P8
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HART PH, 1993, J LEUKOCYTE BIOL, V53, P309
   HOSTETTER MK, 1994, CLIN MICROBIOL REV, V7, P29
   JAKAB E, 1993, APMIS, V101, P187, DOI 10.1111/j.1699-0463.1993.tb00100.x
   KAPLAN SS, 1990, ASAIO T, V36, pMI172
   KAUMA S, 1988, OBSTET GYNECOL, V72, P13
   KLOTZ SA, 1993, MICROB PATHOGENESIS, V14, P133, DOI 10.1006/mpat.1993.1014
   KLOTZ SA, 1992, CLIN INFECT DIS, V14, P340, DOI 10.1093/clinids/14.1.340
   LECULIER C, 1992, BRIT J HAEMATOL, V81, P81, DOI 10.1111/j.1365-2141.1992.tb08176.x
   LI RK, 1993, J BIOL CHEM, V268, P18293
   LOPEZLOPEZ G, 1991, J MED MICROBIOL, V34, P349, DOI 10.1099/00222615-34-6-349
   OPAL SM, 1991, J CLIN INVEST, V88, P885, DOI 10.1172/JCI115390
   QIAN QF, 1994, J IMMUNOL, V152, P5000
   REPENTIGNY L, 1992, INFECT IMMUN, V60, P4907
   SAWYER RT, 1992, INFECT IMMUN, V60, P213
   SPOTL L, 1994, INFECT IMMUN, V6, P1125
   STEVENS MG, 1992, J IMMUNOL METHODS, V157, P225
   TANSHO S, 1994, MICROBIOL IMMUNOL, V38, P379, DOI 10.1111/j.1348-0421.1994.tb01794.x
   VOSS A, 1994, J CLIN MICROBIOL, V32, P975
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   WARD KH, 1992, J MED MICROBIOL, V36, P406, DOI 10.1099/00222615-36-6-406
   WEY SB, 1989, ARCH INTERN MED, V149, P2349, DOI 10.1001/archinte.149.10.2349
NR 29
TC 5
Z9 5
U1 0
U2 0
PU CENTER ACAD PUBL JAPAN
PI TOKYO
PA C/O BUSINESS CTR ACAD SOC JPN, HONKOMAGOME 5-16-9, BUNKYO-KU, TOKYO 113,
   JAPAN
SN 0385-5600
J9 MICROBIOL IMMUNOL
JI Microbiol. Immunol.
PY 1995
VL 39
IS 7
BP 443
EP 450
PG 8
WC Immunology; Microbiology
SC Immunology; Microbiology
GA RJ177
UT WOS:A1995RJ17700002
PM 8569528
DA 2018-10-19
ER

PT S
AU Ljungh, A
   Lundberg, F
AF Ljungh, A
   Lundberg, F
BE Donelli, G
   Mastrantonio, P
   Heidt, PJ
   Rusch, VC
TI Molecular pathogenesis of biomaterial-associated infections
SO MICROECOLOGY AND THERAPY, VOL 25 , 1995
SE MICROECOLOGY AND THERAPY
LA English
DT Proceedings Paper
CT XIXth International Congress on Microbial Ecology and Disease
CY SEP 18-21, 1994
CL ROME, ITALY
SP Inst Microecol
RP Ljungh, A (reprint author), LUND UNIV,DEPT MED MICROBIOL,SOLVEGATAN 23,S-22362 LUND,SWEDEN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INST MICROECOLOGY & BIOCHEM
PI HERBORN-DILL
PA KORNMARKT 34, D-6348 HERBORN-DILL, GERMANY
SN 0720-0536
J9 MICROECOL T
PY 1995
VL 25
BP 95
EP 102
PG 8
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA BH01D
UT WOS:A1995BH01D00015
DA 2018-10-19
ER

PT S
AU Baldassarri, L
   Christensen, GD
   Donelli, G
AF Baldassarri, L
   Christensen, GD
   Donelli, G
BE Donelli, G
   Mastrantonio, P
   Heidt, PJ
   Rusch, VC
TI Is slime the virulence factor in staphylococcal biomaterial-associated
   infections?
SO MICROECOLOGY AND THERAPY, VOL 25 , 1995
SE MICROECOLOGY AND THERAPY
LA English
DT Proceedings Paper
CT XIXth International Congress on Microbial Ecology and Disease
CY SEP 18-21, 1994
CL ROME, ITALY
SP Inst Microecol
RP Baldassarri, L (reprint author), IST SUPER SANITA,ULTRASTRUTTURE LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY.
NR 0
TC 7
Z9 7
U1 0
U2 0
PU INST MICROECOLOGY & BIOCHEM
PI HERBORN-DILL
PA KORNMARKT 34, D-6348 HERBORN-DILL, GERMANY
SN 0720-0536
J9 MICROECOL T
PY 1995
VL 25
BP 103
EP 107
PG 5
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA BH01D
UT WOS:A1995BH01D00016
DA 2018-10-19
ER

PT J
AU NASSAR, U
   MEYER, AE
   OGLE, RE
   BAIER, RE
AF NASSAR, U
   MEYER, AE
   OGLE, RE
   BAIER, RE
TI THE EFFECT OF RESTORATIVE AND PROSTHETIC MATERIALS ON DENTAL PLAQUE
SO PERIODONTOLOGY 2000
LA English
DT Article
ID GLASS IONOMER CEMENT; CLINICAL ADHESIVENESS; MUTANS STREPTOCOCCI;
   BIOMATERIAL SURFACES; TOOTH SURFACE; HUMAN-SALIVA; INVIVO; COMPOSITE;
   ADHESION; TITANIUM
C1 SUNY BUFFALO,SCH DENT MED,DEPT BIOMAT,BUFFALO,NY 14260.
RP NASSAR, U (reprint author), SUNY BUFFALO,SCH DENT MED,DEPT PROSTHODONT,BUFFALO,NY 14260, USA.
FU NIDCR NIH HHS [DE07760]
CR ADAMCZYK E, 1990, International Journal of Prosthodontics, V3, P285
   ARNEBRANT T, 1988, J COLLOID INTERF SCI, V122, P557, DOI 10.1016/0021-9797(88)90392-X
   ATTSTROM R, 1983, J PERIODONTAL RES, V18, P445, DOI 10.1111/j.1600-0765.1983.tb00381.x
   Baier R E, 1988, Int J Oral Maxillofac Implants, V3, P9
   Baier R. E., 1970, ADHESION BIOL SYSTEM, P15
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMED MATER RES, V16, P173, DOI 10.1002/jbm.820160210
   BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360
   BAIER RE, 1978, ACTA ODONTOL SCAND, V36, P289, DOI 10.3109/00016357809029079
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIER RE, 1970, MANAGEMENT ARTERIAL, P147
   BAIER RE, IN PRESS P SURFACES
   BAIER RE, 1973, SURFACE CHEM DENTAL, P337
   BAIER RE, 1983, PHYSICOCHEMICAL ASPE, V2, P895
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   BUSSCHER HJ, 1989, RECENT ADV STUDY DEN, P87
   CARNEVALE G, 1990, J CLIN PERIODONTOL, V17, P313, DOI 10.1111/j.1600-051X.1990.tb01095.x
   CARTER JM, 1981, J BIOMED MATER RES, V15, P843
   CHINDAVANIG V, 1992, THESIS BUFFALO STATE
   CHRISTERSSON CE, 1991, SWED DENT J S, V77
   CHRISTERSSON CE, 1989, J DENT RES, V68, P355
   DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   DUMMER PMH, 1982, J ORAL REHABIL, V9, P413, DOI 10.1111/j.1365-2842.1982.tb01030.x
   FENG L, 1988, J MICROSC-OXFORD, V152, P811, DOI 10.1111/j.1365-2818.1988.tb01453.x
   FORSS H, 1991, Proceedings of the Finnish Dental Society, V87, P343
   GLANTZ PO, 1989, ACTA ODONTOL SCAND, V47, P17, DOI 10.3109/00016358909004795
   GLANTZ PO, 1971, J COLLOID INTERF SCI, V37, P281, DOI 10.1016/0021-9797(71)90294-3
   GLANTZ PO, 1980, ACTA ODONTOL SCAND, V38, P371, DOI 10.3109/00016358009033607
   GLANTZ PO, 1969, ODONTOL REV S17, V20, P48
   GOOD RJ, 1991, FUNDAMENTALS ADHESIO, P153
   Gunyakti N, 1990, Ankara Univ Hekim Fak Derg, V17, P83
   HALLGREN A, 1992, SCAND J DENT RES, V100, P140
   JENDRESEN MD, 1980, ACTA ODONTOL SCAND, V38, P379, DOI 10.3109/00016358009033608
   JENDRESEN MD, 1981, ACTA ODONTOL SCAND, V39, P39, DOI 10.3109/00016358109162257
   JENDRESEN MD, 1981, ACTA ODONTOL SCAND, V39, P47, DOI 10.3109/00016358109162258
   LIN JN, 1990, LANGMUIR, V6, P509, DOI 10.1021/la00092a036
   LINDQUIST B, 1990, J DENT RES, V69, P1160, DOI 10.1177/00220345900690050801
   Lundin S A, 1989, Quintessence Int, V20, P413
   MARZOUK MA, 1991, J PROSTHET DENT, V65, P19, DOI 10.1016/0022-3913(91)90041-T
   MCCARTNEY JW, 1992, J PROSTHET DENT, V67, P896, DOI 10.1016/0022-3913(92)90614-G
   MCCOLLUM J, 1992, J PERIODONTOL, V63, P802, DOI 10.1902/jop.1992.63.10.802
   MCCRACKIN FL, 1963, J RES NBS A PHYS CH, VA 67, P363, DOI 10.6028/jres.067A.040
   MECHEL AH, 1964, ARCH ORAL BIOL, V10, P585
   MEYER A, 1991, DENT IMPLANTS PRINCI, P31
   Meyer A.E., 1990, THESIS LUND U SWEDEN
   MOUTON C, 1979, CURR MICROBIOL, V3, P181, DOI 10.1007/BF02601864
   OGLE R, 1990, J DENT RES, V69, P166
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   RATNER BD, 1988, PROGR BIOMEDICAL ENG, V6
   Rittle K. H., 1990, Biofouling, V2, P121
   SEPPA L, 1992, CARIES RES, V26, P340, DOI 10.1159/000261465
   SIMONSSON T, 1991, ORAL MICROBIOL IMMUN, V6, P305, DOI 10.1111/j.1399-302X.1991.tb00498.x
   Simonsson T, 1991, BIOFOULING, V3, P251
   SMALES RJ, 1981, J DENT, V9, P133, DOI 10.1016/0300-5712(81)90087-7
   SONJU T, 1975, ARCH ORAL BIOL, V20, P687, DOI 10.1016/0003-9969(75)90138-7
   SVANBERG M, 1990, J DENT RES, V69, P861, DOI 10.1177/00220345900690030601
   SVANBERG M, 1990, CARIES RES, V24, P133, DOI 10.1159/000261255
   VANDIJKEN J, 1991, SCAND J DENT RES, V99, P13
   VANDIJKEN JWV, 1991, J CLIN PERIODONTOL, V18, P200
   Zisman W. A., 1964, ADV CHEM SER, V43, P1
   1993, USEN1057 NUSK INT IN
NR 64
TC 13
Z9 13
U1 2
U2 3
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0906-6713
J9 PERIODONTOL 2000
JI Periodontol. 2000
PY 1995
VL 8
BP 114
EP 124
DI 10.1111/j.1600-0757.1995.tb00049.x
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA RJ042
UT WOS:A1995RJ04200010
PM 9567950
DA 2018-10-19
ER

PT J
AU YOSHINAGA, K
   KONDO, K
   KONDO, A
AF YOSHINAGA, K
   KONDO, K
   KONDO, A
TI EFFICIENT IMMOBILIZATION OF PROTEIN ON MONODISPERSED COLLOIDAL SILICA
   PARTICLES MODIFIED BY COPOLYMERS OF MALEIC-ANHYDRIDE AND STYRENE OR
   METHYL-METHACRYLATE
SO POLYMER JOURNAL
LA English
DT Note
DE PROTEIN IMMOBILIZATION; BIOMATERIAL CARRIER; MONODISPERSED COLLOIDAL
   SILICA; SURFACE MODIFICATION; MALEIC ANHYDRIDE COPOLYMER; IMMUNOLOGICAL
   AGGLUTINATION TEST; HYBRID PARTICLES
ID FUNCTIONAL-GROUPS; COMPOSITES; ADSORPTION; SURFACE
RP YOSHINAGA, K (reprint author), KYUSHU INST TECHNOL,FAC ENGN,DEPT APPL CHEM,KITAKYUSHU 804,FUKUOKA,JAPAN.
RI Kondo, Akihiko/A-2130-2015; Kobe Univ, Engineering/D-2028-2017
CR NORDE W, 1978, J COLLOID INTERF SCI, V66, P257, DOI 10.1016/0021-9797(78)90303-X
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   OKUBO M, 1987, KOBUNSHI RONBUNSHU, V44, P123, DOI 10.1295/koron.44.123
   SADA E, 1988, BIOTECHNOL BIOENG, V31, P635, DOI 10.1002/bit.260310702
   SINGER JM, 1987, FUTURE DIRECTIONS PO, P371
   YOSHINAGA K, 1993, COLLOID SURFACE A, V77, P101, DOI 10.1016/0927-7757(93)80106-O
   YOSHINAGA K, 1993, KOBUNSHI RONBUNSHU, V50, P303, DOI 10.1295/koron.50.303
   YOSHINAGA K, 1992, POLYM BULL, V28, P663, DOI 10.1007/BF00295970
   YOSHINAGA K, 1994, COMPOSITE INTERFACES, V2, P95
NR 9
TC 10
Z9 10
U1 0
U2 4
PU SOC POLYMER SCIENCE JAPAN
PI TOKYO
PA TSUKIJI DAISAN NAGAOKA BLDG, 2-4-2 TSUKIJI, CHUO-KU, TOKYO 104, JAPAN
SN 0032-3896
J9 POLYM J
JI Polym. J.
PY 1995
VL 27
IS 1
BP 98
EP 100
DI 10.1295/polymj.27.98
PG 3
WC Polymer Science
SC Polymer Science
GA QJ192
UT WOS:A1995QJ19200012
OA Bronze
DA 2018-10-19
ER

PT S
AU Yaszemski, MJ
   Payne, RG
   Hayes, WC
   Langer, R
   Mikos, AG
AF Yaszemski, MJ
   Payne, RG
   Hayes, WC
   Langer, R
   Mikos, AG
BE Mikos, AG
   Leong, KW
   Yaszemski, MJ
   Tamada, JA
   Radomsky, ML
TI The in vitro mechanical strength and in vivo bone ingrowth of a
   degrading polymeric composite biomaterial
SO POLYMERS IN MEDICINE AND PHARMACY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Polymers in Medicine and Pharmacy, at the 1995 MRS Spring
   Meeting
CY APR 17-19, 1995
CL SAN FRANCISCO, CA
SP Mat Res Soc
C1 UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-297-9
J9 MATER RES SOC SYMP P
PY 1995
VL 394
BP 21
EP 24
PG 4
WC Engineering, Biomedical; Orthopedics; Pharmacology & Pharmacy; Polymer
   Science
SC Engineering; Orthopedics; Pharmacology & Pharmacy; Polymer Science
GA BE31Q
UT WOS:A1995BE31Q00003
DA 2018-10-19
ER

PT S
AU Santerre, JP
   Duguay, DG
   Labow, RS
   Brash, JL
AF Santerre, JP
   Duguay, DG
   Labow, RS
   Brash, JL
BE Horbett, TA
   Brash, JL
TI Interactions of hydrolytic enzymes at an aqueous polyurethane interface
SO PROTEINS AT INTERFACES II: FUNDAMENTALS AND APPLICATIONS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Proteins at Interfaces II - Fundamentals and Applications,
   at the 207th National Meeting of the American-Chemical-Society
CY MAR 13-17, 1994
CL SAN DIEGO, CA
SP Amer Chem Soc, Div Colloid & Surface Sci
ID ENZYMATIC DEGRADATION; POLYMERS; BIODEGRADATION
AB Within seconds of exposure to biological fluids and tissues, the materials making up the surface of medical device implants rapidly become ''hybrid biomembranes'' composed of the synthetic matrix itself and adsorbed proteins, lipids and glycoproteins. The long-term stability of these altered biomaterial interfaces has been a question of concern for the past decade. Key to the degradation processes is the role of hydrolytic enzymes and their interactions at a polymer surface. This papers will present data describing the degradation of a polyester-urethane and two polyether-urethanes by cholesterol esterase. A mechanistic model for the degradation process is presented which highlights the importance of enzyme adsorption and surface chemistry. Data on the adsorption rates of the enzymes and on their activity in the adsorbed state are presented and discussed.
C1 UNIV OTTAWA,INST HEART,OTTAWA CIVIC HOSP,CARDIOVASC DEVICES DIV,OTTAWA,ON K1Y 4E9,CANADA.
   MCMASTER UNIV,DEPT CHEM ENGN,HAMILTON,ON L8S 4L7,CANADA.
RP Santerre, JP (reprint author), UNIV TORONTO,FAC DENT,DEPT BIOMAT,124 EDWARD ST,TORONTO,ON M5G 1G6,CANADA.
CR ANDERSON JM, 1992, BIODEGRADABLE POLYM, P122
   ANDRADE JD, 1988, POLYM SURFACE DYNAMI, P1
   BOYES DC, 1991, CAN MED ASSOC J, V145, P1125
   CHU CC, 1983, J BIOMED MATER RES, V17, P1029, DOI 10.1002/jbm.820170612
   DUGUAY DG, 1995, IN PRESS POLYM DEG S
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   FUKUZAKI H, 1990, POLYMER, V31, P2006, DOI 10.1016/0032-3861(90)90031-S
   HENNIG E, 1988, INT J ARTIF ORGANS, V11, P416
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   JUMAGAI Y, 1992, POLYM DEG STAB, V35, P87
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   Lelah M. D., 1986, POLYURETHANES MED
   PITT CG, 1992, BIODEGRADABLE POLYM, P7
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   ROYER GP, 1982, FUNDAMENTALS ENZYMOL, P1
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SCHOEMAKER HE, 1985, FEBS LETT, V183, P7, DOI 10.1016/0014-5793(85)80942-X
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   SMITH R, 1985, J MATER SCI LETT, V4, P547, DOI 10.1007/BF00720029
   STOKES K, 1993, CARDIOVASC PATHOL, V2, pS111
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   WILLIAMS DF, 1979, SPECH TECH PUBL, V684, P61
   YU XJ, 1993, TEST PROCEDURES BLOO, P287
NR 27
TC 8
Z9 8
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-3304-7
J9 ACS SYM SER
PY 1995
VL 602
BP 352
EP 370
PG 19
WC Chemistry, Physical; Engineering, Biomedical; Engineering, Chemical;
   Materials Science, Biomaterials
SC Chemistry; Engineering; Materials Science
GA BE38N
UT WOS:A1995BE38N00025
DA 2018-10-19
ER

PT J
AU AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
AF AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
TI THE LICHTENSTEIN OPEN TENSION-FREE MESH REPAIR OF INGUINAL-HERNIAS
SO SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
LA English
DT Article
DE INGUINAL HERNIA; TENSION-FREE REPAIR; MESH REPAIR BIOMATERIALS;
   OUTPATIENT HERNIA SURGERY
AB All standard methods of hernia repair involve suturing together tissues which are not normally in apposition. This violates the basic surgical principle that tissue must never be approximated under tension and thus accounts for an unacceptable number of failures, A total reinforcement of the inguinal floor with a sheet of suitable biomaterial and the employment of a ''tension-free'' technique is a more effective approach, Since June 1984, 4,000 primary inguinal hernias have been repaired on an outpatient basis and under local anesthesia at the Lichtenstein Hernia Institute by the open ''tension-free'' technique using Marlex mesh. The patients were followed from 1 to 11 years by physician examination, The follow-up rate was 87%. There were four recurrences, The causes of recurrence and how to avoid them are herein discussed. Three of the recurrences occurred at the pubic tubercle and were caused by placing the mesh in juxtaposition to the tubercle, This error has since been corrected by overlapping the mesh at the pubic bone, One recurrence was caused by a disruption of the lower edge of the mesh from the shelving margin of Poupart's ligament, The error here was the utilization of a patch that was too narrow and therefore under tension, It became apparent that a wider patch, fixed in place with an appropriate degree of laxity, was required.
RP AMID, PK (reprint author), LICHTENSTEIN HERNIA INST,9201 SUNSET BLVD,LOS ANGELES,CA 90069, USA.
NR 0
TC 43
Z9 44
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0941-1291
J9 SURG TODAY
JI Surg. Today-Jpn. J. Surg.
PY 1995
VL 25
IS 7
BP 619
EP 625
DI 10.1007/BF00311436
PG 7
WC Surgery
SC Surgery
GA RN079
UT WOS:A1995RN07900009
PM 7549274
DA 2018-10-19
ER

PT J
AU SATO, O
   OKAMOTO, H
   TAKAGI, A
   MIYATA, T
   TAKAYAMA, Y
AF SATO, O
   OKAMOTO, H
   TAKAGI, A
   MIYATA, T
   TAKAYAMA, Y
TI BIODEGRADATION OF GLUTARALDEHYDE-TANNED HUMAN UMBILICAL VEIN GRAFTS
SO SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
LA English
DT Article
DE HUMAN UMBILICAL VEIN GRAFT; BIOGRAFT; GRAFT ANEURYSM; BIOMATERIAL;
   DEGRADATION
AB A retrospective analysis of the long-term behavior of 111 glutaraldehyde-tanned human umbilical vein (HUV) grafts implanted between September 1977 and December 1993 was conducted. A total of 81 patients, with a mean age of 68.7 years, received the grafts and were followed up for between 1 and 131 months. The 5-year primary cumulative patency rate for above-knee femoropopliteal bypass was 83.1%, whereas that of other bypasses was 60.9%. An aneurysm of the graft was defined as a physically apparent localized dilatation, with diffuse ectasia being excluded. There were 11 aneurysms found in 9 grafts, 2 of which arose at the factory-made suture lines, The accumulated incidence of aneurysms had reached 21.9% by the 6th year. One aneurysm compressed the graft and resulted in limb-threatening ischemia and another resulted in frank rupture, Moreover, reinforcement of the mesh could not prevent aneurysm development, the repair of which is mandatory due to the risk of rupture and acute thrombosis, The HUV grafts showed an acceptable patency rate in the above-knee location, but the incidence of aneurysm formation after 5 years was abnormally high. Thus, both the risks and benefits of HUV grafts must be taken into account when considering their clinical application.
RP SATO, O (reprint author), UNIV TOKYO,FAC MED,DEPT SURG 2,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.
NR 0
TC 9
Z9 9
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0941-1291
J9 SURG TODAY
JI Surg. Today-Jpn. J. Surg.
PY 1995
VL 25
IS 10
BP 901
EP 905
DI 10.1007/BF00311756
PG 5
WC Surgery
SC Surgery
GA TF711
UT WOS:A1995TF71100007
PM 8574057
DA 2018-10-19
ER

PT J
AU TSUBOI, Y
   ALBREKTSSON, T
   SENNERBY, L
   JOHANSSON, C
   EKTESSABI, AM
AF TSUBOI, Y
   ALBREKTSSON, T
   SENNERBY, L
   JOHANSSON, C
   EKTESSABI, AM
TI CHARACTERIZATION OF THIN-FILMS FOR BIOMATERIAL APPLICATIONS USING PIXE
   AND RES
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 8th Symposium on Radiation Measurements and Applications
CY MAY 16-19, 1994
CL ANN ARBOR, MI
ID ION
AB In this paper, the results of applying Proton Induced X-ray Emission (PIXE) and Rutherford Backscattering Spectroscopy (RES) in order to determine the compositions of TiO2 thin films prepared by Ion Beam Assisted Sputter Deposition (IBASD), are presented. The PIXE analysis of the oxide films determined, with high precision, the incorporation of impurities and the variation of the ratio of the constituent elements, possible as a result of preferential sputtering, due to ion beam irradiation. The results of the present investigation showed that the PIXE analysis combined with RES can be effectively used for qualitative and quantitative analysis of thin film on the surface and in the film-substrate interface.
C1 KYOTO UNIV,FAC ENGN,SAKYO KU,KYOTO 60601,JAPAN.
   KYOTO UNIV,FAC MED,DEPT ORAL & MAXILLOFACIAL SURG,SAKYO KU,KYOTO 60601,JAPAN.
RP TSUBOI, Y (reprint author), GOTHENBURG UNIV,DEPT HANDICAP RES,BIOMAT GRP,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
CR BAGLIN JEE, 1984, MATER RES SOC S P, V25, P179
   CARTER G, 1993, VACUUM, V44, P303, DOI 10.1016/0042-207X(93)90174-9
   CHENG YT, 1991, NUCL INSTRUM METH B, V59, P509
   EKTESSABI AM, 1993, VACUUM, V44, P213, DOI 10.1016/0042-207X(93)90156-5
   EKTESSABI AM, 1993, THIN SOLID FILMS, V236, P135, DOI 10.1016/0040-6090(93)90658-C
   EKTESSABI AM, 1993, NUCL INSTRUM METH B, V79, P672, DOI 10.1016/0168-583X(93)95440-G
   EKTESSABI AM, 1994, IN PRESS SURFACE COA
   EKTESSABI AM, 1990, C PHYS, V14, P51
   EKTESSABI AM, 1992, P INT C EVOLUTION BE, P43
   Feldman LC, 1986, FUNDAMENTALS SURFACE, P39
   GALUSKA AA, 1991, NUCL INSTRUM METH B, V59, P487, DOI 10.1016/0168-583X(91)95265-F
   MAYER JW, 1983, SURFACE MODIFICATION
NR 12
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD DEC 30
PY 1994
VL 353
IS 1-3
BP 597
EP 600
DI 10.1016/0168-9002(94)91731-0
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA QB888
UT WOS:A1994QB88800144
DA 2018-10-19
ER

PT J
AU TRUY, E
   DISANT, F
   TIOLLIER, J
   FROEHLICH, P
   MORGON, A
AF TRUY, E
   DISANT, F
   TIOLLIER, J
   FROEHLICH, P
   MORGON, A
TI A CLINICAL-STUDY OF HUMAN TYPE-IV COLLAGEN AS TYMPANIC MEMBRANE GRAFTING
   MATERIAL - PRELIMINARY NONCOMPARATIVE STUDY
SO ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
LA English
DT Article
ID PERFORATIONS
AB Objective: To evaluate tolerance for this middle-ear implant and its effectiveness in eardrum healing under various pathologic conditions.
   Setting: A 12- to 18-month follow-up case series at an institutional referral center offering hospitalized care.
   Patients: Twenty-six eligible volunteers suffering from tympanic perforation or tympanic pocket retraction class II and III in Tos' classification.
   Intervention: Patients underwent implantation with the type IV collagen film (film called ''MTY'' from the French membrane tympanique). The surgical procedure was simi lar to those using the temporal aponeurosis or the tragal perichondrium.
   Outcome Measure: Anatomic criteria was determined by otoscopy, and functional audiometric criteria was determined by air-bone gap measurements and by effects on cochlear function.
   Results: Twenty-two of 26 patients were completely healed after 6 months, with no subsequent evolution. Nineteen of 26 subjects underwent a 1-year postoperative audiometric follow-up examination: 13 (68%) had an air-bone gap less than 10 dB, four (21%) had between 11 and 20 dB, and two (11%) had between 21 and 30 dB. Adverse effects included one patient whose MTY fell into the middle ear, three patients with transient myringitis, and one patient with otitis media with effusion.
   Conclusions: A human type IV collagen film may be a possible alternative to autologous tissue in tympanic membrane reconstruction. This new biomaterial was tested on patients with various diseases common in clinical otology, and demonstrated a good biocompatibility of MTY in the different pathologic conditions of chronic otitis media. A future randomized, controlled trial will randomly allocate patients to receive either MTY collagen film or tissue from the temporal aponeurosis.
C1 HOP EDOUARD HERRIOT,DEPT PHYSIOL SENSORIELLE AUDIT & VOIX,LYON,FRANCE.
   IMEDEX,LYON,FRANCE.
RP TRUY, E (reprint author), HOP EDOUARD HERRIOT,DEPT OTORHINOLARYNGOL,SERV OTORHINOLARYNGOL,5 PL ARSONVAL,F-69437 LYON,FRANCE.
RI truy, eric/J-9097-2017
OI truy, eric/0000-0002-1769-8623
CR ABBENHAUS JI, 1978, OTOLARYNG HEAD NECK, V86, P485, DOI 10.1177/019459987808600320
   DUPONT D, 1989, CORNEA, V8, P251
   LACARTE MPR, 1990, ACTA OTO-LARYNGOL, V110, P110, DOI 10.3109/00016489009122523
   LIM DJ, 1970, ACTA OTO-LARYNGOL, V70, P176, DOI 10.3109/00016487009181875
   MENDEL L, 1985, J LARYNGOL OTOL, V99, P339, DOI 10.1017/S0022215100096808
   MORGON A, 1989, ACTA OTO-LARYNGOL, V107, P450, DOI 10.3109/00016488909127539
   MURRAY JC, 1979, J CELL BIOL, V80, P197, DOI 10.1083/jcb.80.1.197
   PALVA T, 1987, ACTA OTO-LARYNGOL, V104, P279, DOI 10.3109/00016488709107329
   PATTERSON ME, 1967, ARCHIV OTOLARYNGOL, V86, P486
   PERKINS R, 1975, ANN OTO RHINOL LARYN, V84, P518, DOI 10.1177/000348947508400411
   SADE J, 1981, J LARYNGOL OTOL, V93, P653
   TARDY M, 1986, ENJEUX, V74, P79
   TINOIS E, 1991, EXP CELL RES, V193, P310, DOI 10.1016/0014-4827(91)90102-Z
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
   TOS M, 1980, ACTA OTO-LARYNGOL, V89, P479, DOI 10.3109/00016488009127165
   TOS M, 1986, ARCH OTOLARYNGOL, V103, P437
NR 16
TC 7
Z9 7
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0886-4470
J9 ARCH OTOLARYNGOL
JI Arch. Otolaryngol. Head Neck Surg.
PD DEC
PY 1994
VL 120
IS 12
BP 1329
EP 1332
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA PW007
UT WOS:A1994PW00700005
PM 7980896
DA 2018-10-19
ER

PT J
AU PELUSO, G
   PETILLO, O
   RANIERI, M
   SANTIN, M
   AMBROSIO, L
   CALABRO, D
   AVALLONE, B
   BALSAMO, G
AF PELUSO, G
   PETILLO, O
   RANIERI, M
   SANTIN, M
   AMBROSIO, L
   CALABRO, D
   AVALLONE, B
   BALSAMO, G
TI CHITOSAN-MEDIATED STIMULATION OF MACROPHAGE FUNCTION
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Biomedical Applications
CY JUN 06-11, 1993
CL CAPRI, ITALY
SP ASSING SPA, CNR, EASTMAN CHEM EUROPE, ITALPRO SPA, MTS SYST, UNIV NAPLES FEDERICO II
DE CHITOSAN; BIOCOMPATIBILITY; MACROPHAGE ACTIVATION; NO PRODUCTION
ID RECEPTOR; RELEASE; MANNOSE; CHITIN
AB According to the modern definition of biocompatibility, a biocompatible material need not be inert but be bioactive. A benign reactivity implies that the reactivity has to be appropriate for the intended use. Chitosan, a non-acetylated or partially deacetylated chitin (a linear homopolymer of beta(1-4)-linked N-acetylglucosamine) has been proposed as a biomaterial because of its apparent satisfactory biocompatibility, The present investigation demonstrates that chitosan has an in vitro stimulatory effect on both macrophage nitric oxide (NO) production and chemotaxis. The macrophage NO secretion is attributed to the N-acetylglucosamine unit of the chitosan molecule rather than to the glucosamine residue (28 and 15 mu M NO respectively). Moreover, the immune stimulatory effect of chitosan was very specific since other glycosaminoglycans, such as N-acetyl-D-mannosamine and N-acetyl-D-galactosamine, had no effects on NO production (5 and 8 respectively). In vivo experiments strengthen this hypothesis. Transmission electron microscopy analysis identifies the presence of many leucocytes in the specimens after 14 d post-implantation, showing poor healing processes (i.e, fibroblast proliferation and collagen deposition) that characterize the tissue repair at this time in our animal model.
C1 UNIV NAPLES,INST COMPOSITE MAT TECHNOL,CNR,NAPLES,ITALY.
   UNIV NAPLES,DEPT MAT & PROD ENGN,NAPLES,ITALY.
   UNIV NAPLES,FAC SCI,DEPT GENET,NAPLES,ITALY.
RP PELUSO, G (reprint author), CNR,INST PROT BIOCHEM & ENZYMOL,VIA TOIANO 6,I-80072 ARCO,ITALY.
OI Avallone, Bice/0000-0002-5355-1557
CR ANDERSON JM, 1988, ASAIO, V11, P101
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   DING AH, 1988, J IMMUNOL, V141, P2407
   DOMARD A, 1992, INT J BIOL MACROMOL, V14, P100, DOI 10.1016/0141-8130(92)90006-T
   DONG ZY, 1993, J IMMUNOL, V151, P2717
   HIGUCHI M, 1990, J IMMUNOL, V144, P1245
   ICHINOSE Y, 1988, CANCER IMMUNOL IMMUN, V27, P7
   KOMLOS L, 1984, INT J IMMUNOPHARMACO, V6, P593, DOI 10.1016/0192-0561(84)90070-5
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P246
   NATHAN CF, 1982, FED PROC, V41, P2206
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   Palapura S., 1992, J BIOMATER APPL, V6, P216
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SCHLESINGER PH, 1980, BIOCHEM J, V192, P597, DOI 10.1042/bj1920597
   SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423
   TRUDEL J, 1990, ANAL BIOCHEM, V189, P249, DOI 10.1016/0003-2697(90)90116-Q
   WARR GA, 1980, BIOCHEM BIOPH RES CO, V93, P737, DOI 10.1016/0006-291X(80)91139-0
   YOMOTA C, 1990, YAKUGAKU ZASSHI, V110, P442, DOI 10.1248/yakushi1947.110.6_442
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 20
TC 266
Z9 282
U1 3
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1215
EP 1220
DI 10.1016/0142-9612(94)90272-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300005
PM 7703317
DA 2018-10-19
ER

PT J
AU FERRUTI, P
   RANUCCI, E
   SARTORE, L
   BIGNOTTI, F
   MARCHISIO, MA
   BIANCIARDI, P
   VERONESE, FM
AF FERRUTI, P
   RANUCCI, E
   SARTORE, L
   BIGNOTTI, F
   MARCHISIO, MA
   BIANCIARDI, P
   VERONESE, FM
TI RECENT RESULTS ON FUNCTIONAL POLYMERS AND MACROMONOMERS OF INTEREST AS
   BIOMATERIALS OR FOR BIOMATERIAL MODIFICATION
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Biomedical Applications
CY JUN 06-11, 1993
CL CAPRI, ITALY
SP ASSING SPA, CNR, EASTMAN CHEM EUROPE, ITALPRO SPA, MTS SYST, UNIV NAPLES FEDERICO II
DE MACROMONOMERS; MULTIFUNCTIONAL POLYMERS; POLY(AMIDOAMINES);
   POLY(VINYLPYRROLIDINONE); POLY(ACRYLOYL MORPHOLINE)
ID BASIC MULTIFUNCTIONAL POLYMERS; TERTIARY AMINO POLYMERS; POLYADDITION;
   FAMILY; 2,2'-ALKYLENEDIIMINODIETHANETHIOLS; POLY(AMIDO-AMINE)S
AB Different families of functionalized polymers with potential as biomaterials, or for biomaterial modification, have been investigated. In particular, degradation studies have been performed on poly(amidoamines), a family of polymers obtained by polyaddition of amines to bisacrylamides, and endowed with heparin-complexing ability. Some new poly(amidoamines) with more resistance towards hydrolytic degradation than traditional ones have been discovered. Other ter-amino polymers deriving from the polyaddition of ter-amino functionalized bis-thiols to bis-acrylic esters, or other activated unsaturated compounds, have been studied. Their quaternarization products have been proven, in a parallel work, to act as powerful antimicrobial agents. By performing in situ the polyaddition reaction, semi-interpenetrated networks based on silicone rubber and the same polymers have been prepared. Finally, end-functionalized amphiphilic oligomers have been prepared by radical polymerization techniques, and their use for enzyme modification considered.
C1 UNIV MILAN,IST CHIRURG GEN & CARDIOVASC,I-20122 MILAN,ITALY.
   UNIV PADUA,DIPARTIMENTO SCI FARMACEUT,I-35100 PADUA,ITALY.
RP FERRUTI, P (reprint author), UNIV BRESCIA,DIPARTIMENTO CHIM & FIS MAT,VIA BRANZE 38,I-25123 BRESCIA,ITALY.
RI Ranucci, Elisabetta/J-3899-2015; Sartore, Luciana/A-4518-2010
OI Ranucci, Elisabetta/0000-0002-6402-2650; Sartore,
   Luciana/0000-0003-0268-6467; Ferruti, Paolo/0000-0002-5404-440X
CR ABUCHOWSKI A, 1987, J BIOL CHEM, V252, P3582
   BARBUCCI R, 1988, POLYM MED, V3, P3
   BIGNOTTI F, IN PRESS MACROMOLECU
   EPTON R, 1982, INT J BIOL MACROMOL, V4, P233, DOI 10.1016/0141-8130(82)90021-6
   EPTON R, 1982, POLYMER, V23, P1685, DOI 10.1016/0032-3861(82)90194-X
   FARINA M, 1987, MAKROMOL CHEM-M SYMP, V10, P255, DOI 10.1002/masy.19870100114
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1988, J POLYM SCI POL LETT, V26, P357, DOI 10.1002/pol.1988.140260805
   FERRUTI P, 1988, MAKROMOL CHEM-RAPID, V9, P807
   FERRUTI P, 1989, POLYM COMMUN, V30, P157
   FERRUTI P, 1987, MAKROMOL CHEM-RAPID, V8, P549
   FERRUTI P, 1993, MACROMOLECULES 1992, P251
   FERRUTI P, 1991, HIGH PERFORMANCE BIO, P539
   FERRUTI P, 1992, Patent No. 2018
   MARCHISI.MA, 1973, EXPERIENTIA, V29, P93, DOI 10.1007/BF01913274
   MARCHISIO MA, 1988, POLYM MED, V3, P39
   MARCHISIO MA, IN PRESS J BIOMATER
   Mayo FR, 1943, J AM CHEM SOC, V65, P2324, DOI 10.1021/ja01252a021
   RANUCCI E, 1991, Journal of Biomaterials Science Polymer Edition, V2, P303, DOI 10.1163/156856291X00197
   RANUCCI E, 1991, POLYMER, V32, P2876, DOI 10.1016/0032-3861(91)90122-Y
   RANUCCI E, 1991, Journal of Biomaterials Science Polymer Edition, V2, P255, DOI 10.1163/156856291X00151
   RANUCCI E, 1993, POLYM J, V25, P625, DOI 10.1295/polymj.25.625
   RANUCCI E, 1991, MACROMOLECULES, V24, P3747, DOI 10.1021/ma00013a002
   RANUCCI E, IN PRESS POLYMER
   RANUCCI E, 1990, CHIM IND, V72, P49
   Ranucci E, 1989, J BIOACT COMP POLYM, V4, P403
   Sperling L.H., 1981, INTERPENETRATING POL
   VANSTEENKISTE S, 1992, MAKROMOL CHEM, V193, P937
   Veronese F. M., 1990, J BIOACT COMPAT POLY, V5, P167
NR 29
TC 46
Z9 47
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 1994
VL 15
IS 15
BP 1235
EP 1241
DI 10.1016/0142-9612(94)90275-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PY723
UT WOS:A1994PY72300008
PM 7703320
DA 2018-10-19
ER

PT J
AU TANELI, C
   OZCAN, C
   OZDEMIR, N
   GOKDEMIR, A
AF TANELI, C
   OZCAN, C
   OZDEMIR, N
   GOKDEMIR, A
TI CORRECTION OF VESICOURETERAL REFLUX BY SUBURETERIC FIBRIN INJECTION IN
   DOGS
SO BRITISH JOURNAL OF UROLOGY
LA English
DT Article
DE VESICOURETERAL REFLUX; SUBURETERIC INJECTION; TEFLON; FIBRIN; HISTOLOGY;
   RADIOLOGY
ID VESICOURETERAL REFLUX; ENDOSCOPIC CORRECTION; COLLAGEN INJECTION;
   TEFLON-INJECTION; CHILDREN; EXPERIENCE; MIGRATION; BLOOD
AB Objective To study the histological and radiological potential of the biomaterial fibrin in the treatment of vesico-ureteric reflux by a subureteric injection.
   Materials and methods For histological studies the bladders of 22 non-refluxing adult female dogs were exposed and in 20 of these two-component fibrin glue was injected into the right subureteric intramuscular portion of the bladder and teflon was injected into the lamina propria of the left ureter; two of them acted as controls. Two dogs were killed on alternate days over the course of 21 post-operative days and the bladders and distal portions of the meters were examined histologically, For radiological studies micturating cystograms were obtained from 15 female puppies. In only eight puppies was vesico-ureteric reflux naturally present. In six of these two-component fibrin was injected into the right and tenon into the left subureteric areas, and in two puppies fibrin was injected into the subureteric areas, while the left sides acted as controls. Micturating cystograms and intravenous urograms were obtained from all puppies 3 weeks post-operatively.
   Results Histopathological studies showed persistence of increased amounts of endogenous collagen at the fibrin-injected sites; at the Teflon-injected sites a mass surrounded by dense granulation tissue was seen. Radiological studies revealed complete disappearance of reflux in the study group of six fibrin and Teflon-injected puppies; in two control puppies fibrin was injected into the right subureteric area only; the left sides were left untouched to show that maturation did not play a role in abolishing the spontaneously occurring reflux. Follow-up intravenous urography showed no evidence of vesico-ureteric obstruction in the treated ureters.
   Conclusion Fibrin has the properties of a substance inducing a controlled increase in the number of endogenous collagen fibres.
C1 EGE UNIV,TEACHING HOSP,FAC MED,DEPT PAEDIAT SURG,IZMIR,TURKEY.
   EGE UNIV,TEACHING HOSP,FAC MED,DEPT PATHOL,IZMIR,TURKEY.
CR AARONSON IA, 1993, EUR UROL, V23, P394, DOI 10.1159/000474637
   BANERJEE SK, 1960, ANN NY ACAD SCI, V86, P1054
   BROWNE EZ, 1990, PLASTIC SURG, P4430
   FREY P, 1991, PEDIATR SURG INT, V6, P252
   FREY P, 1991, PEDIATR SURG INT, V6, P287
   FREY P, 1992, BRIT J UROL, V69, P1, DOI 10.1111/j.1464-410X.1992.tb15447.x
   FREY P, 1991, PEDIATR SURG INT, V6, P237
   HARTMAN AR, 1992, ARCH SURG-CHICAGO, V127, P357
   KAPLAN WE, 1987, J UROLOGY, V138, P953, DOI 10.1016/S0022-5347(17)43469-0
   KOHRI K, 1989, UROLOGY, V34, P258, DOI 10.1016/0090-4295(89)90320-8
   KOHRI K, 1988, UROL INT, V43, P324, DOI 10.1159/000281383
   Koltai J L, 1990, Prog Pediatr Surg, V25, P71
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MATOUSCHEK E, 1981, UROLOGE A, V20, P263
   ODONNELL B, 1991, PEDIATR SURG INT, V6, P266
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   POHL J, 1979, KLIN WOCHENSCHR, V57, P273, DOI 10.1007/BF01476508
   PURI P, 1984, BRIT MED J, V289, P5, DOI 10.1136/bmj.289.6436.5
   PURI P, 1991, PEDIATR SURG INT, V6, P269
   SCHULMAN CC, 1987, J UROLOGY, V138, P950, DOI 10.1016/S0022-5347(17)43467-7
NR 20
TC 5
Z9 5
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0007-1331
J9 BRIT J UROL
JI Br. J. Urol.
PD DEC
PY 1994
VL 74
IS 6
BP 710
EP 714
DI 10.1111/j.1464-410X.1994.tb07111.x
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA PX214
UT WOS:A1994PX21400006
PM 7827838
DA 2018-10-19
ER

PT J
AU SHARMA, CP
AF SHARMA, CP
TI BIOMATERIALS - ROLE OF SURFACE MODIFICATIONS
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th Annual General Meeting of the Materials-Research-Society-of-India
CY FEB 07-09, 1994
CL HYDERABAD, INDIA
SP MAT RES SOC INDIA
DE BIOMATERIAL; SURFACE MODIFICATION; PROTEIN ADSORPTION; BLOOD
   COMPATIBILITY; TISSUE COMPATIBILITY; CALCIFICATION; HEMOPERFUSION;
   ARTIFICIAL SKIN
ID OXIDE LAYER THICKNESS; PROTEIN-INTERACTION; PLATELET-ADHESION;
   FIBRINOGEN; ADSORPTION; INTERFACE; TISSUE
AB The fundamental concepts related to biomaterials and blood/tissue-material interactions at the interface have been reviewed. The relevance of surface modification to enhance blood and/or tissue compatibility of materials has been discussed and its role in selected prosthetic applications described.
RP SHARMA, CP (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,BIOMED TECHNOL WING,DIV BIOSURFACE TECHNOL,TRIVANDRUM 695012,KERALA,INDIA.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BAIER RE, 1970, T AM SOC ART INT ORG, V16, P50
   BONNE C, 1981, THROMB RES, V21, P13, DOI 10.1016/0049-3848(84)90028-8
   BRASH JL, 1985, J BIOMED MATER RES, V19, P1017, DOI 10.1002/jbm.820190914
   CHANDY T, 1987, POLYM-PLAST TECHNOL, V26, P143, DOI 10.1080/03602558708071937
   CHANDY T, 1989, ARTIF ORGANS, V13, P229, DOI 10.1111/j.1525-1594.1989.tb02868.x
   CHANDY T, 1991, J BIOMED MATER RES, V25, P1085, DOI 10.1002/jbm.820250904
   CHUANG HYK, 1982, 8 INT C THROMB HAEM, V46, P304
   FORBES CD, 1978, BRIT MED BULL, V34, P201, DOI 10.1093/oxfordjournals.bmb.a071492
   Hari P R, 1993, J Biomater Appl, V8, P174, DOI 10.1177/088532829300800205
   Hari P R, 1991, J Biomater Appl, V6, P170, DOI 10.1177/088532829100600205
   ITO Y, 1992, SYNTHESIS BIOCOMPOSI, P285
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KAELBLE DH, 1976, SAMPE Q, V7, P30
   KIM SW, 1973, POLYM S, V22, P289
   LYMAN DJ, 1968, T AM SOC ART INT ORG, V14, P250
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   MARGUERIE GA, 1979, J BIOL CHEM, V254, P53
   MONCADA S, 1979, FED PROC, V38, P66
   RIGBY BJ, 1961, BIOCHIM BIOPHYS ACTA, V113, P472
   RUSK SD, 1979, J POLYM SCI PS, V66, P283
   SAWYER PN, 1953, SURGERY, V34, P491
   SAWYER PN, 1984, BIOMATER ARTIF CELL, V12, P161, DOI 10.3109/10731198409118831
   SHARMA CP, 1983, CURR SCI INDIA, V52, P1057
   SHARMA CP, 1990, BIOMATERIALS, V11, P255, DOI 10.1016/0142-9612(90)90006-C
   SHARMA CP, 1980, J SCI IND RES INDIA, V39, P453
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P585, DOI 10.1016/0021-9797(84)90332-1
   SHARMA CP, 1992, J BIOMED MATER RES, V26, P1179, DOI 10.1002/jbm.820260908
   SHARMA CP, 1991, BLOOD COMPATIBLE MAT, P25
   SHARMA CP, 1984, T BIOMATER      0427, P100
   SHAYANI V, 1992, P CARDIOVASCULAR SCI, P53
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   SUNNY MC, 1990, J BIOMED MATER RES, V24, P455, DOI 10.1002/jbm.820240404
   TOLIA JT, 1986, TRENDS BIOMATER ARTI, V1, P7
   URRY DW, 1992, P CARDIOVASCULAR SCI, P155
   VROMAN L, 1984, BIOMAT MED DEV ARTIF, V121, P307
   Vroman L., 1971, J POLYM SCI, V34, P159
   Williams D. F., 1987, DEFINITIONS BIOMATER
   ZISMAN WA, 1964, ADV CHEM SER, V43, pCH1
NR 39
TC 9
Z9 10
U1 1
U2 6
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD DEC
PY 1994
VL 17
IS 7
BP 1317
EP 1329
DI 10.1007/BF02747230
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA QW701
UT WOS:A1994QW70100011
DA 2018-10-19
ER

PT J
AU HOTZ, G
   HERR, G
AF HOTZ, G
   HERR, G
TI BONE SUBSTITUTE WITH OSTEOINDUCTIVE BIOMATERIALS - CURRENT AND FUTURE
   CLINICAL-APPLICATIONS
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE BONE SUBSTITUTE; BONE INDUCTION; BONE MORPHOGENETIC PROTEIN;
   OSTEOINDUCTIVE BIOMATERIAL; DELIVERY SYSTEM; CARRIER; CALCIUM PHOSPHATE
   CERAMIC; HYDROXYAPATITE
ID MORPHOGENETIC PROTEIN; MOLECULAR-CLONING
AB In craniomaxillofacial surgery, possible indications for the use of osteo-inductive biomaterials are interposition in intraosseous defects, contour augmentation, and reconstruction of segmental defects.  The experimental results in the field of bone morphogenetic protein (BMP) research within the last few years have shown that it is possible to combine osteoinductive proteins with suitable carrier materials to obtain new composite osteoinductive biomaterials.  These carrier materials function as slow-delivery systems for BMP.  By combination of BMP with different carrier materials such as various types of calcium phosphate ceramics, collagen or inactive collagenous bone matrix, and other organic and inorganic carriers, the biomaterial can be adapted to clinical demands in a wide range.  In several experimental animal studies, we investigated nine different calcium phosphate ceramics and inactive rat bone matrix for their use as BMP carrier.  All materials tested seem to be suitable carriers for BMP.  The first clinical applications are discussed.
C1 UNIV HEIDELBERG,DEPT MAXILLOFACIAL SURG,W-6900 HEIDELBERG,GERMANY.
   UNIV TUBINGEN,DEPT ORTHOPED,BONE RES LAB,W-7400 TUBINGEN 1,GERMANY.
CR ALDINGER G, 1991, INT ORTHOP, V15, P169
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   DAMIEN CJ, 1992, 4TH BIOM C BERL
   DEATHERAGE JR, 1987, COLLAGEN REL RES, V7, P225
   HERR G, 1992, ACTA U TEMPERENSIS B, V40, P44
   HERR G, 1993, CALCIF TISSUE INT S1, V52, P49
   HOTZ G, 1991, ELLIPSE, V29, P435
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, V230, P257
   KABAN LB, 1982, J ORAL MAXIL SURG, V40, P623, DOI 10.1016/0278-2391(82)90109-4
   KAKIUCHI M, 1985, INT ORTHOP, V9, P181, DOI 10.1007/BF00268168
   Kawamura M, 1988, Clin Orthop Relat Res, P302
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, V217, P281
   MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   REIS HJ, 1991, FUNDAMENTALS BONE GR, P275
   ROSEN V, 1989, CONNECT TISSUE RES, V20, P313, DOI 10.3109/03008208909023902
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, V234, P250
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   URIST R, 1982, CLIN ORTHOPAEDICS, V163, P219
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMAZAKI Y, 1988, CLIN ORTHOP RELAT R, V234, P240
NR 27
TC 32
Z9 38
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD DEC
PY 1994
VL 23
IS 6
BP 413
EP 417
DI 10.1016/S0901-5027(05)80033-5
PN 2
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA QC186
UT WOS:A1994QC18600009
PM 7890986
DA 2018-10-19
ER

PT J
AU CHAKKALAKAL, DA
   MASHOOF, AA
   NOVAK, J
   STRATES, BS
   MCGUIRE, MH
AF CHAKKALAKAL, DA
   MASHOOF, AA
   NOVAK, J
   STRATES, BS
   MCGUIRE, MH
TI MINERALIZATION AND PH RELATIONSHIPS IN HEALING SKELETAL DEFECTS GRAFTED
   WITH DEMINERALIZED BONE-MATRIX
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
AB Early studies had indicated that tissue repair is initially associated with a lower than normal serum pH that later becomes more alkaline. To determine how tissue pH may affect skeletal healing anti mineralization, we used a rat skeletal repair model consisting of a long bone segmental defect grafted with acid-demineralized bone matrix (DBM), a biomaterial possessing both osteoinductive and osteoconductive repair properties. In this study, femoral and tibial diaphyses from young adult Sprague Dawley rats were cut into cylinders approximately 0.5 cm in length, demineralized in acid, perforated to accommodate a needle-type combination pH microelectrode, and grafted around a 0.3-cm-long diaphyseal fibula defect. The pH of repair tissues was recorded at various time intervals up to 28 days postgrafting. Healing and mineralization were monitored histologically and by the ash and calcium content of repair tissues. During the early healing phase, tissue pH was lower than normal serum pH, presumably because of an accumulation of acidic metabolites in tissue fluids. Subsequent pH increases to more alkaline values were accompanied by a rapid mineral deposition phase and a later phase characterized by a slow, gradual increase in tissue calcium content. The results of this study support previous observations suggesting that the pH of repair tissue fluids may play a regulatory role in the healing and mineralization of bone. (C) 1994 John Wiley and Sons, Inc.
C1 DEPT VET AFFAIRS MED CTR,ORTHOPAED RES LAB,OMAHA,NE 68105.
RP CHAKKALAKAL, DA (reprint author), CREIGHTON UNIV,SCH MED,DEPT SURG,DIV ORTHOPAED SURG,OMAHA,NE 68105, USA.
FU NIAMS NIH HHS [AR40064]
CR EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665
   KUETTNER KE, 1975, CLIN ORTHOPAEDICS, V112, P316
   LEVINSKAS GJ, 1955, J PHYS CHEM-US, V59, P164, DOI 10.1021/j150524a017
   MAKLEY JT, 1967, J BONE JOINT SURG AM, VA 49, P903, DOI 10.2106/00004623-196749050-00007
   MASHOOF A, 1991, J BONE MINER RES  S1, V733, pS267
   Murray C., 1941, IND MED, V10, P171
   NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4
   NEWMAN RJ, 1985, CLIN ORTHOP RELAT R, V198, P297
   NEWMAN RJ, 1987, CLIN ORTHOP RELAT R, V216, P253
   PALMER S, 1987, Surgical Forum (Chicago), V38, P531
   STIRLING RI, 1932, T MED CHIR SOC ED, V3, P203
   STRATES BS, 1972, BIOCHEM BIOPH RES CO, V49, P752, DOI 10.1016/0006-291X(72)90475-5
   STRATES BS, 1957, J PHYS CHEM-US, V61, P279, DOI 10.1021/j150549a005
   STRATES BS, 1971, BIOCHIM BIOPHYS ACTA, V244, P121, DOI 10.1016/0304-4165(71)90127-9
   Strates BS, 1993, EUR J EXP MUSCULOSKE, V2, P61
   SWENSON O, 1946, P SOC EXP BIOL MED, V61, P151
   TIEDEMAN JJ, 1991, CLIN ORTHOP RELAT R, V268, P294
   TIEDEMAN JJ, 1988, J BONE MINER RES  S1, V135, pS102
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   WILLIS JB, 1960, SPECTROCHIM ACTA, V16, P259, DOI 10.1016/0371-1951(60)80089-6
NR 21
TC 33
Z9 35
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1994
VL 28
IS 12
BP 1439
EP 1443
DI 10.1002/jbm.820281209
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU331
UT WOS:A1994PU33100008
PM 7876283
DA 2018-10-19
ER

PT J
AU ITO, Y
   ZHENG, J
   LIU, SQ
   IMANISHI, Y
AF ITO, Y
   ZHENG, J
   LIU, SQ
   IMANISHI, Y
TI NOVEL BIOMATERIALS IMMOBILIZED WITH BIOSIGNAL MOLECULES
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC MATERIALS SENSORS AND
   SYSTEMS
LA English
DT Article; Proceedings Paper
CT Bionic Design Workshop 94
CY FEB 22-23, 1994
CL TSUKUBA, JAPAN
DE BIOMATERIALS; IMMOBILIZATION; GROWTH FACTOR; CELL CULTURE; HYBRID ORGAN;
   BIOSIGNAL PROTEINS
ID CELL-GROWTH FACTOR; FIBROBLAST CELLS; INSULIN; ENHANCEMENT; TRANSFERRIN;
   MEMBRANE; CULTURE
AB Bioinertness, the reducing interactions of the materials with biocomponents, has been considered to be the most important factor in the development of biomaterials.  However, we recently proposed and realized a new strategy to design a bioactive material, on which biosignal molecules such as cell-growth-factor proteins and cell-adhesion-factor proteins were immobilized.  The immobilized biosignal molecules were not only bioactive without being incorporated into the cell, but also more active than free (soluble) ones.  In this review, some evidence to demonstrate that the effect of immobilized biosignal is based on biospecific interactions with cellular receptors is shown.  In addition, the explanation for the strong effect of the biosignalling, some efforts to further enhance the effect, and various applications of the biosignal molecules-immobilized biomaterials are described.  Finally the further outlook of biomaterial research using this type of material is mentioned.
C1 KYOTO UNIV,FAC ENGN,DIV MAT CHEM,KYOTO 60601,JAPAN.
RI Ito, Yoshihiro/F-4370-2012
CR HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ITO Y, 1994, J BIOACT COMPAT POL, V9, P170, DOI 10.1177/088391159400900204
   ITO Y, 1992, BIOTECHNOL BIOENG, V40, P1271, DOI 10.1002/bit.260401017
   ITO Y, 1993, J BIOMED MATER RES, V27, P901, DOI 10.1002/jbm.820270709
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   ITO Y, 1993, POLYM NEWS, V19, P198
   ITO Y, 1993, STP PHARMA SCI, V3, P46
   ITO Y, 1992, SYNTHESIS BIOCOMPOSI, P285
   ITO Y, UNPUB
   ITO Y, 1991, FUNDAMENTAL INVESTIG, P13
   LIU SQ, 1993, ENZYME MICROB TECH, V15, P167, DOI 10.1016/0141-0229(93)90044-3
   LIU SQ, 1993, J BIOMED MATER RES, V27, P909, DOI 10.1002/jbm.820270710
   LIU SQ, 1992, J BIOCHEM BIOPH METH, V25, P139
   LIU SQ, 1993, INT J BIOL MACROMOL, V15, P221, DOI 10.1016/0141-8130(93)90041-J
   ZHENG J, IN PRESS MATERIALS
NR 15
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0928-4931
J9 MAT SCI ENG C-BIOMIM
JI Mater. Sci. Eng. C-Biomimetic Mater. Sens. Syst.
PD DEC
PY 1994
VL 2
IS 1-2
BP 67
EP 72
DI 10.1016/0928-4931(94)90031-0
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA PY907
UT WOS:A1994PY90700011
DA 2018-10-19
ER

PT J
AU YASUE, T
   MASUDA, K
   KOJIMA, Y
   ARAI, Y
AF YASUE, T
   MASUDA, K
   KOJIMA, Y
   ARAI, Y
TI EFFECT OF ADSORPTION OF SUCCINIC ACID ON THE FORMATION OF AMORPHOUS
   CALCIUM-PHOSPHATE
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE AMORPHOUS CALCIUM PHOSPHATE (ACP); SUCCINIC ACID; CRYSTALLIZATION;
   BIOMATERIAL; HYDROXYAPATITE
ID HYDROXYAPATITE; PRECIPITATION
AB Adsorption of dissolved succinic acid on the formation of ACP and its stability were investigated in the synthetic process of ACP by the reaction of CaCl2-(NH4)(2) HPO4-C4H6O4-NH4OH. The crystallization of ACP to HAp and amount of succinic acid adsorbed were affected by some conditions such as initial pH, temperature, aging time and concentration of succinic acid in the mother liquor. The largest amount of succinic acid was adsorbed to ACP when the ACP was produced at 0 degrees C, initial pH 10 and concentration of succinic acid 6.0 mass% and aged at 25 degrees C for 3h. From the result of infrared spectra of the ACP which adsorbed succinic acid, two peaks due to carboxylic acid were newly found at 1400 cm(-1) and 1550 cm(-1). These peaks were not found from the result for a mixture of ACP and succinic acid. The adsorbed succinic acid was decomposed at about 480 degrees C and ACP was crystallized to Ca-3(PO4)(2) at above 600 degrees C by heating.
RP YASUE, T (reprint author), NIHON UNIV,FAC SCI & ENGN,DEPT IND CHEM,CHIYODA KU,1-8 KANDA SURUGADAI,TOKYO 101,JAPAN.
CR DALAS E, 1989, J CHEM SOC FARAD T 1, V85, P2465, DOI 10.1039/f19898502465
   DRIESSENS FCM, 1982, MINERAL ASPECTS DENT, P215
   FAHAO Z, 1991, J ENV SCI CHINA, V3, P60
   INSKEEP WP, 1988, SOIL SCI SOC AM J, V52, P941, DOI 10.2136/sssaj1988.03615995005200040007x
   LERNER E, 1989, J CRYST GROWTH, V97, P725, DOI 10.1016/0022-0248(89)90576-9
   LOPEZACEVEDO V, 1982, ESTUDICES GEOL, V38, P227
   SEDLAK JM, 1974, J COLLOID INTERF SCI, V47, P483, DOI 10.1016/0021-9797(74)90280-X
   YASUE T, 1991, PHOS RES B, V1, P27
   YASUE T, 1993, PHOSPHORUS SULFUR, V77, P290
NR 9
TC 4
Z9 4
U1 0
U2 5
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD DEC
PY 1994
VL 102
IS 12
BP 1122
EP 1127
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA PY540
UT WOS:A1994PY54000006
DA 2018-10-19
ER

PT J
AU ZHANG, MQ
   ZHU, SP
   ZENG, HM
   LU, Y
AF ZHANG, MQ
   ZHU, SP
   ZENG, HM
   LU, Y
TI A BIOMATERIAL-BASED CARBON-FIBER
SO ANGEWANDTE MAKROMOLEKULARE CHEMIE
LA English
DT Article
ID POLYETHYLENE COMPOSITES; RESIN
AB An attempt to convert natural sisal fiber into low cost carbon fibrous material was made. The pretreatment, pyrolysis and carbonization processes of raw sisal fiber as well as structure and properties of the resultant product were investigated. It was found that the sisal-based carbon fiber with moderate mechanical performance can be manufactured under the conditions applied. In addition, the application of the obtained sisal-based carbon fiber serving as functional material is presented.
RP ZHANG, MQ (reprint author), ZHONGSHAN UNIV,INST MAT SCI,CANTON 510275,PEOPLES R CHINA.
CR BARKAKATY BC, 1976, J APPL POLYM SCI, V20, P2921, DOI 10.1002/app.1976.070201101
   BIKALES NM, 1971, CELLULOSES CELLULO 4, P53
   COATS AW, 1964, NATURE, V201, P68, DOI 10.1038/201068a0
   DONNELLAN T, 1982, POLYM ENG SCI, V22, P821, DOI 10.1002/pen.760221306
   JAIN MK, 1987, J MATER SCI, V22, P278, DOI 10.1007/BF01160584
   JIAN N, 1986, P INT S COMPOSITE MA, P925
   JOHNSON W, 1967, NATURE, V215, P384, DOI 10.1038/215384a0
   JOSEPH K, 1993, J REINF PLAST COMP, V12, P139, DOI 10.1177/073168449301200202
   JOSEPH K, 1993, J APPL POLYM SCI, V47, P1731, DOI 10.1002/app.1993.070471003
   KARMAKER AC, 1991, POLYM-PLAST TECHNOL, V30, P609, DOI 10.1080/03602559108019223
   KLASON C, 1992, VISCOELASTICITY BIOM, P82
   Pal P. K., 1984, Plastics and Rubber Processing and Applications, V4, P215
   RAMIAH MV, 1970, J APPL POLYM SCI, V14, P1323, DOI 10.1002/app.1970.070140518
   SEMSARZADEH MA, 1984, POLYM COMPOSITE, V5, P141, DOI 10.1002/pc.750050204
   TANG MM, 1964, CARBON, V2, P211, DOI 10.1016/0008-6223(64)90035-1
   TANG MM, 1964, CARBON, V2, P221
   VARMA IK, 1989, COMPOSITES, V20, P383, DOI 10.1016/0010-4361(89)90664-2
   WANG M, 1984, MANUFACTURE PROPERTI, P183
   WANG M, 1979, SYNTHETIC FIBER IND, V2, P62
   YANG Z, 1993, CELLUL SCI TECHNOL, V1, P38
   YANG Z, 1961, CHEM CELLULOSE, P93
   ZENG H, 1985, SYNTHETIC FIBER IND, V8, P1
   ZENG H, 1991, MATER SCI PROG, V5, P1
   ZENG Q, 1993, ACTA MATERIAE COMPOS, V10, P1
   ZHANG L, 1992, THESIS ZHONGSHAN U
NR 25
TC 7
Z9 7
U1 0
U2 2
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 0003-3146
J9 ANGEW MAKROMOL CHEM
JI Angew. Makromol. Chem.
PD NOV
PY 1994
VL 222
BP 147
EP 163
DI 10.1002/apmc.1994.052220111
PG 17
WC Polymer Science
SC Polymer Science
GA QD957
UT WOS:A1994QD95700011
DA 2018-10-19
ER

PT J
AU BENZINA, A
   KRUFT, MAB
   BAR, F
   VANDERVEEN, FH
   BASTIAANSEN, CW
   HEIJNEN, V
   REUTELINGSPERGER, C
   KOOLE, LH
AF BENZINA, A
   KRUFT, MAB
   BAR, F
   VANDERVEEN, FH
   BASTIAANSEN, CW
   HEIJNEN, V
   REUTELINGSPERGER, C
   KOOLE, LH
TI STUDIES ON A NEW RADIOPAQUE POLYMERIC BIOMATERIAL
SO BIOMATERIALS
LA English
DT Article
DE RADIOPAQUE; HEMOCOMPATIBILITY; ENDOVASCULAR STENTS
ID METHACRYLATE POLYMERS; COPOLYMERS
AB A new radiopaque polymeric biomaterial has been synthesized. The material, which actually represents an entire family of analogous radiopaque materials, is composed of 2-(p-iodobenzoyl)ethyl methacrylate (compound 1, 21 mol%), methyl methacrylate (MMA, 60 mol%), and 2-hydroxyethyl methacrylate (HEMA, 19 mol%). The terpolymer was synthesized in a radical polymerization reaction at elevated temperature in N,N-dimethylformamide (DMF). The product was subjected to a set of physicochemical characterization techniques (gel permeation chromatography, 500 MHz H-1 NMR in deuterated dimethylsulphoxide (d(6)-DMSO) solution, differential scanning calorimetry, dynamic water contact angle measurements), as well as to an in vitro thrombogenicity assay. Furthermore, scanning electron microscopy was used to study interactions of the material with blood platelets. The most important findings are: (a) the material is a genuine polymer with excellent X-ray visibility, even in the form of thin (0.4 mm) drawn fibres. This was established under realistic conditions. (b) The material exhibits low in vitro thrombogenicity, i.e. comparable to polyvinyl chloride, which is known as a passive material. These observations lead us to the suggestion that this type of radiopaque polymer holds promise with respect to application as a construction material for a new type of endovascular stent. This could be relevant in particular to stents to be used in conjunction with percutaneous transluminal coronary angioplasty (PTCA), also known as Dottering. Currently there is a clear trend away from metallic stents towards all-polymeric stents, since the latter have superior biocompatibility. Biocompatibility of the stent material is of vital importance with respect to the long-term performance of the stent, i.e. its ability to prevent the phenomenon of restenosis. Note that both stent material-vessel wall and stent material-blood interactions are crucial. Application of a radiopaque polymer as described herein should enable us to construct a new stent type with improved biocompatibility with respect to the metallic counterparts, combined with excellent X-ray visibility.
C1 UNIV LIMBURG,BIOMAT & POLYMER RES INST MAASTRICHT EINDHOVEN,6200 MD MAASTRICHT,NETHERLANDS.
   ACAD HOSP MAASTRICHT,DEPT CARDIOL,MAASTRICHT,NETHERLANDS.
   EINDHOVEN UNIV TECHNOL,CTR POLYMERS & COMPOSITES,EINDHOVEN,NETHERLANDS.
CR Chandler H H, 1971, J Biomed Mater Res, V5, P335, DOI 10.1002/jbm.820050406
   Hassner A., 1978, TETRAHEDRON LETT, V19, P4475
   HEMKER HC, 1986, THROMB HAEMOSTASIS, V56, P9
   HEMKER HC, 1983, HDB SYNTHETIC SUBSTA
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J COLLOID INTERF SCI, V106, P289, DOI 10.1016/S0021-9797(85)80002-3
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   KRUFT MAB, 1994, IN PRESS J BIOMED MA, V28
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   LINDHOUT T, 1986, BIOCHEMISTRY-US, V25, P5962, DOI 10.1021/bi00368a019
   SIGWART U, 1992, CORONARY STENTS
   VANBEUSEKOM HMM, 1993, CARDIOVASC PATHOL, V2, P41, DOI 10.1016/1054-8807(93)90012-Q
   VANBEUSEKOM HMM, 1993, THESIS U ROTTERDAM
   XIA DW, 1984, J POLYM SCI POL LETT, V22, P617, DOI 10.1002/pol.1984.130221107
NR 15
TC 28
Z9 28
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1994
VL 15
IS 14
BP 1122
EP 1128
DI 10.1016/0142-9612(94)90232-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU591
UT WOS:A1994PU59100002
PM 7893914
DA 2018-10-19
ER

PT J
AU DEQUEIROZ, AAA
   VIANNA, EP
   GENOVA, LA
   HIGA, OZ
   BRESSIANI, JC
   BRESSIANI, AHA
AF DEQUEIROZ, AAA
   VIANNA, EP
   GENOVA, LA
   HIGA, OZ
   BRESSIANI, JC
   BRESSIANI, AHA
TI THE INTERACTION OF BLOOD PROTEINS WITH ALPHA-ALUMINA
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE BIOCERAMICS; BIOMATERIAL; THROMBOGENIC PROPERTIES; ALUMINA
AB The use of alumina (alpha-Al2O3) as a material for cardiovascular applications was investigated on the basis of protein adsorption and thrombus formation on the material. The adsorption of I-125-labelled albumin and fibrinogen from phosphate buffered saline (pH 7.35, 0.100 M NaCl, 8.66 mM KH2PO4 and 41 mM Na2HPO4) solution on ceramic discs of alumina was studied. Both albumin and fibrinogen presented affinity for ceramic surfaces, with adsorptions of 1.47 +/- 0.06 ng/cm(2) and 0.198 +/- 0.01 ng/cm(2), respectively. Scanning electron micrographs of the alpha-Al2O3 surfaces after contact of the discs with whole human blood showed a thrombogenic behavior of alumina alpha. These results indicate a hemoincompatible property. Although critical surface tension (gamma(C): 21.8 dynes/cm) of the disc surfaces determined by contact angle technique of sessile drops indicates that alumina alpha is a biocompatible material, by this criterion, the data reported here indicate that alpha-Al2O3 cannot be used for cardiovascular applications.
C1 CNEN SP,IPEN,BR-05508900 SAO PAULO,BRAZIL.
RP DEQUEIROZ, AAA (reprint author), EFEI,ICI,DEPT CIENCIAS,CAMPUS PROF JOSE RODRIGUES SEABRA,AV BPS,1301 CAI,BR-37500000 ITAJUBA,BRAZIL.
RI Vianna, Eduardo/B-6916-2008; Bressiani, Ana/I-1402-2012; Bressiani,
   Jose/I-1426-2012; Genova, Luis/B-7145-2014
OI Genova, Luis/0000-0002-5172-5082
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   BAYER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BISCAYART PL, 1989, J IMMUNOASSAY, V10, P37, DOI 10.1080/01971528908053226
   DORRE E, 1984, MATERIALS RES ENG, P265
   HULBERT SF, 1971, J BIOMEDICAL MATERIA, V2, P69
   PANJIAN L, 1991, J MATERIALS SCI MATE, V128, P125
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   WILLIAMS DF, 1987, MATER SCI TECH SER, V3, P797, DOI 10.1179/mst.1987.3.10.797
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
NR 9
TC 2
Z9 3
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD NOV
PY 1994
VL 27
IS 11
BP 2569
EP 2571
PG 3
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA PQ376
UT WOS:A1994PQ37600009
PM 7549978
DA 2018-10-19
ER

PT J
AU GUO, WD
   ANDERSSON, R
   LJUNGH, A
   PARSSON, H
   JOHANSSON, K
   BENGMARK, S
AF GUO, WD
   ANDERSSON, R
   LJUNGH, A
   PARSSON, H
   JOHANSSON, K
   BENGMARK, S
TI ORALLY-ADMINISTERED PHOSPHOLIPIDS INHIBIT ABDOMINAL RUBBER-DRAIN-INDUCED
   BACTERIAL TRANSLOCATION IN THE RAT
SO DIGESTION
LA English
DT Article
DE BACTERIAL TRANSLOCATION; PHOSPHOLIPID; RUBBER DRAIN; PERITONEAL CAVITY;
   BACTERIAL ADHERENCE; MACROPHAGE FUNCTION
ID INTRAPERITONEAL PROSTHETIC MATERIALS; ESCHERICHIA-COLI; HYDROPHOBICITY;
   PATHOGENESIS; OVERGROWTH; INFECTIONS; ADHESION; BARRIER; INVITRO; MUCUS
AB In order to determine the influence of phospholipid on abdominal biomaterial-induced bacterial translocation (BT), phsophatidylcholine (PC) or phosphatidylinositol (PI) was administered orally or intraperitoneally in rats with intraperitoneal implantation of 7-cm(2) rubber drain pieces. Two days after surgery, the incidence of translocation to mesenteric lymph nodes and liver significantly decreased, the adherence of H-3-Iabeled Escherichia coli to the ileal mucosa was signifciantly inhibited and the phagocytic and bactericidal capacity of peritoneal macrophages increased in animals with PC or PI administered orally, but not intraperitoneally, as compared with rats without phospholipid administration. Scanning electron microscopy revealed a coating layer on the surface of the intestinal mucosa in phospholipid-gavaged rats. Thus, the results in the present study imply that oral, but not intraperitoneal, PC of PI administration reduces enteric BT induced by intraperitoneal drain implantation.
C1 LUND UNIV, DEPT SURG, S-22185 LUND, SWEDEN.
   LUND UNIV, DEPT MED MICROBIOL, S-22185 LUND, SWEDEN.
   LUND UNIV, DEPT ZOOL, S-22185 LUND, SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ASCENCIO F, 1990, APPL ENVIRON MICROB, V56, P1926
   BARBER AE, 1991, AM J SURG, V161, P300, DOI 10.1016/0002-9610(91)91148-C
   BERG RD, 1988, ARCH SURG-CHICAGO, V123, P1359
   DARFEUILLE-MICHAUD A, 1992, INFECT IMMUN, V60, P44
   FABIA R, 1992, DIGESTION, V53, P35, DOI 10.1159/000200969
   FORSTNER G, 1984, ATTACHMENT ORGANISMS, V2, P13
   FRETER R, 1981, INFECT IMMUN, V34, P241
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   GUO W, 1993, SURG RES COMMUN, V13, P317
   GUO WD, 1993, ZBL BAKT-INT J MED M, V278, P73, DOI 10.1016/S0934-8840(11)80281-1
   GUO WD, 1993, J SURG RES, V55, P80, DOI 10.1006/jsre.1993.1112
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HILLS BA, 1985, AM J PHYSIOL, V249, pG342
   IRIE R, 1983, J LAB CLIN MED, V101, P692
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P129
   KROGFELT KA, 1991, REV INFECT DIS, V13, P721
   LJUNGH A, 1985, INFECT IMMUN, V47, P522
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   MARTIN GP, 1978, GUT, V19, P103, DOI 10.1136/gut.19.2.103
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   PAOLO DN, 1986, NEPHRON, V44, P365
   PASCUAL A, 1988, EUR J CLIN MICROBIOL, P7161
   SAVAGE DC, 1985, BACTERIAL ADHESION, P437
   SCHWEINBURG FA, 1980, NEW ENGL J MED, V242, P747
   SLOMIANY BL, 1984, ATTACHMENT ORGANISMS, V2, P23
   SLOMIANY BL, 1980, J APPL BIOCHEM, V2, P448
   WELLS CL, 1986, ARCH SURG-CHICAGO, V121, P102
   YUI S, 1986, J LEUKOCYTE BIOL, V89, P713
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 32
TC 6
Z9 6
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0012-2823
J9 DIGESTION
JI Digestion
PD NOV-DEC
PY 1994
VL 55
IS 6
BP 417
EP 424
DI 10.1159/000201175
PG 8
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA QC991
UT WOS:A1994QC99100011
PM 7705555
DA 2018-10-19
ER

PT J
AU SCHWARTZ, Z
   BOYAN, BD
AF SCHWARTZ, Z
   BOYAN, BD
TI UNDERLYING MECHANISMS AT THE BONE-BIOMATERIAL INTERFACE
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE IMPLANT; BONE FORMATION; OSTEOBLAST; MATRIX VESICLES; BONE IMPLANT
   INTERFACE
ID RAT TIBIAL BONE; EXTRACELLULAR-MATRIX VESICLES; TITANIUM IMPLANTS;
   GLASS-CERAMICS; INVITRO; MINERALIZATION; SURFACES; TISSUE;
   HYDROXYAPATITE; FIBRONECTIN
AB In order to understand how biomaterials influence bone formation in vivo, it is necessary to examine cellular response to materials in the context of wound healing. Four interrelated properties of biomaterials (chemical composition, surface energy, surface roughness, and surface topography) affect mesenchymal cells in vitro. Attachment, proliferation, metabolism, matrix synthesis, and differentiation of osteoblast-like cell lines and primary chondrocytes are sensitive to one or more of these properties. The nature of the response depends on cell maturation state. Rarely do differentiated osteoblasts or chondrocytes see a material prior to its modification by biological fluids, immune cells and less differentiated mesenchymal cells in vivo. Studies using the rat marrow ablation model of endosteal wound healing indicate that ability of osteoblasts to synthesize and calcify their extracellular matrix is affected by the local presence of the material. Changes in the morphology and biochemistry of matrix vesicles, extracellular organelles associated with matrix maturation and calcification, seen in normal endosteal healing, are altered by implants. Moreover, the material exerts a systemic effect on endosteal healing as well. This may be due to local effects on growth factor production and secretion into the circulation, as well as to the tact that the implant may serve as a bioreactor. (C) 1994 Wiley-Liss, Inc.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT PERIODONT,SAN ANTONIO,TX 78284.
   UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,SAN ANTONIO,TX 78284.
   HEBREW UNIV JERUSALEM,FAC MED DENT,DEPT PERIODONT,IL-91010 JERUSALEM,ISRAEL.
RP SCHWARTZ, Z (reprint author), UNIV TEXAS,HLTH SCI CTR,DEPT ORTHOPAED,SAN ANTONIO,TX 78284, USA.
FU NIDCR NIH HHS [DE-05935, DE-08603]
CR BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BLUMENTHAL NC, 1988, J BIOMED MATER RES, V22, P1033, DOI 10.1002/jbm.820221107
   BOSKEY AL, 1992, J ORTHOP RES, V10, P774, DOI 10.1002/jor.1100100605
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   COOK SD, 1988, CLIN ORTHOP RELAT R, V232, P225
   DANTONIO JA, 1992, J BONE JOINT SURG AM, V74A, P995, DOI 10.2106/00004623-199274070-00006
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   EVANS EJ, 1987, BIOMATERIALS, V8, P377, DOI 10.1016/0142-9612(87)90009-3
   FRENCH HG, 1984, J BIOMED MATER RES, V18, P817, DOI 10.1002/jbm.820180712
   GOLIJANIN L, 1988, Journal of Dental Research, V67, P367
   GROESSNERSCHREI.B, 1992, J CELL SCI, V101, P209
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   HAMBLETON J, IN PRESS J ORTHOP RE
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   ITAKURA Y, 1988, J BIOMED MATER RES, V24, P77
   JARCHO M, 1977, J BIOENG, V1, P79
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KELLER JC, 1989, J ADHESION, V28, P115, DOI 10.1080/00218468908030878
   LEE KL, 1992, J BONE MINER RES, V7, P1211
   Luyten F P, 1992, Acta Orthop Belg, V58 Suppl 1, P263
   Marshall TS, 1991, CLIN ORAL IMPLAN RES, V2, P112, DOI 10.1034/j.1600-0501.1991.020303.x
   MARTIN JY, J BIOMED MATER RES
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   OSBORN JF, 1990, ADV BIOMATER, V1, P75
   PAPPAS AM, 1968, J BONE JOINT SURG AM, VA 50, P535, DOI 10.2106/00004623-196850030-00013
   PEARSON BS, 1988, J DENT RES, V67, P515, DOI 10.1177/00220345880670021701
   RICH A, 1981, J CELL SCI, V50, P1
   SARTORIS D J, 1992, Journal of Foot Surgery, V31, P301
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   SCHWARTZ Z, 1993, J BIOMED MATER RES, V27, P1029, DOI 10.1002/jbm.820270808
   SCHWARTZ Z, 1992, CALCIFIED TISSUE INT, V51, P429, DOI 10.1007/BF00296676
   SCHWARTZ Z, 1991, CALCIFIED TISSUE INT, V49, P359, DOI 10.1007/BF02556260
   SCHWARTZ Z, 1989, BONE, V10, P53, DOI 10.1016/8756-3282(89)90147-6
   SELA J, 1987, BONE, V8, P245, DOI 10.1016/8756-3282(87)90172-4
   STEINEMAN SG, 1989, 6TH WORLD C TIT PAR, P535
   STEINEMAN SG, 1992, TECHNICAL PRINCIPLES, P168
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   WINDELER AS, 1991, BONE-BIOMATERIAL INTERFACE, P205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 49
TC 245
Z9 247
U1 2
U2 41
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD NOV
PY 1994
VL 56
IS 3
BP 340
EP 347
DI 10.1002/jcb.240560310
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA QF985
UT WOS:A1994QF98500009
PM 7876327
DA 2018-10-19
ER

PT J
AU REISSIS, N
   DOWNES, S
   KAYSER, M
   BENTLEY, G
AF REISSIS, N
   DOWNES, S
   KAYSER, M
   BENTLEY, G
TI A SIMPLE METHOD OF CARTILAGE REGENERATION USING A NEW POLYMERIZING
   SYSTEM - ULTRASTRUCTURAL CHARACTERISTICS OF THE REPAIR TISSUE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ARTICULAR-CARTILAGE; VI COLLAGEN; CHONDRONS; MICROENVIRONMENT
AB The ultrastructural characteristics of the repair tissue in large articular cartilage defects, filled with a heterocyclic polymerizing system were studied using transmission electron microscopy (TEM) and energy dispersive micro-analysis (EDMA). By six weeks post-implantation, the defects were resurfaced with predominantly hyaline-like articular cartilage. Chondrocytes in both the superficial and deep zones of the repair tissue were highly productive, secreting large amounts of proteoglycans, into a well-organized, rich in collagen fibrils, extracellular matrix. By contrast, in the repair tissue of the defects treated without the biomaterial, proteoglycan synthesis was less and the structure of the matrix was inferior. We conclude that the polymer enhances both chondrocyte metabolism and matrix organization, thus improving the quality of the repair tissue in articular cartilage defects.
C1 ROYAL NATL ORTHOPAED HOSP, STANMORE HA7 4LP, MIDDX, ENGLAND.
   UCL, IRC BIOMED MAT, LONDON, ENGLAND.
RP REISSIS, N (reprint author), UCL, INST ORTHOPAED, LONDON, ENGLAND.
CR Batchelor G.Y., 1991, ANIMAL TECHNOL, V42, P109
   BAYLISS MT, 1983, BIOCHEM J, V209, P387, DOI 10.1042/bj2090387
   BUCKWALTER JA, 1983, CLIN ORTHOP RELAT R, P207
   CARLSON CS, 1986, CALCIFIED TISSUE INT, V38, P44, DOI 10.1007/BF02556594
   DEBRUIJN WC, 1973, J ULTRA MOL STRUCT R, V42, P29, DOI 10.1016/S0022-5320(73)80004-8
   DVORAK AM, 1972, LAB INVEST, V27, P561
   FARNUM CE, 1983, J HISTOCHEM CYTOCHEM, V31, P765, DOI 10.1177/31.6.6841972
   LINSENMAYER TF, 1986, EXP CELL RES, V165, P518, DOI 10.1016/0014-4827(86)90604-X
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   PEARSON GJ, 1986, INT ENDOD J, V19, P121, DOI 10.1111/j.1365-2591.1986.tb00464.x
   POOLE CA, 1988, HISTOCHEM J, V20, P567, DOI 10.1007/BF01002611
   POOLE CA, 1990, CONNECT TISSUE RES, V24, P319, DOI 10.3109/03008209009152158
   POOLE CA, 1988, J CELL SCI, V90, P635
   POOLE CA, 1988, J ORTHOPAED RES, V6, P408, DOI 10.1002/jor.1100060312
   POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406
   REIMANN I, 1982, CLIN ORTHOP RELAT R, P258
   REISSIS N, 1994, T ORTHOP RES SOC, V19, P482
   Robinson G, 1990, THEORY PRACTICE HIST, P525
NR 18
TC 26
Z9 26
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1994
VL 5
IS 11
BP 793
EP 797
DI 10.1007/BF00213137
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PZ440
UT WOS:A1994PZ44000004
DA 2018-10-19
ER

PT J
AU DUFRESNE, M
   WAROCQUIERCLEROUT, R
   SIGOTLUIZARD, MF
AF DUFRESNE, M
   WAROCQUIERCLEROUT, R
   SIGOTLUIZARD, MF
TI CELL PHENOTYPE CHARACTERIZATION IN VASCULAR ORGANOTYPIC CULTURE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; SCANNING ELECTRON-MICROSCOPY; LOW-DENSITY
   LIPOPROTEIN; ENDOTHELIAL-CELLS; GROWTH-FACTOR; ORGAN-CULTURE; PERICYTES;
   INVITRO; ACTIVATION; COCULTURES
AB An in vitro biocompatibility assessment test has been successfully applied to vascular prostheses. It consists of an organotypic culture of chick embryo vascular explant which preserves wall vessel cell interactions and enables cell growth and migration on biomaterial. This study is an attempt to identify the cell phenotype expressed by scanning electron microscopy, by immunostaining with specific monoclonal antibodies against smooth muscle cell (SMC) or von Willebrand factor (VWF), and by uptake of acetylated low-density lipoprotein. Early migrating cells had an endothelial-like phenotype independent of embryonic or adult vessel, veinous or arterial explants. SMC appeared labelled beyond the inner endothelial area. At the periphery, SMC displayed actin bundles specific to stationary phase. Adult cell cultures differed from embryonic cultures in that endothelial-like cells (EC) were more stable and increased their vWF labelling, whereas in embryonic cultures, some EC rounded up with subsequent detachment. Explant culture in liquid instead of agar medium activated this degenerative process suggesting the effect of diffusible chemotactic factors. Organotypic culture in agar medium provides an in vitro co-culture system of EC and SMC and enables further investigation of spatial and temporal evolution of vascular tissues in contact with various substrate.
RP DUFRESNE, M (reprint author), UNIV TECHNOL COMPIEGNE,BIOL CELLULAIRE EXPTL LAB,BP 649,F-60206 COMPIEGNE,FRANCE.
CR ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544
   ANTONIADES HN, 1991, BAILLIERE CLIN ENDOC, V5, P595, DOI 10.1016/S0950-351X(10)80005-9
   BAITELLAEBERLE G, 1993, J VASC SURG, V18, P1019, DOI 10.1016/0741-5214(93)90557-3
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2
   DUVAL JL, 1990, ADV BIOMAT, V9, P93
   DUVAL JL, 1992, CELL MATER, V2, P179
   GARBARSCH C, 1970, ANGIOLOGICA, V7, P365
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   KOO EWY, 1992, SCANNING MICROSCOPY, V6, P827
   KOO EWY, 1991, LAB INVEST, V64, P743
   LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739
   MORISAKI N, 1993, SCAND J CLIN LAB INV, V53, P347, DOI 10.3109/00365519309086626
   RAINES EW, 1993, BRIT HEART J, V69, pS30
   SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757
   SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   SJOLUND M, 1988, J CELL BIOL, V106, P403, DOI 10.1083/jcb.106.2.403
   SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0
   VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034
   YABLONKAREUVENI Z, 1989, DEV BIOL, V132, P230, DOI 10.1016/0012-1606(89)90219-4
   ZERWES HG, 1987, J CELL BIOL, V105, P2037, DOI 10.1083/jcb.105.5.2037
NR 22
TC 2
Z9 2
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1994
VL 5
IS 11
BP 824
EP 829
DI 10.1007/BF00213142
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PZ440
UT WOS:A1994PZ44000009
DA 2018-10-19
ER

PT J
AU WATTERS, WC
   LEVINTHAL, R
AF WATTERS, WC
   LEVINTHAL, R
TI ANTERIOR CERVICAL DISKECTOMY WITH AND WITHOUT FUSION - RESULTS,
   COMPLICATIONS, AND LONG-TERM FOLLOW-UP
SO SPINE
LA English
DT Article; Proceedings Paper
CT 21st Annual Meeting of the Cervical-Spine-Research-Society
CY DEC 01-04, 1993
CL NEW YORK, NY
SP CERVICAL SPINE RES SOC
DE CERVICAL RADICULOPATHY; ANTERIOR CERVICAL DISKECTOMY; ANTERIOR CERVICAL
   FUSION
AB Study Design.  This study retrospectively reviewed the outcomes of 126 patients treated for cervical radiculopathy with either simple anterior cervical discectomy (ACD) or anterior cervical discectomy and fusion (ACF).
   Objectives.  Complications, short-term, and long-term outcomes were compared to determine which was the superior procedure in the treatment of cervical radiculopathy.
   Summary of Background Data.  Both procedures were performed for identical reasons on similar patient groups in an identical manner.  The ACF group had a tricortical autograft implanted after the discectomy.
   Methods.  Complications and short-term follow-up were determined by review of hospital and office charts and radiographs.  Long-term follow-up was by phone interview.
   Results.  Anterior cervical discectomy had a significantly reduced mean operative time, blood loss, and hospital stay.  There were 16 complications for ACF, 15 of which were graft-related and 4 complications for ACD.  There was, however, no difference in mean time to return to work between the two groups.  Long-term follow-up demonstrated an average low level of neck and arm pain in both groups.  Continued donor site pain was not a long-term problem.  Slightly more ACF than ACD patients were satisfied with the long-term results of their surgery.
   Conclusions.  Neither procedure is ideal for the treatment of cervical radiculopathy.  Anterior cervical discectomy results in decreased hospital cost and surgical morbidity.  Anterior cervical discectomy and fusion results in more rapid resolution of patient pain.  The ideal procedure would appear to be ACF performed with a theoretical biomaterial that would be minimally expensive and consistently promote successful arthrodesis.
RP WATTERS, WC (reprint author), BONE & JOINT CLIN HOUSTON,6624 FANNIN ST 2600,HOUSTON,TX 77030, USA.
NR 0
TC 46
Z9 46
U1 0
U2 3
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0362-2436
J9 SPINE
JI SPINE
PD OCT 15
PY 1994
VL 19
IS 20
BP 2343
EP 2347
DI 10.1097/00007632-199410150-00016
PG 5
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA PM942
UT WOS:A1994PM94200016
DA 2018-10-19
ER

PT J
AU CHANDA, J
   RAO, SB
   MOHANTY, M
   LAL, AV
   MURALEEDHARAN, CV
   BHUVANESHWAR, GS
   VALIATHAN, MS
AF CHANDA, J
   RAO, SB
   MOHANTY, M
   LAL, AV
   MURALEEDHARAN, CV
   BHUVANESHWAR, GS
   VALIATHAN, MS
TI PREVENTION OF CALCIFICATION OF TISSUE VALVES
SO ARTIFICIAL ORGANS
LA English
DT Article
DE CALCIFICATION; PERICARDIUM; BIOPROSTHETIC VALVE; CHITOSAN;
   GLUTARALDEHYDE; COLLAGEN
ID BIOPROSTHETIC HEART-VALVE; BOVINE PERICARDIUM; COLLAGEN; PORCINE;
   BIOMATERIAL
AB In this study an attempt was made to find an optimum method of chemical treatment to prevent the calcification of bioprosthetic heart valves.  Bovine pericardium was washed in a 5% sodium chloride solution followed by trypsin (Tr) treatment and was kept in 0.1% glutaraldehyde (GA) with a gradual increase in concentration up to 0.25% GA and finally posttreated with a 4% chitosan (Ch) solution.  Fresh, 0.2% GA, 0.625% GA, and sodium chloride-Tr-GA treated pericardial samples were taken for comparative study.  Tensile testing showed comparable strength and elongation at the breaking point for all groups.  The thermal shrinkage studies indicated merit of the proposed treatment (5% sodium chloride-trypsin-glutaraldehyde treated pericardia with chitosan and without chitosan posttreatment).  Collagenase assay showed that all differently treated (GA) materials were equally resistant to collagenase.  All samples were implanted subcutaneously in rats for 2, 4, 8, or 12 weeks for calcification study.  Morphological and mineral analyses showed complete prevention of calcification in sodium chloridetrypsin-GA-chitosan treated pericardium (Ca was 1.1 +/- 0.27 mg/g, von Kossa 0) at the 12th week of implantation.
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DEPT ARTIFICIAL INTERNAL ORGANS,TRIVANDRUM,INDIA.
   SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DEPT THORAC & CARDIOVASC SURG,TRIVANDRUM,INDIA.
RI CV, Muraleedharan/B-7060-2009
OI CV, Muraleedharan/0000-0002-8398-0379
CR BERNACCA GM, 1992, BIOMATERIALS, V13, P345
   BRUCK SD, 1981, BIOMATERIALS, V2, P15
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   CHANDA J, 1990, MECHANISM REHABILITA, P70
   DRURY PJ, 1992, J MED ENG TECHNOL, V16, P4, DOI 10.3109/03091909209021950
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   Lynn L. H., 1990, J BIOMED MATER RES, V24, P1185
   Magilligan D J, 1988, ASAIO Trans, V34, P1031
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Schoen F J, 1988, ASAIO Trans, V34, P1040
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1991, REPLACEMENT CARDIAC, P125
   STARR A, 1989, ANN THORAC SURG, V48, P317, DOI 10.1016/S0003-4975(10)62847-0
   STRYER L, 1988, BIOCHEMISTRY-US, P270
   THUBRIKAR MJ, 1983, T AM SOC ART INT ORG, V29, P245
   TSAO JW, 1988, BIOMATERIALS, V9, P393, DOI 10.1016/0142-9612(88)90002-6
   XI TF, 1992, J BIOMED MATER RES, V26, P1241
NR 22
TC 15
Z9 16
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD OCT
PY 1994
VL 18
IS 10
BP 752
EP 757
DI 10.1111/j.1525-1594.1994.tb03314.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA PN587
UT WOS:A1994PN58700008
PM 7832657
DA 2018-10-19
ER

PT J
AU LEUNG, T
   KAKAR, A
   HOBKIRK, JA
   THOROGOOD, P
AF LEUNG, T
   KAKAR, A
   HOBKIRK, JA
   THOROGOOD, P
TI BEHAVIOR OF FIBROBLASTS DURING INITIAL ATTACHMENT TO A GLASS-CERAMIC
   IMPLANT MATERIAL IN-VITRO - A TIME-LAPSE VIDEO-MICROGRAPHIC STUDY
SO BIOMATERIALS
LA English
DT Article
DE DENTAL MATERIALS; GLASS CERAMICS; CELL BEHAVIOR; IMPLANTS
ID CULTURE; FIBRONECTIN; BIOMATERIAL; ADHESION; CELLS
AB The in vitro behaviour of 3T3 fibroblasts plated on a glass-ceramic implant material, Apoceram, and on tissue culture polystyrene (TCP) was monitored using phase-contrast, time-lapse video microscopy and scanning electron microscopy. Significant differences were observed in the short-term cellular response to TCP and Apoceram in the timing of the fibroblasts' morphological changes, with earlier spreading and stabilization of the cells occurring on TCP. Cell surface ruffling activity was greater on the glass-ceramic, reflecting weaker adhesions to the substratum. The experimental method used facilitates direct analysis of the dynamic activity of cells attaching to artificial substrata.
C1 INST CHILD HLTH, DEV BIOL UNIT, LONDON WC1N 1EH, ENGLAND.
RP LEUNG, T (reprint author), UCL EASTMAN DENT INST, DEPT PROSTHET DENT, 256 GRAYS INN RD, LONDON WC1X 8LD, ENGLAND.
CR ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9
   Baier R E, 1984, J BIOMED MATER RES, V18, P327
   Bell P B Jr, 1978, Birth Defects Orig Artic Ser, V14, P177
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   DOILLON CJ, 1990, INT J ARTIF ORGANS, V13, P517
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HAUSTVEIT G, 1984, BIOMATERIALS, V5, P75, DOI 10.1016/0142-9612(84)90004-8
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JOHNSON HJ, 1985, J BIOMED MATER RES, V19, P489, DOI 10.1002/jbm.820190503
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   NAJI A, 1991, BIOMATERIALS, V12, P690, DOI 10.1016/0142-9612(91)90118-T
   RAE T, 1986, TECHNIQUES BIOCOMPAT, V2, P81
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   REVEL JP, 1973, EXP CELL RES, V78, P1, DOI 10.1016/0014-4827(73)90031-1
   REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   SHAREFKIN JB, 1986, TECHNIQUES BIOCOMPAT, V2, P95
   Taylor A. C., 1961, Experimental Cell Research Supplement, VNo. 8, P154, DOI 10.1016/0014-4827(61)90346-9
   WEISS L, 1967, J CELL PHYSIOL, V70, P23, DOI 10.1002/jcp.1040700104
   WOLFE LA, 1990, J DENT RES, V68, P958
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
   1989, ISOTR9966 TECHN REP
NR 23
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 1994
VL 15
IS 12
BP 1001
EP 1007
DI 10.1016/0142-9612(94)90081-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PK886
UT WOS:A1994PK88600007
PM 7841287
DA 2018-10-19
ER

PT J
AU COURTNEY, JM
   FORBES, CD
AF COURTNEY, JM
   FORBES, CD
TI THROMBOSIS ON FOREIGN SURFACES
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
ID BIOCOMPATIBILITY
AB The increasing use of biomaterials in blood-contacting applications underlines the importance of an enhanced understanding of the interactions of blood with foreign surfaces. These interactions constitute a complex response involving the possible participation of proteins, platelets, the intrinsic coagulation, the fibrinolytic system, erythrocytes, leucocytes and the complement system. Interpretation of blood-biomaterial interactions and the development of improved biomaterials require the utilisation of in vitro, ex vivo or in vivo blood compatibility assessment procedures, although there is no ideal procedure for linking assessment to the potential clinical performance of a material. In clinical application, foreign surfaces represent only one of the factors influencing the blood response, with the response also influenced by the presence of antithrombotic agents, the blood condition and the nature of the application.
C1 UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT MED,DUNDEE DD1 9SY,SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,GLASGOW G1 1XW,LANARK,SCOTLAND.
CR BAMBAUER R, 1990, T AM SOC ART INT ORG, V36, pM646
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BURNS GL, 1989, T AM SOC ART INT ORG, V35, P700
   CHENOWETH DE, 1980, MOL IMMUNOL, V17, P151, DOI 10.1016/0161-5890(80)90067-X
   CHENOWETH DE, 1986, T AM SOC ART INT ORG, V32, P226
   COURTNEY JM, 1993, ARTIF ORGANS, V17, P260
   Courtney JM, 1993, INT J ARTIF ORGANS, V16, P165
   COURTNEY JM, 1984, MACROMOLECULAR BIOMA, P143
   COURTNEY JM, 1990, CONCSIE ENCY MED DEN, P212
   COURTNEY JM, 1993, MANAGEMENT BLEEDING, P236
   COURTNEY JM, 1993, EDTNA ERCA J S1, V19, P29
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   DALEN JE, 1986, ARCH INTERN MED, V146, P462, DOI 10.1001/archinte.1986.00360150060007
   DELLSPERGER KC, 1991, BLOOD COMPATIBLE MAT, P153
   Edie RN, 1981, TECHNIQUES EXTRACORP, P179
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   FORBES CD, 1994, HAEMOSTASIS THROMBOS, V2, P1301
   GRIFFIN JH, 1979, SEMIN THROMB HEMOST, V5, P254
   HENSON PM, 1981, PLATELETS BIOL PATHO, P265
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   MADHOK R, 1985, 30 YEARS EXTRACORPOR, P363
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   PAUL JP, 1989, PROGR BIOENGINEERING
   PEARSON DT, 1981, TECHNIQUES EXTRACORP, P155
   RINGOIR S, 1986, ARTIF ORGANS, V10, P20, DOI 10.1111/j.1525-1594.1986.tb02511.x
   Sharma C. P., 1991, BLOOD COMPATIBLE MAT
   SOLEN KA, 1989, T AM SOC ART INT ORG, V35, P370
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P1
   TAENAKA Y, 1989, T ASAIO, V35, P396
   UZIEL L, 1986, BLOOD COMPATIBLE MAT, P29
   VROMAN L, 1983, BIOCOMPATIBLE POLYM, P81
NR 33
TC 32
Z9 35
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF
SN 0007-1420
J9 BRIT MED BULL
JI Br. Med. Bull.
PD OCT
PY 1994
VL 50
IS 4
BP 966
EP 981
DI 10.1093/oxfordjournals.bmb.a072937
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA PU179
UT WOS:A1994PU17900015
PM 7804742
DA 2018-10-19
ER

PT J
AU GREGORY, KW
   GRUNKEMEIER, JM
AF GREGORY, KW
   GRUNKEMEIER, JM
TI INTERNAL ELASTIC LAMINA REPLACEMENT WITH A NEW ELASTIN STENT BIOMATERIAL
SO CIRCULATION
LA English
DT Meeting Abstract
C1 ST VINCENT HOSP,OREGON MED LASER CTR,PORTLAND,OR.
NR 0
TC 2
Z9 2
U1 0
U2 1
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD OCT
PY 1994
VL 90
IS 4
BP 596
EP 596
PN 2
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA PN417
UT WOS:A1994PN41703244
DA 2018-10-19
ER

PT J
AU HABAL, MB
   REDDI, AH
AF HABAL, MB
   REDDI, AH
TI BONE-GRAFTS AND BONE INDUCTION SUBSTITUTES
SO CLINICS IN PLASTIC SURGERY
LA English
DT Article
AB The use of bone grafts is the basis of all craniofacial surgery.  Bone grafts are used to stabilize the open segments, expand the patient's structural boundaries, and fill defects created by trauma or congenital malformations.  Bone grafts are harvested from local or distant sites as indicated.  Biomaterial implants are used as bone substitutes when it is not possible to use bone grafts.
RP HABAL, MB (reprint author), TAMPA BAY CRANIOFACIAL CTR,801 W DR MARTIN LUTHER KING JR BLVD,TAMPA,FL 33603, USA.
NR 0
TC 55
Z9 55
U1 0
U2 5
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0094-1298
J9 CLIN PLAST SURG
JI Clin. Plast. Surg.
PD OCT
PY 1994
VL 21
IS 4
BP 525
EP 542
PG 18
WC Surgery
SC Surgery
GA PN350
UT WOS:A1994PN35000006
PM 7813153
DA 2018-10-19
ER

PT J
AU KASEMO, B
   LAUSMAA, J
AF KASEMO, B
   LAUSMAA, J
TI MATERIAL-TISSUE INTERFACES - THE ROLE OF SURFACE-PROPERTIES AND
   PROCESSES
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT Workshop on Biopersistence of Respirable Synthetic Fibers and Minerals
CY SEP 07-09, 1992
CL LYON, FRANCE
SP INT AGCY RES CANC, INSERM, CNRS
DE SURFACE; INTERFACE; METAL OXIDE; BIOMOLECULES; WATER; IONS; CELL
   MEMBRANE; BIOMATERIALS
ID IMPLANT MATERIALS; OXIDE-FILMS; TITANIUM; BIOMATERIAL; ADSORPTION
AB The introduction of a foreign material into living tissue-intentionally as in biomedical applications (implants, protheses, drugs) or unintentionally as when minerals or fibers are inhaled-results in the creation of interfaces between the material and the surrounding tissue. This article identifies and discusses the possible role of material surface properties and molecular processes occurring at such interfaces. For kinetic and thermodynamic reasons, surfaces are different from the corresponding bulk of the material, and contain reactive (unsaturated) bonds, which in turn lead to the formation of surface reactive layers (e.g., surface oxides on metals) and adsorbed contamination layers. The encounter with the biological environment leads to further surface reactions modifying the surface, and to the adsorption of water, ions, and biomolecules, which are continuously exchanged. The exact nature of the dynamic, adsorbed water, ions, and biomolecule coating in turn influences the behavior of cells approaching the material surface, and hence the tissue response.
RP KASEMO, B (reprint author), CHALMERS UNIV TECHNOL,DEPT APPL PHYS,S-41296 GOTHENBURG,SWEDEN.
CR ANDRADE JD, 1985, PROTEIN ADSORPTION S, V2
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BRANEMARK PI, 1985, TISSUE INTEGRATED PR
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KASEMO B, 1988, SURFACE CHARACTERIZA, P1
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1991, THESIS GOTHENBURG
   Luckey H. A., 1983, ASTM SPECIAL TECHNIC, V796
   LUNDSTROM I, 1985, ORAL INTERACTIONS RE, P9
   MAEUSLI PA, 1986, BIOL BIOMECHANICAL P, P57
   McQueen D, 1982, CLIN APPL BIOMATERIA, P179
   RADEGRAN G, 1991, J ELECTRON MICR TECH, V19, P99, DOI 10.1002/jemt.1060190110
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   WILLIAMS DF, 1977, J MED ENG TECHNOL, V1, P266, DOI 10.3109/03091907709162192
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 27
TC 114
Z9 116
U1 0
U2 9
PU NATL INST ENVIRON HEALTH SCI
PI RES TRIANGLE PK
PA PO BOX 12233, RES TRIANGLE PK, NC 27709
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD OCT
PY 1994
VL 102
SU 5
BP 41
EP 45
DI 10.2307/3432057
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA PT108
UT WOS:A1994PT10800009
PM 7882954
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU SHEPPARD, JI
   MCCLUNG, WG
   FEUERSTEIN, IA
AF SHEPPARD, JI
   MCCLUNG, WG
   FEUERSTEIN, IA
TI ADHERENT PLATELET MORPHOLOGY ON ADSORBED FIBRINOGEN - EFFECTS OF PROTEIN
   INCUBATION-TIME AND ALBUMIN ADDITION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID GLYCOPROTEIN-IIB/IIIA; ELECTRON-MICROSCOPY; SHAPE CHANGE; SURFACE;
   ELUTABILITY; ASSOCIATION; ACTIVATION; ADHESION; RELEASE
AB The composition of the protein layer adsorbed to a polymer has been thought to be important for the adhesion of platelets. The state of activation of adherent platelets is an additional factor that may be a predictor of biocompatibility. Activation refers to the degree of change from discoid shape to any of several spread shapes. The conformation and orientation of adsorbed adhesive proteins, which interact with receptors on the membrane of platelets, such as fibrinogen, fibronectin, and von Willebrand factor, may also be important for platelet adhesion and activation. This work deals with the behavior of fibrinogen adsorbed to PMMA alone, where the experimental variable was incubation time with the substrate, and with adsorbed fibrinogen mixed with albumin, where the experimental variable was the molar percent of fibrinogen in the adsorption solution. Shorter protein incubation times and increased albumin levels in the initial fibrinogen adsorption solution enhanced the percentages of activated platelet morphologies and increased adsorbed fibrinogen redistribution by the platelet. Lower concentrations of albumin in the initial adsorption solution enhanced platelet adhesion numbers; fibrinogen incubation time had no effect. Together, these factors can contribute to the biocompatibility of a biomaterial through their effect on platelet adhesion and activation. (C) 1994 John Wiley & Sons, Inc.
C1 MCMASTER UNIV,DEPT CHEM ENGN,HAMILTON L8S 4L7,ON,CANADA.
   MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L7,ON,CANADA.
CR ADAMS GA, 1981, AM J PHYSIOL, V240, pH99
   ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   ARDAILLOU N, 1974, THROMB RES, V5, P327, DOI 10.1016/0049-3848(74)90171-6
   BAUMGARTNER HR, 1974, THROMB DIATH HAEMO, V60, P39
   BEHNKE O, 1988, EUR J CELL BIOL, V46, P207
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Buck C A, 1987, J Cell Sci Suppl, V8, P231
   CHAN BMC, 1981, J COLLOID INTERF SCI, V82, P217, DOI 10.1016/0021-9797(81)90141-7
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   DAVID GS, 1972, BIOCHEM BIOPH RES CO, V48, P464, DOI 10.1016/S0006-291X(72)80074-3
   FEUERSTEIN IA, 1993, BIOMATERIALS, V14, P137, DOI 10.1016/0142-9612(93)90228-T
   FOX JEB, 1985, PLATELET MEMBRANE GL, P273
   GAEBEL K, 1991, BIOMATERIALS, V12, P597, DOI 10.1016/0142-9612(91)90058-I
   Goodman S L, 1991, J Biomater Sci Polym Ed, V2, P147, DOI 10.1163/156856291X00133
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1990, 12TH P INT C EL MICR, P22
   Lawrie JS, 1979, BIOCHEM SOC T, V7, P693, DOI 10.1042/bst0070693
   LOFTUS JC, 1984, J CELL BIOL, V99, P822, DOI 10.1083/jcb.99.3.822
   MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x
   PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311
   Park K, 1989, Scanning Microsc Suppl, V3, P137
   PEERSCHKE EIB, 1991, BLOOD, V77, P508
   SHEPPECK RA, 1991, BLOOD, V78, P673
   SORIA J, 1985, J COLLOID INTERF SCI, V107, P204, DOI 10.1016/0021-9797(85)90163-8
   SUZUKI H, 1991, HISTOCHEMISTRY, V96, P31, DOI 10.1007/BF00266758
NR 26
TC 47
Z9 48
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1994
VL 28
IS 10
BP 1175
EP 1186
DI 10.1002/jbm.820281008
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PJ304
UT WOS:A1994PJ30400007
PM 7829547
DA 2018-10-19
ER

PT J
AU RUDOLPH, AS
AF RUDOLPH, AS
TI BIOMATERIAL BIOTECHNOLOGY USING SELF-ASSEMBLED LIPID MICROSTRUCTURES
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE SELF-ASSEMBLY; LIPIDS; BLOOD SUBSTITUTES; CONTROLLED RELEASE; MONOLAYER
   FORMATION
ID LIPOSOME-ENCAPSULATED HEMOGLOBIN; BLOOD SUBSTITUTE
AB Lipids are a class of molecules which self-assemble into a variety of phase-dependent morphologies. We have employed self-assembled lipid microstructures in the development of a number of biomedical material applications. The blood substitute, liposome encapsulated hemoglobin, is being investigated for the in vivo delivery of hemoglobin without many of the inherent toxicities associated with the delivery of free hemoglobin. This investigation is currently focused on demonstrations of efficacy in stressed animal models and on the safety of administering this material in models of sepsis. The synthetic modification of phospholipids to include photopolymerizable moieties such as diacetylenes has resulted in the spontaneous self-assembly of a hollow microcylinder which we are investigating for the controlled release of growth factors in soft tissue regeneration. Self-assembled monolayers are also being explored for the ability to surface modify biomaterials for improved cell adhesion. Photolithographic techniques have been combined with monolayer deposition to fabricate coplanar patterns of cell adhesion and inhibiting moieties. This results in the ability to spatially control the adhesion of cells to biomaterial surfaces. These cell patterns can form the basis for understanding two- and three-dimensional cellular events on the biomaterial surface and for the fabrication of improved cell-based biocompatible surfaces. The spontaneous self-assembly of lipids to form structures of biotechnological interest presents a unique opportunity to exploit this class of molecules for biomaterial applications. (C) 1994 Wiley-Liss, Inc.(*)
RP RUDOLPH, AS (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6900,WASHINGTON,DC 20375, USA.
CR ALLEN T, 1992, LIPOSOME TECHNOLOGY, V3, P59
   Bangham A. D., 1983, LIPOSOME LETT
   JULIANO RL, 1980, LIPOSOMES IMMUNOBIOL, P49
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8
   LUZATTI V, 1968, NATURE, V73, P7304
   OSTRO MJ, 1989, AM J HOSP PHARM, V46, P1576
   OSTRO MJ, 1987, LIPOSOMES BIOPHYSICS
   PRICE RR, 1993, J MICROENCAPSUL, V10, P215, DOI 10.3109/02652049309104387
   RABINOVICI R, 1993, J TRAUMA, V35, P121, DOI 10.1097/00005373-199307000-00019
   RUDOLPH AS, 1991, P NATL ACAD SCI USA, V88, P10976, DOI 10.1073/pnas.88.23.10976
   RUDOLPH AS, 1992, BIOMATERIALS, V13, P1085, DOI 10.1016/0142-9612(92)90141-A
   RUDOLPH AS, 1991, NATURE, V352, P52, DOI 10.1038/352052a0
   RUDOLPH AS, 1988, CRYOBIOLOGY, V25, P277, DOI 10.1016/0011-2240(88)90036-3
   RUDOLPH AS, 1989, BIOTECHNOLOGICAL APP, V110, P305
   SCHNUR JM, 1987, THIN SOLID FILMS, V152, P181, DOI 10.1016/0040-6090(87)90416-0
   SPARGO BJ, 1992, MATER RES SOC SYMP P, V252, P285
   Tanford C., 1980, HYDROPHOBIC EFFECT
   YAGER P, 1984, MOL CRYST LIQ CRYST, V106, P371, DOI 10.1080/00268948408071454
NR 19
TC 25
Z9 27
U1 0
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD OCT
PY 1994
VL 56
IS 2
BP 183
EP 187
DI 10.1002/jcb.240560211
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA PJ445
UT WOS:A1994PJ44500010
PM 7829578
DA 2018-10-19
ER

PT J
AU KEOGH, JR
   EATON, JW
AF KEOGH, JR
   EATON, JW
TI ALBUMIN-BINDING SURFACES FOR BIOMATERIALS
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; ARTIFICIAL SURFACES; BLOOD COMPATIBILITY;
   BACTERIAL ADHERENCE; PROTEIN ADSORPTION; FIBRINOGEN; POLYURETHANES;
   ELUTABILITY; POLYMERS; PLASMA
AB The surfaces of medical devices may promote both coagulation and infections caused by adherent microorganisms. In the case of polymeric elastomers, these iatrogenic effects are likely intermediated by absorbed host proteins that spontaneously bind to the device surface, promoting both bacterial adherence and thrombotic events. We earlier attempted to produce biomaterial surfaces that would selectively bind host albumin because albumin-coated surfaces were known to diminish both coagulation and bacterial adherence. To this end, an albumin-binding high molecular weight dextran:Cibacron blue adduct was bulk incorporated into polyetherurethane (Keogh et al., J Biomed Mater Res 1992;26:441). The modified material bound albumin selectively and reversibly and showed evidence of enhanced biocompatibility. However, similar to 30% of the surface of this material was evidently unmodified and still capable of exerting the above adverse effects. In the present work, we have covalently surface-modified polyetherurethane with sequential additions of acrylamide, amino-propylmethacrylamide, dextran, and Cibacron blue. This derivatized polyurethane preferentially and reversibly binds albumin, even from complex mixtures of proteins such as plasma. Furthermore, this material inhibits the clotting of nonanticoagulated whole human blood (for >16 hours at room temperature), perhaps by virtue of binding and activation of antithrombin III by the sulfonic acid residues on the surface-immobilized Cibacron blue. Finally, such surfaces, especially when bearing bound albumin, diminish the adherence of Staphylococcus epidermidis, a pathogen frequently associated with device-centered infections. We conclude that similar albumin-affinity surfaces may hold promise for the development of more biocompatible materials for implantation and blood contact applications.
C1 ALBANY MED COLL, DIV EXPTL PATHOL, ALBANY, NY 12208 USA.
   MEDTRONIC INC, MINNEAPOLIS, MN USA.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   CHINN JA, 1991, J BIOMED MATER RES, V25, P535, DOI 10.1002/jbm.820250410
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COLLINS WE, 1987, ANN NY ACAD SCI, V516, P291, DOI 10.1111/j.1749-6632.1987.tb33049.x
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   FRAUTSCHI JR, 1983, T AM SOC ART INT ORG, V29, P242
   FUKUMURA H, 1987, BIOMATERIALS, V8, P74, DOI 10.1016/0142-9612(87)90035-4
   GOWER DJ, 1986, PEDIATR NEUROSCI, V12, P127
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HOGT AH, 1987, ZENTRALBL BAKTERIO S, V16, P113
   HORBETT TA, 1982, ADV CHEM SER, P233
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   Jansen B, 1988, J Biomater Appl, V2, P520
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KIM SW, 1979, J POLYM SCI PS, V66, P429
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEATHERBARROW RJ, 1980, BIOCHEM J, V189, P27, DOI 10.1042/bj1890027
   LEININGER RI, 1987, ANN NY ACAD SCI, V516, P173, DOI 10.1111/j.1749-6632.1987.tb33039.x
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834
   MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TRAVIS J, 1976, BIOCHEM J, V157, P301, DOI 10.1042/bj1570301
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 37
TC 54
Z9 56
U1 0
U2 11
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD OCT
PY 1994
VL 124
IS 4
BP 537
EP 545
PG 9
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA PM244
UT WOS:A1994PM24400013
PM 7523554
DA 2018-10-19
ER

PT J
AU EPPLEY, BL
   SUMMERLIN, DJ
   PREVEL, CD
   SADOVE, AM
AF EPPLEY, BL
   SUMMERLIN, DJ
   PREVEL, CD
   SADOVE, AM
TI EFFECTS OF A POSITIVELY CHARGED BIOMATERIAL FOR DERMAL AND SUBCUTANEOUS
   AUGMENTATION
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE DERMIS; SUBCUTANEOUS AUGMENTATION; INJECTION; DEXTRAN-BASED BIOMATERIAL
AB Based on previous experimental connective tissue work, the use of a positively charged dextran-based biomaterial in subcutaneous tissue sites was evaluated.  After hydration with saline, the biomaterial was injected beneath the abdominal skin in rats.  A robust macrophage response was initially seen at 30 days without acute inflammation.  By one year postoperatively, extensive intermaterial fibroblast and collagen ingrowth had occurred.  No evidence of a foreign-body or chronic inflammatory response was seen.  These preliminary findings suggest good tissue compatibility of this biomaterial and suggests that when combined with a biocompatible liquid medium, the potential for development of a bioactive dermal and subcutaneous injectable substance exists.
RP EPPLEY, BL (reprint author), INDIANA UNIV,MED CTR,DIV PLAST & RECONSTRUCT SURG,702 BARNHILL DR,RM 2514,INDIANAPOLIS,IN 46202, USA.
NR 0
TC 38
Z9 38
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD FAL
PY 1994
VL 18
IS 4
BP 413
EP 416
DI 10.1007/BF00451350
PG 4
WC Surgery
SC Surgery
GA PH869
UT WOS:A1994PH86900013
PM 7817893
DA 2018-10-19
ER

PT J
AU WAGNER, WR
   JOHNSON, PC
   THOMPSON, KA
   MARRONE, GC
AF WAGNER, WR
   JOHNSON, PC
   THOMPSON, KA
   MARRONE, GC
TI HEPARIN-COATED CARDIOPULMONARY BYPASS CIRCUITS - HEMOSTATIC ALTERATIONS
   AND POSTOPERATIVE BLOOD-LOSS
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID COVALENTLY BONDED HEPARIN; INFLAMMATORY RESPONSE; COMPLEMENT ACTIVATION;
   INHIBITION; RELEASE; SURFACE
AB This prospective, randomized study involving patients undergoing isolated coronary artery bypass grafting investigated whether the use of heparin-coated bypass circuits with an uncoated cardiotomy reservoir (n = 10) compared with standard uncoated bypass circuits (n = 10) resulted in differences in patient outcome and hemostatic alterations. There were no differences in postoperative blood loss, transfusion requirements, and routine coagulation test results between groups. Immunoassays for platelet alpha-granule constituents platelet factor 4 and beta-thromboglobulin, thrombin generation byproduct F1.2, fibrinopeptide A, thrombin-antithrombin complex, and fibrinolysis by-product D-dimer also demonstrated no significant differences between groups, although trends for lower platelet secretion with heparin coating were noted. Increases were found in beta-thromboglobulin and platelet factor 4 concentrations at 10 (p < 0.03) and 30 minutes (p < 0.001) of CPB, respectively, and continuing throughout CPB (p < 0.001) for both groups versus values measured before incision. No significant differences were seen between levels 5 minutes prior to aortic cross-clamp release and those obtained 8 and 45 minutes after cross-clamp release. Conversely, no significant increases in F1.2, thrombin-antithrombin complex, and D-dimer were seen prior to release of the aortic cross-clamp, but afterward increases occurred that were highly significant (p < 0.001). The temporal data suggest that platelet activation occurs primarily as a result of contact with the cardiopulmonary bypass circuitry, whereas thrombin generation and fibrinolytic activity are not significant until reperfusion of the heart and lungs. This latter effect may be due to reperfusion injury, humoral mediators generated by blood-biomaterial contact, or rewarming and increased use of cardiotomy suction and return of shed mediastinal blood.
C1 UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA.
CR ARNANDER C, 1988, J BIOMED MATER RES, V22, P859, DOI 10.1002/jbm.820221003
   BONSER RS, 1990, ANN THORAC SURG, V49, P279, DOI 10.1016/0003-4975(90)90150-5
   BUTLER J, 1993, ANN THORAC SURG, V55, P552, DOI 10.1016/0003-4975(93)91048-R
   DOWNING SW, 1992, ANN THORAC SURG, V54, P1236, DOI 10.1016/0003-4975(92)90113-I
   ESQUIVEL CO, 1984, SURGERY, V95, P102
   FAYMONVILLE ME, 1986, J THORAC CARDIOV SUR, V91, P858
   GU YJ, 1993, ANN THORAC SURG, V55, P917, DOI 10.1016/0003-4975(93)90117-Z
   Gu YJ, 1991, PERFUSION, V6, P221
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   KNOBL PN, 1987, J THORAC CARDIOV SUR, V94, P600
   KODAMA K, 1987, THROMB HAEMOSTASIS, V58, P1064
   MARTIN RR, 1979, QUANTITATIVE CARDIOV, P419
   MOLLNES TE, 1991, ANN THORAC SURG, V52, P92, DOI 10.1016/0003-4975(91)91426-V
   NILSSON L, 1990, ARTIF ORGANS, V14, P46
   PASCHE B, 1986, THROMB RES, V44, P739, DOI 10.1016/0049-3848(86)90020-4
   PRADHAN M J, 1991, Perfusion (London), V6, P235, DOI 10.1177/026765919100600313
   Royston D, 1990, Semin Thorac Cardiovasc Surg, V2, P341
   STAHL RF, 1991, J THORAC CARDIOV SUR, V101, P230
   Utley J R, 1990, Semin Thorac Cardiovasc Surg, V2, P292
   VIDEM V, 1992, J THORAC CARDIOV SUR, V103, P806
   von Segesser L K, 1991, Perfusion, V6, P227, DOI 10.1177/026765919100600312
   von Segesser L K, 1990, Semin Thorac Cardiovasc Surg, V2, P373
NR 22
TC 56
Z9 57
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD SEP
PY 1994
VL 58
IS 3
BP 734
EP 740
DI 10.1016/0003-4975(94)90736-6
PG 7
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA PJ395
UT WOS:A1994PJ39500019
PM 7944696
DA 2018-10-19
ER

PT J
AU SINGH, M
   CLARK, WM
AF SINGH, M
   CLARK, WM
TI PARTITIONING OF VANCOMYCIN USING POLY(ETHYLENE GLYCOL)-COUPLED LIGANDS
   IN AQUEOUS 2-PHASE SYSTEMS
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
ID 2-PHASE SYSTEMS; POLYMER SYSTEMS; AFFINITY; PROTEINS
AB Affinity partitioning describes a process in which a biospecific ligand is used to manipulate the partitioning behavior of a biomolecule by coupling a ligand to one of the phase-forming polymers. It combines the high selectivity of affinity chromatography with the scalability of aqueous two-phase extractions. Fundamental studies have been made on the factors affecting affinity partitioning of the antibiotic vancomycin using a series of polymer-ligands composed of the D-Ala-D-Ala peptide coupled to poly(ethylene glycol) in methoxypoly(ethylene glycol)/dextran aqueous two-phase systems. The effects of varying the ligand molecular weight, the ligand binding interaction, the number of binding sites, the tie-line length, and the aggregation of vancomycin have been measured. A modification of the Flanagan and Barondes model for affinity partitioning has been suggested to explain the results. The modified model accounts for the changes in the surface properties of the biomaterial on complex formation.
C1 WORCESTER POLYTECH INST,WORCESTER,MA 01609.
RP SINGH, M (reprint author), UNIV MARYLAND,DEPT CHEM & BIOCHEM ENGN,BALTIMORE,MD 21228, USA.
CR ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175
   Albertsson P. A., 1986, PARTITION CELL PARTI
   ALBERTSSON PA, 1983, METHOD BIOCHEM ANAL, V29, P1
   BASKIR JN, 1989, BIOTECHNOL BIOENG, V34, P541, DOI 10.1002/bit.260340414
   BEAUCHAMP CO, 1983, ANAL BIOCHEM, V131, P25, DOI 10.1016/0003-2697(83)90131-8
   CONNORS KA, 1987, BINDING CONSTANTS
   CORDES A, 1987, BIOTECHNOL BIOENG, V30, P514, DOI 10.1002/bit.260300408
   DIAMOND AD, 1989, BIOTECHNOL BIOENG, V34, P100
   FLANAGAN SD, 1975, J BIOL CHEM, V250, P1484
   GODBOLE PP, 1991, BIOTECHNOL BIOENG, V38, P535, DOI 10.1002/bit.260380512
   HARTOUNIAN H, 1991, BIOTECHNOL PROGR, V7, P279, DOI 10.1021/bp00009a012
   HUSTEDT H, 1978, BIOTECHNOL BIOENG, V20, P1989, DOI 10.1002/bit.260201212
   JOHANSSON G, 1984, J CHROMATOGR, V284, P63, DOI 10.1016/S0021-9673(01)87802-X
   JOHANSSON G, 1983, EUR J BIOCHEM, V131, P589, DOI 10.1111/j.1432-1033.1983.tb07303.x
   LEE CK, 1990, BIOTECHNOL BIOENG, V35, P408, DOI 10.1002/bit.260350408
   LUONG JHT, 1990, BIO-TECHNOL, V8, P306, DOI 10.1038/nbt0490-306
   MOLINARI H, 1990, BIOCHEMISTRY-US, V29, P2271, DOI 10.1021/bi00461a010
   NIETO M, 1971, BIOCHEM J, V124, P845, DOI 10.1042/bj1240845
   NIETO M, 1971, BIOCHEM J, V123, P773, DOI 10.1042/bj1230773
   PERKINS HR, 1969, BIOCHEM J, V111, P195, DOI 10.1042/bj1110195
   SHAFER SG, 1986, J POLYM SCI POL CHEM, V24, P375, DOI 10.1002/pola.1986.080240214
   SINGH M, 1991, THESIS WORCESTER POL
   TSAI RS, 1989, THESIS WORCESTER POL
   Walter H., 1985, PARTITIONING AQUEOUS
NR 24
TC 5
Z9 5
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD SEP-OCT
PY 1994
VL 10
IS 5
BP 503
EP 512
DI 10.1021/bp00029a008
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA PL091
UT WOS:A1994PL09100008
PM 7765375
DA 2018-10-19
ER

PT J
AU CHANDY, T
   KUMAR, BA
   SHARMA, CP
AF CHANDY, T
   KUMAR, BA
   SHARMA, CP
TI INHIBITION OF IN-VITRO CALCIUM-PHOSPHATE PRECIPITATION IN PRESENCE OF
   POLYURETHANE VIA SURFACE MODIFICATION AND DRUG-DELIVERY
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID ORAL SUSTAINED DELIVERY; BOVINE PERICARDIUM; CONTROLLED RELEASE;
   CALCIFICATION; MINERALIZATION; CHITOSAN; INVITRO; PREVENTION; IMPLANTS;
   MATRIX
AB Biomaterial associated calcification is the principal cause of the clinical failure of bioprosthetic implants. The present investigation describes the mineralization of polymeric substrate in an extracirculatory environment and the possible methods of prevention. Calcification was examined on various polyurethane films (and bioprosthetic tissue) incubated in metastable solutions of calcium phosphate and the role of polymer casting and precipitation was evaluated. The formulation and the in vitro efficacy of prolonged controlled-release chitosan matrices, containing the novel anticalcification agents, such as Fe+++ or protamine sulfate (PS), were also attempted. The in vitro release profiles of PS from chitosan beads was performed in a rotating shaker (100 rpm) in 0.1 M phosphate buffer (pH 7.4) and was monitored spectrophotometrically. The amount and percentage of drug release were much higher initially, which was controlled with the incorporation of egg phosphatidyl choline (EPC). The PS loaded chitosan beads (coincubated in calcium phosphate solution with the calcifiable polyurethane films) significantly inhibited biomaterial calcification (about 40-50% inhibition). Surface modification of polyurethanes with Fe+++ or PS also inhibited the calcification profile of the material. These findings suggest the possibility of a combination therapy for prevention of biomaterial associated calcification via surface modifications in conjunction with long-term controlled release of the anticalcifying drugs. (C) 1994 John Wiley & Sons, Inc.
RP CHANDY, T (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,BIOMED TECHNOL WING,TRIVANDRUM 695012,INDIA.
RI Sharma, Chandra/A-4140-2009
OI Sharma, Chandra/0000-0002-6982-0926
CR BANGHAM AD, 1974, METHODS MEMBRANE BIO, V1, P1
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   CHANDY T, 1984, J BIOMED MATER RES, V18, P1115, DOI 10.1002/jbm.820180913
   CHANDY T, 1992, BIOMATERIALS, V13, P949, DOI 10.1016/0142-9612(92)90119-9
   CHANDY T, 1993, BIOMATERIALS, V14, P939, DOI 10.1016/0142-9612(93)90136-P
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1991, Clinical Materials, V8, P33, DOI 10.1016/0267-6605(91)90007-3
   Golomb G, 1987, J Biomater Appl, V2, P266, DOI 10.1177/088532828700200205
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1992, J APPL BIOMATER, V3, P23, DOI 10.1002/jab.770030105
   GOLOMB G, 1992, J MATER SCI-MATER M, V3, P272, DOI 10.1007/BF00705292
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   HOW WM, 1985, CHEM PHARM BULL, V33, P3986
   IWATA H, 1992, J APPL BIOMATER, V3, P269, DOI 10.1002/jab.770030405
   Levy R J, 1985, Trans Am Soc Artif Intern Organs, V31, P459
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LIAN JB, 1981, T AM SOC ART INT ORG, V27, P683
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAGLLIGAN DJ, 1985, J THORAC CARDIOVASC, V89, P499
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   Sharma C P, 1987, J Biomater Appl, V2, P205, DOI 10.1177/088532828700200202
   SUNNY MC, 1992, J BIOMATER APPLICATI, V6, P251
   WHALEN RL, 1980, T AM SOC ART INT ORG, V26, P487
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
NR 30
TC 23
Z9 23
U1 1
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD FAL
PY 1994
VL 5
IS 3
BP 245
EP 254
DI 10.1002/jab.770050310
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PC764
UT WOS:A1994PC76400009
PM 10147451
DA 2018-10-19
ER

PT J
AU BERGER, M
   BROXUP, B
   SEFTON, MV
AF BERGER, M
   BROXUP, B
   SEFTON, MV
TI USING ELISA TO EVALUATE COMPLEMENT ACTIVATION BY REFERENCE BIOMATERIALS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIO-MEDICAL POLYMERS; HEMODIALYSIS; MEMBRANES; LEUKOPENIA; PROTEINS;
   SYSTEM
AB The interaction between blood and an artificial surface results in the activation of complement and can lead to extensive inflammatory reactions. In vitro work was undertaken to validate a system of assays to evaluate the complement activation of a candidate biomaterial by comparing its capacity of activation with that of reference biomaterials. The biomaterials tested were cellulose acetate, cellulose dialysis tubing, low density polyethylene, polydimethylsiloxane and AN69. Complement activation was assessed using ELISA for iC3b, C3a and Factor Bb. Results showed that (1) iC3b measurements may underestimate complement activation, (2) the presence of Bb in plasma or serum was a reliable indicator of complement activation, (3) measurements of C3a are of interest but are difficult, (4) adsorption or/and binding of complement proteins occured on the surface. Evaluation of complement activation for a biomaterial should include the assessment of the fluid phase (in serum or plasma) as well as the bound phase (on the surface of the biomaterial) of complement.
C1 UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A1,ON,CANADA.
RP BERGER, M (reprint author), BIORES LABS,87 SENNEVILLE RD,SENNEVILLE H9X 3R3,PQ,CANADA.
CR BLAJCHMAN MA, 1986, PROG HEMATOL, V14, P149
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1987, ARTIF ORGANS, V11, P155, DOI 10.1111/j.1525-1594.1987.tb02649.x
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   GAWRYL MS, 1986, J IMMUNOL METHODS, V95, P217, DOI 10.1016/0022-1759(86)90409-6
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HUGLI TE, 1980, IMMUNOASSAYS CLIN LA, P443
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A
   LABARRE D, 1993, J APPL BIOMATER, V4, P231, DOI 10.1002/jab.770040304
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484
   MORGAN BP, 1990, COMPLEMENT CLIN ASPE, P1
   PEKNA M, 1993, BIOMATERIALS, V14, P198
   PENGLOAN J, 1991, NEPHROL DIAL TRANS S, V2, P59
   SAWYER AY, 1990, REPORT IUPAC WORKING
   WEGMULLER E, 1986, INT J ARTIF ORGANS, V9, P85
   WOFFINDIN C, 1988, BIOMATERIALS, V9, P53, DOI 10.1016/0142-9612(88)90069-5
   YOSHIKAWA S, 1988, IMPLANT MAT BIOFUNCT, P187
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 21
TC 22
Z9 22
U1 0
U2 10
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 622
EP 627
DI 10.1007/BF00120343
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500012
DA 2018-10-19
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   LETA, R
   BLAAUW, EH
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   LETA, R
   BLAAUW, EH
   NIEUWENHUIS, P
TI MODULATION OF THE TISSUE REACTION TO BIOMATERIALS .1. BIOCOMPATIBILITY
   OF CROSS-LINKED DERMAL SHEEP COLLAGENS AFTER MACROPHAGE DEPLETION
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FIBROBLAST GROWTH-FACTOR; COMPLEMENT-SYSTEM; MONOCYTES; MEMBRANE;
   NECROSIS; DACRON; RATS
AB Although in the last few years in general the biocompatibility of biomaterials has significantly improved, unwanted tissue reactions are often observed resulting in early resorption of the biomaterial, loosening of the implant or in a chronic (immunologic) response. From immunologic studies it is known that inflammatory reactions can be modulated by use of (anti) growth factors or anti-inflammatory drugs. Before this can be employed the role of individual factors (humoral and cellular) involved in the inflammatory reaction against biomaterials has to be studied. In this part of the study the role of macrophages is studied with and without depletion by use of the liposomes-mediated macrophage suicide technique. Crosslinked dermal sheep collagens were used as biodegradable test materials. The results showed that macrophage depletion increases vascularization, and decreases the infiltration of granulocytess into the collagens. The foreign body reaction, i.e. the infiltration of macrophages and giant cells was significantly inhibited, resulting in a strongly delayed degradation time of the biomaterials. However, macrophage depletion did not inhibit attraction of fibroblasts and even resulted in increased formation of autologous rat-collagen, which improved the biocompatibility and the function of the biomaterials as a tempory scaffold.
C1 UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,9713 EZ GRONINGEN,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,CELL BIOL & ELECTRON MICROSCOPY LAB,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
CR ATKINSON JP, 1987, IMMUNOL TODAY, V8, P212, DOI 10.1016/0167-5699(87)90167-8
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   BONFIELD TL, 1993, J BIOMED MATER RES, V27, P1195, DOI 10.1002/jbm.820270910
   BOOTH SA, 1992, J INVEST DERMATOL, V98, P135, DOI 10.1111/1523-1747.ep12555654
   BROWDER W, 1988, SURGERY, V104, P224
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   CHRISTENSON L, 1989, J BIOMATERIALS RES, V32
   COLEMAN SE, 1986, J BIOMED MATER RES, V20, P301, DOI 10.1002/jbm.820200304
   DAMAS J, 1990, EUR J PHARMACOL, V175, P341, DOI 10.1016/0014-2999(90)90573-O
   DAMINK LHH, UNPUB
   DAMINK LHH, UNPUB J MATER SCI MA
   DERIJK R, 1991, ENDOCRINOLOGY, V129, P330, DOI 10.1210/endo-129-1-330
   GRANT MB, 1992, INVEST OPHTH VIS SCI, V33, P3292
   GREISLER HP, 1993, J BIOMAT SCI-POLYM E, V4, P415, DOI 10.1163/156856293X00672
   MARTIN P, 1992, Progress in Growth Factor Research, V4, P25, DOI 10.1016/0955-2235(92)90003-Z
   Mellin T N, 1992, Growth Factors, V7, P1, DOI 10.3109/08977199209023933
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   PASSANITI A, 1992, LAB INVEST, V67, P519
   POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0
   PUTZ D, 1992, INT J ARTIF ORGANS
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   ROOT LL, 1991, IN VITRO CELL DEV B, V27, P815
   ROZEMA FR, 1992, ADV BIOMAT, V10, P349
   TAKXKOHLEN BCMJ, 1992, PHARM WEEKBLAD, V14, P245, DOI 10.1007/BF01962546
   THOMPSON RC, 1992, INT J IMMUNOPHARMACO, V14, P475, DOI 10.1016/0192-0561(92)90178-N
   VANDERMEER JB, 1992, NETH J MED, V40, P244
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANOTTERLOO JCAD, 1992, J VASC SURG, V16, P774
   VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97
   VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6
   VANROOIJEN N, 1992, RES IMMUNOL, V143, P512
   VANWACHEM PB, 1991, CELL MATER, V1, P251
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WAAGE A, 1990, LANCET, V335, P543, DOI 10.1016/0140-6736(90)90779-5
   WOLFF SM, 1991, NEW ENGL J MED, V324, P486, DOI 10.1056/NEJM199102143240709
   ZAOUI P, 1991, KIDNEY INT, V39, P1020, DOI 10.1038/ki.1991.129
NR 36
TC 14
Z9 14
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 671
EP 678
DI 10.1007/BF00120354
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500023
DA 2018-10-19
ER

PT J
AU HERRMANN, K
   GROTH, T
   SEIFERT, B
   ROMANIUK, P
AF HERRMANN, K
   GROTH, T
   SEIFERT, B
   ROMANIUK, P
TI HEPARIN-MODIFIED POLYLACTIDE AS BIODEGRADABLE HEMOCOMPATIBLE BIOMATERIAL
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMMOBILIZED HEPARIN; BIOCOMPATIBILITY
AB Several medical applications may benefit from biodegradable hemocompatible materials. Therefore a commercial biodegradable polylactide (RESOMER(R) R208; Boehringer-lngelheim, Germany) was modified with heparin. The immobilization of heparin was performed by covalent binding with glutaraldehyde as spacer. Reaction conditions were varied to optimize the coupling of heparin. The efficiency of the immobilization and the biological activity of bonded heparin was estimated with a toluidine blue assay and factor Xa assay, respectively. It was shown that an immobilization at ambient temperature and a reaction time of 2 h yielded maximal heparin binding and biological activity. The hemocompatibility of the modified polylactide was tested after blood/material contact with an enzyme immune assay (EIA) for GMP 140, a marker of platelet activation. The investigated materials were compared with polypropylene and Pellethane(R). After modification it was found that high heparin binding and biological activity were correlated with very small activation of platelets.
C1 HUMBOLDT UNIV BERLIN, KLINIKUM CHARITE, BEREICH INTERVENT RADIOL ANGIOL, INST RONTGENDIAGNOST, D-10098 BERLIN, GERMANY.
RP HERRMANN, K (reprint author), HUMBOLDT UNIV BERLIN, KLINIKUM CHARITE, BIOMATFORSCH & MED WERKSTOFFKUNDE, TUCHOLSKYSTR 2, D-10098 BERLIN, GERMANY.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR ALTANKOV G, 1990, HAEMATOLOGIA, V23, P239
   ALTANKOV G, 1988, HAEMATOLOGIA, V21, P99
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDRADE J D, 1992, Clinical Materials, V11, P19, DOI 10.1016/0267-6605(92)90026-P
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   COHN D, P BIOINTERACTIONS, P3
   EBERT CD, 1982, THROMB RES, V26, P43, DOI 10.1016/0049-3848(82)90149-9
   GROTH T, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P183
   GROTH T, 1994, IN PRESS J BIOMATER
   GROTH T, 1991, BIOMED TECHNIK, V36, P324
   KIM S W, 1985, Critical Reviews in Biocompatibility, V1, P229
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LAITINEN O, 1993, J MATER SCI-MATER M, V4, P547, DOI 10.1007/BF00125592
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   PIAO A, 1992, ASAIO T, V36, pM638
   PLATE NA, 1986, ADV POLYM SCI, V79, P95
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   SEDLARIK KM, 1990, BIOMATERIALS, V11, P4, DOI 10.1016/0142-9612(90)90043-P
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   WILLIAMS SK, 1987, ANN NY ACAD SCI, V516, P145, DOI 10.1111/j.1749-6632.1987.tb33037.x
NR 20
TC 8
Z9 8
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 728
EP 731
DI 10.1007/BF00120365
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500034
DA 2018-10-19
ER

PT J
AU PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
AF PELUSO, G
   PETILLO, O
   AMBROSIO, L
   NICOLAIS, L
TI POLYETHERIMIDE AS BIOMATERIAL - PRELIMINARY IN-VITRO AND IN-VIVO
   BIOCOMPATIBILITY TESTING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NYLON WOOL; PATHOGENESIS; FIBER
AB During the last few years, on the basis of their physico-chemical characteristics, thermoplastic materials, already used in several advanced industries, have become very attractive candidates for biomedical applications as matrix for composite femoral stems and bone plates. In the present study, the biocompatibility of a thermoplastic material, polyetherimide (PEI), was investigated both in vivo, and in vitro. Our results show that PEI did not elicit any toxic response in cell culture testing. It was possible to grow on PEI surfaces not only 3T3 fibroblasts but also human endothelial cells (HEC) from human umbilical cord, with no apparent deleterious effects on the cell viability. The attachment, spreading, and growth of cells on PEI material was followed with respect to time. Both the number of adhering HEC, and the spreading area of individual cells, increased as a function of time. The hydrogen peroxide-sensitive dye DCFH-DA was used to examine the functional activity of cells adherent to PEI or control material implants. PEI material did not induce significant DCFH oxidation until day 14, when levels of DCFH oxidation were significantly higher than observed with PDMS negative control, but lower than those observed on Pellethane positive control.
C1 UNIV NAPLES FEDERICO II,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   UNIV NAPLES FEDERICO II,CNR,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
RP PELUSO, G (reprint author), CNR,INST PROT BIOCHEM & ENZYMOL,VIA TOIANO 6,I-80072 ARCO,ITALY.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
CR BASS DA, 1983, J IMMUNOL, V130, P1910
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KESTON AS, 1965, ANAL BIOCHEM, V11, P1, DOI 10.1016/0003-2697(65)90034-5
   KLOCK JC, 1977, J CLIN INVEST, V60, P1183, DOI 10.1172/JCI108871
   KLOCK JC, 1976, BLOOD, V48, P149
   PELUSO G, 1991, BIOMATERIALS, V12, P231, DOI 10.1016/0142-9612(91)90205-O
   PELUSO G, 1991, Clinical Materials, V8, P99, DOI 10.1016/0267-6605(91)90016-9
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   ROBINSON JP, 1988, J LEUKOCYTE BIOL, V43, P304
   STRAIT LH, 1991, MAY T SOC BIOM SCOOT
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   ZIATS NP, 1989, BIOMATERIALS, V9, P5
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 14
TC 31
Z9 31
U1 1
U2 12
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP-OCT
PY 1994
VL 5
IS 9-10
BP 738
EP 742
DI 10.1007/BF00120367
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PU255
UT WOS:A1994PU25500036
DA 2018-10-19
ER

PT J
AU GUO, WD
   ANDERSSON, R
   WILLEN, R
   LJUNGH, A
   WANG, XD
   LIU, XY
   BENGMARK, S
AF GUO, WD
   ANDERSSON, R
   WILLEN, R
   LJUNGH, A
   WANG, XD
   LIU, XY
   BENGMARK, S
TI BACTERIAL TRANSLOCATION AFTER INTRAPERITONEAL IMPLANTATION OF RUBBER
   FRAGMENTS IN THE SPLENECTOMIZED RAT
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
ID TUMOR NECROSIS FACTOR; GUT; INFECTION; TRAUMA; SEPSIS; INTERLEUKIN-1;
   BIOMATERIALS; MACROPHAGE; GENERATION; RELEASE
AB The aim of the present study was to determine the influence of splenectomy on the incidence of enteric bacterial translocation in rats with intraperitoneal rubber drain implantation. Male Sprague-Dawley rats (250-300 g) underwent splenectomy or sham operation 7 days prior to the intraperitoneal implantation of rubber drain fragments (7 cm(2)). Bacterial translocation was measured 2 days after rubber drain implantation. The incidence of bacterial translocation was significantly higher in the group with intraperitoneal rubber drain implantation plus sham splenectomy than in the groups with sham splenectomy plus sham implantation, splenectomy plus sham implantation or splenectomy plus rubber drain implantation. An increase in ileal permeability of I-125-human serum albumin was induced by intraperitoneal rubber drain implantation and ameliorated by splenectomy. Splenectomy also improved the impaired intestinal motility induced by intraperitoneal rubber drain implantation. Histological examination revealed a preserved normal mucosal architecture in splenectomized rats. Thus, splenectomy reduced the rate of enteric bacterial translocation induced by intraperitoneal biomaterial implantation. (C) 1994 Academic Press, Inc.
C1 UNIV LUND HOSP,DEPT PATHOL,S-22185 LUND,SWEDEN.
   UNIV LUND HOSP,DEPT MED MICROBIOL,LUND,SWEDEN.
RP GUO, WD (reprint author), UNIV LUND HOSP,DEPT SURG,S-22185 LUND,SWEDEN.
RI Wang, Xiangdong/F-2913-2014
OI Bengmark, Stig/0000-0003-1809-8889
CR AMSBAUGH DF, 1978, J IMMUNOL, V121, P1483
   ANDERSON JM, 1988, ASAIO, V11, P101
   ANDERSSON R, 1989, ACTA CHIR SCAND, V163, P181
   BATT RM, 1987, GASTROENTEROLOGY, V93, P986, DOI 10.1016/0016-5085(87)90560-9
   BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   CONSTANTOPOULOS A, 1972, J PEDIATR-US, V80, P564, DOI 10.1016/S0022-3476(72)80051-9
   COODWIN JS, 1980, CLIN IMMUNOL IMMUNOP, V15, P106
   Deitch E A, 1987, J Burn Care Rehabil, V8, P475, DOI 10.1097/00004630-198708060-00005
   DEITCH EA, 1991, SURGERY, V109, P269
   DICATALDO A, 1987, BRIT J SURG, V74, P343, DOI 10.1002/bjs.1800740504
   FINK MP, 1991, CRIT CARE MED, V19, P627, DOI 10.1097/00003246-199105000-00009
   GORBACH SL, 1967, GUT, V8, P530, DOI 10.1136/gut.8.6.530
   GREEN JB, 1986, J TRAUMA, V26, P999, DOI 10.1097/00005373-198611000-00007
   GUE M, 1989, GASTROENTEROLOGY, V97, P1101, DOI 10.1016/0016-5085(89)91678-8
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   GUO WD, 1993, J SURG RES, V55, P80, DOI 10.1006/jsre.1993.1112
   HARDING B, 1987, EUR SURG RES, V19, P135, DOI 10.1159/000128692
   Konigswieser H, 1985, Prog Pediatr Surg, V18, P173
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   LLENDE M, 1986, J SURG RES, V40, P85, DOI 10.1016/0022-4804(86)90149-6
   LLOYDSTILL JD, 1975, AM J DIG DIS, V20, P708, DOI 10.1007/BF01070827
   MAEJIMA K, 1984, INFECT IMMUN, V43, P6
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   NIELSEN JL, 1983, SCAND J HAEMATOL, V31, P85
   PATEK PQ, 1989, IMMUNOLOGY, V67, P509
   POUCHE A, 1987, EUR SURG RES, V19, P86, DOI 10.1159/000128685
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REILLY JA, 1991, GASTROENTEROLOGY, V100, P670, DOI 10.1016/0016-5085(91)80010-7
   RUNKEL NSF, 1991, J SURG RES, V51, P18, DOI 10.1016/0022-4804(91)90064-S
   SAVAGE DC, 1968, J EXP MED, V127, P67, DOI 10.1084/jem.127.1.67
   SCOTT LD, 1982, GASTROENTEROLOGY, V82, P737
   SPAETH G, 1990, J TRAUMA, V30, P1267, DOI 10.1097/00005373-199010000-00012
   SUN XM, 1988, J CLIN INVEST, V81, P1328, DOI 10.1172/JCI113459
   TSUJIMOTO M, 1985, P NATL ACAD SCI USA, V82, P7626, DOI 10.1073/pnas.82.22.7626
   WELLS CL, 1987, ARCH SURG-CHICAGO, V122, P48
   ZAMIR O, 1992, AM J SURG, V163, P181, DOI 10.1016/0002-9610(92)90273-T
NR 37
TC 12
Z9 13
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD SEP
PY 1994
VL 57
IS 3
BP 408
EP 415
DI 10.1006/jsre.1994.1162
PG 8
WC Surgery
SC Surgery
GA PC505
UT WOS:A1994PC50500011
PM 8072289
DA 2018-10-19
ER

PT J
AU LI, HC
   KHOR, E
AF LI, HC
   KHOR, E
TI INTERACTION OF COLLAGEN WITH POLYPYRROLE IN THE PRODUCTION OF HYBRID
   MATERIALS
SO POLYMER INTERNATIONAL
LA English
DT Article
DE COLLAGEN; PYRROLE; POLYPYRROLE; HYBRID MATERIALS; BIOMATERIALS
ID ELECTROCHEMICAL POLYMERIZATION; CHEMICAL SYNTHESIS; CALCIFICATION;
   PREVENTION; BIOMATERIAL; MECHANISMS; MODEL
AB A series of collagen-polypyrrole hybrid materials have been synthesized by the chemical polymerization of pyrrole using FeCl3 as initiator in the presence of soluble collagen.  The black color of the resulting materials indicates the presence of polypyrrole while collagen was verified by amino acid analysis of the hybrids.  Collagen incorporation into the hybrid was found to be a function of pyrrole concentration used in the polymerization.  When the concentration of pyrrole was high, the collagen loading was low and vice versa.  This inverse relationship was also found in the hybrids' electrical conductivity.  A 26% collagen content in the hybrid gave a conductivity of 1.4 S cm-1 while a 4% collagen gave a higher value of 62.4 S cm-1.  Thermogravimetric data suggest that the two polymers exist in the hybrid as a blend.  The nature of the interaction of the components in the hybrid is believed to be strong since collagen could not be extracted despite denaturation with sodium dodecylsulfate.
C1 NATL UNIV SINGAPORE,DEPT CHEM,SINGAPORE 0511,SINGAPORE.
CR ALLCOCK HR, 1990, CONT POLYM CHEM, P570
   Baldwin M T, 1991, ASAIO Trans, V37, pM170
   BLYTHE AR, 1979, ELECTRICAL PROPERTIE, P132
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Colthup N. B., 1964, INTRO INFRARED RAMAN
   DESPOSITO L, 1987, FOURIER TRANSFORM IN, V1
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   DONG SJ, 1987, SYNTHETIC MET, V20, P119, DOI 10.1016/0379-6779(87)90551-0
   ETHERINGTON DJ, 1981, J SCI FOOD AGR, V32, P539, DOI 10.1002/jsfa.2740320603
   ETHERINGTON DJ, 1984, J SCI FOOD AGR, V35, P1262
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1989, T SOC BIOMAT, V12, P118
   GOLOMB G, 1987, T SOC BIOMAT, V10, P179
   KATO H, 1991, J PHYS CHEM-US, V19, P6011
   LEI JT, 1992, SYNTHETIC MET, V46, P53, DOI 10.1016/0379-6779(92)90318-D
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LIM JJ, 1974, BIOPOLYMERS, V13, P1791, DOI 10.1002/bip.1974.360130912
   MACHIDA S, 1989, SYNTHETIC MET, V31, P311, DOI 10.1016/0379-6779(89)90798-4
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATA T, 1976, T AM SOC ART INT ORG, V22, P261
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   ODDI L, 1985, MOL CRYST LIQ CRYST, V118, P179, DOI 10.1080/00268948508076207
   PARKER FS, 1971, APPLICATIONS INFRARE
   PEI QB, 1992, J ELECTROANAL CHEM, V322, P153, DOI 10.1016/0022-0728(92)80073-D
   PROCKOP DJ, 1960, ANAL BIOCHEM, V1, P228, DOI 10.1016/0003-2697(60)90050-6
   RAPI S, 1988, SYNTHETIC MET, V24, P217, DOI 10.1016/0379-6779(88)90259-7
   SCHNEIDER B, 1989, Patent No. 8911648
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Street G.B., 1982, MOL CRYST LIQ CRYST, V83, P253
   STREET GB, 1985, MOL CRYST LIQ CRYST, V118, P137, DOI 10.1080/00268948508076201
   TAN WM, 1993, BIOMATERIALS, V14, P1003, DOI 10.1016/0142-9612(93)90193-6
   THOMAS GJ, 1977, INFRARED RAMAN SPECT, P718
   WEBB CL, 1991, AM J PATHOL, V138, P971
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 38
TC 12
Z9 13
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD SEP
PY 1994
VL 35
IS 1
BP 53
EP 59
DI 10.1002/pi.1994.210350105
PG 7
WC Polymer Science
SC Polymer Science
GA PF698
UT WOS:A1994PF69800005
DA 2018-10-19
ER

PT J
AU KAWAGOISHI, N
   NOJIRI, C
   SENSHU, K
   KIDO, T
   NAGAI, H
   KANAMORI, T
   SAKAI, K
   KOYANAGI, H
   AKUTSU, T
AF KAWAGOISHI, N
   NOJIRI, C
   SENSHU, K
   KIDO, T
   NAGAI, H
   KANAMORI, T
   SAKAI, K
   KOYANAGI, H
   AKUTSU, T
TI IN-VITRO EVALUATION OF PLATELET/BIOMATERIAL INTERACTIONS IN AN
   EPIFLUORESCENT VIDEO MICROSCOPY COMBINED WITH A PARALLEL-PLATE FLOW CELL
SO ARTIFICIAL ORGANS
LA English
DT Article
DE EPIFLUORESCENT VIDEO MICROSCOPY; PARALLEL PLATE FLOW CELL; PLATELET;
   MEPACRINE
ID BIOMATERIAL SURFACES; BLOOD COMPATIBILITY; ADHESION; AGGREGATION;
   INVITRO; COPOLYMERS; FIBRINOGEN; ACTIVATION; CHAMBER; EVM
AB Suitable evaluation systems are critical for ranking various biomaterials in order to develop a method to design and synthesize nonthrombogenic biomaterials. We have recently developed an in vitro test system to evaluate platelet/biomaterial interactions in whole blood. The system consists of a parallel plate flow cell and epifluorescent video microscopy (EVM). A glass coverslip coated with a polymer was incorporated into the flow cell, and blood was perfused using a syringe pump via a polymer-coated PVC tubing connected to the flow cell. Whole human blood was anticoagulated with heparin (2 U/ml), and the platelets were labeled with the fluorescent dye mepacrine (5 mu M). This system permitted real-time and dynamic observations of platelet/biomaterial interactions in whole blood under a defined flow condition. In order to evaluate the feasibility of this system, two different segmented polyether-poryurethanes (SPEUs), PU-PTMG(650) and PU-PTMG(2000), were chosen as test polymers. Surface characteristics verified with electron spectroscopy for chemical analysis (ESCA) and contact angle measurements showed similar results in both SPEUs. Blood was perfused at a wall shear rate of 200 s(-1) for 20 min. Excitation light was applied for 2 s at 1 min intervals. The real-time image was then analyzed at each time point for the percentage of surface area of platelet coverage. Plasma beta-thromboglobulin (beta-TG) levels were also measured before and after each run. PU-PTMG(650) showed a significantly higher number of adhered platelets than PU-PTMG(2000) at each time point. beta-TG levels of PU-PTMG(650) were also higher than those of PU-PTMG(2000), which is comparable to the results of EVM. Thus, this EVM system has been proven to be an excellent and highly sensitive in vitro analytical method for evaluating platelet/biomaterial interactions.
C1 TERUMO CO LTD,CTR RES & DEV,INST BIOMED SCI,NAKAI,KANAGAWA 25901,JAPAN.
   WASEDA UNIV,DEPT CHEM ENGN,TOKYO,JAPAN.
   TOKYO WOMENS MED COLL,TOKYO 162,JAPAN.
CR Andrade J. D., 1987, ASAIO J, V33, P75
   BAMFORD CH, 1986, BIOCHIM BIOPHYS ACTA, V886, P109, DOI 10.1016/0167-4889(86)90216-8
   CASTNER DG, 1992, J BIOMAT SCI-POLYM E, V3, P463, DOI 10.1163/156856292X00448
   GRABOWSKI EF, 1990, BLOOD, V75, P390
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HAYCOX CL, 1991, J BIOMED MATER RES, V25, P1317, DOI 10.1002/jbm.820251011
   HOCHMUTH RM, 1973, BIOPHYS J, V13, P747, DOI 10.1016/S0006-3495(73)86021-7
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   JEN CJ, 1991, AM J PHYSIOL, V261, pH1457
   KAPLAN KL, 1979, BLOOD, V53, P604
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449
   KIM SW, 1987, ANN NY ACAD SCI, V516, P116
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MCCLUNG WG, 1992, BIOMATERIALS, V13, P871, DOI 10.1016/0142-9612(92)90181-M
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1987, AM SOC ARTIF INTERN, V10, P596
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   SAKARIASSEN KS, 1983, J LAB CLIN MED, V102, P522
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   TANGELDER GJ, 1982, THROMB RES, V28, P803, DOI 10.1016/0049-3848(82)90106-2
   TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   WAGNER JL, 1984, ANAL BIOCHEM, V136, P75, DOI 10.1016/0003-2697(84)90308-7
   YUI N, 1992, T BIOMATERIALS, P678
NR 27
TC 17
Z9 17
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 1994
VL 18
IS 8
BP 588
EP 595
DI 10.1111/j.1525-1594.1994.tb03383.x
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA PE215
UT WOS:A1994PE21500008
PM 7993194
DA 2018-10-19
ER

PT J
AU IKADA, Y
AF IKADA, Y
TI SURFACE MODIFICATION OF POLYMERS FOR MEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Molecular Aspects of Biomaterials
   (BIOINTERACTIONS 93)
CY AUG 29-SEP 01, 1993
CL NOORDWIJKERHOUT, NETHERLANDS
DE POLYMER SURFACE MODIFICATION; GRAFT POLYMERIZATION; COUPLING REACTIONS
ID GRAFT-POLYMERIZATION; POLYETHYLENE OXIDE; IMMOBILIZATION; MICROSPHERES;
   LUBRICATION; REDUCTION; GLYCOL)
AB Most of the conventional materials do not meet the demands required for both their surface and bulk properties when used as biomaterials. An effective approach for developing a clinically applicable biomaterial is to modify the surface of the material which already has excellent biofunctionality and bulk properties. This review article focuses on the surface modification of polymers by grafting techniques, which have long been known in polymer chemistry but are not yet widely applied to biomaterials. A grafted surface can be produced primarily either by graft polymerization of monomers or covalent coupling reaction of existing polymer molecules onto the substrate polymer surface. The major surface properties that should be modified include two kinds of biocompatibility. One is the surface property that elicits the least foreign-body reactions and the other is the cell- and tissue-bonding capability. In addition, physiologically active surfaces with, for instance, selective adsorbability may be required. Attempts to produce these biocompatible or biospecific surfaces by grafting techniques are briefly overviewed in this article.
RP IKADA, Y (reprint author), KYOTO UNIV,BIOMED ENGN RES CTR,53 KAWAHARA CHO,KYOTO 606,JAPAN.
CR BARBUCCI R, 1985, ADV BIOMEDICAL POLYM, P259
   BIANCHI JJ, 1993, AM SOC ARTIF INTERN, pM143
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   FALLON RJ, 1985, HEPATOLOGY, V5, P899, DOI 10.1002/hep.1840050532
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   FUJIMOTO K, 1993, J APPL BIOMATER, V4, P347, DOI 10.1002/jab.770040409
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P441
   HAYASHI T, 1990, BIOTECHNOL BIOENG, V35, P518, DOI 10.1002/bit.260350510
   IKADA Y, 1994, ACS SYM SER, V540, P35
   Ikada Y, 1993, LUBRICATING POLYM SU
   IKEUCHI K, 1993, WEAR, V161, P179, DOI 10.1016/0043-1648(93)90467-Z
   INOUE H, 1992, CELL MATER, V2, P21
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   KATCHALSKI EK, 1982, ENZYME ENG
   KATO K, 1993, 7TH P INT C POLYM ME, P193
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P546, DOI 10.1016/0142-9612(93)90244-V
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   KULIK EA, 1993, BIOMATERIALS, V14, P763, DOI 10.1016/0142-9612(93)90041-Y
   KULIK EA, 1993, UNPUB J POLYM SCI A
   MESSERSCHMDIT GL, 1986, J CLIN ONCOL, V6, P203
   OKADA T, 1992, J BIOMED MATER RES, V26, P1569, DOI 10.1002/jbm.820261204
   OKADA T, 1994, IN PRESS J BIOMATERI
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SIGOTLUIZARD MF, 1984, J BIOMED MATER RES, V18, P895, DOI 10.1002/jbm.820180805
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TABATA Y, 1989, J COLLOID INTERF SCI, V127, P132, DOI 10.1016/0021-9797(89)90013-1
   TABATA Y, 1991, CRIT REV THER DRUG, V7, P121
   TAMADA Y, 1986, POLYM MED, V2
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   TOMITA N, 1993, 15TH P ANN M JAP SOC, P47
   TRETINNIKOV ON, 1994, IN PRESS J BIOMED MA
   TSAI CC, 1988, T AM SOC ART INT ORG, V34, P559
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   VANBLITTERSWIJK CA, 1991, BIOMATERIALS, V12, P187, DOI 10.1016/0142-9612(91)90198-J
   VONSEGESSER LK, 1992, J THORAC CARDIOV SUR, V103, P790
NR 39
TC 459
Z9 491
U1 6
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1994
VL 15
IS 10
BP 725
EP 736
DI 10.1016/0142-9612(94)90025-6
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PC347
UT WOS:A1994PC34700002
PM 7986935
DA 2018-10-19
ER

PT J
AU COURTNEY, JM
   LAMBA, NMK
   SUNDARAM, S
   FORBES, CD
AF COURTNEY, JM
   LAMBA, NMK
   SUNDARAM, S
   FORBES, CD
TI BIOMATERIALS FOR BLOOD-CONTACTING APPLICATIONS
SO BIOMATERIALS
LA English
DT Article
DE BIOMATERIALS; BLOOD-BIOMATERIAL INTERACTIONS; EVALUATION
ID POLYMER SURFACES; CELLULOSE MEMBRANE; PLATELET-ADHESION; HUMAN-PLASMA;
   FIBRINOGEN; PHOSPHORYLCHOLINE; BIOMEMBRANES; MODELS; COMPATIBILITY;
   ADSORPTION
AB Consideration of biomaterials for blood-contacting applications should take into account blood-biomaterial interactions, factors influencing the blood response and evaluation procedures. Examination of blood-biomaterial interactions indicates that relevant features are protein adsorption, platelet reactions, intrinsic coagulation, fibrinolytic activity, erythrocytes, leucocytes and complement activation. Factors influencing the blood response to a biomaterial in clinical application are the biomaterial structure, the presence of an antithrombotic agent, the patient status as determined by the disease and drug therapy, and the nature of the application. Evaluation options for biomaterials are clinical, in vivo, ex vivo and in vitro, with ex vivo and in vitro procedures relevant for biomaterial development.
C1 NINEWELLS HOSP & MED SCH, DEPT MED, DUNDEE DD1 95Y, SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE, BIOENGN UNIT, GLASGOW G4 0NW, SCOTLAND.
CR ABSOLOM DR, 1979, T AM SOC ART INT ORG, V25, P152
   ADAMS AL, 1978, J COLLOID INTERF SCI, V65, P468, DOI 10.1016/0021-9797(78)90098-X
   ADAMS GA, 1981, T AM SOC ART INT ORG, V27, P219
   ADLER AJ, 1981, ASAIO J, V4, P100
   ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   BLASS CR, 1992, INT J ARTIF ORGANS, V15, P200
   BOSCH T, 1987, ARTIF ORGANS, V11, P144, DOI 10.1111/j.1525-1594.1987.tb02647.x
   BOWRY SK, 1984, BIOMATERIALS, V5, P289, DOI 10.1016/0142-9612(84)90075-9
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   BRUCK SD, 1982, BIOMATERIALS, V3, P121, DOI 10.1016/0142-9612(82)90047-3
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHAPMAN D, 1992, CHEM BRIT, V28, P253
   CHENOWETH DE, 1986, T AM SOC ART INT ORG, V32, P226
   CHUANG HYK, 1979, THROMB RES, V14, P273, DOI 10.1016/0049-3848(79)90237-8
   COLEMAN DL, 1986, J BIOMED MATER RES, V20, P416
   COURTNEY JM, 1993, INT J ARTIF ORGANS, V16, P164
   COURTNEY JM, 1993, ARTIF ORGANS, V17, P260
   COURTNEY JM, 1993, MANAGEMENT BLEEDING, P236
   COURTNEY JM, 1993, EDTNA ERCA J S1, V19, P29
   COURTNEY JM, 1989, PROGR BIOENGINEERING, P21
   COURTNEY JM, 1991, INFLUENCE NEW TECHNO, P154
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   CUMMING RD, 1980, T AM SOC ART INT ORG, V26, P304
   DAVIES GC, 1980, CIRCULATION, V61, P808, DOI 10.1161/01.CIR.61.4.808
   DIDISHEIM P, 1989, T AM SOC ART INT ORG, V35, P54
   DIMINNO G, 1983, BLOOD, V61, P140
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   DURRANI AA, 1987, POLYM SURFACES INTER, P189
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   EVANS G, 1968, SURGERY, V64, P273
   FELJEN J, 1977, ARTIF ORGANS, P235
   FEUERSTEIN IA, 1975, T AM SOC ART INT ORG, V21, P427
   FORBES CD, 1978, BRIT MED BULL, V34, P201, DOI 10.1093/oxfordjournals.bmb.a071492
   FORBES CD, 1994, HAEMOSTASIS THROMBOS, V2, P1301
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA, P215
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   GRIFFIN JH, 1979, SEMIN THROMB HEMOST, V5, P254
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   HALL B, 1989, BIOMATERIALS, V10, P219, DOI 10.1016/0142-9612(89)90096-3
   HARRISON MJ, 1966, THROMB DIATH HAEMOST, V16, P105, DOI 10.1055/s-0038-1655631
   HAYWARD JA, 1986, BIOMATERIALS, V7, P252, DOI 10.1016/0142-9612(86)90045-1
   HAYWARD JA, 1986, BIOMATERIALS, V7, P126, DOI 10.1016/0142-9612(86)90069-4
   HENSON PM, 1981, PLATELETS BIOL PATHO, P265
   HERZLINGER GA, 1980, T AM SOC ART INT ORG, V26, P165
   HORBETT TA, 1984, THROMB RES, V36, P599, DOI 10.1016/0049-3848(84)90199-3
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1992, BIOMATERIALS, V13, P235, DOI 10.1016/0142-9612(92)90190-Y
   KAGANOV AL, 1976, J BIOMED MATER RES, V10, P1, DOI 10.1002/jbm.820100102
   KAMBIC HE, 1983, BIOCOMPATIBLE POLYM, P179
   KAMBIC HE, 1991, BLOOD COMPATIBLE MAT, P141
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Kim SW, 1983, ASAIO J, V6, P76
   KLINEFELTER H F, 1984, P1
   Klinkmann H., 1987, UREMIA THERAPY, P125
   KOJIMA M, 1991, BIOMATERIALS, V12, P121, DOI 10.1016/0142-9612(91)90189-H
   KORNECKI E, 1981, J BIOL CHEM, V256, P5696
   KURZ H, 1985, CLIN NEPHROL, V24, P1
   KUSSEROW B, 1971, FED PROC, V30, P1516
   Larm O., 1989, HEPARIN CHEM BIOL PR, P597
   LEDERMAN DM, 1978, T AM SOC ART INT ORG, V24, P557
   LINDSAY RM, 1980, T AM SOC ART INT ORG, V26, P603
   LYMAN DJ, 1979, THROMB DIATH HAEMO, V23, P120
   MAHIOUT A, 1987, ARTIF ORGANS, V11, P149, DOI 10.1111/j.1525-1594.1987.tb02648.x
   MASON R G, 1976, Seminars in Thrombosis and Hemostasis, V3, P98
   Mason R G, 1979, Pathobiol Annu, V9, P1
   Mason R G, 1972, Prog Hemost Thromb, V1, P141
   MASON RG, 1977, ARCH PATHOL LAB MED, V101, P61
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   MUSTARD JF, 1977, BRIT MED BULL, V33, P187, DOI 10.1093/oxfordjournals.bmb.a071434
   NEEDLEMAN SW, 1982, HEMOSTASIS THROMBOSI, P716
   NIEMETZ J, 1972, J CLIN INVEST, V51, P307, DOI 10.1172/JCI106815
   NOSE Y, 1988, ARTIF ORGANS, V12, P1
   Owen D R, 1985, Trans Am Soc Artif Intern Organs, V31, P240
   PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   PHILLIPS DR, 1980, J BIOL CHEM, V255, P1629
   PLOW EF, 1980, BLOOD, V56, P553
   QUIJADA VE, 1993, MANAGEMENT BLEDDING, P149
   RATNOFF OD, 1977, HAEMOSTASIS BIOCH PH, P25
   RATNOFF OD, 1984, DISORDERS HAEMOSTASI
   RICHARDSON PD, 1977, P EUR SOC ARTIF ORGA, V4, P175
   RIEGER H, 1980, THROMB HAEMOSTASIS, V44, P166
   RINGOIR S, 1990, CONTRIB NEPHROL, V82, P102
   SABA HI, 1973, P SOC EXP BIOL MED, V142, P614
   Salzman E W, 1969, J Biomed Mater Res, V3, P69
   SHUMAN MA, 1980, J CLIN INVEST, V65, P307, DOI 10.1172/JCI109673
   SUNDARAM S, 1992, INT J ARTIF ORGANS, V15, P243
   SUNDARAM S, 1993, INT J ARTIF ORGANS, V16, P363
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P1
   VROMAN L, 1980, BLOOD, V55, P156
   VROMAN L, 1983, BIOCOMPATIBLE POLYM, P81
   WALSH PN, 1985, HEMOSTASIS THROMBOSI, P404
   Waugh D F, 1969, J Biomed Mater Res, V3, P145, DOI 10.1002/jbm.820030112
   WRIGHT DG, 1978, BLOOD, V52, P770
   WRNG D, 1991, ARTIF ORGANS, V15, P307
   YOUNG BR, 1983, T AM SOC ART INT ORG, V29, P442
   YOUNG BR, 1982, ADV CHEM SER, P317
   YOUNG BR, 1982, T AM SOC ART INT ORG, V28, P498
   YU J, 1991, BIOMATERIALS, V12, P119, DOI 10.1016/0142-9612(91)90188-G
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 104
TC 175
Z9 179
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1994
VL 15
IS 10
BP 737
EP 744
DI 10.1016/0142-9612(94)90026-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PC347
UT WOS:A1994PC34700003
PM 7986936
DA 2018-10-19
ER

PT J
AU MACK, D
   NEDELMANN, M
   KROKOTSCH, A
   SCHWARZKOPF, A
   HEESEMANN, J
   LAUFS, R
AF MACK, D
   NEDELMANN, M
   KROKOTSCH, A
   SCHWARZKOPF, A
   HEESEMANN, J
   LAUFS, R
TI CHARACTERIZATION OF TRANSPOSON MUTANTS OF BIOFILM-PRODUCING
   STAPHYLOCOCCUS-EPIDERMIDIS IMPAIRED IN THE ACCUMULATIVE PHASE OF BIOFILM
   PRODUCTION - GENETIC IDENTIFICATION OF A HEXOSAMINE-CONTAINING
   POLYSACCHARIDE INTERCELLULAR ADHESIN
SO INFECTION AND IMMUNITY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SCANNING ELECTRON-MICROSCOPY; SLIME
   PRODUCTION; EXTRACELLULAR SLIME; CATHETERS INVITRO; ADHERENCE;
   INFECTIONS; AUREUS; PLASMID; VIRULENCE
AB The primary attachment to polymer surfaces followed by accumulation in multilayered cell clusters leads to production of Staphylococcus epidermis biofilms, which are thought to contribute to virulence in biomaterial-related infections. We isolated Tn917 transposon mutants of biofilm-producing S. epidermidis 13-1, which were completely biofilm negative. In pulsed-field gel electrophoresis no obvious deletions of the mutants were noted. The Tn917 insertions of mutants M10 and M11 were located on different EcoRI fragments but on identical 60-kb SmaI and 17-kb BamHI chromosomal fragments. Linkage of transposon insertions of mutants M10 and M11 with the altered phenotype was demonstrated by phage transduction, whereas the several other mutants apparently represented spontaneous variants. In a primary attachment assay with polystyrene spheres, no significant difference between any of the mutants and the wild type could be detected. Cell clustering as an indication of intercellular adhesion, which is a prerequisite for accumulation in multilayered cell clusters, was not detected with any mutant. These results demonstrate that the mutants were impaired in the accumulative phase of biofilm production. Mutants M10 and M11 did not produce detectable amounts of a specific polysaccharide antigen (Ii. Mack, N. Siemssen, and R. Laufs, Infect. Immun. 60:2048-2057, 1992), whereas substantially reduced amounts of antigen were produced by the spontaneous variants. Hexosamine was determined as the major specific component of the antigen enriched by gel filtration of biofilm-producing S. epidermidis 1457 because almost no hexosamine was detected in material prepared from the isogenic biofilm-negative transductant 1457-M11, which differentiates the antigen from other S. epidermidis polysaccharide components. Our results provide direct genetic evidence for a function of the antigen in the accumulative phase of biofilm production by S. epidermidis by mediating intercellular adhesion.
C1 UNIV WURZBURG,INST HYG & MIKROBIOL,D-97080 WURZBURG,GERMANY.
RP MACK, D (reprint author), UNIV HAMBURG,KRANKENHAUS EPPENDORF,INST MED MIKROBIOL & IMMUNOL,MARTINISTR 52,D-20246 HAMBURG,GERMANY.
CR Ames BN., 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   BAYSTON R, 1990, J CLIN PATHOL, V43, P866, DOI 10.1136/jcp.43.10.866
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHAPLIN MF, 1986, CARBOHYDRATE ANAL, P1
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   DEAN BA, 1973, J HYG-CAMBRIDGE, V71, P261, DOI 10.1017/S0022172400022737
   DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442
   DESAXE MJ, 1978, ZBL BAKT-INT J MED M, V241, P46
   DIAZMITOMA F, 1987, J INFECT DIS, V156, P555
   DREWRY DT, 1990, J CLIN MICROBIOL, V28, P1292
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   DUNNE WM, 1987, PEDIATR INFECT DIS J, V6, P1031
   ESPERSEN F, 1990, APMIS, V98, P471, DOI 10.1111/j.1699-0463.1990.tb01059.x
   FOSTER TJ, 1991, VACCINE, V9, P221, DOI 10.1016/0264-410X(91)90103-D
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   GOLDMANN DA, 1993, CLIN MICROBIOL REV, V6, P176
   GRUTER L, 1993, MICROBIOL IMMUNOL, V37, P35
   GRUTER L, 1991, FEMS MICROBIOL LETT, V82, P215
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HUSSAIN M, 1992, J MED MICROBIOL, V37, P368, DOI 10.1099/00222615-37-6-368
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   HUSSAIN M, 1993, FEMS MICROBIOL LETT, V104, P191, DOI 10.1016/0378-1097(93)90596-T
   HUSSAIN M, 1991, J INFECT DIS, V163, P534, DOI 10.1093/infdis/163.3.534
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   KAYSER FH, 1972, ANTIMICROB AGENTS CH, V2, P217, DOI 10.1128/AAC.2.3.217
   LaneSmith R, 1979, ANAL BIOCHEM, V98, P478
   LUDWICKA A, 1984, ZBL BAKT-INT J MED M, V258, P256, DOI 10.1016/S0176-6724(84)80043-7
   MACK D, 1992, INFECT IMMUN, V60, P2048
   MACK D, UNPUB
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9
   MULLER E, 1993, INFECT IMMUN, V61, P551
   MULLER E, 1993, J INFECT DIS, V168, P1211, DOI 10.1093/infdis/168.5.1211
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PETERS G, 1981, ZBL BAKT MIK HYG B, V173, P293
   Peters GF, 1987, ZENTRALBLATT BAKTE S, V16, P15
   PFALLER M A, 1988, Clinical Microbiology Reviews, V1, P281
   ROSDAHL VT, 1990, APMIS, V98, P299, DOI 10.1111/j.1699-0463.1990.tb01036.x
   Sambrook J., 1989, MOL CLONING LABORATO
   SCHMITT DD, 1986, ARCH SURG-CHICAGO, V121, P89
   SCHWARZKOPF A, 1993, J CLIN MICROBIOL, V31, P2281
   SWANSTROM M, 1951, P SOC EXP BIOL MED, V78, P372
   THOMAS WD, 1992, PLASMID, V27, P164, DOI 10.1016/0147-619X(92)90017-5
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TOWNSEND DE, 1985, LETT APPL MICROBIOL, V1, P87, DOI 10.1111/j.1472-765X.1985.tb01496.x
   TOWNSEND DE, 1985, J MED MICROBIOL, V20, P169, DOI 10.1099/00222615-20-2-169
   UDO EE, 1990, FEMS MICROBIOL LETT, V72, P183, DOI 10.1016/0378-1097(90)90369-2
   UDO EE, 1990, J MED MICROBIOL, V31, P207, DOI 10.1099/00222615-31-3-207
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
   Youngman Philip, 1993, P585
NR 59
TC 215
Z9 222
U1 0
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD AUG
PY 1994
VL 62
IS 8
BP 3244
EP 3253
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA NY872
UT WOS:A1994NY87200028
PM 8039894
DA 2018-10-19
ER

PT J
AU GARCIA, AJ
   DUCHEYNE, P
AF GARCIA, AJ
   DUCHEYNE, P
TI NUMERICAL-ANALYSIS OF EXTRACELLULAR FLUID-FLOW AND CHEMICAL-SPECIES
   TRANSPORT AROUND AND WITHIN POROUS BIOACTIVE GLASS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID CALCIUM-PHOSPHATE FORMATION; OSTEOBLAST-LIKE CELLS; CHEMOTACTIC
   RESPONSE; MESENCHYMAL CELLS; SURFACE; INVITRO; ADHESION; PROTEIN
AB Modeling of the physical phenomena present at the biomaterial-tissue interface provides a valuable tool for examining the underlying mechanisms which influence the overall behavior of the implant-host system. Based on histological data from a previous implantation study (E. Schepers, M. De Clercq, P. Ducheyne, and R. Kempeneers, ''Bioactive glass particulate materials as a filler for bone lesions,'' J. Oral Rehab.; 18, 439-452, 1991, Ref. 1) which documented the differentiation of mesenchymal cells to cells expressing the osteoblastic phenotype in porous bioactive glass, a finite element momentum and mass transport model was constructed. In this analysis, the extracellular compositional variations and fluid flow conditions around and within porous bioactive glass granules were determined. Numerical simulations demonstrated that the interstitial fluid flow around these granules (300-360 mu m) is viscosity dominated (low Reynolds number flow) and that the fluid inside the granules remains stagnant. This velocity field results in shear stresses proportional to the velocity gradient at the granule-fluid interface outside the particles and no shear stresses inside the particles. A parametric study on the effect of interstitial fluid flow on chemical species (Na+, Ca+2, HPO4-2) transport outside the granules revealed three domains. At low velocities (0-0.1 mu m/s), the transport of species is diffusion controlled. At intermediate velocities (1.0-10 mu m/s), diffusion and convection contribute to the species transport. The concentration of chemical species is nearly uniform at high velocities (100-800 mu m/s). For all three cases, the transport of chemical species within the granules is diffusion controlled. The differences in transport mechanisms and interstitial fluid flow conditions lead to variations in concentrations, reaction rates, and shear stresses between the inside and the outside of the glass granules. These differences may influence cellular migration, attachment, differentiation, and the overall response to these bioactive materials. (C) 1994 John Wiley and Sons, Inc.
RP GARCIA, AJ (reprint author), UNIV PENN,DEPT BIOENGN,220 S 33RD ST,PHILADELPHIA,PA 19104, USA.
CR ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   BERNE RM, 1988, PHYSIOLOGY
   BIRD RB, 1960, TRANSPORT PHENOMENA
   BISHOP JACK G., 1959, JOUR DENTAL RES, V38, P244, DOI 10.1177/00220345590380020501
   Broyden C.G., 1965, MATH COMPUT, V19, P577, DOI DOI 10.1090/S0025-5718-1965-0198670-6
   CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385
   Crone C, 1979, Int Rev Physiol, V18, P149
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   Ducheyne P, 1993, BONE BIOACTIVE BIOMA, P1
   EVANS HE, 1979, MILLERS ANATOMY DOG
   FORRESTER JV, 1984, J CELL SCI, V70, P93
   HEISE U, 1990, INT ORTHOP, V14, P329
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES 1, V5, P49
   Hille B., 1992, IONIC CHANNELS EXCIT
   JOHNSON MW, 1982, J BIOMECH, V15, P881, DOI 10.1016/0021-9290(82)90054-9
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KUFAHL RH, 1990, J BIOMECH, V23, P171, DOI 10.1016/0021-9290(90)90350-C
   LANDESMAN R, 1986, CALCIFIED TISSUE INT, V39, P259, DOI 10.1007/BF02555215
   LAWRENCE MB, 1987, BLOOD, V70, P1284
   LUCAS PA, 1989, BONE, V10, P459, DOI 10.1016/8756-3282(89)90079-3
   LUCAS PA, 1988, BONE, V9, P319, DOI 10.1016/8756-3282(88)90016-6
   Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299
   Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   PADLEY RA, 1991, J PERIODONTOL, V62, P15, DOI 10.1902/jop.1991.62.1.15
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   ROUSH JK, 1989, AM J VET RES, V50, P904
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   SCHEPERS E, 1993, IN PRESS 6TH P INT S
   SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987
   TIDWELL JK, 1992, INT J ORAL MAX SURG, V21, P204, DOI 10.1016/S0901-5027(05)80219-X
   WILLIAMS DF, 1986, J DENT, V14, P185, DOI 10.1016/0300-5712(86)90001-1
NR 35
TC 16
Z9 16
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1994
VL 28
IS 8
BP 947
EP 960
DI 10.1002/jbm.820280814
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NY064
UT WOS:A1994NY06400013
PM 7983093
DA 2018-10-19
ER

PT J
AU YU, JL
   LJUNGH, A
   ANDERSSON, R
   JAKAB, E
   BENGMARK, S
   WADSTROM, T
AF YU, JL
   LJUNGH, A
   ANDERSSON, R
   JAKAB, E
   BENGMARK, S
   WADSTROM, T
TI PROMOTION OF ESCHERICHIA-COLI ADHERENCE TO RUBBER SLICES BY ADSORBED
   FIBRONECTIN
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID BILIARY STENTS; STAPHYLOCOCCUS-EPIDERMIDIS; BILE; ADSORPTION;
   VITRONECTIN; FIBRINOGEN; BINDING; TRACT; ENDOPROSTHESES; INFECTION
AB Biomaterial associated infections are a problem in the use of endoprosthetic materials in the palliative treatment of malignant obstructive jaundice. Fibronectin has been reported to mediate adherence of bacteria to host tissue and biomaterials. Adsorption of fibronectin to rubber-representing material used for biliary drainage-and subsequent adherence of Escherichia coli strain PSS1 and E. coli strain NG7C (which binds to immobilised fibronectin) were investigated. Quantitative adsorption of fibronectin to rubber slices was studied with I-125-labelled, purified human plasma fibronectin. In buffer solutions, fibronectin showed a high affinity for rubber slices. Adherence of the E. coli strains to uncoated rubber slices tvas similar and was significantly inhibited by the presence of plasma components and bile. Adherence of E. coli PSS1 to fibronectin-coated slices was poor. In contrast, E. coli NG7C adhered efficiently to coated slices in proportion to the amount of adsorbed fibronectin; adherence was not reduced by the presence of albumin or bile, or the fibronectin binding ligands gelatin, heparin and fibrinogen. However, pre-digestion of coated slices with trypsin Significantly reduced adherence.
C1 LUND UNIV, DEPT SURG, LUND, SWEDEN.
   LUND UNIV, DEPT MED MICROBIOL, LUND, SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR CHIJIIWA K, 1991, BIOCHIM BIOPHYS ACTA, V1086, P44, DOI 10.1016/0005-2760(91)90152-8
   COTTON PB, 1987, GASTROINTEST ENDOSC, V33, P411, DOI 10.1016/S0016-5107(87)71675-7
   DOWIDAR N, 1992, SCAND J GASTROENTERO, V27, P77, DOI 10.3109/00365529209011171
   DOWIDAR N, 1991, SCAND J GASTROENTERO, V26, P1132, DOI 10.3109/00365529108998604
   DOWSETT JF, 1988, AM J GASTROENTEROL, V83, P1328
   EVANS DG, 1977, INFECT IMMUN, V18, P330
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   GIBBONS RJ, 1976, INFECT IMMUN, V14, P1109
   GRAY ED, 1984, LANCET, V1, P365
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRISTINA AG, 1990, PATHOGENESIS OF WOUND AND BIOMATERIAL-ASSOCIATED INFECTIONS, P193
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   KLEBE RJ, 1981, J CELL PHYSIOL, V109, P481, DOI 10.1002/jcp.1041090314
   LEUNG JWC, 1988, GASTROINTEST ENDOSC, V34, P19, DOI 10.1016/S0016-5107(88)71223-7
   LJUNGH A, 1990, ZBL BAKT-INT J MED M, V274, P126, DOI 10.1016/S0934-8840(11)80982-5
   LJUNGH A, 1991, CURR MICROBIOL, V22, P97, DOI 10.1007/BF02105383
   MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2
   Mosher D. F., 1989, FIBRONECTIN
   NAIDU AS, 1988, J CLIN MICROBIOL, V26, P1549
   OCONNOR MJ, 1984, SURG FORUM, V35, P122
   PONCHON T, 1989, GASTROINTEST ENDOSC, V35, P490, DOI 10.1016/S0016-5107(89)72896-0
   REUBEN A, 1984, HEPATOLOGY, V4, pS46, DOI 10.1002/hep.1840040808
   SOEHENDRA N, 1980, ENDOSCOPY, V12, P8, DOI 10.1055/s-2007-1021702
   SPEER AG, 1985, GASTROINTEST ENDOSC, V31, P140
   SPEER AG, 1986, GASTROINTEST ENDOSC, V32, P156
   SUNG JY, 1992, DIGEST DIS SCI, V37, P689, DOI 10.1007/BF01296423
   TRAMS EG, 1957, AM J PATHOL, V33, P13
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   WILTON PB, 1987, J SURG RES, V42, P434, DOI 10.1016/0022-4804(87)90179-X
NR 32
TC 9
Z9 9
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD AUG
PY 1994
VL 41
IS 2
BP 133
EP 138
DI 10.1099/00222615-41-2-133
PG 6
WC Microbiology
SC Microbiology
GA PB918
UT WOS:A1994PB91800009
PM 8046737
OA Bronze
DA 2018-10-19
ER

PT J
AU KAKU, M
   GRIMMINGER, LC
   SOGAH, DY
   HAYNIE, SL
AF KAKU, M
   GRIMMINGER, LC
   SOGAH, DY
   HAYNIE, SL
TI NEW FLUORINATED OXAZOLINE BLOCK-COPOLYMER LOWERS THE ADHESION OF
   PLATELETS ON POLYURETHANE SURFACES
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE POLYURETHANE; POLY(OXAZOLINE); FLUOROPOLYMER; BIOMATERIAL
ID POLY(ETHER URETHANES); POLYMERS; BIODEGRADATION; DEGRADATION;
   ADSORPTION; INVITRO
AB We have prepared an amphiphilic oxazoline block copolymer of hydrophilic poly (2-methyl-2-oxazoline) and hydrophobic poly[2-(2-perfluorooctyl)ethyl-2-oxazoline] chains. By controlling the length and composition of polymer chains, we found that this fluorinated block copolymer can be readily dissolved in water. Furthermore, we can achieve a stable surface coating of the fluorinated block copolymer by dissolving the copolymer in water, then coating the aqueous copolymer solution onto surfaces of nonwater-soluble polymers. This is a simple and useful method of modifying the surface character of polymer substrates. We have found that the polyether urethane (PEU) coated by block copolymer has a different surface chemistry and biological reactivity than the uncoated PEU. From XPS analysis, we found the fluorinated copolymer was coated on PEU (atomic % of F: 31.3 on coated PEU, 0.3 on uncoated). The two surfaces have different affinities for biological molecules. Specifically, the fibrinogen adsorption on the fluorinated copolymer-coated PEU was 62 +/- 39 ng/cm2,  compared to a value of 156 +/- 99 ng/cm;2 for uncoated PEU. In an ex vivo evaluation of platelet adhesion, the surface of coated PEU attached a few white cells while uncoated PEU was covered with activated platelets. (C) 1994 John Wiley & Sons, Inc.
RP KAKU, M (reprint author), DUPONT CO INC,EXPTL STN,WILMINGTON,DE 19898, USA.
CR AKEMI H, 1986, MAKROMOL CHEM, V187, P1627
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   BRADY RF, 1990, CHEM BRIT, P427
   BRASH JL, 1981, INTERACTIONS BLOOD N, P37
   Chuang H. Y. K., 1987, BLOOD COMPATIBILITY, V1, P87
   COOPER SL, 1988, BIOMATERIALS, V9, P36
   COOPER SL, 1987, J BIOMED MATER RES, V21, P815
   COOPER SL, 1988, J BIOMED MATER RES, V22, P359
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   EDELMAN FG, 1990, POLYM PREPR, V31, P314
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   GRIMMINGER LC, 1993, Patent No. 5219662
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1987, BIOMATERIALS CLIN AP, P661
   HO T, 1991, POLYM PREPRINTS, V32, P179
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   KAKU M, 1991, POLYM PREPR JPN, V40, pE124
   KOBAYASHI S, 1984, RING OPENING POLYM, pCH11
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   MUNRO MS, 1983, ASAIO J, V6, P65
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   SOGAH DY, 1992, MAKROMOL CHEM-M SYMP, V64, P49, DOI 10.1002/masy.19920640108
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   TAKAKURA T, 1990, MAKROMOL CHEM, V191, P625
   TAKAKURA T, 1984, ASAHI GARASU KENKYU, V34, P35
   TSAI CC, 1988, T AM SOC ART INT ORG, V34, P559
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   Wall L., 1972, FLUOROPOLYMERS HIGH, V25
   WITTE H, 1974, LIEBIGS ANN CHEM, P996
   YOON SC, 1986, MACROMOLECULES, V19, P1068, DOI 10.1021/ma00158a023
   1984, P CONTROL GUIDELINES
NR 37
TC 24
Z9 28
U1 2
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD AUG
PY 1994
VL 32
IS 11
BP 2187
EP 2192
DI 10.1002/pola.1994.080321122
PG 6
WC Polymer Science
SC Polymer Science
GA NX534
UT WOS:A1994NX53400022
DA 2018-10-19
ER

PT J
AU LANDAU, EH
   JAYANTHI, VR
   KHOURY, AE
   CHURCHILL, BM
   GILMOUR, RF
   STECKLER, RE
   MCLORIE, GA
AF LANDAU, EH
   JAYANTHI, VR
   KHOURY, AE
   CHURCHILL, BM
   GILMOUR, RF
   STECKLER, RE
   MCLORIE, GA
TI BLADDER AUGMENTATION - URETEROCYSTOPLASTY VERSUS ILEOCYSTOPLASTY
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Section on Urology of the
   American-Academy-of-Pediatrics
CY OCT 30-NOV 01, 1993
CL WASHINGTON, DC
SP AMER ACAD PEDIAT
DE BLADDER; URETER; URINARY DIVERSION
ID URINARY-TRACT RECONSTRUCTION; FOLLOW-UP; DIVERSION; GASTROCYSTOPLASTY;
   REPLACEMENT; CHILDREN
AB The primary advantages of augmentation ureterocystoplasty include the absence of mucus, lack of electrolyte absorption from the augmenting segment and the avoidance of gastrointestinal complications. We tested whether the ureteral patch offers sufficient biomaterial to increase adequately the storage efficiency of dysfunctional bladders. Between April 1989 and November 1992, 8 children with unilaterally dilated and tortuous ureters underwent bladder augmentation using detubularized reconfigured megaureter. Clinical and urodynamic outcomes were compared between these patients and a control group of 8 children matched in age and diagnosis who had undergone ileocystoplasty during the same time.
   Total bladder capacity, pressure specific bladder volume at pressure less than 30 cm. water, dynamic analysis of bladder compliance, continence and upper tract status were compared between the 2 groups before and after augmentation. Preoperatively, all 16 patients were incontinent with high pressure, small capacity bladders, and all had upper tract changes. Postoperatively, the mean total bladder capacity was 417 ml. in the ureterocystoplasty group and 381 ml. in the ileocystoplasty group (p > 0.05), while the mean pressure specific bladder volume was 413 and 380 mi. (p > 0.05), respectively. Pressure specific bladder volume and dynamic bladder compliance were normal in 7 of 8 patients (87.5%) in the ureterocystoplasty group. All patients in the ileocystoplasty group had normal postoperative urodynamics.
   We conclude that megaureters subtending effete kidneys may be used to improve the storage function of dysfunctional bladders to the same extent as that achieved with ileum without the complications pursuant to ileocystoplasty, and that the improvement is maintained long term.
RP LANDAU, EH (reprint author), HOSP SICK CHILDREN,555 UNIV AVE,TORONTO M5G 1X8,ON,CANADA.
CR ADAMS MC, 1988, J UROLOGY, V140, P1152, DOI 10.1016/S0022-5347(17)41986-0
   BLYTH B, 1992, J UROLOGY, V148, P575, DOI 10.1016/S0022-5347(17)36657-0
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P505, DOI 10.1016/S0022-5347(17)38798-0
   CASTRODIAZ D, 1992, J UROLOGY, V148, P571, DOI 10.1016/S0022-5347(17)36656-9
   CHURCHILL BM, 1993, J UROLOGY, V150, P716, DOI 10.1016/S0022-5347(17)35596-9
   CHURCHILL BM, 1993, TRANSPLANT REV, V7, P21
   FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3
   GILMOUR RF, 1993, J UROLOGY, V150, P1200, DOI 10.1016/S0022-5347(17)35727-0
   GONZALEZ R, 1987, DIAL PED UROL, V10, P4
   HENSLE TW, 1991, UROL CLIN N AM, V18, P701
   HOULE AM, 1993, J UROLOGY, V149, P561, DOI 10.1016/S0022-5347(17)36148-7
   LAPIDES J, 1970, J UROLOGY, V103, P243, DOI 10.1016/S0022-5347(17)61931-1
   LEONG CH, 1978, ANN ROY COLL SURG, V60, P283
   MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1
   MCGUIRE EJ, 1983, J UROLOGY, V129, P823, DOI 10.1016/S0022-5347(17)52384-8
   MCGUIRE EJ, 1981, J UROLOGY, V126, P205, DOI 10.1016/S0022-5347(17)54449-3
   MCLORIE GA, 1988, J UROLOGY, V140, P1289, DOI 10.1016/S0022-5347(17)42027-1
   MITCHELL ME, 1987, J UROLOGY, V138, P579, DOI 10.1016/S0022-5347(17)43264-2
   MURRAY K, 1987, BRIT J UROL, V60, P532, DOI 10.1111/j.1464-410X.1987.tb05037.x
   WEISS RM, 1991, ADULT PEDIATRIC UROL, P881
NR 20
TC 51
Z9 51
U1 0
U2 2
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD AUG
PY 1994
VL 152
IS 2
BP 716
EP 719
DI 10.1016/S0022-5347(17)32689-7
PN 2
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA NW330
UT WOS:A1994NW33000033
PM 8022003
DA 2018-10-19
ER

PT J
AU DAVIES, J
   ROBERTS, CJ
   DAWKES, AC
   SEFTON, J
   EDWARDS, JC
   GLASBEY, TO
   HAYMES, AG
   DAVIES, MC
   JACKSON, DE
   LOMAS, M
   SHAKESHEFF, KM
   TENDLER, SJB
   WILKINS, MJ
   WILLIAMS, PM
AF DAVIES, J
   ROBERTS, CJ
   DAWKES, AC
   SEFTON, J
   EDWARDS, JC
   GLASBEY, TO
   HAYMES, AG
   DAVIES, MC
   JACKSON, DE
   LOMAS, M
   SHAKESHEFF, KM
   TENDLER, SJB
   WILKINS, MJ
   WILLIAMS, PM
TI USE OF SCANNING PROBE MICROSCOPY AND SURFACE-PLASMON RESONANCE AS
   ANALYTICAL TOOLS IN THE STUDY OF ANTIBODY-COATED MICROTITER WELLS
SO LANGMUIR
LA English
DT Article
ID TUNNELING-MICROSCOPY; CAPTURE ANTIBODIES; DENATURATION; POLYSTYRENE;
   ADSORPTION; MOLECULES
AB Scanning tunneling microscopy (STM) and atomic force microscopy (AFM) have been employed to study microtiter wells used for enzyme linked immunosorbant assays of the protein ferritin. Two methods of immobilization of a ferritin antibody on microtiter well surfaces were evaluated. Namely, passive adsorption of unmodified antibody, and specific linking of biotinylated antibody via a streptavidin-coated microtiter well surface. Scanning probe microscopy (SPM) data clearly show films and networks of monoclonal antibody on the well surfaces and individual ferritin molecules bound by the antibody. SPM images give an average molecular diameter for the ferritin bound to the antibody complex of 14.8 +/- 1.0 nm for the STM data and approximately 30 nm for the AFM data. SPM analysis shows that only 5% of total antibody passively adsorbed on the well surface is functional compared with the 60% on biotinylated antibody on the streptavidin surface. In similar experiments using surface plasmon resonance (SPR) experimental data also indicated an increase in the functionality of a streptavidin-coated surface compared with a blank surface. The results highlight the correlation between STM and AFM data and the use of SPR as a correlative technique to SPM for the study of biomaterial surface interactions.
C1 KODAK CLIN DIAGNOST LTD,POLLARDS WOOD LABS,NIGHTINGALES LANE,CHALFONT ST GILES HP8 4SP,BUCKS,ENGLAND.
   UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,BIOPHYS & SURFACE ANAL LAB,NOTTINGHAM NG7 2RD,ENGLAND.
RI Roberts, Clive/C-6970-2009; Williams, Philip/C-6947-2009
OI Roberts, Clive/0000-0001-9443-3445; Williams,
   Philip/0000-0002-1822-2133; Davies, Martyn/0000-0001-7695-0596;
   Shakesheff, Kevin/0000-0003-3236-2439
CR AMREIN M, 1989, SCIENCE, V243, P1708, DOI 10.1126/science.2928803
   BUCKLAND RM, 1986, NATURE, V320, P557, DOI 10.1038/320557a0
   BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005
   BUTLER JE, 1992, J IMMUNOL METHODS, V150, P77, DOI 10.1016/0022-1759(92)90066-3
   CREIGHTON TE, 1989, PROTEIN STRUCTURE, P288
   DAVIES J, 1994, J IMMUNOL METHODS, V167, P263, DOI 10.1016/0022-1759(94)90095-7
   DAVIES J, 1993, 1992 P INT C SURF PR
   DAVIES MC, 1993, POLYM SURFACES, V2, P227
   ENGEL A, 1991, ANNU REV BIOPHYS BIO, V20, P79, DOI 10.1146/annurev.biophys.20.1.79
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   HARRISON PM, ION CARRIERS IRON PR, pCH2
   HOLLANDER Z, 1986, MOL IMMUNOL, V23, P927, DOI 10.1016/0161-5890(86)90122-7
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   LEGGETT GJ, 1993, J PHYS CHEM-US, V97, P8852, DOI 10.1021/j100137a006
   LEGGETT GJ, 1993, LANGMUIR, V9, P2356, DOI 10.1021/la00033a018
   LINDSAY SM, 1990, J PHYS CHEM-US, V94, P4655, DOI 10.1021/j100374a053
   LOK BK, 1983, J COLLOID INTERF SCI, V91, P104, DOI 10.1016/0021-9797(83)90317-X
   MARTI O, 1993, STM SFM BIOL
   MATSUDA H, 1967, J ELECTROANAL CHEM, V15, P325, DOI 10.1016/0022-0728(67)85042-3
   ORESKES I, 1961, J IMMUNOL, V86, P338
   SUTER M, 1986, IMMUNOL LETT, V13, P313, DOI 10.1016/0165-2478(86)90064-7
   WEISENHORN AL, 1992, ULTRAMICROSCOPY, V42, P1125, DOI 10.1016/0304-3991(92)90413-E
   WILCHEK M, METHOD ENZYMOL, P138
   WILKINS MJ, 1993, ULTRAMICROSCOPY, V48, P197, DOI 10.1016/0304-3991(93)90182-W
   WILKINS MJ, 1993, J MICROSC-OXFORD, V172, P215, DOI 10.1111/j.1365-2818.1993.tb03415.x
   Williams P. M., 1991, Nanotechnology, V2, P172, DOI 10.1088/0957-4484/2/4/002
   WILLIAMS PM, IN PRESS J VAC SCI T
   WILSON TE, 1991, J VAC SCI TECHNOL B, V9, P1171, DOI 10.1116/1.585240
   YANG J, 1991, PHYS REV LETT, V67, P863
NR 29
TC 69
Z9 70
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG
PY 1994
VL 10
IS 8
BP 2654
EP 2661
DI 10.1021/la00020a026
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA PC650
UT WOS:A1994PC65000026
DA 2018-10-19
ER

PT J
AU PETROVSKY, BV
   SHUMAKOV, VI
AF PETROVSKY, BV
   SHUMAKOV, VI
TI Overview of a 20-year Russia USA agreement for cooperation in artificial
   heart research and development
SO BIOMATERIAL-LIVING SYSTEM INTERACTIONS
LA English
DT Proceedings Paper
CT Russia/USA Joint 20th Anniversary Symposium on Assist Devices and
   Biomaterials (20 Years of Cooperation)
CY JUN 06-08, 1994
CL MINIST PUBLIC HLTH & MED IND, INST TRANSPLANTOL & ARTIFICIAL ORGANS,
   MOSCOW, RUSSIA
HO MINIST PUBLIC HLTH & MED IND, INST TRANSPLANTOL & ARTIFICIAL ORGANS
DE AGREEMENT; ARTIFICIAL HEART; VENTRICULAR ASSIST DEVICE; BIOMATERIAL;
   BLOOD COMPATIBILITY
ID SURFACE; PARAMETERS
AB This paper surveys a 20-year cooperation between USSR (Russia) and USA in the development and investigation of the artificial heart.
C1 MOSCOW SURG SCI CTR,MOSCOW,RUSSIA.
   MOSCOW TRANSPLANTOL & ARTIFICIAL ORGANS INST,MOSCOW 123436,RUSSIA.
CR EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78
   EBERHART RC, 1987, ACS SYM SER, P378
   Nelson K D, 1993, ASAIO J, V39, pM310
   Nemets E A, 1993, ASAIO J, V39, pM319
   ROSANOVA I, 1991, J BIOMED MATER RES, V25, P459, DOI 10.1002/jbm.820250404
   SEVASTIANOV VI, 1988, T ASAIO, V34, P10
   SEVASTIANOV VI, 1993, BIOMATER LIVING SYST, V1, P85
   SEVASTIANOV VI, 1990, MEDIZINSKAJA TECHNIK, V4, P26
   SEVASTIANOV VI, 1993, BIOMATER LIVING SYST, V1, P3
   SEVASTIANOV VI, 1994, BIOMATER LIVING SYST, V2, P53
   1983, ARTIF ORGANS, V7, P1
   1980, NIH802032 PUBL
   1991, ARTIF ORGANS, V15, P349
   1987, ARTIF ORGANS, V11, P1
NR 14
TC 1
Z9 1
U1 0
U2 1
PU BIOMIR
PI MOSCOW
PA C/O VICTOR I SEVASTIANOV SHUKINSKAYA 1, 123182 MOSCOW, RUSSIA
SN 0869-4842
J9 BIOMATER LIVING SYST
JI Biomat.-Living Syst. Interact.
PD JUL-SEP
PY 1994
VL 2
IS 3
BP 107
EP 114
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA PZ957
UT WOS:A1994PZ95700002
DA 2018-10-19
ER

PT J
AU CHANG, CC
   MERRITT, K
AF CHANG, CC
   MERRITT, K
TI INFECTION AT THE SITE OF IMPLANTED MATERIALS WITH AND WITHOUT PREADHERED
   BACTERIA
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SLIME PRODUCTION; PROSTHETIC DEVICES;
   PROTEUS-MIRABILIS; EPIDERMIDIS SLIME; ADHERENCE; COLONIZATION;
   RESISTANCE; ADHESION; AUREUS
AB A study was undertaken to examine the role of bacterial adherence in the development of infection at the site of an implant. The amount of in vitro adherence of Staphylococcus epidermidis was greatest for stainless steel, followed by polymethylmethacrylate and commercially pure titanium, and was least for polymethylmethacrylate with gentamicin. These materials then were preincubated with S. epidermidis and implanted. The number of organisms that were isolated and the rate of infection followed the same pattern as that in the in vitro studies. Materials that were not preincubated with bacteria also were implanted and bacteria were injected into the site. The number of organisms isolated from the site and the rate of infection were lower than those for the preincubated materials, but the trend was the same as in both the in vitro and the in vivo studies. The rates of infection and colonization correlated with the propensity for the organisms to adhere to a given material. Materials colonized with S. epidermidis at the time of implantation caused a high rate of infection. The ability of organisms to adhere to a material in vitro is correlated with their propensity to cause biomaterial-based infection.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
CR BADDOUR LM, 1987, J CLIN MICROBIOL, V25, P207
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   BISNO AL, 1989, INFECTIONS ASS INDWE
   BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, V190, P96
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   CHANG CC, 1991, J ORTHOPAED RES, V9, P284, DOI 10.1002/jor.1100090217
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   EDLICH RF, 1974, J BIOMED MATER RES, V8, P115
   GEERT HIM, 1986, CLIN ORTHOPAEDICS, V205, P171
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P517
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   JOSEFSSON G, 1990, CLIN ORTHOPAEDICS, V253, P173
   KOTILAINEN P, 1990, J CLIN MICROBIOL, V28, P2779
   LOWY FD, 1983, ANN INTERN MED, V99, P834, DOI 10.7326/0003-4819-99-6-834
   MERGENHAGEN SE, 1985, MOL BASIS ORAL MICRO
   MERRITT K, 1987, J ORTHOPAED RES, V5, P23, DOI 10.1002/jor.1100050105
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MURRAY WR, 1984, CLIN ORTHOP RELAT R, V190, P89
   Naylor P T, 1990, Clin Orthop Relat Res, P126
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   PETTY W, 1988, J BONE JOINT SURG AM, V70A, P536, DOI 10.2106/00004623-198870040-00009
   PICKNELL B, 1977, J BONE JOINT SURG BR, V59, P302
   QUIE PG, 1987, J INFECT DIS, V156, P543, DOI 10.1093/infdis/156.4.543
   SALVATI EA, 1986, CLIN ORTHOP RELAT R, V207, P83
   SUGARMAN B, 1986, AM J MED, V81, P78, DOI 10.1016/0002-9343(86)90517-6
   VAUDAUX PE, 1985, INFECT IMMUN, V50, P472
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
   WEBB LX, 1986, J VASC SURG, V4, P16
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 43
TC 62
Z9 67
U1 0
U2 3
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD JUL
PY 1994
VL 12
IS 4
BP 526
EP 531
DI 10.1002/jor.1100120409
PG 6
WC Orthopedics
SC Orthopedics
GA PC933
UT WOS:A1994PC93300008
PM 8064483
DA 2018-10-19
ER

PT J
AU BEAN, JK
   VERWOERDVERHOEF, HL
   VERWOERD, CDA
AF BEAN, JK
   VERWOERDVERHOEF, HL
   VERWOERD, CDA
TI RECONSTRUCTION OF THE ANTERIOR LARYNGEAL WALL WITH A COMPOSITE CRAFT OF
   DEMINERALIZED BOVINE BONE-MATRIX AND AUTOGENOUS PERICHONDRIUM - AN
   EXPERIMENTAL-STUDY IN ADULT-RABBITS
SO ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES
LA English
DT Article
DE CRICOID; PERICHONDRIUM; SUBGLOTTIC STENOSIS; DEMINERALIZED BOVINE BONE
   MATRIX; LARYNGOTRACHEAL RECONSTRUCTION
AB In this study the feasibility to reconstruct the anterior laryngeal wall in adult rabbits with a composite graft of demineralized bovine bone matrix and autogenous perichondrium was investigated. It is demonstrated that demineralized bovine bone, which is a porous biomaterial, is completely transformed into autologous cartilage, once it is implanted in a vascularized perichondrial pocket. It appeared to be possible to reconstruct the anterior laryngeal wall in adult rabbits with this newly formed cartilage. As the biomaterial has been transformed into autologous tissue it is entirely incorporated at the recipient site giving rise to solid connections (cartilaginous and/or fibrous) with the surrounding tissues.
RP BEAN, JK (reprint author), ERASMUS UNIV ROTTERDAM,HOSP DIJKZIGT,DEPT EAR NOSE & THROAT,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.
NR 0
TC 7
Z9 7
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0301-1569
J9 ORL J OTO-RHINO-LARY
JI ORL-J. Oto-Rhino-Laryngol. Relat. Spec.
PD JUL-AUG
PY 1994
VL 56
IS 4
BP 224
EP 229
DI 10.1159/000276660
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA NU112
UT WOS:A1994NU11200008
PM 8078675
DA 2018-10-19
ER

PT J
AU WALSH, D
   HOPWOOD, JD
   MANN, S
AF WALSH, D
   HOPWOOD, JD
   MANN, S
TI CRYSTAL TECTONICS - CONSTRUCTION OF RETICULATED CALCIUM-PHOSPHATE
   FRAMEWORKS IN BICONTINUOUS REVERSE MICROEMULSIONS
SO SCIENCE
LA English
DT Article
ID INORGANIC-ORGANIC INTERFACES; BIOMINERALIZATION; CHEMISTRY; MODEL
AB The chemical construction of organized architectures is an important aspect of innovative materials synthesis. Bicontinuous water-filled microemulsions can be used as preorganized systems for the fabrication of crystalline calcium phosphate materials with extended reticulated microstructures. These macroporous materials are formed by mineralization reactions located within the interconnecting water channels of the bicontinuous network. The resulting materials represent replicas of the microemulsion architecture, but the pore sizes are incommensurate, suggesting that secondary modifications in the bicontinuous microstructure occur during crystal growth. Synthetic macroporous calcium phosphates could have uses in biomaterial implants.
C1 UNIV BATH,SCH CHEM,BATH BA2 7AY,AVON,ENGLAND.
RI Mann, Stephen/D-1332-2012
OI Mann, Stephen/0000-0003-3012-8964; Hopwood, Jeremy/0000-0002-4199-3366
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   BLUM FD, 1985, J PHYS CHEM-US, V89, P711, DOI 10.1021/j100250a030
   CHEN SH, 1991, J PHYS CHEM-US, V95, P7427, DOI 10.1021/j100172a058
   CHEN V, 1988, J PHYS CHEM-US, V92, P768, DOI 10.1021/j100314a036
   EASTOE J, 1992, LANGMUIR, V8, P1505
   HOLMES R, 1984, CLIN ORTHOPAEDICS, V188, P252
   HYDE ST, 1989, J PHYS CHEM-US, V93, P1464, DOI 10.1021/j100341a056
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   MANN S, 1993, J CHEM SOC DALTON, P1, DOI 10.1039/dt9930000001
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299
   OLSSON U, 1986, J PHYS CHEM-US, V90, P4083, DOI 10.1021/j100408a050
   SKURTVEIT R, 1992, J COLLOID INTERF SCI, V152, P205, DOI 10.1016/0021-9797(92)90020-M
   ZEMB TN, 1987, J PHYS CHEM-US, V91, P3814, DOI 10.1021/j100298a018
NR 15
TC 163
Z9 167
U1 0
U2 27
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD JUN 10
PY 1994
VL 264
IS 5165
BP 1576
EP 1578
DI 10.1126/science.264.5165.1576
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NQ285
UT WOS:A1994NQ28500031
PM 17769602
DA 2018-10-19
ER

PT J
AU ALLIOTLICHT, B
   JEAN, A
   GREGOIRE, M
AF ALLIOTLICHT, B
   JEAN, A
   GREGOIRE, M
TI COMPARATIVE EFFECT OF CALCIUM HYDROXIDE AND HYDROXYAPATITE ON THE
   CELLULAR-ACTIVITY OF HUMAN PULP FIBROBLASTS IN-VITRO
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE PULP FIBROBLAST; HYDROXYAPATITE; CALCIUM HYDROXIDE; CELL-DIFFERENTIATION
ID HUMAN DENTAL-PULP; ALKALINE-PHOSPHATASE ACTIVITY; REPARATIVE DENTIN;
   CAPPING AGENTS; CELLS-INVITRO; CRYSTALS; BONE; DIFFERENTIATION;
   BIOMATERIALS; GROWTH
AB When, in vivo, calcium hydroxide [Ca(OH)(2)] or hydroxyapatite are used as dental pulp-capping agents, a reparative dentine bridge is observed. New hard tissue is formed directly on the hydroxyapatite, whereas a characteristic necrotic area appears under Ca(OH)(2). The differing pulpal reactions to these two capping agents suggest differing cell responses. After isolation and selection of human pulp fibroblasts in vitro, the cells were characterized by their morphology, their high alkaline phosphatase specific activity, and their synthesis of type I and III collagens and fibronectin. They were then incubated in the presence of either hydroxyapatite (1 mg/ml) or Ca(OH)(2) (0.8 mg/ml). With Ca(OH)(2), the cells exhibited dramatical alterations in morphology, DNA synthesis, alkaline phosphatase activity and protein synthesis, in accordance with the necrosis observed in vivo. With hydroxyapatite, phagocytic activity of pulpal fibroblasts toward hydroxyapatite particles (<10 mu m) was seen. As a consequence, DNA synthesis was affected. This inhibitory effect was not due to cell damage, as demonstrated by increased [H-3]-proline and [H-3]-leucine incorporation by the cells. There was also an inhibitory effect of hydroxyapatite on alkaline phosphatase activity, suggesting that the pulp fibroblasts were not in a differentiation stage. In conclusion, compared to the effects of Ca(OH)(2) on human pulp fibroblasts, these data are consistent with the biocompatibility of hydroxyapatite previously described in vivo and testify to the occurrence of a biological response elicited by this synthetic biomaterial.
C1 INST BIOL,INSERM,CJF 9011,F-44035 NANTES,FRANCE.
RP ALLIOTLICHT, B (reprint author), FAC CHIRURG DENT,PL A RICORDEAU,F-44035 NANTES,FRANCE.
RI GREGOIRE, Marc/G-2867-2013
OI GREGOIRE, Marc/0000-0003-3868-0198
CR ALGERNON CK, 1989, ANAL ANZ JENA, V169, P81
   ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   Bonel G, 1988, Ann N Y Acad Sci, V523, P115, DOI 10.1111/j.1749-6632.1988.tb38506.x
   BOONE ME, 1979, ORAL SURG ORAL MED O, V47, P369, DOI 10.1016/0030-4220(79)90262-7
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   EVANS RW, 1984, ARTHRITIS RHEUM, V27, P829, DOI 10.1002/art.1780270717
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   FITZGERALD M, 1990, ARCH ORAL BIOL, V35, P707, DOI 10.1016/0003-9969(90)90093-P
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   FRANK RM, 1991, J APPL BIOMATER, V2, P243, DOI 10.1002/jab.770020405
   FRANZ FE, 1984, J BIOL BUCCALE, V12, P239
   FURUSAWA M, 1991, Bulletin of Tokyo Dental College, V32, P111
   GOSEKI M, 1990, J DENT RES, V69, P909, DOI 10.1177/00220345900690031601
   GRANSTROM G, 1979, CALCIFIED TISSUE INT, V27, P211, DOI 10.1007/BF02441188
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GREGOIRE M, 1987, BIOL CELL, V59, P255, DOI 10.1111/j.1768-322X.1987.tb00538.x
   Heller A L, 1975, J Endod, V1, P95, DOI 10.1016/S0099-2399(75)80025-2
   HEYS DR, 1981, J DENT RES, V60, P1371, DOI 10.1177/00220345810600071401
   IKAMI K, 1990, ARCH HISTOL CYTOL, V53, P227, DOI 10.1679/aohc.53.227
   JABER L, 1992, ORAL SURG ORAL MED O, V73, P92, DOI 10.1016/0030-4220(92)90162-J
   JABER L, 1991, J ORAL PATHOL MED, V20, P502, DOI 10.1111/j.1600-0714.1991.tb00413.x
   JEAN A, 1988, J ENDODONT, V14, P83, DOI 10.1016/S0099-2399(88)80006-2
   Klaiber B, 1979, Dtsch Zahnarztl Z, V34, P846
   KUO MYP, 1992, ARCH ORAL BIOL, V37, P945, DOI 10.1016/0003-9969(92)90066-H
   KWONG CH, 1989, BIOMATERIALS, V10, P579, DOI 10.1016/0142-9612(89)90110-5
   LARMAS M, 1980, ARCH ORAL BIOL, V25, P791, DOI 10.1016/0003-9969(80)90136-3
   LIANG RF, 1992, ARCH ORAL BIOL, V37, P789, DOI 10.1016/0003-9969(92)90112-L
   LINDE A, 1990, J BIOL BUCCALE, V18, P155
   LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206
   MAGLOIRE H, 1984, C INSERM, V125, P119
   MAJESKA RJ, 1982, J BIOL CHEM, V257, P3362
   MATSUDA T, 1987, J BIOMED MATER RES, V21, P499, DOI 10.1002/jbm.820210409
   Miller W A, 1976, J Endod, V2, P385, DOI 10.1016/S0099-2399(76)80103-3
   NAKASHIMA M, 1990, ARCH ORAL BIOL, V35, P493, DOI 10.1016/0003-9969(90)90078-O
   NOGUCHI J, 1989, Tsurumi University Dental Journal, V15, P63
   ORLY I, 1989, J BIOMED MATER RES, V23, P1433, DOI 10.1002/jbm.820231206
   OWENS JL, 1986, CALCIFIED TISSUE INT, V38, P170, DOI 10.1007/BF02556877
   RUCH JV, 1985, J DENT RES, V64, P489, DOI 10.1177/002203458506400402
   SCHRODER U, 1985, J DENT RES, V64, P541, DOI 10.1177/002203458506400407
   SELTZER S, 1959, Oral Surg Oral Med Oral Pathol, V12, P595, DOI 10.1016/0030-4220(59)90162-8
   SEUX D, 1991, ARCH ORAL BIOL, V36, P117, DOI 10.1016/0003-9969(91)90074-5
   TETI A, 1991, J DENT RES, V70, P997, DOI 10.1177/00220345910700061801
   VAKEVA L, 1990, ANAT REC, V228, P69, DOI 10.1002/ar.1092280111
   YAMAMURA T, 1985, J DENT RES, V64, P530, DOI 10.1177/002203458506400406
NR 48
TC 26
Z9 30
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0003-9969
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JUN
PY 1994
VL 39
IS 6
BP 481
EP 489
DI 10.1016/0003-9969(94)90144-9
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA NQ441
UT WOS:A1994NQ44100004
PM 8067917
DA 2018-10-19
ER

PT J
AU BEUMER, GJ
   VANBLITTERSWIJK, CA
   PONEC, M
AF BEUMER, GJ
   VANBLITTERSWIJK, CA
   PONEC, M
TI DEGRADATIVE BEHAVIOR OF POLYMERIC MATRICES IN (SUB)DERMAL AND
   MUSCLE-TISSUE OF THE RAT - A QUANTITATIVE STUDY
SO BIOMATERIALS
LA English
DT Article
DE BIODEGRADATION; SKIN SUBSTITUTE; BIOCOMPATIBILITY
ID BIOCOMPATIBILITY EVALUATION; BIODEGRADATION; COPOLYMERS; INFECTION;
   IMPLANTS; INVITRO
AB Bilayered matrices, made of synthetic degradable polymers, are developed for use as a dermal regeneration template in large surface area full-thickness skin defects. The porous underlayer is designed to allow ingrowth of dermal components and the dense top layer will serve as a substrate for keratinocytes. Considering the importance of the degradation kinetics of tissue regeneration templates, quantification of matrix degradation up to 1 yr post-implantation, and histological and ultrastructural examination of the implants was performed. In this study a moderate foreign body reaction was observed at both the intramuscular and subcutaneous implantation sites, including the presence of mono- and multinucleated phagocytes. Poly(L-lactic acid) underlayers tended to elicit a stronger cellular infiltrate than co-polymeric ones. In the course of the implantation periods this inflammatory response subsided and neovascular ingrowth and the formation of fibrous tissue in the pores was observed. Matrix degradation was demonstrated, starting with the fragmentation of the constituent polymers into increasingly smaller particles. During the implantation period, fragments showed progressive surface erosion. Poly(L-lactic acid) fragments had a more rounded off appearance as compared to co-polymeric ones. Implant surface area had decreased to less than 20%, 1 yr postimplantation. At both implantation sites and with all matrices, polymer particles were observed inside phagocytic cells. Degradation kinetics were similar with the different matrices. Implants fragmented more rapidly at the subcutaneous implantation site as compared to the intramuscular one. Although the data suggest biomaterial degradation, remnants of matrices could still be retrieved 1 yr postimplantation.
C1 LEIDEN UNIV HOSP,DEPT ENT,OTOBIOL & BIOCOMPATIBIL LAB,2333 AA LEIDEN,NETHERLANDS.
   LEIDEN UNIV HOSP,DEPT DERMATOL,BIOMAT RES GRP,2333 AA LEIDEN,NETHERLANDS.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P669, DOI 10.1002/jbm.820240604
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   BAKKER D, 1988, THESIS LEIDEN
   Beumer G. J., 1993, Clinical Materials, V14, P21, DOI 10.1016/0267-6605(93)90043-7
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   BEUMER GJ, 1990, ADV BIOMAT, V9, P169
   BEUMER GJ, IN PRESS J BIOMED MA
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   GOGOLEWSKI S, 1992, Clinical Materials, V10, P13, DOI 10.1016/0267-6605(92)90079-9
   GOODSON WH, 1992, WOUND HEALING BIOCH, P316
   GROTE JJ, 1991, AM J OTOL, V12, P329
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   KIECHEL SF, 1977, SURG GYNECOL OBSTET, V144, P58
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   PITT CG, 1981, BIOMATERIALS, V2, P215
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   SCHAKENRAAD J M, 1991, Clinical Materials, V7, P253, DOI 10.1016/0267-6605(91)90067-P
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   TEEPE RGC, 1990, J TRAUMA, V30, P269, DOI 10.1097/00005373-199003000-00004
   VANBLITTERSWIJK CA, 1991, TISSUE MATERIAL INTE, P295
   VANDERLEI B, 1987, J THORAC CARDIOV SUR, V93, P695
   VERHEYEN, COMMUNICATION
   VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7
   WHITE RA, 1981, BIOMATERIALS, V2, P171, DOI 10.1016/0142-9612(81)90046-6
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   WILLIAMS DF, 1977, J BIOENG, V1, P231
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4, pCH8
   WOOD N K, 1970, Journal of Biomedical Materials Research, V4, P1, DOI 10.1002/jbm.820040102
   ZEDERFELDT B, 1957, Acta Chir Scand Suppl, V224, P1
NR 35
TC 53
Z9 54
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1994
VL 15
IS 7
BP 551
EP 559
DI 10.1016/0142-9612(94)90022-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NQ467
UT WOS:A1994NQ46700009
PM 7918908
DA 2018-10-19
ER

PT J
AU ABDELFATTAH, WI
   OSIRIS, WG
   MOHAMED, SS
   KHALIL, MR
AF ABDELFATTAH, WI
   OSIRIS, WG
   MOHAMED, SS
   KHALIL, MR
TI RECONSTRUCTION OF RESECTED MANDIBLES USING A HYDROXYAPATITE VETERINARY
   BONE-GRAFT
SO BIOMATERIALS
LA English
DT Article
DE HYDROXYAPATITE; BONE-IMPLANT INTERFACE; MANDIBULAR GRAFTING
ID CALCIUM-PHOSPHATE CERAMICS; ALVEOLAR CLEFTS; AUTOGENOUS BONE;
   ILIAC-BONE; CANCER
AB A newly developed bone equivalent hydroxyapatite was derived from veterinary bone (VHAP). Sections of 1 cm of six rabbit mandibles were equally replaced by this VHAP graft. Radiological studies by X-ray were performed pre-operatively, immediately, and 1, 2 and 3 months post-operatively. The graft host-bone interface was examined periodically by scanning electron microscopy (SEM). Accompanying structural changes of the graft 3 months post-operatively were compared with the pre-operative findings by infra-red (IR) spectroscopic analysis. Complete union of the biomaterial to the host bone after 3 months was evidenced radiologically. SEM proved complete graft integration. This was accompanied by a decrease in optical density of the IR analysis of post-operative VHAP, indicating some leaching of the ions. Clinically, the graft was completely incorporated in the mandible without any complications. We discuss the use of VHAP in humans to reconstruct post-surgical mandibular defects.
C1 CAIRO UNIV,FAC SCI,DEPT BIOPHYS,GIZA,EGYPT.
   UNIV ALEXANDRIA,FAC MED,ALEXANDRIA,EGYPT.
   UNIV ALEXANDRIA,FAC DENT,ALEXANDRIA,EGYPT.
RP ABDELFATTAH, WI (reprint author), NATL RES CTR,DEPT CERAM,CAIRO,EGYPT.
CR ABDELFATTAH WI, 1991, CERAMICA ACTA, V4, P65
   BOYNE PJ, 1972, J ORAL SURG, V30, P87
   COBB CM, 1990, J ORAL MAXIL SURG, V48, P268, DOI 10.1016/0278-2391(90)90392-F
   COCKIN J, 1971, J BONE JOINT SURG BR, V53, P153
   COWLEY SP, 1983, J BONE JOINT SURG AM, V65, P1023, DOI 10.2106/00004623-198365070-00022
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DEGROOT K, 1987, INTERCERAM
   DESANTO LW, 1975, ARCH OTOLARYNGOL, V101, P652
   FLYNN MB, 1974, AM J SURG, V128, P490, DOI 10.1016/0002-9610(74)90261-X
   HALL HD, 1983, J ORAL MAXIL SURG, V41, P289, DOI 10.1016/0278-2391(83)90295-1
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HOOPES JE, 1975, S MALIGNANCY HEAD NE, V1, P193
   KAWALARA H, 1978, BIOCERAMICS S KEEL
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   LAVERNIA C, 1991, AM CERAM SOC BULL, V70, P95
   MARDELSON BC, 1977, SURG CLIN N AM, V57, P285
   MARX RE, 1984, J ORAL MAXIL SURG, V42, P3, DOI 10.1016/0278-2391(84)90389-6
   WHITE E, 1986, DENT CLIN N AM, V30, P49
NR 19
TC 13
Z9 13
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1994
VL 15
IS 8
BP 609
EP 614
DI 10.1016/0142-9612(94)90211-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NV145
UT WOS:A1994NV14500007
PM 7948580
DA 2018-10-19
ER

PT J
AU SHIMADA, M
   MATSUMATA, T
   TAKETOMI, A
   NISHIZAKI, T
   ITASAKA, H
   SUGIMACHI, K
AF SHIMADA, M
   MATSUMATA, T
   TAKETOMI, A
   NISHIZAKI, T
   ITASAKA, H
   SUGIMACHI, K
TI MAJOR HEPATIC RESECTION IN PATIENTS WITH A PROSTHETIC HEART-VALVE
   RECEIVING ANTICOAGULATION TREATMENT
SO HEPATO-GASTROENTEROLOGY
LA English
DT Note
DE HEPATIC RESECTION; PROSTHETIC HEART VALVE; ANTICOAGULATION; ACTIVATED
   CLOTTING TIME (ACT); LECITHIN, CHOLESTEROL ACYLTRANSFERASE (LCAT)
ID OPERATIONS; CIRRHOSIS
AB We experienced two patients with a prosthetic heart valve, who underwent hepatic resection for hepatoma while on anticoagulation therapy. Patients with a prosthetic heart valve have the following characteristics; an increased risk of thromboembolism due to diminished anticoagulation in the perioperative period, a greater risk of endocarditis due to the artificial material in the heart, and impaired cardiopulmonary function including possible arrhythmia and heart failure. Furthermore, when such patients also have liver cirrhosis with a hepatoma, there is an increased risk of perioperative bleeding while on anticoagulation due to coagulopathy and also a risk of infection due to decreased cellular immunity. Patients with a prosthetic heart valve therefore require special care and attention whenever they have to undergo hepatic resection. With respect to anticoagulation, a minimal level is required to prevent bleeding and thromboembolism. Warfarin being administered preoperatively may be switched to heparin while closely monitoring the activated clotting time (biomaterial valve: 130-150 sec, non-biomaterial valve: 150-180 sec); the heparin should then be changed back to warfarin immediately after starting oral intake following operation. For the prevention of infection, a broad spectrum antibiotic should be used prophylactically both intra-operatively and postoperatively. The cardiopulmonary function must also be carefully monitored. For the assessment of postoperative liver function, lecithin: cholesterol acyltransferase, sen.im bilirubin and albumin are useful because there is no relevance of coagulation parameters such as prothrombin time under anticoagulation.
RP SHIMADA, M (reprint author), KYUSHU UNIV,FAC MED,DEPT SURG 2,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.
CR AKI BF, 1980, J THORAC CARDIOVASC, V79, P97
   BEHRMAN SJ, 1961, J AM DENT ASSOC, V62, P173
   COON WW, 1974, ARCH INTERN MED, V133, P386, DOI 10.1001/archinte.133.3.386
   EVANS RW, 1987, CIRCULATION S, V38, P74
   FRANK BW, 1963, ANN INTERN MED, V59, P911, DOI 10.7326/0003-4819-59-6-911
   HOLDSTOCK G, 1982, GASTROENTEROLOGY, V82, P206
   HOLDSTOCK GE, 1980, GASTROENTEROLOGY, V79, P1026
   HSU CCS, 1971, CLIN EXP IMMUNOL, V8, P749
   KATHOLI RE, 1978, AM HEART J, V96, P163, DOI 10.1016/0002-8703(78)90080-7
   KATHOLI RE, 1976, AM HEART J, V92, P162, DOI 10.1016/S0002-8703(76)80251-7
   KUDOH T, 1975, JPN J THORAC SURG, V28, P187
   MCINTYRE H, 1966, LANCET, V2, P99
   ROSER SM, 1975, ORAL SURG ORAL MED O, V40, P448, DOI 10.1016/0030-4220(75)90241-8
   SHIMADA M, 1989, TRANSPLANTATION, V48, P600
   TAKENAKA K, 1984, DIS MARKERS, V2, P501
   TULLOCH J, 1959, CIRCULATION, V9, P823
NR 16
TC 4
Z9 4
U1 0
U2 1
PU H G E UPDATE MEDICAL PUBL LTD.
PI ATHENS
PA PO BOX 17160, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD JUN
PY 1994
VL 41
IS 3
BP 290
EP 293
PG 4
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA NW901
UT WOS:A1994NW90100020
PM 7959557
DA 2018-10-19
ER

PT J
AU KAMATH, KR
   PARK, K
AF KAMATH, KR
   PARK, K
TI SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS BY ALBUMIN GRAFTING USING
   GAMMA-IRRADIATION
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID INDUCED PLATELET ACTIVATION; BLOOD COMPATIBILITY; METHACRYLIC-ACID; DRUG
   DELIVERY; HYDROGELS; POLYPROPYLENE; PROTEINS; BINDING; IMMOBILIZATION;
   ADSORPTION
AB Polymeric biomaterial surfaces were modified by albumin grafting to improve their blood compatibility. Albumin molecules were functionalized by introducing double bonds using glycidyl acrylate. The functionalized albumin was covalently attached to various biomaterial surfaces such as polypropylene, polycarbonate, and poly(vinyl chloride) by gamma-irradiation. Surface-induced platelet adhesion and thrombus formation on the albumin-grafted surfaces was examined using computer-enhanced video microscopy and scanning electron microscopy. The amount of the grafted albumin was dependent on the gamma-irradiation dose and the concentration of albumin used for adsorption. The grafted albumin molecules remained on the surface even after exposure to blood for prolonged time periods. This approach was used to graft albumin to polymeric materials of an oxygenator. The albumin grafting resulted in a substantial improvement in blood compatibility as compared to control oxygenators. The covalent grafting of functionalized albumin by gamma-irradiation obviates the need for premodification of chemically inert polymer surfaces. It is useful for albumin grafting to various biomaterial surfaces. (C) 1994 John Wiley & Sons, Inc.
C1 PURDUE UNIV,SCH PHARM,W LAFAYETTE,IN 47907.
FU NHLBI NIH HHS [HL 39081]
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   APLIN JD, 1981, ANAL BIOCHEM, V113, P144, DOI 10.1016/0003-2697(81)90057-9
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   CHANDY T, 1991, BLOOD COMPATIBILITY, P131
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
   Guiseley KB, 1987, IND POLYSACCHARIDES, P139
   HELLER J, 1990, BIOMATERIALS, V11, P345, DOI 10.1016/0142-9612(90)90112-4
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   JAWOREK D, 1974, INSOLUBILIZED ENZYME, P65
   KAMATH KR, IN PRESS SURF INTERF
   KIAEI D, 1991, ARTIF ORGANS, V15, P302
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KOUL V, 1993, POLYM INT, V30, P411, DOI 10.1002/pi.4990300323
   KRISHNAN VK, 1990, J MATER SCI-MATER M, V1, P185, DOI 10.1007/BF00701075
   LIN SC, 1991, J BIOMED MATER RES, V25, P791, DOI 10.1002/jbm.820250608
   MATHIAS CJ, 1984, SEMIN NUCL MED, V14, P118, DOI 10.1016/S0001-2998(84)80025-2
   MATSUDA T, 1990, T AM SOC ART INT ORG, V36, pM161
   MORRISSEY BW, 1977, ANN NY ACAD SCI, V283, P50, DOI 10.1111/j.1749-6632.1977.tb41752.x
   MULVIHILL JN, 1990, J BIOMED MATER RES, V24, P155, DOI 10.1002/jbm.820240203
   MUNRO MS, 1981, T AM SOC ART INT ORG, V27, P499
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311
   Park K, 1989, Scanning Microsc Suppl, V3, P137
   PARK K, 1988, BIOMATERIALS, V9, P435, DOI 10.1016/0142-9612(88)90009-9
   PARK K, 1991, P CARDIOVASC SCI TEC, P143
   PASCHE B, 1991, ARTIF ORGANS, V15, P481
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   PLATE NA, 1982, POLYM SCI USSR, V24, P268
   PLATE NA, 1989, POLYM SCI USSR, V31, P216
   RATNER BD, 1980, SYNTHETIC BIOMEDICAL, P133
   SHALABY WSW, 1990, PHARM RES-DORDR, V7, P816, DOI 10.1023/A:1015956714669
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P38, DOI 10.1016/0021-9797(84)90271-6
   SIGOTLUIZARD MF, 1984, J BIOMED MATER RES, V18, P895, DOI 10.1002/jbm.820180805
   SINGH J, 1990, BRIT POLYM J, V22, P89, DOI 10.1002/pi.4980220202
   SINGH J, 1990, BIOMATERIALS, V11, P473, DOI 10.1016/0142-9612(90)90060-4
   SINGH RP, 1992, PROG POLYM SCI, V17, P251, DOI 10.1016/0079-6700(92)90024-S
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   SIPEHIA R, 1982, BIOMATER ARTIF CELL, V10, P229, DOI 10.3109/10731198209118783
   SNYDER SL, 1975, ANAL BIOCHEM, V64, P284
   TORCHILIN VP, 1979, BIOCHIM BIOPHYS ACTA, V567, P1, DOI 10.1016/0005-2744(79)90165-7
   Tsai C C, 1990, ASAIO Trans, V36, pM307
   TSENG YC, IN PRESS J BIOMATER
   VANHOLDER R, 1982, INT J ARTIF ORGANS, V5, P297
   WOOLSTON J, 1990, MED DEVICE TECHN JUL
NR 48
TC 28
Z9 28
U1 0
U2 8
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SUM
PY 1994
VL 5
IS 2
BP 163
EP 173
DI 10.1002/jab.770050210
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL922
UT WOS:A1994NL92200009
PM 10147177
DA 2018-10-19
ER

PT J
AU TOMITA, N
   TAMAI, S
   OKAJIMA, E
   HIRAO, Y
   IKEUCHI, K
   IKADA, Y
AF TOMITA, N
   TAMAI, S
   OKAJIMA, E
   HIRAO, Y
   IKEUCHI, K
   IKADA, Y
TI BIOMATERIALS LUBRICATED FOR MINIMUM FRICTIONAL RESISTANCE
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID PHOTOINDUCED GRAFT-POLYMERIZATION; MEDICAL USE; CATHETERS; SURFACE
AB To improve the frictional characteristics of a biomaterial, the mechanical performance of a lubricated surface was studied. In vitro friction tests showed that the coefficient of dynamic friction of the lubricated surface was about 0.01 against rabbit bladder and the coefficient of static friction increased with the preload period. The efficacy of a lubricated cystoscope was evaluated by an in vivo test simulating cystoscope operation. The maximal and the total resistance force on the cystoscope model were found to decrease with the surface lubrication. Histological study revealed that urethral damage caused by rubbing with the cystoscope model was reduced by this lubrication technique. Presumably, prolonged retention of water on the lubricated surface region prevented tissue adhesion to the foreign material. (C) 1994 John Wiley & Sons, Inc.
C1 NARA MED UNIV,DEPT UROL,KASHIHARA,NARA 634,JAPAN.
   NARA MED UNIV,DEPT ORTHOPED SURG,KASHIHARA,NARA 634,JAPAN.
RP TOMITA, N (reprint author), KYOTO UNIV,BIOMED ENGN RES CTR,53 KAWAHARA CHO,SAKYO KU,KYOTO 606,JAPAN.
CR CANN C, 1968, UROLOGY, P623
   FAN YL, 1990, POLYM MATER SCI ENG, V63, P709
   FUJIMOTO K, IN PRESS J POLYM SCI
   IKEUCHI K, 1993, WEAR, V161, P179, DOI 10.1016/0043-1648(93)90467-Z
   INOUE H, 1992, CELL MATER, V2, P21
   NACEY JN, 1991, BRIT J UROL, V67, P314, DOI 10.1111/j.1464-410X.1991.tb15143.x
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
NR 9
TC 32
Z9 33
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SUM
PY 1994
VL 5
IS 2
BP 175
EP 181
DI 10.1002/jab.770050211
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL922
UT WOS:A1994NL92200010
PM 10147178
DA 2018-10-19
ER

PT J
AU COURTMAN, DW
   PEREIRA, CA
   KASHEF, V
   MCCOMB, D
   LEE, JM
   WILSON, GJ
AF COURTMAN, DW
   PEREIRA, CA
   KASHEF, V
   MCCOMB, D
   LEE, JM
   WILSON, GJ
TI DEVELOPMENT OF A PERICARDIAL ACELLULAR MATRIX BIOMATERIAL - BIOCHEMICAL
   AND MECHANICAL EFFECTS OF CELL EXTRACTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TENSILE VISCOELASTIC PROPERTIES; BOVINE PERICARDIUM; VALVE
   BIOPROSTHESES; CALCIFICATION; COLLAGEN; PROTEOGLYCANS; PURIFICATION;
   PROSTHESES; XENOGRAFT; FIXATION
AB There is evidence to suggest that the cellular components of homografts and bioprosthetic xenografts may contribute to calcification or immunogenic reactions. A four-step detergent and enzymatic extraction process has been developed to remove cellular components from bovine pericardial tissue. The process results in an acellular matrix material consisting primarily of elastin, insoluble collagen, and tightly bound glycosaminoglycans. Light and electron microscopy confirmed that nearly all cellular constituents are removed without ultrastructural evidence of damage to fibrous components. Collagen denaturation temperatures remained unaltered. Biochemical analysis confirmed the retention of collagen and elastin and some differential extraction of glycosaminoglycans. Low strain rate fracture testing and high strain rate viscoelastic characterization showed that, with the exception of slightly increased stress relaxation, the mechanical properties of the fresh tissue were preserved in the pericardial acellular matrix. Crosslinking of the material in glutaraldehyde or poly(glycidyl ether) produced mechanical changes consistent with the same treatments of fresh tissue. The pericardial acellular matrix is a promising approach to the production of biomaterials for heart valve or cardiovascular patching applications. (C) 1994 John Wiley & Sons, Inc.
C1 TORONTO GEN HOSP,DIV GEN,DIV CARDIOVASC SURG,TORONTO M5G 2C4,ON,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO,ON,CANADA.
   UNIV TORONTO,DEPT CELLULAR & MOLEC PATHOL,TORONTO,ON,CANADA.
   UNIV TORONTO,DEPT SURG,TORONTO,ON,CANADA.
   UNIV TORONTO,DEPT MET & MAT SCI,TORONTO,ON,CANADA.
   HOSP SICK CHILDREN,DEPT PATHOL,TORONTO M5G 1X8,ON,CANADA.
   HOSP SICK CHILDREN,DIV CARCIOVASC RES,TORONTO M5G 1X8,ON,CANADA.
CR [Anonymous], 1990, J VASC SURG, V12, P741
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CROFTS CE, 1988, J BIOMED MATER RES, V22, P89, DOI 10.1002/jbm.820220202
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GRIMM M, 1991, J THORAC CARDIOV SUR, V102, P195
   HABERER S, 1989, THESIS U TORONTO
   HILBERT SL, 1992, AM J PATHOL, V140, P1195
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P249, DOI 10.1016/0142-9612(91)90208-R
   KEELEY FW, 1991, LAB INVEST, V64, P499
   KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1
   KRASOVSKAYA SM, 1991, BIOMATERIALS, V12, P817, DOI 10.1016/0142-9612(91)90067-K
   Lee J. Michael, 1994, V1173, P19
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1989, J BIOMED MATER RES, V23, P477, DOI 10.1002/jbm.820230503
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   Maranto AR, 1988, T AM SOC ART INT ORG, V34, P827
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   RASMUSSEN BL, 1975, ANAL BIOCHEM, V64, P255, DOI 10.1016/0003-2697(75)90426-1
   Schoen F J, 1984, Cardiol Clin, V2, P717
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SIMIONESCU D, 1988, BIOCHEM BIOPH RES CO, V151, P480, DOI 10.1016/0006-291X(88)90618-3
   SIMIONESCU D, 1989, MATRIX, V9, P301, DOI 10.1016/S0934-8832(89)80006-X
   STARCHER BC, 1976, ANAL BIOCHEM, V74, P441, DOI 10.1016/0003-2697(76)90224-4
   VALENTE M, 1985, AM J PATHOL, V119, P12
   WIEBE D, 1988, SURGERY, V104, P26
   WIGHT TN, 1989, ARTERIOSCLEROSIS, V9, P1, DOI 10.1161/01.ATV.9.1.1
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, pM340
NR 32
TC 199
Z9 230
U1 4
U2 43
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1994
VL 28
IS 6
BP 655
EP 666
DI 10.1002/jbm.820280602
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL112
UT WOS:A1994NL11200001
PM 8071376
DA 2018-10-19
ER

PT J
AU TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
AF TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
TI FIXATION OF BIOPROSTHETIC TISSUES WITH MONOFUNCTIONAL AND
   MULTIFUNCTIONAL POLYEPOXY COMPOUNDS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COLLAGEN; GRAFT
AB Collagen from a native tissue is fixed with a polyepoxy compound (PC) for use as a new biologic prosthetic material. Prior studies have shown that this biomaterial has comparable properties with collagen fixed with glutaraldehyde (GA), and thus has great promise for biomedical applications. A prior kinetic study indicated that the reaction between the functional groups of collagen and the multifunctional epoxy EX-313 is a 2.5th-order reaction. The purpose of this study was to understand the mechanism of the amino acid-PC reactions in a fixation process. Bovine arteries were fixed with a monofunctional PC (EX-131) and a multifunctional PC (EX-313) as a function of fixation time. A sequential fixation with a second fixative was used to identify the available remaining reactive sites from a prior fixation. The denaturation temperature (T-d) was measured on each sample. Because the denaturation temperature is a direct indication of crosslinking of individual amino acids with the fixative, the increase in T-d of a subsequent fixation may be indicative of the available remaining amino acids. The fixation index was measured on each sample to reflect the increase of fixation completion in a sequential fixation process. The fixation index and crosslink data also revealed that the reactive amino acids for EX-131 and EX-313 may not be exactly the same. The data in this study suggest that a monofunctional fixative can pre-react with the amino acids of collagen to effectively block further fixation of collagen with a second fixative. This amino acid masking may be associated with collagen branching. Collagen branching and its effect on denaturation temperature are described. (C) 1994 John Wiley & Sons, Inc.
C1 BAXTER EDWARDS CVS DIV,IRVINE,CA.
   YOKOHAMA CITY UNIV,YOKOHAMA 236,JAPAN.
RP TU, R (reprint author), TU BIOSCI LAB,2151 PALERMO,TUSTIN,CA 92680, USA.
CR CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   HATA C, 1992, ARTIF ORGANS, V16, P263, DOI 10.1111/j.1525-1594.1992.tb00307.x
   Hata C., 1992, International Journal of Artificial Organs, V15, P562
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LOHRE J, 1991, ARTIF ORGANS, V15, P124
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MCINTYRE J, 1992, ABSTR ASAIO, V21, P122
   MORRISON RT, 1986, ORGANIC CHEM, P548
   MURAYAMA Y, 1988, T AM SOC ART INT ORG, V34, P546
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SUMA H, 1990, TEX HEART I J, V17, P103
   Sung H. W., 1992, International Journal of Artificial Organs, V15, P562
   SUNG HW, 1992, ARTIF ORGANS, V16, P485, DOI 10.1111/j.1525-1594.1992.tb00328.x
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1993, JUL ESAO ISAO M AMST
   TU R, 1991, 17TH T ANN M SOC BIO, P163
   TU R, 1991, ABSTR ASAIO, V114
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   Tu Roger, 1992, International Journal of Artificial Organs, V15, P548
   WAITE JH, 1981, CRC HDB BIOCH AGING
   Yamauchi M., 1988, COLLAGEN, P157
NR 35
TC 55
Z9 57
U1 3
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1994
VL 28
IS 6
BP 677
EP 684
DI 10.1002/jbm.820280604
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL112
UT WOS:A1994NL11200003
PM 8071378
DA 2018-10-19
ER

PT J
AU SESTAFE, JVG
   PAEZ, JMG
   SANMARTIN, AC
   JORGEHERRERO, E
   NAVIDAD, R
   CANDELA, I
   CASTILLOOLIVARES, JL
AF SESTAFE, JVG
   PAEZ, JMG
   SANMARTIN, AC
   JORGEHERRERO, E
   NAVIDAD, R
   CANDELA, I
   CASTILLOOLIVARES, JL
TI DESCRIPTION OF THE MATHEMATICAL LAW THAT DEFINES THE RELAXATION OF
   BOVINE PERICARDIUM SUBJECTED TO STRESS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID AORTIC-VALVE REPLACEMENT; XENOGRAFT; BIOPROSTHESES; FAILURE; TISSUE
AB A material subjected to traction stress increases in length; if we maintain the elongation constant, the stress varies over a period of time. This phenomenon has been referred to as relaxation. The purpose of this study was to define a mathematical law that relates the variation in stress to time when elongation remains constant in bovine pericardium. The mathematical function obtained after assaying 34 samples to the point of relaxation, subjected to initial stresses ranging from 0.17-10.07 MPa, responds to the following equation: y = -0.0252 + 0.953 alpha - (0.0165 + 0.015 alpha)lnt, where y is the stress withstood at an instant in time, t, after initial stress alpha. A normogram, validated by assays of up to 6,340 min duration (4.40 days), is presented for graphic calculation, permitting the computation of the loss of stress due to relaxation of this biomaterial, with initial stresses ranging from 1-10 MPa. (C) 1994 John Wiley & Sons, Inc.
C1 CLIN PUERTA HIERRO,DEPT EXPTL SURG,SERV MED PREVENT,E-28035 MADRID,SPAIN.
   CLIN PUERTA HIERRO,INST NACL ESTADIST,MADRID,SPAIN.
   ESCUELA SUPER INGN IND,DEPT MAT RESISTANCE,MADRID,SPAIN.
CR BARRATTBOYES BG, 1977, CIRCULATION, V55, P353, DOI 10.1161/01.CIR.55.2.353
   CARPENTIER A, 1974, J THORAC CARDIOVASC, V15, P68
   COHN LH, 1985, J THORAC CARDIOV SUR, V90, P872
   COHN LH, 1984, CHEST, V85, P387, DOI 10.1378/chest.85.3.387
   FUNG YC, 1972, BIOMECHANICS ITS FDN, P181
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P836
   KIRKLIN JW, 1981, NEW ENGL J MED, V304, P291, DOI 10.1056/NEJM198101293040508
   LAKIER JB, 1980, CIRCULATION, V62, P313, DOI 10.1161/01.CIR.62.2.313
   LEE JM, 1981, CIRC RES, V49, P533, DOI 10.1161/01.RES.49.2.533
   LEE JM, 1984, J BIOMED MATER RES, V18, P61, DOI 10.1002/jbm.820180108
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   MASE GE, 1980, SCHAUMS OUTLINE SERI
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   PAEZ JMG, 1990, BIOMATERIALS, V11, P186, DOI 10.1016/0142-9612(90)90153-H
   RABKIN S, 1974, J APPL PHYSIOL, V31, P73
   SHOEN FJ, 1987, J BIOMED MATER RES, V21, P91
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   TROWBRIDGE EA, 1988, J THORAC CARDIOV SUR, V95, P577
   TROWBRIDGE EA, 1985, J MATER SCI, V20, P114, DOI 10.1007/BF00555905
   TROWBRIDGE EA, 1986, BIOMATERIALS, V7, P49, DOI 10.1016/0142-9612(86)90089-X
   WALLEY VM, 1987, J THORAC CARDIOV SUR, V93, P925
NR 21
TC 7
Z9 7
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1994
VL 28
IS 6
BP 755
EP 760
DI 10.1002/jbm.820280613
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL112
UT WOS:A1994NL11200012
PM 8071387
DA 2018-10-19
ER

PT J
AU WILLIAMS, DF
AF WILLIAMS, DF
TI THE BIOMATERIAL HORIZON
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Editorial Material
AB In this beautiful location of Davos, it is easy to ascend a mountain from which you can look all around and witness an incredible panorama. If you are new to the area, the view is one of a rugged horizon which would appear to be similar in appearance in all directions, especially in winter. That is not unusual; there are many places in this world where the horizon, whether beautiful or unappealing, appears to be the same in diametrically opposed directions.
RP WILLIAMS, DF (reprint author), UNIV LIVERPOOL,DEPT CLIN ENGN,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 303
EP 307
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600001
DA 2018-10-19
ER

PT J
AU PATEL, MP
   BRADEN, M
   DOWNES, S
AF PATEL, MP
   BRADEN, M
   DOWNES, S
TI HETEROCYCLIC METHACRYLATE-BASED DRUG-RELEASE POLYMER SYSTEM
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
ID CLINICAL-APPLICATIONS
AB A heterocyclic methacrylate polymer system, developed originally as a low shrinkage polymer system, has been investigated as a drug release polymer and as a biomaterial for encouraging bone or cartilage regeneration. The system is based on poly(ethyl methacrylate) polymer powder mixed with tetrahydrofurfuryl methacrylate monomer and polymerized at room temperature (PEM/THFM). Promising results have been obtained with this biomaterial, and hence its water uptake properties were investigated in detail, in order to throw some light on the release processes that are involved in vivo and in vitro. Water soluble large molecule analogues were incorporated into the system; these additives increased the water uptake of the system. Isobornyl methacrylate was used as a diluent for the monomer to further reduce the water uptake of the system. In all cases the uptake kinetics did not obey simple diffusion theory, the process being very prolonged and complex.
C1 INST ORTHOPAED STANMORE,STANMORE HA7 4LP,MIDDX,ENGLAND.
RP PATEL, MP (reprint author), UNIV LONDON LONDON HOSP,SCH DENT,COLL MED,TURNER ST,LONDON E1 2AD,ENGLAND.
CR DOWNES S, 1992, 4TH WORLD BIOM C BER, P46
   DOWNES S, 1992, 4TH WORLD BIOM C BER, P273
   PATEL MP, 1991, BIOMATERIALS, V12, P653, DOI 10.1016/0142-9612(91)90112-N
   PATEL MP, 1987, BIOMATERIALS, V8, P53, DOI 10.1016/0142-9612(87)90030-5
   PATEL MP, 1991, BIOMATERIALS, V12, P645, DOI 10.1016/0142-9612(91)90110-V
   PEARSON GJ, 1986, INT ENDOD J, V19, P121, DOI 10.1111/j.1365-2591.1986.tb00464.x
NR 6
TC 14
Z9 14
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 338
EP 339
DI 10.1007/BF00058958
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600007
DA 2018-10-19
ER

PT J
AU GWYNN, IA
AF GWYNN, IA
TI CELL BIOLOGY AT INTERFACES
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CYTOSKELETON; MEMBRANE; MICROTUBULES; FIBROBLASTS; RECEPTORS; INTEGRIN;
   PROTEINS; ACTIN; FIBRONECTIN; MORPHOLOGY
AB A brief review is presented of the significant developments in the understanding of the processes involved in cell adhesion both to other cells and to substrates. The relationship between general cellular behaviour and cell adhesion is a result of the importance of the cytoplasmic cytoskeleton to most cellular processes. Interaction between a substrate and the cell is mediated through intramembranous proteins, such as the integrins. The intramembranous proteins, in turn, influence the assembly of the microfilamentous structures in the cytoplasm. Changes in the state of the microfilaments are accompanied by modifications in the behaviour of both microtubules and intermediate filaments. The expression of different types of cytoskeletal configuration result from differing types of cell-cell or cell-substratum encounters. This leads to significant changes in resultant cellular behaviour. It is argued that an understanding of changes that result from cell-biomaterial interactions, at the ultrastructural level, is necessary in order to assess the biocompatability of implant materials.
RP GWYNN, IA (reprint author), UNIV WALES, INST BIOL SCI, ABERYSTWYTH SY23 3DA, DYFED, WALES.
CR ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6
   AKASHI T, 1991, J CELL SCI, V98, P169
   ARCHER C, COMMUNICATION
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BENZEEV A, 1987, J CELL SCI, P293
   BRAY D, 1986, J CELL SCI, P71
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   CROSS SJ, 1987, CYTOBIOS, V50, P41
   CUNNINGHAM CC, 1992, CANCER METAST REV, V11, P69
   CURTIS ASG, 1967, CELL SURFACE ITS MOL, P80
   CURTIS ASG, 1992, SYMB SOC EXPT BIOL, V46, P10
   CURTIS ASG, 1967, CELL SURFACE ITS MOL, P204
   EVERHART LP, 1974, J CELL BIOL, V60, P442, DOI 10.1083/jcb.60.2.442
   GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521
   GOLDSTEIN LSB, 1991, NATURE, V352, P569, DOI 10.1038/352569a0
   GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0
   HEATH JP, 1991, CELL MOTIL CYTOSKEL, V18, P245, DOI 10.1002/cm.970180402
   HYNES RO, 1989, J CELL BIOL, V109, P409, DOI 10.1083/jcb.109.1.409
   IRELAND GW, 1987, J CELL SCI, P19
   ISOBE Y, 1991, ANAT REC, V229, P415, DOI 10.1002/ar.1092290314
   JOCKUSCH BM, 1991, J CELL SCI, P41
   KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49
   KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029
   LAFLAMME SE, 1992, J CELL BIOL, V117, P437, DOI 10.1083/jcb.117.2.437
   LLOYD CW, 1977, EXP CELL RES, V110, P427, DOI 10.1016/0014-4827(77)90309-3
   MANESS PF, 1982, CELL, V30, P253, DOI 10.1016/0092-8674(82)90031-9
   MARCHISIO PC, 1991, J CELL BIOL, V112, P761, DOI 10.1083/jcb.112.4.761
   MILLS JW, 1987, CURR TOP MEMBR TRANS, V30, P75
   NERMUT MV, 1991, EXP CELL RES, V192, P311, DOI 10.1016/0014-4827(91)90192-W
   NERMUT MV, 1993, MICRON, V24, P363, DOI 10.1016/0968-4328(93)90002-I
   PIENTA KJ, 1992, J CELL BIOCHEM, V49, P357, DOI 10.1002/jcb.240490406
   PORTER K, 1973, J CELL BIOL, V57, P815, DOI 10.1083/jcb.57.3.815
   ROBEY HL, 1992, J CELL SCI, V102, P329
   ROGNE S, 1985, J CELL PHYSIOL, V125, P528, DOI 10.1002/jcp.1041250324
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1577, DOI 10.1073/pnas.48.9.1577
   STOKER M, 1964, VIROLOGY, V24, P165, DOI 10.1016/0042-6822(64)90099-6
   SUGI Y, 1991, CELL TISSUE RES, V263, P459, DOI 10.1007/BF00327279
   TIMASHEFF SN, 1980, ANNU REV BIOCHEM, V49, P565, DOI 10.1146/annurev.bi.49.070180.003025
   TINT IS, 1991, J CELL SCI, V98, P375
   UNGER E, 1990, ACTA HISTOCHEM, P303
   VASILIEV JM, 1987, J CELL SCI, P1
NR 44
TC 14
Z9 14
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 357
EP 360
DI 10.1007/BF00058963
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600012
DA 2018-10-19
ER

PT J
AU REUTELINGSPERGER, CPM
   VANGOOL, RGJ
   HEIJNEN, V
   FREDERIK, P
   LINDHOUT, T
AF REUTELINGSPERGER, CPM
   VANGOOL, RGJ
   HEIJNEN, V
   FREDERIK, P
   LINDHOUT, T
TI THE ROTATING-DISC AS A DEVICE TO STUDY THE ADHESIVE PROPERTIES OF
   ENDOTHELIAL-CELLS UNDER DIFFERENTIAL SHEAR STRESSES
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID INTEGRINS; CULTURE
AB Hemocompatibility can be conferred on a biomaterial by covering this material with a monolayer of endothelial cells. The endothelial cell is an epithelial cell of mesenchymal origin, that features a specific phenotype with homotypic intercellular interactions and with specialized cell-matrix interactions. These interactions are mandatory to the normal barrier function and the non-thrombogenicity of the endothelial monolayer and are maintained in vivo at shear stresses ranging from 10(-5) to 10(-3) N cm(-2). The endothelial monolayer grafted on a biomaterial should meet similar requirements. We have constructed a rotating disc device to investigate the effects of differential shear stresses on cell-cell and cell-matrix interactions in a monolayer of endothelial cells grafted on a disc-shaped biomaterial. The range of shear stresses that are being applied by the device vary from 0-10(-4) N cm(-2) to 0-2 x 10(-3) N cm(-2) In a series of experiments with discs of plasma discharge treated polycarbonate (PC) that are coated with fibronectin, it has been shown that a monolayer of endothelial cells grafted on these discs starts to lose intercellular contacts and cell-fibronectin interactions at shear stresses of 10(-4) N cm(-2). Coating of the PC discs with a complex extracellular matrix, synthesized by arterial smooth muscle cells in culture, prior to endothelial cell seeding results in the formation of a monolayer, which retains its integrity at shear stresses up to 2 x 10(-3) N cm(-2).
C1 UNIV LIMBURG, DEPT PATHOL, EM UNIT, 6200 MD MAASTRICHT, NETHERLANDS.
   BIOMAT & POLYMER RES INST MAASTRICHT EINDHOVEN, MAASTRICHT, NETHERLANDS.
RP REUTELINGSPERGER, CPM (reprint author), UNIV LIMBURG, DEPT BIOCHEM, POB 616, 6200 MD MAASTRICHT, NETHERLANDS.
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   DEJANA E, 1989, J CELL BIOL, V109, P367, DOI 10.1083/jcb.109.1.367
   HAUDENSCHILD CC, 1984, BIOL ENDOTHELIAL CEL, P129
   HAY ED, 1981, J CELL BIOL, V91, pS205, DOI 10.1083/jcb.91.3.205s
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   LEVICH VG, 1962, PHYSICOCHEM HYDRODYN, P60
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P133, DOI 10.1002/path.1700750116
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   REGEN CM, 1992, J CELL BIOL, V119, P1347, DOI 10.1083/jcb.119.5.1347
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROSENBERG RD, 1984, J CLIN INVEST, V74, P1, DOI 10.1172/JCI111389
   ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   VANMOURIK JA, 1985, J BIOL CHEM, V260, P1300
NR 16
TC 23
Z9 23
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 361
EP 367
DI 10.1007/BF00058964
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600013
DA 2018-10-19
ER

PT J
AU REISSIS, N
   DOWNES, S
   KAYSER, M
   LEE, D
   BENTLEY, G
AF REISSIS, N
   DOWNES, S
   KAYSER, M
   LEE, D
   BENTLEY, G
TI CHARACTERIZATION OF THE REPAIR TISSUE IN ARTICULAR-CARTILAGE DEFECTS
   USING SILVER-ENHANCED COLLOIDAL GOLD IMMUNOSTAINING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
ID RABBIT; SURFACES; POLYMERS
AB The newly developed silver-enhanced colloidal gold staining method was used in a rabbit model to characterize the repair tissue in large articular cartilage defects filled with a heterocyclic methacrylate polymer. By 6 weeks the resurfacing tissue consisted of highly organized hyaline-like articular cartilage, fully integrated with the adjacent normal cartilage. Immuno-histochemistry detected collagen type II, keratan sulphate, chondroitin 4-sulphate and chondroitin 6-sulphate in the matrix of the neocartilage. The level to which the polymer plug was recessed appeared to be critical to the overall quality of the repair tissue. Optimum results were obtained when the top surface of the biomaterial was at the level of the subchondral bone, below the level of the surrounding articular cartilage. Other technical aspects of implantation, that also affect the repair, are also discussed.
C1 ROYAL NATL ORTHOPAED HOSP,UNIV COLL LONDON,INST ORTHOPAED,STANMORE HA7 4LP,MIDDX,ENGLAND.
   ROYAL NATL ORTHOPAED HOSP,UNIV COLL LONDON,IRC BIOMED MAT,STANMORE HA7 4LP,MIDDX,ENGLAND.
OI Lee, David/0000-0001-7646-4643
CR Batchelor G.Y., 1991, ANIMAL TECHNOL, V42, P109
   BENTLEY G, 1978, ANN RHEUM DIS, V37, P449, DOI 10.1136/ard.37.5.449
   BUCKWALTER JA, 1991, ARTICULAR CARTILAGE, P465
   DOWNES S, IN PRESS J MATER SCI
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   HACKER GW, 1985, VIRCHOWS ARCH A, V406, P449, DOI 10.1007/BF00710236
   HEMMEN B, 1991, T ORTHOP RES SOC, V16, P278
   MINNS RJ, 1989, BIOMATERIALS, V10, P273, DOI 10.1016/0142-9612(89)90105-1
   PATEL MP, 1991, BIOMATERIALS, V12, P649, DOI 10.1016/0142-9612(91)90111-M
   PEARSON GJ, 1986, INT ENDOD J, V19, P121, DOI 10.1111/j.1365-2591.1986.tb00464.x
   REISSIS N, IN PRESS J BONE JOIN
   SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
NR 15
TC 20
Z9 20
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 402
EP 406
DI 10.1007/BF00058973
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600022
DA 2018-10-19
ER

PT J
AU MEYLE, J
   GULTIG, K
   BRICH, M
   HAMMERLE, H
   NISCH, W
AF MEYLE, J
   GULTIG, K
   BRICH, M
   HAMMERLE, H
   NISCH, W
TI CONTACT GUIDANCE OF FIBROBLASTS ON BIOMATERIAL SURFACES
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TO-SUBSTRATE CONTACTS; INTERFERENCE REFLECTION; ADHESIONS;
   MICROMORPHOLOGY
AB The physico-chemical properties of a biomaterial and its surface-texture greatly influence the type of tissue reaction. Grooved substrata provoke cellular orientation which is known as contact guidance. Using gingival fibroblasts it has been demonstrated that microstructured hydrophilic (by glow discharge treatment) silicone also induces cellular alignment. Further analysis of the cell contacts by laser scanning microscopy has revealed that the focal adhesion sites were also oriented along the substratum microstructures. This phenomenon supports earlier hypotheses regarding cellular alignment and may be responsible for the orientation of the whole cell.
C1 NMI INST, D-72762 REUTLINGEN, GERMANY.
RP MEYLE, J (reprint author), UNIV TUBINGEN, ORAL SURG & PERIODONTOL CLIN, SPECIAL COLLABORAT RES PROGRAM DENT IMPLANTOL, D-72076 TUBINGEN, GERMANY.
CR ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9
   ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X
   ABERCROMBIE M, 1982, CELL BEHAVIOUR, P19
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   HEATH JP, 1982, CELL BEHAVIOUR, P77
   HEAYSMAN JEM, 1982, CELL BEHAVIOUR TRIBU, P49
   IZZARD CS, 1980, J CELL SCI, V42, P81
   IZZARD CS, 1976, J CELL SCI, V21, P129
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   MEYLE J, IN PRESS J BIOMED MA
   NERMUT MV, 1991, EXP CELL RES, V193, P382, DOI 10.1016/0014-4827(91)90111-7
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507
   TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6
   TAWIL N, 1993, J CELL BIOL, V120, P261, DOI 10.1083/jcb.120.1.261
   VONRECUM AF, 1990, ADV BIOMAT, V9, P297
NR 20
TC 40
Z9 41
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 463
EP 466
DI 10.1007/BF00058984
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600033
DA 2018-10-19
ER

PT J
AU BUNDY, KJ
   ROBERTS, OC
   OCONNOR, K
   MCLEOD, V
   RAHN, B
AF BUNDY, KJ
   ROBERTS, OC
   OCONNOR, K
   MCLEOD, V
   RAHN, B
TI QUANTIFICATION OF FIBROBLAST ADHESION TO BIOMATERIALS USING A
   FLUID-MECHANICS APPROACH
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
AB Adhesion of cells to the surface of a biomaterial is one of the major factors mediating its biocompatibility. Despite the importance of this parameter, reliable means for its quantification still need to be developed. In the research described here, the jet impingement method has been investigated as to its ability to resolve differences in fibroblast adhesion. A wide spectrum of materials has been studied. To visualize the cell layer on opaque surfaces, a fluorescent staining method has been developed. The measurements show statistically significant differences between material classes, with the highest degree of adhesion about twice that of the lowest degree of adhesion. The greatest adhesion was observed with metallic materials which exhibit a shear stress to erode cells from the material surface of about 5.65 x 10(-3) N cm(-2). The tensile stress of adhesion (about 2.15 x 10(-2) N cm(-2)) was similar for most materials. The interpretation of the results of jet impingement testing and their relation to in vivo cell and soft tissue adherence to biomaterials merits further investigation.
C1 AO,RES INST,DAVOS,SWITZERLAND.
RP BUNDY, KJ (reprint author), TULANE UNIV,SCH ENGN,NEW ORLEANS,LA, USA.
RI O'Connor, Kim/H-3145-2012
CR BUNDY K, 1991, 17TH ANN M SOC BIOM, P229
   BUNDY K, 1993, 19TH ANN M SOC BIOM, P248
   BUNDY KJ, 1993, 39TH T M ORTH RES SO, P513
   DESHPANDE M, 1983, J FLUID MECH, V114, P213
   SCHMALZ G, 1985, J BIOMED MATER RES, V19, P653, DOI 10.1002/jbm.820190605
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
NR 6
TC 6
Z9 6
U1 0
U2 0
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 500
EP 502
DI 10.1007/BF00058991
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600040
DA 2018-10-19
ER

PT J
AU EPPLEY, BL
   SUMMERLIN, DJ
   SADOVE, AM
AF EPPLEY, BL
   SUMMERLIN, DJ
   SADOVE, AM
TI A POTENTIAL BIOMATERIAL COMPOSITE FOR DERMAL AND SUBCUTANEOUS
   AUGMENTATION
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; INJECTABLE COLLAGEN; GRAFT-SURVIVAL;
   BIOACTIVATION; BIOPLASTIQUE; IMPLANTATION; MICROSPHERES
AB Based on previous experimental connective tissue work in cutaneous wound healing, cell culture, and fat transplantation, the use of positively charged dextran beads for subcutaneous and dermal augmentation was evaluated. When combined with a biocompatible liquid medium, the material easily flowed through small-gauge needles. When injected beneath the facial skin in rats, a profound macrophage response was initially seen at 30 days accompanied by fibroblast proliferation and new collagen formation. By 1 year, a quescient, noninflammatory cellular response with extensive intermaterial collagen deposition was evident. No adverse reactions were seen in the contralateral facial sites, which were injected with only the liquid medium. These preliminary findings suggest good tissue compatibility of this composite biomaterial and provide further evidence of the significant regulatory role of the macrophage in the tissue response to implanted biomaterials.
C1 INDIANA UNIV,DEPT ORAL PATHOL,INDIANAPOLIS,IN 46202.
RP EPPLEY, BL (reprint author), INDIANA UNIV,MED CTR,DIV PLAST & RECONSTRUCT SURG,702 BARNHILL DR,ROOM 2514,INDIANAPOLIS,IN 46202, USA.
CR ALLEN O, 1992, AESTHET PLAST SURG, V16, P227, DOI 10.1007/BF00190068
   ANDERSON JM, 1984, BIOMATERIALS, V4, P5
   EDGERTON MT, 1976, PLAST RECONSTR SURG, V58, P157, DOI 10.1097/00006534-197608000-00004
   EPPLEY BL, 1991, AESTHET PLAST SURG, V15, P215, DOI 10.1007/BF02273860
   EPPLEY BL, 1992, PLAST RECONSTR SURG, V90, P1022, DOI 10.1097/00006534-199212000-00013
   EPPLEY BL, 1992, PLAST RECONSTR SURG, V89, P157
   EPPLEY BL, 1992, J ORAL MAXIL SURG, V50, P477, DOI 10.1016/S0278-2391(10)80319-2
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   KAPLAN EN, 1983, ANN PLAS SURG, V10, P437, DOI 10.1097/00000637-198306000-00002
   KLEIN AW, 1985, J DERMATOL SURG ONC, V11, P3
   KNAPP TR, 1977, PLAST RECONSTR SURG, V60, P398
   KRUKOWSKI M, 1991, BONE-BIOMATERIAL INTERFACE, P275
   LEMPERLE G, 1991, ANN PLAS SURG, V26, P57, DOI 10.1097/00000637-199101000-00009
   LEMPERLE G, 1975, PLASTISCHE WIEDERHER, P335
   MILLIKAN L, 1989, J DERMATOL SURG ONC, V15, P837, DOI 10.1111/j.1524-4725.1989.tb01172.x
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305
   REES TD, 1970, PLAST RECONSTR SURG, V16, P50
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   VANMULLE PJ, 1984, BIOMATERIALS BIOMECH, P271
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 22
TC 13
Z9 13
U1 0
U2 1
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD MAY
PY 1994
VL 32
IS 5
BP 463
EP 468
DI 10.1097/00000637-199405000-00004
PG 6
WC Surgery
SC Surgery
GA NM109
UT WOS:A1994NM10900004
PM 8060068
DA 2018-10-19
ER

PT J
AU RASPANTI, M
   GUIZZARDI, S
   DEPASQUALE, V
   MARTINI, D
   RUGGERI, A
AF RASPANTI, M
   GUIZZARDI, S
   DEPASQUALE, V
   MARTINI, D
   RUGGERI, A
TI ULTRASTRUCTURE OF HEAT-DEPROTEINATED COMPACT-BONE
SO BIOMATERIALS
LA English
DT Article
DE BONE; HEAT TREATMENT; ULTRASTRUCTURE; COLLAGEN
AB Heat-deproteinated bone (calcined bone) is a natural candidate for an osteoreproductive biomaterial. Ultrastructural investigation has pointed out an important aspect of the preparation technique. Treatment of bone at temperatures exceeding 500 degrees C causes complete disruption of the tissue architecture and the reorganization of the mineral phase into tightly packed, dense crystals. At 500 degrees C or less the structure and distribution of the mineral phase remain unaffected, so that cross-banded 'shadows' of collagen fibrils are still readily observable, although collagen is no longer present in the samples. By its excellent structural preservation and natural porosity, low-temperature calcined bone seems to be a promising alternative for osteoreproduction.
C1 UNIV PARMA,INST HISTOL,I-43100 PARMA,ITALY.
RP RASPANTI, M (reprint author), UNIV BOLOGNA,INST HUMAN ANAT,I-40126 BOLOGNA,ITALY.
OI Guizzardi, Stefano/0000-0003-2395-8767
CR BASSETT CAL, 1962, TRANSPLAN B, V29, P423
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   CHACHA PB, 1984, INT ORTHOP, V8, P117
   DRISKELL TD, 1973, 1ST IADR GEN M CHIC
   HOHLING HJ, 1990, ULTRASTRUCTURE SKELE, P41
   HOLMSTRAND K, 1957, ACTA ORTHOP SCAND S, V26
   KATTHAGEN BD, 1986, BONE REGENERATION BO, P17
   KUROSAWA H, 1986, BIOMATERIALS, V7, P132, DOI 10.1016/0142-9612(86)90070-0
   LINDHOLM TS, 1982, CLIN ORTHOP RELAT R, V171, P251
   LINDHOLM TS, 1980, CLIN ORTHOP RELAT R, V150, P288
   MAATZ R, 1954, J BONE JOINT SURG AM, V36-A, P721, DOI 10.2106/00004623-195436040-00003
   MATTI H, 1932, LANGENBECKS ARCH KLI, V168, P236
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   OSBORN JF, 1979, S ENWP SOC BIOMATER
   PEELEN JGJ, 1977, SCI CERAM, V9, P226
   RAGNI P, 1987, GIORN IT ORTOP TRAUM, P251
   RUGGERI A, 1987, BIOMATERIALS CLIN AP, P603
   TAYLOR GI, 1975, PLAST RECONSTR SURG, V55, P533, DOI 10.1097/00006534-197505000-00002
   TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822
   URIST MR, 1968, CLIN ORTHOPAEDICS, V61, P61
NR 21
TC 36
Z9 37
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1994
VL 15
IS 6
BP 433
EP 437
DI 10.1016/0142-9612(94)90222-4
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NM163
UT WOS:A1994NM16300006
PM 8080934
DA 2018-10-19
ER

PT J
AU BROWN, RA
   BLUNN, GW
   EJIM, OS
AF BROWN, RA
   BLUNN, GW
   EJIM, OS
TI PREPARATION OF ORIENTATED FIBROUS MATS FROM FIBRONECTIN - COMPOSITION
   AND STABILITY
SO BIOMATERIALS
LA English
DT Article
DE FIBRONECTIN; WOUND HEALING; HEPARIN; FIBROBLAST GROWTH FACTOR;
   CROSS-LINKING; DYE RELEASE
ID PLASMA FIBRONECTIN; GROWTH-FACTOR; HEPARIN; MATRIX; MORPHOGENESIS;
   COLLAGEN; STRENGTH; BINDING; DOMAINS; FIBRIL
AB The biochemical characteristics of a novel biomaterial, based on the aggregated adhesive protein, fibronectin (Fn), are reported here. Fibrous, orientated mats, formed from solution under directional shear, could be made to incorporate heparin (typically 3.2 mu mg/mg fibronectin). Mats were hygroscopic, doubling their mass by water uptake in less than 10 h from humid air. After an initial rapid loss of protein into physiological solutions over 24 h, mats were stable and not rapidly degraded by fibroblasts. With or without heparin, mats bound basic fibroblast growth factor, which was then released only slowly. Such materials: may prove useful models of in vivo tissue Fn function and as clinical implants to organize tissue repair.
C1 UCL, ROYAL NATL ORTHOPAED HOSP, DEPT BIOMED ENGN, STANMORE HA7 4LP, MIDDX, ENGLAND.
RP BROWN, RA (reprint author), UNIV LONDON UNIV COLL, SCH MED, RAYNE INST, DEPT PLAST & RECONSTRUCT SURG, UNIV ST, LONDON WC1E 6JJ, ENGLAND.
CR ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017
   ANKEL EG, 1986, ARCH BIOCHEM BIOPHYS, V24, P50
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEN WT, 1984, J CELL BIOL, V98, P1546, DOI 10.1083/jcb.98.4.1546
   COTTON G, 1985, CLIN CHIM ACTA, V153, P173, DOI 10.1016/0009-8981(85)90349-3
   DUNN GA, 1976, EXP CELL RES, V107, P1
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   FALCONE PA, 1984, PLAST RECONSTR SURG, V74, P809, DOI 10.1097/00006534-198412000-00014
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Gelberman R, 1988, INJURY REPAIR MUSCUL, P5
   GOLD LI, 1983, BIOCHEMISTRY-US, V22, P4113, DOI 10.1021/bi00286a019
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605
   JACKSON DS, 1982, COLLAGEN HLTH DISEAS, P466
   KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033
   MARKOVIC Z, 1983, H-S Z PHYSIOL CHEM, V364, P1795, DOI 10.1515/bchm2.1983.364.2.1795
   MCDONALD JA, 1987, J BIOL CHEM, V262, P2957
   MOSESSON MW, 1970, J BIOL CHEM, V245, P5738
   MOSHER DF, 1980, J BIOL CHEM, V255, P1181
   OBERLEY TD, 1983, EXP CELL RES, V145, P265, DOI 10.1016/0014-4827(83)90005-8
   OH E, 1981, P NATL ACAD SCI-BIOL, V78, P3218, DOI 10.1073/pnas.78.5.3218
   RICHTER H, 1985, BIOL CHEM H-S, V366, P509, DOI 10.1515/bchm3.1985.366.1.509
   SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463
   SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   UNGARI S, 1985, INVAS METAST, V5, P193
   VIIDIK A, 1980, BIOL COLLAGEN, P237
NR 29
TC 49
Z9 49
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1994
VL 15
IS 6
BP 457
EP 464
DI 10.1016/0142-9612(94)90225-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NM163
UT WOS:A1994NM16300009
PM 8080937
DA 2018-10-19
ER

PT J
AU MOORE, MA
   BOHACHEVSKY, IK
   CHEUNG, DT
   BOYAN, BD
   CHEN, WM
   BICKERS, RR
   MCILROY, BK
AF MOORE, MA
   BOHACHEVSKY, IK
   CHEUNG, DT
   BOYAN, BD
   CHEN, WM
   BICKERS, RR
   MCILROY, BK
TI STABILIZATION OF PERICARDIAL TISSUE BY DYE-MEDIATED PHOTOOXIDATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID CARDIAC-VALVE BIOPROSTHESES; BOVINE PERICARDIUM; HEART-VALVES;
   CROSS-LINKS; CALCIFICATION; COLLAGEN; GLUTARALDEHYDE; MINERALIZATION;
   FORMALDEHYDE; REPLACEMENT
AB Bovine pericardial tissue was stabilized through a dye-mediated photooxidation reaction. Shrink temperature analysis of the stabilized tissue indicated a material with similar properties to untreated pericardial tissue and unlike identical tissue treated with glutaraldehyde. Photooxidized tissue was resistant to extraction when compared with untreated tissue or control tissues treated in the absence of light or dye. Photooxidized tissue was also resistant to enzymatic digestion by pepsin and to chemical digestion by cyanogen bromide (CNBr). In contrast, untreated or control treated tissues were readily digested by these reagents. Reduction of photooxidized tissue with beta-mercaptoethanol prior to CNBr digestion partially restored susceptibility of the tissue to CNBr digestion, indicating the photooxidation of methionine residues. Soluble collagen derived from bovine pericardium was used as a model compound for the photooxidation reaction. Polyacrylamide gel electrophoresis analysis indicated the photooxidative conversion of collagen into higher molecular weight aggregates consistent with intermolecular crosslink formation. Photooxidized tissue was stable to in vivo degradation when compared with control tissue. Results presented here indicate a crosslinked pericardial tissue produced by dye-mediated photooxidation possessing properties of chemical stability, enzymatic stability, in vivo stability, and biomechanical integrity suitable for use as a biomaterial. (C) 1994 John Wiley and Sons, Inc.
C1 UNIV SO CALIF,DEPT ORTHOPED,LOS ANGELES,CA.
   UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX.
RP MOORE, MA (reprint author), CARBOMED INC,1300 E ANDERSON LANE,AUSTIN,TX 78752, USA.
CR BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414
   BUTKOWSKI RJ, 1982, METHOD ENZYMOL, V82, P410
   CHENUG DT, 1985, CONNECT TISSUE RES, V13, P109
   CHEUNG DT, 1983, J BIOL CHEM, V258, P7774
   CHEUNG DT, 1990, MATRIX, V10, P164, DOI 10.1016/S0934-8832(11)80165-4
   FERRANS VJ, 1991, EUR J CARDIO-THORAC, V5, P144, DOI 10.1016/1010-7940(91)90213-4
   FOOTE CS, 1976, FREE RADICAL BIO MED, V2, P85
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   GIRARDOT JM, 1991, T SOC BIOMATER, V14, P60
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GONG G, 1991, EUR J CARDIO-THORAC, V5, P288, DOI 10.1016/1010-7940(91)90037-K
   GRABENWOGER M, 1992, J BIOMED MATER RES, V26, P1231, DOI 10.1002/jbm.820260912
   GRIMM M, 1992, SURGERY, V111, P74
   Gurnani S, 1966, Photochem Photobiol, V5, P495
   HARASAKI H, 1990, T SOC BIOMAT, V13, P25
   HILBERT S J, 1988, Medical Progress Through Technology, V14, P115
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   IONESCU MI, 1982, ANN THORAC SURG, V34, P265, DOI 10.1016/S0003-4975(10)62496-4
   JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   JORI G, 1968, J BIOL CHEM, V243, P4272
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   MECHANIC GL, 1992, Patent No. 5147514
   MILLER EJ, 1971, BIOCHEM BIOPH RES CO, V42, P1024, DOI 10.1016/0006-291X(71)90006-4
   MORITZ A, 1991, EUR J CARDIO-THORAC, V5, P155, DOI 10.1016/1010-7940(91)90214-5
   NEUMANN NP, 1962, BIOCHEMISTRY-US, V1, P68, DOI 10.1021/bi00907a011
   NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, TISSUE ENG, P137
   Nimni ME, 1988, COLLAGEN, VIII, P1
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Ray Jr W. J., 1967, METHOD ENZYMOL, V11, P490
   RAY WJ, 1962, J BIOL CHEM, V237, P2493
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SIMIONESCU A, 1991, J BIOMED MATER RES, V25, P1495, DOI 10.1002/jbm.820251207
   SPIKES JD, 1967, ANNU REV PHYS CHEM, V18, P409, DOI 10.1146/annurev.pc.18.100167.002205
   Thyagarajan K, 1992, T SOC BIOMAT, V15, P686
   TOMITA M, 1969, BIOCHEMISTRY-US, V8, P5149, DOI 10.1021/bi00840a069
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEBB CL, 1990, T AM SOC ART INT ORG, V36, P56
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WEIL L, 1965, ARCH BIOCHEM BIOPHYS, V111, P308, DOI 10.1016/0003-9861(65)90191-8
   WEIL L, 1951, ARCH BIOCHEM BIOPHYS, V33, P90, DOI 10.1016/0003-9861(51)90084-7
   WEIL L, 1953, ARCH BIOCHEM BIOPHYS, V46, P266, DOI 10.1016/0003-9861(53)90200-8
   WOODROOF EA, 1978, J BIOENG, V2, P1
NR 51
TC 77
Z9 85
U1 2
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1994
VL 28
IS 5
BP 611
EP 618
DI 10.1002/jbm.820280511
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NG210
UT WOS:A1994NG21000010
PM 8027101
DA 2018-10-19
ER

PT J
AU ZHONG, SP
   CAMPOCCIA, D
   DOHERTY, PJ
   WILLIAMS, RL
   BENEDETTI, L
   WILLIAMS, DF
AF ZHONG, SP
   CAMPOCCIA, D
   DOHERTY, PJ
   WILLIAMS, RL
   BENEDETTI, L
   WILLIAMS, DF
TI BIODEGRADATION OF HYALURONIC-ACID DERIVATIVES BY HYALURONIDASE
SO BIOMATERIALS
LA English
DT Article
DE HYALURONIC ACID; BIODEGRADATION; ENZYMES
AB Hyaluronic acid (salt) (HA) has been chemically modified as a biomaterial for medical applications such as controlled drug release matrices, nerve guides and wound dressings. A series of HA derivatives, which include different ester types and different degrees of esterification, have been used to investigate the stability of these materials in testicular hyaluronidase. Gel permeation chromatography and capillary viscometer have been employed to determine the size of the molecules, the former used for the water insoluble derivatives that dissolve in dimethyl sulphoxide, the latter for the water soluble samples. The preliminary experimental results indicated that the molecular weight of fully esterified hyaluronic acid (both ethyl and benzyl esters) did not decrease after treatment in the enzyme for 7 and 14 days while the water soluble partially esterified HA were degraded by the enzyme producing a sharp reduction of viscosity within minutes. These observations tend to suggest that the carboxylic groups in the beta-glucoronic acid unit are the activation centre of this enzyme and the total blockage of these groups can restrict the cleavage of beta(1 --> 4) glycoside bonds by this enzyme.
C1 UNIV LIVERPOOL, DEPT CLIN ENGN, LIVERPOOL L69 3BX, ENGLAND.
   FIDIA ADV BIOPOLYMERS, I-35301 ABANO TERME, ITALY.
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Williams,
   Rachel/0000-0002-1954-0256
CR Balazs E. A., 1970, CHEM MOL BIOL INTERC
   BARMAN TE, 1969, ENZYME HDB, P2
   Favaro G, 1990, ASAIO Trans, V36, pM291
   GOLDBERG RL, 1987, ARTHRITIS RHEUM, V30, P769, DOI 10.1002/art.1780300707
   HAKENSSON L, 1987, J IMMUNOL, V138, P4347
   HIRATA S, 1988, ARTHRITIS RHEUM S, V31, P562
   HIRO D, 1986, BIOCHEM BIOPH RES CO, V140, P715, DOI 10.1016/0006-291X(86)90790-4
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   IANNACE S, 1992, J MATER SCI-MATER M, V3, P59, DOI 10.1007/BF00702946
   JOSHI HN, 1992, INT J PHARM, V80, P213, DOI 10.1016/0378-5173(92)90279-B
   Meyer K., 1971, ENZYMES, P307
   RASTRELLI A, 1990, CLIN IMPLANT MAT, V9, P199
   RODEN L, 1989, CIBA F S, V143
   SATO H, 1988, ARTHRITIS RHEUM, V31, P63, DOI 10.1002/art.1780310110
NR 14
TC 74
Z9 77
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1994
VL 15
IS 5
BP 359
EP 365
DI 10.1016/0142-9612(94)90248-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NH980
UT WOS:A1994NH98000006
PM 8061127
DA 2018-10-19
ER

PT J
AU RAO, JK
   RAMESH, DV
   RAO, KP
AF RAO, JK
   RAMESH, DV
   RAO, KP
TI IMPLANTABLE CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON COLLAGEN -
   PHEMA HYDROGELS
SO BIOMATERIALS
LA English
DT Article
DE DRUG DELIVERY; HYDROGELS; COLLAGEN; PHEMA; FITC-BSA
ID BIOCOMPATIBILITY; MACROMOLECULES; BIOMATERIAL; WATER
AB Co-polymeric hydrogels of collagen and poly(hydroxyethyl methacrylate) (pHEMA) were prepared using an ammonium persulphate-sodium metabisulphite redox initiation technique. Fluorescein isothiocyanate (FITC)-labelled bovine serum albumin (BSA) was entrapped into these hydrogels. These gels were modified differently by external cross-linking and made highly porous by incorporation of ethylene glycol. The morphological characteristics of the gels containing FITC-BSA before and after release were studied. The in vitro release of FITC-labelled BSA was studied in phosphate buffer, pH 7.4, at 37 degrees C. The results clearly indicated that collagen-pHEMA hydrogels release FITC-BSA in a zero-order fashion. In the case of uncross-linked hydrogels, the release of FITC-BSA was about 81% within 8 d, compared to 49% for the same period in the case of cross-linked hydrogels. It was also observed that in the case of porous hydrogels the release was very fast (19% in the first hour) and lasted for about 12 h, releasing 76% of FITC-BSA. These results clearly indicated that collagen-pHEMA hydrogels released BSA in a zero-order fashion and that the release rate can be programmed by appropriate modification of the hydrogel matrices.
C1 CENT LEATHER RES INST,BIOMAT LAB,MADRAS 600020,INDIA.
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BERGETHON PR, 1989, J CELL SCI, V92, P111
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   FRANZBLAU C, 1988, BIOTECHNOLOGY COLLAG, V3
   HELLER J, 1983, BIOMATERIALS, V4, P262, DOI 10.1016/0142-9612(83)90025-X
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   JEYANTHI R, 1990, J BIOACT COMPAT POL, V5, P194
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   KRONMAN JH, 1979, BIOMATER ARTIF CELL, V7, P299, DOI 10.3109/10731197909117585
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGER R, 1981, J BIOMED MATER RES, V15, P267, DOI 10.1002/jbm.820150212
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   RINDERKNECHT H, 1962, NATURE, V193, P167, DOI 10.1038/193167b0
   ROORDA WE, 1988, J CONTROL RELEASE, V7, P45, DOI 10.1016/0168-3659(88)90079-X
   ROORDA WE, 1986, PHARM WEEKBLAD, V8, P165, DOI 10.1007/BF01959775
   SCHMITT FO, 1964, P NATL ACAD SCI USA, V51, P493, DOI 10.1073/pnas.51.3.493
   SMALLA K, 1988, BIOTECHNOL APPL BIOC, V10, P21
   STOL M, 1991, BIOMATERIALS, V12, P454, DOI 10.1016/0142-9612(91)90142-W
   STOL M, 1991, J BIOACT COMPAT POLY, V6, P309
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WICHTERLE O, 1971, ENCY POLYM SCI TECHN, pCH15
NR 23
TC 25
Z9 26
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1994
VL 15
IS 5
BP 383
EP 389
DI 10.1016/0142-9612(94)90251-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NH980
UT WOS:A1994NH98000009
PM 8061130
DA 2018-10-19
ER

PT J
AU RATHINAM, K
   SIVAKUMAR, R
   SARASWATI, V
AF RATHINAM, K
   SIVAKUMAR, R
   SARASWATI, V
TI IN-VIVO AND IN-VITRO EVALUATION OF A BIOMACHINABLE GLASSCERAMIC
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE MACHINABLE GLASSCERAMIC; BIOGLASSCERAMIC; BIOMATERIAL; TOXICOLOGY TESTS
AB In this paper we describe the toxicological tests done on a machinable glassceramic, prepared at the Defence Metallurgical Research Laboratory. Tests show no toxicity and biocompatibility is inferred.
C1 DEF MET RES LAB,HYDERABAD 500258,INDIA.
   SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,TRIVANDRUM 695012,INDIA.
CR AUTRIAN J, 1977, ARTIFIC ORGAN, V1, P53
   Hulbert S. F., 1987, HIGH TECH CERAMICS
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   MAGNUSSON B, 1969, J INVEST DERMATOL, V52, P268, DOI 10.1038/jid.1969.42
   MANABE M, 1987, HIGH TECH CERAM, P63
   MCMILLAN PW, 1979, GLASSCERAMICS
   OLEAVY, 1968, J PHARM SCI, V57, P12
   SARASWATI V, 1991, MET MATER PROCESS, V3, P75
   SARASWATI V, 1989, MET MAT P, V1, P21
   SARASWATI V, 1993, MET MATER PROCESS, V5, P67
   VEDANARAYANAN PV, 1983, B MATER SCI, V5, P97
   1985, US PHARMACOPEIA, P1235
   1979, J AM DENT ASSOC, V99, P697
NR 13
TC 1
Z9 1
U1 1
U2 2
PU INDIAN ACADEMY SCIENCES
PI BANGALORE
PA P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD APR
PY 1994
VL 17
IS 2
BP 171
EP 179
DI 10.1007/BF02747564
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA NL076
UT WOS:A1994NL07600008
DA 2018-10-19
ER

PT J
AU OLBORSKA, A
   SWIDER, M
   WOLOWIEC, R
   NIEDZIELSKI, P
   RYLSKI, A
   MITURA, S
AF OLBORSKA, A
   SWIDER, M
   WOLOWIEC, R
   NIEDZIELSKI, P
   RYLSKI, A
   MITURA, S
TI AMORPHOUS-CARBON BIOMATERIAL FOR IMPLANT COATINGS
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 4th European Conference on Diamond, Diamond-like and Related Materials
   (Diamond Films 93)
CY SEP 20-24, 1993
CL ALBUFEIRA, PORTUGAL
SP AEA TECHNOL, SURF TECHNOL, HARWELL LAB, ASTEX, COMMISS EUROPEAN COMMUNITIES, DG TEER COATING SERV LTD, DIAMOND & RELATED MAT, DRUKKER INT BV, GENASYSTEMS INC, KOBE STEEL USA INC, ELECTR MAT CTR, NORTON DIAMOND FILM, RENISHHAW TRANSDUCER SYST LTD, US DEPT DEF
ID FILMS
AB Thin, hard amorphous carbon (a-C) layers were the object of investigations, in particular the microstructure of the layer in the carbon layer-steel substrate system with the aim of optimization Of the synthesis and applicability of this new system for medical implants. The results of Auger electron spectroscopy studies show that the composition of the layer is complex. It consists of carbon and a transitional layer containing both carbides and carbon regions. The structure of the coatings ensures a high mechanical strength and very good adhesion to steel. The studies were aimed at investigations of the biological resistance of implants in the oral cavity. Human saliva is an aqueous solution of salts (organic compounds) and contains small amounts of organic substances and gases. The results of the investigations have shown very good resistance of a-C to elements of the oral cavity environment.
C1 TECH UNIV LODZ,INST MAT SCI & ENGN,PL-90924 LODZ,POLAND.
RP OLBORSKA, A (reprint author), MIL MED ACAD,DEPT MAXILLOFACIAL SURG,UL ZEROMSKIEGO 113,PL-90540 LODZ,POLAND.
RI Mitura, Stanislaw/L-6013-2014
OI Mitura, Stanislaw/0000-0001-9280-3748; Niedzielski,
   Piotr/0000-0002-6966-9154
CR BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Bruser D, 1990, INT J ORAL MAXILLOF, V5, P113
   FORMIGGINI M, 1956, DENT ABSTR, V1, P416
   GROTOWSKI JA, 1992, ATLAS WSZCZEPOW DENT
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   LOUDA P, 1993, COMPOSITES SINTERS C, P169
   MARCINIAK J, 1993, WERKST KORROS, V44, P379
   Marciniak J., 1992, BIOMATERIALY CHIRURG
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA S, 1991, SURF COAT TECH, V47, P106, DOI 10.1016/0257-8972(91)90273-Y
   MITURA S, 1994, IN PRESS 8TH CIMTEX
   SCHROEDER A, 1990, ORIGINAL ITI IMPLANT
NR 12
TC 35
Z9 35
U1 2
U2 18
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR
PY 1994
VL 3
IS 4-6
BP 899
EP 901
DI 10.1016/0925-9635(94)90296-8
PG 3
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA NN160
UT WOS:A1994NN16000123
DA 2018-10-19
ER

PT J
AU KE, HYD
   ANDERSON, WL
   MONCRIEF, RM
   RAYSON, GD
   JACKSON, PJ
AF KE, HYD
   ANDERSON, WL
   MONCRIEF, RM
   RAYSON, GD
   JACKSON, PJ
TI LUMINESCENCE STUDIES OF METAL ION-BINDING SITES ON DATURA-INNOXIA
   BIOMATERIAL
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID EU(III) LUMINESCENCE; RAT ONCOMODULIN; ALGAE; SPECTROSCOPY
AB The metal ion-binding interactions between a series of metal ions and Datura innoxia cell wall fragments have been investigated using Eu3+ luminescence. An affinity order of Cu2+ similar to Ag+ > Ni2+ > Cd2+ > Eu3+ > Sr2+ > Ba2+ for total metal ion binding to D. innoxia cell material has been obtained when pH greater than or equal to 5. Both electrostatic and complexation interactions have been verified to be involved in metal ion-binding interactions. Carboxylate groups have been demonstrated to be the dominant functional group responsible for the binding of most of the metal ions studied. At least two binding sites have been demonstrated to be involved in the binding of Ag+ at different Ag+ concentrations. One site is pH-independent and displays a greater affinity with a lower availability than-the other, which is pH-dependent. The studies of competative uptake by carboxylate groups between Eu3+ and the metal ions studied demonstrate an affinity order of Cu2+ > Agn > Ni2+ > Sr2+ > Ba2+ > Cd2+.
C1 NEW MEXICO STATE UNIV,DEPT CHEM & BIOCHEM,LAS CRUCES,NM 88003.
   LOS ALAMOS NATL LAB,DIV LIFE SCI,GENOM & STRUCT BIOL GRP,LOS ALAMOS,NM 87545.
CR ALBIN M, 1985, INORG CHEM, V24, P895, DOI 10.1021/ic00200a020
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P496, DOI 10.1021/es00027a007
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P1523, DOI 10.1021/es00032a004
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GARNHAM GW, 1992, ENVIRON SCI TECHNOL, V26, P1764, DOI 10.1021/es00033a008
   Good N E, 1972, Methods Enzymol, V24, P53
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   Greene B., 1987, METALS SPECIATION SE, P315
   HAPAK RC, 1989, J BIOL CHEM, V264, P18751
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   HENZL MT, 1988, J BIOL CHEM, V263, P10674
   HORROCKS WD, 1981, ACCOUNTS CHEM RES, V14, P384, DOI 10.1021/ar00072a004
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KUBIAK WW, 1989, ANAL CHEM, V61, P468, DOI 10.1021/ac00180a018
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   PALMISANO WA, 1990, J BIOL CHEM, V265, P14450
   PEARSON RG, 1973, HARD SOFT ACIDS BASE, P53
   RAYSON GD, 1992, APPL SPECTROSC, V46, P1245, DOI 10.1366/0003702924123999
   TREVINO CL, 1990, J BIOL CHEM, V265, P9694
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   WRIGHT PJ, 1991, ENVIRON SCI TECHNOL, V25, P287, DOI 10.1021/es00014a011
NR 27
TC 24
Z9 26
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD APR
PY 1994
VL 28
IS 4
BP 586
EP 591
DI 10.1021/es00053a009
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA ND550
UT WOS:A1994ND55000013
PM 22196539
DA 2018-10-19
ER

PT J
AU KIM, HJ
   HAERING, C
AF KIM, HJ
   HAERING, C
TI EVALUATION OF PROTEIN CROSS-LINKING AND BIODEGRADABILITY BY
   DETERMINATION OF TRYPTOPHAN RELEASED BY PRONASE USING REVERSED-PHASE
   HPLC WITH PHOTODIODE-ARRAY DETECTION
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; AROMATIC-AMINO-ACIDS; QUANTITATION;
   PEPTIDES
AB A bioanalytical method for evaluating the extent of protein cross-linking was developed. The method is based on reversed-phase HPLC determination of tryptophan released from the cross-linked proteins by Pronase, a nonspecific proteolytic enzyme. The amounts of tryptophan released from un-cross-linked bovine serum albumin (BSA), a nanopeptide, and Trp-Phe in control experiments were consistent with the tryptophan content of the protein and peptides. However, the amount of tryptophan released decreased significantly when BSA was cross-linked extensively by heating at 120 degrees C in the presence of glucose. The decrease in tryptophan showed a good correlation with the amount of cross-linked BSA that remained insoluble after Pronase digestion, suggesting that tryptophan released by Pronase is a useful measure of the cross-linking and biodegradability of a protein-based biomaterial.
C1 FRAMINGHAM HIGH SCH, FRAMINGHAM, MA 01701 USA.
RP KIM, HJ (reprint author), USA, NATICK RES DEV & ENGN CTR, NATICK, MA 01760 USA.
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CLARK AV, 1974, J AGR FOOD CHEM, V22, P1089, DOI 10.1021/jf60196a002
   DELHAYE S, 1986, ANAL BIOCHEM, V159, P175, DOI 10.1016/0003-2697(86)90324-6
   DELHAYE S, 1992, ANALYST, V117, P1875, DOI 10.1039/an9921701875
   DEVRIES JW, 1980, J AGR FOOD CHEM, V28, P896, DOI 10.1021/jf60231a025
   FELL AF, 1984, J CHROMATOGR, V297, P203, DOI 10.1016/S0021-9673(01)89042-7
   GARCIA SE, 1992, J AOAC INT, V75, P1112
   HUGLI TE, 1972, J BIOL CHEM, V247, P2828
   KIM HJ, 1984, J FOOD SCI, V49, P699, DOI 10.1111/j.1365-2621.1984.tb13191.x
   NG LT, 1987, ANAL BIOCHEM, V167, P47, DOI 10.1016/0003-2697(87)90132-1
   NOMOTO M, 1959, J BIOCHEM-TOKYO, V46, P1645, DOI 10.1093/oxfordjournals.jbchem.a126962
   NOMOTO M, 1960, J BIOCHEM-TOKYO, V48, P593, DOI 10.1093/oxfordjournals.jbchem.a127207
   NYBERG F, 1986, J CHROMATOGR, V359, P541, DOI 10.1016/0021-9673(86)80105-4
   SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936
   SPIES JR, 1967, ANAL CHEM, V39, P1412, DOI 10.1021/ac60256a004
   UY R, 1986, PROTEIN CROSS LINKIN
NR 16
TC 1
Z9 1
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD APR
PY 1994
VL 42
IS 4
BP 915
EP 918
DI 10.1021/jf00040a015
PG 4
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA NH286
UT WOS:A1994NH28600015
DA 2018-10-19
ER

PT J
AU GATTI, AM
   PINCHIORRI, P
   MONARI, E
AF GATTI, AM
   PINCHIORRI, P
   MONARI, E
TI PHYSICAL CHARACTERIZATION OF A NEW BIOMATERIAL FOR WOUND MANAGEMENT
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The aim of this work was to evaluate some physical characteristics of a new biosynthetic membrane (Bioprocess(R)) used as temporary skin substitute for wound management. The tested characteristics, important for the clinical use of the membrane, were: permeability to some gases (O2, CO2 and N2) and water vapour, and absorption of fluids simulating a physiological-like environment. The tests were completed by scanning electron microscope (SEM) observations in order to verify the surface morphology before and after the tests. The results confirmed the good in vivo performance of this material.
C1 UNIV TRENT,DIPARTIMENTO INGN MAT,TRENT,ITALY.
RP GATTI, AM (reprint author), UNIV MODENA,ODONTOIATR CLIN,BIOMAT LAB,I-41100 MODENA,ITALY.
RI Monari, Emanuela/K-7743-2016
OI Monari, Emanuela/0000-0003-0924-4928
CR AIBA S, 1985, BIOMATERIALS, V6, P290, DOI 10.1016/0142-9612(85)90084-5
   ANDREOZZI GM, 1992, MINERVA ANGIOL, V17, P29
   AUDRITO GR, 1992, INTERNAL REPORT BIOP
   BEHAR D, 1986, J BIOMED MATER RES, V20, P731, DOI 10.1002/jbm.820200607
   BRUIN P, 1990, J BIOMED MATER RES, V24, P217, DOI 10.1002/jbm.820240208
   Cospite M, 1991, MIN ANGIOL, V16, P347
   Farah L. F., 1990, US Patent, Patent No. [4.912.049, 4912049]
   JONKMAN MF, 1988, BIOMATERIALS, V9, P263, DOI 10.1016/0142-9612(88)90095-6
   Magnocavallo C, 1993, Minerva Chir, V48, P773
   PEIXOTO R, 1988, Revista Brasileira de Cirurgia, V78, P141
   PITANGUY I, 1988, Revista Brasileira de Cirurgia, V78, P317
   REBELLO C, 1987, Revista Brasileira de Cirurgia, V77, P407
   ZANDERIGHI L, 1990, CHIM IND-MILAN, V72, P147
   1990, ANN BOOK ASTM STANDA, P782
   1982, ANN BOOK ASTM STANDA, P253
NR 15
TC 4
Z9 4
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 1994
VL 5
IS 4
BP 190
EP 193
DI 10.1007/BF00121087
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NN454
UT WOS:A1994NN45400002
DA 2018-10-19
ER

PT J
AU OHASHI, H
   THERIN, M
   MEUNIER, A
   CHRISTEL, P
AF OHASHI, H
   THERIN, M
   MEUNIER, A
   CHRISTEL, P
TI THE EFFECT OF DRILLING PARAMETERS ON BONE .2. THE INFLUENCE OF DRILLING
   SITE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB For orthopaedic biomaterial implantation testing, specimens are often implanted into cortical bone defects. The implantation site is assumed to be one of the factors that influence the bone response to biomaterials. The aim of this study was to investigate the bone-healing process in drilled cortical defects at different sites with respect to time. Sheep metatarsus was implemented, since it is a long straight bone with four flat faces. Thus, the different drilling sites were obtained by changing the longitudinal level (proximal, middle and distal) and bone aspect (anterior, lateral and posterior). Metatarsi were obtained at 1, 2, 3 and 4 months post-operatively and with non-decalcified sections the newly formed bone area was measured using a microscope connected to an image analyser. The rate of bone formation was higher in the anterior aspect (P < 0.05). The new bone did not form concentrically from the hole edge towards the centre, and the principal direction of bone growth was different between the anterior and the posterior aspects (P < 0.05). However, there was no difference with respect to the longitudinal axis. These results indicate that the implantation site must be considered when analysing the bone response to biomaterials implanted in cortical defects.
C1 UNIV PARIS 07,FAC MED LARIBOISIERE ST LOUIS,CNRS,UA 1432,RECH ORTHOPED LAB,F-75010 PARIS,FRANCE.
RP OHASHI, H (reprint author), OSAKA CITY UNIV,SCH MED,DEPT ORTHOPAED SURG,1-5-7 ASAHIMACHI,ABENO KU,OSAKA 545,JAPAN.
CR BERGMANN G, 1981, THESIS U BERLIN
   CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517
   CLAES L, 1982, BIOMECHANICS PRINCIP, P325
   CLAES L, 1981, EXPT THEORETISCHE UN
   PALME U, 1984, THESIS U ULM
   SEVITT S, 1981, BONE REPAIR FRACTURE, P21
   SEVITT S, 1981, BONE REPAIR FRACTURE, P57
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
NR 8
TC 1
Z9 1
U1 0
U2 3
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 1994
VL 5
IS 4
BP 232
EP 236
DI 10.1007/BF00121094
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NN454
UT WOS:A1994NN45400009
DA 2018-10-19
ER

PT J
AU KASEMO, B
   LAUSMAA, J
AF KASEMO, B
   LAUSMAA, J
TI SURFACE-PROPERTIES AND PROCESSES OF THE BIOMATERIAL TISSUE INTERFACE
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC MATERIALS SENSORS AND
   SYSTEMS
LA English
DT Proceedings Paper
CT 1st Japan/Sweden Biomaterial Symposium
CY OCT 05-06, 1992
CL TOKYO, JAPAN
ID TITANIUM
C1 CHALMERS UNIV TECHNOL,DEPT APPL PHYS,S-41296 GOTHENBURG,SWEDEN.
CR Andrade J.D., 1985, PROTEIN ADSORPTION, V2
   HEALY KE, 1992, J BIOMED MATER RES, V26, P319, DOI 10.1002/jbm.820260305
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KASEMO B, 1991, BONE-BIOMATERIAL INTERFACE, P19
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KASEMO B, 1993, ENV HLTH PERSPECTIVE
   KASEMO B, 1988, SURFACE CHARACTERIZA, P1
   KING DA, 1983, CHEM PHYSICS HETEROG, V1
   LUNDSTROM I, 1985, ORAL INTERACTIONS RE, P9
   McQueen D, 1982, CLIN APPL BIOMATERIA, P179
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V110, P9, DOI 10.1016/0021-9797(86)90348-6
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 17
TC 19
Z9 20
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0928-4931
J9 MAT SCI ENG C-BIOMIM
JI Mater. Sci. Eng. C-Biomimetic Mater. Sens. Syst.
PD APR 1
PY 1994
VL 1
IS 3
BP 115
EP 119
DI 10.1016/0928-4931(94)90041-8
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA PU135
UT WOS:A1994PU13500001
DA 2018-10-19
ER

PT J
AU BIZIOS, R
AF BIZIOS, R
TI OSTEOBLASTS - AN IN-VITRO MODEL OF BONE-IMPLANT INTERACTIONS - MINI
   REVIEW
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE OSTEOBLASTS; BIOMATERIALS; BONE IMPLANT; INTERFACE
ID HUMAN-PLASMA FIBRONECTIN; CELL-ADHESION; ATTACHMENT; INVITRO; INTEGRINS;
   HYDROXYAPATITE; IDENTIFICATION; MORPHOLOGY; SEQUENCE; SITE
AB Well-characterized osteoblasts provide a successful in vitro model to study bone-biomaterial interactions. Knowledge of the events occurring at this tissue-biomaterial interface could lead to the design of improved orthopedic/dental biomaterials which elicit specific and desirable responses from surrounding cells/tissues, optimize function of osteoblasts (the bone-forming cells), and enhance long-term bone-implant bonding. (C) 1994 John Wiley and Sons, Inc.
RP BIZIOS, R (reprint author), RENSSELAER POLYTECH INST,DEPT BIOMED ENGN,TROY,NY 12180, USA.
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   BECK K, 1990, FASEB J, V4, P148
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   BROWN SA, 1979, J BIOMED MATER RES, V13, P337, DOI 10.1002/jbm.820130212
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   GARVEY BT, 1993, THESIS RENSSELAER PO
   GRINNELL F, 1978, INT REV CYTOL, V53, P65
   GRINNELL F, 1983, BIOCOMPATIBLE POLYM, P673
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KRAJIAN AA, 1940, HISTOPATHOLOGIC TECH, P183
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PUELO DA, 1989, UNPUB
   PULEO DA, 1993, BIOMATERIALS, V14, P111, DOI 10.1016/0142-9612(93)90220-V
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X
   ROSEN JJ, 1977, EXP CELL RES, V107, P139, DOI 10.1016/0014-4827(77)90395-0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SEFLIK DE, 1992, J BIOMED MATER RES, V26, P529
   SENNERBY L, 1991, THESIS U GOTHENBURG
   SOMERMAN MJ, 1987, J BONE MINER RES, V2, P259
NR 32
TC 27
Z9 29
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR 25
PY 1994
VL 43
IS 7
BP 582
EP 585
DI 10.1002/bit.260430707
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA MY102
UT WOS:A1994MY10200006
PM 18615757
DA 2018-10-19
ER

PT J
AU LEWIS, RV
AF LEWIS, RV
TI SPIDER SILK, AN ANCIENT BIOMATERIAL FOR THE FUTURE
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 1994
VL 207
BP 169
EP IEC
PN 1
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA MY954
UT WOS:A1994MY95402715
DA 2018-10-19
ER

PT J
AU SUYAMA, K
   FUKAZAWA, Y
   UMETSU, Y
AF SUYAMA, K
   FUKAZAWA, Y
   UMETSU, Y
TI A NEW BIOMATERIAL, HEN EGG-SHELL MEMBRANE, TO ELIMINATE HEAVY-METAL ION
   FROM THEIR DILUTE WASTE SOLUTION
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE EGG SHELL MEMBRANE; METAL ION; BIOSORPTION
ID EGGSHELL MEMBRANE; OLD HENS; QUALITY; BIOMASS; YOUNG
AB The egg shell membrane (ESM) is an intricate lattice network of stable and water-insoluble fibers with high surface area. ESM accumulates and eliminates various heavy metal ions from dilute aqueous solution with high affinity and in short contact time, depending on pH and characteristics of the individual ion. Under certain conditions, the level of precious ions, Au, Pt, and Pd accumulation approaches 55, 25, and 22% of dry wt of ESM, respectively. Also uranium uptake 30% of that of ESM. Experiments suggested that ESM is promising to use for the purpose of removal/recovery of metals and water pollution control.
C1 TOHOKU UNIV, INST ADV MAT PROC, SENDAI, MIYAGI 982, JAPAN.
RP SUYAMA, K (reprint author), TOHOKU UNIV, FAC AGR, MOLEC TECHNOL ANIM PROD LAB, 1-1 TSUTSUMIDORI, SENDAI 981, JAPAN.
CR BAKER J. R., 1962, BIOCHEM JOUR, V82, P352
   BLAKE JP, 1985, POULTRY SCI, V64, P176, DOI 10.3382/ps.0640176
   BRITTON WM, 1977, POULTRY SCI, V56, P865, DOI 10.3382/ps.0560865
   BRITTON WM, 1977, POULTRY SCI, V56, P647, DOI 10.3382/ps.0560647
   CREGER CR, 1976, POULTRY SCI, V55, P1717, DOI 10.3382/ps.0551717
   CRIST RH, 1988, ENVIRON SCI TECHNOL, V22, P755, DOI 10.1021/es00172a002
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   KUYUCAK N, 1988, CIM BULL, V81, P95
   STARCHER BC, 1980, CONNECT TISSUE RES, V8, P53, DOI 10.3109/03008208009152122
   STEMBERGER BH, 1977, POULTRY SCI, V56, P537, DOI 10.3382/ps.0560537
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
NR 13
TC 40
Z9 42
U1 6
U2 13
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD SPR
PY 1994
VL 45-6
BP 871
EP 879
DI 10.1007/BF02941856
PG 9
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA NJ697
UT WOS:A1994NJ69700075
PM 8010775
DA 2018-10-19
ER

PT J
AU KIESWETTER, K
   BAUER, TW
   BROWN, SA
   VANLENTE, F
   MERRITT, K
AF KIESWETTER, K
   BAUER, TW
   BROWN, SA
   VANLENTE, F
   MERRITT, K
TI ALTERATION OF HYDROXYLAPATITE COATINGS EXPOSED TO CHEMICALS USED IN
   HISTOLOGICAL FIXATION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BONE TISSUE; PHOSPHATE; INVITRO
AB Histological evaluation of retrieved devices allows for assessment of the biological response to the implants. Interaction between the biomaterial and the fluids used in the processing may alter the appearance or composition of the device. This may result in artifacts due to processing which are misinterpreted as being caused by the biological response. Alteration by the fluids used in fixation may be particularly important with materials that have a propensity to interact with aqueous environments, as in the case of calcium phosphate ceramics. Therefore, we examined the effects of various standard histological fixation techniques on hydroxylapatite coated metal implants. Of the techniques examined, fixation with ethanol appeared to affect the surface morphology the least, whereas fixation in unbuffered formalin appeared to affect the bulk composition of these samples the least. Fixation in buffered formalin resulted in marked changes in both surface morphology and bulk composition. (C) 1994 John Wiley and Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   CLEVELAND CLIN FDN,CLEVELAND,OH 44195.
OI Bauer, Thomas/0000-0003-0976-2119
FU NIGMS NIH HHS [GM 07535]
CR BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   DEGROOT K, 1990, HDB BIOACTIVE CERAMI, V2, P1
   DRIESSENS FCM, 1982, MINERAL ASPECTS DENT
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   EMMANUAL J, 1989, J BIOMED MATER RES-A, V23, P337, DOI 10.1002/jbm.820231408
   FRASER D, 1987, FUNDAMENTALS CLIN CH, P705
   HAGEN AR, 1975, SCAND J DENT RES, V83, P333
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   LEMMONS JE, 1988, CLIN ORTHOP RELAT R, V235, P220
   NEWESELY H, 1980, MECHANICAL PROPERTIE
NR 12
TC 4
Z9 4
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1994
VL 28
IS 3
BP 281
EP 287
DI 10.1002/jbm.820280302
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MX269
UT WOS:A1994MX26900001
PM 8077243
DA 2018-10-19
ER

PT J
AU AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
   SOSTRIN, S
   YOUNG, J
   HAKAKHA, M
AF AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
   SOSTRIN, S
   YOUNG, J
   HAKAKHA, M
TI EXPERIMENTAL EVALUATION OF A NEW COMPOSITE MESH WITH THE SELECTIVE
   PROPERTY OF INCORPORATION TO THE ABDOMINAL-WALL WITHOUT ADHERING TO THE
   INTESTINES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INCISIONAL HERNIA
AB This preliminary study examined the possibility of preventing intestinal adhesions to biomaterials while preserving their incorporation with the abdominal wall. White New Zealand rabbits received intraperitoneal implants of different biomaterials for repair of defects created on the abdominal wall. The following biomaterials were used: polypropylene, polyester, expanded polytetraflueroethylene, polypropylene mesh/polypropylene sheeting (polypropylene mesh covered with polypropylene sheeting on the peritoneal side), polypropylene/silastic, polypropylene/polyglactin, polypropylene/polyglycolic acid, and polypropylene/fibrin. All biomaterials evaluated caused adhesions to the intestines except for polypropylene mesh/polypropylene sheeting and polypropylene mesh/silastic composites. Because adhesion of the intestine to the biomaterial is the first stage of biomaterial-related intestinal fistula, its prevention is logical for the elimination of this complication. Composites with the selective property of adhering to the abdominal wall, yet sparing the viscera, would facilitate thoracic and abdominal wall surgeries, as well as intraperitoneal laparoscopic hernioplasties. (C) 1994 John Wiley and Sons, Inc.
C1 HARBOR UCLA,DEPT SURG,LOS ANGELES,CA.
   HARBOR UCLA,INST RES & EDUC,LOS ANGELES,CA.
   CEDARS SINAI MED CTR,DEPT SURG,LOS ANGELES,CA 90048.
   CEDARS SINAI MED CTR,DEPT COMPARAT MED,LOS ANGELES,CA.
CR GEORGE CD, 1986, ANN ROY COLL SURG, V68, P185
   HORTON RE, 1969, P ROY SOC MED, V62, P513
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Law NW, 1988, CLIN MATER, V3, P95
   LEAPER DJ, 1977, BRIT J SURG, V64, P603, DOI 10.1002/bjs.1800640822
   LEWIS RT, 1962, ARCH SURG-CHICAGO, P325
   LOURY JN, 1993, TRAITEMENT EVENTRATI, P2116
   MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127
   REISFELD D, 1989, SURG ROUNDS, V12, P69
   SCHNEIDER R, 1979, AM SURGEON, V45, P337
   USHER FC, 1970, SURG GYNECOL OBSTETR, V131, P525
   WANTZ GE, 1991, SURG GYNECOL OBSTET, V172, P129
NR 12
TC 96
Z9 98
U1 0
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1994
VL 28
IS 3
BP 373
EP 375
DI 10.1002/jbm.820280312
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MX269
UT WOS:A1994MX26900011
PM 8077252
DA 2018-10-19
ER

PT J
AU KAPLAN, SS
   BASFORD, RE
   JEONG, MH
   SIMMONS, RL
AF KAPLAN, SS
   BASFORD, RE
   JEONG, MH
   SIMMONS, RL
TI MECHANISMS OF BIOMATERIAL-INDUCED SUPEROXIDE RELEASE BY NEUTROPHILS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROTEIN-KINASE-C; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PHORBOL-MYRISTATE
   ACETATE; BIOLOGICAL SURFACES; RESPIRATORY BURST; ANION PRODUCTION;
   PERTUSSIS TOXIN; ACTIVATION; GRANULOCYTES; ADHERENCE
AB Biomaterial-centered infection is an important cause of the failure of prosthetic implants and organs. Because neutrophils mediate host defense against infection, the effect of biomaterials on neutrophil superoxide release and the mechanism of that effect were investigated using three materials commonly employed in surgical practice. The graft materials were expanded polytetrafluorethylene (PTFE), polyurethane and woven dacron. Polystyrene, a commonly used laboratory support vessel, was also studied. Both polystyrene and polyurethane were activating, but serum inhibitable, whereas PTFE was nonactivating, and woven dacron was not activating unless serum was present. The signaling mechanisms used by these materials demonstrated time and material dependency. Pertussis toxin inhibition of G protein-dependent activation had little or no effect on biomaterial induced activation, whereas FMLP-induced activation of the same biomaterial-associated cells was inhibited. Protein kinase C inhibition with staurosporine greatly inhibited polystyrene-induced activation, but had only a partial effect with polyurethane and even less effect with the activation associated with serum-treated woven dacron. These studies demonstrated that biomaterial contact-induced neutrophil activation differed from that described for cells in suspension, and showed that activation mechanisms on one material cannot be extrapolated to mechanisms on other materials. (C) 1994 John Wiley and Sons, Inc.
C1 UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261.
   UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261.
   UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA.
FU NIGMS NIH HHS [GM41734-02 A1]
CR AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587
   BASFORD RE, 1990, AM J RESP CELL MOL, V2, P235, DOI 10.1165/ajrcmb/2.3.235
   BECKER EL, 1986, FASEB J, V45, P2151
   BERGER D, 1987, CLIN CHIM ACTA, V163, P289, DOI 10.1016/0009-8981(87)90247-6
   BIRNBAUMER L, 1990, CRIT REV BIOCHEM MOL, V25, P225, DOI 10.3109/10409239009090610
   BLACKBURN WD, 1988, BIOCHEM BIOPH RES CO, V152, P136, DOI 10.1016/S0006-291X(88)80690-9
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BRANSTEDT MR, 1990, BIOMATERIALS, V11, P370
   DAHINDEN CA, 1983, J CLIN INVEST, V72, P113, DOI 10.1172/JCI110948
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DRAVNA D, 1987, NATURE, V327, P632
   FEHR J, 1985, J CLIN INVEST, V76, P535, DOI 10.1172/JCI112003
   FUJITA I, 1984, BIOCHEM BIOPH RES CO, V120, P318, DOI 10.1016/0006-291X(84)91256-7
   GENIS I, 1990, BLOOD, V76, P1233
   GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226
   GSCHWENDT M, 1989, BIOCHEM BIOPH RES CO, V164, P974, DOI 10.1016/0006-291X(89)91765-8
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   JOHNSTON RB, 1976, J CLIN INVEST, V57, P836, DOI 10.1172/JCI108359
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KAPLAN SS, 1990, ASAIO T, V36, P12
   KLOCK JC, 1976, BLOOD, V48, P149
   KOENDERMAN L, 1990, FEBS LETT, V270, P49, DOI 10.1016/0014-5793(90)81232-D
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KOWNATZKI E, 1987, CLIN EXP IMMUNOL, V69, P213
   KUHNS DB, 1986, BLOOD, V68, P535
   MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285
   MARRA MN, 1992, J IMMUNOL, V148, P532
   MEWRER R, 1989, BIOCHEM BIOPH RES CO, V159, P763
   MILESKI WJ, 1990, SURGERY, V108, P206
   NATHAN CF, 1989, BLOOD, V73, P301
   NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241
   NEWMAN M, 1989, AGENTS ACTIONS, V26, P183
   OKAMURA N, 1985, BIOCHEM BIOPH RES CO, V130, P939, DOI 10.1016/0006-291X(85)91705-X
   REIBMAN J, 1991, P NATL ACAD SCI USA, V88, P6805, DOI 10.1073/pnas.88.15.6805
   ROBERTS AB, 1988, ADV CANCER RES, V51, P107, DOI 10.1016/S0065-230X(08)60221-3
   SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785
   SPRINGER TA, 1986, CIBA F SYMP, V118, P102, DOI 10.1002/9780470720998.ch8
   SUCHARD SJ, 1991, J IMMUNOL, V147, P651
   TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2
   TOBIAS PS, 1988, J BIOL CHEM, V263, P13479
   WALKER BAM, 1991, J IMMUNOL, V146, P735
   WEBSTER RO, 1986, AM J PATHOL, V125, P369
   WOLFSON M, 1985, J IMMUNOL, V135, P2057
   WRIGHT SD, 1989, J EXP MED, V169, P175, DOI 10.1084/jem.169.1.175
   WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876
   WRIGHT SD, 1991, J EXP MED, V173, P1281, DOI 10.1084/jem.173.5.1281
   YAMAMOTO N, 1991, J IMMUNOL, V147, P273
NR 48
TC 38
Z9 39
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1994
VL 28
IS 3
BP 377
EP 386
DI 10.1002/jbm.820280313
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MX269
UT WOS:A1994MX26900012
PM 8077253
DA 2018-10-19
ER

PT J
AU REID, G
AF REID, G
TI APPLICATIONS FROM BACTERIAL ADHESION AND BIOFILM STUDIES IN RELATION TO
   UROGENITAL TISSUES AND BIOMATERIALS - A REVIEW
SO JOURNAL OF INDUSTRIAL MICROBIOLOGY
LA English
DT Article
DE BACTERIAL ADHESION; APPLICATIONS; UROGENITAL TRACT
ID URINARY-TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA-COLI; HUMAN
   POLYMORPHONUCLEAR LEUKOCYTES; HUMAN UROEPITHELIAL CELLS; SPERMICIDAL
   COMPOUND NONOXYNOL-9; HUMAN EPITHELIAL-CELLS; CORD INJURED PATIENTS;
   P-FIMBRIAE; BLOOD-GROUP; LACTOBACILLUS-ACIDOPHILUS
AB The urogenital tract, particularly of the adult female, is the habitat for many species of microorganisms.  These populations are in a state of flux, are susceptible to disruption by antibiotics and spermicides, and are exposed to many different biomaterial substrata.  Infections of the genital area and bladder are common, and are invariably initiated by microbial adhesion to surfaces.  This review examines the actual and potential applications to industry and to patients emerging from the study of bacterial adhesion to surfaces.
C1 UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON N6A 3K7,ONTARIO,CANADA.
   UNIV WESTERN ONTARIO,DEPT SURG UROL,LONDON N6A 3K7,ONTARIO,CANADA.
   UNIV TORONTO,DEPT SURG UROL,TORONTO M5S 1A1,ONTARIO,CANADA.
RP REID, G (reprint author), UNIV WESTERN ONTARIO,OFF RES SERV,SLB 328,LONDON N6A 5B8,ON,CANADA.
CR ABRAHAM SN, 1985, INFECT IMMUN, V48, P625
   ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   BIDWELLGOETZ M, 1987, INFECT IMMUN, V55, P534
   BRUCE AW, 1983, J UROLOGY, V130, P293, DOI 10.1016/S0022-5347(17)51115-5
   BRUCE AW, 1988, CAN J MICROBIOL, V34, P339, DOI 10.1139/m88-062
   Bruce AW, 1992, INT UROGYNECOL J, V3, P22, DOI DOI 10.1007/BF00372644
   CHAN RCY, 1985, INFECT IMMUN, V47, P84
   CHAN RCY, 1984, J UROLOGY, V131, P184
   Costerton J. W., 1985, BACTERIAL ADHESION M, P3
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1989, UROL RES, V17, P349, DOI 10.1007/BF00510523
   DEAN EA, 1988, J CLIN MICROBIOL, V26, P25
   DEMAN P, 1988, J INFECT DIS, V158, P29, DOI 10.1093/infdis/158.1.29
   DEMAN P, 1987, J CLIN MICROBIOL, V25, P401
   DEMAN P, 1989, INFECT IMMUN, V57, P3383
   DEREE JM, 1987, INFECT IMMUN, V55, P2204
   DESNOTTES JF, 1988, DRUG EXP CLIN RES, V14, P629
   DULAWA J, 1988, EUR J CLIN INVEST, V18, P87, DOI 10.1111/j.1365-2362.1988.tb01171.x
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   HAWTHORN LA, 1991, UROL RES, V19, P301, DOI 10.1007/BF00299064
   HAWTHORN LA, 1990, J BIOMED MATER RES, V24, P39, DOI 10.1002/jbm.820240105
   HULTGREN SJ, 1986, INFECT IMMUN, V54, P613
   KAACK MB, 1988, INFECT IMMUN, V56, P1
   KASS EH, 1989, HOST PARASITE INTERA, P1
   KHOURY AE, 1989, BRIT J UROL, V63, P384, DOI 10.1111/j.1464-410X.1989.tb05223.x
   KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7
   KOVARIK JM, 1989, ANTIMICROB AGENTS CH, V33, P684, DOI 10.1128/AAC.33.5.684
   LABIGNEROUSSEL A, 1988, INFECT IMMUN, V56, P640
   LATHAM RH, 1984, J INFECT DIS, V149, P835, DOI 10.1093/infdis/149.6.835
   Leffler H., 1989, HOST PARASITE INTERA, P93
   LICHODZIEJEWSKA M, 1989, LANCET, V1, P1414
   LINDBERG F, 1987, NATURE, V328, P84, DOI 10.1038/328084a0
   LOMBERG H, 1983, NEW ENGL J MED, V308, P1189, DOI 10.1056/NEJM198305193082003
   LOMBERG H, 1986, INFECT IMMUN, V51, P919
   LUNDEBERG T, 1986, LANCET, V2, P1031
   MCGROARTY J A, 1988, Microbial Ecology in Health and Disease, V1, P215
   MCGROARTY JA, 1988, CAN J MICROBIOL, V34, P974, DOI 10.1139/m88-171
   MCGROARTY JA, 1990, CURR MICROBIOL, V21, P219, DOI 10.1007/BF02092159
   MCGROARTY JA, 1990, INFECT IMMUN, V58, P2005
   MCGROARTY JA, 1993, INT UROGYNECOL J PEL, V4, P194
   MCGROARTY JA, 1994, IN PRESS J UROL
   MCMURDO MET, 1992, J EPIDEMIOL COMMUN H, V46, P222, DOI 10.1136/jech.46.3.222
   NICKEL JC, 1985, CAN J SURG, V28, P50
   NICOLLE LE, J INFECT DIS, V157, P1239
   OTT M, 1986, INFECT IMMUN, V54, P646
   PARKKINEN J, 1988, INFECT IMMUN, V56, P2623
   RAMSAY JWA, 1989, BRIT J UROL, V64, P395, DOI 10.1111/j.1464-410X.1989.tb06050.x
   REID G, 1989, COLLOID SURFACE, V42, P299
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   REID G, 1992, CELL MATER, V2, P253
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1992, PARAPLEGIA, V30, P711, DOI 10.1038/sc.1992.138
   REID G, 1984, NEW ZEAL MED J, V97, P439
   REID G, 1987, J UROLOGY, V138, P330, DOI 10.1016/S0022-5347(17)43137-5
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   REID G, 1987, REV INFECT DIS, V9, P470
   REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063
   REID G, 1993, PARAPLEGIA, V31, P494, DOI 10.1038/sc.1993.80
   REID G, 1992, CLIN THER, V14, P11
   REID G, 1993, CELL MATER, V3, P171
   REID G, 1982, STAIN TECHNOL, V57, P5, DOI 10.3109/10520298209066512
   REID G, 1983, J INFECT DIS, V148, P412, DOI 10.1093/infdis/148.3.412
   REID G, 1994, IN PRESS BIOINTERFAC
   REID G, 1992, J MATERIALS SCI MATE, V4, P17
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   ROBERTS JA, 1984, J UROLOGY, V131, P602, DOI 10.1016/S0022-5347(17)50513-3
   RODRIGUEZORTEGA M, 1987, INFECT IMMUN, V55, P968
   RUGGIERI MR, 1988, J UROLOGY, V140, P157, DOI 10.1016/S0022-5347(17)41517-5
   SALIT IE, 1988, CAN J MICROBIOL, V34, P312, DOI 10.1139/m88-057
   SANDBERG T, 1988, J CLIN MICROBIOL, V26, P1471
   SCHAEFFER AJ, 1979, INFECT IMMUN, V24, P753
   SCHEFFER J, 1985, INFECT IMMUN, V50, P271
   SCHMITZ S, 1986, INFECT IMMUN, V51, P54
   SCHULTEWISSERMANN H, 1985, EUR J PEDIATR, V144, P230, DOI 10.1007/BF00451947
   Seeberg S, 1982, J Hosp Infect, V3, P159, DOI 10.1016/0195-6701(82)90008-1
   SHARMA S, 1987, J INFECT DIS, V156, P490
   SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205
   SHINEFIELD HR, 1963, AM J DIS CHILD, V105, P646, DOI 10.1001/archpedi.1963.02080040648015
   SLOTKI IN, 1982, NEPHRON, V30, P262, DOI 10.1159/000182484
   SPRUNT K, 1988, CAN J MICROBIOL, V34, P332, DOI 10.1139/m88-061
   STEADMAN R, 1989, BIOCHIM BIOPHYS ACTA, V1013, P21, DOI 10.1016/0167-4889(89)90122-5
   STEADMAN R, 1990, BIOCHIM BIOPHYS ACTA, V1053, P37, DOI 10.1016/0167-4889(90)90023-7
   STEADMAN R, 1988, INFECT IMMUN, V56, P815
   STICKLER D, 1989, EUR J CLIN MICROBIOL, V8, P974, DOI 10.1007/BF01967568
   TOPLEY N, 1989, KIDNEY INT, V36, P609, DOI 10.1038/ki.1989.237
   TOPLEY N, 1989, HOST PARASITE INTERA, P348
   UEHLING DT, 1991, J UROLOGY, V146, P223, DOI 10.1016/S0022-5347(17)37756-X
   WARREN JW, 1987, J INFECT DIS, V155, P1151, DOI 10.1093/infdis/155.6.1151
NR 88
TC 8
Z9 8
U1 0
U2 3
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS
SN 0169-4146
J9 J IND MICROBIOL
JI J. Indust. Microbiol.
PD MAR
PY 1994
VL 13
IS 2
BP 90
EP 96
DI 10.1007/BF01584104
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA PR146
UT WOS:A1994PR14600004
PM 7765341
DA 2018-10-19
ER

PT J
AU JANVIER, G
   CAIX, J
   BORDENAVE, L
   REVEL, P
   BAQUEY, C
   DUCASSOU, D
AF JANVIER, G
   CAIX, J
   BORDENAVE, L
   REVEL, P
   BAQUEY, C
   DUCASSOU, D
TI AN EX-VIVO ORIGINAL TEST USING RADIOTRACERS FOR EVALUATING
   HEMOCOMPATIBILITY OF TUBULAR BIOMATERIALS
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article
ID THROMBUS DEPOSITION; INVIVO; BLOOD; MODEL
AB The haemocompatibility of a vascular prosthesis can be estimated as the result of its interaction with blood components. The authors describe an ex vivo canine shunt for evaluating isotopic haemocompatibility in blood-wall interactions. Methods employing radioisotopic tracers can be used to dynamically monitor the adsorption of labelled blood cells and proteins on different biomaterial surfaces.
   This ex vivo test should enable materials to be assessed for quality according to two thrombogenic criteria: (i) number of adhered platelets mm(-2) s(-1); (ii) quantity of adsorbed fibrinogen expressed as mu g mm(-2)s(-1), which would provide the basis for a scale of haemocompatibility.
C1 UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
CR BAQUEY C, 1980, EVALUATION BIOMATERI, V53, P497
   BAQUEY C, 1981, CHIRURGIE, V191, P418
   BASSECATHALINAT B, 1980, INT J APPL RADIAT IS, V31, P747, DOI 10.1016/0020-708X(80)90064-2
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   CAIX J, 1988, BIOMATERIALS, V9, P62, DOI 10.1016/0142-9612(88)90071-3
   CAIX J, 1987, APPL RADIAT ISOTOPES, V38, P1003
   DUCASSOU D, 1976, BRIT J RADIOL, V49, P344, DOI 10.1259/0007-1285-49-580-344
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   IHLENFELD JV, 1979, THROMB RES, V14, P953, DOI 10.1016/0049-3848(79)90013-6
   KROHN K, 1972, BIOCHIM BIOPHYS ACTA, V285, P404, DOI 10.1016/0005-2795(72)90327-3
   LAMBRECHT LK, 1983, T AM SOC ART INT ORG, V29, P194
   SCHULTZ JS, 1977, ANN NY ACAD SCI, V283, P494, DOI 10.1111/j.1749-6632.1977.tb41793.x
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
NR 14
TC 1
Z9 1
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD FEB
PY 1994
VL 45
IS 2
BP 207
EP 218
DI 10.1016/0969-8043(94)90013-2
PG 12
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA MT977
UT WOS:A1994MT97700013
PM 8312882
DA 2018-10-19
ER

PT J
AU RAMSBY, ML
   MAKOWSKI, GS
   KHAIRALLAH, EA
AF RAMSBY, ML
   MAKOWSKI, GS
   KHAIRALLAH, EA
TI DIFFERENTIAL DETERGENT FRACTIONATION OF ISOLATED HEPATOCYTES -
   BIOCHEMICAL, IMMUNOCHEMICAL AND 2-DIMENSIONAL GEL-ELECTROPHORESIS
   CHARACTERIZATION OF CYTOSKELETAL AND NONCYTOSKELETAL COMPARTMENTS
SO ELECTROPHORESIS
LA English
DT Article
ID RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; INTERMEDIATE FILAMENTS; RAT
   HEPATOCYTES; MESSENGER-RNA; NUCLEAR MATRIX; ENDOPLASMIC-RETICULUM;
   MEMBRANE-PROTEINS; HELA-CELLS; HEAT-SHOCK; LIVER
AB Two-dimensional (2-D) gel electrophoresis is often used in toxicologic and metabolic studies to assess treatment- or stage-specific changes in protein synthesis, degradation or posttranslational modification. When combined with cell fractionation studies the detectability of low abundance proteins is enhanced, and changes in subcellular distribution of proteins can also be monitored. Detergent fractionation is a simpler alternative to differential pelleting, which partitions cellular constituents into functionally distinct populations while preserving cytoskeletal integrity. We defined and characterized a differential detergent fractionation (DDF) protocol to enable protein dynamics in cytoskeletal and noncytoskeletal compartments of isolated hepatocytes to be monitored simultaneously. Rat hepatocytes were maintained in suspension culture and fractionated by sequential extraction with detergent-containing buffers (digitonin/EDTA, Triton/EDTA, Tween/deoxycholate). DDF reproducibly yielded four electrophoretically distinct fractions enriched in cytosolic, membrane-organelle, nuclear membrane and cytoskeletal-matrix markers, respectively. Immunoblotting with over 20 different antibodies corroborated the selectivity of fractionation and was used to characterize the distribution profiles of cytoskeletal (actin, tubulins, cytokeratins, vinculin, myosin, desmoplakins, fodrin, nuclear lamins) and noncytoskeletal proteins (heat-shock 70 proteins, glutathione-S-transferase, calpains, carbamoyl phosphate synthetase, etc.), as well as to identify spots in 2-D gels. Detergent buffers were compatible with equilibrium or nonequilibrium 2-D gel electrophoretic analysis. Extensive 2-D maps of acidic and basic proteins in each fraction were generated along with a tabular listing of M(r) and pI. Thus, DDF reproducibly partitions hepatocytic proteins into functionally distinct cytoskeletal and noncytoskeletal compartments that are readily analyzed by 2-D gel electrophoresis. DDF is simple, applicable to use with other cell types or culture systems and is especially useful when biomaterial is limited (i.e., clinical studies).
C1 UNIV CONNECTICUT,DEPT MOLEC & CELL BIOL,U125,STORRS,CT 06269.
CR ANDERSON NL, 1991, ELECTROPHORESIS, V12, P907, DOI 10.1002/elps.1150121110
   ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17
   BAG J, 1987, BIOCHEM CELL BIOL, V65, P565, DOI 10.1139/o87-073
   BARRETT AJ, 1972, LYSOSOMES LABORATORY, P111
   BELIN MT, 1985, EXP CELL RES, V160, P356, DOI 10.1016/0014-4827(85)90182-X
   BELKIN AM, 1987, FEBS LETT, V220, P291, DOI 10.1016/0014-5793(87)80832-3
   BELLOMO G, 1990, METHOD ENZYMOL, V186, P627
   BENZEEV A, 1986, EXP CELL RES, V164, P335, DOI 10.1016/0014-4827(86)90033-9
   BENZEEV A, 1990, ELECTROPHORESIS, V11, P191, DOI 10.1002/elps.1150110302
   Bernstein L H, 1975, Methods Enzymol, V41, P47
   BIRD RC, 1986, BIOCHIM BIOPHYS ACTA, V868, P215, DOI 10.1016/0167-4781(86)90057-6
   BONNEAU AM, 1985, J CELL BIOL, V100, P1209, DOI 10.1083/jcb.100.4.1209
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   Cabral F, 1979, Methods Enzymol, V56, P602
   CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2
   CIAMPER F, 1988, ACTA VIROL, V170, P338
   CROALL DE, 1991, PHYSIOL REV, V71, P813
   DARGEL R, 1987, EXP PATHOL-JENA, V32, P1
   DREYFUSS G, 1984, MOL CELL BIOL, V4, P415, DOI 10.1128/MCB.4.3.415
   DUNBAR BS, 1987, BIOTECHNIQUES, V5, P218
   DUNCAN R, 1984, ANAL BIOCHEM, V138, P144, DOI 10.1016/0003-2697(84)90783-8
   EARL RT, 1987, BIOCHEM J, V241, P809, DOI 10.1042/bj2410809
   ENRICH C, 1990, BIOCHEM J, V271, P171, DOI 10.1042/bj2710171
   FABRE G, 1990, EUR J DRUG METAB PH, V15, P165, DOI 10.1007/BF03190200
   FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973
   FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430
   FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392
   FRANKE WW, 1981, EXP CELL RES, V134, P345, DOI 10.1016/0014-4827(81)90435-3
   GERLACH U, 1974, METHOD ENZYMAT AN, P871
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HANSSON GK, 1987, EXP CELL RES, V170, P338, DOI 10.1016/0014-4827(87)90311-9
   HENSLEE JG, 1979, J BIOL CHEM, V254, P5488
   HOCHSTRASSER DF, 1992, ELECTROPHORESIS, V13, P992, DOI 10.1002/elps.11501301201
   KATSUMA Y, 1988, HEPATOLOGY, V8, P559, DOI 10.1002/hep.1840080321
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LECOCQ R, 1990, ELECTROPHORESIS, V11, P200, DOI 10.1002/elps.1150110303
   LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6
   LENSTRA JA, 1983, EUR J BIOCHEM, V135, P413, DOI 10.1111/j.1432-1033.1983.tb07668.x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACKALL J, 1979, ANAL BIOCHEM, V95, P270, DOI 10.1016/0003-2697(79)90216-1
   MARCANTONIO EE, 1984, J CELL BIOL, V99, P2254, DOI 10.1083/jcb.99.6.2254
   Moldeus P, 1978, Methods Enzymol, V52, P60
   MOON RT, 1987, BIOESSAYS, V7, P159, DOI 10.1002/bies.950070405
   MORGENSTERN R, 1980, ANAL BIOCHEM, V166, P308
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3
   Patterson M K Jr, 1979, Methods Enzymol, V58, P141
   PETERS KE, 1980, J CELL BIOL, V86, P135, DOI 10.1083/jcb.86.1.135
   PETERSON GL, 1983, METHOD ENZYMOL, V91, P95
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   PYRDE JG, 1986, BIOCHEM J, V233, P525
   RADFORD J, 1988, CELL BIOL INT REP, V12, P1011, DOI 10.1016/0309-1651(88)90026-4
   RADFORD J, 1987, CELL BIOL INT REP, V11, P43, DOI 10.1016/0309-1651(87)90172-X
   RAMSBY ML, 1987, FASEB J, V46, P1981
   RAMSBY ML, 1991, FASEB J, V5, pA635
   RAMSBY ML, 1990, FASEB J, V4, pA1032
   RAMSBY ML, 1986, J CELL BIOL, V103, P357
   RAMSBY ML, 1993, INVEST OPHTH VIS SCI, V34, P3204
   RAMSBY ML, 1989, J CELL BIOL, V108, P370
   REITER T, 1983, P NATL ACAD SCI-BIOL, V80, P4737, DOI 10.1073/pnas.80.15.4737
   REITER T, 1985, J CELL SCI, V76, P17
   SANDKER GW, 1992, BIOCHEM PHARMACOL, V43, P1479, DOI 10.1016/0006-2952(92)90205-W
   SCHMIDT E, 1974, METHOD ENZYMAT AN, P650
   SCHWARZE PE, 1982, IN VITRO CELL DEV B, V18, P43
   SEGLEN PO, 1976, METHOD CELL BIOL, V13, P30
   SOHERTY FJ, 1987, BIOCHEM J, V241, P793
   TANQUAY RM, 1983, CAN J BIOCHEM CELL B, V61, P387
   THURMAN RG, 1980, PHARMACOL REV, V31, P229
   VINCENS P, 1988, INT J BIOCHEM, V20, P499, DOI 10.1016/0020-711X(88)90498-3
   VLASUK GP, 1980, ANAL BIOCHEM, V105, P112, DOI 10.1016/0003-2697(80)90431-5
   WEIGEL PH, 1983, ANAL BIOCHEM, V133, P437, DOI 10.1016/0003-2697(83)90106-9
   WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198
   WIRTH PJ, 1991, ELECTROPHORESIS, V12, P931, DOI 10.1002/elps.1150121112
   ZUURENDONK PF, 1974, BIOCHIM BIOPHYS ACTA, V333, P393, DOI 10.1016/0005-2728(74)90022-X
NR 75
TC 95
Z9 98
U1 1
U2 7
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD FEB
PY 1994
VL 15
IS 2
BP 265
EP 277
DI 10.1002/elps.1150150146
PG 13
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA NB525
UT WOS:A1994NB52500027
PM 8026443
DA 2018-10-19
ER

PT J
AU DOWNES, S
   ARCHER, RS
   KAYSER, MV
   PATEL, MP
   BRADEN, M
AF DOWNES, S
   ARCHER, RS
   KAYSER, MV
   PATEL, MP
   BRADEN, M
TI THE REGENERATION OF ARTICULAR-CARTILAGE USING A NEW POLYMER SYSTEM
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GROWTH FACTOR-BETA; PERICELLULAR CAPSULE; II COLLAGEN; CHONDRONS;
   RABBIT; MICROENVIRONMENT; ANTIBODIES; DEFECTS; REPAIR; MATRIX
AB A polymer system based on room temperature polymerising poly(ethylmethacrylate) polymer powder and tetrahydrofurfuryl monomer has been investigated as a biomaterial for encouraging articular cartilage repair. This heterocyclic methacrylate polymer system swells slightly in situ and thus provides a good interface with subchondral bone resulting in mechanical stability with favourable uptake kinetics. Another feature of this polymer system is that it exhibits high water uptake which leads to absorption of the surrounding tissue fluid and matrix proteins, including growth factors; this may encourage the formation of new cartilage. Three weeks after implantation the tissue overgrowth contained cartilage components: chondrocytes, collagen type II, chondroitin 4-sulphate and chondroitin 6-sulphate. In addition numerous chondrocyte clones were observed at the edge of the defect and in the newly repaired tissue. By six weeks a superficial articulating surface was continuous with the normal articular cartilage with underlying tissue which showed some evidence of endochondral ossification. By nine weeks the surface covering of new cartilage had a widened and an irregular zone of calcified cartilage with thickened subchondral bone was present. At eight months the resurfaced cartilage remained intact above a remodelled subchondral bone end plate.
C1 UNIV LONDON LONDON HOSP,COLL MED,DEPT BIOMAT RELAT DENT,LONDON E1 2AD,ENGLAND.
RP DOWNES, S (reprint author), ROYAL NATL ORTHOPAED HOSP TRUST,INST ORTHOPAED,IRC BIOMED MAT,STANMORE HA7 4LP,MIDDX,ENGLAND.
CR Batchelor G.Y., 1991, ANIMAL TECHNOL, V42, P109
   BUCKWALTER JA, 1990, OSTEOARTHRITIS DIAGN
   BUCKWALTER JA, 1990, ATRICULAR CARTILAGE, pCH2
   CATERSON B, 1985, FED PROC, V44, P386
   CHEUNG HS, 1980, ARTHRITIS RHEUM, V23, P211, DOI 10.1002/art.1780230212
   COLLINS DH, 1960, ANN RHEUM DIS, V19, P318, DOI 10.1136/ard.19.4.318
   DEBRUIJN WC, 1973, J ULTRA MOL STRUCT R, V42, P29, DOI 10.1016/S0022-5320(73)80004-8
   DOWNES S, 1992, IN PRESS MAY SURF PR
   DVORAK AM, 1972, LAB INVEST, V27, P561
   FARNUM CE, 1983, J HISTOCHEM CYTOCHEM, V31, P765, DOI 10.1177/31.6.6841972
   FURUKAWA T, 1980, J BONE JT SURG A, V62, P179
   HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314
   HUMPHREY CD, 1974, STAIN TECHNOL, V49, P9, DOI 10.3109/10520297409116929
   JAFFE FF, 1974, J BONE JOINT SURG AM, VA 56, P1031, DOI 10.2106/00004623-197456050-00014
   JOHNSON GD, 1982, J IMMUNOL METHODS, V55, P231, DOI 10.1016/0022-1759(82)90035-7
   KARNOVSKY MJ, 1971, 11TH AM SOC CELL BIO
   KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004
   LINN FC, 1965, ARTHRITIS RHEUM-US, V8, P481, DOI 10.1002/art.1780080402
   MANKIN HJ, 1967, CARTILAGE DEGRADATIO, P186
   MANKIN HJ, 1984, ADULT ORTHOPAEDICS, P163
   MEACHIM G, 1962, ANN RHEUM DIS, V21, P45, DOI 10.1136/ard.21.1.45
   MEACHIM G, 1963, J BONE JOINT SURG BR, V45, P150
   MINNS RJ, 1982, BIOMATERIALS, V3, P81, DOI 10.1016/0142-9612(82)90038-2
   MITCHELL N, 1992, J BONE JOINT SURG BR, V74, P33
   MITCHELL N, 1987, J ORTHOPAED RES, V5, P388, DOI 10.1002/jor.1100050311
   PATEL MP, 1991, BIOMATERIALS, V12, P645, DOI 10.1016/0142-9612(91)90110-V
   POOLE CA, 1984, J ANAT, V138, P113
   POOLE CA, 1985, J ULTRA MOL STRUCT R, V91, P13, DOI 10.1016/0889-1605(85)90071-0
   POOLE CA, 1990, CONNECT TISSUE RES, V24, P319, DOI 10.3109/03008209009152158
   POOLE CA, 1988, J CELL SCI, V90, P635
   POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1985, DEGERATIVE JOINTS, V2
   REDDI AH, 1983, RHEUMATOLOGY, V10, P67
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P1750
   SAMPATH TK, 1982, EXP CELL RES, V142, P460, DOI 10.1016/0014-4827(82)90389-5
   SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693
   Speer DP, 1979, CLIN ORTHOP RELAT R, V144, P326
   SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831
   Szirmai JA, 1969, AGING CONNECTIVE SKE, P163
   VONSCHROEDER HP, 1991, J BIOMED MATER RES, V25, P329, DOI 10.1002/jbm.820250305
   WOBST R, 1980, GERONTOLOGY, V26, P311, DOI 10.1159/000212434
NR 43
TC 45
Z9 45
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 1994
VL 5
IS 2
BP 88
EP 95
DI 10.1007/BF00121696
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NC544
UT WOS:A1994NC54400005
DA 2018-10-19
ER

PT B
AU QU, QS
   WU, F
   WANG, MH
AF QU, QS
   WU, F
   WANG, MH
BE Aoki, H
   Miao, X
   Bonfield, W
   Sakurai, Y
   Segawa, K
   MoroOka, Y
   Amor, JN
   Nishi, T
   Kim, SC
   Nakahama, S
   Utracki, LA
   Ichihara, S
   Monnerie, L
   Hasegawa, M
   Baba, N
   Fujishima, A
   Ichimura, K
   Irie, M
TI A NEW BIOMATERIAL - HYALURONAN
SO ADVANCED MATERIALS '93, II - A & B: A: BIOMATERIALS, ORGANIC AND
   INTELLIGENT MATERIALS; B: INFORMATION STORAGE MATERIALS
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT 3rd IUMRS International Conference on Advanced Materials (ICAM)
CY AUG 31-SEP 04, 1993
CL SUNSHINE CITY, JAPAN
SP INT UNION MAT RES SOC, NIKKAN KOGYO SHIMBUN LTD
C1 SHANGHAI JIAN HUA FACTORY FINE BIOL PROD,200232 SHANGHAI,PEOPLES R CHINA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 0-444-81992-4
J9 T MRS JAP
PY 1994
VL 15
IS A & B
BP 43
EP 47
PG 5
WC Computer Science, Hardware & Architecture; Electrochemistry;
   Engineering, Chemical; Materials Science, Multidisciplinary; Polymer
   Science
SC Computer Science; Electrochemistry; Engineering; Materials Science;
   Polymer Science
GA BC69F
UT WOS:A1994BC69F00009
DA 2018-10-19
ER

PT B
AU KURANE, R
AF KURANE, R
BE Yamamoto, R
   Furubayashi, E
   Doi, Y
   Fang, R
   Liu, B
TI TOWARDS NEW-BIOMATERIAL, BIODEGRADABLE HIGHPOLYMER, PRODUCED BY
   MICROORGANISM (BIOFLOCCULANT & BIOABSORBENT)
SO ADVANCED MATERIALS '93, V - A & B: A: ECOMATERIALS; B: SHAPE MEMORY
   MATERIALS AND HYDRIDES
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT 3rd IUMRS International Conference on Advanced Materials (ICAM)
CY AUG 31-SEP 04, 1993
CL SUNSHINE CITY, JAPAN
SP INT UNION MAT RES SOC, NIKKAN KOGYO SHIMBUN LTD
C1 MINIST INT TRADE & IND,AIST,NATL INST BIOSCI & HUMAN TECHNOL,TSUKUBA,IBARAKI 305,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE PUBL B V
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
BN 0-444-81995-9
J9 T MRS JAP
PY 1994
VL 18
IS A & B
BP 437
EP 442
PG 6
WC Engineering, Environmental; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA BC69J
UT WOS:A1994BC69J00093
DA 2018-10-19
ER

PT J
AU REID, G
   KHOURY, AE
   PRESTON, CAK
   COSTERTON, JW
AF REID, G
   KHOURY, AE
   PRESTON, CAK
   COSTERTON, JW
TI INFLUENCE OF DEXTROSE DIALYSIS SOLUTIONS ON ADHESION OF
   STAPHYLOCOCCUS-AUREUS AND PSEUDOMONAS-AERUGINOSA TO 3 CATHETER SURFACES
SO AMERICAN JOURNAL OF NEPHROLOGY
LA English
DT Article
DE BACTERIA; ADHESION; PERITONITIS; DEXTROSE; CATHETERS
ID AMBULATORY PERITONEAL-DIALYSIS; BIOFILM FORMATION; URINARY-TRACT;
   BACTERIAL; ADHERENCE; COLONIZATION; INHIBITION; MANNOSE
AB Peritonitis is a serious problem associated with continuous ambulatory peritoneal dialysis. The process can be initiated by intraluminal contamination and colonization of the peritoneal cavity as well as by bacterial adhesion to biomaterials, including catheters and exit site dressings. The aim of this study was to determine the degree to which two pathogenic organisms could adhere to three biomaterial surfaces, and the extent to which dextrose concentration influenced the binding and survival. Using a 24-hour in vitro assay, it was found that the Staphylococcus aureus strain consistently adhered significantly better than the Pseudomonas aeruginosa isolate, and only the adhesion of the latter was decreased with higher concentrations of dextrose in dialysis solutions. Electron microscopy demonstrates that within this short time period, bacterial biofilms had begun to form on the catheter surfaces.
C1 UNIV WESTERN ONTARIO,DEPT UROL SURG,LONDON,ON,CANADA.
   UNIV TORONTO,DEPT UROL SURG,TORONTO M5S 1A1,ON,CANADA.
   MONTANA STATE UNIV,CTR BIOFILM ENGN,BOZEMAN,MT 59717.
RP REID, G (reprint author), UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,SLB 328,LONDON N6A 5B8,ON,CANADA.
CR CHAN RCY, 1984, J UROLOGY, V131, P596, DOI 10.1016/S0022-5347(17)50512-1
   DASGUPTA MK, 1988, AM J NEPHROL, V8, P118, DOI 10.1159/000167569
   DASGUPTA MK, 1987, PERITON DIALYSIS INT, V7, P168
   DUGUID JP, 1961, S SOC GEN MICROBIOL, V11, P69
   MARRIE TJ, 1983, J CLIN MICROBIOL, V18, P1388
   OFEK I, 1981, INFECT IMMUN, V34, P708
   OLD DC, 1972, J GEN MICROBIOL, V71, P149, DOI 10.1099/00221287-71-1-149
   READ RR, 1989, KIDNEY INT, V35, P614, DOI 10.1038/ki.1989.30
   REID G, 1990, PERITON DIALYSIS INT, V10, P21
   REID G, 1992, INT BIODETER BIODEGR, V30, P105, DOI 10.1016/0964-8305(92)90057-U
   REID G, 1992, J UROLOGY, V148, P1592, DOI 10.1016/S0022-5347(17)36976-8
   REID G, 1992, PARAPLEGIA, V30, P711, DOI 10.1038/sc.1992.138
   REID G, 1993, COLLOID SURFACE B, V1, P9, DOI 10.1016/0927-7765(93)80012-N
   REID G, 1993, PARAPLEGIA, V31, P494, DOI 10.1038/sc.1993.80
   REID G, 1992, AM UROL ASS UPDATE S, V18, P138
   REID G, 1992, J MATERIALS SCI MATE, V4, P17
   REID G, 1982, THESIS MASSEY U
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   VAS SI, 1985, PERITONEAL DIALYSIS, P403
   VERBRUGH HA, 1984, J CLIN MICROBIOL, V20, P199
NR 20
TC 16
Z9 16
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0250-8095
J9 AM J NEPHROL
JI Am. J. Nephrol.
PD JAN-FEB
PY 1994
VL 14
IS 1
BP 37
EP 40
DI 10.1159/000168683
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA NJ282
UT WOS:A1994NJ28200007
PM 8017479
DA 2018-10-19
ER

PT J
AU NAKAYAMA, M
   TANISHITA, K
AF NAKAYAMA, M
   TANISHITA, K
TI MEASUREMENT OF THERMAL-DIFFUSIVITY OF BIOMATERIALS BY FOCUSED ULTRASONIC
   BEAMS (THERMAL PULSE DECAY METHOD BY FOCUSED ULTRASONIC BEAMS)
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Proceedings Paper
CT International Symposium on Advanced Bio-Materials and Engineering 93
   (ISABE 93)
CY SEP 01-04, 1993
CL UTSUNOMIYA, JAPAN
SP JAPAN SOC PROMOT SCI, ADV MAT MECH PROPERTIES 129 COMM
DE THERMOPHYSICAL PROPERTY; THERMAL DIFFUSIVITY; FOCUSED ULTRASONIC BEAMS;
   THERMAL PULSE DECAY; BIOMATERIAL
ID TISSUE; CONDUCTIVITY
C1 KEIO UNIV,FAC SCI & TECHNOL,DEPT MECH ENGN,KOHOKU KU,YOKOHAMA,KANAGAWA 223,JAPAN.
CR BALASUBRAMANIAM TA, 1977, ASME J BIOMECHANICAL, V99, P148
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   BURNSIDE G, 1991, JSME THERM ENG P, V1, P325
   CHATO JC, 1984, HEAT TRANSFER MED BI, V2, P413
   CHATO JC, 1968, ASME, V16
   CHEN MM, 1981, J BIOMECH ENG-T ASME, V103, P253
   Japan Society of Thermophysical Properties, 1990, THERMOPHYSICAL PROPE
   LELE PP, 1980, ANN NY ACAD SCI, V535, P83
   NEWMAN WH, 1985, J BIOMECH ENG-T ASME, V107, P219, DOI 10.1115/1.3138546
   ONEIL HT, 1949, J ACOUST SOC AM, V21, P516, DOI 10.1121/1.1906542
   PARKER KJ, 1983, J ACOUST SOC AM, V74, P1356, DOI 10.1121/1.390159
   PATEL PA, 1987, J BIOMECH ENG-T ASME, V109, P330, DOI 10.1115/1.3138689
   ROBINSON TC, 1969, J ACOUST SOC AM, V51, P1333
   SHITZER A, 1985, HEAT TRANSFER MED TE, V2
   Shitzer A., 1985, HEAT TRANSFER MED BI, V1
   Tanasawa I., 1984, International Journal of Thermophysics, V5, P149, DOI 10.1007/BF00505497
   TANASAWA I, 1973, BIOMECHANISM, V2, P17
   TANISHITA K, 1991, BIOMECHANICS OHMUSHA, P218
   TANISHITA K, 1981, T JSME, V47, P1784
   VALVANO JW, 1985, INT J THERMOPHYS, V6, P301, DOI 10.1007/BF00522151
   VALVANO JW, 1984, J BIOMECH ENG-T ASME, V106, P192
NR 21
TC 2
Z9 2
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 1994
VL 4
IS 2
BP 105
EP 114
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NW368
UT WOS:A1994NW36800006
PM 7920196
DA 2018-10-19
ER

PT J
AU ROSENGREN, A
   JOHANSSON, BR
   THOMSEN, P
   ERICSON, LE
AF ROSENGREN, A
   JOHANSSON, BR
   THOMSEN, P
   ERICSON, LE
TI METHOD FOR IMMUNOLOCALIZATION OF EXTRACELLULAR PROTEINS IN ASSOCIATION
   WITH THE IMPLANT SOFT-TISSUE INTERFACE
SO BIOMATERIALS
LA English
DT Article
DE IMPLANTS; TITANIUM; CRYOSUBSTITUTION; ELECTROPOLISHING;
   IMMUNOLOCALIZATION; EXTRACELLULAR PROTEINS
ID ABDOMINAL-WALL; TITANIUM; METAL; RAT
AB A method allowing immunolocalization of macromolecules surrounding biomaterial implants has been developed. Plugs of pure titanium were inserted into the abdominal wall of rats. One week after implantation plugs with adjacent tissue were gently fixed and cryoprotected before being rapidly frozen in LN(2)-cooled propane, followed by cryosubstitution, using methanol, and low temperature infiltration and UV curing of the methacrylate LR-Gold. Before sectioning, bulk metal was removed electrochemically, leaving the surface oxide intact, appearing in sections as a dense line in contact with the tissue. Postembedding immunolocalization for rat albumin, IgG, C3c, fibrinogen and fibronectin was performed at the light and electron microscopic levels. Our observations indicate that 1 wk after implant insertion, a network of fibrin and fibronectin decorates the tissue surface that faces the implant, but without any obvious concentration to the implant surface.
RP ROSENGREN, A (reprint author), UNIV GOTEBORG,DEPT ANAT,MEDICINAREGATAN 3,S-41390 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ARMBRUSTER BL, 1982, J MICROSC-OXFORD, V126, P77, DOI 10.1111/j.1365-2818.1982.tb00358.x
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KUSHNARYOV VM, 1988, CYTOBIOS, V54, P167
   MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SITTE H, 1988, SCI BIOL SPECIMEN PR, P103
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
NR 11
TC 26
Z9 26
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1994
VL 15
IS 1
BP 17
EP 24
DI 10.1016/0142-9612(94)90190-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MT340
UT WOS:A1994MT34000003
PM 8161652
DA 2018-10-19
ER

PT J
AU RHODES, NP
   WILLIAMS, DF
AF RHODES, NP
   WILLIAMS, DF
TI PLASMA RECALCIFICATION AS A MEASURE OF CONTACT PHASE ACTIVATION AND
   HEPARINIZATION EFFICACY AFTER CONTACT WITH BIOMATERIALS
SO BIOMATERIALS
LA English
DT Article
DE CALCIFICATION; HEPARINIZATION; TESTING
AB The rate of plasma clotting was measured in order to investigate two different processes. In both cases normal, pooled platelet-poor plasma was used as a substrate for measurement of clotting. The intrinsic coagulation pathway was studied by bringing a variety of biomaterials into contact with a plasma aliquot and observing the rate of clotting diminish by virtue of factor XII activation. The efficacy of heparinization was investigated by measuring the increase in clotting time of a plasma aliquot during biomaterial contact. In both cases, clotting time was measured turbidometrically. Marked differences in intrinsic pathway activation were observed between a variety of materials. There were clear differences between the materials and the negative and positive controls. The assay showed that heparinized materials could be distinguished from non-heparinized materials and a non-activated plasma control.
RP RHODES, NP (reprint author), UNIV LIVERPOOL, DEPT CIVIL ENGN, POB 147, LIVERPOOL L69 3BX, ENGLAND.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRODE GA, 1969, T AM SOC ART INT ORG, V15, P1
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   LARSSON R, 1987, ANN NY ACAD SCI, V516, P102, DOI 10.1111/j.1749-6632.1987.tb33034.x
NR 6
TC 34
Z9 35
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 1994
VL 15
IS 1
BP 35
EP 37
DI 10.1016/0142-9612(94)90194-5
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MT340
UT WOS:A1994MT34000006
PM 8161655
DA 2018-10-19
ER

PT S
AU LI, ST
   YUEN, D
   LI, PC
   RODKEY, WG
   STONE, KR
AF LI, ST
   YUEN, D
   LI, PC
   RODKEY, WG
   STONE, KR
BE Mikos, AG
   Murphy, RM
   Bernstein, H
   Peppas, NA
TI COLLAGEN AS A BIOMATERIAL - AN APPLICATION IN KNEE MENISCAL
   FIBROCARTILAGE REGENERATION
SO BIOMATERIALS FOR DRUG AND CELL DELIVERY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomaterials for Drug and Cell Delivery
CY NOV 29-DEC 01, 1993
CL BOSTON, MA
SP MAT RES SOC
C1 REGEN BIOL INC,FRANKLIN LAKES,NJ.
NR 0
TC 8
Z9 8
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-230-8
J9 MATER RES SOC SYMP P
PY 1994
VL 331
BP 25
EP 32
PG 8
WC Materials Science, Multidisciplinary; Pharmacology & Pharmacy
SC Materials Science; Pharmacology & Pharmacy
GA BA69J
UT WOS:A1994BA69J00004
DA 2018-10-19
ER

PT S
AU ZOU, L
   WALSH, WR
   KEEPING, H
   HOWLETT, CR
   STEELE, J
   MCFARLAND, C
   RUSSELL, M
   EHRLICH, MG
AF ZOU, L
   WALSH, WR
   KEEPING, H
   HOWLETT, CR
   STEELE, J
   MCFARLAND, C
   RUSSELL, M
   EHRLICH, MG
BE Mikos, AG
   Murphy, RM
   Bernstein, H
   Peppas, NA
TI OSTEOBLAST - ORTHOPEDIC BIOMATERIAL RESPONSE
SO BIOMATERIALS FOR DRUG AND CELL DELIVERY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomaterials for Drug and Cell Delivery
CY NOV 29-DEC 01, 1993
CL BOSTON, MA
SP MAT RES SOC
C1 BROWN UNIV,RHODE ISL HOSP,SCH MED,DEPT ORTHOPAED,BIOMECH LAB,PROVIDENCE,RI 02903.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-230-8
J9 MATER RES SOC SYMP P
PY 1994
VL 331
BP 127
EP 131
PG 5
WC Materials Science, Multidisciplinary; Pharmacology & Pharmacy
SC Materials Science; Pharmacology & Pharmacy
GA BA69J
UT WOS:A1994BA69J00019
DA 2018-10-19
ER

PT S
AU LATOUR, RA
   BLACK, J
AF LATOUR, RA
   BLACK, J
BE Kambic, HE
   Yokobori, AT
TI FIBER-REINFORCED POLYMER COMPOSITE BIOMATERIALS - CHARACTERIZATION OF
   INTERFACIAL BOND STRENGTH AND ENVIRONMENTAL SENSITIVITY
SO BIOMATERIALS MECHANICAL PROPERTIES
SE AMERICAN SOCIETY FOR TESTING AND MATERIALS SPECIAL TECHNICAL PUBLICATION
LA English
DT Proceedings Paper
CT Symposium on Biomaterials Mechanical Properties
CY MAY 05-06, 1992
CL PITTSBURGH, PA
SP AMER SOC TESTING & MAT, COMM MED & SURG MAT & DEVICE, SUBCOMM CARDIOVASC IM, PLANTS & MAT
DE TEST METHOD; FIBER-REINFORCED POLYMER (FRP) COMPOSITE; INTERFACIAL BOND;
   ULTIMATE STRENGTH (UBS); FATIGUE STRENGTH; COMPOSITE BIOMATERIAL
C1 CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU AMERICAN SOCIETY TESTING AND MATERIALS
PI W CONSHOHOCKEN
PA 100 BARR HARBOR DRIVE, W CONSHOHOCKEN, PA 19428-2959
SN 1071-5827
BN 0-8031-1894-5
J9 AM SOC TEST MATER
PY 1994
VL 1173
BP 193
EP 211
DI 10.1520/STP18105S
PG 19
WC Mechanics; Materials Science, Biomaterials
SC Mechanics; Materials Science
GA BA28K
UT WOS:A1994BA28K00016
DA 2018-10-19
ER

PT S
AU CHITTIBABU, KG
   KAMATH, M
   LIM, JO
   MARX, KA
   KUMAR, J
   TRIPATHY, SK
   SAMUELSON, LA
   KAPLAN, DL
AF CHITTIBABU, KG
   KAMATH, M
   LIM, JO
   MARX, KA
   KUMAR, J
   TRIPATHY, SK
   SAMUELSON, LA
   KAPLAN, DL
BE Alper, M
   Bayley, H
   Kaplan, D
   Navia, M
TI BIOTINYLATED THIOPHENE COPOLYMER - A NOVEL BIOMATERIAL FOR LB FILM
   ASSEMBLY
SO BIOMOLECULAR MATERIALS BY DESIGN
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium S, Biomolecular Materials by Design
CY NOV 29-DEC 03, 1993
CL BOSTON, MA
SP MAT RES SOC
C1 UNIV MASSACHUSETTS,DEPT CHEM,CTR ADV MAT,LOWELL,MA 01854.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-229-4
J9 MATER RES SOC SYMP P
PY 1994
VL 330
BP 185
EP 190
PG 6
WC Biotechnology & Applied Microbiology; Materials Science, Ceramics;
   Materials Science, Coatings & Films
SC Biotechnology & Applied Microbiology; Materials Science
GA BB13M
UT WOS:A1994BB13M00024
DA 2018-10-19
ER

PT J
AU MACHADO, A
   VADGAMA, P
   WATERHOUSE, J
AF MACHADO, A
   VADGAMA, P
   WATERHOUSE, J
TI TEMPORAL RELATIONSHIPS IN RELATION TO IN-VIVO MONITORING 2ND WORKSHOP OF
   THE CONCERTED ACTION - PORTO, OCTOBER 14TH-15TH 1993
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Editorial Material
AB The commencement of the second phase of the Concerted Action has coincided with an expansion of the range of topics defined as being of relevance to in vivo chemical sensing. These further topics have provided a valuable 'backdrop' to the mainstream discussion of chemical sensor technology and science of the earlier Workshops. The last major Workshop (Biosensors: The Biocompatibility Issue, Fontainebleau, June 7-9, 1993) emphasised the biomaterial aspects of sensors, this smaller, more specialist Workshop represented a rather less conventional focus on a purely biological area, but one of relevance to anyone interested in the mechanisms of time-dependent variability of biological systems: Chronobiology. This was a reflection, in many ways, of the progress that had been achieved, hitherto, by the various EC groups as regards the technology and usage of in vivo chemical sensors.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD, OXON, ENGLAND OX5 1GB
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PY 1994
VL 9
IS 4-5
BP R9
EP R14
DI 10.1016/0956-5663(94)80021-9
PG 6
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA NW112
UT WOS:A1994NW11200003
DA 2018-10-19
ER

PT J
AU JOHANSEN, K
   LYMAN, D
   SAUVAGE, L
AF JOHANSEN, K
   LYMAN, D
   SAUVAGE, L
TI BIOMATERIALS FOR HEMODIALYSIS ACCESS
SO BLOOD PURIFICATION
LA English
DT Article
DE OPTIMAL VASCULAR ACCESS, HEMODIALYSIS; BIOMATERIAL CONDUIT; BIOGRAFT;
   DIALYSIS ACCESS GRAFTS
AB While the optimal vascular conduit for hemodialysis is undeniably an arterialized autogenous subcutaneous vein, only a minority of end-stage renal disease patients can count on such access: the remainder require implantation of a biomaterial conduit. This paper will briefly survey current biografts used for hemodialysis access, with an emphasis on their known limitations, and will delineate the questions to be asked - and answered - in the development of optimal dialysis access grafts.
RP JOHANSEN, K (reprint author), PROVIDENCE MED CTR,POB 34008,SEATTLE,WA 98124, USA.
NR 0
TC 3
Z9 3
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0253-5068
J9 BLOOD PURIFICAT
JI Blood Purif.
PD JAN-FEB
PY 1994
VL 12
IS 1
BP 73
EP 77
DI 10.1159/000170148
PG 5
WC Hematology; Urology & Nephrology
SC Hematology; Urology & Nephrology
GA PB932
UT WOS:A1994PB93200011
PM 7986480
DA 2018-10-19
ER

PT J
AU BERTHOD, F
   SAINTIGNY, G
   CHRETIEN, F
   HAYEK, D
   COLLOMBEL, C
   DAMOUR, O
AF BERTHOD, F
   SAINTIGNY, G
   CHRETIEN, F
   HAYEK, D
   COLLOMBEL, C
   DAMOUR, O
TI OPTIMIZATION OF THICKNESS, PORE-SIZE AND MECHANICAL-PROPERTIES OF A
   BIOMATERIAL DESIGNED FOR DEEP BURN COVERAGE
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT BIOMAT 92 - Symposium on Biocompatability of Artificial Organs
CY NOV 02-04, 1992
CL BORDEAUX, FRANCE
SP BIOMAT ASSOC
ID ARTIFICIAL SKIN; CROSS-LINKING; COLLAGEN; KERATINOCYTES; DRESSINGS;
   CHITOSAN
C1 HOP EDOUARD HERRIOT,SERV BIOCHIM C,SUBSTITUTS CUTANES LAB,F-69437 LYON 03,FRANCE.
CR BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   ICRE P, 1982, INTERBLOC, V2, P5
   KISHIMOTO S, 1987, Acta Dermatologica (Kyoto), V82, P471
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1980, BIOTECHNOL BIOENG, V22, P885, DOI 10.1002/bit.260220412
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   OLIVER RF, 1980, BRIT J EXP PATHOL, V61, P544
   OLIVER RF, 1987, BURNS, V13, P49
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   PRUITT BA, 1984, ARCH SURG-CHICAGO, V119, P312
   SHAHABEDDIN L, 1990, Skin Pharmacology, V3, P107
   SHAHABEDDIN L, 1991, J MATER SCI-MATER M, V2, P222, DOI 10.1007/BF00703375
   TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
   TRIANTAFYLLOU N, 1975, EFFECTS STERILIZING, P215
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   WOOLSTON J, 1990, MED DEVICE TECHN JUL, P25
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 25
TC 64
Z9 65
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1994
VL 15
IS 4
BP 259
EP 265
DI 10.1016/0267-6605(94)90055-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL273
UT WOS:A1994NL27300008
PM 10147169
DA 2018-10-19
ER

PT J
AU HARMAND, MF
   NAJI, A
   GONFRIER, P
AF HARMAND, MF
   NAJI, A
   GONFRIER, P
TI IN-VITRO STUDY OF BIOMATERIAL BIODEGRADATION USING HUMAN CELL-CULTURES
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT BIOMAT 92 - Symposium on Biocompatability of Artificial Organs
CY NOV 02-04, 1992
CL BORDEAUX, FRANCE
SP BIOMAT ASSOC
ID CHROMIUM; CORROSION
C1 LEMI,F-33650 MARTILLAC,FRANCE.
   UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
CR BROWN SA, 1980, J BIOMED MATER RES, V14, P173, DOI 10.1002/jbm.820140208
   CARROLL KG, 1968, NATURE, V217, P1172, DOI 10.1038/2171172a0
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   FURST A, 1969, PROG EXP TUMOR RES, V12, P102
   HARMAND MF, 1986, BIOL BIOMECHANICAL P, P361
   LEVIS AG, 1978, BRIT J CANCER, V37, P386, DOI 10.1038/bjc.1978.58
   LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526
   OFFENSMEYER FP, 1980, J ULTRASTRUCT RES, V72, P336
   RONAI PM, 1969, BLOOD-J HEMATOL, V33, P408
   SAMITZ MH, 1975, BRIT J DERMATOL, V92, P287, DOI 10.1111/j.1365-2133.1975.tb03078.x
   SANDERSON CJ, 1976, TRANSPLANTATION, V21, P526
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
NR 14
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1994
VL 15
IS 4
BP 281
EP 285
DI 10.1016/0267-6605(94)90059-0
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL273
UT WOS:A1994NL27300012
DA 2018-10-19
ER

PT J
AU GRISTINA, AG
AF GRISTINA, AG
TI IMPLANT FAILURE AND THE IMMUNE-INCOMPETENT FIBRO-INFLAMMATORY ZONE
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN;
   FOREIGN-BODY INFECTION; SPATIAL ARRANGEMENT; MICROBIAL ADHESION; TISSUE
   INTEGRATION; SEPSIS; BIOMATERIALS; ENDOCARDITIS; PATHOGENESIS
AB Biomaterial implants are surrounded by an immune-incompetent, fibro-inflammatory, integration-deficient zone within which stimulation of cellular immune responses results in superoxide radical and cytokine-mediated tissue damage with increased susceptibility to infection or aseptic loosening. Three important questions that pertain to surgical implants are (1) What are the mechanisms that cause abnormal inflammatory responses in the absence of infection and result in interface cellular disorganization and device failure? (2) What causes host defenses to be compromised to the extent that normal flora organisms like Staphylococcus epidermidis, with little or no virulence potential, can cause life-threatening infections at the implant-host interface? (3) What is the nature of surface regions of biomaterials that facilitate bacterial adherence? Pathogenic strains of S. epidermidis and Staphylococcus aureus have an affinity for biomaterial surfaces and are capable of initiating infection. Binding may be nonspecific and gluelike rather than a receptor-ligand event as for S. aureus and matrix proteins. This study indicates bacterial binding to sites of higher vanadium concentration at grain boundaries and mixed phases in titanium alloys. Repeated macrophage priming by biomaterial particulates results in the production of reactive oxygen intermediates, macrophage exhaustion, and adjacent tissue damage. A cytokine cascade is also initiated. A self-perpetuating enlarging immune-incompetent fibro-inflammatory zone develops about implants, which features tissue cell damage, increased susceptibility to infection, and results in septic or aseptic failure of the implant. These effects are clearly exemplified by fibrosis about breast implants and osteolysis at the interface of total joint replacements.
RP GRISTINA, AG (reprint author), MED SCI RES INST,HERNDON,VA 22071, USA.
FU NIGMS NIH HHS [GM 35939]; NIADDK NIH HHS [AM 26957]
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Barth E, 1988, J Invest Surg, V1, P291, DOI 10.3109/08941938809141095
   Beachey EH, 1980, BACTERIAL ADHERENCE
   BUSSCHER HJ, 1991, J BIOMAT SCI-POLYM E, V3, P85, DOI 10.1163/156856292X00097
   BUSSCHER HJ, 1991, CELL MATER, V1, P49
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dougherty S H, 1982, Curr Probl Surg, V19, P265
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   FLETCHER M, 1980, BACTERIAL ADHERENCE, P345
   GABRIEL BL, IN PRESS BIOMATERIAL
   GRAVES EJ, 1991, VITAL HLTH STAT, V13, P108
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   Gristina AG, 1989, INFECT ORTHOPAEDIC P, P30
   GRISTINA AG, IN PRESS INT J ARTIF
   KLOCK JC, 1976, BLOOD, V48, P149
   KOJIMA Y, 1990, J INFECT DIS, V162, P435, DOI 10.1093/infdis/162.2.435
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   MULLER E, 1991, INFECT IMMUN, V59, P3323
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PAZZAGLIA UE, 1990, ARCH ORTHOP TRAUM SU, V109, P83, DOI 10.1007/BF00439384
   Peters GF, 1987, ZENTRALBLATT BAKTE S, V16, P15
   PREWETT AB, 1991, SOC BIOMATERIALS T, V14, P105
   RYDEN C, 1987, LANCET, V2, P515
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   TABORELLI M, 1992, IN PRESS MAY P SURF
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   VOYTEK A, 1988, BIOMATERIALS, V9, P107, DOI 10.1016/0142-9612(88)90080-4
   ZAK O, 1983, REV INFECT DIS, V5, pS481
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 35
TC 162
Z9 165
U1 0
U2 12
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD JAN
PY 1994
IS 298
BP 106
EP 118
PG 13
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA MQ192
UT WOS:A1994MQ19200016
PM 8118964
DA 2018-10-19
ER

PT B
AU KLEPAL, W
   GRUBER, D
   HAAS, K
AF KLEPAL, W
   GRUBER, D
   HAAS, K
BE Jouffrey, B
   Colliex, C
TI Biomaterial as mechanical device
SO ELECTRON MICROSCOPY 1994, VOLS 3A AND 3B: APPLICATIONS IN BIOLOGICAL
   SCIENCES
LA English
DT Proceedings Paper
CT 13th International Congress on Electron Microscopy
CY JUL 17-22, 1994
CL PARIS, FRANCE
SP Int Federat Soc Electron Microscopy, Minist Enseignement Super & Recher, Acad Sci, Minist Affaires Etrangeres, European Union, CNRS, INSERM, CEA
C1 INST ZOOL,FEINSTUKTUR ABT,A-1090 VIENNA,AUSTRIA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU EDITIONS PHYSIQUE
PI LES ULIS
PA AVENUE DU HOGGAR, ZONE INDUSTRIELLE COURTABOEUF, BP112 91944 LES ULIS,
   FRANCE
BN 2-86883-228-8
PY 1994
BP 919
EP 920
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BE09Z
UT WOS:A1994BE09Z00430
DA 2018-10-19
ER

PT J
AU BELLON, JM
   BUJAN, J
   CONTRERAS, L
   HERNANDO, A
   JURADO, F
AF BELLON, JM
   BUJAN, J
   CONTRERAS, L
   HERNANDO, A
   JURADO, F
TI MACROPHAGE RESPONSE TO EXPERIMENTAL IMPLANTATION OF POLYPROPYLENE
   PROSTHESES
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE MACROPHAGES; MONOCLONAL ANTIBODIES; POLYPROPYLENE MESH
ID ABDOMINAL-WALL; GROWTH-FACTOR; MARLEX MESH; REPAIR; DEFECTS; HERNIA;
   RATS
AB We have assessed the macrophage response to polypropylene mesh (Marlex(R)) implanted into the abdominal wall of New Zealand white rabbits, using RAM-11, a monoclonal antibody specific for rabbit macrophages. The response diminishes during the course of the first 90 days after implantation, although the presence of other cell types typical of foreign-body reactions increases. We have also confirmed the high degree of integration of the biomaterial into the wall achieved after 9 weeks. This has been determined using light and scanning electron microscopy. Likewise, we have observed the formation of numerous adhesions between the polypropylene mesh and the viscera of the abdominal cavity.
RP BELLON, JM (reprint author), UNIV ALCALA DE HENARES, FAC MED, DEPT MORPHOL SCI & SURG, SURG RES LAB, CARRETERA MADRID BARCELONA, E-28871 MADRID, SPAIN.
RI Hernando, Antonio/E-2105-2015
OI Hernando, Antonio/0000-0001-7856-3768; bujan, Julia/0000-0003-2419-2476;
   BELLON, JUAN M./0000-0002-6071-5011
CR BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BJURSTEN LM, 1991, 9TH EUR C BIOM CHEST
   BROWDER W, 1988, SURGERY, V104, P224
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   ELLIOTT MP, 1979, AM J SURG, V137, P342, DOI 10.1016/0002-9610(79)90063-1
   JENKINS SD, 1983, SURGERY, V94, P392
   Law NW, 1988, CLIN MATER, V3, P95
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   LEWIS RT, 1984, CAN J SURG, V27, P155
   MILLIGAN DW, 1974, BRIT J SURG, V61, P274, DOI 10.1002/bjs.1800610406
   MOLLOY RG, 1991, BRIT J SURG, V78, P242, DOI 10.1002/bjs.1800780237
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   MYHREJENSEN O, 1969, ARCH PATHOL, V88, P623
   PANS A, 1992, EUR SURG RES, V24, P54, DOI 10.1159/000129188
   PORTER J M, 1969, Surgical Forum (Chicago), V20, P80
   ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6
NR 17
TC 54
Z9 54
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
EI 1421-9921
J9 EUR SURG RES
JI Eur. Surg. Res.
PD JAN-FEB
PY 1994
VL 26
IS 1
BP 46
EP 53
DI 10.1159/000129317
PG 8
WC Surgery
SC Surgery
GA MR917
UT WOS:A1994MR91700006
PM 8137846
DA 2018-10-19
ER

PT J
AU AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
AF AMID, PK
   SHULMAN, AG
   LICHTENSTEIN, IL
TI A CRITICAL-EVALUATION OF THE LICHTENSTEIN TENSION-FREE HERNIOPLASTY
SO INTERNATIONAL SURGERY
LA English
DT Article
DE HERNIOPLASTY, TENSION-FREE; HERNIA
AB All standard methods of hernia repair involve suturing together tissues which are not normally in apposition. This violates the basic surgical principle that tissue must never be approximated under tension and accounts for an unacceptable number of failures. Total reinforcement of the inguinal floor with a sheet of suitable biomaterial and employment of a ''tension-free'' technique is a more effective approach. Since June of 1984, 3,250 primary inguinal hernias have been repaired at the Lichtenstein Hernia Institute by the open ''tension-free'' technique using Marlex mesh. The patients were followed rom one to 8 years by physician examination. The follow-up rate was 87%. There were four recurrences. The causes of recurrence and how to avoid them are discussed.
RP AMID, PK (reprint author), LICHTENSTEIN HERNIA INST,9201 SUNSET BLVD,SUITE 505,LOS ANGELES,CA 90069, USA.
RI International Surgery, ICS/D-3993-2011
NR 0
TC 38
Z9 38
U1 0
U2 1
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0020-8868
J9 INT SURG
JI Int. Surg.
PD JAN-MAR
PY 1994
VL 79
IS 1
BP 76
EP 79
PG 4
WC Surgery
SC Surgery
GA NF474
UT WOS:A1994NF47400015
PM 8063561
DA 2018-10-19
ER

PT S
AU ESCHBACH, FO
   HUANG, SJ
AF ESCHBACH, FO
   HUANG, SJ
BE Klempner, D
   Sperling, LH
   Utracki, LA
TI HYDROPHILIC-HYDROPHOBIC INTERPENETRATING POLYMER NETWORKS AND
   SEMIINTERPENETRATING POLYMER NETWORKS
SO INTERPENETRATING POLYMER NETWORKS
SE ADVANCES IN CHEMISTRY SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Interpenetrating Polymer Networks, at the 4th Chemical
   Congress of North America (202nd National Meeting of the
   American-Chemical-Society)
CY AUG 25-30, 1991
CL NEW YORK, NY
SP AMER CHEM SOC, DIV POLYM MAT SCI & ENGN
ID COMPOSITE-MATERIALS; PARTICULATE
AB Poly(2-hydroxyethyl methacrylate) (PHEMA) in the water-swollen state is a very soft hydrogel with high water content. Therefore, it is' similar to natural tissues and is widely used as a biomaterial. Unfortunately, PHEMA hydrogels have low mechanical strength and tear resistance. The incorporation of hydrophobic polycaprolactone (PCL) improves the mechanical properties of the swollen networks and preserves their biocompatibility. Three ways to combine PHEMA and PCL were investigated. Semi-interpenetrating polymer networks of PHEMA and low molecular weight PCL diol were prepared. Interpenetrating polymer networks of PHEMA and high molecular weight PCL were synthesized using two different methods depending upon the relative composition (PHEMA:PCL). Mechanical, thermal, and swelling properties were investigated
RP ESCHBACH, FO (reprint author), UNIV CONNECTICUT,INST MAT SCI,U-136,STORRS,CT 06269, USA.
CR ACIERNO D, 1975, J POLYM SCI POL PHYS, V13, P703, DOI 10.1002/pol.1975.180130404
   ANDRADE AD, 1976, ACS S SERIES, V31
   DAVIS PA, 1988, J BIOACT COMPAT POL, V3, P205
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   DAVIS PA, 1990, THESIS U CONNECTICUT
   GUILD FJ, 1989, J MATER SCI, V24, P2454, DOI 10.1007/BF01174511
   Ilavsky M., 1972, International Journal of Polymeric Materials, V1, P187, DOI 10.1080/00914037208075283
   JARRET PK, 1984, BIOMEDICAL APPLICATI, P181
   JARRET PK, 1983, THESIS U CONNECTICUT
   LEWIS TB, 1970, J APPL POLYM SCI, V14, P1449, DOI 10.1002/app.1970.070140604
   NICOLAIS L, 1975, POLYM ENG SCI, V15, P35, DOI 10.1002/pen.760150106
   NICOLAIS L, 1971, POLYM ENG SCI, V11, P194, DOI 10.1002/pen.760110305
   NIELSEN LE, 1970, J APPL PHYS, V41, P4626, DOI 10.1063/1.1658506
   ODIAN G, 1981, PRINCIPLES POLYM
   Sperling L.H., 1981, INTERPENETRATING POL
   SPERLING LH, 1985, POLYM ENG SCI, V25, P517, DOI 10.1002/pen.760250902
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WUNDERLICH B, 1973, MACROMOLECULAR PHYSI, V3
NR 18
TC 12
Z9 12
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0065-2393
BN 0-8412-2528-1
J9 ADV CHEM SER
PY 1994
VL 239
BP 205
EP 219
PG 15
WC Chemistry, Multidisciplinary; Polymer Science
SC Chemistry; Polymer Science
GA BZ87R
UT WOS:A1994BZ87R00010
DA 2018-10-19
ER

PT J
AU HOW, TV
   MAROIS, Y
   GUIDOIN, R
   BLACK, RA
AF HOW, TV
   MAROIS, Y
   GUIDOIN, R
   BLACK, RA
TI EFFECT OF GEOMETRIC TAPER ON THROMBOSIS IN VASCULAR PROSTHESES - AN
   EX-VIVO STUDY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE STENOSIS; TURBULENCE; HEMODYNAMICS; PLATELETS; FIBRINOGEN; POLYURETHANE
ID ARTERIAL PROSTHESES; FLOW DISTURBANCES; PLATELET DEPOSITION; COMPLIANCE
   MISMATCH; FOREIGN SURFACES; BLOOD-FLOW; GRAFTS; POLYURETHANE;
   TURBULENCE; BABOON
AB A common method of assessing the thrombogenicity of prosthetic arterial grafts is to determine the amount of platelets and fibrin that accumulates on their surfaces. This study was designed to compare thrombus formation in cylindrical and tapered vascular grafts (angle of taper 0.5 deg) made from the same biomaterial. Turbulence was generated upstream of the grafts by means of a 75% axi-symmetric stenosis. In general, turbulence is dissipated by the effect of blood viscosity, whereas in a tapered graft, there is an additional reduction in the intensity of turbulence owing to the effect of converging flow through the taper. The aim of this study was to assess the effect of turbulence on thrombus formation in cylindrical and tapered grafts. After blood had circulated for 2 and 4 h through the cylindrical and tapered grafts, which formed part of two parallel ex vivo circuits, platelet deposition and fibrinogen uptake were measured by means of a radioisotope technique. Although the flow disturbances were less in the tapered grafts, no significant difference in platelet and fibrin deposition in the two types of graft was observed at 2 h. For the longer perfusion time, however, increased platelet and fibrin activity was recorded in the annular vortex region in the tapered grafts. In general, neither platelets nor fibrin accumulated in areas of high turbulence intensity.
C1 UNIV LAVAL, DEPT SURG, QUEBEC CITY G1K 7P4, QUEBEC, CANADA.
   ST FRANCIS ASSISI HOSP, INST BIOMAT, QUEBEC CITY G1K 7P4, PQ, CANADA.
RP HOW, TV (reprint author), UNIV LIVERPOOL, DEPT CLIN ENGN, POB 147, LIVERPOOL L69 3BX, ENGLAND.
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Annis D, 1978, Trans Am Soc Artif Intern Organs, V24, P209
   BADIMON L, 1987, ANN NY ACAD SCI, V516, P527
   BANDYK DF, 1983, ULTRASOUND MED BIOL, V9, P79, DOI 10.1016/0301-5629(83)90112-6
   BLACK RA, 1989, J BIOMECH ENG-T ASME, V111, P303, DOI 10.1115/1.3168383
   BLACK RA, 1992, CLIN HEMORHEOL, V12, P45
   BRAIS MP, 1974, ARCH SURG-CHICAGO, V109, P351
   CALLOW AD, 1982, SURG CLIN N AM, V62, P501
   CHARLESWORTH D, 1980, RECENT ADV SURGERY, P93
   CHRISTENSON JT, 1981, T AM SOC ART INT ORG, V27, P188
   CRAWSHAW HM, 1980, ARCH SURG-CHICAGO, V115, P1280
   ELDRUPJORGENSEN J, 1985, AM J SURG, V150, P185, DOI 10.1016/0002-9610(85)90116-3
   ESQUIVEL CO, 1986, J SURG RES, V41, P1, DOI 10.1016/0022-4804(86)90002-8
   FRIEDMAN LI, 1970, T AM SOC ART INT ORG, V16, P63
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   HANSON SR, 1987, ANN NY ACAD SCI, V516, P653, DOI 10.1111/j.1749-6632.1987.tb33082.x
   HASHIMOTO S, 1985, ARTIF ORGANS, V9, P345, DOI 10.1111/j.1525-1594.1985.tb04399.x
   KARINO T, 1977, PHILOS T ROY SOC B, V279, P413, DOI 10.1098/rstb.1977.0095
   KARINO T, 1984, BIORHEOLOGY, V21, P587
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   KOWLIGI RR, 1991, HIGH PERFORMANCE BIO, P425
   LANNERSTAD O, 1986, ACTA CHIR SCAND, V152, P187
   LEIDNER J, 1983, J BIOMED MATER RES, V17, P229, DOI 10.1002/jbm.820170203
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   LYMAN DJ, 1977, T AM SOC ART INT ORG, V23, P253
   MERHI Y, 1988, CLIN INVEST MED, V11, P403
   MIYAWAKI F, 1990, MED BIOL ENG COMPUT, V28, P457, DOI 10.1007/BF02441969
   MORINAGA K, 1985, J VASC SURG, V2, P430, DOI 10.1067/mva.1985.avs0020430
   SAUVAGE LR, 1979, ARCH SURG-CHICAGO, V114, P687
   SMITH RL, 1972, J APPL PHYSIOL, V32, P261
   STEIN PD, 1974, CIRC RES, V35, P608, DOI 10.1161/01.RES.35.4.608
   TEIJEIRA FJ, 1989, BIOMATERIALS, V10, P80, DOI 10.1016/0142-9612(89)90035-5
NR 33
TC 3
Z9 3
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 2
BP 111
EP 122
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA NZ392
UT WOS:A1994NZ39200001
PM 7947477
DA 2018-10-19
ER

PT J
AU LABOW, RS
   DUGUAY, DG
   SANTERRE, JP
AF LABOW, RS
   DUGUAY, DG
   SANTERRE, JP
TI THE ENZYMATIC-HYDROLYSIS OF A SYNTHETIC BIOMEMBRANE - A NEW SUBSTRATE
   FOR CHOLESTEROL AND CARBOXYL ESTERASES
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOMEMBRANE; BIOMATERIAL; ESTERASE; HYDROLYSIS; SERINE ESTERASE
   INHIBITOR
ID DEGRADATION; POLYURETHANES; HYDROLASE; INVITRO
AB With the introduction of artificial implant devices, a new host of biomembrane-like structures have been introduced into the bio-media made up of the synthetic matrix, adsorbed proteins and lipids. Lysosomal hydrolases, e.g. cholesterol esterase (CE), are implicated during the tissue response near the tissue-implant interface. The enzymatic attack on a radiolabelled 'hybrid biomembrane', a polyester-urethane (PUU-CAP), was investigated using two esterases. Membrane stability was monitored by release of radiolabelled molecules. Although some radioactivity was released by buffer controls, upon the addition of CE, a burst of radiolabel release occurred which was due to an enzymatic reaction that could be saturated and inhibited by the specific esterase inhibitor, phenylmethylsulfonylfluoride. Carboxyl esterase (CXE) incubation with PUU-CAP caused less radiolabel release than CE which was similar to the latter's activity when common nitrophenyl ester substrates were used. When a factorial analysis was performed, it was found that side chain length for the common substrates was twice more important for CE, than CXE activity. This would suggest that CE activity is greater for substrates which have spacer segments between potential ester-carbonyl cleavage sites and the rigid ring structure.
C1 UNIV OTTAWA,DEPT CHEM ENGN,OTTAWA K1N 6N5,ONTARIO,CANADA.
RP LABOW, RS (reprint author), UNIV OTTAWA,INST HEART,DIV CARDIOVASC DEVICES,OTTAWA K1N 6N5,ONTARIO,CANADA.
CR BRETSCHER MS, 1973, SCIENCE, V181, P622, DOI 10.1126/science.181.4100.622
   ERFLE D, 1993, 19TH P ANN M SOC BIO, P136
   GRIESSER HJ, 1991, POLYM DEGRAD STABIL, V33, P329, DOI 10.1016/0141-3910(91)90080-B
   GRIESSER HJ, 1990, POLYM MATER SCI ENG, V62, P828
   GUY O, 1981, EUR J BIOCHEM, V117, P457
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   LEALAH MD, 1986, POLYURETHANES MED
   LUNDBERG BB, 1990, BIOCHIM BIOPHYS ACTA, V1042, P301, DOI 10.1016/0005-2760(90)90157-S
   LYNN KR, 1982, BIOORG CHEM, V11, P19, DOI 10.1016/0045-2068(82)90044-X
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P1003, DOI 10.1002/jbm.820260804
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   SANTERRE JP, 1992, P WORLD BIOMATERIALS, P203
   SHARMA CP, 1991, BLOOD COMPATIBLE MAT, P1
   SUTTON LD, 1990, BIOCHIM BIOPHYS ACTA, V1041, P79, DOI 10.1016/0167-4838(90)90125-Y
   TANZI MC, 1991, CLIN MATER, V57
   TYLER BJ, 1993, J BIOMED MATER RES, V27, P327, DOI 10.1002/jbm.820270306
   WILLIAMS DF, 1987, BLOOD COMPATIBILITY, V1
   WIRTZ KWA, 1974, BIOCHIM BIOPHYS ACTA, V344, P95, DOI 10.1016/0304-4157(74)90001-X
   ZAHALKA HA, 1987, BIOCHIM BIOPHYS ACTA, V921, P481, DOI 10.1016/0005-2760(87)90075-0
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
NR 23
TC 52
Z9 52
U1 1
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 2
BP 169
EP 179
DI 10.1163/156856294X00293
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA NZ392
UT WOS:A1994NZ39200006
PM 7947482
DA 2018-10-19
ER

PT J
AU PINCHUK, L
AF PINCHUK, L
TI A REVIEW OF THE BIOSTABILITY AND CARCINOGENICITY OF POLYURETHANES IN
   MEDICINE AND THE NEW-GENERATION OF BIOSTABLE POLYURETHANES
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE BIOMATERIAL; POLYURETHANE; BIOSTABLE; BIODEGRADATION; CARCINOGENICITY;
   REVIEW; POLYCARBONATE URETHANE; PACER LEAD
ID POLY(ETHER URETHANE UREA); LEAD INSULATION; MECHANICAL-PROPERTIES;
   SEGMENT CHEMISTRY; COATED PROSTHESES; HARD SEGMENT; MEME IMPLANT; PACING
   LEADS; CAST BIOMER; INVIVO
AB Polyurethanes are very versatile materials which have been used in the body for over 20 years. In fact, there are probably more scientific papers describing these materials and modifications of these materials for medical use than any other material to dale. Unfortunately, some formulations of these polymers are subject to biodegradation and have limited their application in the body. Extensive investigation of the biodegradation mechanisms of these polymers by many researchers in the field has led to the development of a new generation of what are now called 'biostable' polyurethanes. This article reviews the history of polyurethane in medicine, polyurethane nomenclature, the biodegradation of these materials, the proposed mechanisms of its degradation as well as the carcinogenicity associated with these materials. Included in the discussion are the polyurethanes used as pacemaker lead insulators as well as those used to coat breast implants. The article concludes with a review of the new generation of 'biostable' polyurethanes and their proposed formulations.
RP PINCHUK, L (reprint author), CORVITA CORP,8210 NW 27TH ST,MIAMI,FL 33122, USA.
CR AMIN P, 1993, J BIOMED MATER RES, V27, P655, DOI 10.1002/jbm.820270513
   ANDERSON JM, 1992, BIODEGRADABLE POLYM, P122
   ANGELINE BD, 1990, DEGRADABLE MATERIALS, P295
   APPLE DJ, 1984, AM INTRA-OCUL IMPL J, V10, P53
   AUTIAN J, 1975, CANCER RES, V35, P1591
   BATES RR, 1966, J NATL CANCER I, V37, P145
   BATICH C, 1989, J BIOMED MATER RES-A, V23, P311, DOI 10.1002/jbm.820231406
   BATICH C, 1992, J LONG-TERM EFF MED, V1, P255
   BEYERSDORF F, 1986, CLIN PROG ELECTROPHY, V4, P199
   Blais P., 1990, J APPL BIOMATER, V1, P197
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BRAND KG, 1988, CLIN PLAST SURG, V15, P533
   BRAND KG, 1980, PLAST RECONSTR SURG, V66, P591, DOI 10.1097/00006534-198010000-00015
   BRAND KG, 1973, J NATL CANCER I, V51, P1071, DOI 10.1093/jnci/51.3.1071
   BRANDWOOD A, 1992, C P DEGRADATION PHEN, P59
   BRODY GS, 1984, PLAST RECONSTR SURG, V73, P420
   BRUCK SD, 1992, LONG TERM EFFECTS ME, V1, P357
   BYRD CL, 1987, POLYURETHANES BIOMED, V2, P65
   CHAN SC, 1991, CLIN CHEM, V37, P756
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   COUREY AJ, 1984, 2ND P WORLD C BIOM 1, P252
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1992, 4TH P WORLD BIOM C B, P661
   COURY AJ, 1990, 16TH T ANN M SOC BIO, P158
   DAKA JN, 1993, BIOMAT ARTIF CELL IM, V21, P23, DOI 10.3109/10731199309118294
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P4453
   DEACON J, 1985, 11TH P ANN M SOC BIO, P205
   DILLON JG, 1992, BIOMATERIALS, V13, P240, DOI 10.1016/0142-9612(92)90191-P
   DOLEZEL B, 1989, BIOMATERIALS, V10, P96, DOI 10.1016/0142-9612(89)90039-2
   DUGUAY DG, 1993, 19TH T M SOC BIOM, P313
   DUGUAY DG, 1992, 13TH P ANN C CAN BIO, P7
   DUNAIF CB, 1963, SURG GYNECOL OBSTET, V117, P454
   EKMAN L, 1992, REGULATORY AFFAIRS, P191
   ERFLE D, 1993, 19TH P ANN M SOC BIO, P136
   ERFLE D, 1992, 13TH P ANN C CAN BIO, P46
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   GLASMACHERSEILER B, 1992, J LONG-TERM EFF MED, V2, P113
   GOLDBERG EP, 1985, 11TH P ANN M SOC BIO, P208
   GUNATILLAKE PA, 1992, J APPL POLYM SCI, V46, P319, DOI 10.1002/app.1992.070460213
   GUNATILLAKE PA, 1993, 19TH T ANN M SOC BIO, P55
   HAN DK, 1993, J BIOMED MATER RES, V27, P1063, DOI 10.1002/jbm.820270812
   HAYES DL, 1991, PACE, V14, P694
   HEDDLE JA, 1991, MUTAT RES, V247, P221, DOI 10.1016/0027-5107(91)90018-J
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HERGENROTHER RW, 1992, J APPL BIOMATER, V3, P17, DOI 10.1002/jab.770030104
   HERMAN S, 1984, PLAST RECONSTR SURG, V73, P411, DOI 10.1097/00006534-198403000-00012
   HUEPER WC, 1964, JNCI-J NATL CANCER I, V33, P1005
   HUGHES K, 1984, PB85171619
   HUM LL, 1990, J APPL BIOMATER, V1, P193
   IMAI Y, 1993, BIOMEDICAL APPLICATI, P53
   KOSSOVSKY N, 1992, J APPL BIOMATER, V3, P239, DOI 10.1002/jab.770030313
   LEIDNER J, 1983, J BIOMED MATER RES, V17, P229, DOI 10.1002/jbm.820170203
   Lelah M. D., 1986, POLYURETHANES MED
   LEMM W, 1984, POLYURETHANES BIOMED, P103
   LOVELL DP, 1989, MUTAT RES, V213, P43, DOI 10.1016/0027-5107(89)90031-6
   LUBIN M, 1986, PACE, V9, P1154, DOI 10.1111/j.1540-8159.1986.tb06686.x
   MACGREGOR DC, 1991, PACE, V14, P694
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P799, DOI 10.1002/jbm.820200611
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MCMILLIN CR, 1988, ELASTOMETRICS    NOV, P22
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MORRISON RT, 1972, ORGANIC CHEM, P124
   MUGICA J, 1992, PACE, V15, P1967, DOI 10.1111/j.1540-8159.1992.tb03003.x
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   NORTHDURFT H, 1960, 3 ABH DTSCH AKAD W M, P80
   NUNN DB, 1990, J VASC SURG, V12, P291, DOI 10.1067/mva.1990.22556
   OPPENHEIMER BS, 1955, CANCER RES, V15, P333
   OPPENHEIMER E, 1961, CANCER RES, V21, P132
   PANDE GS, 1983, PACE, V6, P858
   Pangman W.J., 1958, US Patent, Patent No. 2842775
   PANGMAN WJ, 1965, Patent No. 3189921
   PANGMAN WJ, 1971, Patent No. 3559214
   PARINS DJ, 1981, CPI4511281 CARD PAC
   PARINS DJ, 1985, ASTM STP, V859, P322
   PHILLIPS R, 1986, PACE, V9, P1166, DOI 10.1111/j.1540-8159.1986.tb06688.x
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   Pinchuk L, 1988, J Biomater Appl, V3, P260, DOI 10.1177/088532828800300206
   Pinchuk L, 1989, US Patent, Patent No. [4,882,148, 4882148]
   PINCHUK L, 1993, 19TH T ANN M SOC BIO, P22
   Pinchuk L., 1993, U. S. patent, Patent No. [5, 229 , 431 -A, 5229431]
   PINCHUK L, 1991, 17TH T ANN M SOC BIO, P98
   PINCHUK L, 1992, Patent No. 5147725
   PINCHUK L, 1989, Patent No. 4851009
   PINCHUK L, 1989, Patent No. 4810749
   PINCHUK L, 1993, 19TH T ANN M SOC BIO, P233
   Pinchuk L., 1992, US Patent, Patent No. [5,133,742, 5133742]
   RATNER BD, 1984, POLYURETHANES BIOMED, P41
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SCHOEN FJ, 1993, BIOMATERIALS SCI INT
   Sittig M., 1981, HDB TOXIC HAZARDOUS
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   STOKES K, 1988, J BIOMATER APPL, V3, P248
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES KB, 1986, PACE, V9, P1160, DOI 10.1111/j.1540-8159.1986.tb06687.x
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Szycher M, 1992, Med Device Technol, V3, P42
   Szycher M, 1991, J Biomater Appl, V5, P282, DOI 10.1177/088532829100500403
   SZYCHER M, 1988, J BIOMATER APPL, V3, P383
   Szycher M., 1991, BLOOD COMPATIBLE MAT, P33
   SZYCHER M, 1985, ASTM STP, V859, P308
   SZYCHER M, 1983, J ELAST PLAST, V5, P81
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TAKAHARA A, 1985, J BIOMED MATER RES, V19, P13, DOI 10.1002/jbm.820190104
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P342
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   TILTON NH, 1993, SUM GORD C
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   TYLER BJ, IN PRESS J BIOMED MA
   TYLER BJ, 1993, APPL SPECTROSC, V27, P327
   TYLER BJ, IN PRESS J BIOMAT SC
   VONDRACEK P, 1984, BIOMATERIALS, V5, P209, DOI 10.1016/0142-9612(84)90017-6
   WABERS HD, 1992, J BIOMAT SCI-POLYM E, V4, P107
   WHITE KA, 1985, 11TH T ANN M SOC BIO, P57
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZAIKOV GE, 1985, REV MACROMOL CHEM C, V25, P551
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   1991, CAN MED ASSOC J, V145, P1125
   1992, CANADIAN MED ASS J, V147, P1141
   1986, CORDIS CORPORATION P
   1989 90 COMM CARC DE
NR 132
TC 179
Z9 187
U1 4
U2 70
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 3
BP 225
EP 267
DI 10.1163/156856294X00347
PG 43
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA PB976
UT WOS:A1994PB97600001
PM 7986779
DA 2018-10-19
ER

PT J
AU PATHAK, CP
   SAWHNEY, AS
   QUINN, CP
   HUBBELL, JA
AF PATHAK, CP
   SAWHNEY, AS
   QUINN, CP
   HUBBELL, JA
TI POLYIMIDE POLYETHYLENE-GLYCOL BLOCK-COPOLYMERS - SYNTHESIS,
   CHARACTERIZATION, AND INITIAL EVALUATION AS A BIOMATERIAL
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE POLYIMIDE; POLY(ETHYLENE GLYCOL); COPOLYMER; BIOCOMPATIBILITY
ID DEGRADATION; INVITRO; OXIDE
AB Block copolyimides with varying amounts of polyethylene glycol (PEG) were synthesized and characterized by copolymerization of diaminodiphenyl ether (DDE), amino terminated PEG, and benzophenone tetracarboxylic acid dianhydride (BTDA). Strong materials were obtained, with enhanced flexibility as compared to the parent DDE-BTDA polyimide homopolymer. Incorporation of PEG led to an increase in water absorption by these copolymers, and hydrophilicity was increased as reflected by a decrease in air-water-polymer contact angle. These materials supported less cell adhesion in vitro than the parent polyimide homopolymer. Short term in vivo evaluation of these copolymers showed reduced fibrous encapsulation than was observed in the absence of PEG.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
FU NHLBI NIH HHS [HL-39714]
CR BATICH C, 1989, J BIOMED MATER RES-A, V23, P311, DOI 10.1002/jbm.820231406
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   DILLON JG, 1992, BIOMATERIALS, V13, P240, DOI 10.1016/0142-9612(92)90191-P
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   HAGGERTY HS, 1989, ACTA OTO-LARYNGOL, V107, P13, DOI 10.3109/00016488909127474
   Kajiyama T, 1991, J Biomater Appl, V6, P42, DOI 10.1177/088532829100600103
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   MORITA WH, 1981, P NATL SAMPLE S EXHI, V26, P402
   MUKAI K, 1978, IEEE J SOLID-ST CIRC, V13, P462, DOI 10.1109/JSSC.1978.1051077
   NAGOAKA S, 1984, POLYM BIOMATERIALS, P361
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V
   Schollenberger C. S., 1971, J ELASTOPLAST, V3, P28, DOI DOI 10.1177/009524437100300103
   YU XH, 1992, J APPL POLYM SCI, V44, P409, DOI 10.1002/app.1992.070440305
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 20
TC 12
Z9 12
U1 1
U2 8
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 4
BP 313
EP 323
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA PJ422
UT WOS:A1994PJ42200001
PM 7841141
DA 2018-10-19
ER

PT J
AU GROTH, T
   KLOSZ, K
   CAMPBELL, EJ
   NEW, RRC
   HALL, B
   GOERING, H
AF GROTH, T
   KLOSZ, K
   CAMPBELL, EJ
   NEW, RRC
   HALL, B
   GOERING, H
TI PROTEIN ADSORPTION, LYMPHOCYTE ADHESION AND PLATELET-ADHESION ACTIVATION
   ON POLYURETHANE UREAS IS RELATED TO HARD SEGMENT CONTENT AND COMPOSITION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE POLYURETHANE UREAS; PHYSIOCHEMICAL PROPERTIES; BLOOD CELL ADHESION;
   ENZYME IMMUNE ASSAYS; PROTEIN ADSORPTION; PLATELET ACTIVATION
ID PLASMA-PROTEINS; SURFACES; BLOOD; DERIVATIVES; ACTIVATION
AB Segmented polyurethane ureas with different hard segment content and composition were synthesized using 4,4'-diphenylmethane diisocyanate and polytetramethylene glycols. Using polyols with different molecular weights, it was possible to synthesize polyurethane ureas with either: (i) a constant ratio of urethane to urea bonds; (ii) a constant urethane content; or (iii) a constant urea content. Bulk properties were assessed by dynamic mechanical analysis. Surface properties were estimated by contact angle measurements and streaming potential measurements. Haemocompatibility was evaluated in vitro by measuring the adsorption of human serum albumin (HSA) and fibrinogen (Fg), the adhesion of human peripheral blood lymphocytes (PBL), and the presence of activated platelets on the biomaterial surfaces. Enzyme immune assays (EIA) have been specially developed for this purpose for the detection of antibody-recognizable plasma proteins and platelet surface membrane proteins. No simple correlation between chemical structure of the polymers and surface properties was found. Parameters of haemocompatibility correlated more closely with hard segment content and chemical composition than with the surface characteristics of the polymers. Adsorption of plasma proteins, adhesion of lymphocytes and the adhesion/activation of platelets were found to increase with increasing hard segment content of the polyurethane ureas. However, the monoclonal-antibody recognisable fibrinogen and the platelet activation were nearly constant with increasing hard segment content, if the urea content was kept constant.
C1 WIP, D-12489 BERLIN, GERMANY.
   ZMC, KAI E V, D-12489 BERLIN, GERMANY.
   BIOCOMPATIBLES LTD, UXBRIDGE UB8 3PQ, MIDDX, ENGLAND.
RP GROTH, T (reprint author), HUMBOLDT UNIV BERLIN, SCH MED CHARITE, BIOMAT RES UNIT, TUCHOLSKYSTR 2, D-10098 BERLIN, GERMANY.
OI Hall, Belinda/0000-0002-3753-1978; Groth, Thomas/0000-0001-6647-9657
CR ALTANKON G, 1990, DOKL BOLG AKAD NAUK, V43, P107
   ALTANKOV G, 1989, HAEMATOLOGIA, V22, P115
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARBUCCI R, 1992, Clinical Materials, V11, P37, DOI 10.1016/0267-6605(92)90028-R
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   CAMPBELL EJ, 1992, MATER RES SOC SYMP P, V252, P229
   DACOSTA VS, 1981, J COLLOID INTERF SCI, V80, P445
   DACOSTA VS, 1980, J COLLOID INTERF SCI, V76, P594
   DIETERICH D, 1987, POLYURETHANE METHO E, V20, P1561
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GROTH T, 1992, REFERENCE MATERIALS
   HAVERSTICK DM, 1985, BLOOD, V66, P946
   HYNES RO, 1991, THROMB HAEMOSTASIS, V66, P40
   ITO Y, 1986, J BIOMED MATER RES, V20, P1139, DOI 10.1002/jbm.820200807
   LINDON JN, 1986, BLOOD, V68, P355
   LIU S Q, 1989, Journal of Biomaterials Science Polymer Edition, V1, P111
   MERRILL EW, 1987, ANN NY ACAD SCI, V516, P196, DOI 10.1111/j.1749-6632.1987.tb33041.x
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   Rabel W., 1971, FARBE LACK, V77, P997
   SALZMAN EW, 1987, ANN NY ACAD SCI, V516, P184, DOI 10.1111/j.1749-6632.1987.tb33040.x
   SANADA T, 1986, J BIOMED MATER RES, V20, P1179, DOI 10.1002/jbm.820200809
   SRINIVASAN K, 1991, CLIN MATER, V7, P27
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   WOLF H, 1988, ADV BIOMEDICAL MEASU, P411
NR 25
TC 31
Z9 31
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 6
BP 497
EP 510
DI 10.1163/156856294X00464
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA PN439
UT WOS:A1994PN43900001
PM 7873505
DA 2018-10-19
ER

PT J
AU NIMERI, G
   AUGUSTINSSON, A
   LASSEN, B
   STENDAHL, O
   OHMAN, L
   ELWING, H
AF NIMERI, G
   AUGUSTINSSON, A
   LASSEN, B
   STENDAHL, O
   OHMAN, L
   ELWING, H
TI THE CHEMILUMINESCENCE RESPONSE OF NEUTROPHILS ON POLYMER SURFACES MADE
   BY GLOW-DISCHARGE PLASMA POLYMERIZATION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PROTEIN ADSORPTION; NEUTROPHIL ACTIVATION; CHEMILUMINESCENCE RESPONSE;
   POLYMER SURFACES
ID INFLAMMATORY RESPONSES; CHEMI-LUMINESCENCE; RESPIRATORY BURST;
   BIOMATERIALS
AB Polypropylene tubes were coated with different polymers made by glow discharge plasma polymerization. Isolated human blood neutrophils were allowed to interact with the polymer surface and the chemiluminescence response of the cells was recorded as a measure of oxidative activation. The polymers represented surfaces that differed markedly with respect to charge, hardness, and wettability. We found that all polymers stimulated the chemiluminescence response in neutrophils differently; when preincubation with human serum albumin (HSA) there was a general reduction of the chemiluminescence response particularly on one of the positively charged surface 1, 2-diamino-cyclohexane (DACH). Addition of a soluble stimulus, the chemoattractant formylmethionyl-leucylphenylalanine (FMLP), to the cells caused a dramatic increase in the response on one of the hydrophobic surface hexamethylene-isiloxane (HMDSO). However, there was also a pronounced reduction in the response on polymers with acrylic acid (AA). The response was normalized after addition of HSA. Taken together, the chemiluminescene response of the neutrophils interacting with the polymer surfaces differed with regard to the type of surfaces. When HSA and FMLP were added a larger difference in the response was found. Our results showed that the activation of human neutrophil granulocytes influenced by different polymer surfaces, followed unspecific different patterns which were someway related to the specific characteristics of the polymer and from this point we came to similar conclusions made by Kaplan et al. (J. Biomater. Res. 28, 377 (1994)), that it is difficult to extrapolate any activation mechanisms from one material to another. The reproducibility of the reaction patterns, the importance of neutrophil activation, and the relative simplicity of the method indicates, however, that the mechanisms of neutrophil activation at biomaterial surface is well worth further research.
C1 LINKOPING UNIV,DEPT MICROBIOL IMMUNOL & INFECT DIS,LINKOPING,SWEDEN.
   INST SURFACE CHEM,S-11486 STOCKHOLM,SWEDEN.
RP NIMERI, G (reprint author), LINKOPING UNIV,DEPT PHYS & MEASUREMENT TECHNOL,APPL PHYS LAB,INTERFACE BIOL GRP,S-58183 LINKOPING,SWEDEN.
CR ALLRED CD, 1980, BIOCHIM BIOPHYS ACTA, V631, P380, DOI 10.1016/0304-4165(80)90311-6
   ALLRED CD, 1978, INFECT IMMUN, V19, P833
   AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P735
   BATTJES KP, 1992, SILANES OTHER COUPLI, P199
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77
   BURNS NL, UNPUB
   CHO DL, 1990, J APPL POLYM SCI, V41, P1373, DOI 10.1002/app.1990.070410702
   CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140
   DAHLGREN C, 1982, INT ARCH ALLER A IMM, V68, P79, DOI 10.1159/000233070
   DAHLGREN C, 1982, INFECT IMMUN, V37, P34
   DAHLGREN C, 1983, IMMUNOLOGY, V49, P329
   DECHATELET LR, 1982, J IMMUNOL, V129, P1589
   GASIC GJ, 1968, LAB INVEST, V18, P63
   GOLANDER CG, 1993, J APPL POLYM SCI, V49, P39, DOI 10.1002/app.1993.070490106
   HATCH GE, 1978, J EXP MED, V147, P182, DOI 10.1084/jem.147.1.182
   HURST NP, 1980, ANN RHEUM DIS, V42, P265
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   McCord J M, 1978, Ciba Found Symp, P343
   MERISHI JN, 1972, PROG BIOPHYS MOL BIO, V25, P1
   NIMERI G, IN PRESS J BIOMATER
   REMES A, 1992, Clinical Materials, V9, P71, DOI 10.1016/0267-6605(92)90051-T
   SEVASTIANOV VI, 1988, J BIOMED MATER RES, V11, P23
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   VANEPPS DE, 1980, J CLIN INVEST, V66, P167, DOI 10.1172/JCI109841
   WILLIAMS AJ, 1981, IMMUNOLOGY, V43, P733
NR 28
TC 4
Z9 4
U1 0
U2 3
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 6
IS 8
BP 741
EP 749
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA PZ679
UT WOS:A1994PZ67900006
PM 7703189
DA 2018-10-19
ER

PT J
AU NOHR, RS
   MACDONALD, JG
AF NOHR, RS
   MACDONALD, JG
TI NEW BIOMATERIALS THROUGH SURFACE SEGREGATION PHENOMENON - NEW QUATERNARY
   AMMONIUM-COMPOUNDS AS ANTIBACTERIAL AGENTS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE ANTIMICROBIAL COMPOUNDS; SURFACE SEGREGATION; POLYDIMETHYLSILOXANE;
   QUATERNARY AMMONIUM COMPOUNDS; POLYPROPYLENE NONWOVENS
AB Five new trisiloxane quaternary ammonium compounds were synthesized from hydrotrisiloxane with allyl glycidyl ether to yield the epoxy function. Various amines were then reacted to yield trisiloxane amines which were further reacted to methyl substitute or oxidize the beta-carbons in order to provide thermal stability. These new compounds were employed as melt additives in a nonwoven polypropylene fiber extrusion process to produce, through surface segregation, a new biomaterial with antibacterial properties.
RP NOHR, RS (reprint author), KIMBERLY CLARK INC,1400 HOLCOMB BRIDGE RD,ROSWELL,GA 30076, USA.
CR APPEL DW, 1982, Patent No. 4360563
   BENTLEY TW, 1973, ELUCIDATION ORGANI 2, P255
   BOLKO VP, 1978, ZH PRIKL KHIM, V51, P2362
   BROWN DS, 1987, EUR POLYM J, V23, P463, DOI 10.1016/0014-3057(87)90137-6
   CHALK AJ, 1965, J AM CHEM SOC, V87, P6
   Cope AC, 1960, ORG REACTIONS, V11, P317
   DAWKINS JV, 1979, MAKROMOL CHEM, V180, P1737
   GALIN M, 1981, MACROMOLECULES, V14, P677, DOI 10.1021/ma50004a043
   GENDEL SM, 1989, APPL MICROBIOL BIOT, V31, P138, DOI 10.1007/BF00262451
   KENDRICK TC, 1967, J COLLOID INTERF SCI, V24, P135, DOI 10.1016/0021-9797(67)90210-X
   LUKEVICS E, 1977, RUSS CHEM REV, V46, P264
   MACDONALD JG, 1989, Patent No. 4879232
   MACDONALD JG, 1990, Patent No. 4950601
   Margida A.J., 1990, US patent, Patent No. 4895964
   MAYCOCK WE, 1989, Patent No. 4859759
   MCGRATH JE, 1979, POLYM PREPR AM CHEM, V20, P528
   MEISTERS A, 1972, J CHEM SOC CHEM COMM, P595, DOI 10.1039/c39720000595
   Nester E.W., 1978, MICROBIOLOGY
   NOHR RS, 1991, Patent No. 5057262
   NOHR RS, Patent No. 5120888
   NOHR RS, 1990, Patent No. 4923914
   Pappas S. P., 1992, RAD CURING SCI TECHN, P1
   RIFFLE JS, 1983, ACS S SER, V221
   ROBISON RA, 1988, APPL ENVIRON MICROB, V54, P158
   1988, FISHER SURFACE TENSI
NR 25
TC 67
Z9 67
U1 1
U2 11
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1994
VL 5
IS 6
BP 607
EP 619
DI 10.1163/156856294X00239
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA NW111
UT WOS:A1994NW11100007
PM 8086386
DA 2018-10-19
ER

PT J
AU BEAN, TA
   ZHUANG, WC
   TONG, PY
   EICK, JD
   YOURTEE, DM
AF BEAN, TA
   ZHUANG, WC
   TONG, PY
   EICK, JD
   YOURTEE, DM
TI EFFECT OF ESTERASE ON METHACRYLATES AND METHACRYLATE POLYMERS IN AN
   ENZYME SIMULATOR FOR BIODURABILITY AND BIOCOMPATIBILITY TESTING
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COMPOSITE RESINS; DEGRADATION
AB Current in vitro biocompatibility methods do not evaluate the degradation of biomaterials after contact with enzymes that might be present in the oral or systemic environment. In this study, two methods of in vitro enzyme degradation and a method for the separation of the degradative products by high performance thin-layer chromatography (HPTLC) are reported. In the first method two dental adhesives, Scotchbond and Scotchbond II, and two dental composites, Heliomolar and P-50, were evaluated. These materials were incubated with four different enzymatic preparations for periods of up to 72 h. The enzymes were Lipase, esterase, and Liver enzyme extracts from both mouse and rat. Chloroform soluble products extracted from the aqueous phase were examined by HPTLC for decomposition products resulting from enzyme activity. The second method was similar, but analyzed the aqueous fraction directly without chloroform extraction. In this method five dental restorative materials, P-50, P-30, Scotchbond II, Silux, and Silux plus, were incubated with a nonspecific porcine liver esterase. In addition to the polymerized biomaterials, monomers containing methacrylic acid units were also hydrolyzed with esterase and analyzed by ion chromatography to establish the sensitivity of the enzyme simulator. Each biomaterial presented thin-layer zones not present before enzymatic action. These experiments provide support that aqueous enzymatic action may facilitate the hydrolytic weakening of polymeric biomaterials. (C) 1994 John Wiley and Sons, Inc.
C1 UNIV MISSOURI,SCH PHARM,KANSAS CITY,MO 64108.
   UNIV MISSOURI,SCH DENT,KANSAS CITY,MO 64108.
FU NIDCR NIH HHS [DE09696]
CR ATLAS WF, 1979, ECOTOX ENVIRON SAFE, V3, P401
   BEAN T, 1990, J DENT RES, V69, P229
   Bean T., 1993, Journal of Dental Research, V72, P220
   BEAN T, 1992, J DENT RES, V71, P1369
   FERRACANE JL, 1985, J DENT RES, V64, P1332, DOI 10.1177/00220345850640111701
   FERRACANE JL, 1984, J DENT RES, V63, P1093, DOI 10.1177/00220345840630081901
   FREDERICKS HE, 1981, AM J ORTHOD DENTOFAC, V80, P316, DOI 10.1016/0002-9416(81)90293-1
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   ORSTAVIK D, 1983, J DENT RES, V62, P665
   ROULET JF, 1987, DEGRADATION DENT BAS, P193
   SIEBERT G, 1988, ENZYMATIC ATTACK MET
   VANGROENINGEN G, 1986, DENT MATER, V2, P225, DOI 10.1016/S0109-5641(86)80018-5
   VANKERCKHOVEN H, 1982, J DENT RES, V61, P791, DOI 10.1177/00220345820610062801
NR 14
TC 49
Z9 49
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1994
VL 28
IS 1
BP 59
EP 63
DI 10.1002/jbm.820280108
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MM133
UT WOS:A1994MM13300007
PM 8126029
DA 2018-10-19
ER

PT J
AU SPIRA, M
   LIU, BC
   XU, ZL
   HARRELL, R
   CHAHADEH, H
AF SPIRA, M
   LIU, BC
   XU, ZL
   HARRELL, R
   CHAHADEH, H
TI HUMAN AMNION COLLAGEN FOR SOFT-TISSUE AUGMENTATION - BIOCHEMICAL
   CHARACTERIZATIONS AND ANIMAL OBSERVATIONS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INJECTABLE HUMAN AMNION; BOVINE COLLAGEN; IMMUNE-RESPONSE; INACTIVATION;
   ZYDERM; VIRUS; IMPLANTATION; INJECTIONS; PROTEINS; SITE
AB As bovine collagen is currently being scrutinized as to its immunogenicity in clinical use, a human source collagen, human amnion collagen (HAC), has been developed in our laboratory as an injectable biomaterial for soft tissue augmentation. Pepsin-extracted human amnion collagen was highly purified and reconstituted. Gamma irradiation was employed to ensure complete sterility and to produce cross-Linking in collagen chains to improve implant persistence without the use of chemical additives. The purity and characteristics of human amnion collagen were proven by amino acid assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immune blotting, and collagenase digestion. Animal studies comparing both irradiated and nonirradiated amnion collagen to bovine collagen (Zyderm(R) and Zyplast(R)) were carried out in a rat model. Humoral immunity was evaluated by examining the sera for antibody reactivity towards the implanted human collagen by the ELISA test. Insignificant antibody levels against human amnion collagen were found. Animal observation revealed fibroplasia, vascular infiltration, and the development of adipocytes with the implant as well as a lack of inflammatory response following up to 12 months of implantation. The persistence rate of our human amnion collagen was equal to, or even longer than, that of both types of bovine collagen implants. (C) 1994 John Wiley and Sons, Inc.
C1 INST OCCUPAT MED,BEIJING 100050,PEOPLES R CHINA.
   BEIJING UNION MED COLL,BEIJING 100005,PEOPLES R CHINA.
RP SPIRA, M (reprint author), BAYLOR COLL MED,DIV PLAST SURG,6560 FANNIN,SUITE 800,HOUSTON,TX 77030, USA.
CR BARR RJ, 1984, J AM ACAD DERMATOL, V10, P652, DOI 10.1016/S0190-9622(84)80273-X
   CHUNG E, 1974, SCIENCE, V183, P1200, DOI 10.1126/science.183.4130.1200
   ELLINGSWORTH LR, 1986, J IMMUNOL, V136, P877
   FAULK WP, 1976, NATURE, V262, P799, DOI 10.1038/262799a0
   FRANCIS DP, 1986, JAMA-J AM MED ASSOC, V256, P869, DOI 10.1001/jama.256.7.869
   FRANK DH, 1991, PLAST RECONSTR SURG, V87, P1080, DOI 10.1097/00006534-199106000-00010
   Gobel P, 1990, Beitr Orthop Traumatol, V37, P495
   GOODFELLOW PN, 1976, TRANSPLANTATION, V22, P595, DOI 10.1097/00007890-197612000-00009
   GRANT RA, 1973, J ANAT, V115, P29
   HANKE CW, 1983, ARCH DERMATOL, V119, P533, DOI 10.1001/archderm.119.6.533
   JACQUELINE BW, 1984, CONNECTIVE TISSUE MA
   JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   KAPLAN EN, 1983, ANN PLAS SURG, V10, P437, DOI 10.1097/00000637-198306000-00002
   KLIGMAN AM, 1986, J DERMATOL SURG ONC, V12, P351, DOI 10.1111/j.1524-4725.1986.tb01920.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU B, 1989, ARCH DERMATOL, V125, P1084, DOI 10.1001/archderm.125.8.1084
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   PEARL RM, 1978, PLAST RECONSTR SURG, V61, P888, DOI 10.1097/00006534-197861060-00010
   Piez K. A., 1984, EXTRACELLULAR MATRIX
   SIEGLE RJ, 1984, ARCH DERMATOL, V120, P183, DOI 10.1001/archderm.120.2.183
   SPIRE B, 1985, LANCET, V1, P188
   STUDIER FW, 1973, J MOL BIOL, V79, P237, DOI 10.1016/0022-2836(73)90003-X
   SWANSON NA, 1983, J DERMATOL SURG ONC, V9, P377, DOI 10.1111/j.1524-4725.1983.tb00819.x
   TABOR E, 1983, J MED VIROL, V11, P1, DOI 10.1002/jmv.1890110102
   WAIKAKUL S, 1990, B HOSP JOINT DIS ORT, V50, P27
NR 26
TC 23
Z9 26
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1994
VL 28
IS 1
BP 91
EP 96
DI 10.1002/jbm.820280112
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MM133
UT WOS:A1994MM13300011
PM 8126034
DA 2018-10-19
ER

PT J
AU PAN, J
   THIERRY, D
   LEYGRAF, C
AF PAN, J
   THIERRY, D
   LEYGRAF, C
TI ELECTROCHEMICAL AND XPS STUDIES OF TITANIUM FOR BIOMATERIAL APPLICATIONS
   WITH RESPECT TO THE EFFECT OF HYDROGEN-PEROXIDE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID MOTT-SCHOTTKY PLOTS; OXIDE-FILMS; EVOLUTION REACTION; OXIDIZED TITANIUM;
   IMPLANT MATERIALS; PASSIVE FILMS; SURFACE; BEHAVIOR; GROWTH;
   BIOCOMPATIBILITY
AB Electrochemical measurements, x-ray photoelectron spectroscopy, and scanning tunneling microscopy have been used to study the effect of hydrogen peroxide on the passivity of titanium in a phosphate-buffered saline (PBS) solution. The results indicate that the passive film formed in the PBS solution-with and without addition of H2O2-may be described with a two-layer structure model. The inner layer has a structure close to TiO2 whereas the outer layer consists of hydroxylated compounds. The introduction of H2O2 in the PBS solution broadens the hydroxylate-rich region, probably due to the formation of a Ti(IV)-H(2)0(2) complex. Furthermore, the presence of H2O2 results in enhanced dissolution of titanium and a rougher surface on a microscopic scale. Finally, a dark pigmentation (blue color) is observed when titanium has been exposed-for several weeks-to PBS with additions of H2O2. (C) 1994 John Wiley and Sons, Inc.
C1 SWEDISH CORROS INST,S-10405 STOCKHOLM,SWEDEN.
RP PAN, J (reprint author), ROYAL INST TECHNOL,DEPT MAT SCI & ENGN,OSQULDAS VAGEN 4-6,S-10044 STOCKHOLM,SWEDEN.
CR ANDREEVA VV, 1963, 2ND P INT C MET CORR, P535
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BIANCHI G, 1963, 2ND P INT C MET CORR, P893
   BIANCHI G, 1961, 1ST P INT C MET CORR, P78
   BIANCHI G, 1963, 2ND P INT C MET CORR, P905
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P875, DOI 10.1016/0013-4686(89)87123-3
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P1505, DOI 10.1016/0013-4686(89)87033-1
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1, pCH10
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1, pCH3
   COOPER G, 1982, J ELECTROCHEM SOC, V129, P1973, DOI 10.1149/1.2124334
   DEAN MH, 1989, CORROS SCI, V29, P199, DOI 10.1016/0010-938X(89)90030-9
   Diggle J. W., 1972, OXIDES OXIDE FILMS, V1
   ELBASIOUNY MS, 1982, CORROSION, V38, P237, DOI 10.5006/1.3577344
   Fraker A. C., 1987, METALS HDB, V13, P1324
   Fraker AC., 1973, TITANIUM SCI TECHNOL, V4, P2447, DOI 10.1007/BF03354319
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   HEFNY MM, 1982, BRIT CORROS J, V17, P38, DOI 10.1179/000705982798274633
   Hultquist G., 1987, Singapore Journal of Physics, V4, P37
   HURLEN T, 1986, ELECTROCHIM ACTA, V31, P1139, DOI 10.1016/0013-4686(86)80126-8
   HURLEN T, 1991, ELECTROCHIM ACTA, V36, P189, DOI 10.1016/0013-4686(91)85200-Q
   JOBIN M, 1992, ULTRAMICROSCOPY, V42, P637, DOI 10.1016/0304-3991(92)90335-H
   JULIAO JF, 1980, J ELECTROCHEM SOC, V127, P2246
   KOVACS P, 1992, CORROSION 92
   KUHN AT, 1988, STP, V970, P79
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LEE FJ, 1992, J APPL ELECTROCHEM, V22, P156
   LEVY M, 1973, TITANIUM SCI TECHNOL, V4, P2459
   MATTSSON H, 1990, THESIS CHALMERS U TE
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   MOISEEV YN, 1992, ULTRAMICROSCOPY, V42, P1596, DOI 10.1016/0304-3991(92)90490-B
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   OLIN H, 1992, ULTRAMICROSCOPY, V42, P567, DOI 10.1016/0304-3991(92)90325-E
   Silva R., 1990, British Corrosion Journal, V25, P136
   SOLAR RJ, 1979, STP, V684, P161
   TAFALLA D, 1987, J ELECTROANAL CHEM, V237, P225, DOI 10.1016/0022-0728(87)85235-X
   TENGVALL P, 1989, J COLLOID INTERF SCI, V130, P405, DOI 10.1016/0021-9797(89)90117-3
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   TOMASHOV ND, 1974, ELECTROCHIM ACTA, V19, P159, DOI 10.1016/0013-4686(74)85012-7
   TORRESI RM, 1987, ELECTROCHIM ACTA, V32, P1291, DOI 10.1016/0013-4686(87)85058-2
   TORRESI RM, 1987, ELECTROCHIM ACTA, V32, P1357, DOI 10.1016/0013-4686(87)85067-3
   Wagner CD, 1978, HDB XRAY PHOTOELECTR
   YOUNG L, 1962, ANODIC OXIDE FILMS, pCH20
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 47
TC 101
Z9 104
U1 7
U2 29
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1994
VL 28
IS 1
BP 113
EP 122
DI 10.1002/jbm.820280115
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MM133
UT WOS:A1994MM13300014
PM 8126022
DA 2018-10-19
ER

PT J
AU NASSIRI, MR
   ROBINSON, JP
   HANKS, CT
   CRAIG, RG
AF NASSIRI, MR
   ROBINSON, JP
   HANKS, CT
   CRAIG, RG
TI EFFECT OF BIOMATERIAL OLIGOMERS ON DIFFERENTIATION-SPECIFIC SURFACE
   HL-60 CELLS ANTIGEN
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV MICHIGAN,SCH DENT,ANN ARBOR,MI 48109.
   PURDUE UNIV,W LAFAYETTE,IN 47907.
RI Robinson, Joseph/K-8492-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC DENTAL RESEARCH
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PY 1994
VL 73
SI SI
BP 330
EP 330
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA MT325
UT WOS:A1994MT32501820
DA 2018-10-19
ER

PT J
AU GOLDBERG, M
   LASFARGUES, JJ
   LEGRAND, JM
AF GOLDBERG, M
   LASFARGUES, JJ
   LEGRAND, JM
TI CLINICAL-TESTING OF DENTAL MATERIALS - HISTOLOGICAL CONSIDERATIONS
SO JOURNAL OF DENTISTRY
LA English
DT Article; Proceedings Paper
CT International Symposium on Biological Testing of Dental Materials, at
   the 2nd Joint NOF/CED Meeting (The Scandinavian and Central European
   Divisions of IADR)
CY AUG, 1993
CL KOLDING, DENMARK
SP IADR, SCADINAVIAN DIV, IADR, CENT EUROPEAN DIV, BAYER AG DENTAL NORDEN, DE TREY DENTSPLY, ESPE GMBH & CO, GC INT CORP, HEREAUS KULZER GMBH
DE PULP; DENTIN; DEVELOPMENT; EXTRACELLULAR MATRIX; REPAIR; CLINICAL
   TESTING
ID RESTORATIVE MATERIALS; CYTO-TOXICITY; INVITRO; LOCALIZATION;
   OSTEONECTIN; APOPTOSIS; COLLAGEN; TISSUES; TOOTH; PULP
AB In order to assess the biocompatibility of dental materials, clinical studies, as well as in vitro studies, are needed.  Although no bacteria were detected inside tubules, pulp reactions were observed when either adhesives of the last generation aiming to create an hybrid layer were used or restorative materials controlling the interface between the biomaterial and dental tissues.  However, the reactions were feeble to moderate.  Reparative dentine seldom appeared after such treatments.  Differences between odontoblast and pulp cells, the nature of the lesion (necrosis or apoptosis), and differences between sound experimental and carious teeth seen in the real clinical situation are discussed in the context of in vivo human studies.
RP GOLDBERG, M (reprint author), UNIV PARIS 05,FAC CHIRURG DENT,1 RUE MAURICE ARNOUX,F-92120 MONTROUGE,FRANCE.
CR BERGENHOLTZ G, 1982, J ORAL PATHOL MED, V11, P439, DOI 10.1111/j.1600-0714.1982.tb00188.x
   CHEN JK, 1993, ARCH ORAL BIOL, V38, P241, DOI 10.1016/0003-9969(93)90034-J
   DEVRIES IG, 1987, J DENT RES, V66, P784
   ELLINGSON JS, 1975, ARCH ORAL BIOL, V20, P731, DOI 10.1016/0003-9969(75)90043-6
   ELLINGSON JS, 1977, CALC TISS RES, V24, P127, DOI 10.1007/BF02223306
   FESUS L, 1991, EUR J CELL BIOL, V56, P170
   HANKS CT, 1989, J ORAL PATHOL MED, V18, P97, DOI 10.1111/j.1600-0714.1989.tb00744.x
   HOLZ J, 1973, REV MENS SUISSE ODON, V83, P1369
   LANGELAND K, 1957, ODONTOL TIDSKR, V65, P239
   MERYON SD, 1982, J BIOMED MATER RES, V16, P519, DOI 10.1002/jbm.820160417
   Recommended Standard Practices For Biological Evaluation Of Dental Materials, 1980, INT DENT J, V30, P140
   REICHERT T, 1992, CALCIFIED TISSUE INT, V50, P468, DOI 10.1007/BF00296779
   SHUTTLEWORTH CA, 1978, BIOCHIM BIOPHYS ACTA, V535, P348, DOI 10.1016/0005-2795(78)90101-0
   SODEK J, 1982, BIOCHEMISTRY-US, V21, P2011, DOI 10.1021/bi00538a006
   WENNBERG A, 1983, J BIOMED MATER RES, V17, P23, DOI 10.1002/jbm.820170103
   WYLLIE AH, 1992, CANCER METAST REV, V11, P95, DOI 10.1007/BF00048057
   ZIMMERMANN B, 1991, CELL TISSUE RES, V263, P483, DOI 10.1007/BF00327281
NR 17
TC 2
Z9 3
U1 0
U2 2
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0300-5712
J9 J DENT
JI J. Dent.
PY 1994
VL 22
SU 2
BP S25
EP S28
DI 10.1016/0300-5712(94)90036-1
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA PV222
UT WOS:A1994PV22200007
PM 7844272
DA 2018-10-19
ER

PT J
AU BERTOLUZZA, A
   FAGNANO, C
   TINTI, A
   MORELLI, MA
   TOSI, MR
   MAGGI, G
   MARCHETTI, PG
AF BERTOLUZZA, A
   FAGNANO, C
   TINTI, A
   MORELLI, MA
   TOSI, MR
   MAGGI, G
   MARCHETTI, PG
TI RAMAN AND INFRARED SPECTROSCOPIC STUDY OF THE MOLECULAR CHARACTERIZATION
   OF THE BIOCOMPATIBILITY OF PROSTHETIC BIOMATERIALS
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
ID POLYETHYLENE
AB Raman spectra were obtained directly in a non-destructive and non-invasive way from the biomaterials PMMA [poly(methyl methacrylate)], HDPE (high-density polyethylene), alpha-Al2O3 (alumina) and HA (hydroxyapatite) constituting the components (bone cement, acetabular cup, ball and stem coated with ceramic) of a hip prosthesis. The aim was to give an objective contribution at a molecular level to predict their biocompatibility. In particular, Raman spectra of explanted PMMA bone cements do not show the 1640 cm-1 band due to the stretching mode of C=C unsaturated centres. Moreover, conformational changes of PMMA following the implant appear in the spectra in the range 1100-500 cm-1, where conformational marker bands at 985, 968, 601 and 565 cm-1 are present. The limited number of HDPE explanted acetabular cups did not allow unequivocal Raman results to be obtained, by means of band deconvolution in the region between 1500 and 1000 cm-1, regarding the changes in the crystalline, amorphous and interfacial contents of the acetabular cup surfaces following the implant. Alpha-Al2O3 proved to be a ceramic with good biocompatibility as a biomaterial constituting a hip prosthesis. As regards the stem coating, Raman and Fourier transform IR spectra of HA pre-coating and HA coating on metal implants show spectroscopic modifications due to structural and chemical changes with formation of other calcium phosphates. The development of new bioactive coatings containing precursors of bone growth and able to promote osteogenesis is outlined.
C1 UNIV BOLOGNA,CTR STUDIO INTERFAC SPETTROSCOPIA RAMAN,DEPT CHEM,I-40126 BOLOGNA,ITALY.
   IST RIC CODIVILLA PUTTI,CNR,IST CITOMORFOL NORMALE & PATOL,I-40136 BOLOGNA,ITALY.
   UNIV BOLOGNA,IST ORTOPEDICI RIZZOLI,ORTOPED CLIN,I-40136 BOLOGNA,ITALY.
RP BERTOLUZZA, A (reprint author), UNIV BOLOGNA,CTR STUDIO INTERFAC SPETTROSCOPIA RAMAN,DEPT BIOCHEM,I-40126 BOLOGNA,ITALY.
OI TINTI, ANNA/0000-0001-8452-815X
CR BERTOLUZZA A, 1981, J RAMAN SPECTROSC, V11, P10, DOI 10.1002/jrs.1250110105
   BERTOLUZZA A, 1983, J RAMAN SPECTROSC, V14, P178, DOI 10.1002/jrs.1250140309
   BERTOLUZZA A, 1992, VEST SLOV CHEM DRUS, V39, P133
   BERTOLUZZA A, 1991, SPECTROSCOPY BIOL MO, P319
   BERTOLUZZA A, 1976, REND ACCAD NAZ LINCE, V61, P269
   BERTOLUZZA A, 1987, ADV BIOMATER, V7, P791
   BERTOLUZZA A, 1992, LASER STUDY MACROSCO, P172
   BERTOLUZZA A, 1988, ADV BIOMATER, V8, P317
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   DYBAL J, 1983, POLYMER, V24, P971, DOI 10.1016/0032-3861(83)90147-7
   GALLON MA, 1977, AM J OPHTHALMOL, V84, P153
   IWAMOTO R, 1979, J POLYM SCI POL LETT, V17, P441, DOI 10.1002/pol.1979.130170708
   KERESZTURY G, 1990, POLYM TEST, V9, P329, DOI 10.1016/0142-9418(90)90004-W
   KRAJEWSKI A, 1988, BIOMATERIALS, V9, P528, DOI 10.1016/0142-9612(88)90050-6
   KUTTY TRN, 1974, INDIAN J CHEM, V13, P194
   PARRINI L, 1987, PUNTO CEMENTAZIONE, P39
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Schuster P., 1976, HYDROGEN BOND
   STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704
   WEINLAENDER M, 1992, J MATER SCI-MATER M, V3, P397, DOI 10.1007/BF00701234
   WILLIAMS DF, 1981, BIOCOMPATIBILITY CLI, V2, P43
NR 21
TC 8
Z9 8
U1 0
U2 11
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0377-0486
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD JAN
PY 1994
VL 25
IS 1
BP 109
EP 114
DI 10.1002/jrs.1250250116
PG 6
WC Spectroscopy
SC Spectroscopy
GA MY386
UT WOS:A1994MY38600014
DA 2018-10-19
ER

PT J
AU WESSLING, FC
   MAYBEE, GW
AF WESSLING, FC
   MAYBEE, GW
TI CONSORT-3 RESULTS
SO JOURNAL OF SPACECRAFT AND ROCKETS
LA English
DT Article
ID FLIGHT
AB Twelve experiments designed to obtain samples and data for a variety of microgravity materials processing investigations were carried on Consort 3, a sounding rocket flight. The overall purpose of the night was to provide an opportunity to investigate the effects of microgravity on processes with potential for new technology development and commercial applications. The range of experimentation included investigations of immiscible polymer demixing rates, electrodeposition and electrocodeposition, elastomer-modified epoxy resins, foam formation, a number of biomaterial mixing processes, and polymer thin-film formation. Specific objectives and results are summarized for each experiment. The experiments were contained in a payload module which was launched and recovered within 4 h at the White Sands Missile Range in May, 1990. The microgravity portion of the flight lasted approximately 7 min. Apogee occurred 283 s after liftoff at an altitude of 189 statute miles. The integrated payload module configuration and mission sequence of events are briefly described. Evaluation of night samples and recorded night data is discussed for individual experiments. Consort 3 provided a large number of investigators with empirical information on processing materials in microgravity and on the effects of microgravity on the processes performed.
C1 MCDONNELL DOUGLAS AEROSP,SPACE TECHNOL PROJECTS,HUNTSVILLE,AL 35806.
RP WESSLING, FC (reprint author), UNIV ALABAMA,DEPT MECH ENGN,HUNTSVILLE,AL 35899, USA.
CR BAMBERGER S, 1991, LOW GRAVITY FLUID DY, V130
   MOORE RJ, 1987, AFRPL TR86070 AIR FO
   ROMANCHICK WA, 1982, ACS SYM SER, V184, P210
   ROMANCHICK WA, 1983, ACS SYM SER, V221, P95
   VANALSTINE JM, 1989, 7 P EUR S MAT FLUID, V295, P399
   WESSLING FC, 1989, J SPACECRAFT ROCKETS, V26, P343, DOI 10.2514/3.26078
   WESSLING FC, 1990, ACTA ASTRONAUT, V21, P647, DOI 10.1016/0094-5765(90)90076-W
   WESSLING FC, 1991, J SPACECRAFT ROCKETS, V28, P100, DOI 10.2514/3.26215
NR 8
TC 2
Z9 2
U1 0
U2 1
PU AMER INST AERONAUT ASTRONAUT
PI RESTON
PA 1801 ALEXANDER BELL DRIVE, STE 500, RESTON, VA 22091
SN 0022-4650
J9 J SPACECRAFT ROCKETS
JI J. Spacecr. Rockets
PD JAN-FEB
PY 1994
VL 31
IS 1
BP 39
EP 47
DI 10.2514/3.26400
PG 9
WC Engineering, Aerospace
SC Engineering
GA MX220
UT WOS:A1994MX22000006
DA 2018-10-19
ER

PT J
AU KAPLAN, SS
AF KAPLAN, SS
TI BIOMATERIAL HOST INTERACTIONS - CONSEQUENCES, DETERMINED BY IMPLANT
   RETRIEVAL ANALYSIS
SO MEDICAL PROGRESS THROUGH TECHNOLOGY
LA English
DT Article
DE BIOMATERIAL; BIOCOMPATIBILITY; BIOMATERIAL RETRIEVAL; MEDICAL IMPLANTS;
   MEDICAL IMPLANT ANALYSIS; MEDICAL IMPLANT FAILURE
ID TOTAL HIP-REPLACEMENT; POLYTETRAFLUOROETHYLENE ARTERIAL PROSTHESES;
   BIOPROSTHETIC CARDIAC VALVES; TOTAL KNEE REPLACEMENT; JUDE MEDICAL
   VALVE; 10-YEAR FOLLOW-UP; HEART-VALVE; PORCINE BIOPROSTHESES;
   DEGENERATIVE CHANGES; BONE-RESORPTION
AB Prosthetic biomaterials have had a profound impact on reconstructive surgery but complete biocompatability remains illusive. This review considers the retrieval analysis of four common prosthetic structures: the hip, the knee, heart valves, and blood vessels. We show that despite a fine record of early success, deterioration due to mechanical failure or deleterious host responses to the implant may compromise long term function. The eventual retrieval and detailed analysis of implanted structures provides an invaluable opportunity to determine the characteristics of implant success or failure and to provoke the development of still better materials.
RP KAPLAN, SS (reprint author), UNIV PITTSBURGH,SCH MED,DEPT PATHOL,ROOM 5930,CHP MAIN TOWER,200 LOTHROP ST,PITTSBURGH,PA 15213, USA.
FU NIGMS NIH HHS [R01 GM41734-04A1]
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   ABERMAN HM, 1993, J LONG-TERM EFF MED, V3, P119
   ALEXANDER H, 1985, CLIN ORTHOP RELAT R, V196, P2
   AMSTUTZ HC, 1976, HIP, P102
   ANGELL WW, 1980, PROG CARDIOVASC DIS, V23, P141, DOI 10.1016/0033-0620(80)90009-2
   AROM KV, 1989, ANN THORAC SURG, V47, P831, DOI 10.1016/0003-4975(89)90014-3
   ASTION DJ, 1992, T SOC BIOMATERIALS, V15, P18
   BARTEL DL, 1982, J BONE JOINT SURG AM, V64, P1026, DOI 10.2106/00004623-198264070-00009
   BARTOLOTTI U, 1985, J THORAC CARDIOVASC, V90, P564
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BLACK J, 1992, SOC BIOMATERIALS, V15, P21
   BLACK MM, 1983, J ROY SOC MED, V76, P667
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, V269, P120
   BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   BOBYN JD, 1984, ORTHOPEDICS, V7, P1410, DOI 10.3928/0147-7447-19840901-05
   BOLTON CW, 1985, CLIN ORTHOP RELAT R, V196, P202
   BROWN SA, 1992, T SOC BIOMATERIALS I, V15, P59
   BRYON RS, 1982, CLIN ORTHOPAEDICS, V170, P116
   BUCKLEY CA, 1992, T SOC BIOMATER IMPLA, V15, P58
   BUNDY RJ, 1992, T SOC BIOMATERIALS, V15, P55
   Butany J, 1990, ASAIO Trans, V36, pM414
   Cameron H U, 1986, Clin Orthop Relat Res, P81
   CAMPBELL P, 1992, T SOC BIOMATERIALS, V15, P19
   CHANDLER HP, 1981, J BONE JOINT SURG AM, V63, P1426, DOI 10.2106/00004623-198163090-00008
   CHARNLEY J, 1979, LOW FRICTION ARTHROP
   CHIBA J, 1994, CLIN ORTHO RELATED R, V298, P304
   CHIGNIER E, 1993, J BIOMED MATER RES, V27, P1087, DOI 10.1002/jbm.820270814
   COHEN SR, 1984, AM J CARDIOL, V53, P1599, DOI 10.1016/0002-9149(84)90586-1
   COLLIER JP, 1991, J APPL BIOMATER, V2, P95, DOI 10.1002/jab.770020204
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   COLLIER JP, 1991, CLIN ORTHOP RELAT R, V271, P305
   COLLIER JP, 1992, T SOC BIOMATERIALS I, V15, P60
   COLLIER JP, 1992, CLIN ORTHOP RELAT R, V274, P97
   Cook S D, 1988, J Arthroplasty, V3, P249
   Cook S D, 1991, J Arthroplasty, V6 Suppl, pS37, DOI 10.1016/S0883-5403(08)80054-X
   COOK SD, 1988, CLIN ORTHOP RELAT R, V234, P90
   CORNELL CN, 1986, J BONE JOINT SURG AM, V68A, P1430, DOI 10.2106/00004623-198668090-00017
   CRAVER JM, 1973, SURGERY, V74, P839
   CZER LSC, 1990, J THORAC CARDIOV SUR, V100, P44
   DESAI P, 1992, SEP IMPL RETR S SOC, P53
   DICHIARA JF, 1992, T SOC BIOMATERIALS, V15, P44
   DUNN JM, 1985, CARDIOL CLIN, V3, P385
   DWYER KA, 1992, SEP IMPL RETR S SOC, P20
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   ENGH CA, 1989, CLIN ORTHOP RELAT R, V249, P141
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FERRANS VJ, 1987, HUM PATHOL, V18, P586, DOI 10.1016/S0046-8177(87)80358-1
   FRISCH EE, 1992, SEP IMPL RETR S SOC
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P836
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GOLDMAN M, 1982, BRIT J SURG, V69, pS38, DOI 10.1002/bjs.1800691314
   GOLDRING SR, 1993, J BONE JOINT SURG AM, V75A, P799, DOI 10.2106/00004623-199306000-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOODMAN SB, 1992, T SOC BIOMATERIALS, V15, P33
   GREISLER HP, 1992, J BIOMED MATER RES, V26, P1449, DOI 10.1002/jbm.820261105
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V20, P3125
   GRUNKEMEIER GL, 1992, MOSBY YB, V17
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   GUIDOIN R, 1993, BIOMATERIALS, V14, P694, DOI 10.1016/0142-9612(93)90068-D
   GUSTAFSON A, 1993, J LONG-TERM EFF MED, V3, P91
   GUTTMAN D, 1992, T SOC BIOMATERIALS, V15, P84
   HANLON J, 1992, T SOC BIOMATERIALS, V15, P30
   HANSEL BC, 1992, SEP IMPL RETR S SOC
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   HARRIS WH, 1987, J BONE JOINT SURG AM, V69A, P1140, DOI 10.2106/00004623-198769080-00005
   HARRIS WH, 1990, NEW ENGL J MED, V3232, P7225
   Hasson J E, 1985, J Vasc Surg, V2, P419
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   HIRATZKA LF, 1988, J AM COLL CARDIOL, V11, P1130, DOI 10.1016/S0735-1097(98)90075-4
   HOOD RW, 1983, J BIOMED MATER RES, V17, P829, DOI 10.1002/jbm.820170510
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   HUFNAGEL C A, 1951, Bull Georgetown Univ Med Cent, V4, P128
   HYLAN JC, 1972, ANN THORAC SURG, V13, P324
   ISHIHARA T, 1981, AM J CARDIOL, V48, P665, DOI 10.1016/0002-9149(81)90145-4
   ISHIHARA T, 1981, CIRCULATION, V13, P718
   JASTY M, 1991, J BONE JOINT SURG AM, V73A, P1331, DOI 10.2106/00004623-199173090-00007
   JENSEN RE, 1992, SEP IMPL RETR S SOC, P17
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   JONAS RA, 1986, ANN THORAC SURG, V41, P657, DOI 10.1016/S0003-4975(10)63083-4
   JUSTICE TA, 1992, T SOC BIOMATERIALS, V15, P57
   KAHAN JS, 1992, SEP IMPL RETR S SOC
   KAVANAGH BF, 1985, J BONE JOINT SURG AM, V67A, P517, DOI 10.2106/00004623-198567040-00003
   KIM KJ, 1994, J BONE JOINT SURG AM, V76A, P172, DOI 10.2106/00004623-199402000-00002
   KIM KJ, 1993, CLIN ORTHOPAEDICS, V287, P142
   LALOR PG, 1991, J BONE JOINT SURG BR, V37, P25
   LANZER WL, 1990, 16TH SOC BIOM T ANN, V13, P293
   LANZER WL, 1991, 37TH T ANN M ORS, V16, P189
   LANZER WL, 1992, T SOC BIOMATERIALS, V15, P35
   LIANG MH, 1986, ARTHRITIS RHEUM, V29, P937, DOI 10.1002/art.1780290801
   MAGILLIGAN DJ, 1980, ANN THORAC SURG, V30, P259, DOI 10.1016/S0003-4975(10)61254-4
   MALONEY WJ, 1992, T SOC BIOMATER, V15, P28
   MARBARGER JP, 1982, ANN THORAC SURG, V34, P22, DOI 10.1016/S0003-4975(10)60848-X
   MATHIESEN EB, 1991, J BONE JOINT SURG BR, V73, P569
   MCGONAGLEWOLFF K, 1992, AM J CARDIOL, V70, P263, DOI 10.1016/0002-9149(92)91286-D
   MCGOVERN TF, 1992, T SOC BIOMATERIALS, V15, P71
   MILANO A, 1984, AM J CARDIOL, V53, P1066, DOI 10.1016/0002-9149(84)90638-6
   MULLERMAI CM, 1991, J APPL BIOMATER, V2, P29, DOI 10.1002/jab.770020105
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   NELSON KJ, 1990, 36TH T ORTH RES SOC, V15, P30
   NELSON KJ, 1991, 58TH T M AM AC ORTH, P197
   OCONNOR D, 1992, T SOC BIOMATERIALS, V15, P70
   PATTEE GA, 1988, PROSTHETIC LIGAMENT, P29
   PELICCI PM, 1985, J BONE JOINT SURG, V67, P413
   PIDHORZ L, 1992, T SOC BIOMATERIALS, V15, P45
   POMAR JL, 1984, ANN THORAC SURG, V37, P78, DOI 10.1016/S0003-4975(10)60716-3
   RANAWAT CS, 1986, CLIN ORTHOPAEDICS, V209, P244
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   REVELL PA, 1992, T SOC BIOMATERIALS, V15, P32
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   RIMNAC CM, 1992, T SOC BIOMATER IMPLA, V15, P16
   ROBERTS W C, 1973, Progress in Cardiovascular Diseases, V15, P539, DOI 10.1016/S0033-0620(73)80024-6
   ROBERTS WC, 1968, AM J CARDIOL, V22, P614, DOI 10.1016/0002-9149(68)90196-3
   ROBERTS WC, 1976, AM J CARDIOL, V37, P1024, DOI 10.1016/0002-9149(76)90419-7
   SANDERS SP, 1980, AM J CARDIOL, V46, P429, DOI 10.1016/0002-9149(80)90012-0
   SANTAVIRTA S, 1991, J BONE JOINT SURG BR, V73, P38
   SAUER W, 1992, T SOC BIOMATERIALS, V15, P56
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A
   Schoen F J, 1984, Cardiol Clin, V2, P717
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1984, J THORAC CARDIOV SUR, V88, P208
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   SCHOEN FJ, 1987, J BIOMED MATER RES-A, V21, P91
   SCHOEN FJ, 1987, CIRCULATION, V76, P1061, DOI 10.1161/01.CIR.76.5.1061
   SCHOEN FJ, 1992, J BIOMED MATER RES, V16, P559
   SHANBHAG AS, 1992, T SOC BIOMATER, V15, P29
   SILVER MD, 1985, ARTIF ORGANS, V9, P270, DOI 10.1111/j.1525-1594.1985.tb04390.x
   SILVER MD, 1977, CIRCULATION, V56, P617, DOI 10.1161/01.CIR.56.4.617
   SILVER MD, 1987, HUM PATHOL, V81, P577
   STAUFFER RN, 1982, J BONE JOINT SURG AM, V64, P983, DOI 10.2106/00004623-198264070-00003
   STRATTON JR, 1982, CIRCULATION, V66, P1287, DOI 10.1161/01.CIR.66.6.1287
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   THIENE G, 1989, AM J CARDIOL, V63, P129, DOI 10.1016/0002-9149(89)91099-0
   THOMSON GJL, 1991, SURGERY, V109, P20
   URETZKY G, 1988, BIOMATERIALS, V9, P195, DOI 10.1016/0142-9612(88)90122-6
   VALENTE M, 1985, AM J PATHOL, V119, P12
   WARNES CA, 1983, AM J CARDIOL, V51, P965, DOI 10.1016/S0002-9149(83)80174-X
   WHALEN RL, 1992, ASAIO J, pM207
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1992, T SOC BIOMATERIALS, V15, P47
   WRIGHT TM, 1989, 56TH T M AM AC ORTH
   WROBLEWSKI BM, 1988, ORTHOP CLIN N AM, V19, P627
   ZETTLSCHAFFER KF, 1992, T SOC BIOMATERIALS, V15, P43
NR 148
TC 5
Z9 5
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0047-6552
J9 MED PROG TECHNOL
JI Med. Prog. Technol.
PY 1994
VL 20
IS 3-4
BP 209
EP 230
PG 22
WC Engineering, Biomedical
SC Engineering
GA PX916
UT WOS:A1994PX91600012
PM 7877567
DA 2018-10-19
ER

PT J
AU FEWSTER, SD
   COOMBS, RRH
   KITSON, J
   ZHOU, S
AF FEWSTER, SD
   COOMBS, RRH
   KITSON, J
   ZHOU, S
TI PRECISE ULTRAFINE SURFACE TEXTURING OF IMPLANT MATERIALS TO IMPROVE
   CELLULAR ADHESION AND BIOCOMPATIBILITY
SO NANOBIOLOGY
LA English
DT Article
DE BIOIMPLANT; SURFACE; TEXTURE; CELL
ID ARTICULAR-CARTILAGE; CELLS; BEHAVIOR
AB The purpose of this study was to investigate the effect of ultrafine biomaterial surface texture (features less than 15 mum in size) on cellular adhesion.  Commonly used orthopaedic polymers were textured by photoablation using an excimer laser in conjunction with masks made by electron beam lithography.  Surface features were made with an accuracy of 0.1 mum.  Cellular adhesion of isolated epithelial cells and osteoblasts was studied in tissue culture by microscopy (light and scanning electron).  Comparative measurements of the force of cell adhesion were made using a rotating disc system in tissue culture medium.  The results were that cellular adhesion behaviour is affected by ultrafine surface texture.  Cells preferentially adhere to the edges of pores and pillars.  Cells will stretch between closely positioned features.  The force of cellular adhesion is increased by substrate texturing, thus allowing cells to resist detachment by a shear force.  The increase in this cell attachment force for the surfaces studied was small (approximately 5%).  It is possible that other surface textures may result in a large increase in force.  In conclusion, cellular adhesion to orthopaedic implant materials may be improved by ultrafine texturing.  The technique is suitable for large-scale manufacture.  Further development may result in textured biomaterial implants being used in human articular surface reconstruction.  Such implants would allow strong attachment of chondrogenic cells and hopefully prevent the detachment of the repair tissue by the shear stresses usually found at the joint surface.
C1 ROYAL POSTGRAD MED SCH,DEPT SURG,DIV ORTHOPAED,LONDON W12 0HS,ENGLAND.
CR BRADLEY J, 1989, J BONE JOINT SURG BR, V71, P518
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   CZITROM AA, 1985, CLIN ORTHOP RELAT R, V208, P141
   ENGKVIST O, 1975, SCAND J PLAST RECONS, V9, P203, DOI 10.3109/02844317509022867
   GHADIALLY FN, 1981, ELECTRON MICROS, P17
   GILLEY JS, 1981, RADIOLOGY, V138, P51, DOI 10.1148/radiology.138.1.7455096
   Goodall F., 1986, Microelectronic Engineering, V5, P445, DOI 10.1016/0167-9317(86)90075-4
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HUBBARD MJS, 1987, J BONE JOINT SURG BR, V69, P794
   HUNT JS, 1986, J IMMUNOL, V136, P364
   JOHNSONNURSE C, 1985, J BONE JOINT SURG BR, V6, P42
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   ODRISCOLL SW, 1989, J BONE JOINT SURG AM, V70, P595
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   VISHWAKARMA GK, 1986, J BONE JOINT SURG BR, V68, P68
NR 17
TC 13
Z9 13
U1 0
U2 4
PU CARFAX PUBL CO
PI ABINGDON
PA PO BOX 25, ABINGDON, OXON, ENGLAND OX14 3UE
SN 0958-3165
J9 NANOBIOLOGY
JI Nanobiology
PY 1994
VL 3
IS 3-4
BP 201
EP 210
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA QX401
UT WOS:A1994QX40100006
DA 2018-10-19
ER

PT J
AU JOHNSON, RJ
AF JOHNSON, RJ
TI COMPLEMENT ACTIVATION DURING EXTRACORPOREAL THERAPY - BIOCHEMISTRY, CELL
   BIOLOGY AND CLINICAL RELEVANCE
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE COMPLEMENT; HEMODIALYSIS; C5A
ID C5A RECEPTOR MODULATION; DIALYSIS PATIENTS; POLYMORPHONUCLEAR
   LEUKOCYTES; INCREASED EXPRESSION; ALTERNATIVE PATHWAY; ANTITHROMBIN-III;
   FACTOR-B; HEMODIALYSIS; MEMBRANE; NEUTROPHIL
AB Complement is a principal mediator of the acute inflammatory response and contributes to the non-specific recognition and elimination of foreign substances from the body. The system evolved to protect the host from invasion by various pathogens. However, due to the non-selective nature of the alternative pathway, biomaterial surfaces in any medical device used in contact with blood will also activate the system. This review summarizes our current understanding of the biochemistry and cell biology of complement. The relationship of this basic information to clinical observations is discussed in order to affirm the relevance of complement as a critical parameter of biocompatibility.
RP JOHNSON, RJ (reprint author), BAXTER HLTH CARE CORP,BAXTER TECHNOL PK,RLT-12,ROUND LAKE,IL 60073, USA.
CR ALEXIEWICZ JM, 1991, AM J NEPHROL, V11, P102, DOI 10.1159/000168284
   ARNAOUT MA, 1985, NEW ENGL J MED, V312, P457, DOI 10.1056/NEJM198502213120801
   BECHERER JD, 1992, BIOCHEMISTRY-US, V31, P1787, DOI 10.1021/bi00121a029
   BLAJCHMAN MA, 1986, PROG HEMATOL, V14, P149
   BURHOP K, 1989, FED PROC, V48, P910
   CHANARD J, 1982, ARTIF ORGANS, V6, P261
   CHENOWETH D E, 1986, Complement, V3, P152
   CHEUNG AK, 1986, KIDNEY INT, V29, P799, DOI 10.1038/ki.1986.69
   CRADDOCK PR, 1979, SEMIN HEMATOL, V16, P140
   CRADDOCK PR, 1977, NEW ENGL J MED, V296, P769, DOI 10.1056/NEJM197704072961401
   DAVIS AE, 1979, J CLIN INVEST, V64, P721, DOI 10.1172/JCI109515
   DESCAMPSLATSCHA B, 1991, NEPHRON, V59, P279, DOI 10.1159/000186565
   FAIR DS, 1981, THROMB HAEMOSTASIS, V46, P301
   HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5
   HAMILTON KK, 1990, J BIOL CHEM, V265, P3809
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1385, DOI 10.1002/jbm.820241010
   HENSON PM, 1978, J IMMUNOL, V121, P851
   HIMMELFARB J, 1992, KIDNEY INT, V41, P388, DOI 10.1038/ki.1992.54
   HIMMELFARB J, 1991, J AM SOC NEPHROL, V2, P920
   HIMMELFARB J, 1991, AM J KIDNEY DIS, V17, P271, DOI 10.1016/S0272-6386(12)80473-2
   HORL WH, 1990, AM J NEPHROL, V10, P53, DOI 10.1159/000168054
   ITO BR, 1990, CIRC RES, V66, P596, DOI 10.1161/01.RES.66.3.596
   JAGELS MA, 1992, J IMMUNOL, V148, P1119
   KLEMPNER MS, 1980, BLOOD, V55, P777
   KOLB G, 1991, NEPHRON, V57, P64, DOI 10.1159/000186218
   KUWAHARA T, 1988, NEPHROL DIAL TRANSPL, V3, P661, DOI 10.1093/oxfordjournals.ndt.a091724
   LACHMANN PJ, 1991, IMMUNOL TODAY, V12, P312, DOI 10.1016/0167-5699(91)90005-E
   LEE J, 1984, CLIN EXP IMMUNOL, V56, P205
   LEWIS S L, 1987, Blood Purification, V5, P138, DOI 10.1159/000169463
   LEWIS SL, 1987, AM J KIDNEY DIS, V9, P381, DOI 10.1016/S0272-6386(87)80141-5
   LEWIS SL, 1986, CLIN NEPHROL, V26, P37
   LEWIS SL, 1987, KIDNEY INT, V31, P112, DOI 10.1038/ki.1987.17
   LUBLIN DM, 1989, CURR TOP MICROBIOL I, V153, P123
   MAILLOUX LU, 1991, AM J KIDNEY DIS, V18, P326, DOI 10.1016/S0272-6386(12)80091-6
   MULLEREBERHARD HJ, 1992, INFLAMMATION BASIC P, P33
   NAKAMURA Y, 1992, CLIN NEPHROL, V38, P90
   NELSON RD, 1990, TUMOR NECROSIS FACTOR : STRUCTURE, MECHANISM OF ACTION, ROLE IN DISEASE AND THERAPY, P177
   OGSTON D, 1983, PHYSL HEMOSTASIS, P194
   OKUSAWA S, 1987, J IMMUNOL, V139, P2635
   PANGBURN MK, 1989, J IMMUNOL, V142, P2759
   PEERSCHKE EIB, 1990, J IMMUNOL, V144, P221
   PODACK ER, 1986, J BIOL CHEM, V261, P7387
   Ross G.D., 1986, IMMUNOBIOLOGY COMPLE
   SALAMA A, 1988, NEW ENGL J MED, V318, P408, DOI 10.1056/NEJM198802183180704
   SCHAEFER RM, 1989, INT J ARTIF ORGANS, V12, P85
   SCHINDLER R, 1990, KIDNEY INT, V37, P85, DOI 10.1038/ki.1990.12
   SIMON P, NEPHRON, V45, P172
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   SWERLICK RA, 1988, J IMMUNOL, V140, P2376
   TOMURA S, 1990, THROMB RES, V58, P413, DOI 10.1016/0049-3848(90)90212-U
   VANEPPS DE, 1990, J IMMUNOL, V144, P1062
   VANHOLDER R, 1991, KIDNEY INT, V39, P320, DOI 10.1038/ki.1991.40
   WEBSTER RO, 1980, IMMUNOPHARMACOLOGY, V2, P201, DOI 10.1016/0162-3109(80)90050-8
   WEILER JM, 1991, J IMMUNOL, V146, P3889
   WERFEL T, 1991, J IMMUNOL, V147, P3909
   1990, AM J KIDNEY DIS, V16, P44
NR 56
TC 51
Z9 51
U1 0
U2 3
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0931-0509
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PY 1994
VL 9
SU 2
BP 36
EP 45
PG 10
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA NM060
UT WOS:A1994NM06000007
PM 8065616
DA 2018-10-19
ER

PT S
AU Draoui, M
   Imbenotte, M
   Palavit, G
   Montagne, L
   Benarafa, L
AF Draoui, M
   Imbenotte, M
   Palavit, G
   Montagne, L
   Benarafa, L
BE Aride, J
   Bendriss, A
   Benkhouja, K
   Boukhari, A
   ElJazouli, A
   Mansouri, I
   Nadiri, A
   Tanouti, B
   Zahir, M
   Zakaria, D
TI Synthesis and biocompatibility of new materials
SO PHYSICAL CHEMISTRY OF SOLID STATE MATERIALS (REMCES VI)
SE ADVANCED MATERIALS RESEARCH
LA English
DT Proceedings Paper
CT 6th International Seminar on the Physical Chemistry of Solid State
   Materials (REMCES VI)
CY OCT 28-30, 1993
CL EL JADIDA, MOROCCO
SP Minist Natl Educ, Rectorate Hassan II Univ, Ain Chock, Rectorate Cadi Ayad Univ, Marrakech, Rectorate Moulay Ismail Univ, Meknes, Hassan II Univ, Fac Sci, Ain Chock, Hassan II Univ, Fac Sci, Ben Msik, Cadi Ayad Univ, Fac Sci, Semlalia, Moulay Ismail Univ, Fac Sci, Meknes, Ecole Superieure Technol, Casablanca, Ctr Natl Coordinat & Planificat Rech Sci & Tech, ORMVA Doukkala
DE gel; biomaterial; metaphosphates; fluoroapatite; cytotoxicity
C1 FAC PHARM,ANALYT CHEM LAB,RABAT,MOROCCO.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SCITEC PUBLICATIONS LTD
PI ZUG
PA UNTERMUELI 11, 6300 ZUG, SWITZERLAND
SN 1022-6680
BN 3-908450-05-5
J9 ADV MAT RES
PY 1994
VL 1-2
BP 189
EP 193
DI 10.4028/www.scientific.net/AMR.1-2.189
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Condensed Matter
SC Chemistry; Materials Science; Physics
GA BF42D
UT WOS:A1994BF42D00020
DA 2018-10-19
ER

PT J
AU HAYASHI, T
AF HAYASHI, T
TI BIODEGRADABLE POLYMERS FOR BIOMEDICAL USES
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
ID CELL-ATTACHMENT ACTIVITY; HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS;
   CONTROLLED DRUG DELIVERY; N-CARBOXYBUTYL CHITOSAN; ARG-GLY-ASP;
   ALGINATE-POLYLYSINE MICROCAPSULES; ELASTIN FIBRIN BIOMATERIAL;
   HYDROXYALKYL L-GLUTAMINE; ARTIFICIAL SKIN MODEL; LONG-TERM DEGRADATION
RP HAYASHI, T (reprint author), UNIV OSAKA PREFECTURE,ADV SCI & TECHNOL RES INST,1-2 GAKUEN CHO,SAKAI,OSAKA 593,JAPAN.
CR ABATANGELO G, 1982, EXP CELL RES, V137, P73, DOI 10.1016/0014-4827(82)90009-X
   ABATANGELO G, 1983, J SURG RES, V35, P410, DOI 10.1016/0022-4804(83)90030-6
   AIBA S, 1985, BIOMATERIALS, V6, P290, DOI 10.1016/0142-9612(85)90084-5
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   ALI SAM, 1993, IOMATERIALS, V14, P648
   Alvarez O M, 1984, Clin Dermatol, V2, P54, DOI 10.1016/0738-081X(84)90027-0
   AMECKE B, 1992, Clinical Materials, V10, P47, DOI 10.1016/0267-6605(92)90084-7
   AMMON R, 1963, ENZYMOLOGIA, V25, P245
   ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, V1, P67
   ANNAS IV, 1980, J BIOMED MATER RES, V14, P65
   ANSELME K, 1993, BIOMATERIALS, V14, P44, DOI 10.1016/0142-9612(93)90074-C
   ARMANT DR, 1986, P NATL ACAD SCI USA, V83, P6751, DOI 10.1073/pnas.83.18.6751
   Arshady R, 1990, J BIOACT COMPAT POL, V5, P315, DOI 10.1177/088391159000500308
   ARTANDI C, 1981, CHEMTECH, P476
   ARTURSSON P, 1984, J PHARM SCI, V73, P1507, DOI 10.1002/jps.2600731103
   AUBERT N, 1987, BIOMATERIALS, V8, P24, DOI 10.1016/0142-9612(87)90023-8
   BADWAN AA, 1985, DRUG DEV IND PHARM, V11, P239, DOI 10.3109/03639048509056869
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954
   BARKER H, 1980, BIOCHIM BIOPHYS ACTA, V632, P589, DOI 10.1016/0304-4165(80)90335-9
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   BERNATCHEZ SF, 1993, J BIOMED MATER RES, V27, P677, DOI 10.1002/jbm.820270515
   BIAGINI G, 1991, BIOMATERIALS, V12, P287, DOI 10.1016/0142-9612(91)90036-A
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BRAGANTINI A, 1987, CLIN TRIALS J, V24, P333
   BROWNING A, 1986, J BIOMED MATER RES, V20, P613, DOI 10.1002/jbm.820200507
   CAMPBELL P, 1980, ARCH BIOCHEM BIOPHYS, V203, P676, DOI 10.1016/0003-9861(80)90225-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHASIN M, 1990, BIODEGRADABLE POLYM, P43
   CHAVASIT V, 1990, BIOTECHNOL PROGR, V6, P2, DOI 10.1021/bp00001a001
   CHAVES MS, 1985, MAKROMOL CHEM, V186, P17
   CHEDID L, 1982, BACTERIA CANCER, P49
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHOSAKAI K, 1988, HDB APPL NEW FUNCTIO, P217
   CHVAPIL M, 1985, ANGIO ARCH, V9, P7
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   COLLET D, 1991, BIOMATERIALS, V12, P763, DOI 10.1016/0142-9612(91)90027-8
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   COTE MF, 1992, BIOMATERIALS, V13, P612, DOI 10.1016/0142-9612(92)90029-N
   CREPON B, 1991, BIOMATERIALS, V12, P550, DOI 10.1016/0142-9612(91)90049-G
   CREPON B, 1987, BIOMATERIALS, V8, P248, DOI 10.1016/0142-9612(87)90111-6
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   DALY MM, 1988, BIOTECHNOL PROGR, V4, P76, DOI 10.1002/btpr.5420040205
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585
   DEVI KS, 1986, BIOMATERIALS, V7, P193
   DICKINSON HR, 1981, J BIOMED MATER RES, V15, P577, DOI 10.1002/jbm.820150412
   DOI Y, 1990, MACROMOLECULES, V23, P26, DOI 10.1021/ma00203a006
   Doillon C J, 1988, J Biomater Appl, V2, P562
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   DOMB AJ, 1988, MACROMOLECULES, V21, P1925, DOI 10.1021/ma00185a008
   DOMB AJ, 1989, MACROMOLECULES, V22, P3200, DOI 10.1021/ma00198a002
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   DOMB AJ, 1990, BIOMATERIALS, V11, P686, DOI 10.1016/0142-9612(90)90027-N
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
   EGELANDSDAL B, 1984, J FOOD SCI, V49, P1099, DOI 10.1111/j.1365-2621.1984.tb10402.x
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FISCHER AM, 1985, BIOMATERIALS, V6, P198, DOI 10.1016/0142-9612(85)90010-9
   Flory P.J., 1953, PRINCIPLES POLYM CHE, P576
   FUKUDA H, 1979, MAKROMOL CHEM, V180, P1631
   GADE JN, 1991, J BIOMED MATER RES, V25, P799, DOI 10.1002/jbm.820250702
   GIABINI G, 1988, CHITIN CHITOSAN
   Gilding D., 1981, BIOCOMPATIBILITY CLI, V2, P209
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Goodman LS, 1980, PHARM BASIS THERAPEU
   GOOSEN MFA, 1982, BIOMATER ARTIF CELL, V10, P205, DOI 10.3109/10731198209118781
   GRAINGER DA, 1991, J GYNECOL SURG, V7, P97, DOI 10.1089/gyn.1991.7.97
   GREISLER HP, 1991, SURGERY, V110, P645
   Grinstaff M. W., 1991, POLYM PREPR, V32, P255
   HAYASHI T, 1985, KOBUNSHI RONBUNSHU, V42, P777, DOI 10.1295/koron.42.777
   HAYASHI T, 1993, BIOMATERIALS, V14, P497, DOI 10.1016/0142-9612(93)90236-U
   HAYASHI T, 1985, POLYM J, V17, P1273, DOI 10.1295/polymj.17.1273
   HAYASHI T, 1990, BIOMATERIALS, V11, P409, DOI 10.1016/0142-9612(90)90096-9
   HAYASHI T, 1985, POLYM J, V17, P463, DOI 10.1295/polymj.17.463
   HAYASHI T, 1985, POLYM J, V17, P1149, DOI 10.1295/polymj.17.1149
   HAYASHI T, 1990, BIOPOLYMERS, V29, P549, DOI 10.1002/bip.360290310
   HAYASHI T, 1991, J APPL POLYM SCI, V43, P2223, DOI 10.1002/app.1991.070431211
   HAYASHI T, 1990, J APPL POLYM SCI, V39, P1803, DOI 10.1002/app.1990.070390817
   HAYASHI T, 1987, POLYM J, V19, P1025, DOI 10.1295/polymj.19.1025
   HAYASHI T, 1993, POLYM J, V25, P481, DOI 10.1295/polymj.25.481
   HAYASHI T, 1983, REP PROG POLYM PHYS, V26, P591
   HAYASHI T, 1988, REP PROGR POLYM PHYS, V31, P561
   HAYASHI T, 1988, SEN-I GAKKAISHI, V44, P19
   HAYASHI T, 1984, REP PROG POLYM PHYS, V27, P621
   HAYASHI T, 1988, B CHEM I KYOTO U, V66, P251
   HAYASHI T, 1983, REP PROG POLYM PHYS, V26, P587
   HAYASHI T, 1987, REP PROG POLYM PHYS, V30, P669
   HAYASHI T, 1985, REP PROG POLYM PHYS, V28, P527
   HAYASHI T, 1984, REP PROG POLYM PHYS, V27, P617
   HAYASHI T, IN PRESS EUR POLYM J
   HELLER J, 1980, BIOMATERIALS, V1, P51, DOI 10.1016/0142-9612(80)90060-5
   HELLER J, 1980, J POLYM SCI POL LETT, V18, P619, DOI 10.1002/pol.1980.130180907
   HELLER J, 1990, BIOMATERIALS, V11, P345, DOI 10.1016/0142-9612(90)90112-4
   HELLER J, 1990, BIOMATERIALS, V11, P235, DOI 10.1016/0142-9612(90)90003-9
   HIRANO Y, 1993, J BIOMAT SCI-POLYM E, V4, P235, DOI 10.1163/156856293X00546
   HIRANO Y, 1991, POLYM BULL, V26, P363, DOI 10.1007/BF00302601
   HIRANO Y, 1991, J BIOMED MATER RES, V25, P1523, DOI 10.1002/jbm.820251209
   HIRANO Y, 1992, POLYM J, V24, P465, DOI 10.1295/polymj.24.465
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   HUANG SJ, 1976, 3RD P INT BIOD S, P731
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   HUTCHINSON FG, 1990, J CONTROL RELEASE, V13, P279, DOI 10.1016/0168-3659(90)90018-O
   HYMAN EG, 1985, J CELL BIOL, V100, P1948
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   IIZUKA Y, 1993, POLYM J, V25, P659, DOI 10.1295/polymj.25.659
   IIZUKA Y, 1993, POLYM J, V25, P285, DOI 10.1295/polymj.25.285
   IKADA Y, 1989, KOBUNISHI SHINSOZAI, P322
   IKADA Y, 1989, BIOMEDICAL MATERIALS, P84
   ITOYAMA K, IN PRESS POLYM INT
   ITOYAMA K, IN PRESS BIOTECH PRO
   ITOYAMA K, IN PRESS BIOMATERIAL
   JAMSHIDI K, 1986, BIOL BIOMECHANICAL P, P227
   Kamath KR, 1992, P INT S CONTROL RELE, V19, P42
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATSARAVA RD, 1991, ACTA POLYM, V42, P95, DOI 10.1002/actp.1991.010420212
   KEMNITZER JE, 1992, POLYM MATER SCI ENG, V66, P405
   Kifune K, 1988, T SOC BIOMATER, V11, P216
   KIMURA Y, 1991, SHINSOZAI, V2, P71
   KIMURA Y, 1993, BIOMEDICAL APPL POLY, P163
   KIMURA Y, 1991, INT S BIODEG POLYM T, P1606
   KING GA, 1987, BIOTECHNOL PROGR, V3, P231, DOI 10.1002/btpr.5420030407
   KINOSHITA Y, 1993, BIOMATERIALS, V14, P729, DOI 10.1016/0142-9612(93)90036-2
   KNOWLES JC, 1991, BIOMATERIALS, V12, P210, DOI 10.1016/0142-9612(91)90202-L
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   KRONENTHAL RL, 1974, POLYM SCI TECHNOL, V8, P119
   KUKUCHI Y, 1976, J APPL POLYM SCI, V20, P2561
   KUMAGAI Y, 1992, MAKROMOL CHEM, V193, P53
   KUMAGAI Y, 1992, MAKROMOL CHEM-RAPID, V13, P179
   KUROYANAGI Y, 1991, Journal of Burn Care and Rehabilitation, V12, P106, DOI 10.1097/00004630-199103000-00004
   KUROYANAGI Y, 1992, J APPL BIOMATER, V3, P153, DOI 10.1002/jab.770030211
   KWOK KK, 1991, PHARM RES-DORDR, V8, P341, DOI 10.1023/A:1015841531372
   LAIO J, 1993, POLYM J, V25, P401
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   LEE TK, 1981, SCIENCE, V213, P233, DOI 10.1126/science.6787705
   LEFEBVRE F, 1989, J BIOMED MATER RES, V10, P445
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   LESCURE F, 1989, J BIOMED MATER RES, V23, P1299, DOI 10.1002/jbm.820231107
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   LI ST, 1989, COLLAGEN BIOTECHNOLO, V3, P253
   LIN HL, 1993, J BIOMED MATER RES, V27, P153, DOI 10.1002/jbm.820270204
   LLOYD JB, 1989, ANGEW MAKROMOL CHEM, V166, P191, DOI 10.1002/apmc.1989.051660114
   LONGO WE, 1985, METHOD ENZYMOL, V112, P18
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316
   Matsuda T, 1992, ASAIO J, V38, pM154, DOI 10.1097/00002480-199207000-00008
   Matsuda T, 1993, ASAIO J, V39, pM327
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   MAUZAC M, 1985, BIOMATERIALS, V6, P61, DOI 10.1016/0142-9612(85)90040-7
   McCormickThomson LA, 1989, J BIOACT COMPAT POLY, V4, P242
   Mcknight CA, 1988, J BIOACT COMPAT POLY, V3, P334
   MEIJER AEF, 1963, BIOCHEM PHARMACOL, V12, P973, DOI 10.1016/0006-2952(63)90020-0
   MESSMER K, 1988, BLOOD SUBSTITUTES PR, P51
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   MOSHER DF, 1989, BIOL EXTRACELLULAR M
   Murachi T, 1976, Methods Enzymol, V45, P475
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   MUZZARELLI R, 1989, CARBOHYD POLYM, V11, P307, DOI 10.1016/0144-8617(89)90005-2
   MUZZARELLI R, 1990, IND POLYSACCHARIDES
   NAAKAMURA T, 1987, BIOMATERIALS CLIN AP, P759
   NAKAJIMA A, 1990, Journal of Biomaterials Science Polymer Edition, V1, P183
   NAKAMURA T, 1992, 4TH P INT ITV C BIOM, P153
   NAKANISHI E, 1991, POLYM J, V23, P1061, DOI 10.1295/polymj.23.1061
   NAKANISHI E, 1991, POLYM J, V23, P983, DOI 10.1295/polymj.23.983
   NAKANISHI E, 1991, POLYM J, V23, P1053, DOI 10.1295/polymj.23.1053
   NISHIDA H, 1992, J APPL POLYM SCI, V46, P1467, DOI 10.1002/app.1992.070460818
   Niu S, 1993, ASAIO J, V39, pM750
   OKADA T, 1992, BIOMATERIALS, V13, P448, DOI 10.1016/0142-9612(92)90165-K
   ONO M, 1987, MARUZEN TOKYO
   OUCHI T, 1988, T SOC BIOMED, V11, P232
   PARSSON H, 1992, VASA-J VASCULAR DIS, V21, P6
   Petersen R. V., 1985, BIOACTIVE POLYM SYST, P151
   PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137
   PFISTER G, 1986, Journal of Controlled Release, V3, P229, DOI 10.1016/0168-3659(86)90094-5
   PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIETRUCHA K, 1991, BIOMATERIALS, V12, P320, DOI 10.1016/0142-9612(91)90041-8
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PIGNATELLI M, 1988, P NATL ACAD SCI USA, V85, P5561, DOI 10.1073/pnas.85.15.5561
   PISTNER H, 1993, BIOMATERIALS, V14, P671, DOI 10.1016/0142-9612(93)90066-B
   PISTNER H, 1993, BIOMATERIALS, V14, P291, DOI 10.1016/0142-9612(93)90121-H
   PISTNER H, 1991, BIOMED TECH, V36, P114
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   POSILLICO EG, 1986, BIO-TECHNOL, V4, P114, DOI 10.1038/nbt0286-114
   Pouton CW, 1988, P INT S CONTROL REL, V15, P181
   Pulapura S, 1992, J Biomater Appl, V6, P216, DOI 10.1177/088532829200600303
   RASTRELLI A, 1990, ADV BIOMAT, V9, P199
   RAWLS R, 1981, C EN             JAN, P23
   REHM KE, 1992, 4TH P INT C BIOM DEN, P163
   ROGGENDORF E, 1976, J BIOMED MATER RES, V10, P123, DOI 10.1002/jbm.820100112
   ROSATI L, 1988, POLYM MATER SCI ENG, V59, P516
   ROSEMEYER H, 1984, MAKROMOL CHEM, V185, P687
   ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6
   RUIZ EM, 1993, BIOMATERIALS, V14, P491, DOI 10.1016/0142-9612(93)90235-T
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   Samanen J., 1985, BIOACTIVE POLYM SYST, P279
   SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935
   SATO H, 1985, J BIOMED MATER RES, V19, P1135, DOI 10.1002/jbm.820190921
   SCHACHT E, 1988, J BIOACT COMPAT POLY, V3, P71
   SCHACHT E, 1987, IND POLYSACHARIDES G, P389
   Schacht E, 1987, POLYM CONTROLLED DRU, P131
   SCHMITT EE, 1968, Patent No. 3371069
   SCHUERCH C, 1985, BIOACTIVE POLYM SYST
   SENIOR PJ, 1972, BIOCHEM J, V128, P1193, DOI 10.1042/bj1281193
   SHAH CB, 1992, POLYELECTROLYTE GELS, P117
   SHALABY WS, 1992, J BIOACT COMPAT POL, V7, P257, DOI 10.1177/088391159200700303
   SHASHA BS, 1976, J POLYM SCI POL LETT, V14, P417, DOI 10.1002/pol.1976.130140708
   Shinde B. G., 1992, Bio-Medical Materials and Engineering, V2, P123
   Shinde B. G., 1992, Bio-Medical Materials and Engineering, V2, P127
   Silver F.H., 1987, BIOL MAT STRUCTURE M, P7
   SILVERSTEIN ME, 1981, J TRAUMA, V21, P388, DOI 10.1097/00005373-198105000-00011
   SIMIONESCU A, 1991, J BIOMED MATER RES, V25, P1495, DOI 10.1002/jbm.820251207
   SPIRA M, 1969, Journal of Biomedical Materials Research, V3, P213, DOI 10.1002/jbm.820030203
   SUSLICK KS, 1990, J AM CHEM SOC, V112, P7807, DOI 10.1021/ja00177a058
   SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x
   SUZUKI S, 1984, J BIOL CHEM, V259, P5307
   TABATA Y, 1987, J PHARM PHARMACOL, V39, P698, DOI 10.1111/j.2042-7158.1987.tb06972.x
   TABATA Y, 1993, PHARMACEUT RES, V10, P487, DOI 10.1023/A:1018929531410
   TABATA Y, 1993, J CONTROL RELEASE, V27, P79
   TABATA Y, 1989, PHARMACEUT RES, V6, P422, DOI 10.1023/A:1015991617704
   TABATA Y, 1993, JPN J CANCER RES, V84, P681, DOI 10.1111/j.1349-7006.1993.tb02029.x
   TABATA Y, 1989, JPN J CANCER RES, V80, P387, DOI 10.1111/j.1349-7006.1989.tb02324.x
   TABATA Y, 1993, J PHARM PHARMACOL, V45, P303, DOI 10.1111/j.2042-7158.1993.tb05557.x
   TABATA Y, 1993, PHARMACEUT RES, V10, P391, DOI 10.1023/A:1018988222324
   VISAVARUNGROJ N, 1990, INT J PHARM, V59, P73, DOI 10.1016/0378-5173(90)90066-D
   VISSER CE, 1992, BIOMATERIALS, V13, P34, DOI 10.1016/0142-9612(92)90092-3
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEIGEL PH, 1986, J THEOR BIOL, V119, P229
   WILLIAMSON DH, 1958, J GEN MICROBIOL, V19, P198, DOI 10.1099/00221287-19-1-198
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P99, DOI 10.1002/jcb.240280203
   YAN CH, 1988, BIOTECHNOL APPL BIOC, V10, P13
   YAN CH, 1991, BIOMATERIALS, V12, P640
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   YASUTOMI Y, 1993, BURN INJURIES, V19, P102
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
   YOTSUYANAGI T, 1987, CHEM PHARM BULL, V35, P1555
   ZIEGLER GR, 1991, BIOTECHNOL PROGR, V7, P283, DOI 10.1021/bp00009a013
NR 251
TC 223
Z9 234
U1 2
U2 67
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PY 1994
VL 19
IS 4
BP 663
EP 702
DI 10.1016/0079-6700(94)90030-2
PG 40
WC Polymer Science
SC Polymer Science
GA PB187
UT WOS:A1994PB18700003
DA 2018-10-19
ER

PT J
AU LUJAN, JR
   DARNALL, DW
   STARK, PC
   RAYSON, GD
   GARDEATORRESDEY, JL
AF LUJAN, JR
   DARNALL, DW
   STARK, PC
   RAYSON, GD
   GARDEATORRESDEY, JL
TI METAL-ION BINDING BY ALGAE AN HIGHER-PLANT TISSUES - A PHENOMENOLOGICAL
   STUDY OF SOLUTION PH-DEPENDENCE
SO SOLVENT EXTRACTION AND ION EXCHANGE
LA English
DT Article
ID LUMINESCENCE; BIOMASS; RECOVERY; URANIUM; ACCUMULATION; SPECTROMETRY;
   CADMIUM; SITES; GOLD
AB Several biomaterials derived from blue-green algae and cells and tissues from some higher plants were tested for their potential to remove metal ions from solutions at different pH. Most biomaterials displayed pH-dependent binding profiles for Cu(II), Al(III), and Au(III). However, fragments of cultured Datura cells showed pH-independent binding of Au(III) binding of over 97%. Other biomaterials also showed high affinity for Cu(II) and Au(III) at pH 5.0. These included freeze dried roots and stems of cattail plants (Typha latifolia), the leaves of tumble weeds (Salsola spp.). alfalfa sprouts (Medicago sativa), and sphagnum peat. Al(III) binding by most biomaterials was low. An exception to this observation was Al(III) binding to alfalfa sprouts. The highest binding capacities for copper were exhibited by sphagnum peat moss and alfalfa sprouts with 30 and 18 mg Cu/g biomaterial, respectively. The reduction of Au(III) to Au(O) by several of these biomaterials was observed.
C1 NEW MEXICO STATE UNIV,DEPT CHEM & BIOCHEM,BOX 3001,DEPT 3C,LAS CRUCES,NM 88003.
CR BAKER A, 1988, NEW SCI, V44
   BELL PRJ, 1959, ECOLOGY, V47, P351
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   DARNALL DW, 1988, SCI TECHNOLOGY LETT, P487
   FERGUSON J, 1974, CHEM GEOL, V13, P163, DOI 10.1016/0009-2541(74)90018-7
   GALUN M, 1983, WATER AIR SOIL POLL, V20, P221, DOI 10.1007/BF00279632
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1988, THESIS MEW MEXICO ST
   GIRLING CA, 1980, GOLD BULL, V13, P151
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   GREENE B, 1985, THESIS NEW MEXICO ST
   HAGEMAN JH, 1988, RANGE MANGE, V41, P155
   JACKSON PJ, 1984, PLANT PHYSIOL, V75, P914, DOI 10.1104/pp.75.4.914
   KE HYD, 1993, APPL SPECTROSC, V47, P44, DOI 10.1366/0003702934048569
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KE HYD, 1992, ENVIRON SCI TECHNOL, V46, P479
   KE HYD, UNPUB J ENV SCI TECH
   KUYUCAK N, 1988, SYMPOSIUM P
   LEMBRECHTS JFM, 1985, J ENVIRON QUAL, V14, P217, DOI 10.2134/jeq1985.00472425001400020013x
   MAHAN CA, 1989, ANAL CHEM, V61, P624, DOI 10.1021/ac00181a026
   NAKAJIMA A, 1982, EUR J APPL MICROBIOL, V16, P88, DOI 10.1007/BF00500732
   NORBERG AB, 1984, BIOTECHNOL BIOENG, V26, P239, DOI 10.1002/bit.260260307
   PAKARINEN P, 1976, Ambio, V5, P38
   SCOTT CD, 1992, BIOTECHNOL BIOENG, V39, P1064, DOI 10.1002/bit.260391011
   SIEGEL BZ, 1878, CRC CRITICAL REV MIC
   SKOWRONSKI T, 1984, CHEMOSPHERE, V13, P1385, DOI 10.1016/0045-6535(84)90052-3
   SKOWRONSKI T, 1986, CHEMOSPHERE, V51, P69
   TSEZOS M, 1981, BIOTECHNOL BIOENG, V23, P583, DOI 10.1002/bit.260230309
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   WOOD JM, 1984, ENVIRON SCI TECHNOL, V18, P106
NR 34
TC 58
Z9 58
U1 0
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0736-6299
J9 SOLVENT EXTR ION EXC
JI Solvent Extr. Ion Exch.
PY 1994
VL 12
IS 4
BP 803
EP 816
DI 10.1080/07366299408918239
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA NZ155
UT WOS:A1994NZ15500009
DA 2018-10-19
ER

PT S
AU WADSTROM, T
   PAULSSON, M
   LJUNGH, A
AF WADSTROM, T
   PAULSSON, M
   LJUNGH, A
BE Mollby, R
   Flock, JI
   Nord, CE
   Christensson, B
TI MOLECULAR PATHOGENESIS OF STAPHYLOCOCCAL INFECTIONS - MICROBIAL ADHESION
   TO EXTRACELLULAR MATRIX AND COLONIZATION OF WOUNDED TISSUES AND
   BIOMATERIAL SURFACES
SO STAPHYLOCOCCI AND STAPHYLOCOCCAL INFECTIONS
SE ZENTRALBLATT FUR BAKTERIOLOGIE : SUPPLEMENT
LA English
DT Proceedings Paper
CT 7th International Symposium on Staphylococci and Staphylococcal
   Infections
CY JUN 29-JUL 03, 1992
CL STOCKHOLM, SWEDEN
C1 LUND UNIV,DEPT MED MICROBIOL,S-22101 LUND,SWEDEN.
NR 0
TC 7
Z9 7
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI STUTTGART 70
PA WOLLGRASWEG 49, W-7000 STUTTGART 70, GERMANY
SN 0172-5629
BN 3-437-11541-3
J9 ZBL BAKT S
PY 1994
VL 26
BP 343
EP 352
PG 10
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA BC28C
UT WOS:A1994BC28C00080
DA 2018-10-19
ER

PT J
AU FONKALSRUD, EW
   SMITH, MD
   SHAW, KS
   BORICK, JM
   SHAW, A
AF FONKALSRUD, EW
   SMITH, MD
   SHAW, KS
   BORICK, JM
   SHAW, A
TI SELECTIVE MANAGEMENT OF GASTROSCHISIS ACCORDING TO THE DEGREE OF
   VISCEROABDOMINAL DISPROPORTION
SO ANNALS OF SURGERY
LA English
DT Article
AB Objective: This study analyzed the factors influencing the postoperative results after the repair of gastroschisis defects during the past 27 years.
   Summary Background Data: The clinical results after the repair of gastroschisis abdominal defects have improved appreciably during the past 25 years, with the long-term survival rate in most large children's centers currently being approximately 90%. The improvement in survival has been largely attributed to advances in perioperative care, frequent use of parenteral nutrition, and better techniques of surgical repair.
   Methods: Between 1965 and 1992, 84 infants with gastroschisis underwent surgical repair. The management of 52 infants after 1979 was compared with that of 32 during the previous 14 years. Associated anomalies were present in 29%. The average birth weight was 2412 g. In 31%, primary fascial closure was performed. In another 31% with moderate visceroabdominal disproporiion (VAD), a silastic chimney was used initially, and complete repair was performed at a second operation. For 25% who had severe VAD, more than two operative reconstructions were necessary. Seven of 52 infants with moderate VAD underwent initial skin-flap closure and secondary repair within 12 days.
   Results: Almost all complications (27%) and deaths (4%) occurred in infants with severe VAD and were largely unrelated to associated malformations or birth weight. The length of postoperative mechanical ventilation, need for parenteral nutrition, need for multiple operations, and length of hospitalization were all directly related to the severity of the VAD.
   Conclusions: Complete repair of gastroschisis at the initial operation is the optimal goal; however, the severity of VAD has permitted this approach in only one third of patients in this study. Delayed repair with a silastic chimney and one or more reconstructive procedures has Provided excellent long-term survival with low morbidity and mortality rates. Although skin-flap closure is no longer used initially, this technique has been helpful for the residual defect in infants with severe VAD who have had multiple silon chimney repairs (Applied Biomaterial, Silverdale, WA).
RP FONKALSRUD, EW (reprint author), UNIV CALIF LOS ANGELES,MED CTR,SCH MED,DIV PEDIAT SURG,LOS ANGELES,CA 90024, USA.
CR ALLEN RG, 1969, J PEDIATR SURG, V4, P3, DOI 10.1016/0022-3468(69)90177-8
   CANIANO DA, 1990, J PEDIATR SURG, V25, P297, DOI 10.1016/0022-3468(90)90070-P
   FONKALSRUD EW, 1980, ANN SURG, P139
   GROSS RE, 1948, SURGERY, V24, P277
   HARRISON MW, 1986, ANN SURG, V203, P214
   MOORE TC, 1963, ANN SURG, V158, P263, DOI 10.1097/00000658-196308000-00017
   PHILLIPS JD, 1991, J PEDIATR SURG, V26, P784, DOI 10.1016/0022-3468(91)90138-J
   RAFFENSP.JG, 1974, SURG GYNECOL OBSTET, V138, P230
   SCHUSTER SR, 1967, SURG GYNECOL OBSTETR, V125, P837
   SHAH R, 1991, J PEDIATR SURG, V26, P788, DOI 10.1016/0022-3468(91)90139-K
   THOMPSON J, 1976, ARCH SURG-CHICAGO, V111, P684
   WATKINS DE, 1943, VIRGINIA MED MONTH, V78, P42
NR 12
TC 28
Z9 29
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD DEC
PY 1993
VL 218
IS 6
BP 742
EP 747
DI 10.1097/00000658-199312000-00007
PG 6
WC Surgery
SC Surgery
GA ML605
UT WOS:A1993ML60500007
PM 8257224
DA 2018-10-19
ER

PT J
AU RUIJGROK, JM
   BOON, ME
   FEIRABEND, HKP
   PLOEGER, S
AF RUIJGROK, JM
   BOON, ME
   FEIRABEND, HKP
   PLOEGER, S
TI DOES MICROWAVE IRRADIATION HAVE OTHER THAN THERMAL EFFECTS ON
   GLUTARALDEHYDE CROSS-LINKING OF COLLAGEN
SO EUROPEAN JOURNAL OF MORPHOLOGY
LA English
DT Article
ID TISSUE FIXATION METHOD; ELECTRON-MICROSCOPY; CYTOCHEMISTRY; BIOMATERIAL
AB The effects of microwave irradiation (MWI) can theoretically be divided in thermal and nonthermal effects. Because there is still much debate on the contribution of non-thermal microwave effects, experiments were carried out in which the effects of isothermal microwave irradiation on glutaraldehyde (GA) crosslinking of native collagen membranes (NCM) is studied. A total of 20 strips of collagen membrane of porcine origin were isothermally irradiated in 300 ml of a 0.1 (w/w) GA solution, 10 strips at 4 degrees C, and 10 strips at 20 degrees C, A temperature controlled microwave oven (630W) was adapted to allow for simultaneous cooling of the fixation solution preventing the MWI to induce any measurable thermal effects. Any possible temperature variations were recorded employing continuous fiberoptic temperature measurement. Control experiments were carried out under the same (isothermal) fixation conditions, but without MWI. The crosslinking action of the GA was evaluated by determining the shrinkage temperature (Ts) of the collagen strips. No significant difference (p > 0.05) could be observed between the increase in (Ts) of the microwaved and the increase in Ts of the nonmicrowaved strips. The increase in Ts at 4 degrees C (c. 14 degrees C) was lower than that obtained at 20 degrees C (c. 16 degrees C). It was concluded that MWI induces no substantial nonthermal effect on enhancement of GA crosslinking of collagen at these temperatures.
C1 LEIDEN CYTOL & PATHOL LAB,LEIDEN,NETHERLANDS.
   LEIDEN UNIV,DEPT PHYSIOL,NEUROREGULAT GRP,LEIDEN,NETHERLANDS.
RP RUIJGROK, JM (reprint author), LEIDEN UNIV,BIOMAT RES GRP,LEIDEN,NETHERLANDS.
CR ABRAMOVITCH RA, 1991, ORG PREP P INT, V23, P683
   FEIRABEND HKP, 1992, EUR J MORPHOL, V30, P312
   FEIRABEND HKP, IN PRESS J NEUROSC M
   HOPWOOD D, 1988, HISTOCHEM J, V20, P341, DOI 10.1007/BF01002727
   HOPWOOD D, 1984, HISTOCHEM J, V16, P1171, DOI 10.1007/BF01003442
   JULIEN RC, 1992, P INT C MICROWAVES H, V2
   Kok L. P., 1992, MICROWAVE COOKBOOK M
   LELOUS M, 1982, BIOCHIM BIOPHYS ACTA, V717, P295, DOI 10.1016/0304-4165(82)90182-9
   LOGIN GR, 1985, AM J PATHOL, V120, P230
   MARANI E, 1993, EUR J MORPHOL, V31, P141
   MIZUHIRA V, 1990, ACTA HISTOCHEM CYTOC, V23, P501, DOI 10.1267/ahc.23.501
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NOTOYA M, 1990, ACTA HISTOCHEM CYTOC, V23, P525, DOI 10.1267/ahc.23.525
   RUIJGROK JM, IN PRESS J MAT SCI M
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   VANDORP R, 1992, THESIS LEIDEN NETHER
   ZIJLSTRA S, 1993, UNPUB BEHAVIOUR REAC
NR 17
TC 9
Z9 9
U1 0
U2 3
PU SWETS ZEITLINGER PUBLISHERS
PI LISSE
PA P O BOX 825, 2160 SZ LISSE, NETHERLANDS
SN 0924-3860
J9 EUR J MORPHOL
JI Eur. J. Morphol.
PD DEC
PY 1993
VL 31
IS 4
BP 290
EP 297
PG 8
WC Anatomy & Morphology
SC Anatomy & Morphology
GA MX970
UT WOS:A1993MX97000008
PM 8172758
DA 2018-10-19
ER

PT J
AU MARGEL, S
   VOGLER, EA
   FIRMENT, L
   WATT, T
   HAYNIE, S
   SOGAH, DY
AF MARGEL, S
   VOGLER, EA
   FIRMENT, L
   WATT, T
   HAYNIE, S
   SOGAH, DY
TI PEPTIDE, PROTEIN, AND CELLULAR INTERACTIONS WITH SELF-ASSEMBLED
   MONOLAYER MODEL SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID AQUEOUS PERMANGANATE INTERACTION; PENETRATION-CONTROLLED REACTIONS;
   DEPENDENT CONTACT ANGLES; SOLID LIQUID ADSORPTION; LONG-CHAIN
   SURFACTANTS; ENDOTHELIAL-CELLS; PRACTICAL USE; FILMS; BIOMATERIALS;
   MULTILAYERS
AB Model biomaterial surfaces with well defined chemistry were prepared from close-packed alkyltrichlorosilane monolayers on polished silicon and glass. The outermost molecular groups which come in direct contact with the biological environment were varied across a wide range of oxidation states by employing -CF3, -CH3, -CO2CH3, and -CH2OH terminal functionalities. Characterization by contact angles, surface spectroscopy, and ellipsometry verified that these model surfaces could be repeatedly prepared with good consistency for routine use to study biomolecule adsorption onto model surfaces. Adhesion of canine endothelial cells and the adsorption of proteins (human serum albumin and human fibrinogen) as well as a series of synthetic defined oligopeptides to these model surfaces have been studied. Endothelial cells attachment and growth rank order of: -CH2OH > -CO(2)Me > -CH3 > -CF3. The peptides were comprised of different alternating sequences of lysine, leucine, and tryptophan residues. These structural differences imparted different amphiphilic characters that led to measurable differences in the adsorption of these peptides to liquid-vapor interfaces. The adsorption to model surfaces was studied using ESCA, radiometry, and concentration-dependent contact angles. ESCA and radiometry measured irreversible biomolecules adsorption whereas the contact angle method measured steady-state adsorption. Radiometric results were inconsistent with ESCA, possibly due to artifacts associated with protein radiolabeling. (C) 1993 John Wiley and Sons, Inc.
C1 BECTON DICKINSON RES CTR,RES TRIANGLE PK,NC 27709.
   DUPONT CO INC,EXPTL STN,CENT RES & DEV,WILMINGTON,DE 19880.
   CORNELL UNIV,DEPT CHEM,BAKER LAB,ITHACA,NY 14853.
RP MARGEL, S (reprint author), BAR ILAN UNIV,DEPT CHEM,IL-52900 RAMAT GAN,ISRAEL.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ANDRADE JD, 1985, SURFACE INTERFACIAL
   Andreas JM, 1938, J PHYS CHEM-US, V42, P1001, DOI 10.1021/j100903a002
   BAIER RE, 1985, BIOMAT MED EV ARTIF, V12, P133
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   BERGBREITER DE, 1975, J ORG CHEM, V40, P779, DOI 10.1021/jo00894a605
   BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   CHEN QY, 1986, J FLUORINE CHEM, V34, P255, DOI 10.1016/S0022-1139(00)85076-9
   EEARLE WR, 1953, Patent No. 2658021
   EVANS SD, 1991, LANGMUIR, V7, P156, DOI 10.1021/la00049a028
   HAZELL LB, 1986, SURF INTERFACE ANAL, V8, P25, DOI 10.1002/sia.740080106
   HIEMENZ PC, 1986, PRINCIPLES COLLOID S, P326
   HIEMENZ PC, 1986, PRINCIPLES COLLOID S, P385
   HOLMESFARLEY SR, 1987, LANGMUIR, V3, P799, DOI 10.1021/la00077a040
   IMAI H, 1986, J CHROMATOGR, V371, P29, DOI 10.1016/S0021-9673(01)94690-4
   IVARSSON BA, 1985, COLLOID SURFACE, V13, P169
   JOHNSON R, 1969, WETTABILITY CONTACT, P85
   LAZAR A, 1985, DEV BIOL STAND, V60, P457
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   LUBEVICS E, 1977, ORGANOMETALLIC CHEM, V5, P1
   MACRITCHIE F, 1991, ANAL CHIM ACTA, V249, P241, DOI 10.1016/0003-2670(91)87029-7
   MAOZ R, 1987, LANGMUIR, V3, P1045, DOI 10.1021/la00078a028
   MAOZ R, 1987, LANGMUIR, V3, P1034, DOI 10.1021/la00078a027
   MAOZ R, 1984, J COLLOID INTERF SCI, V100, P465, DOI 10.1016/0021-9797(84)90452-1
   MARGEL S, 1991, LANGMUIR, V7, P2317, DOI 10.1021/la00058a057
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   MCCRACKIN FL, 1963, J RES NBS A PHYS CH, VA 67, P363, DOI 10.6028/jres.067A.040
   OMULLANE JE, 1988, BIOMATERIALS, V9, P203, DOI 10.1016/0142-9612(88)90124-X
   Padday J.F., 1969, SURF COLLOID SCI, V1, P110
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   POMERANTZ M, 1985, THIN SOLID FILMS, V132, P153, DOI 10.1016/0040-6090(85)90466-3
   RUSSEL DB, 1981, J COLLOID INTERF SCI, V81, P311
   Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103
   TILLMAN N, 1989, LANGMUIR, V5, P101, DOI 10.1021/la00085a019
   Ulman A, 1992, INTRO ULTRATHIN ORGA
   VANDERSCHEER AT, 1978, J COLLOID INTERF SCI, V66, P136, DOI 10.1016/0021-9797(78)90194-7
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   VANWACHEM PB, 1988, BIOMATERIALS, V9, P121, DOI 10.1016/0142-9612(88)90083-X
   VOGLER DA, 1993, LANGMUIR, V9, P497
   VOGLER EA, 1992, LANGMUIR, V8, P2005, DOI 10.1021/la00044a022
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   VOGLER EA, 1993, WETTABILITY, P183
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WASSERMAN SR, 1989, J MATER RES, V4, P886, DOI 10.1557/JMR.1989.0886
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 46
TC 117
Z9 118
U1 2
U2 21
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1993
VL 27
IS 12
BP 1463
EP 1476
DI 10.1002/jbm.820271202
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH127
UT WOS:A1993MH12700001
PM 8113233
DA 2018-10-19
ER

PT J
AU MEYLE, J
   GULTIG, K
   WOLBURG, H
   VONRECUM, AF
AF MEYLE, J
   GULTIG, K
   WOLBURG, H
   VONRECUM, AF
TI FIBROBLAST ANCHORAGE TO MICROTEXTURED SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ORIENTATION; SUBSTRATA; JUNCTIONS; INVITRO
AB The contact between tissue and the implanted biomaterial is influenced by the micromorphology of the implant surface as well as biomechanical reactions. This effect is mediated by subcellular morphological structures and can affect the anchorage of the material inside the body of the host. The aim of the present study was to ascertain by transmission electron microscopy how human gingival fibroblasts interact with surface events. A special replica technique was used to produce a line pattern of 1 mu m pitch with a depth of 1 mu m. It was demonstrated, by transmission electron microscopy, that cells seeded on this surface extended cellular processes into the grooves, leading to an intensive contact and probably to mechanical interlocking. The typical morphological structures at several points indicated the presence of focal adhesion sites. (C) 1993 John Wiley and Sons, Inc.
C1 UNIV TUBINGEN,INST PATHOL,W-7400 TUBINGEN,GERMANY.
   CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC.
RP MEYLE, J (reprint author), ZENTRUM ZAHN MUND & KIEFERHEILKUNDE,ZAHNARZTLICHE CHIRURG & PARODONTOL POLIKLIN,W-7400 TUBINGEN,GERMANY.
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X
   ABERCROMBIE M, 1982, CELL BEHAVIOUR, P19
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Buck C A, 1987, J Cell Sci Suppl, V8, P231
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   HEAYSMAN JEM, 1982, CELL BEHAVIOUR TRIBU, P49
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   POLANSKI JP, 1983, T ASAIO, V29, P556
   REES DA, 1981, CELLULAR INTERACTION, P67
   TIDBALL JG, 1986, J CELL BIOL, V103, P1465, DOI 10.1083/jcb.103.4.1465
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VONRECUM AF, 1990, CLIN IMPLANT MAT, P297
NR 19
TC 84
Z9 85
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1993
VL 27
IS 12
BP 1553
EP 1557
DI 10.1002/jbm.820271212
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH127
UT WOS:A1993MH12700011
PM 8113243
DA 2018-10-19
ER

PT J
AU LEGEROS, RZ
   CRAIG, RG
AF LEGEROS, RZ
   CRAIG, RG
TI STRATEGIES TO AFFECT BONE REMODELING - OSTEOINTEGRATION
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article; Proceedings Paper
CT NIH Workshop on Osteoporosis and Oral Bone Loss
CY AUG, 1992
CL LEESBURG, VA
SP NIH, NIDR, NIAMSD, NIH, OFF RES WOMENS HLTH
ID TRANSMISSION ELECTRON-MICROSCOPY; CALCIUM-PHOSPHATE CERAMICS; ALLOY
   DENTAL IMPLANTS; TITANIUM INTERFACE; MANDIBULAR BONE; MINERAL CONTENT;
   TISSUE; HYDROXYAPATITE; DOGS; HYDROXYLAPATITE
AB Osteointegration was defined as a ''direct structural and functional connection between ordered living bone and the surface of a load-carrying implant.''(25) Although osteointegration was meant originally to describe a biologic fixation of the titanium dental implants, it is now used to describe the attachment of other materials used for dental and orthopedic applications as well. Analyses of material-bone interface showed that osteointegrated implants can have an intervening fibrous layer or direct bone apposition characterized by bone-bonding(62) depending on the composition and surface properties of the biomaterial. This article reviews biologic (host tissue properties and response), biomechanical, and biomaterial factors affecting osteointegration. Biologic factors include the quality of bone. Biomaterial factors include the effect of material composition on the bone-material interface. Suggested areas for future research include determining the correlation between oral bone status and osteoporsis, the effect of gender, age, and endocrine status (e.g., osteoporosis) on implant success or failure, the effect of calcium phosphate coating composition and crystallinity on in vivo performance of implants, the factors contributing to accelerated osteointegration, and development of osteoinductive implants.
RP LEGEROS, RZ (reprint author), NYU,COLL DENT,345 E 24TH ST,NEW YORK,NY 10010, USA.
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   Albrektsson T., 1985, TISSUE INTEGRATED PR, P129
   AMLER MH, 1987, J PERIODONTOL, V58, P758, DOI 10.1902/jop.1987.58.11.758
   AMLER MH, 1990, J BIOMED MATER RES, V24, P1079, DOI 10.1002/jbm.820240810
   APSE P, 1989, J PERIODONTAL RES, V24, P96, DOI 10.1111/j.1600-0765.1989.tb00863.x
   ASHMAN A, 1965, ORAL SURG MED ORAL P, V60, P146
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   BAXTER KC, 1981, J PROSTHET DENT, V46, P123
   BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31
   BECKER W, 1991, J PERIODONTOL, V62, P703, DOI 10.1902/jop.1991.62.11.703
   BECKHAM CA, 1971, CALC TISS RES, V8, P165, DOI 10.1007/BF02010133
   BJURSTEN LM, 1990, BONE MATERIAL INTERF, P165
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   BOBYN JD, 1987, CLIN ORTHOP RELAT R, V224, P303
   Bonel G, 1988, Ann N Y Acad Sci, V523, P115, DOI 10.1111/j.1749-6632.1988.tb38506.x
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   BRANEMARK PI, 1977, SCAND PLAST RECO S16, V11
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   BREME J, 1990, OSSEO INTEGRATED IMP, V1, P31
   BRUNSKI JB, 1979, J DENT RES, V58, P1953, DOI 10.1177/00220345790580100201
   BUCHARDT H, 1983, CLIN ORTHOP RELAT R, V174, P28
   BUSER D, 1990, J PERIODONTOL, V61, P597, DOI 10.1902/jop.1990.61.9.597
   BUSER HP, 1991, INT J ORAL MAXILLOF, V6, P226
   BUSER HP, 1992, J PERIODONTOL, V61, P226
   CHARNEY J, 1970, ACRYLIC CEMENT ORTHO
   COHEN J, 1983, BIOMATERIALS RECONST, P46
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   COOK SD, 1988, CLIN ORTHOP RELAT R, V230, P303
   Cranin A N, 1987, Compendium, V8, P334
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, CALCIFIED TISSUE INT, V24, P471
   DANIELL HW, 1983, ARCH INTERN MED, V143, P1678, DOI 10.1001/archinte.143.9.1678
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, HDB BIOACTIVE CERAMI, V1
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   DENISSEN H W, 1990, International Journal of Prosthodontics, V3, P53
   DEPORTER DA, 1986, J DENT RES, V65, P1064, DOI 10.1177/00220345860650080501
   DONELY TG, 1991, J PERIODONTOL, V62, P153
   Doyle C, 1990, HDB BIOACTIVE CERAMI, V2, P195
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P213
   GOTTLANDER M, 1991, International Journal of Oral and Maxillofacial Implants, V6, P399
   GOULD TRL, 1981, J PERIODONTAL RES, V16, P611, DOI 10.1111/j.1600-0765.1981.tb00999.x
   GOULD TRL, 1984, J PROSTHET DENT, V52, P418, DOI 10.1016/0022-3913(84)90459-1
   GRISS P, 1982, AKTUELLE PROBLEME CI, V21
   Gross U, 1988, Ann N Y Acad Sci, V523, P211, DOI 10.1111/j.1749-6632.1988.tb38514.x
   GUILEMIN G, 1987, J BIOMED MATER RES, V23, P1247
   HANAWA T, 1990, BONE BIOMATERIAL INT, P49
   HEALEY JH, 1985, J BONE JOINT SURG AM, V67A, P586, DOI 10.2106/00004623-198567040-00013
   HEIMKE G, 1990, OSSEO INTEGRATED IMP, V1, P1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Heughebaert M, 1988, J BIOMED MATER RES, V22, P254
   HILDBOLT CF, INTERRELATIONSHIP BO
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JEMT T, 1991, International Journal of Oral and Maxillofacial Implants, V6, P270
   JOHANSSON C B, 1991, International Journal of Oral and Maxillofacial Implants, V6, P437
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KRIBBS PJ, 1990, J PROSTHET DENT, V63, P218, DOI 10.1016/0022-3913(90)90108-O
   KRIBBS PJ, 1990, J PROSTHET DENT, V63, P86, DOI 10.1016/0022-3913(90)90273-F
   Lang Niklaus P., 1992, P346
   LEGEROS JP, 1991, 17TH ANN M SOC BIOMA
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   Legeros RZ, 1988, J DENT RES, V67, P177
   LEGEROS RZ, 1992, P INT SEM ORTH RES N, P147
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, V2, P17
   LEKHOLM U, 1986, INT J ORAL MAX SURG, V15, P53, DOI 10.1016/S0300-9785(86)80011-4
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   Linkow L I, 1981, J Oral Implantol, V9, P509
   LISTGARTEN MA, 1992, J DENT RES, V71, P364, DOI 10.1177/00220345920710020401
   LYNCH SE, 1991, J PERIODONTOL, V62, P710, DOI 10.1902/jop.1991.62.11.710
   MANLEY M T, 1992, Dental Clinics of North America, V36, P257
   Marden L J, 1990, J Craniofac Surg, V1, P154, DOI 10.1097/00001665-199001030-00006
   MARKS SC, 1988, J ORAL PATHOL MED, V17, P500, DOI 10.1111/j.1600-0714.1988.tb01324.x
   MEMOLI VA, 1986, J ORTHOPAED RES, V4, P346, DOI 10.1002/jor.1100040311
   Mombelli A, 1990, CLIN ORAL IMPLAN RES, V1, P1, DOI 10.1034/j.1600-0501.1990.010101.x
   NAGAI N, 1982, J DENT RES, V25, P581
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   NIKI M, 1991, BONE-BIOMATERIAL INTERFACE, P350
   NYMAN S, 1979, J PERIODONTOL, V50, P163, DOI 10.1902/jop.1979.50.4.163
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   OONISHSI H, 1990, BIOCERAMICS, V2, P286
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   OSBORN JF, 1989, BIOMATERIALS, P388
   PIECUCH JF, 1986, DENT CLIN N AM, V30, P291
   PILLIAR RM, 1991, J DENT RES, V70, P1338, DOI 10.1177/00220345910700100501
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   ROTHMAN RH, 1990, CLIN ORTHOPAEDICS, V254, P153
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   SMITH DC, 1990, BONE MATERIAL INTERF, P1
   SOBALLE K, 1991, CLIN ORTHOP RELAT R, V272, P255
   SPIVAK JM, 1990, J BIOMED MATER RES, V24, P1121, DOI 10.1002/jbm.820240902
   STANFORD C M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P83
   STEFLIK DE, 1992, J PERIODONTOL, V63, P443, DOI 10.1902/jop.1992.63.5.443
   STEIGER P, 1992, J BONE MINER RES, V7, P625
   ten Bruggenkate C M, 1990, Int J Oral Implantol, V7, P45
   TENBRUGGENKATE CM, 1990, INT J ORAL IMPLANT, V7, P53
   THOMAS KA, 1987, T ORTHOP RES SOC, V12, P432
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272
   VONWOWERN N, 1985, SCAND J DENT RES, V93, P162
   VONWOWERN N, 1988, CALCIFIED TISSUE INT, V43, P193, DOI 10.1007/BF02555134
   WEISS C M, 1986, Journal of Oral Implantology, V12, P169
   WILSON J, 1988, J BIOMED MATER RES-A, V22, P159, DOI 10.1002/jbm.820221308
   1988, NIH CONSENSUS DEV C
NR 123
TC 104
Z9 105
U1 2
U2 13
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD DEC
PY 1993
VL 8
SU 2
BP S583
EP S596
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA MQ496
UT WOS:A1993MQ49600026
PM 8122530
DA 2018-10-19
ER

PT J
AU ZENHAUSERN, F
   ADRIAN, M
   DESCOUTS, P
AF ZENHAUSERN, F
   ADRIAN, M
   DESCOUTS, P
TI SOLUTION STRUCTURE AND DIRECT IMAGING OF FIBRONECTIN ADSORPTION TO
   SOLID-SURFACES BY SCANNING FORCE MICROSCOPY AND CRYOELECTRON MICROSCOPY
SO JOURNAL OF ELECTRON MICROSCOPY
LA English
DT Article
DE SCANNING PROBE TECHNIQUES (SPM); CRYO TEM; FIBRONECTIN; ADSORPTION
ID PLASMA FIBRONECTIN; PROTEIN ADSORPTION; SEDIMENTATION; BIOMATERIAL;
   FLEXIBILITY; STABILITY; MOLECULES; DOMAIN; MODELS; FILMS
AB In this study, we present the scanning force and electron microscopic visualization of single molecules of fibronectin either frozen hydrated or adsorbed onto metallic and polymeric surfaces with different solid surface tensions. The surfaces were characterized by dynamic contact angle measurements, X-ray photo emission spectroscopy (XPS or ESCA) and scanning force microscopy. The proteins were prepared by fast protein liquid chromatography (FPLC) and characterized by gel electrophoresis. Protein films on surfaces were investigated by surface plasmon resonance spectroscopy and directly imaged by scanning force microscopy. The spreading of the adsorbed fibronectin revealed dependence on the chemical composition and the solid surface tension. Structure of fibronectin in solution as well as on solid interface appeared as an extended straight strand as obtained by imaging with electron and scanning probe microscopies. Imaging of DNA was performed by scanning force microscopy to test the accuracy and reproducibility of our measurements. The measured contour lengths were accurate and the larger widths were caused by convolution of the tip shape and sample. Frictional forces during the scan have been of significant contribution in the imaging mechanism. Moreover, this work demonstrated that scanning force microscopy can be used for mapping the orientation and organization of protein film adsorbed onto various surfaces at the nanoscale.
C1 APPL PHYS GRP,CH-1211 GENEVA 4,SWITZERLAND.
   ULTRASTRUCT ANAL LAB,CH-1015 DORIGNY,SWITZERLAND.
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   ALBRECHT TR, 1990, JUL P STM 90 NANOI C
   ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   ALBREKTSSON T, 1982, ADV BIOMATER, V4, P167
   ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501
   Andrade J. D., 1988, POLYM SURFACE DYNAMI
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ARWIN H, 1985, ANAL BIOCHEM, V145, P106, DOI 10.1016/0003-2697(85)90334-3
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   EMCH R, 1990, J VAC SCI TECHNOL A, V8, P655, DOI 10.1116/1.576366
   EMCH R, 1992, ULTRAMICROSCOPY, V42, P1155, DOI 10.1016/0304-3991(92)90417-I
   EMCH R, 1991, APR P FOURM GUILB WO
   ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   GRUNBAUM E, 1969, J APPL PHYS, V40, P3364
   HANSMA HG, 1993, NUCLEIC ACIDS RES, V21, P505, DOI 10.1093/nar/21.3.505
   HLENFELD JV, 1984, T AM SOC ART INT ORG, V24, P727
   HOH J H, 1992, Trends in Cell Biology, V2, P208, DOI 10.1016/0962-8924(92)90248-L
   HORMANN H, 1986, BIOPOLYMERS, V25, P947, DOI 10.1002/bip.360250513
   IKADA Y, 1984, ADV POLYM SCI, V57, P104
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   JAHANMIR J, 1992, SCANNING MICROSCOPY, P625
   KNOLL W, 1991, MRS BULL, V16, P29, DOI 10.1557/S0883769400056517
   KOTELIANSKI VE, 1981, EUR J BIOCHEM, V119, P616
   Kretschmann E., 1972, Optics Communications, V6, P185, DOI 10.1016/0030-4018(72)90224-6
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAI CS, 1984, BIOCHEMISTRY-US, V23, P6393, DOI 10.1021/bi00321a017
   LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805
   NORDE W, 1991, BIOL MOFIFIED BIOMAT
   PRICE TM, 1982, EUR J BIOCHEM, V129, P359, DOI 10.1111/j.1432-1033.1982.tb07058.x
   RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505
   REES WA, 1993, SCIENCE, V260, P1646, DOI 10.1126/science.8503010
   ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SCHWARTZ DK, 1992, SCIENCE, V257, P508, DOI 10.1126/science.257.5069.508
   SMITH L, 1982, J APPL POLYM SCI, V26, P1269
   TATUNASHVILI LV, 1990, J MOL BIOL, V211, P161, DOI 10.1016/0022-2836(90)90018-H
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THUNDAT T, 1992, ULTRAMICROSCOPY, V42, P1101, DOI 10.1016/0304-3991(92)90409-D
   TOONEY NM, 1983, J CELL BIOL, V97, P1686, DOI 10.1083/jcb.97.6.1686
   VAUDAUX P, 1986, BIOL BIOMECHANICAL P, P355
   Vuento M, 1988, Electron Microsc Rev, V1, P341, DOI 10.1016/0892-0354(88)90006-8
   VUILLARD L, 1990, EUR J BIOCHEM, V191, P333, DOI 10.1111/j.1432-1033.1990.tb19127.x
   WICKRAMASINGHE HK, 1989, SCI AM, V260, P98
   ZANHAUSERN F, 1992, J STRUCT BIOL, V108, P69
   ZENHAUSERN F, 1992, SCANNING, V14, P212, DOI 10.1002/sca.4950140405
   ZENHAUSERN F, 1993, J APPL PHYS, V73, P7232, DOI 10.1063/1.354010
   ZENHAUSERN F, 1993, COLLOID SURFACE B, V1, P133, DOI 10.1016/0927-7765(93)80044-Y
   ZENHAUSERN F, 1992, HELV PHYS ACTA, P820
NR 49
TC 24
Z9 24
U1 1
U2 8
PU JAPANESE SOC ELECTRON MICRO BUS CENTER ACAD SOC JAPAN
PI TOKYO
PA 16-9 HONKOMAGOME, 5-CHOME BUNKYO-KU, TOKYO 113, JAPAN
SN 0022-0744
J9 J ELECTRON MICROSC
JI J. Electron Microsc.
PD DEC
PY 1993
VL 42
IS 6
BP 378
EP 388
PG 11
WC Microscopy
SC Microscopy
GA MY236
UT WOS:A1993MY23600003
PM 8176331
DA 2018-10-19
ER

PT J
AU GUILLEMIN, G
   LAUNAY, M
   MEUNIER, A
AF GUILLEMIN, G
   LAUNAY, M
   MEUNIER, A
TI NATURAL CORAL AS A SUBSTRATE FOR FIBROBLASTIC GROWTH IN-VITRO
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RAPID COLORIMETRIC ASSAY; BONE-GRAFT; SURVIVAL
AB Coral skeleton is a naturally porous material. This biomaterial is nowadays currently used in humans as a bone graft substitute. Its open porosity provides a large area for potential cell adhesion and for this reason fibroblastic cell proliferation into this material was investigated. McCoy's human fibroblasts were cultured on coral specimens; cell viability and propagation were evaluated by the means of an MTT test and manual counting. Due to the biomaterial porosity, numerous technical adjustments were necessary to ensure an acceptable cell development and evaluation of cell populations. Cell population was evaluated every 3 days over a 24-day period. When compared to cell growth on culture membranes, fibroblasts grew slower on coral during the early time periods, but increased to 2.2 times that of controls from the 12th day after seeding. Natural coral seems to offer a suitable surface for large fibroblastic culture and could be an interesting alternative to synthetic substrates traditionally used for this purpose.
RP GUILLEMIN, G (reprint author), UNIV MED PARIS,ORTHOPAED RES LAB,10 AVE VERDUN,F-75010 PARIS,FRANCE.
CR Charmichael J., 1987, CANCER RES, V47, P936
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FINLAY GJ, 1986, EUR J CANCER CLIN ON, V22, P655, DOI 10.1016/0277-5379(86)90162-8
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   ISELT M, 1989, ARZNEIMITTEL-FORSCH, V39-2, P747
   KUTTAN R, 1975, BIOCHEM BIOPH RES CO, V64, P947, DOI 10.1016/0006-291X(75)90139-4
   MATSUDA T, 1987, J BIOMED MATER RES, V21, P499, DOI 10.1002/jbm.820210409
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OUDADESSSE H, 1989, THESIS CLERMONT FERR
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   SAUVAGE T, 1992, THESIS CLERMONTFERRA
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
NR 15
TC 17
Z9 18
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 1993
VL 4
IS 6
BP 575
EP 581
DI 10.1007/BF00125596
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MN331
UT WOS:A1993MN33100008
DA 2018-10-19
ER

PT J
AU NELSON, SR
   WOLFORD, LM
   LAGOW, RJ
   CAPANO, PJ
   DAVIS, WL
AF NELSON, SR
   WOLFORD, LM
   LAGOW, RJ
   CAPANO, PJ
   DAVIS, WL
TI EVALUATION OF NEW HIGH-PERFORMANCE CALCIUM POLYPHOSPHATE BIOCERAMICS AS
   BONE-GRAFT MATERIALS
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID ALVEOLAR RIDGE AUGMENTATION; POROUS HYDROXYAPATITE; HYDROXYLAPATITE
   BLOCKS; BIOMATERIAL ASPECTS; SUBSTITUTE; REPLAMINEFORM; PARTICLES;
   INTERFACE; STRENGTH; SURGERY
C1 UNIV TEXAS,DEPT CHEM,AUSTIN,TX 78712.
   UNIV TEXAS,DEPT MAT SCI,AUSTIN,TX 78712.
   BAYLOR COLL DENT,DEPT ORAL & MAXILLOFACIAL SURG,DALLAS,TX 75246.
   ABILENE CHRISTIAN UNIV,DEPT BIOL,ABILENE,TX 79699.
CR BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P414, DOI 10.1016/0278-2391(87)90009-7
   CAPANO PJ, 1987, THESIS U TEXAS AUSTI
   DAVIS WL, 1990, J DENT RES, V69, pA168
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   ELDEEB M, 1988, J ORAL MAXIL SURG, V46, P33
   EPPLEY BL, 1990, J CRANIOFAC SURG, V1, P1991
   FONSECA RJ, 1986, RECONSTRUCTIVE PREPR
   FRAME JW, 1981, INT J ORAL MAXILLOF, V10, P88
   FRAME JW, 1981, BIOMATERIALS, V2, P19, DOI 10.1016/0142-9612(81)90082-X
   FRAME JW, 1987, J ORAL MAXIL SURG, V45, P771, DOI 10.1016/0278-2391(87)90200-X
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   FROST HM, 1959, STAIN TECHNOL, V34, P135, DOI 10.3109/10520295909114665
   FURSETH R, 1978, INT J ORAL MAXILLOF, V7, P471, DOI 10.1016/S0300-9785(78)80039-8
   GLOWACKI J, 1981, LANCET, V1, P959
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   HESS JA, 1983, LAB MED, V14, P435
   HOLMES R E, 1986, Surgical Forum (Chicago), V37, P617
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   HOLMES RE, 1988, J ORAL MAXIL SURG, V46, P661, DOI 10.1016/0278-2391(88)90109-7
   HOLMES RE, 1987, J BIOMED MATER RES, V21, P731, DOI 10.1002/jbm.820210605
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KENT JN, 1986, J ORAL MAXIL SURG, V44, P597, DOI 10.1016/S0278-2391(86)80069-6
   LAGOW RJ, 1991, J DENT RES, V70, pA41
   MARTIN RB, 1989, BIOMATERIALS, V10, P481, DOI 10.1016/0142-9612(89)90090-2
   PEDERSEN KN, 1980, INT J ORAL MAXILLOF, V9, P140, DOI 10.1016/S0300-9785(80)80050-0
   PEDERSEN KN, 1974, INT J ORAL MAXILLOF, V3, P158, DOI 10.1016/S0300-9785(74)80020-7
   PIECUCH JF, 1984, J BIOMED MATER RES, V18, P39, DOI 10.1002/jbm.820180106
   REA FD, 1990, J DENT RES, V69, pA290
   TENCER AF, J BIOMED MATER RES, V19, P957
   Urist M. R., 1980, FUNDAMENTAL CLIN BON
   WHITE CA, 1990, J DENT RES, V69, pA168
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   WOLFORD LM, 1987, J ORAL MAXILLOFAC SU, V45, P421
   ZELLER SD, 1986, INT J ORAL MAX SURG, V15, P665, DOI 10.1016/S0300-9785(86)80106-5
NR 38
TC 15
Z9 15
U1 0
U2 1
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD DEC
PY 1993
VL 51
IS 12
BP 1363
EP 1371
DI 10.1016/S0278-2391(10)80143-0
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA MK563
UT WOS:A1993MK56300014
PM 8229417
DA 2018-10-19
ER

PT J
AU DAUBRESSE, C
   GRANDFILS, C
   JEROME, R
   TEYSSIE, P
   GOETHALS, P
   SCHACHT, E
AF DAUBRESSE, C
   GRANDFILS, C
   JEROME, R
   TEYSSIE, P
   GOETHALS, P
   SCHACHT, E
TI SYNTHESIS AND INVERSE EMULSION POLYMERIZATION OF AMINATED
   ACRYLAMIDODEXTRAN
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
ID POLYACRYL STARCH MICROPARTICLES; BIODEGRADABLE MICROSPHERES;
   NANOPARTICLES; PROTEINS; DEXTRAN; ACID
AB A chemically modified form of dextran was prepared, having a polymerizable moiety (acrylamide) and a reactive functional group (primary amine). Dextran was activated with 4-nitrophenyl-chloroformate (24 mol per polysaccharide, 9.8 mol per 100 glucose residues); 9.8% glucose residues were converted to aliphatic carbonates and 5.2% were converted to cyclic carbonates. The activated dextran was coupled with trityldiaminoethane (8 mol per 100 glucose residues), reactivated with 4-nitrophenylchloro-formate, then coupled with acryloamidodiaminohexane (6.8 mol per 100 glucose residues). The trityl group was removed by hydrolysis with trifluoroacetic acid to yield the required animated acryloamidodextran. The modified dextran was shown to be polymerizable by inverse emulsion polymerization. Submicron particles were successfully prepared, containing functional amine groups suitable for preparing drug conjugates or for modifying the surface properties of the biomaterial.
C1 UNIV LIEGE,CTR ETUD & RECH MACROMOLEC,B-4000 LIEGE,BELGIUM.
   RIJKUNIV GENT,ORGAN CHEM LAB,B-9000 GHENT,BELGIUM.
CR ARSHADY R, 1988, J MICROENCAPSUL, V5, P101, DOI 10.3109/02652048809056474
   ARTURSSON P, 1984, J PHARM SCI, V73, P1507, DOI 10.1002/jps.2600731103
   BAILLIE AJ, 1987, J PHARM PHARMACOL, V39, P832, DOI 10.1111/j.2042-7158.1987.tb05126.x
   DELUCA PP, 1988, Patent No. 4741872
   EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
   GLUKHIKH V, 1987, J POLYM SCI POL CHEM, V25, P1127, DOI 10.1002/pola.1987.080250418
   GRAILLAT C, 1986, J POLYM SCI POL CHEM, V24, P427, DOI 10.1002/pola.1986.080240304
   HASTINGS GW, 1985, POLYMERS, V26, P1311
   ILLUM L, 1989, INT J PHARM, V52, P221
   KREUTER J, 1983, INT J PHARM, V14, P43, DOI 10.1016/0378-5173(83)90113-8
   LAAKSO T, 1986, J PHARM SCI, V75, P962, DOI 10.1002/jps.2600751011
   LENAERTS V, 1989, P INT S CONTR REL BI, V16, P199
   MCLEOD AD, 1988, J PHARM SCI, V77, P704, DOI 10.1002/jps.2600770813
   SCHACHT E, 1985, Journal of Controlled Release, V2, P245, DOI 10.1016/0168-3659(85)90049-5
   Schacht E., 1984, J CONTROL RELEASE, V1, P33
   SNYDER SL, 1975, ANAL BIOCHEM, V64, P284
   STAHL GL, 1978, J ORG CHEM, V43, P2285, DOI 10.1021/jo00405a045
   VANDOORNE F, 1991, MAKROMOL CHEM, V192, P673
   VANDOORNE F, 1985, MAKROMOL CHEM, V186, P2455
NR 19
TC 5
Z9 5
U1 1
U2 3
PU ROYAL PHARMACEUTICAL SOC GREAT BRITAIN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON, ENGLAND SE1 7JN
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD DEC
PY 1993
VL 45
IS 12
BP 1018
EP 1023
DI 10.1111/j.2042-7158.1993.tb07172.x
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA MT653
UT WOS:A1993MT65300002
PM 7512648
DA 2018-10-19
ER

PT J
AU WILLNER, I
   RUBIN, S
AF WILLNER, I
   RUBIN, S
TI REVERSIBLE PHOTOREGULATION OF THE ACTIVITIES OF PROTEINS
SO REACTIVE POLYMERS
LA English
DT Article
DE PHOTOSWITCHABLE PROTEINS; PHOTOISOMERIZABLE POLYMERS; PHOTOCHROMIC
   POLYMERS; BIOELECTRONIC MATERIALS; BIOLOGICAL SWITCHES; PHOTOREGULATED
   MEMBRANE PERMEABILITY
ID PHOTORESPONSIVE POLYMERS
AB Reversible photoregulation of the activities of various proteins was achieved by two general approaches. One approach involves the covalent attachment of photoisomerizable components such as azobenzene units or thiophenefulgide components. In one of the photoisomer states of the photoactive units, the tertiary structure of the proteins is retained and, consequently, their biological functionalities are switched ''ON''. In the complementary photoisomer state, the structure of the proteins is distorted and its activities are switched ''OFF''. The hydrolytic activities of papain have been photostimulated by covalent linkage of azobenzene units. While trans-azobenzene-modified papain reveals bioactivity towards hydrolysis of N-alpha-benzoyl-D,L-arginine-nitroanilide (7), cisazobenzene-modified papain is switched ''OFF'' towards the hydrolytic process. Similarly, association of the saccharide 4-nitrophenyl alpha-D-mannopyranoside (11) to thiophenefulgide-modified concanavalin A is photostimulated. The second approach for controlling the activities of biomaterials involves their immobilization in photoisomerizable polymers. In these systems photostimulated transport of the protein substrates across the polymer matrices triggered ''ON-OFF'' the functions of the encapsulated biomaterial. alpha-Chymotrypsin was immobilized in the series of photochromic copolymers consisting of acrylamide and 1-beta-(methacryloxy)ethyl-3,3'-dimethyl-6-nitrospiroindoline-2,2'-[2H-1]benzopyran(l2), bis(4-dimethylaminophenyl)-(4-vinylphenyl)methyl leucohydroxide (14) or 4-(methacryloylamino) azobenzene (15). The hydrolysis of N-(3 -carboxypropionyl) -L-phenylalanine p-nitroanilide (13) by alpha-chymotrypsin is controlled by the permeability properties of 12 across the different photoisomer states of the respective polymers.
C1 HEBREW UNIV JERUSALEM,FARKAS CTR LIGHT INDUCED PROC,IL-91904 JERUSALEM,ISRAEL.
RP WILLNER, I (reprint author), HEBREW UNIV JERUSALEM,INST CHEM,IL-91904 JERUSALEM,ISRAEL.
CR BIETH J, 1973, BIOCHEMISTRY-US, V12, P3023, DOI 10.1021/bi00740a012
   BIETH J, 1969, P NATL ACAD SCI USA, V66, P850
   GALLEY KT, 1973, BIOCHEM BIOPH RES CO, V50, P300, DOI 10.1016/0006-291X(73)90840-1
   IRIE M, 1986, MACROMOLECULES, V19, P2480, DOI 10.1021/ma00164a004
   IRIE M, 1979, MACROMOLECULES, V12, P1176, DOI 10.1021/ma60072a032
   IRIE M, 1985, MACROMOL CHEM RAPID, V5, P829
   TURNER AD, 1987, J AM CHEM SOC, V109, P1274, DOI 10.1021/ja00238a062
   TURNER AD, 1988, J AM CHEM SOC, V110, P244, DOI 10.1021/ja00209a040
   WILLNER I, 1991, J AM CHEM SOC, V113, P3321, DOI 10.1021/ja00009a016
   WILLNER I, 1991, J AM CHEM SOC, V113, P4013, DOI 10.1021/ja00010a065
   WILLNER I, 1992, J AM CHEM SOC, V114, P3150, DOI 10.1021/ja00034a078
   WILLNER I, 1993, J AM CHEM SOC, V115, P8960
   WILLNER I, BIOORGANIC PHOTOCHEM, V2
NR 13
TC 23
Z9 24
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-1137
J9 REACT POLYM
JI React. Polym.
PD DEC
PY 1993
VL 21
IS 3
BP 177
EP 186
DI 10.1016/0923-1137(93)90120-5
PG 10
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA MQ038
UT WOS:A1993MQ03800004
DA 2018-10-19
ER

PT J
AU HERBERT, ST
   BADYLAK, SF
   GEDDES, LA
   HILLBERRY, B
   LANTZ, GC
   KOKINI, K
AF HERBERT, ST
   BADYLAK, SF
   GEDDES, LA
   HILLBERRY, B
   LANTZ, GC
   KOKINI, K
TI ELASTIC-MODULUS OF PREPARED CANINE JEJUNUM, A NEW VASCULAR GRAFT
   MATERIAL
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE BIOMATERIAL; MECHANICAL PROPERTIES; VASCULAR GRAFT
ID DIAMETER
AB The submucosal connective tissue of the jejunum has been shown to be suitable for use as a vascular graft in preliminary dog studies. To partially characterize the mechanical properties of this new graft material, longitudinal stress (sigma)-strain (epsilon)-data were obtained on 13 specimens of canine jejunum, stripped of its mucosal and external smooth-muscle layers. The ratio of stress to strain is the modulus of elasticity (E). It was found that the stress sigma-strain epsilon-data fitted the expression sigma = Kepsilon(alpha) very well. For a typical specimen sigma = 2.69 x 10(6) epsilon 2.33. The modulus of elasticity (E = sigma1-1/alpha K 1/alpha) was found to increase with increasing stress, ranging from about 2,000 to 9,000 mmHg. For the average specimen E = 573 sigma 0.57 sigma 0.57, where sigma is in mmHg, (1 mmHg = 133.3 Pascals).
C1 PURDUE UNIV, WILLIAM A HILLENBRAND BIOMED ENGN CTR, W LAFAYETTE, IN 47907 USA.
OI Badylak, Stephen/0000-0003-3555-0689
FU NHLBI NIH HHS [HL 39724-01A1]
CR BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P458, DOI 10.1113/jphysiol.1961.sp006687
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686
   BLAKEMORE AH, 1954, ANN SURG, V140, P324, DOI 10.1097/00000658-195409000-00008
   CALLOW AD, 1986, ASTM STP, V698, P11
   GOW BS, 1968, CIRC RES, V23, P111, DOI 10.1161/01.RES.23.1.111
   HUGHES DJ, 1985, MED BIOL ENG COMPUT, V23, P197, DOI 10.1007/BF02446857
   KINLEY CE, 1974, SURGERY, V75, P28
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LYMAN DJ, 1973, ESSENTIAL PHYSICAL C, P115
   NICKERSON JL, 1964, AMRLTDR6423 US AER M
   POSEY JA, 1973, CARDIOVASC RES CTR B, V111, P83
   SEIFERT KB, 1979, SURG FORUM, V30, P206
   SUMNER DS, 1969, ARCH SURG-CHICAGO, V99, P606
   SUMNER DS, 1970, SURG GYNECOL OBSTETR, V131, P417
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WESOLOWSKI SA, 1963, SURGERY, V53, P19
   WESOLOWSKI SA, 1965, BIOPHYSICAL MECHANIS, P331
NR 19
TC 13
Z9 15
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD NOV-DEC
PY 1993
VL 21
IS 6
BP 727
EP 733
DI 10.1007/BF02368651
PG 7
WC Engineering, Biomedical
SC Engineering
GA MN227
UT WOS:A1993MN22700014
PM 8116923
DA 2018-10-19
ER

PT J
AU TANNER, PA
AF TANNER, PA
TI COMMENT ON THE LUMINESCENCE STUDIES USING SOLID DATURA-INNOXIA
   BIOMATERIAL
SO APPLIED SPECTROSCOPY
LA English
DT Note
DE LUMINESCENCE; BIOMASS MATERIAL
ID URANYL-ION; ENERGY-TRANSFER; EXCITED-STATE; SPECTROSCOPY; CS2UO2CL4;
   SPECTRA
RP TANNER, PA (reprint author), CITY POLYTECH HONG KONG,DEPT BIOL & CHEM,TAT CHEE AVE,KOWLOON,HONG KONG.
CR BARKER TJ, 1987, INORG CHEM, V26, P1721, DOI 10.1021/ic00258a018
   BRITTAIN HG, 1981, J PHYS CHEM-US, V85, P3073, DOI 10.1021/j150621a012
   DENNING RG, 1981, MOL PHYS, V44, P209, DOI 10.1080/00268978100102391
   DENNING RG, 1992, STRUCT BOND, V79, P215
   DENNING RG, 1975, MOL PHYS, V30, P1819, DOI 10.1080/00268977500103311
   Dieke G.H., 1949, SPECTROSCOPIC PROPER
   FLINT CD, 1983, POLYHEDRON, V2, P623, DOI 10.1016/S0277-5387(00)81522-3
   FLINT CD, 1981, INORG CHEM, V20, P4405, DOI 10.1021/ic50226a073
   FLINT CD, 1982, J PHYS CHEM-US, V86, P1921, DOI 10.1021/j100207a038
   FLINT CD, 1981, MOL PHYS, V44, P411, DOI 10.1080/00268978100102541
   FLINT CD, 1983, CHEM PHYS LETT, V102, P249, DOI 10.1016/0009-2614(83)87401-6
   FLINT CD, 1981, J CHEM SOC FARAD T 2, V77, P1865, DOI 10.1039/f29817701865
   FLINT CD, 1978, J CHEM SOC FARAD T 2, V74, P2210, DOI 10.1039/f29787402210
   FLINT CD, 1979, J CHEM SOC FARAD T 2, V75, P1168, DOI 10.1039/f29797501168
   KE HYD, 1993, APPL SPECTROSC, V47, P44, DOI 10.1366/0003702934048569
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   MORRISON ID, 1988, CHEM PHYS LETT, V143, P409, DOI 10.1016/0009-2614(88)87057-X
   SELZER PM, 1981, LASER SPECTROSCOPY S, P119
   TANNER PA, 1990, SPECTROCHIM ACTA A, V46, P1259, DOI 10.1016/0584-8539(90)80203-B
   THORNE JRG, 1987, J LUMIN, V38, P156, DOI 10.1016/0022-2313(87)90092-5
NR 21
TC 5
Z9 5
U1 0
U2 0
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA PO BOX 1438, FREDERICK, MD 21701
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD NOV
PY 1993
VL 47
IS 11
BP 1949
EP 1950
DI 10.1366/0003702934065894
PG 2
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA MH157
UT WOS:A1993MH15700035
DA 2018-10-19
ER

PT J
AU STASTNY, K
   HORA, K
   STOL, M
AF STASTNY, K
   HORA, K
   STOL, M
TI PRELIMINARY-REPORT ON USE OF A P(HEMA) COLLAGEN COMPOSITE IN
   MAXILLOFACIAL SURGERY
SO BIOMATERIALS
LA English
DT Article
DE P(HEMA); COLLAGEN; COMPOSITE IMPLANT
ID POLY(2-HYDROXYETHYL METHACRYLATE)-COLLAGEN COMPOSITES
AB After being thoroughly tested on animals, a composite polymer material based on poly(2-hydroxyethyl methacrylate) and calf skin collagen has been allowed in a limited clinical trial in the Czech Republic. Up to now, the medical use of the biomaterial comprises implants for maxillo-facial surgery, i.e. augmentation of soft tissues (seven cases); reparation of fractured eye sockets (12 cases) and in special indications (two cases). The clinical results obtained so far are presented here as case reports. These preliminary results are very encouraging for a broader utilization of this type of biomaterial in the surgical fields of human medicine.
C1 INST RHEUMATOL,CS-12850 PRAGUE 2,CZECHOSLOVAKIA.
   CHARLES UNIV,FAC MED 1,STOMATOL CLIN 1,PRAGUE,CZECHOSLOVAKIA.
RI Hora, Karel/D-7059-2018
OI Hora, Karel/0000-0003-3504-855X
CR BILY B, 1977, ACTA FM U BRUNENSIS, V55, P53
   Chvapil M, 1969, J Biomed Mater Res, V3, P315, DOI 10.1002/jbm.820030211
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   KLIMENT K, 1971, Patent No. 3563925
   KLIMENT K, 1966, Patent No. 4659
   KVASNICKA J, 1988, Zahn- Mund- und Kieferheilkunde, V76, P151
   KVASNICKA J, 1988, Zahn- Mund- und Kieferheilkunde, V76, P250
   SMETANA K, 1992, BIOMATERIALS, V9, P639
   STOL M, 1991, BIOMATERIALS, V12, P454, DOI 10.1016/0142-9612(91)90142-W
   STOL M, 1991, J BIOACT COMPAT POL, V6, P308, DOI 10.1177/088391159100600309
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   STOL M, 1980, Patent No. 5125
   STOL M, 1984, Patent No. 2080814
   STOL M, 1986, POLYM SCI TECHNOL, V34, P139
   STOL M, 1984, Patent No. 4463490
   STOL M, 1984, Patent No. 4427802
   STOL M, 1986, Patent No. 3348
   STOL M, 1987, ADV BIOMATER, V7, P575
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
NR 20
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1993
VL 14
IS 14
BP 1105
EP 1108
DI 10.1016/0142-9612(93)90212-K
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH266
UT WOS:A1993MH26600012
PM 8312464
DA 2018-10-19
ER

PT J
AU ZAVREL, V
   STOL, M
AF ZAVREL, V
   STOL, M
TI P(HEMA) COMPOSITE AS ALLOGRAFTING MATERIAL DURING THERAPY OF
   PERIODONTAL-DISEASE - 3 CASE-REPORTS
SO BIOMATERIALS
LA English
DT Article
DE P(HEMA); COMPOSITES; ALLOGRAFTING; PERIODONTAL DISEASE
ID GUIDED TISSUE REGENERATION; HUMAN INTRABONY DEFECTS; IMPLANTS; BONE
AB The p(HEMA) composite is shown to be a possibly effective allografting material for therapy of periodontal disease. Three cases from a clinical pilot study are presented in this report. The p(HEMA) composite may be used alone or as a part of more complex biomaterial, together with tricalcium phosphate ceramics. Further scientific and clinical work is needed for definitive judgement on the use of the p(HEMA) composite in periodontology.
C1 INST RHEUMATOL PRAGUE,PRAGUE,CZECHOSLOVAKIA.
RP ZAVREL, V (reprint author), CHARLES UNIV,DEPT PERIODONTOL,DENT CLIN 2,KARLOVO NAM 32,CS-12111 PRAGUE 2,CZECHOSLOVAKIA.
CR BECKER W, 1987, J PERIODONTOL, V58, P819, DOI 10.1902/jop.1987.58.12.819
   BECKER W, 1986, J PERIODONTOL, V57, P277, DOI 10.1902/jop.1986.57.5.277
   BIRKEDALHANSEN H, 1988, PERIODONTOLOGY TODAY, P227
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   BRANDTZAEG P, 1988, PERIODONTOLOGY TODAY, P196
   CAFFESSE RG, 1991, J PERIODONTOL, V62, P21, DOI 10.1902/jop.1991.62.1.21
   GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338
   KON S, 1991, INT J PERIODONT REST, V11, P59
   LISTGARTEN MA, 1987, J PERIODONTAL RES, V22, P172, DOI 10.1111/j.1600-0765.1987.tb01560.x
   MELLONIG JT, 1990, INT J PERIODONT REST, V10, P289
   SCHROEDER HE, 1991, ORAL STRUCTURAL BIOL, P407
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   STOL M, 1991, BIOMATERIALS, V12, P454, DOI 10.1016/0142-9612(91)90142-W
   STOL M, 1991, J BIOACT COMPAT POL, V6, P308, DOI 10.1177/088391159100600309
   YUKNA RA, 1992, J PERIODONTOL, V63, P431, DOI 10.1902/jop.1992.63.5.431
NR 16
TC 4
Z9 4
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1993
VL 14
IS 14
BP 1109
EP 1112
DI 10.1016/0142-9612(93)90213-L
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH266
UT WOS:A1993MH26600013
PM 8312465
DA 2018-10-19
ER

PT J
AU OGBAN, IU
   OTAIGBE, JOE
AF OGBAN, IU
   OTAIGBE, JOE
TI CATIONIC EXCHANGER FROM POLYMERIZED BIG-MATERIAL WASTES - DEVICE FOR
   CONCENTRATING AND RECOVERING METAL-IONS FROM EFFLUENTS
SO BULLETIN OF ELECTROCHEMISTRY
LA English
DT Article
DE CATIONIC EXCHANGER; BIOMATERIAL; EFFLUENTS
AB Peanut and onion skin tannins were respectively co-polymerized, under acid and base catalysis, with palm-nut fibre and corn cob hydroxylate to produce cation exchangers. These were used for the optimum removal of toxic and electroplating effluent metal ions.
   Evaluation of the exchangers under static and dynamic tests showed that 70 - 90% and 60 - 98% of the heavy metal ions studied were sorbed by the acid and base-catalysed resins respectively. These results indicate a higher degree of polymerization with corresponding high exchange sites with the base catalysed resin. The maximum sorptive capacity of the resins for the various ions (1.82 meq/g and 1.85 meq/g of sorbent) compared favourably with the maximum sorptive capacity of some commercial cation exchange resins based on phenol formaldehyde e.g. Wofatit P. (1.9 meq/g).
   Based on the result of this study, and with our interests focused on the study of opportunities for waste material utilization as well as exploring new sources of raw material, peanunt/onion skin, palm-nut fibre and corn cob show promise as substrate for the production of cation exchanger capable of concentrating and recovering metal ions from electroplating and allied industrial or domestic effluents. With this demonstration, the use of relatively inexpensive agro-waste products - peanut and onion skin as source of tanning and palm nut fibre and corn cob as source of furfuraldehyde - for the production of industrial water treatment device should be given adequate consideration.
C1 CRS COLL EDUC,SCH NAT & APPL SCI,GULABAR,NIGERIA.
CR Adams B.A., 1935, J SOC CHEM IND LOND, V54, p1T, DOI DOI 10.1002/JCTB.5000540214
   BLAEDEL WJ, 1972, ANAL CHEM, V43, P109
   BUCHUALD H, 1960, ION EXCHANGE RESINS, V6, P25
   DOMPIER FW, 1973, J APPL ELECTROCHEM, V3, P169
   FREIDIGER TW, 1972, ANAL CHEM, V43, P707
   HANER JE, 1975, ANAL CHEM, V47, P601
   ODOZI TO, 1985, J OIL COLOUR CHEM AS, V68, P94
   OGBAN IU, 1989, B ELECTROCHEM, V5, P667
   PASSION H, 1961, PHARMACOL REV, V13, P85
   PAUL NE, 1980, AGR WASTES, V2, P42
   PETERING HG, 1978, ENVIRON HEALTH PERSP, V25, P141, DOI 10.2307/3428725
   PIZZI A, 1980, MACROMOL SC REV, V18
   ROBERT L, 1973, ANAL CHEM, V24, P2681
   SUSSAN M, 1981, ANAL J ROYAL SOC
NR 14
TC 0
Z9 0
U1 0
U2 0
PU CENTRAL ELECTROCHEM RES INST
PI KARAIKKUDI
PA ATTN: DIRECTOR, KARAIKKUDI 623 006, INDIA
SN 0256-1654
J9 B ELECTROCHEM
JI Bull. Electrochem.
PD NOV-DEC
PY 1993
VL 9
IS 11-12
BP 644
EP 655
PG 12
WC Electrochemistry
SC Electrochemistry
GA RA876
UT WOS:A1993RA87600027
DA 2018-10-19
ER

PT J
AU WAGNER, WR
   JOHNSON, PC
   KORMOS, RL
   GRIFFITH, BP
AF WAGNER, WR
   JOHNSON, PC
   KORMOS, RL
   GRIFFITH, BP
TI EVALUATION OF BIOPROSTHETIC VALVE-ASSOCIATED THROMBUS IN VENTRICULAR
   ASSIST DEVICE PATIENTS
SO CIRCULATION
LA English
DT Article
DE THROMBOEMBOLISM; LEFT VENTRICULAR ASSIST DEVICE; BIOPROSTHESIS; NOVACOR
ID ARTIFICIAL SURFACES; SYSTEM; COMPLICATIONS; EXPERIENCE; HEART
AB Background. Thromboembolic events may be related to thrombotic deposition on prosthetic valves. In a left ventricular assist device (LVAD) that contains two porcine pericardial bioprosthetic valves in addition to significant associated biomaterial placement, this may be particularly true. Thrombotic deposits on valves removed from LVADs at autopsy or heart transplantation were scored to determine (1) the nature and location of valvular deposition, (2) whether deposition was related to thromboembolic events, (3) correlations between deposition and patient hemodynamic and coagulation parameters, and (4) implant time dependency.
   Methods and Results. Novacor LAVDs were implanted in 23 patients as a bridge to transplantation for 1 to 303 days. Photographs of the concave (downstream) and convex (upstream) side of the inflow and outflow valve were made at explant and later scored for (1) total thrombus area (10=equivalent of cusp area), (2) percent of cusp area occupied by solid thrombus, (3) thrombus color (10=dark red, 0=white), and (4) average percent of valve strut height involved with thrombus (from a side view). The inflow valve was shown to have heavier and redder deposition than the outflow valve. This was also true for the concave versus the convex side. Heaviest deposition was seen on the inflow valve concave side, which rests within the LVAD pumping sac and may be subject to poor convection. Patients with neurological thromboembolic events (8/23) during implantation had heavier deposition on the inflow valve concave side (5.7+/-2.7 versus 4.6+/-2.2, P<.05). Pump volumetric output was also found to negatively correlate with thrombus area on this valve and side (r=-.61, P=.002). Platelet release (platelet factor 4) was correlated with thrombus involvement on the upstream (convex) side of the inflow valve (r=.82, P=.002). No significant dependence of deposition on the implant time was found.
   Conclusions. Valve thrombus deposition was related to thromboembolic events. Pump volumetric output and platelet release were found to be related to deposition. These results may have implications for the role of hemodynamics and platelet activation in thromboembolism associated with prosthetic valve placement in general.
C1 UNIV PITTSBURGH,ARTIFICIAL HEART & LUNG PROGRAM,PITTSBURGH,PA 15260.
   UNIV PITTSBURGH,DEPT SURG,DIV CARDIOTHORAC SURG,PITTSBURGH,PA 15260.
   UNIV PITTSBURGH,DEPT SURG,DIV PLAST & RECONSTRUCT SURG,PITTSBURGH,PA 15260.
CR ADDONIZIO VP, 1985, CARDIOL CLIN, V3, P431
   ANDERSON JM, 1987, BLOOD COMPATIBILITY, P103
   DIDISHEIM P, 1989, T AM SOC ART INT ORG, V35, P54
   FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080, DOI 10.1016/0003-4975(92)90393-I
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   ICENOGLE TB, 1989, ARTIF ORGANS, V13, P532
   IP JH, 1991, AORTIC VALVE, P319
   JAMIESON WRE, 1990, J THORAC CARDIOV SUR, V99, P543
   JOHNSON PC, 1991, BLOOD, V78, pA215
   KORMOS RL, 1990, ANN THORAC SURG, V49, P261, DOI 10.1016/0003-4975(90)90148-Y
   MCCARTHY PM, 1991, J THORAC CARDIOV SUR, V102, P578
   PANTALOS GM, 1990, ARTIF ORGANS, V14, P348, DOI 10.1111/j.1525-1594.1990.tb02979.x
   PIFARRE R, 1991, THROMB HAEMOSTASIS, V65, P850
   PORTNER PM, 1983, ANN NY ACAD SCI, V416, P471, DOI 10.1111/j.1749-6632.1983.tb35207.x
   PORTNER PM, 1984, ASSISTED CIRCULATION, V2, P115
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   TANAKA K, 1991, ARTIF ORGANS, V15, P59
   TANAKA K, 1992, ARTIF ORGANS, V16, P182
   Wagner W R, 1992, ASAIO J, V38, pM634, DOI 10.1097/00002480-199207000-00114
   Woodard J C, 1992, ASAIO J, V38, pM216, DOI 10.1097/00002480-199207000-00023
   ZEIEN LB, 1990, ARCH PATHOL LAB MED, V114, P933
   COMBINED REGISTRY CL
NR 22
TC 36
Z9 37
U1 1
U2 1
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD NOV
PY 1993
VL 88
IS 5
BP 2023
EP 2029
DI 10.1161/01.CIR.88.5.2023
PN 1
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA ME833
UT WOS:A1993ME83300004
PM 8222094
OA Bronze
DA 2018-10-19
ER

PT J
AU KE, HYD
   RAYSON, GD
   JACKSON, PJ
AF KE, HYD
   RAYSON, GD
   JACKSON, PJ
TI LUMINESCENCE STUDY OF EU3+ BINDING TO IMMOBILIZED DATURA-INNOXIA
   BIOMATERIAL
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID EU(III) LUMINESCENCE; RAT ONCOMODULIN; ALGAE; SITE; SPECTROSCOPY; ION
AB The spectrally and temporally resolved Eu3+ excitation signals have been measured for solid samples of Eu3+-(silicate polymer), Eu3+-(immobilized Datura), and Eu3+-Datura at liquid nitrogen temperature. The binding capacity of Eu3+ to Datura innoxia cell material has been found to be significantly enhanced when immobilized in a polysilicate matrix. New binding sites inaccessible to Eu3+ in free cell material have been observed for the binding of Eu3+ after immobilization of the cultured biomaterials. However, chemical alteration of the cell material resulting from this immobilization process has not been observed. The chemical environment of the binding sites responsible for the binding of Eu3+ in immobilized and free D. innoxia cell material has been demonstrated to be significantly different. This difference results from the immobilization of the cell material within a polysilicate matrix.
C1 NEW MEXICO STATE UNIV,DEPT CHEM & BIOCHEM,LAS CRUCES,NM 88003.
CR ALBIN M, 1985, INORG CHEM, V24, P895, DOI 10.1021/ic00200a020
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P496, DOI 10.1021/es00027a007
   CRIST RH, 1992, ENVIRON SCI TECHNOL, V26, P1523, DOI 10.1021/es00032a004
   DARNALL DW, 1991, Patent No. 4992207
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GARNHAM GW, 1992, ENVIRON SCI TECHNOL, V26, P1764, DOI 10.1021/es00033a008
   Good N E, 1972, Methods Enzymol, V24, P53
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   HAPAK RC, 1989, J BIOL CHEM, V264, P18751
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   HENZL MT, 1988, J BIOL CHEM, V263, P10674
   HORROCKS WD, 1981, ACCOUNTS CHEM RES, V14, P384, DOI 10.1021/ar00072a004
   KE HD, IN PRESS ENV SCI TEC
   KE HYD, 1993, APPL SPECTROSC, V47, P44, DOI 10.1366/0003702934048569
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KUBIAK WW, 1989, ANAL CHEM, V61, P468, DOI 10.1021/ac00180a018
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   PALMISANO WA, 1990, J BIOL CHEM, V265, P14450
   RAYSON GD, 1992, APPL SPECTROSC, V46, P1245, DOI 10.1366/0003702924123999
   TREVINO CL, 1990, J BIOL CHEM, V265, P9694
   WRIGHT PJ, 1991, ENVIRON SCI TECHNOL, V25, P287, DOI 10.1021/es00014a011
NR 25
TC 7
Z9 7
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD NOV
PY 1993
VL 27
IS 12
BP 2466
EP 2471
DI 10.1021/es00048a024
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA ME578
UT WOS:A1993ME57800038
DA 2018-10-19
ER

PT J
AU GRISTINA, AG
   GIRIDHAR, G
   GABRIEL, BL
   NAYLOR, PT
   MYRVIK, QN
AF GRISTINA, AG
   GIRIDHAR, G
   GABRIEL, BL
   NAYLOR, PT
   MYRVIK, QN
TI CELL BIOLOGY AND MOLECULAR MECHANISMS IN ARTIFICIAL DEVICE INFECTIONS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE ARTIFICIAL DEVICE INFECTION; BACTERIA; PATHOGENESIS; MOLECULAR MECHANISM
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; FOREIGN-BODY INFECTION; SPATIAL
   ARRANGEMENT; MICROBIAL ADHESION; TISSUE INTEGRATION; BACTERIAL ADHESION;
   EPIDERMIDIS SLIME; SURFACES; INVITRO; PATHOGENESIS
AB Biomaterials are being used with increasing frequency for tissue substitution. Complex devices such as total joint replacement and the total artificial heart represent combinations of polymers and metal alloys for system and organ replacement. The major barrier to the extended use of these devices is bacterial adhesion to biomaterials, which causes biomaterial-centered infection, and the lack of successful tissue integration or compatibility with biomaterial surfaces. Adhesion-mediated infections are extremely resistant to antibiotics and host defenses and frequently persist until the biomaterial or foreign body is-removed. The pathogenesis of adhesive infections is related, in part, to preferential colonization of ''inert'' substrata whose surfaces are not integrated with healthy tissues composed of living cells and intact extracellular polymers. Tissue integration is an interesting parallel to microbial adhesion and is a desired phenomenon for the biocompatibility of certain implants and biomaterials. Tissue integration requires a form of eukaryocytic adhesion or compatibility with possible chemical integration to an implant surface. Many of the fundamental principles of interfacial science apply to both microbial adhesion and to tissue integration and are general to and independent of the substratum materials involved. interactions of biomaterials with bacteria and tissue cells are directed not only by specific receptors and outer membrane molecules on the cell surface, but also by the atomic geometry and electronic state of the biomaterial surface. An understanding of these mechanisms is important to all fields of medicine and is derived from and relevant to studies in microbiology, biochemistry, and physics. modifications of biomaterial surfaces at an atomic level will allow the programming of cell-to-substratum events, thereby diminishing infection by enhancing tissue compatibility or integration, or by directly inhibiting bacterial adhesion.
C1 INST KNOXVILLE,KNOXVILLE,TN.
RP GRISTINA, AG (reprint author), MSRI,2190 FOX MILL RD,HERNDON,VA 22071, USA.
CR Andrade JD, 1985, SURFACE INTERFACIAL, VI, P15
   ARCHER GL, 1984, J INFECT DIS, V149, P913, DOI 10.1093/infdis/149.6.913
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BUSSCHER HJ, 1991, J BIOMAT SCI-POLYM E, V3, P85, DOI 10.1163/156856292X00097
   BUSSCHER HJ, 1991, CELL MATER, V1, P49
   CHAUDHARI P, 1986, SCI AM, V255, P136, DOI 10.1038/scientificamerican1086-136
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   CHRISTENSEN GD, 1985, BACTERIAL ADHESION M, P278
   CIERNY G, 1986, 53 ANN M FEBR 20 25, P86
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Dougherty S H, 1982, Curr Probl Surg, V19, P265
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   ENGEL T, 1986, SCIENCE, V234, P327, DOI 10.1126/science.234.4774.327
   Fletcher M, 1980, BACTERIAL ADHERENC B, V6, P345
   GIBBONS RJ, 1980, BACTERIAL ADHERENC B, V6, P63
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147
   GOMER R, 1982, SCI AM, V247, P98, DOI 10.1038/scientificamerican0882-98
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1983, J BONE JOINT SURG AM, V65, P128, DOI 10.2106/00004623-198365010-00021
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   Gristina AG, 1989, INFECT ORTHOPAEDIC P, P30
   Gristina AG, 1987, PATHOGENICITY CLIN S, P143
   HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211
   ICHIMAN Y, 1981, J APPL BACTERIOL, V51, P229, DOI 10.1111/j.1365-2672.1981.tb01237.x
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   JONES GW, 1983, CRC CR REV MICROBIOL, V10, P229
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   KLOCK JC, 1976, BLOOD, V48, P149
   MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   NAYLOR P, 1988, ORTHOP T, V12, P524
   NICHOLS WW, 1988, ANTIMICROB AGENTS CH, V32, P518, DOI 10.1128/AAC.32.4.518
   NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291
   NOONAN JR, 1986, SCIENCE, V234, P310, DOI 10.1126/science.234.4774.310
   PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349
   PULVERER G, 1987, ZENTRALBL BAKTER A S, V16
   Savage D. C., 1985, BACTERIAL ADHESION M
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110
   SUGARMAN B, 1984, INFECTIONS ASS PROST
   TROMP RM, 1986, SCIENCE, V234, P304, DOI 10.1126/science.234.4774.304
   VOYTEK A, 1988, BIOMATERIALS, V9, P107, DOI 10.1016/0142-9612(88)90080-4
   WRANGSTADH M, 1986, ARCH MICROBIOL, V145, P220, DOI 10.1007/BF00443649
   YOSHIDA K, 1979, J APPL BACTERIOL, V47, P299, DOI 10.1111/j.1365-2672.1979.tb01758.x
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 53
TC 83
Z9 83
U1 2
U2 9
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD NOV
PY 1993
VL 16
IS 11
BP 755
EP 763
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA MU176
UT WOS:A1993MU17600003
PM 8150521
DA 2018-10-19
ER

PT J
AU WERKMEISTER, JA
   TEBB, TA
   WHITE, JF
   RAMSHAW, JAM
AF WERKMEISTER, JA
   TEBB, TA
   WHITE, JF
   RAMSHAW, JAM
TI MONOCLONAL-ANTIBODIES TO TYPE-VI COLLAGEN DEMONSTRATE NEW TISSUE
   AUGMENTATION OF A COLLAGEN-BASED BIOMATERIAL IMPLANT
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE COLLAGEN TYPE-VI; MONOCLONAL ANTIBODIES; IMMUNOHISTOLOGY; VASCULAR
   PROSTHESIS; BIOMATERIAL
ID PROTEINS
AB We developed a panel of highly specific monoclonal antibodies (MAb) to either human or dog collagen Type VI. Various degrees of species crossreactivities were found with ELISA and immunohistology. Because of these differentiating species specificities, which allowed distinction between the original donor collagen and newly formed host collagen, the MAb proved to be valuable tools in examination of explanted samples of an ovine composite vascular prosthesis retrieved from a canine model. With an MAb that reacts with dog but not sheep collagen Type VI, newly synthesized pockets of collagen Type VI could readily be detected within the prosthesis as early as 3 months after implantation. These areas were associated with regions of cell infiltration, presumably derived from the host. This association was also apparent in the newly formed intimal region of the prosthesis where only host cells were found. Another of the MAb, which was positive against human but not sheep collagen, was also used to demonstrate marked deposition of host collagen Type VI in a retrieved human sample of the prosthesis. In this case the antibody was able to detect collagen on a formalin-fixed tissue, which would broaden the scope of its use in clinical and pathological situations. Use of these novel antibody probes provides a rapid marker for new tissue augmentation of implanted biological devices which would be an indicator of the long-term performance of a prosthesis.
C1 CSIRO,DIV BIOMOLEC ENGN,343 ROYAL PARADE,PARKVILLE,VIC 3052,AUSTRALIA.
RI White, Jacinta/D-6961-2013; Ramshaw, John/A-9411-2011
OI White, Jacinta/0000-0002-4855-0170; 
CR AYAD S, 1984, COLLAGEN REL RES, V4, P165
   HESSLE H, 1984, J BIOL CHEM, V259, P3955
   KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINSENMAYER TF, 1986, EXP CELL RES, V165, P518, DOI 10.1016/0014-4827(86)90604-X
   MURATA Y, 1990, OPHTHALMIC RES, V22, P144, DOI 10.1159/000267015
   PERLOFF LJ, 1981, SURGERY, V89, P31
   RAMSHAW JAM, 1988, ANAL BIOCHEM, V168, P82, DOI 10.1016/0003-2697(88)90013-9
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TRUEB B, 1987, EUR J BIOCHEM, V166, P699, DOI 10.1111/j.1432-1033.1987.tb13568.x
   Werkmeister J A, 1991, J Long Term Eff Med Implants, V1, P107
   WERKMEISTER J A, 1990, Clinical Materials, V6, P13, DOI 10.1016/0267-6605(90)90040-3
   WERKMEISTER JA, 1991, J HISTOCHEM CYTOCHEM, V39, P1215, DOI 10.1177/39.9.1918939
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1989, J BIOMED MATER RES-A, V23, P273, DOI 10.1002/jbm.820231403
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
NR 16
TC 16
Z9 17
U1 0
U2 1
PU HISTOCHEMICAL SOC INC
PI NEW YORK
PA MT SINAI MEDICAL CENTER 19 EAST 98TH ST SUTIE 9G, NEW YORK, NY 10029
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD NOV
PY 1993
VL 41
IS 11
BP 1701
EP 1706
DI 10.1177/41.11.8409376
PG 6
WC Cell Biology
SC Cell Biology
GA MD734
UT WOS:A1993MD73400015
PM 8409376
OA Bronze
DA 2018-10-19
ER

PT J
AU IRIGARAY, JL
   SAUVAGE, T
   OUDADESSE, H
   ELFADL, H
   DESCHAMPS, N
   LEFAIVRE, J
   BARLET, JP
   TERVERS, S
   TIXER, H
AF IRIGARAY, JL
   SAUVAGE, T
   OUDADESSE, H
   ELFADL, H
   DESCHAMPS, N
   LEFAIVRE, J
   BARLET, JP
   TERVERS, S
   TIXER, H
TI STUDY OF THE MINERALIZATION OF CORAL IMPLANTED IN-VIVO BY
   RADIOACTIVE-TRACERS
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article
AB Coral has ben used for the last ten years as bone substitution in the body because of its mechanical an osteoconductor properties. Our primary studies have shown, for the first time, the quantitative behavior of the atomic components. We study by some physical method of analysis a biocoral implanted ''in vivo''. The natural biocorals used in this work are the calcium carbonated exoskeletons built by Madrepian coral polyps. Neutron activation analysis showed that initial coral, essentially CaCO3, becomes a new material which has a mineral composition close to that of bone. In this work, we have studied the calcification mechanism of this implant by using radioactive tracers. We have established the transfer kinetics of calcium biomaterial in the blood circuit and showed its use by the organism for skeleton mineralization.
C1 INRA,F-63122 ST GENES CHAMPANE,FRANCE.
   CENS,LAB PIERRE SUE,F-91191 GIF SUR YVETTE,FRANCE.
   UNIV CLERMONT FERRAND,CLERMONT FERRAND,FRANCE.
   CHR UNIV CLERMONT FERRAND,SERV PROF LEVAI,CLERMONT FERRAND,FRANCE.
RP IRIGARAY, JL (reprint author), IN2P3,LAB PHYS CORPUSCULAIRE CLERMONT FERRAND,CNRS,F-63177 CLERMONT FERRAND,FRANCE.
CR ANDERSON ND, 1979, JOHNS HOPKINS MED J, V145, P73
   BESANCON P, 1971, THESIS PARIS
   ELFADL H, THESIS U BLAISE PASC
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   IRIGARAY JL, 1989, APR INT C GAITH MAR
   OUDADESSE H, 1989, THESIS U BLAISE PASC
   SAUVAGGE T, 1992, THESIS U BLAISE PASC
NR 7
TC 11
Z9 11
U1 0
U2 2
PU AKADEMIAI KIADO
PI BUDAPEST
PA PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD NOV
PY 1993
VL 174
IS 1
BP 93
EP 102
DI 10.1007/BF02040337
PG 10
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA MV755
UT WOS:A1993MV75500012
DA 2018-10-19
ER

PT J
AU BATAILLARD, P
AF BATAILLARD, P
TI CALORIMETRIC SENSING IN BIOANALYTICAL CHEMISTRY - PRINCIPLES,
   APPLICATIONS AND TRENDS
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Article
ID ENZYME THERMISTOR ANALYSIS; BATCH INJECTION-ANALYSIS; STANDARD
   SOLUTIONS; GLUCOSE; BIOSENSORS; OXIDASE; SENSOR; SYSTEM; BIOTECHNOLOGY;
   CHOLESTEROL
AB Calorimetry has shown great potential in bioanalytical chemistry as most biochemical processes involve a change in enthalpy. Two types of approach have been developed: (1) adiabatic calorimetry, which relies on the absence of heat exchange between the reaction vessel and the external environment, and (2) heat conduction calorimetry, involving measurement of the heat transferred from the vessel to a surrounding heat sink. Both principles, with their respective advantages and drawbacks, have been applied to microcalorimetry for the analysis of (bio)chemical compounds. Immobilization of the biomaterial in the vicinity of, or directly onto a small temperature or heat sensitive transducer has led to the concept of a calorimetric biosensor. In comparison to the traditional calorimeter, the calorimetric biosensor is better suited to continuous monitoring and size reduction. This simplified but sensitive device is expected to solve numerous problems in various fields of analytical chemistry.
RP BATAILLARD, P (reprint author), CIBA GEIGY AG,CORP ANALYT RES DEPT,CH-4002 BASEL,SWITZERLAND.
CR AIZAWA M, 1979, Journal of Solid-Phase Biochemistry, V4, P131
   BATAILLARD P, 1993, BIOSENS BIOELECTRON, V8, P89, DOI 10.1016/0956-5663(93)80057-V
   BATAILLARD P, 1992, 14TH P ANN INT C IEE, P147
   BATAILLARD P, 1992, 2ND P WORLD C BIOS G, P243
   BEAUDETTE NV, 1978, ANAL BIOCHEM, V90, P693, DOI 10.1016/0003-2697(78)90162-8
   BIRNBAUM S, 1986, ANAL BIOCHEM, V158, P12, DOI 10.1016/0003-2697(86)90581-6
   BOE IN, 1992, J BIOCHEM BIOPH METH, V24, P309, DOI 10.1016/0165-022X(94)90082-5
   BOWERS LD, 1976, CLIN CHEM, V22, P1427
   COONEY CL, 1974, ENZYME ENG, V2, P411
   DANIELSSON B, 1979, PURE APPL CHEM, V51, P1443, DOI 10.1351/pac197951071443
   DANIELSSON B, 1991, BIOCHEM SOC T, V19, P26, DOI 10.1042/bst0190026
   DANIELSSON B, 1992, SENSOR ACTUAT B-CHEM, V6, P138, DOI 10.1016/0925-4005(92)80045-Y
   DANIELSSON B, 1988, METHOD ENZYMOL, V137, P181
   DANIELSSON B, 1977, CLIN CHIM ACTA, V81, P163, DOI 10.1016/0009-8981(77)90008-0
   DANIELSSON B, 1982, APPL BIOCHEM BIOTECH, V7, P127, DOI 10.1007/BF02798634
   Danielsson B, 1981, APPL BIOCHEM BIOTECH, V6, P207, DOI 10.1007/BF02780799
   DANIELSSON B, 1979, FEBS LETT, V101, P47, DOI 10.1016/0014-5793(79)81292-2
   DANIELSSON B, 1989, ANAL LETT, V22, P1417
   DANIELSSON B, 1990, BIOSENSORS PRACTICAL, P195
   Danielsson B., 1981, APPLIED BIOCH BIOENG, V3, P97
   DANIELSSON B, 1977, ACTA SOC MED SUEC, V86, P282
   DECRISTOFORO G, 1984, ANAL CHEM, V56, P263, DOI 10.1021/ac00266a032
   DESSY R, 1990, BIOSENSOR TECHNOLOGY, P251
   DESSY RE, 1985, ANAL CHEM, V57, P1188
   FERREY ML, 1993, TALANTA, V40, P127, DOI 10.1016/0039-9140(93)80311-E
   FULTON SP, 1980, ANAL CHEM, V52, P505, DOI 10.1021/ac50053a029
   GRIME JK, 1980, ANAL CHIM ACTA, V118, P191
   GRIME JK, 1979, ANAL CHIM ACTA, V107, P319
   GUILBAULT GG, 1983, ANAL CHEM, V55, P1582, DOI 10.1021/ac00260a031
   GUILBEAU EJ, 1987, T AM SOC ART INT ORG, V33, P329
   HANSEN LD, 1974, ANAL CALORIMETRY, V3, P7
   HESKETH PJ, 1990, 3RD P M CHEM SENS CL, P385
   HUNDECK HG, 1990, ANAL CHIM ACTA, V238, P211, DOI 10.1016/S0003-2670(00)80539-5
   JANATA J, 1989, PRINCIPLES CHEM SENS, P287
   JESPERDEN ND, 1990, SENSORS BIOPROCESS C, P193
   KIBA N, 1984, TALANTA, V31, P131, DOI 10.1016/0039-9140(84)80030-2
   KIRSTEIN D, 1989, BIOSENSORS, V4, P231, DOI 10.1016/0265-928X(89)80037-9
   KONICKOVA J, 1971, ACTA CHEM SCAND, V25, P2360, DOI 10.3891/acta.chem.scand.25-2360
   LOVRIEN RE, 1990, THERMOCHIM ACTA, V172, P187, DOI 10.1016/0040-6031(90)80573-H
   MARCONI W, 1978, ENZYME ENG, V4, P179
   MARESGUJA M, 1990, THERMOCHIM ACTA, V172, P203, DOI 10.1016/0040-6031(90)80575-J
   MATTAISSON B, 1977, BIOTECHNOL BIOENG, V19, P16
   MATTIASSON B, 1978, CLIN CHEM, V24, P1770
   MATTIASSON B, 1977, BIOCHIM BIOPHYS ACTA, V483, P221, DOI 10.1016/0005-2744(77)90050-X
   MATTIASSON B, 1982, CARBOHYD RES, V102, P273, DOI 10.1016/S0008-6215(00)88069-6
   MATTIASSON B, 1976, ANAL LETT, V9, P867
   MATTIASSON B, 1978, FEBS LETT, V85, P203, DOI 10.1016/0014-5793(78)80455-4
   MATTIASSON B, 1981, APPL ENVIRON MICROB, V41, P903
   MATTIASSON B, 1976, ANAL LETT, V9, P217, DOI 10.1080/00032717608059098
   MATTIASSON B, 1979, J SOL-PHASE BIOCHEM, V4, P263
   MCKINNON IR, 1984, ANAL BIOCHEM, V139, P134, DOI 10.1016/0003-2697(84)90398-1
   MONTI M, 1987, THERMAL ENERGETIC ST, P131
   MOSBACH K, 1975, BIOCHIM BIOPHYS ACTA, V403, P256, DOI 10.1016/0005-2744(75)90027-3
   MUEHLBAUER MJ, 1990, SENSOR ACTUAT B-CHEM, V2, P223, DOI 10.1016/0925-4005(90)85009-N
   MUEHLBAUER MJ, 1990, BIOSENS BIOELECTRON, V5, P1, DOI 10.1016/0956-5663(90)80022-6
   MUEHLBAUER MJ, 1989, ANAL CHEM, V61, P77, DOI 10.1021/ac00176a016
   MURAMATSU H, 1987, ANAL CHIM ACTA, V197, P347, DOI 10.1016/S0003-2670(00)84749-2
   OWUSU RK, 1986, BIOCHIM BIOPHYS ACTA, V872, P83, DOI 10.1016/0167-4838(86)90150-0
   PENNINGTON SN, 1974, ANAL BIOCHEM, V3, P105
   REHAK NN, 1977, CLIN CHEM, V23, P195
   REHAK NN, 1977, CLIN CHEM, V23, P188
   SATOH I, 1981, ANAL CHIM ACTA, V131, P255, DOI 10.1016/S0003-2670(01)93557-3
   SATOH I, 1991, BIOSENS BIOELECTRON, V6, P375, DOI 10.1016/0956-5663(91)85025-R
   SATOH I, 1991, SENSOR ACTUAT B-CHEM, V5, P245, DOI 10.1016/0925-4005(91)80256-J
   SATOH I, 1991, SENSOR ACTUAT B-CHEM, V5, P249, DOI 10.1016/0925-4005(91)80257-K
   SCHELLER F, 1985, ANAL CHEM, V57, P1740, DOI 10.1021/ac00285a053
   SCHEPER T, 1991, ANAL CHIM ACTA, V249, P25, DOI 10.1016/0003-2670(91)87004-Q
   SCHIFREEN RS, 1977, ANAL CHEM, V49, P1929, DOI 10.1021/ac50021a014
   SCHIMDT HL, 1976, BIOCHIM BIOPHYS ACTA, V429, P283
   THAVARUNGKUL P, 1991, ANAL CHIM ACTA, V249, P17, DOI 10.1016/0003-2670(91)87003-P
   TRAN-MINH C, 1978, Analytical Chemistry, V50, P1874
   URBAN G, 1991, BIOSENS BIOELECTRON, V6, P275, DOI 10.1016/0956-5663(91)80013-N
   VANHERWAARDEN AW, 1986, SENSOR ACTUATOR, V10, P321, DOI 10.1016/0250-6874(86)80053-1
   VANHERWAARDEN AW, 1989, SENSOR ACTUAT A-PHYS, V21, P621
   WADSO I, 1987, THERMAL ENERGETIC ST, P34
   WANG J, 1991, ANAL LETT, V24, P1389, DOI 10.1080/00032719108052979
   WANG J, 1992, ANAL CHIM ACTA, V267, P171, DOI 10.1016/0003-2670(92)85020-7
   WENDLANDT WW, 1987, THERMOCHIM ACTA, V193, P147
   WENDLANDT WW, 1987, THERMOCHIM ACTA, V193, P131
   WINQUIST F, 1985, ANAL LETT PT B, V18, P573, DOI 10.1080/00032718508066157
   XIE B, 1992, SENSOR ACTUAT B-CHEM, V6, P127, DOI 10.1016/0925-4005(92)80043-W
   XIE B, 1989, SENSOR ACTUATOR, V19, P53
NR 82
TC 26
Z9 27
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-9936
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD NOV-DEC
PY 1993
VL 12
IS 10
BP 387
EP 394
DI 10.1016/0165-9936(93)80002-2
PG 8
WC Chemistry, Analytical
SC Chemistry
GA MJ910
UT WOS:A1993MJ91000005
DA 2018-10-19
ER

PT J
AU PAPACHARALAMBOUS, SK
   ANASTASOFF, KI
AF PAPACHARALAMBOUS, SK
   ANASTASOFF, KI
TI NATURAL CORAL SKELETON USED AS ONLAY GRAFT FOR CONTOUR AUGMENTATION OF
   THE FACE - A PRELIMINARY-REPORT
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE CORAL; ONLAY GRAFT; CONTOUR AUGMENTATION
ID BONE; SUBSTITUTE
AB The skeletons of two different genera of Madreporaria were used as onlay graft material for contour augmentation of the face. With coral blocks or granules in a subperiosteal fashion, patients with hemifacial microsomia, maxillary hypoplasia, microgenia, and Treacher Collins' syndrome have been adequately treated. Sixteen augmentations were performed in 14 patients, followed up for 6-34 months. One graft had to be removed because its inadequate fixation resulted in mobility. Delayed healing was observed in another case for the same reason. Coral skeleton is a cheap, natural biomaterial with excellent biocompatibility. It can easily be prepared and shaped, and it maintained its form over the period observed.
C1 FAC STOMATOL SOFIA,DEPT PLAST RECONSTRUCT SURG,BU-1431 SOFIA,BULGARIA.
RP PAPACHARALAMBOUS, SK (reprint author), FAC STOMATOL SOFIA,DEPT ORAL & MAXILLOFACIAL SURG,G SOFIISKI 1,BU-1431 SOFIA,BULGARIA.
CR Bajpai P. K., 1983, BIOMATERIALS RECONST, P312
   BESINS T, 1988, ANN CHIR PLAST ESTH, V33, P225
   Boiteux J P, 1988, Rev Odontostomatol (Paris), V17, P291
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   ISSAHAKIAN S, 1987, INFORMATION DENTAIRE, V24, P2123
   JAMMET P, 1992, BIOCERAMICS AND THE HUMAN BODY, P383
   LEVET Y, 1983, ANN CHIR PLAST ESTH, V28, P180
   LEVET Y, 1988, ANN CHIR PLAST ESTH, V33, P279
   Mass CS, 1990, ARCH OTOLARYNGOL, V116, P551
   Ouhayoun J P, 1989, Inf Dent, V71, P225
   OUHAYOUN JP, 1988, 74TH M AM AC PER SAN
   PATEL A, 1980, CHIRURGIE, V106, P199
   PATEL A, 1980, Calcified Tissue International, V31, P108
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   Robier A, 1987, Ann Otolaryngol Chir Cervicofac, V104, P303
   ROUX FX, 1988, NEUROCHIRURGIE, V34, P110
   ROUX FX, 1988, J NEUROSURG, V69, P510, DOI 10.3171/jns.1988.69.4.0510
   SERVERA C, 1987, REV STOMATOL CHIR, V88, P326
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   SOUYRIS F, 1984, ANN CHIR PLAST ESTH, V29, P256
NR 23
TC 19
Z9 20
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD OCT
PY 1993
VL 22
IS 5
BP 260
EP 264
DI 10.1016/S0901-5027(05)80511-9
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA MC225
UT WOS:A1993MC22500002
PM 7902384
DA 2018-10-19
ER

PT J
AU FERRAND, BK
   KOKINI, K
   BADYLAK, SF
   GEDDES, LA
   HILES, MC
   MORFF, RJ
AF FERRAND, BK
   KOKINI, K
   BADYLAK, SF
   GEDDES, LA
   HILES, MC
   MORFF, RJ
TI DIRECTIONAL POROSITY OF PORCINE SMALL-INTESTINAL SUBMUCOSA
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
AB Small-intestinal submucosa (SIS) has been shown to be a promising biomaterial for vascular graft applications. This study. examines the directionality property of SIS porosity using 35 SIS specimens from 13 pigs. In addition, the effects of the weight of the donor pig, preconditioning of 13 additional SIS specimens, and the duration of the test of five additional SIS specimens on such porosity are reported. The porosity from serosal to mucosal direction was found to be four times greater than the porosity in the opposite direction. The weight of the donor pig was not found to be an important factor in SIS porosity. Preconditioning served to increase the average serosal porosity index at 120 mm Hg static water pressure from 2.99 to 8.33 mL/(min cm2). The porosity in the mucosal direction was not affected by preconditioning. Porosity in both directions decreased with increasing test duration. The directionality property of SIS porosity may be an important factor in its success as a vascular graft. The term 'porosity' is used throughout this article, but current standards also refer to the term 'permeability' to describe the passage of liquid through a vascular graft. (C) 1993 John Wiley & Sons, Inc.
C1 PURDUE UNIV,SCH MECH ENGN,1288 MECH ENGN BLDG,W LAFAYETTE,IN 47907.
   PURDUE UNIV,HILLENBRAND BIOMED ENGN CTR,W LAFAYETTE,IN 47907.
   ELI LILLY & CO,INDIANAPOLIS,IN 46285.
OI Badylak, Stephen/0000-0003-3555-0689
CR BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   FUNG YC, 1981, BIOMECHANICS PROPERT
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   HILES MC, UNPUB CIRCUMFERENTIA
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   WESOLOW A, 1986, ASTM STP, V898, P253
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   1986, ANSI AAMI VASCULAR G
   1985, DHHS NIH PUBLICATION, V8523
NR 9
TC 36
Z9 41
U1 1
U2 6
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1993
VL 27
IS 10
BP 1235
EP 1241
DI 10.1002/jbm.820271004
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LY240
UT WOS:A1993LY24000003
PM 8245038
DA 2018-10-19
ER

PT J
AU OKAMOTO, Y
   MINAMI, S
   MATSUHASHI, A
   SASHIWA, H
   SAIMOTO, H
   SHIGEMASA, Y
   TANIGAWA, T
   TANAKA, Y
   TOKURA, S
AF OKAMOTO, Y
   MINAMI, S
   MATSUHASHI, A
   SASHIWA, H
   SAIMOTO, H
   SHIGEMASA, Y
   TANIGAWA, T
   TANAKA, Y
   TOKURA, S
TI APPLICATION OF POLYMERIC N-ACETYL-D-GLUCOSAMINE (CHITIN) TO VETERINARY
   PRACTICE
SO JOURNAL OF VETERINARY MEDICAL SCIENCE
LA English
DT Article
DE BIOMATERIAL; CHITIN; FILLING AGENT; WOUND DRESSING AGENT; WOUND HEALING
ID PARTIALLY DEACETYLATED CHITIN; MOUSE-PERITONEAL-MACROPHAGES;
   ABDOMINAL-WALL DEFECTS; INCISIONAL HERNIAS; REPAIR; DERIVATIVES;
   ACTIVATION; MICE; STIMULATION; COLLAGENASE
AB The sponge-, cotton-, and flake-type remedies made of chitin (chitin-sponge, chitin-cotton, and chitin-flake, respectively), and non-woven fabric of polyester (NWF) composited with chitin (chitin-NWF) were applied to various types of trauma, abscess, surgical tissue defect and herniorrhaphy in 147 clinical cases including 72 dogs, 38 cows, 33 cats, 2 rabbits, one monkey and one horse. Chitin-sponge was applied in 30 cases as filling agent of surgical tissue defect, and in 25 cases of trauma, 31 cases of abscess as wound dressing or tissue defect filling agent. In 77 out of 86 cases (89.5%), good healing developed. When chitin-sponge was buried in surgical tissue defects due to oncotomy in 20 cases, recurrence of the tumor developed in one case on one month post-operatively, but wag not recognized for 3-24 months in 19 cases. Chitin-NWF was applied in 2 cases of trauma and 12 cases of abscess as wound dressing or tissue defect filling agent, 6 cases as filling agent of surgical tissue defect, and 12 cases of umbilical hernia as prosthesis of suture site of hernia ring. In 28 out of 32 cases (87.5%), good healing developed. Chitin-cotton was applied in 8 cases of trauma and 12 cases of abscess as wound dressing or tissue defect filling agent. In 18 out of 20 cases (90.0%), good healing developed. Chitin-flake was applied in 9 cases of trauma as wound dressing or tissue defect filling agent. In 8 out of 9 cases (88.9%), good healing developed. In all cases, no side effects were observed.
C1 TOTTORI UNIV,FAC ENGN,DEPT MAT SCI,TOTTORI 680,JAPAN.
   TOTTORI UNIV,FAC MED,DEPT BACTERIOL,YONAGO,TOTTORI 683,JAPAN.
   HOKKAIDO UNIV,FAC SCI,DEPT POLYMER SCI,SAPPORO,HOKKAIDO 060,JAPAN.
RP OKAMOTO, Y (reprint author), TOTTORI UNIV,FAC AGR,DEPT VET SURG,101 MINAMI,4-CHOME,KOYAMA CHO,TOTTORI 680,JAPAN.
CR BERGER LR, 1957, BIOCHIM BIOPHYS ACTA, V26, P517, DOI 10.1016/0006-3002(57)90098-7
   BROMBERG B E, 1965, Plast Reconstr Surg, V36, P80, DOI 10.1097/00006534-196507000-00011
   Chang W H, 1973, Br J Plast Surg, V26, P147, DOI 10.1016/S0007-1226(73)80008-6
   CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7
   DONOFF RB, 1971, BIOCHIM BIOPHYS ACTA, V227, P639, DOI 10.1016/0005-2744(71)90014-3
   IIDA J, 1987, VACCINE, V5, P270, DOI 10.1016/0264-410X(87)90150-2
   JEWETT TC, 1963, AM J SURG, V106, P24, DOI 10.1016/0002-9610(63)90184-3
   JOHNSON JH, 1969, J AM VET MED ASSOC, V154, P779
   KISHIMOTO S, 1987, Acta Dermatologica (Kyoto), V82, P471
   MANSBERGER AR, 1973, J TRAUMA, V13, P766, DOI 10.1097/00005373-197309000-00002
   MINAMI S, 1992, ADVANCES IN CHITIN AND CHITOSAN, P61
   Minami S., 1992, CHITIN DERIVATIVES L, P68
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   NISHIMURA K, 1985, VACCINE, V3, P379, DOI 10.1016/0264-410X(85)90127-6
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   NISHIMURA K, 1987, VACCINE, V5, P136, DOI 10.1016/0264-410X(87)90061-2
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   NISHIMURA SI, 1986, CARBOHYD RES, V146, P251, DOI 10.1016/0008-6215(86)85044-3
   OKAMOTO Y, 1992, ADVANCES IN CHITIN AND CHITOSAN, P70
   ROBERTSO.PR, 1972, SCIENCE, V177, P64, DOI 10.1126/science.177.4043.64
   SCOTT EA, 1979, J AM VET MED ASSOC, V175, P1203
   TOKORO A, 1988, CHEM PHARM BULL, V36, P784
   Tokura S., 1983, SEN-I GAKKAISHI, V39, P45
   TULLENERS EP, 1983, J AM VET MED ASSOC, V182, P258
   USHER FC, 1979, AM J SURG, V138, P740
   WERB Z, 1975, J EXP MED, V142, P346, DOI 10.1084/jem.142.2.346
   YANO H, 1985, Mie Medical Journal, V35, P53
NR 27
TC 86
Z9 91
U1 0
U2 10
PU JAPAN SOC VET SCI
PI TOKYO
PA UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO 103, JAPAN
SN 0916-7250
J9 J VET MED SCI
JI J. Vet. Med. Sci.
PD OCT
PY 1993
VL 55
IS 5
BP 743
EP 747
DI 10.1292/jvms.55.743
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA MD735
UT WOS:A1993MD73500008
PM 8286525
OA Bronze
DA 2018-10-19
ER

PT J
AU ROSIAK, JM
   OLEJNICZAK, J
AF ROSIAK, JM
   OLEJNICZAK, J
TI MEDICAL APPLICATIONS OF RADIATION FORMED HYDROGELS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8TH INTERNATIONAL MEETING ON RADIATION PROCESSING
CY SEP 13-18, 1992
CL BEIJING, PEOPLES R CHINA
DE MEDICINE; BIOMATERIAL; HYDROGEL; CROSS-LINKING; POLYMER; RADIATION
AB Polyvinylpyrrolidone was used as a main component of two new biomaterials: hydrogel wound dressings and therapeutic system for induction of labour. Ionizing radiation was applied as a tool for initiation of crosslinking and sterilization of these materials. Both products successfully passed clinical tests and have been commercialized. Draft of technology and some properties are shortly reviewed in this report.
RP ROSIAK, JM (reprint author), TECH UNIV LODZ,INST APPL RADIAT CHEM,WROBLEWSKIEGO 15,PL-93590 LODZ,POLAND.
CR DAVIS JE, 1981, AUST J CHEM, V34, P1423, DOI 10.1071/CH9811423
   ROSIAK J, 1988, RADIAT PHYS CHEM, V32, P691
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J, 1989, Polim Med, V19, P93
   ROSIAK J, 1991, RAD EFFECTS POLYM, V475, P271
NR 5
TC 60
Z9 62
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1993
VL 42
IS 4-6
BP 903
EP 906
DI 10.1016/0969-806X(93)90398-E
PG 4
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA LK325
UT WOS:A1993LK32500072
DA 2018-10-19
ER

PT J
AU GUO, WD
   ANDERSSON, R
   ODSELIUS, R
   LJUNGH, A
   WADSTROM, T
   BENGMARK, S
AF GUO, WD
   ANDERSSON, R
   ODSELIUS, R
   LJUNGH, A
   WADSTROM, T
   BENGMARK, S
TI PHOSPHOLIPID IMPREGNATION OF ABDOMINAL RUBBER DRAINS - RESISTANCE TO
   BACTERIAL ADHERENCE BUT NOT EFFECT ON DRAIN-INDUCED BACTERIAL
   TRANSLOCATION
SO RESEARCH IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE BACTERIAL ADHERENCE; RUBBER DRAIN; PHOSPHOLIPID IMPREGNATION; BACTERIAL
   TRANSLOCATION
ID ADHESION; INFECTIONS; INVITRO
AB In order to evaluate the effect of surface modification of biomaterials on bacterial adherence and bacterial translocation after intraperitoneal biomaterial implantation, phosphatidylcholine- or phosphatidylinositol-impregnated rubber drain pieces, which had been intraperitoneally implanted in the rat for 2 and 7 days, or unimplanted, were incubated in vitro with H-3-labelled Escherichia coli and Enterobacter cloacae. As compared with unimpregnated pieces, the adherence of bacteria significantly decreased to phosphatidylcholine- and phosphatidylinositol-impregnated rubber drain pieces that were either unimplanted or implanted for 2 days, but not for 7 days. The supplementation of albumin in the medium reduced the adherence of bacteria to the unimplanted, unimpregnated drain pieces, but did not further decrease adherence of bacteria to the unimplanted, phospholipid-impregnated brain pieces. Bacterial growth was inhibited after incubation in nutrient broth supplemented with phospholipids. The incidence of enteric bacterial translocation induced by intraperitoneal drain implantation did not differ between phospholipid-impregnated and unimpregnated drain pieces. Scanning electron microscopy revealed a large amount of biofilm and fibrous deposition on the surface of the implanted, phospholipid-impregnated rubber drain pieces. Thus, phospholipid impregnation of rubber drains reduces bacterial adherence and inhibits bacterial growth, without influencing the incidence of bacterial translocation.
C1 LUND UNIV,DEPT SURG,S-22185 LUND,SWEDEN.
   LUND UNIV,ELECTRON MICROSCOPY UNIT,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT MED MICROBIOL,S-22362 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR ARRAJAB A, 1991, J SURG RES, V50, P212, DOI 10.1016/0022-4804(91)90180-T
   BISNO AL, 1990, INFECTIONS ASS INDWE
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, IN PRESS J SURG RES
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   HARRIS JM, 1987, ANN SURG, V206, P612
   HILLS BA, 1982, J APPL PHYSIOL, V53, P463
   ILLNER H, 1989, SURG GYNECOL OBSTET, V168, P481
   JANSEN B, 1990, ZBL BAKT-INT J MED M, V272, P401, DOI 10.1016/S0934-8840(11)80040-X
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   PAOLO DN, 1986, NEPHRON, V44, P365
   RODRIGUEZ JL, 1986, CURR SURG        SEP, P423
   ROGZA J, 1990, NEPHRON, V54, P134
   RUGGIERI MR, 1987, J UROLOGY, V138, P423, DOI 10.1016/S0022-5347(17)43177-6
   SAWANT AD, 1991, CURR MICROBIOL, V22, P285, DOI 10.1007/BF02091956
   SHENK JS, 1989, J SURG RES, V47, P487, DOI 10.1016/0022-4804(89)90125-X
   SUGARMAN B, 1982, UROL RES, V10, P37
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   WELLS CL, 1986, ARCH SURG-CHICAGO, V121, P102
   YUI S, 1986, J LEUKOCYTE BIOL, V39, P713
NR 21
TC 10
Z9 10
U1 0
U2 1
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0300-9130
J9 RES EXP MED
JI Res. Exp. Med.
PD OCT
PY 1993
VL 193
IS 5
BP 285
EP 296
DI 10.1007/BF02576236
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA MD357
UT WOS:A1993MD35700003
PM 8278675
DA 2018-10-19
ER

PT J
AU MIKOS, AG
   SARAKINOS, G
   LYMAN, MD
   INGBER, DE
   VACANTI, JP
   LANGER, R
AF MIKOS, AG
   SARAKINOS, G
   LYMAN, MD
   INGBER, DE
   VACANTI, JP
   LANGER, R
TI PREVASCULARIZATION OF POROUS BIODEGRADABLE POLYMERS
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE PREVASCULARIZATION; CELL TRANSPLANTATION; BIODEGRADABLE POLYMERS; ORGAN
   REGENERATION; TISSUE ENGINEERING
ID SYSTEMIC DELIVERY; ENDOTHELIAL-CELLS; TRANSPLANTATION; MYOBLASTS
AB Highly porous biocompatible and biodegradable polymers in the form of cylindrical disks of 13.5 mm diameter were implanted in the mesentery of male syngeneic Fischer rats for a period of 35 days to study the dynamics of tissue ingrowth and the extent of tissue vascularity, and to explore their potential use as substrates for cell transplantation. The advancing fibrovascular tissue was characterized from histological sections of harvested devices by image analysis techniques. The rate of tissue ingrowth increased as the porosity and/or the pore size of the implanted devices increased. The time required for the tissue to fill the device depended on the polymer crystallinity and was smaller for amorphous polymers. The vascularity of the advancing tissue was consistent with time and independent of the biomaterial composition and morphology. Poly(L-lactic acid) (PLLA) devices of 5 mm thickness, 24.5% crystallinity, 83% porosity, and 166 mum median pore diameter were filled by tissue after 25 days. However, the void volume of prevascularized devices (4%) was minimal and not practical for cell transplantation. In contrast, for amporphous PLLA devices of the same dimensions, and the similar porosity of 87% and median pore diameter of 179 mum, the tissue did not fill completely prevascularized devices, and an appreciable percentage (21%) of device volume was still available for cell engraftment after 25 days of implantation. These studies demonstrate the feasibility of creating vascularized templates of amorphous biodegradable polymers for the transplantation of isolated or encapsulated cell populations to regenerate metabolic organs and tissues. (C) 1993 John Wiley & Sons, Inc.
C1 MIT,DEPT CHEM ENGN,ROOM E25-342,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139.
   MIT,DEPT CHEM,CAMBRIDGE,MA 02139.
   HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT SURG,BOSTON,MA 02115.
CR BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   COLTON CK, 1991, J BIOMECH ENG-T ASME, V113, P152, DOI 10.1115/1.2891229
   DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   JAMSHIDI K, 1988, POLYMER, V29, P2229, DOI 10.1016/0032-3861(88)90116-4
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, IN PRESS POLYMER
   MIKOS AG, IN PRESS BIOMATERIAL
   NABEL EG, 1989, SCIENCE, V244, P1342, DOI 10.1126/science.2499928
   UYAMA S, 1992, POLYM MAT SCI ENG PR, V66, P182
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VACANTI JP, 1988, ARCH SURG-CHICAGO, V123, P545
   WALD HL, 1993, BIOMATERIALS, V14, P270, DOI 10.1016/0142-9612(93)90117-K
   WANG HT, 1990, BIOMATERIALS, V11, P679, DOI 10.1016/0142-9612(90)90026-M
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
NR 18
TC 230
Z9 236
U1 0
U2 17
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP 5
PY 1993
VL 42
IS 6
BP 716
EP 723
DI 10.1002/bit.260420606
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA LT780
UT WOS:A1993LT78000005
PM 18613104
DA 2018-10-19
ER

PT J
AU CHAUHAN, SK
   SINGH, VR
AF CHAUHAN, SK
   SINGH, VR
TI ULTRASONIC-ATTENUATION OF BONE AS A COMPOSITE BIOMATERIAL
SO INDIAN JOURNAL OF PURE & APPLIED PHYSICS
LA English
DT Article
AB Variation of ultrasonic attenuation with respect to density and hydration at 2.5 MHz for composite biomaterials (e.g. bone, in this case), is reported. The density of condyle is found to vary from 0.79 to 0.91 g cm-3 while for the femur and tibia from 1.0 to 1.90 g cm-3 respectively. The density of condyle is found to be lower than that of the femur and tibia. Ultrasonic attenuation for condyle is found to be higher than that for the femur and tibia.
RP CHAUHAN, SK (reprint author), CENT SCI INSTRUMENTS ORG,NEW DELHI 110012,INDIA.
NR 0
TC 7
Z9 7
U1 0
U2 0
PU COUNCIL SCIENTIFIC INDUSTRIAL RESEARCH
PI NEW DELHI
PA PUBL & INFO DIRECTORATE, NEW DELHI 110012, INDIA
SN 0019-5596
J9 INDIAN J PURE AP PHY
JI Indian J. Pure Appl. Phys.
PD SEP
PY 1993
VL 31
IS 9
BP 635
EP 638
PG 4
WC Physics, Multidisciplinary
SC Physics
GA MB829
UT WOS:A1993MB82900007
DA 2018-10-19
ER

PT J
AU DION, I
   BAQUEY, C
   MONTIES, JR
AF DION, I
   BAQUEY, C
   MONTIES, JR
TI DIAMOND - THE BIOMATERIAL OF THE 21ST-CENTURY
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Editorial Material
ID CHEMICAL-VAPOR-DEPOSITION; MICROWAVE PLASMA; LOW-PRESSURE; GROWTH; GAS;
   METHANE; FILMS; PHASE; PARTICLES
C1 UNIV BORDEAUX 2,BIOPHYS LAB,F-33076 BORDEAUX,FRANCE.
   UNIV BORDEAUX 2,INSERM,U306,F-33076 BORDEAUX,FRANCE.
CR ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   ANTHONY TR, 1990, JUL P NATO ADV STUD
   ANTHONY TR, 1990, DIAMOND DIAMOND LI 1
   BACHMANN PK, 1991, DIAM RELAT MATER, V1, P1, DOI 10.1016/0925-9635(91)90005-U
   BADZIAN AR, 1988, MATER RES BULL, V23, P385, DOI 10.1016/0025-5408(88)90013-X
   BROOKES CA, 1991, DIAM RELAT MATER, V1, P13, DOI 10.1016/0925-9635(91)90006-V
   CHALKER PR, 1990, CHARACTERIZATION DIA
   CHANG CP, 1988, J APPL PHYS, V63, P1744, DOI 10.1063/1.339912
   CHIGNIER E, 1987, BIOMATERIALS, V8, P18, DOI 10.1016/0142-9612(87)90022-6
   CHIGNIER E, 1984, COLLOQUE, V3, P5
   DEVRIES RC, 1987, ANNU REV MATER SCI, V17, P161
   DION I, 1993, BIOMATERIALS, V14, P169, DOI 10.1016/0142-9612(93)90019-X
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   DION I, 1992, COMPLEMENT ACTIVATIO, P345
   DION I, 1992, THESIS U BORDEAUX 2, P202
   DION I, 1992, IN PRESS J MATER SCI
   ELOY R, 1992, BIOMATERIAUX, P10
   GICQUEL A, 1989, ATTT CETIM      1018, P139
   GLASS JT, 1990, ANAL IDENTIFICATION
   HARDING WB, 1986, ASTM PUBLICATION, P310
   HAVLIK P, 1985, RBM, V7, P110
   HUONG PV, 1991, DIAM RELAT MATER, V1, P33, DOI 10.1016/0925-9635(91)90009-Y
   JOHNSTON C, 1990, AEA TEC         1009
   KOBASHI K, 1988, PHYS REV B, V38, P4067, DOI 10.1103/PhysRevB.38.4067
   KOBASHI K, MICRO FABRICATION DI
   KURIHARA K, 1988, APPL PHYS LETT, V52, P437, DOI 10.1063/1.99435
   KURITA S, 1990, NEW DIAMOND JAPAN RE, P113
   MA GHM, 1991, DIAM RELAT MATER, V1, P25, DOI 10.1016/0925-9635(91)90008-X
   MATSUMOTO S, 1982, J MATER SCI, V17, P3106, DOI 10.1007/BF01203472
   MATSUMOTO S, 1983, J MATER SCI, V18, P1785, DOI 10.1007/BF00542075
   MATSUMOTO S, 1985, J MATER SCI LETT, V4, P600, DOI 10.1007/BF00720043
   MESSIER R, 1987, THIN SOLID FILMS, V153, P1, DOI 10.1016/0040-6090(87)90164-7
   MESSIER R, 1991, DIAMOND RELATER MATE, V1, pR5
   MITSUDA Y, 1987, J MATER SCI, V22, P1557, DOI 10.1007/BF01132374
   MONTIES JR, 1990, T AM SOC ART INT ORG, V36, P258
   NOSE Y, 1991, ARTIF ORGANS, V15, P1
   ROBINSON AL, 1986, SCIENCE, V234, P1074, DOI 10.1126/science.234.4780.1074
   SAITO Y, 1988, J MATER SCI, V23, P842, DOI 10.1007/BF01153976
   SAITO Y, 1990, J MATER SCI, V25, P1246
   SAITO Y, 1986, J MATER SCI LETT, V5, P565, DOI 10.1007/BF01728692
   SINGH BP, 1990, J MATER SCI, V25, P1487
   SPEAR KE, 1989, J AM CERAM SOC, V72, P171, DOI 10.1111/j.1151-2916.1989.tb06099.x
   SPEAR KE, VAPOR DEPOSITION CRY, P1085
   SUBRAMANIAN K, 1988, CERAMIC B, V87, P1026
   WENTORF RH, DIAMOND
NR 45
TC 21
Z9 21
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 1993
VL 16
IS 9
BP 623
EP 627
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA MH819
UT WOS:A1993MH81900001
PM 8294153
DA 2018-10-19
ER

PT J
AU LABARRE, D
   MONTDARGENT, B
   CARRENO, MP
   MAILLET, F
AF LABARRE, D
   MONTDARGENT, B
   CARRENO, MP
   MAILLET, F
TI STRATEGY FOR IN-VITRO EVALUATION OF THE INTERACTIONS BETWEEN
   BIOMATERIALS AND COMPLEMENT-SYSTEM
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID HEMODIALYSIS MEMBRANES; HUMAN-SERUM; ACTIVATION; ADSORPTION; CELLULOSE;
   PATHWAY; BIOCOMPATIBILITY; ANTIBODIES; FRAGMENTS; SURFACES
AB Because of the importance of complement activation in the induced activation of leukocytes in vivo, determination of the complement-activating capacity of a candidate biomaterial is an important step in evaluating its biocompatibility. In vitro evaluation can be performed in the presence of human serum by means of techniques described in the literature and reviewed in this paper. Certain physical and chemical parameters involved in complement activation by materials have to be assessed: the chemical composition of the surface, surface area in contact with serum, temperature and duration of contact, and ionic environment with emphasis on divalent ions. Concerning materials evaluation, the adsorption of complement proteins or protein fragments has to be determined in addition to activation. Following screening tests using CH50 determination, activation of both classical and alternative pathways leading to formation of C3 convertases and formation of C5 convertase should be assessed. An example of the determination of the complement-activating capacity of two hydroxylated materials is presented and guidelines for in vitro evaluation are proposed.  (C) 1993 John Wiley & Sons, Inc.
C1 UNIV PARIS 13,RECH MACROMOLEC LAB,CNRS,URA 502,F-93430 VILLETANEUSE,FRANCE.
   HOP BROUSSAIS,IMMUNOPATHOL LAB,INSERM,U28,F-75674 PARIS 14,FRANCE.
RP LABARRE, D (reprint author), UNIV PARIS 11,CTR ETUD PHARMACEUT,CNRS,URA 1218,5 RUE JEAN BAPTISTE CLEMENT,F-92290 CHATENAY MALABRY,FRANCE.
CR BHAKDI S, 1988, J IMMUNOL, V141, P3117
   BINGEL M, 1988, NEPHRON, V50, P273, DOI 10.1159/000185186
   BOISSON C, 1988, BIOMATERIALS, V9, P47, DOI 10.1016/0142-9612(88)90068-3
   Bommer J, 1987, Contrib Nephrol, V59, P154
   BOSCH T, 1987, ARTIF ORGANS, V11, P144, DOI 10.1111/j.1525-1594.1987.tb02647.x
   CARRENO MP, 1988, MOL IMMUNOL, V25, P165, DOI 10.1016/0161-5890(88)90064-8
   CARRENO MP, 1988, BIOMATERIALS, V9, P514, DOI 10.1016/0142-9612(88)90047-6
   CARRENO MP, 1989, EUR J IMMUNOL, V19, P2145, DOI 10.1002/eji.1830191126
   Cazenave J.-P., 1986, BLOOD SURFACE INTERA
   Chenoweth D E, 1987, Contrib Nephrol, V59, P51
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1987, ARTIF ORGANS, V11, P155, DOI 10.1111/j.1525-1594.1987.tb02649.x
   CHENOWITH DE, 1980, FUTURE PERSPECTIVES, P443
   CHEUNG AK, 1989, KIDNEY INT, V35, P576, DOI 10.1038/ki.1989.26
   CHEUNG AK, 1989, AM J KIDNEY DIS, V14, P472, DOI 10.1016/S0272-6386(89)80147-7
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DEBAILLOU N, 1985, COLLOID SURFACE, V16, P271, DOI 10.1016/0166-6622(85)80258-4
   FEARON DT, 1977, TRANSPL P, V9, P729
   FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I
   HACK CE, 1990, J IMMUNOL, V144, P4249
   HAKIM RM, 1986, CLIN NEPHROL, V26, pS9
   HENDERSON L W, 1983, Blood Purification, V1, P3, DOI 10.1159/000166438
   HERZLINGER GA, 1981, BLOOD, V57, P764
   JAHNS G, IN PRESS CRC CRIT RE
   KAZATCHKINE MD, 1982, PROG ALLERGY, V30, P193
   KAZATCHKINE MD, 1986, TECHNIQUES COMPLENET
   KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A
   LACHMANN PJ, 1984, SPRINGER SEMIN IMMUN, V7, P143, DOI 10.1007/BF01893018
   LAW SKA, 1981, BIOCHEMISTRY-US, V20, P7457, DOI 10.1021/bi00529a020
   MAHIOUT A, 1987, ARTIF ORGANS, V11, P149, DOI 10.1111/j.1525-1594.1987.tb02648.x
   MAILLET F, 1990, TRANSFUS SCI, V11, P33, DOI 10.1016/0955-3886(90)90005-4
   MAYER MM, 1961, EXPT IMMUNOCHEMISTRY, P133
   MOLL S, 1990, INT J ARTIF ORGANS, V13, P273
   MONTDARGENT B, 1991, Journal of Biomaterials Science Polymer Edition, V2, P25, DOI 10.1163/156856291X00034
   MONTDARGENT B, 1992, BIOMATERIALS, V13, P571, DOI 10.1016/0142-9612(92)90024-I
   MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321
   NIINOBE M, 1988, ADV BIOMATER, V8, P181
   OPPERMANN M, 1992, IMMUNOPHARMACOLOGY, V24, P119, DOI 10.1016/0162-3109(92)90018-8
   RATNER BD, 1988, PROGR BIOMEDICAL ENG, V6
   SCHULZE M, 1986, Complement, V3, P25
   TOUFIK J, 1991, 7TH INT C SURF COLL
   1991, TEHCNICAL INFORMATIO
NR 42
TC 18
Z9 18
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD FAL
PY 1993
VL 4
IS 3
BP 231
EP 240
DI 10.1002/jab.770040304
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LT931
UT WOS:A1993LT93100003
DA 2018-10-19
ER

PT J
AU LARSEN, NE
   POLLAK, CT
   REINER, K
   LESHCHINER, E
   BALAZS, EA
AF LARSEN, NE
   POLLAK, CT
   REINER, K
   LESHCHINER, E
   BALAZS, EA
TI HYLAN GEL BIOMATERIAL - DERMAL AND IMMUNOLOGICAL COMPATIBILITY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INJECTABLE COLLAGEN
AB Hylan, a hyaluronan derivative, was chemically cross-linked with divinyl sulfone to produce a water-insoluble gel. This gel was fragmented into a gel slurry and evaluated for particle size, biocompatibility, and residence times in selected tissues. Hylan gels used in this study are made up of pseudoplastic, deformable gel particles with greater elasticity (at all frequencies) and greater viscosity (shear rates, 0.01 sec-1) than the water soluble hylan polymer.
   Hylan gel was injected intradermally and subdermally in mice and was found to produce a minimal reaction at 24 h; thereafter (up to 7 weeks) there was no significant tissue reaction. Intradermal injection of [H-3]-hylan gel in guinea pigs revealed a minimal tissue reaction after 1 week, and measurement of radioactivity in the tissue at 1, 2, and 4 weeks revealed only a slight decrease in the total amount of injected radioactivity. The immunogenic activity of hylan gel was evaluated in rabbits; unmodified hylan gel, degraded hylan gel, and hylan gel ovalbumin conjugate were used to immunize rabbits. No antibody production to any hylan gel sample was detected, although control rabbits immunized with ovalbumin developed titers >400 of antiovalbumin antibodies by day 21, as measured by the passive cutaneous anaphylaxis assay (PCA). Last, serum from owl monkeys (Aotus trivirgatus) in which hylan gel had been placed intravitreally for up to 3 years contained no detectable anti-hylan gel antibodies (PCA assay). Skin tests on these monkeys were also negative.  (C) 1993 John Wiley & Sons, Inc.
C1 BIOMATRIX INC,DEPT HISTOL,RIDGEFIELD,NJ 07657.
   BIOMATRIX INC,DEPT CHEM,RIDGEFIELD,NJ 07657.
RP LARSEN, NE (reprint author), BIOMATRIX INC,DEPT BIOCHEM,65 RAILROAD AVE,RIDGEFIELD,NJ 07657, USA.
CR AREM A, 1985, CLIN PLAST SURG, V12, P209
   Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   Balazs E A, 1986, US patent, Patent No. [4582865, 4,582,865]
   Balazs E. A., 1985, US Patent, Patent No. 4500676
   BALAZS EA, 1984, COSMET TOILETRIES, V99, P65
   BALAZS EA, 1988, BIOTECH US      1114, P442
   BALAZS EA, 1988, P INT C CELLULOSICS, P233
   BARTON JL, 1986, TXB DERMATOLOGY, P1870
   BENTLEY JP, 1971, BIOCHIM BIOPHYS ACTA, V224, P35
   DALY CH, 1979, J INVEST DERMATOL, V73, P84, DOI 10.1111/1523-1747.ep12532770
   DONALD PJ, 1986, OTOLARYNG HEAD NECK, V95, P607, DOI 10.1177/019459988609500516
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   KNAPP TR, 1977, PLAST RECONSTR SURG, V60, P398
   LARSEN NE, 1990, 16TH T ANN M SOC BIO
   MATTON G, 1985, AESTHET PLAST SURG, V9, P133, DOI 10.1007/BF01570345
   PEARCE RH, 1970, ADV BIOL SKIN, V2, P89
   POULSEN JH, 1982, SCAND J CLIN LAB INV, V42, P545
   RICHTER AW, 1979, INT ARCH ALLER A IMM, V59, P45, DOI 10.1159/000232238
   RICHTER AW, 1974, INT ARCH ALLER A IMM, V47, P211
   Selmanowitz V J, 1977, J Dermatol Surg Oncol, V3, P597
   SMITH JG, 1966, ADV BIOL SKIN, V6, P211
   SZIRMAI JA, 1965, AMINO SUGARS B, V11, P129
   UZUKA M, 1980, BIOCHIM BIOPHYS ACTA, V627, P199, DOI 10.1016/0304-4165(80)90321-9
   Yates J. R., 1971, BIOPHYSICAL PROPERTI, P485
   1985, US PHARMACOPIA, V21
   1978, PLAST RECONSTR SURG, V61, P892
NR 26
TC 115
Z9 117
U1 0
U2 13
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1993
VL 27
IS 9
BP 1129
EP 1134
DI 10.1002/jbm.820270903
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LR717
UT WOS:A1993LR71700002
PM 8126011
DA 2018-10-19
ER

PT J
AU HAYCOX, CL
   RATNER, BD
AF HAYCOX, CL
   RATNER, BD
TI IN-VITRO PLATELET INTERACTIONS IN WHOLE HUMAN BLOOD EXPOSED TO
   BIOMATERIAL SURFACES - INSIGHTS ON BLOOD COMPATIBILITY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ALPHA-GRANULE RELEASE; HYDROGEL; INVIVO; CONSUMPTION
AB A short-term in vitro test to study platelet interactions with biomaterials is described. Using fresh human blood and a modified Chandler loop system, beta-thromboglobulin release was measured. Also, adherent platelets were observed by using scanning electron microscopy (SEM) and a colorimetric stain specific for human platelet GPIIIa. Materials studied in these experiments were polyethylene (PE), Biomer, poly(vinyl alcohol) (PVA), and a polyurethane prepared with octadecyl pendant groups (ODCE). Four blood reactions were observed: (1) Platelets continually adhere and activate on the Biomer; (2) platelets initially adhere and activate but then spread to a thin, passivating film on the PE; (3) platelets do not adhere to the PVA surface but continually react with il upon contact; and (4) platelets neither adhere to nor activate on the ODCE surface. Reactions (2) and (4) are considered characteristic ot blood-compatible materials.  (C) 1993 John Wiley & Sons, Inc.
C1 UNIV WASHINGTON,CTR BIOENGN BF-10,SEATTLE,WA 98195.
FU NCRR NIH HHS [RR01296]; NHLBI NIH HHS [HL 25951]
CR CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P133
   CASTNER DG, 1988, J VAC SCI TECHNOL A, V6, P964, DOI 10.1116/1.575040
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P417, DOI 10.1002/jbm.820230404
   CHOLAKIS CH, 1989, J BIOMED MATER RES, V23, P399, DOI 10.1002/jbm.820230403
   DODDS WJ, 1978, PLATELETS MULTIDISCI, P45
   EDELMAN PG, 1988, ACS POLYM MATER SCI, V59, P253
   FILES JC, 1981, BLOOD, V58, P607
   GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582
   GOOSEN MFA, 1983, J BIOMED MATER RES, V17, P359, DOI 10.1002/jbm.820170212
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HARKER LA, 1980, BLOOD, V56, P824
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   IP WF, 1991, J BIOMED MATER RES, V25, P1321, DOI 10.1002/jbm.820251012
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LUDLAM CA, 1976, BRIT J HAEMATOL, V33, P239, DOI 10.1111/j.1365-2141.1976.tb03535.x
   MUSIAL J, 1990, CIRCULATION, V82, P261, DOI 10.1161/01.CIR.82.1.261
   MUSIAL J, 1985, J LAB CLIN MED, V105, P514
   PELZER H, 1986, J BIOMED MATER RES, V20, P1401, DOI 10.1002/jbm.820200913
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   Ratner B. D., 1984, CONT BIOMATERIALS MA, P193
   WARD CA, 1974, T AM SOC ART INT ORG, VA 20, P77
   WARD CA, 1984, J BIOMED MATER RES, V18, P255, DOI 10.1002/jbm.820180303
   WILLIAMS DF, 1987, DEFINITIONS BIOMEDIC, V4
NR 24
TC 82
Z9 86
U1 0
U2 19
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1993
VL 27
IS 9
BP 1181
EP 1193
DI 10.1002/jbm.820270909
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LR717
UT WOS:A1993LR71700008
PM 8126017
DA 2018-10-19
ER

PT J
AU OSHIDA, Y
   SACHDEVA, R
   MIYAZAKI, S
   DALY, J
AF OSHIDA, Y
   SACHDEVA, R
   MIYAZAKI, S
   DALY, J
TI EFFECTS OF SHOT-PEENING ON SURFACE-CONTACT ANGLES OF BIOMATERIALS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SUBSTRATE WETTABILITY; ADHESION; CELLS
AB It was shown previously that (i) if the surface of a biomaterial is covered with TiO2 (tetragonal structure oxide), it shows a high initial contact angle and a high change rate in contact angle (i.e. a higher spreading process); while (ii) cubic structure oxides show relatively lower spreading rates in 1 % NaCl solution at 25-degrees-C. Shot-peening has been applied to biomaterials (especially titanium and its alloys) to improve their fatigue strength. It is well known that shot-peening causes surface roughening. The effects of surface roughness on wettability are not well documented. Therefore, in the present study, the effects of shot peening on the initial contact angle and changes in it as a function of time, were investigated. In addition, the spontaneous half-cell potential of all tested biomaterials were measured to correlate the wettability phenomenon to initial surface chemistry. Pure titanium and its alloys, including Ti-6Al-4V and NiTi alloys, AISI Type 316L stainless, Co-Cr alloy, and pure nickel, were mechanically polished, shot-peened and pre-oxidized at 300-degrees-C for 30 min in pure oxygen. It was found that (i) shot-peening homogenized the surface conditions in terms of initial contact angles, (ii) TiO2 oxide shows a higher spreading coefficient, while cubic structure oxides show a lower value, and (iii) the spreading coefficient was correlated to the magnitude of the spontaneous half-cell potential.
C1 BAYLOR COLL DENT,DEPT ORTHODONT,DALLAS,TX 75246.
   UNIV TSUKUBA,INST MAT SCI,TSUKUBA,IBARAKI 305,JAPAN.
   MET IMPROVEMENT CO,CTR RES & DEV,PARAMUS,NJ 07652.
RP OSHIDA, Y (reprint author), INDIANA UNIV,SCH DENT,DEPT DENT MAT,INDIANAPOLIS,IN 46202, USA.
RI Miyazaki, Shuichi/A-3113-2012
OI Miyazaki, Shuichi/0000-0003-3849-4176
CR BAIER RE, 1972, J BIOMED MATER RES, V6, P465, DOI 10.1002/jbm.820060511
   CHANG SK, 1977, MED PROG TECHNOL, V5, P57
   Davies J. T., 1963, INTERFACIAL PHENOMEN, P35
   DEXTER SC, 1975, APPL MICROBIOL, V30, P298
   DOBBS HS, 1983, ASTM STP, V796, P227
   EYLON D, 1983, ASTM STP, V796, P43
   GRINNELL F, 1972, ARCH BIOCHEM BIOPHYS, V153, P193, DOI 10.1016/0003-9861(72)90436-5
   KIRK D, 1984, 2ND P INT C SHOT PEE, P133
   KUBASCHEWSKI O, 1962, OXIDATION METALS ALL, P24
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   OSHIDA Y, 1990, J MATER SCI-MATER M, V3, P306
   OSHIDA Y, 1990, ICP 4
   Oshida Y, 1990, SURFACE ENG, P404
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   RYMUZA Z, 1989, TRIBOLOGY SERIES, V13, P346
   SEMLITSCH MF, 1983, ASTM STP, V796, P120
   Wohlfahrt H., 1982, Residual Stress and Stress Relaxation. Proceedings of the Twenty-Eighth Sagamore Army Materials Research Conference, P71
   YASUDA H, 1978, J BIOMED MATER RES, V12, P701, DOI 10.1002/jbm.820120510
   1971, T JPN I MET, V12, P214
NR 19
TC 22
Z9 22
U1 2
U2 10
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1993
VL 4
IS 5
BP 443
EP 447
DI 10.1007/BF00120123
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MG125
UT WOS:A1993MG12500002
DA 2018-10-19
ER

PT J
AU YU, JL
   ANDERSSON, R
   LJUNGH, A
   WANG, LQ
   JAKAB, E
   PERSSON, BG
   WADSTROM, T
   BENGMARK, S
AF YU, JL
   ANDERSSON, R
   LJUNGH, A
   WANG, LQ
   JAKAB, E
   PERSSON, BG
   WADSTROM, T
   BENGMARK, S
TI REDUCTION OF ESCHERICHIA-COLI ADHERENCE TO RUBBER SLICES TREATED WITH
   PHOSPHOLIPIDS
SO APMIS
LA English
DT Article
DE BACTERIAL ADHERENCE; FOREIGN BODY INFECTION; COMMON BILE DUCT; RAT;
   PHOSPHOLIPID TREATMENT
ID MALIGNANT OBSTRUCTIVE-JAUNDICE; RANDOMIZED TRIAL; BILIARY STENTS;
   FIBRONECTIN; FIBRINOGEN; BLOCKAGE
AB The present study aimed at modifying the surface of biliary drain material to reduce bacterial adherence. The adherence of cells of seven E. coli strains to rubber slices treated with phosphatidylcholin (PC) or phosphatidylinositol (PI) and the adherence of cells of E. coli strain NG7C to PC- or PI-treated rubber slices implanted in the common bile duct in rats were studied in vitro. The rubber slices were incubated with 1x10(7) cfu radiolabeled E. coli cells/ml at 37 degrees C for 60 min and then drained and washed thrice in 2 ml PBS, and adherent E. coli cells were quantified by radioactivity counting. The results show that both PC and PI absorbed on the surface of slices reduced the adherence of E. coli cells in at least two ways, i.e. by changing surface properties in vitro and by reducing deposition of host-derived molecules on phospholipid-treated surfaces in vivo. The results may be of use for modification of the biomaterial surface in the clinical situation.
C1 LUND UNIV,DEPT SURG,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR ARRAJAB A, 1991, J SURG RES, V50, P212, DOI 10.1016/0022-4804(91)90180-T
   COTTON PB, 1984, WORLD J SURG, V8, P854, DOI 10.1007/BF01656025
   DOWIDAR N, 1991, SCAND J GASTROENTERO, V26, P1137, DOI 10.3109/00365529108998605
   DOWSETT JF, 1988, AM J GASTROENTEROL, V83, P1328
   GRAHAME GR, 1985, PERITON DIALYSIS B, V5, P109
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   LEUNG JWC, 1988, GASTROINTEST ENDOSC, V34, P19, DOI 10.1016/S0016-5107(88)71223-7
   LJUNGH A, 1990, ZBL BAKT-INT J MED M, V274, P126, DOI 10.1016/S0934-8840(11)80982-5
   MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2
   SHEPHERD HA, 1988, BRIT J SURG, V75, P1166, DOI 10.1002/bjs.1800751207
   SMITH AC, 1989, GUT, V30, pA1513
   SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546
   SPEER AG, 1985, GASTROINTEST ENDOSC, V31, P140
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   YU JL, IN PRESS EUR J SURG
   YU JL, IN PRESS J MED MICRO
NR 18
TC 3
Z9 3
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0903-4641
J9 APMIS
JI APMIS
PD AUG
PY 1993
VL 101
IS 8
BP 582
EP 586
DI 10.1111/j.1699-0463.1993.tb00150.x
PG 5
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA ME953
UT WOS:A1993ME95300002
PM 8217110
DA 2018-10-19
ER

PT J
AU GOODMAN, SB
   DAVIDSON, JA
   FORNASIER, VL
AF GOODMAN, SB
   DAVIDSON, JA
   FORNASIER, VL
TI HISTOLOGICAL REACTION TO TITANIUM-ALLOY AND HYDROXYAPATITE PARTICLES IN
   THE RABBIT TIBIA
SO BIOMATERIALS
LA English
DT Article
DE JOINT REPLACEMENT; WEAR; TITANIUM ALLOY; HYDROXYAPATITE
ID SYNOVIAL-LIKE MEMBRANE; BONE-CEMENT INTERFACE; REPLACEMENTS; WEAR
AB The interfacial membrane harvested from failed joint replacements contains particulate debris from the materials used for the implant. To define the tissue response to particulate titanium alloy and hydroxyapatite (HA) alone, 16 mature New Zealand white rabbits were divided into 2 groups of 8 rabbits. Using sterile technique, a drill hole was placed anteromedially in the tibia, 1 cm distal to the knee joint bilaterally. The marrow was scooped out and 0.25 mg of either titanium alloy particles or HA particles were inserted in the right tibia. The titanium alloy particles had a diameter averaging 4.0 +/- 4.4 mum (mean +/- standard deviation) and an aspect ratio (the ratio of the maximum length divided by the maximum width) of 1.84. The HA particles had a diameter of 4.4 +/- 3.3 mum and an aspect ratio of 1.76. The left leg was prepared, in a similar fashion, but no biomaterial was implanted. The animals were killed after 16 wk. The harvested tibiae were processed with decalcification and the plastic-embedded sections were subjected to histomorphological analysis. Black titanium alloy particles were present within the bone marrow fat between haematopoietic cells, and within scattered macrophages. The surrounding bone appeared to be unaffected. Within the spongiosa, the HA particles were surrounded by small numbers of mononuclear histiocytes or encased within a shell of new appositional bone. Where HA deposits were exposed to the endosteal aspect of bone, there was scalloping of the surface of the HA in a pattern suggestive of resorption or dissolution of the HA particles. Haematopoietic activity was present at the margins of the surgically operated zone and the HA particles were intermingled with haematopoietic cells. Intracortical deposits of HA were totally encased by layers of appositional lamellar bone. The findings in this in vivo study contrast with the florid foreign body and chronic inflammatory reaction associated with particles of poly(methyl methacrylate) and polyethylene in similar experimental studies, and in failed arthroplasties in humans.
C1 SMITH & NEPHEW RICHARDS INC, ORTHOPAED RES DEPT, MEMPHIS, TN 38116 USA.
   WELLESLEY COLL HOSP, DEPT PATHOL, BONE & JOINT PATHOL LAB, TORONTO M4Y 1J3, ONTARIO, CANADA.
RP GOODMAN, SB (reprint author), STANFORD UNIV, MED CTR, DIV ORTHOPAED SURG R171, 300 PASTEUR DR, STANFORD, CA 94305 USA.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   BRIEN WW, 1990, 36TH ANN M ORTH RES, P27
   BULLOUGH PG, 1973, HIP, P80
   CAMPBELL PA, 1992, 38TH T ANN M ORTH RE, V17, P393
   CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340
   CHARNLEY J, 1979, LOW FRICTION ARTHROP
   DAVIDSON JA, 1991, 5TH P INT C SURF MOD
   De Groot K, 1981, BIOCOMPATIBILITY CLI, V1, P199
   FORNASIER VL, 1992, J APPL BIOMATER, V3, P59, DOI 10.1002/jab.770030110
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   GOODMAN SB, 1988, CLIN ORTHOP RELAT R, P255
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P517, DOI 10.1002/jbm.820240408
   GOODMAN SB, 1990, J BIOMED MATER RES, V24, P1539, DOI 10.1002/jbm.820241109
   GOODMAN SB, 1988, J ARTHROPLASTY S, V3, P41
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   HOWIE DW, 1988, CLIN ORTHOP RELAT R, P244
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JASTY MJ, 1986, J BONE JOINT SURG AM, V68A, P912, DOI 10.2106/00004623-198668060-00014
   JOHANSON NA, 1987, CLIN ORTHOP RELAT R, P123
   JONE SLC, 1987, CLIN ORTHOP RELAT R, V225, P193
   KUMAR P, 1990, CLIN IMPLANTS MATERI, V9, P373
   MAGUIRE JK, 1987, CLIN ORTHOP RELAT R, P213
   MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011
   MIRRA JM, 1982, CLIN ORTHOP RELAT R, P175
   SCHULLER HM, 1990, ACTA ORTHOP SCAND, V61, P240, DOI 10.3109/17453679008993508
   VERNONROBERTS B, 1976, ADV ARTIFICIAL HIP K, P148
   Weber B G, 1981, Hip, P264
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P108
NR 32
TC 25
Z9 28
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 1993
VL 14
IS 10
BP 723
EP 728
DI 10.1016/0142-9612(93)90035-Z
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LT996
UT WOS:A1993LT99600001
PM 8218720
DA 2018-10-19
ER

PT J
AU HAN, DK
   PARK, KD
   JEONG, SY
   KIM, YH
   KIM, UY
   MIN, BG
AF HAN, DK
   PARK, KD
   JEONG, SY
   KIM, YH
   KIM, UY
   MIN, BG
TI IN-VIVO BIOSTABILITY AND CALCIFICATION-RESISTANCE OF SURFACE-MODIFIED
   PU-PEO-SO3
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID HEPARIN-IMMOBILIZED POLYURETHANES; VALVE PROSTHESES; INVITRO; PEO;
   BIOPROSTHESES; FORMALDEHYDE; PREVENTION; COLLAGEN; CRACKING; BINDING
AB To examine the biostability and calcification-resistance of polyurethanes (PUs), the surface of PU was grafted with hydrophobic perfluorodecanoic acid (PFDA) (PU-PFDA), hydrophilic polyethyleneoxide (PEO) (PU-PEO1000), and further negatively charged sulfonate groups (PU-PEO1000-SO3). An in vivo animal test was conducted by subcutaneous implantation in rats during 2, 4 and 6 months. A scanning electron microscope study demonstrated that the degree of surface cracking on explanted PUs was increased in the following order: PU-PFDA > PU > PU-PEO1000 > PU-PEO1000-SO3. In the results of energy dispersive x-ray analysis and inductively coupled plasma atomic emission spectrometry, the deposition of calcium was found abundantly, but that of phosphorus was hardly in existence in all implanted PUs, suggesting that this calcium compound is not a hydroxyapatite. The calcium contents, regardless of implantation time, were also increased in the same order (PU-PFDA > PU > PU-PEO1000 > PU-PEO1000-SO3). After 6 months implantation, no severe tissue reactions were observed and calcification almost occurred on polymer surfaces in all implants. Such superior biostability and anticalcification of PU-PEO1000-SO3 might be attributed to synergistic effects of its excellent surface smoothness, sulfonate acid (SO3-) groups, nonadhesive and mobile PEO, and the high hydrophilicity and enhanced blood compatibility. Therefore, PU-PEO1000-SO3 is promising as biostable and calcification-resistant biomaterial.  (C) 1993 John Wiley & Sons, Inc.
C1 SEOUL NATL UNIV,COLL MED,DEPT BIOMED ENGN,SEOUL 110744,SOUTH KOREA.
RP KIM, YH (reprint author), KOREA INST SCI & TECHNOL,POLYMER CHEM LAB,POB 131,SEOUL 130650,SOUTH KOREA.
OI jeong, seo young/0000-0002-3035-0867; Han, Dong Keun/0000-0003-4641-7883
CR BILGE FH, 1991, AM SOC ARTIF INTERN, V20, P27
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   DOSTAL M, 1990, INT J ARTIF ORGANS, V13, P498
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FIESISCH H, 1989, RECENT RES CANCER, V16, P1
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1992, J MATER SCI-MATER M, V3, P272, DOI 10.1007/BF00705292
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   HAN DK, 1993, J APPL POLYM SCI, V47, P761, DOI 10.1002/app.1993.070470502
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAN DK, 1992, J BIOMAT SCI-POLYM E, V3, P229
   HAN DK, IN PRESS J BIOMATER
   HARASAKI H, 1987, T AM SOC ART INT ORG, V33, P643
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   JONES M, 1988, T AM SOC ART INT ORG, V34, P1027
   Khatib H., 1990, TRANSPLANTATION, V49, P765
   Lelah M. D., 1986, POLYURETHANES MED
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   MARECHANT RE, 1988, SURFACE CHARACTERIZA, P297
   NANCOLLAS GH, 1977, J CRYST GROWTH, V42, P185, DOI 10.1016/0022-0248(77)90194-4
   OWEN DR, 1981, T AM SOC ART INT ORG, V27, P528
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1984, J THORAC CARDIOV SUR, V88, P208
   SPRINCL L, 1973, CALC TISS RES, V13, P63, DOI 10.1007/BF02015397
   STOKES KB, 1987, POLYM SCI TECHNOL, V35, P147
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810
   VANBLITTERSWIJK CA, 1991, T SOC BIOMATER, V14, P11
   WEBB CL, 1988, T AM SOC ART INT ORG, V34, P851
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WILLIAMS RG, 1990, SCIENCE, V249, P178
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 44
TC 36
Z9 36
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1993
VL 27
IS 8
BP 1063
EP 1073
DI 10.1002/jbm.820270812
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LM052
UT WOS:A1993LM05200011
PM 8408119
DA 2018-10-19
ER

PT J
AU CHIGNIER, E
   GUIDOLLET, J
   FREYRIA, AM
   ARDAIL, D
   MCGREGOR, JL
   LOUISOT, P
AF CHIGNIER, E
   GUIDOLLET, J
   FREYRIA, AM
   ARDAIL, D
   MCGREGOR, JL
   LOUISOT, P
TI DACRON VASCULAR BIOMATERIAL TRIGGERS MACROPHAGE ECTOENZYME ACTIVITY
   WITHOUT CHANGE IN CELL-MEMBRANE FLUIDITY
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID 5'-NUCLEOTIDASE ACTIVITY; PLASMA-MEMBRANES
AB Biomaterials induce an inflammatory reaction characterized by a rapid recruitment at the implantation site of polymorphonuclear cells and macrophages. In the course of the inflammatory response, the cellular activation triggers expression of a number of enzymes, such as 5'-nucleotidase, which is widely distributed in animal cell membranes as an ectoenzyme. It is now well established that 5'-nucleotidase activity decreases following the contact of inflammatory cells with foreign particles. In this paper we investigate a possible correlation between the enzymatic activities and the dynamic properties of the cell membrane bilayer. Dacron pieces were introduced into rats' peritoneal cavities for a period of 6 h, after which the peritoneal cells were harvested, and various enzyme assays performed, including those for cytoplasmic, lysosomal, and ectoenzymes. In parallel, we studied cell membrane fluidity, using fluorescence polarization of 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH), and cellular ultrastructural alteration resulting from the cell-biomaterial interactions using scanning and transmission electron microscopy. Our results show that: 1) macrophages spread around the Dacron fibers with cytoplasmic finger-like projections, but no phagolysosomes, 2) 5'-nucleotidase levels decrease with surgical trauma in comparison with the resident cell exudate, 3) implantation of biomaterials slightly modify the 5'-nucleotidase levels observed in the sham animal, 4) no differences in the anisotropy values indicating that membrane lipid order within the cells could not account for the observed decrease of 5'-nucleotidase activity. Thus, we can suggest that 5'-nucleotidase expression may reflect a particular feature of cell activation without a phagocytic process.  (C) 1993 John Wiley & Sons, Inc.
C1 LYON SUD MED SCH,INSERM,U189,F-69921 OULLINS,FRANCE.
   CNRS,UPR 412,IBCP,F-69367 LYON 07,FRANCE.
RP CHIGNIER, E (reprint author), A CARREL MED SCH,INSERM,U331,8 RUE G PARADIN,F-69372 LYON 8,FRANCE.
CR ABSOLOM DR, 1986, METHODS ENZYMOLOGY 1, V132
   ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   ARDAIL D, 1990, J BIOL CHEM, V265, P18797
   BERTRAND A, 1982, CLIN CHIM ACTA, V119, P275, DOI 10.1016/0009-8981(82)90340-0
   CHIGNIER E, 1987, J BIOMED MATER RES, V21, P1415, DOI 10.1002/jbm.820211206
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   FRENCH RR, 1983, COMP BIOCHEM PHYS B, V76, P309, DOI 10.1016/0305-0491(83)90075-5
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   FREYRIA AM, 1991, COMP BIOCHEM PHYS A, V99, P517, DOI 10.1016/0300-9629(91)90125-V
   KURHY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60
   LEMAIRE G, 1982, RES J RETICULOENDOTH, V32, P87
   MARCHANT R, 1983, J BIOMED MATER RES, V2, P283
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MOMCHILOVA A, 1985, INT J BIOCHEM, V17, P787, DOI 10.1016/0020-711X(85)90265-4
   NICOLAS C, 1990, COMP BIOCHEM PHYS B, V96, P195, DOI 10.1016/0305-0491(90)90362-W
   SHINITZKY M, 1984, PHYSL MEMBRANE FLUID, V1, P1
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SWEET W D, 1988, P17
   VAES G, 1965, METHOD ENZYMOL, V14, P509
   WERB Z, 1972, J BIOL CHEM, V247, P2439
   WROBLEWSKI F, 1956, P SOC EXP BIOL MED, V91, P569
   YORK DA, 1985, P NUTR SOC, V44, P189, DOI 10.1079/PNS19850038
NR 22
TC 3
Z9 3
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1993
VL 27
IS 8
BP 1087
EP 1094
DI 10.1002/jbm.820270814
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LM052
UT WOS:A1993LM05200013
PM 8408121
DA 2018-10-19
ER

PT J
AU DION, I
   ROQUES, X
   MORE, N
   LABROUSSE, L
   CAIX, J
   LEFEBVRE, F
   ROUAIS, F
   GAUTREAU, J
   BAQUEY, C
AF DION, I
   ROQUES, X
   MORE, N
   LABROUSSE, L
   CAIX, J
   LEFEBVRE, F
   ROUAIS, F
   GAUTREAU, J
   BAQUEY, C
TI EX-VIVO LEUKOCYTE ADHESION AND PROTEIN ADSORPTION ON TIN
SO BIOMATERIALS
LA English
DT Article
DE TITANIUM NITRIDE; HEMOCOMPATIBILITY; LEUKOCYTE ADHESION; PROTEIN
   ADSORPTION
ID INVIVO; SHUNT
AB Titanium nitride (TiN) is regarded as a potential biomaterial for blood-contact applications. Its in vitro haemocompatibility has been evaluated already and gave promising results. The purpose of this study was to continue studying its 'biological' behaviour through an ex vivo evaluation. The material was a physical vapour deposition elaborated TiN coating and the phenomena observed were leucocyte adhesion and albumin and fibrinogen adsorption. These ex vivo results were compared with in vitro results obtained previously. Two reference medical grade silicone elastomer and three TIN arterio-arterial extra-corporeal circuits were tested. No leucocyte was retained by TiN, as in in vitro experiments; the ex vivo fibrinogen adsorbed quantity was higher and albumin adsorption was about the same in in vitro ard in ex vivo situations. TIN can be considered as a suitable blood-contacting material.
C1 LAB BIOPHYS,F-33076 BORDEAUX,FRANCE.
   HOP CARDIOL HAUT LEVEQUE,SERV CHIRURG CARDIOVASC PR BAUDET,F-33604 PESSAC,FRANCE.
RP DION, I (reprint author), INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR BAQUEY C, 1989, BIOMATERIALS, V10, P435, DOI 10.1016/0142-9612(89)90082-3
   BAQUEY C, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P3
   BASSECATHALINAT B, 1980, INT J APPL RADIAT IS, V31, P747, DOI 10.1016/0020-708X(80)90064-2
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BULL SJ, 1990, SURF COAT TECH, V41, P269, DOI 10.1016/0257-8972(90)90138-3
   CAIX J, 1993, IN PRESS J BIOMATER
   COLL BF, 1988, SURF COAT TECH, V36, P867, DOI 10.1016/0257-8972(88)90027-8
   DION I, 1992, BIOCERAMICS AND THE HUMAN BODY, P345
   DION I, 1993, BIOMATERIALS, V14, P107, DOI 10.1016/0142-9612(93)90218-Q
   DION I, 1992, INT J ARTIF ORGANS, V15, P457
   DION I, 1992, UNPUB J APPL BIOMATE
   DION I, 1992, EMBS IEEE, V1, P5
   DION I, 1993, IN PRESS INT J ARTIF
   DUCASSOU D, 1976, BRIT J RADIOL, V49, P344, DOI 10.1259/0007-1285-49-580-344
   DUCHATEAU D, 1991, CETIM INFORMATIONS, V122, P42
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   GROSSESIESTRUP C, 1979, J BIOMED MATER RES, V13, P15, DOI 10.1002/jbm.820130104
   JANVIER G, 1993, OUNPUB J APPL RAD IS
   KUSSEROW BK, 1976, ANN REPORT MATERIAL, P1
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   MITAMURA Y, 1990, Artificial Organs, V14, P94
   RABAUD M, 1987, BIOMATERIALS, V8, P217, DOI 10.1016/0142-9612(87)90067-6
   SCHULTZ HA, 1991, MED DEVICE TECHNOL, V2, P12
   STEWART GJ, 1983, ANN NY ACAD SCI, P179
NR 24
TC 39
Z9 43
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 1993
VL 14
IS 9
BP 712
EP 719
DI 10.1016/0142-9612(93)90070-I
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LQ251
UT WOS:A1993LQ25100009
PM 8399968
DA 2018-10-19
ER

PT J
AU ANDERSON, JM
AF ANDERSON, JM
TI MECHANISMS OF INFLAMMATION AND INFECTION WITH IMPLANTED DEVICES
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID INVIVO LEUKOCYTE INTERACTIONS; GROWTH-FACTOR-BETA; STAPHYLOCOCCAL
   ADHERENCE; CELL-ADHESION; TISSUE; NEUTROPHILS; INVITRO; INJURY;
   BIOCOMPATIBILITY; BIOMATERIALS
AB Inflammation, wound healing, and foreign body responses are generally considered as parts of the tissue or cellular host responses to injury. Table 1 lists the sequence of these events following injury. From the biomaterials perspective, placement of a biomaterial in the in vivo environment involves injection, insertion, or surgical implantation, all of which injure the tissues or organs involved (1,2).
   The implantation procedure initiates a response to injury, and mechanisms are activated to produce healing (3,4). The degree to which the homeostatic mechanisms are perturbed and the extent of pathophysiologic responses and their resolution are measures of the host reactions to the biomaterial, and they may ultimately determine its biocompatibility and its success or failure as a device or prosthesis. Although it is convenient to consider blood-material interactions separately from tissue-material interactions, it should be kept in mind that the mechanisms involved in both sets of interactions involve both blood and tissue. Furthermore, host reactions are tissue dependent, organ dependent, and species dependent. Obviously, the extent of injury varies depending on the implantation procedure.
   This chapter is intended as an overview of the inflammatory and infectious responses to implanted devices. Specific details regarding components of the inflammatory and wound healing processes are found in other chapters in this volume.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA.
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   BISNO AL, 1989, INFECTIONS ASSOCIATE
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P370, DOI 10.1016/0142-9612(90)90089-9
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   CHEUNG AL, 1990, J INFECT DIS, V161, P1177, DOI 10.1093/infdis/161.6.1177
   Clark R.A.F., 1988, MOL CELLULAR BIOL WO
   COTRAN RS, 1990, J AM SOC NEPHROL, V1, P225
   COTRAN RZ, 1989, PATHOLOGIC BASIS DIS, P33
   CROMACK DT, 1987, J SURG RES, V42, P622, DOI 10.1016/0022-4804(87)90005-9
   DIDISHEIM P, 1989, T AM SOC ART INT ORG, V35, P54
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363
   GALLIN JI, 1988, INFLAMMATION BASIC P
   GOLDEN MA, 1991, J CLIN INVEST, V87, P406, DOI 10.1172/JCI115011
   Greisler H, 1988, ASAIO Trans, V34, P1051
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hunt TK, 1984, SOFT HARD TISSUE REP
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   JUTILA MA, 1992, APMIS, V100, P191, DOI 10.1111/j.1699-0463.1992.tb00861.x
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   LEHRER RI, 1988, ANN INTERN MED, V109, P127, DOI 10.7326/0003-4819-109-2-127
   Maciag T, 1990, Important Adv Oncol, P85
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P309, DOI 10.1002/jbm.820180307
   MOELLEKEN BRW, 1991, ARCH SURG-CHICAGO, V126, P225
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   PATY PB, 1990, ARCH SURG-CHICAGO, V125, P65
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   RAJA RH, 1990, INFECT IMMUN, V58, P2593
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   SPILIZEWSKI K L, 1985, Journal of Controlled Release, V2, P197, DOI 10.1016/0168-3659(85)90045-8
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SPORN MB, 1990, PEPTIDE GROWTH FACTO, V1
   SPRUGEL KH, 1987, AM J PATHOL, V129, P601
   SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080
   THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952
   VAUDAUX P, 1989, J INFECT DIS, V160, P865, DOI 10.1093/infdis/160.5.865
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WADSTROM T, 1990, PATHOGENESIS WOUND B
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   WEISSMANN G, 1980, NEW ENGL J MED, V303, P27
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wokalek H, 1991, J Biomater Appl, V5, P337, DOI 10.1177/088532829100500405
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 55
TC 133
Z9 134
U1 0
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S33
EP S41
PG 9
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500005
DA 2018-10-19
ER

PT J
AU COURY, AJ
AF COURY, AJ
TI PREPARATION OF SPECIMENS FOR BLOOD COMPATIBILITY TESTING
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID PROTEIN ADSORPTION; SURFACES; THROMBOGENICITY; BIOMATERIAL
AB This chapter addresses fabrication variables that affect the intrinsic blood compatibility of biomaterial test specimens. The primary focus, therefore, is on surface chemical composition, which can vary instantaneously with processing conditions and environmental changes. The relevance of blood compatibility testing is dependent on the control of applicable variables and an understanding of the state of the biomaterial at the time of testing. An appropriate fabrication protocol includes rigorous planning for and execution of quality control measures in collaboration with those who will design, run, and interpret the actual tests. Adequate documentation, quality monitoring, operator training, and safe laboratory practices contribute to a valid test outcome. Controllable environmental variables include air composition and flow, light composition and intensity, temperature, electrostatic charge, and particulates. To minimize particulate contamination, handling and processing of biomaterials should take place in clean spaces. Substrate effects involving the contact of biomaterials with processing tools, handling implements, or packaging materials must be controlled to minimize mechanical damage or the transfer of contaminants to test specimens. In preparing the test specimen, different primary fabrication processes and subsequent treatments can produce widely divergent properties in the same biomaterial. Therefore a detailed understanding of the physical and chemical consequences of the chosen process (e.g., thermal, solution, reactive, mechanical) is necessary. Secondary procedures such as cleaning, extraction, surface modification, prehydration, and storage will affect important surface and bulk properties of the biomaterial. Commitment to the quality of a study from design through test execution is necessary to provide assurance of validity and reproducibility.
RP COURY, AJ (reprint author), MEDTRONIC INC, 6700 SHINGLE CREEK PKWY, MINNEAPOLIS, MN 55430 USA.
CR BAGRODIA S, 1976, J BIOMED MATER RES, V10, P101, DOI 10.1002/jbm.820100110
   BARENBERG SA, 1981, J BIOMED MATER RES, V15, P231, DOI 10.1002/jbm.820150210
   BARENBERG SA, 1979, T AM SOC ART INT ORG, V25, P159
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BELL JP, 1977, J APPL POLYM SCI, V21, P1095, DOI 10.1002/app.1977.070210423
   BENSEN CV, 1991, J BIOMED MATER RES, V25, P373, DOI 10.1002/jbm.820250309
   BILLAT S, 1991, MICROCONTAMINATION, V9, P56
   CAHALAN P, 1989, Patent No. 4768523
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COURY A, 1991, BIOMATERIALS INTRO T
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1983, ADHESIUN ASPECTS POL, P163
   DESTEFANI J, 1988, METAL PROGR, P39
   HATTORI T, 1989, MICROCONTAMINATION, V7, P100
   HATTORI T, 1989, MICROCONTAMINATION, V7, P41
   HECKER JF, 1981, J BIOMED MATER RES, V15, P1, DOI 10.1002/jbm.820150104
   HENKE C, 1991, MED DEVICE DIAGN IND, V13, P40
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   HOBBS C, 1991, MICROCONTAMINATION, V9, P19
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   KALMAN PG, 1991, J BIOMED MATER RES, V25, P199, DOI 10.1002/jbm.820250207
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KESSLER TR, 1978, T AM SOC ART INT ORG, V24, P532
   LANDFIELD H, 1983, BIOCOMPATIBLE POLYM, P975
   LELAH M, 1986, POLYURETHANES MED, V7, P85
   LINDON JN, 1980, CIRC RES, V46, P84, DOI 10.1161/01.RES.46.1.84
   MCMILLIN C, 1983, BIOCOMPATIBLE POLYM, P461
   NYILAS E, 1977, J BIOMED MATER RES, V11, P69, DOI 10.1002/jbm.820110108
   OLSEN D, 1980, NIH802032 PUBL
   PARK J, 1988, ENCY MED DEVICES INS, V1, P328
   RATNER BD, 1981, ACS SYM SER, V162, P371
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SCHOEN FJ, 1983, BIOCOMPATIBLE POLYM, P239
   Skeist I. E., 1990, HDB ADHESIVES
   SKIENS WE, 1983, BIOCOMPATIBLE POLYM, P1001
   SUNG CSP, 1978, J BIOMED MATER RES, V12, P791, DOI 10.1002/jbm.820120603
   SUNNY MC, 1990, J BIOMED MATER RES, V24, P455, DOI 10.1002/jbm.820240404
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P103
   TOLLIVER DL, 1983, MICROCONTAMINATION, V1, P34
   VANKAMPEN CL, 1979, J BIOMED MATER RES, V13, P517, DOI 10.1002/jbm.820130402
   VIG JR, 1979, SURFACE CONTAMINATIO, V1, P235
   Wiegler N., 1991, Microcontamination, V9, P39
   WILKES GL, 1979, J BIOMED MATER RES, V13, P189, DOI 10.1002/jbm.820130204
   WILLIAMS RL, 1989, J BIOMED MATER RES, V23, P339, DOI 10.1002/jbm.820230305
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   1991, MED PRODUCT MANUFACT, V7, P22
   1991, 1991 1992 CATALOG, P1081
NR 48
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S101
EP S110
PG 10
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500010
DA 2018-10-19
ER

PT J
AU HELMUS, MN
   HUBBELL, JA
AF HELMUS, MN
   HUBBELL, JA
TI MATERIALS SELECTION
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID COMPLEMENT ACTIVATION; PERICARDIAL XENOGRAFT; INVITRO; SURFACES; INVIVO;
   ADSORPTION; STRESS; GRAFT
AB Cardiovascular devices have diverse requirements for the materials used in their construction. A range of physical and biological properties must be evaluated along with the materials' processability in order to fabricate an economical, safe, and effective device. The materials used in cardiovascular devices include a broad range of commercially available materials; however, these materials must meet stringent requirements to be acceptable for use in the body. Specifically, these biomaterials include synthetic polymers, biodegradable polymers, biologically derived materials, bioderived macromolecules, passive coatings, bioactive coatings, tissue adhesives, metal alloys, ceramics, and carbons. Applications for these blood-contacting materials include extracorporeal devices, catheters, and tubing devices, which are inserted into a blood vessel, or permanently implanted devices. In the most basic sense, the materials constituting the device, as fabricated and sterilized, must be nontoxic, noncarcinogenic, nonantigenic, and nonmutagenic. Implanted devices impose a new set of requirements, both biologically and from a materials viewpoint. The effect of a foreign body in the cardiovascular system essentially involves the study of thrombosis and wound healing in the presence of a sterile foreign material in flowing blood. The outcome of this healing process can have profound implications for the success of a device and can be dependent on material properties. The durability of the device will be determined by its fatigue resistance and its resistance to biodegradation. Designs will be increasingly scrutinized for durability by regulatory agencies. Each class of biomaterial for cardiovascular applications is categorized by the material properties. The biologic and physical criteria need to be evaluated in the context of the entire device, its application and duration of use, and how it interfaces with the body.
C1 UNIV TEXAS, DEPT CHEM ENGN, AUSTIN, TX 78712 USA.
RP HELMUS, MN (reprint author), SCHNEIDER USA INC, PFIZER HOSP PROD GRP, 5905 NATHAN LANE, MINNEAPOLIS, MN 55442 USA.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR ABELE JE, 1983, TRANSLUMINAL ANGIOPL, P20
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   ASLAKSEN E, 1991, SYSTEMS ENG
   BARENBERG SA, 1990, DEGRADABLE MATERIALS
   BORETOS JW, 1984, CONT BIOMATERIALS MA
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   BURKEL WE, 1987, ANN NY ACAD SCI, V516, P131, DOI 10.1111/j.1749-6632.1987.tb33036.x
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   EBERHART RC, 1991, MRS BULL, V16, P50
   GABBAY S, 1984, J THORAC CARDIOV SUR, V87, P836
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GRAYSON M, 1978, KIRKOTHMER ENCY CHEM, V3
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   HECKER JF, 1985, J BIOMED MATER RES, V19, P381, DOI 10.1002/jbm.820190404
   HELMUS M, 1986, ASTM SPEC TECH PUBL, V898, P236
   HELMUS MN, 1991, MRS BULL, V16, P33
   HELMUS MN, 1990, ADV MATERIALS LOOKIN, P113
   HENCH LL, 1982, BIOMATERIALS INTERFA
   HOFFMAN AS, 1987, ANN NY ACAD SCI, V516, P96, DOI 10.1111/j.1749-6632.1987.tb33033.x
   HORBETT TA, 1986, J BIOMED MATER RES, V20, P739, DOI 10.1002/jbm.820200608
   HORBETT TA, 1990, Patent No. 4919659
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   JURAN R, 1990, MODERN PLASTICS ENCY
   King M. W., 1991, CAN TEXT J, V108, P24
   KIRALY RJ, 1980, SYNTHETIC BIOMEDICAL, P59
   LEE JM, 1989, J BIOMED MATER RES, V23, P491, DOI 10.1002/jbm.820230504
   Lelah M. D., 1986, POLYURETHANES MED
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LONDSDALE HK, 1982, J MEMBRANE SCI, V10, P81
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   MITAMURA Y, 1985, PROGR ARTIFICIAL ORG, P508
   MUELLER E, 1991, MRS BULL, V16, P39, DOI 10.1557/S0883769400056037
   NAGAOKA S, 1990, BIOACTIVE COMPATIBLE, V5, P212
   NOSE Y, 1975, 2ND NAT I HLTH ANN R
   PINCHUK L, 1990, ADV MATERIALS LOOKIN, P133
   RASHKIND WJ, 1981, VASCULAR CATHETER DE
   REED CC, 1985, CARDIOPULMONARY BYPA
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   SALZMAN EW, 1987, HEMOSTASIS THROMBOSI, P1335
   SCHOEN FJ, 1989, INTERVENTIONAL SURGI
   SHIMIZU T, 1989, TRANSFUSION, V29, P292, DOI 10.1046/j.1537-2995.1989.29489242792.x
   SNYDER RW, 1988, ENCY MED DEVICES INS, V4, P2839
   SPECTOR M, 1990, INT SAMPE TECH CONF, V25, P1119
   STOKES K, 1987, T SOC BIOMATER, V10, P52
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P149, DOI 10.1002/jbm.820170112
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P129, DOI 10.1002/jbm.820170111
   VANDERGIESSEN WJ, 1991, CIRCULATION, V83, P1788, DOI 10.1161/01.CIR.83.5.1788
   VANDOMAEL M, 1986, PRACTICE CORONARY AN, P93
   VANRECUM AF, 1986, HDB BIOMATERIALS EVA
   Williams DF, 1981, BIOCOMPATIBILITY CLI
   1978, FED REG 5, P27474
   DESIGN HDB DUPONT EN
   ELGILOY DATA SHEET
NR 62
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S53
EP S71
PG 19
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500007
DA 2018-10-19
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI CHARACTERIZATION OF BIOMATERIAL SURFACES
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID SCANNING TUNNELING MICROSCOPY; ION MASS-SPECTROMETRY; TRANSFORM
   INFRARED-SPECTROSCOPY; ATOMIC FORCE MICROSCOPY; REFLECTION SPECTROSCOPY;
   FILMS; SIMS; TIME
AB The surface of a biomaterial can alter or influence proteins and cells. Such interaction leads to the responses we call biocompatibility and blood compatibility. Thus, an understanding of the surface can offer insight into the nature of biological reaction. Since surfaces are inevitably different in chemistry and structure from the bulk of materials and since surfaces are comprised of a minute amount of material, special analytical techniques are needed to study surfaces. Contact angle methods, surface infrared techniques, electron spectroscopy for chemical analysis (ESCA), secondary ion mass spectrometry (SIMS), surface imaging methods, and the scanning probe microscopies are briefly outlined with an emphasis on new developments that will enhance our abilities to study biomaterial surfaces.
RP RATNER, BD (reprint author), UNIV WASHINGTON, CTR ENGN, BF-10, SEATTLE, WA 98195 USA.
CR ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   ALBRECHT TR, 1988, J APPL PHYS, V64, P1178, DOI 10.1063/1.341881
   ALLARA DL, 1982, ACS SYM SER, V199, P33
   ALLARA DL, 1980, ACS SYM SER, V137, P37
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   BENNINGHOVEN A, 1983, SPRINGER SERIES CHEM, V25, P64
   BINNIG G, 1986, IBM J RES DEV, V30, P355
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   Briggs D., 1983, PRACTICAL SURFACE AN
   BROOKER AD, 1986, SURF INTERFACE ANAL, V8, P13, DOI 10.1002/sia.740080104
   CHALMERS JM, 1985, APPL SPECTROSC, V39, P634, DOI 10.1366/0003702854250329
   CHILKOTI A, 1990, J VAC SCI TECHNOL A, V8, P2274, DOI 10.1116/1.576750
   CHILKOTI A, 1991, ANAL CHEM, V63, P1612, DOI 10.1021/ac00015a022
   CHILKOTI A, 1991, SURF INTERFACE ANAL, V17, P567, DOI 10.1002/sia.740170805
   CHILKOTI A, 1993, SURFACE CHARACTERIZA
   Clark D. T., 1978, POLYM SURFACES
   DAVIES MC, 1990, CRIT REV BIOCOMPAT, V5, P297
   DILKS A, 1981, ELECTRON SPECTROSCOP, V4, P277
   DIXON AJ, 1987, AM BIOTECHNOL LAB, V5, P20
   Echlin P., 1984, ANAL ORGANIC BIOL SU
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   GILLEN G, 1990, ANAL CHEM, V62, P2122, DOI 10.1021/ac00218a014
   Goldstein J. I., 1975, PRACTICAL SCANNING E
   GOOD RJ, 1979, SURF COLLOID SCI, V11, P1, DOI DOI 10.1007/978-1-4615-7969-4_1
   Goodman S. L., 1991, COLLOIDAL GOLD PRINC, V3, P369
   GOODMAN SL, 1988, SURFACE CHARACTERIZA, P281
   Graham J. A., 1985, FOURIER TRANSFORM IN, V4, P345
   HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380
   HARNIMAN RJ, 1988, RES DEV, V30, P112
   Harrick N. J, 1967, INTERNAL REFLECTION
   HOLLY FJ, 1976, ACS SYM SER, P252
   ISHINO Y, 1988, APPL SPECTROSC, V42, P1296, DOI 10.1366/0003702884429959
   KATON JE, 1986, ANAL CHEM, V58, pA465, DOI 10.1021/ac00294a002
   LEGGETT GJ, 1990, SURF INTERFACE ANAL, V16, P3, DOI 10.1002/sia.740160104
   LOEB G, 1977, ACS ORG COAT PLAST C, V37, P662
   MANTUS DS, 1990, J VAC SCI TECHNOL A, V8, P2209, DOI 10.1116/1.577027
   MILES MJ, 1990, J VAC SCI TECHNOL A, V8, P698, DOI 10.1116/1.576986
   MIRABELLA FM, 1989, J APPL POLYM SCI, V37, P851, DOI 10.1002/app.1989.070370320
   MIRABELLA FM, 1985, APPL SPECTROSC REV, V21, P45, DOI 10.1080/05704928508060428
   NGUYEN T, 1985, PROG ORG COAT, V13, P1, DOI 10.1016/0033-0655(85)80001-7
   PAYNTER RW, 1986, TECHNIQUES BIOCOMPAT, V2, P49
   PORTER MD, 1988, ANAL CHEM, V60, pA1143, DOI 10.1021/ac00171a001
   PRICE D, 1990, TRAC-TREND ANAL CHEM, V9, P21, DOI 10.1016/0165-9936(90)80012-W
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1993, IN PRESS BIOMATERIAL
   RATNER BD, IN PRESS SURFACE ANA
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REICHERT WM, 1989, CRIT REV BIOCOMPAT, V5, P173
   SACHER E, 1988, CHARACTERIZATION BIO, P53
   SALMON T, 1989, BIOTECHNIQUES, V7, P624
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SEAH MP, 1988, SURF INTERFACE ANAL, V11, P69, DOI 10.1002/sia.740110109
   SHUMAN H, 1989, BIOTECHNIQUES, V7, P154
   Somorjai G. A., 1981, CHEM 2 DIMENSIONS SU
   Sung CSP, 1984, CHEM ENG COMMUN, V30, P229, DOI 10.1080/00986448408911130
   TYLER BJ, 1989, SURF INTERFACE ANAL, V14, P443, DOI 10.1002/sia.740140804
   Vickerman J. C., 1989, SECONDARY ION MASS S
   Wu S., 1982, POLYM INTERFACE ADHE
NR 58
TC 42
Z9 42
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S87
EP S100
DI 10.1016/1054-8807(93)90049-8
PG 14
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500009
DA 2018-10-19
ER

PT J
AU UMAMAHESWARARAO, S
   RAO, BV
   ZACHARIAH, K
   RAO, KM
AF UMAMAHESWARARAO, S
   RAO, BV
   ZACHARIAH, K
   RAO, KM
TI ISOLATION AND PURIFICATION OF YOLK IGG (YIGG) FROM DUCK EGGS
SO INDIAN JOURNAL OF ANIMAL SCIENCES
LA English
DT Article
AB The methodology of chloroform extraction from duck egg-yolk was standardized. The aqueous portion of the extract was rich in IgG when subjected to salt precipitation followed by fractionation and purification by gel-filtration and ion-exchange chromatography. The identity of IgG was established by immunoelectrophoretic studies. The yolk extract was the choice of biomaterial for fractionation and recovery of fairly pure IgG.
RP UMAMAHESWARARAO, S (reprint author), ANDHRA PRADESH AGR UNIV,DEPT MICROBIOL,TIRUPATI 517502,ANDHRA PRADESH,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INDIAN COUNC AGRICULTURAL RES
PI NEW DELHI
PA ICAR BHAWAN PUSA, NEW DELHI 110 012, INDIA
SN 0367-8318
J9 INDIAN J ANIM SCI
JI Indian J. Anim. Sci.
PD JUL
PY 1993
VL 63
IS 7
BP 720
EP 723
PG 4
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA LP506
UT WOS:A1993LP50600007
DA 2018-10-19
ER

PT J
AU TU, R
   QUIJANO, RC
   LU, CL
   SHEN, S
   WANG, E
   HATA, C
   LIN, D
AF TU, R
   QUIJANO, RC
   LU, CL
   SHEN, S
   WANG, E
   HATA, C
   LIN, D
TI A PRELIMINARY-STUDY OF THE FIXATION MECHANISM OF COLLAGEN REACTION WITH
   A POLYEPOXY FIXATIVE
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE FIXATION; KINETIC STUDY; POLYEPOXY COMPOUNDS; AMINO ACIDS; COLLAGEN
ID GLUTARALDEHYDE; GRAFT
AB A new biomaterial has been developed by fixing native collagens with a polyepoxy compound (PC) fixative. Prior studies have shown that this biomaterial has comparable properties as compared to collagen fixed with glutaraldehyde (GA) and thus has a great promise for use as an implantable bioprosthesis. The purpose of this study was to understand the mechanism of the amino acids-PC reactions in the fixation process. Bovine arteries were fixed with PC under various pH, concentration and temperature conditions as a function of fixation time. Individual amino acid components in the fresh and the fixed arteries were assayed using a Beckman amino acid analyzer to determine the degree of tanning. The denaturation temperature (T(d)) was also measured on each sample. Since the denaturation temperature is a direct indication of cross-linking of individual amino acids with the fixative, the difference in the degree of tanning for the same increase in T(d) may be indicative of the quantity of the masked, non-cross-linked amino acids. The fixation reaction data indicated that not all amino acids were cross-linked upon contacting the PC fixative. Masking appeared to be more substantial with a fixation at higher pH values.
C1 BAXTER HEALTHCARE CORP,EDWARDS CVS DIV,MAIL STN 22,17221 RED HILL AVE,IRVINE,CA 92714.
CR ALLAIN JC, 1980, CONNECT TISSUE RES, V7, P127, DOI 10.3109/03008208009152104
   BAILEY AJ, 1968, BIOCHEM BIOPH RES CO, V33, P812, DOI 10.1016/0006-291X(68)90233-7
   BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   HATA C, 1992, ARTIF ORGANS, V16, P263, DOI 10.1111/j.1525-1594.1992.tb00307.x
   HATA C, 1992, 1992 ESAO M ROD
   Heidemann E., 1988, COLLAGEN, VIII, P39
   HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   KORN AH, 1972, J MOL BIOL, V65, P525, DOI 10.1016/0022-2836(72)90206-9
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LOHRE J, 1991, 7 WORLD C ISAO MONTR
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MONSAN P, 1975, BIOCHIMIE, V57, P12181
   MORRISON RT, 1986, ORGANIC CHEM, P548
   MURAYAMA Y, 1988, T AM SOC ART INT ORG, V34, P546
   NIMNI ME, 1988, COLLAGEN, V1, P1
   NIMNI ME, 1988, COLLAGEN, V111, P1
   NIOSHIKI Y, 1986, T ASAIO, V32, P114
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   PAYNE JW, 1973, BIOCHEM J, V135, P867, DOI 10.1042/bj1350867
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SUMA H, 1990, TEX HEART I J, V17, P103
   SUNG H, IN PRESS NONINVASIVE
   SUNG H, 1992, 1992 ESAO M ROD
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1991, 1991 ASAIO M CHIC
   TU R, 1991, T ASAIO, V37, pM470
   TU R, 1991, 1991 SOC BIOM M SCOT
   VONVERZAR F, 1960, GERONTOLOGIA, V4, P112
   WAITE JH, 1981, CRC HDB BIOCH AGING
   Yamauchi M., 1988, COLLAGEN, P157
NR 42
TC 23
Z9 24
U1 1
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 1993
VL 16
IS 7
BP 537
EP 544
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LQ459
UT WOS:A1993LQ45900007
PM 8370609
DA 2018-10-19
ER

PT J
AU DION, I
   BAQUEY, C
   HAVLIK, P
   MONTIES, JR
AF DION, I
   BAQUEY, C
   HAVLIK, P
   MONTIES, JR
TI A NEW MODEL TO TEST PLATELET-ADHESION UNDER DYNAMIC CONDITIONS -
   APPLICATION TO THE EVALUATION OF A TITANIUM NITRIDE COATING
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE PLATELET RETENTION TEST; TITANIUM NITRIDE; BIOMATERIALS; LEFT
   VENTRICULAR ASSIST DEVICE
AB In order to evaluate under dynamic circumstances the in vitro platelet adhesion induced by rigid materials such as ceramic coatings deposited on selected substrates, a new model simulating a tube has been designed. In vitro platelet adhesion was assessed with this new mode/: the material was titanium nitride (TiN) deposited on Ti6A14V (TA6V) titanium alloy by a physical vapor deposition (PVD) process. The results were compared to those obtained with complete titanium carbide (TiC) graphite tubes coated with TiN by a chemical vapor deposition (CVD) process. The difference observed (less than 25%) in favour of the new system, could be due to the better surface state of the construction materials of this system. In fact it is a systemic error. However TiN confirms its good performance as a blood-contacting biomaterial.
C1 TERACOR,TOULON,FRANCE.
   UNIV AIX MARSEILLE 2,LRC,F-13007 MARSEILLE,FRANCE.
RP DION, I (reprint author), UNIV BORDEAUX 2,BIOPHYS LAB,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR BAQUEY C, 1989, BIOMATERIALS, V10, P435, DOI 10.1016/0142-9612(89)90082-3
   BORDENAVE L, 1987, RBM, V6, P283
   CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167
   DION I, 1992, INT J ARTIF ORGANS, V15, P617
   DUCASSOU D, 1976, BRIT J RADIOL, V49, P344, DOI 10.1259/0007-1285-49-580-344
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
NR 6
TC 18
Z9 18
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 1993
VL 16
IS 7
BP 545
EP 550
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LQ459
UT WOS:A1993LQ45900008
PM 8370610
DA 2018-10-19
ER

PT J
AU GILARDI, G
   CASS, AEG
AF GILARDI, G
   CASS, AEG
TI ASSOCIATIVE AND COLLOIDAL BEHAVIOR OF LIGNIN AND IMPLICATIONS FOR ITS
   BIODEGRADATION IN-VITRO
SO LANGMUIR
LA English
DT Article
ID KRAFT LIGNIN; PHANEROCHAETE-CHRYSOSPORIUM; DEGRADABILITY; COMPONENTS;
   CHEMISTRY
AB Lignin is a relatively complex aromatic biopolymer that occurs in woody plant cell walls. This biomaterial can be degraded by extracellular enzymes from white rot fungi, a process that has attracted much attention. Although the enzymes that catalyze such a biodegradation process have been identified and isolated, the rate of lignin biodegradation in vitro has been found to be quite low. The view presented in this paper is that this may be due to the way that the substrate, lignin, is presented to the enzyme. In fact, little is known about the substrate in its natural physical state or about the modifications that it undergoes during the solubilization process. In this paper a solvent-extracted lignin from spruce has been characterized in terms of its molecular weight and size. Evidence is presented that shows that this lignin sample forms aggregates in a dioxane-water (5:1) solvent system, having a hydrodynamic radius of 60 nm. Each aggregate is formed with an average of 256 molecules and has a cross-sectional area of 190 nm2, as determined using a Langmuir-Blodgett trough. Furthermore, in water solutions the pH was found to influence the molecular weight of lignin, as seen by high-pressure liquid chromatography and scanning electron microscopy. As the pH was lowered from 12 to 2, lignin aggregates with a discrete pattern of molecular weight increments. These results are interpreted in terms of electrostatic and van der Waals forces interacting between polar and apolar groups of the lignin molecules. These findings stress the importance of controlling the conditions under which lignin is presented to the ligninolytic enzymes during in vitro degradation experiments.
C1 UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,CTR BIOTECHNOL,LONDON SW7 2AZ,ENGLAND.
RI Gilardi, Gianfranco/B-4523-2010
OI Gilardi, Gianfranco/0000-0002-6559-276X
CR ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615
   CHEN Y, 1976, SOIL SCI SOC AM J, V40, P682, DOI 10.2136/sssaj1976.03615995004000050024x
   DUTTA S, 1990, MATERIALS INTERACTIO
   GAINES GL, 1966, INSOLUBLE MONOLAYERS
   GARVER TM, 1989, 5TH P INT S WOOD PUL, P113
   GILARDI G, UNPUB
   GILARDI G, 1990, BIOTECHNOLOGY PULP P, P35
   GILARDI G, 1991, THESIS U LONDON
   HAEMMERLI SD, 1986, FEMS MICROBIOL LETT, V35, P33, DOI 10.1016/0378-1097(86)90157-6
   HAMMEL KE, 1991, ENZYME MICROB TECH, V13, P15, DOI 10.1016/0141-0229(91)90182-A
   KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153
   KUREK B, 1990, ENZYME MICROB TECH, V12, P771, DOI 10.1016/0141-0229(90)90150-O
   KUREK B, 1990, HOLZFORSCHUNG, V44, P407, DOI 10.1515/hfsg.1990.44.6.407
   LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323
   LINDSTROM T, 1979, COLLOID POLYM SCI, V257, P277, DOI 10.1007/BF01382370
   MOHWALD H, 1990, ANNU REV PHYS CHEM, V41, P441, DOI 10.1146/annurev.pc.41.100190.002301
   Pecora R., 1985, DYNAMIC LIGHT SCATTE
   PROST J, 1991, NATURE, V350, P11
   Sarkanen K. V., 1971, OCCURRENCE FORMATION
   SARKANEN S, 1982, MACROMOLECULES, V15, P1098, DOI 10.1021/ma00232a027
   SARKANEN S, 1981, MACROMOLECULES, V14, P426, DOI 10.1021/ma50003a037
   SARKANEN S, 1984, MACROMOLECULES, V17, P2588, DOI 10.1021/ma00142a022
NR 22
TC 30
Z9 31
U1 1
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL
PY 1993
VL 9
IS 7
BP 1721
EP 1726
DI 10.1021/la00031a019
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA LN721
UT WOS:A1993LN72100019
DA 2018-10-19
ER

PT J
AU BOLZ, A
   SCHALDACH, M
AF BOLZ, A
   SCHALDACH, M
TI HEMOCOMPATIBILITY OPTIMIZATION OF IMPLANTS BY HYBRID STRUCTURING
SO MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
LA English
DT Article
DE AMORPHOUS SILICON CARBIDE; CLOTTING PROTEINS; HEMOCOMPATIBILITY; HYBRID
   DESIGN; FIBRINOGEN; PECVD
AB State of the art in biomaterial research and implant design is a compromise between functionality and biocompatibility. Consequently, results often have disadvantages with respect to both aspects. With regard to biocompatibility, the activation of the clotting system by alloplastic materials is of great significance, because it necessitates anticoagulant therapy. Further improvements in implant technology require an understanding of the interactions between blood and implants. Therefore a microscopic model of thrombogenesis at alloplastic surfaces is briefly presented, relating thrombogenicity of a material to the electronic structure of its surface. The electronic requirements for high haemocompatibility, which result from this model (especially a low band-gap density of states and a high surface conductivity) are fulfilled by an amorphous alloy of silicon and carbon (a-SiC:H). The advantage of amorphous materials is that they do not obey stoichiometric rules. Thus they allow a continuous adjustment of the electronic parameters without fundamental changes in their mechanical and chemical properties. The theoretical results were checked in vitro by total internal reflection intrinsic fluorescence (TIRIF) spectroscopy as well as thrombelastography experiments (TEG). In comparison with conventional materials such as titanium or LTI carbon, the TEG-clotting time of a-SiC:H-coatings was prolonged by in excess of 200 per cent. As a consequence, a-SiC:H is well suited as a haemocompatible coating material for hybrid structuring of cardiovascular implants.
RP BOLZ, A (reprint author), UNIV ERLANGEN NURNBERG,ZENT INST BIOMED TECH,TURNSTR 5,D-91054 ERLANGEN,GERMANY.
CR AUGHTUN M, 1988, Z ZAHNARZTL IMPLANTO, V4, P228
   BAKSHI AK, 1986, CHEM PHYS, V108, P233
   BAURSCHMIDT P, 1977, J BIOENG, V1, P261
   Bolz A, 1990, Biomed Tech (Berl), V35 Suppl 3, P21
   BOLZ A, 1991, THESIS U ERLANGEN GE
   BONE S, 1981, INT J QUANTUM CHEM Q, V8, P307
   COHEN JD, 1984, SEMICONDUCTORS SEM C, V21
   DAWYDOW AS, 1977, J THEOR BIOL, V66, P379
   DOOLITTLE R, 1981, SCI AM, V244, P92
   EBELING W, 1991, BER BUNSEN PHYS CHEM, V95, P356, DOI 10.1002/bbpc.19910950323
   ELEY DD, 1960, T FARADAY SOC, V56, P1432, DOI 10.1039/tf9605601432
   FRISCH MJ, 1988, PROGRAM GAUSSIAN 88
   GEIGER J, 1981, BERGMANN SCHAFER LEH, V4, P274
   HARTERT H, 1948, KLIN WOCHENSCHR, V37, P115
   KASHIMORI Y, 1982, J CHEM PHYS, V77, P1904, DOI 10.1063/1.444043
   LADIK J, 1986, CHEM PHYS, V108, P203, DOI 10.1016/0301-0104(86)85042-X
   MOTT NF, 1979, ELECTRONIC PROCESSES
   ROSENBERG B, 1962, J CHEM PHYS, V36, P816, DOI 10.1063/1.1732615
   SALZMAN EW, 1981, INTERACTION BLOOD NA
   SAWYER PN, 1974, J ELECTROCHEM SOC, V121, pC221, DOI 10.1149/1.2402384
   SAWYER PN, 1965, BIOPHYSICAL MECHANIS, P337
   SZENT-GYORGYI A., 1941, Nature, V148, P157, DOI 10.1038/148157a0
   VANWAGENEN RA, 1981, ADV CHEM SER, V199, P351
   1985, NIH822185 REP
NR 24
TC 12
Z9 12
U1 0
U2 3
PU PETER PEREGRINUS LTD
PI HERTS
PA SOUTHGATE HOUSE STEVENAGE PO BOX 8, HERTS, ENGLAND SG1 1HQ
SN 0140-0118
J9 MED BIOL ENG COMPUT
JI Med. Biol. Eng. Comput.
PD JUL
PY 1993
VL 31
SU S
BP S123
EP S130
DI 10.1007/BF02446660
PG 8
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology; Medical Informatics
SC Computer Science; Engineering; Mathematical & Computational Biology;
   Medical Informatics
GA LR748
UT WOS:A1993LR74800019
PM 8231315
DA 2018-10-19
ER

PT J
AU DEWANJEE, MK
   KAPADVANJWALA, M
   RUZIUS, K
   SERAFINI, AN
   ZILLERUELO, GE
   SFAKIANAKIS, GN
AF DEWANJEE, MK
   KAPADVANJWALA, M
   RUZIUS, K
   SERAFINI, AN
   ZILLERUELO, GE
   SFAKIANAKIS, GN
TI QUANTITATION OF THROMBOGENICITY OF HEMODIALYZER WITH TC-99M AND IN-111
   LABELED PLATELETS
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
AB The platelet thrombogenicity of a hemodialyzer was quantified with Tc-99m- and In-111-labeled platelets. The platelets collected from blood of Beagle dogs, Yorkshire pigs and human volunteers were labeled with In-111-tropolone (detergent-free) and Tc-99m-HMPAO. Hemodialysis was performed with a hollow-fiber dialyzer (HFD) in a flow-loop, the temperature of which was maintained at 37-degrees-C, with flow-rates of 7, 150 and 270 mL/min; after dialysis, the HFD radioactivity was measured with an ionization chamber and imaged with a gamma-camera. The radioactivity of samples of hollow-fibers taken from the top, middle and bottom of the dialyzer was determined with a gamma-counter. The mean values of hemodialyzer-adherent platelet radioactivity were calculated for both radionuclides. The canine platelets were found to be more thrombogenic than porcine and human platelets. The adhesivity of porcine platelets to the biomaterial (cellulose acetate) of the dialyzer approximated that of human platelets. The Tc-99m label underestimated the thrombus formation (P < 0.01). The dynamic processes of thrombosis and embolization from the hemodialyzer resulted in the large standard deviations around the mean values of the adherent thrombus. In spite of this limitation of the dynamic pathology, the quantitation of comparative thrombogenicity with In-111- and Tc-99m-labeled platelets suggests that both radionuclides could be used for measurement of device-induced thrombogenicity and may provide an estimation of prosthesis-induced thrombogenicity of human platelets from animal studies.
C1 UNIV MIAMI,SCH MED,DEPT RADIOL,MIAMI,FL 33101.
   UNIV MIAMI,SCH MED,DEPT PEDIAT NEPHROL,MIAMI,FL 33101.
   UNIV MIAMI,DEPT BIOMED ENGN,MIAMI,FL 33101.
   ALTHIN CD MED INC,MIAMI LAKES,FL.
FU NHLBI NIH HHS [NHLBI HL47201]
CR BECKER W, 1987, EUR J NUCL MED, V13, P267
   DEWANJEE M K, 1989, Journal of Nuclear Medicine, V30, P737
   Dewanjee M K, 1992, ASAIO J, V38, pM317, DOI 10.1097/00002480-199207000-00045
   DEWANJEE M K, 1990, Journal of Nuclear Medicine, V31, P820
   DEWANJEE MK, 1981, J NUCL MED, V22, P981
   DEWANJEE MK, 1984, SEMIN NUCL MED, V14, P154, DOI 10.1016/S0001-2998(84)80013-6
   DEWANJEE MK, 1984, CIRCULATION, V69, P350, DOI 10.1161/01.CIR.69.2.350
   DEWANJEE MK, 1990, THROMB HAEMORRHAGIC, V1, P37
   DEWANJEE MK, 1983, J LABELLED CMPD RADI, V19, P193
   DEWANJEE MK, 1991, J LABELLED CMPD RADI, V30, P24
   DEWANJEE MK, 1992, T ASAIO, V21, P114
   Dewanjee MK, 1990, T ASAIO, V36, pM668
   DIDISHEIM P, 1984, CONT BIOMATERIALS MA, P132
   FOLIE BJ, 1989, BIOPHYS J, V56, P1121, DOI 10.1016/S0006-3495(89)82760-2
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   HAWIGER J, 1987, HEMOSTASIS THROMBOSI, P182
   Jain NC, 1986, SCHALMS VET HEMATOLO, P103
   Koleski J. F., 1991, T ASAIO, V37, P9
   MACKEY ST, 1985, J LABELLED COMPD RAD, V21, P1058
   MOHAMMED SF, 1989, REPLACEMENT RENAL FU, P229
   OSTER ZH, 1985, P NATL ACAD SCI USA, V82, P3465, DOI 10.1073/pnas.82.10.3465
   PETERS AM, 1992, J NUCL MED, V33, P65
   ROBERTSON JS, 1992, J NUCL MED, V33, P777
   SCHMIDT DA, 1985, SWINE BIOMEDICAL RES, V2, P767
   SIGDELL JE, 1985, ARTIF ORGANS, V3, P205
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
   1991, DHHS PHS9150213 US D, P112
NR 27
TC 4
Z9 4
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0883-2897
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD JUL
PY 1993
VL 20
IS 5
BP 579
EP 587
DI 10.1016/0969-8051(93)90026-Q
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA LK303
UT WOS:A1993LK30300003
PM 8358343
DA 2018-10-19
ER

PT J
AU JOHNSON, PC
   CONNOLLY, KL
   LEE, MC
   GARRETT, KO
   RUGGERI, Z
   HRIBAR, S
AF JOHNSON, PC
   CONNOLLY, KL
   LEE, MC
   GARRETT, KO
   RUGGERI, Z
   HRIBAR, S
TI PLATELET-ADHESION FROM FLOWING BLOOD TO BIOMATERIAL-ASSOCIATED
   FIBRINOGEN - CAN IT BE INHIBITED BY LOCAL PREINCUBATION WITH
   EPITOPE-SPECIFIC ANTIBODIES
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 SCRIPPS INST,LA JOLLA,CA.
   UNIV PITTSBURGH,DIV PLAST & RECONSTRUCT SURG,PITTSBURGH,PA 15260.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN 30
PY 1993
VL 69
IS 6
BP 692
EP 692
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA LT577
UT WOS:A1993LT57700543
DA 2018-10-19
ER

PT J
AU WELLISZ, T
   DOUGHERTY, W
AF WELLISZ, T
   DOUGHERTY, W
TI THE ROLE OF ALLOPLASTIC SKELETAL MODIFICATION IN THE RECONSTRUCTION OF
   FACIAL BURNS
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID POROUS POLYETHYLENE; BONE; PROPLAST; IMPLANTS; GROWTH
AB The external appearance of the face is largely dictated by its supporting facial skeleton. After an extensive thermal injury, the underlying facial skeleton may need to be either augmented or restored to maintain the functional and aesthetic appearance of the face. The factors that make a structural reconstruction difficult are poor vascularity and compliance of the scar tissue, extreme contractile forces of the scar, and unstable skin coverage. The use of an alloplast in the setting of facial burn scars may be one of the greatest challenges for an implant material. We reviewed our experience with the use of the Medpor porous polyethylene implant in facial burn reconstruction. This biomaterial has structural characteristics that allow for tissue ingrowth, yet it resists deformation by contractile forces. A total of 57 consecutive implants were placed in 24 patients with facial burns. Implants were used for the chin, the nose, the malar region, and as an ear framework. Patient follow-up ranged from 6 months to 3 years. Although 4 implants became exposed and 1 was thought to become infected, only 1 of the implants was removed. There were no other implant-related complications. We believe that skeletal modification is an important step for a successful facial burn reconstruction. Porous polyethylene offers a promising solution for the complex reconstructive problem of using an alloplast in the environment of a facial burn.
C1 UNIV SO CALIF,DIV PLAST SURG,LOS ANGELES,CA 90089.
RP WELLISZ, T (reprint author), RANCHO LOS AMIGOS MED CTR,7601 E IMPERIAL HIGHWAY,DOWNEY,CA 90242, USA.
CR BERGHAUS A, 1984, ARCH OTO-RHINO-LARYN, V240, P115
   BERGHAUS A, 1986, ARCH OTOLARYNGOL, V112, P388
   BIKHAZI HB, 1990, PLASTIC RECONSTRUCTI, P271
   BOSSE JP, 1992, 46TH CAN SOC PLAST S
   BROWN BL, 1979, ARCH OTOLARYNGOL, V105, P605
   Davis P K, 1971, Br J Plast Surg, V24, P405, DOI 10.1016/S0007-1226(71)80099-1
   DOUGHERTY W, 1991, 45TH CAN SOC PLAST S
   ERIKSSON C, 1985, J BIOMED MATER RES, V19, P833, DOI 10.1002/jbm.820190709
   FRIEDLAND JA, 1976, PLAST RECONSTR SURG, V57, P144, DOI 10.1097/00006534-197602000-00002
   HABAL MB, 1978, PLAST RECONSTR SURG, V61, P394, DOI 10.1097/00006534-197803000-00014
   HABAL MB, 1992, J CRANIOFAC SURG, V2, P27
   HOLMES RE, 1988, PLAST RECONSTR SURG, V81, P662, DOI 10.1097/00006534-198805000-00003
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   JOBE R, 1973, PLAST RECONSTR SURG, V51, P169, DOI 10.1097/00006534-197302000-00012
   KAWAMOTO HK, 1981, ANN PLAST SURG, V7, P502
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   LASH H, 1979, ANN PLAST SURG, V2, P97
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   LILLA JA, 1976, PLAST RECONSTR SURG, V59, P14
   NGUYEN PN, 1992, CLIN PLAST SURG, V19, P87
   OUSTERHOUT DK, 1991, AESTHETIC CONTOURING, P248
   ROMANO JJ, 1993, IN PRESS J CRANIOFAC
   RUBIN LR, 1983, BIOMATERIALS PLASTIC, P477
   SHANBHAG A, 1990, ANN PLAS SURG, V24, P32, DOI 10.1097/00000637-199001000-00006
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   WELLISZ T, 1993, PLAST RECONSTR SURG, V91, P811, DOI 10.1097/00006534-199304001-00009
   Wellisz T, 1992, J Craniofac Surg, V3, P101, DOI 10.1097/00001665-199209000-00009
   WELLISZ T, 1993, IN PRESS LONG TERM E
   WHITAKER LA, 1991, CLIN PLAST SURG, V18, P197
   Wolfe SA, 1989, PLASTIC SURG FACIAL, P687
   YAREMCHUK MJ, 1992, CLIN PLAST SURG, V19, P113
NR 31
TC 25
Z9 26
U1 1
U2 2
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD JUN
PY 1993
VL 30
IS 6
BP 531
EP 536
DI 10.1097/00000637-199306000-00011
PG 6
WC Surgery
SC Surgery
GA LH469
UT WOS:A1993LH46900011
PM 8368781
DA 2018-10-19
ER

PT J
AU CHAPPARD, D
   FRESSONNET, C
   GENTY, C
   BASLE, MF
   REBEL, A
AF CHAPPARD, D
   FRESSONNET, C
   GENTY, C
   BASLE, MF
   REBEL, A
TI FAT IN BONE XENOGRAFTS - IMPORTANCE OF THE PURIFICATION PROCEDURES ON
   CLEANLINESS, WETTABILITY AND BIOCOMPATIBILITY
SO BIOMATERIALS
LA English
DT Article
DE BONE; GRAFTING; IMPLANTS; STEREOLOGICAL PROCEDURE; BONE MORPHOMETRY
AB Xenografting is a promising alternative to allografts and autografts. The remaining lipids in bone are known to influence the biocompatibility. A comparative study of wettability was done on standardized blocks of two biomaterials. A highly purified and defatted bovine bone graft (T650) was found to retain more water (2.06 g/block) than a less defatted biomaterial (T360, 0.3 g/block). Wettability, observed in the laboratory, may reflect an important in vivo property: the rapidity for extracellular fluids and blood cells to invade the graft and carry bone forming cells. When implanted in rabbit cancellous bone, T650 appears to be osteoconductive in a manner that allows trabecular architecture to be restored within 6 months.
C1 LAB BIOL TISSU OSSEUX, ST ETIENNE, FRANCE.
RP CHAPPARD, D (reprint author), FAC MED ANGERS, HISTOL EMBRYOL LAB, RUE HAUTE RECULEE, F-49045 ANGERS, FRANCE.
CR ASPENBERG P, 1990, ACTA ORTHOP SCAND, V61, P546, DOI 10.3109/17453679008993579
   BUCK BE, 1989, CLIN ORTHOP RELAT R, V240, P129
   BURWELL RG, 1985, CLIN ORTHOP RELAT R, V200, P125
   CABANNE F, 1980, ANATOMIE PATHOLOGIQU
   CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0
   CHAPPARD D, 1991, INNOV TECH BIOL MED, V12, P685
   Chutro P, 1918, B MEMOIRES SOC CHIRU, V44, P570
   CLAIRET A, 1991, INF DENT, V22, P1775
   COWLEY SP, 1983, J BONE JOINT SURG AM, V65, P1023, DOI 10.2106/00004623-198365070-00022
   DELLING G, 1990, BONE MORPHOMETRY, P256
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   GLANCY GL, 1991, CLIN ORTHOP RELAT R, P28
   JOHNSON CA, 1985, NEW ENGL J MED, V312, P121
   KRAMER IRH, 1968, ARCH ORAL BIOL, V13, P1263, DOI 10.1016/0003-9969(68)90082-4
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Linsenmayer T. F., 1981, CELL BIOL EXTRACELLU, P5
   MULARCHUK P, 1990, CALCIFIED TISSUE INT, V46, P57, DOI 10.1007/BF02555825
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, V200, P322
   SALAMA R, 1983, CLIN ORTHOP RELAT R, V174, P113
   URIST MR, 1980, FUNDAMENTAL CLIN BON, P331
   WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1
NR 22
TC 38
Z9 43
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1993
VL 14
IS 7
BP 507
EP 512
DI 10.1016/0142-9612(93)90238-W
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LG269
UT WOS:A1993LG26900005
PM 8329523
DA 2018-10-19
ER

PT J
AU GOODMAN, SL
AF GOODMAN, SL
TI COMMENTS ON THE MEASUREMENT OF HEIGHT OF CELLS ADHERENT TO BIOMATERIAL
   SURFACES
SO BIOMATERIALS
LA English
DT Letter
C1 UNIV WISCONSIN, BIOMAT SPECIMEN PREPARAT ELECTRON MICROSCOPY LAB, MADISON, WI 53706 USA.
RP GOODMAN, SL (reprint author), UNIV WISCONSIN, DEPT ANIM HLTH & BIOMED SCI, 1655 LINDEN DR, MADISON, WI 53706 USA.
CR BOYDE A, 1974, SCANNING ELECTRON MI, P227
   BOZZOLA JJ, 1992, ELECTRON MICROS, P201
   Goodman S. L., 1991, COLLOIDAL GOLD PRINC, V3, P369
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   INOUE S, 1989, METHOD CELL BIOL, V30, P85
   PAWLEY JB, 1990, HDB BIOL CONFOCAL MI
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P483, DOI 10.1016/0142-9612(92)90171-J
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1993
VL 14
IS 7
BP 556
EP 558
DI 10.1016/0142-9612(93)90247-Y
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LG269
UT WOS:A1993LG26900013
PM 8329531
DA 2018-10-19
ER

PT J
AU SCHMIDT, JA
   BLACK, J
AF SCHMIDT, JA
   BLACK, J
TI COMMENTS ON THE MEASUREMENT OF HEIGHT OF CELLS ADHERENT TO BIOMATERIAL
   SURFACES
SO BIOMATERIALS
LA English
DT Letter
RP SCHMIDT, JA (reprint author), CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634, USA.
CR ROBINSON GM, 1991, SCI AM, V265, P66, DOI 10.1038/scientificamerican0791-66
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P483, DOI 10.1016/0142-9612(92)90171-J
   SCHMIDT JA, IN PRESS J APPL BIOM
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 1993
VL 14
IS 7
BP 558
EP 558
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LG269
UT WOS:A1993LG26900014
DA 2018-10-19
ER

PT J
AU SKINNER, RA
   NICHOLAS, RW
   STEWART, CL
   VIREDAY, C
AF SKINNER, RA
   NICHOLAS, RW
   STEWART, CL
   VIREDAY, C
TI RESECTED ALLOGRAFT BONE CONTAINING AN IMPLANTED EXPANDED
   POLYTETRAFLUOROETHYLENE PROSTHETIC LIGAMENT - COMPARISON OF PARAFFIN,
   GLYCOLMETHACRYLATE, AND EXACT GRINDING TECHNIQUES
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE BIOMATERIAL; EXAKT GRINDING SYSTEM; EXPANDED POLYTETRAFLUOROETHYLENE
   (EPTFE); LIGAMENT IMPLANT; PARAFFIN PROCESSING; UNDECALCIFIED BONE
AB As the numbers and diversity of orthopedic prosthetic devices increase and the service life of implants nears expiration, surgical pathology laboratories can expect to receive specimens containing softer polymeric materials such as the expanded polytetrafluoroethylene (ePTFE) comprising the Gore-Tex Cruciate Ligament Prosthesis. This report suggests a systematic approach to the processing of a surgically resected bone specimen that may contain such biomaterial. Suggestions for specimen documentation include photography specimen radiography. Protocols for decalcified paraffin processing and for undecalcified polymer processing in glycolmethacrylate and the Exakt grinding system are reviewed with consideration for the needs of both the clinical and research aspects of specimen management.
C1 WL GORE & ASSOCIATES,FLAGSTAFF,AZ.
RP SKINNER, RA (reprint author), UNIV ARKANSAS MED SCI HOSP,DEPT ORTHOPAED SURG,4301 W MARKHAM,MS 644,LITTLE ROCK,AR 72205, USA.
CR BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BOLTON CW, 1985, CLIN ORTHOP RELAT R, V196, P202
   BOYCE B, 1982, BIOL SYNTHETIC VASCU, P553
   CAMPBELL P, 1992, T ORTHOP RES SOC, V38, P393
   EVANDER S, 1991, BONE ARTICULATION RE
   LILLIE RD, 1954, HISTOLOGIC TECHNIC P, P424
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   ROSAI J, 1981, ACKERMANS SURGICAL P, P19
   SKINNER R, 1990, HT2 TECH SAMPL
   SKINNER RA, 1989, HT5 TECH SAMPL
   SKINNER RA, 1991, HT2 TECH SAMPL
   1992, T ORTHOP RES SOC, V38, P346
NR 12
TC 10
Z9 10
U1 0
U2 1
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD JUN
PY 1993
VL 16
IS 2
BP 129
EP 137
DI 10.1179/his.1993.16.2.129
PG 9
WC Cell Biology
SC Cell Biology
GA LE357
UT WOS:A1993LE35700007
DA 2018-10-19
ER

PT J
AU STEWART, CL
   SKINNER, RA
   HOLLIS, JM
AF STEWART, CL
   SKINNER, RA
   HOLLIS, JM
TI PLEXIGLAS-MODIFIED SPURR LOW-VISCOSITY EMBEDDING MEDIUM COMPOSITE MOLD
   SYSTEM FOR STUDY OF THE EFFECT OF MICROMOTION ON BONE INGROWTH
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE BIOMATERIAL; IMPLANT; PLEXIGLAS; SPURR MEDIUM; TITANIUM
ID POLY(METHYL METHACRYLATE; TISSUE
AB Whole segments of canine femoral shaft, each containing two porous coated, rod-like titanium implants, were evaluated for the effects of micromotion on bony ingrowth. The specimens were processed for nondecalcified histologic study. Precise cross-section orientation of the cortico-implant surface had to be established and maintained throughout the sectioning process. This paper reports on an embedding system that meets the intended goals by utilizing a modified Spurr embedding medium polymerized in custom-made Plexiglas molds. The polymer/mold composite is sectioned as a unit and ground to the desired thickness for histologic evaluation.
C1 UNIV ARKANSAS MED SCI HOSP,DEPT ORTHOPAED SURG,LITTLE ROCK,AR 72205.
CR BORYSKO E, 1956, J BIOPHYS BIOCH CYTO, V2, P4
   BUIJS R, 1983, STAIN TECHNOL, V58, P135, DOI 10.3109/10520298309066774
   DURBIN LE, COMMUNICATION
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   HOLLIS JM, 1992, 38TH T ANN M ORTH RE, P564
   JOWSEY J, 1965, J BONE JOINT SURG AM, VA 47, P785, DOI 10.2106/00004623-196547040-00014
   MURICELAMBERT E, 1989, STAIN TECHNOL, V64, P19, DOI 10.3109/10520298909108039
   SANDERSON C, 1989, 33 NAT SOC HIST ANN
   STERCHI D, 1989, 21 NAT SOC HIST ANN
   STERCHI DL, 1989, 35TH T ANN M ORTH RE, P110
   WOODRUFF LA, 1955, STAIN TECHNOL, V30, P179, DOI 10.3109/10520295509114462
   YAEGER JA, 1958, STAIN TECHNOL, V33, P229, DOI 10.3109/10520295809111855
   1973, 127 POL INC DAT SHEE
NR 13
TC 2
Z9 2
U1 0
U2 0
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD JUN
PY 1993
VL 16
IS 2
BP 145
EP 149
DI 10.1179/his.1993.16.2.145
PG 5
WC Cell Biology
SC Cell Biology
GA LE357
UT WOS:A1993LE35700011
DA 2018-10-19
ER

PT J
AU POISSON, DM
   TOUQUET, S
   BERCAULT, N
   ARBEILLE, B
AF POISSON, DM
   TOUQUET, S
   BERCAULT, N
   ARBEILLE, B
TI ELECTRON-MICROSCOPIC DESCRIPTION OF ACCRETIONS OCCURRING IN
   ENDOTRACHEAL-TUBES USED IN ADULTS
SO PATHOLOGIE BIOLOGIE
LA English
DT Article
DE ADHERENCE; BIOMATERIAL; ENDOTRACHEAL; INTUBATION; TUBE;
   ELECTRON-MICROSCOPY
ID ADHERENCE; INFECTION; DEVICES
AB The purpose of the study was to describe the architecture of accretions occurring in endotracheal tubes used in adults by using a conservative procedure and transmission electron microscopy. The study included 12 tubes for which microbiological data of the tracheobronchial secretions were available. Observations were performed on enducted areas of the lumen. All tubes were covered with a several micrometers-to several millimeters-thick layer of mucus. The layers displayed stratified structures and showed granulations, neutrophils or cellular elements. When bacteria were seen, they made no contact with the polymer. This data suggest that adherence properties of bacteria towards the polymer were not involved at these stages of colonization and that a bacterial bio-films is a rare opportunity.
C1 CHR ORLEANS,INTENS CARE UNIT,F-45032 ORLEANS,FRANCE.
   CTR ORLEANS,MICROBIOL UNIT,F-45032 ORLEANS,FRANCE.
   CHR TOURS,ELECTRON MICROSCOPY UNIT,F-37044 TOURS,FRANCE.
CR CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   DIAZBLANCO J, 1989, CRIT CARE MED, V17, P1335, DOI 10.1097/00003246-198912000-00019
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014
   POISSON DM, 1990, ANN PEDIATR-PARIS, V37, P423
   POISSON DM, 1991, RES MICROBIOL, V142, P1019, DOI 10.1016/0923-2508(91)90013-Z
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
NR 8
TC 4
Z9 4
U1 0
U2 0
PU EXPANSION SCI FRANCAISE
PI PARIS
PA 31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE
SN 0369-8114
J9 PATHOL BIOL
JI Pathol. Biol.
PD JUN
PY 1993
VL 41
IS 6
BP 537
EP 541
PG 5
WC Pathology
SC Pathology
GA LT085
UT WOS:A1993LT08500006
PM 8247633
DA 2018-10-19
ER

PT J
AU MANTUS, DS
   RATNER, BD
   CARLSON, BA
   MOULDER, JF
AF MANTUS, DS
   RATNER, BD
   CARLSON, BA
   MOULDER, JF
TI STATIC SECONDARY-ION MASS-SPECTROMETRY OF ADSORBED PROTEINS
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID ALPHA-AMINO-ACIDS; BIOLOGICALLY IMPORTANT COMPOUNDS; DRUG DELIVERY;
   SURFACES; ADSORPTION; POLYMERS; ALBUMIN; ESCA; ORGANIZATION;
   SPECTROSCOPY
AB Static secondary ion mass spectrometry (SIMS) was used to analyze proteins adsorbed to biomaterial surfaces. A spectral interpretation protocol was established by examining homopolymers of 16 amino acids. This protocol allows for the assignment of peaks unique to the various amino acids. Static SIMS was used to analyze plasma proteins adsorbed to titanium. The various factors that contributed to the relative intensities observed in the spectra were explored. The potential application of the technique for studying protein-fouled materials was investigated by analyzing a fouled sensor membrane.
C1 UNIV WASHINGTON,DEPT CHEM ENGN,BF-10,SEATTLE,WA 98195.
   PERKIN ELMER PHYS ELECTR DIV,EDEN PRAIRIE,MN 55344.
FU PHS HHS [R01296]
CR ABEYSEKARA AM, 1987, J CHEM SOC CHEM COMM, V13, P1000
   ARPINO PJ, 1976, DETERMINATION ORGANI, V6, pCH1
   BAMFORD CH, 1956, SYNTHETIC POLYPEPTID
   BEAVIS RC, 1986, J CHROMATOGR, V359, P489, DOI 10.1016/0021-9673(86)80101-7
   BENNINGHOVEN A, 1978, ANAL CHEM, V50, P1180, DOI 10.1021/ac50030a043
   BENNINGHOVEN A, 1977, ORG MASS SPECTROM, V12, P595, DOI 10.1002/oms.1210120914
   BENNINGHOVEN A, 1985, J VAC SCI TECHNOL A, V3, P451, DOI 10.1116/1.573015
   BENNINGHOVEN A, 1976, APPL PHYS, V11, P35, DOI 10.1007/BF00895013
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BOMBEN KD, 1988, ANAL CHEM, V60, P1393, DOI 10.1021/ac00165a009
   Brash JL, 1987, ACS S SERIES, V343
   Briggs D., 1989, HDB STATIC SECONDARY
   CARMONA P, 1991, APPL SPECTROSC, V45, P977, DOI 10.1366/0003702914336345
   CHILKOTI A, IN PRESS MACROMOLECU
   DICKINSON HR, 1981, J BIOMED MATER RES, V15, P577, DOI 10.1002/jbm.820150412
   ECKERSLEY M, 1989, INT J MASS SPECTROM, V93, P199, DOI 10.1016/0168-1176(89)80097-7
   ENS W, 1982, ANAL CHEM, V54, P960, DOI 10.1021/ac00243a028
   GARDELLA JA, 1990, ANAL CHEM, V62, pA645, DOI 10.1021/ac00210a002
   GRAINGER DW, 1990, J BIOMED MATER RES, V24, P547, DOI 10.1002/jbm.820240503
   HANABUSA K, 1989, J POLYM SCI POL CHEM, V27, P1665, DOI 10.1002/pola.1989.080270518
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   HEERMA W, 1988, BIOMED ENVIRON MASS, V16, P155, DOI 10.1002/bms.1200160127
   ITSUNO S, 1990, J ORG CHEM, V55, P6047, DOI 10.1021/jo00311a024
   KINIWA H, 1987, MAKROMOL CHEM, V188, P1841
   KLAPPER MH, 1977, BIOCHEM BIOPH RES CO, V78, P1018, DOI 10.1016/0006-291X(77)90523-X
   KOPECEK J, 1984, BIOMATERIALS, V5, P19, DOI 10.1016/0142-9612(84)90062-0
   KULIK W, 1988, BIOMED ENVIRON MASS, V15, P419, DOI 10.1002/bms.1200150803
   Lalande M., 1988, FOULING SCI TECHNOLO, P557
   LENK TJ, 1989, J BIOMED MATER RES, V23, P549, DOI 10.1002/jbm.820230603
   LEWIS KB, UNPUB J COLLOID INTE
   LIEBL V, 1990, ORIGINS LIFE EVOL BI, V20, P269
   MAIN DE, 1987, BIOMED ENVIRON MASS, V14, P91, DOI 10.1002/bms.1200140207
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MCMILLIN CR, 1974, J COLLOID INTERF SCI, V48, P345, DOI 10.1016/0021-9797(74)90170-2
   MORRISSEY BW, 1974, J COLLOID INTERF SCI, V46, P152, DOI 10.1016/0021-9797(74)90036-8
   NEWMAN JC, 1991, STATIC SIMS HDB POLY
   PAUL L, 1981, J COLLOID INTERF SCI, V84, P546, DOI 10.1016/0021-9797(81)90245-9
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PAYNTER RW, 1985, SURFACE INTERFACIAL, V2, P189
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1
   SCHMITT EE, 1968, Patent No. 3371069
   SPALTRO SM, 1990, J APPL POLYM SCI, V41, P1235, DOI 10.1002/app.1990.070410532
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   TANG XJ, 1988, ANAL CHEM, V60, P1791, DOI 10.1021/ac00168a029
   TORII M, 1990, MACROMOLECULES, V23, P2748
   VOIGT D, 1978, BIOMED MASS SPECTROM, V5, P44, DOI 10.1002/bms.1200050109
   WILDING IR, 1990, J APPL POLYM SCI, V39, P1827, DOI 10.1002/app.1990.070390901
   ZUNINO F, 1989, J CONTROL RELEASE, V10, P65, DOI 10.1016/0168-3659(89)90018-7
   1988, NEWER KNOWLEDGE MILK
NR 54
TC 145
Z9 146
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD MAY 15
PY 1993
VL 65
IS 10
BP 1431
EP 1438
DI 10.1021/ac00058a021
PG 8
WC Chemistry, Analytical
SC Chemistry
GA LC098
UT WOS:A1993LC09800022
PM 8517550
DA 2018-10-19
ER

PT J
AU BUI, LN
   THOMPSON, M
   MCKEOWN, NB
   ROMASCHIN, AD
   KALMAN, PG
AF BUI, LN
   THOMPSON, M
   MCKEOWN, NB
   ROMASCHIN, AD
   KALMAN, PG
TI SURFACE MODIFICATION OF THE BIOMEDICAL POLYMER
   POLY(ETHYLENE-TEREPHTHALATE)
SO ANALYST
LA English
DT Article
DE BIOMATERIAL; BIOCOMPATIBILITY; POLY(ETHYLENE TEREPHTHALATE);
   SILANIZATION; X-RAY PHOTOELECTRON SPECTROSCOPY
ID RAY PHOTOELECTRON-SPECTROSCOPY; SILICA SURFACES; ADHESION; OXIDE
AB X-ray photoelectron spectroscopy was used to characterize modified surfaces of a biomedically important polymer, poly(ethylene terephthalate). Several modification schemes were investigated and direct silanization with 3-aminopropyltriethoxysilane was found to be the optimum procedure, resulting in an aminated surface. Surface coverage of up to 100% was achieved with retention of the polymeric structural integrity. Further activation of the silanized surface was accomplished with two cross-linkers, glutaraldehyde and sebacoyl chloride. A simple biomolecule, L-cysteine, was successfully immobilized onto a surface pre-treated with 3-aminopropyltriethoxysilane and glutaraldehyde, with a coverage of 42%.
C1 UNIV TORONTO,DEPT CHEM,80 ST GEORGE ST,TORONTO M5S 1A1,ONTARIO,CANADA.
   TORONTO GEN HOSP,DIV VASC SURG,TORONTO M5G 2C4,ON,CANADA.
RI McKeown, Neil/A-2451-2011
OI McKeown, Neil/0000-0002-6027-261X
CR ANDERSON J M, 1985, Critical Reviews in Biocompatibility, V1, P111
   Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   AVNY Y, 1986, J APPL POLYM SCI, V32, P4009, DOI 10.1002/app.1986.070320318
   BARBUCCI R, 1984, INORG CHIM ACTA, V93, P47
   BOERIO FJ, 1978, J APPL POLYM SCI, V22, P203, DOI 10.1002/app.1978.070220114
   CHIANG CH, 1982, J COLLOID INTERF SCI, V86, P26, DOI 10.1016/0021-9797(82)90037-6
   COLLINS RJ, 1960, Patent No. 2955954
   DAVE J, 1987, J APPL POLYM SCI, V33, P155
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DURRANI AA, 1987, POLYM SURFACES INTER, P189
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HECKL WM, 1990, ANAL CHEM, V62, P32, DOI 10.1021/ac00200a007
   JOZEFOWICZ M, 1984, PURE APPL CHEM, V56, P1335, DOI 10.1351/pac198456101335
   KALLURY KMR, 1988, ANAL CHEM, V60, P169, DOI 10.1021/ac00153a014
   KALLURY KMR, 1989, ANAL CHIM ACTA, V225, P369, DOI 10.1016/S0003-2670(00)84626-7
   KANNUCK RM, 1988, ANAL CHEM, V60, P142, DOI 10.1021/ac00153a009
   KIM K, 1986, J APPL POLYM SCI, V32, P6019
   KOTTKEMARCHANT K, 1987, J BIOMED MATER RES, V21, P379, DOI 10.1002/jbm.820210310
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LLONOS G, 1988, BIOMATERIALS, V9, P429
   Lord R S, 1988, Ann Vasc Surg, V2, P248, DOI 10.1016/S0890-5096(07)60010-7
   LOSCASCIOBROWN L, 1990, ANAL CHIM ACTA, V228, P102
   Murray R. W., 1980, SILYLATED SURFACES, P125
   Pluddeman E. D., 1980, SILYLATED SURFACES, P31
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROSEN MR, 1978, J COATING TECHNOL, V50, P70
   SCHIFREEN RS, 1977, ANAL CHEM, V49, P1929, DOI 10.1021/ac50021a014
   SCHMIDT RG, 1986, ADV POLYM SCI, V75, P33
   SPORTSMAN JR, 1980, ANAL CHEM, V52, P2013, DOI 10.1021/ac50063a006
   VANDENBERG ET, 1991, J COLLOID INTERF SCI, V149, P1
NR 30
TC 79
Z9 79
U1 2
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0003-2654
J9 ANALYST
JI Analyst
PD MAY
PY 1993
VL 118
IS 5
BP 463
EP 474
PG 12
WC Chemistry, Analytical
SC Chemistry
GA LD922
UT WOS:A1993LD92200002
PM 8323042
DA 2018-10-19
ER

PT J
AU SENNERBY, L
   THOMSEN, P
AF SENNERBY, L
   THOMSEN, P
TI TISSUE-RESPONSE TO TITANIUM IMPLANTS IN EXPERIMENTAL ANTIGEN-INDUCED
   ARTHRITIS
SO BIOMATERIALS
LA English
DT Article
DE TITANIUM; JOINT; ARTHRITIS; MORPHOLOGY
ID RABBIT KNEE JOINTS; REPLACEMENT
AB The healing of threaded, non-alloyed titanium implants in bone was studied in an experimental model of monoarticular arthritis in New Zealand white rabbits. Immunization with bovine serum albumin (BSA) and repeated intra-articular injections with BSA elicited an immune response and clinical signs of inflammation. Implants were inserted and 6 wk after surgery, with full weight-bearing, the rabbits were killed by perfusion fixation. Light microscopic morphometry showed that the cartilage was thinner and the subchondral bone had a lower density in the arthritic joints compared to the control side. The titanium implants in the arthritic joints had a lesser degree of mineralized bone-implant contact and surrounding bone than the implants inserted in control joints. The present study shows that the healing of titanium implants in the rabbit knee joint is impaired in experimental immunologic arthritis. This model may be useful for the study of biomaterial-tissue interactions under pathological conditions.
C1 UNIV GOTHENBURG,DEPT ANAT,S-41312 GOTHENBURG,SWEDEN.
RP SENNERBY, L (reprint author), UNIV GOTHENBURG,DEPT HANDICAP RES,BIOMAT GRP,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1988, J PROSTHET DENT, V60, P75, DOI 10.1016/0022-3913(88)90355-1
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   BRATTSTROM J, 1963, ACTA RHEUMATOL SCAND, V9, P102
   CARLSSON LV, 1989, THESIS U GOTHENBURG
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   DONATH K, 1984, FORTSCHR ZAHNARZTL I, V1, P55
   GREAVES M, 1974, J EXP MED, V140, P1, DOI 10.1084/jem.140.1.1
   HAGERT CG, 1986, SCAND J PLAST RECONS, V20, P207, DOI 10.3109/02844318609006321
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   LINDER L, 1990, ACTA ORTHOP SCAND, V61, P87
   LUNDBORG G, 1992, TISSUE INTEGRATION IN ORAL, ORTHOPEDIC, AND MAXILLOFACIAL RECONSTRUCTION, P287
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   ROSTLUND TV, 1990, THESIS U GOTHENBURG
   SENNERBY L, 1992, J MATER SCI-MATER M, V3, P262, DOI 10.1007/BF00705291
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   Sennerby L, 1991, CLIN ORAL IMPLAN RES, V2, P103, DOI 10.1034/j.1600-0501.1991.020302.x
   SENNERBY L, IN PRESS J MATER SCI
   SHAPIRO F, 1982, J BONE JOINT SURG AM, V64, P639, DOI 10.2106/00004623-198264050-00001
   Soballe K, 1991, J Arthroplasty, V6, P307, DOI 10.1016/S0883-5403(06)80181-6
   THOMSEN P, 1985, SCAND J RHEUMATOL, V14, P239, DOI 10.3109/03009748509100401
   THOMSEN P, 1987, ACTA ORTHOP SCAND, V58, P265, DOI 10.3109/17453678709146481
   THOMSEN P, 1989, BRANEMARK OSSEOINTEG, P25
   Tjellstrom A, 1989, BRANEMARK OSSEOINTEG, P235
   WOODS CG, 1970, ANN RHEUM DIS, V29, P138, DOI 10.1136/ard.29.2.138
NR 26
TC 16
Z9 16
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1993
VL 14
IS 6
BP 413
EP 422
DI 10.1016/0142-9612(93)90143-P
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LC035
UT WOS:A1993LC03500003
PM 8507787
DA 2018-10-19
ER

PT J
AU DARQUY, S
   HONIGER, J
   PUEYO, M
   CAPRON, F
   POITOUT, V
   REACH, G
   COLLIER, C
   MUSCAT, E
AF DARQUY, S
   HONIGER, J
   PUEYO, M
   CAPRON, F
   POITOUT, V
   REACH, G
   COLLIER, C
   MUSCAT, E
TI USE OF A BIOCOMPATIBLE BIOMATERIAL (AN69) FOR MICROENCAPSULATION OF
   ISLETS OF LANGERHANS
SO DIABETES
LA English
DT Meeting Abstract
RI Darquy, Sylviane/M-7858-2018
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1660 DUKE ST, ALEXANDRIA, VA 22314
SN 0012-1797
J9 DIABETES
JI Diabetes
PD MAY
PY 1993
VL 42
SU 1
BP A139
EP A139
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA KZ626
UT WOS:A1993KZ62600433
DA 2018-10-19
ER

PT J
AU GUO, W
   WILLEN, R
   ANDERSSON, R
   PARSSON, H
   LIU, X
   JOHANSSON, K
   BENGMARK, S
AF GUO, W
   WILLEN, R
   ANDERSSON, R
   PARSSON, H
   LIU, X
   JOHANSSON, K
   BENGMARK, S
TI MORPHOLOGICAL RESPONSE OF THE PERITONEUM AND SPLEEN TO INTRAPERITONEAL
   BIOMATERIALS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE INTRAPERITONEAL IMPLANTATION; PERITONEUM; SPLEEN; MICROSCOPY; SCANNING;
   MORPHOLOGY
ID BIOCOMPATIBILITY; INTERLEUKIN-1; MACROPHAGE
AB The present study was performed to evaluate the morphological response of the peritoneum and spleen to biomaterials. Silicone elastomer, knitted dacron or rubber was implanted, respectively, into a rat's peritoneal cavity and the morphology of the peritoneum and spleen was studied at 4 hours and on the lst, 4th, 7th and 21st day after surgery. The morphological changes were identical among groups with different implanted materials. After intraperitoneal implantation of biomaterials from 4 hours and on, an infiltration of inflammatory cells was found in the slackened edematous superficial part of the peritoneum. Also noted in the spleen were stasis, vessel dilatation and fibrin deposition. With the help of scanning electron microscopy, a marked denudation and separation of the mesothelial cells, with infiltration of inflammatory cells, were observed. Peripheral leucocytes significantly increased in number one day after intraperitoneal implantation. Three weeks after intraperitoneal implantation, the materials were completely encapsulated and the morphological aberration of the peritoneum and spleen disappeared. The findings reveal the consequence and the resolution of the host-biomaterial interaction, which could contribute to the explaination of various pathophysiological alterations, including the translocation of enteric bacteria and the development of infectious complications after intraperitoneal biomaterial implantation.
C1 LUND UNIV,DEPT SURG,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT PATHOL,S-22185 LUND,SWEDEN.
   LUND UNIV,DEPT ZOOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSSON R, 1990, SCAND J GASTROENTERO, V25, P405, DOI 10.3109/00365529009095507
   BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405
   BRUCK SD, 1990, INT J ARTIF ORGANS, V13, P469
   DAVIDSOHN I, 1969, CLIN DIAGNOSIS LABOR, P155
   DIPAOLO N, 1986, NEPHRON, V44, P204, DOI 10.1159/000183987
   DOBBIE JW, 1989, BLOOD PURIFICAT, V7, P74, DOI 10.1159/000169580
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   GUO W, 1993, IN PRESS J SURG RES
   HABAL MB, 1984, ARCH SURG-CHICAGO, V119, P843
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P215
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   LLENDE M, 1986, J SURG RES, V40, P85, DOI 10.1016/0022-4804(86)90149-6
   MANENTI A, 1991, Pathologica (Genoa), V83, P65
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MEACHIM G, 1982, BIOMATERIALS, V3, P213, DOI 10.1016/0142-9612(82)90022-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Norgren L, 1990, Ann Vasc Surg, V4, P575, DOI 10.1016/S0890-5096(06)60842-X
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   TIGHE D, 1989, CLIN SCI, V76, P269, DOI 10.1042/cs0760269
   VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101
   VOLK HW, 1990, EUR SURG RES, V22, P347, DOI 10.1159/000129121
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 24
TC 26
Z9 26
U1 1
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAY
PY 1993
VL 16
IS 5
BP 276
EP 284
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LM845
UT WOS:A1993LM84500008
PM 8354587
DA 2018-10-19
ER

PT J
AU BASLE, MF
   REBEL, A
   GRIZON, F
   DACULSI, G
   PASSUTI, N
   FILMON, R
AF BASLE, MF
   REBEL, A
   GRIZON, F
   DACULSI, G
   PASSUTI, N
   FILMON, R
TI CELLULAR-RESPONSE TO CALCIUM-PHOSPHATE CERAMICS IMPLANTED IN RABBIT BONE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SOFT-TISSUE RESPONSES; OSTEOCLAST-LIKE CELLS; MARROW CULTURES;
   HYDROXYLAPATITE INTERFACE; MULTINUCLEATED CELLS; PROGENITOR CELLS;
   CRYSTALS; GENERATION; PARTICLES; RATS
AB Two hydroxyapatite ceramics, synthesized by sintering from bovine bone and from a mixture of phosphate tricalcium and natural hydroxyapatite, were implanted in bone sites in rabbits. From day 7 after implantation, osteoblast-like cells were visible with thin layers of new bone on both biomaterials. Histomorphometry showed progressive increase in volume and surface of newly formed bone. Signs of cell-dependent resorption were visible at the surface of biomaterials and newly formed bone. There was a progressive decrease in relative volume and trabecular thickness of the biomaterials. Resorption of biomaterials appears to involve two cell types: multinucleated giant cells and osteoclast-like cells. The multinucleated giant cells observed had neither tartrate resistant acid phosphatase activity (TRAP) nor a ruffled border. Vesicles and vacuoles containing crystals observed in these cells suggest phagocytosis of biomaterials. The number of these cells decreased after day 14 following implantation. The osteoclast-like cells were TRAP positive. The structured modification and the TRAP activity demonstrated in the subjacent biomaterial suggest that the dissolution of the implant may be associated to an extracellular enzymatic activity of these cells. Electron microscopy revealed a clear zone and cytoplasmic membrane infolding in these cells, suggesting a ruffled border differentiation. The number of these cells increased with delay after implantation. It was concluded that the implantation of calcium phosphate ceramics in bone leads to new bone formation as well as to resorption of the biomaterials. The mechanism of resorption appears to associate crystal endocytosis by multinucleated giant cells and more classical resorption by osteoclast-like cells.
C1 FAC CHIRURG DENTAIRE, RECH TISSUS CALCIFIES & BIOMAT LAB, F-44042 NANTES 01, FRANCE.
   UNIV ANGERS, SERV COMMUN MICROSCOPIE ELECTRON, F-49045 ANGERS, FRANCE.
RP BASLE, MF (reprint author), FAC MED ANGERS, HISTOL & EMBRYOL LAB, ETUDE & RECH TISSU OSSEUX GRP, RUE HAUTE RECULEE, F-49045 ANGERS, FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BAGI CM, 1991, CLIN ORTHOP RELAT R, P257
   BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313
   Caplan AI, 1987, BONE MINERAL RES, P117
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DEGROOT K, BIOCERAMICS CALCIUM
   DONATH K, 1989, 1ST P INT S CER MED, P96
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   EVANS RW, 1984, ARTHRITIS RHEUM, V27, P829, DOI 10.1002/art.1780270717
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   FROUM SJ, 1982, J PERIODONTOL, V53, P719, DOI 10.1902/jop.1982.53.12.719
   FULLER K, 1987, J CELL PHYSIOL, V132, P441, DOI 10.1002/jcp.1041320306
   GLOWACKI J, 1986, J BONE MINER RES, V1, P327
   GLOWACKI J, 1986, CALCIFIED TISSUE INT, V39, P97, DOI 10.1007/BF02553297
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   HAGENAARS CE, 1989, BONE MINER, V6, P179, DOI 10.1016/0169-6009(89)90049-4
   HALL BK, 1971, CLIN ORTHOP RELAT R, V71, P249
   Ham AW, 1930, J BONE JOINT SURG, V12, P827
   HATTERSLEY G, 1989, ENDOCRINOLOGY, V125, P1606, DOI 10.1210/endo-125-3-1606
   HENCH LL, 1989, 1ST P INT S CER MED, P27
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLTROP ME, 1979, CALCIFIED TISSUE INT, V27, P129, DOI 10.1007/BF02441175
   HOLTROP ME, 1982, CALCIFIED TISSUE INT, V34, P488, DOI 10.1007/BF02411290
   HOOGENDOORN HA, 1987, ADV BIOMATER, V7, P81
   HUBBARD WG, 1974, THESIS MILWAUKEE
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   JONES SJ, 1977, CELL TISSUE RES, V185, P387
   KRUKOWSKI M, 1982, CALCIFIED TISSUE INT, V34, P474, DOI 10.1007/BF02411288
   KUKITA T, 1989, LAB INVEST, V60, P532
   KURIHARA N, 1989, BLOOD, V74, P1295
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   MARKS SC, 1991, J BONE MINER RES, V6, P395
   MARQUIS PM, 1990, ADV BIOMAT, V9, P243
   MCDAVID PT, 1979, J DENT RES, V58, P1478, DOI 10.1177/00220345790580050901
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MINKIN C, 1982, CALCIF TISSUE RES, V17, P57
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   MODDERMAN WE, 1991, BONE, V12, P81, DOI 10.1016/8756-3282(91)90004-3
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   MUNDY GR, 1987, BONE MINERAL RES ANN, V5, P209
   NOLAN P, 1991, J ANAT, V174, P97
   OGISO M, 1982, ADV BIOMATER, V3, P59
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1990, 2ND P INT S CER MED, P65
   OKUMURA M, 1991, CELL MATER, V1, P29
   OSDOBY P, 1982, J EXP ZOOL, V224, P331, DOI 10.1002/jez.1402240306
   OWENS JL, 1986, CALCIFIED TISSUE INT, V38, P170, DOI 10.1007/BF02556877
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PARFITT AM, BONE HISTOMORPHOMETR, P53
   PASSUTI N, 1990, ADV BIOMAT, V9, P255
   PIERCE AM, 1991, ELECTRON MICROSC REV, V4, P1, DOI 10.1016/0892-0354(91)90015-5
   ROODMAN GD, 1985, P NATL ACAD SCI USA, V82, P8213, DOI 10.1073/pnas.82.23.8213
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   SMINIA T, 1986, CALCIFIED TISSUE INT, V39, P263, DOI 10.1007/BF02555216
   TAKAHASHI N, 1986, J CLIN INVEST, V78, P894, DOI 10.1172/JCI112677
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   USHIDA T, 1990, 2ND P INT S CER MED, P33
   WEBBER D, 1990, J BONE MINER RES, V5, P401, DOI 10.1002/jbmr.5650050414
NR 62
TC 30
Z9 30
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 1993
VL 4
IS 3
BP 273
EP 280
DI 10.1007/BF00122280
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LR926
UT WOS:A1993LR92600009
DA 2018-10-19
ER

PT J
AU LEGEAY, G
   PONCINEPAILLARD, F
AF LEGEAY, G
   PONCINEPAILLARD, F
TI SURFACE-TREATMENT AND BIOMATERIAL
SO VIDE-SCIENCE TECHNIQUE ET APPLICATIONS
LA English
DT Article
AB Biomaterial can be defined as material with specific use in biological surroundings. Therefore, beyond toxicity aspects, biocompatibility is mainly due to adhesion phenomena (mechanical anchoring, dipole-dipole and acid-base interactions...). Only few molecular layers are concerned. Common materials treatment , such as cold plasma and radiation methods, leads largely to a modification of the surface chemistry which, for biological applications, must be taken into account. Different examples are given.
RP LEGEAY, G (reprint author), IRAP,AVE O MESSIAEN,F-72000 LE MANS,FRANCE.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC FRANCAISE DU VID
PI PARIS
PA 19 RUE DU RENARD, 75004 PARIS, FRANCE
SN 1266-0167
J9 VIDE
JI Vide-Sci. Techn. Appl.
PD MAY-JUL
PY 1993
VL 49
IS 267
BP 161
EP 170
PG 10
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA LX240
UT WOS:A1993LX24000001
DA 2018-10-19
ER

PT J
AU CHUARD, C
   VAUDAUX, P
   WALDVOGEL, FA
   LEW, DP
AF CHUARD, C
   VAUDAUX, P
   WALDVOGEL, FA
   LEW, DP
TI SUSCEPTIBILITY OF STAPHYLOCOCCUS-AUREUS GROWING ON FIBRONECTIN-COATED
   SURFACES TO BACTERICIDAL ANTIBIOTICS
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID FOREIGN-BODY INFECTION; COAGULASE-NEGATIVE STAPHYLOCOCCI; GROWTH-RATE;
   PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL AGENTS; RESISTANCE; BIOFILMS;
   ADHERENCE; CIPROFLOXACIN; COMBINATION
AB Several recent studies have shown that bacteria either grown in vitro as adherent biofilms or recovered from infected prosthetic devices have decreased susceptibilities to antimicrobial killing. To further study the microbial and environmental factors responsible for this decreased antibiotic susceptibility, we developed an in vitro model of surface-adherent Staphylococcus aureus growing on polymethylmethacrylate coverslips coated with pure fibronectin. After exponential growth for 4 h, the population of fibronectin-attached S. aureus remained constant for a further 48-h period, as evaluated by CFU counts of organisms quantitatively removed from the coverslips. At selected time points, surface-bound organisms were exposed to bactericidal concentrations of either oxacillin, vancomycin, fleroxacin, or gentamicin in short-term (0.5 to 2 h) or long-term (24 h) killing assays. Whereas at 2 h surface-growing organisms were still optimally killed by all antimicrobial agents, at 4 and 24 h attached bacteria expressed markedly altered susceptibilities to these agents. The decrease in susceptibility was moderate for fleroxacin, more important for oxacillin and vancomycin, and extensive for gentamicin. When surface-attached S. aureus was compared with bacteria grown in a fluid phase, both populations showed a parallel time-dependent decrease in their susceptibilities to either oxacillin, vancomycin, or fleroxacin. In contrast, attached organisms became considerably more resistant to gentamicin than suspended bacteria did. Subpopulations of organisms spontaneously released from coverslips during antibiotic exposure also showed markedly reduced susceptibilities to antimicrobial killing. This simple model of S. aureus colonization of in vitro fibronectin-coated surfaces might represent a useful approach to the study of the physiological and biochemical changes that underlie the decreased antibiotic susceptibilities of biomaterial-attached organisms.
RP CHUARD, C (reprint author), UNIV GENEVA,HOP CANTONAL,DIV INFECT DIS,CH-1211 GENEVA 4,SWITZERLAND.
CR ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824
   ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   BISNO AL, 1989, INFECTIONS ASS INDWE, P93
   Brause BD, 1989, INFECT ASS INDWELLIN, P111
   BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777
   BROWN MRW, 1990, ANTIMICROB AGENTS CH, V34, P1623, DOI 10.1128/AAC.34.9.1623
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHUARD C, 1991, J INFECT DIS, V163, P1369
   CHUARD C, 1991, ANTIMICROB AGENTS CH, V35, P2611, DOI 10.1128/AAC.35.12.2611
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DWORKIN R, 1990, ANTIMICROB AGENTS CH, V34, P1014, DOI 10.1128/AAC.34.6.1014
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V25, P585, DOI 10.1093/jac/25.4.585
   EVANS RC, 1987, ANTIMICROB AGENTS CH, V31, P889, DOI 10.1128/AAC.31.6.889
   GANDER S, 1992, 92ND GEN M AM SOC MI
   GILBERT P, 1989, APPL ENVIRON MICROB, V55, P1308
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   HENRY NK, 1987, AM J MED, V82, P73
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   KARCHMER AW, 1989, INFECTIONS ASS INDWE, P129
   LUCET JC, 1990, ANTIMICROB AGENTS CH, V34, P2312, DOI 10.1128/AAC.34.12.2312
   MILLER MH, 1978, ANTIMICROB AGENTS CH, V14, P336, DOI 10.1128/AAC.14.3.336
   MILLER MH, 1980, ANTIMICROB AGENTS CH, V18, P722, DOI 10.1128/AAC.18.5.722
   MUSHER DM, 1977, J INFECT DIS, V136, P360, DOI 10.1093/infdis/136.3.360
   NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   PELLETIER LL, 1979, J LAB CLIN MED, V94, P324
   PROSSER BL, 1987, ANTIMICROB AGENTS CH, V31, P1502, DOI 10.1128/AAC.31.10.1502
   SHETH NK, 1985, LANCET, V2, P1266
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX PE, 1984, INFECT IMMUN, V45, P768
   VERGERES P, 1992, J INFECT DIS, V165, P281, DOI 10.1093/infdis/165.2.281
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   WIDMER AF, 1991, ANTIMICROB AGENTS CH, V35, P741, DOI 10.1128/AAC.35.4.741
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIMMERLI W, 1986, EXPT MODELS ANTIMICR, P295
   1987, METHODS DETERMINING
NR 42
TC 57
Z9 60
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD APR
PY 1993
VL 37
IS 4
BP 625
EP 632
DI 10.1128/AAC.37.4.625
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA KV991
UT WOS:A1993KV99100002
PM 8494358
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU COURTNEY, JM
   SUNDARAM, S
   LAMBA, NMK
   FORBES, CD
AF COURTNEY, JM
   SUNDARAM, S
   LAMBA, NMK
   FORBES, CD
TI MONITORING OF THE BLOOD RESPONSE IN BLOOD PURIFICATION
SO ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; BLOOD RESPONSE; BLOOD PURIFICATION
AB A principal objective of monitoring the blood response in procedures such as hemodialysis and cardiopulmonary bypass is to achieve an enhanced understanding of the relationship between blood component alterations and the biomaterials employed. The aim in a study of blood-biomaterial interactions of deriving a correlation between a characteristic of the biomaterial and a representative parameter of the blood response can be influenced in a clinical situation by antithrombotic agents, multimaterial contact, device utilization, blood condition, drug therapy, and the nature of the application. The selection of parameters representative of the blood response may require a compromise between the advantages of multiparameter assessment and the benefit of measuring a single parameter by a consistent methodology. Representative parameters are protein adsorption, platelet reactions, intrinsic coagulation and the contact activation phase, fibrinolysis, leukocyte alterations, and complement activation. Assessment during clinical application can be approached by consideration of blood response patterns.
C1 UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT MED,DUNDEE DD1 9SY,SCOTLAND.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,106 ROTTEROW,GLASGOW G4 0NW,SCOTLAND.
CR BLASS CR, 1992, INT J ARTIF ORGANS, V15, P200
   BRASH JL, 1983, BIOCOMPATIBLE POLYM, P35
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHENOWETH DE, 1986, T AM SOC ART INT ORG, V32, P226
   Courtney JM, 1992, CARDIOVASCULAR BIOMA, P37
   COURTNEY JM, 1992, MANAGEMENT BLEEDING, P236
   COURTNEY JM, 1991, INFLUENCE NEW TECHNO, P154
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   FEIJEN J, 1987, ARTIF ORGANS, P235
   FORBES CD, 1987, HAEMOSTASIS THROMBOS, P902
   HERZLINGER GA, 1983, BIOCOMPATIBLE POLYM, P89
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Klinkmann H., 1987, UREMIA THERAPY, P125
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   Ogston D., 1983, PHYSL HEMOSTASIS
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   SZYCHER M, 1983, BIOCOMPATIBLE POLYM, P1
   VROMAN L, 1980, BLOOD, V55, P156
NR 18
TC 7
Z9 7
U1 0
U2 1
PU BLACKWELL SCIENCE INC
PI CAMBRIDGE
PA 238 MAIN ST, CAMBRIDGE, MA 02142
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD APR
PY 1993
VL 17
IS 4
BP 260
EP 266
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA KW369
UT WOS:A1993KW36900011
PM 8498906
DA 2018-10-19
ER

PT J
AU CIAPETTI, G
   CENNI, E
   PRATELLI, L
   PIZZOFERRATO, A
AF CIAPETTI, G
   CENNI, E
   PRATELLI, L
   PIZZOFERRATO, A
TI INVITRO EVALUATION OF CELL BIOMATERIAL INTERACTION BY MTT ASSAY
SO BIOMATERIALS
LA English
DT Article
DE CELL-BIOMATERIAL INTERACTIONS; CYTOTOXICITY; MTT ASSAY
ID RAPID COLORIMETRIC ASSAY; GROWTH; PROLIFERATION; CYTOTOXICITY;
   BIOCOMPATIBILITY; FIBROBLASTS; COMPOSITES; SILICONE; SURVIVAL; STATE
AB The tetrazolium-based colorimetric assay (MTT test) measures only in vitro living cells and the results are directly related to the number of viable cultured cells. It has been adopted in immunological investigations, cancer research and, recently, biocompatibility evaluation. We used the MTT method with minor modifications to fit it to an in vitro study of biomaterial-cell interactions. The MTT assay was confirmed to be feasible, rapid and reproducible. Moreover, it showed a good correlation with other in vitro proliferation assays, such as the H-3-thymidine uptake assay. By using the MTT method and the ASTM procedure for extracting biomaterials, we quantified the in vitro cell compatibility of different metals and polymers.
RP CIAPETTI, G (reprint author), 1ST ORTOPED RIZZOLI,BIOCOMPATIBIL RES IMPLANT MAT LAB,VIA BARBIANO 1-10,I-40136 BOLOGNA,ITALY.
OI Ciapetti, Gabriela/0000-0001-6740-0357
CR BRANTLEY SK, 1990, PLAST RECONSTR SURG, V86, P1131, DOI 10.1097/00006534-199012000-00015
   CAUGHMAN WF, 1991, BIOMATERIALS, V12, P737, DOI 10.1016/0142-9612(91)90022-3
   CIAPETTI G, 1989, BIOMATERIALI, V3, P5
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FALEZZA A, 1992, 1 C NAZ ASS IT TOSS
   FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   GIVENS KT, 1990, INVEST OPHTH VIS SCI, V31, P1856
   GREEN LM, 1984, J IMMUNOL METHODS, V70, P257, DOI 10.1016/0022-1759(84)90190-X
   HANAWA T, 1992, BIOMATERIALS, V13, P20, DOI 10.1016/0142-9612(92)90089-7
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   HANSON JA, 1991, LEUKEMIA RES, V15, P565, DOI 10.1016/0145-2126(91)90024-N
   HARMAND M-F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P67, DOI 10.1163/156856291X00070
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   OEZ S, 1990, BLUT, V60, P97, DOI 10.1007/BF01720515
   Patterson M K Jr, 1979, Methods Enzymol, V58, P141
   ROSDY M, 1991, BIOMATERIALS, V12, P511, DOI 10.1016/0142-9612(91)90151-Y
   SCHAUER U, 1989, J IMMUNOL METHODS, V116, P221, DOI 10.1016/0022-1759(89)90207-X
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3
   ULUDAG H, 1990, BIOMATERIALS, V11, P708, DOI 10.1016/0142-9612(90)90032-L
   VANDELOOSDRECHT AA, 1991, J IMMUNOL METHODS, V141, P15, DOI 10.1016/0022-1759(91)90205-T
   WATAHA JC, 1991, J BIOMED MATER RES, V25, P1133, DOI 10.1002/jbm.820250907
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207
   WILSON JK, 1990, BRIT J CANCER, V62, P189, DOI 10.1038/bjc.1990.258
   1991, BIOL EVALUATION MED
   1985, ASTM STANDARDS, P176
NR 30
TC 242
Z9 268
U1 4
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 1993
VL 14
IS 5
BP 359
EP 364
DI 10.1016/0142-9612(93)90055-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KY998
UT WOS:A1993KY99800007
PM 8507779
DA 2018-10-19
ER

PT J
AU SIEGEL, JF
   SMITH, AD
AF SIEGEL, JF
   SMITH, AD
TI THE IDEAL URETERAL STENT FOR ANTEGRADE AND RETROGRADE ENDOPYELOTOMY -
   WHAT WOULD IT BE LIKE
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
AB Current endopyelotomy stents are composed of polyurethane, which is an adequate biomaterial for 6 to 8 weeks of dwell time. It is easy to insert, has good internal now, and resists encrustation. Several designs are available. External designs have the advantage of providing easy access, while the internal designs appeal to patients because no external dressing is required. On the basis of our experience, we continue to advocate the tapering external endopyelotomy stent (14F to 8F) for 6 weeks of postoperative intubation. Although urologic catheters have progressed, the perfect endopyelotomy stent has yet to be produced.
C1 LONG ISL JEWISH MED CTR,DEPT UROL,278-05 76TH AVE,NEW HYDE PK,NY 11042.
CR ABDELHAKIM AM, 1987, J ENDOUROL, V1, P265
   BADLANI GH, 1988, J UROLOGY, V15, P439
   Bitschay J., 1956, HIST UROLOGY EGYPT, P76
   CLAYMAN RV, 1988, UROL CLIN N AM, V15, P433
   KARLIN GS, 1988, UROL CLIN N AM, V15, P445
   KUENKEL M, 1990, Journal of Endourology, V4, P109, DOI 10.1089/end.1990.4.109
   MACALUSO JN, 1990, J ENDOUROL, V4, P114
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   MARDIS HK, 1987, SEMIN INTERVENT RAD, V4, P34
   MOTOLA J, IN PRESS J UROL
   OPPENHEIMER R, 1955, J Urol, V74, P476
   SALTZMAN B, 1988, UROL CLIN N AM, V15, P481
   SMITH AD, 1984, UROLOGY, V23, P37, DOI 10.1016/0090-4295(84)90240-1
   VANCANGH PJ, 1989, J UROLOGY, V141, P1317, DOI 10.1016/S0022-5347(17)41293-6
NR 14
TC 20
Z9 20
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD APR
PY 1993
VL 7
IS 2
BP 151
EP 154
DI 10.1089/end.1993.7.151
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA LB019
UT WOS:A1993LB01900010
PM 8518829
DA 2018-10-19
ER

PT J
AU PAZIRANDEH, M
   CAMPBELL, JR
AF PAZIRANDEH, M
   CAMPBELL, JR
TI PROTEIN-COMPOSITION OF RHAPIDOSOMES ISOLATED FROM
   AQUASPIRILLUM-ITERSONII
SO JOURNAL OF GENERAL MICROBIOLOGY
LA English
DT Article
AB Rhapidosomes are tubular microstructures composed of proteins that are found in a variety of bacteria and algae. These structures, which are resistant to disruption by many denaturing agents, have potential application as a biomaterial and may serve as a new model for the study of self assembly. When rhapidosomes were purified and analysed by SDS-PAGE the presence of three proteins with molecular masses of 53, 29 and 18 kDa was revealed. However, lysozyme treatment of the rhapidosome preparations containing the three proteins resulted in the selective release of the 18 kDa protein from the rhapidosome complex. N-Terminal sequence analysis and amino acid composition analysis were performed on all three proteins. The amino acid composition of the 18 kDa protein closely matched the amino acid composition of protein H (a peptidoglycan-associated protein from Pseudomonas aeruginosa). These results suggest that the 18 kDa protein may be a contaminating peptidoglycan-associated protein and not part of the rhapidosome structure. Western blot analysis using antisera raised against rhapidosomes revealed that the 53 kDa component protein does not react with the antisera. We speculate that the 53 kDa protein may form the inner core of the rhapidosomes, whilst the 29 kDa protein forms the outer sheath of these structures.
RP PAZIRANDEH, M (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,WASHINGTON,DC 20375, USA.
CR CHANG HY, 1974, J GEN MICROBIOL, V18, P121
   CORRELL DL, 1964, CAN J MICROBIOL, V10, P63, DOI 10.1139/m64-010
   DELK AS, 1972, J MOL BIOL, V64, P287, DOI 10.1016/0022-2836(72)90336-1
   EVERS MCJM, 1980, CAN J MICROBIOL, V26, P1312, DOI 10.1139/m80-218
   FARALDO MLM, 1991, J BACTERIOL, V173, P5346, DOI 10.1128/jb.173.17.5346-5351.1991
   HYLEMON PB, 1973, INT J SYST BACTERIOL, V23, P340, DOI 10.1099/00207713-23-4-340
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
   MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P979, DOI 10.1093/oxfordjournals.jbchem.a132630
   MIZUNO T, 1987, J BIOCH, V86, P991
   PARGE HE, 1990, J BIOL CHEM, V265, P2278
   Pazirandeh M, 1992, BIOMIMETICS, V1, P39
   ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 14
TC 3
Z9 3
U1 0
U2 0
PU SOC GENERAL MICROBIOLOGY
PI READING
PA HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS
SN 0022-1287
J9 J GEN MICROBIOL
JI J. Gen. Microbiol.
PD APR
PY 1993
VL 139
BP 859
EP 864
DI 10.1099/00221287-139-4-859
PN 4
PG 6
WC Microbiology
SC Microbiology
GA KY980
UT WOS:A1993KY98000026
PM 8515241
OA Bronze
DA 2018-10-19
ER

PT J
AU TANINGHER, M
   PELLERANO, P
   TERRANOVA, MP
   MALACARNE, D
   BONATTI, S
AF TANINGHER, M
   PELLERANO, P
   TERRANOVA, MP
   MALACARNE, D
   BONATTI, S
TI A GENOTOXICITY STUDY ON N-ACRYLOYL-N'-PHENYLPIPERAZINE - IMPLICATIONS OF
   ANEUGENIC EFFECTS IN RISK EVALUATIONS
SO MUTATION RESEARCH
LA English
DT Article
DE BIOMATERIALS; AROMATIC TERTIARY AMINES; DNA DAMAGE REPAIR; ANEUPLOIDY
ID DNA DAMAGE; REPAIR
AB Further to a previous genotoxicity study, we analyzed sister-chromatid exchange (SCE) and DNA-repair induction (V79 and EUE cells in vitro) and DNA damage (rat liver in vivo) with regard to N-acryloyl-N'-phenylpiperazine (AcrNPP), a chemical proposed for biomaterial polymerization which contains an aromatic tertiary amine function in a piperazine cycle. This chemical induced SCEs in a dose-dependent fashion (up to approximately 3.7 times the control value), while it was negative for DNA-repair induction and weakly yet significantly positive for in vivo DNA damage (maximum increase approximately 1.4 times the control value). Taken together with our previous genotoxicity data on AcrNPP and structurally related compounds, the present results confirm that aneuploidy is a possible major effect of aromatic tertiary amines. As regards exposure to aneugenic agents, considerations on cancer risk evaluation are presented.
C1 UNIV GENOA,CIRC,INST ONCOL,I-16132 GENOA,ITALY.
   CNR,IST MUTAGENESI & DIFFERENZIAMENTO,I-56100 PISA,ITALY.
RP TANINGHER, M (reprint author), UNIV GENOA,NATL INST CANC RES,IST,VIALE BENEDETTO XV NO 10,I-16132 GENOA,ITALY.
CR ASHBY J, 1991, MUTAT RES, V257, P229, DOI 10.1016/0165-1110(91)90003-E
   BIANCHI V, 1982, MUTAT RES, V93, P447, DOI 10.1016/0027-5107(82)90157-9
   BONATTI S, 1992, MUTAGENESIS, V7, P111, DOI 10.1093/mutage/7.2.111
   COX R, 1973, CANCER RES, V33, P2114
   DANESINO C, 1975, B SOC MED CHIR PA, V85, P275
   DANUSSO F, 1990, POLYMER, V31, P1577, DOI 10.1016/0032-3861(90)90168-X
   Evans H. J., 1985, ANEUPLOIDY ETIOLOGY, P165
   KOHN KW, 1986, MECHANISMS DNA DAMAG, P101
   PARODI S, 1978, MUTAT RES, V54, P39, DOI 10.1016/0165-1161(78)90133-4
   TANINGHER M, 1992, MUTAT RES, V282, P99, DOI 10.1016/0165-7992(92)90081-R
   TANINGHER M, 1992, UNPUB GENOTOXICITY A
   TANZI MC, 1990, POLYMER, V31, P1735, DOI 10.1016/0032-3861(90)90194-4
   1987, MONOGRAPHS EVALUA S7
   1987, MONOGRAPHS EVALUA S6
   1990, MUTAT RES, V241, P325
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD APR
PY 1993
VL 301
IS 4
BP 275
EP 279
DI 10.1016/0165-7992(93)90069-8
PG 5
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA KU561
UT WOS:A1993KU56100011
PM 7680763
DA 2018-10-19
ER

PT J
AU BERLINER, SD
AF BERLINER, SD
TI CLINICAL-EXPERIENCE WITH AN INLAY EXPANDED POLYTETRAFLUOROETHYLENE
   SOFT-TISSUE PATCH AS AN ADJUNCT IN INGUINAL-HERNIA REPAIR
SO SURGERY GYNECOLOGY & OBSTETRICS
LA English
DT Article
AB Fifteen percent of 2,331 inguinal hernias required a biomaterial to effect a tension-free repair- Using the anterior approach, a graft placed deep to the posterior wall fulfills all the requirements of a sound operation. The procedure is normally performed using local anesthesia in an ambulatory facility. Three hundred fifty inguinal hernias were repaired using an expanded polytetrafluoroethylene soft tissue inlay patch. Ninety-one percent of the patients had personal follow-up examination with a mean follow-up period of 41.8 months. There were four recurrences.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED,SURG SERV,BRONX,NY 10461.
RP BERLINER, SD (reprint author), LONG ISL JEWISH MED CTR,SURG SERV,NEW HYDE PK,NY 11042, USA.
CR BALL L, 1958, BRIT J SURG, V45, P562, DOI 10.1002/bjs.18004519326
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   BERLINER SD, 1984, SURG CLIN N AM, V64, P197
   Berliner SD, 1989, HERNIA, P541
   Downes WA, 1920, ARCH SURG-CHICAGO, V1, P53, DOI 10.1001/archsurg.1920.01110010066005
   GLASSOW F, 1984, ANN ROY COLL SURG, V66, P382
   Harrison PW, 1922, ARCH SURG-CHICAGO, V4, P680, DOI 10.1001/archsurg.1922.01110120197008
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   READ RC, 1987, AM J SURG, V153, P324, DOI 10.1016/0002-9610(87)90620-9
   SHEARBURN EW, 1969, SURGERY, V66, P450
   Stoppa RE, 1989, HERNIA, P199
   WANTZ GE, 1989, SURG GYNECOL OBSTET, V168, P67
   WANTZ GE, 1989, SURG GYNECOL OBSTET, V169, P408
NR 13
TC 19
Z9 20
U1 0
U2 0
PU FRANKLIN H MARTIN FOUNDATION
PI CHICAGO
PA 55 E ERIE ST, CHICAGO, IL 60611
SN 0039-6087
J9 SURG GYNECOL OBSTET
JI Surg. Gynecol. Obstet.
PD APR
PY 1993
VL 176
IS 4
BP 323
EP 326
PG 4
WC Obstetrics & Gynecology; Surgery
SC Obstetrics & Gynecology; Surgery
GA KV571
UT WOS:A1993KV57100005
PM 8460406
DA 2018-10-19
ER

PT J
AU OHLIN, A
   LINDER, L
AF OHLIN, A
   LINDER, L
TI BIOCOMPATIBILITY OF POLYOXYMETHYLENE (DELRIN(R)) IN BONE
SO BIOMATERIALS
LA English
DT Article
DE DELRIN(R); PROSTHESES; HIPS; BIOCOMPATIBILITY
ID HIP; PROSTHESES; INTERFACE; IMPLANTS
AB The bone tissue reaction to bulk polyoxymethylene (Delrin(R)) was studied in eight adult albino rabbits followed for up to 5 months after insertion of implants into the tibial metaphyses. Each animal received two implants, one of pure Delrin, the other a 'mosaic' plug with alternating areas of commercially pure titanium and Delrin. At the passage through the cortex, a direct bone-Delrin contact was seen in more than half of the cases, but the contact was usually limited in extent. At the same time, in virtually all sections, a foreign-body reaction with macrophages and giant cells was prominent. It was concluded that bulk Delrin has inferior biocompatibility to titanium, and the advisability of using Delrin as a biomaterial for bone anchorage is questionable.
RP OHLIN, A (reprint author), MALMO GEN HOSP,DEPT ORTHOPAED SURG,S-21401 MALMO,SWEDEN.
CR AHNFELT L, 1990, ACTA ORTHOP SCAND, V61, P1
   ANDREW TA, 1986, CLIN ORTHOP RELAT R, V206, P127
   BOSS JH, 1990, INT ORTHOP, V14, P399
   FISTER JS, 1985, J BIOMED MATER RES, V19, P519, DOI 10.1002/jbm.820190505
   Jakim I, 1988, J Arthroplasty, V3, P191
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   LINDER L, 1986, BIOMATERIALS, V7, P17, DOI 10.1016/0142-9612(86)90082-7
   MAISTRELLI GL, 1991, J BONE JOINT SURG BR, V73, P43
   MATHYS R, 1984, CEMENTLESS FIXATION, P71
   OHLIN A, 1990, ACTA ORTHOP SCAND, V61, P7, DOI 10.3109/17453679008993055
   SUNDAL B, 1974, ACTA CHIR SCAND, V140, P189
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
NR 13
TC 6
Z9 7
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1993
VL 14
IS 4
BP 285
EP 289
DI 10.1016/0142-9612(93)90120-Q
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KU449
UT WOS:A1993KU44900006
PM 8476998
DA 2018-10-19
ER

PT J
AU COURTNEY, JM
   IRVINE, L
   JONES, C
   MOSA, SM
   ROBERTSON, LM
   SRIVASTAVA, S
AF COURTNEY, JM
   IRVINE, L
   JONES, C
   MOSA, SM
   ROBERTSON, LM
   SRIVASTAVA, S
TI BIOMATERIALS IN MEDICINE - A BIOENGINEERING PERSPECTIVE
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; ARTIFICIAL ORGANS; BLOOD-BIOMATERIAL INTERACTIONS;
   CELL-BIOMATERIAL INTERACTIONS
ID HEMODIALYSIS; ADHESION
AB Biomaterials are considered with an emphasis on those use in artificial organs. Attention is drawn to the importance of the polymeric biomaterials and factors which affect their properties. Functions of membranes, sorbents, blood tubing, ventricular diaphragms and cell culture substrates are examined in order to obtain a summary of fundamental properties. Observations are made on the importance of blood compatibility assessment and its association with a biomaterial structure-property relationship. Blood-biomaterial interactions are discussed in terms of an overall relationship between the three components - blood, biomaterial and antithrombotic agent, with examples given of factors influencing each component. Cell-biomaterial interactions are examined in the areas of toxicity evaluation and the promotion of cell attachment and growth, where an overall relationship is described for the cell, growth medium and growth factors, and the biomaterial acting as a substrate.
RP COURTNEY, JM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,106 ROTTENROW,GLASGOW G4 0NW,SCOTLAND.
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   BEHM E, 1988, INFLUENCE NEW TECHNO, P75
   BIGGS MS, 1984, POLYM MED, P375
   BLASS CR, 1991, PLAST RUB COMPOS PRO, V15, P221
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHANG TMS, 1987, BIOMATER ARTIF CELL, V15, P1
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   Courtney J. M., 1980, A textbook of biomedical engineering, P77
   COURTNEY JM, 1989, BLOOD FLOW ARTIFICIA, P104
   FORBES CD, 1987, HAEMOSTASIS THROMBOS, P902
   GAYLOR JDS, 1988, J BIOMED ENG, V10, P541, DOI 10.1016/0141-5425(88)90113-6
   GURLAND HJ, 1987, UREMIA THERAPY, P64
   HASTINGS GW, 1984, MACROMOLECULAR BIOMA
   HENDERSON LW, 1987, UREMIA THERAPY, P74
   IRVINE L, 1989, INT J ARTIF ORGANS, V12, P502
   IRVINE L, 1991, T AM SOC ART INT ORG, V37, P569
   JONES C, 1989, INT J ARTIF ORGANS, V12, P466
   Klinkmann H., 1987, UREMIA THERAPY, P125
   KLINKMANN H, 1989, PROGR BIOENGINEERING, P7
   MOSA SM, 1989, THESIS U STRATHCLYDE
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   PAUL JP, 1984, BIOMATERIALS ARTIFIC
   Piskin E, 1986, Life Support Syst, V4 Suppl 1, P2
   ROBERTSON LM, 1988, THESIS U STRATHCLYDE
   RUOSLAHTI E, 1985, ARTERIOSCLEROSIS, V5, P581, DOI 10.1161/01.ATV.5.6.581
   SCHAEFER RM, 1986, PROGR ARTIFICIAL ORG, P966
   SEVASTIANOV VI, 1987, ARTIF ORGANS, V11, P20, DOI 10.1111/j.1525-1594.1987.tb02621.x
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P133, DOI 10.1016/0142-9612(90)90129-E
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P162, DOI 10.1016/0142-9612(90)90149-K
   SRIVASTAVA S, 1988, THESIS U STRATHCLYDE
   Szycher M., 1983, BIOCOMPATIBLE POLYM
   VONSENGBUSCH G, 1987, UREMIA THERAPY, P64
   Williams D. F., 1987, DEFINITIONS BIOMATER
NR 33
TC 10
Z9 11
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 1993
VL 16
IS 3
BP 164
EP 171
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA LC859
UT WOS:A1993LC85900011
PM 8314641
DA 2018-10-19
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI THE BLOOD COMPATIBILITY CATASTROPHE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Editorial Material
ID BIOMATERIAL SURFACES; PLATELET CONSUMPTION; ARTERIAL; THROMBOEMBOLISM;
   THROMBOSIS; INHIBITION; POLYMERS
C1 UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
RP RATNER, BD (reprint author), UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195, USA.
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   ENGBERS GH, 1991, INT J ARTIF ORGANS, V14, P199
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1985, J CLIN INVEST, V75, P1591, DOI 10.1172/JCI111865
   HARKER LA, 1974, THROMB DIATH HAEMOST, V31, P188, DOI 10.1055/s-0038-1649157
   HARKER LA, 1980, BLOOD, V56, P824
   HARKER LA, 1977, ANN SURG, V186, P594, DOI 10.1097/00000658-197711000-00009
   HAYCOX CL, 1992, 4TH P INT C BIOM BER
   HAYCOX CL, IN PRESS J BIOMED MA
   HOFFMAN AS, 1982, ACS ADV CHEM SERIES, V199, P59
   IKADA Y, 1984, ADV POLYM SCI, V57, P103
   IP WF, 1991, J BIOMED MATER RES, V25, P875, DOI 10.1002/jbm.820250707
   JOZEFOWICZ M, 1984, PURE APPL CHEM, V56, P1335, DOI 10.1351/pac198456101335
   KUSSEROW BK, 1972, B NEW YORK ACAD MED, V48, P468
   MALPASS TW, 1981, BLOOD, V57, P736
   MCINTIRE LV, 1985, NIH852185 NAT HEART
   Ratner B. D., 1984, CONT BIOMATERIALS MA, P193
   RATNER BD, 1987, TREATISECLEAN SURFAC, V1, P247
   RATNER BD, IN PRESS CLIN MATER
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SOLEN KA, 1989, T AM SOC ART INT ORG, V35, P370
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
NR 26
TC 150
Z9 151
U1 1
U2 20
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAR
PY 1993
VL 27
IS 3
BP 283
EP 287
DI 10.1002/jbm.820270302
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KL907
UT WOS:A1993KL90700001
PM 8360198
DA 2018-10-19
ER

PT J
AU VANDERTWEEL, I
   VANNOORD, PAH
   KAAKS, R
AF VANDERTWEEL, I
   VANNOORD, PAH
   KAAKS, R
TI APPLICATION OF A SEQUENTIAL T-TEST IN A COHORT NESTED CASE-CONTROL STUDY
   WITH MULTIPLE CONTROLS PER CASE
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE SEQUENTIAL T-TEST; MULTIPLE CONTROLS; SIMULATIONS; EFFICIENCY;
   BIOBANKING; COHORT NESTED STUDIES
ID CLINICAL-TRIALS; SAMPLE; DESIGN
AB Application of sequential analysis may avoid unnecessary experimentation and achieve economical use of available biomaterial stored in biological banks. When, as often happens in cohort case-control studies, cases are scarce, it may be possible to use multiple control observations per case to increase the power of a test for detecting differences between cases and controls. Samples from a biological data bank were analysed. We compared results of a non-sequential analysis with results of sequential t-tests for 1 to 5 controls matched per case in a cohort nested case-control study. Simulations are performed to get an idea of the unreliability and the power of the sequential test. In general the sequential t-tests are too conservative with respect to the achieved power. Average sample numbers are lower for the sequential tests and decrease with multiple controls. More than 3 or 4 controls per case does not give a meaningful increase in efficiency.
C1 UNIV UTRECHT,DEPT EPIDEMIOL,3511 CK UTRECHT,NETHERLANDS.
   WHO,IARC,ANALYT EPIDEMIOL UNIT,F-69372 LYON 08,FRANCE.
RP VANDERTWEEL, I (reprint author), UNIV UTRECHT,CTR BIOSTAT,CENTRUMGEBOUW NOORD C122,PADUALAAN 14,3584 CH UTRECHT,NETHERLANDS.
CR ABRAMOWITZ M, 1968, HDB MATH FUNCTIONS
   GAIL M, 1976, J CHRON DIS, V29, P723, DOI 10.1016/0021-9681(76)90073-4
   LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5
   NOORD PA, 1987, INT J EPIDEMOL, V16, P318
   ONEILL RT, 1978, AM J EPIDEMIOL, V108, P415, DOI 10.1093/oxfordjournals.aje.a112639
   PASTERNACK BS, 1982, AM J EPIDEMIOL, V115, P778, DOI 10.1093/oxfordjournals.aje.a113359
   PASTERNACK BS, 1981, AM J EPIDEMIOL, V113, P182, DOI 10.1093/oxfordjournals.aje.a113082
   PASTERNAK BS, 1980, J CHRON DIS, V33, P365, DOI 10.1016/0021-9681(80)90046-6
   POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191
   RUSHTON S, 1952, BIOMETRIKA, V39, P302, DOI 10.1093/biomet/39.3-4.302
   SKOVLUND E, 1991, J CLIN EPIDEMIOL, V44, P265, DOI 10.1016/0895-4356(91)90038-B
   SKOVLUND E, 1987, SCAND J STAT, V14, P347
   Sokal R. R., 1981, BIOMETRY
   URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548
   VANNOORD PAH, 1992, THESIS U UTRECHT
   Wald A., 1947, SEQUENTIAL ANAL
   WALD NJ, 1985, MATURITAS, V7, P59, DOI 10.1016/0378-5122(85)90035-0
   WETHERILL GB, 1908, SEQUENTIAL METHODS S
NR 18
TC 5
Z9 5
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD MAR
PY 1993
VL 46
IS 3
BP 253
EP 259
PG 7
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA KV165
UT WOS:A1993KV16500006
PM 8455050
DA 2018-10-19
ER

PT J
AU CLARKE, KI
   GRAVES, SE
   WONG, ATC
   TRIFFITT, JT
   FRANCIS, MJO
   CZERNUSZKA, JT
AF CLARKE, KI
   GRAVES, SE
   WONG, ATC
   TRIFFITT, JT
   FRANCIS, MJO
   CZERNUSZKA, JT
TI INVESTIGATION INTO THE FORMATION AND MECHANICAL-PROPERTIES OF A
   BIOACTIVE MATERIAL BASED ON COLLAGEN AND CALCIUM-PHOSPHATE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE; HYDROXYAPATITE; OSTEONECTIN; APATITE
AB A biomaterial composite was formed by the room-temperature precipitation of calcium phosphate (in the form of brushite) on to collagen. It was found that the addition of 1 mm 0-phosphoserine (Ser P) causes the morphology of the brushite crystals to change from large plates to small needles. An increase in the surface coverage and weight fraction of brushite incorporated into the collagen was observed. The mechanical properties of this composite were tested in the wet state. The ultimate tensile strength (UTS) was 45 MPa compared with 34 MPa for the wet collagen. Osteoblastic differentiation was promoted on the surface of the material and new bone formed.
C1 NUFFIELD ORTHOPAED CTR,NUFFIELD DEPT ORTHOPAED SURG,OXFORD OX3 7LD,ENGLAND.
   NUFFIELD ORTHOPAED CTR,MRC,BONE RES LAB,OXFORD OX3 7LD,ENGLAND.
RP CLARKE, KI (reprint author), UNIV OXFORD,DEPT MAT,PK RD,OXFORD OX1 3PH,ENGLAND.
OI Graves, Stephen/0000-0002-1629-319X
CR BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X
   Billmeyer FW, 1984, TXB POLYM SCI
   BIOSTELLE R, 1990, J CRYST GROWTH, V102, P609
   CLARKE KI, 1991, BIOCERAMICS, V4, P107
   CLARKE KIJ, 1991, THESIS U OXFORD
   CURREY JD, 1990, J MATER SCI-MATER M, V1, P14, DOI 10.1007/BF00705348
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   DOI Y, 1989, CALCIFIED TISSUE INT, V44, P200, DOI 10.1007/BF02556565
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GLIMCHER MJ, 1989, CONNECT TISSUE RES, V21, P179
   HARRIS B, 1986, ENG COMPOSITE MAT, pCH2
   MATHERS NJ, 1991, J MATER SCI LETT, V10, P992, DOI 10.1007/BF00721823
   MATHERS NJ, 1990, THESIS U OXFORD
   Nancollas G H, 1989, Connect Tissue Res, V21, P239, DOI 10.3109/03008208909050013
   NANCOLLAS GH, 1989, BIOMINERALIZATION CH, pCH6
   SASAKI N, 1989, BIOMATERIALS, V10, P129, DOI 10.1016/0142-9612(89)90046-X
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
NR 18
TC 75
Z9 79
U1 3
U2 6
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 107
EP 110
DI 10.1007/BF00120378
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900003
DA 2018-10-19
ER

PT J
AU ERIKSSON, AS
   THOMSEN, P
AF ERIKSSON, AS
   THOMSEN, P
TI IMPLANT EXUDATE LEUKOCYTE RESPONSE TO ANTIINFLAMMATORY DRUG-TREATMENT
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NEUTROPHIL FUNCTION; PROSTAGLANDIN
   BIOSYNTHESIS; RHEUMATOID-ARTHRITIS; CHEMI-LUMINESCENCE;
   IMMUNE-COMPLEXES; GLUCOCORTICOIDS; CHEMOTAXIS; INVITRO; INVIVO
AB Implantation of artificial materials elicits a local inflammatory response. In this study a chamber model technique, allowing sampling of the inflammatory exudate for further analysis in vitro, was used. Male Sprague Dawley rats were injected daily with two different anti-inflammatory drugs, betamethasone and indomethacin, and the local cellular response was compared with a control group. The retrieved exudate was evaluated with respect to the number of leucocytes, cell viability, differential counts and serum-opsonized zymosan stimulated chemiluminescence (CL). In all groups the majority of cells were polymorphonuclear granulocytes (PMNGs). Betamethasone and high-dose indomethacin (1.92 mg kg-1 body weight day-1) treatment caused a marked reduction in the number of accumulated leucocytes 6 days after implantation. A substantial inhibition of the CL response was observed 6 days after treatment with betamethasone (4.23 mg kg-1 body weight day-1). An increased CL responsiveness was observed after 24 h with low-dose indomethacin (0.03 mg kg-1 body weight day-1) and after 6 days with high-dose indomethacin (1.92 mg kg 1 body weight day-1) treatment. In summary, depending on the anti-inflammatory drug treatment, dose and time after implant surgery, either an inhibition or stimulation of leucocyte accumulation and activation was observed. This study shows the possibilities of sampling the inflammatory exudate adjacent to a biomaterial implanted in vivo. This chamber model may be useful for the analysis of the inflammatory reaction around an implanted biomaterial during pharmacological treatment.
RP ERIKSSON, AS (reprint author), UNIV GOTEBORG, DEPT ANAT, MEDICINAREGATAN 3, S-41390 GOTHENBURG, SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ABRAMSON S, 1989, CLIN EXP RHEUMATOL, V7, pS163
   ABRAMSON S, 1985, P NATL ACAD SCI USA, V82, P7227, DOI 10.1073/pnas.82.21.7227
   ABRAMSON SB, 1990, INFLAMMATION, V14, P11, DOI 10.1007/BF00914026
   ALLRED CD, 1978, INFECT IMMUN, V19, P833
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BELCH JJF, 1989, SCAND J RHEUMATOL, V18, P213, DOI 10.3109/03009748909099931
   BJURSTEN LM, 1988, ADV BIOMATER, V8, P37
   BRIHEIM G, 1988, INFLAMMATION, V12, P141, DOI 10.1007/BF00916397
   BURKER K, 1913, HDB PHYSL METHODIK, P1
   CHANG DM, 1990, J RHEUMATOL, V17, P1148
   CHESON BD, 1976, J CLIN INVEST, V58, P789, DOI 10.1172/JCI108530
   CHEUNG K, 1984, AUST J EXP BIOL MED, V62, P403, DOI 10.1038/icb.1984.39
   CLARK RAF, 1979, BLOOD, V53, P633
   CROWELL RE, 1990, INFLAMMATION, V14, P163, DOI 10.1007/BF00917455
   DANON A, 1978, NATURE, V273, P552, DOI 10.1038/273552a0
   DAYNES RA, 1989, EUR J IMMUNOL, V19, P2319, DOI 10.1002/eji.1830191221
   DIROSA M, 1979, BRIT J PHARMACOL, V66, P161
   DIROSA M, 1972, J PATHOL, V105, P239
   ERIKSSON AS, 1992, ANESTHESIOLOGY, V77, P74, DOI 10.1097/00000542-199207000-00011
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   FLOMAN Y, 1976, PROSTAGLANDINS, V12, P403, DOI 10.1016/0090-6980(76)90021-6
   FLOWER R, 1972, NATURE-NEW BIOL, V238, P104
   FRANK DE, 1986, J LEUKOCYTE BIOL, V40, P693
   GRETZER C, IN PRESS
   HIGGS GA, 1980, EUR J PHARMACOL, V66, P81, DOI 10.1016/0014-2999(80)90297-6
   HIGGS GA, 1984, ADV INFLAMMAT RES, P223
   HIRSCHELMANN R, 1988, BIOMED BIOCHIM ACTA, V47, pS316
   HORAN TD, 1983, IMMUNOPHARMACOLOGY, V6, P97, DOI 10.1016/0162-3109(83)90003-6
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P160, DOI 10.1007/BF00713443
   IP M, 1990, BRIT J RHEUMATOL, V29, P363
   KANTROWITZ F, 1975, NATURE, V258, P737, DOI 10.1038/258737a0
   KAPLAN HB, 1984, BIOCHEM PHARMACOL, V33, P371, DOI 10.1016/0006-2952(84)90228-4
   KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129
   KURIHARA A, 1984, J PHARMACOBIO-DYNAM, V7, P747
   LACKIE JM, 1988, J CELL SCI, V89, P449
   MACGREGOR RR, 1977, ANN INTERN MED, V86, P35, DOI 10.7326/0003-4819-86-1-35
   MAJESKI JA, 1976, J SURG RES, V21, P265, DOI 10.1016/0022-4804(76)90036-6
   MCGILLEN J, 1980, J INFECT DIS, V141, P382, DOI 10.1093/infdis/141.3.382
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   PARENTE L, 1978, POL J PHARMACOL PHAR, V30, P141
   RINGROSE PS, 1975, BIOCHEM PHARMACOL, V24, P607, DOI 10.1016/0006-2952(75)90181-1
   ROBINSON DR, 1989, CLIN EXP RHEUMATOL, V7, pS155
   ROLAPLESZCZYNSKI M, 1985, IMMUNOL TODAY, V6, P302, DOI 10.1016/0167-5699(85)90181-1
   SAEED SA, 1988, BIOCHEM MED METAB B, V40, P143, DOI 10.1016/0885-4505(88)90115-6
   SAMUELSSON B, 1979, PATHWAYS ARACHIDONIC, P405
   SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598
   SCREIBER H, 1990, J EXP CHIR TRANSPLAN, V23, P23
   SEKIZUKA E, 1989, AM J PHYSIOL, V256, pH594
   SHEA C, 1978, ANN CLIN LAB SCI, V8, P30
   THOMPSON EB, 1974, METABOLISM, V23, P159, DOI 10.1016/0026-0495(74)90113-9
   THOMSEN P, 1986, INFLAMMATION, V10, P243, DOI 10.1007/BF00916120
   THOMSEN P, 1987, BIOMATERIALS CLIN AP, P615
   VANDYKE K, 1977, MICROCHEM J, V22, P463, DOI 10.1016/0026-265X(77)90114-X
   VANEPPS DE, 1987, INFLAMMATION, V11, P59, DOI 10.1007/BF00917772
   VANEPPS DE, 1980, J CLIN INVEST, V66, P167, DOI 10.1172/JCI109841
   WEBB DSA, 1987, J LEUKOCYTE BIOL, V41, P156
   WILDFEUR A, 1983, Z RHEUMATOL, V42, P356
NR 59
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 186
EP 191
DI 10.1007/BF00120390
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900015
DA 2018-10-19
ER

PT J
AU LAQUERRIERE, A
   YUN, J
   TIOLLIER, J
   HEMET, J
   TADIE, M
AF LAQUERRIERE, A
   YUN, J
   TIOLLIER, J
   HEMET, J
   TADIE, M
TI EXPERIMENTAL EVALUATION OF BILAYERED HUMAN COLLAGEN AS A DURAL
   SUBSTITUTE
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE DURAL DEFECT REPAIR; DURAL SUBSTITUTE; COLLAGEN; BIOMATERIAL
ID GRAFT; FILM
AB Many substances have been tried as possible dural substitutes, and different tissues and materials have been evaluated for use in dural repair; however, an entirely satisfactory solution still remains to be found. The authors report an experimental study involving the closure of dural defects in dogs with a new biomaterial, resorbable bilayered human placental collagen, using two types of collagen material. These include a collagen bilayered dural substitute made of oxidized type III + I collagen layer covered by a type IV oxidized collagen film (collagen dural substitute I) and a collagen bilayered dural substitute made of oxidized type III + I collagen layer covered by a type III + I collagen film (collagen dural substitute II). Macroscopic and histological examination, performed over a period of between 15 and 180 days after implantation, showed the resorption of collagen graft and formation of a neomembrane that looked like a neodura within 3 months. No infection and no cerebrospinal fluid fistulae were noticed. Nevertheless, one slight cerebromembranous adhesion was found with collagen dural substitute II. The authors suggest that human resorbable collagen biomaterial could be used as a very satisfactory dural substitute.
C1 VER MED, NEUROCHIRURG EXPTL LAB, BLVD UNIV, F-76800 ST ETIENNE, FRANCE.
   LAB ANAT & CYTOL PATHOL, ROUEN, FRANCE.
   IMEDEX CORP, CHAPONOST, FRANCE.
CR ADEGBITE AB, 1983, J NEUROSURG, V58, P295, DOI 10.3171/jns.1983.58.2.0295
   CAMPBELL JB, 1958, J NEUROSURG, V15, P207, DOI 10.3171/jns.1958.15.2.0207
   Chao YC, 1940, BMJ-BRIT MED J, V1940, P517, DOI 10.1136/bmj.1.4134.517
   COHEN AR, 1989, J NEUROSURG, V70, P633, DOI 10.3171/jns.1989.70.4.0633
   Delarue NC, 1944, J NEUROSURG, V1, P239, DOI 10.3171/jns.1944.1.4.0239
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   DUPONT D, 1989, CORNEA, V8, P251
   INGRAHAM FD, 1945, JAMA-J AM MED ASSOC, V128, P1088, DOI 10.1001/jama.1945.02860320030008
   KEENER EB, 1959, J NEUROSURG, V16, P415, DOI 10.3171/jns.1959.16.4.0415
   KLINE DG, 1965, ARCH SURG-CHICAGO, V91, P924
   LEHMAN RAW, 1967, J NEUROSURG, V26, P92, DOI 10.3171/jns.1967.26.1part1.0092
   MASON MS, 1961, ANN SURG, V153, P423, DOI 10.1097/00000658-196103000-00014
   MAURER PK, 1985, J NEUROSURG, V63, P448, DOI 10.3171/jns.1985.63.3.0448
   MORGON A, 1989, ACTA OTO-LARYNGOL, V107, P450, DOI 10.3109/00016488909127539
   NUSSBAUM CE, 1989, J NEUROSURG, V71, P124, DOI 10.3171/jns.1989.71.1.0124
   ONEILL P, 1984, J NEUROSURG, V61, P351, DOI 10.3171/jns.1984.61.2.0351
   ONGKIKO CM, 1984, J NEUROSURG, V60, P1076, DOI 10.3171/jns.1984.60.5.1076
   PENFIELD WG, 1924, SURG GYNECOL OBSTET, V39, P903
   Pudenz RH, 1942, SURGERY, V12, P318
   ROBERTSON RCL, 1945, J NEUROSURG, V2, P281, DOI 10.3171/jns.1945.2.4.0281
   ROSOMOFF HL, 1959, J NEUROSURG, V16, P197, DOI 10.3171/jns.1959.16.2.0197
   SARMAH BD, 1984, BRIT J SURG, V71, P524, DOI 10.1002/bjs.1800710717
   SHARKEY PC, 1958, J NEUROSURG, V15, P192, DOI 10.3171/jns.1958.15.2.0192
   SIMPSON D, 1984, J NEUROSURG, V60, P408, DOI 10.3171/jns.1984.60.2.0408
   TENG P, 1955, J NEUROSURG, V12, P591, DOI 10.3171/jns.1955.12.6.0591
   THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766
   TINOIS E, 1991, EXP CELL RES, V193, P310, DOI 10.1016/0014-4827(91)90102-Z
   TIOLLIER J, 1990, EXP CELL RES, V191, P95, DOI 10.1016/0014-4827(90)90041-8
NR 28
TC 64
Z9 66
U1 0
U2 1
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 0022-3085
EI 1933-0693
J9 J NEUROSURG
JI J. Neurosurg.
PD MAR
PY 1993
VL 78
IS 3
BP 487
EP 491
DI 10.3171/jns.1993.78.3.0487
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA KN936
UT WOS:A1993KN93600018
PM 8433154
DA 2018-10-19
ER

PT J
AU IRIGARAY, JL
   OUDADESSE, H
   BLONDIAUX, G
   COLLANGETTES, D
AF IRIGARAY, JL
   OUDADESSE, H
   BLONDIAUX, G
   COLLANGETTES, D
TI KINETICS OF THE DIFFUSION OF SOME ELEMENTS EVALUATED BY
   NEUTRON-ACTIVATION IN A CORAL IMPLANTED INVIVO
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article; Proceedings Paper
CT 8TH INTERNATIONAL CONF ON MODERN TRENDS IN ACTIVATION ANALYSIS ( MTAA 8
   )
CY SEP 16-20, 1991
CL AUSTRIA
SP AUSTRIAN SOC ENVIRONM & RADIOCHEM, INT ATOM ENERGY AGCY
AB Some studies show that a coral implanted on bone tissue is gradually transformed to become a neoformed bone. In our work, we have, for the first time, determined quantitatively by NAA the transformation of a coral used as a biomaterial implanted ''in vivo'' in some ovine jaw-bones. Each month and during 9 months, biopsies were extracted. For neutron production, the nuclear reaction Be-9(d, n)B-10 was used with 17.5 MeV energy deuterons- The neutrons had a mean energy of 7 McV and a flux of 10(12) n CM-2 S-1. The radioactivation generated permitted concentration measurements of Ca, P, Mg, Sr and F in each part of the biopsies and a study of mineral transformations versus time in the coral implanted. Three months after implantation, Ca belonging to CaCO3 represented 11 % and Ca provided by the apatite formed represented 20% of the total mass. These quantitative evaluations clearly showed that five months after implantation, the coral had become a neo-formed bone.
C1 CERI,CNRS,F-45071 ORLEANS 2,FRANCE.
   CTR JEAN PERRIN,F-63000 CLERMONT FERRAND,FRANCE.
   UNIV CLERMONT FERRAND,F-63177 CLERMONT FERRAND,FRANCE.
RP IRIGARAY, JL (reprint author), LAB PHYS CORPUSCULAIRE CLERMONT FERRAND,IN2P3,NCRS,F-63177 CLERMONT FERRAND,FRANCE.
CR BREBERI N, 1983, MED MED, V57, P4
   GUILLEMIN G, 1987, BIOMAT 87
   HEUGUEBAERT JC, 1977, THESIS I NATIONAL PO
   IRIGARAY JL, 1989, APR C INT GAITH MAR
   IRIGARAY JL, 1987, DEC C INT BIOMAT
   MELKI S, 1986, THESIS CERI ORLEANS
   SIMONNET G, 1980, MESURES RADIOACTIVIT
NR 7
TC 10
Z9 11
U1 0
U2 1
PU AKADEMIAI KIADO
PI BUDAPEST
PA PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD MAR
PY 1993
VL 169
IS 2
BP 339
EP 346
DI 10.1007/BF02042992
PG 8
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA KX898
UT WOS:A1993KX89800010
DA 2018-10-19
ER

PT J
AU ASHOUR, I
   HAMMAM, H
AF ASHOUR, I
   HAMMAM, H
TI EQUILIBRIUM SOLUBILITY OF PURE MONOLAURIN, DILAURIN, AND TRILAURIN IN
   SUPERCRITICAL CARBON-DIOXIDE - EXPERIMENTAL MEASUREMENTS AND MODEL
   PREDICTION
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE EQUILIBRIUM SOLUBILITY; BIOMATERIAL; EQUATION-OF-STATE; SUPERCRITICAL
   CARBON DIOXIDE; SOLUTE SOLUTE INTERACTION
ID VAPOR LIQUID EQUILIBRIA; FATTY-ACIDS; BINARY-MIXTURES; ESTERS; OILS
AB By use of an experimental dynamic apparatus, the solubility of lipids in supercritical carbon dioxide has been established at 308, 313, 323, and 333 K for trilaurin and at 313 and 338 K for mono- and dilaurin, at a pressure ranging from 150 to 400 bar. The solubility data obtained at 308 and 313 K was correlated with a cubic equation-of-state. The effect of solute-solute interaction parameter has been studied. The equation with three binary interaction parameters gave accurate predictions.
C1 LUND UNIV,DEPT FOOD TECHNOL,S-22100 LUND,SWEDEN.
RP ASHOUR, I (reprint author), LUND UNIV,DEPT CHEM ENGN 1,POB 124,S-22100 LUND,SWEDEN.
CR ADAMS WR, 1988, AICHE J, V34, P1387, DOI 10.1002/aic.690340820
   ASHOUR I, 1989, THESIS LUND U
   ASHOUR I, 1990, PHASE EQUILIBRIA NON
   ASHOUR I, 1990, AUG CHISA 90 PRAH
   BAMBERGER T, 1988, J CHEM ENG DATA, V33, P327, DOI 10.1021/je00053a029
   BHARATH R, 1989, FLUID PHASE EQUILIBR, V50, P315, DOI 10.1016/0378-3812(89)80298-5
   BRENNECKE JF, 1989, ACS S SERIES, V406
   BRUNETTI L, 1989, J AM OIL CHEM SOC, V66, P209, DOI 10.1007/BF02546062
   BRUNNER G, 1978, THESIS U ERLANGEN
   CHRASTIL J, 1982, J PHYS CHEM-US, V86, P3016, DOI 10.1021/j100212a041
   HAMMAM H, IN PRESS FAT SCI
   HIROHAMA S, 1986, THESIS TOKOKU U
   INOMATA H, 1989, FLUID PHASE EQUILIBR, V46, P41, DOI 10.1016/0378-3812(89)80273-0
   KING MB, 1983, CHEM ENG SUPERCRITIC, pCH2
   KRAMER A, 1988, J CHEM ENG DATA, V33, P230, DOI 10.1021/je00053a002
   LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905
   MCHUGH MA, 1986, SUPERCRITICAL FLUID
   OHGAKI K, 1989, INT CHEM ENG, V29, P302
   PETER S, 1980, EFCE PUBLICATION SER, P355
   Prausnitz J. M., 1986, MOL THERMODYNAMICS F
   QUIRIN KW, 1982, FETT WISS TECHNOL, V84, P460, DOI 10.1002/lipi.19820841203
   REID R.C., 1987, PROPERTIES GASES LIQ
   SAITO K, 1989, Patent No. 1117845
   SANDERS TAB, 1981, BRIT J NUTR, V45, P613, DOI 10.1079/BJN19810139
   SCHMITT WJ, 1988, CHEM ENG COMMUN, V64, P155, DOI 10.1080/00986448808940234
   Stahl E., 1987, DENSE GASES EXTRACTI
   Swern D., 1979, BAILEYS IND OIL FAT
   von Lossonczy T O, 1978, Am J Clin Nutr, V31, P1340
   WU AH, 1987, LBL24201 U CAL
   Zou M., 1990, J SUPERCRIT FLUID, V3, P85
   Zou M., 1990, J SUPERCRIT FLUID, V3, P23
NR 31
TC 20
Z9 20
U1 0
U2 4
PU PRA PRESS
PI CINCINNATI
PA POLYMER RES ASSOC INC 9200 MONTGOMERY RD, SUITE 23B, CINCINNATI, OH
   45242
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD MAR
PY 1993
VL 6
IS 1
BP 3
EP 8
DI 10.1016/0896-8446(93)90003-G
PG 6
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA LU706
UT WOS:A1993LU70600001
DA 2018-10-19
ER

PT J
AU WALTON, RL
   BROWN, RE
AF WALTON, RL
   BROWN, RE
TI TISSUE ENGINEERING OF BIOMATERIALS FOR COMPOSITE RECONSTRUCTION - AN
   EXPERIMENTAL-MODEL
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID REGENERATION; GAP
AB The fibrovascular integration of a biomaterial scaffold was examined in a rabbit model. Eight disks of expanded polytetrafluoroethylene measuring 2 x 2 x 0.2 cm were placed adjacent to dissected vascular pedicles in the ears of four rabbits and sealed between leaves of silicone sheeting. Fibrovascular outgrowth from the vascular pedicles completely integrated the biomaterial scaffolds by 6 weeks and was sufficient to sustain split-thickness skin grafts. Division of the distal vascular pedicle allowed isolation of the blood flow circuit to the construct. Successful microsurgical transfer was achieved in one construct. This model has proved useful in the study of tissue engineering of biomaterials for reconstruction and may well have use in the study of neovascularization as an isolated event.
C1 SO ILLINOIS UNIV,DIV PLAST SURG,SPRINGFIELD,IL 62708.
RP WALTON, RL (reprint author), UNIV MASSACHUSETTS,MED CTR,DIV PLAST & RECONSTRUCT SURG,55 LAKE AVE N,S4-751,WORCESTER,MA 01655, USA.
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ARNOLD J, 1872, VIRCHOWS ARCH PATH A, V54, P1
   BRENT B, 1980, PLAST RECONSTR SURG, V66, P1
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   CRONIN TD, 1966, PLAST RECONSTR SURG, V37, P399, DOI 10.1097/00006534-196605000-00003
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   FISHER J, 1988, PLAST RECONSTR SURG, V82, P857, DOI 10.1097/00006534-198811000-00021
   FOLKMAN J, 1974, CANCER RES, V34, P2109
   GREENBLATT M, 1971, TRANSPLANTATION, V2, P50
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   HUDLICKA O, 1986, GROWTH VESSELS INVIT, P27
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   KHOURI RK, 1991, 36TH ANN M CHARL
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   LANGHAM M, 1953, BRIT J OPHTHALMOL, V37, P210, DOI 10.1136/bjo.37.4.210
   LUNDBORG G, 1982, J NEUROPATH EXP NEUR, V41, P412, DOI 10.1097/00005072-198207000-00004
   PADGETT EC, 1938, GYNECOL OBSTET, V67, P761
   Sandison JC, 1928, AM J ANAT, V41, P447, DOI 10.1002/aja.1000410303
   SEVASTJANOVA NA, 1987, BIOMATERIALS, V8, P242, DOI 10.1016/0142-9612(87)90110-4
   TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1
   ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24
NR 23
TC 24
Z9 25
U1 1
U2 7
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD FEB
PY 1993
VL 30
IS 2
BP 105
EP 110
DI 10.1097/00000637-199302000-00002
PG 6
WC Surgery
SC Surgery
GA KL870
UT WOS:A1993KL87000002
PM 7683854
DA 2018-10-19
ER

PT J
AU KINOSHITA, Y
   KUZUHARA, T
   KIRIGAKUBO, M
   KOBAYASHI, M
   SHIMURA, K
   IKADA, Y
AF KINOSHITA, Y
   KUZUHARA, T
   KIRIGAKUBO, M
   KOBAYASHI, M
   SHIMURA, K
   IKADA, Y
TI SOFT-TISSUE REACTION TO COLLAGEN-IMMOBILIZED POROUS POLYETHYLENE -
   SUBCUTANEOUS IMPLANTATION IN RATS FOR 20 WK
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN IMMOBILIZATION; POLYETHYLENE; BIOCOMPATIBILITY; TISSUE ADHESION
AB Collagen-immobilized porous polyethylene, in which the immobilization was through covalent bonding, and virgin porous polyethylene were implanted subcutaneously in rats from 1 to 20 wk. The results were the ingrowth of the connective tissue into collagen-immobilized porous polyethylene was rich and contained a low level of inflammatory cellular infiltration compared with that of virgin porous polyethylene. The material-tissue interface showed that the living body-originated collagen fibres were firmly anchored into the immobilized collagen layer. These results suggested that covalent immobilization of collagen on to the biomaterial surface is useful in promoting the ingrowth of soft tissue and the tissue adhesion.
C1 KYOTO UNIV,BIOMED ENGN RES CTR,DEPT BIOMAT,REG MOLEC DESIGN BIOMAT,KYOTO 606,JAPAN.
RP KINOSHITA, Y (reprint author), KANAGAWA DENT COLL,DEPT ORAL & MAXILLOFACIAL SURG,YOKOSUKA,JAPAN.
CR BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   BOLTONMAGGS PHB, 1979, THORAX, V34, P561, DOI 10.1136/thx.34.4.561
   EDGERTON M T, 1958, Plast Reconstr Surg Transplant Bull, V21, P279, DOI 10.1097/00006534-195804000-00005
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   HINO T, 1983, BIOMATERIALS, V1, P5
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LEWIN-EPSTEIN J, 1960, J Oral Surg Anesth Hosp Dent Serv, V18, P453
   OKADA T, 1987, BIOMATERIALS CLIN AP, P465
   Osborn J. F., 1980, DENT IMPLANTS MAT SY, P111
   PANGMAN WJ, 1960, W J SURG OBSTET  AUG, P503
   PETERS WJ, 1981, PLAST RECONSTR SURG, V67, P514, DOI 10.1097/00006534-198104000-00017
   ROB CG, 1956, BRIT J SURG, V43, P449, DOI 10.1002/bjs.18004318102
   SHABER EP, 1987, INT J ORAL MAX SURG, V16, P678, DOI 10.1016/S0901-5027(87)80052-8
   SHIMIZU Y, 1977, BIOMATER ARTIF CELL, V5, P49, DOI 10.3109/10731197709118665
   SHIMIZU Y, 1978, BIOMATER ARTIF CELL, V6, P375, DOI 10.3109/10731197809119795
NR 15
TC 30
Z9 30
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 1993
VL 14
IS 3
BP 209
EP 215
DI 10.1016/0142-9612(93)90025-W
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KR055
UT WOS:A1993KR05500008
PM 8476994
DA 2018-10-19
ER

PT J
AU FRADIN, D
   CAUSS, T
   RABAUD, M
   DEMASCAREL, A
   FONTAN, F
AF FRADIN, D
   CAUSS, T
   RABAUD, M
   DEMASCAREL, A
   FONTAN, F
TI PRELIMINARY EXPERIMENTAL RESULTS OF A NEW RESORBABLE BIOMATERIAL AS
   PERICARDIAL SUBSTITUTE
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Letter
RP FRADIN, D (reprint author), HOP CARDIOL HAUT LEVEQUE,F-33604 PESSAC,FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
NR 2
TC 3
Z9 3
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD FEB
PY 1993
VL 105
IS 2
BP 364
EP 365
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA KL967
UT WOS:A1993KL96700024
PM 8429665
DA 2018-10-19
ER

PT J
AU GUO, WD
   ANDERSSON, R
   SHEN, W
   LJUNGH, A
   BENGMARK, S
   WADSTROM, T
AF GUO, WD
   ANDERSSON, R
   SHEN, W
   LJUNGH, A
   BENGMARK, S
   WADSTROM, T
TI BINDING OF ESCHERICHIA-COLI TO PENROSE RUBBER DRAINS - AN INVITRO STUDY
SO ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL
   MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; SURFACE HYDROPHOBICITY; AGGREGATION;
   ADHERENCE; ADHESION; BACTERIA; COAGGREGATION; BIOMATERIAL; TRANSLOCATE;
   CATHETERS
AB Ten different isolates of Escherichia coli were used to compare bacterial attachment to Penrose rubber drains at different temperatures and to investigate a possible relation with cell surface hydrophobicity and charges, as well as the capacity of autoaggregation. Penrose rubber drain pieces of 1 cm2 were incubated with 4.8 X 10(6)  E. coli cells for 1 h at 22, 37 and 42-degrees-C, respectively. After rinsing with phosphate buffered saline (PBS), the number of adhering bacteria on the drain pieces was calculated by measuring cellular ATP (adenosine triphosphate) bioluminescence. Bacterial cell surface properties at different temperatures were determined by two-phase partitioning and autoaggregation was determined by arbitrary scoring under the dissecting microscope. For most strains of E. coli, the number of adherence to Penrose rubber drain was higher at 22-degrees-C than at 37-degrees-C and 42-degrees-C. Bacterial cell-surface properties and autoaggregation capacity were influenced by the growth temperature, but without correlation to bacterial ability to attach to rubber drains. Thus, the present study demonstrates that attachment of E. coli to Penrose rubber drains was significantly influenced by temperature, but bacterial cell-surface hydrophobicity and charge as well as autoaggregation capacity had no influence on bacterial attachment ability.
C1 UNIV LUND,DEPT SURG,S-22185 LUND,SWEDEN.
   UNIV LUND,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN.
OI Bengmark, Stig/0000-0003-1809-8889
CR ASCENCIO F, 1990, APPL ENVIRON MICROB, V56, P1926
   BLAKE M, 1989, J MED MICROBIOL, V28, P9, DOI 10.1099/00222615-28-1-9
   BRUCE AW, 1984, J UROLOGY, V132, P184, DOI 10.1016/S0022-5347(17)49516-4
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HARTY D W S, 1991, Microbial Ecology in Health and Disease, V4, P19
   HOGT AH, 1985, A VAN LEEUW J MICROB, V51, P510, DOI 10.1007/BF00404506
   KLUGER MJ, 1991, FEVER BASIC MECHANIS, P105
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   LJUNGH A, 1985, INFECT IMMUN, V47, P522
   Loosdrecht MCV, 1987, APPL ENVIRON MICROB, V53, P1893
   LUDWICKA A, 1985, J MICROBIOL METH, V4, P164
   LUNDIN A, 1986, METHOD ENZYMOL, V133, P27
   Mackowiak P.A., 1991, FEVER BASIC MECH MAN, P167
   MORA EM, 1989, MICROECOL T, V19, P185
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   REID G, 1990, CURR MICROBIOL, V20, P185, DOI 10.1007/BF02091995
   REID G, 1988, CAN J MICROBIOL, V34, P344, DOI 10.1139/m88-063
   REID G, 1990, CURR MICROBIOL, V20, P47, DOI 10.1007/BF02094024
   REIFSTECK F, 1987, J MED MICROBIOL, V24, P65, DOI 10.1099/00222615-24-1-65
   RIDRIGUEZ JL, 1986, CURR SURG, P423
   Roberts Jr N. J., 1991, FEVER BASIC MECHANIS, P125
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   VANHAECKE E, 1990, APPL ENVIRON MICROB, V56, P788
   WELLS CL, 1986, ARCH SURG-CHICAGO, V121, P102
NR 27
TC 1
Z9 1
U1 0
U2 0
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8840
J9 ZBL BAKT-INT J MED M
JI Zent.bl. Bakteriol.-Int. J. Med. Microbiol. Virol. Parasitol. Infect.
   Dis.
PD FEB
PY 1993
VL 278
IS 1
BP 73
EP 82
DI 10.1016/S0934-8840(11)80281-1
PG 10
WC Microbiology; Virology
SC Microbiology; Virology
GA KY780
UT WOS:A1993KY78000007
PM 8518515
DA 2018-10-19
ER

PT J
AU VAQUERO, J
   ARIAS, A
   OYA, S
   MARTINEZ, R
   ZURITA, M
AF VAQUERO, J
   ARIAS, A
   OYA, S
   MARTINEZ, R
   ZURITA, M
TI EFFECT OF FIBRIN GLUE ON POSTLAMINECTOMY SCAR FORMATION
SO ACTA NEUROCHIRURGICA
LA English
DT Article
DE FIBRIN GLUE; EPIDURAL SCAR; LAMINECTOMY
ID LUMBAR SPINE; LAMINECTOMY; SURGERY; GRAFTS
AB An experimental study in rats has been carried out with the aim of studying the scar formation over the spinal dura in the presence of fibrin glue. Although the main action of fibrin glue is the enhancement of wound healing by increasing the fibrous tissue, our present data suggest that this re-absorbable biomaterial diminishes the epidural scar formation, at least the first two weeks after laminectomy. This finding leads us to consider the use of fibrin glue over spinal duramater when it is likely that reoperation may become necessary in a short period of time after a laminectomy .
C1 UNIV COMPLUTENSE MADRID, DEPT CELLULAR BIOL, MADRID 3, SPAIN.
RP VAQUERO, J (reprint author), AUTONOMOUS UNIV MADRID, PUERTA HIERRO CLIN, DEPT NEUROSURG, SAN MARTIN DE PORRES 4, E-28035 MADRID, SPAIN.
CR BARBERA J, 1978, J NEUROSURG, V49, P419, DOI 10.3171/jns.1978.49.3.0419
   BENOIST M, 1980, SPINE, V5, P432, DOI 10.1097/00007632-198009000-00007
   BRODSKY AE, 1976, CLIN ORTHOP RELAT R, P130
   BRYANT MS, 1983, NEUROSURGERY, V13, P367, DOI 10.1227/00006123-198310000-00003
   CABEZUDO JM, 1985, J NEUROSURG, V63, P633, DOI 10.3171/jns.1985.63.4.0633
   DEVILLIERS PD, 1976, CLIN ORTHOP RELAT R, P140
   Gill G G, 1979, Spine (Phila Pa 1976), V4, P176, DOI 10.1097/00007632-197903000-00016
   JACOBS RR, 1980, SPINE, V5, P223, DOI 10.1097/00007632-198005000-00004
   KELLER JT, 1978, J NEUROSURG, V49, P412, DOI 10.3171/jns.1978.49.3.0412
   KIVILUOTO O, 1988, ACTA ORTHOP SCAND S, V164, P3
   LANGENSKIOLD A, 1976, CLIN ORTHOP RELAT R, V115, P92
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   LEE CK, 1984, SPINE, V9, P305, DOI 10.1097/00007632-198404000-00016
   MARTINFERRER S, 1989, NEUROSURGERY, V24, P718, DOI 10.1227/00006123-198905000-00010
   NUSSBAUM CE, 1990, NEUROSURGERY, V26, P649, DOI 10.1227/00006123-199004000-00014
   ROSSITCH E, 1990, NEUROSURGERY UPDATE, V1, P195
NR 16
TC 29
Z9 29
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
EI 0942-0940
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PY 1993
VL 120
IS 3-4
BP 159
EP 163
DI 10.1007/BF02112036
PG 5
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA KQ283
UT WOS:A1993KQ28300011
PM 8460569
DA 2018-10-19
ER

PT J
AU KE, HYD
   RAYSON, GD
AF KE, HYD
   RAYSON, GD
TI LUMINESCENCE STUDY OF UO-2(2+) BINDING TO IMMOBILIZED DATURA-INNOXIA
   BIOMATERIAL
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE LASER-INDUCED FLOURESCENCE SPECTROSCOPY; URANYL LUMINESCENCE;
   FLUORESCENCE LIFETIME; LUMINESCENCE SPECTRAL ANALYSIS; FLUORESCENCE
   EMISSION SPECTRA; BIOMASS MATERIAL
ID METAL
AB The spectrally and temporally resolved UO2(2+) fluorescence signals have been measured for solid samples of UO2(2+)-Datura, UO2(2+)-immobilized Datura), and UO2(2+)-(silicate polymer) at liquid nitrogen temperature. The binding capacity of UO2(2+) to Datura innoxia cell material has been enhanced significantly at pH 5 and 6 when immobilized in a polysilicate matrix. New binding sites having a greater binding strength with a lower availability have been observed for the binding of UO2(2+) after immobilization of the cultured biomaterial. However, chemical alteration of the cell material resulting from this immobilization process has not been observed. The chemical environment of the binding sites responsible for the binding of UO2(2+) in immobilized and free D. innoxia cell material has been demonstrated to be different. This difference results from the immobilization of the cell material within a polysilicate matrix.
C1 NEW MEXICO STATE UNIV,DEPT CHEM,LAS CRUCES,NM 88003.
CR BELL JT, 1968, J MOL SPECTROSC, V25, P312, DOI 10.1016/S0022-2852(68)80045-1
   DARNALL DW, 1991, Patent No. 4992207
   DIEKE GH, 1949, SPECTROSCOPIC PROPER, P36
   GARDEATORRESDEY J, 1988, ANAL CHEM, V60, P72, DOI 10.1021/ac00152a018
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   Good N E, 1972, Methods Enzymol, V24, P53
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   Iler RK, 1979, CHEM SILICA, P172
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KUBIAK WW, 1989, ANAL CHEM, V61, P468, DOI 10.1021/ac00180a018
   LARA AS, 1990, ORGANIC AMINE TAILOR, P10
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   RAYSON GD, 1992, APPL SPECTROSC, V46, P1245, DOI 10.1366/0003702924123999
   Weigel F, 1986, CHEM ACTINIDE ELEMEN, P169
NR 19
TC 9
Z9 9
U1 0
U2 0
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA PO BOX 1438, FREDERICK, MD 21701
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD JAN
PY 1993
VL 47
IS 1
BP 44
EP 51
DI 10.1366/0003702934048569
PG 8
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA KK259
UT WOS:A1993KK25900010
DA 2018-10-19
ER

PT B
AU ECKERT, KL
   ROSLER, U
   MATHEY, M
   MAYER, J
   WINTERMANTEL, E
   HOFMANN, H
AF ECKERT, KL
   ROSLER, U
   MATHEY, M
   MAYER, J
   WINTERMANTEL, E
   HOFMANN, H
BE Ducheyne, P
   Christiansen, D
TI OPEN POROUS CERAMICS FOR CELL TRANSPLANTATION DEVICES - A NEW
   BIOMATERIAL 1ST RESULTS
SO BIOCERAMICS, VOL 6
LA English
DT Proceedings Paper
CT 6th International Symposium on Ceramics in Medicine
CY NOV, 1993
CL PHILADELPHIA, PA
C1 ETH ZURICH,CHAIR BIOCOMPATIBLE MAT SCI & ENGN,CH-8952 SCHLIEREN,SWITZERLAND.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BUTTERWORTH-HEINEMANN
PI OXFORD
PA LINACRE HOUSE, JORDAN HILL, OXFORD, OXON, ENGLAND OX2 8DP
BN 0-7506-1884-1
PY 1993
BP 251
EP 255
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BA02R
UT WOS:A1993BA02R00039
DA 2018-10-19
ER

PT J
AU SERRE, CM
   PAPILLARD, M
   CHAVASSIEUX, P
   BOIVIN, G
AF SERRE, CM
   PAPILLARD, M
   CHAVASSIEUX, P
   BOIVIN, G
TI INVITRO INDUCTION OF A CALCIFYING MATRIX BY BIOMATERIALS CONSTITUTED OF
   COLLAGEN AND OR HYDROXYAPATITE - AN ULTRASTRUCTURAL COMPARISON OF 3
   TYPES OF BIOMATERIALS
SO BIOMATERIALS
LA English
DT Article
DE COLLAGEN SPONGE; HYDROXYAPATITE; CALCIFICATION; OSTEOBLASTS
ID PERIODONTAL DEFECTS; BONE-CELLS; OSTEOBLASTS; MINERALIZATION; RESPONSES;
   SUBSTRATA; IMPLANTS; CULTURES; CERAMICS; BEHAVIOR
AB The induction of a calcifying matrix was studied in vitro and compared for three biomaterials (collagen sponge, hydroxyapatite material and a mixture of both (Biostite(R))) cultured with human osteoblast-like cells. The influence of biomaterials on organic matrix synthesis and the calcification process was analysed at the ultrastructural level (transmission electron microscopy and X-ray microanalysis). Biomaterials were well tolerated by bone cells. Whichever biomaterial was used, osteoblasts proliferated and synthesized a new matrix constituted of fibrillar and non-fibrillar elements. This activity appeared earlier and was more intense with Biostite than with collagen sponge alone. A deposition of a mineral substance in this newly formed matrix was observed with the collagen sponge and Biostite, but never with hydroxyapatite alone. The mineral deposits were identified as hydroxyapatite crystals, similar to those observed and analysed in bone tissue. These in vitro observations clearly demonstrated the property of Biostite to produce a calcified collagenous matrix similar to bone tissue. However, in vivo confirmation is required before extending the use of this biomaterial to periodontology.
C1 FAC ODONTOL LYON,LYON,FRANCE.
RP SERRE, CM (reprint author), FAC A CARREL,INSERM,U234,LYON,FRANCE.
RI Chavassieux, Pascale/L-9071-2018
CR BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BARNEY VC, 1986, J PERIODONTOL, V57, P764, DOI 10.1902/jop.1986.57.12.764
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BYE FL, 1987, J PERIODONTOL, V58, P110, DOI 10.1902/jop.1987.58.2.110
   CHAVASSIEUX PM, 1990, J BONE MINER RES, V5, P337, DOI 10.1002/jbmr.5650050406
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298
   LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526
   MAOR G, 1987, COLLAGEN REL RES, V7, P351
   MINABE M, 1988, J PERIODONTOL, V59, P671, DOI 10.1902/jop.1988.59.10.671
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   PAPILLARD M, 1986, REACTIONS TISSULAIRE
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RODAN GA, 1975, SCIENCE, V189, P467, DOI 10.1126/science.168639
   ROSEN HM, 1990, PLAST RECONSTR SURG, V85, P718, DOI 10.1097/00006534-199005000-00011
   SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
   YAMADA S, 1986, Shikwa Gakuho, V86, P687
   YUKNA RA, 1989, J CLIN PERIODONTOL, V16, P398, DOI 10.1111/j.1600-051X.1989.tb01667.x
NR 24
TC 68
Z9 68
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 97
EP 106
DI 10.1016/0142-9612(93)90217-P
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500003
PM 8382091
DA 2018-10-19
ER

PT J
AU PULEO, DA
   PRESTON, KE
   SHAFFER, JB
   BIZIOS, R
AF PULEO, DA
   PRESTON, KE
   SHAFFER, JB
   BIZIOS, R
TI EXAMINATION OF OSTEOBLAST ORTHOPEDIC BIOMATERIAL INTERACTIONS USING
   MOLECULAR TECHNIQUES
SO BIOMATERIALS
LA English
DT Article
DE OSTEOBLASTS; OSTEONECTIN; OSTEOPONTIN; MESSENGER RNA; GENE EXPRESSION
ID BONE; OSTEOPONTIN; EXPRESSION; DIFFERENTIATION; OSTEONECTIN; PROTEIN;
   CLONING; INVITRO; GENE; RNA
AB Molecular techniques can be used to elucidate the effects of extended periods of cell-biomaterial interactions on the time-course and level of expression of particular genes which determine cellular phenotype. We used the polymerase chain reaction to demonstrate the expression of genes for the bone-related proteins osteocalcin, osteonectin and osteopontin by neonatal rat calvarial osteoblasts. In addition, Northern blotting was subsequently used to show that messenger RNAs encoding osteonectin and osteopontin were consistently expressed during a 5 wk period of interaction of osteoblasts with Ti-6Al-4V, a commercial brand of hydroxyapatite, and tissue culture polystyrene.
C1 RENSSELAER POLYTECH INST,DEPT BIOMED ENGN,TROY,NY 12180.
   NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201.
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   BUTLER WT, 1985, CHEM BIOL MINERALIZE, P107
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   FRANZEN A, 1985, CHEM BIOL MINERALIZE, P279
   JINGUSHI S, 1990, BONE BIOMATERIAL INT
   KLEINSMITH LJ, 1988, PRINCIPLES CELL BIOL, P385
   MALIK MA, 1990, THESIS RENSSELAER PO
   MARK MP, 1987, J BONE MINER RES, V2, P337, DOI 10.1002/jbmr.5650020411
   MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Price PA., 1983, BONE MINERAL RES ANN, V1, P157
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   SHAFFER JB, 1990, BIOCHEM BIOPH RES CO, V173, P1043, DOI 10.1016/S0006-291X(05)80891-5
   SHAFFER JB, 1990, FREE RADICAL BIO MED, V8, P497, DOI 10.1016/0891-5849(90)90064-P
   STEIN GS, 1990, FASEB J, V4, P3111
   STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   TERMINE JD, 1985, CHEM BIOL MINERALIZE, P94
   WEINREB M, 1990, J BONE MINER RES, V5, P831
   YOON K, 1987, BIOCHEM BIOPH RES CO, V148, P1129, DOI 10.1016/S0006-291X(87)80250-4
   YOON K, 1988, BIOCHEMISTRY-US, V27, P8521, DOI 10.1021/bi00423a003
   YOUNG MF, 1986, NUCLEIC ACIDS RES, V14, P4483, DOI 10.1093/nar/14.11.4483
NR 26
TC 34
Z9 34
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 111
EP 114
DI 10.1016/0142-9612(93)90220-V
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500005
PM 8382089
DA 2018-10-19
ER

PT J
AU DION, I
   BAQUEY, C
   MONTIES, JR
   HAVLIK, P
AF DION, I
   BAQUEY, C
   MONTIES, JR
   HAVLIK, P
TI HEMOCOMPATIBILITY OF TI6AL4V-ALLOY
SO BIOMATERIALS
LA English
DT Article
DE TI ALLOY; HEMOCOMPATIBILITY
ID PROTEIN ADSORPTION; SURFACES
AB Ti6Al4V alloy has been mainly used as a biomaterial in the orthopaedic field. The present study describes the surface state of the Ti6Al4V material and evaluates its in vitro haemocompatibility in terms of protein adsorption, platelet retention and haemolysis. The behaviour of the Ti6Al4V alloy towards albumin and fibrinogen was compared to that of a reference medical-grade elastomer. The platelet retention test gave better results than those achieved with the elastomer. The haemolysis percentage of the alloy was almost zero. These results indicate that the Ti6Al4V alloy is well tolerated by blood.
C1 UNIV AIX MARSEILLE 2,LRC,F-13385 MARSEILLE,FRANCE.
   TERACOR,ZI TOULON EST,F-83089 TOULON,FRANCE.
RP DION, I (reprint author), UNIV BORDEAUX 2,INSERM,PHYS & INORGAN CHEM RES LABS,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAQUEY C, 1989, BIOMATERIALS, V10, P435, DOI 10.1016/0142-9612(89)90082-3
   BORDENAVE L, 1987, RBM, V6, P283
   CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167
   DION I, 1992, INT J ARTIF ORGANS, V15, P457
   DUCASSOU D, 1976, BRIT J RADIOL, V49, P344, DOI 10.1259/0007-1285-49-580-344
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   ELWING H, 1991, J BIOMAT SCI-POLYM E, V3, P7
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   ERIKSSON AS, 1988, BIOMATERIALS, V9, P86, DOI 10.1016/0142-9612(88)90076-2
   GRAHAM TR, 1990, EUR J CARDIO-THORAC, V4, P182, DOI 10.1016/1010-7940(90)90002-H
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KIM SW, 1977, J BIOMED MATER RES, V8, P23
   MERRITT K, 1988, J BIOMED MATER RES, V22, P99, DOI 10.1002/jbm.820220203
   MONTIES JR, 1990, T AM SOC ART INT ORG, V36, P258
   MUTLU M, 1990, Artificial Organs, V14, P81
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   THAKUR ML, 1976, THROMB RES, V9, P345, DOI 10.1016/0049-3848(76)90135-3
   THERIN M, 1991, INNOV TECH BIOL MED, V12, P29
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
NR 21
TC 25
Z9 26
U1 1
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 122
EP 126
DI 10.1016/0142-9612(93)90222-N
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500007
PM 8435455
DA 2018-10-19
ER

PT J
AU MAROM, G
   REUVENI, A
   COHN, D
AF MAROM, G
   REUVENI, A
   COHN, D
TI STIFFNESS VARIABILITY AND STRESS-DEPENDENT ELASTIC RESPONSE OF SYNTHETIC
   FIBER-REINFORCED COMPOSITES FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Article
DE MECHANICAL PROPERTIES; COMPOSITE MATERIALS; SYNTHETIC FIBER; YOUNG
   MODULUS
AB A major design requirement of biomaterial prostheses is to match their elastic properties with those of the natural host tissue. Composite materials address this requirement because their elastic properties can be altered accurately through composition and directionality parameters, and they can be designed to match closely the elastic properties of the biological tissues, in isocompliance, modulus gradient and anisotropy. This adds to a range of advantages of synthetic composite materials with respect to potential biomedical applications, which draw on their heterogeneity and anisotropy. This paper focuses on the elastic properties of synthetic fibre-reinforced composite materials that pertain to biomedical applications, and demonstrates the range of stiffnesses obtainable through selection of constituents and by choice of angle of reinforcement.
RP MAROM, G (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI & TECHNOL,CASALI INST APPL CHEM,IL-91904 JERUSALEM,ISRAEL.
CR AGARWLA BD, 1990, ANAL PEFORMANCE COMP
   Chou TW, 1992, MICROSTRUCTURAL DESI
   COHN D, 1992, J BIOMED MATER RES, V26, P1185, DOI 10.1002/jbm.820260909
   GERSHON B, 1990, Clinical Materials, V5, P13, DOI 10.1016/0267-6605(90)90068-7
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1982, BIOMATERIALS, V13, P38
   SCHEER W, 1981, PROCESSING USES CARB, P251
NR 7
TC 10
Z9 10
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 127
EP 131
DI 10.1016/0142-9612(93)90224-P
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500008
PM 8435456
DA 2018-10-19
ER

PT S
AU LIM, JO
   KAMATH, M
   MARX, KA
   TRIPATHY, SK
   KAPLAN, DL
   SAMUELSON, LA
AF LIM, JO
   KAMATH, M
   MARX, KA
   TRIPATHY, SK
   KAPLAN, DL
   SAMUELSON, LA
BE Viney, C
   Case, ST
   Waite, JH
TI BIOTINYLATED POLYTHIOPHENE COPOLYMER - A NOVEL ELECTROACTIVE BIOMATERIAL
   UTILIZING THE BIOTIN-STREPTAVIDIN INTERACTION
SO BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT SYMP ON BIOMOLECULAR MATERIALS
CY DEC 01-03, 1992
CL BOSTON, MA
SP MAT RES SOC, USN, OFF NAVAL RES, JOHNSON & JOHNSON, DUPONT CO
NR 0
TC 2
Z9 2
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA PITTSBURGH
SN 0272-9172
BN 1-55899-187-5
J9 MATER RES SOC SYMP P
PY 1993
VL 292
BP 141
EP 146
PG 6
WC Biochemistry & Molecular Biology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Materials Science
GA BY40A
UT WOS:A1993BY40A00016
DA 2018-10-19
ER

PT S
AU ZENG, SX
   YANG, ZX
   LING, P
   XU, GG
   CAO, WP
AF ZENG, SX
   YANG, ZX
   LING, P
   XU, GG
   CAO, WP
BE Viney, C
   Case, ST
   Waite, JH
TI HYDROXYAPATITE/AL2O3 COMPOSITE BIOMATERIAL IMPLANT
SO BIOMOLECULAR MATERIALS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT SYMP ON BIOMOLECULAR MATERIALS
CY DEC 01-03, 1992
CL BOSTON, MA
SP MAT RES SOC, USN, OFF NAVAL RES, JOHNSON & JOHNSON, DUPONT CO
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA PITTSBURGH
SN 0272-9172
BN 1-55899-187-5
J9 MATER RES SOC SYMP P
PY 1993
VL 292
BP 271
EP 275
PG 5
WC Biochemistry & Molecular Biology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Materials Science
GA BY40A
UT WOS:A1993BY40A00033
DA 2018-10-19
ER

PT J
AU SZULCZEWSKI, DH
   MEYER, U
   MOLLER, K
   STRATMANN, U
   DOTY, SB
   JONES, DB
AF SZULCZEWSKI, DH
   MEYER, U
   MOLLER, K
   STRATMANN, U
   DOTY, SB
   JONES, DB
TI CHARACTERIZATION OF BOVINE OSTEOCLASTS ON AN IONOMERIC CEMENT INVITRO
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIAL TESTING; OSTEOCLASTS; CELL CULTURE METHODS
ID RESISTANT ACID-PHOSPHATASE; BONE-MARROW CULTURES; MONOCLONAL-ANTIBODIES;
   PARATHYROID-HORMONE; CHICK OSTEOCLASTS; GLASS-CERAMICS; CELL-FORMATION;
   MOUSE BONE; OSTEOBLASTS; RESORPTION
AB Primary bovine osteoclasts were obtained by an outgrowth method from bovine periosteum and cultured for 7 days on an ionomeric cement for biomaterial testing. Osteoclasts cultured on slices of bovine bone and on glass microscope cover-slides served as a control. The cells were characterised as osteoclasts by a number of tests. Osteoclasts showed positive staining for tartrate resistant acid phosphatase and reactivity with the antibodies 13C2 and 23C6, which react with the alpha-chain of the vitronectin receptor. Addition of salmon calcitonin to the culture medium led to sudden cessation of lamellipodial activity. The cells resorbed bone by making pits. In mixed cultures with osteoblasts, the morphology of the osteoclasts on the smooth ionomeric cement surface was comparable to the one on glass cover-slides, revealing broad cytoplasmatic extensions on the material. Acridine orange staining demonstrated viability of cells until the end of the culture period and increased acidification after parathyroid hormone (PTH) stimulation. Scanning electron microscopy did not reveal erosion of the material by osteoclasts. No signs of aluminium toxicity on osteoclasts could be detected during the 7 day culture period, although an increased uptake of aluminium into the cell was demonstrated.
C1 UNIV MUNSTER,INST ANAT,DENT SECT,CELL BIOL EXPTL ORTHOPAED LAB,DOMAGKSTR 3,W-4400 MUNSTER,GERMANY.
   HOSP SPECIAL SURG,NEW YORK,NY 10021.
CR ALI NN, 1984, ANAT EMBRYOL, V170, P51, DOI 10.1007/BF00319457
   ANDERSON RE, 1985, CALCIFIED TISSUE INT, V37, P646, DOI 10.1007/BF02554924
   ATHANASOU NA, 1990, BONE MINER, V8, P7, DOI 10.1016/0169-6009(91)90136-N
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BARON R, 1986, AM J PATHOL, V122, P363
   BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   BIANCO P, 1988, CALCIFIED TISSUE INT, V43, P167, DOI 10.1007/BF02571315
   CHAMBERS TJ, 1984, CALCIFIED TISSUE INT, V36, P556, DOI 10.1007/BF02405365
   CHAMBERS TJ, 1983, CALCIFIED TISSUE INT, V35, P566, DOI 10.1007/BF02405095
   CHAMBERS TJ, 1984, J CELL SCI, V66, P383
   CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104
   CHAMBERS TJ, 1985, J PATHOL, V145, P297, DOI 10.1002/path.1711450403
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203, DOI 10.1177/35.2.3540104
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1986, INTERACTION PRIMAR 1, P72
   GOMI K, 1992, 4 WORLD BIOM C EUR S, P531
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   HEFLEY TJ, 1984, CALCIFIED TISSUE INT, V34, P480
   HORTON MA, 1986, J BONE MINER RES, V1, P5
   HORTON MA, 1985, CANCER RES, V45, P5663
   HORTON MA, 1986, BRIT J EXP PATHOL, V67, P95
   HUNTER SJ, 1988, J BONE MINER RES, V3, P297
   ITTEL TH, 1992, AKTUELLE ASPEKTE OST, P139
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONCK LM, 1989, CLIN MATER, V4, P85
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   JONES DB, 1990, 01VG86603 GERM MIN R
   JONES DB, 1988, Z ZAHNARZTL IMPLANTO, V4, P290
   JONES SJ, 1986, ANAT EMBRYOL, V174, P265, DOI 10.1007/BF00824342
   JONES SJ, 1986, SCANNING ELECTRON MI, V4, P1555
   LAMBRECHT JT, 1990, DEUT ZAHNAERZTL Z, V45, P82
   MACDONALD BR, 1986, J BONE MINER RES, V1, P227
   MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696
   MASON DY, 1978, J CLIN PATHOL, V31, P454, DOI 10.1136/jcp.31.5.454
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   OHTSUKI Y, 1989, STAIN TECHNOL, V64, P55, DOI 10.3109/10520298909108046
   OURSLER MJ, 1985, J CELL BIOL, V100, P1592, DOI 10.1083/jcb.100.5.1592
   PHAROAH MJ, 1985, CALCIFIED TISSUE INT, V37, P276, DOI 10.1007/BF02554874
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373
   VANDEWIJNGAERT FP, 1986, J HISTOCHEM CYTOCHEM, V34, P1317, DOI 10.1177/34.10.3745910
   Zambonin Zallone A, 1982, Anat Embryol (Berl), V165, P405
NR 47
TC 6
Z9 6
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 1
BP 83
EP 92
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA LA850
UT WOS:A1993LA85000008
DA 2018-10-19
ER

PT J
AU MEYER, U
   SZULCZEWSKI, DH
   MOLLER, K
   HEIDE, H
   JONES, DB
   GROSS, U
   VANWACHEM, PB
   BAGAMDISA, FB
   DEKKER, A
   DAVIES, JE
AF MEYER, U
   SZULCZEWSKI, DH
   MOLLER, K
   HEIDE, H
   JONES, DB
   GROSS, U
   VANWACHEM, PB
   BAGAMDISA, FB
   DEKKER, A
   DAVIES, JE
TI ATTACHMENT KINETICS AND DIFFERENTIATION OF OSTEOBLASTS ON DIFFERENT
   BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOCOMPATIBILITY; OSTEOBLASTS; PLATING EFFICIENCY; KINETICS
ID HUMAN-ENDOTHELIAL-CELLS; POLYMER SURFACES; GLASS-CERAMICS; ADHESION;
   FIBRONECTIN; GROWTH; ADSORPTION; BINDING; CALCIUM; CULTURE
AB Primary bovine osteoblast cell cultures were used to study the response of osteoblasts ton three different biomaterials, ionomeric cement (IC), tri-calcium phosphate poly-L-lactic acid composite foil (TCP) and poly-L-lactate-polycitric acid composite foil (PLA). The cells which grew on the materials produced all typical bone matrix proteins and were osteoblast-like as shown by immuno-staining. Analysis of the cell attachment kinetics revealed significant differences within the first 7 hours between the various materials. The best rate of cell attachment was found on the IC surface, followed by the TCP and then the PLA surface. The kinetics of attachment appeared to be due to different surface wettabilities and could be expressed by a linear equation. Further investigations showed an ion mediated attachment of osteoblasts on the surfaces. Quantitative analysis of non-collagenous protein matrix production and DNA content per cell was carried out, showing the best results for PLA, followed by IC and TCP, indicating that the material with the best primary attachment characteristics is not necessarily that on which the cells differentiate the best. Scanning electron microscopy observations of primary outgrowth cultures showed close contact of osteoblasts on all surfaces. It was concluded that such techniques may be developed as a means of batch testing bioactive biomaterials and investigating bone cell/biomaterial interactions.
C1 WESTFAL WILHEMS UNIV,CELL BIOL LAB,DOMAGKSTR 3,D-48129 MUNSTER,GERMANY.
   GESELL GESUNDHEIT & UMWELTFORSCH MBH,FRANKFURT,GERMANY.
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P271, DOI 10.1002/jbm.820220403
   AMPHLETT GW, 1983, BIOCHEM BIOPH RES CO, V111, P1045, DOI 10.1016/0006-291X(83)91405-5
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355
   CURTIS ASG, 1973, PROGR BIOPHYS MOL BI, V27, P317
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1986, 6TH P EUR C BIOM BOL, P24
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GRINNELL F, 1976, EXP CELL RES, V97, P265, DOI 10.1016/0014-4827(76)90616-9
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   GROSS UM, 1980, J BIOMED MATER RES, V14, P607, DOI 10.1002/jbm.820140507
   Hatton S., 1985, J COLLOID INTERF SCI, V104, P73
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   JOHNSONWINT B, 1982, ANAL BIOCHEM, V122, P338, DOI 10.1016/0003-2697(82)90292-5
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   JONES DB, 1988, Z ZAHNARZTL IMPLANTO, V4, P290
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   OLANDER JV, 1982, IN VITRO CELL DEV B, V18, P99, DOI 10.1007/BF02796401
   RABINOVITCH M, 1973, J CELL BIOL, V59, P165, DOI 10.1083/jcb.59.1.165
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   SCHIRRMACHER K, 1992, CALCIFIED TISSUE INT, V51, P1
   SORGER T, 1983, ANAL BIOCHEM, V131, P245
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WESISS L, 1967, J CELL PHYSIOL, V70, P23
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
NR 36
TC 83
Z9 84
U1 1
U2 10
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 2
BP 129
EP 140
PG 12
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA MA395
UT WOS:A1993MA39500002
DA 2018-10-19
ER

PT J
AU CHRISTIANSEN, DL
   PINS, G
   SILVER, FH
AF CHRISTIANSEN, DL
   PINS, G
   SILVER, FH
TI A SIMPLE FREEZE-FRACTURE TECHNIQUE FOR SCANNING ELECTRON-MICROSCOPY OF
   COLLAGENOUS BIOMATERIALS
SO CELLS AND MATERIALS
LA English
DT Note
DE FREEZE FRACTURE; SCANNING ELECTRON MICROSCOPY; BIOMATERIALS; COLLAGEN;
   SAMPLE PREPARATION TECHNIQUE
AB A simple freeze fracture technique for the ultrastructural analysis of fragile collagenous biomaterials is presented. Following standard methods of preparation and dehydration, fragile biomaterials are fractured with a sharp blade attached to a modified slide hammer. The sliding mass imparts a sudden impact load on the frozen surface of the material, creating a distortion free cleavage plane across the material. More traditional methods including bending and cutting with scissors introduce artifacts indirectly associated with stress concentration produced by bending, and sample compression at the edges with cutting. The impact loading of the sample during fracture results in preservation of edge detail, showing clear structural features up to the surface of the collagenous biomaterial.
C1 UMDNJ,ROBERT WOOD JOHNSON MED SCH,CTR BIOMAT,ROOM V-14,675 HOES LANE,PISCATAWAY,NJ 08854.
   UNIV PENN,DEPT ORTHOPAED,PHILADELPHIA,PA 19104.
CR DUNN MG, 1993, 39TH P ANN M, P334
   ROBARDS AW, 1985, LOW TEMPERATURE METH, P336
   WASSERMAN AJ, 1991, CELL MATER, V1, P41
NR 3
TC 0
Z9 0
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 2
BP 189
EP 191
PG 3
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA MA395
UT WOS:A1993MA39500008
DA 2018-10-19
ER

PT J
AU KAWAGUCHI, H
   MCKEE, MD
   OKAMOTO, H
   NANCI, A
AF KAWAGUCHI, H
   MCKEE, MD
   OKAMOTO, H
   NANCI, A
TI IMMUNOCYTOCHEMICAL, AND LECTIN-GOLD CHARACTERIZATION OF THE INTERFACE
   BETWEEN ALVEOLAR BONE AND IMPLANTED HYDROXYAPATITE IN THE RAT
SO CELLS AND MATERIALS
LA English
DT Article
DE HYDROXYAPATITE; BIOMATERIAL; BONE; INTERFACE; ULTRASTRUCTURE; LECTIN
   CYTOCHEMISTRY; IMMUNOCYTOCHEMISTRY; OSTEOPONTIN; OSTEOCALCIN; ALBUMIN;
   ALPHA-2HS-GLYCOPROTEIN
ID HUMAN CORTICAL BONE; SYNTHETIC HYDROXYAPATITE; ELECTRON-MICROSCOPY;
   OSTEOBLAST CULTURES; PHOSPHATE CERAMICS; PERIODONTAL TISSUE;
   PLASMA-PROTEINS; INVITRO; OSTEOCALCIN; GLYCOPROTEIN
AB The tissue response to implanted hydroxyapatite (HAP) in rat alveolar bone was investigated using morphological and cytochemical approaches. High-resolution immunogold labeling was used to examine the distribution of two non-collagenous bone proteins, osteopontin and osteocalcin, and two plasma proteins, alpha(2)HS-glycoprotein (fetuin) and albumin. Glycoconjugates were characterized by lectin-gold cytochemistry using Ricinus communis I agglutinin and Wheat germ agglutinin. Transmission electron microscopy demonstrated the presence of an electron-dense, lamina limitans-like layer at the HAP particle-bone interface and organic material within the micropores of the particles. Mineral was observed in relation to both these sites. The HAP particle-bone interface was strongly immunoreactive for osteopontin; moderately to weakly reactive for osteocalcin, alpha(2)HS-glycoprotein and albumin, and rich in glycoconjugates containing galactose and/or N-acetyl-glucosamine/sialic acid. Organic material within the micropores of the HAP particles was also labeled with the various antibodies and lectins. These results indicate that the lamina limitans at the HAP particle-bone interface is enriched in osteopontin as well as in sugars present in this and other molecules. Similarly, certain bone and plasma proteins infiltrate the micropores of HAP and distribute differentially throughout the particles.
C1 UNIV MONTREAL,FAC DENT,DEPT STOMATOL,MONTREAL H3C 3J7,PQ,CANADA.
   HIROSHIMA UNIV,SCH DENT,DEPT ENDODONTOL & PERIODONTOL,HIROSHIMA,JAPAN.
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   ASHTON BA, 1976, CALC TISS RES, V22, P27
   ASHTON BA, 1974, EUR J BIOCHEM, V45, P525, DOI 10.1111/j.1432-1033.1974.tb03577.x
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BENDAYAN M, 1989, COLLOIDAL GOLD PRINC, V1, P33
   BENHAMOU N, 1989, COLLOIDAL GOLD PRINC, V1, P95
   BOSKEY AL, 1992, CLIN ORTHOP RELAT R, V281, P244
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   COLE DE, 1991, BONE BONE MATRIX BON, V3, P239
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DAVIES JE, 1991, CELL MATER, V1, P3
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1990, CRC HDB BIOACTIVE CE, V2, P61
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FRAME JW, 1987, INT J ORAL MAX SURG, V16, P642, DOI 10.1016/S0901-5027(87)80048-6
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GROSS UM, 1990, CRC HDB BIOACTIVE CE, V1, P25
   HAUSCHKA PV, 1983, J BIOL CHEM, V258, P176
   HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258
   HENCH LL, 1974, J BIOMED MATER RES 1, V5, P49
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1978, 4TH T ANN M SOC BIOM, P112
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KAWAGUCHI H, 1992, J PERIODONTAL RES, V27, P48, DOI 10.1111/j.1600-0765.1992.tb02085.x
   Kenney E B, 1991, Dent Clin North Am, V35, P541
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   Linde A, 1989, Connect Tissue Res, V21, P197, DOI 10.3109/03008208909050009
   MATUKAS VJ, 1991, DENTAL IMPLANTS PRIN, P229
   MBUYI JM, 1982, CALCIFIED TISSUE INT, V34, P229, DOI 10.1007/BF02411242
   MCKEE MD, 1990, ANAT REC, V228, P77, DOI 10.1002/ar.1092280112
   MCKEE MD, 1993, J BONE MINER RES, V8, P485
   MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404
   MCKEE MD, 1991, J BONE MINER RES, V6, P937
   MCKEE MD, 1993, CELL MATER, V3, P219
   MIZUNO M, 1991, BONE MINER, V13, P1, DOI 10.1016/0169-6009(91)90046-3
   NANCI A, 1989, J HISTOCHEM CYTOCHEM, V37, P1619, DOI 10.1177/37.11.2809173
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NISHIYAMA K, 1990, CRC HDB BIOACTIVE CE, V2, P87
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   ORR RD, 1992, CELL MATER, V2, P241
   PRINCE CW, 1987, J BIOL CHEM, V262, P2900
   RAVAGLIOLI A, 1992, BIOMATERIALS, V13, P162, DOI 10.1016/0142-9612(92)90065-V
   RITTER NM, 1992, J BONE MINER RES, V7, P877
   ROTH J, 1983, J HISTOCHEM CYTOCHEM, V31, P987, DOI 10.1177/31.8.6190857
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   SLAVKIN HC, 1982, DIFFERENTIATION, V23, P73, DOI 10.1111/j.1432-0436.1982.tb01268.x
   SMITH AJ, 1985, CALCIFIED TISSUE INT, V37, P208, DOI 10.1007/BF02554843
   SODEK J, 1992, CHEM BIOL MINERALIZE, P297
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   TRIFFITT JT, 1977, CALC TISS RES, V23, P303, DOI 10.1007/BF02012801
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998
   Young M F, 1992, Clin Orthop Relat Res, P275
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 63
TC 46
Z9 46
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 337
EP 350
PG 14
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300001
DA 2018-10-19
ER

PT J
AU RADDER, AM
   DAVIES, JE
   LEENDERS, H
   VANBLITTERSWIJK, CA
AF RADDER, AM
   DAVIES, JE
   LEENDERS, H
   VANBLITTERSWIJK, CA
TI THE PEO/PBT COPOLYMER-MINERALIZED MATRIX INTERFACE IN-VITRO
SO CELLS AND MATERIALS
LA English
DT Article
DE INTERFACE; BONE-BONDING; IN-VITRO; PEO/PBT COPOLYMER
ID HYDROXYAPATITE INTERFACE; BIOMATERIAL INTERFACE; ELECTRON-MICROSCOPY;
   OSTEOBLAST CULTURES; BONE INTERFACE; INVITRO; CELLS; TITANIUM; MARROW
AB Previous implantation experiments have investigated the interaction between a series of PEO/PBT copolymers (Polyactive(R)) and bone tissue, and shown the morphology of bone-bonding with several PEO/PBT ratios. However, the underlying mechanism of bone-bonding remains largely unknown. Therefore, an invitro approach was chosen to obtain more information on the events occurring at the PEO/PBT copolymer-bone interface. Rat marrow cells were cultured on two PEO/PBT copolymer proportions: a 60/40 ratio which is known to bond with bone tissue in-vivo and a 30/70 ratio which, within one year of implantation, does not bond with bone. Evaluation was performed with light microscopy, scanning, backscatter and transmission electron microscopy and X-ray microanalysis.
   Surface calcification of the 60/40 material was observed. Undecalcified specimens revealed a continuum between material calcification and biologically elaborated mineralized matrix. An electron-dense region was frequently observed at the interface of this material. No signs of calcification were seen within the surface of the stiffer 30/70 polymer. Mineralized matrix was found in contact with the surface of the 30/70 but the absence of a continuity was evident at all resolutions. These results indicate that reproduction of the in-vivo findings and a rapid differentiation between different PEO/PBT ratios can be accomplished in-vitro. The rat marrow system may therefore represent a controlled tool to achieve a better understanding of the events occurring at the bone-PEO/PBT copolymer interface.
C1 UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A1,ON,CANADA.
RP RADDER, AM (reprint author), LEIDEN UNIV HOSP,BIOMAT RES GRP,OTOBIOL & BIOCOMPATIBIL LAB,BLD 55,RIJNSBURGERWEG 10,2333 AA LEIDEN,NETHERLANDS.
CR ALBREKTSSON T, 1990, International Journal of Prosthodontics, V3, P30
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119
   BETTE MC, 1990, CALCIFIED TISSUE INT, V46, P46
   BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P214
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, HDB BIOACTIVE CERAMI, V1, P1
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DEBRUIJN JD, 1992, BONE BONDING BIOMATE, P57
   DUCHEYNE P, 1991, BONE-BIOMATERIAL INTERFACE, P62
   ERICSON LE, 1991, BONE-BIOMATERIAL INTERFACE, P425
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   HANAWA T, 1990, J DENT RES S, V69, P1247
   HARMAND MF, 1986, BIOL BIOMECHANICAL P, P361
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KASSEM M, 1991, APMIS, V99, P269, DOI 10.1111/j.1699-0463.1991.tb05149.x
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   OKUMURA M, 1992, BONE BONDING BIOMATE, P189
   ORR RD, 1992, CELL MATER, V2, P241
   OWEN M, 1980, ARTHRITIS RHEUM-US, V23, P1073, DOI 10.1002/art.1780231002
   PILLIAR RM, 1991, MRS BULL, V16, P55
   RADDER AM, 1993, IN PRESS J BIOMED MA
   RADDER AM, 1990, 11TH P ANN C CAN BIO, P17
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   SHEN X, 1993, CELL MATER, V3, P257
   TAKEUCHI Y, 1990, BIOCHEM J, V266, P15, DOI 10.1042/bj2660015
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P23
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   WEINER S, 1992, FASEB J, V6, P879
   WILLIAMS DF, 1991, ADV BIOMATERIALS BIO, P525
NR 37
TC 1
Z9 1
U1 0
U2 2
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 367
EP 376
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300004
DA 2018-10-19
ER

PT J
AU DERSOT, JM
   SEPTIER, D
   LLORENS, A
   SAFFAR, JL
AF DERSOT, JM
   SEPTIER, D
   LLORENS, A
   SAFFAR, JL
TI MULTINUCLEATED GIANT CELLS-HYDROXYAPATITE INTERACTIONS - A TIME-RELATED
   QUANTITATIVE STUDY IN A RAT SKULL DEFECT
SO CELLS AND MATERIALS
LA English
DT Article
DE MULTINUCLEATED GIANT CELLS; DEGRADATION; HYDROXYAPATITE; BIOMATERIAL;
   OSTEOCONDUCTION; CERAMIC; MORPHOMETRY
ID CALCIUM-PHOSPHATE CERAMICS; TRICALCIUM PHOSPHATE; BONE SUBSTITUTE;
   TISSUE; MACROPHAGES; CRYSTALS; INVITRO; IMPLANTATION; DISSOLUTION;
   OSTEOCLASTS
AB The implantation of calcium phosphate ceramics in the bone environment elicits the differentiation of multinucleated giant cells (MNGCs). MNGC interactions with both crushed and standard hydroxyapatite (HA, Bioapatite(R)) particles (cHA and sHA) were studied in rat skull defects. Light microscopy (LM) of undemineralized material after 21 and 42 days of implantation showed that the number of particles in the defect significantly decreased (about 50%) with the two HA forms. Concomitantly, average cHA particle size increased significantly due to the elimination of the smallest particles by the MNGCs. The number of MNGCs per mm(2) of defect decreased significantly between 21 and 42 days with the two HA forms as did the number of MNGCs per particle. MNGC-HA interactions were observed at the ultrastructural level with transmission electron microscopy (TEM) in 21 day demineralized samples. MNGCs appeared smaller than in the LM, since several MNGCs formed aggregates of interwoven cells. They were closely apposed to the particle surface but no typical ruffled border or clear zone were seen in any case. An organic material had penetrated the HA particles and scattered in centripetal direction. These results show that (a) the HA conditioning form had no effect on its degradation and integration behavior, (b) the HA was extensively degraded by MNGCs before the embedding of the remaining particles in bone, and (c) MNGCs did not exhibit the distinctive functional apparatus of osteoclasts.
C1 UNIV PARIS 05,FAC CHIRURG DENT,BIOL & BIOMAT MILIEU BUCCAL & OSSEUX LAB,F-92120 MONTROUGE,FRANCE.
CR BARON R, 1984, BONE MINERAL RES ANN, V2, P175
   BECK LS, 1991, J BONE MINER RES, V6, P1257
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, V275, P287
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DEPORTER DA, 1988, CALCIFIED TISSUE INT, V42, P321, DOI 10.1007/BF02556367
   DERSOT JM, 1992, THESIS U PARIS 5 FRA
   DONATH K, 1987, Journal of Oral Implantology, V13, P120
   DONATH K, 1992, VIRCHOWS ARCH A, V420, P131, DOI 10.1007/BF02358804
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, V232, P127
   FRAME JW, 1980, J ORAL SURG, V38, P176
   FRANK RM, 1991, J CLIN PERIODONTOL, V18, P669, DOI 10.1111/j.1600-051X.1991.tb00108.x
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   HOLTROP ME, 1978, MECHANISMS LOCALIZED, P13
   Hulth A, 1989, Clin Orthop Relat Res, P265
   KAWAGUCHI H, 1992, J PERIODONTAL RES, V27, P48, DOI 10.1111/j.1600-0765.1992.tb02085.x
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   KWONG CH, 1989, BIOMATERIALS, V10, P579, DOI 10.1016/0142-9612(89)90110-5
   MCMILLAN PJ, 1989, CALCIFIED TISSUE INT, V44, P399, DOI 10.1007/BF02555968
   MELLONIG JT, 1981, J PERIODONTOL, V52, P297, DOI 10.1902/jop.1981.52.6.297
   MULLERMAI CM, 1990, SCANNING MICROSCOPY, V4, P613
   NAKAMURA H, 1992, BONE, V13, P411, DOI 10.1016/8756-3282(92)90083-9
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   OWEN M, 1968, NATURE, V220, P1335, DOI 10.1038/2201335a0
   Owen M., 1985, BONE MINERAL RES ANN, V1, P1
   OWENS JL, 1986, CALCIFIED TISSUE INT, V38, P170, DOI 10.1007/BF02556877
   Parfitt A. M., 1988, BONE MINERAL MEASURE, P9
   REDDI AH, 1985, BONE MINERAL RES, V3, P27
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, V197, P272
   ROBERTS WE, 1987, J PERIODONTAL RES, V22, P461, DOI 10.1111/j.1600-0765.1987.tb02056.x
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   UCHIDA A, 1985, J ORTHOPAED RES, V3, P65, DOI 10.1002/jor.1100030108
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   VIGNERY A, 1991, AM J PHYSIOL, V260, pF704
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   VILLANUEVA JE, 1990, J BONE MINER RES, V7, P733
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   YAMAMOTO T, 1992, J BONE MINER RES, V7, P1267
NR 48
TC 12
Z9 12
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1993
VL 3
IS 4
BP 395
EP 405
PG 11
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA NA053
UT WOS:A1993NA05300007
DA 2018-10-19
ER

PT J
AU WU, SG
   ELLERBY, LM
   COHAN, JS
   DUNN, B
   ELSAYED, MA
   VALENTINE, JS
   ZINK, JI
AF WU, SG
   ELLERBY, LM
   COHAN, JS
   DUNN, B
   ELSAYED, MA
   VALENTINE, JS
   ZINK, JI
TI BACTERIORHODOPSIN ENCAPSULATED IN TRANSPARENT SOL-GEL GLASS - A NEW
   BIOMATERIAL
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID PHOTOCYCLE; DEPROTONATION; MEMBRANE; MODEL
AB The Photosynthetic membrane protein of bacteriorhodopsin (bR) was encapsulated in an optically transparent and porous silica matrix using a modified sol-gel procedure. The absorption spectra and the kinetics of the photocycle characteristic of the proton pumping function of bR were studied systematically throughout the different stages of the glass formation process. This new biomaterial was characterized by means of its optical absorption, circular dichroism (CD), and Raman spectra; its photocycle kinetics; the characteristic activation parameters of its photocycle; and its deionization and cation regeneration properties. The global trimeric bR structure, the local structure of the retinal chromophore, and the proton pumping function of bR were not affected by the encapsulation process. It was also found that the bR glass formed allowed transport of small ions such as Ca2+ in to and out of the glass medium, and those ions were found to affect the properties of the protein just as they do in aqueous suspensions. The bR protein was found to bleach if delipidated prior to encapsulation. These observations as well as analysis of the CD spectrum suggest that the bR is encapsulated along with its membrane lipids. These results taken together suggest that this optically transparent system offers a potentially useful new bR-containing material for optical imaging and optically based ion-sensoring devices as developed and proposed for other bR-based systems.
C1 UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA.
RI Valentine, Joan/B-6665-2008
OI Valentine, Joan/0000-0002-7174-925X
CR BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343
   BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X
   BRAUCHLE C, 1991, ADV MATER, V3, P420, DOI 10.1002/adma.19910030903
   BRAUN S, 1990, MATER LETT, V10, P1, DOI 10.1016/0167-577X(90)90002-4
   CHANG CH, 1985, P NATL ACAD SCI USA, V82, P396, DOI 10.1073/pnas.82.2.396
   DUPUIS P, 1985, P NATL ACAD SCI USA, V82, P3662, DOI 10.1073/pnas.82.11.3662
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   ELSAYED MA, 1989, P NATL ACAD SCI USA, V86, P5376, DOI 10.1073/pnas.86.14.5376
   FISCHER U, 1979, BIOPHYS J, V28, P211, DOI 10.1016/S0006-3495(79)85172-3
   HAMPP N, 1990, BIOPHYS J, V58, P83, DOI 10.1016/S0006-3495(90)82355-9
   HAMPP N, 1989, SPIE, V1125, P2
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HUANG JY, 1989, J PHYS CHEM-US, V93, P3314, DOI 10.1021/j100345a086
   KHORANA HG, 1988, J BIOL CHEM, V263, P7439
   KORENSTEIN R, 1977, NATURE, V270, P184, DOI 10.1038/270184a0
   LIN GC, 1991, J PHYS CHEM-US, V95, P10442, DOI 10.1021/j100178a035
   MIYASAKA T, 1992, SCIENCE, V255, P342, DOI 10.1126/science.255.5042.342
   OESTERHELT D, 1991, Q REV BIOPHYS, V24, P425, DOI 10.1017/S0033583500003863
   SMITH SO, 1985, J MEMBRANE BIOL, V85, P95, DOI 10.1007/BF01871263
   STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587
   VANDENBERG R, 1990, BIOPHYS J, V58, P135, DOI 10.1016/S0006-3495(90)82359-6
   WU SG, 1992, BIOPHYS J, V61, P1281, DOI 10.1016/S0006-3495(92)81936-7
   WU SG, 1991, BIOPHYS J, V60, P190, DOI 10.1016/S0006-3495(91)82042-2
   YAMANAKA SA, 1992, CHEM MATER, V4, P495, DOI 10.1021/cm00021a001
NR 24
TC 139
Z9 142
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD JAN
PY 1993
VL 5
IS 1
BP 115
EP 120
DI 10.1021/cm00025a022
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA KH609
UT WOS:A1993KH60900022
DA 2018-10-19
ER

PT J
AU STOL, M
   SMETANA, K
   KORBELAR, P
   ADAM, M
AF STOL, M
   SMETANA, K
   KORBELAR, P
   ADAM, M
TI POLY(HEMA) COLLAGEN COMPOSITE AS A BIOMATERIAL FOR HARD-TISSUE
   REPLACEMENT
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT CONF ON BIOMEDICAL POLYMERS
CY JUN 10-12, 1991
CL JERUSALEM, ISRAEL
SP UNESCO
ID HYDROXYETHYLMETHACRYLATE HYDROGELS; CELL; COPOLYMERS; GROWTH
RI Smetana, Karel/D-7039-2017
OI Smetana, Karel/0000-0002-7878-8403
CR BARVIC M., 1967, J BIOMED MAT RES, V1, P313, DOI 10.1002/jbm.820010303
   BILY B, 1977, ACTA FM U BRUNENSIS, V55, P53
   Chvapil M, 1969, J Biomed Mater Res, V3, P315, DOI 10.1002/jbm.820030211
   CIFKOVA I, 1987, BIOMATERIALS, V8, P30, DOI 10.1016/0142-9612(87)90024-X
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   FLEISHMAJER R, 1985, BIOL CHEM PATHOLOGY
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   KLIMENT K, 1971, Patent No. 3563925
   KOPECEK J, 1968, J POLYM SCI POL SYM, P3877
   KORBELAR P, 1988, J BIOMED MATER RES, V22, P751, DOI 10.1002/jbm.820220902
   KUHN K, 1986, CONNECTIVE TISSUE BI, P29
   KVASNICKA J, 1988, Zahn- Mund- und Kieferheilkunde, V76, P151
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   Ramachandran G. N., 1976, BIOCH COLLAGEN
   SMETANA K, 1992, BIOMATERIALS, V13, P639, DOI 10.1016/0142-9612(92)90033-K
   SPRINCL L, 1971, J BIOMED MATER RES, V4, P447
   STOL M, 1985, BIOMATERIALS, V6, P193, DOI 10.1016/0142-9612(85)90009-2
   STOL M, 1986, POLYM MED, V2, P139
   TOSELLI P, 1983, J ULTRA MOL STRUCT R, V83, P220, DOI 10.1016/S0022-5320(83)90079-5
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   1986, Patent No. 334886
NR 25
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCI PUBL LTD
PI OXFORD
PA OXFORD
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1993
VL 13
IS 1-4
BP 19
EP 20
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LQ932
UT WOS:A1993LQ93200004
PM 10146239
DA 2018-10-19
ER

PT J
AU HLADY, V
   ANDRADE, JD
   HO, CH
   FENG, L
   TINGEY, K
AF HLADY, V
   ANDRADE, JD
   HO, CH
   FENG, L
   TINGEY, K
TI PLASMA-PROTEIN ADSORPTION ON MODEL BIOMATERIAL SURFACES
SO CLINICAL MATERIALS
LA English
DT Proceedings Paper
CT CONF ON BIOMEDICAL POLYMERS
CY JUN 10-12, 1991
CL JERUSALEM, ISRAEL
SP UNESCO
ID COMPETITIVE ADSORPTION; SOLID-SURFACES; FIBRINOGEN; ELECTROPHORESIS;
   HYDROXYAPATITE; GRADIENT; ALBUMIN
CR ANDERSON L, 1977, P NATL ACAD SCI USA, V74, P5421, DOI 10.1073/pnas.74.12.5421
   ANDERSON NL, 1984, PLASMA PROTEINS, V4, P221
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   BETT JAS, 1967, J AM CHEM SOC, V89, P5535, DOI 10.1021/ja00998a003
   BOCKOR JC, 1972, CHEM PHYS CARBON, V9, P103
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   CHEN JH, 1990, J COLLOID INTERF SCI, V135, P496, DOI 10.1016/0021-9797(90)90020-O
   De Groot K, 1981, BIOCOMPATIBILITY CLI, V1, P199
   FABRIZIUSHOMAN DJ, 1991, J BIOMED MATER RES, V25, P953, DOI 10.1002/jbm.820250804
   FENG L, IN PRESS J BIOMED MA
   GOLANDER CG, 1990, COLLOID SURFACE, V49, P289, DOI 10.1016/0166-6622(90)80111-G
   GOODMAN SL, 1988, SURFACE CHARACTERIZA
   HAUBOLD A, 1977, ANN NY ACAD SCI, V283, P383, DOI 10.1111/j.1749-6632.1977.tb41783.x
   HAUBOLD AD, 1981, CLIN IMPLANT MATERIA, V2, P4
   HLADY V, 1979, J COLLOID INTERF SCI, V69, P460, DOI 10.1016/0021-9797(79)90135-8
   HLADY V, 1991, APPL SPECTROSC, V45, P246, DOI 10.1366/0003702914337533
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   HO CH, 1990, THESIS U UTAH US
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   HORBETT TA, 1986, J COLLOID INTERFACE, V111
   HORBETT TA, 1987, ACS S SER
   LAMBERT JM, 1989, POLYM PREP-ACS, V30, P583
   LEA AS, 1992, LANGMUIR, V8, P68, DOI 10.1021/la00037a015
   Lelah M. D., 1986, POLYURETHANES MED
   LEONARD EF, 1987, ANN NEW YORK ACAD SC, V516
   LIN JN, 1990, LANGMUIR, V6, P509, DOI 10.1021/la00092a036
   MAKINO K, 1989, J CHROMATOGR SCI, V27, P659, DOI 10.1093/chromsci/27.11.659
   ORANG F, 1991, 7TH ICSCS COMP, V3, P365
   PACCAGNELLA A, 1986, INT J ARTIF ORGANS, V9, P127
   SCOTT SM, 1990, J SURG RES, V29, P395
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   STROUP EW, 1991, AUG INT C STM INT, P238
   SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1982, ADV CHEM SER, V199, P264
   WEI AP, 1990, THESIS U UTAH US
   TABLE HUMAN BLOOD PL
NR 40
TC 9
Z9 9
U1 0
U2 2
PU ELSEVIER SCI PUBL LTD
PI OXFORD
PA OXFORD
SN 0267-6605
J9 CLIN MATER
JI Clin. Mat.
PY 1993
VL 13
IS 1-4
BP 85
EP 93
DI 10.1016/0267-6605(93)90094-N
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LQ932
UT WOS:A1993LQ93200014
DA 2018-10-19
ER

PT J
AU THOMPSON, KP
   HANNA, KD
   GIPSON, IK
   GRAVAGNA, P
   WARING, GO
   JOHNSONWINT, B
AF THOMPSON, KP
   HANNA, KD
   GIPSON, IK
   GRAVAGNA, P
   WARING, GO
   JOHNSONWINT, B
TI SYNTHETIC EPIKERATOPLASTY IN RHESUS-MONKEYS WITH HUMAN TYPE-IV COLLAGEN
SO CORNEA
LA English
DT Article
DE SYNTHETIC EPIKERATOPLASTY; REFRACTIVE SURGERY; COLLAGEN; BIOMATERIALS
AB Human type IV collagen discs were found to support proliferation and adhesion of rabbit corneal epithelial cells in tissue culture. To assess the biocompatibility of this synthetic collagen for epikeratoplasty, seven eyes of seven rhesus monkeys underwent epikeratoplasty with lenticules made of human type IV collagen. Eye rubbing by the animals expulsed two of the lenticules and caused failure of two to epithelialize completely. The remaining three lenticules epithelialized, remained clear, and caused no adverse effects on the eye. Two of these lenticules developed focal areas of subepithelial thinning 3 months postoperatively and the third lenticule has remained stable for 30 months. The presence of epithelial attachment components at the epithelial-lenticule interface was demonstrated by immunolocalization. Histopathologic and ultrastructural examination revealed focal areas of epithelial invasion and degradation of the lenticule. Neutral proteases were detected in the thinning region of one specimen. Human type IV collagen supports epithelialization in vivo and may have potential as a biomaterial for epikeratoplasty, but the stability of the material must be improved.
RP THOMPSON, KP (reprint author), EMORY UNIV,YERKES REG PRIMATE RES CTR,954 GATEWOOD RD NE,ATLANTA,GA 30329, USA.
FU NEI NIH HHS [EY007388-02, P30 EY06360]; NCRR NIH HHS [RR-00165]
NR 0
TC 23
Z9 23
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0277-3740
J9 CORNEA
JI Cornea
PD JAN
PY 1993
VL 12
IS 1
BP 35
EP 45
DI 10.1097/00003226-199301000-00007
PG 11
WC Ophthalmology
SC Ophthalmology
GA KE951
UT WOS:A1993KE95100007
PM 8458230
DA 2018-10-19
ER

PT J
AU SHEU, MS
   HOFFMAN, AS
   RATNER, BD
   FEIJEN, J
   HARRIS, JM
AF SHEU, MS
   HOFFMAN, AS
   RATNER, BD
   FEIJEN, J
   HARRIS, JM
TI IMMOBILIZATION OF POLYETHYLENE OXIDE SURFACTANTS FOR NON-FOULING
   BIOMATERIAL SURFACES USING AN ARGON GLOW-DISCHARGE TREATMENT
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE SURFACE MODIFICATION; GLOW DISCHARGE TREATMENT; NON-FOULING SURFACES;
   WETTABLE POLYMER SURFACES; POLY(ETHYLENE OXIDE) SURFACTANTS
ID POLY(ETHYLENE OXIDE); POLYMERS; PLASMA; POLYMERIZATION; ADSORPTION;
   FIBRINOGEN; COPOLYMERS; INVITRO; EXVIVO
AB A non-fouling (protein-resistant) polymer surface is achieved by the covalent immobilization of polyethylene oxide (PEO) surfactants using an inert gas discharge treatment. Treated surfaces have been characterized using electron spectroscopy for chemical analysis (ESCA), static secondary ion mass spectrometry (SSIMS), water contact angle measurement, fibrinogen adsorption, and platelet adhesion. This paper is intended to review our recent work in using this simple surface modification process to obtain wettable polymer surfaces in general, and non-fouling biomaterial surfaces in particular.
C1 UNIV WASHINGTON,CTR BIOENGN,SEATTLE,WA 98195.
   UNIV TWENTE,DEPT CHEM ENGN,7500 AE ENSCHEDE,NETHERLANDS.
   UNIV ALABAMA,DEPT CHEM,HUNTSVILLE,AL 35899.
CR ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   BRIDGETT MJ, 1989, BIOMATERIALS, V10, P411
   BROSSE JC, 1983, EUR POLYM J, V19, P743, DOI 10.1016/0014-3057(83)90142-8
   DENNISON KA, 1986, THESIS MIT CAMBRIDGE
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   EPAILLARD F, 1990, J APPL POLYM SCI, V38, P887
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   GRAINGER DW, 1988, J BIOMED MATER RES, V22, P231, DOI 10.1002/jbm.820220307
   GREGONIS DE, 1984, 2ND T C BIOM WASH DC, P266
   HANSEN RH, 1966, J POLYM SCI POL LETT, V4, P203, DOI 10.1002/pol.1966.110040309
   HERMANS J, 1982, J CHEM PHYS, V77, P2193, DOI 10.1063/1.444026
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   KIAEI D, 1992, J BIOMED MATER RES, V26, P357, DOI 10.1002/jbm.820260307
   KIM SW, 1988, ANN NY ACAD SCI, V516, P116
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OMULLANE JE, 1988, BIOMATERIALS, V9, P203, DOI 10.1016/0142-9612(88)90124-X
   Randerson DH, 1983, PLASMAPHERESIS NEW T
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   Sharpe L.S., 1964, ADV CHEM SER, V43, P189
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   SHEU MS, IN PRESS CLIN MATER
   SHEU MT, UNPUB
   SIMIONESCU CI, 1984, MAKROMOL CHEM S, V8, P17
   SUN YH, 1986, J BIOACT COMPAT POLY, V1, P3146
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   TERLINGEN JGA, UNPUB J BIOMATER SCI
   WANG SG, 1989, J MACROMOL SCI CHEM, VA26, P505, DOI 10.1080/00222338908051990
NR 32
TC 54
Z9 55
U1 0
U2 8
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1993
VL 7
IS 10
BP 1065
EP 1076
DI 10.1163/156856193X00583
PG 12
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA MF059
UT WOS:A1993MF05900006
DA 2018-10-19
ER

PT J
AU FURUZONO, T
   YASHIMA, E
   KISHIDA, A
   MARUYAMA, I
   MATSUMOTO, T
   AKASHI, M
AF FURUZONO, T
   YASHIMA, E
   KISHIDA, A
   MARUYAMA, I
   MATSUMOTO, T
   AKASHI, M
TI A NOVEL BIOMATERIAL - POLY(DIMETHYLSILOXANE)-POLYAMIDE MULTIBLOCK
   COPOLYMER .1. SYNTHESIS AND EVALUATION OF BLOOD COMPATIBILITY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE POLY(DIMETHYLSILOXANE); ARAMID; MULTIBLOCK COPOLYMER; BLOOD
   COMPATIBILITY; ELECTRON PROBE MICROANALYSIS; X-RAY PHOTOELECTRON
   SPECTROSCOPY; DYNAMIC CONTACT ANGLE
ID MEMBRANES
AB Aramid-silicone resins (PASs) consisting of aromatic polyamide (aramid) and poly(dimethylsiloxane) (PDMS) segments were synthesized by low temperature solution polycondensation. For the evaluation of blood compatibility in vitro, two kinds of experiments were carried out. One was the thromboxane B2(TXB2) release test from platelets attaching to PAS and Biomer(R). The other was the observation of the platelet adhesion on the surfaces of PAS by scanning electron microscopy (SEM). The results indicated that PAS was bio-inert in vitro. The surface chemical composition of PAS films was investigated by means of electron probe micro analysis (EPMA), X-ray photoelectron spectroscopy (XPS), and dynamic contact angle measurements. The relationship between blood compatibility and surface composition of PAS is discussed.
C1 KAGOSHIMA UNIV,FAC ENGN,DEPT APPL CHEM & CHEM ENGN,1-21-40 KORIMOTO,KAGOSHIMA 890,JAPAN.
   NOF CORP LTD,TSUKUBA RES LAB,TSUKUBA 30026,JAPAN.
   KAGOSHIMA UNIV,FAC MED,DEPT CLIN LAB MED,KAGOSHIMA 890,JAPAN.
RI Yashima, Eiji/H-5380-2011
OI Yashima, Eiji/0000-0001-6307-198X
CR Andrade J. D., 1985, SURFACE INTERFACIAL, V1, P105
   Asakawa S., 1983, National Technical Report, V29, P93
   FRISCH EE, 1984, ACS SYM SER, V256, P63
   GOLDBERG EP, 1961, Patent No. 2999845
   HARTMAN LC, 1988, J BIOMED MATER RES, V22, P475, DOI 10.1002/jbm.820220604
   IMAI Y, 1990, POLYM APPL, V39, P438
   IMAI Y, 1990, POLYM PREPR-JAPAN, V39, P1850
   KAJIYAMA M, 1989, MACROMOLECULES, V22, P4143, DOI 10.1021/ma00201a001
   KISHIDA A, 1992, BIOMATERIALS, V13, P113, DOI 10.1016/0142-9612(92)90006-A
   KOGA K, 1991, HYOMEN, V30, P288
   KOINUMA Y, 1992, POLYM PREP JAPAN, V41, P489
   Kurimoto F, 1990, Nihon Rinsho, V48 Suppl, P167
   LAURIN D, 1976, Patent No. 3994988
   LEGRAND DG, 1969, J POLYM SCI POL LETT, V7, P597
   LEGRAND DG, 1970, J ENG SCI, V10, P349
   Lynch W, 1978, HDB SILICONE RUBBER
   NYILAS E, 1971, Patent No. 3562352
   POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6
   RUDOLPH R, 1978, PLAST RECONSTR SURG, V62, P185, DOI 10.1097/00006534-197808000-00006
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1988, HYOMEN, V26, P233
   TAKAHARA A, 1989, J BIOMAT SCI-POLYM E, V1, P29
   WARD WJ, 1976, J MEMBRANE SCI, V1, P99, DOI 10.1016/S0376-7388(00)82259-0
   1974, Patent No. 3821325
NR 24
TC 25
Z9 25
U1 3
U2 12
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 1-2
BP 89
EP 98
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MG099
UT WOS:A1993MG09900007
PM 8297834
DA 2018-10-19
ER

PT J
AU STEELE, JG
   MCFARLAND, C
   DALTON, BA
   JOHNSON, G
   EVANS, MDM
   HOWLETT, CR
   UNDERWOOD, PA
AF STEELE, JG
   MCFARLAND, C
   DALTON, BA
   JOHNSON, G
   EVANS, MDM
   HOWLETT, CR
   UNDERWOOD, PA
TI ATTACHMENT OF HUMAN BONE-CELLS TO TISSUE-CULTURE POLYSTYRENE AND TO
   UNMODIFIED POLYSTYRENE - THE EFFECT OF SURFACE-CHEMISTRY UPON INITIAL
   CELL ATTACHMENT
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BONE-DERIVED CELLS; CELL ATTACHMENT; SERUM VITRONECTIN; FIBRONECTIN;
   TISSUE CULTURE POLYSTYRENE; UNMODIFIED POLYSTYRENE; HUMAN OSTEOBLASTS;
   BIOMATERIALS
ID HUMAN-ENDOTHELIAL-CELLS; VITRONECTIN RECEPTOR; ADHESION RECEPTORS;
   MONOCLONAL-ANTIBODIES; PROTEIN ADSORPTION; SERUM FIBRONECTIN; MATRIX
   PRODUCTION; POLYMER SURFACES; OSTEOBLASTS; GROWTH
AB Cell culture studies have often been used in the determination of the suitability of biomaterials as surfaces for the attachment and growth of cells. For such studies of surfaces for potential use in bone implants, cells derived from bone may be maintained in culture on tissue culture polystyrene (TCPS). We have determined the contribution that serum fibronectin (FN) or vitronectin (VN) make to the attachment and spreading of cells cultured from explanted human bone (bone-derived cells) during the first 90 min following seeding on culture surfaces.
   The attachment of bone-derived cells to TCPS was simulated two-fold by the addition of 10% (v/v) fetal bovine serum (FBS) to the seeding culture medium. The roles of FN and VN were determined by selective removal of the FN or VN from the FBS prior to addition to the culture medium. FBS from which the VN had been removed did not have this stimulatory activity. In contrast, the attachment of bone-derived cells onto TCPS from medium containing FN-depleted serum (which contained VN) was the same as when intact FBS was used. There was incomplete attachment of bone-derived cells (27% of cells) when seeded in medium containing FBS depleted of both VN and FN. Our results show that for human bone-derived cells, the attachment onto TCPS of cells planted in medium containing FBS during the first 90 min of culture is principally as a result of adsorption onto the surface of serum VN.
   As unmodified polystyrene (PS) has also been used previously as a model biomaterial surface, PS was compared to TCPS for attachment of the bone-derived cells. Attachment of bone-derived cells to TCPS was twice that onto PS, both when the medium was serum-free and when it contained FBS. Bone-derived cells attached to TCPS or PS onto which purified VN or FN had been precoated, with VN adsorbed onto PS being as effective as was VN adsorbed onto TCPS. With FN, there was an effect of the polystyrene surface chemistry which was evident in that suboptimal concentrations of FN had a slightly higher potency when adsorbed onto TCPS than did the same concentrations of FN coated onto PS. When preadsorbed onto TCPS, the potency of FN for attachment of bone-derived cells was at least equal to that of VN.
C1 UNIV NEW S WALES,SCH PATHOL,KENSINGTON,NSW 2033,AUSTRALIA.
RP STEELE, JG (reprint author), CSIRO,DIV BIOMOLEC ENGN,SYDNEY LABS,POB 184,N RYDE,NSW 2113,AUSTRALIA.
RI Evans, Margaret/B-3261-2011
OI Evans, Margaret/0000-0003-3078-1576
CR ANDERSON RC, 1983, CLIN ORTHOP RELAT R, V182, P242
   ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   Brash JL, 1987, ACS S SERIES, V343
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, 1991, BONE-BIOMATERIAL INTERFACE, P285
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DAVIES JE, 1990, CRC HDB BIOACTIVE CE, V1, P195
   DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215
   DIDISHEIM P, 1984, T AM SOC ART INT ORG, V30, P370
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORTON M, 1990, INT J EXP PATHOL, V71, P741
   HORTON MA, 1989, J BONE MINER RES, V4, P803
   IGNOTZ RA, 1989, J BIOL CHEM, V264, P389
   JANECZKO RA, 1992, 4TH WORLD BIOM C
   KABAT D, 1985, J CELL BIOL, V101, P2274, DOI 10.1083/jcb.101.6.2274
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MAGLOIRE H, 1991, BONE-BIOMATERIAL INTERFACE, P229
   MOSKALEWSKI S, 1983, AM J ANAT, V167, P249, DOI 10.1002/aja.1001670210
   NORRIS WD, 1990, J CELL SCI, V95, P255
   OLIVER MH, 1989, J CELL SCI, V92, P513
   PEEL SAF, 1992, MATER RES SOC SYMP P, V252, P71
   PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   PUELO DA, 1991, BONE, V12, P271
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   RAMSEY WS, 1984, IN VITRO CELL DEV B, V20, P802
   REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269
   SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STAHLI C, 1983, METHOD ENZYMOL, V92, P242
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   SUSUKI T, 1991, J FERMENT BIOENG, V72, P450
   TARRANT SF, 1986, 6TH EUR C BIOM ELS
   UNDERWOOD PA, 1991, J IMMUNOL METHODS, V142, P83, DOI 10.1016/0022-1759(91)90295-Q
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   UNDERWOOD PA, 1992, J CELL SCI, V102, P833
   VANDERSTEENHOVEN JJ, 1983, J BIOMED MATER RES, V17, P793, DOI 10.1002/jbm.820170507
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
NR 53
TC 116
Z9 116
U1 2
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 3
BP 245
EP 257
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MR116
UT WOS:A1993MR11600006
PM 7512377
DA 2018-10-19
ER

PT J
AU RATNER, BD
   HORBETT, TA
AF RATNER, BD
   HORBETT, TA
TI HOFFMAN,ALLAN,S. - OVERVIEW AND APPRECIATION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
ID RADIATION-GRAFTED HYDROGELS; THERMALLY REVERSIBLE HYDROGELS; BIOMATERIAL
   APPLICATIONS; POLY(ETHYLENE OXIDE); SURFACES; POLYMERS; IMMOBILIZATION;
   SEPARATION; COPOLYMER; INVIVO
C1 UNIV WASHINGTON, DEPT CHEM ENGN, SEATTLE, WA 98195 USA.
RP RATNER, BD (reprint author), UNIV WASHINGTON, CTR BIOENGN, BF-10, SEATTLE, WA 98195 USA.
CR ANTONSEN KP, IN PRESS BIOMAT ART
   AUDITOREHARGREAVES K, 1987, CLIN CHEM, V33, P1509
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   BOHNERT J L, 1990, Journal of Biomaterials Science Polymer Edition, V1, P279
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   COLE CA, 1987, ACS SYM SER, V350, P245
   DONG LC, 1987, ACS SYM SER, V350, P236
   DONG LC, 1986, RADIAT PHYS CHEM, V28, P177
   DONG LC, 1989, P INT S CONTR REL BI, V16, P95
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   GOMBOTZ W, 1985, RADIAT PHYS CHEM, V25, P549, DOI 10.1016/0146-5724(85)90134-7
   GOMBOTZ W R, 1985, Journal of Controlled Release, V2, P375, DOI 10.1016/0168-3659(85)90059-8
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GOMBOTZ WR, 1987, ACS POLYM MATER SCI, V56, P720
   GOMBOTZ WR, 1988, J APPL POLYM SCI, V35, P1
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   HANSON SR, 1979, ANN BIOMED ENG, V7, P357, DOI 10.1007/BF02364122
   HARKER LA, 1977, ANN NY ACAD SCI, V283, P317, DOI 10.1111/j.1749-6632.1977.tb41778.x
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   Hoffman A S, 1973, Biomater Med Devices Artif Organs, V1, P453, DOI 10.3109/10731197309118556
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOFFMAN AS, 1988, ARTIF ORGANS, V12, P504, DOI 10.1111/j.1525-1594.1988.tb02813.x
   HOFFMAN AS, 1984, PURE APPL CHEM, V56, P1329, DOI 10.1351/pac198456101329
   HOFFMAN AS, 1991, POLYMER GELS, P289
   HOFFMAN AS, 1977, BIOMATER ARTIF CELL, V5, P121
   HOFFMAN AS, 1969, J APPL POLYM SCI, V13, P2223, DOI 10.1002/app.1969.070131016
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1970, J APPL POLYM SCI, V14, P285, DOI 10.1002/app.1970.070140203
   HOFFMAN AS, 1980, BIORHEOLOGY, V17, P45
   HOFFMAN AS, 1959, J POLYM SCI, V34, P461, DOI 10.1002/pol.1959.1203412734
   HOFFMAN AS, 1986, CHEMTECH, V16, P426
   HOFFMAN AS, 1982, ACS ADV CHEM SERIES, V199, P59
   HOFFMAN AS, 1974, ACS COATINGS PLASTIC, V34, P568
   HOFFMAN AS, 1991, POLYM MED, V3, P161
   HOFFMAN AS, 1972, POLYM PREPR, V13, P740
   HOFFMAN AS, 1973, CURRENT TOPICS COAGU, P201
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HOFFMAN AS, 1975, PERMEABILITY PLASTIC
   HOFFMAN AS, 1975, POLYM MED SURG, P33
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   HORBETT TA, 1975, ADV CHEM SER, P230
   JADWIN TA, 1970, J APPL POLYM SCI, V14, P1339, DOI 10.1002/app.1970.070140519
   KIAEI D, 1988, J APPL POLYM SCI APP, V42, P269
   KO YC, 1981, J COLLOID INTERF SCI, V82, P25, DOI 10.1016/0021-9797(81)90120-X
   KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0
   MATE TP, 1974, ENZYME ENG, V2, P137
   MEYERS AW, 1960, J APPL POLYM SCI, V4, P159
   MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429
   MUKHERJEE DP, 1974, BIOPOLYMERS, V13, P2447, DOI 10.1002/bip.1974.360131205
   MUKHERJEE DP, 1971, PHYSICAL PROPERTIE 1, P219
   PARK JB, 1978, ANN BIOMED ENG, V6, P167, DOI 10.1007/BF02584543
   PARK JB, 1976, FRONT MATRIX BIOL, V3, P218
   PARK TG, 1990, J BIOMED MATER RES, V24, P21, DOI 10.1002/jbm.820240104
   PARK TG, 1989, BIOTECHNOL LETT, V11, P17, DOI 10.1007/BF01026779
   PARKER L, 1988, LEARN MOTIV, V19, P1, DOI 10.1016/0023-9690(88)90022-7
   PETTIT DK, 1990, INVEST OPHTH VIS SCI, V31, P2269
   RAMAN SV, 1977, J MOL CATAL, V2, P275
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   RATNER BD, 1978, J BIOENG, V2, P313
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1975, BIOMATER ARTIF CELL, V3, P115, DOI 10.3109/10731197509118616
   RATNER BD, 1976, ACS SYM SER, P1
   RATNER BD, 1979, J POLYM SCI POL SYM, P363
   RATNER BD, 1973, A C S ORG COAT PLAST, V33, P386
   REYNOLDS LO, 1982, T SOC BIOMATER, V5, P37
   ROSSIN AD, 1955, NUCLEONICS, V13, P10
   SASAKI T, 1976, ACS SYM SER, P283
   SHEU MS, UNPUB J CLIN MAT
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   VENKATARAMAN S, 1977, J BIOMED MATER RES, V11, P111, DOI 10.1002/jbm.820110111
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   YANG HJ, 1990, J POLYM SCI POL CHEM, V28, P219, DOI 10.1002/pola.1990.080280116
   YANG HJ, 1989, PREPRINTS IUPAC INT
NR 76
TC 1
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 3
BP 155
EP 164
DI 10.1163/156856293X00492
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA KV023
UT WOS:A1993KV02300002
PM 8476788
DA 2018-10-19
ER

PT J
AU GREISLER, HP
   HENDERSON, SC
   LAM, TM
AF GREISLER, HP
   HENDERSON, SC
   LAM, TM
TI BASIC FIBROBLAST GROWTH-FACTOR PRODUCTION IN-VITRO BY MACROPHAGES
   EXPOSED TO DACRON AND POLYGLACTIN-910
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE MACROPHAGE; DACRON; POLYGLACTIN; VASCULAR GRAFTS; BASIC FIBROBLAST
   GROWTH FACTOR; SMOOTH MUSCLE CELLS
ID SMOOTH-MUSCLE CELLS
AB Macrophage activation by implanted bood-contacting biomaterials modulates smooth muscle cell and endothelial cell ingrowth. The present study evaluates the in vitro interactions between Dacron or polyglactin 910 with macrophages derived from rabbits fed either normal or atherogenic diets. Peritoneal macrophages were cultured in the presence or absence (negative controls) of either biomaterial for 7 weeks. Conditioned media was evaluated for mitogenic activity using a rabbit aortic smooth muscle cell bioassay with or without preincubation with neutralizing anti-basic-FGF antibody. Results demonstrated increased mitogen release from macrophages harvested from the atherosclerotic rabbits. Only macrophages harvested from normal diet fed rabbits increased their mitogen release following exposure to either polyglactin 910 (p < 0.05) or to Dacron (p < 0.005) over controls. The stimulation of mitogen release by polyglactin 910 did not significantly exceed that in response to Dacron. In rabbits fed normal diets neutralization with the anti-basic-FGF antibody inhibited 100% of the Dacron induced mitogen release as compared to 36% of the polyglactin 910 induced mitogen release (p < 0.01). These results demonstrate significant induced mitogen release from macrophages exposed to biomaterials in vitro, much of the smooth muscle cell mitogen represented by basic-FGF.
C1 HINES VA HOSP,HINES,IL.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   GONZALEZ AM, 1990, J CELL BIOL, V109, P203
   GOSPODAROWICZ D, 1991, FIBROBLAST GROWTH FA, V638, P1
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1991, J VASC SURG, V14, P10
   LAM TM, 1992, ANGIOGENESIS KEY PRI, P346
   LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217
   LINDNER V, 1991, CIRC RES, V68, P106, DOI 10.1161/01.RES.68.1.106
   LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739
   PETSIKAS D, 1991, Surgical Forum (Chicago), V42, P326
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 13
TC 13
Z9 13
U1 0
U2 0
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 5
BP 415
EP 430
DI 10.1163/156856293X00672
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA LU040
UT WOS:A1993LU04000002
PM 8241060
DA 2018-10-19
ER

PT J
AU DAHIYAT, BI
   HOSTIN, E
   POSADAS, EM
   LEONG, KW
AF DAHIYAT, BI
   HOSTIN, E
   POSADAS, EM
   LEONG, KW
TI SYNTHESIS AND CHARACTERIZATION OF PUTRESCINE-BASED
   POLY(PHOSPHOESTER-URETHANES)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE DEGRADABLE POLYMERS; POLY(PHOSPHOESTERS); POLYURETHANES; DRUG DELIVERY
AB A novel set of putrescine-based segmented polyurethanes was synthesized using 1,4-butane-diisocyante and phosphoester diols, and was characterized for its potential as a degradable biomaterial. These poly(phosphoester-urethanes) (PPU) were flexible polymers with ultimate tensile strength (UTS) from 2 to 3 MPa, elongations up to 80% and tan delta near 0. 15. The incorporation of phosphoester bonds in the backbone of the polymer by using bis(2-hydroxyethyl)phosphite (BGP) and bis(6-hydroxyhexyl)-phosphite (BHP) as chain extenders resulted in hydrolytic degradation which was evaluated in vitro. By varying the content of the phosphoester diol BGP, degradation rate, as followed by mass loss and GPC, could be modulated. Polymers based on the more hydrophobic monomer, BHP, showed slower degradation than corresponding BGP based polymers. Tensile properties of PPU-B2 after 22 days in vitro degradation show more than a 50% drop in UTS and ultimate elongation, likely caused by void spaces left behind in the polymer after mass loss and swelling. The attachment of a drug, PAS, pendant to the phosphoester group of the PPU was demonstrated. PAS was linked via the spacer 4-hydroxybenzaldehyde, and free, intact drug was released in about 5 h from a thin film.
C1 JOHNS HOPKINS UNIV,DEPT BIOMED ENGN,CHARLES & 34TH STS,BALTIMORE,MD 21218.
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
CR BORISOV G, 1973, EUR POLYM J, V9, P1077, DOI 10.1016/0014-3057(73)90085-2
   DAHIYAT BI, 1992, P ACS DIV PMSE, V67, P87
   DAHIYAT BI, 1992, POLYM MAT SCI ENG, V66, P87
   ECKERT P, 1944, CHEM ABS, P1564
   GUISE GB, 1980, J APPL POLYM SCI, V25, P149, DOI 10.1002/app.1980.070250203
   Lelah M. D., 1986, POLYURETHANES MED
   PRETULA J, 1986, MACROMOLECULES, V19, P1797, DOI 10.1021/ma00161a003
   RICHARDS M, 1991, J BIOMED MATER RES, V25, P1151, DOI 10.1002/jbm.820250908
   Sander M., 1967, J MACROMOL SCI REV C, VC1, P91
   SZYCHER M, 1991, HIGH PERFORMANCE BIO, pCH3
   VOGT W, 1973, MAKROMOL CHEM, V163, P111
NR 11
TC 26
Z9 26
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 5
BP 529
EP 543
DI 10.1163/156856293X00186
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA LU040
UT WOS:A1993LU04000011
PM 8241068
DA 2018-10-19
ER

PT J
AU VANKOOTEN, TG
   SCHAKENRAAD, JM
   VANDERMEI, HC
   BUSSCHER, HJ
AF VANKOOTEN, TG
   SCHAKENRAAD, JM
   VANDERMEI, HC
   BUSSCHER, HJ
TI INFLUENCE OF PULSATILE FLOW ON THE BEHAVIOR OF HUMAN FIBROBLASTS ADHERED
   TO GLASS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE CELLULAR ADHESION; CELLULAR SPREADING; CELLULAR DETACHMENT; HUMAN
   FIBROBLASTS; PULSATIONS; PULSATILE FLOW; PARALLEL PLATE FLOW CHAMBER
ID SHEAR-STRESS; ENDOTHELIAL-CELLS; ADHESION; SURFACES
AB In the human body, cells contacting biomaterials surfaces are frequently exposed to pulsatile shear stresses, e.g. blood vessel prostheses. Most studies involving shear, however, try to achieve a steady, pulse-free shear stress in studying cell-biomaterial interactions. In this study, human fibroblasts adhering to glass were exposed to an applied 0.5 Hz square-wave pulsatile shear, created in a parallel plate flow chamber by a computer-driven pump. Cells were also exposed to the single lower and higher shear stresses making up the square wave in the presence or absence of pressure variations due to the peristaltic roller pump. Results indicate that cells exposed to the applied square-wave regime showed a detachment rate in between that of the single shear stresses making up the square wave. Furthermore, the presence of the pulsations gave rise to elongated cell shapes in the direction of flow and the formation of a more extensive filopodial network than in the absence of pulsations. This was also true for cells exposed to the high shear component in the presence of pressure variations. Cells exposed to the high shear component without any pressure variations, however, adapted spherical shapes after the onset of flow.
C1 UNIV GRONINGEN,MAT TECHN LAB,ANTONIUS DEUSINGLAAN 1,9713 AV GRONINGEN,NETHERLANDS.
   UNIV GRONINGEN,CTR BIOMED TECHNOL,9713 EZ GRONINGEN,NETHERLANDS.
CR DAVIES PF, 1991, J VASC SURG, V13, P729
   DEWEY CF, 1979, ADV EXPT MED BIOL, V115, P61
   HERMAN IM, 1987, J CELL BIOL, V105, P291, DOI 10.1083/jcb.105.1.291
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   KIM DW, 1989, ARTERIOSCLEROSIS, V9, P439, DOI 10.1161/01.ATV.9.4.439
   LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   MIYATA T, 1991, J SURG RES, V50, P485, DOI 10.1016/0022-4804(91)90029-L
   NAKAJIMA T, 1990, AM J PHYSIOL, V259, pH1071
   NEREM RM, 1990, BLOOD FLOW LARGE ART, P117
   PADDOCK SW, 1989, J CELL SCI, V93, P142
   SCHAPERS A, 1990, TURBO PASCAL 5 5 CON, P223
   SUMPIO BE, 1991, J VASC SURG, V13, P744, DOI 10.1016/0741-5214(91)90372-2
   TRUSKEY GA, 1990, J BIOMED MATER RES, V24, P1333, DOI 10.1002/jbm.820241006
   VANDIJK LJ, 1991, J CLIN PERIODONTOL, V18, P196
   VANKOOTEN TG, 1992, J BIOMED MATER RES, V26, P725, DOI 10.1002/jbm.820260604
   VIGGERS RF, 1986, J BIOMECH ENG-T ASME, V108, P332, DOI 10.1115/1.3138624
NR 17
TC 6
Z9 6
U1 0
U2 1
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 6
BP 601
EP 614
DI 10.1163/156856293X00249
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MA277
UT WOS:A1993MA27700004
PM 8280674
DA 2018-10-19
ER

PT J
AU GUERRA, GD
   BARBANI, N
   LAZZERI, L
   LELLI, L
   PALLA, M
   RIZZO, C
AF GUERRA, GD
   BARBANI, N
   LAZZERI, L
   LELLI, L
   PALLA, M
   RIZZO, C
TI THE ACTIVATION OF HUMAN PLASMA PREKALLIKREIN AS A HEMOCOMPATIBILITY TEST
   FOR BIOMATERIALS .2. CONTACT ACTIVATION BY EVAL AND EVAL SMA COPOLYMERS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE KALLIKREIN; CONTACT ACTIVATION IN PLASMA; HEMOCOMPATIBILITY;
   BIOMATERIALS; EVAL SMA COPOLYMERS
ID MEMBRANES; DIALYSIS
AB The activation of human plasma prekallikrein (PKK) to kallikrein (KK), induced by the contact of blood with foreign materials, is a useful in vitro hemocompatibility test. Kallikrein is easily detected by its reaction with the chromogenic substrate H-D-Pro-Phe-Arg-pNA, which releases p-nitroaniline, revealed by its absorption at 405 nm. This test, which was already carried out by evaluating PKK activation by the 'end-point' method, has been carried out in this work by the more accurate 'initial velocity' method, i.e. by evaluating the activation from the initial rates of the KK-substrate reaction. The tests were carried out on the following materials: borosilicate glass (as a high-activation reference material), silicone (as a low-activation reference material), the commercial biomaterial Cardiothane 51, three graft copolymers synthesized in our laboratory by reacting ethylene-vinyl alcohol copolymer (EVAL) with styrene-maleic anhydride copolymer (SMA), and EVAL itself. A mathematical treatment based on a simple kinetic model has been used for a first-approximation evaluation of the PKK-activating power of the materials tested. The quite low activating power of the EVAL-SMA copolymers, which are easily processable into water-permeable hollow fibers, suggests the possibility of their use in blood dialyzers.
C1 UNIV PISA,DIPARTIMENTO INGN CHIM,I-56100 PISA,ITALY.
RP GUERRA, GD (reprint author), CNR,CTR STUDI PROC ION POLIMERIZZAZ,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR BASILE C, 1989, NEPHRON, V52, P113, DOI 10.1159/000185612
   BERRETTINI M, 1989, J BIOL CHEM, V264, P11738
   BOTS JGF, 1986, DEV HEMATOL IMMUNOL, V14, P277
   CHEN LW, 1990, MAKROMOL CHEM-M SYMP, V33, P183, DOI 10.1002/masy.19900330116
   CHRISTENSEN U, 1980, THROMB HAEMOSTASIS, V43, P169
   FELICIANGELI G, 1991, BIOMATERIALI, V5, P70
   FRIBERGER P, 1982, SCAND J CLIN LA S162, V42, P3
   GALLIMORE MJ, 1982, THROMB RES, V25, P293
   GIUSTI P, 1970, MAKROMOLEKUL CHEM, V136, P97
   GIUSTI P, 1988, PROGR BIOMED ENG, V5, P51
   LAMMLE B, 1985, CLIN HAEMATOL, V14, P281
   RHODES NP, 1992, 4TH WORLD BIOM C BER, P239
   SAKURADA Y, 1987, POLYM J, V19, P501, DOI 10.1295/polymj.19.501
   SCHIFANO S, 1989, PRODUZIONE FIBRE CAV
   SCOTT CF, 1981, BLOOD, V57, P553
NR 15
TC 10
Z9 10
U1 0
U2 0
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 4
IS 6
BP 643
EP 652
DI 10.1163/156856293X00852
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MA277
UT WOS:A1993MA27700007
PM 8280677
DA 2018-10-19
ER

PT J
AU TU, R
   LU, CL
   THYAGARAJAN, K
   WANG, E
   NGUYEN, H
   SHEN, S
   HATA, C
   QUIJANO, RC
AF TU, R
   LU, CL
   THYAGARAJAN, K
   WANG, E
   NGUYEN, H
   SHEN, S
   HATA, C
   QUIJANO, RC
TI KINETIC-STUDY OF COLLAGEN FIXATION WITH POLYEPOXY FIXATIVES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID GLUTARALDEHYDE
AB A new biomaterial has been developed by fixing native collagen with a polyepoxy compound (PC) fixative. In this study, bovine internal thoracic arteries were fixed with PC under various conditions to help understand the kinetics of the collagen-PC reactions and optimize the fixation process. At predetermined time intervals, small samples were cut from the arteries to determine the quantities of the remaining unreacted amino acids in the collagen. Temperature, concentration, and solution pH were among the key parameters studied. The overall fixation rate was found to be reaction-rate controlled, as the rate of fixation was relatively slow compared with the rate of diffusion of PC. As might be expected, the reaction rate was favored by a higher temperature, concentration, and solution pH. A kinetic model, with a 2.5th reaction order with respect to the reactive functional groups of collagen and a first order with respect to PC, was developed that gave a good fit to the experimental data. Based on this model, the degree of fixation, X, as a function of time, t, is given by (1 - X)-1.5 = 1 + Kt, where K is a constant related to the initial concentrations and the reaction rate constant.
RP TU, R (reprint author), BAXTER HEALTHCARE CORP,EDWARDS CVS DIV,IRVINE,CA, USA.
CR BOWES JH, 1968, BIOCHIM BIOPHYS ACTA, V168, P341, DOI 10.1016/0005-2795(68)90156-6
   CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   HATA C, 1991, 8 WORLD C ISAO MONTR
   Heidemann E., 1988, COLLAGEN, VIII, P39
   HOPWOOD D, 1972, HISTOCHEM J, V4, P267, DOI 10.1007/BF01005005
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   KORN AH, 1972, J MOL BIOL, V65, P525, DOI 10.1016/0022-2836(72)90206-9
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LEVENSPIEL O, 1972, CHEM REACTION ENG, P35
   LOHRE J, 1991, 8 WORLD C ISAO MONTR
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MONSAN P, 1975, BIOCHIMIE, V57, P1281
   MORRISON RT, 1986, ORGANIC CHEM, P548
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   PAYNE JW, 1973, BIOCHEM J, V135, P867, DOI 10.1042/bj1350867
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   SUNG H, 1991, 8 WORLD C ISAO MONTR
   TOMIZAWA Y, 1990, T AM SOC ART INT ORG, V36, P734
   TOMIZAWA Y, 1989, T AM SOC ART INT ORG, V35, P199
   TU R, 1991, 1991 ASAIO M CHIC
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   TU R, 1991, 1991 SOC BIOM M SCOT
   Yamauchi M., 1988, COLLAGEN, P157
NR 34
TC 51
Z9 51
U1 1
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 3
EP 9
DI 10.1002/jbm.820270103
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600002
PM 8420998
DA 2018-10-19
ER

PT J
AU KOIDE, M
   OSAKI, K
   KONISHI, J
   OYAMADA, K
   KATAKURA, T
   TAKAHASHI, A
   YOSHIZATO, K
AF KOIDE, M
   OSAKI, K
   KONISHI, J
   OYAMADA, K
   KATAKURA, T
   TAKAHASHI, A
   YOSHIZATO, K
TI A NEW TYPE OF BIOMATERIAL FOR ARTIFICIAL SKIN - DEHYDROTHERMALLY
   CROSS-LINKED COMPOSITES OF FIBRILLAR AND DENATURED COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID WOUND DRESSINGS; PORE STRUCTURE; FIBROBLASTS; GLUTARALDEHYDE;
   MORPHOLOGY; DESIGN; CELLS
AB A new type of biomaterial for artificial skin was developed as a form of sponge by combining fibrillar collagen (F-collagen) with gelatin. The sponge was physically and metabolically stabilized by introducing dehydrothermal cross links. To get the final product, various conditions in the preparation of sponges were evaluated by in vitro cellular responses and in vivo tissue reactions. Fibroblasts placed on a sponge of gelatin attached themselves to it, migrated well into the sponge, and remained inside it for at least 7 days. However, sponges of gelatin showed structural instability for hydrolytic degradation by the cells. Most fibroblasts appeared not to penetrate into the interior of a sponge of F-collagen but to remain on its surface when fibroblasts were placed on the sponge, suggesting poor attraction of F-collagen toward cells. Implantation experiments of sponges of F-collagen revealed an intense infiltration of neutrophils into the sponge, indicating F-collagen as an inducer of the inflammatory reaction. These aggravating characters of F-collagen sponges were greatly improved by blending gelatin with F-collagen. The new type of collagen-based biomaterials developed in the present study is expected to become a useful matrix substance for artificial skin.
C1 HIROSHIMA UNIV,FAC SCI,INST ZOOL,MOLEC CELL SCI LAB,1-3-1 HIGASHIHIROSHIMA SHI,HIROSHIMA 724,JAPAN.
   TERUMO CO,CTR R&D,KANAGAWA 25901,JAPAN.
CR BELL E, 1981, SCIENCE, V211, P1042
   BISWAS C, 1979, CELL, V18, P1035, DOI 10.1016/0092-8674(79)90216-2
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DOILLON CJ, 1984, SCANNING ELECTRON MI, V3, P1313
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Linsenmayer TF, 1985, CELL BIOL EXTRACELLU, P5
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   NIMINI ME, 1987, J BIOMEDICAL MAT RES, V21, P741
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   NORTON L, 1981, J TRAUMA, V21, P463
   OLIVER RF, 1981, CONNECT TISSUE RES, V9, P59, DOI 10.3109/03008208109160240
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STRIVASTAVA S, 1990, BIOMATERIALS, V11, P162
   TAKEDA U, 1983, Journal of Dermatology (Tokyo), V10, P593
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YOSHIZATO K, 1980, BIOCHIM BIOPHYS ACTA, V627, P23, DOI 10.1016/0304-4165(80)90119-1
   YOSHIZATO K, 1988, BIOMED RES-TOKYO, V9, P33, DOI 10.2220/biomedres.9.33
   YOSHIZATO K, 1985, BIOMED RES-TOKYO, V6, P61
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
NR 27
TC 144
Z9 147
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 79
EP 87
DI 10.1002/jbm.820270111
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600010
PM 8421002
DA 2018-10-19
ER

PT J
AU SMITH, BAH
   SEFTON, MV
AF SMITH, BAH
   SEFTON, MV
TI THROMBIN AND ALBUMIN ADSORPTION TO PVA AND HEPARIN PVA HYDROGELS .2.
   COMPETITION AND DISPLACEMENT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMATERIAL
AB Thrombin adsorption to polyvinyl alcohol (PVA) was different from its adsorption to polyethylene (PE)-not so much in amount, but in its affinity. Thrombin was more easily displaced from polyethylene and its adsorption was more readily prevented by prior or simultaneous exposure to albumin. From PVA (or heparin-PVA), only approximately 30% of the adsorbed protein could be removed by a series of eluents, including even harsh ones such as 2.5M NaOH and 6M guanidine; >85% could be removed from PE. Thrombin adsorption to PVA was not affected by the presence of BSA in solution or at the surface, but was virtually prevented on PE by preexposure to or adsorption with BSA. Heparin-PVA was not much different than PVA in most of these experiments, but did exhibit a ''Vroman effect''. In the absence of fibrinogen or antithrombin III, there was a maximum in thrombin adsorption from plasma at a plasma concentration of 1%. The behavior on this surface was dependent on both exposure time and protein concentration. These studies highlight the complexity of the interaction between plasma proteins and polymer surfaces (particularly hydrogel surfaces) and the difficulty of obtaining a clear picture of what happens when a single protein interacts with a polymer in the presence of other proteins.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A4,ONTARIO,CANADA.
FU NHLBI NIH HHS [HL24020]
CR BRASH JL, 1974, T AM SOC ART INT ORG, VA 20, P69
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HATTON MWC, 1983, THROMB HAEMOSTASIS, V50, P873
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   ROLLASON G, 1989, Journal of Biomaterials Science Polymer Edition, V1, P31, DOI 10.1163/156856289X00046
   SMITH BAH, 1992, J BIOMED MATER RES, V26, P947, DOI 10.1002/jbm.820260709
NR 7
TC 8
Z9 8
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 89
EP 95
DI 10.1002/jbm.820270112
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600011
PM 8421003
DA 2018-10-19
ER

PT J
AU SANTERRE, JP
   LABOW, RS
   ADAMS, GA
AF SANTERRE, JP
   LABOW, RS
   ADAMS, GA
TI ENZYME BIOMATERIAL INTERACTIONS - EFFECT OF BIOSYSTEMS ON DEGRADATION OF
   POLYURETHANES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIODEGRADATION; POLYMERS; INVITRO; PROPERTY
AB Enzyme-induced liberation of hard-segment-containing components from polyurethanes was evaluated using two C-14-labeled polyurethanes. A polyester urea-urethane and polyether urea-urethane were synthesized from toluene-2,4-diisocyanate (TDI)/polycaprolactone diol (PCL) or TDI/polyethylene glycol (PEO) with C-14-labeled ethylene diamine. Both materials were characterized using electron spectroscopy for chemical analysis (ESCA), differential scanning calorimetry (DSC), size exclusion chromatography, and material chemistry by Fourier transform infrared (FTIR) spectroscopy. Biodegradation assays were carried out using cholesterol esterase (CE), collagenase (CO), cathepsin B (CB), and xanthine oxidase (XO) at the pH optimum conditions for each enzyme at 37-degrees-C. Biodegradation was analyzed by monitoring the release of radiolabel, by weight change, and by surface analysis using scanning electron microscopy. The polyester urea-urethane was shown to be susceptible to enzymatic degradation above the effect of the buffer control solution by the CE but not by the other enzyme systems as monitored by radiolabel released. In the initial period of incubation, the rate of degradation was increased for all systems, including buffer controls; however, the rates dropped off rapidly by day 28. The change in weight data for the polyester urea-urethane and polyether urea-urethane showed no enzyme-dependent biodegradation above the buffer controls. However, in sodium acetate buffer at pH = 5, the polymers showed a significant weight loss relative to other buffers. In conclusion, this study showed that the biological component responsible for the onset of the biodegradation process is more likely the result of a multitude of biologically mediated compounds acting synergistically, with the process being enhanced by physical parameters such as material dissolution. In addition characterization of surface and bulk chemistry as well as material structure evaluation have been shown to be essential to interpret degradation data.
C1 UNIV OTTAWA,OTTAWA K1H 8M5,ONTARIO,CANADA.
RP SANTERRE, JP (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,DIV CARDIOVASC DEVICES,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR BORETOS JW, 1981, BIOCOMPATIBILITY CLI, V2, P127
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   KAMBIC HE, 1986, CHEM ENG NEWS   0414, P31
   LABOW RS, 1983, BIOCHIM BIOPHYS ACTA, V749, P32, DOI 10.1016/0167-4838(83)90147-4
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1986, POLYURETHANES MED, pCH4
   Lemm W., 1983, BIOMATERIALS BIOMECH, P319
   LYNN KR, 1984, CAN J BIOCHEM CELL B, V62, P1301, DOI 10.1139/o84-166
   MIRKOVITCH V, 1969, J APPL PHYS, V16, P2
   PARINS DJ, 1981, REPORT CARDIAC PACEM
   PIERCE WS, 1975, POLYM MED SURGERY
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RODELL TC, 1987, J APPL PHYSIOL, V63, P2159
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES KB, 1985, ACS POLYM MAT SCI EN, V53, P1
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 24
TC 68
Z9 69
U1 3
U2 21
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1993
VL 27
IS 1
BP 97
EP 109
DI 10.1002/jbm.820270113
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KC876
UT WOS:A1993KC87600012
PM 8421004
DA 2018-10-19
ER

PT J
AU SUNG, JY
   LEUNG, JWC
   SHAFFER, EA
   LAM, K
   COSTERTON, JW
AF SUNG, JY
   LEUNG, JWC
   SHAFFER, EA
   LAM, K
   COSTERTON, JW
TI BACTERIAL BIOFILM, BROWN PIGMENT STONE AND BLOCKAGE OF BILIARY STENTS
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE BIOFILM; PIGMENT STONE; STENT
ID COMMON BILE-DUCT; ENDOSCOPIC PALLIATIVE TREATMENT; MALIGNANT
   OBSTRUCTIVE-JAUNDICE; ELECTRON-MICROSCOPY; PANCREATIC-CANCER; CALCIUM
   SECRETION; SOLID-SURFACES; SPHINCTER; TRACT; ODDI
AB Bacterial pathogens pin access into the biliary system by descending via the portal venous circulation or ascending through the sphincter of Oddi in duodenal-biliary reflux. Bacteria thrive as glycocalyx-enclosed microcolonies, coalescing to form an adherent biofilm. The establishment of biofilm is a key event in the formation of biliary sludge and pigment gallstones, and the blockage of biliary stents. The biofilm mode of growth is very effective because it provides bacteria with a measure of protection from antibacterial agents and phagocytic leucocytes. Calcification of the matrix confers further protection for the micro-organisms living inside the biofilm. To date, attempts to prevent blockage of biliary stent have employed physical methods by using large self-expandable stents and stents without side hole. Incorporation of antibiotics within stents has not been successful presumably because bacteria once living in their biofilm are quite resistant to antimicrobial agents. Even the most toxic bile salts have no effect on the biofilm bacteria. Yet, hydrophobic bile salts reduce bacterial adhesion on biomaterial, suggesting that incorporation of such bile salts might prevent the formation of bacterial biofilm.
C1 CHINESE UNIV HONG KONG,DEPT MED,SHA TIN,HONG KONG.
   UNIV CALGARY,DEPT MED,CALGARY T2N 1N4,ALBERTA,CANADA.
   UNIV CALGARY,DEPT BIOL SCI,CALGARY T2N 1N4,ALBERTA,CANADA.
   DUKE UNIV,MED CTR,DIV GASTROENTEROL,DURHAM,NC 27710.
RI Sung, Joseph J. Y./R-3203-2018; Hossain, Sarah/C-7332-2009
OI Sung, Joseph J. Y./0000-0003-3125-5199; Hossain,
   Sarah/0000-0003-1355-0979
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   BAKER MS, 1979, ARCH SURG-CHICAGO, V114, P748
   Charcot JM, 1877, LECONS MALADIES FOIE
   Christensen GD, 1989, INFECT ASS INDWELLIN, P4
   COENE PPLO, 1990, GUT, V31, P913, DOI 10.1136/gut.31.8.913
   COLEMAN R, 1980, BIOCHIM BIOPHYS ACTA, V242, P825
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COTTON PB, 1990, ANNU REV MED, V41, P211
   CSENDES A, 1975, AM J SURG, V129, P629, DOI 10.1016/0002-9610(75)90334-7
   DEMASI E, 1984, GUT, V25, P275, DOI 10.1136/gut.25.3.275
   DICKINSON GM, 1989, ANTIMICROB AGENTS CH, V33, P602, DOI 10.1128/AAC.33.5.602
   DINEEN P, 1964, SURG GYNECOL OBSTET, V119, P1001
   Dodds W. Y, 1989, HDB PHYSL, P1055
   DYE M, 1978, BRIT J SURG, V65, P285, DOI 10.1002/bjs.1800650419
   FERETIS CB, 1984, SURG GYNECOL OBSTET, V159, P363
   FLETCHER M, 1979, APPL ENVIRON MICROB, V37, P67
   FRENCH GL, 1990, J ANTIMICROB CHEMO S, V25, P137
   GEENEN JE, 1980, GASTROENTEROLOGY, V78, P317
   Geoghegan J, 1991, GASTROINTEST ENDOSC, V37, P257
   GREGG JA, 1985, AM J SURG, V149, P668, DOI 10.1016/S0002-9610(85)80152-5
   GROEN AK, 1987, ENDOSCOPY, V19, P57, DOI 10.1055/s-2007-1018235
   HELM JF, 1985, AM J PHYSIOL, V249, pG572
   HOSMIN A, 1990, ANTIMICROB AGENTS CH, V34, P2043
   HOYLE BD, 1989, FEMS MICROBIOL LETT, V60, P339
   HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1
   HUIBREGTSE K, 1986, GASTROINTEST ENDOSC, V32, P334, DOI 10.1016/S0016-5107(86)71878-6
   HUIBREGTSE K, 1989, ENDOSCOPY, V21, P280, DOI 10.1055/s-2007-1012969
   HUMPHRIES M, 1987, FEMS MICROBIOL LETT, V42, P91, DOI 10.1111/j.1574-6968.1987.tb02305.x
   JACQUES M, 1987, MICROBIAL ECOL, V13, P173, DOI 10.1007/BF02024996
   KLOTZ SA, 1985, INFECT IMMUN, V50, P97
   Klotz SA, 1990, MICROBIAL CELL SURFA, P107
   LEE SP, 1990, HEPATOLOGY, V12, pS200
   LEUNG JWC, 1988, GASTROINTEST ENDOSC, V34, P19, DOI 10.1016/S0016-5107(88)71223-7
   LEUNG JWC, 1983, BRIT J SURG, V70, P584, DOI 10.1002/bjs.1800701006
   LEUNG JWC, 1989, J CLIN MICROBIOL, V27, P915
   Li A K, 1985, Trop Gastroenterol, V6, P119
   MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   MCSHERRY CK, 1970, SURG GYNECOL OBSTETR, V130, P829
   MOORE EW, 1985, HEPATOLOGY, V5, P994
   MOORE EW, 1990, HEPATOLOGY, V12, pS206
   NICKEL JC, 1985, ANTIMICROB AGENT CHE, V27, P19
   NICKEL JC, 1986, INVEST UROL, V6, P512
   ONG GB, 1962, ARCH SURG-CHICAGO, V84, P199
   REGE RV, 1990, J LAB CLIN MED, V115, P593
   SCHATTEN WE, 1955, ARCH SURG-CHICAGO, V71, P404, DOI 10.1001/archsurg.1955.01270150098011
   SEIGEL JH, 1988, ENDOSCOPY, V20, P137
   SMIT JM, 1989, GASTROINTEST ENDOSC, V35, P485, DOI 10.1016/S0016-5107(89)72895-9
   SPEER AG, 1987, LANCET, V2, P57
   SPEER AG, 1988, ANN INTERN MED, V108, P546, DOI 10.7326/0003-4819-108-4-546
   STEWART L, 1987, ANN SURG, V206, P242, DOI 10.1097/00000658-198709000-00002
   SUNG J Y, 1990, Microbial Ecology in Health and Disease, V3, P199
   SUNG JY, 1991, DIGEST DIS SCI, V36, P943, DOI 10.1007/BF01297145
   SUNG JY, 1992, J GASTROEN HEPATOL, V7, P240, DOI 10.1111/j.1440-1746.1992.tb00971.x
   SUNG JY, 1991, HEPATOLOGY, V14, P313, DOI 10.1016/0270-9139(91)91421-V
   SUNG JY, 1991, HEPATOLOGY, V14, pA262
   SUNG JY, 1992, GASTROINTEST ENDOSC, V38, P263
   TOOULI J, 1982, GASTROENTEROLOGY, V82, P111
   TROTMAN BW, 1991, GASTROENTEROL CLIN N, V20, P111
   TURNER WW, 1983, SURGERY, V93, P397
   VELARDI ALM, 1991, GASTROENTEROLOGY, V101, P457, DOI 10.1016/0016-5085(91)90025-G
   WOSIEWITZ U, 1985, GASTROENTEROLOGY, V88, P1076
NR 62
TC 64
Z9 68
U1 0
U2 5
PU BLACKWELL SCIENCE
PI CARLTON
PA 54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA
SN 0815-9319
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD JAN-FEB
PY 1993
VL 8
IS 1
BP 28
EP 34
DI 10.1111/j.1440-1746.1993.tb01171.x
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA KP907
UT WOS:A1993KP90700005
PM 8439659
DA 2018-10-19
ER

PT J
AU FOX, WC
   AUFDEMORTE, TB
AF FOX, WC
   AUFDEMORTE, TB
TI EXPERIENCE WITH OSSEOUS IMPLANTS FOR BONE AND BIOMATERIALS RESEARCH
SO JOURNAL OF LONG-TERM EFFECTS OF MEDICAL IMPLANTS
LA English
DT Article
DE CANCELLOUS ACCESS PORT; ANALYTIC BONE IMPLANT; BIOCOMPATIBILITY;
   TITANIUM BONE IMPLANT; OSSEOUS INFUSION; BONE AND MARROW BIOPSY
ID GROWTH CHAMBER; IRRADIATION; TISSUE; REGENERATION; DEFECTS
AB A Cancellous Access Port (CAP) osseous implant for repeated sampling of cancellous tissue was developed and tested for experimental studies of bone, marrow, and materials biocompatibility. The CAP and associated methods were shown in a series of studies to allow the repeated biopsy of unstrained cancellous tissue with little morbidity and no mortality when used in baboons, rhesus, sheep, and horses. CAP infusion, material testing, and biopsy core assemblies were developed and tested for the administration and assessment of the effects of pharmaceuticals and biologics; the placement and retrieval of a biomaterial with the surrounding tissue; and studies of cancellous bone healing and remodeling.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT OTOLARYNGOL HEAD & NECK SURG,SAN ANTONIO,TX 78284.
   UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284.
RP FOX, WC (reprint author), BIOMED ENTERPRISES INC,TEXAS RES PK,14785 OMICRON DR,SAN ANTONIO,TX 78245, USA.
CR ALBREKTSSON T, 1982, ACTA ORTHOP SCAND, V53, P757, DOI 10.3109/17453678208992288
   ALBREKTSSON T, 1980, Scandinavian Journal of Plastic and Reconstructive Surgery, V14, P1
   ALBREKTSSON T, 1980, J BONE JOINT SURG BR, V62, P403
   ALBREKTSSON T, 1980, ACTA RADIOL ONCOL, V19, P235, DOI 10.3109/02841868009130158
   ALBREKTSSON T, 1979, THESIS U GOTEBORG SW
   ANDERSON C, 1982, HISTOMORPHOMETRY
   AUFDEMORTE TB, 1992, J BONE JT SURG, P1153
   BRANEMAR.PI, 1964, ACTA ANAT, V59, P1
   BUCH F, 1984, BIOMATERIALS, V5, P341, DOI 10.1016/0142-9612(84)90032-2
   BUCH F, 1986, J ORTHOPAED RES, V4, P194, DOI 10.1002/jor.1100040208
   BUCH F, 1986, J BIOELECTRICITY, V5, P105, DOI 10.3109/15368378609027721
   BUCH F, 1985, THESIS U GOTEBORG SW
   DEHOFF RT, 1983, J MICROSC-OXFORD, V131, P259, DOI 10.1111/j.1365-2818.1983.tb04254.x
   GLOWACKI J, 1981, CALCIFIED TISSUE INT, V33, P71, DOI 10.1007/BF02409414
   GRIGIS FG, 1958, J BONE JT SURG B, V40, P274
   HALLEN O, 1976, ACTA OTO-LARYNGOL, V82, P394, DOI 10.3109/00016487609120924
   JACOBSSON M, 1985, INT J RADIAT ONCOL, V11, P1963, DOI 10.1016/0360-3016(85)90278-0
   JACOBSSON M, 1985, ACTA ONCOL, V24, P343, DOI 10.3109/02841868509136063
   JACOBSSON M, 1985, SCAND J PLAST RECONS, V19, P231, DOI 10.3109/02844318509074508
   JACOBSSON M, 1986, ACTA ONCOL, V25, P57, DOI 10.3109/02841868609136379
   JACOBSSON M, 1985, THESIS U GOTEBORG SW
   JACOBSSON MG, 1985, PLAST RECONSTR SURG, V76, P841, DOI 10.1097/00006534-198512000-00006
   KALEBO P, 1986, ARCH ORTHOP TRAUM SU, V105, P321, DOI 10.1007/BF00449935
   KETENJIAN AY, 1975, CLIN ORTHOP RELAT R, V107, P266
   LISTROM RD, 1984, THESIS U TORONTO CAN
   MATHOG RH, 1975, LARYNGOSCOPE, V83, P908
   NETO FLD, 1984, CLIN ORTHOP RELAT R, V187, P260
   PARFITT AM, 1987, J BONE MINER RES, V2, P545
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   SIROLA K, 1960, Ann Med Exp Biol Fenn, V38(Suppl 2), P1
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   TJELLSTROM A, 1978, ACTA OTO-LARYNGOL, V85, P33, DOI 10.3109/00016487809121420
   TJELLSTROM A, 1978, ACTA OTO-LARYNGOL, V85, P232
   Urist MR, 1943, J BONE JOINT SURG, V25, P375
   WILLIAMS G, 1988, 4TH P ANN SCI SESS A
   1985, SAS STATISTICS USERS
   1987, ANN BOOK ASTM STANDA
NR 37
TC 4
Z9 4
U1 0
U2 2
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 1050-6934
J9 J LONG-TERM EFF MED
JI J. Long-Term Eff. Med. Implants
PY 1993
VL 3
IS 1
BP 1
EP 27
PG 27
WC Engineering, Biomedical; Medicine, Research & Experimental; Orthopedics;
   Pathology
SC Engineering; Research & Experimental Medicine; Orthopedics; Pathology
GA KZ655
UT WOS:A1993KZ65500001
PM 10171653
DA 2018-10-19
ER

PT J
AU NAGARAJAN, VS
   RAO, KJ
AF NAGARAJAN, VS
   RAO, KJ
TI STRUCTURAL, MECHANICAL AND BIOCOMPATIBILITY STUDIES OF
   HYDROXYAPATITE-DERIVED COMPOSITES TOUGHENED BY ZIRCONIA ADDITION
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
DE HYDROXYAPATITE; ZIRCONIA; COMPOSITE; BIOMATERIAL
ID FRACTURE-TOUGHNESS; TETRAGONAL ZRO2; GELS; CRYSTALLINE; EVOLUTION;
   MICROSTRUCTURE
AB Hydroxyapatite(OHAp)-based ceramic composites with added ZrO2 have been prepared both by sintering at 1400-degrees-C and by hot isostatic pressing (HIP) at 1450-degrees-C and 140 MPa pressure (argon atmosphere). The development of the crystalline phases and the microstructure of the composites have been examined using X-ray diffraction, electron microscopy, infrared and magic-angle spinning nuclear magnetic resonance (MASNMR) spectroscopic techniques. The fracture toughness and biocompatibility of the composites have also been studied. The effect of the addition of CeO2- and Y2O3-stabilized ZrO2 and of simple monoclinic ZrO2 to the initial physical mixture, on the structure and properties of the resulting composites has been investigated. In most of the sintered or HIP samples, the OHAp decomposes into tricalcium phosphate (beta-TCP). CaO, which forms as a product of decomposition, dissolves completely in ZrO2 and stabilizes the latter in its cubic/tetragonal phase. Presence of the beta-TCP phase in the product seems to be the result of a structural synergistic effect of hexagonal OHAp. Two structurally distinct orthophosphate groups have been identified in the composites by MASNMR of P-31 and attributed to decomposition products of OHAp at higher temperatures. The composites possess high K(IC) values (2-3 times higher than that of pure OHAp). Decomposition of hydroxyapatite gives rise to differences in microstructure between HIP and simply sintered composites although fracture toughness values are similar in magnitude indicating the presence of several toughening mechanisms. The in vitro SP2-O cell test suggests that these composites possess good biocompatibility. The combination of good biocompatibility, desirable microstructure and easy availability of initial reactants indicates that the simply sintered composite of OHAp and monoclinic ZrO2 (ZAP-30) appears to be the most suitable for prosthetic applications.
C1 INDIAN INST SCI,MAT RES CTR,BANGALORE 560012,KARNATAKA,INDIA.
CR CAMPBELL AM, LABORATORY TECHNIQUE, V13, P74
   CLAUSSEN N, 1976, J AM CERAM SOC, V59, P49, DOI 10.1111/j.1151-2916.1976.tb09386.x
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Evans A. G., 1984, ADV CERAM, P193
   Francis M D, 1968, Adv Oral Biol, V3, P83
   HEUER AH, 1982, J AM CERAM SOC, V65, P642, DOI 10.1111/j.1151-2916.1982.tb09946.x
   IOKU K, 1987, DEC P 87 FALL M MRS
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JORCHA M, 1977, J BIOENG, V1, P79
   KATZ JL, 1986, ENCY MAT SCI ENG, V1, P474
   KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x
   KUTTY TRN, 1973, INDIAN J CHEM, V11, P695
   LEE RR, 1987, J AM CERAM SOC, V70, P208, DOI 10.1111/j.1151-2916.1987.tb04969.x
   LIN FH, 1987, J MATER SCI LETT, V6, P501, DOI 10.1007/BF01739266
   NAGARAJAN VS, 1990, J SOLID STATE CHEM, V88, P419, DOI 10.1016/0022-4596(90)90237-R
   NAGARAJAN VS, 1991, J MATER RES, V6, P2688, DOI 10.1557/JMR.1991.2688
   NAGARAJAN VS, 1989, J MATER SCI, V24, P2140, DOI 10.1007/BF02385434
   NAGARAJAN VS, 1991, J SOLID STATE CHEM, V94, P149, DOI 10.1016/0022-4596(91)90228-A
   NAGARAJAN VS, 1991, PHILOS MAG A, V65, P771
   NAKAJIMA K, 1984, ADV CERAM, V12, P399
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M, P39
   NIIHARA K, 1982, J MATER SCI LETT, V1, P13, DOI 10.1007/BF00724706
   NOGAMI M, 1988, J NON-CRYST SOLIDS, V100, P298, DOI 10.1016/0022-3093(88)90036-1
   PRABAKAR S, 1991, J MATER RES, V6, P592, DOI 10.1557/JMR.1991.0592
   PRABHAKAR S, 1987, CHEM PHYS LETT, V139, P96, DOI 10.1016/0009-2614(87)80158-6
   RAO ECS, 1981, ADV CERAM, V3, P1
   REJDA BV, 1977, J BIOENG, V1, P93
   SANDERSON RT, 1979, POLAR COVALENCE, P39
   TSUKUMA K, 1985, J MATER SCI, V20, P1178, DOI 10.1007/BF01026311
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
   YYOSHIMURA M, 1989, EUROCERAMICS, V3
NR 31
TC 27
Z9 27
U1 0
U2 2
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND
   CB4 4WF
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JAN
PY 1993
VL 3
IS 1
BP 43
EP 51
DI 10.1039/jm9930300043
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA KH254
UT WOS:A1993KH25400008
DA 2018-10-19
ER

PT J
AU SOUZA, R
AF SOUZA, R
TI BEHAVIOR OF A 316L STAINLESS-STEEL IMPLANT PROCESSED BY SANDING OR
   ALUMINA-COATED IN THE METACARPUS BONE OF SHEEP
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOMATERIAL
AB The behaviour of bone was studied in the presence of two implant materials, a 316L stainless steel with its surface roughened by sanding (type I) and the same steel coated with alumina by plasma-spraying (type II). Twelve nails of types I and II were implanted in the medullary canal of previously fractured metacarpal bones of 12 sheep. Samples were taken from six sheep at 90 days (group A) and 180 days (group B) post-surgery. Clinical examination of the operated sheep as well as radiographic analysis did not show any difference between the two types of implants. Bone ingrowth was studied by optical microscopy and microradiography, by measuring the angle of bone growth around the implants and the minimum distance between the newly formed bone and the implants. Differences between the two types of implants were not statistically significant.
RP SOUZA, R (reprint author), ECOLE NATL VET LYON,SERV CHIRURG,1 AVE BOURGELAT,BP 83,F-69280 MARCY LETOILE,FRANCE.
CR BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   BOUTIN P, 1971, PRESSE MED, V79, P639
   BROW SD, 1984, INT C METALLURGICAL
   BUNNY F, 1975, ACTA ORTHOP BELG, V41, P6
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   DOREMUS RH, 1986, METAL CERAMIC BIOMAT, V1, P107
   GILL BJ, 1986, MATER SCI TECH SER, V2, P207, DOI 10.1179/mst.1986.2.3.207
   Kruger J., 1979, ASTM SPECIAL TECHNIC, P107
   MASSE Y, 1976, ANN ORTHOP OUEST, V8, P117
   NODA I, 1986, JPN SOC ORTHOP CERAM, V6, P1
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   TULI SM, 1978, J BONE JOINT SURG, V3, P16
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
NR 14
TC 0
Z9 0
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 1993
VL 4
IS 1
BP 55
EP 57
DI 10.1007/BF00122978
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK181
UT WOS:A1993KK18100010
DA 2018-10-19
ER

PT J
AU DEGEE, P
   DUBOIS, P
   JEROME, R
   TEYSSIE, P
AF DEGEE, P
   DUBOIS, P
   JEROME, R
   TEYSSIE, P
TI SYNTHESIS AND CHARACTERIZATION OF BIOCOMPATIBLE AND BIODEGRADABLE POLY
   (EPSILON-CAPROLACTONE-B-GAMMA-BENZYLGLUTAMATE) DIBLOCK COPOLYMERS
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Note
DE BIODEGRADABILITY; BIOCOMPATIBILITY; BIOMATERIAL
   POLY(EPSILON-CAPROLACTONE); POLYPEPTIDE; POLY-GAMMA-BENZYLGLUTAMATE;
   BLOCK COPOLYMER
ID BLOCK COPOLYMERS; POLYLACTONES
C1 STATE UNIV LIEGE,CTR ETUD & RECH MACROMOLEC,SART TILMAN B6,B-4000 LIEGE,BELGIUM.
RI DUBOIS, Philippe/B-9983-2008
CR CHO CS, 1988, MAKROMOL CHEM, V189, P1505
   DEGEE P, UNPUB MACROMOLECULES
   DUBOIS P, 1991, MACROMOLECULES, V24, P977, DOI 10.1021/ma00005a002
   DUBOIS P, 1989, POLYM BULL, V22, P475, DOI 10.1007/BF00718922
   DUBOIS P, UNPUB MACROMOLECULES
   FULLER WD, 1976, BIOPOLYMERS, V15, P1869, DOI 10.1002/bip.1976.360150922
   JANSSEN K, 1988, POLYMER, V29, P1513, DOI 10.1016/0032-3861(88)90318-7
   Kricheldorf H. R., 1987, ALPHA AMINO ACID N C, P59
   KUGO K, 1987, POLYM J, V19, P375, DOI 10.1295/polymj.19.375
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1991, MAKROMOL CHEM MACROM, V42, P103
   ORY SJ, 1983, AM J OBSTET GYNECOL, V145, P600, DOI 10.1016/0002-9378(83)91204-8
   OVSIANNIKOVA LA, 1986, MAKROMOL CHEM, V187, P2351
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   Pitt C G, 1980, CONTROLLED RELEASE B
NR 15
TC 21
Z9 21
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN
PY 1993
VL 31
IS 1
BP 275
EP 278
DI 10.1002/pola.1993.080310132
PG 4
WC Polymer Science
SC Polymer Science
GA KB969
UT WOS:A1993KB96900032
OA Bronze
DA 2018-10-19
ER

PT J
AU DENDUNNEN, WFA
   VANDERLEI, B
   SCHAKENRAAD, JM
   BLAAUW, EH
   STOKROOS, I
   PENNINGS, AJ
   ROBINSON, PH
AF DENDUNNEN, WFA
   VANDERLEI, B
   SCHAKENRAAD, JM
   BLAAUW, EH
   STOKROOS, I
   PENNINGS, AJ
   ROBINSON, PH
TI LONG-TERM EVALUATION OF NERVE REGENERATION IN A BIODEGRADABLE NERVE
   GUIDE
SO MICROSURGERY
LA English
DT Article
AB Nerve regeneration using artificial biodegradable conduits is of increasing interest. The aim of this study is to evaluate the regeneration and maturation of a nerve after long-term implantation (2 years) of a biodegradable poly-L-lactide/poly-E-caprolactone (PLLA/PCL) copolymeric nerve guide in the sciatic nerve of the rat. After harvesting, we evaluated both the regenerated nerves and the controls, using light microscopy, transmission electron microscopy, and morphometric techniques. Remnants of biomaterial were still present after 2 years of implantation, but the foreign body reaction was very mild at this stage, due to the rounded shapes of the polymer debris. Morphometric analysis showed significant differences between the regenerated nerve and the normal sciatic nerve: the number of myelinated fibers is higher, and the mean fiber diameter of the myelinated fibers in the regenerated nerve is smaller. In conclusion, the results demonstrate that the new PLLA/PCL nerve guide can provide optimal conditions for regeneration and maturation of damaged nerves. (C) 1993 Wiley-Liss, Inc.
C1 UNIV GRONINGEN,CTR BIOMED TECHNOL,DIV BIOMAT & BIOCOMPATIBIL,OOSTERSINGEL 59,9713 EZ GRONINGEN,NETHERLANDS.
RI den Dunnen, Wilfred/A-4034-2009
NR 0
TC 102
Z9 103
U1 4
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 1993
VL 14
IS 8
BP 508
EP 515
DI 10.1002/micr.1920140808
PG 8
WC Surgery
SC Surgery
GA ME285
UT WOS:A1993ME28500007
PM 8271930
DA 2018-10-19
ER

PT B
AU HANSON, SR
AF HANSON, SR
BE Missirlis, YF
   Wautier, JL
TI ROLE OF THROMBIN IN PLATELET-BIOMATERIAL INTERACTIONS
SO ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS
LA English
DT Proceedings Paper
CT Expert Meeting on the Role of Platelets in Blood, Biomaterials
   Interactions
CY MAY, 1992
CL PYTHAGORION, GREECE
SP EUROPEAN ECON COMMUNITIES
C1 EMORY UNIV,SCH MED,ATLANTA,GA 30322.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-2162-6
PY 1993
BP 81
EP 93
PG 13
WC Biochemistry & Molecular Biology; Engineering, Biomedical; Engineering,
   Chemical; Hematology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Engineering; Hematology; Materials
   Science
GA BZ40L
UT WOS:A1993BZ40L00007
DA 2018-10-19
ER

PT B
AU DAVIES, A
   HANSON, S
   ORDINAS, A
   MISSIRLIS, YF
   WAUTIER, JL
   MULVIHILL, J
   KIEFFER, N
   LEMM, W
AF DAVIES, A
   HANSON, S
   ORDINAS, A
   MISSIRLIS, YF
   WAUTIER, JL
   MULVIHILL, J
   KIEFFER, N
   LEMM, W
BE Missirlis, YF
   Wautier, JL
TI BIOLOGICAL TESTS FOR EVALUATING PLATELET BIOMATERIAL INTERACTION
SO ROLE OF PLATELETS IN BLOOD-BIOMATERIAL INTERACTIONS
LA English
DT Proceedings Paper
CT Expert Meeting on the Role of Platelets in Blood, Biomaterials
   Interactions
CY MAY, 1992
CL PYTHAGORION, GREECE
SP EUROPEAN ECON COMMUNITIES
C1 UNIV LEEDS,GEN INFIRM,ACAD UNIT MED,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 0-7923-2162-6
PY 1993
BP 181
EP 198
PG 18
WC Biochemistry & Molecular Biology; Engineering, Biomedical; Engineering,
   Chemical; Hematology; Materials Science, Multidisciplinary
SC Biochemistry & Molecular Biology; Engineering; Hematology; Materials
   Science
GA BZ40L
UT WOS:A1993BZ40L00014
DA 2018-10-19
ER

PT B
AU SCHAMBERGER, PC
   GARDELLA, JA
   MCKEOWAN, PJ
   DAVIS, LE
AF SCHAMBERGER, PC
   GARDELLA, JA
   MCKEOWAN, PJ
   DAVIS, LE
GP SURFACES BIOMAT FDN
TI METHOD DEVELOPMENT FOR IMAGING CELL CONDITIONING FILM BIOMATERIAL
   INTERFACES - IMAGING A CRATER EDGE DEPTH PROFILE OF MODEL BIOFILM
   INTERFACES BY AUGER-ELECTRON SPECTROSCOPY AND TIME-OF-FLIGHT SIMS
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 82
EP 87
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00016
DA 2018-10-19
ER

PT B
AU PASCHALIS, EP
   TUCKER, BE
   SPECTOR, M
   NANCOLLAS, GH
AF PASCHALIS, EP
   TUCKER, BE
   SPECTOR, M
   NANCOLLAS, GH
GP SURFACES BIOMAT FDN
TI MODIFICATION AND CHARACTERIZATION OF BIOMATERIAL SURFACES BY KINETICALLY
   CONTROLLED MINERALIZATION AND DEMINERALIZATION
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 124
EP 128
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00024
DA 2018-10-19
ER

PT B
AU MARCHANT, RE
AF MARCHANT, RE
GP SURFACES BIOMAT FDN
TI CELL AND MOLECULAR ADHESION TO BIOMATERIAL SURFACES
SO SURFACES IN BIOMATERIALS SYMPOSIUM
LA English
DT Proceedings Paper
CT Surfaces in Biomaterials Symposium
CY SEP 13-15, 1993
CL CAMBRIDGE, MA
SP SURFACES BIOMAT FDN INC
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SURFACES BIOMATERIALS FDN
PI MINNEAPOLIS
PA PO BOX 26111, MINNEAPOLIS, MN 55426-0111
PY 1993
BP 177
EP 184
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA BA72K
UT WOS:A1993BA72K00033
DA 2018-10-19
ER

PT B
AU BADYLAK, SF
AF BADYLAK, SF
BE Bell, E
TI SMALL-INTESTINAL SUBMUCOSA (SIS) - A BIOMATERIAL CONDUCIVE TO SMART
   TISSUE REMODELING
SO TISSUE ENGINEERING: CURRENT PERSPECTIVES
LA English
DT Proceedings Paper
CT Tissue Engineering Meeting
CY 1992
CL KEYSTONE, CO
SP KEYSTONE ORG, GENETECH INC, KEYSTONE SYMP MOLEC & CELLULAR BIOL
C1 PURDUE UNIV,HILLENBRAND BIOMED ENGN CTR,W LAFAYETTE,IN 47907.
NR 0
TC 81
Z9 82
U1 0
U2 8
PU BIRKHAUSER BOSTON
PI CAMBRIDGE
PA 675 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139-2333
BN 0-8176-3687-0
PY 1993
BP 179
EP 189
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BZ63F
UT WOS:A1993BZ63F00017
DA 2018-10-19
ER

PT J
AU CARROLL, JC
   SCHWAITZBERG, SD
   UCCI, AA
   SCHLESINGER, RM
   LAURITZEN, D
   SANT, GR
AF CARROLL, JC
   SCHWAITZBERG, SD
   UCCI, AA
   SCHLESINGER, RM
   LAURITZEN, D
   SANT, GR
TI NEW MATRIX MATERIAL FOR POTENTIAL USE IN REVERSIBLE VASECTOMY -
   PRELIMINARY ANIMAL BIOCOMPATIBILITY STUDIES
SO UROLOGY
LA English
DT Article
AB The biocompatibility of a new elastomeric-hydrogel matrix biomaterial for use as an intravasal occlusive device was assessed by inserting it into the vas deferens of dogs. The vas was removed and examined histologically after varying periods of time. The biomaterial resulted in total occlusion of the vas. Epithelial changes were limited to squamous metaplasia in areas adjacent to the implant. Changes in the subepithelium were minimal. This new material is biocompatible with the dog vas, and it has potential as an occlusive device for ''reversible'' vasectomy in men. Semen analysis studies are needed to assess the completeness and reversibility of the vasal occlusion achieved with this implant.
C1 NEW ENGLAND MED CTR,DEPT UROL,BOSTON,MA.
   NEW ENGLAND MED CTR,DEPT SURG,BOSTON,MA.
   NEW ENGLAND MED CTR,DEPT PATHOL,BOSTON,MA.
   LEMUEL SHATTUCK HOSP,BOSTON,MA 02130.
   TUFTS UNIV,SCH MED,BOSTON,MA 02111.
CR BREUSCHKE EE, 1975, FERTIL STERIL, V26, P29
   BRUESCHKE EE, 1975, FERTIL STERIL, V26, P40
   BRUESCHKE EE, 1974, FERTIL STERIL, V25, P659
   COOKE J E, 1987, Anesthesiology (Hagerstown), V67, pA208, DOI 10.1097/00000542-198709001-00208
   COS LR, 1983, UROLOGY, V22, P567, DOI 10.1016/0090-4295(83)90297-2
   DERRICK FC, 1974, J UROLOGY, V111, P523, DOI 10.1016/S0022-5347(17)60005-3
   FALLON B, 1981, J UROLOGY, V126, P361, DOI 10.1016/S0022-5347(17)54527-9
   HICKEY RF, 1987, ANESTH ANALG, V68, pS121
   HRDLICKA JG, 1967, FERTIL STERIL, V18, P289
   HULKA JF, 1972, FERTIL STERIL, V23, P683
   JHAVER PS, 1971, FERTIL STERIL, V22, P263
   JONES BR, 1989, ANESTHESIOLOGY, V71, P430
   LEE HY, 1969, FERTIL STERIL, V20, P735
NR 13
TC 4
Z9 4
U1 0
U2 1
PU CAHNERS PUBL CO
PI NEW YORK
PA 249 WEST 17 STREET, NEW YORK, NY 10011
SN 0090-4295
J9 UROLOGY
JI UROLOGY
PD JAN
PY 1993
VL 41
IS 1
BP 34
EP 37
DI 10.1016/0090-4295(93)90240-B
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA KW024
UT WOS:A1993KW02400008
PM 8420076
DA 2018-10-19
ER

PT J
AU ARIZONO, T
   OGA, M
   SUGIOKA, Y
AF ARIZONO, T
   OGA, M
   SUGIOKA, Y
TI INCREASED RESISTANCE OF BACTERIA AFTER ADHERENCE TO POLYMETHYL
   METHACRYLATE - AN INVITRO STUDY
SO ACTA ORTHOPAEDICA SCANDINAVICA
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; PSEUDOMONAS-AERUGINOSA; COLONIZATION;
   BIOMATERIALS; SLIME
AB The pathobiology of total joint prosthesis infection was investigated in vitro. Discs of polymethylmethacrylate (PMMA) were exposed to a suspension containing cells of 10(8) per mL Staphylococcus epidermidis E-46. After 12 hours, exposed discs were rinsed with phosphate-buffered saline and placed in brain heart infusion broth containing antibiotics (2.5 mg per mL of Cephaloridine). After gentle shaking for 24 hours at 37-degrees-C, the bacteria on the PMMA surface were detached and washed with phosphate-buffered saline to remove the antibiotics. Compared with the free bacteria which were detached from the PMMA by sonication immediately after exposure to the antibiotic solution, those allowed to remain adhered to the PMMA surface were more resistant to antibiotics. Scanning electron microscopy showed accumulation of bacteria surrounded by slime on PMMA discs exposed for 12 hours.
   Our results indicate that resistance of bacteria to antibiotics is increased after adherence to the biomaterial and formation of a slime layer.
RP ARIZONO, T (reprint author), KYUSHU UNIV,FAC MED,DEPT ORTHOPED,3-1-1 MAEDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.
CR BALTIMORE RS, 1980, J INFECT DIS, V141, P238, DOI 10.1093/infdis/141.2.238
   Dougherty S H, 1982, Curr Probl Surg, V19, P217
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   Poika I. A., 1990, ACTA ORTHOP SCAND, V61, P163
   SCHWARZMANN S, 1971, INFECT IMMUN, V3, P762
   UMEDA A, 1987, J BACTERIOL, V169, P2482, DOI 10.1128/jb.169.6.2482-2487.1987
   YAMAMOTO M, 1986, MICROBIOL IMMUNOL, V30, P969, DOI 10.1111/j.1348-0421.1986.tb03027.x
NR 11
TC 29
Z9 29
U1 2
U2 3
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 0001-6470
J9 ACTA ORTHOP SCAND
JI Acta Orthop. Scand.
PD DEC
PY 1992
VL 63
IS 6
BP 661
EP 664
PG 4
WC Orthopedics
SC Orthopedics
GA KD134
UT WOS:A1992KD13400019
PM 1471518
DA 2018-10-19
ER

PT J
AU ARNOCZKY, SP
   DICARLO, EF
   OBRIEN, SJ
   WARREN, RF
AF ARNOCZKY, SP
   DICARLO, EF
   OBRIEN, SJ
   WARREN, RF
TI CELLULAR REPOPULATION OF DEEP-FROZEN MENISCAL AUTOGRAFTS - AN
   EXPERIMENTAL-STUDY IN THE DOG
SO ARTHROSCOPY
LA English
DT Article
DE MENISCUS; CELL REPOPULATION; AUTOGRAFT, DEEP-FROZEN
AB This study evaluated the cellular repopulation of deep-frozen meniscal autografts. Medial menisci of adult dogs were excised, deep-frozen in liquid nitrogen (- 196-degrees-C) for 10 min, and orthotopically reimplanted into the joint. Deep-freezing was found to effectively kill all the cells within the meniscus as determined by the absence of (Na2SO4)-S-35 incorporation. Following orthotopic replacement within the knee joint, menisci were repopulated with cells that seemed to originate from the adjacent synovium. These cells migrated over the surface of the meniscus and began to invade the deeper layers of the tissue. However, even after 6 months, the central core of the meniscus remained acellular. While the new cells appeared to modulate into cells that are similar in appearance to meniscal fibrochondrocytes, the exact phenotypic expression of these newly differentiated cells has yet to be determined. Histological alterations, as manifested by a loss of normal orientation of the collagen architecture of the superficial layers of the meniscus, was evident at 6 months and suggests that a remodeling phenomenon may be associated with the cellular repopulation. While biomaterial studies have not been carried out on these specimens, the morphologic alterations observed in the collagen orientation would suggest a possible alteration in the material properties of the repopulated meniscus. The clinical implication of this study is that the structural remodeling associated with the cellular repopulation of deep-frozen meniscal allografts may make the transplanted meniscus more susceptible to injury.
RP ARNOCZKY, SP (reprint author), MICHIGAN STATE UNIV,COLL VET MED,COMPARAT ORTHOPAED RES LAB,E LANSING,MI 48824, USA.
NR 0
TC 82
Z9 85
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0749-8063
J9 ARTHROSCOPY
JI Arthroscopy
PD DEC
PY 1992
VL 8
IS 4
BP 428
EP 436
DI 10.1016/0749-8063(92)90003-T
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA JZ034
UT WOS:A1992JZ03400003
PM 1466700
DA 2018-10-19
ER

PT J
AU OTSUKA, M
   MATSUDA, Y
   KOKUBO, T
   YOSHIHARA, S
   NAKAMURA, T
   YAMAMURO, T
AF OTSUKA, M
   MATSUDA, Y
   KOKUBO, T
   YOSHIHARA, S
   NAKAMURA, T
   YAMAMURO, T
TI NEW SKELETAL DRUG DELIVERY SYSTEM CONTAINING ANTIBIOTICS USING
   SELF-SETTING BIOACTIVE GLASS CEMENT
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Note
DE DRUG DELIVERY SYSTEM; BIOMATERIAL; CEPHALEXIN; CALCIUM PHOSPHATE GLASS;
   CRYSTALLINE TRANSFORMATION; HYDROXYAPATITE; SELF-SETTING CEMENT;
   CONTROLLED RELEASE
ID BONE-CEMENT
AB A novel device containing cephalexin as a model drug using a self-setting bioactive cement basing on CaO-SiO2-P2O5 glass was investigated. Glass powders contained 5% cephalexin powder hardened within 5 min after being mixed with a phosphate buffer. After hardening, in vitro drug release from homogeneous or heterogeneous drug-loaded cement pellets in a simulated body fluid at pH 7.25 and 37-degrees-C continued for more than 2 weeks.
C1 NIPPON ELECT GLASS CO, OTSU 520, JAPAN.
   KYOTO UNIV, FAC ENGN, KYOTO 606, JAPAN.
   KYOTO UNIV, BIOMED ENGN RES CTR, KYOTO 606, JAPAN.
   KYOTO UNIV, FAC MED, KYOTO 606, JAPAN.
RP OTSUKA, M (reprint author), KOBE WOMENS COLL PHARM, KOBE 658, JAPAN.
CR Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   MATSUDA T, 1990, SEITAI KOROIDO, P777
   NISHIMURA N, 1991, J APPL BIOMATER, V2, P219, DOI 10.1002/jab.770020402
   OTSUKA M, 1990, CHEM PHARM BULL, V38, P3500, DOI 10.1248/cpb.38.3500
   SALVATI EA, 1986, CLIN ORTHOP RELAT R, P83
   YOSHIHARA S, 1992, BIOCERAMICS, V3, P231
NR 7
TC 2
Z9 2
U1 0
U2 3
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD DEC
PY 1992
VL 40
IS 12
BP 3346
EP 3348
DI 10.1248/cpb.40.3346
PG 3
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA KH957
UT WOS:A1992KH95700046
OA Bronze
DA 2018-10-19
ER

PT J
AU GUIDOIN, R
   KING, MW
AF GUIDOIN, R
   KING, MW
TI THE POLYURETHANE FOAM COVERING THE MEME BREAST PROSTHESIS - A BIOMEDICAL
   BREAKTHROUGH OR A BIOMATERIAL TAR BABY - REPLY
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
RP GUIDOIN, R (reprint author), UNIV LAVAL,CHIRURG EXPTL LAB,LOCAL 1701,PAVILLON SERV,QUEBEC CITY G1K 7P4,QUEBEC,CANADA.
CR ADAMS G, 1990, DEV TECHNIQUES MONIT
   BROWN DL, 1988, CUSTOM MADE ALIPHATI
   DUGUAY DG, 1992, 13TH P ANN C CAN BIO, P7
   ERFLE D, 1992, 13TH P ANN C CAN BIO, P46
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
NR 5
TC 1
Z9 1
U1 0
U2 0
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD NOV
PY 1992
VL 29
IS 5
BP 477
EP 478
DI 10.1097/00000637-199211000-00025
PG 2
WC Surgery
SC Surgery
GA JX808
UT WOS:A1992JX80800025
DA 2018-10-19
ER

PT J
AU SANTERRE, JP
   LABOW, RS
   ADAMS, GA
AF SANTERRE, JP
   LABOW, RS
   ADAMS, GA
TI THE POLYURETHANE FOAM COVERING THE MEME BREAST PROSTHESIS - A BIOMEDICAL
   BREAKTHROUGH OR A BIOMATERIAL TAR BABY
SO ANNALS OF PLASTIC SURGERY
LA English
DT Letter
C1 UNIV OTTAWA,DEPT SURG,OTTAWA K1H 8M5,ONTARIO,CANADA.
RP SANTERRE, JP (reprint author), UNIV OTTAWA,INST HEART,DIV CARDIOVASC DEVICES,1053 CARLING AVE,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR ADAMS G, 1990, DEV TECHNIQUES MONIT
NR 1
TC 1
Z9 1
U1 0
U2 1
PU LITTLE BROWN CO
PI BOSTON
PA 34 BEACON STREET, BOSTON, MA 02108-1493
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD NOV
PY 1992
VL 29
IS 5
BP 477
EP 477
DI 10.1097/00000637-199211000-00024
PG 1
WC Surgery
SC Surgery
GA JX808
UT WOS:A1992JX80800024
PM 1444145
DA 2018-10-19
ER

PT J
AU SILVE, C
   LOPEZ, E
   VIDAL, B
   SMITH, DC
   CAMPRASSE, S
   CAMPRASSE, G
   COULY, G
AF SILVE, C
   LOPEZ, E
   VIDAL, B
   SMITH, DC
   CAMPRASSE, S
   CAMPRASSE, G
   COULY, G
TI NACRE INITIATES BIOMINERALIZATION BY HUMAN OSTEOBLASTS MAINTAINED
   INVITRO
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
ID BONE-MARROW; CELLS-INVITRO; MINERALIZATION; MATRIX; CALCIUM;
   DIFFERENTIATION; PHENOTYPE; PHOSPHATE; CALVARIA; CULTURES
AB When nacreous shell produced by the marine oyster Pinctada maxima, used as a biomaterial in oral surgery, is implanted in human bone, new bone formation occurs, resulting in a tight welding of the bone to the nacre [16]. These findings are consistent with the possibility that nacre adjacent to bone can locally stimulate osteogenic activity. To test this hypothesis, we have evaluated the effect of the simultaneous presence of bone and nacre on human osteoblasts in vitro. Nacre chips (1 mm3) were placed at almost-equal-to 1 mm distance from a similarly sized bone chip on a layer of first passage human osteoblasts. None of the chemical inducers generally required to obtain bone mineralization in vitro (in particular, beta-glycerophosphate) was added to the cultures. Mineralized sections of the cultures were evaluated by light and electron microscopy, contact microradiography, and Laser Raman Spectroscopy. The results demonstrated that nacre has strong osteogenic effects on human osteoblasts when placed in proximity to bone in vitro. New bone formation occurred by both appositional growth on the existing bone and by the formation of mineralized nodules within the matrix adjacent to the bone explant. Electron microscopic evaluation of these sites demonstrated findings typical of those described in the course of bone formation in vivo, and no evidence of toxicity was observed. In addition, under the conditions of culture used, nacre can also promote the formation by osteoblasts of a structure with characteristics similar to nacre (e.g., lamellar organic matrix mineralized with aragonite, as demonstrated by Laser Raman Spectroscopy). Given the unusual capacity of nacre in the presence of human osteoblasts in vitro to induce different types of mineralization, this model should provide insights into the specific interactions between matrix proteins and minerals that control the type of mineral produced in the course of biomineralization.
C1 HOP NECKER ENFANTS MALAD,SERV STOMATOL,F-75730 PARIS 15,FRANCE.
   MUSEUM NATL HIST NAT,PHYSIOL GEN & COMPAREE LAB,CNRS,URA 90,F-75231 PARIS 05,FRANCE.
   CABINET DENTAIRE,CHELLES,FRANCE.
   MUSEUM NATL HIST NAT,MINERAL LAB,F-75231 PARIS 05,FRANCE.
RP SILVE, C (reprint author), HOP NECKER ENFANTS MALAD,CNRS,URA 583,149 RUE SEVRES,F-75730 PARIS 15,FRANCE.
CR ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   BENAYAHU D, 1989, J CELL PHYSIOL, V140, P1, DOI 10.1002/jcp.1041400102
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   DELHAYE M, 1975, J RAMAN SPECTROSC, V3, P33, DOI 10.1002/jrs.1250030105
   ECAROTCHARRIER B, 1988, BONE, V9, P147, DOI 10.1016/8756-3282(88)90004-X
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GOTOH Y, 1990, BONE MINER, V8, P39
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115
   KHOUJA HI, 1990, BONE, V11, P385, DOI 10.1016/8756-3282(90)90131-H
   Landis WJ, 1985, CHEM BIOL MINERALIZE, P360
   LOPEZ E, 1976, CALC TISS RES, V20, P173, DOI 10.1007/BF02546406
   LOPEZ E, 1978, ANN BIOL ANIM BIOCH, V18, P105, DOI 10.1051/rnd:19780113
   LURIA EA, 1987, CELL TISSUE RES, V248, P449
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   MARKS SC, 1988, AM J ANAT, V183, P1, DOI 10.1002/aja.1001830102
   NEFUSSI JR, 1985, DIFFERENTIATION, V29, P160, DOI 10.1111/j.1432-0436.1985.tb00310.x
   PINET M, IN PRESS B ASS FRANC
   RAISZ LG, 1983, NEW ENGL J MED, V309, P83, DOI 10.1056/NEJM198307143090206
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   SILVE C, 1986, J CLIN ENDOCR METAB, V62, P583, DOI 10.1210/jcem-62-3-583
   Simkiss K., 1989, BIOMINERALIZATION CE, P337
   SMITH DC, 1987, TERRA COGNITA, V7, P20
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3
   TENENBAUM HC, 1982, CALCIFIED TISSUE INT, V34, P76, DOI 10.1007/BF02411212
   VENECPEYRE MT, 1978, CR ACAD SCI D NAT, V287, P607
   WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G
   WHEELER AP, 1981, SCIENCE, V212, P1397, DOI 10.1126/science.212.4501.1397
   Woodard H Q, 1964, Clin Orthop Relat Res, V37, P187
NR 32
TC 96
Z9 99
U1 0
U2 21
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD NOV
PY 1992
VL 51
IS 5
BP 363
EP 369
DI 10.1007/BF00316881
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA JU767
UT WOS:A1992JU76700007
PM 1458341
DA 2018-10-19
ER

PT J
AU LEGEAIS, JM
   ROSSI, C
   RENARD, G
   SALVOLDELLI, M
   DHERMIES, F
   POULIQUEN, YJ
AF LEGEAIS, JM
   ROSSI, C
   RENARD, G
   SALVOLDELLI, M
   DHERMIES, F
   POULIQUEN, YJ
TI A NEW FLUOROCARBON FOR KERATOPROSTHESIS
SO CORNEA
LA English
DT Article
DE KERATOPROSTHESIS; BIOMATERIAL; POLYMER; FLUOROCARBON;
   POLYTETRAFLUOROETHYLENE; PROPLAST; GORE-TEX; IMPRA
AB Previous studies have demonstrated the potential use of microporous, biocompatible materials to improve the long-term stability of keratoprosthesis. To determine the factors that will influence corneal tissue ingrowth into biocompatible, microporous materials, we have compared three types of fluorocarbon polymers-Impra, Gore-Tex, and Proplast-after intrastromal implantation in rabbit corneas. Despite similar physicochemical structures, a great difference was observed in histologic and ultrastructural cross sections after 4- and 8-month follow-ups. For Gore-Tex, we observed extrusion of the implant and infiltration of necrotic and inflammatory cells. All implants of Proplast also led to significant corneal damage resulting in extrusion of the material. Through the use of electron and light microscopy and image analysis, this study demonstrates the presence of cell differentiation and collagen synthesis in the pores of the Impra implant. Apart from biocompatibility, this experiment demonstrates the influence of pore size, porous microorganization, and biomechanical factors on prosthetic corneal material. Only Impra offers satisfactory interface, allowing fibroblastic cells and neocollagen synthesis into its pores, and it can become transparent.
RP LEGEAIS, JM (reprint author), HOP HOTEL DIEU,INSERM,DEPT OPHTHALMOL,U86,1 PL PARVIS NOTRE DAME,F-75181 PARIS 04,FRANCE.
NR 0
TC 39
Z9 45
U1 0
U2 2
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0277-3740
J9 CORNEA
JI Cornea
PD NOV
PY 1992
VL 11
IS 6
BP 538
EP 545
DI 10.1097/00003226-199211000-00010
PG 8
WC Ophthalmology
SC Ophthalmology
GA JU431
UT WOS:A1992JU43100010
PM 1468216
DA 2018-10-19
ER

PT J
AU GREISLER, HP
   JOYCE, KA
   KIM, DU
   PHAM, SM
   BERCELI, SA
   BOROVETZ, HS
AF GREISLER, HP
   JOYCE, KA
   KIM, DU
   PHAM, SM
   BERCELI, SA
   BOROVETZ, HS
TI SPATIAL AND TEMPORAL CHANGES IN COMPLIANCE FOLLOWING IMPLANTATION OF
   BIORESORBABLE VASCULAR GRAFTS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID MACROPHAGE BIOMATERIAL INTERACTIONS; GROWTH-FACTOR; CHARACTERIZATION
   INVITRO; BIOMECHANICAL PROPERTIES; ATHEROGENIC DIET; PROLIFERATION;
   COMBINATIONS; PROSTHESES; KINETICS
AB Compliance matching between the host vessel and vascular grafts used for small-diameter arterial replacements is thought to be important for long-term patency. However, currently available grafts elicit fibroplastic reactions, resulting in decreasing compliance with time after implantation. Bioresorbable prostheses elicit ingrowth of myofibroblasts containing abundant contractile elements. This led us to investigate whether compliance of implanted bioresorbable prostheses decreased as a function of time and if the kinetics of change correlated with the progession of tissue ingrowth. Woven polyglactin 910 prostheses (10 mm x 4 mm i.d.) were implanted into adult NZW rabbit infrarenal aortas and replicates were harvested serially through 8 months. Control grafts were implanted, and immediately resected. Dynamic compliance was measured at 1-mm axial increments along each explant using a pulse duplicator apparatus which exposed the harvested samples to realistic pulsatile hemodynamics. Compliance was calculated for proximal, mid, and distal segments of each graft and averaged at each time point by grouping into control (zero time, n = 3), early (1-4 weeks, n = 13), and late (6-36 weeks, n = 9) explant periods. At late explant periods both proximal and distal compliance were significantly greater than mid graft compliance (p < .02 and p < .03, respectively). There was a significant increase in proximal compliance between early and late explant times (p < .01). Measured increases in mid and distal segment compliance over time did not reach statistical significance. Myofibroblast laden tissue ingrowth into the inner capsule followed macrophage phagocytosis and was nearly complete prior to the time that an increase in compliance was demonstrated. Thus since the major histologic episodes precede the change in compliance, these are not likely initiated by this biomechanical change. We hypothesize the graft resorption coupled with the ingrowth of more compliant tissue likely leads to the increased compliance of the graft material.
C1 ST BARNABAS HOSP,DEPT PATHOL,LIVINGSTON,NJ 07039.
   UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA 15260.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,MAYWOOD,IL 60153, USA.
OI Berceli, Scott/0000-0003-2257-0111
FU NHLBI NIH HHS [R01 HL41272, R01 HL34739]
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BAIRD RN, 1976, LANCET, V30, P948
   BERGEL DH, 1961, J PHYSIOL-LONDON, V156, P445, DOI 10.1113/jphysiol.1961.sp006686
   BRANT AM, 1986, ARTIF ORGANS, V10, P419, DOI 10.1111/j.1525-1594.1986.tb02591.x
   BRANT AM, 1987, J APPL PHYSIOL, V62, P679
   BUNTIN CM, 1990, ANN BIOMED ENG, V18, P549, DOI 10.1007/BF02364617
   CLOWES AW, 1983, LAB INVEST, V49, P327
   ENDEAN ED, 1987, SURG FORUM, V38, P323
   FRY DL, 1969, CIRC RES, V24, P93, DOI 10.1161/01.RES.24.1.93
   GOW BS, 1968, CIRC RES, V23, P111, DOI 10.1161/01.RES.23.1.111
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H. P., 1991, VASCULAR ENDOTHELIUM, P253
   GREISLER HP, 1987, J VASC SURG, V5, P572, DOI 10.1067/mva.1987.avs0050572
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1991, J VASC SURG, V14, P10
   GREISLER HP, 1990, CARDIOVASCULAR SCI T, P55
   Hasson J E, 1985, J Vasc Surg, V2, P419
   KIDSON IG, 1978, CIRCULATION S, V1, P1
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   MELLISINOS AC, 1966, EXPT MODERN PHYSICS, P469
   O'ROURKE MICHAEL F., 1967, CARDIOVASC RES, V1, P313, DOI 10.1093/cvr/1.4.313
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   RODGERS VGJ, 1986, J VASC SURG, V4, P396, DOI 10.1067/mva.1986.avs0040396
   RODGERS VGJ, 1987, J BIOMECH, V8, P795
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   ZWOLAK RM, 1987, J VASC SURG, V5, P126, DOI 10.1067/mva.1987.avs0050126
NR 34
TC 22
Z9 22
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 1992
VL 26
IS 11
BP 1449
EP 1461
DI 10.1002/jbm.820261105
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JU766
UT WOS:A1992JU76600004
PM 1447229
DA 2018-10-19
ER

PT J
AU DRIESSENS, FCM
   RAMSELAAR, MMA
   SCHAEKEN, HG
   STOLS, ALH
   VANMULLEM, PJ
   DEWIJN, JR
AF DRIESSENS, FCM
   RAMSELAAR, MMA
   SCHAEKEN, HG
   STOLS, ALH
   VANMULLEM, PJ
   DEWIJN, JR
TI CHEMICAL-REACTIONS OF CALCIUM-PHOSPHATE IMPLANTS AFTER IMPLANTATION
   INVIVO
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CERAMICS; BETA-CA3(PO4)2; BEHAVIOR; DYNAMICS
AB Sintered microporous cylinders of hydroxyapatite (OHA), tertiary calcium phosphate (beta-TCP and rhenanite (CaNaPO4) were implanted in the bone of the forehead of the domestic pig (Sus scrofa). Implants together with the surrounding bone were retrieved after 6 and 12 weeks. X-ray diffraction showed that OHA and beta-TCP maintain their crystal structure upon implantation. However, rhenanite is transformed completely into an apatite within 6 weeks. This apatite later incorporates sodium and carbonate. Both beta-TCP and rhenanite implants showed some resorption but were otherwise covered with new bone. Electron microprobe analysis showed that the mineral at the interface had a Ca/P ratio characteristic of new bone. At a certain distance from the interface lower Ca/P ratios were found, characteristic of precursor phases of bone mineral. This suggests that the deposition of new bone starts, at least partially, from the surface of the implant. Therefore, beta-TCP as well as rhenanite may be called an osteoconductive biomaterial.
C1 CATHOLIC UNIV NIJMEGEN,SCH MED,SCH ORAL HISTOL DENT,DEPT CELL BIOL & HISTOL,NIJMEGEN,NETHERLANDS.
   LEIDEN UNIV,DEPT BIOMAT,2300 RA LEIDEN,NETHERLANDS.
RP DRIESSENS, FCM (reprint author), CATHOLIC UNIV NIJMEGEN,SCH MED,SCH ORAL HISTOL DENT,DEPT ORAL FUNCT & PROSTHET DENT,NIJMEGEN,NETHERLANDS.
CR CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   de Groot K, 1985, Zahnarztl Mitt, V75, P1938
   Driessens F C, 1988, Ann N Y Acad Sci, V523, P131, DOI 10.1111/j.1749-6632.1988.tb38507.x
   Driessens F. C. M., 1988, IMPLANT MAT BIOFUNCT, P105
   DRIESSENS FCM, 1987, B SOC CHIM BELG, V96, P173
   DRIESSENS FCM, 1987, Z NATURFORSCH C, V42, P916
   DRIESSENS FCM, 1986, Z NATURFORSCH C, V41, P468
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P1
   DRIESSENS FCM, 1989, 1ST EUR CER SOC C B, V1, P15
   DRIESSENS FCM, 1989, BIOMINERALS
   Driessens FCM, 1990, BIOMINERALS
   DRISKELL TD, 1973, IADR ABSTR, P259
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P634, DOI 10.1097/00006534-197905000-00005
   FISCHERBRANDIES E, 1989, DEUT ZAHNAERZTL Z, V44, P436
   GREGORY TM, 1974, J RES NBS A PHYS CH, VA 78, P667, DOI 10.6028/jres.078A.042
   GUILLEMIN G, 1989, 8TH EUR C BIOM HEID
   JACOBS HG, 1984, STSCH Z MUND KIEFER, V85, P38
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   KLEIN CPAT, 1989, BIOMATERIALS, V10, P59
   KRAUSE A, 1986, STSCH Z MUND KIEFER, V10, P108
   Newesely H, 1984, Zahn Mund Kieferheilkd Zentralbl, V72, P230
   OONISHI H, 1989, 2ND INT S CER MED BI
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   RABALAIS ML, 1981, J PERIODONTOL, V52, P680, DOI 10.1902/jop.1981.52.11.680
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   RENOOIJ W, 1985, CLIN ORTHOP RELAT R, V197, P272
   SCHAEKEN HG, 1983, Z ANORG ALLG CHEM, V505, P48, DOI 10.1002/zaac.19835051006
   VERBEECK RMH, 1986, B SOC CHIM BELG, V95, P455
   VERBEECK RMH, 1980, Z ANORG ALLG CHEM, V466, P76, DOI 10.1002/zaac.19804660109
   VERBEECK RMH, 1980, Z PHYS CHEM NEUE FOL, V119, P79, DOI 10.1524/zpch.1980.119.1.079
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
NR 32
TC 25
Z9 25
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 1992
VL 3
IS 6
BP 413
EP 417
DI 10.1007/BF00701237
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JY820
UT WOS:A1992JY82000005
DA 2018-10-19
ER

PT J
AU REID, G
   DENSTEDT, JD
   KANG, YS
   LAM, D
   NAUSE, C
AF REID, G
   DENSTEDT, JD
   KANG, YS
   LAM, D
   NAUSE, C
TI MICROBIAL ADHESION AND BIOFILM FORMATION ON URETERAL STENTS INVITRO AND
   INVIVO
SO JOURNAL OF UROLOGY
LA English
DT Article
DE BACTERIA; STENTS; URETER
ID URINARY-TRACT INFECTION; CATHETERS; SURFACES; THERAPY; FLORA
AB Thirty ureteral stents, inserted for 5 to 128 days following extracorporeal shock wave lithotripsy, were examined for the presence of bacterial biofilms. Of these, 90% had adherent pathogens (44% mixed organisms) on the stents, 45% of which were present in low numbers (10(1)-10(2) per 1 cm3 section) and 55% were in small and large microcolony biofilms (>2 x 10(2)-10(7)). The organisms were recovered from the stents even though urine culture was only positive in 27% of patients. Of the organisms isolated, 77% were Gram positive cocci, 15% Gram negative rods and 8% Candida. No blockage of the stents occurred. All of the patients had received antimicrobial therapy post-insertion, and in 15 cases biofilms were found while on treatment. None of the patients received therapy for urinary tract infections while the stent remained in place. In vitro experiments demonstrated the ability of Escherichia coli, Proteus mirabilis, Staphylococcus epidermidis and Enterococcus faecalis uropathogens to adhere and form biofilms on ureteral stents within 24 hours. Clearly, bacterial biofilms do occur on ureteral stents and urinary culture may not detect their presence. The high recovery rate of Gram positive organisms may indicate a preferential adhesion to the biomaterial surface. The findings also indicate that unlike biofilm formation on many other prosthetic implants, colonization with Gram positive organisms on ureteral stents does not necessarily coincide with the development symptomatic infection.
C1 UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5S 1A1,ONTARIO,CANADA.
   UNIV WESTERN ONTARIO,ST JOSEPHS HLTH CTR,DIV UROL,LONDON,ONTARIO,CANADA.
RP REID, G (reprint author), UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON N6A 5B8,ONTARIO,CANADA.
CR ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   ANWAR H, 1992, IN PRESS INT BIODETE
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DASGUPTA MK, 1989, BLOOD PURIFICAT, V7, P144, DOI 10.1159/000169586
   FRANCO G, 1990, BRIT J UROL, V65, P10, DOI 10.1111/j.1464-410X.1990.tb14650.x
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   KUNIN CM, 1985, J CLIN MICROBIOL, V21, P902
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   NICKEL JC, 1985, CAN J SURG, V28, P50
   RAMSAY JWA, 1987, BRIT J UROL, V60, P504, DOI 10.1111/j.1464-410X.1987.tb05029.x
   REID G, 1988, MICROBIAL ECOL, V16, P241, DOI 10.1007/BF02011698
   REID G, 1990, SCAND J INFECT DIS, V22, P43, DOI 10.3109/00365549009023118
   REID G, 1987, REV INFECT DIS, V9, P470
   REID G, 1992, AM UROLOGICAL ASS UP, V11, P138
   REID G, 1991, BIOFOULING, V4, P171, DOI DOI 10.1080/08927019109378207
   SPIRNAK JP, 1985, J UROLOGY, V134, P349, DOI 10.1016/S0022-5347(17)47163-1
NR 16
TC 120
Z9 122
U1 0
U2 15
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD NOV
PY 1992
VL 148
IS 5
BP 1592
EP 1594
DI 10.1016/S0022-5347(17)36976-8
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA JW460
UT WOS:A1992JW46000068
PM 1433574
DA 2018-10-19
ER

PT J
AU LEWANDOWSKA, K
   PERGAMENT, E
   SUKENIK, CN
   CULP, LA
AF LEWANDOWSKA, K
   PERGAMENT, E
   SUKENIK, CN
   CULP, LA
TI CELL-TYPE-SPECIFIC ADHESION MECHANISMS MEDIATED BY FIBRONECTIN ADSORBED
   TO CHEMICALLY DERIVATIZED SUBSTRATA
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FLUORESCENCE ENERGY-TRANSFER; SITE-DIRECTED MUTAGENESIS; NEURO-BLASTOMA
   CELLS; PLASMA FIBRONECTIN; BINDING DOMAIN; FRAGMENTS; ADSORPTION;
   FIBROBLASTS; MODULATION; SEQUENCE
AB Plasma fibronectin (pFN) adhesion mechanisms on inert substrata were evaluated for murine fibroblasts (3T3) and human neuroblastoma (Platt) cells using glass coverslips chemically derivatized with a self-assembled monolayer of aliphatic chains terminated with a specific end-group to interact with adsorbed pFN: [CH3], [SH], [SCOCH3], [NH2], [SO3H], or underivatized glass [SiOH]. All surfaces bound similar amounts of pFN and facilitated attachment of both cell types within narrow ranges. However, spreading/differentiation responses of cells differed considerably among the surfaces. While 3T3 cells spread and developed microfilament stress fibers comparably on all surfaces, inclusion of an RGDS-containing synthetic peptide in the medium revealed variation in resistance to stress fiber formation mediated by an RGDS-recognizing integrin: [NH2] > [CH3] >> [SiOH],[SH],[SCOCH3]. Different patterns of neurite formation were observed for neuroblastoma cells: [SiOH], [SO3H] > [SCOCH3],[SH] >> [CH3] > [NH2]. Similarity in cell responses to both [CH3] and [NH2] surfaces argues against a pattern dependent upon the hydrophobicity of substrata. When pFN was diluted to a subsaturable concentration with albumin for adsorption, neuroblastoma responses changed significantly from those observed on pFN-saturated surfaces, for both spreading and neurite generation: [NH2],[SO3H] >> [SH], [SCOCH3] > [SiOH],[CH3]. Responses to the pFN:albumin mixture were markedly improved from responses after sequential adsorptions, demonstrating "optimization" of pFN conformation (not merely binding) by coadsorption of albumin molecules. In most cases, the [NH2] surface yielded responses distinctively different from the other surfaces. Overall, these data suggest many variations in the conformation of pFN molecules adsorbed to specific inert surfaces, as well as variations in the responses of cell surface receptors to conformationally specific pFNs. They also reveal cell-type-specific changes in differentiated cell responses on derivatized substrata, mediated by different classes of cell surface receptors for the two cell types, and provide optimism for regulating FN-dependent adhesion mechanisms in either positive or negative contexts on biomaterial surfaces derivatized with one or more of these chemical end-groups.
C1 CASE WESTERN RESERVE UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, CLEVELAND, OH 44106 USA.
   CASE WESTERN RESERVE UNIV, DEPT CHEM, CLEVELAND, OH 44106 USA.
FU NINDS NIH HHS [NS17139]; NCI NIH HHS [CA27755]
CR AOTA S, 1991, J BIOL CHEM, V266, P15938
   BALACHANDER N, 1990, LANGMUIR, V6, P1621, DOI 10.1021/la00101a001
   BALACHANDER N, 1988, TETRAHEDRON LETT, V29, P5593, DOI 10.1016/S0040-4039(00)80820-5
   BENECKY MJ, 1990, BIOCHEMISTRY-US, V29, P3082, DOI 10.1021/bi00464a027
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   CULP LA, 1986, CIBA F SYMP, V124, P158
   CULP LA, 1991, BIOCH MOL ASPECTS SE, V1, P99
   CULP LA, 1990, SEMINARS DEV BIOL DE, V1, P437
   DAVIES JS, 1990, BIOCHEM SOC T, V18, P1326, DOI 10.1042/bst0181326
   GIROUX TA, 1990, J COLLOID INTERF SCI, V139, P351, DOI 10.1016/0021-9797(90)90109-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GRINNELL F, 1989, EXP CELL RES, V182, P668, DOI 10.1016/0014-4827(89)90270-X
   HAAS R, 1982, J CELL PHYSIOL, V113, P289, DOI 10.1002/jcp.1041130217
   HALL MD, 1988, EXP CELL RES, V179, P115, DOI 10.1016/0014-4827(88)90353-9
   HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   KHAN MY, 1988, J BIOL CHEM, V263, P11314
   LEWANDOWSKA K, 1990, J CELL SCI, V95, P75
   LEWANDOWSKA K, 1988, FEBS LETT, V237, P35, DOI 10.1016/0014-5793(88)80166-2
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MCABEE DD, 1983, J CELL BIOL, V97, P1515, DOI 10.1083/jcb.97.5.1515
   MCCARTHY JB, 1988, J NATL CANCER I, V80, P108, DOI 10.1093/jnci/80.2.108
   MIYAMOTO Y, 1988, BIOCHIM BIOPHYS ACTA, V953, P306, DOI 10.1016/0167-4838(88)90039-8
   MUGNAI G, 1988, EXP CELL RES, V175, P229, DOI 10.1016/0014-4827(88)90189-9
   MUGNAI G, 1988, J CELL BIOL, V106, P931, DOI 10.1083/jcb.106.3.931
   NAGATA K, 1985, J CELL BIOL, V101, P386, DOI 10.1083/jcb.101.2.386
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RADINSKY R, 1990, CANCER RES, V50, P4388
   ROGERS SL, 1985, J NEUROSCI, V5, P369
   SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   WOLFF C, 1989, ARCH BIOCHEM BIOPHYS, V268, P536, DOI 10.1016/0003-9861(89)90320-2
   WOLFF CE, 1990, BIOCHEMISTRY-US, V29, P3354, DOI 10.1021/bi00465a030
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 42
TC 115
Z9 115
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1992
VL 26
IS 10
BP 1343
EP 1363
DI 10.1002/jbm.820261007
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JM852
UT WOS:A1992JM85200006
PM 1429751
DA 2018-10-19
ER

PT J
AU DEBRUIJN, JD
   KLEIN, CPAT
   DEGROOT, K
   VANBLITTERSWIJK, CA
AF DEBRUIJN, JD
   KLEIN, CPAT
   DEGROOT, K
   VANBLITTERSWIJK, CA
TI THE ULTRASTRUCTURE OF THE BONE HYDROXYAPATITE INTERFACE INVITRO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ELECTRON-MICROSCOPY; HYDROXYLAPATITE INTERFACE; MATRIX PRODUCTION;
   OSTEOBLASTS; TISSUE; APATITE; BIOMATERIALS; SUBSTRATA; IMPLANTS;
   CERAMICS
AB Rat bone marrow cells were cultured on plasma-sprayed hydroxyapatite (HA). The cells formed a mineralized extracellular matrix (ECM) that exhibited several characteristics of bone tissue. The interface between this mineralized ECM and the HA was studied at the ultrastructural level with scanning and transmission electron microscopy and x-ray microanalysis. Initially, the deposition of a globular, afibrillar matrix was observed on HA. This was followed by the integration of collagen fibers in this matrix and their subsequent mineralization. At the bone-HA interface two distinctly different interfacial structures were observed. An electron-dense layer with a thickness of 20-60 nm was regularly present, which contained both organic and inorganic material and was rich in glycosaminoglycans. The interfaces differed however, in the presence or absence of an amorphous zone which was free of collagen fibers and had an average thickness of 0.7-0.8-mu-m. It was frequently seen interposed between the electron-dense layer and the hydroxyapatite. Similar interfacial structures have also been described in the in vivo environment, where they were referred to as lamina limitans-like or cement linelike. From the results of this study, it can be concluded that the described in vitro system is a suitable model to study bone-biomaterial interactions.
RP DEBRUIJN, JD (reprint author), LEIDEN UNIV, DEPT EAR NOSE & THROAT, BIOMAT RES GRP, OTOBIOL & BIOCOMPATIBIL LAB, BLDG 25, 2333 AA LEIDEN, NETHERLANDS.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   BANCROFT JD, 1982, THEORY PRACTICE HIST, P383
   BIANCO P, 1988, CALCIFIED TISSUE INT, V43, P167, DOI 10.1007/BF02571315
   BOIVIN G, 1990, ACTA ORTHOP SCAND, V61, P170, DOI 10.3109/17453679009006514
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   DAVIES JE, 1990, HDB BIOACTIVE CERAMI, V1, P1
   DEBRUIJN JD, 1991, INTERFACES MED MECHA, V2, P420
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   FRASCA P, 1981, ACTA ANAT, V109, P115
   FUJIU T, 1984, J BIOMED MATER RES, V18, P845, DOI 10.1002/jbm.820180714
   GANELES J, 1986, J PERIODONTOL, V57, P133, DOI 10.1902/jop.1986.57.3.133
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GROOT CG, 1982, THESIS U LEIDEN NETH
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   HARMAND MF, 1987, BIOL BIOMECHANICAL P, P361
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   KLEIN CPAT, 1983, BIOMATERIALS, V4, P181, DOI 10.1016/0142-9612(83)90007-8
   LOWENBERG B, 1991, CELL MATER, V1, P177
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   OSBORN JF, 1980, BIOMATERIALS, P51
   SAUTIER JM, 1991, CELL MATER, V1, P209
   SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302
   SCHERFT JP, 1968, J ULTRA MOL STRUCT R, V23, P333, DOI 10.1016/S0022-5320(68)80010-3
   SCHERFT JP, 1978, J ULTRA MOL STRUCT R, V64, P173, DOI 10.1016/S0022-5320(78)80035-5
   SCOTT BL, 1971, J ULTRA MOL STRUCT R, V36, P565, DOI 10.1016/S0022-5320(71)90015-3
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   UCHIDA A, 1987, J BIOMED MATER RES, V21, P1, DOI 10.1002/jbm.820210106
   VAN PT, 1982, CELL TISSUE RES, V225, P283
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   VANBLITTERSWIJK CA, 1985, BIOMATERIALS, V6, P243, DOI 10.1016/0142-9612(85)90020-1
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P331
   VEERMAN ECI, 1988, IMPLANT MATERIALS BI, V8, P337
NR 43
TC 115
Z9 115
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 1992
VL 26
IS 10
BP 1365
EP 1382
DI 10.1002/jbm.820261008
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JM852
UT WOS:A1992JM85200007
PM 1331114
DA 2018-10-19
ER

PT J
AU WU, H
   ZHU, TB
   DU, JY
   HONG, GX
   SUN, SZ
   XU, XH
AF WU, H
   ZHU, TB
   DU, JY
   HONG, GX
   SUN, SZ
   XU, XH
TI NEW BONE-FORMATION IN THE INVIVO IMPLANTATION OF BIOCERAMICS - A
   QUANTITATIVE-ANALYSIS
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
ID ELECTROMAGNETIC-FIELDS
AB Two kinds of synthetic biomaterial, porous tricalcium phosphate (PTCP) and magnetic porous tricalcium phosphate (MPTCP) ceramic granules were implanted in rat femur. In the period of 4 months, the assessment of serial histological sections, scanning electron microphotographs and quantitative analysis of bone formation in the sections showed that both ceramics are biocompatible and degradable in vivo. More new bone formation occurred in the MPTCP group. Endochondral ossification was seen in both groups. The quantitative analysis in this study is reliable, and may be suitable to the similar experimental models.
C1 WUHAN TECHNOL UNIV,WUHAN 430070,PEOPLES R CHINA.
RP WU, H (reprint author), TONGJI MED UNIV,UNION HOSP,DEPT ORTHOPED,WUHAN 430022,PEOPLES R CHINA.
CR BASSETT CAL, 1984, ORTHOP CLIN N AM, V15, P61
   BRUCE GK, 1987, CLIN ORTHOP RELAT R, V222, P300
   BUCHOLZ RW, 1989, CLIN ORTHOPAEDICS, V248, P169
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, V232, P127
   ELLIES LG, 1988, J BIOMED MATER RES, V22, P137, DOI 10.1002/jbm.820220206
   HOLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   LAVINE LS, 1987, J BONE JOINT SURG AM, V69A, P626, DOI 10.2106/00004623-198769040-00024
   PASSUTI N, 1989, CLIN ORTHOPAEDICS, V240, P53
   RENOOIJ W, 1985, CLIN ORTHOPAEDICS, V197, P292
   SHARRARD WJW, 1984, ORTHOP CLIN N AM, V15, P143
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
NR 11
TC 3
Z9 6
U1 0
U2 3
PU CHINESE MEDICAL ASSOCIATION
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD SEP
PY 1992
VL 105
IS 9
BP 753
EP 757
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA JU435
UT WOS:A1992JU43500011
PM 1288979
DA 2018-10-19
ER

PT J
AU DACQUET, V
   VARLET, A
   TANDOGAN, RN
   TAHON, MM
   FOURNIER, L
   JEHL, F
   MONTEIL, H
   BASCOULERGUE, G
AF DACQUET, V
   VARLET, A
   TANDOGAN, RN
   TAHON, MM
   FOURNIER, L
   JEHL, F
   MONTEIL, H
   BASCOULERGUE, G
TI ANTIBIOTIC-IMPREGNATED PLASTER OF PARIS BEADS - TRIALS WITH TEICOPLANIN
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; LOADED PLASTER; OSTEOMYELITIS; PELLETS
AB Teicoplanin-impregnated plaster of paris beads were made and in vitro release properties were studied. Teicoplanin was released in an initial massive dose, with a rapid decline during the first three days, followed by a slowly declining prolonged release up to 30 days. The release tested by diffusion in gelose and high-performance liquid chromatography was found to be 21.4% and 28.2%, respectively, of the amount theoretically present in the beads. Plaster of paris is a resorbable, nontoxic biomaterial that has already been used to fill dead spaces in bone and deliver antibiotics in the treatment of chronic osteomyelitis. The addition of teicoplanin, a new antistaphylococcal agent with low known bacterial resistance, is a promising alternative. Follow-up tests in vivo, simulating local conditions of the osteomyelitic bone, are necessary to prove efficacy.
RP DACQUET, V (reprint author), UNITE SEPT,INST CALOT,F-62608 BERCK,FRANCE.
CR BABUL N, 1988, DRUG INTEL CLIN PHAR, V22, P218, DOI 10.1177/106002808802200309
   BASCOULERGUE G, 1983, 2ND ANN M EUR GROUP
   BERNAREGGI A, 1986, ANTIMICROB AGENTS CH, V30, P733, DOI 10.1128/AAC.30.5.733
   BOIFFARD O, 1989, SEM HOP PARIS, V45, P2752
   Bouillet R, 1989, Acta Orthop Belg, V55, P1
   CARBON C, 1988, LETT INFECTIOLOG S20, V3, P13
   CARPER HT, 1987, J ANTIMICROB CHEMOTH, V19, P659, DOI 10.1093/jac/19.5.659
   DACQUET V, 1989, OCT JOURN I CAL BERC
   DAOUD A, 1979, REV CHIR ORTHOP, V65, P441
   Debeaumont D., 1982, CLIN ORTHOPAEDICS, V167, P263
   DINGELDEIN E, 1976, Z UNFALLCHIRUGI 1112
   DRESSMANN H, 1892, BEITR KLIN CHIR, V9, P804
   EVRARD J, 1971, SPECIAL MAI, V57, P439
   GREENWOOD D, 1988, J ANTIMIC CHEMOTH SA, V2
   GRIEBEN A, 1981, S AFR MED J, V60, P395
   GRISTINA AG, 1983, J BONE JOINT SURG AM, V65, P128, DOI 10.2106/00004623-198365010-00021
   GROVE DC, 1955, ASSAY METHODS ANTIBI
   JEHL F, 1988, J ANTIMICROB CHEMOTH, V21, P53, DOI 10.1093/jac/21.suppl_A.53
   Jenny G, 1988, Reconstr Surg Traumatol, V20, P36
   Jenny J Y, 1986, Acta Orthop Belg, V52, P113
   KORACEVIC B, 1953, DTSCH ZENTRALBLATT C, V276, P432
   KORENDIASEV M A, 1959, Ortop Travmatol Protez, V20, P18
   LEMAN G, 1986, ACTA CHIR BELG, V86, P41
   LEWIS P, 1988, J ANTIMICROB CHEMOTH, V21, P61, DOI 10.1093/jac/21.suppl_A.61
   LOPITAUX R, 1978, REV RHUM, V45, P193
   Martini M, 1981, Acta Orthop Belg, V47, P79
   NIKULIN A, 1956, ACTA MED IUGOSL, V10, P1
   NORDEN CW, 1988, REV INFECT DIS, V10, P103
   NORDEN CW, 1986, INFECTION, V14, P136, DOI 10.1007/BF01643479
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   PALLANZA R, 1989, EFFECT ANAEROBIOSIS
   PATTON KR, 1987, DRUG EXP CLIN RES, V13, P547
   PAULUZZI S, 1987, J ANTIMICROB CHEMOTH, V20, P431, DOI 10.1093/jac/20.3.431
   PELTIER L F, 1961, Clin Orthop, V21, P1
   PELTIER LF, 1978, J BONE JOINT SURG AM, V60, P820, DOI 10.2106/00004623-197860060-00017
   PETROVA A, 1927, TRAUMATOL I LENINGRA, V2, P1071
   PIGANIOL G, 1982, CHIRURGIE, V108, P484
   PINON P, 1981, REV CHIR ORTHOP, V67, P35
   SIX B, 1987, THESIS U LILLE I FRA
   TSUKAYAMA DT, 1988, ORTHOPEDICS, V11, P1285
   VARLET A, 1985, REV CHIR ORTHOP, V71, P73
   VARLET A, 1983, REV CHIR ORTHOP, V69, P239
   VARLET A, 1984, TECNICIEN BIOL, V6, P297
   VINCENEUX P, 1984, ACTUALITE RHUMATOLOG, P284
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
   WALEMKAMP GH, 1983, GENTAMYCIN PMMA BEAD
   WALENKAMP GHI, 1986, CLIN ORTHOP RELAT R, V205, P171
NR 47
TC 54
Z9 55
U1 0
U2 3
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD SEP
PY 1992
IS 282
BP 241
EP 249
PG 9
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA JM402
UT WOS:A1992JM40200032
PM 1387599
DA 2018-10-19
ER

PT J
AU BANDYK, DF
AF BANDYK, DF
TI DIAGNOSIS AND TREATMENT OF BIOMATERIAL-ASSOCIATED VASCULAR INFECTIONS
SO INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
LA English
DT Article
ID AORTIC GRAFT INFECTION; STAPHYLOCOCCUS-EPIDERMIDIS; PROSTHESES; CULTURES
C1 UNIV S FLORIDA, COLL MED, DEPT SURG, TAMPA, FL 33612 USA.
CR BANDYK DF, 1984, ARCH SURG-CHICAGO, V119, P102
   BANDYK DF, 1991, J VASC SURG, V13, P575
   BERGAMINI TM, 1989, J VASC SURG, V9, P665, DOI 10.1067/mva.1989.vs0090665
   DURHAM JR, 1987, J VASC SURG, V5, P160, DOI 10.1067/mva.1987.avs0050160
   ERNST CB, 1977, ANN SURG, V185, P626, DOI 10.1097/00000658-197706000-00003
   GEARY KJ, 1990, J VASC SURG, V11, P339, DOI 10.1067/mva.1990.17626
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   KAEBNICK HW, 1987, SURGERY, V102, P756
   KINNEY EV, 1991, J SURG RES, V50, P430, DOI 10.1016/0022-4804(91)90020-M
   LEVY MF, 1990, J CLIN MICROBIOL, V28, P664
   LIEKWEG WG, 1977, SURGERY, V81, P335
   MACBETH GA, 1984, J VASC SURG, V1, P750, DOI 10.1067/mva.1984.avs0010750
   OLOFSSON PA, 1988, J VASC SURG, V8, P99, DOI 10.1067/mva.1988.avs0080099
   REILLY LM, 1987, J VASC SURG, V5, P421, DOI 10.1067/mva.1987.avs0050421
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   SEDWITZ MM, 1987, J VASC SURG, V6, P476, DOI 10.1067/mva.1987.avs0060476
   SHAH PM, 1987, J SURG RES, V42, P298, DOI 10.1016/0022-4804(87)90147-8
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
NR 19
TC 12
Z9 12
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0891-5520
EI 1557-9824
J9 INFECT DIS CLIN N AM
JI Infect. Dis. Clin. North Am.
PD SEP
PY 1992
VL 6
IS 3
BP 719
EP 729
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA JT668
UT WOS:A1992JT66800014
PM 1431048
DA 2018-10-19
ER

PT J
AU XI, TF
   MA, JZ
   TIAN, WH
   LEI, XH
   LONG, SH
   XI, BS
AF XI, TF
   MA, JZ
   TIAN, WH
   LEI, XH
   LONG, SH
   XI, BS
TI PREVENTION OF TISSUE CALCIFICATION ON BIOPROSTHETIC HEART-VALVE BY USING
   EPOXY COMPOUNDS - A STUDY OF CALCIFICATION TESTS INVITRO AND INVIVO
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BOVINE PERICARDIUM; MINERALIZATION; BIOMATERIAL; MECHANISMS
AB Calcification is the principal cause of the clinical failures of the bioprosthetic heart valves fabricated from glutaraldehyde pretreated porcine aortic valves or bovine pericardium. In this paper, we compared the calcification on various types of bovine pericardiums pretreated with two hydrophilic epoxy compounds adding GA post-treatment (EP 1 and EP 2), glutaraldehyde (GA)- and nontreated pericardium (Fresh), respectively, by in vitro and in vivo tests. Significant decrease of calcification was found by pretreatment with both epoxy compounds rather than with glutaraldehyde: 0.250 +/- 0.001 (Fresh), 0.276 +/- 0.058 (EP 1), 0.302 +/- 0.071 (EP 2), and 0.478 +/- 0.172 (G )mu-g (Ca)/mg (dried tissue), respectively, after 20 days dipping in a simulating serum solution in vitro; 115.13 +/- 60.11 (Fresh), 129.84 +/- 51.08 (EP 1), 167.39 +/- 20.81 (EP 2), and 205.19 +/- 16.86 (GA) mu-g/mg, respectively, after 3 months subcutaneous implantation in rabbits. The in vitro method for evaluating calcification designed by us gave the similar order among four samples with that obtained by in vivo test. Because the bovine pericardium pretreated with the epoxy compounds adding GA post-treatment possesses the greater tenacity than that pretreated only with epoxy compounds or GA, meanwhile the calcification is also significantly decreased with this pretreatment, it may be expected that the bovine pericardium with this pretreatment will have the greater anticalcification and durability in dynamic stress.
C1 NATL INST CONTROL PHARMACEUT & BIOL PROD,CTR MED DEVICES,BEIJING 100050,PEOPLES R CHINA.
   TSING HUA UNIV,BIOMECH LAB,BEIJING 100084,PEOPLES R CHINA.
CR COSGROVE DM, 1985, J THORAC CARDIOV SUR, V89, P358
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   IONESCU MI, 1979, TISSUE HEART VALVES, P201
   Levy R J, 1985, Trans Am Soc Artif Intern Organs, V31, P459
   LEVY RJ, 1991, BIOMATERIALS, V12, P707, DOI 10.1016/0142-9612(91)90017-5
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   Reul G J Jr, 1985, J Vasc Surg, V2, P192
   Schoen F.J., 1987, T AM SOC ART INT ORG, V33, P8
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   TOMAZIC BB, 1987, SCANNING MICROSCOPY, V1, P95
   WEBB CL, 1990, T AM SOC ART INT ORG, V36, P56
   WEBB CL, 1988, T AM SOC ART INT ORG, V34, P855
   WOODWARD SC, 1981, T AM SOC ART INT ORG, V27, P697
   XI TF, IN PRESS EFFECT PORE
NR 21
TC 32
Z9 32
U1 3
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1992
VL 26
IS 9
BP 1241
EP 1251
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JJ464
UT WOS:A1992JJ46400012
PM 1429769
DA 2018-10-19
ER

PT J
AU COLLET, D
   RABAUD, M
   LEFEBVRE, F
   COUDERC, B
   QUENTIN, C
   PERISSAT, J
AF COLLET, D
   RABAUD, M
   LEFEBVRE, F
   COUDERC, B
   QUENTIN, C
   PERISSAT, J
TI EVALUATION OF ELASTIN FIBRIN BIOMATERIAL IN EXPERIMENTAL PANCREATIC
   SURGERY
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB Artificial connective soft tissue, so-called "Elastin-Fibrin" biomaterial, was investigated to reinforce a pancreato-jejunum anastomosis in the dog. The ambiguous results invite us, however, to improve the quality of the material, especially against proteolytic degradation: elastinolysis and fibrinolysis. Antibiotic was also added. The improved material was tested, first in rabbit then in dog, to repair a large loss of substance in the duodenum, just in front of the Wirsung duct. In view of the successful results, we are now attempting an evaluation in humans, for all indications throughout the digestive system.
C1 UNIV BORDEAUX 2, HISTOL EMBRYOL LAB, F-33076 BORDEAUX, FRANCE.
   UNIV BORDEAUX 2, DETERCA, F-33076 BORDEAUX, FRANCE.
   HOSP PELLEGRIN, SERV MICROBIOL, F-33000 BORDEAUX, FRANCE.
RP COLLET, D (reprint author), UNIV BORDEAUX 2, INSERM, U306, 146 RUE LEO SAIGNAT, F-33076 BORDEAUX, FRANCE.
CR APRAHAMIAN M, 1987, J BIOMED MATER RES, V21, P965, DOI 10.1002/jbm.820210803
   BARBIE C, 1989, BIOMATERIALS, V10, P445, DOI 10.1016/0142-9612(89)90084-7
   CHAPUIS Y, 1987, CHIRURGIE, V113, P262
   COLLET D, 1991, BIOMATERIALS, V12, P763, DOI 10.1016/0142-9612(91)90027-8
   COLLET D, 1991, OCT POST SESS ASS FR
   DUBOIS F, 1988, ANN CHIR, V42, P319
   GRIPON S, 1988, J CHIR-PARIS, V125, P161
   LEFEBVRE F, 1989, J BIOMED MATER RES, V23, P1423, DOI 10.1002/jbm.820231205
   MARTIN MT, 1988, BIOMATERIALS, V9, P519, DOI 10.1016/0142-9612(88)90048-8
   MINABE M, 1989, J CLIN PERIODONTOL, V16, P291, DOI 10.1111/j.1600-051X.1989.tb01657.x
   RABAUD M, 1986, THROMB RES, V43, P205, DOI 10.1016/0049-3848(86)90061-7
   RABAUD M, 1987, BIOMATERIALS CLIN AP, P453
   RIQUET M, 1990, BIOMATERIALS, V11, P518, DOI 10.1016/0142-9612(90)90069-3
   SHUE WB, 1988, J VASC SURG, V8, P600, DOI 10.1067/mva.1988.avs0080600
NR 14
TC 1
Z9 1
U1 1
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1992
VL 3
IS 5
BP 382
EP 386
DI 10.1007/BF00705372
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JP861
UT WOS:A1992JP86100012
DA 2018-10-19
ER

PT J
AU NERY, EB
   LEGEROS, RZ
   LYNCH, KL
   LEE, K
AF NERY, EB
   LEGEROS, RZ
   LYNCH, KL
   LEE, K
TI TISSUE-RESPONSE TO BIPHASIC CALCIUM-PHOSPHATE CERAMIC WITH DIFFERENT
   RATIOS OF HA/BETA-TCP IN PERIODONTAL OSSEOUS DEFECTS
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE PERIODONTAL DISEASES THERAPY; BONE LOSS THERAPY; BETA-TRICALCIUM
   PHOSPHATE THERAPEUTIC USE
ID POROUS HYDROXYAPATITE; BIOMATERIAL ASPECTS; IMPLANT; BONE
AB THE PURPOSE OF THIS STUDY was to determine the optimal ratio of calcium hydroxyapatite (HA) to beta tricalcium phosphate (betaTCP) in a biphasic porous calcium phosphate (BCP) ceramic for effective repair of periodontal osseous defects. Defects were surgically produced in beagle dogs and made chronic for 4 months to simulate periodontal disease. Mucoperiosteal periodontal flaps were reflected, followed by osseous defect debridement and root planing. Specially prepared ceramic with different HA/betaTCP ratios were implanted into the prepared defects. The sites were allowed to heal for 6 months, animals were euthanized, and site-blocks were removed for histological study. During the follow-up phase, scaling and polishing were done once a month, and standardized probing attachment levels were recorded pre- and 6-months postoperatively. The Duncan's multiple range test showed that all the treatments produced statistically significant higher gain in probing attachment levels than the control group (OHA/ObetaTCP) (P <0.05). Among the 7 "active" treatment groups, 2 (65/35 and 85/15) had significantly higher gain in probing attachment levels than those in 3 groups (50/50, 100/0, and 0/100) (P < 0.05). Histologically, higher HA ratio (but not 100% HA) showed accelerated new bone formation and new attachment levels. Based on histological results, the 85HA/15betaTCP ratio appears to demonstrate greater gain in attachment level and bone regeneration in the treatment of periodontal osseous defects.
C1 NYU,CTR DENT,OFF RES PROGRAM,NEW YORK,NY 10003.
   VET ADM MED CTR,COOPERAT STUDIES PROGRAM,CTR COORDINAT,PALO ALTO,CA 94304.
   MED COLL WISCONSIN,DEPT ORTHOPAED SURG,MILWAUKEE,WI 53226.
RP NERY, EB (reprint author), CLEMENT J ZABLOCKI VET ADM MED CTR,DENT RES SECT,MILWAUKEE,WI 53295, USA.
FU NIDCR NIH HHS [DE04123]
CR Biederman W, 1968, DENT CLIN N AM, V12, P409
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DEGROOT K, 1983, BIOCERAMIC CALCIUM P, P91
   DUNCAN DB, 1975, BIOMETRICS, V31, P339, DOI 10.2307/2529425
   ELLINGER RF, 1986, INT J PERIDONTICS RE, V6, P223
   FROUM SJ, 1982, J PERIODONTOL, V53, P719, DOI 10.1902/jop.1982.53.12.719
   Hubbard W, 1974, THESIS MARQUETTE U M
   ITATANI C, 1984, T ORTHOPED RES SOC, V9, P123
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, V157, P259
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, V2, P17
   LEGEROS RZ, 1983, 9TH P ANN M SOC BIOM, P86
   Levin M P, 1974, J Clin Periodontol, V1, P197
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   Levitt S R, 1969, J Biomed Mater Res, V3, P683, DOI 10.1002/jbm.820030413
   LYNCH KL, 1992, BIOCERAMICS, V3, P295
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MOSKOW BS, 1983, J PERIODONTOL, V54, P455, DOI 10.1902/jop.1983.54.8.455
   NERY EB, 1990, J PERIODONTOL, V61, P166, DOI 10.1902/jop.1990.61.3.166
   OSBORN JF, 1985, IMPLANTATWERKSTOFF H
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   ROBALAIS ML, 1981, J PERIODONTOL, V52, P680
   SHAFER WB, 1983, ORAL PATHOL, P540
   VITEK RM, 1979, J PERIODONTAL RES, V14, P93, DOI 10.1111/j.1600-0765.1979.tb00222.x
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Yukna R A, 1986, Int J Periodontics Restorative Dent, V6, P34
   YUKNA RA, 1985, J PERIODONTOL, V56, P540, DOI 10.1902/jop.1985.56.9.540
NR 30
TC 222
Z9 225
U1 1
U2 14
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD SEP
PY 1992
VL 63
IS 9
BP 729
EP 735
DI 10.1902/jop.1992.63.9.729
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JP674
UT WOS:A1992JP67400002
PM 1335498
DA 2018-10-19
ER

PT J
AU ITO, Y
   IMANISHI, Y
AF ITO, Y
   IMANISHI, Y
TI A BIOMATERIAL AS A STRONG BIOSIGNAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 KYOTO UNIV,DEPT POLYMER CHEM,KYOTO 606,JAPAN.
RI Ito, Yoshihiro/F-4370-2012
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 23
PY 1992
VL 204
BP 303
EP POLY
PN 2
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA JJ313
UT WOS:A1992JJ31301499
DA 2018-10-19
ER

PT J
AU DACULSI, G
   DARC, MB
   CORLIEU, P
   GERSDORFF, M
AF DACULSI, G
   DARC, MB
   CORLIEU, P
   GERSDORFF, M
TI MACROPOROUS BIPHASIC CALCIUM-PHOSPHATE EFFICIENCY IN MASTOID CAVITY
   OBLITERATION - EXPERIMENTAL AND CLINICAL FINDINGS
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE BIOMATERIAL; CALCIUM PHOSPHATE; CERAMIC; MASTOID CAVITY OBLITERATION;
   OTOLOGIC SURGERY; TYMPANOPLASTY
ID HYDROXYLAPATITE INTERFACE; ELECTRON-MICROSCOPY; BONE; DOGS
AB Following our previous experimental studies on the performance of macroporous biphasic calcium phosphate (MBCP) in canine mastoid cavities, we used this material in patients requiring surgical intervention. Twenty-two cases were selected, and in eight specific cases a biopsy specimen was taken. Histologic, ultrastructural, and microanalysis studies were performed. This study demonstrates the effectiveness of MBCP implants as bone graft substitutes for mastoid cavity obliteration. Clinical evaluation of the series and histologic and ultrastructural results demonstrated the bioactivity and osteoconduction of this material, with partial transformation of MBCP granules into lamellar bone after several months.
C1 HOP COCHIN, DEPT OTOLARYNGOL, F-75674 PARIS 14, FRANCE.
   CATHOLIC UNIV LOUVAIN, DEPT OTOLARYNGOL, B-1200 BRUSSELS, BELGIUM.
RP DACULSI, G (reprint author), FAC CHIRURG DENT, CALCIFIED TISSUES & BIOMAT RES LAB, PL A RICORDEAU, F-44042 NANTES, FRANCE.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR Bebear J P, 1985, Rev Laryngol Otol Rhinol (Bord), V106, P325
   CORLIEU P, 1989, CHOLESTEATOMA MASTOI, P935
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1989, REV CHIR ORTHOP, V75, P65
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P115
   GERSDORFF MCH, 1987, AM J OTOL, V8, P133
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1977, J BIOENG, V1, P79
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   NERY E B, 1988, Journal of Dental Research, V67, P178
   NERY EB, 1978, J PERIODONTOL, V49, P523, DOI 10.1902/jop.1978.49.10.523
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   WULLSTEIN SR, 1984, BIOMATERIALS OTOLOGY, P250, DOI DOI 10.1007/978-94-009-6756-4_30
NR 17
TC 61
Z9 61
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD AUG
PY 1992
VL 101
IS 8
BP 669
EP 674
DI 10.1177/000348949210100808
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA JH737
UT WOS:A1992JH73700008
PM 1497273
DA 2018-10-19
ER

PT J
AU JOOS, UE
   FEHRENBACH, E
   HOGHJANOVSKY, K
   WIMMER, FM
   SCHNEIDER, EM
   SCHMIDT, KH
AF JOOS, UE
   FEHRENBACH, E
   HOGHJANOVSKY, K
   WIMMER, FM
   SCHNEIDER, EM
   SCHMIDT, KH
TI EFFECTS OF A NEW BONE-INDUCING BIOMATERIAL ON MESENCHYMAL CELLS-INVITRO
SO ARTIFICIAL ORGANS
LA English
DT Article
DE OSTEOBLASTS; TRANSFORMING GROWTH FACTOR BETA; EPIDERMAL GROWTH FACTOR;
   NEUTRALIZING ANTIBODY; RAT
ID GROWTH FACTOR-BETA; PHENOTYPES INVITRO; INDUCTION; MATRIX;
   DIFFERENTIATION; EXPRESSION; PURIFICATION; STIMULATION; OSTEOBLAST;
   PLATELETS
AB A purified bone-inducing protein complex (BIC), isolated from bovine bone and causing de novo bone formation in vivo, induces defined effects on rat mesenchymal cells in vitro. Spindle-like mesenchymal cells growing in monolayers change to polygonal cells, forming a multilayered growth pattern. The mesenchymal cells acquire alkaline phosphatase activity. Upon culture with BIC, the typical collagen Type III deposition of these mesenchymal cells is remarkably reduced whereas the collagen Type I expression remains unaffected. All these in vitro effects are consistent with the strong bone-forming capacity of BIC in vivo. A combination of two cytokines, transforming growth factor beta-1 (TGF-beta-1) and epidermal growth factor (EGF), shows a similar activity to BIC. Neutralizing anti-TGF-beta antibodies interfere with all in vitro effects of BIC. The neutralization of BIC and the inductive capacity of the combination of TGF-beta-1 plus EGF point to the substantial role of TGF-beta or TGF-beta-like molecules in BIC; whether the active polypeptides are identical to TGF-beta or somewhat structurally homologous to TGF-beta remains to be elucidated.
C1 UNIV TUBINGEN, CHIRURG KLIN, PULVERMUHLSTR 3, W-7400 TUBINGEN 1, GERMANY.
   UNIV DUSSELDORF, INST BLUTGERINNUNG & TRANSFUS MED, W-4000 DUSSELDORF, GERMANY.
CR ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   CANALIS E, 1989, J ENDOCRINOL INVEST, V12, P577, DOI 10.1007/BF03350764
   CANALIS E, 1985, CLIN ORTHOP RELAT R, P246
   CENTRELLA M, 1986, ENDOCRINOLOGY, V119, P2306, DOI 10.1210/endo-119-5-2306
   CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
   ELLINGSWORTH LR, 1986, J BIOL CHEM, V261, P2362
   FIRSCHEIN HE, 1971, CALC TISS RES, V7, P108, DOI 10.1007/BF02062599
   HALL BK, 1987, CLIN ORTHOP RELAT R, P255
   KOSHIHARA Y, 1987, BIOCHEM BIOPH RES CO, V145, P651, DOI 10.1016/0006-291X(87)91014-X
   MASSAGUE J, 1987, J CELL PHYSIOL, P43
   NIJWEIDE PJ, 1986, PHYSIOL REV, V66, P855
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   ROBERTS AB, 1980, P NATL ACAD SCI-BIOL, V77, P3494, DOI 10.1073/pnas.77.6.3494
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   ROSEN DM, 1988, J CELL PHYSIOL, V134, P337, DOI 10.1002/jcp.1041340304
   ROSEN DM, 1986, EXP CELL RES, V165, P127, DOI 10.1016/0014-4827(86)90538-0
   SCHONFELD HJ, 1991, BONE MINER, V13, P171, DOI 10.1016/0169-6009(91)90067-A
   SWOBODA HF, 1990, BIOMATER ARTIF CELL, V18, P383, DOI 10.3109/10731199009117316
   THIELEMANN FW, 1982, ARCH ORTHOP TRAUM SU, V99, P217, DOI 10.1007/BF00381396
   URIST MR, 1987, METHOD ENZYMOL, V146, P294
   VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793
   WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484
   WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167
   WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915
NR 24
TC 1
Z9 1
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 1992
VL 16
IS 4
BP 354
EP 360
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA JH743
UT WOS:A1992JH74300006
PM 10078274
DA 2018-10-19
ER

PT J
AU KAPLAN, SS
   BASFORD, RE
   MORA, E
   JEONG, MH
   SIMMONS, RL
AF KAPLAN, SS
   BASFORD, RE
   MORA, E
   JEONG, MH
   SIMMONS, RL
TI BIOMATERIAL-INDUCED ALTERATIONS OF NEUTROPHIL SUPEROXIDE PRODUCTION
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FOREIGN-BODY INFECTION; MICROBIAL ADHESION; TISSUE INTEGRATION;
   PATHOGENESIS; GRAFTS; DEFECT
AB Because periprosthetic infection remains a vexing problem for patients receiving implanted devices, we evaluated the effect of several materials on neutrophil free radical production.  Human peripheral blood neutrophils were incubated with several sterile, lipopolysaccharide (LPS)-free biomaterials used in surgically implantable prosthetic devices:  polyurethane, woven dacron, and velcro.  Free radical formation as the superoxide (O2-) anion was evaluated by cytochrome c reduction in neutrophils that were exposed to the materials and then removed and in neutrophils allowed to remain in association with the materials.  Neutrophils exposed to polyurethane or woven dacron for 30 or 60 min and then removed consistently exhibited an enhanced release of O2- after simulation via receptor engagement with formyl methionyl-leucyl-phenylalanine.  Enhanced reactivity to stimulation via protein kinase C with phorbol myristate acetate, however, was not consistently observed.  The cells evaluated for O2- release during continous association with the biomaterials showed enhanced metabolic activity during short periods of association (especially with polyurethane and woven dacron).  Although O2- release by neutrophils in association with these materials decreased with longer periods of incubation, it was not obliterated.  These studies, therefore, show that several commonly used biomaterials activate neutrophils soon after exposure and that this activated state diminishes with prolonged exposure but nevertheless remains measurable.  The diminishing level of activity with prolonged exposure, however, suggests that ultimately a depletion of reactivity may occur and may result in increased susceptibility to periprosthetic infection.
C1 UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15213.
   UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15213.
RP KAPLAN, SS (reprint author), UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15213, USA.
FU NIGMS NIH HHS [R01-GM41734-01]
CR Almgren B, 1985, Acta Chir Scand Suppl, V529, P91
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   BERNHARD VM, 1975, SURG CLIN N AM, V55, P1412
   BOYUM A, 1968, SCAND J CLIN LAB S97, V21, P1
   Charnley J, 1972, Clin Orthop Relat Res, V87, P167, DOI 10.1097/00003086-197209000-00020
   DISABATO G, 1986, METHOD ENZYMOL, V132, P407
   Dougherty S H, 1989, Infect Dis Clin North Am, V3, P199
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1988, JAMA-J AM MED ASSOC, V259, P870, DOI 10.1001/jama.259.6.870
   HEIPLE JM, 1990, CELL MOTIL CYTOSKEL, V15, P260, DOI 10.1002/cm.970150408
   HURST NP, 1987, ANN RHEUM DIS, V46, P265, DOI 10.1136/ard.46.4.265
   KAPLAN SS, 1987, ANN ALLERGY, V59, P213
   KLOCK JC, 1976, BLOOD, V48, P149
   KLOCK JC, 1983, J CLIN INVEST, V60, P1183
   LEVINE M, 1988, CLIN ORTHOPAEDICS, V226, P235
   MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107
   MARASCUILO LA, 1983, MULTIVARIATE STATIST
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   PARTHASARATHY T, 1986, INDIAN J MED RES, V84, P440
   ROSENMAN JE, 1985, J SURG RES, V38, P648, DOI 10.1016/0022-4804(85)90088-5
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008
   WADE BH, 1983, AM J MED, V74, P686, DOI 10.1016/0002-9343(83)91028-8
   YOUNG EJ, 1988, SURG CLIN N AM, V68, P167
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   ZIPSER RD, 1986, AM J MED A S, V1, P78
NR 28
TC 49
Z9 49
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1039
EP 1051
DI 10.1002/jbm.820260806
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200005
PM 1331115
DA 2018-10-19
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI RELATIONS BETWEEN INVITRO CYTOTOXICITY AND CROSS-LINKED DERMAL SHEEP
   COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIXED PERICARDIUM; GLUTARALDEHYDE; BIOMATERIALS; TOXICITY; DEGRADATION;
   CELLS; RAT
AB Collagen-based biomaterials have found various applications in the biomedical field.  However, collagen-based biomaterials may induce cytotoxic effects.  This study evaluated possible cytotoxic effects of (crosslinked) dermal sheep collagen (DSC) using a 7-d-methylcellulose cell culture with human skin fibroblasts.  Noncrosslinked DSC (NDSC), hexamethylene-diisocyanate-crosslinked DSC (HDSC), and glutaraldehyde-crosslinked DSC (GDSC), their extracts (1 x 10 d to 4 x 10 d extracts), or the corresponding extracted DSC samples were tested.  Cell growth was evaluated by cell counting, while cell morphology was assessed by light microscopy and transmission-electron microscopy.  Both GDSC and, to a lesser extent, HDSC, induced cytotoxicity, observed as inhibited cell growth and deviant cell morphology.  The deviant morphology consisted of extensive accumulations of lipid, reduction in the amount and dilatation of rough endoplasmatic reticulum, increased inclusions of cell remnants, and relatively rounded cell membranes.  With HDSC, both primary cytotoxicity, due to extractable products from the material, and secondary cytotoxicity, possibly due to a release of cytotoxic products resulting from enzymatic cell-biomaterial interactions, could be discriminated.  With GDSC, however, no clear distinction between primary and secondary cytotoxicity could be made.  With NDSC, only primary cytotoxicity, measured as low inhibition of cell proliferation, but without deviant morphology, was observed.  These remarkable differences in cytotoxicity are discussed in relation to residual agents and specific crosslinks present in DSCs as a consequence of processing and the crosslinking agents used.  The residual agents and the specific crosslinks give rise to differences in direct release of products and in sensitivity to hydrolysis and enzymatic breakdown.
C1 TWENTE UNIV,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT RES SECT,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   BERODE M, 1988, BIOCH INT, V17, P1
   BROWN WE, 1982, TOXICOL APPL PHARM, V63, P45, DOI 10.1016/0041-008X(82)90025-4
   CHANG KC, 1984, CLIN ALLERGY, V14, P329, DOI 10.1111/j.1365-2222.1984.tb02213.x
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   EVERTS V, 1987, THESIS U AMSTERDAM N
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113
   ISCOVE NN, 1979, IMMUNOLOGICAL METHOD, P379
   JOHANNSEN FR, 1987, J APPL TOXICOL, V7, P259, DOI 10.1002/jat.2550070407
   KENNEDY GL, 1986, J APPL TOXICOL, V6, P145, DOI 10.1002/jat.2550060302
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LAZARUS SL, 1969, J INVEST DERMATOL, V52, P6
   MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN, V1, P1
   PHARRISS BB, 1980, J AM LEATHER CHEM AS, V75, P474
   SHUBIK VM, 1978, J HYG EPID MICROB IM, V22, P408
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPEER DP, 1981, J BIOMED MATER RES, V15, P913
   TRAUBEL H, 1977, LEDER, P150
   TRAUBEL H, 1977, LEDER, P181
   ULREICH JB, 1981, J BIOMED MATER RES, V15, P913, DOI 10.1002/jbm.820150615
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANGULIK TM, 1981, THESIS U AMSTERDAM
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, IN PRESS CELLS MATER
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   YAJIMA T, 1986, CELL TISSUE RES, V245, P253
   YANO E, 1981, Japanese Journal of Industrial Health, V23, P537
NR 38
TC 112
Z9 112
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1091
EP 1110
DI 10.1002/jbm.820260810
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200009
PM 1429758
DA 2018-10-19
ER

PT J
AU CHRISTOFFERSEN, MR
   CHRISTOFFERSEN, J
AF CHRISTOFFERSEN, MR
   CHRISTOFFERSEN, J
TI POSSIBLE MECHANISMS FOR THE GROWTH OF THE BIOMATERIAL, CALCIUM
   HYDROXYAPATITE MICROCRYSTALS
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
ID AQUEOUS-SOLUTION; SURFACE-TENSION; CRYSTAL-GROWTH; CONSTANT PH;
   DISSOLUTION; KINETICS; NUCLEATION; SOLUBILITY; PHOSPHATE; WATER
AB Experimental data for the growth of calcium hydroxyapatite crystals, HA, are reported. The rate is shown to be controlled by a surface process. Two models, the spiral growth model and the polynuclear model, may explain the results. From the polynuclear theory, the surface tension is found to be 80 mJ/m2. The deviation of this value from the value expected from theory, 240 mJ/m2. is suggested to be due to imperfections in the surface of HA. If all rates are dependent on activities and not concentrations, the frequency of ion integration is found to be 9 X 10(4) s-1 for the polynuclear model, close to the value 1.6 X 10(5) s-1, expected if the rate-determining step is partial dehydration of calcium ions. If the rate of lateral growth of nuclei is concentration-dependent, the value of the frequency of ion integration depends on assumptions made for the value of the activity coefficient of a monomer in the adsorbed layer, or the adsorption constant. For the spiral mechanism, the frequency of ion integration is also dependent on the value assumed for the surface tension. If similar assumptions to those used for the application of the polynuclear theory are applied to the spiral theory, similar values of the ion integration frequency are obtained, thus making it difficult to distinguish the rate-controlling mechanism.
RP CHRISTOFFERSEN, MR (reprint author), UNIV COPENHAGEN,PANUM INST,DEPT BIOCHEM A,BLEGDAMSVEJ 3,DK-2200 COPENHAGEN,DENMARK.
CR ARENDS J, 1987, J CRYST GROWTH, V84, P515, DOI 10.1016/0022-0248(87)90284-3
   BELL RP, 1959, PROTON CHEM, P120
   BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006
   CHRISTOFFERSEN J, 1992, J CRYST GROWTH, V121, P608, DOI 10.1016/0022-0248(92)90568-4
   CHRISTOFFERSEN J, 1979, J CRYST GROWTH, V47, P671, DOI 10.1016/0022-0248(79)90011-3
   CHRISTOFFERSEN J, 1980, J CRYST GROWTH, V49, P29, DOI 10.1016/0022-0248(80)90057-3
   CHRISTOFFERSEN J, 1976, J CRYST GROWTH, V35, P79, DOI 10.1016/0022-0248(76)90247-5
   CHRISTOFFERSEN J, 1978, J CRYST GROWTH, V43, P501, DOI 10.1016/0022-0248(78)90350-0
   CHRISTOFFERSEN J, 1988, J CRYST GROWTH, V87, P41, DOI 10.1016/0022-0248(88)90342-9
   CHRISTOFFERSEN J, 1991, J CRYST GROWTH, V113, P599, DOI 10.1016/0022-0248(91)90096-N
   CHRISTOFFERSEN J, 1982, J CRYST GROWTH, V57, P21, DOI 10.1016/0022-0248(82)90244-5
   CHRISTOFFERSEN J, 1990, J CRYST GROWTH, V10, P203
   CHRISTOFFERSEN MR, 1988, J CRYST GROWTH, V87, P51, DOI 10.1016/0022-0248(88)90343-0
   CHUGHTAI A, 1968, J PHYS CHEM-US, V72, P208, DOI 10.1021/j100847a039
   FLODGAARD H, 1974, J BIOL CHEM, V249, P3465
   GREGORY TM, 1970, J RES NBS A PHYS CH, VA 74, P461, DOI 10.6028/jres.074A.036
   INSKEEP WP, 1988, GEOCHIM COSMOCHIM AC, V52, P1883, DOI 10.1016/0016-7037(88)90012-9
   Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032
   KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015
   MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017
   MORENO EC, 1977, CALC TISS RES, V24, P47, DOI 10.1007/BF02223296
   MORENO EC, 1981, J CRYST GROWTH, V53, P20, DOI 10.1016/0022-0248(81)90052-X
   NANCOLLAS GH, 1974, J PHYS CHEM-US, V78, P2218, DOI 10.1021/j100615a007
   NANCOLLAS GH, 1980, PROG CRYST GROWTH CH, V3, P77, DOI 10.1016/0146-3535(80)90013-1
   NIELSEN AE, 1984, J CRYST GROWTH, V67, P289, DOI 10.1016/0022-0248(84)90189-1
   NIELSEN AE, 1971, J CRYST GROWTH, V11, P233, DOI 10.1016/0022-0248(71)90090-X
   ZHANG JW, 1990, J CRYST GROWTH, V106, P181, DOI 10.1016/0022-0248(90)90062-P
NR 27
TC 27
Z9 27
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD AUG
PY 1992
VL 121
IS 4
BP 617
EP 630
DI 10.1016/0022-0248(92)90569-5
PG 14
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA JK560
UT WOS:A1992JK56000009
DA 2018-10-19
ER

PT J
AU PINHOLT, EM
   RUYTER, IE
   HAANAES, HR
   BANG, G
AF PINHOLT, EM
   RUYTER, IE
   HAANAES, HR
   BANG, G
TI CHEMICAL, PHYSICAL, AND HISTOLOGIC-STUDIES ON 4 COMMERCIAL APATITES USED
   FOR ALVEOLAR RIDGE AUGMENTATION
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID BONE-GRAFT SUBSTITUTE; POROUS HYDROXYLAPATITE; BIOMATERIAL ASPECTS;
   AUTOGENOUS BONE; HYDROXYAPATITE; CARBONATE; PARTICLES; TISSUE
C1 SCANDINAVIAN INST DENT MAT,NIOM,DIV PHYS CHEM,HASLUM,NORWAY.
   UNIV BERGEN,HAUKELAND HOSP,DEPT ORAL PATHOL & FORENS ODONTOL,N-5016 BERGEN,NORWAY.
   UNIV OSLO,DEPT ORAL & MAXILLOFACIAL SURG,OSLO 3,NORWAY.
   NATL HOSP NORWAY,INST SURG RES,NORWEGIAN RES COUNCIL SCI & HUMANITIES,OSLO 1,NORWAY.
CR BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BLOCK MS, 1985, J ORAL MAXIL SURG, V43, P3, DOI 10.1016/S0278-2391(85)80005-7
   BONEL G, 1964, CR HEBD ACAD SCI, V258, P923
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, V174, P28
   CHANG CS, 1983, J ORAL MAXIL SURG, V41, P729, DOI 10.1016/0278-2391(83)90190-8
   CHIROFF RT, 1975, J BIOMED MATER RES, V9, P29, DOI 10.1002/jbm.820090407
   CRANIN AN, 1988, J BIOMED MATER RES, V22, P1165, DOI 10.1002/jbm.820221208
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Donath K, 1985, Dtsch Z Mund Kiefer Gesichtschir, V9, P438
   DONATH K, 1987, ORAL SURG ORAL MED O, V63, P651, DOI 10.1016/0030-4220(87)90362-8
   DONATH K, 1987, J ORAL IMPLANTS, V13, P11
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   FRAME JW, 1987, J ORAL MAXIL SURG, V45, P771, DOI 10.1016/0278-2391(87)90200-X
   GREGOIRE M, 1988, ADV BIOMATER, V8, P215
   HJOERTINGHANSEN E, 1970, STUDIES IMPLANTATION, P1
   HOLMES RE, 1987, INT J ORAL MAX SURG, V16, P718, DOI 10.1016/S0901-5027(87)80059-0
   HOLMES RE, 1987, J ORAL MAXIL SURG, V45, P421, DOI 10.1016/0278-2391(87)90010-3
   JANICKE S, 1988, Z ZAHNARZTL IMPLANTO, V4, P101
   JARCHO M, 1977, J BIOENG, V1, P79
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   Kasperk C, 1986, Z ZAHNARZTL IMPLANTO, V2, P242
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   KAWAMURA M, 1987, CLIN ORTHOP RELAT R, V217, P281
   KENNEY EB, 1988, J BIOMED MATER RES, V22, P1233, DOI 10.1002/jbm.820221211
   KLEIN CPAT, 1980, J BIOMED MATER RES, V14, P705, DOI 10.1002/jbm.820140602
   KLEIN CPAT, 1986, BIOMATERIALS, V7, P144
   MARIE PJ, 1987, MAGNESIUM, V6, P100
   ORLY I, 1988, ADV BIOMATER, V8, P211
   OSBORN JF, 1983, HYDROXYLAPATITKERAMI, P37
   PINHOLT EM, 1992, J ORAL MAXIL SURG, V50, P250, DOI 10.1016/0278-2391(92)90321-P
   PINHOLT EM, 1990, SCAND J DENT RES, V98, P434
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   ROTHSTEIN SS, 1984, J AM DENT ASSOC, V109, P571, DOI 10.14219/jada.archive.1984.0127
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SCHOLL FK, 1973, INFRARED ANAL POLYM, V2, P76
   SOEVIK T, 1979, J FISH RES BOARD CAN, V36, P1414, DOI 10.1139/f79-204
   STUTMAN JM, 1965, T NEW YORK ACAD SCI, V27, P669, DOI 10.1111/j.2164-0947.1965.tb02224.x
   TROMBE JC, 1973, CR ACAD SCI C CHIM, V276, P1271
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1987, CLIN ORTHOPAEDICS, V214, P295
   VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WORSAAE N, 1988, ODONTOLOGI 88, P159
NR 46
TC 25
Z9 25
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD AUG
PY 1992
VL 50
IS 8
BP 859
EP 867
DI 10.1016/0278-2391(92)90280-D
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA JH473
UT WOS:A1992JH47300016
PM 1321896
DA 2018-10-19
ER

PT J
AU WALKER, RD
   WILSON, J
   CLARK, AE
AF WALKER, RD
   WILSON, J
   CLARK, AE
TI INJECTABLE BIOGLASS AS A POTENTIAL SUBSTITUTE FOR INJECTABLE
   POLYTETRAFLUOROETHYLENE
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT 1991 ANNUAL MEETING OF THE SECTION OF UROLOGY OF THE AMERICAN ACADEMY OF
   PEDIATRICS
CY OCT 26-31, 1991
CL NEW ORLEANS, LA
SP AMER ACAD PEDIAT
DE URINARY INCONTINENCE; VESICOURETERAL REFLUX; POLYTETRAFLUOROETHYLENE;
   COLLAGEN; ANIMALS, LABORATORY
ID PERIURETHRAL TEFLON INJECTION; URINARY-INCONTINENCE; MIGRATION;
   COLLAGEN; IMPLANTS; REFLUX
AB Injectable polytetrafluoroethylene (Teflon) and collagen have inherent problems that may prevent their long-term success. In search of a different injectable biomaterial we confirmed in rabbits the safety of injected Bioglass* particles suspended in sodium hyaluronate. A second study was performed testing the ability of the Bioglass suspension to increase urethral resistance in pigs. Bioglass particles in suspension have the potential to substitute for polytetrafluoroethylene or collagen in the treatment of urinary incontinence or vesicoureteral reflux.
RP WALKER, RD (reprint author), UNIV FLORIDA,DEPT SURG,DIV UROL,GAINESVILLE,FL 32611, USA.
CR APPELL R A, 1991, Journal of Urology, V145, p225A
   BALASZ EA, 1988, BIOL HYALURONAN, P265
   BURKE KE, 1985, ANN PLAS SURG, V14, P515, DOI 10.1097/00000637-198506000-00004
   CANNING CA, 1991, DIAL PED UROL, V14, P6
   CARLISLE EM, 1974, FED PROC, V33, P1758
   FERRO MA, 1988, UROLOGY, V31, P422, DOI 10.1016/0090-4295(88)90740-6
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   MERGUERIAN PA, 1990, J UROLOGY, V144, P531, DOI 10.1016/S0022-5347(17)39514-9
   MITTLEMAN RE, 1983, ARCH PATHOL LAB MED, V107, P611
   ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7
   POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8
   RAMER M, 1990, 16TH T ANN M SOC BIO
   RAMES RA, 1991, PEDIATR SURG INT, V6, P239
   STEGMAN SJ, 1987, ARCH DERMATOL, V123, P1644, DOI 10.1001/archderm.123.12.1644
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1, P283
   WILSON J, IN PRESS J APPL BIOM
NR 18
TC 39
Z9 39
U1 0
U2 3
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD AUG
PY 1992
VL 148
IS 2
BP 645
EP 647
DI 10.1016/S0022-5347(17)36680-6
PN 2
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA JF961
UT WOS:A1992JF96100044
PM 1640537
DA 2018-10-19
ER

PT J
AU ANSELME, K
   PETITE, H
   HERBAGE, D
AF ANSELME, K
   PETITE, H
   HERBAGE, D
TI INHIBITION OF CALCIFICATION INVIVO BY ACYL AZIDE CROSS-LINKING OF A
   COLLAGEN-GLYCOSAMINOGLYCAN SPONGE
SO MATRIX
LA English
DT Article
DE ACYL AZIDE; COLLAGEN-BASED BIOMATERIALS; CROSS-LINKING; DYSTROPHIC
   CALCIFICATION; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN
ID BOVINE PERICARDIUM; CONTROLLED RELEASE; HYALURONIC-ACID; ARTIFICIAL
   SKIN; CELLS; MINERALIZATION; SULFATE; FIBRONECTIN; BIOMATERIAL;
   PREVENTION
AB A collagen-glycosaminoglycan sponge composed of collagen (80%), chondroitin-4-sulfate (13.3%) and heparan sulfate (6.6%) was cross-linked using the acyl azide methode or glutaraldehyde (0.0075%). Under optimal conditions, the denaturation temperature (T(d)) was raised to 69-degrees-C (+ 23-degrees-C) for the sponge treated by the acyl azide method and to 68-degrees-C (+ 22-degrees-C) for that treated with glutaraldehyde. The biocompatibility of the treated and control sponges was studied up to 3 months after subcutaneous implantation in rats by analysing cellular responses and calcification by histological and ultrastructural methods. A control collagen-glycosaminoglycan sponge was rapidly invaded by mononuclear cells (8 days), with the formation of granulation tissue. Calcification was observed at the periphery of the implant after 8 days, and the implant was entirely calcified after 15 days; it was degraded progressively after 30 days. Acyl azide treatment increased the persistence of the sponge in vivo up to 90 days and inhibited its calcification. A glutaraldehyde-treated sponge was completely calcified after 15 days, and calcified nodules persisted after 90 days. Thus, acyl azide method efficiently cross-linked a collagen-glycosaminoglycan sponge and inhibited calcification after subcutaneous implantation in rats (at least up to 90 days after implantation).
RP ANSELME, K (reprint author), UNIV LYON 1,INST BIOL & CHIM PROT,CNRS,URA 412,CYTOL MOLEC LAB,F-69622 VILLEURBANNE,FRANCE.
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Anselme, Karine/0000-0002-6669-205X
CR ANSELME K, 1990, J BIOMED MATER RES, V24, P689, DOI 10.1002/jbm.820240605
   ANSELME K, 1990, TISSUE CELL, V22, P881
   BERTOLOTTO A, 1984, ELECTROPHORESIS, V5, P97, DOI 10.1002/elps.1150050207
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1987, BIOMATERIALS, V8, P195, DOI 10.1016/0142-9612(87)90063-9
   DOILLON CJ, 1988, BIOMATERIALS, V9, P91, DOI 10.1016/0142-9612(88)90077-4
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GLIMCHER MJ, 1968, TREATISE COLLAGEN  B, V2, P68
   JOHNSTON TP, 1990, INT J PHARM, V59, P95, DOI 10.1016/0378-5173(90)90083-G
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   LEVY RJ, 1986, AM J PATHOL, V122, P741
   MARTIN G, 1990, ACTUALITES BIOMATERI, P20
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MCPHERSON JM, 1986, J BIOMED MATER RES, V20, P79, DOI 10.1002/jbm.820200108
   MCPHERSON JM, 1988, COLLAGEN REL RES, V1, P83
   MURATA K, 1976, CONNECT TISSUE RES, V4, P131, DOI 10.3109/03008207609152208
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   OLIVER RF, 1980, BRIT J EXP PATHOL, V64, P544
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PRIVALOV PL, 1970, BIOPOLYMERS, V9, P127, DOI 10.1002/bip.1970.360090202
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   ROUSSILLE G, 1991, J MATER SCI-MATER M, V2, P208, DOI 10.1007/BF00703372
   SABELMAN EE, 1985, BIOCOMPATIBILITY TIS, V1, P27
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SHAHABEDDIN L, 1990, Skin Pharmacology, V3, P107
   SILVER FH, 1978, THROMB RES, V13, P267, DOI 10.1016/0049-3848(78)90014-2
   UMEMURA Y, 1988, BIOMATERIALS, V9, P133, DOI 10.1016/0142-9612(88)90111-1
   URIST MR, 1966, ARCH PATHOL, V81, P325
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 39
TC 26
Z9 26
U1 1
U2 3
PU GUSTAV FISCHER VERLAG
PI JENA
PA VILLENGANG 2, D-07745 JENA, GERMANY
SN 0934-8832
J9 MATRIX
JI Matrix
PD AUG
PY 1992
VL 12
IS 4
BP 264
EP 273
DI 10.1016/S0934-8832(11)80078-8
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA JK670
UT WOS:A1992JK67000003
PM 1435510
DA 2018-10-19
ER

PT J
AU GREISLER, HP
   CZIPERLE, DJ
   KIM, DU
   GARFIELD, JD
   PETSIKAS, D
   MURCHAN, PM
   APPLEGREN, EO
   DROHAN, W
   BURGESS, WH
AF GREISLER, HP
   CZIPERLE, DJ
   KIM, DU
   GARFIELD, JD
   PETSIKAS, D
   MURCHAN, PM
   APPLEGREN, EO
   DROHAN, W
   BURGESS, WH
TI ENHANCED ENDOTHELIALIZATION OF EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS
   BY FIBROBLAST GROWTH-FACTOR TYPE-1 PRETREATMENT
SO SURGERY
LA English
DT Article; Proceedings Paper
CT 53RD ANNUAL MEETING OF THE SOC OF UNIV SURGEONS
CY FEB 13-15, 1992
CL CINCINNATI, OH
SP SOC UNIV SURGEONS
ID SMOOTH-MUSCLE; PROSTHESES; MECHANISMS; EXPRESSION; RECEPTOR
AB Background. Biomaterial pretreatment with endothelial cell mitogens may enhance endothelialization.
   Methods. Modified fibrin glue (FG) containing 1 ng/cm2 recombinant I-125-labeled fibroblast growth factor type 1 (I-125-FGF-1), 20-mu-g/cm2 heparin, 2.86 mg/cm2 fibrinogen, and 2.86 X 10(-2) units/cm2 thrombin was pressure perfused into expanded polytetrafluoroethylene (ePTFE) grafts. Grafts were interposed into infrarenal aortas of 24 New Zealand white rabbits and explanted after 0, 5, 30, and 60 minutes and 1, 7, 14, and 30 days. Residual radioactivity was determined by gamma-counting. Remaining I-125-FGF-1 is expressed as percent of value at time 0. To determine the effect of the FG/FGF-1 on graft healing, three groups of 50 X 4 mm 60-mu-m internodal-distance nonreinforced ePTFE grafts were implanted in the aortoiliac position of 12 dogs. Group I (n = 12) contained the complete modified FG, group II (n = 6) contained FG with heparin but no FGF-1, and group III (n = 6) contained untreated identical ePTFE. Tritiated thymidine (0.5-mu-Ci/kg) was injected intramuscularly 10 hours before explantation after 7 and 28 days for light and electron microscopy and en face autoradiography.
   Results. Retention of I-125-FGF-1 showed rapid initial loss (DELTA-%/DELTA-min = -24.1) followed by slow loss after 1 hour (DELTA-%/DELTA-min = -0.03), with 13.4% +/- 6.9% remaining at 1 week and 3.8% +/- 1.1% at 30 days. Every FG/FGF-1 graft at 28 days showed extensive capillary ingrowth and confluent endothelialized luminal surfaces, not seen in any specimen of the other two groups. Autoradiography revealed a significant increase (p < 0.05) in H-3-thymidine incorporation in the FG/FGF-1 grafts at 28 days versus all groups as a function of time and graft treatment.
   Conclusions. Pressure perfusion of an FGF-1/FG suspension into 60-mu-m internodal-distance ePTFE grafts promotes endothelialization through capillary ingrowth and increased endothelial cell proliferation.
C1 VET ADM MED CTR,HINES,IL 60141.
   ST BARNABAS HOSP,LIVINGSTON,NJ 07039.
   AMER RED CROSS,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,ROOM 2675,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR BJORNSSON TD, 1991, P NATL ACAD SCI USA, V88, P8651, DOI 10.1073/pnas.88.19.8651
   BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129
   CLOWES AW, 1991, J VASC SURG, V13, P734
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   FRIESEL R, 1986, J BIOL CHEM, V261, P7581
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H P, 1986, ASAIO Trans, V32, P346
   Greisler H. P., 1991, NEW BIOL SYNTHETIC V
   GREISLER HP, 1991, SURGERY, V110, P645
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1988, CIRCULATION, V78, P6
   GREISLER HP, 1982, ARCH SURG-CHICAGO, V117, P1425
   GREISLER HP, 1990, J CARDIOVASC SURG, V31, P712
   GREISLER HP, 1987, J VASC SURG, V2, P393
   TAN EML, 1991, BIOCHEM J, V278, P863, DOI 10.1042/bj2780863
   WINKLES JA, 1991, BIOCHEM BIOPH RES CO, V180, P519, DOI 10.1016/S0006-291X(05)81095-2
NR 16
TC 110
Z9 110
U1 0
U2 2
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0039-6060
J9 SURGERY
JI Surgery
PD AUG
PY 1992
VL 112
IS 2
BP 244
EP 255
PG 12
WC Surgery
SC Surgery
GA JG451
UT WOS:A1992JG45100016
PM 1641764
DA 2018-10-19
ER

PT J
AU GROTH, T
   DERDAU, K
   STRIETZEL, F
   FOERSTER, F
   WOLF, H
AF GROTH, T
   DERDAU, K
   STRIETZEL, F
   FOERSTER, F
   WOLF, H
TI THE HEMOCOMPATIBILITY OF BIOMATERIALS INVITRO - INVESTIGATIONS ON THE
   MECHANISM OF THE WHOLE-BLOOD CLOT FORMATION TEST
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE BIOMATERIALS INVITRO HEMOCOMPATIBILITY; CLOT FORMATION TEST; PLATELETS;
   CONTACT ACTIVATION
ID ARTIFICIAL SURFACES; PLATELET; INHIBITORS
AB Twenty years ago Imai & Nose introduced a whole-blood clotting test for the estimation of haemocompatibility of biomaterials in vitro. In our paper, a modification of this assay is discribed and the mechanism of clot formation further elucidated. It was found that neither the inhibition of platelet function nor the removal of platelets from blood significantly changed the clot formation rate on glass and polyvinyl chloride in comparison to the rate for whole blood. Scanning electron microscopy demonstrated that platelets were not involved in clot formation near the blood/biomaterial interface. Thus, it was concluded that the system of contact activation of the coagulation cascade dominates during clot formation under static conditions. The latter conclusion was supported by the fact that preadsorption of human serum albumin or human fibrinogen onto the glass plates used, decreased the clot formation rate in the same manner.
RP GROTH, T (reprint author), HUMBOLDT UNIV,FACHBEREICH MED CHARITE,BIOMAT FORSCH & MED WERKSTOFFKUNDE ABT,O-1040 BERLIN,GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR GROTH T, 1991, BIOMED TECH, V36, P322
   HARKER LA, 1986, J AM COLL CARDIOL, V8, pB21, DOI 10.1016/S0735-1097(86)80004-3
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   KARWATH R, 1989, STUD BIOPHYS, V131, P117
   KARWATH R, 1987, ADV BIOMATER, V7, P557
   KOMAI T, 1975, ARTIF ORGANS JPN, V4, P114
   PACKHAM MA, 1983, THROMB HAEMOSTASIS, V50, P610
   SCOTT CF, 1991, J BIOMAT SCI-POLYM E, V3, P173
   SILVERBERG M, 1987, ANN NY ACAD SCI, V516, P268
   STRIETZEL F, 1990, THESIS HUMBOLDT U BE
   WACHTFOGEL YT, 1987, ANN NY ACAD SCI, V516, P253
   WOLF H, 1987, ARTIF ORGANS, V11, P325
NR 12
TC 5
Z9 5
U1 0
U2 2
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM, NOTTS,
   ENGLAND NG1 4EE
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUL
PY 1992
VL 20
IS 3
BP 390
EP 395
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA JG146
UT WOS:A1992JG14600004
DA 2018-10-19
ER

PT J
AU CARDONA, MA
   SIMMONS, RL
   KAPLAN, SS
AF CARDONA, MA
   SIMMONS, RL
   KAPLAN, SS
TI TNF AND IL-1 GENERATION BY HUMAN MONOCYTES IN RESPONSE TO BIOMATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID TUMOR NECROSIS FACTOR; INTERLEUKIN-1; MACROPHAGE; INVIVO; CELLS;
   IMMUNOFLUORESCENCE; BIOCOMPATIBILITY; INHIBITOR; INVITRO
AB The biocompatibility of surgically implanted materials may be compromised as a consequence of inflammatory reactions associated with phagocyte activation.  Two important mediators of the inflammatory response are Interleukin-1 (IL-1) and tumor necrosis factor (TNF), both of which exert a wide range of biologic effects on many cells.  This study was designed to evaluate the release of these cytokines by human monocytes (HM) brought into contact with four biomaterials utilized in clinical practice:  polyurethane, expanded polytetrafluorethylene (ePTFE), Dacron velour, and woven Dacron.  In vitro cultures for the generation of IL-1 and TNF by HM in the presence of the above biomaterials were established by exposing cells to each biomaterial in the presence and absence of lipopolysaccharide (LPS) with harvest of supernatants after 6 or 18 h.  These studies showed that in the absence of LPS, IL-1 was released only by Dacron velour and woven Dacron associated monocytes while TNF was secreted in response to all of the materials.  When LPS was present, however, monocytes associated with all of the materials released IL-1; and TNF release was greatly augmented.  Further, the quantity of released cytokine was directly related to the duration of the association time.  This study demonstrated that HM in association with various biomaterials were activated to produce both TNF and IL-1 and that the addition of nanogram quantities of LPS, such as would be produced if infection were present, greatly increased the amount of cytokines released.
C1 UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15261.
   UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261.
FU NIGMS NIH HHS [R01-GM-41734]
CR AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
   ANDERSON JE, 1991, POLITICAL EC INT TRA, P49
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BARKLEY D, 1989, J IMMUNOL METHODS, V120, P277, DOI 10.1016/0022-1759(89)90253-6
   BENTLEY C, 1981, LYMPHOKINES, V4, P197
   BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   CARTY TJ, 1989, AGENTS ACTIONS, V26, P391, DOI 10.1007/BF01967307
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   DECKER T, 1987, J IMMUNOL, V138, P957
   DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433
   HALME J, 1989, AM J OBSTET GYNECOL, V161, P1718, DOI 10.1016/0002-9378(89)90957-5
   HAMISH R, 1988, NEW ENGL J MED, V318, P1481
   HENSON PM, 1980, AM J PATHOL, V101, P494
   HOFSLI E, 1989, CELL IMMUNOL, V122, P405, DOI 10.1016/0008-8749(89)90087-7
   IWAMOTO G, 1989, AM J PHYSIOL, V132, pC1012
   KAPLAN SS, IN PRESS J BIOMED MA
   KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   LARSON C, 1990, INFLAMMATION DIFFERE, P419
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   OFLAHERTY JT, 1991, J IMMUNOL, V147, P3842
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   RIBEIRO RA, 1991, IMMUNOLOGY, V73, P472
   Rosen J J, 1988, ASAIO Trans, V34, P163
   SCHUR PH, 1990, CLIN IMMUNOL IMMUNOP, V57, P45, DOI 10.1016/0090-1229(90)90021-H
   SHALDON S, 1987, LIFE SUPPORT SYST, V5, P341
   YUO A, 1991, BLOOD, V78, P2708
   ZIFF M, 1988, ADV INFLAMMAT RES, V12, P1
NR 34
TC 74
Z9 74
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 851
EP 859
DI 10.1002/jbm.820260703
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200002
PM 1535076
DA 2018-10-19
ER

PT J
AU STEELE, JG
   JOHNSON, G
   UNDERWOOD, PA
AF STEELE, JG
   JOHNSON, G
   UNDERWOOD, PA
TI ROLE OF SERUM VITRONECTIN AND FIBRONECTIN IN ADHESION OF FIBROBLASTS
   FOLLOWING SEEDING ONTO TISSUE-CULTURE POLYSTYRENE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID HUMAN-ENDOTHELIAL CELLS; RADIOFREQUENCY PLASMA DEPOSITION; SPREADING
   FACTOR; ADSORPTION; ATTACHMENT; SURFACES; PROTEINS; COLLAGEN;
   ENHANCEMENT; COPOLYMERS
AB The suitability of polymeric biomaterials as surfaces for the attachment and growth of cells has often been investigated in tissue culture.  In this study the contribution that adsorption of serum fibronectin (Fn) or vitronectin (Vn) make to the attachment and spreading of fibroblast cells during the first 90 min following seeding was determined for two modified tissue culture polystyrenes, as model biomaterial surfaces.  The amount of serum Vn and Fn which adsorbed onto tissue culture grade polystyrene (TCP) from different serum concentrations over the range of 0.1-30% (v/v) were determined and compared to attachment of cells of the BHK-21 and HT1080 fibroblast lines.  There was no simple correlation between the amount of Fn or the amount of Vn adsorbed and cell attachment and spreading.  The requirement for Fn or Vn for attachment and spreading of BHK-21 or HT1080 cells onto modified polystyrene (either TCP or to Primaria) during the first 90 min of cell culture was directly tested by selective removal of Fn or Vn from the serum prior to addition to the culture medium.  Attachment and spreading of BHK-21 or HT1080 cells onto TCP or Primaria surfaces were reduced in a concentration-dependent manner when the cells were seeded in medium containing 2% (v/v) or higher concentrations of Vn-depleted serum.  BHK-21 cells or HT1080 cells seeded in medium containing Fn-depleted serum (which contained Vn) attached and spread onto TCP or Primaria.  Both BHK-21 cells and HT1080 cells failed to attach to TCP or Primaria when seeded in medium containing serum depleted of both Vn and Fn.  The requirement for serum Vn or Fn for fibroblast attachment to TCP was also tested using cells of a human dermal fibroblast strain.  The attachment of the dermal fibroblasts to TCP during the first 90 min of culture was not decreased by depletion of Vn from the 15% (v/v) serum, but there was a reduction in the proportion of the attached cells which had spread.  Selective depletion of serum Fn did not have any effect on either cell attachment or spreading.  Our results show that for fibroblast cells, particularly with cell lines such as BHK-21 or HT1080 but also with cell strains, the first binding of cells onto tissue culture polystyrene when plated in medium containing serum is a result of adsorption onto the surface of serum Vn.  The adsorption of serum Vn onto the surface overcomes the effect of serum components which tend to decrease cell attachment.
RP STEELE, JG (reprint author), CSIRO,DIV BIOMOLEC ENGN,MOLEC BIOL LAB,POB 184,N RYDE,NSW 2113,AUSTRALIA.
CR BALE MD, 1989, BLOOD, V74, P2698
   BENTLEY KL, 1985, J BIOMED MATER RES, V19, P757, DOI 10.1002/jbm.820190704
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   CINATL J, 1990, IN VITRO CELL DEV B, V26, P841
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1983, J CELL PHYSIOL, V116, P289, DOI 10.1002/jcp.1041160305
   GRINNELL F, 1981, J CELL SCI, V48, P19
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P763, DOI 10.1002/jbm.820220903
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   KNOX P, 1980, J CELL SCI, V46, P97
   KNOX P, 1984, J CELL SCI, V71, P51
   LAUG WE, 1985, THROMB HAEMOSTASIS, V54, P498
   LYDON MJ, 1988, BIOMATERIALS, V9, P525, DOI 10.1016/0142-9612(88)90049-X
   MATSUDA T, 1974, J POLYM SCI POL CHEM, V12, P489, DOI 10.1002/pol.1974.170120301
   NORRIS WD, 1990, J CELL SCI, V95, P255
   PITT WG, 1989, J COLLOID INTERF SCI, V129, P231, DOI 10.1016/0021-9797(89)90435-9
   PREISSNER KT, 1988, BLOOD, V71, P1581
   SHAFFER MC, 1984, J LAB CLIN MED, V103, P783
   STEELE JG, 1991, BIOMATERIALS, V12, P531, DOI 10.1016/0142-9612(91)90046-D
   STENN KS, 1987, J INVEST DERMATOL, V89, P59, DOI 10.1111/1523-1747.ep12580392
   UNDERWOOD PA, 1991, J IMMUNOL METHODS, V142, P83, DOI 10.1016/0022-1759(91)90295-Q
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P1317, DOI 10.1002/jbm.820211104
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
NR 32
TC 135
Z9 135
U1 1
U2 18
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 861
EP 884
DI 10.1002/jbm.820260704
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200003
PM 1376730
DA 2018-10-19
ER

PT J
AU SMITH, BAH
   SEFTON, MV
AF SMITH, BAH
   SEFTON, MV
TI THROMBIN AND ALBUMIN ADSORPTION TO PVA AND HEPARIN-PVA HYDROGELS .1.
   SINGLE PROTEIN ISOTHERMS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ANTITHROMBIN-III; BIOMATERIAL
AB More radiolabeled thrombin was adsorbed to heparin-polyvinyl alcohol (PVA) than to PVA, consistent with a specific interaction with the immobilized heparin.  The maximum surface concentration on heparin-PVA was estimated to be approximately 450 nmol/m2 with an apparent affinity constant (K(a)) of 2.5-mu-M-1; on PVA, the plateau concentration was 10 nmol/m2 with a K(a) < 1 nM-1.  There was little difference in bovine serum albumin (BSA) adsorption between PVA and heparin-PVA.  Interestingly, thrombin adsorption to polyethylene was indistinguishable from that to PVA despite the large difference in surface chemistry.  BSA adsorbed to polyethylene with higher affinity than to the hydrogels, although the plateau concentrations were comparable.  The adsorbed thrombin was biologically inactive at least towards chromogenic substrate, with the residual activity on PVA unaffected by subsequent incubations with antithrombin III.  PVA and heparin-PVA presented a heterogeneous and complex substrate for interaction with proteins.  The adsorbed protein was likely present in multiple states depending on the groups with which it interacted.
C1 UNIV TORONTO,DEPT CHEM ENGN & APPL CHEM,TORONTO M5S 1A4,ONTARIO,CANADA.
   UNIV TORONTO,CTR BIOMAT,TORONTO M5S 1A4,ONTARIO,CANADA.
FU NHLBI NIH HHS [HL24020]
CR BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRASH JL, 1974, T AM SOC ART INT ORG, VA 20, P69
   CHUANG HYK, 1979, THROMB RES, V14, P273, DOI 10.1016/0049-3848(79)90237-8
   FOUGNOT C, POLYM MED BIOMEDICAL, P261
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HATTON MWC, 1983, THROMB HAEMOSTASIS, V50, P873
   IP WF, 1985, J BIOMED MATER RES, V19, P161, DOI 10.1002/jbm.820190206
   ROLLASON G, 1989, Journal of Biomaterials Science Polymer Edition, V1, P31, DOI 10.1163/156856289X00046
   SMITH BA, UNPUB THROMBIN ALBUM, V2
   SMITH BAH, 1988, J BIOMED MATER RES, V22, P673, DOI 10.1002/jbm.820220802
   WAIEWSKI WG, 1976, THRMB RES, V8, P881
   WAUGH DF, 1975, J BIOMED MATER RES, V9, P511, DOI 10.1002/jbm.820090513
NR 13
TC 9
Z9 9
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 947
EP 958
DI 10.1002/jbm.820260709
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200008
PM 1607375
DA 2018-10-19
ER

PT J
AU GOLOMB, G
AF GOLOMB, G
TI CALCIFICATION OF POLYURETHANE-BASED BIOMATERIALS IMPLANTED
   SUBCUTANEOUSLY IN RATS - ROLE OF POROSITY AND FLUID ABSORPTION IN THE
   MECHANISM OF MINERALIZATION
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HEART-VALVE CALCIFICATION; BIOPROSTHESES; PREVENTION
AB The object of this study was to investigate the mineralization of polyurethane in the rat subcutaneous environment, in comparison to collageneous biomaterials, which would facilitate investigation of the calcification mechanism in implantable biomaterials. This model was compared to an in vitro model of non-spontaneous formation of calcium phosphate precipitate. To study the role of porosity/fluid absorption capacity, various biomaterials such as polyurethane, hydrophilic polyurethane foam, Type I collagen sponges, and bioprosthetic heart valve tissue were examined in in vitro and in vivo models. In view of the exceedingly low levels of polyurethane calcification, it seems that the rat subcutaneous model is not suitable for routine studies of the mechanism of polyurethane calcification. The calcification extent of both collageneous and hydrophilic polyurethane, was found to be in good correlation with the water absorption capacity of these biomaterials. It is suggested that the water capacity of the biomaterial determines the bulk level of calcification, which in turn is generated and propagates via the inherent affinity sites of the biomaterial to Ca2+.
RP GOLOMB, G (reprint author), HEBREW UNIV JERUSALEM,SCH PHARM,DEPT PHARM,POB 12065,IL-91120 JERUSALEM,ISRAEL.
OI Golomb, Gershon/0000-0002-7369-9831
CR ANDERSON HC, 1983, ARCH PATHOL LAB MED, V107, P341
   BOSKEY AL, 1977, CALC TISS RES, V23, P251, DOI 10.1007/BF02012794
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COLEMAN DL, 1985, CALCIUM BIOL SYSTEMS, P661
   CUMMING RD, 1985, DEVICES TECHNOLOGY B, P104
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   FISHBEIN MC, 1982, J THORAC CARDIOV SUR, V83, P602
   GLIMCHER MJ, 1976, HDB PHYSIOLOGY     7, V7, P25
   GOFFIN YA, 1986, BIOL BIOPROSTHETIC V, P405
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1986, Journal of Controlled Release, V4, P181, DOI 10.1016/0168-3659(86)90002-7
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOLOMB G, 1991, BIOMATERIALS, V12, P397, DOI 10.1016/0142-9612(91)90008-X
   GOLOMB G, 1987, J PHARM SCI-US, V76, P271, DOI 10.1002/jps.2600760402
   Harasaki H, 1985, Trans Am Soc Artif Intern Organs, V31, P489
   HARASAKI H, 1980, J THORAC CARDIOV SUR, V79, P125
   HARASAKI H, 1987, T AM SOC ART INT ORG, V33, P643
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   ISHIHARA T, 1982, J THORAC CARDIOV SUR, V83, P399
   KRONMAN JH, 1979, BIOMATER ARTIF CELL, V7, P299, DOI 10.3109/10731197909117585
   LEVY RJ, 1986, CRIT REV BIOCOMPAT, V2, P147
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LEVY RJ, 1983, AM J PATHOL, V113, P142
   LIAN JB, 1981, T AM SOC ART INT ORG, V27, P683
   MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4
   POLLOCK E, 1981, T AM SOC ART INT ORG, V27, P405
   Ratner B. D., 1983, PHYSICOCHEMICAL ASPE, P969
   Schoen F J, 1987, J Card Surg, V2, P65, DOI 10.1111/j.1540-8191.1987.tb00174.x
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   SCHOEN FJ, 1989, INTERVENTIONAL SURGI, P41
   SCHOEN FJ, 1986, AM J PATHOL, V123, P143
   SINGH PI, 1984, CONTRACTORS M NHLBI, P78
   STRATES BS, 1957, J PHYS CHEM-US, V61, P279, DOI 10.1021/j150549a005
   Thoma R J, 1987, J Biomater Appl, V1, P449
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   THOMA RJ, 1987, T SOC BIOMATER, V10, P245
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TSAO JW, 1987, T SOC BIOMATER, V10, P180
   URRY DW, 1976, BIOCHEMISTRY-US, V15, P4089, DOI 10.1021/bi00663a027
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   WESOLOWSKI SA, 1963, SURGERY, V53, P19
   WHALEM RL, 1980, T AM SOC ART INT ORG, V24, P487
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
NR 49
TC 16
Z9 16
U1 1
U2 7
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1992
VL 3
IS 4
BP 272
EP 277
DI 10.1007/BF00705292
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD706
UT WOS:A1992JD70600007
DA 2018-10-19
ER

PT J
AU BERNACCA, GM
   FISHER, AC
   MACKAY, TG
   WHEATLEY, DJ
AF BERNACCA, GM
   FISHER, AC
   MACKAY, TG
   WHEATLEY, DJ
TI A DYNAMIC INVITRO METHOD FOR STUDYING BIOPROSTHETIC HEART-VALVE
   CALCIFICATION
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FAILURE; CUSPS
AB The most predictable cause of failure of a biological prosthetic heart valve is calcification. The deposition process appears to be related both to the biomaterial composition and to the presence of dynamic stresses in the leaflets. A dynamic in vitro test has been developed to investigate the calcification process. The test apparatus consists of a modified Rowan Ash fatigue tester with the test fluid maintained at 37-degrees-C. Six valves can be tested simultaneously under similar physical conditions, but with individual incubation media. The valves tested were glutaraldehyde-fixed bovine pericardial valves (the Glasgow Heart Valve). These have been tested in a range of different simple salt solutions containing approximately physiological concentrations of calcium and phosphate. Calcification has been analysed by assay of the incubation media for depletion of calcium and phosphate and direct measurement of uptake of calcium by the valves. There is a wide variability among pericardial valves treated similarly. This may be related to the variability in calcification rate seen in patients with valve implants.
C1 GLASGOW ROYAL INFIRM,DEPT CARDIAC SURG,GLASGOW G4 0SF,SCOTLAND.
RP BERNACCA, GM (reprint author), UNIV STRATHCLYDE,BIOENGN UNIT,GLASGOW G1 1XW,SCOTLAND.
CR ADAMIC R J, 1988, Journal of Colloid and Interface Science, V124, P111, DOI 10.1016/0021-9797(88)90331-1
   ANDERSON HC, 1981, T AM SOC ART INT ORG, V27, P702
   CASTANEDA AR, 1982, CARDIAC BIOPROSTHESE, P205
   DECK JD, 1982, CARDIAC BIOPROSTHESE, P293
   FERRANS VJ, 1980, AM J CARDIOL, V46, P721, DOI 10.1016/0002-9149(80)90421-X
   Fisher J, 1987, Eur J Cardiothorac Surg, V1, P71, DOI 10.1016/1010-7940(87)90015-7
   GABBAY S, 1986, T AM SOC ART INT ORG, V32, P282
   GLASMACHER B, 1987, POLYURETHANES BIOMED, V2, P151
   HARASAKI H, 1987, T AM SOC ART INT ORG, V32, P643
   Jones M, 1989, J Card Surg, V4, P69, DOI 10.1111/j.1540-8191.1989.tb00258.x
   LEVY RJ, 1983, AM J CARDIOL, V52, P629, DOI 10.1016/0002-9149(83)90040-1
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LONG MM, 1981, T AM SOC ART INT ORG, V27, P690
   NISTAL F, 1990, J THORAC CARDIOV SUR, V99, P1074
   NISTAL F, 1986, AM J CARDIOL, V57, P161, DOI 10.1016/0002-9149(86)90972-0
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   Reul G J Jr, 1985, J Vasc Surg, V2, P192
   RUSSELL RGG, 1984, METABOLIC BONE STONE, P344
   SABBAH HN, 1985, AM J CARDIOL, V55, P1091, DOI 10.1016/0002-9149(85)90752-0
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   VARLEY H, 1980, PRACTICAL CLIN BIOCH, V1, P850
   VILLANI M, 1982, CARDIAC BIOPROSTHESI, P248
   WADKINS CL, 1978, CALC TISS RES, V26, P51, DOI 10.1007/BF02013234
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WOUTERS LHG, 1987, POLYURETHANES BIOMED, V2, P169
NR 27
TC 18
Z9 18
U1 1
U2 6
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 1992
VL 3
IS 4
BP 293
EP 298
DI 10.1007/BF00705296
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD706
UT WOS:A1992JD70600011
DA 2018-10-19
ER

PT J
AU WOLF, RFE
   LAM, KH
   MOOYAART, EL
   BLEICHRODT, RP
   NIEUWENHUIS, P
   SCHAKENRAAD, JM
AF WOLF, RFE
   LAM, KH
   MOOYAART, EL
   BLEICHRODT, RP
   NIEUWENHUIS, P
   SCHAKENRAAD, JM
TI MAGNETIC-RESONANCE-IMAGING USING A CLINICAL WHOLE-BODY SYSTEM - AN
   INTRODUCTION TO A USEFUL TECHNIQUE IN SMALL ANIMAL-EXPERIMENTS
SO LABORATORY ANIMALS
LA English
DT Article
DE MAGNETIC RESONANCE IMAGING; ANIMAL; RAT; INVIVO; ANIMAL SAVING
AB A clinical whole body magnetic resonance imaging (MRI) system with high resolution coils was used to obtain non-invasive images of the living rat. The results demonstrate the feasibility of the set-up and the advantages of this new imaging technique: detailed information, no extra costs, longitudinal studies without killing animals and simple anaesthesia. It is concluded that in small animal experimentation, this use of high resolution coils in whole body magnetic resonance systems may be particularly helpful in establishing effects of experimental procedures. Whenever non-invasive visualization is required, especially in longitudinal animal studies, e.g. biomaterial research or tumour investigation, this use of MRI will offer challenging possibilities.
C1 UNIV GRONINGEN, FAC MED, DEPT HISTOL & CELL BIOL, OOSTERSINGEL 69-1, 9713 EZ GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN HOSP, DEPT MAGNET RESONANCE, 9700 RB GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN, FAC MED, DEPT SURG, 9700 RB GRONINGEN, NETHERLANDS.
   UNIV GRONINGEN, FAC MED, CTR BIOMED TECHNOL, 9700 RB GRONINGEN, NETHERLANDS.
CR ALLEGRINI PR, 1990, LAB INVEST, V63, P568
   Brady T.J., 1991, 10 ANN M SOC MAGN RE, P2
   BULTE JWM, 1992, MAGNET RESON MED, V23, P215, DOI 10.1002/mrm.1910230203
   Bushong S. C., 1988, MAGNETIC RESONANCE I
   Hebel R., 1976, ANATOMY LABORATORY R
   LEE R, 1989, SMALL ANIMAL PRACTIC
   MOONEN CTW, 1990, SCIENCE, V250, P53, DOI 10.1126/science.2218514
   RUDIN M, 1988, MAGNET RESON MED, V7, P285, DOI 10.1002/mrm.1910070305
   RUSSEL WMS, 1959, PRINCIPLES HUMAN EXP
   SECRIST RD, 1989, MAGN RESON IMAGING, V7, P149, DOI 10.1016/0730-725X(89)90698-X
NR 10
TC 13
Z9 13
U1 0
U2 0
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD JUL
PY 1992
VL 26
IS 3
BP 222
EP 227
DI 10.1258/002367792780740495
PG 6
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA JC833
UT WOS:A1992JC83300012
PM 1501439
DA 2018-10-19
ER

PT J
AU EMCH, R
   ZENHAUSERN, F
   JOBIN, M
   TABORELLI, M
   DESCOUTS, P
AF EMCH, R
   ZENHAUSERN, F
   JOBIN, M
   TABORELLI, M
   DESCOUTS, P
TI MORPHOLOGICAL DIFFERENCE BETWEEN FIBRONECTIN SPRAYED ON MICA AND ON PMMA
SO ULTRAMICROSCOPY
LA English
DT Article
ID ADSORPTION; SURFACES
AB We have imaged with scanning force microscopy in air fibronectin (Fn) molecules sprayed on mica and on polymethylmetacrylate (PMMA), the latter being extensively used as biomaterial for implants. On mica we can observe small aggregates as well as individual molecules whose shape is influenced by the tip interaction during the scanning process, most of the isolated molecules showing a V-shape oriented in the scan direction. This indicates that the arms of the molecules are relatively free to move and the binding to the mica substrate is located near the disulfide bridge between the two subunits of the molecule. On the other side, when Fn molecules are sprayed on PMMA under the same conditions as for mica, we observe a thin network which we interpret as Fn molecules bound to each other. We relate our observation to the fact that mica is known to be strongly hydrophilic, which could reduce the Fn binding properties by interacting relatively strongly with molecules. On the other side, PMMA being hydrophobic, would interact less with molecules, leaving more binding sites for inter-molecular attachment.
RP EMCH, R (reprint author), UNIV GENEVA,PHYS APPL GRP,20 RUE ECOLE MED,CH-1211 GENEVA 4,SWITZERLAND.
CR EMCH R, 1990, J VAC SCI TECHNOL A, V8, P655, DOI 10.1116/1.576366
   GOELANDER CG, 1990, COLLOID SURF, V50, P113
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   IWAMOTO GK, 1985, J COLLOID INTERF SCI, V106, P459, DOI 10.1016/S0021-9797(85)80020-5
   MURTHY KD, 1987, SCANNING MICROSCOPY, V1, P765
   PROCTOR RA, 1987, REV INFECT DIS S4, V9, P317
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   VAUDAUX P, 1984, J INFECT DIS, V150, P546, DOI 10.1093/infdis/150.4.546
   VAUDAUX P, 1990, ADV BIOMAT, V9, P31
   WATKINS RW, 1977, J BIOMED MATER RES, V11, P915, DOI 10.1002/jbm.820110611
   ZENHAUSERN F, 1992, ULTRAMICROSCOPY, V42, P1167
NR 12
TC 27
Z9 27
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD JUL
PY 1992
VL 42
BP 1155
EP 1160
DI 10.1016/0304-3991(92)90417-I
PN B
PG 6
WC Microscopy
SC Microscopy
GA JM423
UT WOS:A1992JM42300032
PM 1413252
DA 2018-10-19
ER

PT J
AU CHEN, G
   VANDERDOES, L
   BANTJES, A
AF CHEN, G
   VANDERDOES, L
   BANTJES, A
TI INVESTIGATIONS ON VINYLENE CARBONATE .4. RADIATION-INDUCED
   GRAFT-COPOLYMERIZATION OF VINYLENE CARBONATE AND
   N-VINYL-N-METHYLACETAMIDE ONTO POLYETHYLENE FILMS
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID METHYL-METHACRYLATE; BIOMATERIAL APPLICATIONS; CELLULOSE-ACETATE;
   POLYMERS; STYRENE; ACRYLAMIDE; MONOMERS; MIXTURES; SOLVENTS; SURFACE
AB Graft copolymerization of binary mixtures of vinylene carbonate (VCA) and N-vinyl N-methylacetamide (VIMA) onto low density polyethylene (LDPE) films was studied by the mutual gamma-irradiation technique. Sufficient amounts of functionally active VCA groups could be grafted onto the surface and the hydrophilicity of the surface was also improved. The grafting of VCA onto polyethylene films in the binary solutions was found to be promoted by the presence of VIMA, thus showing a positive synergism. The VCA content in the graft copolymers was always higher than in the copolymers obtained by homogeneous copolymerization using the same monomer feed composition. The monomer reactivity ratios, as well as a preferential partitioning of the monomers surrounding the polymeric substrate, were considered to explain the grafting reactions in the binary systems.
RP CHEN, G (reprint author), TWENTE UNIV TECHNOL,DEPT CHEM TECHNOL,BIOMAT SECT,POB 217,7500 AE ENSCHEDE,NETHERLANDS.
CR ALLMER K, 1990, J POLYM SCI POL CHEM, V28, P173, DOI 10.1002/pola.1990.080280112
   ANBAR M, 1967, INT J APPL RADIAT IS, V18, P493, DOI 10.1016/0020-708X(67)90115-9
   Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   BHATTACHARYYA SN, 1982, J POLYM SCI POL CHEM, V20, P939, DOI 10.1002/pol.1982.170200404
   BHATTACHARYYA SN, 1986, J POLYM SCI POL CHEM, V24, P2507, DOI 10.1002/pola.1986.080241011
   CHEN G, 1991, J APPL POLYM SCI APP, V48, P545
   CHEN G, UNPUB
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   DAVIS TP, 1990, POLYM COMMUN, V31, P442
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   FENG XD, 1985, POLYM J, V17, P189, DOI 10.1295/polymj.17.189
   FISCHER JP, 1979, J POLYM SCI POLYM S, V66, P443
   GERMAN AL, COMMUNICATION
   HARRIS JA, 1970, J APPL POLYM SCI, V14, P3113, DOI 10.1002/app.1970.070141214
   HARWOOD HJ, 1987, MAKROMOL CHEM-M SYMP, V10, P331, DOI 10.1002/masy.19870100117
   HEBEISH A, 1982, J APPL POLYM SCI, V27, P197, DOI 10.1002/app.1982.070270121
   HEGAZY ESA, 1990, J APPL POLYM SCI, V39, P1029, DOI 10.1002/app.1990.070390502
   HOFFMAN AS, 1981, RADIAT PHYS CHEM, V18, P323, DOI 10.1016/0146-5724(81)90085-6
   HSIUE GH, 1990, ANGEW MAKROMOL CHEM, V179, P149, DOI 10.1002/apmc.1990.051790111
   HUEMER H, 1977, Patent No. 2552510
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   JANSEN B, 1986, MAKROMOL CHEM-M SYMP, V5, P237, DOI 10.1002/masy.19860050122
   JANSEN B, 1979, J POLYM SCI PS, V66, P465
   KAELBLE D, 1976, 1ST P CLEV S MACR PR
   KELEN T, 1975, J MACROMOL SCI CHEM, VA  9, P1, DOI 10.1080/00222337508068644
   KING RN, 1985, J COLLOID INTERF SCI, V103, P62, DOI 10.1016/0021-9797(85)90077-3
   KOVACS G, 1982, IUPAC MACROMOL S, V28, P396
   LAWRENCE KDN, 1973, J APPL POLYM SCI, V17, P2658
   LEE HB, 1972, POLYM PREPR, V13, P729
   LOKHANDE HT, 1984, J APPL POLYM SCI, V29, P1843, DOI 10.1002/app.1984.070290535
   MAUZ O, 1984, ANN NY ACAD SCI, V434, P251, DOI 10.1111/j.1749-6632.1984.tb29836.x
   MAUZ O, 1982, Patent No. 3243591
   MULLERSCHULTE D, 1982, POLYM BULL, V7, P77
   ODIAN G, 1971, J POLYM SCI A1, V9, P91, DOI 10.1002/pol.1971.150090108
   ODIAN G, 1961, J POLYM SCI, V54, P159
   PARK KY, 1989, EUR POLYM J, V25, P651, DOI 10.1016/0014-3057(89)90024-4
   PLOCHOCKA K, 1978, AM CHEM SOC DIV POLY, V19, P240
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   SANKHOLKAR S, 1990, J APPL POLYM SCI, V39, P1681, DOI 10.1002/app.1990.070390806
   Sasaki T., 1976, ACS SYM SER, V31, P283
   黄家贤, 1990, Chinese Journal of Polymer Science, V8, P197
   TIJSMA EJ, 1990, MAKROMOL CHEM-RAPID, V11, P501
   WILSON JE, 1981, POLYM-PLAST TECHNOL, V16, P119, DOI 10.1080/03602558108067692
NR 46
TC 9
Z9 9
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 1992
VL 45
IS 5
BP 853
EP 864
DI 10.1002/app.1992.070450512
PG 12
WC Polymer Science
SC Polymer Science
GA HV698
UT WOS:A1992HV69800012
DA 2018-10-19
ER

PT J
AU IYENGAR, V
AF IYENGAR, V
TI EMERGING CONCEPTS IN BIOANALYTICAL CHEMISTRY OF TRACE-ELEMENTS
SO ANALYTICAL SCIENCES
LA English
DT Article; Proceedings Paper
CT JOINT AND SATELLITE KITAMI CONF OF THE 1991 INTERNATIONAL CONGRESS ON
   ANALYTICAL SCIENCES ( ICAS 91 )
CY SEP 02-04, 1991
CL KITAMI, JAPAN
SP INT UNION PURE & APPL CHEM
DE BIOLOGICAL TRACE ELEMENT RESEARCH; BIOLOGICAL STANDARDIZATION;
   ANALYTICAL STANDARDIZATION; MULTIDISCIPLINAL APPROACH; PRESERVATION;
   STORAGE; PRESAMPLING FACTOR; POSTMORTEM CHANGE; INTERNAL CONTAMINATION
ID BOTANICAL REFERENCE MATERIALS
AB The emerging discipline of Biological Trace Element Research (BTER) demands that adequate considerations be given to both biological and analytical standardization while planning an investigation. Unfortunately, the "bio" dimension of the analytical problem in the BTER area, has been rather slow in unfolding. This lack of appreciation has been a major setback since the early days of BTER, delaying the onset of multidisciplinary approaches that are vital for conceiving meaningful investigations. The presampling factors e.g., biological variations, environmental influences, post-mortem changes and intrinsic (e.g. differences in residence times of various elements in the blood stream) and inadvertent situations (e.g. medico-legal restrictions), are potential sources of serious errors, and require careful evaluation and data interpretation,   Yet, these are poorly identified and currently, very little effort is expended to evaluate them. Concerning analytical standardization, progress in technical aspects of sampling are preparation, instrumentation, calibration procedures, increased awareness of matrix interferences and preparation of primary standards have collectively contributed to several improvements. However, information on long-term storage (several years) and its impact on the validity of the stored biomaterial, and experimental findings on the quantitative recovery of biominerals during acid decomposition of different types of sample matrices are still scarce.
RP IYENGAR, V (reprint author), NATL INST STAND & TECHNOL,INT HUMAN NUTR PROJECT,BLDG 235,RM B125,GAITHERSBURG,MD 20899, USA.
CR BRAODHEAD GD, 1965, BRIT MED J, V1, P343
   DAHL K, 1990, FRESEN J ANAL CHEM, V338, P526, DOI 10.1007/BF00322530
   GHELBERG NW, 1979, P MANAGEMENT HEAVY M, P163
   GREENBERG RR, 1990, FRESEN J ANAL CHEM, V338, P394, DOI 10.1007/BF00322502
   IYENGAR GV, 1981, J PATHOL, V134, P173, DOI 10.1002/path.1711340302
   IYENGAR GV, 1986, TRACE ELEM MED, V3, P25
   IYENGAR GV, 1980, SCI TOTAL ENVIRON, V15, P217, DOI 10.1016/0048-9697(80)90051-0
   IYENGAR GV, 1991, SCI TOTAL ENVIRON, V100, P1, DOI 10.1016/0048-9697(91)90370-T
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   IYENGAR GV, 1982, ANAL CHEM, V54, pA554
   IYENGAR V, 1988, CLIN CHEM, V34, P474
   KARTHA KK, 1985, CRYOPRESERVATION PLA
   KASPEREK K, 1981, SCI TOTAL ENVIRON, V17, P133, DOI 10.1016/0048-9697(81)90179-0
   KASPEREK K, 1977, EUR J PEDIATR, V126, P199, DOI 10.1007/BF00477045
   KASPEREK K, 1972, P IAEA S NUCLEAR ACT, P517
   LINDSTROM RM, 1990, FRESEN J ANAL CHEM, V338, P569, DOI 10.1007/BF00322541
   MERTZ W, 1975, CLIN CHEM, V21, P468
   Muramatsu Y, 1983, HOKEN BUTSURI, V18, P113
   PARR RM, 1991, BIOL TRACE ELE RES, V29, P52
   PERSIGEHL M, 1976, BEITR PATHOL, V157, P260, DOI 10.1016/S0005-8165(76)80086-8
   STOEPPLER M, 1982, TALANTA, V29, P963, DOI 10.1016/0039-9140(82)80237-3
   Stoeppler M., 1985, P281
   SUBRAMANIAN KS, 1990, ACS S, V445
   TURLE R, 1988, NBS SPEC PUBL, V740, P171
   VANEIJK HG, 1974, CLIN CHIM ACTA, V50, P278
   WISE SA, 1989, INT J ENVIRON AN CH, V37, P91, DOI 10.1080/03067318908026889
   ZEISLER R, 1988, FRESEN Z ANAL CHEM, V332, P612, DOI 10.1007/BF00472652
   1991, MONITORING HUMAN TIS
NR 28
TC 4
Z9 4
U1 0
U2 0
PU JAPAN SOC ANALYTICAL CHEM
PI TOKYO
PA 26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO 141, JAPAN
SN 0910-6340
J9 ANAL SCI
JI Anal. Sci.
PD JUN
PY 1992
VL 8
IS 3
BP 399
EP 404
DI 10.2116/analsci.8.399
PG 6
WC Chemistry, Analytical
SC Chemistry
GA HY446
UT WOS:A1992HY44600025
OA Bronze
DA 2018-10-19
ER

PT J
AU JOHNSON, PC
   GARRETT, KO
   BRASH, JL
   CORNELIUS, RM
   KAPLAN, SS
   WARTY, V
AF JOHNSON, PC
   GARRETT, KO
   BRASH, JL
   CORNELIUS, RM
   KAPLAN, SS
   WARTY, V
TI DELIVERY OF PASSIVATING PROTEINS TO SUTURES DURING PASSAGE THROUGH THE
   VESSEL WALL REDUCES SUBSEQUENT PLATELET DEPOSITION BY BLOCKING
   FIBRINOGEN ADSORPTION
SO ARTERIOSCLEROSIS AND THROMBOSIS
LA English
DT Article
DE BIOMATERIALS; PLATELETS; MICROSURGERY; VASCULAR ANASTOMOSIS;
   SUBENDOTHELIUM
ID MICROVASCULAR SURGERY; THROMBUS FORMATION; FOREIGN SURFACES; PLASMA;
   POLYETHYLENE; ANASTOMOSES; STRATEGIES; HEMOGLOBIN; TRAUMA
AB Intraluminal vascular suture material, which attracts fewer than the expected number of platelets compared with the same biomaterial exposed to blood in vitro, differs from the untreated biomaterial in that it has been passed once through the vessel wall. The mechanism by which this apparently trivial maneuver reduces platelet deposition was investigated. Polypropylene suture (7-0 Prolene) was passed through human arteries (fetal and adult), and platelet deposition to the suture was measured in a standardized perfusion chamber. Single vessel passage of the sutures reduced platelet deposition by 68+/-23%, which contrasts sharply with the power of prostaglandin E1 (1-mu-M PGE1 is sufficient to abolish platelet shape change and aggregation), which inhibited only 11% of platelet deposition to the sutures. Aspirin treatment of the vessel (to prevent PGI2 formation) or endothelial stripping (to remove the ability to produce nitric oxide) had no effect on the degree of inhibition. Passage of the suture through a vessel analogue (expanded polytetrafluoroethylene) did not inhibit platelet deposition. I-125-fibrinogen adsorption to the suture after vessel passage was reduced to a degree similar to that of platelet deposition. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of proteins eluted from vessel-passed sutures revealed bands at 66, 47, and 16 kd. Western blotting indicated the presence of large amounts of albumin and hemoglobin, a moderate amount of haptoglobin, and only trace amounts of fibrinogen. When sutures were exposed to each of these proteins in vitro before perfusion, albumin and hemoglobin were found to reproduce the effect of vessel passage alone on platelet deposition. We conclude that albumin and hemoglobin adsorb to sutures during their passage through the vessel subendothelium. This reduces the subsequent adsorption of fibrinogen from blood, thereby reducing the ability of platelets to attach to the suture.
C1 UNIV PITTSBURGH, SCH MED, DEPT SURG, PITTSBURGH, PA 15261 USA.
   UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15261 USA.
   MCMASTER UNIV, DEPT CHEM ENGN, HAMILTON L8S 4L8, ONTARIO, CANADA.
RP JOHNSON, PC (reprint author), UNIV PITTSBURGH, DIV PLAST & RECONSTRUCT SURG, 676 SCAIFE HALL, PITTSBURGH, PA 15261 USA.
FU NHLBI NIH HHS [R29 HL-45891]
CR ACLAND R, 1973, SURGERY, V73, P766
   ACLAND RD, 1980, PLAST RECONSTR SURG, V65, P460, DOI 10.1097/00006534-198004000-00010
   ACLAND RD, 1977, PLAST RECONSTR SURG, V60, P868, DOI 10.1097/00006534-197712000-00004
   ACLAND RD, 1989, PLAST RECONSTR SURG, V84, P280, DOI 10.1097/00006534-198908000-00015
   ADAMS PC, 1987, AM J CARDIOL, V60, pG9, DOI 10.1016/0002-9149(87)90586-8
   BENTZ ML, 1991, PLAST RECONSTR SURG, V88, P851, DOI 10.1097/00006534-199111000-00018
   BIRD RB, 1960, TRANSPORT PHENOMENA, P51
   BRASH JL, 1988, BLOOD, V71, P932
   BRUNELLI G, 1982, INT SURG, V67, P163
   CASNOCHA SA, 1989, J APPL PHYSIOL, V67, P1997
   DAHLKE H, 1980, J BIOMED MATER RES, V14, P251, DOI 10.1002/jbm.820140307
   DRYJSKI M, 1985, THROMB HAEMOSTASIS, V54, P773
   EBERHART RC, 1989, IEEE ENG MED BIOL, V8, P26
   GOLDSMITH MF, 1990, JAMA-J AM MED ASSOC, V263, P789, DOI 10.1001/jama.263.6.789
   GREENBERG BM, 1988, PLAST RECONSTR SURG, V82, P463, DOI 10.1097/00006534-198809000-00016
   GREGORIUS F K, 1975, Surgical Neurology, V4, P258
   HARASHINA T, 1976, PLAST RECONSTR SURG, V58, P608, DOI 10.1097/00006534-197611000-00012
   HAWKER RJ, 1980, CLIN SCI, V58, P243, DOI 10.1042/cs0580243
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1978, THROMB RES, V12, P319, DOI 10.1016/0049-3848(78)90302-X
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   IGNARRO LJ, 1989, FASEB J, V3, P31
   ISOGAI N, 1988, Microsurgery, V9, P87, DOI 10.1002/micr.1920090206
   JAMES MJ, 1985, THROMB RES, V39, P587, DOI 10.1016/0049-3848(85)90238-5
   JOHNSON PC, 1990, PLAST RECONSTR SURG, V86, P359, DOI 10.1097/00006534-199008000-00032
   JOHNSON PC, 1991, ARTERIOSCLER THROMB, V11, P552, DOI 10.1161/01.ATV.11.3.552
   JOHNSON PC, 1992, J APPL BIOMATER, V3, P1, DOI 10.1002/jab.770030102
   JOHNSON PC, IN PRESS PLAST RECON
   KHOURI RK, 1990, PLAST RECONSTR SURG, V86, P110, DOI 10.1097/00006534-199007000-00017
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   LELAH MD, 1986, POLYURETHANES MED, P125
   LINDON JN, 1986, BLOOD, V68, P355
   MALIK AB, 1989, J INVEST DERMATOL, V93, pS62, DOI 10.1111/1523-1747.ep12581072
   MATTOX D E, 1980, Otolaryngology - Head and Neck Surgery, V88, P252
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   NEMERSON Y, 1988, BLOOD, V71, P1
   NIEVELSTEIN PFEM, 1988, HAEMOSTASIS, V18, P342
   OSGOOD CP, 1976, ANGIOLOGY, V27, P96, DOI 10.1177/000331977602700203
   PACKHAM MA, 1988, P SOC EXP BIOL MED, V189, P261
   PAGNANELLI DM, 1980, J NEUROSURG, V53, P32, DOI 10.3171/jns.1980.53.1.0032
   RICHLING B, 1979, J NEUROSURG, V51, P654, DOI 10.3171/jns.1979.51.5.0654
   ROSENBAUM TJ, 1977, J NEUROSURG, V47, P430, DOI 10.3171/jns.1977.47.3.0430
   SHAW WW, 1987, PLAST SURG FORUM, V4, P93
   SHEPPECK RA, 1991, BLOOD, V78, P673
   SLACK SM, 1988, J COLLOID INTERF SCI, V124, P535, DOI 10.1016/0021-9797(88)90190-7
   SMITH EB, 1990, ARTERIOSCLEROSIS, V10, P263, DOI 10.1161/01.ATV.10.2.263
   TOMASELLO F, 1981, J NEUROSURG, V54, P525, DOI 10.3171/jns.1981.54.4.0525
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   YAREMCHUK MJ, 1987, PLAST RECONSTR SURG, V80, P1
   YUDONG G, 1989, J RECONSTR MICROSURG, V5, P327
NR 51
TC 3
Z9 3
U1 0
U2 2
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596 USA
SN 1049-8834
J9 ARTERIOSCLER THROMB
JI Arterioscler. Thromb.
PD JUN
PY 1992
VL 12
IS 6
BP 727
EP 735
DI 10.1161/01.ATV.12.6.727
PG 9
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA HX939
UT WOS:A1992HX93900011
PM 1591232
OA Bronze
DA 2018-10-19
ER

PT J
AU OGA, M
   ARIZONO, T
   SUGIOKA, Y
   NAYLOR, PT
   MYRVIK, QN
   GRISTINA, AG
AF OGA, M
   ARIZONO, T
   SUGIOKA, Y
   NAYLOR, PT
   MYRVIK, QN
   GRISTINA, AG
TI INVITRO ANALYSIS OF THE EFFECTS OF BIOMATERIAL ADHERENCE ON A
   STAPHYLOCOCCUS-EPIDERMIDIS STRAIN SENSITIVITY TO CEPHALORIDINE
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
AB This study examined the effects biomaterial adherence had on Staphylococcus epidermidis-46 morphology and sensitivity to the antibiotic cephaloridine. Polymethylmethacrylate (PMMA) discs served as the biomaterial substratum in this study. Suspension cultures of SE-46 at 10(8) CFU/mL were allowed to adhere to PMMA discs for 2, 6, or 12 h prior to exposure to cephaloridine at 250-mu-g/mL, which is 500 times greater than the MIC of 0.5-mu-g/mL. After a 24-h exposure to the antibiotic viable bacteria adherent to the disc were removed and counted. Those data revealed that at shorter adherence times a larger percentage of the adherent organism were erradicated by antibiotic exposure, 83.6% versus 15.6% for 2-h and 12-h adherence times, respectively. Although a significant percent of the organisms were killed with short adherence times, the organism still persisted in the face of high concentrations of cephaloridine. Scanning electron micrographs of organism adherent for 2 and 12 h revealed distinct morphological changes in the extracellular matrix indicating increased matrix production with longer adherence. Thus, these data reveal that adherence to biomaterials provides a protected environment for the bacteria and the time an organism is adherent to a biomaterial surface prior to antibiotic exposure can also increase the organism's resistance to antibiotics.
C1 KYUSHU UNIV,FAC MED,DEPT ORTHOPED SURG,FUKUOKA 812,JAPAN.
   MED SCI RES INST,SCI ADVISORY BOARD,KNOXVILLE,TN.
   MED SCI RES INST,HERNDON,VA.
CR ATKINSON RM, 1966, C TOXICAL APPL PHARM, V8, P389
   BROWN MRW, 1985, ANNU REV MICROBIOL, V39, P525
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COSTERTON JW, 1977, MICROBIOLOGY 1977, P151
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P221
   DOUGHERTY SH, 1982, CURR PROB SURG, V19, P269
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1976, J BIOMED MATER RES, V10, P273, DOI 10.1002/jbm.820100208
   GRISTINA AG, 1984, ORTHOP CLIN N AM, V15, P517
   Naylor P T, 1990, Clin Orthop Relat Res, P126
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   YAMAMOTO M, 1986, MICROBIOL IMMUNOL, V30, P969, DOI 10.1111/j.1348-0421.1986.tb03027.x
NR 15
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD SUM
PY 1992
VL 3
IS 2
BP 95
EP 98
DI 10.1002/jab.770030205
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HT988
UT WOS:A1992HT98800004
DA 2018-10-19
ER

PT J
AU MENCONI, MJ
   OWEN, T
   DASSE, KA
   STEIN, G
   LIAN, JB
AF MENCONI, MJ
   OWEN, T
   DASSE, KA
   STEIN, G
   LIAN, JB
TI MOLECULAR APPROACHES TO THE CHARACTERIZATION OF CELL AND BLOOD
   BIOMATERIAL INTERACTIONS
SO JOURNAL OF CARDIAC SURGERY
LA English
DT Article
DE GENE EXPRESSION; BIOMATERIALS; ENDOTHELIAL CELLS; LEFT VENTRICULAR
   ASSIST DEVICE; BIOMER; RIBONUCLEIC ACID
AB In order to address questions related to cell/biomaterial interactions with respect to cell function and production of extracellular matrix proteins that support or maintain cell/tissue specific properties, we have developed molecular approaches for analysis of in vivo implanted materials and in vitro studies. In an explant of a human left ventricular assist device (LVAD), intact total cellular RNA could be isolated in sufficient quantities for hybridization analyses with gene-specific probes to evaluate cell growth, cytoskeletal organization, and production of extracellular matrix proteins. Cells harvested from a 132-day implanted LVAD exhibited proliferative activity and expressed genes for fibronectin and collagen types I, III, and IV. In vitro studies revealed that endothelial cells cultured on two different segmented polyurethane biomaterials (Biomer and Tecoflex 60D) exhibited different patterns of gene expression that reflected differences in cell growth rates, morphology, and composition of the extracellular matrix. These methodologies provide a valuable approach for a detailed evaluation of: (1) the biocompatibility of cells colonizing implanted cardiac assist devices; and (2) the functionality of cells seeded onto biomaterials.
C1 UNIV MASSACHUSETTS,SCH MED,DEPT CELL BIOL,55 LAKE AVE N,WORCESTER,MA 01655.
NR 0
TC 14
Z9 14
U1 0
U2 2
PU FUTURA PUBL CO
PI ARMONK
PA 135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418
SN 0886-0440
J9 J CARDIAC SURG
JI J. Card. Surg.
PD JUN
PY 1992
VL 7
IS 2
BP 177
EP 187
DI 10.1111/j.1540-8191.1992.tb00794.x
PG 11
WC Cardiac & Cardiovascular Systems; Surgery
SC Cardiovascular System & Cardiology; Surgery
GA HY504
UT WOS:A1992HY50400009
PM 1606370
DA 2018-10-19
ER

PT J
AU TANINGHER, M
   PASQUINI, R
   TANZI, MC
   BONATTI, S
AF TANINGHER, M
   PASQUINI, R
   TANZI, MC
   BONATTI, S
TI GENOTOXICITY OF N-ACRYLOYL-N'-PHENYLPIPERAZINE, A REDOX ACTIVATOR FOR
   ACRYLIC RESIN POLYMERIZATION
SO MUTATION RESEARCH
LA English
DT Article
DE BIOMATERIALS; DNA DAMAGE; GENE MUTATIONS; GENOMIC MUTATIONS
ID DNA DAMAGE
AB N-Acryloyl-N'-phenylpiperazine is a promoter of redox reactions synthesized recently, and proposed as an activator for the polymerization of acrylic resins for biomedical use. The chemical was analyzed for different genotoxicity endpoints, to obtain both information on its possible mutagenic/carcinogenic potential and a model analysis of a tertiary arylamine, which belongs to a class of chemicals commonly used as polymerization accelerators in the biomaterial field. The genotoxicity endpoints considered were: gene mutation in the Salmonella test; structural and numerical chromosome alterations in Chinese hamster V79 cells, evaluated by the micronucleus test together with an immunofluorescent staining specific for kinetochore proteins; in vitro and in vivo DNA damage, evaluated in V79 cells and in mouse liver by the alkaline DNA elution technique. On the whole, the results indicate that N-acryloyl-N'-phenylpiperazine is to be regarded not so much as a DNA-damaging agent, but as a genomic mutagen. Indeed, it was not mutagenic in Salmonella (though its toxicity did not allow testing concentrations over 70-mu-g/plate), and it was weakly positive in inducing chromosomal fragmentation in vitro (one positive, not dose-related, result out of five different doses tested) and in vivo DNA damage (increases in DNA elution rate never doubling control values). The chemical was, however, clearly positive (with dose-dependent effects up to about 25 times the control value) in causing numerical chromosome alterations, at the maximal non-toxic doses.
C1 UNIV GENOA,CIRC,INST ONCOL,I-16132 GENOA,ITALY.
   UNIV PERUGIA,DEPT HYG,I-06100 PERUGIA,ITALY.
   UNIV MILAN,DEPT BIOENGN,I-20133 MILAN,ITALY.
   CNR,IST MUTAGENESI & DIFFERENZIAMENTO,I-56100 PISA,ITALY.
RP TANINGHER, M (reprint author), NATL INST CANC RES,VIALE BENEDETTO XV NO 10,I-16132 GENOA,ITALY.
RI Tanzi, Maria Cristina/I-4620-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633
CR COX R, 1973, CANCER RES, V33, P2114
   Lawley P. D., 1976, IARC SCI PUBL, V12, P181
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   NUSSE M, 1989, MUTAGENESIS, V4, P174, DOI 10.1093/mutage/4.3.174
   PARODI S, 1978, MUTAT RES, V54, P39, DOI 10.1016/0165-1161(78)90133-4
   SINA JF, 1983, MUTAT RES, V113, P357, DOI 10.1016/0165-1161(83)90228-5
   TANZI MC, 1990, POLYMER, V31, P1735, DOI 10.1016/0032-3861(90)90194-4
   WARREN W, 1979, BIOCHIM BIOPHYS ACTA, V563, P82, DOI 10.1016/0005-2787(79)90009-1
   WILLIAMS JR, 1974, NATURE, V252, P754, DOI 10.1038/252754a0
NR 9
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
PD JUN
PY 1992
VL 282
IS 2
BP 99
EP 105
DI 10.1016/0165-7992(92)90081-R
PG 7
WC Genetics & Heredity; Toxicology
SC Genetics & Heredity; Toxicology
GA HY734
UT WOS:A1992HY73400007
PM 1377358
DA 2018-10-19
ER

EF